0000742112-20-000109.txt : 20201029 0000742112-20-000109.hdr.sgml : 20201029 20201029164532 ACCESSION NUMBER: 0000742112-20-000109 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 128 CONFORMED PERIOD OF REPORT: 20200930 FILED AS OF DATE: 20201029 DATE AS OF CHANGE: 20201029 FILER: COMPANY DATA: COMPANY CONFORMED NAME: INVACARE CORP CENTRAL INDEX KEY: 0000742112 STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842] IRS NUMBER: 952680965 STATE OF INCORPORATION: OH FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-15103 FILM NUMBER: 201273226 BUSINESS ADDRESS: STREET 1: ONE INVACARE WAY STREET 2: P O BOX 4028 CITY: ELYRIA STATE: OH ZIP: 44036 BUSINESS PHONE: 4403296000 MAIL ADDRESS: STREET 1: ONE INVACARE WAY STREET 2: P O BOX 4028 CITY: ELYRIA STATE: OH ZIP: 44036 10-Q 1 ivc-20200930.htm 10-Q ivc-20200930
000074211212/312020Q3FALSEP5YP5YP5YP5YP3YP3Y00007421122020-01-012020-09-30xbrli:shares0000742112us-gaap:CommonStockMember2020-10-270000742112us-gaap:CommonClassBMember2020-10-27iso4217:USD00007421122020-07-012020-09-3000007421122019-07-012019-09-3000007421122019-01-012019-09-30iso4217:USDxbrli:sharesxbrli:pure00007421122020-09-3000007421122019-12-310000742112us-gaap:CommonStockMember2020-09-300000742112us-gaap:CommonStockMember2019-12-310000742112us-gaap:CommonClassBMember2020-09-300000742112us-gaap:CommonClassBMember2019-12-3100007421122018-12-310000742112us-gaap:CarryingReportedAmountFairValueDisclosureMember2020-09-3000007421122019-09-300000742112us-gaap:CommonStockMember2020-06-300000742112us-gaap:CommonClassBMember2020-06-300000742112us-gaap:AdditionalPaidInCapitalMember2020-06-300000742112us-gaap:RetainedEarningsMember2020-06-300000742112us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-06-300000742112us-gaap:TreasuryStockMember2020-06-3000007421122020-06-300000742112us-gaap:CommonStockMember2020-07-012020-09-300000742112us-gaap:AdditionalPaidInCapitalMember2020-07-012020-09-300000742112us-gaap:TreasuryStockMember2020-07-012020-09-300000742112us-gaap:RetainedEarningsMember2020-07-012020-09-300000742112us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-07-012020-09-300000742112us-gaap:CommonStockMember2020-09-300000742112us-gaap:AdditionalPaidInCapitalMember2020-09-300000742112us-gaap:RetainedEarningsMember2020-09-300000742112us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-09-300000742112us-gaap:TreasuryStockMember2020-09-300000742112us-gaap:CommonStockMember2019-06-300000742112us-gaap:CommonClassBMember2019-06-300000742112us-gaap:AdditionalPaidInCapitalMember2019-06-300000742112us-gaap:RetainedEarningsMember2019-06-300000742112us-gaap:AccumulatedOtherComprehensiveIncomeMember2019-06-300000742112us-gaap:TreasuryStockMember2019-06-3000007421122019-06-300000742112us-gaap:CommonStockMember2019-07-012019-09-300000742112us-gaap:AdditionalPaidInCapitalMember2019-07-012019-09-300000742112us-gaap:TreasuryStockMember2019-07-012019-09-300000742112us-gaap:RetainedEarningsMember2019-07-012019-09-300000742112us-gaap:AccumulatedOtherComprehensiveIncomeMember2019-07-012019-09-300000742112us-gaap:CommonStockMember2019-09-300000742112us-gaap:CommonClassBMember2019-09-300000742112us-gaap:AdditionalPaidInCapitalMember2019-09-300000742112us-gaap:RetainedEarningsMember2019-09-300000742112us-gaap:AccumulatedOtherComprehensiveIncomeMember2019-09-300000742112us-gaap:TreasuryStockMember2019-09-300000742112us-gaap:CommonStockMember2019-12-310000742112us-gaap:AdditionalPaidInCapitalMember2019-12-310000742112us-gaap:RetainedEarningsMember2019-12-310000742112us-gaap:AccumulatedOtherComprehensiveIncomeMember2019-12-310000742112us-gaap:TreasuryStockMember2019-12-310000742112us-gaap:CommonStockMember2020-01-012020-09-300000742112us-gaap:AdditionalPaidInCapitalMember2020-01-012020-09-300000742112us-gaap:TreasuryStockMember2020-01-012020-09-300000742112us-gaap:RetainedEarningsMember2020-01-012020-09-300000742112us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-01-012020-09-300000742112us-gaap:CommonStockMember2018-12-310000742112us-gaap:CommonClassBMember2018-12-310000742112us-gaap:AdditionalPaidInCapitalMember2018-12-310000742112us-gaap:RetainedEarningsMember2018-12-310000742112us-gaap:AccumulatedOtherComprehensiveIncomeMember2018-12-310000742112us-gaap:TreasuryStockMember2018-12-310000742112us-gaap:CommonStockMember2019-01-012019-09-300000742112us-gaap:AdditionalPaidInCapitalMember2019-01-012019-09-300000742112us-gaap:TreasuryStockMember2019-01-012019-09-300000742112us-gaap:RetainedEarningsMember2019-01-012019-09-300000742112us-gaap:AccumulatedOtherComprehensiveIncomeMember2019-01-012019-09-3000007421122020-01-012020-03-0700007421122019-01-012019-12-3100007421122020-03-070000742112us-gaap:RiskLevelLowMember2020-01-012020-09-300000742112us-gaap:RiskLevelMediumMember2020-01-012020-09-300000742112us-gaap:RiskLevelHighMember2020-01-012020-09-30ivc:payment0000742112country:US2020-09-300000742112country:US2020-01-012020-09-300000742112country:CA2020-09-300000742112country:CA2020-01-012020-09-300000742112country:US2019-12-310000742112country:US2019-01-012019-12-310000742112country:CA2019-12-310000742112country:CA2019-01-012019-12-310000742112us-gaap:MachineryAndEquipmentMember2020-09-300000742112us-gaap:MachineryAndEquipmentMember2019-12-310000742112us-gaap:LandBuildingsAndImprovementsMember2020-09-300000742112us-gaap:LandBuildingsAndImprovementsMember2019-12-310000742112ivc:CapitalizedSoftwareMember2020-09-300000742112ivc:CapitalizedSoftwareMember2019-12-310000742112us-gaap:FurnitureAndFixturesMember2020-09-300000742112us-gaap:FurnitureAndFixturesMember2019-12-310000742112us-gaap:LeaseholdImprovementsMember2020-09-300000742112us-gaap:LeaseholdImprovementsMember2019-12-3100007421122018-07-012018-09-3000007421122020-04-012020-06-300000742112us-gaap:CustomerListsMember2020-09-300000742112us-gaap:CustomerListsMember2019-12-310000742112us-gaap:TrademarksMember2020-09-300000742112us-gaap:TrademarksMember2019-12-310000742112us-gaap:DevelopedTechnologyRightsMember2020-09-300000742112us-gaap:DevelopedTechnologyRightsMember2019-12-310000742112us-gaap:PatentsMember2020-09-300000742112us-gaap:PatentsMember2019-12-310000742112us-gaap:LicensingAgreementsMember2020-09-300000742112us-gaap:LicensingAgreementsMember2019-12-310000742112us-gaap:OtherIntangibleAssetsMember2020-09-300000742112us-gaap:OtherIntangibleAssetsMember2019-12-310000742112srt:MinimumMember2020-01-012020-09-300000742112srt:MaximumMember2020-01-012020-09-300000742112srt:WeightedAverageMember2020-01-012020-09-300000742112ivc:ConvertibleSeniorNotesat5.00February2021Memberus-gaap:ConvertibleSubordinatedDebtMember2020-09-300000742112ivc:ConvertibleSeniorNotesat5.00February2021Memberus-gaap:ConvertibleSubordinatedDebtMember2019-12-310000742112us-gaap:ConvertibleSubordinatedDebtMemberivc:ConvertibleSeniorNotesat4.50February2022Domain2020-09-300000742112us-gaap:ConvertibleSubordinatedDebtMemberivc:ConvertibleSeniorNotesat4.50February2022Domain2019-12-310000742112us-gaap:ConvertibleSubordinatedDebtMemberivc:ConvertibleSeniorNotesat5.00November2024Domain2020-09-300000742112us-gaap:ConvertibleSubordinatedDebtMemberivc:ConvertibleSeniorNotesat5.00November2024Domain2019-12-310000742112us-gaap:ConvertibleSubordinatedDebtMemberivc:SeriesIIConvertibleSeniorNotesAt500November2024Domain2020-09-300000742112us-gaap:ConvertibleSubordinatedDebtMemberivc:SeriesIIConvertibleSeniorNotesAt500November2024Domain2019-12-310000742112ivc:OtherNotesandCapitalLeaseObligationsMember2020-09-300000742112ivc:OtherNotesandCapitalLeaseObligationsMember2019-12-310000742112ivc:ConvertibleSeniorSubordinatedDebenturesat5.00February2021Domainus-gaap:ConvertibleSubordinatedDebtMember2020-01-012020-09-300000742112us-gaap:LetterOfCreditMember2020-09-300000742112us-gaap:LetterOfCreditMember2019-12-310000742112ivc:RevolvingCreditandSecurityAgreementNewCreditAgreementMemberus-gaap:LineOfCreditMemberus-gaap:RevolvingCreditFacilityMember2020-09-300000742112ivc:RevolvingCreditandSecurityAgreementNewCreditAgreementMembercurrency:EURus-gaap:LineOfCreditMemberus-gaap:RevolvingCreditFacilityMember2020-09-300000742112ivc:RevolvingCreditandSecurityAgreementNewCreditAgreementMemberus-gaap:LineOfCreditMembercurrency:GBPus-gaap:RevolvingCreditFacilityMember2020-09-300000742112us-gaap:LineOfCreditMemberus-gaap:RevolvingCreditFacilityMember2020-09-300000742112us-gaap:LineOfCreditMemberus-gaap:RevolvingCreditFacilityMember2019-12-310000742112us-gaap:LetterOfCreditMemberivc:RevolvingCreditandSecurityAgreementNewCreditAgreementMemberus-gaap:LineOfCreditMember2020-09-300000742112ivc:RevolvingCreditandSecurityAgreementNewCreditAgreementMemberus-gaap:LineOfCreditMemberus-gaap:RevolvingCreditFacilityMember2020-01-012020-09-300000742112ivc:RevolvingCreditandSecurityAgreementNewCreditAgreementMemberus-gaap:LondonInterbankOfferedRateLIBORMemberus-gaap:LineOfCreditMembersrt:MinimumMemberus-gaap:RevolvingCreditFacilityMember2020-01-012020-09-300000742112ivc:RevolvingCreditandSecurityAgreementNewCreditAgreementMemberus-gaap:LondonInterbankOfferedRateLIBORMembersrt:MaximumMemberus-gaap:LineOfCreditMemberus-gaap:RevolvingCreditFacilityMember2020-01-012020-09-300000742112ivc:RevolvingCreditandSecurityAgreementNewCreditAgreementMemberus-gaap:BaseRateMemberus-gaap:LineOfCreditMembersrt:MinimumMemberus-gaap:RevolvingCreditFacilityMember2020-01-012020-09-300000742112ivc:RevolvingCreditandSecurityAgreementNewCreditAgreementMemberus-gaap:BaseRateMembersrt:MaximumMemberus-gaap:LineOfCreditMemberus-gaap:RevolvingCreditFacilityMember2020-01-012020-09-300000742112ivc:RevolvingCreditandSecurityAgreementNewCreditAgreementMemberus-gaap:LineOfCreditMembersrt:MinimumMemberus-gaap:RevolvingCreditFacilityMember2020-01-012020-09-300000742112ivc:RevolvingCreditandSecurityAgreementNewCreditAgreementMembersrt:MaximumMemberus-gaap:LineOfCreditMemberus-gaap:RevolvingCreditFacilityMember2020-01-012020-09-300000742112ivc:RevolvingCreditandSecurityAgreementEuropeCreditAgreementMemberDomainus-gaap:LineOfCreditMemberus-gaap:RevolvingCreditFacilityMember2020-09-300000742112us-gaap:LetterOfCreditMemberivc:RevolvingCreditandSecurityAgreementEuropeCreditAgreementMemberDomainus-gaap:LineOfCreditMember2020-09-300000742112ivc:RevolvingCreditandSecurityAgreementEuropeCreditAgreementMemberDomainivc:SwingLineLoansDomainus-gaap:LineOfCreditMember2020-09-300000742112ivc:RevolvingCreditandSecurityAgreementEuropeCreditAgreementMemberDomainus-gaap:LineOfCreditMemberivc:AmountAvailabletoInvacareLimitedandInvacarePoirierSASDomain2020-09-300000742112ivc:RevolvingCreditandSecurityAgreementEuropeCreditAgreementMemberDomainus-gaap:LineOfCreditMemberus-gaap:RevolvingCreditFacilityMember2020-01-012020-09-300000742112ivc:RevolvingCreditandSecurityAgreementEuropeCreditAgreementMemberDomainus-gaap:LondonInterbankOfferedRateLIBORMemberus-gaap:LineOfCreditMembersrt:MinimumMemberus-gaap:RevolvingCreditFacilityMember2020-01-012020-09-300000742112ivc:RevolvingCreditandSecurityAgreementEuropeCreditAgreementMemberDomainus-gaap:LondonInterbankOfferedRateLIBORMembersrt:MaximumMemberus-gaap:LineOfCreditMemberus-gaap:RevolvingCreditFacilityMember2020-01-012020-09-300000742112ivc:RevolvingCreditandSecurityAgreementEuropeCreditAgreementMemberDomainus-gaap:BaseRateMemberus-gaap:LineOfCreditMembersrt:MinimumMemberus-gaap:RevolvingCreditFacilityMember2020-01-012020-09-300000742112ivc:RevolvingCreditandSecurityAgreementEuropeCreditAgreementMemberDomainus-gaap:BaseRateMembersrt:MaximumMemberus-gaap:LineOfCreditMemberus-gaap:RevolvingCreditFacilityMember2020-01-012020-09-300000742112ivc:RevolvingCreditandSecurityAgreementEuropeCreditAgreementMemberDomainus-gaap:LineOfCreditMembersrt:MinimumMemberus-gaap:RevolvingCreditFacilityMember2020-01-012020-09-300000742112ivc:RevolvingCreditandSecurityAgreementEuropeCreditAgreementMemberDomainsrt:MaximumMemberus-gaap:LineOfCreditMemberus-gaap:RevolvingCreditFacilityMember2020-01-012020-09-300000742112ivc:ConvertibleSeniorNotesat5.00February2021Memberus-gaap:ConvertibleSubordinatedDebtMember2016-03-310000742112ivc:ConvertibleSeniorNotesat5.00February2021Memberus-gaap:ConvertibleSubordinatedDebtMember2019-09-300000742112ivc:ConvertibleSeniorNotesat5.00February2021Memberus-gaap:ConvertibleSubordinatedDebtMember2020-01-012020-09-300000742112ivc:ConvertibleSeniorNotesat5.00February2021Memberus-gaap:ConvertibleSubordinatedDebtMember2019-01-012019-09-3000007421122016-01-012016-03-310000742112ivc:ConvertibleSeniorNotesat5.00February2021Memberus-gaap:ConvertibleSubordinatedDebtMember2016-12-310000742112ivc:ConvertibleSeniorNotesat5.00February2021Memberus-gaap:ConvertibleSubordinatedDebtMember2016-01-012016-03-310000742112ivc:ConvertibleSeniorNotesat5.00February2021Memberus-gaap:ConvertibleSubordinatedDebtMember2020-07-012020-09-300000742112ivc:ConvertibleSeniorNotesat5.00February2021Memberus-gaap:ConvertibleSubordinatedDebtMember2019-07-012019-09-300000742112us-gaap:ConvertibleSubordinatedDebtMemberivc:ConvertibleSeniorNotesat4.50February2022Domain2017-06-300000742112us-gaap:ConvertibleSubordinatedDebtMemberivc:ConvertibleSeniorNotesat4.50February2022Domain2020-01-012020-09-300000742112us-gaap:ConvertibleSubordinatedDebtMemberivc:ConvertibleSeniorNotesat4.50February2022Domain2019-01-012019-09-300000742112us-gaap:ConvertibleSubordinatedDebtMemberivc:ConvertibleSeniorNotesat4.50February2022Domain2017-04-012017-06-300000742112us-gaap:ConvertibleSubordinatedDebtMemberivc:ConvertibleSeniorNotesat4.50February2022Domain2020-07-012020-09-300000742112us-gaap:ConvertibleSubordinatedDebtMemberivc:ConvertibleSeniorNotesat4.50February2022Domain2019-07-012019-09-300000742112ivc:ConvertibleSeniorNotesat5.00February2021Memberus-gaap:ConvertibleSubordinatedDebtMember2019-10-012019-12-310000742112us-gaap:ConvertibleSubordinatedDebtMemberivc:ConvertibleSeniorNotesat5.00November2024Member2019-12-310000742112us-gaap:ConvertibleSubordinatedDebtMemberivc:ConvertibleSeniorNotesat5.00November2024Member2020-09-300000742112us-gaap:ConvertibleSubordinatedDebtMemberivc:ConvertibleSeniorNotesat5.00November2024Member2020-01-012020-09-300000742112us-gaap:ConvertibleSubordinatedDebtMemberivc:ConvertibleSeniorNotesat5.00November2024Domain2020-01-012020-09-300000742112us-gaap:ConvertibleSubordinatedDebtMemberivc:ConvertibleSeniorNotesat5.00November2024Member2019-10-012019-12-310000742112us-gaap:ConvertibleSubordinatedDebtMemberivc:ConvertibleSeniorNotesat5.00November2024Member2020-07-012020-09-300000742112ivc:ConvertibleSeniorNotesat5.00February2021Memberus-gaap:ConvertibleSubordinatedDebtMember2020-04-012020-06-300000742112us-gaap:ConvertibleSubordinatedDebtMemberivc:ConvertibleSeniorNotesat4.50February2022Domain2020-04-012020-06-300000742112us-gaap:ConvertibleSubordinatedDebtMemberivc:SeriesIIConvertibleSeniorNotesAt500November2024Member2020-04-012020-06-300000742112us-gaap:ConvertibleSubordinatedDebtMemberivc:SeriesIIConvertibleSeniorNotesAt500November2024Member2020-09-300000742112us-gaap:ConvertibleSubordinatedDebtMemberivc:SeriesIIConvertibleSeniorNotesAt500November2024Member2020-01-012020-09-300000742112us-gaap:ConvertibleSubordinatedDebtMemberivc:SeriesIIConvertibleSeniorNotesAt500November2024Domain2020-01-012020-09-300000742112us-gaap:ConvertibleSubordinatedDebtMemberivc:SeriesIIConvertibleSeniorNotesAt500November2024Member2020-06-300000742112us-gaap:ConvertibleSubordinatedDebtMemberivc:SeriesIIConvertibleSeniorNotesAt500November2024Member2020-07-012020-09-300000742112ivc:CARESActLoanMember2020-05-150000742112ivc:CARESActLoanMember2020-09-3000007421122015-04-2300007421122015-04-012015-06-3000007421122015-04-222015-04-2300007421122020-07-010000742112srt:EuropeMemberus-gaap:ProductMember2020-07-012020-09-300000742112srt:EuropeMemberivc:ServicesMember2020-07-012020-09-300000742112srt:EuropeMember2020-07-012020-09-300000742112srt:NorthAmericaMemberus-gaap:ProductMember2020-07-012020-09-300000742112srt:NorthAmericaMemberivc:ServicesMember2020-07-012020-09-300000742112srt:NorthAmericaMember2020-07-012020-09-300000742112srt:AsiaPacificMemberus-gaap:ProductMember2020-07-012020-09-300000742112srt:AsiaPacificMemberivc:ServicesMember2020-07-012020-09-300000742112srt:AsiaPacificMember2020-07-012020-09-300000742112us-gaap:ProductMember2020-07-012020-09-300000742112ivc:ServicesMember2020-07-012020-09-300000742112srt:EuropeMemberus-gaap:ProductMember2020-01-012020-09-300000742112srt:EuropeMemberivc:ServicesMember2020-01-012020-09-300000742112srt:EuropeMember2020-01-012020-09-300000742112srt:NorthAmericaMemberus-gaap:ProductMember2020-01-012020-09-300000742112srt:NorthAmericaMemberivc:ServicesMember2020-01-012020-09-300000742112srt:NorthAmericaMember2020-01-012020-09-300000742112srt:AsiaPacificMemberus-gaap:ProductMember2020-01-012020-09-300000742112srt:AsiaPacificMemberivc:ServicesMember2020-01-012020-09-300000742112srt:AsiaPacificMember2020-01-012020-09-300000742112us-gaap:ProductMember2020-01-012020-09-300000742112ivc:ServicesMember2020-01-012020-09-300000742112srt:EuropeMemberus-gaap:ProductMember2019-07-012019-09-300000742112srt:EuropeMemberivc:ServicesMember2019-07-012019-09-300000742112srt:EuropeMember2019-07-012019-09-300000742112srt:NorthAmericaMemberus-gaap:ProductMember2019-07-012019-09-300000742112srt:NorthAmericaMemberivc:ServicesMember2019-07-012019-09-300000742112srt:NorthAmericaMember2019-07-012019-09-300000742112srt:AsiaPacificMemberus-gaap:ProductMember2019-07-012019-09-300000742112srt:AsiaPacificMemberivc:ServicesMember2019-07-012019-09-300000742112srt:AsiaPacificMember2019-07-012019-09-300000742112us-gaap:ProductMember2019-07-012019-09-300000742112ivc:ServicesMember2019-07-012019-09-300000742112srt:EuropeMemberus-gaap:ProductMember2019-01-012019-09-300000742112srt:EuropeMemberivc:ServicesMember2019-01-012019-09-300000742112srt:EuropeMember2019-01-012019-09-300000742112srt:NorthAmericaMemberus-gaap:ProductMember2019-01-012019-09-300000742112srt:NorthAmericaMemberivc:ServicesMember2019-01-012019-09-300000742112srt:NorthAmericaMember2019-01-012019-09-300000742112srt:AsiaPacificMemberus-gaap:ProductMember2019-01-012019-09-300000742112srt:AsiaPacificMemberivc:ServicesMember2019-01-012019-09-300000742112srt:AsiaPacificMember2019-01-012019-09-300000742112us-gaap:ProductMember2019-01-012019-09-300000742112ivc:ServicesMember2019-01-012019-09-300000742112ivc:GeneralTermsandConditionsMember2020-01-012020-09-300000742112ivc:LargeNationalCustomersMember2020-01-012020-09-300000742112ivc:GovernmentTendersMember2020-01-012020-09-300000742112ivc:OtherCustomersMember2020-01-012020-09-30ivc:votes0000742112us-gaap:CommonClassBMember2020-01-012020-09-300000742112us-gaap:CommonStockMember2020-01-012020-09-300000742112us-gaap:EmployeeStockOptionMember2020-09-300000742112ivc:A2018PlanMember2020-01-012020-09-300000742112ivc:A2018PlanMember2020-04-012020-06-300000742112ivc:A2013PlanMember2020-09-300000742112ivc:RestrictedStockandRestrictedStockUnitsRSUsMemberus-gaap:SellingGeneralAndAdministrativeExpensesMember2020-01-012020-09-300000742112ivc:RestrictedStockandRestrictedStockUnitsRSUsMemberus-gaap:SellingGeneralAndAdministrativeExpensesMember2019-01-012019-09-300000742112us-gaap:PerformanceSharesMemberus-gaap:SellingGeneralAndAdministrativeExpensesMember2020-01-012020-09-300000742112us-gaap:PerformanceSharesMemberus-gaap:SellingGeneralAndAdministrativeExpensesMember2019-01-012019-09-300000742112us-gaap:EmployeeStockOptionMemberus-gaap:SellingGeneralAndAdministrativeExpensesMember2020-01-012020-09-300000742112us-gaap:EmployeeStockOptionMemberus-gaap:SellingGeneralAndAdministrativeExpensesMember2019-01-012019-09-300000742112us-gaap:SellingGeneralAndAdministrativeExpensesMember2020-01-012020-09-300000742112us-gaap:SellingGeneralAndAdministrativeExpensesMember2019-01-012019-09-300000742112ivc:RestrictedStockandRestrictedStockUnitsRSUsMember2020-09-300000742112us-gaap:PerformanceSharesMember2020-09-300000742112us-gaap:EmployeeStockOptionMember2020-01-012020-09-300000742112ivc:RangeOfExercisePriceOneMember2020-01-012020-09-300000742112ivc:RangeOfExercisePriceFourMember2020-01-012020-09-300000742112us-gaap:RestrictedStockMember2020-01-012020-09-300000742112us-gaap:PerformanceSharesMember2020-01-012020-09-300000742112ivc:RangeOfExercisePriceOneMembersrt:MinimumMember2020-01-012020-09-300000742112ivc:RangeOfExercisePriceOneMembersrt:MaximumMember2020-01-012020-09-300000742112ivc:RangeOfExercisePriceOneMemberus-gaap:EmployeeStockOptionMember2020-09-300000742112ivc:RangeOfExercisePriceOneMemberus-gaap:EmployeeStockOptionMember2020-01-012020-09-300000742112ivc:RangeOfExercisePriceTwoMembersrt:MinimumMember2020-01-012020-09-300000742112ivc:RangeOfExercisePriceTwoMembersrt:MaximumMember2020-01-012020-09-300000742112ivc:RangeOfExercisePriceTwoMemberus-gaap:EmployeeStockOptionMember2020-09-300000742112ivc:RangeOfExercisePriceTwoMemberus-gaap:EmployeeStockOptionMember2020-01-012020-09-300000742112ivc:RangeOfExercisePriceThreeMembersrt:MinimumMember2020-01-012020-09-300000742112srt:MaximumMemberivc:RangeOfExercisePriceThreeMember2020-01-012020-09-300000742112us-gaap:EmployeeStockOptionMemberivc:RangeOfExercisePriceThreeMember2020-09-300000742112us-gaap:EmployeeStockOptionMemberivc:RangeOfExercisePriceThreeMember2020-01-012020-09-300000742112ivc:RangeOfExercisePriceFourMembersrt:MinimumMember2020-01-012020-09-300000742112ivc:RangeOfExercisePriceFourMembersrt:MaximumMember2020-01-012020-09-300000742112ivc:RangeOfExercisePriceFourMemberus-gaap:EmployeeStockOptionMember2020-09-300000742112ivc:RangeOfExercisePriceFourMemberus-gaap:EmployeeStockOptionMember2020-01-012020-09-300000742112ivc:RestrictedStockandRestrictedStockUnitsRSUsMember2019-12-310000742112ivc:RestrictedStockandRestrictedStockUnitsRSUsMember2020-01-012020-09-300000742112us-gaap:PerformanceSharesMember2019-12-310000742112srt:WeightedAverageMemberus-gaap:PerformanceSharesMember2020-01-012020-09-300000742112us-gaap:AccumulatedTranslationAdjustmentMember2020-06-300000742112ivc:AccumulatedLongTermNotesAdjustmentMember2020-06-300000742112us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2020-06-300000742112us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2020-06-300000742112us-gaap:AccumulatedTranslationAdjustmentMember2020-07-012020-09-300000742112ivc:AccumulatedLongTermNotesAdjustmentMember2020-07-012020-09-300000742112us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2020-07-012020-09-300000742112us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2020-07-012020-09-300000742112us-gaap:AccumulatedTranslationAdjustmentMember2020-09-300000742112ivc:AccumulatedLongTermNotesAdjustmentMember2020-09-300000742112us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2020-09-300000742112us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2020-09-300000742112us-gaap:AccumulatedTranslationAdjustmentMember2019-12-310000742112ivc:AccumulatedLongTermNotesAdjustmentMember2019-12-310000742112us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2019-12-310000742112us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2019-12-310000742112us-gaap:AccumulatedTranslationAdjustmentMember2020-01-012020-09-300000742112ivc:AccumulatedLongTermNotesAdjustmentMember2020-01-012020-09-300000742112us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2020-01-012020-09-300000742112us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2020-01-012020-09-300000742112us-gaap:AccumulatedTranslationAdjustmentMember2019-06-300000742112ivc:AccumulatedLongTermNotesAdjustmentMember2019-06-300000742112us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2019-06-300000742112us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2019-06-300000742112us-gaap:AccumulatedTranslationAdjustmentMember2019-07-012019-09-300000742112ivc:AccumulatedLongTermNotesAdjustmentMember2019-07-012019-09-300000742112us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2019-07-012019-09-300000742112us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2019-07-012019-09-300000742112us-gaap:AccumulatedTranslationAdjustmentMember2019-09-300000742112ivc:AccumulatedLongTermNotesAdjustmentMember2019-09-300000742112us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2019-09-300000742112us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2019-09-300000742112us-gaap:AccumulatedTranslationAdjustmentMember2018-12-310000742112ivc:AccumulatedLongTermNotesAdjustmentMember2018-12-310000742112us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2018-12-310000742112us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2018-12-310000742112us-gaap:AccumulatedTranslationAdjustmentMember2019-01-012019-09-300000742112ivc:AccumulatedLongTermNotesAdjustmentMember2019-01-012019-09-300000742112us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2019-01-012019-09-300000742112us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2019-01-012019-09-300000742112us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2020-07-012020-09-300000742112us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2019-07-012019-09-300000742112us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2020-01-012020-09-300000742112us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2019-01-012019-09-300000742112us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMemberus-gaap:ForeignExchangeForwardMember2020-07-012020-09-300000742112us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMemberus-gaap:ForeignExchangeForwardMember2019-07-012019-09-300000742112us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMemberus-gaap:ForeignExchangeForwardMember2020-01-012020-09-300000742112us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMemberus-gaap:ForeignExchangeForwardMember2019-01-012019-09-300000742112us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2020-07-012020-09-300000742112us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2019-07-012019-09-300000742112us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2020-01-012020-09-300000742112us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2019-01-012019-09-300000742112us-gaap:AllOtherSegmentsMember2020-01-012020-09-300000742112srt:EuropeMemberus-gaap:EmployeeSeveranceMember2020-01-012020-09-300000742112srt:EuropeMemberus-gaap:ContractTerminationMember2020-01-012020-09-300000742112srt:EuropeMemberus-gaap:EmployeeSeveranceMember2019-01-012019-09-300000742112us-gaap:EmployeeSeveranceMemberus-gaap:AllOtherSegmentsMember2019-01-012019-09-300000742112us-gaap:EmployeeSeveranceMembersrt:NorthAmericaMember2019-01-012019-09-300000742112srt:NorthAmericaMemberus-gaap:ContractTerminationMember2019-01-012019-09-300000742112us-gaap:EmployeeSeveranceMembersrt:NorthAmericaMember2019-12-310000742112srt:NorthAmericaMemberus-gaap:ContractTerminationMember2019-12-310000742112srt:NorthAmericaMember2019-12-310000742112srt:EuropeMemberus-gaap:EmployeeSeveranceMember2019-12-310000742112srt:EuropeMemberus-gaap:ContractTerminationMember2019-12-310000742112srt:EuropeMember2019-12-310000742112us-gaap:EmployeeSeveranceMemberus-gaap:AllOtherSegmentsMember2019-12-310000742112us-gaap:ContractTerminationMemberus-gaap:AllOtherSegmentsMember2019-12-310000742112us-gaap:AllOtherSegmentsMember2019-12-310000742112us-gaap:EmployeeSeveranceMember2019-12-310000742112us-gaap:ContractTerminationMember2019-12-310000742112us-gaap:EmployeeSeveranceMembersrt:NorthAmericaMember2020-01-012020-03-310000742112srt:NorthAmericaMemberus-gaap:ContractTerminationMember2020-01-012020-03-310000742112srt:NorthAmericaMember2020-01-012020-03-310000742112srt:EuropeMemberus-gaap:EmployeeSeveranceMember2020-01-012020-03-310000742112srt:EuropeMemberus-gaap:ContractTerminationMember2020-01-012020-03-310000742112srt:EuropeMember2020-01-012020-03-310000742112us-gaap:EmployeeSeveranceMemberus-gaap:AllOtherSegmentsMember2020-01-012020-03-310000742112us-gaap:ContractTerminationMemberus-gaap:AllOtherSegmentsMember2020-01-012020-03-310000742112us-gaap:AllOtherSegmentsMember2020-01-012020-03-310000742112us-gaap:EmployeeSeveranceMember2020-01-012020-03-310000742112us-gaap:ContractTerminationMember2020-01-012020-03-3100007421122020-01-012020-03-310000742112us-gaap:EmployeeSeveranceMembersrt:NorthAmericaMember2020-03-310000742112srt:NorthAmericaMemberus-gaap:ContractTerminationMember2020-03-310000742112srt:NorthAmericaMember2020-03-310000742112srt:EuropeMemberus-gaap:EmployeeSeveranceMember2020-03-310000742112srt:EuropeMemberus-gaap:ContractTerminationMember2020-03-310000742112srt:EuropeMember2020-03-310000742112us-gaap:EmployeeSeveranceMemberus-gaap:AllOtherSegmentsMember2020-03-310000742112us-gaap:ContractTerminationMemberus-gaap:AllOtherSegmentsMember2020-03-310000742112us-gaap:AllOtherSegmentsMember2020-03-310000742112us-gaap:EmployeeSeveranceMember2020-03-310000742112us-gaap:ContractTerminationMember2020-03-3100007421122020-03-310000742112us-gaap:EmployeeSeveranceMembersrt:NorthAmericaMember2020-04-012020-06-300000742112srt:NorthAmericaMemberus-gaap:ContractTerminationMember2020-04-012020-06-300000742112srt:NorthAmericaMember2020-04-012020-06-300000742112srt:EuropeMemberus-gaap:EmployeeSeveranceMember2020-04-012020-06-300000742112srt:EuropeMemberus-gaap:ContractTerminationMember2020-04-012020-06-300000742112srt:EuropeMember2020-04-012020-06-300000742112us-gaap:EmployeeSeveranceMemberus-gaap:AllOtherSegmentsMember2020-04-012020-06-300000742112us-gaap:ContractTerminationMemberus-gaap:AllOtherSegmentsMember2020-04-012020-06-300000742112us-gaap:AllOtherSegmentsMember2020-04-012020-06-300000742112us-gaap:EmployeeSeveranceMember2020-04-012020-06-300000742112us-gaap:ContractTerminationMember2020-04-012020-06-300000742112us-gaap:EmployeeSeveranceMembersrt:NorthAmericaMember2020-06-300000742112srt:NorthAmericaMemberus-gaap:ContractTerminationMember2020-06-300000742112srt:NorthAmericaMember2020-06-300000742112srt:EuropeMemberus-gaap:EmployeeSeveranceMember2020-06-300000742112srt:EuropeMemberus-gaap:ContractTerminationMember2020-06-300000742112srt:EuropeMember2020-06-300000742112us-gaap:EmployeeSeveranceMemberus-gaap:AllOtherSegmentsMember2020-06-300000742112us-gaap:ContractTerminationMemberus-gaap:AllOtherSegmentsMember2020-06-300000742112us-gaap:AllOtherSegmentsMember2020-06-300000742112us-gaap:EmployeeSeveranceMember2020-06-300000742112us-gaap:ContractTerminationMember2020-06-300000742112us-gaap:EmployeeSeveranceMembersrt:NorthAmericaMember2020-07-012020-09-300000742112srt:NorthAmericaMemberus-gaap:ContractTerminationMember2020-07-012020-09-300000742112srt:EuropeMemberus-gaap:EmployeeSeveranceMember2020-07-012020-09-300000742112srt:EuropeMemberus-gaap:ContractTerminationMember2020-07-012020-09-300000742112us-gaap:EmployeeSeveranceMemberus-gaap:AllOtherSegmentsMember2020-07-012020-09-300000742112us-gaap:ContractTerminationMemberus-gaap:AllOtherSegmentsMember2020-07-012020-09-300000742112us-gaap:AllOtherSegmentsMember2020-07-012020-09-300000742112us-gaap:EmployeeSeveranceMember2020-07-012020-09-300000742112us-gaap:ContractTerminationMember2020-07-012020-09-300000742112us-gaap:EmployeeSeveranceMembersrt:NorthAmericaMember2020-09-300000742112srt:NorthAmericaMemberus-gaap:ContractTerminationMember2020-09-300000742112srt:NorthAmericaMember2020-09-300000742112srt:EuropeMemberus-gaap:EmployeeSeveranceMember2020-09-300000742112srt:EuropeMemberus-gaap:ContractTerminationMember2020-09-300000742112srt:EuropeMember2020-09-300000742112us-gaap:EmployeeSeveranceMemberus-gaap:AllOtherSegmentsMember2020-09-300000742112us-gaap:ContractTerminationMemberus-gaap:AllOtherSegmentsMember2020-09-300000742112us-gaap:AllOtherSegmentsMember2020-09-300000742112us-gaap:EmployeeSeveranceMember2020-09-300000742112us-gaap:ContractTerminationMember2020-09-300000742112us-gaap:EmployeeStockOptionMember2020-01-012020-09-300000742112us-gaap:EmployeeStockOptionMember2020-09-300000742112us-gaap:EmployeeStockOptionMember2020-07-012020-09-300000742112us-gaap:EmployeeStockOptionMember2019-01-012019-09-300000742112us-gaap:EmployeeStockOptionMember2019-09-300000742112us-gaap:EmployeeStockOptionMember2019-07-012019-09-300000742112us-gaap:ForeignExchangeForwardMember2020-01-012020-09-300000742112us-gaap:ForeignExchangeForwardMember2019-01-012019-09-300000742112ivc:ForeignExchangeForwardUSDAUDMemberus-gaap:DesignatedAsHedgingInstrumentMember2020-09-300000742112ivc:ForeignExchangeForwardUSDAUDMemberus-gaap:DesignatedAsHedgingInstrumentMember2020-01-012020-09-300000742112ivc:ForeignExchangeForwardUSDAUDMemberus-gaap:DesignatedAsHedgingInstrumentMember2019-12-310000742112ivc:ForeignExchangeForwardUSDAUDMemberus-gaap:DesignatedAsHedgingInstrumentMember2019-01-012019-12-310000742112us-gaap:DesignatedAsHedgingInstrumentMemberivc:ForeignExchangeForwardUSDCADMember2020-09-300000742112us-gaap:DesignatedAsHedgingInstrumentMemberivc:ForeignExchangeForwardUSDCADMember2020-01-012020-09-300000742112us-gaap:DesignatedAsHedgingInstrumentMemberivc:ForeignExchangeForwardUSDCADMember2019-12-310000742112us-gaap:DesignatedAsHedgingInstrumentMemberivc:ForeignExchangeForwardUSDCADMember2019-01-012019-12-310000742112ivc:ForeignExchangeForwardUSDEURMemberus-gaap:DesignatedAsHedgingInstrumentMember2020-09-300000742112ivc:ForeignExchangeForwardUSDEURMemberus-gaap:DesignatedAsHedgingInstrumentMember2020-01-012020-09-300000742112ivc:ForeignExchangeForwardUSDEURMemberus-gaap:DesignatedAsHedgingInstrumentMember2019-12-310000742112ivc:ForeignExchangeForwardUSDEURMemberus-gaap:DesignatedAsHedgingInstrumentMember2019-01-012019-12-310000742112ivc:ForeignExchangeForwardUSDGBPMemberus-gaap:DesignatedAsHedgingInstrumentMember2020-09-300000742112ivc:ForeignExchangeForwardUSDGBPMemberus-gaap:DesignatedAsHedgingInstrumentMember2020-01-012020-09-300000742112ivc:ForeignExchangeForwardUSDGBPMemberus-gaap:DesignatedAsHedgingInstrumentMember2019-12-310000742112ivc:ForeignExchangeForwardUSDGBPMemberus-gaap:DesignatedAsHedgingInstrumentMember2019-01-012019-12-310000742112ivc:ForeignExchangeForwardUSDNZDMemberus-gaap:DesignatedAsHedgingInstrumentMember2020-09-300000742112ivc:ForeignExchangeForwardUSDNZDMemberus-gaap:DesignatedAsHedgingInstrumentMember2020-01-012020-09-300000742112ivc:ForeignExchangeForwardUSDNZDMemberus-gaap:DesignatedAsHedgingInstrumentMember2019-12-310000742112ivc:ForeignExchangeForwardUSDNZDMemberus-gaap:DesignatedAsHedgingInstrumentMember2019-01-012019-12-310000742112ivc:ForeignExchangeForwardUSDSEKMemberus-gaap:DesignatedAsHedgingInstrumentMember2020-09-300000742112ivc:ForeignExchangeForwardUSDSEKMemberus-gaap:DesignatedAsHedgingInstrumentMember2020-01-012020-09-300000742112ivc:ForeignExchangeForwardUSDSEKMemberus-gaap:DesignatedAsHedgingInstrumentMember2019-12-310000742112ivc:ForeignExchangeForwardUSDSEKMemberus-gaap:DesignatedAsHedgingInstrumentMember2019-01-012019-12-310000742112ivc:ForeignExchangeForwardUSDMXPMemberus-gaap:DesignatedAsHedgingInstrumentMember2020-09-300000742112ivc:ForeignExchangeForwardUSDMXPMemberus-gaap:DesignatedAsHedgingInstrumentMember2020-01-012020-09-300000742112ivc:ForeignExchangeForwardUSDMXPMemberus-gaap:DesignatedAsHedgingInstrumentMember2019-12-310000742112ivc:ForeignExchangeForwardUSDMXPMemberus-gaap:DesignatedAsHedgingInstrumentMember2019-01-012019-12-310000742112ivc:ForeignExchangeForwardEURCADMemberus-gaap:DesignatedAsHedgingInstrumentMember2020-09-300000742112ivc:ForeignExchangeForwardEURCADMemberus-gaap:DesignatedAsHedgingInstrumentMember2020-01-012020-09-300000742112ivc:ForeignExchangeForwardEURCADMemberus-gaap:DesignatedAsHedgingInstrumentMember2019-12-310000742112ivc:ForeignExchangeForwardEURCADMemberus-gaap:DesignatedAsHedgingInstrumentMember2019-01-012019-12-310000742112ivc:ForeignExchangeForwardEURCHFMemberus-gaap:DesignatedAsHedgingInstrumentMember2020-09-300000742112ivc:ForeignExchangeForwardEURCHFMemberus-gaap:DesignatedAsHedgingInstrumentMember2020-01-012020-09-300000742112ivc:ForeignExchangeForwardEURCHFMemberus-gaap:DesignatedAsHedgingInstrumentMember2019-12-310000742112ivc:ForeignExchangeForwardEURCHFMemberus-gaap:DesignatedAsHedgingInstrumentMember2019-01-012019-12-310000742112ivc:ForeignExchangeForwardEURGBPMemberus-gaap:DesignatedAsHedgingInstrumentMember2020-09-300000742112ivc:ForeignExchangeForwardEURGBPMemberus-gaap:DesignatedAsHedgingInstrumentMember2020-01-012020-09-300000742112ivc:ForeignExchangeForwardEURGBPMemberus-gaap:DesignatedAsHedgingInstrumentMember2019-12-310000742112ivc:ForeignExchangeForwardEURGBPMemberus-gaap:DesignatedAsHedgingInstrumentMember2019-01-012019-12-310000742112ivc:ForeignExchangeForwardEURSEKMemberus-gaap:DesignatedAsHedgingInstrumentMember2020-09-300000742112ivc:ForeignExchangeForwardEURSEKMemberus-gaap:DesignatedAsHedgingInstrumentMember2020-01-012020-09-300000742112ivc:ForeignExchangeForwardEURSEKMemberus-gaap:DesignatedAsHedgingInstrumentMember2019-12-310000742112ivc:ForeignExchangeForwardEURSEKMemberus-gaap:DesignatedAsHedgingInstrumentMember2019-01-012019-12-310000742112ivc:ForeignExchangeForwardEURNOKMemberus-gaap:DesignatedAsHedgingInstrumentMember2020-09-300000742112ivc:ForeignExchangeForwardEURNOKMemberus-gaap:DesignatedAsHedgingInstrumentMember2020-01-012020-09-300000742112ivc:ForeignExchangeForwardEURNOKMemberus-gaap:DesignatedAsHedgingInstrumentMember2019-12-310000742112ivc:ForeignExchangeForwardEURNOKMemberus-gaap:DesignatedAsHedgingInstrumentMember2019-01-012019-12-310000742112ivc:ForeignExchangeForwardDKKSEKMemberus-gaap:DesignatedAsHedgingInstrumentMember2020-09-300000742112ivc:ForeignExchangeForwardDKKSEKMemberus-gaap:DesignatedAsHedgingInstrumentMember2020-01-012020-09-300000742112ivc:ForeignExchangeForwardDKKSEKMemberus-gaap:DesignatedAsHedgingInstrumentMember2019-12-310000742112ivc:ForeignExchangeForwardDKKSEKMemberus-gaap:DesignatedAsHedgingInstrumentMember2019-01-012019-12-310000742112ivc:ForeignExchangeForwardNOKSEKMemberus-gaap:DesignatedAsHedgingInstrumentMember2020-09-300000742112ivc:ForeignExchangeForwardNOKSEKMemberus-gaap:DesignatedAsHedgingInstrumentMember2020-01-012020-09-300000742112ivc:ForeignExchangeForwardNOKSEKMemberus-gaap:DesignatedAsHedgingInstrumentMember2019-12-310000742112ivc:ForeignExchangeForwardNOKSEKMemberus-gaap:DesignatedAsHedgingInstrumentMember2019-01-012019-12-310000742112us-gaap:DesignatedAsHedgingInstrumentMember2020-09-300000742112us-gaap:DesignatedAsHedgingInstrumentMember2020-01-012020-09-300000742112us-gaap:DesignatedAsHedgingInstrumentMember2019-12-310000742112us-gaap:DesignatedAsHedgingInstrumentMember2019-01-012019-12-310000742112us-gaap:NondesignatedMemberivc:ForeignExchangeForwardAUDUSDMember2020-09-300000742112us-gaap:NondesignatedMemberivc:ForeignExchangeForwardAUDUSDMember2020-01-012020-09-300000742112us-gaap:NondesignatedMemberivc:ForeignExchangeForwardAUDUSDMember2019-12-310000742112us-gaap:NondesignatedMemberivc:ForeignExchangeForwardAUDUSDMember2019-01-012019-12-310000742112us-gaap:NondesignatedMemberivc:ForeignExchangeForwardCADUSDMember2020-09-300000742112us-gaap:NondesignatedMemberivc:ForeignExchangeForwardCADUSDMember2020-01-012020-09-300000742112us-gaap:NondesignatedMemberivc:ForeignExchangeForwardCADUSDMember2019-12-310000742112us-gaap:NondesignatedMemberivc:ForeignExchangeForwardCADUSDMember2019-01-012019-12-310000742112us-gaap:NondesignatedMemberivc:ForeignExchangeForwardEURUSDMember2020-09-300000742112us-gaap:NondesignatedMemberivc:ForeignExchangeForwardEURUSDMember2020-01-012020-09-300000742112us-gaap:NondesignatedMemberivc:ForeignExchangeForwardEURUSDMember2019-12-310000742112us-gaap:NondesignatedMemberivc:ForeignExchangeForwardEURUSDMember2019-01-012019-12-310000742112us-gaap:NondesignatedMemberivc:ForeignExchangeForwardDKKUSDMember2020-09-300000742112us-gaap:NondesignatedMemberivc:ForeignExchangeForwardDKKUSDMember2020-01-012020-09-300000742112us-gaap:NondesignatedMemberivc:ForeignExchangeForwardDKKUSDMember2019-12-310000742112us-gaap:NondesignatedMemberivc:ForeignExchangeForwardDKKUSDMember2019-01-012019-12-310000742112us-gaap:NondesignatedMemberivc:ForeignExchangeForwardGBPUSDMember2020-09-300000742112us-gaap:NondesignatedMemberivc:ForeignExchangeForwardGBPUSDMember2020-01-012020-09-300000742112us-gaap:NondesignatedMemberivc:ForeignExchangeForwardGBPUSDMember2019-12-310000742112us-gaap:NondesignatedMemberivc:ForeignExchangeForwardGBPUSDMember2019-01-012019-12-310000742112us-gaap:NondesignatedMemberivc:ForeignExchangeForwardNOKUSDMember2020-09-300000742112us-gaap:NondesignatedMemberivc:ForeignExchangeForwardNOKUSDMember2020-01-012020-09-300000742112us-gaap:NondesignatedMemberivc:ForeignExchangeForwardNOKUSDMember2019-12-310000742112us-gaap:NondesignatedMemberivc:ForeignExchangeForwardNOKUSDMember2019-01-012019-12-310000742112us-gaap:NondesignatedMemberivc:ForeignExchangeForwardNZDUSDMember2020-09-300000742112us-gaap:NondesignatedMemberivc:ForeignExchangeForwardNZDUSDMember2020-01-012020-09-300000742112us-gaap:NondesignatedMemberivc:ForeignExchangeForwardNZDUSDMember2019-12-310000742112us-gaap:NondesignatedMemberivc:ForeignExchangeForwardNZDUSDMember2019-01-012019-12-310000742112us-gaap:NondesignatedMemberivc:ForeignExchangeForwardEURCADMember2020-09-300000742112us-gaap:NondesignatedMemberivc:ForeignExchangeForwardEURCADMember2020-01-012020-09-300000742112us-gaap:NondesignatedMemberivc:ForeignExchangeForwardEURCADMember2019-12-310000742112us-gaap:NondesignatedMemberivc:ForeignExchangeForwardEURCADMember2019-01-012019-12-310000742112us-gaap:NondesignatedMemberivc:ForeignExchangeForwardEURGBPMember2020-09-300000742112us-gaap:NondesignatedMemberivc:ForeignExchangeForwardEURGBPMember2020-01-012020-09-300000742112us-gaap:NondesignatedMemberivc:ForeignExchangeForwardEURGBPMember2019-12-310000742112us-gaap:NondesignatedMemberivc:ForeignExchangeForwardEURGBPMember2019-01-012019-12-310000742112us-gaap:NondesignatedMemberivc:ForeignExchangeForwardAUDNZDMember2020-09-300000742112us-gaap:NondesignatedMemberivc:ForeignExchangeForwardAUDNZDMember2020-01-012020-09-300000742112us-gaap:NondesignatedMemberivc:ForeignExchangeForwardAUDNZDMember2019-12-310000742112us-gaap:NondesignatedMemberivc:ForeignExchangeForwardAUDNZDMember2019-01-012019-12-310000742112us-gaap:NondesignatedMemberivc:ForeignExchangeForwardEURNOKMember2020-09-300000742112us-gaap:NondesignatedMemberivc:ForeignExchangeForwardEURNOKMember2020-01-012020-09-300000742112us-gaap:NondesignatedMemberivc:ForeignExchangeForwardEURNOKMember2019-12-310000742112us-gaap:NondesignatedMemberivc:ForeignExchangeForwardEURNOKMember2019-01-012019-12-310000742112us-gaap:NondesignatedMember2020-09-300000742112us-gaap:NondesignatedMember2020-01-012020-09-300000742112us-gaap:NondesignatedMember2019-12-310000742112us-gaap:NondesignatedMember2019-01-012019-12-310000742112us-gaap:OtherCurrentAssetsMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ForeignExchangeForwardMember2020-09-300000742112us-gaap:AccruedLiabilitiesMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ForeignExchangeForwardMember2020-09-300000742112us-gaap:OtherCurrentAssetsMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ForeignExchangeForwardMember2019-12-310000742112us-gaap:AccruedLiabilitiesMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ForeignExchangeForwardMember2019-12-310000742112us-gaap:NondesignatedMemberus-gaap:OtherCurrentAssetsMemberus-gaap:ForeignExchangeForwardMember2020-09-300000742112us-gaap:NondesignatedMemberus-gaap:AccruedLiabilitiesMemberus-gaap:ForeignExchangeForwardMember2020-09-300000742112us-gaap:NondesignatedMemberus-gaap:OtherCurrentAssetsMemberus-gaap:ForeignExchangeForwardMember2019-12-310000742112us-gaap:NondesignatedMemberus-gaap:AccruedLiabilitiesMemberus-gaap:ForeignExchangeForwardMember2019-12-310000742112us-gaap:OtherCurrentAssetsMember2020-09-300000742112us-gaap:AccruedLiabilitiesMember2020-09-300000742112us-gaap:OtherCurrentAssetsMember2019-12-310000742112us-gaap:AccruedLiabilitiesMember2019-12-310000742112us-gaap:CashFlowHedgingMemberus-gaap:ForeignExchangeForwardMember2020-07-012020-09-300000742112us-gaap:CashFlowHedgingMemberus-gaap:ForeignExchangeForwardMember2020-01-012020-09-300000742112us-gaap:CashFlowHedgingMemberus-gaap:ForeignExchangeForwardMember2019-07-012019-09-300000742112us-gaap:CashFlowHedgingMemberus-gaap:ForeignExchangeForwardMember2019-01-012019-09-300000742112us-gaap:SellingGeneralAndAdministrativeExpensesMemberus-gaap:ForeignExchangeForwardMember2020-07-012020-09-300000742112us-gaap:SellingGeneralAndAdministrativeExpensesMemberus-gaap:ForeignExchangeForwardMember2020-01-012020-09-300000742112us-gaap:NondesignatedMemberus-gaap:ForeignExchangeForwardMember2019-07-012019-09-300000742112us-gaap:NondesignatedMemberus-gaap:ForeignExchangeForwardMember2019-01-012019-09-300000742112us-gaap:SalesMemberus-gaap:CashFlowHedgingMember2020-07-012020-09-300000742112us-gaap:SalesMemberus-gaap:CashFlowHedgingMember2020-01-012020-09-300000742112us-gaap:CostOfSalesMemberus-gaap:CashFlowHedgingMember2020-07-012020-09-300000742112us-gaap:CostOfSalesMemberus-gaap:CashFlowHedgingMember2020-01-012020-09-300000742112us-gaap:CashFlowHedgingMember2020-07-012020-09-300000742112us-gaap:CashFlowHedgingMember2020-01-012020-09-300000742112us-gaap:SalesMemberus-gaap:CashFlowHedgingMember2019-07-012019-09-300000742112us-gaap:SalesMemberus-gaap:CashFlowHedgingMember2019-01-012019-09-300000742112us-gaap:CostOfSalesMemberus-gaap:CashFlowHedgingMember2019-07-012019-09-300000742112us-gaap:CostOfSalesMemberus-gaap:CashFlowHedgingMember2019-01-012019-09-300000742112us-gaap:CashFlowHedgingMember2019-07-012019-09-300000742112us-gaap:CashFlowHedgingMember2019-01-012019-09-300000742112us-gaap:SellingGeneralAndAdministrativeExpensesMemberus-gaap:ForeignExchangeForwardMember2019-07-012019-09-300000742112us-gaap:SellingGeneralAndAdministrativeExpensesMemberus-gaap:ForeignExchangeForwardMember2019-01-012019-09-300000742112us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Memberivc:ConvertibleDebt2021ConversionFeatureMember2020-09-300000742112us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Memberivc:ConvertibleDebt2022ConversionFeatureDomain2020-09-300000742112ivc:ConvertibleDebtBondHedgeMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2020-09-300000742112us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Memberus-gaap:ForeignExchangeForwardMember2020-09-300000742112us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Memberus-gaap:ForeignExchangeForwardMember2020-09-300000742112us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:ForeignExchangeForwardMember2020-09-300000742112us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Memberus-gaap:ForeignExchangeForwardMember2019-12-310000742112us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Memberus-gaap:ForeignExchangeForwardMember2019-12-310000742112us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:ForeignExchangeForwardMember2019-12-310000742112us-gaap:EstimateOfFairValueFairValueDisclosureMember2020-09-300000742112us-gaap:CarryingReportedAmountFairValueDisclosureMember2019-12-310000742112us-gaap:EstimateOfFairValueFairValueDisclosureMember2019-12-310000742112us-gaap:OtherCurrentAssetsMemberus-gaap:CarryingReportedAmountFairValueDisclosureMemberus-gaap:ForeignExchangeForwardMember2020-09-300000742112us-gaap:OtherCurrentAssetsMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:ForeignExchangeForwardMember2020-09-300000742112us-gaap:OtherCurrentAssetsMemberus-gaap:CarryingReportedAmountFairValueDisclosureMemberus-gaap:ForeignExchangeForwardMember2019-12-310000742112us-gaap:OtherCurrentAssetsMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:ForeignExchangeForwardMember2019-12-310000742112us-gaap:AccountsPayableAndAccruedLiabilitiesMemberus-gaap:CarryingReportedAmountFairValueDisclosureMemberus-gaap:ForeignExchangeForwardMember2020-09-300000742112us-gaap:AccountsPayableAndAccruedLiabilitiesMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:ForeignExchangeForwardMember2020-09-300000742112us-gaap:AccountsPayableAndAccruedLiabilitiesMemberus-gaap:CarryingReportedAmountFairValueDisclosureMemberus-gaap:ForeignExchangeForwardMember2019-12-310000742112us-gaap:AccountsPayableAndAccruedLiabilitiesMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:ForeignExchangeForwardMember2019-12-310000742112srt:EuropeMemberus-gaap:IntersegmentEliminationMember2020-07-012020-09-300000742112srt:EuropeMemberus-gaap:IntersegmentEliminationMember2019-07-012019-09-300000742112srt:EuropeMemberus-gaap:IntersegmentEliminationMember2020-01-012020-09-300000742112srt:EuropeMemberus-gaap:IntersegmentEliminationMember2019-01-012019-09-300000742112srt:NorthAmericaMemberus-gaap:IntersegmentEliminationMember2020-07-012020-09-300000742112srt:NorthAmericaMemberus-gaap:IntersegmentEliminationMember2019-07-012019-09-300000742112srt:NorthAmericaMemberus-gaap:IntersegmentEliminationMember2020-01-012020-09-300000742112srt:NorthAmericaMemberus-gaap:IntersegmentEliminationMember2019-01-012019-09-300000742112srt:AsiaPacificMemberus-gaap:IntersegmentEliminationMember2020-07-012020-09-300000742112srt:AsiaPacificMemberus-gaap:IntersegmentEliminationMember2019-07-012019-09-300000742112srt:AsiaPacificMemberus-gaap:IntersegmentEliminationMember2020-01-012020-09-300000742112srt:AsiaPacificMemberus-gaap:IntersegmentEliminationMember2019-01-012019-09-300000742112us-gaap:IntersegmentEliminationMember2020-07-012020-09-300000742112us-gaap:IntersegmentEliminationMember2019-07-012019-09-300000742112us-gaap:IntersegmentEliminationMember2020-01-012020-09-300000742112us-gaap:IntersegmentEliminationMember2019-01-012019-09-300000742112us-gaap:AllOtherSegmentsMember2019-07-012019-09-300000742112us-gaap:AllOtherSegmentsMember2019-01-012019-09-300000742112srt:EuropeMemberivc:LifestyleProductsDomainus-gaap:OperatingSegmentsMember2020-07-012020-09-300000742112srt:EuropeMemberivc:LifestyleProductsDomainus-gaap:OperatingSegmentsMember2019-07-012019-09-300000742112srt:EuropeMemberivc:LifestyleProductsDomainus-gaap:OperatingSegmentsMember2020-01-012020-09-300000742112srt:EuropeMemberivc:LifestyleProductsDomainus-gaap:OperatingSegmentsMember2019-01-012019-09-300000742112srt:EuropeMemberivc:MobilityandSeatingDomainus-gaap:OperatingSegmentsMember2020-07-012020-09-300000742112srt:EuropeMemberivc:MobilityandSeatingDomainus-gaap:OperatingSegmentsMember2019-07-012019-09-300000742112srt:EuropeMemberivc:MobilityandSeatingDomainus-gaap:OperatingSegmentsMember2020-01-012020-09-300000742112srt:EuropeMemberivc:MobilityandSeatingDomainus-gaap:OperatingSegmentsMember2019-01-012019-09-300000742112srt:EuropeMemberus-gaap:OperatingSegmentsMemberivc:RespiratoryTherapyDomain2020-07-012020-09-300000742112srt:EuropeMemberus-gaap:OperatingSegmentsMemberivc:RespiratoryTherapyDomain2019-07-012019-09-300000742112srt:EuropeMemberus-gaap:OperatingSegmentsMemberivc:RespiratoryTherapyDomain2020-01-012020-09-300000742112srt:EuropeMemberus-gaap:OperatingSegmentsMemberivc:RespiratoryTherapyDomain2019-01-012019-09-300000742112srt:EuropeMemberus-gaap:OperatingSegmentsMemberivc:OtherDomain2020-07-012020-09-300000742112srt:EuropeMemberus-gaap:OperatingSegmentsMemberivc:OtherDomain2019-07-012019-09-300000742112srt:EuropeMemberus-gaap:OperatingSegmentsMemberivc:OtherDomain2020-01-012020-09-300000742112srt:EuropeMemberus-gaap:OperatingSegmentsMemberivc:OtherDomain2019-01-012019-09-300000742112srt:EuropeMemberus-gaap:OperatingSegmentsMember2020-07-012020-09-300000742112srt:EuropeMemberus-gaap:OperatingSegmentsMember2019-07-012019-09-300000742112srt:EuropeMemberus-gaap:OperatingSegmentsMember2020-01-012020-09-300000742112srt:EuropeMemberus-gaap:OperatingSegmentsMember2019-01-012019-09-300000742112srt:NorthAmericaMemberivc:LifestyleProductsDomainus-gaap:OperatingSegmentsMember2020-07-012020-09-300000742112srt:NorthAmericaMemberivc:LifestyleProductsDomainus-gaap:OperatingSegmentsMember2019-07-012019-09-300000742112srt:NorthAmericaMemberivc:LifestyleProductsDomainus-gaap:OperatingSegmentsMember2020-01-012020-09-300000742112srt:NorthAmericaMemberivc:LifestyleProductsDomainus-gaap:OperatingSegmentsMember2019-01-012019-09-300000742112srt:NorthAmericaMemberivc:MobilityandSeatingDomainus-gaap:OperatingSegmentsMember2020-07-012020-09-300000742112srt:NorthAmericaMemberivc:MobilityandSeatingDomainus-gaap:OperatingSegmentsMember2019-07-012019-09-300000742112srt:NorthAmericaMemberivc:MobilityandSeatingDomainus-gaap:OperatingSegmentsMember2020-01-012020-09-300000742112srt:NorthAmericaMemberivc:MobilityandSeatingDomainus-gaap:OperatingSegmentsMember2019-01-012019-09-300000742112srt:NorthAmericaMemberus-gaap:OperatingSegmentsMemberivc:RespiratoryTherapyDomain2020-07-012020-09-300000742112srt:NorthAmericaMemberus-gaap:OperatingSegmentsMemberivc:RespiratoryTherapyDomain2019-07-012019-09-300000742112srt:NorthAmericaMemberus-gaap:OperatingSegmentsMemberivc:RespiratoryTherapyDomain2020-01-012020-09-300000742112srt:NorthAmericaMemberus-gaap:OperatingSegmentsMemberivc:RespiratoryTherapyDomain2019-01-012019-09-300000742112srt:NorthAmericaMemberus-gaap:OperatingSegmentsMemberivc:OtherDomain2020-07-012020-09-300000742112srt:NorthAmericaMemberus-gaap:OperatingSegmentsMemberivc:OtherDomain2019-07-012019-09-300000742112srt:NorthAmericaMemberus-gaap:OperatingSegmentsMemberivc:OtherDomain2020-01-012020-09-300000742112srt:NorthAmericaMemberus-gaap:OperatingSegmentsMemberivc:OtherDomain2019-01-012019-09-300000742112srt:NorthAmericaMemberus-gaap:OperatingSegmentsMember2020-07-012020-09-300000742112srt:NorthAmericaMemberus-gaap:OperatingSegmentsMember2019-07-012019-09-300000742112srt:NorthAmericaMemberus-gaap:OperatingSegmentsMember2020-01-012020-09-300000742112srt:NorthAmericaMemberus-gaap:OperatingSegmentsMember2019-01-012019-09-300000742112srt:AsiaPacificMemberivc:MobilityandSeatingDomainus-gaap:OperatingSegmentsMember2020-07-012020-09-300000742112srt:AsiaPacificMemberivc:MobilityandSeatingDomainus-gaap:OperatingSegmentsMember2019-07-012019-09-300000742112srt:AsiaPacificMemberivc:MobilityandSeatingDomainus-gaap:OperatingSegmentsMember2020-01-012020-09-300000742112srt:AsiaPacificMemberivc:MobilityandSeatingDomainus-gaap:OperatingSegmentsMember2019-01-012019-09-300000742112srt:AsiaPacificMemberivc:LifestyleProductsDomainus-gaap:OperatingSegmentsMember2020-07-012020-09-300000742112srt:AsiaPacificMemberivc:LifestyleProductsDomainus-gaap:OperatingSegmentsMember2019-07-012019-09-300000742112srt:AsiaPacificMemberivc:LifestyleProductsDomainus-gaap:OperatingSegmentsMember2020-01-012020-09-300000742112srt:AsiaPacificMemberivc:LifestyleProductsDomainus-gaap:OperatingSegmentsMember2019-01-012019-09-300000742112srt:AsiaPacificMemberus-gaap:OperatingSegmentsMemberivc:RespiratoryTherapyDomain2020-07-012020-09-300000742112srt:AsiaPacificMemberus-gaap:OperatingSegmentsMemberivc:RespiratoryTherapyDomain2019-07-012019-09-300000742112srt:AsiaPacificMemberus-gaap:OperatingSegmentsMemberivc:RespiratoryTherapyDomain2020-01-012020-09-300000742112srt:AsiaPacificMemberus-gaap:OperatingSegmentsMemberivc:RespiratoryTherapyDomain2019-01-012019-09-300000742112srt:AsiaPacificMemberus-gaap:OperatingSegmentsMemberivc:OtherDomain2020-07-012020-09-300000742112srt:AsiaPacificMemberus-gaap:OperatingSegmentsMemberivc:OtherDomain2019-07-012019-09-300000742112srt:AsiaPacificMemberus-gaap:OperatingSegmentsMemberivc:OtherDomain2020-01-012020-09-300000742112srt:AsiaPacificMemberus-gaap:OperatingSegmentsMemberivc:OtherDomain2019-01-012019-09-300000742112srt:AsiaPacificMemberus-gaap:OperatingSegmentsMember2020-07-012020-09-300000742112srt:AsiaPacificMemberus-gaap:OperatingSegmentsMember2019-07-012019-09-300000742112srt:AsiaPacificMemberus-gaap:OperatingSegmentsMember2020-01-012020-09-300000742112srt:AsiaPacificMemberus-gaap:OperatingSegmentsMember2019-01-012019-09-30

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q
[☒] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended September 30, 2020
OR
[☐] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from            to           
Commission File Number 001-15103
INVACARE CORPORATION
(Exact name of registrant as specified in its charter)
ivc-20200930_g1.jpg 
Ohio95-2680965
(State or other jurisdiction of
incorporation or organization)		(IRS Employer Identification No.)
One Invacare Way,Elyria,Ohio44035
(Address of principal executive offices)(Zip Code)
(440) 329-6000
(Registrant's telephone number, including area code)
(Former name, former address and former fiscal year, if changed since last report)
Securities registered pursuant to Section 12(b) of the Exchange Act:
Title of each classTrading SymbolName of exchange on which registered
Common Shares, without par valueIVCNew York Stock Exchange
Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15 (d) of the Securities Exchange Act of 1934 (the “Exchange Act”) during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes ☒  No ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).  Yes ☒ No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “small reporting company” in Rule 12b-2 of the Exchange Act. (Check One):    Large accelerated filer ☐    Accelerated filer ☒  Non-accelerated filer  ☐ Smaller reporting company ☐ Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes ☐  No  ☒
As of October 27, 2020, the registrant had 34,411,688 Common Shares and 6,357 Class B Common Shares outstanding.


ivc-20200930_g1.jpg

Table of Contents
 
 ItemPage
PART I: FINANCIAL INFORMATION
2
1
3
4
PART II: OTHER INFORMATION
1
1A
2
5
6

About Invacare Corporation

Invacare Corporation (NYSE: IVC) ("Invacare" or the "company") is a leading manufacturer and distributor in its markets for medical equipment used in non-acute care settings. At its core, the company designs, manufactures and distributes medical devices that help people to move, breathe, rest and perform essential hygiene. The company provides clinically complex medical device solutions for congenital (e.g., cerebral palsy, muscular dystrophy, spina bifida), acquired (e.g., stroke, spinal cord injury, traumatic brain injury, post-acute recovery, pressure ulcers) and degenerative (e.g., ALS, multiple sclerosis, chronic obstructive pulmonary disease (COPD), age related, bariatric) conditions. The company's products are important parts of care for people with a wide range of challenges, from those who are active and heading to work or school each day and may need additional mobility or respiratory support, to those who are cared for in residential care settings, at home and in rehabilitation centers. The company sells its products principally to home medical equipment providers with retail and e-commerce channels, residential care operators, dealers and government health services in North America, Europe and Asia Pacific. For more information about the company and its products, visit the company's website at www.invacare.com. The contents of the company's website are not part of this Quarterly Report on Form 10-Q and are not incorporated by reference herein.



MD&AOverview

Item 2.    Management's Discussion and Analysis of Financial Condition and Results of Operations.

The discussion and analysis presented below is concerned with material changes in financial condition and results of operations between the periods specified in the condensed consolidated balance sheets at September 30, 2020 and December 31, 2019, and in the condensed consolidated statement of comprehensive income (loss) for the three and nine months ended September 30, 2020 and September 30, 2019. All comparisons


presented are with respect to the same period last year, unless otherwise stated. This discussion and analysis should be read in conjunction with the condensed consolidated financial statements and accompanying notes that appear elsewhere in this Quarterly Report on Form 10-Q and the MD&A included in the company's Annual Report on Form 10-K for the year ended December 31, 2019. For some matters, SEC filings from prior periods may be useful sources of information.
OVERVIEW

OVERVIEW
Invacare is a multi-national company with integrated capabilities to design, manufacture and distribute durable medical devices. The company makes products that help people move, breathe, rest and perform essential hygiene, and with those products the company supports people with congenital, acquired and degenerative conditions. The company's products and solutions are important parts of care for people with a range of challenges, from those who are active and involved in work or school each day and may need additional mobility or respiratory support, to those who are cared for in residential care settings, at home and in rehabilitation centers. The company operates in facilities in North America, Europe and Asia Pacific, which are the result of dozens of acquisitions made over the company's forty-year history. Some of these acquisitions have been combined into integrated operating units, while others have remained relatively independent.
COVID-19 Impact
The company continues to actively monitor the impact of the coronavirus (COVID-19), which negatively impacted the company’s business in the second and third quarters with regard to reduced net sales on a global basis year-over-year primarily related to mobility and seating products. In addition, we experienced a decrease in the year-to-date operating profit of the European segment as a result of a significant decline in net sales related to the pandemic. The company achieved sequential net sales growth in the third quarter of 2020, primarily driven by the European segment, with the loosening of public health restrictions and resumption of access to clinics and elective care facilities for its products. In addition, the company also anticipates sequential net sales growth in the fourth quarter of 2020. However, these anticipated net sales levels will remain at lower levels than the same periods in 2019. The extent to which the company’s operations will be impacted by the pandemic will depend largely on future
developments, which remain highly uncertain and difficult to accurately predict, including, among other things new information which may emerge concerning the severity of the pandemic and actions by government authorities to contain COVID-19 or treat its impact, such as reimposed public health restrictions or restrictions on access to healthcare facilities.
As an “essential” business making medical devices, the company has continued to operate in all of its facilities, having taken the recommended public health measures to ensure worker and workplace safety. The company continues to experience high demand globally for its respiratory products. These products are being deployed in the fight against the COVID-19 pandemic in expanded medical facilities to relieve the strain on hospital systems by providing more medical beds and access to purified oxygen needed in respiratory care. The company continues to work to increase its capacity to produce these critical products and resolve global supply chain challenges that are compounded by the effects of the pandemic. As a result, there are practical limits to the extent the company can increase output. In addition, the company continues to take steps to offset cost increases from pandemic-related supply chain disruptions.
The initial stages of the pandemic appropriately focused the provision of healthcare to urgent non-elective care, reducing access to clinicians and healthcare facilities on which other parts of the company’s business rely to engage with customers for product trials and fittings. As a result, and combined with various stay-at-home orders, the company experienced a global decline in quotes for mobility and seating products, and a resultant decline in orders primarily in the second quarter of 2020. In the third quarter of 2020, quotes and orders for mobility and seating products improved sequentially in the major markets the company serves. We expect that the higher quote volume received in the third quarter of 2020 will be converted to sales during the fourth quarter of 2020 and first quarter of 2021. While we believe the decline in demand for mobility and seating product is
1
MD&AOverview
temporary in nature, the rebound of the business will depend on the continued restoration of access to healthcare and loosening of public health measures, and will be impacted by several items including government actions and policies related to the pandemic, and the magnitude of the pandemic.
The company continues to optimize its balance sheet for the current environment. In the third quarter of 2020, the company repurchased $24,466,000 aggregate principal amount of its 2021 Notes. Earlier in the year, the company entered into separate privately negotiated agreements with certain holders to exchange an aggregate of $73,875,000 of its 2021 and 2022 Notes into new 5% Series II Convertible Senior Exchange Notes (the "2024 Series II Notes") of the company. This transaction enhanced our financial flexibility in reducing short-term debt by extending a significant portion of our near-term convertible debt to November 2024. These actions, as well as other actions completed in the first half of 2020, for example completing the divestiture of Dynamic Controls and obtaining an unsecured loan under the Coronavirus Aid, Relief, and Economic Security ("CARES") Act, borrowing availability under the ABL revolver, and the anticipated generation of Adjusted EBITDA and free cash flow, should provide the company sufficient liquidity to manage the business and meet its obligations.
Strategy
The company had a strategy to be a leading provider of durable medical equipment to health care providers in global markets by providing the broadest portfolio available. This strategy has not kept pace with certain reimbursement changes, competitive dynamics and company-specific challenges. Since 2015, the company has made a major shift in its strategy. The company has since been aligning its resources to produce products and solutions that assist customers and end-users with their most clinically complex needs. By focusing the company's efforts to provide the best possible assistance and outcomes to the people and caregivers who use its products, the company aims to improve its financial condition for sustainable profit and growth. To execute this transformation, the company is undertaking a substantial multi-year transformation plan.
Transformation
The company is executing a multi-year transformation to return the company to profitability by focusing its resources on products and solutions that provide greater healthcare value in clinically complex rehabilitation and post-acute care. The company's transformation and growth plan balances innovative organic growth, product portfolio changes across all regions, and cost improvements in supply chain and administrative functions. Key elements of the enhanced transformation and growth plan are:
•Globally, continue to drive all business segments and product lines based on their potential to achieve a leading market position and to support profitability goals;
•In Europe, leverage centralized innovation and supply chain capabilities while reducing the cost and complexity of a legacy infrastructure;
•In North America, adjust the portfolio to consistently grow profitability amid cost increases by adding new products, reducing costs and continuing to improve customers' experience;
•In Asia Pacific, remain focused on sustainable growth and expansion in the southeast Asia region; and
•Take actions globally to reduce working capital and improve free cash flow.
As it navigates the uncertain business environment resulting from COVID-19, the company continues to allocate more resources to the business units experiencing increased demand and expects to continue taking actions to mitigate the potential negative financial and operational impacts on other parts of the company's business that have declined. In the medium-term, the company still expects to execute on its transformation, such as the previously announced German plant consolidation and the global IT modernization initiative.
Favorable Long-Term Demand
Ultimately, demand for the company's products and services is based on the need to provide care for people with certain conditions. The company's medical devices provide solutions for end-users and caregivers. Therefore, the demand for the company's medical equipment is largely driven by population growth and the incidence of certain conditions where treatment may be supplemented by the company's devices. The company also provides solutions to help equipment providers and residential care operators deliver cost-effective and high-quality care. The company believes that its commercial team, customer relationships, products and solutions, supply chain infrastructure, and strong research and development pipeline will create sustainable and favorable business potential.
2
MD&ANet Sales
RESULTS OF OPERATIONS - NET SALES

The company operates in two primary business segments: North America and Europe with each selling the company's primary product categories, which include: lifestyle, mobility and seating and respiratory therapy products. Sales in Asia Pacific are reported in All Other and include products similar to those sold in North America and Europe.
($ in thousands USD)3Q20*3Q19% Change
Fav/(Unfav)		Foreign Exchange % ImpactDivestiture % ImpactConstant Currency % Change
Fav/(Unfav)
Europe116,285 137,371 (15.3)2.2 — (17.5)
North America88,055 87,118 1.1 (0.1)— 1.2 
All Other (Asia Pacific)7,566 11,285 (33.0)3.2 (33.1)(3.1)
Consolidated211,906 235,774 (10.1)1.5 (1.6)(10.0)
($ in thousands USD)YTD 3Q20**YTD 3Q19Reported % ChangeForeign Exchange % ImpactDivestiture % ImpactConstant Currency % Change
Fav/(Unfav)
Europe339,147 396,206 (14.4)(1.1)— (13.3)
North America261,595 262,915 (0.5)(0.2)— (0.3)
All Other (Asia Pacific)25,904 35,930 (27.9)(3.5)(26.9)2.5 
Consolidated626,646 695,051 (9.8)(0.7)(1.4)(7.7)
* Date format is quarter and year in each instance.
** YTD means the first nine months of the year in each instance.
The table above provides net sales change as reported and as adjusted to exclude the impact of foreign exchange translation and divestitures (constant currency net sales). “Constant currency net sales" is a non-Generally Accepted Accounting Principles ("GAAP") financial measure, which is defined as net sales excluding the impact of foreign currency translation and divestitures. The current year's functional currency net sales are translated using the prior year's foreign exchange rates. These amounts are then compared to the prior year's sales to calculate the constant currency net sales change. For the divestiture impact, the company adjusted a portion of net sales as the Dynamic Controls business was divested as of March 7, 2020.
"Constant currency sequential net sales," as shown on the next page, is a non-GAAP financial measure in which a given quarter's net sales are compared to the most recent quarter's net sales with each quarter's net sales translated at the foreign exchange rates for the most recent prior quarter. These amounts are then compared to the prior quarter's sales to calculate the constant currency sequential net sales change. Management believes that both financial measures provide meaningful information for evaluating the core operating performance of the company.
Europe - Constant currency net sales decreased $24,030,000, or 17.5% in 3Q20 compared to 3Q19 as sales continued to be significantly impacted by the pandemic and with public health restrictions in certain countries continuing
to limit access to healthcare professionals and institutions needed for certain product selections. These measures lowered sales for mobility and seating products and were partially offset by growth in bed systems and respiratory products. The countries which the company has a significant portion of the operations are France, Germany, UK and the Nordic countries. Constant currency net sales decreased 13.3% YTD 3Q20 compared to YTD 3Q19 primarily due to the impact of the pandemic.
North America - Constant currency net sales for 3Q20 increased $1,009,000 or 1.2% compared to 3Q19 driven by respiratory products partially offset with declines in sales of mobility and seating and non-bed lifestyle products. Demand for mobility and seating and non-bed lifestyle products continued to be impacted by the pandemic, with public restrictions limiting access to healthcare professionals and institutions to provide certain products. In addition, both power and manual wheelchair net sales declined given lower levels of quotes for these products in the early part of 2Q20, which would normally convert to sales in 3Q20. Due to higher quote levels in 3Q20, sales of mobility and seating products are expected to recover somewhat in 4Q20. Constant currency net sales decreased YTD 3Q20 or 0.3% compared to YTD 3Q19 with mobility and seating and lifestyle products sales decreases largely offset by an increase in respiratory product sales.
3
MD&ANet Sales
All Other - Constant currency net sales, which relate entirely to the Asia Pacific region, decreased $233,000 or 3.1% for 3Q20 compared to 3Q19 driven by declines in mobility and seating products and service revenue partially offset by growth in lifestyle products. Constant currency net sales increased 2.5% YTD 3Q20 compared to YTD 3Q19 primarily driven by increased sales in lifestyle products, primarily mattress products.






($ in thousands USD)3Q20 at Reported Foreign Exchange RatesForeign Exchange Translation Impact3Q20 at 2Q20 Foreign Exchange Rates2Q20 at Reported Foreign Exchange RatesSequential Growth $Sequential Growth %
Europe116,285 (6,276)110,009 101,894 8,115 8.0 
North America88,055 (342)87,713 86,569 1,144 1.3 
All Other (Asia Pacific)7,566 (534)7,032 7,837 (805)(10.3)
Consolidated211,906 (7,152)204,754 196,300 8,454 4.3 %

The above table provides net sales at foreign currency exchange rates for the quarters ended September 30 and June 30, 2020, respectively, and net sales for the quarter ended September 30, 2020 translated at the foreign exchange rates for the quarter ended June 30, 2020 with each then compared to each other (constant currency sequential net sales).
Constant currency sequential net sales grew by 4.3% driven primarily by mobility and seating product sales in Europe due to increased access to healthcare professionals and institutions in certain countries.

Europe - Constant currency sequential net sales increased 8.0% driven by a 30.4% increase in mobility and seating products partially offset by lower sales of in lifestyle products, primarily bed and bed-related products, with respiratory product sales flat.

North America - Constant currency sequential net sales increased 1.3% primarily driven by growth in non-bed lifestyle products.

All Other - Constant currency sequential net sales declined 10.3% primarily due to lifestyle products.





















4
MD&ANet Sales
ivc-20200930_g2.jpg
Constant currency net sales of mobility and seating products, which comprise most of the company's clinically complex product portfolio, decreased to 40.2% of net sales in 3Q20 from 44.5% in 3Q19 and decreased to 38.9% YTD 3Q20 from 42.2% YTD 3Q19.

This decrease reflects the significant impacts of the pandemic limiting the access to healthcare professionals and institutions needed for certain product selections, specifically for mobility and seating product and non-bed related lifestyle products as well as higher pandemic related respiratory and bed and mattress products during 3Q20.
5
MD&AGross Profit

GROSS PROFIT
ivc-20200930_g3.jpg
Gross profit as a percentage of net sales for 3Q20 decreased 40 basis points to 28.3%, primarily attributable to unfavorable manufacturing variances as a result of reduced net sales primarily in Europe partially offset by favorable sales mix including pricing and favorable foreign exchange.

ivc-20200930_g4.jpg
Gross profit as a percentage of net sales for YTD 3Q20 increased 80 basis points to 28.7%, attributable to the company's continuous improvement initiatives driving material and freight cost savings, favorable product mix, including pricing and reduced R&D expense partially offset by unfavorable manufacturing variances and foreign exchange.







Gross profit drivers by segment:
Europe - Gross profit as a percentage of net sales for 3Q20 decreased 2.3 percentage points and $8,103,000, compared to 3Q19 driven by lower sales, unfavorable manufacturing variances and sales mix partially offset by favorable foreign exchange.
Gross profit as a percentage of net sales for YTD 3Q20 decreased 0.7 of a percentage point or a decrease of $17,434,000, compared to YTD 3Q19. The decrease in gross profit dollars was driven by lower sales, unfavorable manufacturing variances and foreign exchange.
North America - Gross profit as a percentage of net sales for 3Q20 increased 1.7 percentage points or $2,634,000, compared to 3Q19 driven by favorable sales mix including pricing, lower material and freight costs partially offset by unfavorable manufacturing variances and warranty costs.
Gross profit as a percentage of net sales for YTD 3Q20 increased 1.9 percentage points, or $6,783,000, compared to YTD 3Q19. The increase in gross profit dollars was driven by favorable sales mix including pricing, lower material, freight costs partially offset by increased warranty costs.
All Other - Gross profit as a percentage of net sales for Asia Pacific increased 6.2 percentage points while gross profit dollars declined $1,227,000 primarily driven by reduced sales and divestiture of the Dynamic Controls business as of March 7, 2020.
Gross profit as a percentage of net sales for Asia Pacific for YTD 3Q20 increased 5.9 percentage points while gross profit dollars declined $2,459,000 primarily attributable to the Dynamic Controls divestiture.
All Other also includes the impact of intercompany profit eliminations for the consolidated company of increased expense of $849,000 for 3Q20 as compared to 3Q19; and $1,318,000 for YTD 3Q20 as compared to YTD 3Q19. This is the result of increased inventory levels.
6
MD&AGross Profit


ivc-20200930_g5.jpg
Gross profit as a percentage of net sales for 3Q20 decreased 60 basis points to 28.3%, attributable to unfavorable sales mix with a return to a more normal product acuity mix, unfavorable manufacturing variances partially offset by reduced material and R&D costs. Gross profit dollars increased primarily in the European segment as a result of sequential net sales growth primarily in mobility and seating products as public health restrictions eased.
7
SELLING, GENERAL AND ADMINISTRATIVE EXPENSES
($ in thousands USD)3Q203Q19Reported ChangeForeign Exchange ImpactDivestiture % ImpactConstant Currency Change
SG&A expenses - $55,530 63,539 (8,009)(814)1,020 (7,803)
SG&A expenses - % change(12.6)1.5 (1.6)(12.5)
% to net sales26.2 26.9 
($ in thousands USD)YTD 3Q20YTD 3Q19Reported ChangeForeign Exchange ImpactDivestiture % ImpactConstant Currency Change
SG&A expenses - $174,672 197,035 (22,363)364 2,446 (19,553)
SG&A expenses - % change(11.3)(0.1)(1.2)(10.0)
% to net sales27.9 28.3 
SG&A expenses excluding the impact of foreign currency translation and divestitures, which is referred to as "constant currency SG&A," decreased for 3Q20 and YTD 3Q20 compared to the same periods last year primarily due to reduced employment costs and favorable foreign currency transactions.

The divestiture impact is related to a portion of the SG&A expenses related to the Dynamic Controls business divested as of March 7, 2020.

In general, SG&A expense for 3Q20 was impacted by the pandemic and includes the benefit of programs offered by European countries related to furloughs and reduced workhours as well as a continued general reduction in discretionary spending.

SG&A expense drivers by segment:

Europe - SG&A expenses for 3Q20 decreased $4,338,000 or 14.8% compared to 3Q19 with foreign currency translation increasing SG&A expenses by $819,000, or 2.8%. Constant currency SG&A expenses decreased $5,157,000, or 17.6%. The decreased expense was primarily attributable to lower employment costs. Employment costs and favorable currency transactions.

SG&A expense for YTD 3Q20 decreased $11,440,000 or 12.5% compared to YTD 3Q19 with foreign currency translation decreasing SG&A expenses by $236,000, or 0.3%. Constant currency SG&A expenses decreased $11,204,000, or 12.2%. The decreased expense was primarily attributable to lower employment costs, favorable foreign currency transactions and lower sales and marketing spending.

North America - SG&A expenses for 3Q20 decreased $2,052,000 or 8.5%, compared to 3Q19 with foreign currency translation decreasing SG&A expenses by $69,000. Constant
currency SG&A expenses decreased $1,983,000, or 8.2% driven primarily by employment, sales and marketing and product liability costs.

SG&A expenses for YTD 3Q20 decreased $6,291,000 or 8.4%, compared to YTD 3Q19 with foreign currency translation decreasing SG&A expenses by $111,000. Constant currency SG&A expenses decreased $6,180,000, or 8.2% driven primarily by employment and consulting costs.

All Other - SG&A expenses for 3Q20 decreased by $1,619,000 compared to 3Q19 with foreign currency translation increasing SG&A expenses by $64,000 and divestitures decreasing SG&A expenses by $1,020,000. Constant currency SG&A expenses increased by $663,000. All Other includes SG&A related to the Asia Pacific businesses and non-allocated corporate costs. SG&A expenses related to non-allocated corporate costs for 3Q20 decreased 9.6%, or $645,000, compared to 3Q19 driven primarily by decreased consulting and employment costs partially offset by unfavorable foreign currency transactions. Related to the Asia Pacific businesses, constant currency SG&A expenses decreased $18,000, or 0.8%, due to reduced employment costs.

SG&A expense for YTD 3Q20 decreased by $4,632,000 compared to YTD 3Q19 with foreign currency translation decreasing SG&A expenses by $17,000 and divestitures decreasing SG&A expense by $2,446,000. Constant currency SG&A expenses decreased by $2,169,000. SG&A expenses related to non-allocated corporate costs for YTD 3Q20 increased 1.8%, or $350,000, compared to YTD 3Q19 driven primarily by increased equity compensation expense. Related to the Asia Pacific businesses constant currency SG&A expenses decreased $2,519,000, or 30.4%, due to reduced employment costs and foreign currency transactions.

8
($ in thousands USD)3Q202Q20Reported ChangeForeign Exchange ImpactConstant Currency Change
SG&A expenses - $55,530 57,404 (1,874)(1,560)(3,434)
SG&A expenses - % change(3.3)(2.7)(6.0)
% to net sales26.2 29.2 

The above table provides SG&A expenses at reported foreign currency exchange rates for the quarters ended September 30, and June 30, 2020, respectively, and SG&A expenses excluding foreign currency impact for the quarter ended September 30, 2020 by applying foreign exchange rates for the quarter ended June 30, 2020 (constant currency sequential SG&A expenses).
Constant currency sequential SG&A expenses decreased for 3Q20 compared to 2Q20 primarily due to reduced employment costs, including stock compensation expense, and favorable foreign currency transactions.

In general, SG&A expense for 3Q20 includes the benefits offered by European countries related to furloughs and reduced work hours as well as a continued general reduction in discretionary spending, however at a reduced level from 2Q20.
9
MD&AOperating Income (Loss)
OPERATING INCOME (LOSS)
($ in thousands USD)3Q203Q19$ Change% ChangeYTD 3Q20YTD 3Q19$
Change		% Change
Europe7,600 11,365 (3,765)(33.1)16,624 22,617 (5,993)(26.5)
North America2,992 (1,694)4,686 276.6 5,759 (7,316)13,075 178.7 
All Other(6,082)(5,625)(457)(8.1)(17,377)(18,230)853 4.7 
Gain on sale of business— — — — 9,790 — 9,790 — 
Charges related to restructuring(1,580)(1,628)48 2.9 (4,657)(3,641)(1,016)(27.9)
Consolidated Operating Income (Loss)2,930 2,418 512 (21.2)10,139 (6,570)16,709 254.3 

For 3Q20, consolidated operating income improved due to reduced SG&A expenses offsetting unfavorable gross profit on reduced net sales impacted by the pandemic. For YTD 3Q20, consolidated operating profitability improved significantly due to a $9,790,000 gain from the divestiture of Dynamic Controls as well as reduced SG&A expenses offsetting lower gross profit on net sales declines impacted by the pandemic.

Operating income (loss) by segment:
Europe - Operating income for 3Q20 declined by $3,765,000, or 33.1%, due to a $8,103,000 decrease in gross profit from 15.3% lower net sales offset by favorable foreign exchange translation and reduced SG&A expenses. Operating income for YTD 3Q20 decreased $5,993,000 compared to YTD 3Q19 due to lower net sales and unfavorable foreign exchange partially offset by reduced SG&A expenses.

North America - Operating income for 3Q20 improved by $4,686,000 primarily due to improved gross profit due to lower material and freight costs as well as improved product mix and pricing and reduced SG&A expenses. Operating income for YTD 3Q20 increased $13,075,000 compared to YTD 3Q19 driven primarily by margin improvements and reduced SG&A expenses.















All Other - Operating loss for All Other includes the operating income of the Asia Pacific businesses, offset by unallocated SG&A expenses and intercompany eliminations. Operating loss increased $457,000 primarily driven by divestiture of Dynamic Controls. Operating loss for YTD 3Q20 improved $853,000 compared to YTD 3Q19 primarily due to improved operating profit in the Asia Pacific business partially offset by increased equity compensation expense and the divestiture of Dynamic Controls.

Charges Related to Restructuring Activities
Restructuring charges totaled $4,657,000 for YTD 3Q20 principally related to severance costs. Restructuring charges were incurred in the Europe segment of $3,674,000, North America segment of $865,000, and All Other of $118,000.

Restructuring charges totaled $3,641,000 for YTD 3Q19 principally related to severance costs. Restructuring charges were incurred in the Europe segment of $1,903,000, North America segment of $1,539,000, and All Other of $199,000.

10
MD&AOperating Income (Loss)

($ in thousands USD)3Q202Q20$ Change% Change
Europe7,600 2,174 5,426 249.6 
North America2,992 4,812 (1,820)37.8 
All Other(6,082)(7,740)1,658 21.4 
Gain on sale of business— 200 (200)(100.0)
Charges related to restructuring(1,580)(1,685)105 6.2 
Consolidated Operating Income (Loss)2,930 (2,239)5,169 230.9 

Operating income improved sequentially driven by net sales growth and reduced SG&A expenses.

Operating income (loss) by segment:
Europe - Operating income for 3Q20 increased by $5,426,000, or 249.6%, primarily due to increased gross profit driven by increased net sales including favorable product mix due to higher sales of mobility and seating products and favorable foreign exchange partially offset by unfavorable manufacturing variances.
North America - Operating income for 3Q20 decreased by $1,820,000 primarily due to lower gross margin driven by a return to more normal acuity product mix as well as reduced bed and bed-related net sales which were higher in 2Q20 as a result of the pandemic.
All Other - Operating loss for All Other includes the operating income of the Asia Pacific businesses, offset by unallocated SG&A expenses and intercompany eliminations. Operating loss improved $1,658,000 primarily driven by reduced SG&A expense, primarily stock compensation expense, and lower gross margin in the Asia Pacific business as a result of lower sequential net sales.

11
MD&AOther Items
OTHER ITEMS

Net Gain (Loss) on Convertible Debt Derivatives
($ in thousands USD)Change in Fair Value Gain (Loss)
3Q19YTD 3Q19
Convertible Note Hedge Assets— 9,600 
Convertible Debt Conversion Liabilities— (8,403)
Net Gain on Convertible Debt Derivatives— 1,197 
The company recognized a net gain of $0 and $1,197,000 in 3Q19 and YTD 3Q19, respectively related to the fair value of convertible debt derivatives. As a result of the company’s receipt of shareholder approval authorizing the company to elect to settle future conversions of its convertible notes in common shares, 2Q19 was the last quarter for which the company recognized any gain or loss on the fair value of its note hedge assets and convertible debt conversion liabilities.
Loss on debt extinguishment including debt finance changes and fees
($ in thousands USD)3Q203Q19
Loss on debt extinguishment including debt finance fees761 280 

During the third quarter of 2020, the company repurchased and retired $24,466,000 its 2021 Notes. The result of the transaction was a loss on debt extinguishment including debt and finance fees of $761,000.
($ in thousands USD)YTD 3Q20YTD 3Q19
Loss on debt extinguishment including debt finance fees7,360 280 
During the second quarter of 2020, the company entered into separate, privately negotiated agreements with certain holders of its 2021 Notes and certain holders of its 2022 Notes to exchange $35,375,000 in aggregate principal amount of 2021 Notes and $38,500,000 in aggregate principal amount of 2022 Notes, for aggregate consideration of $73,875,000 in aggregate principal amount of new Series II 2024 Notes of the company and $5,593,000 in cash.

The 2Q20 and 3Q20 transactions resulted in a YTD 3Q20 loss on debt extinguishment including debt and finance fees of $7,360,000.




Interest
($ in thousands USD)3Q203Q19$ Change% Change
Interest expense7,402 6,992 410 5.9 
Interest income(7)(113)106 (93.8)
($ in thousands USD)YTD 3Q20YTD 3Q19$ Change% Change
Interest expense21,132 22,027 (895)(4.1)
Interest income(90)(361)271 (75.1)
The increase in interest expense for 3Q20 compared to the same period of prior year was primarily related to the addition of financing leases.

The decrease in interest expense for YTD 3Q20 compared to the same period last year was primarily related to the repurchase and retirement of $16,000,000 in principal amount of 2021 Notes in 3Q19.

Income Taxes
The company had an effective tax rate of 39.2% and 26.8% on losses before tax for the three and nine months ended September 30, 2020, respectively, compared to an expected benefit of 21.0% on pre-tax loss for each period. The company had an effective tax rate of 69.6% and 26.8% on losses before tax for the three and nine months ended and September 30, 2019, respectively, compared to an expected benefit for the three and nine months ended September 30, 2019 of 21.0% on the pre-tax loss for each period. The company's effective tax rate for the three and nine months ended September 30, 2020 and September 30, 2019 were unfavorable as compared to the U.S. federal statutory rate expected benefit, principally due to the negative impact of the company not being able to record tax benefits related to the significant losses in countries which had tax valuation allowances. The effective tax rate was increased for the three and nine months ended September 30, 2020 and September 30, 2019 by certain taxes outside the United States, excluding countries with tax valuation allowances, that were at an effective rate higher than the U.S. statutory rate, except for the gain on the disposition of Dynamic Controls which was not taxable locally. In addition, the company had accrued withholding taxes on earnings of its Chinese subsidiary based on the expectation of not permanently reinvesting those earnings. The sale of this entity, without such distribution resulted in the reversal of this accrual in the amount of $988,000 for the nine months ended September 30, 2020.

12
MD&AOther Items
As a result of the COVID-19 pandemic and the global impact on business activity, various governments have provided programs to help offset the liquidity pressures and impact on society. The company has taken advantage of some of these programs and will continue to consider other programs as they are announced. To date, the company has determined it will benefit by: 1) deferral of U.S. payroll tax related to employer portion of social security through 2020, to be paid over 2 years, 2) a U.S. business interest limitation increase from 30% to 50% of after-tax income 3) the treatment of qualified improvement property as 15-year property in the U.S., 4) and the deferral of income and indirect tax payments over various periods in other countries around the world where the company operates. Such programs have resulted in tax deferrals totaling approximately $10,100,000 through September 30, 2020 as a benefit to cash flows for the period.



13
MD&ALiquidity and Capital Resources
LIQUIDITY AND CAPITAL RESOURCES

The company continues to maintain an adequate liquidity position through its cash balances and bank lines of credit (see Long-Term Debt in the Notes to Condensed Consolidated Financial Statements included in this report). Key balances on the company's balance sheet and related metrics:
($ in thousands USD)September 30, 2020December 31, 2019$ Change% Change
Cash and cash equivalents86,825 80,063 6,762 8.4 
Working capital (1)
145,850 137,220 8,630 6.3 
Total debt (2)
340,241 283,256 56,985 20.1 
Long-term debt (2)
332,827 280,684 52,143 18.6 
Total shareholders' equity330,489 308,516 21,973 7.1 
Credit agreement gross borrowing availability (3)
32,264 34,516 (2,252)(6.5)
(1)    Current assets less current liabilities.
(2)    Total debt and Long-term debt at gross carrying amounts which excludes debt issuance costs and debt discounts classified as debt and includes long-term and total obligations for financing leases.
(3)    Reflects the combined availability of the company's North American and European asset-based revolving credit facilities as of September 30, 2020. The change in borrowing availability is due to changes in the calculated borrowing base, primarily due to lower accounts receivable balances as a result of reduced net sales impacted by the pandemic. At September 30, 2020, the company had drawn $23,700,000 on the North American credit facility and $8,460,000 on the European credit facility. Outstanding borrowings are based on credit availability calculated on a month lag related to the European credit facility.
The company's cash and cash equivalents balances were $86,825,000 and $80,063,000 at September 30, 2020 and December 31, 2019, respectively. The increase in cash in the first nine months of 2020 is attributable to borrowing of $32,160,000 on the North America and Europe credit facilities under the company's credit agreement which provides for an asset-based-lending senior secured revolving credit facility; the proceeds of $14,563,000 from the sale of Dynamic Controls in March 2020; and an unsecured loan of $10,000,000 pursuant to sections 1102 and 1106 of the Coronavirus Aid, Relief, and Economic Security ("CARES") Act in May 2020. This increase in cash was primarily offset by cash used for continued investment in our transformation strategy and debt related payments.

In the third quarter of 2020, the company repurchased $24,466,000 aggregate principal amount of its 2021 Notes, resulting in a $761,000 loss on debt extinguishment.

In the second quarter of 2020, the company entered into separate privately negotiated agreements with certain holders of its 2021 and 2022 Notes to exchange $35,375,000 in aggregate principal amount of the company's 2021 Notes and $38,500,000 in aggregate principal amount of the company's 2022 Notes, for $73,875,000 in aggregate principal amount of new 2024 Series II Notes approximately $5,593,000 in cash. Debt issuance costs of $1,518,000 were capitalized. These debt issuance costs are being amortized as interest expense through November 2024 of which $1,368,000 have yet to be amortized as of September 30, 2020. The fees paid in the second quarter totaled $1,307,000.

See "Long-Term Debt" in the Notes to the Condensed Consolidated Financial statements included in this report for a summary of the material terms of the Company's long-term indebtedness.

Debt repayments, acquisitions, divestitures, the timing of vendor payments, the timing of customer rebate payments, the granting of extended payment terms to significant national accounts and other activity can have a significant impact on the company's cash flow and borrowings outstanding such that the cash reported at the end of a given period may be materially different than cash levels during a given period. While the company has cash balances in various jurisdictions around the world, there are no material restrictions regarding the use of such cash for dividends within the company, loans or other purposes.

The company's total debt outstanding, inclusive of the company's Convertible Senior Notes due 2021, 2022 and 2024 and financing lease obligations, increased by $56,985,000 to $340,241,000 at September 30, 2020 from $283,256,000 as of December 31, 2019. The increase is primarily driven by borrowing on the company's credit agreement of $32,160,000, new financing leases in the third quarter of 2020 and $10,000,000 of loan proceeds obtained pursuant to the CARES Act. The CARES Act funds may be forgivable partially or in full, if certain conditions are met. While the company believes it has utilized the funds for forgivable eligible expenditures under the program, there is no certainty at this time that the loan will be forgiven. The company may from time to time seek to retire or purchase its convertible
14
MD&ALiquidity and Capital Resources
senior notes, in open market purchases, privately negotiated transactions or otherwise. Such purchases, if any, will depend on prevailing market conditions, the company’s liquidity requirements, contractual restrictions and other factors. The amounts involved in any such transactions, individually or in the aggregate, may be material.

In addition during the second quarter of 2020, the company accessed government programs to bolster short-term liquidity including the temporary delay of direct and indirect tax payments, with repayment beginning later in the year and into 2021 and 2022. Such programs have deferred approximately $10,100,000 of payments through the third quarter of 2020.

See "Long-Term Debt" and "Leases and Commitments" in the Notes to Condensed Consolidated Financial Statements for more details regarding the company's convertible notes and credit facilities and lease liabilities, respectively.

The company is actively managing its business to maintain cash flow and liquidity. As discussed elsewhere in this report, the company has taken several defensive measures to enhance liquidity in response to the COVID-19 pandemic, including reducing expenses, managing capital expenditure, suspending its cash dividend, borrowing substantially all of the amounts available under its credit facilities, obtaining a loan pursuant to the CARES Act and accessing other government programs in the US and Europe. Based on the company's current expectations, the company believes that its cash flow from operations, cash and cash equivalent balances, and available borrowing capacity under its credit facilities should be sufficient to meet working capital needs, capital requirements, and commitments for at least the next twelve months. Notwithstanding the company's expectations, if the company's operating results decrease as the result of pressures on the business due to, for example, the impact of COVID-19, currency fluctuations or regulatory issues or the company's failure to execute its business plans or if the company's transformation takes longer than expected, the company may require additional financing, or may be unable to comply with its obligations under the credit facilities, and its lenders could demand repayment of any amounts outstanding under the company's credit facilities. As the company cannot predict the duration or scope of the COVID-19 pandemic and its impact on the company’s customers and suppliers, the negative financial impact to the company’s results cannot be reasonably estimated, but could be material.

The company also has an agreement with De Lage Landen, Inc. (“DLL”), a third-party financing company, to provide lease financing to the company's U.S. customers. Either party could terminate this agreement with 180 days notice or 90 days notice by DLL upon the occurrence of certain events. Should this agreement be terminated, the
company's borrowing needs under its credit facilities could increase.

While most of the company's debt has fixed interest, should interest rates increase, the company expects that it would be able to absorb modest rate increases without any material impact on its liquidity or capital resources. The weighted average interest rate on revolving credit borrowings, excluding capital leases, was 4.62% and 4.63%, respectively, for the three and nine months ended September 30, 2020 and 4.78% for the year ended December 31, 2019. See "Long-Term Debt" in the Notes to the Condensed Consolidated Financial Statements for more details regarding the company's credit facilities.


CAPITAL EXPENDITURES

The company estimates that capital investments for 2020 could be approximately $23,000,000 compared to actual capital expenditures of $10,874,000 in 2019. The anticipated increase relates primarily to the company's investments to transform the company, including investments related to the ERP project and new products. The company believes that its balances of cash and cash equivalents and existing borrowing facilities will be sufficient to meet its operating cash requirements and fund capital expenditures (see "Liquidity and Capital Resources"). However, because the company cannot predict the duration or scope of the COVID-19 pandemic and its impact on the company, the pandemic may cause delay or curtailment of the company’s planned capital expenditures. The Credit Agreement limits the company's annual capital expenditures to $35,000,000.


DIVIDEND POLICY

On May 21, 2020, the Board of Directors decided to suspend the quarterly dividend on the company's common shares in light of the impacts of COVID-19 on the business.
15
MD&ACash Flows
CASH FLOWS
ivc-20200930_g6.jpg
The significant improvement in cash provided by operating activities for the nine months ended September 30, 2020 was driven primarily by reduced net loss partially offset by increased inventory. Inventories increased significantly as a result of the pandemic and the company's long lead supply chain. This inventory should largely convert to cash over the next few quarters if sales growth progresses as expected. In addition, YTD 3Q20 operating cash flow benefited from deferrals of a total of $10,100,000 of indirect and payroll taxes. Such deferrals will be substantially paid out over the next four quarters.
ivc-20200930_g7.jpg
Cash flows used by investing activities for the first nine months of 2020 were lower compared to cash flows used in the same period last year, driven by gross proceeds of

$14,563,000 from the sale of Dynamic Controls in the first quarter of 2020. In addition, the company used $2,113,000 to purchase SAP licenses related to its ERP implementation and capitalized other ERP-related implementation costs in the first nine months of 2020.
ivc-20200930_g8.jpg
Cash flows provided by financing activities increased in the first nine months of 2020 compared to the same period last year driven primarily by borrowing of $32,160,000 on the North America and Europe credit facility under the company's credit agreement which provides for an asset-based-lending senior secured revolving credit facility as well as an unsecured CARES Act loan of $10,000,000. This was offset by cash paid of $24,466,000 to retire the majority of the company's outstanding 2021 Notes in the third quarter; and $6,900,000 of cash paid in connection with the exchange of 2021 and 2022 Notes for 2024 Series II Notes executed during the second quarter of 2020 for debt fees and payments to note holders.
16
MD&ACash Flows
Free cash flow is a non-GAAP financial measure and is reconciled to the corresponding GAAP measure as follows:
 ($ in thousands USD)3Q203Q19YTD 3Q20YTD 3Q19
Net cash provided (used) by operating activities4,147 15,121 822 (4,732)
Plus: Sales of property and equipment3 9 396 73 
Less: Purchases of property and equipment(5,945)(2,856)(16,824)(7,177)
Free Cash Flow(1,795)12,274 (15,606)(11,836)
 
Free cash flow for the first nine months 2020 and 2019 was primarily impacted by the same items that affected cash flows used by operating activities. Free cash flow is a non-GAAP financial measure that is comprised of net cash used by operating activities plus purchases of property and equipment less proceeds from sales of property and equipment.
Management believes that this financial measure provides meaningful information for evaluating the overall financial performance of the company and its ability to repay debt or make future investments (including acquisitions, etc.).
Generally, the first half of the year is cash consumptive and impacted by significant disbursements related to annual customer rebate payments which normally occur in the first quarter of the year and earned employee bonuses historically paid in the second quarter of the year. In addition, investment in inventory is typically heavy in the first half of the year with planning around the company's supply chain to fulfill shipments in the second half of the year and can be impacted by footprint rationalization projects. As a result, historically, the company realizes stronger cash flow in the second half of the year versus the first half of the year. However, because the company cannot predict the duration or scope of the COVID-19 pandemic and its negative impact on the company’s cash flow, these historic trends may not apply in 2020 or beyond.

The company's approximate cash conversion days at September 30, 2020, December 31, 2019 and September 30, 2019 were as follows:
ivc-20200930_g9.jpg
For the quarter ended September 30, 2020, days in inventory and days in accounts payable were both impacted by the business disruption due to the COVID-19 pandemic. As a result of the company's long lead time supply chain, inventory level increased and accounts payable levels were elevated for the quarter ended September 30, 2020.

Days in receivables are equal to current quarter net current receivables divided by trailing four quarters of net sales multiplied by 365 days. Days in inventory and accounts
payable are equal to current quarter net inventory and accounts payable, respectively, divided by trailing four quarters of cost of sales multiplied by 365 days. Total cash conversion days are equal to days in receivables plus days in inventory less days in accounts payable.

The company provides a summary of days of cash conversion for the components of working capital so investors may see the rate at which cash is disbursed, collected and how quickly inventory is converted and sold.
17
MD&AAccounting Estimates and Pronouncements
ACCOUNTING ESTIMATES AND PRONOUNCEMENTS

CRITICAL ACCOUNTING ESTIMATES

The Condensed Consolidated Financial Statements included in the report include accounts of the company and all majority-owned subsidiaries. The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions in certain circumstances that affect amounts reported in the accompanying Condensed Consolidated Financial Statements and related footnotes. In preparing the financial statements, management has made its best estimates and judgments of certain amounts included in the financial statements, giving due consideration to materiality. However, application of these accounting policies involves the exercise of judgment and use of assumptions as to future uncertainties and, thus, actual results could differ from these estimates. Please refer to the Critical Accounting Estimates section within MD&A of company's Annual Report on Form 10-K for the period ending December 31, 2019 as well as the revenue recognition and warranty disclosure below.































RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS

For the company’s disclosure regarding recently issued accounting pronouncements, see Accounting Policies - Recent Accounting Pronouncements in the Notes to the Condensed Consolidated Financial Statements contained in this Quarterly Report on Form 10-Q.

18
MD&AForward-Looking Statements
FORWARD-LOOKING STATEMENTS

This Form 10-Q contains forward-looking statements within the meaning of the “Safe Harbor” provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are those that describe future outcomes or expectations that are usually identified by words such as “will,” “should,” “could,” “plan,” “intend,” “expect,” “continue,” “forecast,” “believe,” and “anticipate” and include, for example, statements related to the expected effects on the company’s business of the COVID-19 pandemic; sales and free cash flow trends; the impact of contingency plans and SG&A and investment reductions; the company’s liquidity and working capital expectations; the company’s future financial results; and similar statements. Actual results may differ materially as a result of various risks and uncertainties, including the duration and scope of the COVID-19 pandemic, the resumption of access to healthcare including clinics and elective care, and loosening of public health restrictions, or any reimposed restrictions on access to healthcare or tightening of public health restrictions, and impact on the demand for the company’s products; the ability of the company to obtain needed raw materials and components from its suppliers; actions that governments, businesses and individuals take in response to the pandemic, including mandatory business closures and restrictions on onsite commercial interactions; the impact of the pandemic and actions taken in response to the pandemic on global and regional economies and economic activity; the pace of recovery when the COVID-19 pandemic subsides; general economic uncertainty in key global markets and a worsening of global economic conditions or low levels of economic growth; the effects of steps the company takes to reduce operating costs; the inability of the company to sustain profitable sales growth, achieve anticipated improvements in segment operating performance, convert high inventory or accounts receivable levels to cash or reduce its costs to maintain competitive prices for its products; lack of market acceptance of the company's new product innovations; circumstances or developments that may make the company unable to implement or realize the anticipated benefits, or that may increase the costs, of its current and planned business initiatives, in particular the key elements of its enhanced transformation and growth plan such as its new product introductions, additional investments in sales force and demonstration equipment, plant consolidation in Germany, supply chain actions and global information technology outsourcing and ERP implementation activities; possible adverse effects on the company's liquidity, including the company's ability to address future debt maturities, that may result from delays in the implementation of, any failure to realize benefits from, its current and planned business initiatives; adverse changes in government and third-party payor reimbursement levels and practices in the U.S.; adverse impacts of new tariffs or increases in commodity prices or
freight costs; regulatory proceedings or the company's failure to comply with regulatory requirements or receive regulatory clearance or approval for the company's products or operations; adverse effects of regulatory or governmental inspections of the company's facilities at any time and governmental investigations or enforcement actions; exchange rate fluctuations; and those other risks and uncertainties expressed in the cautionary statements and risk factors in the company's annual report on Form 10-K, quarterly reports on Form 10-Q and other filings with the Securities and Exchange Commission. The company may not be able to predict and may have little or no control over many factors or events that may influence its future results and, except as required by law, shall have no obligation to update any forward-looking statements.
19
Financial Statements
Part I.    FINANCIAL INFORMATION
Item 1.    Financial Statements.

INVACARE CORPORATION AND SUBSIDIARIES
Condensed Consolidated Statement of Comprehensive Income (Loss) (unaudited)
 (In thousands, except per share data)Three Months Ended September 30,Nine Months Ended September 30,
2020201920202019
Net sales$211,906 $235,774 $626,646 $695,051 
Cost of products sold151,866 168,189 446,968 500,945 
Gross Profit60,040 67,585 179,678 194,106 
Selling, general and administrative expenses55,530 63,539 174,672 197,035 
Gain on sale of business— — (9,790)— 
Charges related to restructuring activities1,580 1,628 4,657 3,641 
Operating Income (Loss)2,930 2,418 10,139 (6,570)
Net gain on convertible debt derivatives— — — (1,197)
Loss on debt extinguishment including debt finance charges and fees761 280 7,360 280 
Interest expense7,402 6,992 21,132 22,027 
Interest income(7)(113)(90)(361)
Loss Before Income Taxes(5,226)(4,741)(18,263)(27,319)
Income tax provision2,050 3,300 4,900 7,325 
Net Loss$(7,276)$(8,041)$(23,163)$(34,644)
Dividends Declared per Common Share$— $0.0125 $0.0125 $0.0375 
Net Loss per Share—Basic$(0.21)$(0.24)$(0.68)$(1.03)
Weighted Average Shares Outstanding—Basic34,419 33,660 34,213 33,571 
Net Loss per Share—Assuming Dilution$(0.21)$(0.24)$(0.68)$(1.03)
Weighted Average Shares Outstanding—Assuming Dilution34,530 33,668 34,313 33,581 
Net Loss$(7,276)$(8,041)$(23,163)$(34,644)
Other comprehensive income (loss):
Foreign currency translation adjustments35,944 (9,057)36,859 (13,041)
Defined Benefit Plans:
Amortization of prior service costs and unrecognized losses(193)(201)(362)(276)
Deferred tax adjustment resulting from defined benefit plan activity9 38 25 54 
Valuation reserve associated with defined benefit plan activity(9)(38)(25)(54)
Current period (loss) gain on cash flow hedges(2,047)(315)(1,159)861 
Deferred tax benefit (provision) related to gain on cash flow hedges285 12 171 (127)
Other Comprehensive Income (Loss)33,989 (9,561)35,509 (12,583)
Comprehensive Income (Loss)$26,713 $(17,602)$12,346 $(47,227)
(Elements as a % of Net Sales)
Net sales100.0 %100.0 %100.0 %100.0 %
Cost of products sold71.7 71.3 71.3 72.1 
Gross Profit28.3 28.7 28.7 27.9 
Selling, general and administrative expenses26.2 26.9 27.9 28.3 
Gain on sale of business— — (1.6)— 
Charges related to restructuring activities0.7 0.7 0.7 0.5 
Operating Income (Loss)1.4 1.0 1.6 (0.9)
Net gain on convertible debt derivatives— — — (0.2)
Loss on debt extinguishment including debt finance charges and fees0.4 0.1 1.2 0.04 
Interest expense3.5 3.0 3.4 3.2 
Interest income— — — (0.1)
Loss Before Income Taxes(2.5)(2.0)(2.9)(3.9)
Income tax provision1.0 1.4 0.8 1.1 
Net Loss(3.4)%(3.4)%(3.7)%(5.0)%
See notes to condensed consolidated financial statements.
20
Financial Statements
INVACARE CORPORATION AND SUBSIDIARIES
Condensed Consolidated Balance Sheets (unaudited)
September 30,
2020		December 31,
2019
Assets(In thousands)
Current Assets
Cash and cash equivalents$86,825 $80,063 
Trade receivables, net108,957 116,669 
Installment receivables, net261 736 
Inventories, net145,452 120,500 
Other current assets37,635 37,909 
Total Current Assets379,130 355,877 
Other Assets3,991 4,216 
Intangibles27,770 26,447 
Property and Equipment, net53,112 46,607 
Financing Lease Assets, net65,108 26,900 
Operating Lease Assets, net13,075 18,676 
Goodwill401,665 373,403 
Total Assets$943,851 $852,126 
Liabilities and Shareholders’ Equity
Current Liabilities
Accounts payable$93,160 $88,003 
Accrued expenses124,666 120,947 
Current taxes payable2,197 345 
Current portion of financing lease obligations3,352 2,514 
Current portion of operating lease obligations5,843 6,790 
Short-term debt and current maturities of long-term obligations4,062 58 
Total Current Liabilities233,280 218,657 
Long-Term Debt238,202 219,464 
Finance Lease Long-Term Obligations63,950 26,480 
Operating Leases Long-Term Obligations 7,182 12,060 
Other Long-Term Obligations70,748 66,949 
Shareholders’ Equity
Preferred Shares (Authorized 300 shares; none outstanding)
— — 
Common Shares (Authorized 150,000 shares; 38,596 and 37,609 issued and outstanding at September 30, 2020 and December 31, 2019, respectively)—no par
9,815 9,588 
Class B Common Shares (Authorized 12,000 shares; 6 shares issued and outstanding at September 30, 2020 and December 31, 2019, respectively)—no par
2 2 
Additional paid-in-capital324,409 312,650 
Retained earnings63,655 87,475 
Accumulated other comprehensive income 38,637 3,128 
Treasury Shares (4,184 and 3,953 shares at September 30, 2020 and December 31, 2019, respectively)
(106,029)(104,327)
Total Shareholders’ Equity330,489 308,516 
Total Liabilities and Shareholders’ Equity$943,851 $852,126 
See notes to condensed consolidated financial statements.
21
Financial Statements
INVACARE CORPORATION AND SUBSIDIARIES
Condensed Consolidated Statement of Cash Flows (unaudited)
 
For the Nine Months Ended September 30,
20202019
Operating Activities(In thousands)
Net loss$(23,163)$(34,644)
Adjustments to reconcile net loss to net cash used by operating activities:
Gain on sale of business(9,790)— 
Depreciation and amortization10,360 11,800 
Amortization of operating lease right of use assets5,284 6,927 
Provision for losses on trade and installment receivables554 923 
(Provision) benefit for deferred income taxes111 (232)
Provision for other deferred liabilities594 837 
Provision for equity compensation6,965 5,873 
Loss (gain) on disposals of property and equipment(1,066)186 
Loss on debt extinguishment including debt finance charges and fees7,360 280 
Amortization of convertible debt discount8,629 9,429 
Amortization of debt fees1,329 1,860 
Gain on convertible debt derivatives— (1,197)
Changes in operating assets and liabilities:
Trade receivables6,160 1,501 
Installment sales contracts, net532 405 
Inventories, net(22,021)3,173 
Other current assets1,691 (2,099)
Accounts payable5,903 (1,226)
Accrued expenses1,616 (7,749)
Other long-term liabilities(226)(779)
Net Cash Provided (Used) by Operating Activities822 (4,732)
Investing Activities
Purchases of property and equipment(16,824)(7,177)
Proceeds from sale of property and equipment396 73 
Proceeds from sale of business14,563 — 
Change in other long-term assets67 (72)
Other(2,176)— 
Net Cash Used by Investing Activities(3,974)(7,176)
Financing Activities
Proceeds from revolving lines of credit and long-term borrowings72,551 — 
Repurchases of convertible debt, payments on revolving lines of credit and financing leases(59,483)(16,339)
Payment of financing costs(1,307)— 
Payment of dividends(414)(1,234)
Payments to debt holders(5,593)— 
Purchase of treasury shares(1,702)(860)
Net Cash Provided (Used) by Financing Activities4,052 (18,433)
Effect of exchange rate changes on cash5,862 (1,526)
Increase (decrease) in cash and cash equivalents6,762 (31,867)
Cash and cash equivalents at beginning of year80,063 116,907 
Cash and cash equivalents at end of period$86,825 $85,040 
See notes to condensed consolidated financial statements.
22
Financial Statements
INVACARE CORPORATION AND SUBSIDIARIES
Condensed Consolidated Statement of Shareholders' Equity (unaudited)
(In thousands)Common
Shares		Class B
Shares		Additional
Paid-in-
Capital		Retained
Earnings		Accumulated Other
Comprehen-sive
Income		Treasury
Shares		Total
June 30, 2020 Balance$9,815 $2 $322,770 $70,931 $4,648 $(106,020)$302,146 
Exercise of share options— — — — — — — 
Performance awards— — 818 — — — 818 
Restricted share awards— — 821 — — (9)812 
Net loss— — — (7,276)— — (7,276)
Foreign currency translation adjustments— — — — 35,944 — 35,944 
Unrealized loss on cash flow hedges— — — — (1,762)— (1,762)
Defined benefit plans: Amortization of prior service costs and unrecognized losses and credits— — — — (193)— (193)
Total comprehensive income— — — — — — 26,713 
September 30, 2020 Balance$9,815 $2 $324,409 $63,655 $38,637 $(106,029)$330,489 
June 30, 2019 Balance$9,588 $2 $301,833 $115,025 $9,771 $(104,293)$331,926 
Performance awards— — 649 — — — 649 
Non-qualified share options— — 123 — — — 123 
Restricted share awards— — 798 — — 798 
Net loss— — — (8,041)— — (8,041)
Foreign currency translation adjustments— — — — (9,057)— (9,057)
Unrealized loss on cash flow hedges— — — — (303)— (303)
Defined benefit plans: Amortization of prior service costs and unrecognized losses and credits— — — — (201)— (201)
Total comprehensive loss— — — — — — (17,602)
Dividends— — — (415)— — (415)
September 30, 2019 Balance$9,588 $2 $303,403 $106,569 $210 $(104,293)$315,479 
See notes to condensed consolidated financial statements.
23
Financial Statements
INVACARE CORPORATION AND SUBSIDIARIES
Condensed Consolidated Statement of Shareholders' Equity (unaudited)
(In thousands)Common
Shares		Class B
Shares		Additional
Paid-in-
Capital		Retained
Earnings		Accumulated Other
Comprehen-sive
Income		Treasury SharesTotal
January 1, 2020 Balance$9,588 $2 $312,650 $87,475 $3,128 $(104,327)$308,516 
Exercise of share options90 — (90)— — (1,121)(1,121)
Performance awards— — 2,494 — — 2,494 
Restricted share awards137 — 4,334 — — (581)3,890 
Net loss— — — (23,163)— — (23,163)
Foreign currency translation adjustments— — — — 36,859 — 36,859 
Unrealized loss on cash flow hedges— — — — (988)— (988)
Defined benefit plans: Amortization of prior service costs and unrecognized losses and credits— — — — (362)— (362)
Total comprehensive income12,346 
Exchange of convertible notes— — 5,021 — — — 5,021 
Dividends— — — (414)— — (414)
Adoption of credit loss standard— — — (243)— — (243)
September 30, 2020 Balance$9,815 $2 $324,409 $63,655 $38,637 $(106,029)$330,489 
January 1, 2019 Balance$9,419 $2 $297,919 $142,447 $12,793 $(103,433)$359,147 
Performance awards29 — 1,619 — — (348)1,300 
Non-qualified share options— — 334 — — 334 
Restricted share awards140 — 3,751 — — (512)3,379 
Net loss— — — (34,644)— — (34,644)
Foreign currency translation adjustments— — — — (13,041)— (13,041)
Unrealized gain on cash flow hedges— — — — 734 — 734 
Defined benefit plans: Amortization of prior service costs and unrecognized losses and credits— — — — (276)— (276)
Total comprehensive loss(47,227)
Convertible debt derivative adjustments— — (220)— — — (220)
Dividends— — — (1,234)— — (1,234)
September 30, 2019 Balance$9,588 $2 $303,403 $106,569 $210 $(104,293)$315,479 
See notes to condensed consolidated financial statements.
24
Notes to Financial StatementsAccounting Policies

Accounting Policies

Principles of Consolidation:  The condensed consolidated financial statements include the accounts of the company and its wholly owned subsidiaries and include all adjustments, which were of a normal recurring nature, necessary to present fairly the financial position of the company as of September 30, 2020 and the results of its operations and changes in its cash flow for the nine months ended September 30, 2020 and 2019, respectively. Certain foreign subsidiaries, represented by the European segment, are consolidated using an August 31 quarter end to meet filing deadlines. No material subsequent events have occurred related to the European segment, which would require disclosure or adjustment to the company's financial statements. All significant intercompany transactions are eliminated. The results of operations for the three and nine months ended September 30, 2020 are not necessarily indicative of the results to be expected for the full year.

Use of Estimates:  The condensed consolidated financial statements are prepared in conformity with accounting principles generally accepted in the United States, which require management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results may differ from these estimates.

Recent Accounting Pronouncements (Already Adopted): 
In June 2016, the FASB issued ASU 2016-13, "Measurement of Credit Losses on Financial Statements." ASU 2016-13 requires a new credit loss standard for most financial assets and certain other instruments. For example, entities are required to use an "expected loss" model that will generally require earlier recognition of allowances for losses for trade receivables. The standard also requires additional disclosures, including disclosures regarding how an entity tracks credit quality. The company adopted ASU 2016-13, effective on January 1, 2020, which resulted in an increase for credit losses of $243,000 with the offsetting impact recorded to retained earnings.

In January 2017, the FASB issued ASU 2017-04, "Intangibles - Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment." The guidance in ASU 2017-04 eliminates the requirement to determine the fair value of individual assets and liabilities of a reporting unit to measure goodwill impairment. Under the amendments in the new ASU, goodwill impairment testing will be performed by comparing the fair value of the reporting unit with its carrying amount and recognizing an impairment charge for the amount by which the carrying amount exceeds the reporting unit’s fair
value. The company adopted ASU 2017-04 as of January 1, 2020 with no impact to the company's financial statements upon adoption.

In December 2019, the FASB issued ASU 2019-12, "Income Taxes (Topic 740) - Simplifying the Accounting for Income Taxes," which simplifies the accounting for income taxes by removing certain exceptions to the general principles in Topic 740. ASU 2019-12 removes the following exceptions: 1) exception to the incremental approach for intraperiod tax allocation when there is a loss from continuing operations and income or a gain from other items (for example, discontinued operations or other comprehensive income), 2) exception to the requirement to recognize a deferred tax liability for equity method investments when a foreign subsidiary becomes an equity method investment, 3) exception to the ability not to recognize a deferred tax liability for a foreign subsidiary when a foreign subsidiary becomes a subsidiary and 4) the exception to the general methodology for calculating income taxes in an interim period when a year-to-date loss exceeds the anticipated loss for the year. The ASU also simplifies other areas of Topic 740 by clarifying and amending existing guidance. The amendments in the ASU will be applied using different approaches depending on what the specific amendments relate to. The company early adopted ASU 2019-12 on a prospective basis as of January 1, 2020 with no impact to the company's financial statements upon adoption.

25
Notes to Financial StatementsDivested Businesses
Divested Businesses
On March 7, 2020, the company, completed the sale (the “Transaction”) of its indirect subsidiary, Dynamic Controls, a New Zealand incorporated unlimited company (“Dynamic Controls”), to Allied Motion Christchurch Limited, a New Zealand limited company (the “Purchaser”), pursuant to a Securities Purchase Agreement among the company, Invacare Holdings New Zealand, a New Zealand incorporated unlimited company, and the Purchaser, dated March 6, 2020 (the “Purchase Agreement”). Dynamic Controls is a producer of electronic control systems for powered medical mobility devices, including systems incorporating the LiNX™ technology platform. Dynamic Controls was a component of the All Other Segment.
Dynamic Controls is a supplier of power mobility products and respiratory components to the company as well as supplying power mobility products to external customers. Sales in 2020 through the date of disposition were $5,331,000, including intercompany sales of $2,532,000, compared to sales for the full year of 2019 of $30,261,000, including intercompany sales of $13,087,000. Income before income taxes was approximately $445,000 in 2020, through the date of disposition, compared to $853,000 in 2019, inclusive of intercompany profits on sales to the company.
The transaction was the result of considering options for the products sold by Dynamic Controls which resulted in selling the business to a third-party which can provide access to further technological innovations to further differentiate the company’s power mobility products.
The gross proceeds from the Transaction were $14,563,000, net of taxes and expenses. The company realized a pre-tax gain of $9,790,000 and recorded expenses related to the sale of the business totaling $2,150,000, of which $1,789,000 have been paid as of September 30, 2020.
The Purchase Agreement contains customary indemnification obligations of each party with respect to breaches of their respective representations, warranties and covenants, and certain other specified matters, which are subject to certain exceptions, terms and limitations described further in the Purchase Agreement.

At the closing of the Transaction, the parties entered into a supply agreement pursuant to which Dynamic Controls will supply certain electronic components as required by the company for a five-year period following the Transaction, including ongoing supply and support of the LiNX™ electronic control system with informatics technology, continued contract manufacturing of certain electronic components for the company’s respiratory products and
continued infrastructure and applications support for the informatics solution for the company’s respiratory products. The estimated continued inflows and outflows following the disposal with the Purchaser are not expected to be material to the company.
The assets and liabilities of Dynamic Controls as of March 7, 2020 and December 31, 2019 consisted of the following (in thousands):
March 7, 2020December 31, 2019
Trade receivables, net$4,129 $1,804 
Inventories, net3,082 3,008 
Other assets855 933 
Property and equipment, net600 707 
Operating lease assets, net2,127 1,870 
Total assets$10,793 $8,322 
Accounts payable$4,692 $4,501 
Accrued expenses2,473 2,108 
Current taxes payable41 92 
Current portion of operating lease obligations366 393 
Long-term obligations1,019 1,754 
Total liabilities$8,591 $8,848 

Trade receivables as of March 7, 2020 includes receivables previously classified as intercompany related to product sold by Dynamic Controls to other Invacare entities.
26
Notes to Financial StatementsCurrent Assets
Current Assets

Receivables

Receivables consist of the following (in thousands):
September 30, 2020December 31, 2019
Accounts receivable, gross$132,809 $141,732 
Customer rebate reserve(13,075)(13,922)
Cash discount reserves(5,290)(5,326)
Allowance for doubtful accounts(4,697)(4,804)
Other, principally returns and allowances reserves(790)(1,011)
Accounts receivable, net$108,957 $116,669 

Reserves for customer rebates and cash discounts are recorded as a reduction in revenue and netted against gross accounts receivable. Customer rebates in excess of a given customer's accounts receivable balance are classified in Accrued Expenses. Customer rebates and cash discounts are estimated based on the most likely amount principle as well as historical experience and anticipated performance. In addition, customers have the right to return product within the company’s normal terms policy, and as such, the company estimates the expected returns based on an analysis of historical experience and adjusts revenue accordingly.

Accounts receivable are reduced by an allowance for amounts that may become uncollectible in the future. Substantially all the company’s receivables are due from health care, medical equipment providers and long-term care facilities predominantly located throughout the United States, Australia, Canada, New Zealand, China and Europe. A significant portion of products sold to providers, both foreign and domestic, are ultimately funded through government reimbursement programs such as Medicare and Medicaid in the U.S. As a consequence, changes in these programs can have an adverse impact on dealer liquidity and profitability.

The company adopted ASU 2016-13, "Measurement of Credit Losses on Financial Statements" on January 1, 2020. Accordingly, the company is now applying an "expected loss" model that will generally require earlier recognition of allowances for losses for trade receivables. In addition, the company expects more variability in its allowance for doubtful accounts as it previously provided for bad debts based on a specific reserve methodology while the new expected loss methodology requires companies to provide for estimated losses beginning at the time of sale. The adoption of the new standard resulted in an increase in credit losses of $243,000 as
disclosed in the Condensed Consolidated Statement of Shareholders' Equity.

The company's approach is to separate its receivables into good-standing and collection receivables. Good-standing receivables are assigned to risk pools of high, medium and low. The risk pools are driven by the specifics associated with the geography of origination. Expected loss percentages are calculated and assigned to each risk pool, driven primarily by historical experience. The historical loss percentages are calculated for each risk pool and then judgmentally revised to consider current risk factors as well as consideration of the impact of forecasted events, as applicable. The expected loss percentages are then applied to receivables balances each period to determine the allowance for doubtful accounts.

In North America, excluding Canada, good-standing receivables are assigned to the low risk pool and assigned an expected loss percentage of 1.0% as these receivables are deemed to share the same risk profile and collections efforts are the same. Installment receivables in North America are characterized as collection receivables and thus reserves based on specific analysis of each customer. In Canada, good-standing receivables and installment receivables are deemed low risk and assigned a loss percentage of 0.2%.

In Europe, expected losses are determined by each location in each region. Most locations have a majority of their receivables assigned to the low risk pool, which has an average expected loss percentage of 0.3%. About half of the locations have a portion of their receivables assigned as medium risk with an average expected loss percentage of 0.9%. Only a few locations have any receivables characterized as high risk and the average credit loss percentage for those locations is 2.7%. Collection risk is generally low as payment terms in certain key markets, such as Germany, are immediate and in many locations the ultimate customer is the government.

In the Asia Pacific region, receivables are characterized as low risk, which have an average expected loss percentage of 0.3%. Historical losses are low in this region where the use of credit insurance is often customary.

27
Notes to Financial StatementsCurrent Assets
The movement in the trade receivables allowance for doubtful accounts was as follows (in thousands):
 Nine Months Ended
September 30, 2020
Balance as of beginning of period$4,804 
Current period provision522 
Direct write-offs charged against the allowance(629)
Balance as of end of period$4,697 

The current period provision includes the immaterial impact of the adoption of ASU 2016-03. The company did not make any material changes to the assignment of receivables to the different risk pools or to the expected loss reserves in the quarter. The company is monitoring the impacts of the COVID-19 pandemic and the possibility for an impact on collections, but to date this has not materially impacted 2020.

For collections receivables, the estimated allowance for uncollectible amounts is based primarily on management’s evaluation of the financial condition of each customer. In addition, as a result of the company's financing arrangement with DLL, a third-party financing company which the company has worked with since 2000, management monitors the collection status of these contracts in accordance with the company’s limited recourse obligations and provides amounts necessary for estimated losses in the allowance for doubtful accounts and establishes reserves for specific customers as needed.

The company writes off uncollectible trade accounts receivable after such receivables are moved to collection status and legal remedies are exhausted. See Concentration of Credit Risk in the Notes to the Condensed Consolidated Financial Statements for a description of the financing arrangement. Long-term installment receivables are included in “Other Assets” on the condensed consolidated balance sheet.

Upon adoption of ASU 2016-03, the company recorded a new contingent liability in the amount of $306,000 related to the contingent aspect of the company's guarantee associated with its arrangement with DLL. The contingent liability is recorded applying the same expected loss model used for the trade and installment receivables recorded on the company's books. Specifically, historical loss history is used to determine the expected loss percentage, which is then adjusted judgmentally to consider other factors, as needed.

The company’s U.S. customers electing to finance their purchases can do so using DLL. In addition, the company, prior to 2020, provided financing directly for its Canadian customers for which DLL is not an option, as DLL typically
provides financing to Canadian customers only on a limited basis. The installment receivables recorded on the books of the company represent a single portfolio segment of finance receivables to the independent provider channel and long-term care customers. The portfolio segment is comprised of two classes of receivables distinguished by geography and credit quality. The U.S. installment receivables are the first class and represent installment receivables repurchased from DLL because the customers were in default. Default with DLL is defined as a customer being delinquent by three payments. The Canadian installment receivables represent the second class of installment receivables which were originally financed by the company because third party financing was not available to the HME providers. The Canadian installment receivables were typically financed for twelve months and historically have had a very low risk of default.

The estimated allowance for uncollectible amounts and evaluation for both classes of installment receivables is based on the company’s quarterly review of the financial condition of each individual customer with the allowance for doubtful accounts adjusted accordingly. Installments are individually and not collectively reviewed. The company assesses the bad debt reserve levels based upon the status of the customer’s adherence to a legally negotiated payment schedule and the company’s ability to enforce judgments, liens, etc.

For purposes of granting or extending credit, the company utilizes a scoring model to generate a composite score that considers each customer’s consumer credit score and/or D&B credit rating, payment history, security collateral and time in business. Additional analysis is performed for most customers desiring credit greater than $250,000, which generally includes a detailed review of the customer’s financial statements as well as consideration of other factors such as exposure to changing reimbursement laws.

Interest income is recognized on installment receivables based on the terms of the installment agreements. Installment accounts are monitored and if a customer defaults on payments and is moved to collection, interest income is no longer recognized. Subsequent payments received once an account is put on non-accrual status are generally first applied to the principal balance and then to the interest. Accruing of interest on collection accounts would only be restarted if the account became current again.

All installment accounts are accounted for using the same methodology regardless of the duration of the installment agreements. When an account is placed in collection status, the company goes through a legal process for pursuing collection of outstanding amounts, the length of which typically approximates eighteen months. Any write-offs are made after the legal process has been completed.
28
Notes to Financial StatementsCurrent Assets
Installment receivables consist of the following (in thousands):
 September 30, 2020December 31, 2019
 CurrentLong-
Term		TotalCurrentLong-
Term		Total
Installment receivables$555 $228 $783 $1,192 $1,257 $2,449 
Less: Unearned interest(3)— (3)(22)— (22)
552 228 780 1,170 1,257 2,427 
Allowance for doubtful accounts(291)(164)(455)(434)(1,080)(1,514)
Installment receivables, net$261 $64 $325 $736 $177 $913 

Installment receivables purchased from DLL during the nine months ended September 30, 2020 increased the gross installment receivables balance by $343,000, which will be part of the company's 2020 class of installment receivables. No sales of installment receivables were made by the company


during the quarter. There was no impact on the allowance for doubtful accounts for installment receivables as a result of the adoption of ASU 2016-03 as the installment receivables in the U.S. are specifically reserved for by account and no adjustment was needed to the allowance for doubtful accounts for Canada installment receivables.

The movement in the installment receivables allowance for doubtful accounts was as follows (in thousands):
 Nine Months Ended
September 30, 2020		Year Ended December 31, 2019
Balance as of beginning of period$1,514 $1,542 
Current period provision32 479 
Direct write-offs charged against the allowance(1,091)(507)
Balance as of end of period$455 $1,514 
 
Installment receivables by class as of September 30, 2020 consist of the following (in thousands):
 Total
Installment
Receivables		Unpaid
Principal
Balance		Related
Allowance for
Doubtful
Accounts		Interest
Income
Recognized
U.S.
Impaired installment receivables with a related allowance recorded$649 $649 $453 $— 
Canada
Non-Impaired installment receivables with no related allowance recorded132 129 — 26 
Impaired installment receivables with a related allowance recorded2 2 2 — 
Total Canadian installment receivables134 131 2 26 
Total
Non-Impaired installment receivables with no related allowance recorded132 129 — 26 
Impaired installment receivables with a related allowance recorded651 651 455 — 
Total installment receivables$783 $780 $455 $26 
29
Notes to Financial StatementsCurrent Assets
Installment receivables by class as of December 31, 2019 consist of the following (in thousands):
 Total
Installment
Receivables		Unpaid
Principal
Balance		Related
Allowance for
Doubtful
Accounts		Interest
Income
Recognized
U.S.
Impaired installment receivables with a related allowance recorded$1,762 $1,762 $1,497 $— 
Canada
Non-Impaired installment receivables with no related allowance recorded670 648 — 92 
Impaired installment receivables with a related allowance recorded17 17 17 — 
Total Canadian installment receivables687 665 17 92 
Total
Non-Impaired installment receivables with no related allowance recorded670 648 — 92 
Impaired installment receivables with a related allowance recorded1,779 1,779 1,514 — 
Total installment receivables$2,449 $2,427 $1,514 $92 

Installment receivables with a related allowance recorded as noted in the table above represent those installment receivables on a non-accrual basis in accordance with ASU 2010-20. As of September 30, 2020, the company had no U.S. installment receivables past due of 90 days or more for which the company is still accruing interest. Individually, all U.S. installment receivables are assigned a specific allowance for doubtful accounts based on management’s review when the
company does not expect to receive both the contractual principal and interest payments as specified in the loan agreement. In Canada, the company had an immaterial amount of Canadian installment receivables which were past due of 90 days or more as of December 31, 2019 for which the company was still accruing interest.


The aging of the company’s installment receivables was as follows (in thousands):
September 30, 2020December 31, 2019
TotalU.S.CanadaTotalU.S.Canada
Current$132 $— $132 $659 $— $659 
0-30 Days Past Due— — — 2 — 2 
31-60 Days Past Due— — — 4 — 4 
61-90 Days Past Due— — — — — — 
90+ Days Past Due651 649 2 1,784 1,762 22 
$783 $649 $134 $2,449 $1,762 $687 

30
Notes to Financial StatementsCurrent Assets
Inventories, Net

Inventories consist of the following (in thousands):
September 30, 2020December 31, 2019
Finished goods$68,599 $54,064 
Raw materials66,093 54,638 
Work in process10,760 11,798 
Inventories, net$145,452 $120,500 

As a result of COVID-19 which significantly reduced net sales in the second quarter of 2020, and given the company's long lead-time supply chain, inventory levels increased
significantly. The company believes such inventory levels will be reduced over the next few quarters with sequential sales growth for the company.

Other Current Assets


Other current assets consist of the following (in thousands):
September 30, 2020December 31, 2019
Tax receivables principally value added taxes$23,188 $16,049 
Receivable due from information technology provider2,402 6,262 
Prepaid inventory1,392 684 
Derivatives (foreign currency forward exchange contracts)599 838 
Service contracts446 2,013 
Prepaid insurance341 2,918 
Deferred financing fees209 207 
Prepaid social charges95 1,216 
Recoverable income taxes50 297 
Prepaid and other current assets8,913 7,425 
Other Current Assets$37,635 $37,909 

In the fourth quarter of 2019, the company entered into an agreement to outsource substantially all of the company’s information technology ("IT") business service activities, including, among other things, support, rationalization and upgrading of the company’s legacy information technology systems and implementation of a global enterprise resource planning system. The agreement provides for reimbursement by the IT provider of IT expenses incurred by the company
which are shown as Receivable due from IT provider above. The amount of pass through charges will diminish as IT expenses are recorded directly by the IT provider. In addition, a corresponding current payable is due to the IT provider. See "Accrued Expenses" in the notes to the Condensed Consolidated Financial Statements included elsewhere in this report.

31
Notes to Financial StatementsLong-Term Assets
Long-Term Assets

Other Long-Term Assets


Other long-term assets consist of the following (in thousands):
September 30, 2020December 31, 2019
Cash surrender value of life insurance policies$2,224 $2,124 
Deferred income taxes1,032 928 
Deferred financing fees461 602 
Investments85 85 
Installment receivables64 177 
Other125 300 
Other Long-Term Assets$3,991 $4,216 

Property and Equipment
Property and equipment consist of the following (in thousands):
September 30, 2020December 31, 2019
Machinery and equipment$291,902 $296,078 
Land, buildings and improvements28,088 33,054 
Capitalized software13,787 3,509 
Furniture and fixtures9,866 9,898 
Leasehold improvements8,087 9,023 
Property and Equipment, gross351,730 351,562 
Accumulated depreciation(298,618)(304,955)
Property and Equipment, net$53,112 $46,607 

Machinery and equipment includes demonstration units placed in provider locations which are depreciated to their estimated recoverable values over their estimated useful lives. In the fourth quarter of 2019, the company initiated the first stage of an Enterprise Resource Planning ("ERP") software implementation. As a result of the initiation of the ERP project, the company capitalized certain costs in accordance with ASC 350 as shown in capitalized software above.













In the third quarter of 2018, the company agreed to sell its Isny, Germany location with a net book value at the signing of the agreement of approximately $2,900,000, which is included in Land, buildings and improvements in the table above as of December 31, 2019. In accordance with the agreement, control transferred to the buyer in April 2020. The company recorded a gain on the transaction of $971,000.

32
Notes to Financial StatementsLong-Term Assets
Goodwill
The change in goodwill from December 31, 2019 to September 30, 2020 was due to foreign currency translation.

In accordance with Intangibles—Goodwill and Other, ASC 350, goodwill is tested annually for impairment. The company first estimates the fair value of each reporting unit and compares the calculated fair value to the carrying value of each reporting unit. A reporting unit is defined as an operating segment or one level below. The company has determined that its reporting units are North America / HME, Europe, Institutional Products Group and Asia Pacific.

In consideration of the negative impact of COVID-19 on the global economy, the company performed an interim test of
goodwill for impairment in the first quarter of 2020 and no impairment was recorded. For the second and third quarters of 2020, the company concluded that the facts and circumstances driving the conclusions from the first quarter review had not changed materially. While there was no indication of impairment in the second or third quarter of 2020 related to goodwill for the Europe or Institutional Products Group reporting units, a future potential impairment is possible for these reporting units should actual results differ materially from the company's current forecasted results or market inputs used to determine the discount rate change significantly. Please refer to Goodwill in the company's Annual Report on Form 10-K for the period ending December 31, 2019 for further disclosure regarding the company's impairment analysis review methodology.
Intangibles

The company's intangibles consist of the following (in thousands):
 
 September 30, 2020December 31, 2019
 Historical
Cost		Accumulated
Amortization		Historical
Cost		Accumulated
Amortization
Customer lists$54,267 $54,267 $51,108 $51,108 
Trademarks25,019 — 23,479 — 
Developed technology7,918 7,150 7,483 6,642 
Patents5,514 5,514 5,521 5,521 
License agreements2,864 891 2,884 770 
Other1,161 1,151 1,163 1,150 
Intangibles$96,743 $68,973 $91,638 $65,191 

All the company’s intangible assets have been assigned definite lives and continue to be amortized over their useful lives, except for trademarks shown above, which have indefinite lives. The changes in intangible balances reflected on the balance sheet from December 31, 2019 to September 30, 2020 were the result of foreign currency translation and amortization.

The company evaluates the carrying value of definite-lived assets annually in the fourth quarter and whenever events or circumstances indicate possible impairment. In consideration of the negative impact of COVID-19 on the global economy, the company performed a review of intangibles for impairment in the first quarter of 2020 and concluded there was no impairment to be recorded. For the second and third quarters of 2020, the company concluded that the facts and circumstances driving the conclusions from the first quarter review had not changed materially. Definite-lived assets are determined to be impaired if the future undiscounted cash flows expected to be generated by the asset are less than the carrying value. Actual impairment amounts for definite-
lived assets are then calculated using a discounted cash flow calculation.

Any impairment amounts for indefinite-lived assets are calculated as the difference between the future discounted cash flows expected to be generated by the asset less than the carrying value for the asset.

Amortization expense related to intangibles was $276,000 in the first nine months of 2020 and is expected to be $419,000 in 2020, $390,000 in 2021, $390,000 in 2022, $389,000 in 2023, $355,000 in 2024 and $212,000 in 2025. Amortized intangibles are being amortized on a straight-line basis over remaining lives of 1 to 10 years with most of the intangibles being amortized over an average remaining life of approximately 8 years.

33
Notes to Financial StatementsCurrent Liabilities
Current Liabilities

Accrued Expenses

Accrued expenses consist of accruals for the following (in thousands):
September 30, 2020December 31, 2019
Salaries and wages$34,612 $29,725 
Taxes other than income taxes, primarily Value Added Taxes29,830 22,194 
Warranty11,144 11,626 
Professional8,481 6,869 
Severance5,988 7,023 
Interest4,663 3,608 
Rebates4,146 10,743 
IT service contracts3,790 6,125 
Freight3,710 3,744 
Deferred revenue3,436 3,173 
Derivative liabilities (foreign currency forward exchange contracts)2,824 905 
Product liability, current portion2,810 2,736 
Insurance781 699 
Rent568 415 
Supplemental Executive Retirement Program liability391 391 
Advance payment on sale of land & buildings— 3,471 
IT licenses— 2,114 
Other items, principally trade accruals7,492 5,386 
Accrued Expenses$124,666 $120,947 

Generally, the company's products are covered by warranties against defects in material and workmanship for various periods depending on the product from the date of sales to the customer. Certain components carry a lifetime warranty. A provision for estimated warranty cost is recorded at the time of sale based upon actual experience. In addition, the company has sold extended warranties that, while immaterial, require the company to defer the revenue associated with those warranties until earned. The company has established procedures to appropriate defer such revenue. The company continuously assesses the adequacy of its product warranty accrual and makes adjustments as needed. Historical analysis is primarily used to determine the company's warranty reserves. Claims history is reviewed and provisions are adjusted as needed. However, the company does consider other events, such as a product field action and recalls, which could require additional warranty reserve provision.





Accrued rebates relate to several volume incentive programs the company offers its customers. The company accounts for these rebates as a reduction of revenue when the products are sold. Rebates are netted against gross accounts receivables. If rebates are in excess of such receivables, they are then classified as accrued expenses. The reduction in accrued rebates from December 31, 2019 to September 30, 2020 primarily relates to payments principally made in the first quarter each year.

In the fourth quarter of 2019, the company entered into an agreement with an IT provider to outsource substantially all of the company’s information technology business service activities, including, among other things, support, rationalization and upgrading of the company’s legacy information technology systems and implementation of a global enterprise resource planning (“ERP”) system. Accrued expenses related to IT outsourcing are reflected in IT service contracts. Separately, the company entered into licenses for a new ERP system which are shown as IT licenses.


34
Notes to Financial StatementsCurrent Liabilities
The following is a reconciliation of the changes in accrued warranty costs for the reporting period (in thousands):
Balance as of January 1, 2020$11,626 
Warranties provided during the period4,311 
Settlements made during the period(5,926)
Changes in liability for pre-existing warranties during the period, including expirations1,133 
Balance as of September 30, 2020$11,144 

Warranty reserves are subject to adjustment in future periods as new developments change the company's estimate of the total cost. In the third quarter of 2020, warranty expense includes a provision of $768,000 for a product recall which was related to a component on a respiratory product, recorded in the North America segment.










































35
Notes to Financial StatementsLong-Term Liabilities
Long-Term Debt

Debt consists of the following (in thousands):
September 30, 2020December 31, 2019
Convertible senior notes at 5.00%, due in February 2021$1,224 $56,628 
Convertible senior notes at 4.50%, due in June 202272,652 101,815 
Convertible senior notes Series I at 5.00%, due in November 202462,443 60,817 
Convertible senior notes Series II at 5.00%, due November 202463,556 — 
Other obligations42,389 262 
242,264 219,522 
Less current maturities of long-term debt(4,062)(58)
Long-Term Debt$238,202 $219,464 

On September 30, 2015, the company entered into an Amended and Restated Revolving Credit and Security Agreement, which was subsequently amended (the “Credit Agreement”) and which matures on January 16, 2024. The Credit Agreement was entered into by and among the company, certain of the company’s direct and indirect U.S. and Canadian subsidiaries and certain of the company’s European subsidiaries (together with the company, the “Borrowers”), certain other of the company’s direct and indirect U.S., Canadian and European subsidiaries (the “Guarantors”), and PNC Bank, National Association (“PNC”), JPMorgan Chase Bank, N.A., J.P. Morgan Europe Limited, KeyBank National Association, and Citizens Bank, National Association (the “Lenders”). PNC is the administrative agent (the “Administrative Agent”) and J.P. Morgan Europe Limited is the European agent (the “European Agent”) under the Credit Agreement. In connection with entering into the company's Credit Agreement, the company incurred fees which were capitalized and are being amortized as interest expense. As of September 30, 2020, debt fees yet to be amortized through January 2024 totaled $670,000.

The company had outstanding letters of credit of $7,740,000 and $8,011,000 as of September 30, 2020 and December 31, 2019, respectively. Outstanding letters of credit and other reserves impacting borrowing capacity were $7,653,000 and $8,827,000 as of September 30, 2020 and December 31, 2019, respectively. The company had outstanding borrowings of $23,700,000 under its U.S. and Canadian Credit Facility as of September 30, 2020. The company had outstanding borrowings of $6,322,000 (€5,300,000) under its French Credit Facility and $2,138,000 (£1,600,000) under its UK Credit Facility as of September 30, 2020, together referred to as the European Credit Facility. The company had no borrowings under the Credit Facilities as of December 31, 2019. The weighted average interest rate on all borrowings, excluding financing leases, was 4.63% for the
nine months ended September 30, 2020 and 4.78% for the year ended December 31, 2019.

U.S. and Canadian Borrowers Credit Facility

For the company's U.S. and Canadian Borrowers, the Credit Agreement provides for an asset-based-lending senior secured revolving credit facility which is secured by substantially all the company’s U.S. and Canadian assets, other than real estate. The Credit Agreement provides the company and the other Borrowers with a credit facility in an aggregate principal amount of $60,000,000, subject to availability based on a borrowing base formula, under a senior secured revolving credit, letter of credit and swing line loan facility (the “U.S. and Canadian Credit Facility”). Up to $20,000,000 of the U.S. and Canadian Credit Facility will be available for issuance of letters of credit. The aggregate principal amount of the U.S. and Canadian Credit Facility may be increased by up to $25,000,000 to the extent requested by the company and agreed to by any Lender or new financial institution approved by the Administrative Agent.

The aggregate borrowing availability under the U.S. and Canadian Credit Facility is determined based on a borrowing base formula. The aggregate usage under the U.S. and Canadian Credit Facility may not exceed an amount equal to the sum of (a) 85% of eligible U.S. accounts receivable plus (b) the lesser of (i) 70% of eligible U.S. inventory and eligible foreign in-transit inventory and (ii) 85% of the net orderly liquidation value of eligible U.S. inventory and eligible foreign in-transit inventory (not to exceed $4,000,000), plus (c) the lesser of (i) 85% of the net orderly liquidation value of U.S. eligible machinery and equipment and (ii) $0 as of September 30, 2020 (subject to reduction as provided in the Credit Agreement), plus (d) 85% of eligible Canadian accounts receivable, plus (e) the lesser of (i) 70% of eligible Canadian inventory and (ii) 85% of the net orderly liquidation value of eligible Canadian inventory, less (f) swing loans
36
Notes to Financial StatementsLong-Term Liabilities
outstanding under the U.S. and Canadian Credit Facility, less (g) letters of credit issued and undrawn under the U.S. and Canadian Credit Facility, less (h) a $3,000,000 minimum availability reserve, less (i) other reserves required by the Administrative Agent, and in each case subject to the definitions and limitations in the Credit Agreement. As of September 30, 2020, the company was in compliance with all covenant requirements. As of September 30, 2020, the company had gross borrowing availability of $23,700,000 under the U.S. and Canadian Credit Facility under the Credit Agreement, considering the minimum availability reserve, then-outstanding letters of credit, other reserves and the $7,500,000 dominion trigger amount described below. Borrowings under the U.S. and Canadian Credit Facility are secured by substantially all of the company’s U.S. and Canadian assets, other than real estate.

Interest will accrue on outstanding indebtedness under the Credit Agreement at the LIBOR rate, plus a margin ranging from 2.25% to 2.75%, or at the alternate base rate, plus a margin ranging from 1.25% to 1.75%, as selected by the company. Borrowings under the U.S. and Canadian Credit Facility are subject to commitment fees of 0.25% or 0.375% per year, depending on utilization.

The Credit Agreement contains customary representations, warranties and covenants. Exceptions to the operating covenants in the Credit Agreement provide the company with flexibility to, among other things, enter into or undertake certain sale and leaseback transactions, dispositions of assets, additional credit facilities, sales of receivables, additional indebtedness and intercompany indebtedness, all subject to limitations set forth in the Credit Agreement, as amended. The Credit Agreement also contains a covenant requiring the company to maintain minimum availability under the U.S. and Canadian Credit Facility of not less than the greater of (i) 11.25% of the maximum amount that may be drawn under the U.S. and Canadian Credit Facility for five (5) consecutive business days, or (ii) $6,000,000 on any business day. The company also is subject to dominion triggers under the U.S. and Canadian Credit Facility requiring the company to maintain borrowing capacity of not less than $7,500,000 on any business day in order to avoid triggering full control by an agent for the Lenders of the company's cash receipts for application to the company’s obligations under the agreement.

The Credit Agreement contains customary default provisions, with certain grace periods and exceptions, which provide for events of default that include, among other things, failure to pay amounts due, breach of covenants, representations or warranties, bankruptcy, the occurrence of a material adverse effect, exclusion from any medical reimbursement program, and an interruption of any material manufacturing facilities for more than 10 consecutive days.
There was $23,700,000 outstanding under the U.S. and Canadian Credit Facility at September 30, 2020.

European Credit Facility

The Credit Agreement also provides for a revolving credit, letter of credit and swing line loan facility which gives the company and the European Borrowers the ability to borrow up to an aggregate principal amount of $30,000,000, with a $5,000,000 sublimit for letters of credit and a $2,000,000 sublimit for swing line loans (the “European Credit Facility”). Up to $15,000,000 of the European Credit Facility will be available to each of Invacare Limited (the “UK Borrower”) and Invacare Poirier SAS (the “French Borrower” and, together with the UK Borrower, the “European Borrowers”). The European Credit Facility matures in January 2024, together with the U.S. and Canadian Credit Facility.

The aggregate borrowing availability for each European Borrower under the European Credit Facility is determined based on a borrowing base formula. The aggregate borrowings of each of the European Borrowers under the European Credit Facility may not exceed an amount equal to (a) 85% of the European Borrower’s eligible accounts receivable, less (b) the European Borrower’s borrowings and swing line loans outstanding under the European Credit Facility, less (c) the European Borrower’s letters of credit issued and undrawn under the European Credit Facility, less (d) a $3,000,000 minimum availability reserve, less (e) other reserves required by the European Agent, and in each case subject to the definitions and limitations in the Credit Agreement. As of September 30, 2020, the gross borrowing availability to the European Borrowers under the European Credit Facility was $8,564,000, considering the $3,000,000 minimum availability reserve and the $3,750,000 dominion trigger amount described below.

The aggregate principal amount of the European Credit Facility may be increased by up to $10,000,000 to the extent requested by the company and agreed to by any Lender or Lenders that wish to increase their lending participation or, if not agreed to by any Lender, a new financial institution that agrees to join the European Credit Facility and that is approved by the Administrative Agent and the European Agent.

Interest will accrue on outstanding indebtedness under the European Credit Facility at the LIBOR rate, plus a margin ranging from 2.50% to 3.00%, or for swing line loans, at the overnight LIBOR rate, plus a margin ranging from 2.50% to 3.00%, as selected by the company. The margin that will be adjusted quarterly based on utilization. Borrowings under the European Credit Facility are subject to commitment fees of 0.25% or 0.375% per year, depending on utilization.
37
Notes to Financial StatementsLong-Term Liabilities
The European Credit Facility is secured by substantially all the personal property assets of the UK Borrower and its in-country subsidiaries, and all the receivables of the French Borrower and its in-country subsidiaries. The UK and French facilities (which comprise the European Credit Facility) are cross collateralized, and the US personal property assets previously pledged under the U.S. and Canadian Credit Facility also serve as collateral for the European Credit Facility.

The European Credit Facility is subject to customary representations, warranties and covenants generally consistent with those applicable to the U.S. and Canadian Credit Facility. Exceptions to the operating covenants in the Credit Agreement provide the company with flexibility to, among other things, enter into or undertake certain sale/leaseback transactions, dispositions of assets, additional credit facilities, sales of receivables, additional indebtedness and intercompany indebtedness, all subject to limitations set forth in the Credit Agreement. The Credit Agreement also contains a covenant requiring the European Borrowers to maintain undrawn availability under the European Credit Facility of not less than the greater of (i) 11.25% of the maximum amount that may be drawn under the European Credit Facility for five (5) consecutive business days, or (ii) $3,000,000 on any business day. The European Borrowers also are subject to cash dominion triggers under the European Credit Facility requiring the European Borrower to maintain borrowing capacity of not less than $3,750,000 on any business day in order to avoid triggering full control by an agent for the Lenders of the European Borrower’s cash receipts for application to its obligations under the European Credit Facility.

The European Credit Facility is subject to customary default provisions, with certain grace periods and exceptions, consistent with those applicable to the U.S. and Canadian Credit Facility, which provide that events of default include, among other things, failure to pay amounts due, breach of covenants, representations or warranties, cross-default, bankruptcy, the occurrence of a material adverse effect, exclusion from any medical reimbursement program, and an interruption in the operations of any material manufacturing facility for more than 10 consecutive days. The proceeds of the European Credit Facility will be used to finance the working capital and other business needs of the company. As of September 30, 2020, the company had borrowings of $6,322,000 (€5,300,000) under its French Credit Facility and $2,138,000 (£1,600,000) under its UK Credit Facility as of September 30, 2020, together referred to as the European Credit Facility.

Convertible senior notes due 2021

In the first quarter of 2016, the company issued $150,000,000 aggregate principal amount of 5.00%
Convertible Senior Notes due 2021 (the “2021 notes”) in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act. The 2021 notes bear interest at a rate of 5.00% per year payable semi-annually in arrears on February 15 and August 15 of each year, beginning August 15, 2016. The 2021 notes will mature on February 15, 2021, unless repurchased or converted in accordance with their terms prior to such date. Prior to August 15, 2020, the 2021 notes were convertible only upon satisfaction of certain conditions and during certain periods, and thereafter, at any time until the close of business on the second scheduled trading day immediately preceding the maturity date. Prior to May 16, 2019, the 2021 notes were convertible, subject to certain conditions, into cash only. On May 16, 2019, the company obtained shareholder approval under applicable New York Stock Exchange rules such that conversion of the 2021 notes may be settled in cash, the company’s common shares or a combination of cash and the company’s common shares, at the company’s election. At September 30, 2020, $1,250,000 aggregate principal amount of the 2021 Notes remained outstanding, following the repurchase of $16,000,000 aggregate principal amount of 2021 Notes for cash in the third quarter of 2019, the exchange transactions completed in the fourth quarter of 2019 and the second quarter of 2020, as further discussed below, and the repurchases of $24,466,000 aggregate principal amount in the third quarter of 2020. The $24,466,000 repurchases in the third quarter of 2020, resulted in a $761,000 loss on debt extinguishment.

Holders of the 2021 notes may convert their 2021 notes at their option at any time prior to the close of business on the business day immediately preceding August 15, 2020 only under the following circumstances: (1) during any fiscal quarter commencing after March 31, 2016 (and only during such fiscal quarter), if the last reported sale price of the company’s Common Shares for at least 20 trading days (whether or not consecutive) during the period of 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding fiscal quarter is greater than or equal to 130% of the applicable conversion price for the 2021 notes on each applicable trading day; (2) during the five business day period after any 10 consecutive trading day period (the “measurement period”) in which the “trading price” (as defined in the Indenture) per one thousand U.S. dollar principal amount of 2021 notes for each trading day of such measurement period was less than 98% of the product of the last reported sale price of the company’s Common Shares and the applicable conversion rate for the 2021 notes on each such trading day; or (3) upon the occurrence of specified corporate events described in the Indenture. On or after August 15, 2020 until the close of business on the second scheduled trading day immediately preceding the maturity of the 2021 Notes, holders may convert their 2021 Notes, at the option of the holder, regardless of the foregoing circumstances.
38
Notes to Financial StatementsLong-Term Liabilities

Holders of the 2021 notes will have the right to require the company to repurchase all or some of their 2021 notes at 100% of their principal, plus any accrued and unpaid interest, upon the occurrence of certain fundamental changes. The initial conversion rate is 60.0492 common shares per $1,000 principal amount of 2021 notes (equivalent to an initial conversion price of approximately $16.65 per common share). Until the company received shareholder approval on May 16, 2019 authorizing it to elect to settle future conversions of the 2021 Notes in common shares, the company separately accounted for the conversion features as a derivative. The derivative was capitalized on the balance sheet as a long-term liability with adjustment to reflect fair value each quarter until the change to the conversion features as a result of the shareholder approval received on May 16, 2019 resulted in the termination of the derivative. The fair value of the convertible debt conversion liability at issuance was $34,480,000. The company recognized a loss of $2,210,000 for the nine months ended September 30, 2019 related to the convertible debt conversion liability.

In connection with the offering of the 2021 notes, the company entered into privately negotiated convertible note hedge transactions with two financial institutions (the “option counterparties”). These transactions cover, subject to customary anti-dilution adjustments, the number of the company’s common shares that will initially underlie the 2021 notes, and are expected generally to reduce the potential equity dilution, and/or offset any cash payments in excess of the principal amount due, as the case may be, upon conversion of the 2021 notes. The company evaluated the note hedges under the applicable accounting literature, including Derivatives and Hedging, ASC 815, and determined that the note hedges should be accounted for as derivatives. These derivatives were capitalized on the balance sheet as long-term assets and will be adjusted to reflect fair value each quarter. The fair value of the convertible note hedge assets at issuance was $27,975,000. The company recognized a gain of $2,852,000 for the nine months ended September 30, 2019 related to the convertible note hedge asset.

The company entered into separate, privately negotiated warrant transactions with the option counterparties at a higher strike price relating to the same number of the company’s common shares, subject to customary anti-dilution adjustments, pursuant to which the company sold warrants to the option counterparties. The warrants could have a dilutive effect on the company’s outstanding common shares and the company’s earnings per share to the extent that the price of the company’s common shares exceeds the strike price of those warrants. The initial strike price of the warrants is $22.4175 per share and is subject to certain adjustments under the terms of the warrant transactions. The company evaluated the warrants under the applicable accounting literature, including
Derivatives and Hedging, ASC 815, and determined that the warrants meet the definition of a derivative, are indexed to the company's own stock and should be classified in shareholder's equity. The amount paid for the warrants and capitalized in shareholder's equity was $12,376,000.

The net proceeds from the offering of the 2021 notes were approximately $144,034,000, after deducting fees and offering expenses of $5,966,000, which were paid in 2016. These debt issuance costs were capitalized and are being amortized as interest expense through February 2021. Debt issuance costs are presented on the balance sheet as a direct deduction from the carrying amount of the related debt liability. Approximately $5,000,000 of the net proceeds from the offering were used to repurchase the company’s common shares from purchasers of 2021 notes in the offering in privately negotiated transactions. A portion of the net proceeds from the offering were used to pay the cost of the convertible note hedge transactions (after such cost is partially offset by the proceeds to the company from the warrant transactions), with a net cost of $15,600,000.
The liability components of the 2021 notes consist of the following (in thousands):
September 30, 2020December 31, 2019
Principal amount of liability component$1,250 $61,091 
Unamortized discount(22)(3,916)
Debt fees(4)(547)
Net carrying amount of liability component$1,224 $56,628 

The unamortized discount of $22,000 is to be amortized through February 2021. The effective interest rate on the liability component was 11.1%. Non-cash interest expense of $261,000 and $1,767,000 was recognized for the three and nine months ended September 30, 2020, respectively, compared to $1,444,000 and $5,391,000 for the three and nine months ended September 30, 2019, respectively. Actual interest expense accrued was $241,000 and $1,617,000 for the three and nine months ended September 30, 2020, respectively, compared to $1,834,000 and $5,584,000 for the three and nine months ended September 30, 2019, respectively, based on the stated coupon rate of 5.0%. The 2021 notes were not convertible as of September 30, 2020 nor was the applicable conversion threshold met.

Convertible senior notes due 2022

In the second quarter of 2017, the company issued $120,000,000 aggregate principal amount of 4.50% Convertible Senior Notes due 2022 (the “2022 notes”) in a private offering to qualified institutional buyers pursuant to
39
Notes to Financial StatementsLong-Term Liabilities
Rule 144A under the Securities Act. The 2022 notes bear interest at a rate of 4.50% per year payable semi-annually in arrears on June 1 and December 1 of each year, beginning December 1, 2017. The 2022 notes will mature on June 1, 2022, unless repurchased or converted in accordance with their terms prior to such date. Prior to December 1, 2021, the 2022 notes will be convertible only upon satisfaction of certain conditions and during certain periods, and thereafter, at any time until the close of business on the second scheduled trading day immediately preceding the maturity date. Prior to May 16, 2019, the 2022 notes were convertible, subject to certain conditions, into cash only. On May 16, 2019, the company obtained shareholder approval under applicable New York Stock Exchange rules such that conversion of the 2022 notes may be settled in cash, the company’s common shares or a combination of cash and the company’s common shares, at the company’s election. At September 30, 2020, $81,500,000 aggregate principal amount of the 2022 Notes remained outstanding, following the exchange transactions completed in the second quarter of 2020, as further discussed below.

Holders of the 2022 notes may convert their 2022 notes at their option at any time prior to the close of business on the business day immediately preceding December 1, 2021 only under the following circumstances: (1) during any fiscal quarter commencing after September 30, 2017 (and only during such fiscal quarter), if the last reported sale price of the company’s Common Shares for at least 20 trading days (whether or not consecutive) during the period of 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding fiscal quarter is greater than or equal to 130% of the applicable conversion price for the 2022 notes on each applicable trading day; (2) during the five business day period after any 10 consecutive trading day period (the “measurement period”) in which the “trading price” (as defined in the Indenture) per one thousand U.S. dollar principal amount of 2022 notes for each trading day of such measurement period was less than 98% of the product of the last reported sale price of the company’s Common Shares and the applicable conversion rate for the 2022 notes on each such trading day; or (3) upon the occurrence of specified corporate events described in the Indenture. On or after December 1, 2021 until the close of business on the second scheduled trading day immediately preceding the maturity of the 2022 Notes, holders may convert their 2022 Notes, at the option of the holder, regardless of the foregoing circumstances.

Holders of the 2022 notes will have the right to require the company to repurchase all or some of their 2022 notes at 100% of their principal, plus any accrued and unpaid interest, upon the occurrence of certain fundamental changes. The initial conversion rate is 61.6095 common shares per $1,000 principal amount of 2022 notes (equivalent to an initial conversion price of approximately $16.23 per common share).
Until the company received shareholder approval on May 16, 2019 authorizing it to elect to settle future conversions of the 2022 Notes in common shares, the company separately accounted for the conversion features as a derivative. The derivative was capitalized on the balance sheet as a long-term liability with adjustment to reflect fair value each quarter until the change to the conversion features as a result of the shareholder approval received on May 16, 2019 resulted in the termination of the derivative. The fair value of the convertible debt conversion liability at issuance was $28,859,000. The company recognized a loss of $6,193,000 for the nine months ended September 30, 2019 related to the convertible debt conversion liability.

In connection with the offering of the 2022 notes, the company entered into privately negotiated convertible note hedge transactions with one financial institution (the “option counterparty”). These transactions cover, subject to customary anti-dilution adjustments, the number of the company’s common shares that will initially underlie the 2022 notes, and are expected generally to reduce the potential equity dilution, and/or offset any cash payments in excess of the principal amount due, as the case may be, upon conversion of the 2022 notes. The company evaluated the note hedges under the applicable accounting literature, including Derivatives and Hedging, ASC 815, and determined that the note hedges should be accounted for as derivatives. These derivatives were capitalized on the balance sheet as long-term assets and will be adjusted to reflect fair value each quarter. The fair value of the convertible note hedge assets at issuance was $24,780,000. The company recognized a gain of $6,748,000 for the nine months ended September 30, 2019 related to the convertible note hedge asset.

The company entered into separate, privately negotiated warrant transactions with the option counterparty at a higher strike price relating to the same number of the company’s common shares, subject to customary anti-dilution adjustments, pursuant to which the company sold warrants to the option counterparties. The warrants could have a dilutive effect on the company’s outstanding common shares and the company’s earnings per share to the extent that the price of the company’s common shares exceeds the strike price of those warrants. The initial strike price of the warrants is $21.4375 per share and is subject to certain adjustments under the terms of the warrant transactions. The company evaluated the warrants under the applicable accounting literature, including Derivatives and Hedging, ASC 815, and determined that the warrants meet the definition of a derivative, are indexed to the company's own shares and should be classified in shareholder's equity. The amount paid for the warrants and capitalized in shareholder's equity was $14,100,000.

The net proceeds from the offering of the 2022 notes were approximately $115,289,000, after deducting fees and offering
40
Notes to Financial StatementsLong-Term Liabilities
expenses of $4,711,000, which were paid in 2017. These debt issuance costs were capitalized and are being amortized as interest expense through June 2022. Debt issuance costs are presented on the balance sheet as a direct deduction from the carrying amount of the related debt liability. A portion of the net proceeds from the offering were used to pay the cost of the convertible note hedge transactions (after such cost is partially offset by the proceeds to the company from the warrant transactions), which net cost was $10,680,000.

The liability components of the 2022 notes consist of the following (in thousands):
September 30, 2020December 31, 2019
Principal amount of liability component$81,500 $120,000 
Unamortized discount(7,837)(16,027)
Debt fees(1,011)(2,158)
Net carrying amount of liability component$72,652 $101,815 

The unamortized discount of $7,837,000 is to be amortized through June 2022. The effective interest rate on the liability component was 10.9%. Non-cash interest expense of $1,046,000 and $3,829,000 was recognized for the three and nine months ended September 30, 2020, respectively, compared to $1,320,000 and $4,038,000 for the three and nine months ended September 30, 2019, respectively. Actual interest expense accrued of $917,000 and $3,487,000 for the three and nine months ended September 30, 2020, respectively, compared to $1,350,000 and $4,050,000 for the three and nine months ended September 30, 2019, respectively, based on the stated coupon rate of 4.5%. The 2022 notes were not convertible as of September 30, 2020 nor was the applicable conversion threshold met.

Convertible senior notes Series I due 2024

During the fourth quarter of 2019, the company entered into separate privately negotiated agreements with certain holders of its 2021 Notes to exchange $72,909,000 in aggregate principal amount of 2021 Notes for aggregate consideration of $72,909,000 in aggregate principal amount of new 5.00% Convertible Senior Exchange Notes due 2024 (the “2024 Notes”) of the company and $6,928,000 in cash.

The notes bear interest at a rate of 5.00% per year payable semi-annually in arrears on May 15 and November 15 of each year, beginning May 15, 2020. The notes will mature on November 15, 2024, unless repurchased, redeemed or converted in accordance with their terms prior to such date. Prior to May 15, 2024, the 2024 notes will be convertible only upon satisfaction of certain conditions and during certain periods, and thereafter, at any time until the close of business
on the second scheduled trading day immediately preceding the maturity date. The 2024 notes may be settled in cash, the company’s common shares or a combination of cash and the company’s common shares, at the company’s election.

Prior to the maturity of the 2024 Notes, the company may, at its election, redeem for cash all or part of the 2024 Notes if the last reported sale price of the company’s common shares equals or exceeds 130% of the conversion price then in effect for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading day period (including the last trading day of such period) ending on, and including, the trading day immediately preceding the date on which the company provides notice of redemption. The redemption price will be equal to 100% of the principal amount of the 2024 Notes to be redeemed, plus accrued and unpaid interest to, but excluding, the redemption date (subject to certain limited exceptions). No sinking fund is provided for the 2024 Notes, which means the company is not required to redeem or retire the 2024 Notes periodically.

Holders of the 2024 notes may convert their 2024 notes at their option at any time prior to the close of business on the business day immediately preceding May 15, 2024 only under the following circumstances: (1) during any calendar quarter commencing after the calendar quarter ending December 31, 2019 (and only during such calendar quarter), if the last reported sale price of the company’s Common Shares for at least 20 trading days (whether or not consecutive) during the period of 30 consecutive trading days ending on the last trading day of the immediately preceding calendar quarter is greater than or equal to 130% of the conversion price for the 2024 notes on each applicable trading day; (2) during the five business day period after any 10 consecutive trading day period (the “measurement period”) in which the “trading price” (as defined in the Indenture) per one thousand U.S. dollar principal amount of 2024 notes for each trading day of such measurement period was less than 98% of the product of the last reported sale price of the company’s Common Shares and the applicable conversion rate for the 2024 notes on each such trading day; (3) upon the occurrence of specified corporate events described in the Indenture; or (4) if the company calls the 2024 Notes for redemption pursuant to the terms of the Indenture. Holders of the 2024 notes will have the right to require the company to repurchase all or some of their 2024 notes at 100% of their principal, plus any accrued and unpaid interest, upon the occurrence of certain fundamental changes. The initial conversion rate is 67.6819 common shares per $1,000 principal amount of 2024 notes (equivalent to an initial conversion price of approximately $14.78 per common share). On or after May 15, 2024 until the close of business on the second scheduled trading day immediately preceding the maturity of the 2024 Notes, holders may convert their 2024 Notes, at the option of the holder, regardless of the foregoing circumstances.
41
Notes to Financial StatementsLong-Term Liabilities

A loss of $5,885,000 was recorded a part of the exchange transaction, which included the write-off of fees related to the portion of the 2021 note exchanged. Debt issuance costs of $1,394,000 were capitalized and are being amortized as interest expense through November 15. Debt issuance costs are presented on the balance sheet as a direct deduction from the carrying amount of the related debt liability.
The liability components of the 2024 notes consist of the following (in thousands):
September 30, 2020December 31, 2019
Principal amount of liability component$72,909 $72,909 
Unamortized discount(9,363)(10,733)
Debt fees(1,103)(1,359)
Net carrying amount of liability component$62,443 $60,817 

The unamortized discount of $9,363,000 is to be amortized through November 15, 2024. The effective interest rate on the liability component was 8.77%. Non-cash interest expense of $468,000 and $1,370,000 was recognized for the three and nine months ended September 30, 2020, respectively. Actual interest expense accrued $912,000 and $2,735,000 for the three and nine months ended September 30, 2020, respectively, based on the stated coupon rate of 5.0%. The 2024 notes were not convertible as of September 30, 2020 nor was the applicable conversion threshold met.


Convertible senior notes Series II due 2024

During the second quarter of 2020, the company entered into separate, privately negotiated agreements with certain holders of its 2021 Notes and certain holders of its 2022 Notes to exchange $35,375,000 in aggregate principal amount of 2021 Notes and $38,500,000 in aggregate principal amount of 2022 notes, for aggregate consideration of $73,875,000 in aggregate principal amount of new 5.00% Series II Convertible Senior Exchange Notes due 2024 (the “Series II Notes”) of the company and $5,593,000 in cash.

The notes bear interest at a rate of 5.00% per year, payable semi-annually in arrears on May 15 and November 15 of each year, beginning November 15, 2020. The notes will mature on November 15, 2024, unless repurchased, redeemed or converted in accordance with their terms prior to such date. Prior to May 15, 2024, the Series II Notes will be convertible only upon satisfaction of certain conditions and during certain periods, and thereafter, at any time until the close of business on the second scheduled trading day immediately preceding the maturity date. The Series II Notes may be settled in cash,
the company’s common shares or a combination of cash and the company’s common shares, at the company’s election.

Prior to the maturity of the Series II Notes, the company may, at its election, redeem for cash all or part of the Series II Notes, if the last reported sale price of the company’s common shares equals or exceeds 130% of the conversion price then in effect for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading day period (including the last trading day of such period) ending on, and including, the trading day immediately preceding the date on which the company provides notice of redemption. The redemption price will be equal to 100% of the accreted principal amount of the Series II Notes to be redeemed, plus any accrued and unpaid interest, if any, on the original principal amount of the New Notes redeemed to, but excluding, the redemption date (subject to certain limited exceptions). No sinking fund is provided for the Series II Notes, which means the company is not required to redeem or retire the Series II Notes periodically.

Holders of the Series II notes may convert their Series II notes at their option at any time prior to the close of business on the business day immediately preceding May 15, 2024 only under the following circumstances: (1) during any calendar quarter commencing after the calendar quarter ending June 30, 2020 (and only during such calendar quarter), if the last reported sale price of the company’s Common Shares for at least 20 trading days (whether or not consecutive) during the period of 30 consecutive trading days ending on the last trading day of the immediately preceding calendar quarter is greater than 130% of the conversion price for the Series II notes on each applicable trading day; (2) during the five business day period after any 10 consecutive trading day period (the “measurement period”) in which the “trading price” (as defined in the Indenture) per one thousand U.S. dollar principal amount of Series II notes for each trading day of such measurement period was less than 98% of the product of the last reported sale price of the company’s Common Shares and the applicable conversion rate for the Series II notes on each such trading day; (3) upon the occurrence of specified corporate events described in the Indenture; or (4) if the company calls the Series II Notes for redemption pursuant to the terms of the Indenture. Holders of the Series II notes will have the right to require the company to repurchase all or some of their Series II at 100% of the accreted principal amount, plus any accrued and unpaid interest, upon the occurrence of certain fundamental changes. The initial conversion rate is 67.6819 common shares per $1,000 principal amount of Series II Notes (equivalent to an initial conversion price of approximately $14.78 per common share). On or after May 15, 2024 until the close of business on the second scheduled trading day immediately preceding the maturity of the Series II, holders may convert their Series II, at
42
Notes to Financial StatementsLong-Term Liabilities
the option of the holder, regardless of the foregoing circumstances.

The principal amount of the Series II Notes also will accrete at a rate of approximately 4.7% per year commencing June 4, 2020, compounding on a semi-annual basis. The accreted portion of the principal is payable in cash upon maturity but does not bear interest and is not convertible into the company’s common shares. The amount accreted as of September 30, 2020 was $1,016,000.

A loss of $6,599,000 was recorded a part of the exchange transaction, which included the write-off of fees related to portions of the 2021 and 2022 note exchanged. Debt issuance costs of $1,518,000 were capitalized and are being amortized as interest expense through November 2024. Debt issuance costs are presented on the balance sheet as a direct deduction from the carrying amount of the related debt liability.

The liability components of the Series II Notes consist of the following (in thousands):
September 30, 2020
Principal amount of liability component - including accretion$74,891 
Unamortized discount(9,967)
Debt fees(1,368)
Net carrying amount of liability component$63,556 

The unamortized discount of $9,967,000 is to be amortized through November 15, 2024. The effective interest rate on the liability component was 8.99%. Non-cash interest expense, including accretion, of $1,260,000 and $1,663,000 was recognized for the three and nine months ended September 30, 2020, respectively. Actual interest expense accrued of $923,000 and $1,200,000 for the three and nine months ended September 30, 2020, respectively, based on the stated coupon rate of 5.0%. The 2024 notes were not convertible as of June 30, 2020 nor was the applicable conversion threshold met.

CARES Act Loan

On May 15, 2020 the company entered into an unsecured loan agreement in the aggregate amount of $10,000,000 pursuant to sections 1102 and 1106 of the Coronavirus Aid, Relief and Economic Security, "CARES," Act which was evidenced by a promissory note, dated May 13, 2020, and bears interest at a fixed rate of 1.00%, payable in monthly payments commencing on December 13, 2020. Payments were subsequently deferred to commence on March 13, 2021. This loan may be forgivable, partially or in full, if certain conditions are met, principally based on having been disbursed
for permissible purposes and based on average levels of employment over a designated period of time. No assurance can be given that the company will be granted forgiveness of the loan in whole or in part. The company has recorded $2,816,000 of the amount borrowed in current maturities of long term debt.
43
Notes to Financial StatementsLong-Term Liabilities
Other Long-Term Obligations


Other long-term obligations consist of the following (in thousands):
September 30, 2020December 31, 2019
Deferred income taxes$24,223 $23,376 
Product liability13,545 13,414 
Pension 7,586 7,006 
Deferred gain on sale leaseback5,582 5,819 
Deferred compensation5,318 5,354 
Supplemental Executive Retirement Plan liability5,245 5,433 
Uncertain tax obligation including interest2,660 2,612 
Other6,589 3,935 
Other Long-Term Obligations$70,748 $66,949 

On April 23, 2015, the company entered into a real estate sale leaseback transaction which resulted in the company recording an initial deferred gain of $7,414,000, the majority of which is included in Other Long-Term Obligations and will be recognized over the 20-year life of the leases. The gains realized were $77,000 and $228,000 for the for the three and nine months ended September 30, 2020, respectively, compared to $74,000 and $220,000 for the three and nine months ended September 30, 2019, respectively.














44
Notes to Financial StatementsLeases and Commitments
Leases and Commitments

The company reviews new contracts in accordance with ASU 2016-02, "Leases" to determine if the contracts include a lease. To the extent a lease agreement includes an extension option that is reasonably certain to be exercised, the company has recognized those amounts as part of the right-of-use assets and lease liabilities. The company combines lease and non-lease components, such as common area maintenance, in the calculation of the lease assets and related liabilities. As most lease agreements do not provide an implicit rate, the company uses an incremental borrowing rate (IBR) based on information available at commencement date in determining the present value of lease payments and to help classify the lease as operating or financing. The company calculates its IBR based on the secured rates of the company's recent debt issuances, the credit rating of the company, changes in currencies, lease repayment timing as well as other publicly available data.

The company leases a portion of its facilities, transportation equipment, data processing equipment and certain other equipment. These leases have terms from 1 to 20 years and provide for renewal options. Generally, the company is required to pay taxes and normal expenses associated with operating the facilities and equipment. As of September 30, 2020, the company is committed under non-cancelable operating leases, which have initial or remaining terms in excess of one year and expire on various dates through 2035.

On April 23, 2015, the company sold and leased back, under four separate lease agreements, four properties located in Ohio and one property in Florida for net proceeds of $23,000,000, which were used to reduce debt under the U.S. and Canadian Credit Facility. The initial total annual rent for the properties was $2,275,000 and can increase annually over the 20-year term of the leases based on the applicable geographical consumer price index (CPI). Each of the four lease agreements contains three 10-year renewals with the rent for each option term based on the greater of the then-current fair market rent for each property or the then- current rate and increasing annually by the applicable CPI. Under the terms of the lease agreements, the company is responsible for all taxes, insurance and utilities. The company is permitted to sublet the properties; however, the properties are currently being utilized exclusively by the company and there is no current subletting. The company is required to adequately maintain each of the properties and any leasehold improvements will be amortized over the lesser of the lives of the improvements or the remaining lease lives, consistent with any other company leases.



In connection with the transaction, the requirements for sale lease-back accounting were met. Accordingly, the company recorded the sale of the properties, removed the related property and equipment from the company's balance sheet, recognized an initial deferred gain of $7,414,000 and an immediate loss of $257,000 related to one property and recorded new lease liabilities. Specifically, the company recorded four capital leases totaling $32,339,000 and one operating lease related to leased land, which was not a material component of the transaction. The gains on the sales of the properties were required to be deferred and recognized over the life of the leases as the property sold is being leased back. The deferred gain is classified under Other Long-Term Obligations on the condensed consolidated balance sheet. The gains realized were $77,000 and $228,000 for the three and nine months ended September 30, 2020, respectively, compared to $74,000 and $220,000 for the three and nine months ended September 30, 2019, respectively.

In December 2018, the company entered into a 20-year lease agreement in Germany. The lease commenced in July 2020. The lease increased the company's financing lease obligations by $36,916,000.
Lease expense for the three and nine months ended September 30, 2020 and September 30, 2019, respectively, were as follows (in thousands):
For the Three Months Ended September 30,For the Nine Months Ended September 30,
2020201920202019
Operating leases$1,926 $2,696 $6,210 $8,175 
Variable and short-term leases1,077 894 2,936 1,974 
Total operating leases$3,003 $3,590 $9,146 $10,149 
Finance lease interest cost$829 $346 $1,483 $977 
Finance lease depreciation980 706 2,346 1,957 
Total finance leases$1,809 $1,052 $3,829 $2,934 





45
Notes to Financial StatementsLeases and Commitments
Future minimum operating and finance lease commitments, as of September 30, 2020, are as follows (in thousands):
Finance 
Leases		Operating Leases
2020$1,873 $1,842 
20217,416 6,027 
20226,487 3,466 
20236,421 1,407 
20246,365 890 
Thereafter84,251 786 
Total future minimum lease payments112,813 14,418 
Amounts representing interest(45,511)(1,393)
Present value of minimum lease payments67,302 13,025 
Less: current maturities of lease obligations(3,352)(5,843)
Long-term lease obligations$63,950 $7,182 
Supplemental cash flow amounts for the nine months ended September 30, 2020 were as follows (in thousands):
Cash Activity: Cash paid in measurement of amounts for lease liabilitiesSeptember 30, 2020
Operating Leases$9,407 
Financing Leases3,429 
Total$12,836 
Non-Cash Activity: Right-of-use assets obtained in exchange for lease obligationsSeptember 30, 2020
Operating Leases$2,789 
Financing Leases39,942 
Total$42,731 



















Weighted-average remaining lease terms and discount rates for finance and operating leases are as follows as of September 30, 2020:
September 30, 2020
Weighted-average remaining lease term - finance leases17.2 years
Weighted-average remaining lease term - operating leases3.2 years
Weighted-average discount rate - finance leases6.32%
Weighted-average discount rate - operating leases7.74%


46
Notes to Financial StatementsRevenue
Revenue

The company has two revenue streams: products and services. Services include repair, refurbishment, preventive maintenance and rental of product. Services for the North America segment include maintenance and repair of product. Services for the Europe segment include repair, refurbishment and preventive maintenance services. Services in All Other, are in the Asia Pacific region, and include rental and repair of product. The following tables disaggregate the company’s revenues by major source and by reportable segment for the three and nine months ended September 30, 2020 and September 30, 2019 (in thousands):
Three Months Ended September 30, 2020
ProductServiceTotal
Europe$113,043 $3,242 $116,285 
North America87,821 234 88,055 
Other (Asia/Pacific)6,428 1,138 7,566 
Total$207,292 $4,614 $211,906 
% Split98%2%100%
Nine Months Ended September 30, 2020
ProductServiceTotal
Europe$329,943 $9,204 $339,147 
North America260,999 596 261,595 
Other (Asia/Pacific)22,565 3,339 25,904 
Total$613,507 $13,139 $626,646 
% Split98%2%100%
Three Months Ended September 30, 2019
ProductServiceTotal
Europe$133,839 $3,532 $137,371 
North America86,761 357 87,118 
Other (Asia/Pacific)10,047 1,238 11,285 
Total$230,647 $5,127 $235,774 
% Split98%2%100%
Nine Months Ended September 30, 2019
ProductServiceTotal
Europe$386,007 $10,199 $396,206 
North America261,707 1,208 262,915 
Other (Asia/Pacific)32,242 3,688 35,930 
Total$679,956 $15,095 $695,051 
% Split98%2%100%
The company's revenues are principally related to the sale of products, approximately 98%, with the remaining 2% related to services including repair, refurbishment, preventive maintenance and rental of product. While the company has a significant amount of contract types, the sales split by contract type is as follows: general terms and conditions (31%), large national customers (26%), governments, principally pursuant to tender contracts (20%) and other customers including buying groups and independent customers (23%).

All product and substantially all service revenues are recognized at a point in time. The remaining service revenue, recognized over time, are reflected in the Europe segment and include multiple performance obligations. For such contracts, the company allocates revenue to each performance obligation based on its relative standalone selling price. The company generally determines the standalone selling price based on the expected cost-plus margin methodology.    

Revenue is recognized when obligations under the terms of a contract with the customer are satisfied; generally, this occurs with the transfer of control of the company’s products and services. Revenue is measured as the amount of consideration expected to be received in exchange for transferring product or providing services. The amount of consideration received and revenue recognized by the company can vary as a result of variable consideration terms included in the contracts related to customer rebates, cash discounts and return policies. Customer rebates and cash discounts are estimated based on the most likely amount principle and these estimates are based on historical experience and anticipated performance. In addition, customers have the right to return product within the company’s normal terms policy, and as such the company estimates the expected returns based on an analysis of historical experience. The company adjusts its estimate of revenue at the earlier of when the most likely amount of consideration it expects to receive changes or when the consideration becomes fixed. The company generally does not expect that there will be significant changes to its estimates of variable consideration (see “Receivables” and "Accrued Expenses" in the Notes to the Condensed Consolidated Financial Statements include elsewhere in this report for more detail).

Depending on the terms of the contract, the company may defer the recognition of a portion of the revenue at the end of a reporting period to align with transfer of control of the company’s products to the customer. In addition, to the extent performance obligations are satisfied over time, the company defers revenue recognition until the performance obligations
47
Notes to Financial StatementsRevenue
are satisfied. As of September 30, 2020 and December 31, 2019, the company had deferred revenue of $3,436,000 and $3,173,000, respectively, related to outstanding performance obligations.
48
Notes to Financial StatementsEquity Compensation
Equity Compensation

The company’s Common Shares have a $0.25 stated value. The Common Shares and the Class B Common Shares generally have identical rights, terms and conditions and vote together as a single class on most issues, except that the Class B Common Shares have ten votes per share, carry a 10% lower cash dividend rate and, in general, can only be transferred to family members or for estate planning purposes. Holders of Class B Common Shares are entitled to convert their shares into Common Shares at any time on a share-for-share basis. When Class B Common Shares are transferred out of a familial relationship, they automatically convert to Common Shares. The Board of Directors suspended further dividends on the Common Shares and the Class B Common Shares.

As of September 30, 2020, 6,357 Class B Common Shares remained outstanding. Prior conversions of Class B Common Shares have substantially diminished the significance of the company’s dual class voting structure. As of September 30, 2020, the holders of the Common Shares represented approximately 99.9% of the company’s total outstanding voting power.

Equity Compensation Plan

On May 17, 2018, the shareholders of the company approved the Invacare Corporation 2018 Equity Compensation Plan (the “2018 Plan”), which was adopted on March 27, 2018 by the company's Board of Directors (the “Board”). The company’s Board adopted the 2018 Plan in order to authorize additional Common Shares for grant as equity compensation, and to reflect changes to Section 162(m) of the Internal Revenue Code (the “Code”) resulting from the U.S. Tax Cuts and Jobs Act of 2017.
Following shareholder approval of the 2018 Plan, all of the Common Shares then-remaining available for issuance under the Invacare Corporation 2013 Equity Compensation Plan (the “2013 Plan”) and all of the Common Shares that were forfeited or remained unpurchased or undistributed upon termination or expiration of awards under the 2013 Plan and under the Invacare Corporation 2003 Performance Plan (the “2003 Plan”), become available for issuance under the 2018 Plan. Awards granted previously under the 2013 Plan and 2003 Plan will remain in effect under their original terms.
The 2018 Plan uses a fungible share-counting method, under which each Common Share underlying an award of share options or share appreciation rights ("SAR") will count against the number of total shares available under the 2018 Plan as one share; and each Common Share underlying any award other than a share option or a SAR will count against
the number of total shares available under the 2018 Plan as two shares. Shares underlying awards made under the 2003 Plan or 2013 Plan that are forfeited or remain unpurchased or undistributed upon termination or expiration of the awards will become available under the 2018 Plan for use in future awards. Any Common Shares that are added back to the 2018 Plan as the result of forfeiture, termination or expiration of an award granted under the 2018 Plan or the 2013 Plan will be added back in the same manner such shares were originally counted against the total number of shares available under the 2018 Plan or 2013 Plan, as applicable. Each Common Share that is added back to the 2018 Plan due to a forfeiture, termination or expiration of an award granted under the 2003 Plan will be added back as one Common Share.
The Compensation and Management Development Committee of the Board (the “Compensation Committee”), in its discretion, may grant an award under the 2018 Plan to any director or employee of the company or an affiliate. As of September 30, 2020, 3,513,468 Common Shares were available for future issuance under the 2018 Plan in connection with the following types of awards with respect to the company's Common Shares: incentive share options, nonqualified share options, SARs, restricted shares, restricted share units, unrestricted shares and performance shares. The Compensation Committee also may grant performance units that are payable in cash. The Compensation Committee has the authority to determine which participants will receive awards, the amount of the awards and the other terms and conditions of the awards. The Common Shares authorized for issuance under the 2018 Plan includes an additional 1,400,000 Common Shares that were approved by shareholders at the company’s 2020 annual meeting on May 21, 2020.

In the second quarter of 2020 the company transferred a total of 1,004,079 shares into the 2018 Plan from the 2003 and 2013 Plans. At September 30, 2020, an aggregate of 328,274 Common Shares underlie awards which were forfeited or expired unexercised under the 2003 and 2013 Plans and thus are available to be transferred into the 2018 Plan.
The 2018 Plan provides that shares granted come from the company's authorized but unissued Common Shares or treasury shares. In addition, the company's equity compensation plans allow employee participants to exchange shares for minimum withholding taxes, which results in the company acquiring treasury shares.
49
Notes to Financial StatementsEquity Compensation
The amounts of equity-based compensation expense recognized as part of SG&A expenses in All Other in business segments were as follows (in thousands):
For the Nine Months Ended September 30,
20202019
Restricted share / units$4,471 $3,891 
Performance shares / units2,494 1,648 
Non-qualified and performance share options— 334 
Total share-based compensation expense$6,965 $5,873 

As of September 30, 2020, unrecognized compensation expense related to equity-based compensation arrangements granted under the company's 2018 Plan and previous plans, which is related to non-vested shares, was as follows (in thousands):
September 30, 2020
Restricted share and restricted share units$8,443 
Performance shares and performance share units11,144 
Total unrecognized share-based compensation expense$19,587 



Total unrecognized compensation cost will be adjusted for future changes in actual and estimated forfeitures and for updated vesting assumptions for the performance share awards (see "Share Options" and "Performance Shares and Performance Share Units" below). No tax benefits for share-based compensation were realized during the three and nine months ended September 30, 2020 and 2019, respectively, due to a valuation allowance against deferred tax assets. In accordance with ASC 718, any tax benefits resulting from tax deductions in excess of the compensation expense recognized is classified as a component of financing cash flows.

Share Options

Generally, non-qualified share option awards have a term of ten years and were granted with an exercise price per share equal to the fair market value of one of the company’s Common Shares on the date of grant. Share option awards granted in 2017 were performance-based awards and became exercisable based upon achievement of performance goals established by the Compensation Committee and achieved over the three-year period ended in 2019 and were subject to the Compensation Committee's exercise of negative discretion to reduce the number of options vested based on the progress towards the company's transformation. The company recognized the compensation expense over a weighted-average period of approximately two years.
The following table summarizes information about share option activity for the nine months ended September 30, 2020:
Weighted Average
Exercise Price
Options outstanding at January 1, 20201,441,202 $18.26 
Canceled(354,006)24.88
Options outstanding at September 30, 20201,087,196 $16.12 
Options exercise price range at September 30, 2020$12.15 to$33.36 
Options exercisable at September 30, 20201,087,196 
Shares available for grant at September 30, 2020*3,513,468 
________
 *    Shares available for grant under the 2018 Plan as of September 30, 2020 reduced by net restricted share and restricted share unit award activity of 696,058 shares and performance share and performance share unit award activity of 1,859,054 shares.












50
Notes to Financial StatementsEquity Compensation
The following table summarizes information about stock options outstanding at September 30, 2020:
 Options OutstandingOptions Exercisable
Exercise PricesNumber
Outstanding at
September 30, 2020		Weighted Average
Remaining
Contractual Life (Years)		Weighted Average
Exercise Price		Number
Exercisable at
September 30, 2020		Weighted Average
Exercise Price
$12.15 – $20.00
777,159 5.1$12.74 777,159 $12.73 
$20.01 – $25.00
300,149 0.924.45 300,149 24.45 
$25.01 – $30.00
5,392 0.227.82 5,392 27.82 
$30.01 – $33.36
4,496 0.633.36 4,496 33.36 
Total1,087,196 3.9$16.12 1,087,196 $16.12 

The 2018 Plan provides for a one-year minimum vesting period for share options and, generally, options must be exercised within ten years from the date granted. No share options were issued in 2020 or 2019. The performance-based options issued in 2017 vested after the conclusion of the three-year performance period ending December 31, 2019.

Restricted Share and Restricted Share Units

The following table summarizes information about restricted shares and restricted share units (primarily for non-U.S. recipients):
Weighted Average Fair Value
Shares / Units unvested at
January 1, 2020		965,085 $11.32 
Granted764,012 7.11 
Vested(452,922)11.47 
Canceled(94,993)10.19 
Shares / Units unvested at
September 30, 2020		1,181,182 $8.63 

The 2018 Plan provides for a one-year minimum vesting period for restricted share awards, the outstanding restricted share awards generally vest ratably over the three years after the award date. Unearned restricted share compensation, determined as the market value of the shares at the date of grant, is being amortized on a straight-line basis over the vesting period.












Performance Shares and Performance Share Units

The following table summarizes information about performance shares and performance share units (for non-U.S. recipients):
 Weighted Average Fair Value
Shares / Units unvested at January 1, 2020753,272 $11.82 
Granted523,329 7.08 
Canceled(65,976)9.48 
Shares / Units unvested at
September 30, 2020		1,210,625 $9.90 

During the nine months ended September 30, 2020, performance shares and performance share units (for non-U.S. recipients) were granted as performance awards with a three-year performance period with payouts based on achievement of certain performance goals. The awards are classified as equity awards as they will be settled in Common Shares upon vesting. The number of shares earned will be determined at the end of the three-year performance period based on achievement of performance criteria for January 1, 2020 through December 31, 2022 established by the Compensation Committee at the time of grant. Recipients will be entitled to receive a number of Common Shares equal to the number of performance shares that vest based upon the levels of achievement which may range between 0% and 150% of the target number of shares with the target being 100% of the initial grant.

The fair value of the performance awards is based on the share price on the date of grant discounted for the estimated value of dividends foregone as the awards are not eligible for dividends except to the extent vested. The company assesses the probability that the performance targets will be met with expense recognized whenever it is probable that at least the minimum performance criteria will be achieved. Depending upon the company's assessment of the probability of achievement of the goals, the company may not recognize any expense associated with performance awards in a given
51
Notes to Financial StatementsEquity Compensation
period, may reverse prior expense recorded or record additional expense to make up for expense not recorded in a prior period. Performance award compensation expense is generally expected to be recognized over three years. Expense is being recognized for the 2018, 2019 and 2020 awards as it is considered probable that the performance goals for those awards will be met.
52
Notes to Financial StatementsAccumulated Other Comprehensive Income
Accumulated Other Comprehensive Income (Loss) by Component

Changes in accumulated other comprehensive income ("OCI") (in thousands):
Foreign CurrencyLong-Term NotesDefined Benefit PlansDerivativesTotal
June 30, 2020$16,455 $(9,133)$(3,468)$794 $4,648 
OCI before reclassifications35,231 713 281 (2,501)33,724 
Amount reclassified from accumulated OCI— — (474)739 265 
Net current-period OCI35,231 713 (193)(1,762)33,989 
September 30, 2020$51,686 $(8,420)$(3,661)$(968)$38,637 
Foreign CurrencyLong-Term NotesDefined Benefit PlansDerivativesTotal
December 31, 2019$8,898 $(2,491)$(3,299)$20 $3,128 
OCI before reclassifications42,788 (5,929)122 (1,340)35,641 
Amount reclassified from accumulated OCI— — (484)352 (132)
Net current-period OCI42,788 (5,929)(362)(988)35,509 
September 30, 2020$51,686 $(8,420)$(3,661)$(968)$38,637 
Foreign CurrencyLong-Term NotesDefined Benefit PlansDerivativesTotal
June 30, 2019$13,122 $(2,200)$(2,778)$1,627 $9,771 
OCI before reclassifications(5,729)(3,328)(504)557 (9,004)
Amount reclassified from accumulated OCI— — 303 (860)(557)
Net current-period OCI(5,729)(3,328)(201)(303)(9,561)
September 30, 2019$7,393 $(5,528)$(2,979)$1,324 $210 
Foreign CurrencyLong-Term NotesDefined Benefit PlansDerivativesTotal
December 31, 2018$12,244 $2,662 $(2,703)$590 $12,793 
OCI before reclassifications(4,851)(8,190)(922)2,179 (11,784)
Amount reclassified from accumulated OCI— — 646 (1,445)(799)
Net current-period OCI(4,851)(8,190)(276)734 (12,583)
September 30, 2019$7,393 $(5,528)$(2,979)$1,324 $210 











53
Notes to Financial StatementsAccumulated Other Comprehensive Income
Reclassifications out of accumulated OCI were as follows (in thousands):
Amount reclassified from OCIAffected line item in the Statement of Comprehensive (Income) Loss
For the Three Months Ended September 30,For the Nine Months Ended September 30,
2020201920202019
Defined Benefit Plans 
Service and interest costs$(474)$303 $(484)$646 Selling, general and administrative expenses
Tax— — — — Income tax provision
Total after tax$(474)$303 $(484)$646 
Derivatives
Foreign currency forward contracts hedging sales$(481)$(197)$(692)$(189)Net sales
Foreign currency forward contracts hedging purchases1,259 (747)1,029 (1,375)Cost of products sold
Total loss (income) before tax778 (944)337 (1,564)
Tax(39)84 15 119 Income tax provision (benefit)
Total after tax$739 $(860)$352 $(1,445)
54
Notes to Financial StatementsCharges Related to Restructuring Activities
Charges Related to Restructuring Activities

The company's restructuring charges were originally necessitated primarily by continued declines in Medicare and Medicaid reimbursement by the U.S. government, as well as similar healthcare reimbursement pressures abroad, which negatively affect the company's customers (e.g. home health care providers) and continued pricing pressures faced by the company due to the outsourcing by competitors to lower cost locations. Restructuring decisions were also the result of reduced profitability in North America and Asia Pacific. In addition, as a result of the company's transformation strategy, additional restructuring actions were implemented in 2017 and have continued into 2020.

For the nine months ended September 30, 2020, charges totaled $4,657,000 which were related to North America of $865,000, Europe of $3,674,000 and All Other of $118,000. In North America and All Other, costs were incurred related to severance. The European charges were for severance costs of $3,328,000 and contract terminations of $346,000 primarily related to the closure of a German manufacturing facility. Payments for the nine months ended September 30, 2020 were $5,692,000 and the cash payments were funded with the company's cash on hand. The 2020 charges are expected to be paid out within twelve months.
For the nine months ended September 30, 2019, charges totaled $3,641,000 which were related to North America of
$1,539,000, Europe of $1,903,000 and All Other of $199,000. In North America, costs were incurred related to severance of $1,495,000 and contract terminations of $44,000. The European and All Other charges were for severance costs. Payments for the nine months ended September 30, 2019 were $4,152,000 and the cash payments were funded with company's cash on hand. Most of the 2019 charges have been paid out.
There have been no material changes in accrued balances related to the charges, either as a result of revisions to the plans or changes in estimates. In addition, the savings anticipated as a result of the company's restructuring plans have been or are expected to be achieved, primarily resulting in reduced salary and benefit costs principally impacting Selling, General and Administrative expenses, and to a lesser extent, Costs of Products Sold. To date, the company's liquidity has not been materially impacted by the restructuring plans. Please refer to Charges Related to Restructuring Activities of company's Annual Report on Form 10-K for the period ending December 31, 2019 for disclosure of restructuring activity prior to 2020.

55
Notes to Financial StatementsCharges Related to Restructuring Activities
A progression by reporting segment of the accruals recorded as a result of the restructuring for the nine months ended September 30, 2020 is as follows (in thousands):
SeveranceContract TerminationsTotal
December 31, 2019 Balances
North America$211 $— $211 
Europe6,406 4 6,410 
All Other406 — 406 
Total7,023 4 7,027 
Charges
North America 691 — 691 
Europe592 73 665 
All Other36 — 36 
Total 1,319 73 1,392 
Payments
North America (562)— (562)
Europe (959)(73)(1,032)
All Other(276)— (276)
Total (1,797)(73)(1,870)
March 31, 2020 Balances
North America340 — 340 
Europe6,039 4 6,043 
All Other166 — 166 
Total$6,545 $4 $6,549 
Charges
North America$28 $— $28 
Europe1,302 273 1,575 
All Other82 — 82 
Total1,412 273 1,685 
Payments
North America(265)— (265)
Europe(1,596)(273)(1,869)
All Other(82)— (82)
Total(1,943)(273)(2,216)
June 30, 2020 Balances
North America103 — 103 
Europe5,745 4 5,749 
All Other166 — 166 
Total$6,014 $4 $6,018 
Charges
North America146 — 146 
Europe1,434 — 1,434 
All Other— — — 
Total1,580 — 1,580 
Payments
North America(151)— (151)
Europe(1,455)— (1,455)
All Other— — — 
Total(1,606)— (1,606)
56
Notes to Financial StatementsCharges Related to Restructuring Activities
SeveranceContract TerminationsTotal
September 30, 2020 Balances
North America98 — 98 
Europe5,724 4 5,728 
All Other166 — 166 
Total$5,988 $4 $5,992 
57
Notes to Financial StatementsIncome Taxes
Income Taxes

The company had an effective tax rate of 39.2% and 26.8% on losses before tax for the three and nine months ended September 30, 2020, respectively, compared to an expected benefit of 21.0% on the pre-tax loss for each period. The company had an effective tax rate of 69.6% and 26.8% on losses before tax for the three and nine months ended and September 30, 2019, respectively, compared to an expected benefit for the three and nine months ended September 30, 2019 of 21.0% on the pre-tax loss for each period. The company's effective tax rate for the three and nine months ended September 30, 2020 and September 30, 2019 were unfavorable as compared to the U.S. federal statutory rate expected benefit, principally due to the negative impact of the company not being able to record tax benefits related to the significant losses in countries which had tax valuation allowances. The effective tax rate was increased for the three and nine months ended September 30, 2020 and September 30, 2019 by certain taxes outside the United States, excluding countries with tax valuation allowances, that were at an effective rate higher than the U.S. statutory rate, except for the gain on the disposition of Dynamic Controls which was not taxable locally. In addition, the company had accrued withholding taxes on earnings of its Chinese subsidiary based on the expectation of not permanently reinvesting those earnings. The sale of this entity, without such distribution resulted in the reversal of this accrual in the amount of $988,000 for the nine months ended September 30, 2020.

58
Notes to Financial StatementsNet Earnings (Loss) Per Common Share
Net Loss Per Common Share

The following table sets forth the computation of basic and diluted net loss per common share for the periods indicated.
(In thousands except per share data)For the Three Months Ended September 30,For the Nine Months Ended September 30,
2020201920202019
Basic
Weighted average common shares outstanding34,419 33,660 34,213 33,571 
Net loss$(7,276)$(8,041)$(23,163)$(34,644)
Net loss per common share$(0.21)$(0.24)$(0.68)$(1.03)
Diluted
Weighted average common shares outstanding34,419 33,660 34,213 33,571 
Share options and awards111 8 100 10 
Weighted average common shares assuming dilution34,530 33,668 34,313 33,581 
Net loss$(7,276)$(8,041)$(23,163)$(34,644)
Net loss per common share *$(0.21)$(0.24)$(0.68)$(1.03)
________
* Net loss per common share assuming dilution calculated utilizing weighted average shares outstanding-basic for the periods in which there was a net loss.

At September 30, 2020, 300,149 shares associated with shares options were excluded from the average common shares assuming dilution for the three and nine months ended September 30, 2020 as they were anti-dilutive. At September 30, 2020, the majority of the anti-dilutive shares were granted at an exercise price of $24.45, which was higher than the average fair market value price of $6.93 and $7.12 for the three and nine months ended September 30, 2020.

At September 30, 2019, 326,799 shares associated with share options were excluded from the average common shares assuming dilution for the three and nine months ended September 30, 2019 as they were anti-dilutive. At September 30, 2019, the majority of the anti-dilutive shares were granted at an exercise price of $25.24, which was higher than the average fair market value price of $5.61 and $6.43 for the three and nine months ended September 30, 2019.










For the three and nine months ended September 30, 2020 and September 30, 2019, respectively, no shares were included in the common shares assuming dilution related to the company's issued warrants as the average market price of the company shares for these periods did not exceed the strike price of the warrants.

59
Notes to Financial StatementsConcentration of Credit Risk
Concentration of Credit Risk

The company manufactures and distributes durable medical equipment to the home health care, retail and extended care markets. The company performs credit evaluations of its customers’ financial condition. The company utilizes De Lage Landen, Inc. (“DLL”), a third-party financing company, to provide lease financing to Invacare's U.S. customers. The DLL agreement provides for direct leasing between DLL and the Invacare customer. The company retains a recourse obligation of $2,682,000 at September 30, 2020 to DLL for events of default under the contracts, which total $8,262,000 at September 30, 2020. Guarantees, ASC 460, requires the company to record a guarantee liability as it relates to the limited recourse obligation. The company's recourse is reevaluated by DLL biannually, considers activity between the biannual dates and excludes any receivables purchased by the company from DLL. The company monitors the collections status of these contracts and has provided amounts for estimated losses in its allowances for doubtful accounts in accordance with Receivables, ASC 310-10-05-4. Credit losses are provided for in the financial statements.

































Substantially all the company’s receivables are due from health care, medical equipment providers and long-term care facilities located throughout the United States, Australia, Canada, New Zealand and Europe. A significant portion of products sold to dealers, both foreign and domestic, is ultimately funded through government reimbursement programs such as Medicare and Medicaid. The company has also seen a significant shift in reimbursement to customers from managed care entities. As a consequence, changes in these programs can have an adverse impact on dealer liquidity and profitability. In addition, reimbursement guidelines in the home health care industry have a substantial impact on the nature and type of equipment an end user can obtain as well as the timing of reimbursement and, thus, affect the product mix, pricing and payment patterns of the company’s customers.

60
Notes to Financial StatementsDerivatives
Derivatives

ASC 815 requires companies to recognize all derivative instruments as either assets or liabilities at fair value. The accounting for changes in fair value of a derivative is dependent upon whether or not the derivative has been designated and qualifies for hedge accounting treatment and the type of hedging relationship. For derivatives designated and qualifying as hedging instruments, the company must designate the hedging instrument, based upon the exposure being hedged, as a fair value hedge, cash flow hedge, or a hedge of a net investment in a foreign operation.

Cash Flow Hedging Strategy

The company uses derivative instruments in an attempt to manage its exposure to transactional foreign currency exchange risk. Foreign forward exchange contracts are used to manage the price risk associated with forecasted sales denominated in foreign currencies and the price risk associated with forecasted purchases of inventory over the next twelve months.

The company recognizes its derivative instruments as assets or liabilities measured at fair value. A majority of the company’s derivative instruments are designated and qualify as cash flow hedges. Accordingly, the effective portion of the gain or loss on the derivative instrument is reported as a component of other comprehensive income and reclassified into earnings in the same period or periods during which the hedged transaction affects earnings. The remaining gain or loss on the derivative instrument in excess of the cumulative change in the fair value of the hedged item, if any, is recognized in current earnings during the period of change.





















To protect against increases/decreases in forecasted foreign currency cash flows resulting from inventory purchases/sales over the next year, the company utilizes foreign currency forward contracts to hedge portions of its forecasted purchases/sales denominated in foreign currencies. The gains and losses are included in cost of products sold and selling, general and administrative expenses on the condensed consolidated statement of comprehensive income (loss). If it is later determined that a hedged forecasted transaction is unlikely to occur, any prospective gains or losses on the forward contracts would be recognized in earnings. The company does not expect any material amount of hedge ineffectiveness related to forward contract cash flow hedges during the next twelve months.

The company has historically not recognized any material amount of ineffectiveness related to forward contract cash flow hedges because the company generally limits its hedges to between 50% and 90% of total forecasted transactions for a given entity’s exposure to currency rate changes and the transactions hedged are recurring in nature. Furthermore, most of the hedged transactions are related to intercompany sales and purchases for which settlement occurs on a specific day each month. Forward contracts with a total notional amount in USD of $155,783,000 and $110,373,000 matured for the nine months ended September 30, 2020 and September 30, 2019, respectively.






61
Notes to Financial StatementsDerivatives
Outstanding foreign currency forward exchange contracts qualifying and designated for hedge accounting treatment were as follows (in thousands USD):
 September 30, 2020December 31, 2019
 Notional
Amount		Unrealized
Net Gain
(Loss)		Notional
Amount		Unrealized
Net Gain
(Loss)
USD / AUD$960 $(41)$3,840 $(106)
USD / CAD1,138 (2)3,888 32 
USD / EUR17,468 (1,061)110,905 122 
USD / GBP387 (11)3,972 (8)
USD / NZD290 (13)2,760 (166)
USD / SEK876 (88)5,062 (38)
USD / MXN3,901 (58)6,763 346 
EUR / CAD915 (42)4,151 24 
EUR / CHF2,703 (45)9,821 10 
EUR / GBP6,325 178 29,824 (216)
EUR / SEK2,330 (72)9,493 (46)
EUR / NOK1,490 14 5,797 15 
DKK / SEK1,402 40 5,936 24 
NOK / SEK1,490 53 5,151 18 
$41,675 $(1,148)$207,363 $11 

Derivatives Not Qualifying or Designated for Hedge Accounting Treatment

The company utilizes foreign currency forward contracts that are not designated as hedges in accordance with ASC 815. These contracts are entered into to eliminate the risk associated with the settlement of short-term intercompany trading receivables and payables between Invacare Corporation and its foreign subsidiaries. The currency forward contracts are entered into at the same time as the intercompany
receivables or payables are created so that upon settlement, the gain/loss on the settlement is offset by the gain/loss on the foreign currency forward contract. No material net gain or loss was realized by the company in 2020 or 2019 related to these contracts and the associated short-term intercompany trading receivables and payables.



















62
Notes to Financial StatementsDerivatives
Foreign currency forward exchange contracts not qualifying or designated for hedge accounting treatment, as well as ineffective hedges, entered into in 2020 and 2019, respectively, and outstanding were as follows (in thousands USD):
 September 30, 2020December 31, 2019
 Notional
Amount		Gain
(Loss)		Notional
Amount		Gain
(Loss)
AUD / USD$6,149 $96 $10,000 $(94)
CAD / USD8,321 88 8,000 (50)
EUR / USD11,735 (745)10,000 104 
DKK / USD15,081 (137)— — 
GBP / USD650 (18)7,000 40 
NOK / USD8,986 (427)— — 
NZD / USD309 (9)4,500 (101)
EUR / CAD130 (6)— — 
EUR / GBP2,086 59 — — 
AUD / NZD6,438 21 7,900 23 
EUR / NOK80 1 — — 
$59,965 $(1,077)$47,400 $(78)

The fair values of the company’s derivative instruments were as follows (in thousands):
 September 30, 2020December 31, 2019
 AssetsLiabilitiesAssetsLiabilities
Derivatives designated as hedging instruments under ASC 815
Foreign currency forward exchange contracts$334 $1,482 $668 $657 
Derivatives not designated as hedging instruments under ASC 815
Foreign currency forward exchange contracts265 1,342 170 248 
Total derivatives$599 $2,824 $838 $905 

The fair values of the company’s foreign currency forward exchange contract assets and liabilities are included in Other Current Assets and Accrued Expenses, respectively in the condensed consolidated balance sheets.




















63
Notes to Financial StatementsDerivatives

The effect of derivative instruments on Accumulated Other Comprehensive Income (OCI) and the Statement of Comprehensive Income (Loss) and was as follows (in thousands):
Derivatives in ASC 815 cash flow hedge
relationships		Amount of Gain
(Loss) Recognized  in Accumulated OCI on Derivatives
(Effective Portion)		Amount of Gain (Loss)
Reclassified from
Accumulated  OCI into
Income (Effective
Portion)		Amount of Gain (Loss)
Recognized in Income on
Derivatives (Ineffective  Portion and Amount Excluded from
Effectiveness Testing)
Three months ended September 30, 2020
Foreign currency forward exchange contracts$(2,501)$(739)$(662)
Nine months ended September 30, 2020
Foreign currency forward exchange contracts$(1,340)$(352)$(718)
Three months ended September 30, 2019
Foreign currency forward exchange contracts$557 $860 $(2)
Nine months ended September 30, 2019
Foreign currency forward exchange contracts$2,179 $1,445 $50 
Derivatives not designated as hedging
instruments under ASC 815		  Amount of Gain (Loss)
Recognized in Income on Derivatives
Three months ended September 30, 2020
Foreign currency forward exchange contracts$(1,320)
Nine months ended September 30, 2020
Foreign currency forward exchange contracts$(1,077)
Three months ended September 30, 2019
Foreign currency forward exchange contracts$317 
Nine months ended September 30, 2019
Foreign currency forward exchange contracts$103 
The gains or losses recognized as the result of the settlement of cash flow hedge foreign currency forward contracts are recognized in net sales for hedges of inventory sales and in cost of product sold for hedges of inventory purchases. For the three and nine months ended September 30, 2020, net sales were increased by $481,000 and $692,000 while cost of product sold was increased by $1,259,000 and $1,029,000 for net pre-tax realized loss of $778,000 and $337,000, respectively. For the three and nine months ended September 30, 2019, net sales were increased by $197,000 and $189,000 while cost of product sold was decreased by $747,000 and $1,375,000 for net realized pre-tax gains of $944,000 and $1,564,000, respectively.

Losses of $1,320,000 and $1,077,000 were recognized in selling, general and administrative (SG&A) expenses for the three and nine months ended September 30, 2020 compared to gains of $317,000 and $103,000 for the three and nine months ended September 30, 2019 related to forward contracts not designated as hedging instruments. The forward contracts were entered into to offset gains/losses that were also recorded in SG&A expenses on intercompany trade receivables or payables. The gains/losses on the non-designated hedging
instruments were substantially offset by gains/losses on intercompany trade payables.

The company's derivative agreements provide the counterparties with a right of set off in the event of a default. The right of set off would enable the counterparty to offset any net payment due by the counterparty to the company under the applicable agreement by any amount due by the company to the counterparty under any other agreement. For example, the terms of the agreement would permit a counterparty to a derivative contract that is also a lender under the company's Credit Agreement to reduce any derivative settlement amounts owed to the company under the derivative contract by any amounts owed to the counterparty by the company under the Credit Agreement. In addition, the agreements contain cross-default provisions that could trigger a default by the company under the agreement in the event of a default by the company under another agreement with the same counterparty. The company does not present any derivatives on a net basis in its financial statements, other than the conversion and bond hedge derivatives which are presented net on the condensed consolidated statement of comprehensive income (loss), and
64
Notes to Financial StatementsDerivatives
all derivative balances presented are subject to provisions that are similar to master netting agreements.

During the first quarter of 2016, the company entered into privately negotiated convertible 2021 note hedges and 2021 warrants in connection with its sale of $150,000,000 in aggregate principal amount of the company’s 5.00% Convertible Senior Notes due 2021. The 2021 warrants, which increased paid in capital by $12,376,000, are clearly and closely related to the convertible 2021 notes and thus classified as equity. The 2021 note hedge asset and 2021 convertible debt conversion liability were recorded, based on initial fair values, as an asset of $27,975,000 and a liability of $34,480,000, respectively, with the offset to the income statement.
During the second quarter of 2017, the company entered into privately negotiated convertible 2022 note hedges and

warrants in connection with its sale of $120,000,000 in aggregate principal amount of the company’s 4.50% Convertible Senior Notes due 2022. The 2022 warrants, which increased paid in capital by $14,100,000, are clearly and closely related to the convertible 2022 notes and thus classified as equity. The 2022 note hedge assets and 2022 convertible debt conversion liability were recorded, based on initial fair values, as an asset of $24,780,000 and a liability of $28,859,000, respectively, with the offset to the income statement. See "Long-Term Debt" in the Notes to the Condensed Consolidated Financial Statements included elsewhere in this report for more detail.
The fair values of the outstanding convertible note derivatives as of September 30, 2020 and their effect on the Statement of Comprehensive Income (Loss) were as follows (in thousands):
 Gain (Loss)Gain (Loss)
 Fair ValueThree Months EndedNine Months Ended
September 30, 2020September 30, 2020September 30, 2019September 30, 2020September 30, 2019
Convertible 2021 debt conversion long-term liability$— $— $— $— $(2,210)
Convertible 2022 debt conversion long-term liability— — — — (6,193)
Convertible 2021 note hedge long-term asset— — — — 2,852 
Convertible 2022 note hedge long-term asset— — — — 6,748 
Net fair value and net gain on convertible debt derivatives$— $— $— $— $1,197 
The 2021 and 2022 convertible debt conversion liability amounts and the 2021 and 2022 note hedge asset amounts are included in Other Long-Term Obligations and Other Long-Term Assets, respectively, in the company's condensed consolidated balance sheets. The 2019 year-to-date changes in the fair values of the convertible debt conversion liabilities and note hedge derivatives were significantly impacted by the change in the company's share price.
On May 16, 2019, the company received shareholder approval authorizing it to elect to settle future conversions of convertible notes in common shares. As a result of the shareholder approval, the note hedge assets and conversion liabilities may no longer be bifurcated and accounted for as separate derivatives and thus were eliminated together with a corresponding offset to additional paid-in-capital.
65
Notes to Financial StatementsFair Values
Fair Values

Pursuant to ASC 820, the inputs used to derive the fair value of assets and liabilities are analyzed and assigned a level I, II or III priority, with level I being the highest and level III being the lowest in the hierarchy. Level I inputs are quoted prices in active markets for identical assets or liabilities.



Level II inputs are quoted prices for similar assets or liabilities in active markets: quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations in which all significant inputs are observable in active markets. Level III inputs are based on valuations derived from valuation techniques in which one or more significant inputs are unobservable.
The following table provides a summary of the company’s assets and liabilities that are measured on a recurring basis (in thousands):
 Basis for Fair Value Measurements at Reporting Date
Quoted Prices in Active
Markets for Identical
Assets / (Liabilities)		Significant Other
Observable
Inputs		Significant Other
Unobservable
Inputs
Level ILevel IILevel III
September 30, 2020
Forward exchange contracts—net—$(2,225)—
December 31, 2019
Forward exchange contracts—net—$(67)—

The carrying values and fair values of the company’s financial instruments are as follows (in thousands):
 September 30, 2020December 31, 2019
 Carrying ValueFair ValueCarrying ValueFair Value
Cash and cash equivalents$86,825 $86,825 $80,063 $80,063 
Other investments85 85 85 85 
Installment receivables, net of reserves325 325 913 913 
Total debt (including current maturities of long-term debt) *(242,264)(218,231)(219,522)(207,193)
Forward contracts in Other Current Assets599 599 838 838 
Forward contracts in Accrued Expenses(2,824)(2,824)(905)(905)
________
* The company's total debt is shown net of discount and fees associated with the Convertible Senior Notes due in 2021, 2022 and 2024 on the company's condensed consolidated balance sheet. Accordingly, the fair values of the Convertible Senior Notes due in 2021, 2022 and 2024 are included in the long-term debt presented in this table are also shown net of the discount and fees. Total debt amounts exclude operating and financing leases obligations.
66
Notes to Financial StatementsFair Values
The company, in estimating its fair value disclosures for financial instruments, used the following methods and assumptions:

Cash, cash equivalents: The carrying value reported in the balance sheet for cash, cash equivalents equals its fair value.

Other investments: The company has made an investment in a limited partnership, which is accounted for using the cost method, adjusted for any estimated declines in value. The investment was acquired in private placement and there is no quoted market price or stated rate of return. The company does not have the ability to easily sell the investment. The company completes an evaluation of the residual value related to such investments in the fourth quarter each year.

Installment receivables: The carrying value reported in the balance sheet for installment receivables approximates its fair value. The interest rates associated with these receivables have not varied significantly since inception. Management believes that after consideration of the credit risk, the net book value of the installment receivables approximates market value.
































Total debt: Fair value for the company’s convertible debt is based on quoted market-based estimates as of the end of the period, while the revolving credit facility fair value is based upon an estimate of the market for similar borrowing arrangements. The fair values are deemed to be categorized as Level 2 in the fair value hierarchy.

Forward contracts: The company operates internationally, and as a result, is exposed to foreign currency fluctuations. Specifically, the exposure includes intercompany loans and third-party sales or payments. In an attempt to reduce this exposure, foreign currency forward contracts are utilized and accounted for as hedging instruments. The forward contracts are used to hedge the following currencies: AUD, CAD, CHF, DKK, EUR, GBP, MXN, NOK, NZD, SEK and USD. The company does not use derivative financial instruments for speculative purposes. Fair values for the company’s foreign exchange forward contracts are based on quoted market prices for contracts with similar maturities. The company’s forward contracts are included in Other Current Assets or Accrued Expenses in the condensed consolidated balance sheets.
67
Notes to Financial StatementsBusiness Segments
Business Segments
The company operates in two primary business segments: North America and Europe with each selling the company's primary product categories, which include: lifestyle, mobility and seating and respiratory therapy products. Sales in Asia Pacific are reported in All Other and include products similar to those sold in North America and Europe. The accounting policies of each segment are the same as those described in the summary of significant accounting policies for the company's consolidated financial statements. Intersegment sales and transfers are based on the costs to manufacture plus a reasonable profit element.

Segment performance is measured and resources are allocated based on a number of factors, with the primary profit or loss measure being segment operating profit (loss). Segment operating profit (loss) represents net sales less cost of products sold less selling general and administrative expenses. Segment operating profit (loss) excludes unallocated corporate
general and administrative expenses not allocated to the segments and intersegment sales and profit eliminations, which are included in All Other. In addition, segment operating profit (loss) further excludes charges related to restructuring activities, asset impairments and gain on sale of business (as applicable).

This performance measure, segment operating income (loss), is used by the Chief Operating Decision Maker (CODM) for purposes of making decisions about allocating resources to a segment and assessing its performance. In addition, this metric is reviewed by the company's Board of Directors regarding segment performance and is a key metric in the performance management assessment of the company's employees.




68
Notes to Financial StatementsBusiness Segments
The information by segment is as follows (in thousands):
 For the Three Months Ended September 30,For the Nine Months Ended September 30,
2020201920202019
Revenues from external customers
Europe$116,285 $137,371 $339,147 $396,206 
North America88,055 87,118 261,595 262,915 
All Other (Asia Pacific)7,566 11,285 25,904 35,930 
Consolidated$211,906 $235,774 $626,646 $695,051 
Intersegment revenues
Europe$6,027 $3,124 $14,438 $10,396 
North America23,625 21,130 66,356 61,109 
All Other (Asia Pacific)1,116 3,904 3,645 9,776 
Consolidated$30,768 $28,158 $84,439 $81,281 
Restructuring charges before income taxes
Europe$1,434 $1,263 $3,674 $1,903 
North America146 331 865 1,539 
All Other— 34 118 199 
Consolidated$1,580 $1,628 $4,657 $3,641 
Operating income (loss)
Europe$7,600 $11,365 $16,624 $22,617 
North America2,992 (1,694)5,759 (7,316)
All Other(6,082)(5,625)(17,377)(18,230)
Charge expense related to restructuring activities(1,580)(1,628)(4,657)(3,641)
Gain on sale of business— — 9,790 — 
Consolidated operating income (loss)2,930 2,418 10,139 (6,570)
Net gain on convertible debt derivatives— — — 1,197 
Loss on debt extinguishment including debt finance charges and associated fees(761)(280)(7,360)(280)
Net Interest expense(7,395)(6,879)(21,042)(21,666)
Loss before income taxes$(5,226)$(4,741)$(18,263)$(27,319)
69
Notes to Financial StatementsBusiness Segments
Net sales by product, are as follows (in thousands):
For the Three Months Ended September 30,For the Nine Months Ended September 30,
2020201920202019
Europe
Lifestyle$50,307 $59,403 $160,628 $182,103 
Mobility and Seating54,851 68,286 147,275 184,819 
Respiratory Therapy6,070 4,919 16,680 14,875 
Other(1)5,057 4,763 14,564 14,409 
$116,285 $137,371 $339,147 $396,206 
North America
Lifestyle$41,845 $43,401 $124,888 $131,259 
Mobility and Seating26,572 31,252 82,485 89,638 
Respiratory Therapy19,405 12,108 53,626 40,811 
Other(1)233 357 596 1,207 
$88,055 $87,118 $261,595 $262,915 
All Other (Asia Pacific)
Mobility and Seating$2,670 $6,645 $10,757 $21,986 
Lifestyle3,375 3,001 10,176 8,261 
Respiratory Therapy195 175 1,043 1,063 
Other(1)1,326 1,464 3,928 4,620 
$7,566 $11,285 $25,904 $35,930 
Total Consolidated$211,906 $235,774 $626,646 $695,051 
   ________________________
(1)Includes various services, including repair services, equipment rentals and external contracting.

70
Notes to Financial StatementsContingencies
Contingencies
General

In the ordinary course of its business, the company is a defendant in a number of lawsuits, primarily product liability actions in which various plaintiffs seek damages for injuries allegedly caused by defective products. All the product liability lawsuits that the company faces in the United States have been referred to the company's captive insurance company and/or excess insurance carriers while all non-U.S. lawsuits have been referred to the company's commercial insurance carriers. All such lawsuits are generally contested vigorously. The coverage territory of the company's insurance is worldwide with the exception of those countries with respect to which, at the time the product is sold for use or at the time a claim is made, the U.S. government has suspended or prohibited diplomatic or trade relations. The amount recorded for identified contingent liabilities is based on estimates. Amounts recorded are reviewed periodically and adjusted to reflect additional technical and legal information that becomes available. Actual costs to be incurred in future periods may vary from the estimates, given the inherent uncertainties in evaluating certain exposures.

As a medical device manufacturer, the company is subject to extensive government regulation, including numerous laws directed at preventing fraud and abuse and laws regulating reimbursement under various government programs. The marketing, invoicing, documenting, developing, testing, manufacturing, labeling, promoting, distributing and other practices of health care suppliers and medical device manufacturers are all subject to government scrutiny. Most of the company's facilities are subject to inspection at any time by the FDA or similar medical device regulatory agencies in other jurisdictions. Violations of law or regulations can result in administrative, civil and criminal penalties and sanctions, which could have a material adverse effect on the company's business.

Medical Device Regulatory Matters
The FDA in the United States and comparable medical device regulatory authorities in other jurisdictions regulate virtually all aspects of the marketing, invoicing, documenting, development, testing, manufacturing, labeling, promotion, distribution and other practices regarding medical devices. The company and its products are subject to the laws and regulations of the FDA and other regulatory bodies in the various jurisdictions where the company's products are manufactured or sold. The company's failure to comply with the regulatory requirements of the FDA and other applicable medical device regulatory requirements can subject the company to administrative or judicially imposed sanctions or
enforcement actions. These sanctions include injunctions, consent decrees, warning letters, civil penalties, criminal penalties, product seizure or detention, product recalls and total or partial suspension of production.
In December 2012, the company became subject to a consent decree of injunction filed by FDA with respect to the company's Corporate facility and its Taylor Street manufacturing facility in Elyria, Ohio. The consent decree initially limited the company's (i) manufacture and distribution of power and manual wheelchairs, wheelchair components and wheelchair sub-assemblies at or from its Taylor Street manufacturing facility, except in verified cases of medical necessity, (ii) design activities related to wheelchairs and power beds that take place at the impacted Elyria facilities and (iii) replacement, service and repair of products already in use from the Taylor Street manufacturing facility. Under the terms of the consent decree, in order to resume full operations, the company had to successfully complete independent, third-party expert certification audits at the impacted Elyria facilities, comprising three distinct certification reports separately submitted to, and subject to acceptance by, FDA; submit its own report to the FDA; and successfully complete a reinspection by FDA of the company's Corporate and Taylor Street facilities.
On July 24, 2017, following its June 2017 reinspection of the Corporate and Taylor Street facilities, FDA notified the company that it is in substantial compliance with the FDA Act, FDA regulations and the terms of the consent decree and, that the company was permitted to resume full operations at those facilities including the resumption of unrestricted sales of products made in those facilities.
The consent decree will continue in effect for at least five years from July 2017, during which time the company's Corporate and Taylor Street facilities must complete two semi-annual audits in the first year and then four annual audits in the next four years performed by a company-retained expert firm. The expert audit firm will determine whether the facilities remain in continuous compliance with the FDA Act, FDA regulations and the terms of the consent decree. The FDA has the authority to inspect these facilities and any other FDA registered facility, at any time.
The FDA has continued to actively inspect the company's facilities, other than through the processes established under the consent decree. The company expects that the FDA will, from time to time, inspect substantially all the company's domestic and foreign FDA-registered facilities.
The results of regulatory claims, proceedings, investigations, or litigation are difficult to predict. An
71
Notes to Financial StatementsContingencies
unfavorable resolution or outcome of any FDA warning letters or inspectional observations, or other FDA enforcement related to company facilities, could materially and adversely affect the company's business, financial condition, and results of operations.
The limitations previously imposed by the FDA consent decree negatively affected net sales in the North America segment and, to a certain extent, the Asia Pacific region beginning in 2012. The limitations led to delays in new product introductions. Further, uncertainty regarding how long the limitations would be in effect limited the company's ability to renegotiate and bid on certain customer contracts and otherwise led to a decline in customer orders.
Although the company has been permitted to resume full operations at the Corporate and Taylor Street facilities, the negative effect of the consent decree on customer orders and net sales in the North America segment and Asia Pacific region has been considerable, and it is uncertain as to whether, or how quickly, the company will be able to rebuild net sales to more typical historical levels, irrespective of market conditions. Accordingly, when compared to the company's 2010 results, the previous limitations in the consent decree had, and likely may continue to have, a material adverse effect on the company's business, financial condition and results of operations.
Warranty Matters
The company's warranty reserves are subject to adjustment in future periods based on historical analysis of warranty claims and as new developments occur that may change the company's estimates related to specific product recalls. See Current Liabilities in the Notes to the Condensed Consolidated Financial Statements for the total provision amounts and a reconciliation of the changes in the warranty accrual.
Any of the above contingencies could have an adverse impact on the company's financial condition or results of operations.
For additional information regarding the consent decree, other regulatory matters, and risks and trends that may impact the company’s financial condition or results of operations, please see the following sections of the company's Annual Report on Form 10-K for the year ended December 31, 2019: Item 1. Business - Government Regulation and Item 1A. Risk Factors; Item 3. Legal Proceedings; and Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations - Liquidity and Capital Resources.
72
Notes to Financial StatementsMarket Risk and Controls
Item 3. Quantitative and Qualitative Disclosures About Market Risk.

The company is at times exposed to market risk through various financial instruments, including fixed rate and floating rate debt instruments. Additionally, the company operates internationally and, as a result, is exposed to foreign currency fluctuations. Specifically, the exposure results from intercompany loans, intercompany sales or payments and third-party sales or payments. While the company is exposed to increases in interest rates, including on borrowings under its Credit Agreement, its exposure to the volatility of the current market environment is currently limited until the Credit Agreement expires in 2024. Should the company be required to seek and obtain additional or alternative financing, such financing, if available, may require the company to pay substantially higher interest rates. As discussed elsewhere in this report, the COVID-19 pandemic has negatively impacted, and will continue to negatively impact the company’s business and results of operations. As we cannot predict the duration or scope of the COVID-19 pandemic, the negative financial impact to the company’s results cannot be reasonably estimated, but could be material.
































Item 4.    Controls and Procedures.

(a) Evaluation of Disclosure Controls and Procedures
As of September 30, 2020, an evaluation was performed, under the supervision and with the participation of the company’s management, including the Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of the company’s disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)). Based on that evaluation, the company’s management, including the Chief Executive Officer and Chief Financial Officer, concluded that the company’s disclosure controls and procedures were effective as of September 30, 2020, in ensuring that information required to be disclosed by the company in the reports it files and submits under the Exchange Act is (1) recorded, processed, summarized and reported, within the time periods specified in the Commission’s rules and forms and (2) accumulated and communicated to the company’s management, including the Chief Executive Officer and the Chief Financial Officer, as appropriate to allow for timely decisions regarding required disclosure.

(b) Changes in Internal Control Over Financial Reporting
There have been no changes in the company’s internal control over financial reporting that occurred during the company’s last fiscal quarter that have materially affected, or are reasonably likely to materially affect, the company’s internal control over financial reporting.


73
Part IIOther Information
Part II. OTHER INFORMATION


Item 1.    Legal Proceedings.
In the ordinary course of its business, the company is a defendant in a number of lawsuits, primarily product liability actions in which various plaintiffs seek damages for injuries allegedly caused by defective products. All the product liability lawsuits that the company faces in the United States have been referred to the company's captive insurance company and/or excess insurance carriers while all non-U.S. lawsuits have been referred to the company's commercial insurance carriers. All such lawsuits are generally contested vigorously. The coverage territory of the company's insurance is worldwide with the exception of those countries with respect to which, at the time the product is sold for use or at the time a claim is made, the U.S. government has suspended or prohibited diplomatic or trade relations. Management does not believe that the outcome of any of these actions will have a material adverse effect upon the company's business or financial condition.
In December 2012, the company became subject to a consent decree of injunction filed by FDA in the U.S. District Court for the Northern District of Ohio with respect to the company's Corporate facility and its Taylor Street manufacturing facility in Elyria, Ohio. On July 24, 2017, following its reinspection of the Corporate and Taylor Street facilities, FDA notified the company that it was in substantial compliance with the FDA Act, FDA regulations and the terms of the consent decree and that the company was permitted to resume full operations at those facilities, including the resumption of unrestricted sales of products made in those facilities. The consent decree will continue in effect for at least five years from July 24, 2017, during which time the company's Corporate and Taylor Street facilities must complete to two semi-annual audits in the first year and then four annual audits in the next four years performed by a company-retained expert firm. The expert audit firm will determine whether the facilities remain in continuous compliance with the FDA Act, regulations and the terms of the consent decree.
FDA has the authority to inspect the Corporate and Taylor Street facilities, and any other FDA registered facility, at any time. FDA also has the authority to order the company to take a wide variety of actions if the FDA finds that the company is not in compliance with the consent decree, FDA Act or FDA regulations, including requiring the company to cease all operations relating to Taylor Street products. The FDA also can order the company to undertake a partial cessation of operations or a recall, issue a safety alert, public health advisory, or press release, or to take any other corrective action the FDA deems necessary with respect to Taylor Street products.


FDA also has authority under the consent decree to assess liquidated damages of $15,000 per violation per day for any violations of the consent decree, FDA Act or FDA regulations. FDA also may assess liquidated damages for shipments of adulterated or misbranded devices in the amount of twice the sale price of any such adulterated or misbranded device. The liquidated damages, if assessed, are limited to a total of $7,000,000 for each calendar year. The authority to assess liquidated damages is in addition to any other remedies otherwise available to FDA, including civil money penalties.

For additional information regarding the consent decree, please see the "Contingencies" note to the financial statements contained in Part I of this Quarterly Report on Form 10-Q, the risk factors referred to in Part I, Item 1A of this Quarterly Report on Form 10-Q, and the following sections of the company's Annual Report on Form 10-K for the period ending December 31, 2019: Item 1. Business - Government Regulation; Item 1A. Risk Factors; and Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations - Outlook and - Liquidity and Capital Resources.
74
Part IIOther Information
Item 1A. Risk Factors
The COVID-19 pandemic has disrupted, and may continue to disrupt, the company’s operations and could have a material adverse effect on the company’s business, financial condition and liquidity.
The company’s business could be materially and adversely affected by the outbreak of a widespread health epidemic. The present coronavirus (or COVID-19) pandemic has disrupted the company’s operations and affected the company’s business due to many factors, including imposition by government authorities of mandatory closures, work-from-home orders and social distancing protocols, and voluntary facility closures or other restrictions that could materially adversely affect the company’s ability to adequately staff and maintain its operations. Specifically, the company had experienced at least one mandatory temporary facility closure, and may experience in the future additional temporary facility closures in response to government mandates in certain jurisdictions in which the company operates and in response to positive diagnoses for COVID-19 in certain facilities for the safety of the company’s associates.
The COVID-19 pandemic has also disrupted the company’s operations and supply chain and could materially adversely impact its ability to secure raw materials, components and supplies for its facilities and to provide personal protective equipment for its employees. There may also be long-term effects on the company’s customers and in the economies of affected countries. The pandemic has caused temporary closure of, or restricted access to, health care provider facilities where the company's products are demonstrated, trialed, fitted and sold. Limitations on non-acute care due to the pandemic have delayed or reduced the ability for end users to gain access to the company's products.
The government actions to address the COVID-19 pandemic continue to change. As a result, the countries in which the company’s products are manufactured and distributed remain in varying stages of restrictions. Certain jurisdictions have had to re-establish restrictions due to a resurgence in COVID-19 cases. Additionally, although access to elective healthcare by patients and access to healthcare for many of the company’s customers has begun to be restored or increased, such access may be forced to be limited or closed if a resurgence of COVID-19 cases occurs. Even as government restrictions have been lifted and economies gradually reopened, the shape of the economic recovery remains uncertain and may continue to negatively impact the company's results of operations, cash flows and financial position in subsequent quarters. Given this current level of economic and operational uncertainty over the impacts of COVID-19, the ultimate financial impact cannot be reasonably estimated at this time.
The COVID-19 pandemic and similar issues in the future could have a material adverse effect on the company’s ability to operate, results of operations, financial condition and liquidity. In addition, public health restrictions and preventive measures the company may voluntarily put in place, could have a material adverse effect on the company's business for an indefinite period of time, such as the potential shut down of certain locations, decreased employee availability, border closures, among others. The company’s suppliers and customers may also face these and other challenges, which could lead to continued disruption in the company’s supply chain, as well as decreased customer demand for the company’s products. These issues may also materially affect the company’s future access to its sources of liquidity, particularly its cash flows from operations, financial condition and capitalization. Although these disruptions may continue to occur, the long-term economic impact and near-term financial impacts of such issues, may not be reasonably estimated due to the uncertainty of future developments.
In addition to the foregoing risk factor and the other information set forth in this report, you should carefully consider the risk factors disclosed in Item 1A of the company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2019 and Part II, Item 1A of the company's Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2020 and the company's Quarterly Report on Form 10-Q for the fiscal quarter ended June 30, 2020.
75
Part IIOther Information
Item 2.    Unregistered Sales of Equity Securities and Use of Proceeds

The following table presents information with respect to repurchases of common shares made by the company during the three months ended September 30, 2020.
PeriodTotal Number
of Shares
Purchased (1)		Avg. Price Paid
Per Share $		Total Number
of Shares Purchased 
as Part of Publicly
Announced Plans 
or Programs		Maximum Number
of Shares That May 
Yet Be Purchased Under the Plans or 
Programs (2)
7/1/2020-7/31/2020—$— —2,453,978
8/1/2020-8/31/20201,2846.80 —2,453,978
9/1/2020-9/30/2020—— —2,453,978
Total
1,284$6.80 —2,453,978
________ 
(1)All 1,284 shares repurchased between July 1, 2020 and September 30, 2020 were surrendered to the company by employees for minimum tax withholding purposes in conjunction with the vesting of restricted shares awarded to the employees or the exercise of non-qualified options by employees under the company's equity compensation plans.

(2)In 2001, the Board of Directors authorized the company to purchase up to 2,000,000 Common Shares, excluding any shares acquired from employees or directors as a result of the exercise of options or vesting of restricted shares pursuant to the company’s performance plans. The Board of Directors reaffirmed its authorization of this repurchase program on November 5, 2010, and on August 17, 2011 authorized an additional 2,046,500 shares for repurchase under the plan. To date, the company has purchased 1,592,522 shares under this program, with authorization remaining to purchase 2,453,978 shares. The company purchased no shares pursuant to this Board authorized program during the quarter ended September 30, 2020.

Under the terms of the company's Credit Agreement, repurchases of shares by the company generally are not permitted except in certain limited circumstances in connection with the vesting or exercise of employee equity compensation awards. See Item 2. Management's Discussion
and Analysis of Financial Condition and Results of Operations - Liquidity and Capital Resources, regarding covenants of the company's senior credit facilities with respect to share purchases.

76
Part IIOther Information
Item 5.    Other Information

As previously disclosed in March 2020, the named executive officers in the company's most recent proxy statement filed with the SEC, agreed to defer payment of (i) 100% of their respective annual cash bonuses earned in 2019, (ii) 20% of their respective base salaries for April 2020, and (iii) any salary increase in 2020, in order to mitigate the financial and operational impacts of the COVID-19 pandemic. The aggregate amount of deferrals was approximately $2,200,000. The company expects to pay all of these deferred amounts during the fourth quarter of 2020.
77
Part IIOther Information
Item 6.    Exhibits
Exhibit      
No. 		 
Chief Executive Officer Rule 13a-14(a)/15d-14(a) Certification (filed herewith).
Chief Financial Officer Rule 13a-14(a)/15d-14(a) Certification (filed herewith).
Certification of the Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (furnished herewith).
Certification of the Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (furnished herewith).
101.INS*XBRL instance document
101.SCH*XBRL taxonomy extension schema
101.CAL*XBRL taxonomy extension calculation linkbase
101.DEF*XBRL taxonomy extension definition linkbase
101.LAB*XBRL taxonomy extension label linkbase
101.PRE*XBRL taxonomy extension presentation linkbase
104Cover page of the Quarterly Report on Form 10-Q formatted in Inline XBRL.
 
* Pursuant to Rule 406T of Regulation S-T, the Interactive Data Files on Exhibit 101 hereto are deemed not filed or part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933, as amended, are deemed not filed for purposes of Section 18 of the Securities and Exchange Act of 1934, as amended, and otherwise are not subject to liability under those sections.

78
SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
 
  INVACARE CORPORATION
Date:October 29, 2020By: /s/ Kathleen P. Leneghan
Name:  Kathleen P. Leneghan
   Title:  Senior Vice President and Chief Financial Officer
   (As Principal Financial and Accounting Officer and on behalf of the registrant)

79
 EX-31.1 2 q32020ivcex311.htm EX-31.1 Document

Exhibit 31.1
CERTIFICATIONS
I, Matthew E. Monaghan, certify that:
1.    I have reviewed this quarterly report on Form 10-Q of Invacare Corporation;
2.    Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.    Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.    I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a)    Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under my supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to me by others within those entities, particularly during the period in which this report is being prepared;
b)    Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under my supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c)    Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report my conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d)    Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.    I have disclosed, based on my most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
a)    All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b)    Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
 /s/ MATTHEW E. MONAGHAN
Date:October 29, 2020
Matthew E. Monaghan
President and Chief Executive Officer
(Principal Executive Officer)


 EX-31.2 3 q32020ivcex312.htm EX-31.2 Document

Exhibit 31.2
CERTIFICATIONS
I, Kathleen P. Leneghan, certify that:
1.    I have reviewed this quarterly report on Form 10-Q of Invacare Corporation;
2.    Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.    Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.    I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a)    Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under my supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to me by others within those entities, particularly during the period in which this report is being prepared;
b)    Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under my supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c)    Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report my conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d)    Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.    I have disclosed, based on my most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
a)    All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b)    Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
 /s/ KATHLEEN P. LENEGHAN
Date:October 29, 2020
Kathleen P. Leneghan
Senior Vice President and Chief Financial Officer
(Principal Financial Officer)


 EX-32.1 4 q32020ivcex321.htm EX-32.1 Document

Exhibit 32.1
Certification
Pursuant to Section 18 U.S.C. Section 1350,
as adopted pursuant to Section 906
of the Sarbanes-Oxley Act of 2002
In connection with the Quarterly Report of Invacare Corporation (the “company”) on Form 10-Q for the period ending September 30, 2020 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Matthew E. Monaghan, President and Chief Executive Officer of the company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
(1)The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the company.
 /s/ MATTHEW E. MONAGHAN
Date:October 29, 2020Matthew E. Monaghan
President and Chief Executive Officer
(Principal Executive Officer)
A signed original of this written statement required by Section 906 has been provided to Invacare Corporation and will be retained by Invacare Corporation and furnished to the Securities and Exchange Commission or its staff upon request.

 EX-32.2 5 q32020ivcex322.htm EX-32.2 Document

Exhibit 32.2
Certification
Pursuant to Section 18 U.S.C. Section 1350,
as adopted pursuant to Section 906
of the Sarbanes-Oxley Act of 2002
In connection with the Quarterly Report of Invacare Corporation (the “company”) on Form 10-Q for the period ending September 30, 2020 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Kathleen P. Leneghan, Senior Vice President and Chief Financial Officer of the company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
(1)The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the company.
 /s/ KATHLEEN P. LENEGHAN
Date:October 29, 2020Kathleen P. Leneghan
Senior Vice President and Chief Financial Officer
(Principal Financial Officer)
A signed original of this written statement required by Section 906 has been provided to Invacare Corporation and will be retained by Invacare Corporation and furnished to the Securities and Exchange Commission or its staff upon request.


 EX-101.SCH 6 ivc-20200930.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 000010001 - Document - DEI Document link:presentationLink link:calculationLink link:definitionLink 100010002 - Statement - Condensed Consolidated Statement of Comprehensive Income (Loss) link:presentationLink link:calculationLink link:definitionLink 100020003 - Statement - Condensed Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 100030004 - Statement - Condensed Consolidated Balance Sheets (Parentheticals) link:presentationLink link:calculationLink link:definitionLink 100040005 - Statement - Condensed Consolidated Statement Of Cash Flows link:presentationLink link:calculationLink link:definitionLink 100050006 - Statement - Condensed Consolidated Statement of Shareholders' Equity Statement link:presentationLink link:calculationLink link:definitionLink 210011001 - Disclosure - Accounting Policies link:presentationLink link:calculationLink link:definitionLink 220022001 - Disclosure - Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 240034001 - Disclosure - Accounting Policies (Details) link:presentationLink link:calculationLink link:definitionLink 210041002 - Disclosure - Divested Businesses (Notes) link:presentationLink link:calculationLink link:definitionLink 230053001 - Disclosure - Divested Businesses (Tables) link:presentationLink link:calculationLink link:definitionLink 240064002 - Disclosure - Divested Businesses (Details) link:presentationLink link:calculationLink link:definitionLink 210071003 - Disclosure - Receivables link:presentationLink link:calculationLink link:definitionLink 230083002 - Disclosure - Receivables (Tables) link:presentationLink link:calculationLink link:definitionLink 240094003 - Disclosure - Receivables (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 240104004 - Disclosure - Receivables (Schedule of Accounts Receivable) (Details) link:presentationLink link:calculationLink link:definitionLink 240114005 - Disclosure - Receivables Schedule for Allowance for Credit Losses (Details) link:presentationLink link:calculationLink link:definitionLink 240124006 - Disclosure - Receivables (Installment Recevables) (Details) link:presentationLink link:calculationLink link:definitionLink 240134007 - Disclosure - Receivables (Rollforward of Allowance for Doubtful Accounts) (Details) link:presentationLink link:calculationLink link:definitionLink 240144008 - Disclosure - Receivables (Installment Receivables by Class) (Details) link:presentationLink link:calculationLink link:definitionLink 240154009 - Disclosure - Receivables (Aging of Installment Receivables) (Details) link:presentationLink link:calculationLink link:definitionLink 210161004 - Disclosure - Inventories link:presentationLink link:calculationLink link:definitionLink 230173003 - Disclosure - Inventories (Tables) link:presentationLink link:calculationLink link:definitionLink 240184010 - Disclosure - Inventories (Details) link:presentationLink link:calculationLink link:definitionLink 210191005 - Disclosure - Other Current Assets link:presentationLink link:calculationLink link:definitionLink 230203004 - Disclosure - Other Current Assets (Tables) link:presentationLink link:calculationLink link:definitionLink 240214011 - Disclosure - Other Current Assets Components of Other Current Assets (Details) link:presentationLink link:calculationLink link:definitionLink 210221006 - Disclosure - Other Long-Term Assets link:presentationLink link:calculationLink link:definitionLink 230233005 - Disclosure - Other Long-Term Assets (Tables) link:presentationLink link:calculationLink link:definitionLink 240244012 - Disclosure - Other Long-Term Assets Components of Other Long-Term Assets (Details) link:presentationLink link:calculationLink link:definitionLink 240254013 - Disclosure - Other Long-Term Assets Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 210261007 - Disclosure - Property And Equipment link:presentationLink link:calculationLink link:definitionLink 230273006 - Disclosure - Property And Equipment (Tables) link:presentationLink link:calculationLink link:definitionLink 240284014 - Disclosure - Property And Equipment (Details) link:presentationLink link:calculationLink link:definitionLink 210291008 - Disclosure - Goodwill link:presentationLink link:calculationLink link:definitionLink 240304015 - Disclosure - Goodwill Goodwill Details (Details) link:presentationLink link:calculationLink link:definitionLink 210311009 - Disclosure - Intangibles link:presentationLink link:calculationLink link:definitionLink 230323007 - Disclosure - Intangibles (Tables) link:presentationLink link:calculationLink link:definitionLink 240334016 - Disclosure - Intangibles (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 240344017 - Disclosure - Intangibles (Intangible Table) (Details) link:presentationLink link:calculationLink link:definitionLink 240354018 - Disclosure - Intangibles (Finite-Lived Intangible Asset Future Amortization Expense) (Details) link:presentationLink link:calculationLink link:definitionLink 210361010 - Disclosure - Accrued Expenses link:presentationLink link:calculationLink link:definitionLink 230373008 - Disclosure - Accrued Expenses (Tables) link:presentationLink link:calculationLink link:definitionLink 240384019 - Disclosure - Accrued Expenses Components of Accrued Expenses (Details) link:presentationLink link:calculationLink link:definitionLink 240394020 - Disclosure - Accrued Expenses Warranty Schedule (Details) link:presentationLink link:calculationLink link:definitionLink 210401011 - Disclosure - Long-Term Debt link:presentationLink link:calculationLink link:definitionLink 230413009 - Disclosure - Long-Term Debt (Tables) link:presentationLink link:calculationLink link:definitionLink 240424021 - Disclosure - Long-Term Debt (Details) link:presentationLink link:calculationLink link:definitionLink 240434022 - Disclosure - Long-Term Debt Leverage Ratios (Details) link:presentationLink link:calculationLink link:definitionLink 240444023 - Disclosure - Long-Term Debt Components of Convertible Debt (Details) link:presentationLink link:calculationLink link:definitionLink 240454024 - Disclosure - Long-Term Debt Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 240464025 - Disclosure - Long-Term Debt Sale Leaseback Transactions (Details) link:presentationLink link:calculationLink link:definitionLink 210471012 - Disclosure - Other Long-Term Obligations link:presentationLink link:calculationLink link:definitionLink 230483010 - Disclosure - Other Long-Term Obligations (Tables) link:presentationLink link:calculationLink link:definitionLink 240494026 - Disclosure - Other Long-Term Obligations (Details) link:presentationLink link:calculationLink link:definitionLink 210501013 - Disclosure - Leases and Commitments (Notes) link:presentationLink link:calculationLink link:definitionLink 230513011 - Disclosure - Leases and Commitments (Tables) link:presentationLink link:calculationLink link:definitionLink 240524027 - Disclosure - Leases and Commitments (Details) link:presentationLink link:calculationLink link:definitionLink 240534028 - Disclosure - Leases and Commitments Lease Expenses (Details) link:presentationLink link:calculationLink link:definitionLink 240544029 - Disclosure - Leases and Commitments Future Minimum Operating and Financing Lease Commitments (Details) link:presentationLink link:calculationLink link:definitionLink 240554030 - Disclosure - Leases and Commitments Supplemental Cash Flow Information (Details) link:presentationLink link:calculationLink link:definitionLink 240564031 - Disclosure - Leases and Commitments Weighted-Average Remaining Lease Terms and Discount Rates (Details) link:presentationLink link:calculationLink link:definitionLink 210571014 - Disclosure - Revenue Revenue link:presentationLink link:calculationLink link:definitionLink 230583012 - Disclosure - Revenue (Tables) link:presentationLink link:calculationLink link:definitionLink 240594032 - Disclosure - Revenue (Details) link:presentationLink link:calculationLink link:definitionLink 210601015 - Disclosure - Equity Compensation link:presentationLink link:calculationLink link:definitionLink 230613013 - Disclosure - Equity Compensation (Tables) link:presentationLink link:calculationLink link:definitionLink 240624033 - Disclosure - Equity Compensation (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 240634034 - Disclosure - Equity Compensation Share-based Compensation Expense (Details) link:presentationLink link:calculationLink link:definitionLink 240644035 - Disclosure - Equity Compensation Unrecognized Compensation Expense (Details) link:presentationLink link:calculationLink link:definitionLink 240654036 - Disclosure - Equity Compensation (Options Activity) (Details) link:presentationLink link:calculationLink link:definitionLink 240664037 - Disclosure - Equity Compensation (Stock Options Outstanding by Exercise Price) (Details) link:presentationLink link:calculationLink link:definitionLink 240674038 - Disclosure - Equity Compensation Restricted Stock Activity (Details) link:presentationLink link:calculationLink link:definitionLink 240684039 - Disclosure - Equity Compensation Performance Share Activity (Details) link:presentationLink link:calculationLink link:definitionLink 240694040 - Disclosure - Equity Compensation Assumptions (Details) link:presentationLink link:calculationLink link:definitionLink 210701016 - Disclosure - Accumulated Other Comprehensive Income (Loss) by Component link:presentationLink link:calculationLink link:definitionLink 230713014 - Disclosure - Accumulated Other Comprehensive Income (Loss) by Component (Tables) link:presentationLink link:calculationLink link:definitionLink 240724041 - Disclosure - Accumulated Other Comprehensive Income (Loss) by Component (Changes in Accumulated Other Comprehensive Income) (Details) link:presentationLink link:calculationLink link:definitionLink 240734042 - Disclosure - Accumulated Other Comprehensive Income (Loss) by Component (Reclassified Out of Accumulated Other Comprehensive Income) (Details) link:presentationLink link:calculationLink link:definitionLink 210741017 - Disclosure - Charges Related To Restructuring Activities link:presentationLink link:calculationLink link:definitionLink 230753015 - Disclosure - Charges Related To Restructuring Activities (Tables) link:presentationLink link:calculationLink link:definitionLink 240764043 - Disclosure - Charges Related To Restructuring Activities (Details) link:presentationLink link:calculationLink link:definitionLink 240774044 - Disclosure - Charges Related To Restructuring Activities Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 210781018 - Disclosure - Income Taxes link:presentationLink link:calculationLink link:definitionLink 240794045 - Disclosure - Income Taxes (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 210801019 - Disclosure - Net Earnings (Loss) Per Common Share link:presentationLink link:calculationLink link:definitionLink 230813016 - Disclosure - Net Earnings (Loss) Per Common Share (Tables) link:presentationLink link:calculationLink link:definitionLink 240824046 - Disclosure - Net Earnings (Loss) Per Common Share Computation of Basic and Diluted Net Earnings (Loss) Per Common Share (Details) link:presentationLink link:calculationLink link:definitionLink 240834047 - Disclosure - Net Earnings (Loss) Per Common Share Textuals (Details) link:presentationLink link:calculationLink link:definitionLink 210841020 - Disclosure - Concentration Of Credit Risk link:presentationLink link:calculationLink link:definitionLink 240854048 - Disclosure - Concentration Of Credit Risk (Details) link:presentationLink link:calculationLink link:definitionLink 210861021 - Disclosure - Derivatives link:presentationLink link:calculationLink link:definitionLink 230873017 - Disclosure - Derivatives (Tables) link:presentationLink link:calculationLink link:definitionLink 240884049 - Disclosure - Derivatives Notional Amounts - Designated as Hedges (Details) link:presentationLink link:calculationLink link:definitionLink 240894050 - Disclosure - Derivatives Notional Amounts - Not Designated as Hedges (Details) link:presentationLink link:calculationLink link:definitionLink 240904051 - Disclosure - Derivatives Balance Sheet Location (Details) link:presentationLink link:calculationLink link:definitionLink 240914052 - Disclosure - Derivatives Gain (Loss) in Statement of Finacial Position (Details) link:presentationLink link:calculationLink link:definitionLink 240924053 - Disclosure - Derivatives Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 240934054 - Disclosure - Derivatives Fair Value of Convertible Debt Hedges (Details) link:presentationLink link:calculationLink link:definitionLink 210941022 - Disclosure - Fair Values link:presentationLink link:calculationLink link:definitionLink 230953018 - Disclosure - Fair Values (Tables) link:presentationLink link:calculationLink link:definitionLink 240964055 - Disclosure - Fair Values (Assets and Liabilities Measured at Fair Value on a Recurring Basis) (Details) link:presentationLink link:calculationLink link:definitionLink 240974056 - Disclosure - Fair Values (Details of Book Value and Fair Value of Financial Instruments) (Details) link:presentationLink link:calculationLink link:definitionLink 210981023 - Disclosure - Business Segments link:presentationLink link:calculationLink link:definitionLink 230993019 - Disclosure - Business Segments (Tables) link:presentationLink link:calculationLink link:definitionLink 241004057 - Disclosure - Business Segments (Information by Segment) (Details) link:presentationLink link:calculationLink link:definitionLink 211011024 - Disclosure - Contingencies link:presentationLink link:calculationLink link:definitionLink 241024058 - Disclosure - Contingencies Contingencies (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 7 ivc-20200930_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 8 ivc-20200930_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 9 ivc-20200930_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT EUR / SEK Foreign Exchange Forward EUR / SEK [Member] Foreign Exchange Forward EUR / SEK [Member] Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period Restatement [Axis] Revision of Prior Period [Axis] Receivable Type [Axis] Receivable Type [Axis] Other, principally returns and allowances reserves Returns and Allowances Reserve Returns and Allowances Reserve Amortization of convertible debt discount Amortization of Debt Discount (Premium) Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized Deferred financing fees Debt Issuance Costs, Noncurrent, Net Revolving Credit and Security Agreement (New Credit Agreement) Revolving Credit and Security Agreement (New Credit Agreement) [Member] Revolving Credit and Security Agreement (New Credit Agreement) [Member] Installment receivable purchased from DLL Notes, Loans and Financing Receivables, Purchase of Finance Receivables Notes, Loans and Financing Receivables, Purchase of Finance Receivables License agreements Licensing Agreements [Member] Large National Customers Large National Customers [Member] Large National Customers [Member] Range [Domain] Statistical Measurement [Domain] Liabilities and Shareholders’ Equity Liabilities and Equity [Abstract] Risks and Uncertainties [Abstract] Risks and Uncertainties [Abstract] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Finance Lease, Right-of-Use Asset, Amortization Finance Lease, Right-of-Use Asset, Amortization Deferred tax benefit (provision) related to gain on cash flow hedges Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, Tax Current Fiscal Year End Date Current Fiscal Year End Date Debt Instrument, Fee Amount Debt fees Debt Instrument, Fee Amount, Net Balance Shown as a Liability Debt Instrument, Fee Amount, Net Balance Shown as a Liability Proceeds from revolving lines of credit and long-term borrowings Proceeds from Issuance of Long-term Debt Total Current Liabilities Liabilities, Current EUR / GBP Foreign Exchange Forward EUR / GBP [Member] Foreign Exchange Forward EUR / GBP [Member] Reclassification out of Accumulated Other Comprehensive Income Reclassification out of Accumulated Other Comprehensive Income [Member] Performance Shares Performance Shares [Member] Other [Domain] Other [Domain] Other Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value, Beginning Balance Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value, Ending Balance Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Net Gain (Loss), as a percent of Net Sales Net Gain (Loss), as a percent of Net Sales Net Gain (Loss), as a percent of Net Sales Variable Rate [Domain] Variable Rate [Domain] Professional Accrued Professional Fees, Current Right-of-Use Asset Obtained in Exchange for Total Lease Liability Right-of-Use Asset Obtained in Exchange for Total Lease Liability Right-of-Use Asset Obtained in Exchange for Total Lease Liability Fair value stock price Average Fair Value Stock Price Average Fair Value Stock Price Finance Lease, Liability, Payments, Due Finance Lease, Liability, Payment, Due Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures Assets Assets [Abstract] Schedule of Property, Plant and Equipment [Table] Property, Plant and Equipment [Table] Accounting Policies [Abstract] Accounting Policies [Abstract] Unearned Interest - Noncurrent Unearned Interest - Noncurrent Unearned Interest - Noncurrent Cover [Abstract] Cover [Abstract] Document Type Document Type Accumulated Other Comprehensive Income (Loss) by Component Comprehensive Income (Loss) Note [Text Block] Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] Operating Leases, Future Minimum Payments, Present Value of Net Minimum Payments Operating Leases, Future Minimum Payments, Present Value of Net Minimum Payments Operating Leases, Future Minimum Payments, Present Value of Net Minimum Payments Class B Common Shares [Member] Class B Common Shares [Member] Common Class B [Member] Options outstanding at beginning of period (in shares) Options outstanding at end of period (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount Long-term debt net of current maturities Long-term Debt and Lease Obligation Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward] AOCI Attributable to Parent, Net of Tax [Roll Forward] CANADA CANADA Total Unearned Interest Deferred Revenue Deferred Revenue Preferred Shares (Authorized 300 shares; none outstanding) Preferred Stock, Value, Issued Exercise price range, lower limit (in dollars per share) Share-based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit 90+ Days Past Due Installment Receivable, Greater than 90 Days Past Due Installment Receivable, Greater than 90 Days Past Due Percentage of eligible domestic inventory and in-transit inventory Line of Credit, Covenant Compliance, Maximum Borrowing Capacity, Inventories, Domestic, Percent Line of Credit, Covenant Compliance, Maximum Borrowing Capacity, Inventories, Domestic, Percent Other comprehensive income (loss): Other Comprehensive Income (Loss), Net of Tax [Abstract] Common Stock, Par or Stated Value Per Share Common Stock, Par or Stated Value Per Share Allowance for doubtful accounts, long-term Financing Receivable, Allowance for Credit Loss, Noncurrent Other Long-Term Obligations Other Long-Term Obligations Other Liabilities, Noncurrent Amount of Gain (Loss) Recognized in Income on Derivatives (Ineffective Portion and Amount Excluded from Effectiveness Testing) Derivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net Work in process Inventory, Work in Process, Net of Reserves Impaired installment receivables with a related allowance recorded Impaired Financing Receivable, with Related Allowance, Recorded Investment Net loss (gain) on debt extinguishment, as a Percent of Net Sales [Line Items] Net loss (gain) on debt extinguishment, as a Percent of Net Sales Net loss (gain) on debt extinguishment, as a Percent of Net Sales Liability Components of Convertible 2024 Note Liability Components of Convertible 2024 Note [Table Text Block] Liability Components of Convertible 2024 Note Inventories, net Inventory, net Inventory, Net Fair Value, Measurement Frequency [Domain] Measurement Frequency [Domain] Current Financing Receivable, Not Past Due Percentage of eligible Canadian accounts receivable Line of Credit, Covenant Compliance, Maximum Borrowing Capacity, Trade Receivables, Foreign, Percent Line of Credit, Covenant Compliance, Maximum Borrowing Capacity, Trade Receivables, Foreign, Percent Expiration period Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period Statement [Line Items] Statement [Line Items] Class of Stock [Domain] Class of Stock [Domain] Weighted average interest rate (as a percent) Long-term Debt, Weighted Average Interest Rate, at Point in Time Tax Period [Axis] Tax Period [Axis] Receivables Loans, Notes, Trade and Other Receivables Disclosure [Text Block] Net gain on convertible debt derivatives Gain on convertible debt derivatives Net gain on convertible debt derivatives Loss (gain) on Convertible Debt Derivatives Gain (loss) on Convertible Debt Derivatives Consecutive business days for minimum undrawn balance Line of Credit, Covenant Compliance, Consecutive Business Days for Undrawn Balance Line of Credit, Covenant Compliance, Consecutive Business Days for Undrawn Balance Statement [Table] Statement [Table] Type of Restructuring [Domain] Type of Restructuring [Domain] Range [Axis] Statistical Measurement [Axis] Deferred income taxes Deferred Tax Assets, Tax Deferred Expense Interest Income, Other Interest Income, Other Derivative, Price Risk Option Strike Price Class of Warrant or Right, Exercise Price of Warrants or Rights Installment Receivables Net of Unearned Interest Current Notes Loans and Financing Receivable Net of Unearned Interest Current Notes Loans and Financing Receivable Net of Unearned Interest Current Weighted Average Weighted Average [Member] Line of Credit Facility, Fair Value of Amount Outstanding Line of Credit Facility, Fair Value of Amount Outstanding Principles of Consolidation Consolidation, Policy [Policy Text Block] Financing Leases, Cash Paid in Measurement of Amounts for Lease Liabilities Financing Leases, Cash Paid in Measurement of Amounts for Lease Liabilities Financing Leases, Cash Paid in Measurement of Amounts for Lease Liabilities Derivative Instruments and Hedging Activities Disclosures [Table] Derivative Instruments and Hedging Activities Disclosures [Table] Fair Value Hierarchy and NAV [Domain] Fair Value Hierarchy and NAV [Domain] Total installment receivables Financing Receivable, Interest Income, Accrual Method Financing Receivable, Interest Income, Accrual Method Disposal Group, Including Discontinued Operation, Revenue Disposal Group, Including Discontinued Operation, Revenue Cost of products sold Cost of Products Sold Cost of Revenue Deferred gain on sale leaseback Sale Leaseback Transaction, Deferred Gain, Net Percentage of domestic accounts receivable Line of Credit, Covenant Compliance, Maximum Borrowing Capacity, Trade Receivables, Domestic, Percent Line of Credit, Covenant Compliance, Maximum Borrowing Capacity, Trade Receivables, Domestic, Percent USD / CAD Foreign Exchange Forward USD / CAD [Member] Foreign Exchange Forward USD / CAD [Member] Finite-Lived Intangible Assets, Major Class Name [Domain] Finite-Lived Intangible Assets, Major Class Name [Domain] Minimum required undrawn balance (as a percent) Line of Credit, Covenant Compliance, Required Undrawn Balance, Minimum, Percent Line of Credit, Covenant Compliance, Required Undrawn Balance, Minimum, Percent Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant Options available for grant at end of period (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant Other items, principally trade accruals Other Accrued Liabilities, Current Convertible Debt 2022 Conversion Feature Convertible Debt 2022 Conversion Feature [Domain] Convertible Debt 2022 Conversion Feature [Domain] Receivables, Expected Loss Percentage, North America excluding Canada Receivables, Expected Loss Percentage, North America excluding Canada Receivables, Expected Loss Percentage, North America excluding Canada Sale Leaseback Transaction, Net Proceeds, Investing Activities Sale Leaseback Transaction, Net Proceeds, Investing Activities Charges Related To Restructuring Activities Restructuring and Related Activities Disclosure [Text Block] Measurement Frequency [Axis] Measurement Frequency [Axis] Convertible Senior Notes at 5.00% November 2024 [Member] Convertible Senior Notes at 5.00% November 2024 [Member] Convertible Senior Subordinated Debentures at 4.125% February 2027 [Member] Financial Instruments [Domain] Financial Instruments [Domain] Fair Value, by Balance Sheet Grouping Fair Value, by Balance Sheet Grouping [Table Text Block] Gain (Loss) Gain (Loss) Gain (Loss) Derivative, Gain (Loss) on Derivative, Net Fair Value Measurement [Domain] Fair Value Measurement [Domain] Line of Credit Facility, Foreign Currency Fair Value of Amount Outstanding (France) Line of Credit Facility, Foreign Currency Fair Value of Amount Outstanding (France) Line of Credit Facility, Foreign Currency Fair Value of Amount Outstanding (France) Impaired installment receivables with a related allowance recorded Impaired Financing Receivable, with Related Allowance, Unpaid Principal Balance Deferred financing fees Prepaid Debt Fees Prepaid Debt Fees Local Phone Number Local Phone Number Debt Instrument, Net Proceeds Debt Instrument, Net Proceeds Debt Instrument, Net Proceeds Average period of adjudication Notes, Loans, Financing Receivable, Average Period of Adjudication Notes, Loans, Financing Receivable, Average Period of Adjudication Weighted Average Exercise Price Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract] Product liability Product Liability, Noncurrent Product Liability, Noncurrent Total Cash Paid in Measurement of Amounts for Lease Liabilities Total Cash Paid in Measurement of Amounts for Lease Liabilities Total Cash Paid in Measurement of Amounts for Lease Liabilities Property, Plant and Equipment by Type [Axis] Long-Lived Tangible Asset [Axis] Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity Share-based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block] Revenue from External Customers by Products and Services [Table Text Block] Revenue from External Customers by Products and Services [Table Text Block] Income Statement Location [Domain] Income Statement Location [Domain] Adjustments to Additional Paid in Capital, Share-based Compensation, Stock Options, Requisite Service Period Recognition APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition Financing Activities Net Cash Provided by (Used in) Financing Activities [Abstract] Selling, general and administrative expenses Amortization of prior service costs and unrecognized gains Selling, General and Administrative Expense Lease, Cost [Table] Lease, Cost [Table Text Block] Amortization of operating lease right of use assets Operating Lease, Right-of-Use, Amortization Operating Lease, Right-of-Use, Amortization Long-term debt Long-term debt Long-term Debt and Lease Obligation, Including Current Maturities Other Assets Other Long-Term Assets Other Assets, Noncurrent Lifestyle Products [Domain] Lifestyle Products [Domain] Lifestyle Products Plan Name [Axis] Plan Name [Axis] Cash and cash equivalents Cash and Cash Equivalents, Fair Value Disclosure Net loss from Continuing Operations Net loss from continuing operations Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent Total Assets Assets Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Domain] Exercise Price Range [Domain] Accounting Policies Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block] Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number, Beginning Balance Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number, Ending Balance Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number Advance Payment from Sale of Property Advance Payment from Sale of Property Advance Payment from Sale of Property Antidilutive Securities [Axis] Antidilutive Securities [Axis] Cost of Sales [Member] Cost of Sales [Member] Reclassification out of Accumulated Other Comprehensive Income [Axis] Reclassification out of Accumulated Other Comprehensive Income [Axis] Debt Instrument Exchange Amount Debt Instrument Exchange Amount Debt Instrument Exchange Amount IT service contracts IT Service Contract IT Service Contract Schedule of Other Assets, Noncurrent Schedule of Other Assets, Noncurrent [Table Text Block] Share-based Compensation Arrangement by Share-based Payment Award, Description Share-based Compensation Arrangement by Share-based Payment Award, Description Divested Businesses Mergers, Acquisitions and Dispositions Disclosures [Text Block] Options Exercisable - Weighted Average Exercise Price (in dollars per share) Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price Financing Receivable Portfolio Segment Financing Receivable Portfolio Segment [Domain] Other Other Intangible Assets [Member] 61-90 Days Past Due Installment Sales, 60 to 89 Days Past Due Installment Sales, 60 to 89 Days Past Due Share-based Compensation, Performance Shares Award Unvested Activity Share-based Payment Arrangement, Performance Shares, Activity [Table Text Block] Uncertain tax obligation including interest Liability for Uncertainty in Income Taxes, Noncurrent Entity Address, City or Town Entity Address, City or Town Sales [Member] Sales [Member] GBP / USD Foreign Exchange Forward GBP / USD [Member] Foreign Exchange Forward GBP / USD [Member] Schedule of Amounts Recognized in Other Comprehensive Income (Loss) Schedule of Amounts Recognized in Other Comprehensive Income (Loss) [Table Text Block] All Other Other Segments [Member] Total installment receivables Financing Receivable, Unpaid Principal Balance Financing Receivable, Unpaid Principal Balance Required undrawn balance, minimum Line of Credit, Covenant Compliance, Required Undrawn Balance, Amount Line of Credit, Covenant Compliance, Required Undrawn Balance, Amount Net orderly liquidation value of domestic eligible machinery and equipment Line of Credit, Covenant Compliance, Maximum Borrowing Capacity, Property, Plant and Equipment, Liquidation Value, Percent Line of Credit, Covenant Compliance, Maximum Borrowing Capacity, Property, Plant and Equipment, Liquidation Value, Percent Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Disclosure [Abstract] Fair Value, Inputs, Level 1 [Member] Fair Value, Inputs, Level 1 [Member] Adoption of Credit Loss Standard Adoption of Credit Loss Standard Adoption of Credit Loss Standard Schedule of Accounts, Notes, Loans and Financing Receivable [Table] Schedule of Accounts, Notes, Loans and Financing Receivable [Table] Inventories, net Increase (Decrease) in Inventories Tax receivables principally value added taxes Value Added Tax Receivable, Current Legal Entity Type of Counterparty [Domain] Legal Entity Type of Counterparty [Domain] Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] Series II Convertible Senior Notes at 5.00% November 2024 [Domain] Series II Convertible Senior Notes at 5.00% November 2024 [Domain] Series II Convertible Senior Notes at 5.00% November 2024 Additional Paid-in Capital [Member] Additional Paid-in Capital [Member] Line of Credit, Covenant Compliance, Consecutive Business Days for Undrawn_Balance Line of Credit, Covenant Compliance, Consecutive Business Days for Undrawn_Balance Line of Credit, Covenant Compliance, Consecutive Business Days for Undrawn_Balance Finance Lease, Interest Expense Finance Lease, Interest Expense Accrued Expenses Accounts Payable and Accrued Liabilities [Member] Machinery and equipment Machinery and Equipment [Member] Common Stock, Shares, Issued Common Stock, Shares, Outstanding Schedule of Other Current Assets Schedule of Other Current Assets [Table Text Block] Income Tax Disclosure [Abstract] Income Tax Disclosure [Abstract] Schedule of Derivative Instruments, Effect on Other Comprehensive Income (Loss) Schedule of Derivative Instruments, Effect on Other Comprehensive Income (Loss) [Table Text Block] Liability Components of Convertible 2022 Note Liability Components of Convertible 2022 Note [Table Text Block] Liability Components of Convertible 2022 Note [Table Text Block] [Table Text Block] Customer rebate reserve Customer Rebate Reserve Customer Rebate Reserve Performance achievement level, upper range Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Performance Award Target Acheivement, Upper Range, Percentage Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Performance Award Target Acheivement, Upper Range, Percentage Senior secured revolving credit facility, due in October 2015 Revolving Credit Facility Revolving Credit Facility [Member] Schedule of Goodwill [Table] Schedule of Goodwill [Table] Other Current Assets Other Current Assets [Text Block] Derivative Instruments and Hedging Activities [Abstract] Derivative Instruments and Hedging Activities [Abstract] Derivative Instruments and Hedging Activities [Abstract] Loss Before Income Taxes Earnings (loss) before income taxes Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Options outstanding at beginning of period - Weighted Average Exercise Price (in dollars per share) Options outstanding at end of period - Weighted Average Exercise Price (in dollars per share) Options Outstanding - Weighted Average Exercise Price (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price Restricted Stock and Restricted Stock Units (RSUs) Restricted Stock and Restricted Stock Units (RSUs) [Member] Restricted Stock and Restricted Stock Units (RSUs) [Member] Common Stock, Shares Authorized Common Stock, Shares Authorized Stock options and awards Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements Property and equipment, gross Property, Plant and Equipment, Gross Foreign Exchange Forward Contracts, by Exchange [Domain] Foreign Exchange Forward Contracts, by Exchange [Domain] Foreign Exchange Forward Contracts, by Exchange [Domain] Schedule of Segment Reporting Information, by Segment Schedule of Segment Reporting Information, by Segment [Table Text Block] Line of Credit, Covenant Compliance, Maximum Borrowing Capacity, Trade Receivables, Europe, Percent Line of Credit, Covenant Compliance, Maximum Borrowing Capacity, Trade Receivables, Europe, Percent Line of Credit, Covenant Compliance, Maximum Borrowing Capacity, Trade Receivables, Europe, Percent Sale Leaseback Transaction, Description [Axis] Sale Leaseback Transaction, Description [Axis] Impaired installment receivables with a related allowance recorded Impaired Financing Receivable, Related Allowance AOCI Attributable to Parent [Member] AOCI Attributable to Parent [Member] Insurance Accrued Insurance, Current Sale Leaseback Transaction [Table] Sale Leaseback Transaction [Table] Schedule of Segment Reporting Information, by Segment [Table] Schedule of Segment Reporting Information, by Segment [Table] Use of Estimates Use of Estimates, Policy [Policy Text Block] Performance achievement level, target range Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Performance Award Target Acheivement, Percentage Level of Performance Award Achievement, Target Typical financing period Notes, Loans and Financing Receivables, Average Financing Period Notes, Loans and Financing Receivables, Average Financing Period Series II Convertible Senior Notes at 5.00% November 2024 [Member] Series II Convertible Senior Notes at 5.00% November 2024 [Member] Series II Convertible Senior Notes at 5.00% November 2024 Restructuring Reserve [Roll Forward] Restructuring Reserve [Roll Forward] Scenario, Unspecified [Domain] Scenario [Domain] Counterparty Name [Domain] Counterparty Name [Domain] Purchases of property and equipment Payments to Acquire Property, Plant, and Equipment Consolidation Items [Domain] Consolidation Items [Domain] Entity Tax Identification Number Entity Tax Identification Number Property, Plant and Equipment [Abstract] Property, Plant and Equipment [Abstract] Valuation Allowance [Table] Valuation Allowance [Table] Convertible Preferred Stock, Shares Issued upon Conversion Convertible Preferred Stock, Shares Issued upon Conversion Convertible Debt 2022 Conversion Feature, Initial Fair Value Convertible Debt 2022 Conversion Feature, Initial Fair Value Convertible Debt 2022 Conversion Feature, Initial Fair Value Other Long-Term Obligations Other Liabilities Disclosure [Text Block] Advance payment on sale of land & buildings Advance Payment on Sale of Land Advance Payment on Sale of Land Income (Loss) from Continuing Operations before Income Taxes Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest Customer lists Customer Lists [Member] Trading Symbol Trading Symbol Hedging Designation [Axis] Hedging Designation [Axis] Reclassification out of Accumulated Other Comprehensive Income [Domain] Reclassification out of Accumulated Other Comprehensive Income [Domain] Percent of the Applicable Conversion Price Percent of the Applicable Conversion Price Percent of the Applicable Conversion Price Schedule of Inventory Schedule of Inventory, Current [Table Text Block] Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net Risk Level, Medium Risk Level, Medium [Member] Designated as Hedging Instrument [Member] Designated as Hedging Instrument [Member] Non-Impaired installment receivables with no related allowance recorded Financing Receivable, with No Related Allowance, Interest Income, Accrual Method Financing Receivable, with No Related Allowance, Interest Income, Accrual Method Convertible 2021 note hedge asset Convertible due 2021 - Bond Hedge Convertible due 2021 - Bond Hedge, Fair Value Convertible due 2021 - Bond Hedge, Fair Value Schedule of Other Derivatives Not Designated as Hedging Instruments, Statements of Financial Performance and Financial Position, Location Derivatives Not Designated as Hedging Instruments [Table Text Block] Gain on sale of business, as a Percent of Net Sales Gain on sale of business, as a Percent of Net Sales Gain on sale of business, as a Percent of Net Sales Other Intangibles Intangible Assets Disclosure [Text Block] Goodwill [Line Items] Goodwill [Line Items] Operating Leases, Future Minimum Payments, Due Thereafter Operating Leases, Future Minimum Payments, Due Thereafter Lessee, Lease, Description [Line Items] Lessee, Lease, Description [Line Items] Fair Value Disclosures [Abstract] Fair Value Disclosures [Abstract] Operating Leases, Future Minimum Payments Due, Next Twelve Months Operating Leases, Future Minimum Payments Due, Next Twelve Months Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range [Table] Share-based Payment Arrangement, Option, Exercise Price Range [Table] City Area Code City Area Code Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table] Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table] Unearned Interest Unearned Interest Unearned Interest Title of 12(b) Security Title of 12(b) Security Restricted Stock Restricted Stock [Member] Settlements made during the period Standard and Extended Product Warranty Accrual, Decrease for Payments Finished goods Inventory, Finished Goods, Net of Reserves Total Installment Receivables Past Due Financing Receivable, Past Due Disclosure of Compensation Related Costs, Share-based Payments [Abstract] Share-based Payment Arrangement [Abstract] Legal Entity of Counterparty, Type [Axis] Legal Entity of Counterparty, Type [Axis] Revenue from External Customer [Line Items] Revenue from External Customer [Line Items] Current portion of operating lease obligations Operating Lease, Liability, Current Operating Lease, Liability, Current Notional amount of derivatives, matured during period Notional Amount of Derivatives, Matured During Period Notional Amount of Derivatives, Matured During Period Industry Sector [Domain] Industry Sector [Domain] Right-of-Use Asset Obtained in Exchange for Finance Lease Liability Right-of-Use Asset Obtained in Exchange for Finance Lease Liability Convertible due 2021 - Bond Hedge, Fair Value at Issuance Convertible due 2021 - Bond Hedge, Fair Value at Issuance Convertible due 2021 - Bond Hedge, Fair Value at Issuance Class of Financing Receivable, Type Class of Financing Receivable [Domain] Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value Derivative Instruments, Gain (Loss) [Line Items] Derivative Instruments, Gain (Loss) [Line Items] Schedule of Derivatives Instruments Statements of Financial Position, Fair Value Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block] Fair Value of Financial Instruments Fair Value Disclosures [Text Block] Accounts, Notes, Loans and Financing Receivable [Line Items] Accounts, Notes, Loans and Financing Receivable [Line Items] Schedule for Allowance for Credit Losses Allowance for Credit Losses [Table Text Block] Allowance for Credit Losses Derivatives, Fair Value [Line Items] Derivatives, Fair Value [Line Items] Interest Income Recognized Impaired Financing Receivable, Interest Income, Accrual Method [Abstract] United Kingdom, Pounds United Kingdom, Pounds Industry of Counterparty [Domain] Industry of Counterparty [Domain] Liability Components of Convertible Series II 2024 Note Liability Components of Convertible Series II 2024 Note [Table Text Block] Liability Components of Convertible Series II 2024 Note Operating Lease, Weighted Average Discount Rate, Percent Operating Lease, Weighted Average Discount Rate, Percent Debt Instrument, Fee Amount Debt Instrument, Fee Amount Intersegment revenues Intersegment Eliminations [Member] Issuance of warrants Proceeds from Issuance of Warrants Proceeds from Issuance of Warrants Line of Credit Facility, Foreign Currency Fair Value of Amount Outstanding (UK) Line of Credit Facility, Foreign Currency Fair Value of Amount Outstanding (UK) Line of Credit Facility, Foreign Currency Fair Value of Amount Outstanding (UK) Contract Termination Contract Termination [Member] Warranties provided during the period Standard and Extended Product Warranty Accrual, Increase for Warranties Issued Contract Type [Axis] Contract Type [Axis] Contract Type [Axis] Payment of dividends Payments of Ordinary Dividends, Common Stock Payments of Ordinary Dividends, Common Stock Service contracts Prepaid Service Contracts Prepaid Service Contracts Beginning Balance Ending Balance Restructuring Reserve Restructuring Reserve 0-30 Days Past Due Installment Receivable, 1 to 29 Days Past Due Installment Receivable, 1 to 29 Days Past Due Adjustments for New Accounting Pronouncements [Axis] Accounting Standards Update [Axis] Convertible Senior Notes at 5.00% November 2024 [Domain] Convertible Senior Notes at 5.00% November 2024 [Domain] Convertible Senior Notes at 5.00% November 2024 [Domain] Restructuring Cost and Reserve [Axis] Restructuring Type [Axis] Foreign currency translation adjustments Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent Accrued Expenses Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block] Goodwill Goodwill USD / AUD Foreign Exchange Forward USD / AUD [Member] Foreign Exchange Forward USD / AUD [Member] Arrangements and Non-arrangement Transactions [Domain] Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items] Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] Dividends Declared per Common Share Common Stock, Dividends, Per Share, Declared Debt Instrument, Face Amount Debt Instrument, Face Amount Other long-term liabilities Increase (Decrease) in Other Deferred Liability Other current assets Other current assets Other Assets, Current Canceled (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period Financing Lease Liability, non-current Financing Lease Liability, non-current Financing Lease Liability, non-current Entities [Table] Entities [Table] Equity [Abstract] Equity [Abstract] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Entity Central Index Key Entity Central Index Key Entity Emerging Growth Company Entity Emerging Growth Company Derivative Contract [Domain] Derivative Contract [Domain] Weighted Average Shares Outstanding—Assuming Dilution Average common shares assuming dilution Weighted Average Number of Shares Outstanding, Diluted Letter of Credit Letter of Credit [Member] Performance achievement level, lower range Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Performance Award Target Acheivement, Lower Range, Percentage Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Performance Award Target Acheivement, Lower Range, Percentage Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period Debt Disclosure [Abstract] Debt Disclosure [Abstract] Assets and Liabilities of Divested Business [Table Text Block] Assets and Liabilities of Divested Business [Table Text Block] Assets and Liabilities of Divested Business Schedule of Accounts Receivable [Abstract] Schedule of Accounts Receivable [Abstract] Schedule of Accounts Receivable [Abstract] Net Cash Provided (Used) by Financing Activities Net Cash Provided by (Used in) Financing Activities Repurchases of convertible debt, payments on revolving lines of credit and financing leases Repayments of Long-term Debt Disposal Group, Including Discontinued Operation, Inventory Disposal Group, Including Discontinued Operation, Inventory Schedule of Share-based Compensation, Stock Options Outstanding Share-based Payment Arrangement, Option, Exercise Price Range [Table Text Block] Selling, general and administrative expenses, as a Percent of Net Sales Selling, general and administrative expenses, as a Percent of Net Sales Selling, general and administrative expenses, as a Percent of Net Sales Investments Long-term Investments Counterparty Name [Axis] Counterparty Name [Axis] Line of Credit Facility, Covenant Feature, Dominion Trigger Line of Credit Facility, Covenant Feature, Dominion Trigger Line of Credit Facility, Covenant Feature, Dominion Trigger Finite-Lived Intangible Assets [Line Items] Finite-Lived Intangible Assets [Line Items] Non-Impaired installment receivables with no related allowance recorded Financing Receivable, with No Related Allowance, Recorded Investment Financing Receivable, with No Related Allowance, Recorded Investment USD / EUR Foreign Exchange Forward USD / EUR [Member] Foreign Exchange Forward USD / EUR [Member] Future amortization expense, 2022 Finite-Lived Intangible Asset, Expected Amortization, Year Two Installment Receivables, Current Financing Receivable, before Allowance for Credit Loss, Current Short-term debt and current maturities of long-term obligations Long-term Debt, Current Maturities Total installment receivables Financing Receivable, Recorded Investment Financing Receivable, Recorded Investment Other Liabilities Disclosure [Abstract] Other Liabilities Disclosure [Abstract] Inventory Disclosure [Abstract] Inventory Disclosure [Abstract] Common Stock, Shares, Issued Common Stock, Shares, Issued Cash and cash equivalents Cash and cash equivalents at beginning of year Cash and cash equivalents at end of period Cash and Cash Equivalents, at Carrying Value Schedule of Impaired Financing Receivable [Table] Schedule of Impaired Financing Receivable [Table] Options Outstanding - Number Outstanding at end of period (in shares) Share-based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding Long-Term Debt Long-term Debt, Excluding Current Maturities Segment Reporting [Abstract] Segment Reporting [Abstract] Accounts Receivable, Net Accounts Receivable, after Allowance for Credit Loss USD / MXN Foreign Exchange Forward USD / MXP [Member] Foreign Exchange Forward USD / MXP [Member] Debt Instrument [Line Items] Debt Instrument [Line Items] Total Shareholders’ Equity Total Shareholders’ Equity Total Shareholders’ Equity Stockholders' Equity Attributable to Parent Revenue Recognition, Deferred Revenue [Policy Text Block] Revenue Recognition, Deferred Revenue [Policy Text Block] Convertible 2021 debt conversion liability Convertible Debt 2021 Conversion Feature, Fair Value Convertible Debt 2021 Conversion Feature, Fair Value Severance Other Employee-related Liabilities, Current Derivative assets (liabilities), at fair value, net Derivative Assets (Liabilities), at Fair Value, Net Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] Financial Instrument [Axis] Financial Instrument [Axis] Disposal Group, Including Discontinued Operation, Other Assets Disposal Group, Including Discontinued Operation, Other Assets Type of Adoption [Domain] Accounting Standards Update [Domain] Debt Instrument Repurchase Amount, Cash Paid Debt Instrument Repurchase Amount, Cash Paid Debt Instrument Repurchase Amount, Cash Paid Operating Leases, Future Minimum Payments, Due in Four Years Operating Leases, Future Minimum Payments, Due in Four Years Product Product [Member] Short-term Lease, Cost Short-term Lease, Cost Deferred tax adjustment resulting from defined benefit plan activity Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, Tax Loss (gain) on disposals of property and equipment Gain (Loss) on Disposition of Property Plant Equipment Indefinite-lived Intangible Assets by Major Class [Axis] Indefinite-lived Intangible Assets [Axis] Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] Entity Address, Address Line One Entity Address, Address Line One Future amortization expense, 2023 Finite-Lived Intangible Asset, Expected Amortization, Year Three ERROR in label resolution. Disposal Group, Including Discontinued Operation, Assets Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Transferred from Prior Plans Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Transferred from Prior Plans Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Transferred from Prior Plans Prepaid insurance Prepaid Insurance Schedule of Notional Amounts of Outstanding Derivative Positions Schedule of Notional Amounts of Outstanding Derivative Positions [Table Text Block] Entity Address, State or Province Entity Address, State or Province Finance Lease Long-Term Obligations Finance Lease, Liability, Noncurrent Sale Leaseback Transaction, Immediate Loss Recognized Sale Leaseback Transaction, Immediate Loss Recognized Sale Leaseback Transaction, Immediate Loss Recognized Schedule of Future Minimum Lease Payments for Capital Leases [Table] Schedule of Future Minimum Lease Payments for Capital Leases [Table Text Block] Other Comprehensive Income (Loss) Other Comprehensive Income (Loss), Net of Tax Related Allowance for Doubtful Accounts Impaired Financing Receivable, Related Allowance [Abstract] Impaired Financing Receivable, Related Allowance [Abstract] Leases [Abstract] Leases [Abstract] Interest expense, as a Percent of Net Sales Interest expense, as a Percent of Net Sales Interest expense, as a Percent of Net Sales Long-term Debt, Type [Axis] Long-term Debt, Type [Axis] Total Current Assets Assets, Current Goodwill Goodwill Disclosure [Text Block] Earnings Per Share [Abstract] Earnings Per Share [Abstract] Charges related to restructuring activities Charges Charges Restructuring Charges Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Other Notes and Capital Lease Obligations Other Notes and Capital Lease Obligations [Member] Other Notes and Capital Lease Obligations [Member] Amortization of prior service costs and unrecognized losses Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), Reclassification Adjustment from AOCI, before Tax Accumulated Defined Benefit Plans Adjustment [Member] Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member] Gain on sale of business Gain (Loss) on Disposition of Business Disposal Groups, Including Discontinued Operations, Name [Domain] Disposal Group Name [Domain] Shareholders’ Equity Stockholders' Equity Attributable to Parent [Abstract] Entity Interactive Data Current Entity Interactive Data Current Future amortization expense, 2025 Finite-Lived Intangible Asset, Expected Amortization, Year Five Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Pension Liability, Defined Benefit Pension Plan, Noncurrent Class of Financing Receivable, Type of Borrower [Domain] Class of Financing Receivable, Type of Borrower [Domain] Common Shares [Member] Common Stock [Member] Common Stock [Member] Accumulated Translation Adjustment [Member] Accumulated Foreign Currency Adjustment Attributable to Parent [Member] Product and Service [Domain] Product and Service [Domain] Risk Level, High Risk Level, High [Member] Disposal Group, Including Discontinued Operation, Inter-Company Revenue Disposal Group, Including Discontinued Operation, Inter-Company Revenue Disposal Group, Including Discontinued Operation, Inter-Company Revenue Concentration Risk Benchmark [Domain] Concentration Risk Benchmark [Domain] Schedule of Financing Receivable, Allowance for Credit Losses [Table] Financing Receivable, Allowance for Credit Loss [Table] Finance Lease, Weighted Average Discount Rate, Percent Finance Lease, Weighted Average Discount Rate, Percent Disposal Group, Including Discontinued Operation, Operating Lease, Liability, NonCurrent Disposal Group, Including Discontinued Operation, Operating Lease, Liability, NonCurrent Disposal Group, Including Discontinued Operation, Operating Lease, Liability, NonCurrent Notional Amount Notional Amount, Derivative Notional Amount, Derivative Net Revenue Net Revenue Net Revenue Leasehold improvements Leasehold Improvements [Member] Restatement [Domain] Revision of Prior Period [Domain] Interest rate (as a percent) Debt Instrument, Interest Rate, Stated Percentage Other Customers Other Customers [Member] Other Customers [Member] Total Installment Receivables Financing Receivable, before Allowance for Credit Loss Net Loss per Share—Assuming Dilution Earnings Per Share, Diluted [Abstract] Cash, Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Derivative, Amount of Hedged Item Derivative, Amount of Hedged Item Loss Contingency, Nature [Domain] Loss Contingency, Nature [Domain] Stock Options Share-based Payment Arrangement, Option [Member] Non-Impaired installment receivables with no related allowance recorded Financing Receivable, with No Related Allowance, Unpaid Principal Balance Financing Receivable, with No Related Allowance, Unpaid Principal Balance Capital Lease Obligations Capital Lease Obligations Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax Treasury Stock, Shares Treasury Stock, Shares Severance Employee Severance [Member] Disposal Group, Including Discontinued Operation, Accrued Income Tax Payable Disposal Group, Including Discontinued Operation, Accrued Income Tax Payable Disposal Group, Including Discontinued Operation, Divestiture Costs Incurred Disposal Group, Including Discontinued Operation, Divestiture Costs Incurred Disposal Group, Including Discontinued Operation, Divestiture Costs Incurred Debt Instrument, Net Carrying Amount Debt Instrument, Net Carrying Amount Debt Instrument, Net Carrying Amount Debt Instrument, Net Carrying Amount Tax Period [Domain] Tax Period [Domain] Supplemental Executive Retirement Program liability Deferred Compensation Cash-based Arrangements, Liability, Current Financing Receivable, Recorded Investment, Past Due [Line Items] Financing Receivable, Past Due [Line Items] Additional paid-in-capital Additional Paid in Capital Future amortization expense, 2021 Finite-Lived Intangible Asset, Expected Amortization, Year One Net Sales Net Sales Revenues Operating Leases, Future Minimum Payments, Due in Three Years Operating Leases, Future Minimum Payments, Due in Three Years Class of Stock [Axis] Class of Stock [Axis] Supplemental Executive Retirement Plan liability Deferred Compensation Cash-based Arrangements, Liability, Classified, Noncurrent Product liability, current portion Product Liability, Current Product Liability, Current Accrued expenses Accrued expenses Accrued Liabilities, Current Net Loss per Share—Assuming Dilution Net earnings (loss) per per common share—assuming dilution (in dollars per share) Earnings Per Share, Diluted Operating Leases, Future Minimum Payments, Due in Two Years Operating Leases, Future Minimum Payments, Due in Two Years Type of Arrangement and Non-arrangement Transactions [Axis] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Schedule of Long-term Debt Instruments Schedule of Long-term Debt Instruments [Table Text Block] Proceeds from sale of business Proceeds from Divestiture of Businesses, Net of Cash Divested Historical Cost Indefinite-lived Intangible Assets (Excluding Goodwill) Debt Instrument, Convertible, Threshold Consecutive Trading Days Debt Instrument, Convertible, Threshold Consecutive Trading Days (Provision) benefit for deferred income taxes Deferred Income Tax Expense (Benefit) Derivative liabilities Derivative Liability, Fair Value, Gross Liability Rent Accrued Rent, Current Accumulated Amortization Finite-Lived Intangible Assets, Accumulated Amortization Maximum Maximum [Member] Preferred Stock, Shares Authorized Preferred Stock, Shares Authorized Dividends, Common Stock, Cash Dividends, Common Stock, Cash Convertible Debt, Conversion Rate of Commmon Shares, Principal Convertible Debt, Conversion Rate of Commmon Shares, Principal Convertible Debt, Conversion Rate of Commmon Shares, Principal Financing Leases, Future Minimum Payments, Interest Included in Payments Financing Leases, Future Minimum Payments, Interest Included in Payments Financing Leases, Future Minimum Payments, Interest Included in Payments Gross Profit, as a Percent of Net Sales Gross Profit, as a Percent of Net Sales Gross Profit, as a Percent of Net Sales 31-60 Days Past Due Installment Receivable, 30 to 59 Days Past Due Installment Receivable, 30 to 59 Days Past Due Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Effective income tax rate, continuing operations Effective Income Tax Rate Reconciliation, Percent Concentration Of Credit Risk Concentration Risk Disclosure [Text Block] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Allowance for doubtful accounts Accounts Receivable, Allowance for Credit Loss Number of missed payments before delinquent Notes, Loans, and Financing Receivables, Number of Missed Payments before Delinquent Notes, Loans, and Financing Receivables, Number of Missed Payments before Delinquent Interest Revenue (Expense), Net Interest Revenue (Expense), Net Other Prepaid Expense and Other Assets, Noncurrent Accumulated Other Comprehensive Income (Loss) [Table] Accumulated Other Comprehensive Income (Loss) [Table] Debt Instrument, Repurchase Amount Debt Instrument, Repurchase Amount Gain (Loss) on Sale of Properties Gain (Loss) on Sale of Properties Valuation reserve associated with defined benefit plan activity Other Comprehensive Income (Loss), Deferred Tax Valuation Reserve Other Comprehensive Income (Loss), Deferred Tax Valuation Reserve Debt Instrument, Increase, Accrued Interest Debt Instrument, Increase, Accrued Interest Segment Reporting Information [Line Items] Segment Reporting Information [Line Items] Fair Value, Measurements, Recurring Fair Value, Recurring [Member] Finance Lease, Liability, Payments, Due Year Two Finance Lease, Liability, to be Paid, Year Two Convertible Senior Notes at 5.00% February 2021 [Member] Convertible Senior Notes at 5.00% February 2021 [Member] Convertible Senior Notes at 5.00% February 2021 [Member] Schedule of Product Warranty Liability Schedule of Product Warranty Liability [Table Text Block] Schedule for Allowance for Credit Losses [Abstract] Schedule for Allowance for Credit Losses [Abstract] Schedule for Allowance for Credit Losses [Abstract] Convertible Senior Notes, Percentage of Principal Required for Repurchase Convertible Senior Notes, Percentage of Principal Required for Repurchase Convertible Senior Notes, Percentage of Principal Required for Repurchase Treasury Stock [Member] Treasury Stock [Member] Payables and Accruals [Abstract] Payables and Accruals [Abstract] Credit Loss Status [Domain] Credit Loss Status [Domain] Events of Default Under Contract by Third Party Concentration Risk, Recourse for Customer Lease Obligation Under Default Concentration Risk, Recourse for Customer Lease Obligation Under Default Segments [Axis] Segments [Axis] Respiratory Therapy [Domain] Respiratory Therapy [Domain] Respiratory Therapy Schedule of Accumulated Other Comprehensive Income (Loss) Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block] Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, Net of Tax Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, Net of Tax Fair Value, Inputs, Level 3 [Member] Fair Value, Inputs, Level 3 [Member] Schedule of Restructuring and Related Costs [Table] Schedule of Restructuring and Related Costs [Table] Share-based Compensation Arrangement by Share-based Payment Award, Number of Share Awards Underlying from 2003 Plan Share-based Compensation Arrangement by Share-based Payment Award, Number of Share Awards Underlying from 2003 and 2013 Plans Share-based Compensation Arrangement by Share-based Payment Award, Number of Share Awards Underlying from 2003 and 2013 Plans Payments to debt holders Payments to Debt Holders Payments to Debt Holders Other Current Assets Other Current Assets [Member] Derivative assets Derivative Asset Convertible Senior Subordinated Debentures at 5.00% February 2021 [Domain] Convertible Senior Subordinated Debentures at 5.00% February 2021 [Domain] Convertible Senior Subordinated Debentures at 5.00% February 2021 General Terms and Conditions General Terms and Conditions [Member] General Terms and Conditions [Member] Line of Credit Line of Credit [Member] Restructuring Cost and Reserve [Line Items] Restructuring Cost and Reserve [Line Items] Derivatives Derivative Instruments and Hedging Activities Disclosure [Text Block] Warranty Balance as of January 1, 2020 Balance as of September 30, 2020 Product Warranty Accrual, Current Intangibles Intangible Assets, Net (Excluding Goodwill) Deferred revenue Deferred Revenue, Current Operating Income (Loss) Operating Income (Loss) Operating Income (Loss) Entity Address, Postal Zip Code Entity Address, Postal Zip Code Swing Line Loans Swing Line Loans [Domain] Swing Line Loans [Domain] Gain recognized in income Derivative, Gain on Derivative $25.01 – $30.00 Range of Exercise Price Three [Member] Range of Exercise Price Three [Member] Variable Rate [Axis] Variable Rate [Axis] Purchase of treasury shares Payments for Repurchase of Common Stock Payments for Repurchase of Common Stock EUR / NOK Foreign Exchange Forward EUR / NOK [Member] Foreign Exchange Forward EUR / NOK [Member] Furniture and fixtures Furniture and Fixtures [Member] Current taxes payable Taxes Payable, Current Entity Shell Company Entity Shell Company Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period Common Stock, Holders Percentage of Total Outstanding Common Stock, Holders Percentage of Total Outstanding Common Stock, Holders Percentage of Total Outstanding Accounts payable Accounts Payable, Current Product Liability Contingency Product Liability Contingency [Line Items] Derivatives (foreign currency forward exchange contracts) Derivative Asset, Current Retained earnings Retained Earnings (Accumulated Deficit) Operating Lease, Right-of-Use Asset Operating Lease, Right-of-Use Asset Other Long-Term Assets Other Assets Disclosure [Text Block] Adjustments for Error Correction [Domain] Error Correction, Type [Domain] Debt Instrument, Unamortized Discount Unamortized discount Debt Instrument, Unamortized Discount Loss on debt extinguishment including debt finance charges and fees Loss on debt extinguishment including debt finance charges and fees Gain (Loss) on Extinguishment of Debt Convertible 2022 note hedge asset Convertible due 2022 - Bond Hedge, Fair Value Convertible due 2022 - Bond Hedge, Fair Value Unamortized Financing Costs Unamortized Financing Costs Unamortized Financing Costs Operating Leases, Future Minimum Payments, Interest Included in Payments Operating Leases, Future Minimum Payments, Interest Included in Payments Operating Leases, Future Minimum Payments, Interest Included in Payments 2013 Plan [Member] 2013 Plan [Member] 2013 Plan [Member] Finance Lease, Liability, Payments, Due Next Twelve Months Finance Lease, Liability, to be Paid, Year One NZD / USD Foreign Exchange Forward NZD / USD [Member] Foreign Exchange Forward NZD / USD [Member] Net award activity (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Period Increase (Decrease) Hedging Designation [Domain] Hedging Designation [Domain] Document Quarterly Report Document Quarterly Report Options exercisable at end of period (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number Exchange of Convertible Notes Exchange of Convertible Notes Exchange of Convertible Notes Other Noncurrent Liabilities Other Noncurrent Liabilities [Table Text Block] Payment of financing costs Payments of Financing Costs Other Payments for (Proceeds from) Other Investing Activities Accumulated Long-Term Notes Adjustment [Member] Accumulated Long-Term Notes Adjustment [Member] Accumulated Long-Term Notes Adjustment [Member] Receivable due from information technology provider Receivable Due From Information Technology Provider Receivable Due From Information Technology Provider Net loss (gain) on convertible debt derivatives, as a Percent of Net Sales Net loss (gain) on convertible debt derivatives, as a Percent of Net Sales Net loss (gain) on convertible debt derivatives, as a Percent of Net Sales North America North America North America [Member] AUD / USD Foreign Exchange Forward AUD / USD [Member] Foreign Exchange Forward AUD / USD [Member] Convertible Debt Conversion Feature Gain (Loss) Convertible Debt Conversion Feature Gain (Loss) Convertible Debt Conversion Feature Gain (Loss) Convertible Debt Conversion Feature Gain (Loss) Disposal Group, Including Discontinued Operation, Operating Lease, Liability, Current Disposal Group, Including Discontinued Operation, Operating Lease, Liability, Current Disposal Group, Including Discontinued Operation, Operating Lease, Liability, Current Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract] Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract] Percentage of net orderly liquidation value of eligible Canadian inventory Line of Credit, Covenant Compliance, Maximum Borrowing Capacity, Inventories, Foreign, Liquidation Value, Percent Line of Credit, Covenant Compliance, Maximum Borrowing Capacity, Inventories, Foreign, Liquidation Value, Percent Entity File Number Entity File Number Geographical [Domain] Geographical [Domain] Contract Type [Domain] Contract Type [Domain] [Domain] for Contract Type [Axis] Financing Receivable Portfolio Segment [Axis] Financing Receivable Portfolio Segment [Axis] EUR / CHF Foreign Exchange Forward EUR / CHF [Member] Foreign Exchange Forward EUR / CHF [Member] Derivative Instruments and Hedging Activities Disclosures [Line Items] Derivative Instruments and Hedging Activities Disclosures [Line Items] Document Fiscal Period Focus Document Fiscal Period Focus Interest Interest Payable, Current Risk Factor [Domain] Risk Factor [Domain] [Domain] for Risk Factor Current period provision Allowance for Loan and Lease Losses, Adjustments, Other Credit Facility [Axis] Credit Facility [Axis] Total debt (including current maturities of long-term debt) * Debt Instrument, Fair Value Disclosure Schedule of Aging of Installment Receivables Financing Receivable, Past Due [Table Text Block] Convertible Debt Conversion Feature Convertible Debt 2021 Conversion Feature [Member] Convertible Debt 2021 Conversion Feature Revolving Credit and Security Agreement (Europe Credit Agreement) Revolving Credit and Security Agreement (Europe Credit Agreement) [Member] [Domain] Revolving Credit and Security Agreement (Europe Credit Agreement) [Member] [Domain] Industry Sector [Axis] Industry Sector [Axis] Convertible Debt Derivative Adjustments Convertible Debt Derivative Adjustments Convertible Debt Derivative Adjustments Restructuring and Related Activities [Abstract] Restructuring and Related Activities [Abstract] USD / GBP Foreign Exchange Forward USD / GBP [Member] Foreign Exchange Forward USD / GBP [Member] Accounts receivable, gross Accounts Receivable, before Allowance for Credit Loss Selling, General and Administrative Expenses Selling, General and Administrative Expenses [Member] EUR / CAD Foreign Exchange Forward EUR / CAD [Member] Foreign Exchange Forward EUR / CAD [Member] Accretion Rate Accretion Rate Accretion Rate Class of Financing Receivable, Type of Borrower [Axis] Type of Borrower [Axis] Schedule of Earnings Per Share, Basic and Diluted Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Operating Leases, Future Minimum Payments Due Operating Leases, Future Minimum Payments Due Impaired installment receivables with a related allowance recorded Impaired Financing Receivable, with Related Allowance, Interest Income, Accrual Method Revenue Recognition, Multiple-deliverable Arrangements [Line Items] Revenue Recognition, Multiple-deliverable Arrangements [Line Items] Change in other long-term assets Payments for (Proceeds from) Long-term Investments Liability Components of Convertible 2021 Note Liability Components of Convertible 2021 Note [Table Text Block] [Table Text Block] for Liability Components of Convertible 2021 Note Accretion Expense Accretion Expense Amendment Flag Amendment Flag Maximum value of net orderly liquidation value domestic inventory and in-transit inventory Line of Credit, Covenant Compliance, Maximum Borrowing Capacity, Inventories, Liquidation Value, Amount Line of Credit, Covenant Compliance, Maximum Borrowing Capacity, Inventories, Liquidation Value, Amount $20.01 – $25.00 Range of Exercise Price Two [Member] Range of Exercise Price Two [Member] Net Cash Provided by (Used in) Operating Activities Net Cash Provided by (Used in) Operating Activities Billing Status, Type [Axis] Billing Status, Type [Axis] Line of Credit Facility, Current Borrowing Capacity Line of Credit Facility, Current Borrowing Capacity Derivative Instrument [Axis] Derivative Instrument [Axis] Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets by Major Class [Axis] Schedule of Finite-Lived Intangible Assets Schedule of Finite-Lived Intangible Assets [Table Text Block] Schedule of Financing Receivables Past Due [Table] Financing Receivable, Past Due [Table] Disposal Group, Including Discontinued Operation, Liabilities Disposal Group, Including Discontinued Operation, Liabilities Recoverable income taxes Income Taxes Receivable, Current Geographical [Axis] Geographical [Axis] Percent of the Product of the Last Reported Sale Price, Common Shares Percent of the Product of the Last Reported Sale Price, Common Shares Percent of the Product of the Last Reported Sale Price, Common Shares Convertible Debt 2022 Conversion Feature, Fair Value Convertible Debt Conversion Feature Convertible Debt 2022 Conversion Feature, Fair Value Convertible Debt 2022 Conversion Feature, Fair Value Segments [Domain] Segments [Domain] Allowance for Loan and Lease Losses, Adjustments, Other Allowance for Losses, Adjustments, Other Allowance for Losses, Adjustments, Other Risk Level, Low Risk Level, Low [Member] $30.01 – $33.36 Range of Exercise Price Four [Member] Range of Exercise Price Four [Member] Statement of Cash Flows [Abstract] Statement of Cash Flows [Abstract] Revenue Recognition, Multiple-deliverable Arrangements Revenue Recognition, Multiple-deliverable Arrangements [Table Text Block] Effect of exchange rate changes on cash Effect of Exchange Rate on Cash and Cash Equivalents Income Statement Location [Axis] Income Statement Location [Axis] Options Outstanding - Weighted Average Remaining Contractual Life Share-based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Remaining Contractual Term Receivables, Expected Loss Percentage, Europe Receivables, Expected Loss Percentage, Europe Receivables, Expected Loss Percentage, Europe Foreign Exchange Forward Contracts, by Exchange [Axis] Foreign Exchange Forward Contracts, by Exchange [Axis] Foreign Exchange Forward Contracts, by Exchange [Axis] General Lease Term General Lease Term General Lease Term Rebates Accrued Marketing Costs, Current Adjustments for Change in Accounting Principle [Domain] Change in Accounting Principle, Type [Domain] Last Reported Sales Price Period, Common Stock Last Reported Sales Price Period, Common Stock Last Reported Sales Price Period, Common Stock Amortization expense Amortization of Intangible Assets Revenue [Abstract] Revenue [Abstract] Revenue [Abstract] Entity Current Reporting Status Entity Current Reporting Status Business Segments Segment Reporting Disclosure [Text Block] Operating Gain (Loss), as a Percent of Net Sales Operating Gain (Loss), as a Percent of Net Sales Operating Gain (Loss), as a Percent of Net Sales Sale Leaseback Transaction [Line Items] Sale Leaseback Transaction [Line Items] Scenario [Axis] Scenario [Axis] Derivative liabilities (foreign currency forward exchange contracts) Derivative Liability, Current Schedule of Accrued Expenses Schedule of Accrued Liabilities [Table Text Block] Reversal of Accrued Withholding Taxes on Earnings Reversal of Accrued Withholding Taxes on Earnings Reversal of Accrued Withholding Taxes on Earnings Industry of Counterparty, Type [Axis] Industry of Counterparty, Type [Axis] Geographic Distribution [Axis] Geographic Distribution [Axis] Entity Small Business Entity Small Business NOK / USD Foreign Exchange Forward NOK / USD [Member] Foreign Exchange Forward NOK / USD [Member] Vesting [Domain] Vesting [Domain] Interest expense Interest Expense Depreciation and amortization Depreciation, Depletion and Amortization Entity Filer Category Entity Filer Category Convertible Subordinated Debt Convertible Subordinated Debt [Member] Product and Service [Axis] Product and Service [Axis] Convertible Debt Bond Hedge Convertible Debt Bond Hedge [Member] Convertible Debt Bond Hedge Period for recognition of unrecognized compensation costs Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Finance Lease, Liability, Payments, Due Year Five Finance Lease, Liability, to be Paid, Year Five Extended Product Warranty Accrual, Increase for Warranties Issued Extended Product Warranty Accrual, Increase for Warranties Issued Unsecured Debt, Current Unsecured Debt, Current Convertible Debt Conversion Feature, Fair Value at Issuance Convertible Debt Conversion Feature, Fair Value at Issuance Convertible Debt Conversion Feature, Fair Value at Issuance Allowance for Doubtful Accounts [Roll Forward] Financing Receivable, Allowance for Credit Loss [Roll Forward] Operating Lease, Expense Operating Lease, Expense Sale Leaseback Transactions [Abstract] Sale Leaseback Transactions [Abstract] Sale Leaseback Transactions [Abstract] Sale Leaseback Transaction, Annual Rental Payments Sale Leaseback Transaction, Annual Rental Payments Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Table] Fair Value, Recurring and Nonrecurring [Table] Document Fiscal Year Focus Document Fiscal Year Focus Accounts payable Increase (Decrease) in Accounts Payable Raw materials Inventory, Raw Materials, Net of Reserves Allowance for doubtful accounts Balance as of beginning of period Balance as of end of period Financing Receivable, Allowance for Credit Loss Unrealized Gain (Loss) Unrealized Gain (Loss) on Derivatives Debt Instrument [Axis] Debt Instrument [Axis] Fair Values Convertible Debt Hedges, Gain (Loss) Fair Values Convertible Debt Hedges, Gain (Loss) Fair Values Convertible Debt Hedges, Gain (Loss) Antidilutive Securities, Name [Domain] Antidilutive Securities, Name [Domain] Operating Segments [Member] Operating Segments [Member] Sale Leaseback Transaction, Deferred Gain, Gross Sale Leaseback Transaction, Deferred Gain, Gross USD / SEK Foreign Exchange Forward USD / SEK [Member] Foreign Exchange Forward USD / SEK [Member] IT licenses IT Licenses IT Licenses Accrued expenses Increase (Decrease) in Accrued Liabilities Derivative liabilities Derivative Liability Adjustments to reconcile net loss to net cash used by operating activities: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Financing Receivable, Allowance for Credit Losses, Write-downs Allowance for Credit Losses, Write-downs Allowance for Credit Losses, Write-downs Options Exercisable - Number Exercisable At end of period (in shares) Share-based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable Loss Contingency Nature [Axis] Loss Contingency Nature [Axis] Revenue Recognition, Multiple-deliverable Arrangements [Table] Revenue Recognition, Multiple-deliverable Arrangements [Table] Common Stock, Difference in Dividend Rate Common Stock, Difference in Dividend Rate Common Stock, Difference in Dividend Rate Letters of Credit Outstanding, Amount Letters of Credit Outstanding, Amount Leases of Lessee Disclosure [Text Block] Leases of Lessee Disclosure [Text Block] Concentration Risk Type [Axis] Concentration Risk Type [Axis] Long-term Debt and Capital Lease Obligations, Current Long-term Debt and Lease Obligation, Current Schedule of Installment Receivables by Class Impaired Financing Receivables [Table Text Block] Contingent Liability, Guarantee Contingent Liability, Guarantee Contingent Liability, Guarantee Document Period End Date Document Period End Date Entity Registrant Name Entity Registrant Name Fair Value Estimate of Fair Value Measurement [Member] Award requisite service period Share-based Compensation Arrangement by Share-based Payment Award, Award Requisite Service Period Minimum availability reserve Line of Credit, Covenant Compliance, Maximum Borrowing Capacity, Availability Reserve, Minimum Line of Credit, Covenant Compliance, Maximum Borrowing Capacity, Availability Reserve, Minimum Operating Leases Long-Term Obligations Operating Lease, Liability, Noncurrent Future amortization expense, 2024 Finite-Lived Intangible Asset, Expected Amortization, Year Four Adjustments for Change in Accounting Principle [Axis] Change in Accounting Principle, Type [Axis] Current period (loss) gain on cash flow hedges Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, before Tax Receivables, Expected Loss Percentage, Canada Receivables, Expected Loss Percentage, Canada Receivables, Expected Loss Percentage, Canada Non-Impaired Financing Receivable, Related Allowance Non-Impaired Financing Receivable, Related Allowance Non-Impaired Financing Receivable, Related Allowance Current Assets Assets, Current [Abstract] Common Stock, Number of Votes Common Stock, Number of Votes Common Stock, Number of Votes Interest income, as a Percent of Net Sales Interest income, as a Percent of Net Sales Interest income, as a Percent of Net Sales Financing Receivable, Allowance for Credit Losses [Line Items] Financing Receivable, Allowance for Credit Loss [Line Items] Subsegments [Domain] Subsegments [Domain] Comprehensive Income (Loss) Comprehensive Income (Loss), Net of Tax, Attributable to Parent Comprehensive Income (Loss), Net of Tax, Attributable to Parent Finance Lease, Liability, Payments, Due Year Three Finance Lease, Liability, to be Paid, Year Three Patents Patents [Member] Interruption of material manufacturing facilities, period Line of Credit, Covenant Compliance, Interruption of Manufacturing Facilities Period Line of Credit, Covenant Compliance, Interruption of Manufacturing Facilities Period Collateral [Axis] Collateral Held [Axis] Debt Instrument, Non-Cash Interest Expense Recognized in the Period Debt Instrument, Non-Cash Interest Expense Recognized in the Period Debt Instrument, Non-Cash Interest Expense Recognized in the Period Asia/Pacific Asia Pacific [Member] Allowance for Credit Losses Allowance for Credit Losses Allowance for Credit Losses AUD / NZD Foreign Exchange Forward AUD / NZD [Member] Foreign Exchange Forward AUD / NZD [Member] Percentage of net orderly liquidation value of domestic inventory Line of Credit, Covenant Compliance, Maximum Borrowing Capacity, Inventories, Liquidation Value, Percent Line of Credit, Covenant Compliance, Maximum Borrowing Capacity, Inventories, Liquidation Value, Percent Installment sales contracts, net Increase (Decrease) in Finance Receivables Amount reclassified from accumulated OCI Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax Cash discount reserves Cash Discount Reserves Cash Discount Reserves Entity Information [Line Items] Entity Information [Line Items] Receivables, Expected Loss Percentage, AsiaPac Receivables, Expected Loss Percentage, AsiaPac Receivables, Expected Loss Percentage, AsiaPac Land, buildings and improvements Land, Buildings and Improvements [Member] Schedule of Compensation Cost for Share-based Payment Arrangements, Allocation of Share-based Compensation Costs by Plan Share-based Payment Arrangement, Cost by Plan [Table Text Block] Long-term Debt, Type [Domain] Long-term Debt, Type [Domain] Provision for equity compensation Share-based Payment Arrangement, Noncash Expense Installment Receivables, Net of Unearned Interest Notes, Loans and Financing Receivable, Net of Unearned Interest Notes, Loans and Financing Receivable, Net of Unearned Interest Unsecured Debt Unsecured Debt Base Rate Base Rate [Member] Restructuring Reserve, Accrual Adjustment Restructuring Reserve, Accrual Adjustment OCI before reclassifications Other Comprehensive Income (Loss), before Reclassifications, Net of Tax Derivative, Loss on Derivative Loss on derivative Derivative, Loss on Derivative Derivative Instruments, Gain (Loss) by Hedging Relationship, by Income Statement Location, by Derivative Instrument Risk [Table] Derivative Instruments, Gain (Loss) [Table] Mobility and Seating [Domain] Mobility and Seating [Domain] Mobility and Seating Weighted-Average Remaining Lease Terms and Discount Rates [Table] Weighted-Average Remaining Lease Terms and Discount Rates [Table Text Block] Weighted-Average Remaining Lease Terms and Discount Rates [Table Text Block] Concentration Risk Benchmark [Axis] Concentration Risk Benchmark [Axis] Award Date [Domain] Award Date [Domain] Convertible Debt Note Hedge Gain (Loss) Convertible Debt Note Hedge Gain (Loss) Convertible Debt Note Hedge Gain (Loss) Gain (loss) Before Income Taxes, as a Percent of Net Sales Gain (loss) Before Income Taxes, as a Percent of Net Sales Gain (loss) Before Income Taxes, as a Percent of Net Sales Equity Components [Axis] Equity Components [Axis] Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] Minimum Minimum [Member] Receivables [Abstract] Receivables [Abstract] Balance Sheet Location [Domain] Balance Sheet Location [Domain] Additional amount of machinery and equipment Line of Credit, Covenant Compliance, Maximum Borrowing Capacity, Additional Long-Lived Asset Amount Line of Credit, Covenant Compliance, Maximum Borrowing Capacity, Additional Long-Lived Asset Amount Award Date [Axis] Award Date [Axis] Europe Europe [Member] Schedule of Cash Flow, Supplemental Disclosures [Table] Schedule of Cash Flow, Supplemental Disclosures [Table Text Block] NOK / SEK Foreign Exchange Forward NOK / SEK [Member] Foreign Exchange Forward NOK / SEK [Member] USD / NZD Foreign Exchange Forward USD / NZD [Member] Foreign Exchange Forward USD / NZD [Member] Salaries and wages Accrued Salaries, Current U.S. UNITED STATES Operating Activities Net Cash Provided by (Used in) Operating Activities [Abstract] Schedule of Share-based Compensation, Stock Options, Activity Share-based Payment Arrangement, Option, Activity [Table Text Block] Installment Receivables Net of Unearned Interest Noncurrent Notes Loans and Financing Receivable Net of Unearned Interest Noncurrent Notes Loans and Financing Receivable Net of Unearned Interest Noncurrent Future amortization expense, remainder of fiscal year Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year Business Day Period Business Day Period Business Day Period Derivative [Table] Derivative [Table] Statement of Stockholders' Equity [Abstract] Statement of Stockholders' Equity [Abstract] Government Tenders Government Tenders [Member] Government Tenders [Member] Total Installment Receivables Impaired Financing Receivable, Recorded Investment [Abstract] Proceeds from sale of property and equipment Proceeds from Sale of Property, Plant, and Equipment Schedule of Unrecognized Compensation Cost, Nonvested Awards Share-based Payment Arrangement, Nonvested Award, Cost [Table Text Block] Exercise Price Range [Axis] Exercise Price Range [Axis] Debt Instrument, Interest Rate, Effective Percentage Debt Instrument, Interest Rate, Effective Percentage Consolidation Items [Axis] Consolidation Items [Axis] Not Designated as Hedging Instrument [Member] Not Designated as Hedging Instrument [Member] Accrued Expenses Accrued Liabilities [Member] Trade receivables, net Accounts Receivable, after Allowance for Credit Loss, Current Convertible Debt Conversion Feature, Initial Fair Value Convertible Debt 2021 Conversion Feature, Initial Fair Value Convertible Debt 2021 Conversion Feature, Initial Fair Value Debt Instrument, Convertible, Threshold Trading Days Debt Instrument, Convertible, Threshold Trading Days Trademarks Trademarks [Member] Prepaid and other current assets Other Prepaid Expense, Current Payments Payments for Restructuring Financing Receivable, Impaired [Line Items] Financing Receivable, Impaired [Line Items] Income Tax Provision, as a Percent of Net Sales Income Tax Provision, as a Percent of Net Sales Income Tax Provision, as a Percent of Net Sales Amount of Gain (Loss) Reclassified from Accumulated OCI into Income (Effective Portion) Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net Derivative assets Derivative Asset, Fair Value, Gross Asset Sale Leaseback Transaction, Name [Domain] Sale Leaseback Transaction, Name [Domain] Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), Reclassification Adjustment from AOCI, after Tax Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), Reclassification Adjustment from AOCI, after Tax $12.15 – $20.00 Range of Exercise Price One [Member] Range of Exercise Price One [Member] Fair Value, Inputs, Level 2 Fair Value, Inputs, Level 2 [Member] Derivative, percentage of forcasted transactions with currency rate exposure Derivative, Percentage of Forcasted Transactions With Currency Rate Exposure Derivative, Percentage of Forcasted Transactions With Currency Rate Exposure 2018 Plan [Member] 2018 Plan [Member] 2018 Plan Vesting [Axis] Vesting [Axis] Installment receivables, net Installment receivables, net Financing Receivable, after Allowance for Credit Loss, Current Changes in liability for pre-existing warranties during the period, including expirations Standard and Extended Product Warranty Accrual, Increase (Decrease) for Preexisting Warranties Percentage of eligible Canadian inventory Line of Credit, Covenant Compliance, Maximum Borrowing Capacity, Inventories, Foreign, Percent Line of Credit, Covenant Compliance, Maximum Borrowing Capacity, Inventories, Foreign, Percent Credit Facility [Domain] Credit Facility [Domain] Debt Instrument, Convertible, Conversion Price Debt Instrument, Convertible, Conversion Price Net Loss per Share—Basic Net earnings (loss) per common share Earnings Per Share, Basic Contingencies Contingencies Disclosure [Text Block] Operating Leases, Cash Paid in Measurement of Amounts for Lease Liabilities Operating Leases, Cash Paid in Measurement of Amounts for Lease Liabilities Operating Leases, Cash Paid in Measurement of Amounts for Lease Liabilities Taxes other than income taxes, primarily Value Added Taxes Accrual for Taxes Other than Income Taxes, Current Installment receivables, net, long-term Installment receivables Financing Receivable, after Allowance for Credit Loss, Noncurrent Operating Lease, Weighted Average Remaining Lease Term Operating Lease, Weighted Average Remaining Lease Term Collateral [Domain] Collateral Held [Domain] CAD / USD Foreign Exchange Forward CAD / USD [Member] Foreign Exchange Forward CAD / USD [Member] Geographic Distribution [Domain] Geographic Distribution [Domain] Adjustments to reconcile net loss to net cash used by operating activities: Net Cash Provided by (Used in) Operating Activities, Continuing Operations [Abstract] Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items] Share-based Payment Arrangement, Option, Exercise Price Range [Line Items] Common Shares Common Stock, Value, Outstanding Cost of Products Sold, as a Percent of Net Sales Cost of Products Sold, as a Percent of Net Sales Cost of Products Sold, as a Percent of Net Sales Allocated Share-based Compensation Expense Share-based Payment Arrangement, Expense Balance Sheet Location [Axis] Balance Sheet Location [Axis] Charges related to restructuring activities, as a Percent of Net Sales Charges related to restructuring activities, as a Percent of Net Sales Charges related to restructuring activities, as a Percent of Net Sales Goodwill and Intangible Assets Disclosure [Abstract] Goodwill and Intangible Assets Disclosure [Abstract] Disposal Group Name [Axis] Disposal Group Name [Axis] Schedule of Installment Receivables Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block] Finance Lease, Liability, Payments, Due Year Four Finance Lease, Liability, to be Paid, Year Four All Currencies [Domain] All Currencies [Domain] Receivable [Domain] Receivable [Domain] Schedule of Long-term Debt Instruments [Table] Schedule of Long-term Debt Instruments [Table] Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Investing Activities Net Cash Provided by (Used in) Investing Activities [Abstract] Revenue from External Customers by Products and Services [Table] Revenue from External Customers by Products and Services [Table] Foreign currency forward contracts Forward exchange contracts—net Foreign Exchange Forward [Member] Defined Benefit Plans: Other Comprehensive (Income) Loss, Defined Benefit Plan, before Tax, after Reclassification Adjustment, Attributable to Parent [Abstract] Trade receivables Increase (Decrease) in Accounts Receivable Statement of Comprehensive Income [Abstract] Statement of Comprehensive Income [Abstract] Share Based Compensation Arrangement By Share Based Payment Award Performance Period Share Based Compensation Arrangement By Share Based Payment Award Performance Period Share Based Compensation Arrangement By Share Based Payment Award Performance Period Concentration Risk Type [Domain] Concentration Risk Type [Domain] Finite-Lived and Indefinite-Lived Intangible Assets [Line Items] Finite-Lived and Indefinite-Lived Intangible Assets [Line Items] [Line Items] for Schedule of Finite-Lived and Indefinite-Lived Intangible Assets [Table] Installment receivables, net of reserves Receivables, Fair Value Disclosure Total Liabilities and Shareholders’ Equity Liabilities and Equity Financing Leases, Future Minimum Payments, Present Value of Net Minimum Payments Financing Leases, Future Minimum Payments, Present Value of Net Minimum Payments Financing Leases, Future Minimum Payments, Present Value of Net Minimum Payments Schedule of Financing Receivables Financing Receivables [Table Text Block] Financing Receivables [Table Text Block] Accumulated other comprehensive income Beginning Balance Ending Balance Accumulated Other Comprehensive Income (Loss), Net of Tax Income Taxes Income Tax Disclosure [Text Block] Schedule of Accounts Receivable Schedule of Accounts Receivable [Table Text Block] [Table Text Block] for Schedule of Accounts Receivable [Table] Portion at Fair Value Measurement Portion at Fair Value Measurement [Member] Service Services [Member] Services [Member] Disposal Group, Including Discontinued Operation, Accounts Payable Disposal Group, Including Discontinued Operation, Accounts Payable Retained Recourse Obligation For Events Of Default Under Contracts Concentration Risk, Retained Recourse Obligation For Default of Customer Lease Obligations Under Contract Concentration Risk, Retained Recourse Obligation For Default of Customer Lease Obligations Under Contract Operating Lease, Cost Operating Lease, Cost Unearned Interest Unearned Interest - Current Unearned Interest - Current Hedging Relationship [Axis] Hedging Relationship [Axis] Installment receivables, net Financing Receivable, after Allowance for Credit Loss Disposal Group, Including Discontinued Operation, Earnings Before Taxes Disposal Group, Including Discontinued Operation, Earnings Before Taxes Disposal Group, Including Discontinued Operation, Earnings Before Taxes Antidilutive securities excluded from computation of earnings per share, amount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Convertible due 2021 - Bond Hedge, Initial Fair Value Convertible due 2021 - Bond Hedge, Initial Fair Value Convertible due 2021 - Bond Hedge, Initial Fair Value Net Sales, as a Percent of Net Sales Net Sales, as a Percent of Net Sales Net Sales, as a Percent of Net Sales Finance Lease, Weighted Average Remaining Lease Term Finance Lease, Weighted Average Remaining Lease Term Provision for other deferred liabilities Other Noncash Income (Expense) Finite-Lived intangible assets, useful life Finite-Lived Intangible Asset, Useful Life Equity Component [Domain] Equity Component [Domain] Gross Profit Gross Profit Property and Equipment, net Property and equipment, net Property, Plant and Equipment, Net Disposal Group, Including Discontinued Operation, Payments for Divestiture Costs Disposal Group, Including Discontinued Operation, Payments for Divestiture Costs Disposal Group, Including Discontinued Operation, Payments for Divestiture Costs Lessee, Lease, Description [Table] Lessee, Lease, Description [Table] Deferred compensation Deferred Compensation Liability, Classified, Noncurrent Shareholders' Equity Transactions Share-based Payment Arrangement [Text Block] Net Loss Net loss Net Loss Net Income (Loss) Attributable to Parent Receivables Billing Status [Domain] Receivables Billing Status [Domain] Changes in operating assets and liabilities: Increase (Decrease) in Operating Capital [Abstract] London Interbank Offered Rate (LIBOR) London Interbank Offered Rate (LIBOR) [Member] Inventories Inventory Disclosure [Text Block] Schedule of Finite-Lived and Indefinite-Lived Intangible Assets [Table] Schedule of Finite-Lived and Indefinite-Lived Intangible Assets [Table] Schedule of Finite-Lived and Indefinite-Lived Intangible Assets [Table] Restructuring and Related Activities, Expected Payout Period Restructuring and Related Activities, Expected Payout Period Restructuring and Related Activities, Expected Payout Period Contract Type Sales Split Contract Type Sales Split Contract Type Sales Split Adjustments for Error Corrections [Axis] Error Correction, Type [Axis] Disposal Group, Including Discontinued Operation, Property, Plant and Equipment Disposal Group, Including Discontinued Operation, Property, Plant and Equipment Finance Lease, Liability Finance Lease, Liability Convertible Senior Notes at 4.50% February 2022 [Domain] Convertible Senior Notes at 4.50% February 2022 [Domain] Convertible Senior Notes at 4.50% February 2022 Freight Accrued Freight Expense, Current Freight Accrual, Current [Line Items] Accumulated Other Comprehensive Income (Loss) [Line Items] Accumulated Other Comprehensive Income (Loss) [Line Items] Developed technology Developed Technology Rights [Member] Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward] Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward] Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Euro Member Countries, Euro Euro Member Countries, Euro Finance Lease, Liability, Payments, Due after Year Five Finance Lease, Liability, to be Paid, after Year Five Other Other Sundry Liabilities, Noncurrent Property, Plant and Equipment [Line Items] Property, Plant and Equipment [Line Items] Disposal Group, Including Discontinued Operation, Accrued Liabilities Disposal Group, Including Discontinued Operation, Accrued Liabilities Property, Plant and Equipment, Type [Domain] Long-Lived Tangible Asset [Domain] Disposal Group, Including Discontinued Operation, Operating Lease Right-of-Use Asset Disposal Group, Including Discontinued Operation, Operating Lease Right-of-Use Asset Disposal Group, Including Discontinued Operation, Operating Lease Right-of-Use Asset Debt and Capital Leases Disclosures Debt and Capital Leases Disclosures [Text Block] Property, Plant and Equipment Property, Plant and Equipment [Table Text Block] Fair Values Convertible Debt Hedges, Net Fair Values Convertible Debt Hedges, Net Fair Values Convertible Debt Hedges, Net EUR / USD Foreign Exchange Forward EUR / USD [Member] Foreign Exchange Forward EUR / USD [Member] Reclassification out of Accumulated Other Comprehensive Income [Table] Reclassification out of Accumulated Other Comprehensive Income [Table] Line of Credit Facility, Remaining Borrowing Capacity Line of Credit Facility, Remaining Borrowing Capacity Historical Cost Finite-Lived Intangible Assets, Gross Provision for losses on trade and installment receivables Accounts Receivable, Credit Loss Expense (Reversal) CARES Act Loan [Member] CARES Act Loan [Member] CARES Act Loan Less allowance for depreciation Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Allowance for doubtful accounts, current Financing Receivable, Allowance for Credit Loss, Current Currency [Axis] Currency [Axis] Convertible due 2022 - Bond Hedge, Fair Value at Issuance Convertible due 2022 - Bond Hedge, Fair Value at Issuance Convertible due 2022 - Bond Hedge, Fair Value at Issuance Capitalized Software [Member] Capitalized Software [Member] Capitalized Software [Member] Product Liability Contingency [Table] Product Liability Contingency [Table] Hedging Relationship [Domain] Hedging Relationship [Domain] Finance Lease, Right-of-Use Asset Finance Lease, Right-of-Use Asset, after Accumulated Amortization Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table] Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table] Risk Factor [Axis] Risk Factor [Axis] Risk Factor Prepaid social charges Prepaid Social Charges Prepaid Social Charges Weighted Average Shares Outstanding—Basic Average common shares outstanding Weighted Average Number of Shares Outstanding, Basic Basis spread on variable rate Debt Instrument, Basis Spread on Variable Rate Schedule of Fair Value Hedging Instruments, Statements of Financial Performance and Financial Position, Location Schedule of Fair Value Hedging Instruments, Statements of Financial Performance and Financial Position, Location [Table Text Block] Sale Leaseback Transaction, Current Period Gain Recognized Sale Leaseback Transaction, Current Period Gain Recognized Canceled - Weighted Average Exercise Price (in dollars per share) Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Financing Lease, Cost Financing Lease, Cost Financing Lease, Cost Cash Flow Hedging [Member] Cash Flow Hedging [Member] Schedule of Future Minimum Rental Payments for Operating Leases [Table] Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block] Carrying Value Reported Value Measurement [Member] Additional increase in borrowing capacity available Line of Credit Facility, Additional Borrowing Capacity Line of Credit Facility, Additional Borrowing Capacity Plan Name [Domain] Plan Name [Domain] Prepaid inventory Prepaid Inventory Prepaid Inventory Installment Receivables, Long-Term Financing Receivable, before Allowance for Credit Loss, Noncurrent Right-of-Use Asset Obtained in Exchange for Operating Lease Liability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability Income tax provision Income tax provision Income Tax Expense (Benefit) Operating Leases, Future Minimum Payments, Due in Five Years Operating Leases, Future Minimum Payments, Due in Five Years Credit amount requiring additional analysis Financing Receivable Credit Limit Financing Receivable Credit Limit Indefinite-lived Intangible Assets, Major Class Name [Domain] Indefinite-lived Intangible Assets, Major Class Name [Domain] Current portion of financing lease obligations Finance Lease, Liability, Current Finance Lease, Liability, Current Derivative Instruments and Hedging Activities Disclosure [Abstract] Derivative Instruments and Hedging Activities Disclosure [Abstract] Derivative [Line Items] Derivative [Line Items] Exercise price range, upper limit (in dollars per share) Share-based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit Schedule of Indefinite-Lived Intangible Assets Schedule of Indefinite-Lived Intangible Assets [Table Text Block] Accumulated Net Gain (Loss) from Designated or Qualifying Cash Flow Hedges [Member] Accumulated Net Gain (Loss) from Cash Flow Hedges Attributable to Parent [Member] Other current assets Increase (Decrease) in Other Operating Assets Stock Issued During Period, Value, Stock Options Exercised Stock Issued During Period, Value, Stock Options Exercised Schedule of Finite-Lived Intangible Assets by Major Class [Table] Schedule of Finite-Lived Intangible Assets [Table] Remaining borrowing capacity Line of Credit Facility, Covenant Feature, Increase Limit Line of Credit Facility, Covenant Feature, Increase Limit DKK / USD Foreign Exchange Forward DKK / USD [Member] Foreign Exchange Forward DKK / USD [Member] Borrowing capacity Line of Credit Facility, Maximum Borrowing Capacity Award Type [Axis] Award Type [Axis] Deferred income taxes Deferred Income Taxes and Other Tax Liabilities, Noncurrent Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract] Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract] Valuation Allowance [Line Items] Valuation Allowance [Line Items] Class of Financing Receivable, Type [Axis] Class of Financing Receivable [Axis] Amortization of debt fees Amortization of Debt Issuance Costs Security Exchange Name Security Exchange Name Debt Instrument, Loss on Exchange Debt Instrument, Loss on Exchange Debt Instrument, Loss on Exchange Retained Earnings [Member] Retained Earnings [Member] Preferred Stock, Shares Outstanding Preferred Stock, Shares Outstanding Measurement Basis [Axis] Measurement Basis [Axis] Divested Businesses [Abstract] Divested Businesses [Abstract] Divested Businesses [Abstract] Direct write-offs charged against the allowance Financing Receivable, Allowance for Credit Loss, Writeoff Amount Available to Invacare Limited and Invacare Poirier SAS Amount Available to Invacare Limited and Invacare Poirier SAS [Domain] Invacare Limited and Invacare Poirier SAS Net Cash Used by Investing Activities Net Cash Provided by (Used in) Investing Activities Equity Award [Domain] Award Type [Domain] Document Transition Report Document Transition Report Schedule of Installment Receivables Allowance for Doubtful Accounts Financing Receivable, Allowance for Credit Loss [Table Text Block] Schedule of Restructuring and Related Costs Schedule of Restructuring Reserve by Type of Cost [Table Text Block] Antidilutive share granted, average exercise price Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price Other investments Cost Method Investments, Fair Value Disclosure Property And Equipment Property, Plant and Equipment Disclosure [Text Block] Commitment fee percentage Line of Credit Facility, Unused Capacity, Commitment Fee Percentage Fair Value, by Balance Sheet Grouping [Table] Fair Value, by Balance Sheet Grouping [Table] Cash surrender value of life insurance policies Cash Surrender Value of Life Insurance Treasury Shares (4,184 and 3,953 shares at September 30, 2020 and December 31, 2019, respectively) Treasury Stock, Value Sale Leaseback Transaction, Lease Terms Sale Leaseback Transaction, Lease Terms Net Earnings (Loss) Per Common Share Earnings Per Share [Text Block] DKK / SEK Foreign Exchange Forward DKK / SEK [Member] Foreign Exchange Forward DKK / SEK [Member] Current Liabilities Liabilities, Current [Abstract] U.S. statutory income tax rate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent Recent Accounting Pronouncements New Accounting Pronouncements, Policy [Policy Text Block] Credit Loss Status [Axis] Credit Loss Status [Axis] Statement of Financial Position [Abstract] Statement of Financial Position [Abstract] Unpaid Principal Balance Impaired Financing Receivable, Unpaid Principal Balance [Abstract] Net Loss per Share—Basic Earnings Per Share, Basic [Abstract] Subsegments [Axis] Subsegments [Axis] EX-101.PRE 10 ivc-20200930_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT GRAPHIC 11 ivc-20200930_g1.jpg begin 644 ivc-20200930_g1.jpg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ivc-20200930_g2.jpg begin 644 ivc-20200930_g2.jpg M_]C_X 02D9)1@ ! @$ 8 !@ #_[@ .061O8F4 90 !_]L 0P " 0$! M 0$" 0$! @(" @($ P(" @(%! 0#! 8%!@8&!08&!@<)" 8'"0<&!@@+" D* M"@H*"@8("PP+"@P)"@H*_]L 0P$" @(" @(% P,%"@<&!PH*"@H*"@H*"@H* M"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*_\ $0@" MO 4T P$B (1 0,1 ?_$ !\ $% 0$! 0$! ! @,$!08'" D* M"__$ +40 (! P,"! ,%!00$ !?0$" P $$042(3%!!A-180'EZ@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>H MJ:JRL[2UMK>XN;K"P\3%QL?(R;GZ.GJ\?+S]/7V M]_CY^O_$ !\! ,! 0$! 0$! 0$ ! @,$!08'" D*"__$ +41 (! M @0$ P0'!00$ $"=P ! @,1! 4A,08205$'87$3(C*!"!1"D:&QP0DC,U+P M%6)RT0H6)#3A)?$7&!D:)BH*#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6V MM[BYNL+#Q,7&Q\C)RM+3U-76U]C9VN+CY.7FY^CIZO+S]/7V]_CY^O_: P# M 0 "$0,1 #\ _?RBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *** M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *** M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *** M* "BBB@ HHHH **** "BBB@ HHHH **** "BO%_^"@7[=7P5_P""<7[*WB7] MJ[XZWY\%_"K5I-,&HSRY>/35F3YKAEB D MFN)_,V[T$<:>8/+ /Z":*^*%_P""%?[,7PW\+./V1?C=\:_@]XNCAS:>,?#7 MQ@UN^:291\K7=CJ%U/9W4>X M$8E##(!3@CCO^"'U]^WY9_&+]I_X<_\%'?B ML_C+Q]X1\?:/IEMKL-A#:6=YI@TWS+2XMH((XXHXY8Y%D(5 V]W#Y<-0!^A% M%%% !1110 4444 %%%% !117\Q/_ 7)^/W[3W[)_P#P7-?X&_ +]KSXQ:!X M-N]3\,7Q\-1?%C6I;2)[I8&N$1)+IL1NQ9O+SM&\JH"X4 '].U%?!'_!Q5^R M'_P4 _;1_83L_A5_P3U\37,/B&#QA;7OB3P]9>(X])FUW35AG0VZW,LD<>%F M>&4Q2.B.(\Y+(JMZE_P1B_9__:]_9@_X)T> /@K^W)XWDUSXA:1#=?;VGU?^ MT)+"V>YD>VLWNLMY[0Q,B;@S*N BLRHI(!]2T53\0:'8>)] OO#6JFX%KJ-G M+;7)M+R6VE$ZCXD\3VA$ MB:EKZZGI]OY-O(#AH+>.65"Z\22R/C*QJS 'W!1110 445\_?\%1_AQ8^/OV M#?BIJA\7>*]!U3PQ\/\ 6];\/:SX/\8:AHUW9W]MIUQ)#+YEE-$TJJX!\J3= M&V/F4T ?0-%?@!_P9S_M7?M2?M#_ +2GQDT;X_\ [2?C_P G>!K";3[3Q MCXQOM3BM96O"K/&MS*X1B."0 2.*_?\ H **^-O^"UW_ 5]^&O_ 2%_9DB M^)&HZ-!XA\>^*9Y;'X>>$9IBB7MPBJ9;F,OM^9FDCC!4OO7X,_X( MW?LH_M9_\%Q?!5__ ,%$/^"K?[4WQ#UCP%JFN7-I\/OA-X4\57>@:+=);R&. M>ZDBL)(B(5E5X$"L)6:"1I)&XW '[>45\1?%'_@B3\+O#'AF;7?^">7[0?Q. M_9]\?6<&[1]9\/?$#5-3TFYE4?)'J&EZC<3V]U!D#("HW0[CC:>&_P"" &N_ MMI_$OX5?M)>%/^"D7C#4-9^)VF_'N_T'Q/<+*MHB11:'I,4?V/[(L2P0-$5D MC>%8\B02#YG+$ _1:BOYG?@K^T1^U+\-/^#H:S_9(T;]KKXN7WPYTOX]WFEV M?A/7?B?J^H6GV >:R6LB7-R_G(@(4>9N)"@DD\U_3%0 445\O_\ !9S0)[W_ M ()B_&KQIH_C+Q1X>UOP;\.=9\1>'-9\(^*[[2+NTO[2QFEA?S;.6-I$W#YH MW+(PZJ< @ ^H**_#G_@S(_:;_:2_:,_X:1_X:$_:#\<>._[&_P"$/_LC_A,_ M%EYJGV'S?[;\WR?M,C^5O\J/=MQN\M,YVC'[C4 %%%% !17S9_P5_P##+ZS_ M ,$S?C?XJT[QAXGT#6/!OPO\0>)O#FL^$?%5[I%W::E8Z7=3V\GG6ZFMFTDU\':(7,KB,L%4$KC.T9Z"@#]XZ**^!/^"]/_ 6Y\)?\$AO@CIMC MX,T.P\2?%KQM',O@WP]?R-]FLX(\+)J-X$(8PHQ55C!5I7R P"2,H!]]T5^) M_P#P2:_X)I_M4_\ !7'X4Z?_ ,%$/^"OW[8GQ2\1:/XQEDN_ GPK\/\ B^YT M33%L1(RB[FBLFB$*R%28X[<1'RPDC2/O"K]9?M$?\$D?C)^SY\(M6\:?\$]N?$5YJV?M,MZVI7 M9F,H(!#[]V1@8QC QBOK"@ HHHH **** "BBN5^-_P ;OA3^S?\ ";7OCE\< M/'%CX;\*>&=/>]UK6=1DVQV\2_3)=F)"JB@L[,JJ"Q (!U5%?(?_ 1E_P"" MCFL?\%2?V>O''[3\OA]=)T,?%O5M&\&::T06:#1[:WL_LYG()W3N9'E?DA6D M*J2JBOKR@ HHHH **** "BOA[_@L;_P6$\ ?\$Y]/\$_!;P7J^GZC\7?B9XH MTS3O#V@N1*=,TZ:\CBN-3N4S\J!"\<0;'F2G@,L4NW[AH ***_"7_@LA_P ' M"W[4/Q3_ &R+?_@E1_P2$U2.R\0W7BF+PKK?Q#MXTDN;O5Y)A ]G8NX9+:&% MRRRW94ON1S&8UC\R0 _=JBOSM_9F_P"#=']G/PAX,M==_;/^/GQ?^-7Q-NH% MFUSQGJWQ=U^P6*[/+&T2SO(G5%;.TS/*QY)QG:/+OVU_V9?^"B'[$/[2/[.M MG\$OVY/B+XU_9N\4_M"^#M,\;>#O'5[%JNJZ',=7MY+91JLL1O)M/DDC6,QR M2Y1UC1C(LN% /UCHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#\ _\ @^%^+/BV M"']G[X%VMS-%H5RVO:]?0@GR[F[B%I;P,1_>B26X ]K@U]=?\&A/AC0=!_X( MX:3JVCV\:7.M_$+7;S563&9)UDCMU+8[^3!".>P%)_P=2_\ !,#X@_M__L3: M/\6?@1X9N-:\??!V_NM3LM#LHC)<:II-S'&M_;P(.9)E\BWG5!DL('159W45 M\Q?\&9'[?_PYL_A=XU_X)P_$7Q1;Z9XJM_$\OB;P/9ZA,(VU.WF@BCO+6$-C M=)"]N)C&/F*SNP!$;E0#]X*Y7XA>(/AI\#O!_B_X_P#B?3+/3[;2M FU7Q5K M%O9()YK.Q@DE)D< -)Y<8DVAB<9(&,FNBU?5]*T#2KG7==U.WLK&S@>>\O+N M98XH(E!9G=V("J "22< #-?,NM?&#X>_\%8OV&?CY\._V:Y[ZXT#Q#X=\2> MO#GC.[M3#IWB">?2F@>]L)&_X^+-)[EH!< ;'>WEV[E 9@#\D/\ @CE\:_&O M_!P[_P %2?B?\4?V\]6UC6/AQX,\)2W_ ()^$EOXANK;1=)>>[C@MMT,$D8G MD2#SM\C M)(P8D!$07?V./\ @HO\6O\ @E?_ ,' ?BK_ ()3ZK\5->\2? 7Q M)\1H?#WAC0O$^L3ZA)X5FU&*&73A9SW#-(D22W,5NZ%BK(QD(+KN/)_\&6]K MJ'PV_;:_:!^"_CS19=*\46?@VV2]TJ_C,=S:R6>I&"YB9",J4DFC5AV( /MY M5\=_@=XJ_;)_X.]-1\%_"RREO8M+^-VBZIKUU;+N6RL='@L9;Z5V'";?LLD8 M+8S(R)]Y@" >]_\ !XM\1/B]^S'^T'\(?&W[//QX^(7@R[\;^']6/B6W\-^/ M=2M+6[>TDM$@D%O'.(HW"2LI**N[ SDC-<7_ ,%5/V//C5!_P0?^"/\ P4J^ M,O[=?Q4\5_$*;PSX-.GZ2WB!H=#L-+O=.C\F)+91YC7H3R7FO7E:2>;S6889 M G0?\'Q?_)5/V=O^Q?\ $?\ Z/T^O8/^"QY!_P"#1_X"8/\ S3_X8?\ IIMZ M /H7_@W[_;R_:&^.'_!"W5/CK\2-0OO'/C;X8Q>(M-TVYU*1YKO6O[/M1=6< M4SYW2R;98X-Y^=@@+$L2Q_,O_@BE^VS^PI^VG\4/'OA/_@K?\;/'.F_'/Q]X ME^V?#_XU2_$;4=*CTL-&JQ65G-;SI#IDL4V^2+_\ !9O_ ().^([#3?#^K>$YO&?BSX;M(BV?V=(FGOGL67BU MN("LWFV3?)OCD6,QE5B< _33X2>-_BU_P1;_ ."+OC7Q[^UWXHOO''B'X4W_ M (KO;77=7U4W$WBMKS7[N32YYIB[NINGO;;?O9GC,K YVBO@[_@WL^$TG_!< M.3X[_M@_\%/?%?B+XD:FNN6NA^%M.F\37UE8>'4EADGN#86]M,B6Q >W"%1E M/++ [G9CA?L,Z1^UW_P4I_X-+?C5\%?$D^K^(]7\(^()+7X<27.^6ZU#2=(D MTK519H22T^UDNK>(6T 5,*Y ^1_P#@Y4_Y M6(;?_N3/_1<%;G_! ;X->,?VFO\ @Y'\4_M$^#+)[CPQX&\9>,_$^O:M F8$ MBO3?VEK&'Y7=)+=JRKDEDBD(X4D8?_!RJ0/^#B"W)/\ T)O_ *+@H _1W_@\ M+U#QS\%/V,/A_P#M+?!3XM>,_!OBMOBC9^&KJ^\*^,=0T];G3YM-U.Z,Y\1:O-=7.IW,>M7T-G;23RLSX>3R(023M4C' KC?\ @]8GA7_@ES\/[5I M)'^/NF,J9Y*C1-;!/X;A^=>;_L>? [QE^T?_ ,&7^M_"GX=V$M[K,F@>(M2M M+*V0O+<'3_%-QJ#0HHY9W2V954
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end GRAPHIC 13 ivc-20200930_g3.jpg begin 644 ivc-20200930_g3.jpg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end GRAPHIC 14 ivc-20200930_g4.jpg begin 644 ivc-20200930_g4.jpg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end GRAPHIC 15 ivc-20200930_g5.jpg begin 644 ivc-20200930_g5.jpg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ivc-20200930_g6.jpg begin 644 ivc-20200930_g6.jpg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ivc-20200930_g7.jpg begin 644 ivc-20200930_g7.jpg M_]C_X 02D9)1@ ! @$ 8 !@ #_[@ .061O8F4 90 !_]L 0P " 0$! M 0$" 0$! @(" @($ P(" @(%! 0#! 8%!@8&!08&!@<)" 8'"0<&!@@+" D* M"@H*"@8("PP+"@P)"@H*_]L 0P$" @(" @(% P,%"@<&!PH*"@H*"@H*"@H* M"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*_\ $0@" M2@*T P$B (1 0,1 ?_$ !\ $% 0$! 0$! ! @,$!08'" D* M"__$ +40 (! P,"! ,%!00$ !?0$" P $$042(3%!!A-180'EZ@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>H MJ:JRL[2UMK>XN;K"P\3%QL?(R;GZ.GJ\?+S]/7V M]_CY^O_$ !\! ,! 0$! 0$! 0$ ! @,$!08'" D*"__$ +41 (! M @0$ P0'!00$ $"=P ! @,1! 4A,08205$'87$3(C*!"!1"D:&QP0DC,U+P M%6)RT0H6)#3A)?$7&!D:)BH*#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6V MM[BYNL+#Q,7&Q\C)RM+3U-76U]C9VN+CY.7FY^CIZO+S]/7V]_CY^O_: P# M 0 "$0,1 #\ _?RBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *** M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KR#XV_\ M!0']AK]FKQ?_ ,*__:'_ &O/AQX&USR%F&D^+/&%GI]PT; %7$<\BDJ01R!B MO7Z_/#_@O1_P39\*_P#!4J3X7?LTZAKR:'K\FG>*;_PCX@,6X6>HPVMH\2RX M!9K>0C9(HYP0P!9%H ^\M8^)WPZ\/^ /^%K:QXWTN#PS]BBO!K[WJ?8S;R;3 M',)0=IC8.I# X(8'.*Q_@;^TC^S_ /M-^&9?&O[.OQH\,>.-'AF\J75?"FM0 MW]LLF2"OFPLRY!4@C/XH_\&Y'_!5CXK?L?_'&]_X(:_\ !247/A_7?#VL MR:5\-M0UV89L;O=D:*\I.'AEW"2SD!*L'$:LRR0 ?HC^SI^U3\#/V /^".FG M?M.?&JZ.E^$?!UAJ=Q95EF\L\(TE?(.N?\%._^"@_ MQ;_X.2'_ &9-$_9VT_4+'X/^%]6@\/?#)?'D-C'=M=6-O.VK75Z89(VN#;S1 M[8@A6)6:-6+&1W /VOKC/CK^T7\!/V8? \GQ+_:+^,OAGP/H$<@B_M;Q3K4- ME \A!(C1I67>Y .$7+'' -==8RW4]E#-?6H@G>)6F@$F\1N1RN[ W8/&>]?S MY?\ !+?XBG_@O+_P<#^._P!HW]J.!?$7P_\ @]HFH:A\+_!&J*)=.T]$OH;2 MPW6[Y1GV/)=2,1EIT0_=554 _9KX<_\ !4'_ ()Y_%;Y?!?[87@21VLGO((= M1UQ+&2XMD7>\\*77EM-&J\LZ!E (R17M^C:QIGB'2+37]%O$N;.^MH[BTN(S M\LL3J&5A[$$'\:\R_;5_8Y^"G[=_[-7B?]F3XZ>%+/4='\0Z9+!;7$]JLDNE MW91A#>VY/,'EUO6)-(T:VC@A,*375W';74J&>:%HH8HX)"S\.8UPQ /L>BOB/_@F[ M_P %D++]M?\ :>^,W[$OQ>^!B?#[XF_!/4;J+7(-,\2G6-)U*U@NC:R7-O=- M;V[KB39\DD2DK*C YWJG"?LU?\%VO&G[8GPPU_\ :4_9L_92T'Q-\-] ^)%M MX8U%+?XG%?%.FV4UY! NMW>D?V<5BM"DSS;5N7D"1,<$"1HP#[+\2?MH?LC> M#OC?9?LS^+?VF/ VF?$34I88].\#ZAXGM8=5NGE&8A':NXD??SMPIS@XZ5Z9 M7X3?\%T?%=YX#_X.;OV0/&.E^"M4\17ECX4T1[70M#BC:\U"7^V]6$<$7F.D M89F(&Z1T1F MOJ5I';>-8=K*7!*% ' /NGQ#XAT/PGHMSXC M\2ZK#8V%G&9+J[N7VI$G]YB>@KQWX>?\%*_^">WQ=\91_#KX4_ML?"[Q+K\I M(CT30?&UE=W9PP4_NHI&?@D \<$\U[=7\]W_ ;36]O'_P '#O[7'EP(OEZ; MXQ6/"@;5_P"$MLN!Z#@?E0!^Y/Q-_;$_93^"WCW3OA9\7/VB?!WAKQ+K#[-( MT#7/$$%M>7S84[88I&#RG#*<(#]X>M>C0RQ3Q+/"X9'4,C \$'H:^;?VQK&R MG_;5_9'NY[.)Y8?B?XD$,KQ@L@/@S7,X/49P,X]!Z5YOXJ_X*]ZSXF_X**>/ M/^"ZRFN)8U$,<$DBQRSF/Y6*@(2P6MS]GW_@IP/%?[='C3_@G M#^TU\,]*\"_$WPMX3M_%.EW&B>*7U31M>T>1$,DL-Q/:VLD4L+/M>)XN0C.K M%5; !]'_ !2^+/PQ^"'@F]^)7QB\?Z1X7\/:M?FMXU_X+/^/_ /@HY^R5^U-KG[)/[%9=6.E-:E)H(HVCF=)+J*4PRJ51I/W-1_\&;?_*(_4O\ LL&L M_P#I)I] 'Z/_ !\_:M_9F_96TJPU[]I?X^^$/ %CJEPT&G7OC#Q!;Z=#&O$OA[QGX5 M \2 '_@D?IN1T^,&C8_\!-0JO:?\%OOB9_P3 M0_9B_9-? N@Z)9_$>Q\=P76IV3Q:9;?Z1<:5%;E4C>,-, MD:W+2&)6)"R P4 ?K/17Y^?\%-/^"Y]W_P $TOVB/AK\*?&G[+$&O^#/BPUN M/"/Q1C^(*VNFKNE@CN#=)]BD,0A\^.4E&D#0R(ZG<61?J3Q1^T1\3M'_ &Q/ M"O[+^@?!C3=4TO7/!]]XAUOQ8OBQXVT."VFMX DEJ;,B1YY;D"$"4;Q;W+'9 MY6& /2O&WCGP=\-_#=SXQ\?>);/2-*LU!NM0U"<10P@G&68\ >YKRWX1?\%& M/V!_V@/%T?@#X%?ME_#/QEKDJADTCPOXSL[^Y*E@H;RX9&8#*/B1\/K._DM7TOXD6L>FW[VTD #S7%U:P_ M8X&6=29"LC!RD8C2%(+_ .RC:\HBF0*\( D0 MM;S ?>M%?"/\ P2?_ ."W M&B?\%5/@[\4_BIX9^!MAX"G^%\B17VB^)/'!DD9F@EF6:X:.R'V6W/E2+YFV M1LQ2_N_D&[6^-W_!9#3_ -FG]B7X6_M*_'']G.^TSX@?&N^L+#X9_!JQ\2+< M7]]=WPC:WBN+E[>-;4*DL9F;RW\HR*GSNP6@#[8HKX^^%?\ P5@TJR_;'^(/ M[!O[7OPVTSX?^/? W@)?&UK?:!XEDUC2-2, _0=G1" S ;C@9/4UYS\0/VO MOV7_ (4_'+PM^S1\2/COX9T3Q_XVB,OA3PEJ.J)'>ZD@+*&CC)SAF1U7.-[( MRKN((K\H?VY_^"E?[=^L?\'&/P9_8A\%?!"QG\/> K[4-:\.^"E\8QVC>+[B M?0M2C2_N[LQNELJ0-,T4!1BOS;SOD B[C]N+XZ_LI0?\%V?V6_ O[7?_ 3K M2]^,NKZ%HESX+\=:7\49I;;0O.N[O9#I=/&P)5MZ.&YV( ?K; M17Y[?M#?\%V=>^ G_!4VP_X)867[$.L^,?%&NV:W'AS5?#/C2#_3%ELIKF$2 M0W-O$L',)$K-*4B0-)N<+M.Y_P $N?\ @M->?M[?M,?&/]C3XU_LQR?"CXD_ M!R[F&KZ7'XNCUJSN8(;HVL[K?-&SJR K&Q8+]1?\$P/V]]3_X*3?LPV'[5=O\ Z7P5X>UVXD7PVLWBFVU M-[^*-VBF=O(53;LD\A!(!]&5DQ>._!D_CF?X91>*+%O$-MI,6J M3Z*+E?M*64LLD4=P8\Y\MI(I$#=-R$5H:AJ%AI-A/JNJ7L5M;6T+2W-Q/($2 M*-02SLQX4 DD\ "OYWOB1_P42_:+_9!_P"#B?X=?\% OVB9IM)^$G[0'A2U MT_P]%.SI#:>!;FX>VLI)@X'E2QR16VJ31\E/M++_ !T ?T3T5R_QJ^,GPY_9 MZ^$/B7XZ_%OQ'%I/ACPEHEQJVNZE*"P@MH(S([!1R[8&%502S$ D@5^=6N_ M\'&&M^ ?!OP*_:7^*'[$5YI7P3_:!\5WFB^$_$MIXT-WKNF)%<"&"ZOM-6R$ M*"<;Y%ABNY7$<;G+, A /T\9T3&]@,G R>IKSGXE_M?_ ++OP:^,GA+]GKXJ M_'CPQH'C?QV^WPAX8U354BO-4.[8HB0G)W/E$SC>X*KN88K\I_\ @HI_P4M_ M;HN/^#@GX'_L)^ _@I92>'/"&JR^(=$\)KXOBM'\:3RZ9?QQ75W=>6Z6L<:" M=HX"K<_,_P S(L75_P#!1;]H?]E71_\ @L_^R-X1_;,_X)S+JGQ++N-_#OQ!N_'P_LZ_L);>::&XCB^P[S([026PBR!]I4Q^9 MM_>5[+\5?VI/B'XAUK]H'X17?[+^A^(/"7PQ\#B;5-2NO'LD,6OR75B]S)I+ M1"P8V\HL\22$NX475M@D2LT8!ZS^S=^U7^SA^V#X!F^*/[,'QGT#QSX?M]2E MT^YU7P]?K/%#=1A6>%\]\*^*OB#)J:S7,&EV%S)J4]U*JRR110SQ(MJF&?R ZF1I%U M/^"(W[7G[5_QJ_X)!_$?XP?M$?LYZ?\ $/P[JUKXX\0^)/%.L?$-+1_$T[W# MO>:8;2.T=[5&@:X1'!*#RT0!%8,@!^HO[./[4O[.O[7OP];XK_LQ?&30?''A MR/49;"75O#U\L\45U$%+POCE'"NC;6 )5T89# GOJ_*[_@AU^W!_P3?^!/\ MP1T^)'[8OP<_9VU+X*_"SP3X[U27Q-I-_P"*)->O;^]6UT_;(L\H0O)+Y]K: MQ1' W(@SEB:]2\'?\%P-3T?4OV=/%O[3?[,5OX$\ ?M32F#X9>(K/QN=1O-. MFE\EK!-5M39PI;K=QW$+J\,TXB+[7X!>@#[_ **^#X_^"S/BGXJ_M??&_P#9 M0_9'_9S\/^.=3^ MNA\1:5K/Q*_L?7/$MP%D^TQ:+8_8)TN1;O'Y3O+-"IDD MC'RAU8_8_P #OB/)\8_@IX/^+LVB'37\5>%M/UAM.,ID-J;FVCF,6XJI;;OV MY*KG&<#I0!U-%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 % M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5\H?M4_M7?LT_#'_@H MI\ OAE\0OCMX3T;7KFR\4H-+U+7K>&6%I+*U:(2JSCRO, /E[\>8>%W&OJ^B M@#\M_P#@Y#_X(@?\/"_A.G[5_P"S%H?V;XZ_#^P\RT2P_=R^*=/B)D^Q%A@_ M:HSE[=^I):(\.C1^'?M7?L\_'_\ :L_X-&? &G> ]%UC7O%FA:-IGB;7=)2* M22_U".WOIS>93[TDB"5YV4_,?); +8!_;FHK.QLM.@^RZ?9Q01;V?RX8PJ[F M8LQP.Y8DD]R2>] 'XL_\$E/BO_P1K_;Z^ O[//A_Q-\/O$_CO]H/X>V^DVUO MX+U+Q1XDOY?#NHV36T<^LPK/=-9V5B!;17192L858X K2^7">&N_&_AW]D/_ M (/%_'_Q2_:"GN= T/Q7X*1O"EY)IT\IUQY?#]A#'#9I&A:YE>>":!4C#%IH MS&N6P#^Z6B>#O"'AF\O-0\-^%=-T^XU"3S+^>QL8XGN7R3ND90"YY/)SU/K5 MN?3--NKR#4;G3X)+BVW?9IY(@7BW##;6(RN1P<=: )8G,D2R&-D+*"5;J/8^ M]?SU_LI?"'Q+_P &W'_!/:W-AH4Q@EDM;C9%^]E@1YPMS T:A@ WZ MO^#OAQ\//AW!-;?#_P !:+H4=P^Z>/1]+AM5D;).6$:KDY)Z^M:ESIVGWD\% MU=V,,LMLY>VDDB#-$Q!!*D_=."1D=C0!^!__ 01\3> _AS_ ,'&O[47@I]. M\5:,GBG1]5_X1'3/&.G:F=6N+=M3M+N)[K[:K7*.UL1,SW1#G=ESN)KY_P#C M-\%/!'[,WQ9^$O\ P50_X(+?M(0Z=XD^)_CJRT75/V;(M6$NJZ1JET&FGTLV MHQ)<:;OC9'2:,!%>&:-V1XVC_IP33M/COY-5CL(5NI8UCEN5B D=%)*J6QD@ M$G [9-4H?!7@VVUN'Q-;^$M,CU*WM1;0:@EA&)XX0,")9 NX)C^$'% 'X@UR:;4(U33I9-9U)D2K_@FMK?AO\ X)(_\')_[0&B_MX^(+7X=Z'\ M3K'Q*? WB_Q1(+/2]2CO-H616 /O0!\QR_'#X5?ML_MO?"67]F# MQII/COPS\)9=;\0>,?&_AF[COM(LKRYTN73+/3H[V(M#+=R+?7$S11LS11V^ M9-GFQA_S'_X+Y_LC?L8_M#_M!?'#]JCX&_M/6'P3_:=_9\CLM0U[2]4\1K9# MQM:PZ+8ZA:7M@^Y)([U8IXK5&A+YE@BC=4\V.4_O#HVB:-XSLK=8HHESG"HH 4>P%5M9\%^#O$;Q2^(?">F7[072W,#7MA'*8YP !* MNX'#@*H##D #GB@#^=[_ (+(6?[>/Q+_ .";7[!?_!3;]I7P#KVJ:Q\.)+BZ M^)L=LLUC=P?:+RQFT^^F:WV26;W-O8)OF7R_+FFC V,RBOT _9CT+_@D3_P4 M%UC5OC/_ ,$]=!\0^*?BAK'PLU72;[XD:YK_ (AO)O"$-YI\MO'97UQJ5S(H MG+SE5MD,C )+*N$0.?TPO+.TU"TEL+^UCG@FC*30S(&212,%6!X((X(-5?#O MACPUX0TM=$\)^'K'2[)&+)::=:)!$I)R2$0 D]>* /YV_\ @B9^U#\*OV+O M^"5G[9/_ 3Z_::U*?PK\8;2Z\2O:?#Z]M'.JZC)<>'UL_+MH%!:;RY+1VD9 M';O_@EMKW@N#5HCJUA\5=3NKO3F.V5()K6R$4V MT\F-C'(H<94M&XSE2!^K=UX)\&7VL3>(;WPCIDVH7%F;2XOI;"-II;<]86U:%O;P6D"6MK D442!(XXU"JB@8 '0 =J /RQ_X.__ SXD\:? M\$K]!\)>#O#]]JVJZC\:-#M]/TS3+1Y[BZF:UOPL<<: L[DD *H))KY3_P"" MROB3P_\ M\_\$H/V'_V%OV1->T_QU\3O$MUX=DC\+Z#>I<76FK9: ]E=M>QQ M[FLUAGN0LK2A1'Y4N[_5MC]^+BRL[N2&:ZM(I7MY?,MVDC#&)]K+N4G[IVLP MR.<,1WJEI?@SP?H>LWGB/1?"FFV>H:@.H#/SSR30!^?/_ M 72_P""7_\ PT[_ ,$7)?@AX7MSJ_C/X*>%['6?!MVD/[Z\ETNS\JYA4#YB M9[43A4'67R2<[174?\&]MY\=?C%^P5X4_;"_:@;S?&7CCPKI6CZ9-(#YO_". MZ/');6+RD_>DN)GO[YG'WA?K_=KHOVG/"G_!934/V]1#^SMXO\&O^S[XE^'$ MFBW*7UQ;VU[X6UJ1F#ZSS;O<7/3]!\,:+:Z3HEA%]VVM+>)888Q[*B*/PH L>+_ !IX.^'WAZY\7>/O M%FF:'I-FF^[U36+^.VMX%]7DD(51[DU_//\ \&<'Q0^'%A^V[^T-IFI^.M)M M+OQ-I=G)X=M+R_CBFU(#4+@MY".0TI ECR%!(WCUK^BNB@#\$/\ @F+\6OA7 M8?\ !V?^U%XOOOB5H$.DWWA3Q''9ZI+J\*VT[PW.E2RJDI;:Q2.WG=L'Y5AD M)P%.-W_@S"\;>#[_ %G]J;P[9^)[&2_O?%VD:C9V2W2^;/:;M17ST3.7C!90 M6&0"ZYQN&?W2HH _"^Y_X)V?'K]G?_@XZ\;?L\? O3S:?!/]J;P3=>(OB%&( M6-K%H8NXIM8M0%P%DDNE>T7 _=0ZVH'6NG_X/!_A'\5M+TO]F[]MGPCX+U+6 M_"7P?\97Q\66^EW$T)LOM$VFS6\AE@(>V1S8R0^>I4H[P@,&9:_:1[&R>]CU M)[.(W$43Q17!C&]$8J64-U )1"1T)5?04MW:6E_:RV%_;1SP3QM'-#,@9)$( MP58'@@@X(- 'YN_L:^+O^",/[4/Q#_X;)_8I^%NN_$SQWI7P_OI/$7B;7]RE4Z5?SZK/+$)IO,>%;9?-.TRRJ/+3>?S+T7]G_PO^Q/^V_\ L^?M ML?\ !"#]K :WX;^/'CJPTK5/@:-7$^K:1#*RSW>GZA;!B\EC#%YJO)<*KVI6 M-_,[T^&/ ]_X/067B?4H)%M)W_L?4K+RT<*=[_:)(HRBY8&6/(^ M=,[OQG8Z=9:9X<\-G7/[5N%MI-'DFU?4I$AO$<@ MVLH66,M')M90ZD@ @U^\5UING7TL$]]80326TOF6SRQ!C$^"-RDCY3@D9'8F MIJ /P8_:-^(OP_3_ (/2/A7JS>.-(%K9Z)#IEY<_VE%Y<%[)X?U&)+9VW865 MI)8D$9^8M(HQEA5O_@AU\1_AIK__ -M'O(/$R^(UT-H[^-X]4": M[;-(("#B;"!F(7/RJQZ D?NY39EE:%U@D".5(1V7<%/8D9&?I0!_/%^QWKG[ M!G@3X$_M8?L:_LT?\%,OA=\+_A%\6_&=[H%I:_&5F3Q'HMHL7V:\NK6%9HDN M[::)VBMS*\;A8@\GS[DK]E_^"4_P-_9-_9L_80\"?!/]BGXMZ9X\\!:':3I: M>+]*UJWOTU6[DGDFNIVEMV,>]IY)"8P?W8PG\-?GU\'/^"!?P_L-.UNX_P"" M@'_!+30?C;\4-8\5ZIJ>L_%;P/\ %0Z)INNBYNY)HI3IJW%BNG%8W1&BA@D! M*,^YV3:Q;0W&C>&Q!+<:EH55_+<#XI_ MX.@O^"<%QXJ_X)RK^T%XX_;)U3Q-K/PFN8[KPAI'BK3?#NG13V=S)!!=VUJ; M"PM7=_+$,JQAF4BW "DE2/VCHH _%;X ?M/^+/\ @MK_ ,&RWCS]FCX>>*XM M7^._A/P+%HNO>&DO0=2U0Z5=6UQ;S+&3OD^V6L$#5C_@WH_X+ M'_LDC]@KP+^P5\?;'5W^,_PUU6XT?0_A]'X0N;W4-:=;N66TDM%$9CBEC63R M7,KQ"$P/)(T<>7'[0UFV7@[PAINOW/BS3O"NFV^JWB;+S4H+&-+B=>.'D W, M.!P3V% 'X<_\%/==T/\ 9I_X.Q?V>_VDOCEJ!\-^!;WP=;+'XIU*!ULC*MMJ MEJT0D (9Q++""HY7SXR0 P)PO^"Y'QC^&NL?\'%O[$'C)_%UG86>G?\ "(7F MMKJTZVLNCQR^(9)U%['*0UHXB=69)0I4') K][KS3--U%X)=0TZ"=K:82VS3 M0JQBD P'7(^5N3R.>:GH _(G_@[)_8[\:>+/V??AW_P4L_9UBGB^(7P'\56< M_P#:&EQ;[AM-GNHC#,H4$R-;WRV[H,8"SSMTK[,@\,ZU\!O^"7WQ"\>?M+ZM MI6C^,?%'@?7?%7Q.O9;D0VMKK%_9R/):K)(W,5LI@L82QW&*UA!R>OU+>65G MJ-L]EJ%I%/#(,20S1AE8=>0>#4M '\\__!!6RE^*O_!LW^V-\"/AXZ:OXTN- M4\675MX6L&\V_FBE\-:8D+) N7;S'MYHTP/F="HYKUW_ (()?M._ W2_^#=[ MXE?!O4?']I;Z[X5\(^.;KQ3#<*T<.C),)%MEN9G CADG,Z^3&S;I=DFP'RWV M_MW4%CIFFZ8LB:;I\%N)IFEF$$00/(WWG.!RQ[D\F@#^:'_@GK\'/&/[6?\ MP:C_ +0_P%^ THUOQOH/QE_X2.Y\'Z:XDO[JQMXM%G?; N78-'#.\> ?,>W* M+E@0/I?_ ()"?%?_ ((Z?MS_ +(7P/\ @K\7?A_XJ\=?'KX?1V&EV/PTU#Q7 MXEO'LKZR*0)JEM$]T;*SM%ACCGDD41QP*K1[@^ M%--L;W4'WW]W9V,<4MRV2 I_$8M+KQ!/#+'#;ZKI1!299YXGCR(U>.67S( MCMD5WE_/B+^Q3\*?'O[4.AMIOQ$UGP!I5YXRLY+06[QZA);(TN^ M$ "&0L=S18&QBRX&W%>CZCX+\':O>6FH:MX3TRZN+"X:XL9[BPC=[:9CN,D; M,"48GDL,$GFM.@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB MB@ HHHH **** "BBN#^(/[3WP ^%7B-O"7Q$^*FEZ1J20I*UG=R,'"-RK< \ M&@#O**\U\.?MA_LQ^+]7]Y)LMK6&5BTC8S@?+Z UW'_"8^&/ M^@U!_P!]4 :5%9O_ F/AC_H-0?]]4?\)CX8_P"@U!_WU0!I45F_\)CX8_Z# M4'_?5'_"8^&/^@U!_P!]4 :5%9O_ F/AC_H-0?]]4?\)CX8_P"@U!_WU0!I M45F_\)CX8_Z#4'_?5'_"8^&/^@U!_P!]4 :5%9O_ F/AC_H-0?]]4?\)CX8 M_P"@U!_WU0!I45F_\)CX8_Z#4'_?5'_"8^&/^@U!_P!]4 :5%9O_ F/AC_H M-0?]]4?\)CX8_P"@U!_WU0!I45F_\)CX8_Z#4'_?5'_"8^&/^@U!_P!]4 :5 M%9O_ F/AC_H-0?]]4?\)CX8_P"@U!_WU0!I45F_\)CX8_Z#4'_?5'_"8^&/ M^@U!_P!]4 :5%9O_ F/AC_H-0?]]4?\)CX8_P"@U!_WU0!I45F_\)CX8_Z# M4'_?5'_"8^&/^@U!_P!]4 :5%9O_ F/AC_H-0?]]4?\)CX8_P"@U!_WU0!I M45F_\)CX8_Z#4'_?5'_"8^&/^@U!_P!]4 :5%9O_ F/AC_H-0?]]4?\)CX8 M_P"@U!_WU0!I45F_\)CX8_Z#4'_?5'_"8^&/^@U!_P!]4 :5%9O_ F/AC_H M-0?]]4?\)CX8_P"@U!_WU0!I45F_\)CX8_Z#4'_?5'_"8^&/^@U!_P!]4 :5 M%9O_ F/AC_H-0?]]4?\)CX8_P"@U!_WU0!I45F_\)CX8_Z#4'_?5'_"8^&/ M^@U!_P!]4 :5%9O_ F/AC_H-0?]]4?\)CX8_P"@U!_WU0!I45F_\)CX8_Z# M4'_?5'_"8^&/^@U!_P!]4 :5%9O_ F/AC_H-0?]]4?\)CX8_P"@U!_WU0!I M45F_\)CX8_Z#4'_?5'_"8^&/^@U!_P!]4 :5%9O_ F/AC_H-0?]]4?\)CX8 M_P"@U!_WU0!I45F_\)CX8_Z#4'_?5'_"8^&/^@U!_P!]4 :5%9O_ F/AC_H M-0?]]4?\)CX8_P"@U!_WU0!I45F_\)CX8_Z#4'_?5'_"8^&/^@U!_P!]4 :5 M%9O_ F/AC_H-0?]]4?\)CX8_P"@U!_WU0!I45F_\)CX8_Z#4'_?5'_"8^&/ M^@U!_P!]4 :5%9O_ F/AC_H-0?]]4?\)CX8_P"@U!_WU0!I45F_\)CX8_Z# M4'_?5'_"8^&/^@U!_P!]4 :5%9O_ F/AC_H-0?]]4?\)CX8_P"@U!_WU0!I M45F_\)CX8_Z#4'_?5'_"8^&/^@U!_P!]4 :5%9O_ F/AC_H-0?]]4?\)CX8 M_P"@U!_WU0!I45F_\)CX8_Z#4'_?5'_"8^&/^@U!_P!]4 :5%9O_ F/AC_H M-0?]]4?\)CX8_P"@U!_WU0!I44B.LB"1&RK#(([BEH **** "BBB@ HHHH * M*** "LO5O!'@O7KPZAKGA#2[VX*A3/=Z?'(Y Z#+KQO(ET+&T2+SE%NQ"OM W#/.#7OG]G:?\ \^,/_?H5XC^U MA_R6SX'_ /8]R_\ I,U>Z4 ?A;_P=IP00?'OX0B"%$!\(:AD(H&?]*2OR1K] MV?\$U/^4BOP&_[+)X9_P#3I;UP9M_R*Z_^"7_I+.G!?[Y3 M_P 2_-']9W]G:?\ \^,/_?H4?V=I_P#SXP_]^A4U%?P\?OY#_9VG_P#/C#_W MZ%?R&?\ !TE''%_P7/\ C5'%&JJ(?#6%48 _XIO3*_KYK^0?_@Z6_P"4Z/QK M_P"N/AG_ -1O2Z /S[HHHH **** "BBB@ HHHH **** "BBB@ HHHH _4/\ MX-"8HIO^"Q6FI-&KK_PKK7>&7(^Y#7]6?]G:?_SXP_\ ?H5_*;_P:"?\IC-- M_P"RK"BBBN@S"BBB@ HHHH **** "BBB@ HHHH *_:+_ (-%;>WN+/\ M: \^!'Q+X6QO4''&K^M?B[7[2_\ !H?_ ,>?[0/_ %U\*_RU>O@_$W_DB,7_ M -P__3D#Z+A/_D?T?^WO_29'[*_V=I__ #XP_P#?H4?V=I__ #XP_P#?H5-1 M7\EG[,> ?\%4+"Q3_@F%^T>Z6<0(^ WC @B,9!_L6[K^(*O[@O\ @JG_ ,HP M/VD/^R"^,/\ TRW=?P^T %%%% !1110 4444 %%%% !1110 4444 %%%% '] M7_\ P:-V=I-_P1I\.O-:QNW_ G6OY?\ TF:O=*\+_:P_Y+9\#_\ L>Y?_29J]TH M_##_ (.V/^2^?"#_ +$_4/\ TJ2OR.K]&?_3I;UXG7MG_!-3_E(K\!O^RR>&?_ M $Z6]<&;?\BNO_@E_P"DLZ<%_OE/_$OS1_6I1117\/'[^%?R#_\ !TM_RG1^ M-?\ UQ\,_P#J-Z77]?%?R#_\'2W_ "G1^-?_ %Q\,_\ J-Z70!^?=%%% !11 M10 4444 %%%% !1110 4444 %%%% 'ZB?\&@G_*8S3?^RY?_29J]TKPO\ :P_Y+9\#_P#L>Y?_ $F: MO=* /PP_X.V/^2^?"#_L3]0_]*DK\CJ_7'_@[8_Y+Y\(/^Q/U#_TJ2OR.K^N M_#K_ )(O!^DO_2Y'XKQ1_P CZOZK_P!)04445]J>"%%%% !1110 4444 %%% M% !1110 5[9_P34_Y2*_ ;_LLGAG_P!.EO7B=>V?\$U/^4BOP&_[+)X9_P#3 MI;UP9M_R*Z_^"7_I+.G!?[Y3_P 2_-']:E%%%?P\?OX5_(/_ ,'2W_*='XU_ M]OQ:K]I?^#0_P#X M\_V@?^NOA7^6KU\'XF_\D1B_^X?_ *<@?1<)_P#(_H_]O?\ I,C]FZ***_DL M_9CP7_@JG_RC _:0_P"R"^,/_3+=U_#[7]P7_!5/_E&!^TA_V07QA_Z9;NOX M?: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#^L/_@T6_P"4,WAW_L>M M>_\ 2D5^G-?F-_P:+?\ *&;P[_V/6O?^E(K].: "BBB@ HHHH **** "BBB@ M HHHH **** /"_VL/^2V? __ +'N7_TF:O=*\+_:P_Y+9\#_ /L>Y?\ TF:O M=* /PP_X.V/^2^?"#_L3]0_]*DK\CJ_7'_@[8_Y+Y\(/^Q/U#_TJ2OR.K^N_ M#K_DB\'Z2_\ 2Y'XKQ1_R/J_JO\ TE!1117VIX(4444 %%%% !1110 4444 M%%%% !7MG_!-3_E(K\!O^RR>&?\ TZ6]>)U[9_P34_Y2*_ ;_LLGAG_TZ6]< M&;?\BNO_ ()?^DLZ<%_OE/\ Q+\T?UJ4445_#Q^_A7\@_P#P=+?\IT?C7_UQ M\,_^HWI=?U\5_(/_ ,'2W_*='XU_]_[3O_)RGQ#_ .QYU;_TLEKAZ[C]IW_DY3XA M_P#8\ZM_Z62UP]?W1@_]TI_X5^1_/=;^-+U84445T&84444 %%%% !1110 4 M444 %%%% !7[2_\ !H?_ ,>?[0/_ %U\*_RU>OQ:K]I?^#0__CS_ &@?^NOA M7^6KU\'XF_\ )$8O_N'_ .G('T7"?_(_H_\ ;W_I,C]FZ***_DL_9CP7_@JG M_P HP/VD/^R"^,/_ $RW=?P^U_<%_P %4_\ E&!^TA_V07QA_P"F6[K^'V@ MHHHH **** "BBB@ HHHH **** "BBB@ HHHH _K#_P"#1;_E#-X=_P"QZU[_ M -*17ZY?_ $F:O=*\+_:P_P"2V? __L>Y?_29 MJ]TH _##_@[8_P"2^?"#_L3]0_\ 2I*_(ZOUQ_X.V/\ DOGP@_[$_4/_ $J2 MOR.K^N_#K_DB\'Z2_P#2Y'XKQ1_R/J_JO_24%%%%?:G@A1110 4444 %%%% M!1110 4444 %>V?\$U/^4BOP&_[+)X9_].EO7B=>V?\ !-3_ )2*_ ;_ ++) MX9_].EO7!FW_ "*Z_P#@E_Z2SIP7^^4_\2_-']:E%%%?P\?OX5_(/_P=+?\ M*='XU_\ 7'PS_P"HWI=?U\5_(/\ \'2W_*='XU_]=6_]+):X M>NX_:=_Y.4^(?_8\ZM_Z62UP]?W1@_\ =*?^%?D?SW6_C2]6%%%%=!F%%%% M!1110 4444 %%%% !1110 5^TO\ P:'_ /'G^T#_ -=?"O\ +5Z_%JOVE_X- M#_\ CS_:!_ZZ^%?Y:O7P?B;_ ,D1B_\ N'_Z<@?1<)_\C^C_ -O?^DR/V;HH MHK^2S]F/!?\ @JG_ ,HP/VD/^R"^,/\ TRW=?P^U_<%_P53_ .48'[2'_9!? M&'_IENZ_A]H **** "BBB@ HHHH **** "BBB@ HHHH **** /ZP_P#@T6_Y M0S>'?^QZU[_TI%?IS7YC?\&BW_*&;P[_ -CUKW_I2*_3F@ HHHH **** "BB MB@ HHHH **** "BBB@#PO]K#_DMGP/\ ^Q[E_P#29J]TKPO]K#_DMGP/_P"Q M[E_])FKW2@#\,/\ @[8_Y+Y\(/\ L3]0_P#2I*_(ZOUQ_P"#MC_DOGP@_P"Q M/U#_ -*DK\CJ_KOPZ_Y(O!^DO_2Y'XKQ1_R/J_JO_24%%%%?:G@A1110 444 M4 %%%% !1110 4444 %>V?\ !-3_ )2*_ ;_ ++)X9_].EO7B=>V?\$U/^4B MOP&_[+)X9_\ 3I;UP9M_R*Z_^"7_ *2SIP7^^4_\2_-']:E%%%?P\?OX5_(/ M_P '2W_*='XU_P#7'PS_ .HWI=?U\5_(/_P=+?\ *='XU_\ 7'PS_P"HWI= M'Y]T444 %%%% !1110 4444 %%%% !1110 4444 ?J)_P:"?\IC--_[)SKO_ M *!#7]7%?RC_ /!H)_RF,TW_ +)SKO\ Z!#7]7% !1110!_'O^T[_P G*?$/ M_L>=6_\ 2R6N'KN/VG?^3E/B'_V/.K?^EDMO MQ:K]I?\ @T/_ .//]H'_ *Z^%?Y:O7P?B;_R1&+_ .X?_IR!]%PG_P C^C_V M]_Z3(_9NBBBOY+/V8\%_X*I_\HP/VD/^R"^,/_3+=U_#[7]P7_!5/_E&!^TA M_P!D%\8?^F6[K^'V@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH _K#_X M-%O^4,WAW_L>M>_]*17Z+PUM=>AQX*_#MQ_P $QOVC;>#5X6>3X#^+U10>23HM MV *_B-H **** "BBB@ HHHH **** "BBB@ HHHH **** /ZP_P#@T6_Y0S>' M?^QZU[_TI%?IS7Y<_P#!I)XBT33?^"-WAVUOM2BBD'CG7B48\X^TBOTT_P"$ MQ\,?]!J#_OJ@#2HI$=9$$B-E6&01W%+0 4444 %%%% !1110 4444 %9>K>" M/!>O7AU#7/"&EWMP5"F>[T^.1R!T&YE)Q6I10!\\?M.>#?"&A?&WX)MHGA33 M;,R^.9!*;6QCCW@6[$ [0,\\U] _V=I__/C#_P!^A7B/[6'_ "6SX'_]CW+_ M .DS5[I0!^%O_!VG!!!\>_A"((40'PAJ&0B@9_TI*_)&OUQ_X.V/^2^?"#_L M3]0_]*DK\CJ_KOPZ_P"2+P?I+_TN1^*\4?\ (^K^J_\ 24%%%%?:G@A1110 M4444 %%%% !1110 4444 %>V?\$UE5_^"B?P'1U!!^,?AH$$<$?VI;UXG7MG M_!-3_E(K\!O^RR>&?_3I;UP9M_R*Z_\ @E_Z2SIP7^^4_P#$OS1_6=_9VG_\ M^,/_ 'Z%']G:?_SXP_\ ?H5-17\/'[^0_P!G:?\ \^,/_?H5_(9_P=)1QQ?\ M%S_C5'%&JJ(?#6%48 _XIO3*_KYK^0?_ (.EO^4Z/QK_ .N/AG_U&]+H _/N MBBB@ HHHH **** "BBB@ HHHH **** "BBB@#]0_^#0F**;_ (+%::DT:NO_ M KK7>&7(^Y#7]6?]G:?_P ^,/\ WZ%?RF_\&@G_ "F,TW_LG.N_^@0U_5Q0 M!#_9VG_\^,/_ 'Z%']G:?_SXP_\ ?H5-10!_'O\ M. #]I/XA # 'CC5L ?] M?DM=6_]+):X>O[HP?\ NE/_ K\C^>ZW\:7JPHHHKH, MPHHHH **** "BBB@ HHHH **** "OVB_X-%;>WN+/]H#SX$?$OA;&]0<<:OZ MU^+M?M+_ ,&A_P#QY_M _P#77PK_ "U>O@_$W_DB,7_W#_\ 3D#Z+A/_ )'] M'_M[_P!)D?LK_9VG_P#/C#_WZ%']G:?_ ,^,/_?H5-17\EG[,> ?\%4+"Q3_ M ()A?M'NEG$"/@-XP((C&0?[%NZ_B"K^X+_@JG_RC _:0_[(+XP_],MW7\/M M !1110 4444 %%%% !1110 4444 %%%% !1110!_5_\ \&C=G:3?\$:?#KS6 ML;M_PG6O&?_ $Z6]>)U[9_P34_Y2*_ ;_LLGAG_ -.EO7!FW_(KK_X)?^DLZ<%_OE/_ M !+\T?UJ4445_#Q^_A1110 4444 %%%% !1110!F^,?^18O?^N!JYIW_ "#X M/^N*_P A5/QC_P BQ>_]<#5S3O\ D'P?]<5_D* )J*** "BBB@ HHHH **** M "BBB@#^/?\ :=_Y.4^(?_8\ZM_Z62UP]=Q^T[_R=6_]+):X>O[ MHP?^Z4_\*_(_GNM_&EZL****Z#,**** "BBB@ HHHH **** "BBB@ K]I?\ M@T/_ .//]H'_ *Z^%?Y:O7XM5^TO_!H?_P >?[0/_77PK_+5Z^#\3?\ DB,7 M_P!P_P#TY ^BX3_Y']'_ +>_])D?LW1117\EG[,>"_\ !5/_ )1@?M(?]D%\ M8?\ IENZ_A]K^X+_ (*I_P#*,#]I#_L@OC#_ -,MW7\/M !1110 4444 %%% M% !1110 4444 %%%% !1110!_6'_ ,&BW_*&;P[_ -CUKW_I2*_3FOS&_P"# M1;_E#-X=_P"QZU[_ -*17Z* /)?VX?B-\5_A?^SI?>(/@;K^BZ3XMO\ Q+X=T/0M4\1Z>UW8V<^IZY8Z M;YT\*R1M(B"[+%0ZDXX(-?%O[3?[4_\ P4 _:/\ ^"@'AC_@D]^P=^U-I?A3 M5_ WA3_A)?VB?C;9^!;.^_LTR'%IIEO8W32PQ32;HW,98OME4A\13*]+XL_\ M'#'[,?C?X)^*I/C#_P $C/VP]8^' @O-.\7ZAJ?P.LKG0_*CD:WN8Y[C^TC; M[5D5D8EL!EQG(KSWX#?MR?L._L\_!SQ-\/\ ]EO_ (-]OV\/"^@^/'2]\07W MA;X,7]I=:L1RCMJ<.JFZV %L;9=H$D@ Q(^X _1[]B#XF_$7XG? @2_%KQ=I M7B/Q)X;\4:WX8UCQ1H=C]EM-;FTS4KBQ-XD 9A \GD9DB5F6.82HI*J*]>KY MC_X(X>*?ASXU_P"";WPT\3_"?]G?6/A3H-[8WDUGX%UN"\26Q+WUP[RI]L=Y M6BG9FN(VWNI2=<,17TY0!X7^UA_R6SX'_P#8]R_^DS5[I7A?[6'_ "6SX'_] MCW+_ .DS5[I0!^&'_!VQ_P E\^$'_8GZA_Z5)7Y'5^N/_!VQ_P E\^$'_8GZ MA_Z5)7Y'5_7?AU_R1>#])?\ IR?L5?L]?\+4T[2+"\U75/$FF^']$_MB=HK"WN[V<1+<73I\P@B7? M*X7!8)M!7=N'N5<'^TO^SA\'_P!K7X+:W^S_ /'3PXNJ>'?$, BN8!+YGR1W4@B6%[K>;>59 4#MY@8?-ZW\?\ ]HG4/!_Q/\'?LS_"M+.Y^('C MS[3<69O8VEMM$TFU4&ZU2Y165G52T<4409?-FE1=RJLC+\ _LS?&#]I3_@C_ M /%S5/@W\8+VY^)'[.^K?%F/PI9?$.[DSK7AK4Y;2S%N;P9_>VQB:&//.!"2 MFS"P/[5^SOX@U#QQ_P ' O[0CZ_YDA\$_"+P]H>@M)TBL[E;6_E5?0&>5B<= MP:^QQ^315>IB)*$J4*3J1E!)*?P02E%6LXRFG*+5[:.Z:9X>'QS=.--74Y34 M6FVW'XF[/JFHM)K2^N]T>X?M$7_[=WB/7;3X+?L>ZWX6T=]*T2WN?$_Q,^(N MF270GG"YC60ED;&PD<9\T#8C(ZCZ@^(?Q!\ M(?"KP7J/Q!\>:REAI6EP>;=7#J6/4*J(B@M)([%42-07=V55!9@#XW^QM^S_ M .(_#GCSXC?M>_%K03IGCGXP:I:7%SHTC*SZ%HUE!]GTW3W*DJ9Q%NEG*DKY MTS*"RQJ[>%0Q.%GD]:%:C%:)0DE:?M.:+>O6/)S77PKW;6;3?H5*5:..IRIS M>[YE?W>6SMIT?-:SW>NZ/0?VH_BGIOP,_9O\=_&G6-,GO;3PEX4O]8N+.V.) M)TMH'F,:GH"P3&3P,Y/%?,?C#]KG]I7X2?\ !/?2/^"D>I?$[PKXCL&T#2-? MU;P#I^@B&QDL+R2!6LK2\\UIA=QK.%$TF]))8R#"@?"?4/[2OC#X>_#[]G[Q MGXX^+3P+X7TKPW=W7B$74'FQM9I$QE4I@^9N3*[,'=G&#FOR9TWX2_&?_@GM MX!\"_MF7OPZU'QG^R9JNO0^+;GX(ZAJTMY=?#I;MUDL=14$A+HQB19O)?=%# M+)@[I$6\'I<,9?A,;0?M(KGYXV4DK559MTHM_#-]'INE=/E4N7-L36P\_=;M MRN]K^X[JTVEO%=5^#5VOT>_:R\5_\%!=8U[PWX0_8*\+> +1I-/DU'Q9XB^+ M,%\MC;QN0EM:6Z6A\R2Y8K,[C&V-43<094SY9^SW\;?^"IEC^WEH?[+_ .U5 MK/P.U'19? E[XIU^3X'K]+K3]2LXKJQNHONS0R('1Q[%2#^-?.?[ P'Q@^)7QF_;0N0) M8/&WCA_#O@^?JI\/Z$7L(GC)Y"37O]HS^A$JGTQP8/%4XY97C4H0M"/*FX^\ MYS=E[SV:7-)67V+'37HR>+IN-25Y.]D].5+73LW9/U,7X._M"_M._MT^"/&W MQN_9<^(_ACPIX>T3Q/J.B?#RQUCPT=07Q%)8MYC16\\P9$2$*\:+O M9W+>6NS^S-^V#\1OVXOV,M._:1^ NC6FC^-M+NKJT\0^ =9=6MI=5M"8[G2Y M9]N^$.<-%<+]SS(G=) 'B/C_ .R5\*?VK?\ @DYX1^)GPGN_AEH'B_X.V&NZ MGXM\)>.[GQK%IO\ 8EA(GFSVNHQ/$\N(A&6\R".7<68[?F 33_X-[OA[XZ\- M?L%7GQ5\?Z1)I]S\5OB-K'C6SL)008;6Z\F&,@'D*XMC(I_B216_BKULRP>7 M4<#B,304)4X5*:I-EKMI6T:WV/JS]FK]H7P#^U1\$M!^.OPUEG&F:Y;,S6EY&$N+&YC=HKB MTG7)V30S))$XR1N0X)&">ZKX1_X(SZMJ.C?&K]KSX-03$Z)X=_:,U6]T> DD M6WVUY&DB7/11Y*8'J6/4G/W=7S6=X&GEN:5*%/X59KORRBI)/S2:3\SU_[3O_ "NX_: M=_Y.4^(?_8\ZM_Z62UP]?W1@_P#=*?\ A7Y'\]UOXTO5A111709A1110 444 M4 %%%% !1110 4444 %?M+_P:'_\>?[0/_77PK_+5Z_%JOVE_P"#0_\ X\_V M@?\ KKX5_EJ]?!^)O_)$8O\ [A_^G('T7"?_ "/Z/_;W_I,C]FZ***_DL_9C MP7_@JG_RC _:0_[(+XP_],MW7\/M?W!?\%4_^48'[2'_ &07QA_Z9;NOX?: M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@#^L/_@T6_Y0S>'?^QZU[_TI M%?IS7YC?\&BW_*&;P[_V/6O?^E(K].: "BBB@ HHHH **** "BBB@#R/]K[X M&>)OBC^S;J_@+X)Z7X?MO$-IKVF>)_#UAK$'EZ;>ZIIVLVVLI#<^6I*1W-S; M;)954N//>3#,.?CKXK?\%V/VJOA_-/\ "G3?^"%W[3%W\4"IAM-*CT**Z\/2 M7/W=RZQ:&5);<,1F98PN.3M[?4G_ 5$^./Q_P#V;OV"_B+\:_V7=$TV]\<: M'IMLVD-K,#2VEC')>P0W-_,J\F.UMI)[INHQ;G((R#\ZZ5_P3\_X+SZAIT-] MJG_!PY:6UQ,@>6WL/V4?#5Q#&3SA)'E1G7T8J"10![U_P2B^!W[1G[/_ .Q# MX<\'_M:7UBWQ$U;6=;\2>*M/TJ7?::5=:KJMUJ36,)#,-D)NMGRDH&#!690& M/T;7A/\ P3;^%WQL^"_[(^E?#;]HSXU6_P 1?&NG>+/%3:_XVM4BC75Y)?$6 MI3+,8H69+=O+D16MU/[EE:+@I@>[4 >%_M8?\EL^!_\ V/Z5X7^UA M_P EL^!__8]R_P#I,U>Z4 ?AA_P=L?\ )?/A!_V)^H?^E25^1U?KC_P=L?\ M)?/A!_V)^H?^E25^1U?UWX=?\D7@_27_ *7(_%>*/^1]7]5_Z2@HHHK[4\$* M*** "BBB@ HHHH **** "BBB@ KVS_@FI_RD5^ W_99/#/\ Z=+>O$Z]L_X) MJ?\ *17X#?\ 99/#/_ITMZX,V_Y%=?\ P2_])9TX+_?*?^)?FC^M2BBBOX>/ MW\**** "O,_VG_@G\0?C/X=\.3_";XN)X*\3>$O%D&O:-J]SHG]HVTKI!<6\ MEM<0>;$7AEAN98VVR(P#94@BO3**VH5ZF&JJI3W7=)KYIW37DU8BI3C5@XRV M?R_%:GQSIG["/Q\^/?B75M(_:X\7>';7P3#\7X?&4GAOPMI3AO$]Q;6EFML9 M9Y;B0V]FLT.YK?897:/F14QON_$7X6O^S9_P54T3]LUX_+\'?%?P.O@3Q?>X MQ'IFN17$4NEW,[?PQW"H;)6/RB4PJ3F5:^N:K:UHNC>)-(N?#_B+2;:_L+V! MH+RRO8%EAGB889'1@592"00000:]:.?8N51JI;D<7!Q2LK22NUYW497=]8I; M)(XGEU%1]WXDU*[U=U?\+-JWF^NI\T_MA?L:?MC_ +1'QG\/_$CX/_M[:?\ M#G1?"J^=H?AE_A);ZVBW[(4:^F>YO5268!F6,^4OE*QV_,6<[O[,?[,?[8_P MX^)TOQ _:H_;_N?BS9P:1)::)X?M?AS9^'+6SGDD0O=2"UF?[3)L0QJ'X02. M1RU>]:5I=EHFEVVC:9$8[:TMT@MT:1G*HBA5&YB2> .223WJQ6$LYQKPBPON M?7J^:[N[LT6!H*O[;WN9N_QRM?_#?E_ ^+?V9/A!\?_B=\ M"OCE^SY^V5^T7'\9_"&LROIVE>,;318].$JW,,@O;6W:,LLD<&Z +*N1',9H M@$+JUM8$BBBMMD<<:A511@ #@ #M5_ M3O\ D'P?]<5_D*UK9YBYXB52FHQ3DI)*,4E))+F2223=KNR2;Z:*TPR^C&FH MRN]&KW=VF[V;O=KM?7\3G_%O@S6K7X.:E\//@WJ-KX?U"/PU-IWA:[DB9X=, MF%N8K:0H#N9(VV':""0N,CK5#]F_X)^'_P!F[X!>#O@)X7D\RR\(^'+32X[@ MKM:X:*)5>=A_>D<-(W^TYKM:*\QXBLZ#I7]UOF?F[-)M^5W][[G5[*'M%.VJ M5OE_5CPSXZ_LJ^,_VMI(_ W[0WCNRA^&D5_'R.& M>UW*K-;0Q1;F4;I77Y*]6\5^*/ 7P7^'-[XK\17=GH?AOPUI337#K&(X;.UA M3A511P H"JBCT4#H*W:S=?\ "'AGQ5-83^)=$@OCIEZEY8)=)O2&X3[DP4_+ MO4\JQ&5/*D'FM98N=:,*=5_NX]%9;[OU=DG)W>BW22(5&--RE#XGU?X?)=E9 M?>?.?_!*W]G#Q?\ !;X-^+/BW\5M"FTSQK\:/B'JOCSQ'I5TN)M+%],7MK%P M.C10!"R_P222+SM%?3U%%+'XVKF&,GB*F\G>W1+9)>25DO)#PU"&&H1I1V7] M-_-ZA1117(;!1110!_'O^T[_ ,G*?$/_ +'G5O\ TLEKAZ[C]IW_ ).4^(?_ M &/.K?\ I9+7#U_=&#_W2G_A7Y'\]UOXTO5A111709A1110 4444 %%%% !1 M110 4444 %?M+_P:'_\ 'G^T#_UU\*_RU>OQ:K]I?^#0_P#X\_V@?^NOA7^6 MKU\'XF_\D1B_^X?_ *<@?1<)_P#(_H_]O?\ I,C]FZ***_DL_9CP7_@JG_RC M _:0_P"R"^,/_3+=U_#[7]P7_!5/_E&!^TA_V07QA_Z9;NOX?: "BBB@ HHH MH **** "BBB@ HHHH **** "BBB@#^L/_@T6_P"4,WAW_L>M>_\ 2D5^G-?F M-_P:+?\ *&;P[_V/6O?^E(K].: "BBB@ HHHH **** "BBB@#R']OKX(WW[1 MO[&WQ#^#>E_&O4_AQ=ZOX=D-IXYTG7)=-ET:6%EN$G:YB96BA#1 2\X,1D4Y M!(/YJ:7_ ,$^_P#@D_X5T.WT#0_^#F_X\6=GIUJEO9Z?8_MHZ##%!'&H58HT M$ 5% 4+P !P!7Z$_\ !47X677QF_8=\8> U^%NK^.;%KW1;_Q#X)\/SF.^ M\0Z/9ZQ97FI:=;X="\MQ96]S"L8=#(T@3%_M8?\ );/@?_V/N#-O^177_ ,$O M_26=."_WRG_B7YH_K4HHHK^'C]_"BBB@ HHHH **** "BBB@#-\8_P#(L7O_ M %P-7-._Y!\'_7%?Y"J?C'_D6+W_ *X&KFG?\@^#_KBO\A0!-1110 4444 % M%%% !1110 4444 %%%% !1110 4444 %8_B7_D+Z/_U^G_T$UL5C^)?^0OH_ M_7Z?_030!L4444 %%%% !1110 4444 %%%% '@O_ 53_P"48'[2'_9!?&'_ M *9;NOX?:_N"_P""J?\ RC _:0_[(+XP_P#3+=U_#[0 4444 %%%% !1110 M4444 %%%% !1110 4444 ?UA_P#!HM_RAF\._P#8]:]_Z4BOTYK\QO\ @T6_ MY0S>'?\ L>M>_P#2D5^G- !1110 4444 %%%% !1110!X[^WKX\^)7PZ_9EU M+6_A!\1+7PCXBO?$GAW1].\4W^GPW<&D_P!H:Y86$EU+#-\DD<<=R[LK%+4;KQ#]NNH;%;*.UE^2X,CW"KY1SO!(P20#^<7PZ_;T^! MG[-?P5\3_"CX.?\ !M/^U)X+\(ZZ'O/%&GZ#\)!I\=]L&XM<2PS"1D"@K@D@ M(67&TE2 ?HI^PE\2/'/Q*_9^2;XC?$6S\9ZMX>\4ZYX;N?&MA8QVL>O_ -F: MGV?\$U/^4BOP&_ M[+)X9_\ 3I;UXG7MG_!-3_E(K\!O^RR>&?\ TZ6]<&;?\BNO_@E_Z2SIP7^^ M4_\ $OS1_6I1117\/'[^%%%% !1110 4444 %%%% &;XQ_Y%B]_ZX&KFG?\ M(/@_ZXK_ "%4_&/_ "+%[_UP-7-._P"0?!_UQ7^0H FHHHH **** "BBB@ H MHHH **** "BBB@#YB_; _:X\>^%/VD?"7[%?P?UG2- \0>+O!6M>)+WQ3K=F MUU]FM+*,A;>S@62,2W4C!VW.VV*.)FV2$@#0_8T\:?M9.?!.A?&OQ+H?BWPQ MXG^$]MK^F^*;71Y;/4K6_060EM+S,TD4^];OS$F41LQCD#)QN-/_ (*7_P#! M/CX5?MP_#&'7=6\3:IX3\=^!+>YU#P3X[\.SF.^TJ4IN9#@J9(7,:[DRIRN5 M93G/C7_!*3]MC]HG1_$?A/\ X)]_MO> K*S\3R_#6SU_X8^-="8&Q\3:&D$8 M6-U 'EW42$!L!0PC;*J0K2_9TL-A<7PVZF#C%SIK][%I<_VG[2$MVDG&\5;E MY7=--L\*=6M1S7EKMJ,O@:>G3W9+9.][-[WWOH?3/A[X^ZS\;_VDO$7P9^$6 MIQVN@?#.XM(_'WB)8%F>[U.51.FCVVX%%V0['N92"RB=(HPLC-)%YG^V5XC_ M ."I6E>&?%OQG_9GU[X:>&]#\%VUY=Z=X1\5:+/?7_B2"T#-+++32 MQ!V8GG.$4?A7O7_!0OX _M-_M*?L[:Y\*?V:?CSI/@>_U33I8+O^TO#8O!JD M;*0UF\K28MXI%)1W$4C88]L@Y5:.&RCB7ZE)04::.EN=M)-ZN]M'R MJUFMRX3JXW*O;KFO).2479Z_"EMLK>KWOL=7^QG\?[[]JG]E7P#^T7J?A&30 M;GQCX9MM2N-)D)(@>1?FV$\M&2"R,>61E/>N'_;J_: MIE,:M%N4FHO:S:TYFEWM>R[FEXE_:?\ C5^R9^V!\./V?_VB_%^F>+?!WQB- MU8>$_%UMHBZ==Z1KL"HXLKE$D:.:&X5P(G55=7!5MP^<0?&/6_\ @L3XV^,/ MB&3]E+2O@?X<^'VG78LM$D^*5MJSZKJM!IQM&4;^TE&,DHOEO))+33K: M[N<]&?UCVZMDW?OTV1XY_P38^.G[9/QND^*EK^UK=_#NZ M/@GQVWA;1[[X=:=>P6MU14EF2 ':F'@F'S<$)IL(R,W3VX,[M_RQC: M D'SU(NP>)?$?_!,;_@EYH-WJNA7NK>-5L[?^V9K?1Y[[_BHM5N#/>WUQ%;* MTLL,5S<3S.$&]DBV+@LN/BK]L#]MG]C[3X?V7_"_PPN?B%?GP9^T1I7BCQEK M?B'XCEF44\TSFIB*>'YZ-Y MPBHQ?)>,'[S2VN[-+K*7]UI\N+QTL)@8TI5>6=HMW>NLMOS3?9>9^E?[5?QX M\3_LFVMI^T!XFNH[_P"&EO>6MCXZMVMU%QX?AFF6&/5H749EA221!<0ON(C/ MFQLOE-'+[)!/#N^#/VB_^"9GQ/\4Z M+%=G1?%'P:UJ\L/[2L);6=$?39I(G>&55>)U.UMK $$%%%% '@O M_!5/_E&!^TA_V07QA_Z9;NOX?:_N"_X*I_\ *,#]I#_L@OC#_P!,MW7\/M ! M1110 4444 %%%% !1110 4444 %%%% !1110!_6'_P &BW_*&;P[_P!CUKW_ M *4BOTYK\QO^#1;_ )0S>'?^QZU[_P!*17Z_\'&UPI@@_X)"?"JW=QM2>X^.EJ\<9/1F53N8# MJ0.2.E?5W[>WQ1^,7PC_ &6M=\1?L]'28_'6JZIHOAOPA=Z\I:RL=1U?5K/2 M8+N=1DO'!)>K.R $L(BN#G!^0_ __!O_ /$K3M?3XR_$'_@M-^UEJ/Q.8^=< M^(]%\;V]EI;3DY*KIDMO.@MLG MS(8]ORX XH ^FO^"7'[//Q^_9=_8J\,?" M3]I[Q7I&J^-8[_5=2UA/#Q1;I.L*# "A J_*JU]!UX MW^PA\9/&'QJ_9]CU/XB>+]+\1^(?#?BC7/"NM^)M$ME@M-:N-*U.XL&OHXE9 MEB,PMQ(\2DK'(TB*2J@G4^*WQY^)7P^\7/X<\+_LR^*/%-HL"2#5M)GA6%F8 M!]5FA871:$J538>H!W'/85]2_P#"2ZO_ -"A>_\ ?2T ?B1_P=L? M\E\^$'_8GZA_Z5)7Y'5^LW_!V%J%UJ'QX^$;W6E36I7PCJ "S$?-_I2<\5^3 M-?UWX=?\D7@_27_IO$Z]I_P"";LKP?\%#?@5-'"TC M)\8?#3+&O5B-4M^!7!FW_(KK_P""7_I+.G!?[Y3_ ,2_-']:]%8__"2ZO_T* M%[_WTM'_ DNK_\ 0H7O_?2U_#Q^_FQ16/\ \)+J_P#T*%[_ -]+1_PDNK_] M"A>_]]+0!L45C_\ "2ZO_P!"A>_]]+1_PDNK_P#0H7O_ 'TM &Q16/\ \)+J M_P#T*%[_ -]+1_PDNK_]"A>_]]+0!L45C_\ "2ZO_P!"A>_]]+1_PDNK_P#0 MH7O_ 'TM $WC'_D6+W_K@:N:=_R#X/\ KBO\A7/^)=>U.YT&Z@F\,74*M$09 M79<+[FK-EXCU5+.)%\)7C 1* P9<'CK0!NT5C_\ "2ZO_P!"A>_]]+1_PDNK M_P#0H7O_ 'TM &Q16/\ \)+J_P#T*%[_ -]+1_PDNK_]"A>_]]+0!L45C_\ M"2ZO_P!"A>_]]+1_PDNK_P#0H7O_ 'TM &Q16/\ \)+J_P#T*%[_ -]+1_PD MNK_]"A>_]]+0!L45C_\ "2ZO_P!"A>_]]+1_PDNK_P#0H7O_ 'TM &Q16/\ M\)+J_P#T*%[_ -]+1_PDNK_]"A>_]]+0!Y'\?_V?_P!H/6?BQ>_&_P#9_P#B M_H]B^H^!/^$&[U]G9O>WNWY=#D>"H2K>T=][VN[7[V_I7UM?4^7O^"*I+";Q#\-)+N32[^.]TV:54+VMPF<21M MU1L%E."-RLRG*LP.E_PDNK_]"A>_]]+6F)SBK7Q$J[C%SFES7,G9 MRM=VW;?3112P4*=-4[OEC>UFUH^CL];;+_,\9^)W[.,OP1_8(U3]GW]E_P". M\7PGGTO2@NG?$/6DCN6LY7NUGN[NX,A56FN"T^^3C$EP74 A15?X(W/[7&K? MLK_#5O&OB'1[CX@36[KJ?B#Q3HQ -9^N:YJ,^HZ;))X;N8S'[3=KJ]M[Z+"PC54HMI*/+9- MVM?MM?I>U_/8Y#]G']D;PC\!O$_B7XMZWXBO/%WQ&\;3I)XN\=:Q"B7%RD8 MBM+>-/EM+.( ".!,X !=I&^>K/[5G[/NH_M+>%O#'P]D\1P66@V7CW2-<\66 M4T!D_M:RL)Q=I9#! 4/_\ ?2UGA<57P5=5 MJ+M)7UT>Z:>]ULV56HT\13<*BNG^CN>,?\%,]:\2WW[(OBGX&?#2V%[XV^*V MGS>#?"&F*V&FFOXVAGG)_@BM[9I[B23HB0D]< ^E?LW_ 1\._LU_ #P;\ / M"DP7#IM:X\F)4:9AV9V#.?=C5N.UT^/Q4_CD?#65M8DLA9_VD MX5IDM]V[R58DE$+ ,57 9@"02 :TO^$EU?\ Z%"]_P"^EK:IC6\OCA(?"I.; M\Y-)+Y)+3S;?5)1&@OK+K2WM9>2W_%[^B-BBL?\ X275_P#H4+W_ +Z6C_A) M=7_Z%"]_[Z6N$Z#8HK'_ .$EU?\ Z%"]_P"^EH_X275_^A0O?^^EH \=_P"" MJ?\ RC _:0_[(+XP_P#3+=U_#[7]MO\ P5*\0ZI-_P $R/VC(9/"MW&K_ CQ M>K2,RX4'1;OD_2OXDJ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#^L/ M_@T6_P"4,WAW_L>M>_\ 2D5^G-?EK_P:4:UJ%C_P1P\.P6_AZYN5'CG7CYL3 M+@_Z2..:_3+_ (275_\ H4+W_OI: -BBDC8O&KLA4E02IZCVI: "BBB@ HHH MH ***21S'&T@1FVJ3M7J?84 <=^T/X4^"WC?X&>*_"G[1S"$R3/<%D^S^6!O$P93&RAPRE01^,_Q,TW]B#QUXBE\":O\ \'<' MQ _X5@SF&[\'CQW;RZE/;9PUNVL1NIF0KE=TD,FX'G=SGTS_ (*(_P#!;O\ MX)K?M\_L9>/?V5$T;XRP'7S!%YK?";4FMVN]/U&&Z%I<-%EA$\UH()MN65'D M !(Q2^%O^"L?_!ON/#.G?:?^"8>H:3+]AB\W2Q^RQ _V-M@S#N2WVMM/RY7@ MXR* /T'_ ."9^J_LA:G^Q)X)M_V"[>%/A+I0U+1_!\L!;S6^:3S-YY8U[M7SE_P2@^*/P ^-/[#?A[XH?LM?"Z3P7X"U?Q5XLE M\.^&I=-2R-HB^)=320_9D 6WWRK)((0/W8DV?PU]&T >%_M8?\EL^!__ &/< MO_I,U>Z5X7^UA_R6SX'_ /8]R_\ I,U>Z4 ?AA_P=L?\E\^$'_8GZA_Z5)7Y M'5^N/_!VQ_R7SX0?]B?J'_I4E?D=7]=^'7_)%X/TE_Z7(_%>*/\ D?5_5?\ MI*"BBBOM3P0HHHH **** "BBB@ HHHH **** "O;/^":G_*17X#?]ED\,_\ MITMZ\3KVS_@FI_RD5^ W_99/#/\ Z=+>N#-O^177_P $O_26=."_WRG_ (E^ M:/ZU****_AX_?PHHHH **** "BBB@ HHHH S?&/_ "+%[_UP-7-._P"0?!_U MQ7^0JGXQ_P"18O?^N!JYIW_(/@_ZXK_(4 34444 %%%% !1110 4444 %%%% M !1110 4444 %%%% !6/XE_Y"^C_ /7Z?_036Q6/XE_Y"^C_ /7Z?_030!L4 M444 %%%% !1110 4444 %%%% '@O_!5/_E&!^TA_V07QA_Z9;NOX?:_N"_X* MI_\ *,#]I#_L@OC#_P!,MW7\/M !1110 4444 %%%% !1110 4444 %%%% ! M1110!_6'_P &BW_*&;P[_P!CUKW_ *4BOTYK\QO^#1;_ )0S>'?^QZU[_P!* M17Z_;C^+W_!.#X,6,GP$_8]\>:QIN MK>,-*2+Q5X L-.O[>TN+S6H9;NTFM)9#,DEV)+B&.01%#-=( Z.R5Q-U_P % MVOC/@#P7_@F3KW[0GBK]BCPCXJ_:G^#Y\">.M6N- M5OM:\-S111W,7GZG=2Q3W20JL:7<\3QSSA%4>=-(=D>?+7WJH[:[M+V,S6=S M',BR/&7B<, Z,59E24 >%_M8?\EL^!_\ V/Z5X7^UA M_P EL^!__8]R_P#I,U>Z4 ?AA_P=L?\ )?/A!_V)^H?^E25^1U?KC_P=L?\ M)?/A!_V)^H?^E25^1U?UWX=?\D7@_27_ *7(_%>*/^1]7]5_Z2@HHHK[4\$* M*** "BBB@ HHHH **** "BBB@ KVS_@FI_RD5^ W_99/#/\ Z=+>O$Z]L_X) MJ?\ *17X#?\ 99/#/_ITMZX,V_Y%=?\ P2_])9TX+_?*?^)?FC^M2BBBOX>/ MW\**** "BBB@ HHHH **** ,WQC_ ,BQ>_\ 7 U"_\ !5/_ )1@?M(?]D%\8?\ IENZ_A]K^X+_ (*I_P#*,#]I M#_L@OC#_ -,MW7\/M !1110 4444 %%%% !1110 4444 %%%% !1110!_6'_ M ,&BW_*&;P[_ -CUKW_I2*_3FOS&_P"#1;_E#-X=_P"QZU[_ -*17Z _P#!4KQE^U!\/?V!/B1XR_8V MOEL_B)8:5;OH^I'3!>MI]N;R!;Z\2W*L)I(+(W4R1[6W/$H"L3M/SAX:_P"" M.G[7>M^'+36I?^"_/[1FJ->VR3Q:EI%U81VEPKJ&62) KCRVSN7#D8(P>]>U M_MD^,?V&/V\?^":7Q N-?_:V\)Z?\)O$>GMIUS\4M/\ %4$>GZ5>Q7L<<$IN MO,"*T=\D VEAN.U?XQGX M?^"?O_ :DV5M'9VO_ 4(\.I'$@2-$_:D*A0! M@ 78 'L* /TH_X)H?!7Q!^SM^R%I?P9\5_':^^)FI:'XQ\6QWWCG5;AI;O5 M)7\2ZG*S7#,23.A?RY!D@21N!P!7O5?-/_!(?P5^S'\.OV!_"_@K]C7XA7'B MOX9:?XE\5Q^$]?N;D3FZA/B74VDVS;F\]%E,J)-G,J(LAP6P/I:@#PO]K#_D MMGP/_P"Q[E_])FKW2O"_VL/^2V? _P#['N7_ -)FKW2@#\,/^#MC_DOGP@_[ M$_4/_2I*_(ZOZS/VMO\ @FM^Q3^W3K^C^*/VJ/@O_P )3?:#9R6NDS_\)'J5 MCY$+N'==MG<1!LL V?\$U/^4B MOP&_[+)X9_\ 3I;U_0)_Q#U?\$?_ /HT3_R__$'_ ,GUM_#3_@A?_P $L?@_ M\1=!^+/PZ_9<_L[Q!X8UFVU70]0_X3;7)OLUY;RK+#)LEO61]KHIVNK*<8(( MXKEQOB]PUB<%5HQI5KRC)*\86NTU_P _#;#\%9K2KPFYPLFGO+H_\)]:T445 M_.9^GA1110 4444 %%%% !1110!F^,?^18O?^N!JYIW_ "#X/^N*_P A5/QC M_P BQ>_]<#5S3O\ D'P?]<5_D* )J*** "BBB@ HHHH **** "BBB@ HHHH M**** "BBB@ K'\2_\A?1_P#K]/\ Z":V*Q_$O_(7T?\ Z_3_ .@F@#8HHHH M**** "BBB@ HHHH **** /!?^"J?_*,#]I#_ +(+XP_],MW7\/M?W!?\%4_^ M48'[2'_9!?&'_IENZ_A]H **** "BBB@ HHHH **** "BBB@ HHHH **** / MZP_^#1;_ )0S>'?^QZU[_P!*17Z(/V-+#X(>'="^&_ MB33[NTO_ MX;T>"QM$%PYDDDCBB0(DGFGS VW[X!YQ7*K_P2;_X)8HH4?\ M!-/X 8 P,_!S1"?_ $EK4_99_:<^+?[3>L>(/%47[/\ 9^'OAQ8^(M3TKPOX MLO\ Q?YM_P"(TL[J2U^W1:>EIMAM9)(I"C27 =E"N(RK@U\L:]_P6*_:W_:3 M_:B\:?!3_@DU^P]I'QC\(_"J]_L_Q]\1_$?CJ/1=,O-4',FFZ;*R,LTB@$>= MEER'?"VGZCJ-YINAZ;;I#;6 M37M]/?310QH%6*(37,FR-0 B[5' KLZX#]F#X_:5^TW\$](^,&G>$=5\.W%Y M)=6>L^&==C5;W1=2M+F6TO;&<*2IDAN898RRDJVP,I*L">_H \+_ &L/^2V? M _\ ['N7_P!)FKW2O"_VL/\ DMGP/_['N7_TF:O=* "BBB@ HKAOVBOVAOAO M^R]\++OXM?%"[NA8075O9VEEIUMY]WJ-[<2K#;VEO$"/,FDD=549 &26*J&8 M>0_#_P#;X\=S>-+G0/C1^RMXH\-Z7-\2(/"%AKMA>V%_#I]Y<0VK6\6HK#2Y5/-B62$,R*7!(+=^'RS&XJ@ZU./NJ_5*[5KI)M-M75TK[KN<]3%T*51 M0D]?GIZ]MNI]+T5QWQD^-GA7X,:=I?\ :]O%/#EU;F73KCQ;U*"RL;&V>XO;RZE$<4$2*6> M1V/"JJ@DD\ #-35H5*-7V!K/X7Z5^T#XD^%?B#2O@_P"(?$:Z?I?Q,OIK=8%$]QY%O?7% MKO\ .MK&64HB3N-P\V-GCC1MX^@_C'\5]!^"7PXU7XG>)-$US4;+2;.2YFL_ M#NBS7]U(J(SD)%$I/13\S%5'&6&1736RW'8>I&$X.\FTMG[RM>.FTE=73U5U M=(RABL/4BY1EHE?Y/9^CZ/9]#IZ*\U_8_P#VF_"G[9/[.'AG]I?P-H&H:7I' MBJ">>PL=5V?:8XX[F6 >8(V90Q\K=@,0,XR>M>+?M-_\%5+?]G!=2\=0_L=_ M%'Q9\-?#UXUMXD^)>@6-J+"V*2>7+)!%+,LUS#&X*M.%6+*G:[#DZ4,HS'$8 MR6$A3_>1;BTVE[R=N6[:3=]$D[OI&=/\ &?@[7+74])U:RBO-,U*QG$D-U;R('CE1 MUX964@@C@@UQSP]>E#FE&RNU\UNGV?DS>-6G.5D_/Y=R_1116)84444 %%%% M !1110 4444 %%%% &;XQ_Y%B]_ZX&KFG?\ (/@_ZXK_ "%4_&/_ "+%[_UP M-7-._P"0?!_UQ7^0H FHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M "L?Q+_R%]'_ .OT_P#H)K8K'\2_\A?1_P#K]/\ Z": -BBBB@ HHHH **** M "BBB@ HHHH \%_X*I_\HP/VD/\ L@OC#_TRW=?P^U_<%_P53_Y1@?M(?]D% M\8?^F6[K^'V@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH _K#_X-%O\ ME#-X=_['K7O_ $I%?IS7YC?\&BW_ "AF\._]CUKW_I2*_3F@ HHHH **** " MBBB@ JMK.CZ9XATB[T#6K-+FSOK:2WN[>0?++$ZE64^Q!(_&K-% 'Y!_M0?\ M$P_^"DUGX8U;]B/]D#]E[X,6OA+6M3N;?1OVB;[Q/-#JN@Z)Y?_ $F:O=*\+_:P_P"2V? __L>Y?_29 MJ]TH **** /"_P#@HM^QO/\ MR_LQ:C\%]$\>3>%_$%MJ=IK7A+Q#$I86.J6 MDGF0.ZCDH3E21RH;< 2H!^3/^"?7[?>K>$/CEXF_85_X*9^#K?PW\4=>^(R7 M>D>)H(?^*>\3:G!!8>5';S#Y8[G=!;3*G"EY57$;E8C]M?M0^)?VA?!?A[PU MXQ_9X^'4GB^?3?%L$GBOPO:ZA:6MQJ.C-;W$V2.:266^E"^6-BF%4D+-(/E!^XR&=*ME4\+C7'V#O)24DITI75WW:=D^6S4 MK>ZU*Y\_F,9PQD:U!/VFS5FXS6NG:ZN]>G70[[P!X_O?CE_P7D\=>%=UNKB\ [2-;M'"3_<7'7GP$_P""[7B?QUJT'EZ-\>O@]$^D7[#"S:SH[VT,UF#_ 'Q9(L_N MH;^Z<=7^TK^S9\3_ /^WWX"_P""B_P1\&S^*#8^$[GP7\2?"FGW$,5[VOG.DB51TVI:Z6;G[1 M)WTD]UN9RI5JN&G%W_C7E;?EYDUZ^[ROT%^ /[<_QHA_;JUS_@GM^UUX \.Z M=XJ_X19?$_@;Q5X.DN!IWB#3-YC=3#<%I()T99,C>RGRI.FU3)#_ ,%T/&?B M+P'_ ,$G_C+KGA>:6.YGT*TT^1HC@_9[O4;6TN!]##/(#[$UK>#/V>?%OQH_ MX*'0?MW^/? U[X7TGPA\.F\*^"-)U*2#>4/!VQ.,+(!7#3A@J.:8?,*<8J%'V,JT5)?%S>]RQ;NTTES* M-U&3MIHC>4J]3"5<-)OFGSJ#:>UM+NVG6U[-I7U.0_:@\':!IW_!O[XF\'Q6 MD4MCIGP1M%M$ &T?9[6W:)A]&C5A[BO:?V8?%?B#QU_P2H\">,O%=U)<:GJG MP$T^YO[F7.Z>5]&0M(<]V)W?C7@>H_!3]KSX[?\ !.?3?^":>O?"F_T;Q%-; MV/A?QC\2I+NUDT2+1[.>(2ZA;,)O.N9;BW@"I 8D99)F\SRU3"6^ M&_[,-W\*?A!\/-0UB/2_!QT/P]H&F7-K'*8TM3;PH'NIH8@ H)9Q4XVK1IX M*.&D;O2Q6'A.6(=51:BJ<8[/>[=K>7Z^IX;_P M0G_Y1-_!K_L"WO\ Z"%]\LTXMO,"[8F6,NLAW!&2M?_ ()"?"3XT?L]?L"> M _V?_CY\*+_PIXE\)6=S;7]O=:G87<4YDO;B97BDL[B8%=CIG=M.3C!P35GP MO^UC^UKXXTWQ!X+U;_@F]XPT#Q1!/<6NDS:MXGTBX\/7"9*Q7$UXMPLOE'AG M2.WED"G"JYSA8B7_ !E>(QE-0J0A6E+6I%1:$=%\BZU.1=@N;EY'GN)0I/R(TTLC*I)VJ0,G&:\#_P""-'P[U.YT3XV_ MM>:A"T5G\;OC5K6O^%588\W0X[B2*SG_ .VG[U@<89"C#(85FY8)X',W3DY4 MW.'LV]V^>7*WYNGSW^925?ZQA.96ERRYDMDN577ISR%%%% !1 M110 4444 %%%% !1110!F^,?^18O?^N!JYIW_(/@_P"N*_R%4_&/_(L7O_7 MUM>_]*17Z@ZQI\HBO- M)OXL^7=6\A!VN S*0P9)$=XY%>-W1NBTJWO[32[:UU74!=W4=NB7-TL(C$T@ M4!GV D+DY.W)QG%6**T=6I*FH-Z+;RN2H14G)+5A6%X!^&_A+X:V%U9>%[*4 M2ZC>F\U6_O+E[BZO[DHB&:>:0EY'V1QH,G"I&B*%1%4;M%2IS47%/1[C<4VF MS'\#_P#((E_Z_9O_ $*MBL?P/_R")?\ K]F_]"K8J1A1110!S'Q:^&5O\7_" M5-J%JRD/:^_]<#5S M3O\ D'P?]<5_D*I^,?\ D6+W_K@:N:=_R#X/^N*_R% $U%%% !1110 4444 M%%%% !1110 4444 %%%% !1110 5C^)?^0OH_P#U^G_T$UL5C^)?^0OH_P#U M^G_T$T ;%%%% !1110 4444 %%%% !1110!X+_P53_Y1@?M(?]D%\8?^F6[K M^'VO[H?V_OACXX^-O["'QL^#/PQT/^T_$OB[X1^)-%\/:;]IBA^UWUUI=Q!! M#YDK+''NDD1=SLJC.6( )K^5W_B%Q_X+K_\ 1C/_ )DWPQ_\LZ /@"BOO_\ MXA\N-(_MBSOMD$TX:)_-LYI8CN'. ^1W K[KH **** "BBB@ HHH MH **** "BBB@ HHKR_XK>%/VL]7\7/>?!_XK^%](T4P($LM6T)[B82 ?.Q<$ M<$]!0!S?[6'_ "6SX'_]CW+_ .DS5[I7R%\7?#'[46D_'+X/-\7?B?X:U>.3 MQH1IRZ5HC6YAD$)+E\D[@5R /6OJ7[%XW_Z#=E_X#'_&@#8HK'^Q>-_^@W9? M^ Q_QH^Q>-_^@W9?^ Q_QH V**Q_L7C?_H-V7_@,?\:/L7C?_H-V7_@,?\: M-BBL?[%XW_Z#=E_X#'_&C[%XW_Z#=E_X#'_&@#8HK'^Q>-_^@W9?^ Q_QH^Q M>-_^@W9?^ Q_QH / _\ R")?^OV;_P!"K8KE/"MKXIDTZ1K#5+:-/M,@*R0$ MG=NY-:?V+QO_ -!NR_\ 8_XT ;%%8_V+QO_ -!NR_\ 8_XT?8O&_\ T&[+ M_P !C_C0!L45C_8O&_\ T&[+_P !C_C1]B\;_P#0;LO_ &/^- &Q16/]B\; M_P#0;LO_ &/^-'V+QO_ -!NR_\ 8_XT ;%%8_V+QO_ -!NR_\ 8_XT?8O M&_\ T&[+_P !C_C0!L45C_8O&_\ T&[+_P !C_C1]B\;_P#0;LO_ &/^- & MQ16/]B\;_P#0;LO_ &/^-'V+QO_ -!NR_\ 8_XT ;%%8_V+QO_ -!NR_\ M 8_XT?8O&_\ T&[+_P !C_C0!L45C_8O&_\ T&[+_P !C_C1]B\;_P#0;LO_ M &/^- $WC'_ )%B]_ZX&KFG?\@^#_KBO\A7/^);3Q:F@W3WVK6KQ"(^8B6Y M!(]C5FRL_&ALXC%K-F%\I=H-L<@8^M &[16/]B\;_P#0;LO_ &/^-'V+QO_ M -!NR_\ 8_XT ;%%8_V+QO_ -!NR_\ 8_XT?8O&_\ T&[+_P !C_C0!L45 MC_8O&_\ T&[+_P !C_C1]B\;_P#0;LO_ &/^- &Q16/]B\;_P#0;LO_ &/ M^-'V+QO_ -!NR_\ 8_XT ;%%8_V+QO_ -!NR_\ 8_XT?8O&_\ T&[+_P ! MC_C0!L45C_8O&_\ T&[+_P !C_C1]B\;_P#0;LO_ &/^- &Q16/]B\;_P#0 M;LO_ &/^-'V+QO_ -!NR_\ 8_XT ;%%8_V+QO_ -!NR_\ 8_XT?8O&_\ MT&[+_P !C_C0!L5C^)?^0OH__7Z?_031]B\;_P#0;LO_ &/^-9FN6OBE=1T MU;K5+9W:Y(@98" K;>I]: .KHK'^Q>-_^@W9?^ Q_P :/L7C?_H-V7_@,?\ M&@#8HK'^Q>-_^@W9?^ Q_P :/L7C?_H-V7_@,?\ &@#8HK'^Q>-_^@W9?^ Q M_P :/L7C?_H-V7_@,?\ &@#8HK'^Q>-_^@W9?^ Q_P :/L7C?_H-V7_@,?\ M&@#8HK'^Q>-_^@W9?^ Q_P :/L7C?_H-V7_@,?\ &@#8HK'^Q>-_^@W9?^ Q M_P :/L7C?_H-V7_@,?\ &@#8HK'^Q>-_^@W9?^ Q_P :KW\_B32DCEU3Q9I= MLLTZ00M<1A \KL%1!D\LQ( Y).!32;=D!T%%8_V+QO_ -!NR_\ 8_XT?8O M&_\ T&[+_P !C_C2 V**Q_L7C?\ Z#=E_P" Q_QH^Q>-_P#H-V7_ (#'_&@ MLO\ D=[W_KRB_F:V*Y2UM?%)\4W4<>J6PN!;1F20P':5R< "M/[%XW_Z#=E_ MX#'_ !H V**Q_L7C?_H-V7_@,?\ &C[%XW_Z#=E_X#'_ !H V**Q_L7C?_H- MV7_@,?\ &C[%XW_Z#=E_X#'_ !H V**Q_L7C?_H-V7_@,?\ &C[%XW_Z#=E_ MX#'_ !H V**Q_L7C?_H-V7_@,?\ &C[%XW_Z#=E_X#'_ !H V**2,.(U$K M MM&X@<$TM !1110 4444 %%%% !1110 4444 >%_M8?\ );/@?_V/%_M8?\EL^!_\ V/Z4 %%%% !1110 4444 %%%% &/X'_Y!$O\ MU^S?^A5L5C^!_P#D$2_]?LW_ *%6Q0 4444 %%%% !1110 4444 %%%% !11 M10 4444 %%%% &;XQ_Y%B]_ZX&KFG?\ (/@_ZXK_ "%4_&/_ "+%[_UP-7-. M_P"0?!_UQ7^0H FHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "L? MQ+_R%]'_ .OT_P#H)K8K'\2_\A?1_P#K]/\ Z": -BBBB@ HHHH **** "BB MB@ HHHH **** "ORZ^(WQL\+?'G]OWXA_LR?M7>*]8M/$^B?&;PC;?"_P7<: MW=V%C/X;>>W,MU:10R(D]S(6:229MTJJRB,JL;A?U%KXN_X*;_LP_LQ_M\?" MCPWK$ZB'Q%IGQ5L/"^F^/-$3R-7T*==7^Q74<();"SAB ^[%$;>6? 5[F=#O956,1?"GQ_P#B[^UGXN_X(\_M:_LQ_'CQ M>/&/BCX)^*=/\-Q^/[:(JVO:8+^PG=I\$YN$MB_FG).'4.68,[_I]^R[+8S_ M +,_PZGTQD-L_@72&MS&/E*&RBVX]L8KJS7!5,LP$JU249U)U>5R6SC&G":> MRTGSINZN[:K(CB\2H1345"]GNFY2BU_V[RV5N_H?"'[8/_!-'3?V5_V3 M/%?QD@_X*)?M7ZWXDTK2%@T&UD^,LB1ZGK5S(EM90>6L((22[FA3:&R%;[Q/ M-?>_[/'PWUSX/_ ?P=\+?%/B_4/$&JZ!X;L[+5==U6^DN;C4;J.%5FN))927 M=GD#-DG^+'05XU^U5GXW?MH?!']EVWS+IWA^]NOB;XRC7^&'3<6^EQMGC#ZC MCW%I::OK-I:RW\_D6,5S<*C7$N"VR,,07; )P,G - M<>;9CCL7EV'IXB7-*3E/9:+X8K1+^64O22-\%AJ9 M\M_\%;9/'>D?L4_%[QQ\.OB[XG\'ZIX>\#RW]M>>%[V.VFF=""$:7RS*BD @ M^4\;88\],>M?LKZAXMU/]B+X<:IH]U#=Z[O5E*_\ :\E?["_]*9\=_M'?\$S_ ]^SG^S9XS_ &B?BG_P M4J_:HU34?#?AR\U?4&T[XLM8V]]>K&S+#!;I"PA668K&D09MN]5W'K7I7BC] MH'Q-_P $J?\ @EUX%O\ XN76M^/OB8^F:?HNFZ9K.KRW5[KWBF_W2FV:>5F< MQI*TW).1%#M7G:M=C^W?_P 7B^+OP5_8TMOWMMXK\:CQ7XRA'S*="T$QWACD M7^Y+J#:;%SP0SCUQXQ_P6P\#Z7XF^-_[(VM?$G1X;[X?VWQVMK'Q5#?0K):& M:Z\D6HN%8%3&3',IW?+AB#UKWL#B*F<3PF&S&7-&=B*<<#&M5PRLXJ,$]7K)J[=[[)Q?WGM_[('@3P'XAF3Q)\8OVDM& M^+7Q>LPE[XG%CXGCNK'P[]AIL4ABLHHF)C64QB>0KND2#L65B.V+W_ <%PW5Q^S3\)(-&W_VP_P"T;X770A%_K#>% M+P)L_P!K&[%987!TL=F.%YI\U/%1FG%I+D:ZU>>'PM M:T;2I.+O>_->SU;UNUH[W[]C[SHHHKX4^A"BBB@ HHHH **** "BBB@ HHHH M **** "BBB@#PO\ :P_Y+9\#_P#L>Y?_ $F:O=*\+_:P_P"2V? __L>Y?_29 MJ]TH **** "BBB@ HHHH **** ,?P/\ \@B7_K]F_P#0JV*Q_ __ "")?^OV M;_T*MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** ,WQC_R+%[_ M -<#5S3O^0?!_P!<5_D*I^,?^18O?^N!JYIW_(/@_P"N*_R% $U%%% !1110 M 4444 %%%% !1110 4444 %%%% !1110 5C^)?\ D+Z/_P!?I_\ 036Q6/XE M_P"0OH__ %^G_P!!- &Q1110 4444 %%%% !1110 4444 %%%% !7SQ\4/\ M@FW\&O&?B*]\6_#_ ,6^+/ ]]KGC>R\3>*$\.^*;]+35+R&=)9)OLWGB&"XD M"!?M$2JX(5CNV@5]#T5U87&XO!3W7KJMGKKKU,:U"CB(VJ13/-=)_ M9$_9\T#]G[7OV8M"^'\5MX0\3V5_;^(+0W,LT^HM>JRW5Q/1 MFD)P2W KF/V%]"\??!#X1Z3^R)\6XIYM7^'>F+I>@^(1 ?LWB+0[?;%9WD;# M(6983##/"QWI*A;!CDB=_<:*MX_$5*$Z55N2DU*[>O,KJ]_--I]].J1*PU.- M2,X*UE;3:W;_ "[?,Y/0_@MX"T#XR>(/CW9V$[^)O$FBV&DW][<7+.J65F]Q M)#!$IXB7?*?\%%?V&_ O[:?_""0ZIX*U2X\4>%M9DNO"GBR MTUN2SM_#!>6V:>\D$55A1H8@K[I8U#&.,R./I>BGA*L MG=[6Y;>EM+;6T>@5L+0KT72E%SFB=T..4+%3W%=1\(_A+X(^!OP^TSX M6_#>TO[;0]&M([72[34-;N]0:V@CC6..)9;N6638J(H"[L #BKEE_P CO>_] M>47\S6Q7/]9Q#P_L.=\E[\MWRW[VVOYFGLJ7M/: D^ M.,O[1+V$\GBA_"B>'8[J2Y8QPZ>+EKEHTC^ZK/*5+MU;RXP>$%3_ !@^#OPQ M^/WPXU3X1_&/P99Z_P"'-9@$6HZ7>J=D@#!E8,I#(ZLJLKH0R,H92" :Z6BA M8BNJD9J3YHVL[ZJVUGTMT'[.FXN-E9[^=][GG'P^_99^%OP_\86'Q#>XU_Q% MK^D:9)IVBZSXO\1W6J3Z;:R;?,C@,[L(V<(H>4#S90JB1W"@#SKXH?!RY_; M_:K^'WBO6])FC^'?P7UB?7K6:[B*+X@\3[##:F!6P3;V2-+*9_NR32QJA81R MU]&45TTLQQ-*JZO,W/E<4V]DTT[?)NW:[:ULUC/"TIP4+6C=-KO;57^:7K:V MP4445P'2%%%% !1110 4444 %%%% !1110 4444 %%%% 'A?[6'_ "6SX'_] MCW+_ .DS5[I7A?[6'_);/@?_ -CW+_Z3-7NE !1110 4444 %%%% !1110!C M^!_^01+_ -?LW_H5;%8_@?\ Y!$O_7[-_P"A5L4 %%%% !1110 4444 %%%% M !1110 4444 %%%% !1110!F^,?^18O?^N!JYIW_ "#X/^N*_P A5/QC_P B MQ>_]<#5S3O\ D'P?]<5_D* )J*** "BBB@ HHHH **** "BBB@ HHHH **** M "BBB@ K'\2_\A?1_P#K]/\ Z":V*Q_$O_(7T?\ Z_3_ .@F@#8HHHH **** M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#'LO\ D=[W_KRB_F:V*Q[+ M_D=[W_KRB_F:V* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ** M** "BBB@#PO]K#_DMGP/_P"Q[E_])FKW2O"_VL/^2V? _P#['N7_ -)FKW2@ M HHHH **** "BBB@ HHHH Q_ _\ R")?^OV;_P!"K8K'\#_\@B7_ *_9O_0J MV* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH S?&/\ R+%[_P!< M#5S3O^0?!_UQ7^0JGXQ_Y%B]_P"N!JYIW_(/@_ZXK_(4 34444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% !6/XE_Y"^C_]?I_]!-;%8_B7_D+Z/_U^ MG_T$T ;%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 8]E_R M.][_ ->47\S6Q6/9?\CO>_\ 7E%_,UL4 %%%% !1110 4444 %%%% !1110 M4444 %%%% !1110 4444 %%%% 'A?[6'_);/@?\ ]CW+_P"DS5[I7A?[6'_) M;/@?_P!CW+_Z3-7NE !1110 4444 %%%% !1110!C^!_^01+_P!?LW_H5;%8 M_@?_ )!$O_7[-_Z%6Q0 4444 %%%% !1110 4444 %%%% !1110 4444 %%% M% &;XQ_Y%B]_ZX&KFG?\@^#_ *XK_(53\8_\BQ>_]<#5S3O^0?!_UQ7^0H F MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "L?Q+_ ,A?1_\ K]/_ M *":V*Q_$O\ R%]'_P"OT_\ H)H V**** "BBB@ HHHH **** "BBB@ HHHH M **** "BBB@ HHHH Q[+_D=[W_KRB_F:V*Q[+_D=[W_KRB_F:V* "BBB@ HH MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#PO]K#_ )+9\#_^ MQ[E_])FKW2O"_P!K#_DMGP/_ .Q[E_\ 29J]TH **** "BBB@ HHHH **** M,?P/_P @B7_K]F_]"K8K'\#_ /((E_Z_9O\ T*MB@ HHHH **** "BBB@ HH MHH **** "BBB@ HHHH **** ,WQC_P BQ>_]<#5S3O\ D'P?]<5_D*I^,?\ MD6+W_K@:N:=_R#X/^N*_R% $U%%% !1110 4444 %%%% !1110 4444 %%%% M !1110 5C^)?^0OH_P#U^G_T$UL5C^)?^0OH_P#U^G_T$T ;%%%% !1110 4 M444 %%%% !1110 4444 %%%% !1110 4444 8]E_R.][_P!>47\S6Q6/9?\ M([WO_7E%_,UL4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444 M4 %%%>7_ !6_9*^&OQB\7/XT\4:_XHM[MX$A,>D^(YK:':@P#L0XSZGO0!S? M[6'_ "6SX'_]CW+_ .DS5[I7A#_\$\?@7)(LLWB/QK(R!A&TOBV=]A92I(W9 MP<'K3/\ AW5\#_\ H;O'?_A7ST >]45X+_P[J^!__0W>._\ PKYZ/^'=7P/_ M .AN\=_^%?/0![U17@O_ [J^!__ $-WCO\ \*^>C_AW5\#_ /H;O'?_ (5\ M] 'O5%>"_P##NKX'_P#0W>.__"OGH_X=U? __H;O'?\ X5\] 'O5%>"_\.ZO M@?\ ]#=X[_\ "OGH_P"'=7P/_P"AN\=_^%?/0![%X'_Y!$O_ %^S?^A5L5\9 M?LB?LC_AW5\#_ /H;O'?_ M (5\] 'O5%>"_P##NKX'_P#0W>.__"OGH_X=U? __H;O'?\ X5\] 'O5%>"_ M\.ZO@?\ ]#=X[_\ "OGH_P"'=7P/_P"AN\=_^%?/0![U17@O_#NKX'_]#=X[ M_P#"OGH_X=U? _\ Z&[QW_X5\] 'O5%>"_\ #NKX'_\ 0W>._P#PKYZ/^'=7 MP/\ ^AN\=_\ A7ST >]45X+_ ,.ZO@?_ -#=X[_\*^>C_AW5\#_^AN\=_P#A M7ST >]45X+_P[J^!_P#T-WCO_P *^>C_ (=U? __ *&[QW_X5\] 'O5%>"_\ M.ZO@?_T-WCO_ ,*^>C_AW5\#_P#H;O'?_A7ST >T>,?^18O?^N!JYIW_ "#X M/^N*_P A7R9^U)^Q+\*OAE^SYXK\>^&_%?C)K[2]*:>V6[\432Q%@RCYE/## MGI75>!O^"?WP8UOP3H^LWGBWQP)KO2K>:41^+9U7<\:L<#L,GI0!]'T5X+_P M[J^!_P#T-WCO_P *^>C_ (=U? __ *&[QW_X5\] 'O5%>"_\.ZO@?_T-WCO_ M ,*^>C_AW5\#_P#H;O'?_A7ST >]45X+_P .ZO@?_P!#=X[_ /"OGH_X=U? M_P#Z&[QW_P"%?/0![U17@O\ P[J^!_\ T-WCO_PKYZ/^'=7P/_Z&[QW_ .%? M/0![U17@O_#NKX'_ /0W>.__ KYZ/\ AW5\#_\ H;O'?_A7ST >]45X+_P[ MJ^!__0W>._\ PKYZ/^'=7P/_ .AN\=_^%?/0![U17@O_ [J^!__ $-WCO\ M\*^>C_AW5\#_ /H;O'?_ (5\] 'O5%>"_P##NKX'_P#0W>.__"OGH_X=U? _ M_H;O'?\ X5\] 'O58_B7_D+Z/_U^G_T$UX[_ ,.ZO@?_ -#=X[_\*^>O+/C[ M^QQ\,_ GQ-^%_AO1/%7B]K?Q+XJDLM1-SXFFD<1" N/+)^XV1U% 'V;17@O_ M [J^!__ $-WCO\ \*^>C_AW5\#_ /H;O'?_ (5\] 'O5%>"_P##NKX'_P#0 MW>.__"OGH_X=U? __H;O'?\ X5\] 'O5%>"_\.ZO@?\ ]#=X[_\ "OGH_P"' M=7P/_P"AN\=_^%?/0![U17@O_#NKX'_]#=X[_P#"OGH_X=U? _\ Z&[QW_X5 M\] 'O5%>"_\ #NKX'_\ 0W>._P#PKYZ/^'=7P/\ ^AN\=_\ A7ST >]45X+_ M ,.ZO@?_ -#=X[_\*^>C_AW5\#_^AN\=_P#A7ST >]45X+_P[J^!_P#T-WCO M_P *^>C_ (=U? __ *&[QW_X5\] 'O5%>"_\.ZO@?_T-WCO_ ,*^>C_AW5\# M_P#H;O'?_A7ST >]45X+_P .ZO@?_P!#=X[_ /"OGH_X=U? _P#Z&[QW_P"% M?/0![%9?\CO>_P#7E%_,UL5\9>$_V./AGJO[7/BWX477BKQ>-+TKPK87MJR> M)IA,9978-N?JR\<#M7J?_#NKX'_]#=X[_P#"OGH ]ZHKP7_AW5\#_P#H;O'? M_A7ST?\ #NKX'_\ 0W>._P#PKYZ />J*\%_X=U? _P#Z&[QW_P"%?/1_P[J^ M!_\ T-WCO_PKYZ />J*\%_X=U? __H;O'?\ X5\]'_#NKX'_ /0W>.__ KY MZ />J*\%_P"'=7P/_P"AN\=_^%?/1_P[J^!__0W>._\ PKYZ />J*KZ1IEOH MNDVNCVCR-%:6Z0QM,Y9RJJ%!8GJ<#D]ZL4 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% 'GW[-?P9U/X&> KWPAJNM07\EUXAOM16 M:WC9559Y2X3![@'!KT&BB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M**** .._:"^&=]\9?@OXB^%^F:G%97&MZ+['6H+6/P=XA?4;F&:-BUPIB*;% M(Z')SS7H-% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% ' MGWASX,ZGHG[27B3XXRZU ]IKGAZSTZ*Q6-A)$T+$ER>A!S7H-%% !1110 44 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111 M0!ROQJ\#>,?B7\-]0\!^!_B7?>#[O53'!/XCTF)&O;.U,B_:/LI<%8KAHMZ1 MRE6\IG$FUB@4_GMH/[$/Q*_8@_X+&_!/3/V(_CG\3M9\#^,_#'B.]_: \(>- MO'E]KUC9V4$*+8:D[7DDCQ7%Q>2F.,EMSM;2;/W:W K],Z_+;_@I)^P=I7[+ M/_!0C]F[_@H+^Q9XI\4Z-\2_'GQ\T3P5\1=&E\57M_#XKT"[2:6]:6.ZED;; M;VMK*Y5<1H@,FT/$C4 >@_MP?M>_%_\ :%_X*E> /^"-?[.7Q)U7P387'A67 MQE\M>*/V$_&_C7X:_%W0=)EO/!7BC3/'6J7?V^_A0R16NIP7EQ-%J4$SJ$D% MRDAP^X'-W&JY)P/TY^,OQ:\#? 7X2^)?C;\3-:BT[P]X3T*ZU;6;V M9PJQ6UO$TKG)[X4@#N2!WH ^+OV"?VU/BM_P6S_X)=^&?B'\-?'=Q\+_ !1K M.OOX9^+FN>%)0E]H1M4\R\;2FE#B*:YC:U$;MN:V2^+@N\*EO"_C5^R?\4?^ M"0W_ 4#_9E\<_L:?M/?%7Q'X3^-'Q4B\$?$WX:?$'QIX%?5/@OP;:?%+XSQ?\%(/VG8?^$6 MT'P5H%[:?"3P_P")A]D?P_I]R%%[KE^LN/(O;N-(XUB;#VUJ CA9I[B- #Q[ MXG?&35_VVO\ @M1=?\$X]1\0:E:_"WX.?"=/%WQ T;2M3FLSXEUZ]F@2RL[M MX'1WLX;:<7'D[@DDI'F*ZJH%_P#8=^/WBOX+?\%5?C=_P2C\1>)]1UCPMI'A M#3?B'\(I-9U"6[N]*TJX,-O?Z6T\S-)+!%=RJUNK,6CC=H\E40+Q'[//@W4O M@O\ \'/'[0,WBR%X(?C-\!M!\1>$[B7B.Z33/L.F7,*-T:17BWE!R%(8C!S2 M? /P5JOQ-_X.@?CI\:]#MWDT/X:_L\:)X1UF\091=5U">UU"&'=TW"WBD8J. M1\N<9&0#]):*** "BBB@ HHHH **** "BBB@ KS#]J']G*__ &HO#%E\,-6^ M+_BCPKX3FFDD\4V_@K59-,U+6$"@16GVZ%A-;6Y)9I1"4DDVQIYBQF1)/3ZJ MZYH]GXAT>ZT+49+E8+R!H9FL[V6WE"L,'9+$RR1M@\,K!AU!% 'Y]_\ !+O] MG7XU_LF?\%(_V@?V?OAM\8/&OBW]G/1O#^C3Z+#XX\13:L^@^*+A1-/IMI'/V?/V:[VWT M'6M%\)ZW<:5=^.?$\DL\H:] M16GFF2-&D9GS]I4-L.U,#_@AMX9U+]C_ /X*L_MO?L3_ !93[!KOBCQS#\1/ M OVCY3K>@W5U>L;B(\!Q&+FU1]N<2-(O!0X /2/^"IGP>\7_ /!+_P#9PO\ M_@HG_P $[M?UO0=1^&=W:7WCCX:WWB:^O?#WC'0VGC@N89K2YED2WN(UD\U+ MN )*%20$OE0/L#X3_%'PU^W7^R#X7^,_PD\?Z_X7TGXD>$;/5M-U;0WMEU&P MBN85=H@T\,L:2IN:-CL)5E.T@@&O O\ @X6^)V@?#G_@D/\ -1WW&J>-- M&A\*>%M(M4+W.J:IJ$\=O#;P1KEI9,,\FQ03MB$?\&TGQ M%^)7Q6_X),^$O'7Q=^(FM>*_$-[XN\3?VCK_ (AU*6[O+MEUBZ4-)+*S,QP! MU/ X'%8/[ 4_A;_@KWJ_[1OQJ_:/UKQ%=V?ACXXZU\._ 'AS2O%=]IT/A?2M M-M[81W=NEK-'Y>H3R3R3R71W2*1&B,J1A:G_ .#6O_E#IX+_ .QP\4?^GJ[K M1^,/[&/@O_@F%XQ^-G_!1+X0_MO:U\(OAYXQ,GB;XJ^!G\+V.K6UWJWS9N=+ M:Z.;6\N))-BQE)EDEF5=A C1 #=_X(8_M;_%[X]_"#XJ_LZ_M#>-IO%'C?\ M9W^,VM_#K4?%MV0;G7K.RF*6M[<$8W3,JR1LV,OY(=B6=C7W#7P3_P &\G[( M'QG_ &;/V-O$/QC_ &FM.OK/XE?'GXAZE\0_%6GZLH6\L!>E3!!<*J(%F**9 MG78I1[ED*J4VC[VH **** "BBB@ HHHH ^(+/\ :5U[6?#/Q!_9\BN=&_:#L_&GB&\O]2M;ZSB*/J$D MES+),1)+_1$N[O39[N%2%F:*>QLI!NR"UK&2/O;@#Z4_9A_8%^ M*^K?LQ?%3XB>)/BY\4/#'Q&^-^F:]-X5TOQ!\3]8NU^&5EJ,$T6G6EO%)<21 MQ75M%+'-)(JEEN-R(P2./'S;_P %J?V;='_8M\"?LS6?P ^._P <--N/&'[3 M'ACPEXMU&\_:"\674^KZ57>.(E:.YGD4-@MY &9(PWZV4 ?G7_P %9O\ @G0OB;]FOXI_MB>(OVQ? MC#IGQ9\-Z-?ZQ\.+_P (>.K[3;#2[R(,=,T>QTRWD\MS-(+>V+;7N;B:8LK! MG2->V_:K_P""A7QF_P""97_!%O1OVM?VKM"M-5^,5AX T2QU#1I=J17OBRZ@ MBC9)1$0NU)3+-*(RH*PR",C*UZE_P4E_X)J?LU_\%*_@?>?##]H>XUNS%G;2 M3Z!KFE^);NU71+Q58QWP@25;>9XR<_OD;*Y&1P1^6W[7GP=_;%_;G_X-'_ ? MB[XCS:IXJ\=^"[B/Q3=3LTDUYK6AV%]?VD-V2WS3?\2R6*Z+MDR1Q^8+=6U#QEJ5E;:18?L@?M8_%_P#9 _X*W>(O^",_[07Q M.UKQQX9\1>#5\:? +QAXKO6NM:BL<2FXT>\N7R]Z(S;WABN)2TNRU(=WWJ$^ MTOV0_CKX(_:<_9;^'W[0/PYU2&\T;Q=X1L-2LY() P3S(5+Q-CH\;[HW4\JZ M,IY!K\\O%O@;4_VLO^#KWPE\4?AE&UUX>_9D^![67C[5XQN@@U;4H=6C@T_> M,CSC#JB2[."!!+G[N" =Q^UU_P $=_B)\=OA'XN_:=^(_P"WW\9/#GQRBTJ\ MUS0=4\+?$&XL?#WA.XC1YH=-M+*$(GV.(*D3RD^=-M:9G#/M'G_C+_@K=^U9 M\._^#<3X9_MCZ\8D^.?Q2M+#PEX7U.ZLD59-5N[R>VAU1HL;-[6=N]XJ[?+, MA4;=AVU]F_M0W&I_ME7NM_L+_"K6[BUT"YC^P_&WQGI\A7^RM-EC#2:):RC@ MZE>0N$;!S:6TS3-MDDM5E^2O^#CWX=^#6_X)H^#->^"EA8OX9_9N^.OA+5_$ M&B^'@KIH^G64+V9MO+3/E^3%J%LQ7&43!( !H V?^"C-N_\ P1A^#7PG_;9^ M#OQ \6:A'X:^(.CZ#\<'\1^*+W4!XUT._#0W=[>+<2NOV])Q%/#.H4QEGC'[ MIS'7Z4@@C(-?FU_P= :-??&S_@F[X7_9R^';QW^O_&'XR^%O#?A.&V/F?:9Y MIGG5UVGE D)8MT"\D@'O!/@:#Q/1R"XB>&=7::X#YCMX);C)C7)L> M O\ @E3K/A;]D;P/^S)X@_:X^+>K:G%K>FZA\5/B!)\5];36-?%O'++-;VMQ M]H,EG!+<&*,QPM$1;[OG,@W-\F_\$G?V>/A;\)O^"_W[7_PA\#:+-:>$OAQ+ MIWB#P)X7%VYT_0M3UZPM7U*ZMK?/EQ2N@\A74 I 6B4A&(/Z[4 ?DO\ M"? M#0O W_!>K]GO]CGPM\7_ (S6OPV\9?"C7]5\2^&O^&@/%TBWUY;1WAAE,SZH M9U*F).%D4';R#DY^F_BY^PK8?L\?L^_M%ZUX3^./Q1NO#6L?#E]6\+6&L_%W M7KZ^\-:Q96&IB:6SO)[IKF*)Q):.$\YAYD3D@ (!X[^UB0/^#H7]E0$CGX(> M*<>_[J_K[@_;=_Y,O^+W_9+]?_\ 3=/0!\&?\$-_V2_"O[87_!)7X6_M _'/ MX[?'6_\ 'GBNSU:35/%MG^T1XNMKD21:M>VT3QQQZD($VQ0QKM\O:VTEE;-_"LGB?X"?$KQ!!$NLO; M1I.\NF:C)$BI*/@7*-6\'?LJ_#VZA^(_BBQ_>6D.M727Z1Z:LP^1I0US#N0$ ML##M_#_P 8:5XLOAY0^%?".OW] MJMQ#X:J8FRLCQ?:H0B,-N69R&\O8WH[_\$F?V:;KX?_V!J7C;XIW' MBYK8;OBLWQ7UE?$PO=O%ZMTMR%1PWS"%4%N/N>3Y?R5\/_\ !;SP]\4?AE\? M/V _^"FWQJT1[;1/AMXUT^P^,]S#&?(\/RZ@^GLURX'$<2R1W:EC@;A$FX+BWNK=+NVG22*1 \)_C1^P7 M^UWKUOK/Q;_9R\9OH6I^++>T6V'BO26EF2SU-HE^5)F$)\P* ,/$V 78#G#J M?Q=\&_\ !R]H'PMU/]H;QMXA\):O^RUJ'B&#PKK6J)_9^G7K:W]G9H+:WCBB M7]U!$H=D:7@[I&SQP7_!#SP-JGQK_P""HG[:_P#P4?\ #43M\//%WCF/PGX& MU@#,.NG3W:.[NX&_Y:0 Q0;9%)5C*PZHP'H?CO\ Y6D_ W_9F%]_ZD=VV@>(=)BBN(]1L1.[M;+.EQ#!+#&5B8DRE=ZYKWK_@H M9_P35\'?MW:C\//BCHWQ8UOX;]W= M6THC3?$Q7.P#=M9U?XX^%/P;^,G[!/V0=!U"RUK MQHHHH **** " MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH \S_:V_9&^"'[;GP9NO M@-^T#H>H7WA^ZOK>]4:5KEUIUS!MV'C#2;CQ;XI\1:5ILFGZ5XE^(OCG4O$5_86TFWS(K:34)Y1:B0(@D\D(9 MB[RVU<>OT4 >)0\8N((I+.=U7< MKJDH*!@K ;E!'BO@+_@W3_X(X_#3Q[H7Q,\(_LAS1ZQX;UFUU;1YKWXC^([R M*&[MY5FAD:"XU%XI0KHIV2(R-C#*02*^VJ* /.?CU^RM\'OVC+_P[XD\>:;J M%IXB\'WDUSX1\6^'=7GT[5=&DFC\J<07-NRN(Y8_DDA;=%( N]&VKB]\!/V< MOA#^S1X6O?"GPC\,O9KJVK3:KKVI7U_->W^L:C-CS;R\NKAWFN9VVJ"\C,0J MJBX554=Q10 4444 %%%% !1110 4444 %%%% !7B?[7G[ /[/W[;&K>#?%'Q M>E\6Z?KOP^OKF[\'^(O!7C;4-#OM-DN!$)]LMG-'N#B&+[P)&WY2-S9]LHH MX'X)?LS_ B_9_DU/4O .D:C/K&N"$:]XG\2:]=ZOJ^IB$,(DGO;V66>2./> M_EQ;_+C\Q]BKN.PD2(IS\T+[X90-LD;KQ7K5% 'Y>_LR?LD?MM?L@_MPW?CW_@I'9> M(OVI/!UH1+\'OC39QSZG?^ YSE)(Y_#T;-Y,DR8!OK*":13& [A)"(OTEU33 M?#GQ9\#-937>L0Z=JL /FZ?J%[I%XJYSQ)"T-Q W'."C=0>XK=HH \D_8_\ MV&OV9_V"_AT_PC_96\%:IX;\,M=27$>B77C'5=4MX)9'+R-$M_=3^268EFV; M=Q))R35GQ)^Q]\&?B#\4-.^+?Q;M=4\9ZEH6J'4?#%CXHU62XTS1+G)V36U@ M"MJ)X\D1W#QO/&,[9!DY]2HH **** "BBB@ HHHH **** "O _B)_P $R/V- M_BM^U'HG[:7CKP/XGNOB=X:@D@\.^*8/BAXAMGTR&02B2&"&"_2&*)A/,K1J M@1ED92"#BO?** $CC6*-8E+$*H +,2?Q)Y/U->&_M<_\$WOV0/VZ]0T#4OVI M/ .N>(V\*ZHFI^'8;;X@ZYID&GWJ !+J.&QO88UF4#B3;N&3@\G/N=% &3#X M*T>#P@/!"7FK&R$!A\Y]?O&O-N]?.7PO_P""-_[!OP1O MO$6I?!GPY\3?"<_BW59=3\3R>&_VA/&MC_:M](27NI_)UA?-F8DYD;+<]:^H MZ* /+/V;_P!B;]E?]D>75[_]GWX,:9H.I^(9O.\1>('DFO=6U=\Y#7=_=/)= M7.#DCS9&P22.2:]3HHH ^6_ G_!'K]C/X=:KXD_X1O\ X6,OAWQ;JMQJ.O\ M@&;XMZZ_AV\GG=GG\W3_ +7Y,LULK6W6"UL[:%4BAB50JQJB@!5"@ *!@ 8JQ10!^??[>?_!(?X]Q?#+6M5_X M(X?M3ZU^SYXDO[F>]U7P)I&JS6_A?79I#ND>.! PTBY8@?O[145SPZ9/FKZ] M_P $U(/"/PZ^!5A\"-=_8X\0_!/QK<&:?QMH3V=Y>VVHZLZ$W6H)X@1YTU%I MBK.L\MTUWM"B0*P%?4U% 'PQK'_!MI_P1G\0ZU>^)-?_ &4M8OM1U.\EN]1O M[OXO^+))KJXD8O)-([:H6=V8EF8DDDDDYKZ3^ _[$G[*_P"S1^S2/V//@W\& M].T[X:FVOK>?PK?3SZC#=17DDDETD[WDDLEP)#+(&\UV^4A>% ]4HH \0^$ M/_!//]F;X,>,/#GC?0-'\0ZO=^"+"6Q^'T/BWQ?J&KP>$[62,1/%IT5W-(ML M3$!%Y@!E$0$0<1_)7M]%% !1110 4RX@2ZMY+:5G"R(58QR,C $8X92"I]P0 M1VI]% '@GPC_ ."9G[''P+_:0\2?M<_##P-XEL/B)XPV#Q5XBN/B;XANSJRH M5*+<0W%_)#*J;%"*R$(HVJ O%>]T44 > ^/O^"8O[&GQ._:ET7]M7QIX'\3W M7Q/\.6LEMH'BN'XH^(K>33K=Q,'@@BAOUABB87$P:-4"$2L""#BO4?C3\$?A M[^T%\+]4^#7Q1MM5N?#VM6,EGJMII?B6_P!,ENK>2-HI(GGLIXIBC([*R[\- MGG/%=;10!\P_#O\ X(]?L+_"3X7P_!#X8Z'\3M!\&6Z2);^$M*_:%\:PZ9&D MCM))&MLNKB(([L[,FW:Q=B0=QS[1\ /V;?@'^RK\.X/A/^SC\(= \%^';>5I M5TKP_IR6\/?$^D^%KV*[\*Z!X_^)>KZYIFC31-NADM[&[N'ME>)@&B"/BCX-U/X=?$GPCINOZ!K5F]IJ^BZQ9)-X>N?^"=?QX\6>)_@OIEU GC']D_Q!\1[S M3[75-*4A9K#2]6,RSVT#QY46OU"HH \P_92\5?"BZ^%.C^ ? MA-\$M<^&^FZ!I<-O;^!]9\$SZ,-'C Q]GC4QBWE"G(+V\DL9.2'8')P=1_X) MW_LI:K^U9;?MNWWA/Q,_Q0M-(;2;7Q./B5KZ^5IYE:8V0MA?"W%MYCL_D^7Y M>XYVU[;10!Q_Q?\ @UI/QJT>/PUXD\;>*M,TME=+^R\+^(IM*:^1L J]S:E+ ME!@$?NI8S\QR35WX3_"+X7_ CX?Z;\*?@UX"TKPSX GRAPHIC 18 ivc-20200930_g8.jpg begin 644 ivc-20200930_g8.jpg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end GRAPHIC 19 ivc-20200930_g9.jpg begin 644 ivc-20200930_g9.jpg M_]C_X 02D9)1@ ! @$ 8 !@ #_[@ .061O8F4 90 !_]L 0P " 0$! M 0$" 0$! @(" @($ P(" @(%! 0#! 8%!@8&!08&!@<)" 8'"0<&!@@+" D* M"@H*"@8("PP+"@P)"@H*_]L 0P$" @(" @(% P,%"@<&!PH*"@H*"@H*"@H* M"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*_\ $0@" MF@2P P$B (1 0,1 ?_$ !\ $% 0$! 0$! ! @,$!08'" D* M"__$ +40 (! P,"! ,%!00$ !?0$" P $$042(3%!!A-180'EZ@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>H MJ:JRL[2UMK>XN;K"P\3%QL?(R;GZ.GJ\?+S]/7V M]_CY^O_$ !\! ,! 0$! 0$! 0$ ! @,$!08'" D*"__$ +41 (! M @0$ P0'!00$ $"=P ! @,1! 4A,08205$'87$3(C*!"!1"D:&QP0DC,U+P M%6)RT0H6)#3A)?$7&!D:)BH*#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6V MM[BYNL+#Q,7&Q\C)RM+3U-76U]C9VN+CY.7FY^CIZO+S]/7V]_CY^O_: P# M 0 "$0,1 #\ _?RBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *** M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *** M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *** M* "BBB@ HHHH **** "BBB@ HHHH **_ K_@IE_P7\_;#_;C_;KT_P#X)5?\ M$=NM 'Z"45^3_[1'[/_P#P4<_8J_X* ?LQ>"O#_P"W'\0/B-^S M1XM^,-K:WNB^.)K>]UC1=32VN)H+6YU/R1=7MI($D:/S9#M:$*^YMCM^L% ! M1110 445^8?_ =F6=EJO@SQSJ. ME"2VN7=)HIHK6=(Y@<*074LI0;2 6! /T\HK\Q_^#3/XU?&3X]?\$M]0\)O&FM)\5=6M4UCQ9KUQJ-TL"6MB5B$MP[N$!9B%S@%C@(-(AU_P :>(KB33_A]X0>X,?]HWBJ&DFE(^9; M:!65I&')+QQ@AI%( /KZBOPE_P""3'[*'[=/_!?71K_]OO\ X*>_MD_$2U^% MESK4]IX)^%O@'7YM#T[53 Y2:4I;,!':QN&@4C-Q*\"\85 MDW;@'P48 ^Y:*^(O^#?[QA^TSXW_ &#-0UG]LG6[^_\ BA%\6O%EIXVEU%46 M2/4(-4EBEB"1A8T1&0JJ1@(JJ H Q7V[0 4444 %%%% !1110 4444 %%%% M!1110 45^.'_ <$_P#!,_\ X+2_MB_MS_#3XJ_L"_$G4(? ^CZ%:VT T_X@ M)HJ^%M52ZE>;4)8FF1YMZ- 1)"LLN(2FP!5W?L%X;L]8T_P[86'B'55O]0@L MHH[Z^6$1BXF5 'D"CA=S G Z9Q0!=HHHH **** "BBB@ HHHH **** "BBB@ M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** " MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ** M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "OGS_ (*Q?%GQ=\#/ M^"9OQX^+'@"[EMM;T;X5ZU+I-Y 2'M;AK21$G4CH8V82 ^J5]!URGQW^#OA# M]H?X(^,/@'\0(7DT+QMX8O\ 0M86(@/]FN[=X)"I/1@LA(/8@&@#^7#_ (-" M/#&@:_\ \%CM)U768D:YT3X>:[>Z277)6X:.*V)7T/DW$P^A-?U=5_(K^QC' M\3_^#>S_ (+H>%;#]KW1[G3-(\.:["_$-EJVD:K:1W6F:IIMTD]O=P2*&2 M6.1"5=&4@A@2"#D4 +KGACPUXG6T3Q+X>L=1%A?17MB+ZT2;[/\'9 M(IY5QAAV(K\<_P#@X'_:N_X*.Z-_P4<^"'[(_P (_@S\2-4^!^M3:5=^*+#X M>2W]A-XWEEOGCN].DU.QQ);QQP*@,2NG^N,DFY3'M_3_ ,5_MJ?!'P[^U?X5 M_8LTG5I]>^(/B.VNK_4M&T&+[2?#6F0VLLW]H:FR\6<,DJPV\6\AI9;F,*I M9E_(O_@Y+_X+D?M"?!#]KC2?^"9?[.7Q-N?A9H\MOIDGQ-^)]A&?[3@AOBK% M+1Q\UO'%;NLK2QXE9CM5HPC>8 ?,W_!PMJ6F?\$=?^"E_P /?&?_ 3!^*^L M?#_57\'Q:GXFT#2/&5U>VZWJ7LM2U[1'=+C0[+4;.2ZFD@E'S0LQC M2W$F0R_:,J5?:1^,O_!R?X;_ ."?WP_^,?PC^&7_ 3U\=>%/%'A_1/A[*/$ MWB/PSKT6KRZGJLMX\LES?W\3/]JO9$9'=F=U.8-DPM3YFZ-H?- M28,-@R ?F7^Q9X,_8J_X*<_\$Q;OX9?\$[?C9XX^&'[87A[P&#XJ\.S_ !0U M*WG^(=U#&'O([A);H07]G>.KD$;3:O*@D"1 B3[8_P"#N\[O^"-6M-M(SX_T M'@]1^^>OR%_X+;_\$0OBI_P0[^)'A;]L']EGXW:E22/:)@8X)62= N?*9713M,GZ;?\'&OCOXB_%#_@V[\$_$SXPZ M5]@\7>(X_ ^I^*;'R?+^SZE<6R2W,>SC;ME=QM[8Q0!\:?\ !(#_ ()\>.?V MRO\ @@E\7O&OBW]K;Q]X9\,^#=3\3ZEX*\!^!-133[2YUBUTNWN6N]50N>2!?'/\ ,?G0!_1_7\MO M_!Y/\6/%WC+_ (*FZ-\,=4NI1H_@WX8Z6VTU)I M)[74=BC+1QO-/',W)56A8_(CLH!^EW_!#KPMX?\ !_\ P2$_9UTGPU&BVTWP MJTJ^D$:X'VBYA%S.?J9I9"3W.37U57Y9_P#!J!_P4%^&O[2W_!.'0/V5K_Q= M:I\0_@^L^FZCH2SO8D)R\2I*MNQ&=KP?-M\Q-WZ6?%3XK_#/X M'?#[5?BO\8O'FE>&?#6AVC7.K:YK=ZEO;6L2]6=W( ] .I) )(% 'DG[?W[ M4/P[_P"":G[#WQ1_:\A\$Z:J>&M/FU5=,M;=;=-5UBZF2"W$QC )::ZFA5Y. M6PQ/)%?DQ_P;V?!)/^"W7A_XZ?MB_P#!3KQ=XF^)&M3>(X?#_AF&?Q/?65GX M=1K8SSG3X+:6..V;]] $VCY/*R.7_ MWB2&;7M'C\1^$](UC2I;6^U.QTS5TN5E6V8"3%U:6K3P(P#LL\.5#'%?,/\ MP9(>(-*N?V)_C#X5ANE-]9?%.&[N( PRD4VFVZ1L1UP6@E'_ $^AH XK_@V MH_X*R_M&V7[%]*U_1M M$U@Z%;_$35ET]+^YED60B$7!$<3M&K-&@"C%U7.62"0X(5JH_P#! MUK<6\?\ P71T&62=%6+P=X8\UBP 3_29CSZ<<_2@#TC_ (.>OV1/C1^P5/\ M!O\ :\L_V\OBYXL^)OB[5M0@\4:[J/B,VEM;7EO';S1R:3;6JQC3(%:24+ K M,%7R_F+!F?\ 5WX*^&OB!_P5]_X(:> =7\9_%;7/#GQ%\8_#&&[L/''A;7[G M3+BU\0PPR0)>LUF\99&F0M+#]PAW4*"%*_#?_!\$RCX!_ )"PR?%^M$#/./L MMM7Z ?\ !O%_RA<_9_\ ^Q/E_P#2ZYH _'G_ (-A/VQ/B]HO_!6S5_V7OV[? MC+\0M9\27&BZKH_A?3_&/CS4;J'3/$%G)FXMW@EN#"TC017:!F#$/&%7E\U^ ML-E^SAH_[2/_ 6Q\4_$[1?'_C>U\$_!CP3I4'BC0-.\>:I!I6K^-;YY+R(2 M6L=P(6%KIQMI)(PH5VO8-RL$(/Y#_P#!SY^R[\0O^"=?_!6SP3_P48_9RM9- M.3X@:G:^)=*N+6$E+;Q3ITL/VF,JO43#[-.03^\:><8P#7[\?\$Z/@;XV^"/ M[,6G77QAMT7XB^.]3N_&GQ-=.VO:G)]IN+/!7B2XM/B0MCXC;2%\4W=A837MW;W MMTCHXMS/"+)80X!.YS\S)Y>3\5OVU?#?_!(/_@X*\ ?!O]D'XK17W[/?QFTO M01XO\!Z=XG.IZ-I-W?7MQISW5H#+(+26*2"*Y94(+*[IC:R ?$W[4DWA'_@G M!_P<[>*OB5^V!\-K/7? US\:-0\1ZU8Z]HJ7]K=:#KIGD-RL$J,MP(([UF"@ M'$ML5&&7C^@S5$_X(U>$=,\%>,_A_P# SX%^)=0\;:W8VOP\LO O@_0[S4-9 MN9I%*2VBQH"4A7=/)-N"PQ0O([*%H _+#_@\6^(GQ>_9C_:$^$/C?]GKX\_$ M+P9=^-_#VJGQ+;^&_'NI6EK=O:26B02"WCG$4;A)F4E%7< N"M%AT#X7ZUJ^HV<,-A%9Q1)KUSJ$'FM M>:C=,ANFWP@I'.J+*Q0A^3_X/BG0_%;]G= PW#P]XC)&>0#/8?X'\J_:W_@F M''!#_P $U?V>8;:-%C7X&^$A&L8 4*-&M< =L4 ?C)_P<=_MP_&#]E[]LS] MFK]C+]HKQ/XQ\2_!?POX&T'7?BI8Z!K$VFW/Q"E%W-;7K32Q2(9!LL]RQ,ZX M>9R67(-;^ D=KKNG^/_A3-X\OK MG3_"^HW&F2&"\73[V=GLYVD5898^)NE_#6'QM\+_ !Q83(+^*.>]N[2[B@1@!/'$UI;O-;L2)$G# M+Y;0^:OXY?\ !-C]FW]N'_@BW_P<4> _V)X/%@U5/%NHPVNN#09G-AXE\-7$ M4[_;)(3RC0+%+-AN8I+=P&9"6< VO^#K3XP?'C]DS_@J#:^%/VZ=XC:W4L+6'5H++R;E\=(Q+8I%N/&^XC'\5 &-\-/V O#7B?_@V^ MU+_@HYK?Q&\?2_M&2^"-3^(B?%\>/=4.L0SVUU--'$DGVCB(VD(C9<')=I.& MP5^E_P#@VC_X*D^/_P#@JY^QEXS^#'[5FK/K7CGX=2V^EZ]KD4K6T^MZ3?13 M"VN)&A*%;@&"XB>2/:3Y<;D[W)KE?A=\0O#]G_P9TW7B.UUF(6Y_9RUC26F5 ME(^T/)^&OAG\;/VI_$&E3VN@>*M0TG0/# M&M&/Q)\:Z'976I^+[W6!I^E6MIJH<1PWLLD3W*VL+B"657$<_E2E6* M8-K_ (*'3?&7_@B'_P %X- M?V;/VH?B9KEC)-H.MWTGC;Q9)J%UJUO=R!+R MSO7^1;J.0QR_>4$!U(.Y ]-_X(^,J?\ !V@A9@!_PN#XEC)/?^S=>J]_P=9W M%N/^"Z>@L9TQ%X/\+^:=P^3_ $F8\^G!!^AH _J0HHHH **** "BBB@ HHHH M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *** M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH \G_ &M_V%OV M1?V[_ B?#C]K?X!Z!XWTR LUB=4MV6ZL68 ,UM&Y9FDD\'^%OCEJUCIC;B2RF.)PY!SR= M^3ZU]\44 >6_LK?L4_LN?L3>$+OP7^S'\'=-\+VVIW/VG6;V)Y;F_P!5GY_? M7=Y<.]Q=R5_MO_\ !%O_ ()N_P#!17XEZ3\8?VLOV>(]?\2Z M39I91ZM8Z[?:=+=6JL66"^'R3)X0MO"]U<:2]@DVTS)YEI)&THD9%=_-+EG M!%=7\=VGQ$\;^'O 5VEUX$ M^'GQ ^*.K:WX=T"5 AM[&[G=2JJ H20NFT ;<<5Z]^VI_P3N_9'_P""AWA/ M3O 7[7_P\U7Q7H.EW?VJTT.'QQK&F69G (6:2"PNX(YY%#,%>0,R!F"D;CGV MRB@#Y<^$G_!&;_@G=\!OV?O&/[*_P=^$7B7P]\/O'Y)\6^%].^+/B9+>^W(( MY.?[1+Q>;&JQ2^6R>=&HCDWH M5?V1?^")/_ 30_8-^*@^-/[(_P"U7P5XC M-HUI<7FG_$KQ%+%=V[$,89[>?4'AN(]RJP25&4,JL "H(^K:* "FS0PW,+V] MQ$LD&/@KJOPS\8?:6 MG_X2#X2^*+K0)%D.1$QR M=]TL@C0.[;%QZM^R5^QQ^SY^PW\*(/@;^S)X6U70?"5I,\EAH=_XOU35H;(N MS.RV_P#:%S.;="[,Y2,JA9F;&237I]% 'EO[4?[&O[/O[9%CX,T[]H#P2FM0 M^ O'>G^+_#BL^WR=2LRQB+\?/$0[*\9^5P<'H*]2HHH ^;O^"@7_ 27_80_ MX*;Z9IL'[6_P8CU?5-$B:+1?$VF7TMCJ=E$S%C$L\+ R19+'RI Z!F+!0QS6 M!_P3Y_X(F_\ !.W_ ()F:[=^./V8O@Q)'XJOK4VMQXP\1ZG+J&HBW.-T43R' M9;JV/F\I$+X 8L /K"B@#Y:_;$_X(M_\$W?V_OB9'\7_P!K_P" ^J>-=>M[ M-;2RFO?B/XAMX+. ?\LX+:VOXX+=2?F81QKN8EFRQ)KVC]FO]F;X0?LC_"?3 MO@?\"-+UC3_"VCQ+#I&EZOXMU+6/L,*(J)!#)J-Q/)%"BJH6%&$:@?*HR:[V MB@#YW_:K_P""67[&?[9WQ>TSX_?'7P-K-QXV\/Z)#IGA;Q5H/B[4-)OM"2*> M:X6:TFLIHFBF\R9B7R69-OR@2.V !@ 5WE% 'PN?^#=[_ ()T)X(N/@E:CXHV_P *KO61JMU\ M'(/BWJZ^&);H.)-YM?/WXWJK8\S&Y0>H!'UYX1^!WPJ^'?PI_%#Q-O? 1 M$1-15(8T4!4BC5410%55 K[(HH R? O@O1OAUX0T_P/X=N=4FL=+ME@M9=: MUR[U.[9!T\VZO)99YV_VY'9CZUK444 %%%% !1110 4444 %%%% !1110 44 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 % M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 % M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M!1110 4444 %%%% !1110 4444 %%%>2_L:_M7:/^V)\+M0^)VB>#KG1(K#Q M->Z,UI=72S,[6Y7,@90 P<<=O4T >M4444 %%%% !1110 4444 %%%% !15 M2'58YM8FT<1,&AB60OG@@]JMT %%%% !1110 4444 %%%% !1152'58YM8FT M<1,&AB60OG@@]J +=%%% !1110 4444 %%%% !1110 454U#58]/NK6U>)F- MU+Y:D'[IQG)JW0 4444 %%%% !1110 4444 %%%5]5U!-*TZ;49(RZPIN*J> M30!8HID$HG@2<# = P![9%/H **** "BBB@ HHHH **** "BBJFCZK'K%JUU M%$R!96CPQ[J<9H MT444 %%%% !1110 4444 %%%% !1531]5CUBU:ZBB9 L MK1X8]U.,U;H **** "BBB@ HHHH **** "BBJD.JQS:Q-HXB8-#$LA?/!![4 M 6Z*** "BBB@ HHHH **** "BBB@ HJIJ&JQZ?=6MJ\3,;J7RU(/W3C.35N@ M HHHH **** "BBB@ HHHH ***KZKJ":5ITVHR1EUA3<54\F@"Q13()1/ DX& M Z!@#VR*?0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4 M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11 M10 4444 %%%% !7Y,?\ !/3_ (+%?L'_ +$WPI\3_ _]H3XDZII?B*+XAZI> MO:VGAJ[ND$,OE%#YD4;+D[3QG(K]9Z_D"_:S_P"3D/&/_8:D_D*^Z\/N&\OX MISFIA,8Y*,:;DN5I.ZE!=4]+29\]Q)FN)RC QK4$FW)+772S?1KL?T(?\1(? M_!)[_HM>N_\ A$:C_P#&J/\ B)#_ ."3W_1:]=_\(C4?_C5?S645^P?\0>X5 M_GJ_^!1_^0/B?]=\W_EA]S_^2/Z4_P#B)#_X)/?]%KUW_P (C4?_ (U1_P 1 M(?\ P2>_Z+7KO_A$:C_\:K^:RBC_ (@]PK_/5_\ H__ " ?Z[YO_+#[G_\ M)']*?_$2'_P2>_Z+7KO_ (1&H_\ QJC_ (B0_P#@D]_T6O7?_"(U'_XU7\UE M%'_$'N%?YZO_ (%'_P"0#_7?-_Y8?<__ )(_I3_XB0_^"3W_ $6O7?\ PB-1 M_P#C5'_$2'_P2>_Z+7KO_A$:C_\ &J_FLHH_X@]PK_/5_P# H_\ R ?Z[YO_ M "P^Y_\ R1_2G_Q$A_\ !)[_ *+7KO\ X1&H_P#QJC_B)#_X)/?]%KUW_P ( MC4?_ (U7\UE%'_$'N%?YZO\ X%'_ .0#_7?-_P"6'W/_ .2/Z0;;_@XR_P"" M5$7B>ZU-_C1KGDRVR(C?\(5J')!YX\JM+_B)#_X)/?\ 1:]=_P#"(U'_ .-5 M_-911_Q![A7^>K_X%'_Y /\ 7?-_Y8?<_P#Y(_I3_P"(D/\ X)/?]%KUW_PB M-1_^-4?\1(?_ 2>_P"BUZ[_ .$1J/\ \:K^:RBC_B#W"O\ /5_\"C_\@'^N M^;_RP^Y__)']*?\ Q$A_\$GO^BUZ[_X1&H__ !JC_B)#_P""3W_1:]=_\(C4 M?_C5?S644?\ $'N%?YZO_@4?_D _UWS?^6'W/_Y(_I3_ .(D/_@D]_T6O7?_ M B-1_\ C5'_ !$A_P#!)[_HM>N_^$1J/_QJOYK**/\ B#W"O\]7_P "C_\ M(!_KOF_\L/N?_P D?TI_\1(?_!)[_HM>N_\ A$:C_P#&J/\ B)#_ ."3W_1: M]=_\(C4?_C5?S644?\0>X5_GJ_\ @4?_ ) /]=\W_EA]S_\ DC^E/_B)#_X) M/?\ 1:]=_P#"(U'_ .-5FVW_ <9?\$J(O$]UJ;_ !HUSR9;9$1O^$*U#D@\ M\>57\WU%'_$'N%?YZO\ X%'_ .0#_7?-_P"6'W/_ .2/Z4_^(D/_ ()/?]%K MUW_PB-1_^-4?\1(?_!)[_HM>N_\ A$:C_P#&J_FLHH_X@]PK_/5_\"C_ /(! M_KOF_P#+#[G_ /)']*?_ !$A_P#!)[_HM>N_^$1J/_QJC_B)#_X)/?\ 1:]= M_P#"(U'_ .-5_-911_Q![A7^>K_X%'_Y /\ 7?-_Y8?<_P#Y(_I3_P"(D/\ MX)/?]%KUW_PB-1_^-4?\1(?_ 2>_P"BUZ[_ .$1J/\ \:K^:RBC_B#W"O\ M/5_\"C_\@'^N^;_RP^Y__)']*?\ Q$A_\$GO^BUZ[_X1&H__ !JC_B)#_P"" M3W_1:]=_\(C4?_C5?S644?\ $'N%?YZO_@4?_D _UWS?^6'W/_Y(_I3_ .(D M/_@D]_T6O7?_ B-1_\ C5'_ !$A_P#!)[_HM>N_^$1J/_QJOYK**/\ B#W" MO\]7_P "C_\ (!_KOF_\L/N?_P D?T@ZW_P<9?\ !*B]U#3KBW^-&N%;>Y+R MD^"M0&!C'_/+FM+_ (B0_P#@D]_T6O7?_"(U'_XU7\UE%'_$'N%?YZO_ (%' M_P"0#_7?-_Y8?<__ )(_I3_XB0_^"3W_ $6O7?\ PB-1_P#C5'_$2'_P2>_Z M+7KO_A$:C_\ &J_FLHH_X@]PK_/5_P# H_\ R ?Z[YO_ "P^Y_\ R1_2G_Q$ MA_\ !)[_ *+7KO\ X1&H_P#QJC_B)#_X)/?]%KUW_P (C4?_ (U7\UE%'_$' MN%?YZO\ X%'_ .0#_7?-_P"6'W/_ .2/Z4_^(D/_ ()/?]%KUW_PB-1_^-4? M\1(?_!)[_HM>N_\ A$:C_P#&J_FLHH_X@]PK_/5_\"C_ /(!_KOF_P#+#[G_ M /)']*?_ !$A_P#!)[_HM>N_^$1J/_QJC_B)#_X)/?\ 1:]=_P#"(U'_ .-5 M_-911_Q![A7^>K_X%'_Y /\ 7?-_Y8?<_P#Y(_I3_P"(D/\ X)/?]%KUW_PB M-1_^-52\1_\ !QM_P2FU'0[FQM?C1KC22Q%4!\%:@,G_ +]5_-S11_Q![A7^ M>K_X%'_Y /\ 7?-_Y8?<_P#Y(_I/L_\ @X__ ."4,-I%#)\:M=#+&H8?\(3J M/4#_ *Y5)_Q$A_\ !)[_ *+7KO\ X1&H_P#QJOYK**/^(/<*_P ]7_P*/_R M?Z[YO_+#[G_\D?TI_P#$2'_P2>_Z+7KO_A$:C_\ &J/^(D/_ ()/?]%KUW_P MB-1_^-5_-911_P 0>X5_GJ_^!1_^0#_7?-_Y8?<__DC^E/\ XB0_^"3W_1:] M=_\ "(U'_P"-4?\ $2'_ ,$GO^BUZ[_X1&H__&J_FLHH_P"(/<*_SU?_ */ M_P @'^N^;_RP^Y__ "1_2G_Q$A_\$GO^BUZ[_P"$1J/_ ,:K[MK^+^O[0*_, MO$;@[*N$_JOU*4W[3GOS-/X>2UK17\SN?5\+YYC,Y]M[=)&OCY\&?&/Q?\ $OP! M\*_$G2M0\9^#K*SN_%/ARTN0]SI4-VK-;-.H^YYBH64'DK@XP02 =?1110 4 M444 %%%% !1110!C^!_^01+_ -?LW_H5;%8_@?\ Y!$O_7[-_P"A5L4 %%%% M !1110 4444 %%%% !6/9?\ ([WO_7E%_,UL5CV7_([WO_7E%_,T ;%%%% ! M1110 4444 %%%% !1110!C^)?^0OH_\ U^G_ -!-;%8_B7_D+Z/_ -?I_P#0 M36Q0 4444 %%%% !1110 4444 %9OC'_ )%B]_ZX&M*LWQC_ ,BQ>_\ 7 T M7-._Y!\'_7%?Y"IJAT[_ )!\'_7%?Y"IJ "BBB@ HHHH **** "BBB@ HHHH M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ MHHHH **** "BBB@ HHHH **** "BBB@ HHHH *_D"_:S_P"3D/&/_8:D_D*_ MK]K^0+]K/_DY#QC_ -AJ3^0K]:\&O^2GK?\ 7F7_ *73/C..?^13#_&O_29' MGE%%%?TL?E04444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4 M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11 M10 4444 %%%% !1110 5_:!7\7]?V@5^#^-O_,!_W%_]QGZ)P#_S$_\ ;G_M MQX]^UO\ &WQKX(TW1?@E\!_LTWQ2^(DTUCX/6ZA\V#2((PIO=;ND[VUG&ZN5 M) FGDMK<,K7"L/BC_@A+\(O#OP'_ &^_V[OA+X6U#4;VTT;XB^%XVU+6+QKB M\OYWTRXDGN[B5N9)YIGDED;C+R,0 .*]\_:3_P"":G[0'Q@_:HUK]J3X+?\ M!2GQ_P#"N[UKPY8:))HV@^%=)OX;>UM3(X2*2]AD>-7EFDE=5P&9@3G:N/D# M_@BG^S1^T'X3_P""MW[6VJ^)OVY/%_B&V\"^/M'M_&6GWWA_38D\=2W&C72P M3WACB#6[6[,KH(-@8H P()K\'/T0I?LV_M[:+^V+^UA\7_\ @IO\:_@+\5/B M5\./@EXJN_#/P*\+^"?!DFHV&@V]I'F^\2LLKQPW%_.&4*8FDN+>+>NP*4<_ MIG^Q;^TU\$_VPOV>M'_:'_9Y\;P>(/"GB*2:73[^*-HV!60J\4D;@-%(C JR M, 01]#7P[_P0SUWX=?\ !-'X)_%S_@GS^UAX\T;P/XD^%7Q*UC68+GQ3JD5G M%KWAB\*2V>MVTDS*)X&"R1N5+&)X]DFUB%JM_P $DO%/P^_X)%?\$CO'O[4W M[6RZIX,\ ZW\8-8\6Z-I4FAW#WFD:/J5Y:V6FP-:(IDC:39%)Y9 *"X&_:0V M #[L_:P^/>O?!GP;IWAKX7:);:U\1_&^H_V+\._#]TS"*>^9&=[NYV_,EE:Q M*]S<..?+B*)F22)&^#?^"2/P5M/V??\ @MY^VE\,8_%>H^(+RW\)?#^[UOQ% MJ\FZZU?4KG3I+F\O) .$,MQ++((TPD88(@5$51]$?M'_ +!WQ3_:\^.GA[]M M']G/_@HQXY^%JW/PZM](TFU\/>%=-O8GL9IS>O.G]H0N\#3[K;S H4N+2 /G MRU"_&G_!-_\ 95_:3\*_\%_/VE]*\2?\% O&GB"Y\$:/X&N_&&H7OAO2XW\< M03Z66AM;L1P@6Z0*0BM!L9@,L2: /V)HHHH **** "BBB@ HHHH Q_ __((E M_P"OV;_T*MBL?P/_ ,@B7_K]F_\ 0JV* "BBB@ HHHH **** "BBB@ K'LO^ M1WO?^O*+^9K8K'LO^1WO?^O*+^9H V**** "BBB@ HHHH **** "BBB@#'\2 M_P#(7T?_ *_3_P"@FMBL?Q+_ ,A?1_\ K]/_ *":V* "BBB@ HHHH **** " MBBB@ K-\8_\ (L7O_7 UI5F^,?\ D6+W_K@: +FG?\@^#_KBO\A4U0Z=_P @ M^#_KBO\ (5-0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M 45\@?'/_@K=:_!']N+PY_P3Y3]BKXI>*/B#XPT";7/"\?A[4/#RV=_I\+7 MDF\^\U2 1%1;2L4DVM@# )8"K'Q _P""P7P@_9Q\<^'_ 5^W-^SW\3_ ($V MWBC4%L-$\8>.]/TR[\/3W3 E('U+2+Z]AMG(!.+@Q8"LQ.U2U 'UO138)X+J M!+FVF22.1 T*?B#\._AC= M^-=?T3P_=WVB^$+"]CMI]:NHH6>*S260%8VE90@8@XW9P>A .GHKD_@-X\\< M?%'X*^%?B/\ $SX47O@3Q#KF@6M]K7@S4;Y+F?1;F2)7DM'EC 61HV)7< N< M/M/ MT/Q%%I&MP61\.Z9/O\[5Y#*I\V.':N8QMW;^70#)]4H **** "BOFOXU_P#! M0^?X,?\ !17X*_L :E^SSKDJ_&>+7I=*\?W&LVD=A$NE:5)?SK%!&TD\K@B& M)A*MN!YN]3(%P?I0D@$@$\=!WH **^:?V*_^"BS[_P!,^9_^(<_]B?\ Z*G\4_\ P=:; M_P#*^C_B'/\ V)_^BI_%/_P=:;_\KZ^^Z*]W_7SC#_H,G^'^1Y_^KN2?\^(_ MB? G_$.?^Q/_ -%3^*?_ (.M-_\ E?1_Q#G_ +$__14_BG_X.M-_^5]??=%' M^OG&'_09/\/\@_U=R3_GQ'\3X$_XAS_V)_\ HJ?Q3_\ !UIO_P KZ/\ B'/_ M &)_^BI_%/\ \'6F_P#ROK[[HH_U\XP_Z#)_A_D'^KN2?\^(_B? G_$.?^Q/ M_P!%3^*?_@ZTW_Y7T?\ $.?^Q/\ ]%3^*?\ X.M-_P#E?7WW11_KYQA_T&3_ M _R#_5W)/\ GQ'\3X$_XAS_ -B?_HJ?Q3_\'6F__*^C_B'/_8G_ .BI_%/_ M ,'6F_\ ROK[[HH_U\XP_P"@R?X?Y!_J[DG_ #XC^)\!_P#$.?\ L4Y_Y*I\ M4L?]AG3?_D"E_P"(<_\ 8G_Z*G\4_P#P=:;_ /*^OONBC_7SC#_H,G^'^0?Z MNY)_SXC^)\"?\0Y_[$__ $5/XI_^#K3?_E?1_P 0Y_[$_P#T5/XI_P#@ZTW_ M .5]??=%'^OG&'_09/\ #_(/]7)+;PXGQA^*5L;G?B]UY&:Y_G&>*'U^LZG)?EO;2]K_?9 M?<=N#R[ Y?S?5X*/-:]NMKV_-A17C_[;_P"U2O[)7P,OO'/A_P *-XF\8:CY MECX"\'Q2['UK5/(DF6-F_P"6<$444MQ/+_RR@@E?DJ%/!_\ !(#]K+XF?MD_ M\$S/AA^UG\?]1TQ?$?BC1KV\UZYL;86MJGE7]U"&5,D(HCB7.3V))KR#M/HW M5_"GA?7[VSU+7O#=A>W&GR^;87%W9I(]L_\ >C9@2AX'(P>*S?#^C:1X@\+7 M6C:_I5M?6=Q=RK/:7D"RQ2#?G#*P((R!U':OF;]FW]L3XY?\%)M>U?XA_LGW M^G>"_@/H^KW&E:3\2=3TC[=J_CFYMY#%<3Z5!(X@M+!)%9%NITN&F96 ACVE MJ^G?AU!+:^'!:SWLMR\=Q(KW,X4/*0<%V"*J@GJ=H R> !Q0!N@ # %%?'_[ M4NK?\%?OC5X^\1:1^P#KOPI^'7A7PG+]CL]<^)NCWE_>^+=16-7F\F.+"6=C M&[FW\UEDEDEAE95$81GL_P#!';_@H3\4OV_O@)XLD_:*^%5IX,^*GPJ^(>H^ M!OB5HFER,UE_:EF(R\UMN9RL;>9MV%W(:-L,RE20#ZWHHHH **** "BBB@ H MHHH Q_ __((E_P"OV;_T*MBL?P/_ ,@B7_K]F_\ 0JV* "BBB@ HHHH **** M "BBB@ K'LO^1WO?^O*+^9K8K'LO^1WO?^O*+^9H V**** "BBB@ HHHH ** M** "BBB@#'\2_P#(7T?_ *_3_P"@FMBL?Q+_ ,A?1_\ K]/_ *":V* "BBB@ M HHHH **** "BBB@ K-\8_\ (L7O_7 UI5F^,?\ D6+W_K@: +FG?\@^#_KB MO\A4U0Z=_P @^#_KBO\ (5-0 4444 %%%% !1110 4444 %%%% !1110 444 M4 %%%% !1110!^8/[5'_ "M7?LP_]F_^(/\ T'5Z^K?^"P?P>^'OQR_X)=?' MKP-\3=.MI].B^%FM:I#+KWVD^*_"T%W=W=T=0"R6]O>:Q S M1*+F(DR&-L;L*2 #W'[?W@/_ (*/?\%,/A/??L7_ M^ -U\!/ 'C%5L_B3\ M1OB+XDTB]U9M)+ SV6FZ?HUY>([S+\C23SQ+Y9D7;E@P /$?^"5O[0__ 4" M^(__ 1-_9-NO@ZD$,>I^(;OP_\ $[XG:G$_!^F7VH6XOH8[YA%)*(+ M2&!7D29$VDF)]PV^O?L.?MR?%CXU_P#!0[XZ?L%6?[5"?$?P=H7P\TSQ+\// MBK:Z-IB:C:-='R9HO,M+:.POTCE8/%*MOMPA5C)R1A_M^_L,_''X%_#3]DWX M4_L2?LZWWQ0^"OP3\5K_ ,+'^#UMKMG;W'B*TC@1;*\F^V/%#>-!<":Y:)V" MR3R1N5 4O'9_9X^#G[?.C_\ !;WQA^U_XZ_8XAT+P)\2/@UI&C#4_P#A.[&= M?#QM;H.T%TL67ENRB']W;K) K.H%PR@R4 =)_P $J?VO_P!I+Q1\1?VD/V:/ M^"AOQTMKOXD?!+Q?MD:WT"RTK3V\*S6HGL-:B5(]Q,RK,\F]W2-1", DEN,^ M*W_!07]I3]E?_@F_\.?VO?V@OB_K,>E?%?XN:?;ZMXR/@FS:Y^'W@?49+N6R MOWM8+;8]V;2*Q25IHI$2XO2!"VQ8G/\ @K#^PCXC^,/_ 43^!'C[X&>.UT# M4/BWIFK?#;XY:7;H1)KW@-(#J%X[%<;-@C-IYIRPDU"U X7!^L_VV-=^,O@K MP5X(L/@U^R\?BKX8O/&::9\4? ]D--#MX6DTK4%EDBBU"6*"7R[H6!\@-ND3 M=&!AB0 97[$GBWXF?$+Q=XK^(.E_M?:7\:O@UK'A[0Y_AGXLM8](-S%?^9J0 MU6WGETN*&*;:HTUE)BCV[V0J61V;6_X*3?%+XX? G]A'XK_'K]GGQ/H.E>)_ M ?@#5_$EK-XBT&348)4L;&:Z:$1I<0[)'\H!9&+JIY,;CBOFS_@FC_P3P3]E MO_@H3\6/V@OV;/@]K_PC^!/C/P+I]JOPUURX2)+_ ,4+=/)/J5K9)-)]BMH[ M<+"JOL)DFFV((@E?2?\ P4N\#_$_XK?\$_/C/\&O@Q\-;_Q9XI\;_##7O#>A M:/I]_96K/=7^G3VL;O+>SP1)&KRJ6)?=M!PK'B@#XJ_;-_X**_M[_";_ ((6 M_ W]O7X2_%/PU!XT\5:!X,E\:W6J^$(YIM0GU2.V$LEL0ZVUH?,D)(:VE7:W MRA-HSW7Q_P#VD/\ @HK^QA_P4"_9UL/B_P#M!^$_&'P]^/?C.[\*:W\.M(\# M1V,?ABY-N)+::SU!I&N;O:Q"R/-M5PC%8H_,58O+?VMOV,/V[OBG_P $"?@Q M^PSX&_8Y\0W?Q,\*VW@ZQ\0Z#)XL\.Q)9C1OLYGF^T/J8AD20PD1A'9SGYU2 MO9O^"G_P5_:O_:'_ &E/V1OBE\&OV2O%.LZ5\+OBRGBGQRS>(O#]M)IUF8EB M,86;4T\Z89+%8MRX4X.I1ZC+IUQ%I%U#!=M"XM9[FW,L<$;GX*_M+7GA>/4I M?A@L\&MZ9:-$DMDL+3.]G'L#3%VDN)I'G$:RP+%O?]0Y[NXBTU[Z/3)Y95@, MBV2-'YKL%SY8)8)N)XY8+GOCFOAC_@CG\!?VI_@!\8_VI=0_:$_9DU[P9I?Q M3_:!UGQUX-U74/$&B7D=QI]V56.*1+"_GDBG C#%2NS#8#D@B@#&G_;=^-G[ M9.E?%[Q/^SQ\??B!\.4\#^-=:\)_#JW\&_ RY\2VFM7FF'R9;O4[F32[I'BF MNED5(+62W>.%59Y&>3;'!X%_X*@?MD>*OV<_V;?A1\6/@&WPM_:-^/GC"^\- M7^G>*-"GCMM"MM,BDN-2UN*TE97FS:I$\,#.%$MRH9W2)@_G7PD\(?\ !5K_ M ()"?M._%GX7_ ;]A>;]H?X%_%/XB:AXT\#7>@>-[+2;_P +W^H.'N;&Y%V2 M!"'"@,0$POF[RSR1KVG_ 4C_8E_X*._&_X2_!#]M;X0_P#".ZA^T=\#O']U MXOMO $6IJNEW-A>A$N?#]O=2",2%+>&WA,\AC$Y%PX\HR(B@'O?P[T[_ (*, M?!3]N*X\)^/O'R_$O]G/4?AZ^I3^/O%BZ-8:UX:U^*9@UGY6FV]JMS;20A9 MYMR4)(,HV8D^:-6_;U_;0_:L_8BU']N']C[XH?$'1O%E_!>ZO\,/A+IG[/UY MJVA:QI\%Q(MM97U^^FO)-=7440+3VUY;PPO.$VMY9D;Z0_94^,_[>7[9&LV^ ML?M(?L777P!\$:9I]RFIZ'KGC&UU75?$]Y-"T A5;9 MK91"260NY$LLJP;5 M1%??\E?L'VO_ 6;_P""3WA^X_X)OZ3_ ,$_HOCM\/\ 0=9O!\'OBM8_$6RT M>WM]+N+F29(M4$RR2((VD=FVIO49CC691&U 'I'[;_\ P4&_;Q^&'P)_8\^. M>@:-I_PQG^,GQL\%^#?BG\/O$/A%IM7TZ747EDO(8KB>79%%MM98@&M_-VR* MXD0C;73?M^_M+?M9_L@_\%&/V=O[2_:!FL?V>OC#XQD\*>)K4>&=.:XT77FM MG;3;=+N2 L+>[F"JV_=(@CG(D7*;,C_@K+^S#^V[\<_A-^RYX0\ ?"'4?BGX MG^''[1/A7XA_$C7-$U71]+M!!IXNS>1VT>H7L#\O<@01@-B- 'DW#+>[_P#! M53]C6;_@H1_P3W\=? "PL)=.\4WVC)JW@B6:=$GTS7[0BYLCYL;,L9\Y!$[H MQ 223!(.2 ;-OXM^,OCG]OK5O!_@CXL7L7@#P%X(M9_%WAY=*L6BO==OGD-I M:)=% M\*?'*P\5PW_B']EH6.B:AIEOX?FUIK*& RVT.M7:!?+MO$EY:JL<;*NY62SCCM M+-<;@8[)>N6?Q8?78=2\;> M.=8^(.E3R^/[U->BO&O;>1)I);NY:)5W&[:!5BB"QO(0D( /J#_@K9%\6KC_ M (+(_P#!/ZU^!=WH-MXKGB^+46CWOB>*:6QM'?PY:*]Q+%"5><1QEY!"'C\U MD6,R1!S(MGX+_M5?\%%OV,_^"K'@K_@GM^WO\;?#WQA\'_'+P]JNH?"_XB:5 MX*@\/W>G:AIT#7%S83VUNS1F,1+PQ9V)EA._ET&W^VK\+?VS?&W[5_[&_P#P M47TC]DF_U5?@W<>-3\1_AIX<\5:?\OIH+>65+:UBMHECC1W$SRDN4140N >/_\ !/+QWX<^%O\ P5+_ M ."EWQ.\8W30:1X)?#GP'M/V?[V^\,ZCI5S)')'ISZDVF"XDN1:2!G MO(;U('D1O+C1&4CL_P!D#]CW]HB__;>_;CU?]H?]FGQ)X5^'?[2":1:>&?$, MWB#0[@O:6^DW>GW7F16E_--"[>>K1YC((/S;",5YS^P'XJ_X+C_\$_\ X;:= M_P $U_%'_!//2_BG9>#7;2/AO\<8/B):Z;HAT?>PMY=0A99+@+ AQY:*)F1% MC"$@2N >F_M"?\%3&\(?M,?!3X'_ +2GQ7UW]E[PW\4?@Q%XKC\1ZGI-@)E\ M32S1(_AVYNM4M+BULS:Q,[R%XE+N\0\V,827ZY_9$M_C]:_!>*#]I+XA:9XM M\0C7M5-GXGTBRM[>#5-)-_.=-N!%;DQHSV1MBP!/S%N:\%_:5\"^.?&OBJV_ M9;_;&_8NU#]H+X)WWPKTA-0\8VFDZ9/-;^*XIKZ.\F>S:>.ZC,\'V619K4'[ M.XPI'F%DG_X(E_L;?%;]AK]DWQ!\&_B&VL6.A77Q2UW5_ACX1\0:LE[?^%?" MT\D8L-,N)8GDC,P$T M >QT444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M%%%% !1110 4444 ='\)DOI/B!IZ:;.D-_^@W9 M?^ Q_P :\<^"W_)3-,_[;?\ HF2O>Z /R*\3_P#!6W]G3Q+XY^*OQF^/<'Q( MMO$]OH>N>#_AUX?_ .%+:]/;^'](!>.6X\]+4P_:=0EBCGED5BJ016L6T+-Y?1L$BOW@^(7A3_A// .N>!_M_V3^V='N;'[5Y7F>3YT31 M[]N1NQNSC(SC&17@'[)'_!-+X=?L_?\ !,C1O^"8OQ<\21?$7PQ:^%-1T#7= M1ETDZ<-4MKR>XE/-*\1_!SX:Z'KUOH%UJ<3^'M7T]8H'NK2?34B6W93'++()-OG.XR M\C,Q\M8K@QYSSM,F M/PKPVR_X)E?'GQ!^QS8_\$V_BU^U!INN?!RPMK;1I]5@\-2P>*-5\,V\B-#H M\]P+DV\;^5'';27D<6Z2%6VQ12/YJ^E^*/V?/VCM:^+/P=\2?L\?M+P_#[X< M> -3U%/'?P\MO"\%S'XHLVBCCM+9)6(-JL.QP-O:3<.444 =K^T-\:M:_9\^ M'C^+[XC6]6O;E=/\*>%-+M@;[Q!JDBL8+&W!.-[[69G;"11I)-(5CB=UX#_@ MGC^QEX\_8^^"FJZ?XM\4:1?>//B'XTU3QU\4-4L;9O(NO$&IR^=-_^@W9?^ Q_P :/L7C?_H-V7_@,?\ &MBB@#'^Q>-_^@W9?^ Q_P : M/L7C?_H-V7_@,?\ &MBB@#'^Q>-_^@W9?^ Q_P :/L7C?_H-V7_@,?\ &MBB M@#'^Q>-_^@W9?^ Q_P :/L7C?_H-V7_@,?\ &MBB@#E/"MKXIDTZ1K#5+:-/ MM,@*R0$G=NY-:?V+QO\ ]!NR_P# 8_XT>!_^01+_ -?LW_H5;% &/]B\;_\ M0;LO_ 8_XT?8O&__ $&[+_P&/^-;%% &/]B\;_\ 0;LO_ 8_XT?8O&__ $&[ M+_P&/^-;%% &/]B\;_\ 0;LO_ 8_XT?8O&__ $&[+_P&/^-;%% &/]B\;_\ M0;LO_ 8_XT?8O&__ $&[+_P&/^-;%% &/]B\;_\ 0;LO_ 8_XUF6MKXI/BFZ MCCU2V%P+:,R2& [2N3@ 5U=8]E_R.][_ ->47\S0 ?8O&_\ T&[+_P !C_C1 M]B\;_P#0;LO_ &/^-;%% &/]B\;_P#0;LO_ &/^-'V+QO_ -!NR_\ 8_X MUL44 8_V+QO_ -!NR_\ 8_XT?8O&_\ T&[+_P !C_C6Q10!C_8O&_\ T&[+ M_P !C_C1]B\;_P#0;LO_ &/^-;%% &/]B\;_P#0;LO_ &/^-'V+QO_ -!N MR_\ 8_XUL44 -_\ H-V7_@,?\:TM._Y!\'_7 M%?Y"IJ ,?[%XW_Z#=E_X#'_&C[%XW_Z#=E_X#'_&MBB@#'^Q>-_^@W9?^ Q_ MQJUI4&OPR.=8OX)E*_((HMI!J]10 4444 %%%% !1110 4444 %%%% !1110 M 4444 %%%% !5+Q+H\WB'PYJ&@6^M7FFR7UE+;QZCI[JMQ:LZ%1+$6# .N=R MD@C(&0>E7:* /F3]@S_@G#>_L?ZI<_$'XP?M;_$?XY^.Y-+DTC3O&'Q+U3SY M=)TIYUGDL[6,$^6)98X7FD9G>0V\()"Q(H^FZ** "BBB@ HHHH **** "BBB M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *_BT_;R_:M_:C^&/[8/C[ MP5\-?VD_'_A[1K36\VNDZ'XQOK2VA+PQNY2**5471\5?_ M X>I?\ Q^O*J* /5?\ ANS]M[_H\CXJ_P#AP]2_^/T?\-V?MO?]'D?%7_PX M>I?_ !^O*J* /5?^&[/VWO\ H\CXJ_\ AP]2_P#C]'_#=G[;W_1Y'Q5_\.'J M7_Q^O*J* /5?^&[/VWO^CR/BK_X1\5?_ X>I?\ Q^O* MJ* /5/\ ANK]MW.[_AL?XJY]?^%A:E_\?I?^&[/VWO\ H\CXJ_\ AP]2_P#C M]>544 >J_P##=G[;W_1Y'Q5_\.'J7_Q^C_ANS]M[_H\CXJ_^'#U+_P"/UY51 M0!ZK_P -V?MO?]'D?%7_ ,.'J7_Q^C_ANS]M[_H\CXJ_^'#U+_X_7E5% 'JO M_#=G[;W_ $>1\5?_ X>I?\ Q^C_ (;L_;>_Z/(^*O\ X544 >J_ M\-V?MO?]'D?%7_PX>I?_ !^C_ANS]M[_ */(^*O_ (1\5?_#AZE_\?I/^&ZOVW<[O^&Q_BKGU_P"%A:E_\?KRNB@#U7_A MNS]M[_H\CXJ_^'#U+_X_1_PW9^V]_P!'D?%7_P .'J7_ ,?KRJB@#U7_ (;L M_;>_Z/(^*O\ X1\5?_#AZE_\?KRJB@#U7_ANS]M[_H\C MXJ_^'#U+_P"/T?\ #=G[;W_1Y'Q5_P##AZE_\?KRJB@#U7_ANS]M[_H\CXJ_ M^'#U+_X_1_PW9^V]_P!'D?%7_P .'J7_ ,?KRJB@#U0_MU?MND@G]L?XJ\=/ M^+A:E_\ 'Z7_ (;L_;>_Z/(^*O\ X544 >J_\-V?MO?]'D?%7_PX M>I?_ !^C_ANS]M[_ */(^*O_ (1\5?_#A MZE_\?H_X;L_;>_Z/(^*O_AP]2_\ C]>544 >J_\ #=G[;W_1Y'Q5_P##AZE_ M\?H_X;L_;>_Z/(^*O_AP]2_^/UY510!ZK_PW9^V]_P!'D?%7_P .'J7_ ,?H M_P"&[/VWO^CR/BK_ .'#U+_X_7E5% 'JO_#=G[;W_1Y'Q5_\.'J7_P ?H/[= M?[;I&#^V/\52/?XAZE_\?KRJB@#U7_ANS]MX=/VR/BK_ .'#U+_X_1_PW9^V M]_T>1\5?_#AZE_\ 'Z\JHH ]5_X;L_;>_P"CR/BK_P"'#U+_ ./T?\-V?MO? M]'D?%7_PX>I?_'Z\JHH ]5_X;L_;>_Z/(^*O_AP]2_\ C]?N9_P9??&#XM_' M[_AI+_A>_P 4O$?C;^R?^$._LK_A+M;N-2^Q>;_;GF^5]H=_+W^7'NVXW>6N M<[1C^=ZOW^_X,8_^;HO^Y)_]S] '[Y6OA_0;&=;JRT2SAE7.V2*V16&1@X(' MI5RBOR?_ .#BK]J/XZ^)OV;=?T3]FKX@7WASP5\._B)X;TOX@>)M)G>*;7M: MN-0M\:+;S(01#:Q.LUTZGF:2W@!S'"OBG\79;NUT^:XA>,->Z6]I M;R;PID\II,Q%E+IO*!E /TNK'\#_ /((E_Z_9O\ T*MBOS3_ &PM5^+?P_\ M^"VO[$6DZ5^T'XUE\+>/=;^(7]L>!7U1(M'5]/T4-!((((X_.8&\D^:_]>47\S6Q6/9?\ MCO>_]>47\S0!L4444 %%%% !1110 4444 %%%% &/XE_Y"^C_P#7Z?\ T$UL M5C^)?^0OH_\ U^G_ -!-;% !1110 4444 %%%% !1110 5F^,?\ D6+W_K@: MTJS?&/\ R+%[_P!<#0!T@UFRU.QBC>:&&)9$VS3H^5/'3'I0!^>E%?;?_ !#B_P#!;'_H MP;Q)_P"#O2__ )+H_P"(<7_@MC_T8-XD_P#!WI?_ ,ET ?$E%?;?_$.+_P % ML?\ HP;Q)_X.]+_^2Z/^(<7_ (+8_P#1@WB3_P '>E__ "70!\245]M_\0XO M_!;'_HP;Q)_X.]+_ /DNC_B'%_X+8_\ 1@WB3_P=Z7_\ET ?$E%?;?\ Q#B_ M\%L?^C!O$G_@[TO_ .2Z/^(<7_@MC_T8-XD_\'>E_P#R70!\245]M_\ $.+_ M ,%L?^C!O$G_ (.]+_\ DNC_ (AQ?^"V/_1@WB3_ ,'>E_\ R70!\245]K)_ MP;I_\%II+Q[!/V#/$9FC0,Z?VWI? /0_\?52_P#$.+_P6Q_Z,&\2?^#O2_\ MY+H ^)**^V_^(<7_ (+8_P#1@WB3_P '>E__ "71_P 0XO\ P6Q_Z,&\2?\ M@[TO_P"2Z /B2BOMO_B'%_X+8_\ 1@WB3_P=Z7_\ET?\0XO_ 6Q_P"C!O$G M_@[TO_Y+H ^)**^V_P#B'%_X+8_]&#>)/_!WI?\ \ET?\0XO_!;'_HP;Q)_X M.]+_ /DN@#XDHK[;_P"(<7_@MC_T8-XD_P#!WI?_ ,ET?\0XO_!;'_HP;Q)_ MX.]+_P#DN@#XDHK[;_XAQ?\ @MC_ -&#>)/_ =Z7_\ )=1)_P &Z?\ P6FD MO'L$_8,\1F:- SI_;>E\ ]#_ ,?5 'Q317VW_P 0XO\ P6Q_Z,&\2?\ @[TO M_P"2Z/\ B'%_X+8_]&#>)/\ P=Z7_P#)= 'Q)17VW_Q#B_\ !;'_ *,&\2?^ M#O2__DNC_B'%_P""V/\ T8-XD_\ !WI?_P ET ?$E%?;?_$.+_P6Q_Z,&\2? M^#O2_P#Y+H_XAQ?^"V/_ $8-XD_\'>E__)= 'Q)17VW_ ,0XO_!;'_HP;Q)_ MX.]+_P#DNC_B'%_X+8_]&#>)/_!WI?\ \ET ?$E%?;?_ !#B_P#!;'_HP;Q) M_P"#O2__ )+H_P"(<7_@MC_T8-XD_P#!WI?_ ,ET ?$E%?:UQ_P;I_\ !::U MEBAN/V#/$:M.^V('6]+^8^G_ !]5+_Q#B_\ !;'_ *,&\2?^#O2__DN@#XDH MK[;_ .(<7_@MC_T8-XD_\'>E_P#R71_Q#B_\%L?^C!O$G_@[TO\ ^2Z /B2B MOMO_ (AQ?^"V/_1@WB3_ ,'>E_\ R71_Q#B_\%L?^C!O$G_@[TO_ .2Z /B2 MBOMO_B'%_P""V/\ T8-XD_\ !WI?_P ET?\ $.+_ ,%L?^C!O$G_ (.]+_\ MDN@#XDHK[;_XAQ?^"V/_ $8-XD_\'>E__)='_$.+_P %L?\ HP;Q)_X.]+_^ M2Z /B2BOMO\ XAQ?^"V/_1@WB3_P=Z7_ /)=1W?_ ;G_P#!:FQMGN[K]@KQ M&D<8R['6]+X'_@50!\445]M1_P#!N1_P6NE198_V!_$95@"I_MO2^1_X%TO_ M !#B_P#!;'_HP;Q)_P"#O2__ )+H ^)**^V_^(<7_@MC_P!&#>)/_!WI?_R7 M1_Q#B_\ !;'_ *,&\2?^#O2__DN@#XDK]_O^#&/_ )NB_P"Y)_\ <_7YN?\ M$.+_ ,%L?^C!O$G_ (.]+_\ DNOV1_X-*O\ @G%^VQ_P3]_X7_\ \-B? +4O M _\ PEO_ BG_"._VA?6LWVW[+_;'VC;]GEDQL^TP9W8SY@QG!P ?J3^UW)^ MT@G[,WC5/V0K#2KCXF2Z%+%X,76[E8;:.]?"+*[L"H\L,T@# J60 @@D5^-7 M_!8>[_X*5_"W_@E+I_P&^*/[ 7P^\#> =&\;>'MNO:7\9FUK4+F_.II,))U: MSC,\US5Y#N)-?NY7G?[4'[*7P"_;-^%;_!/]I3P%_PDGAB35+3 M47TS^U+JSS9:RQ2?*Z@[=VTXP01Q0!8_9U\8_&_Q5\'M!UO]J+X; MZ'X(\>7[7*ZKX6T/Q(-4M;._A_XP_P"%^:1H$:P6^H:7;PVPL-0N(8\*LK:C M/ GF$9E,0/)B_9NT^]A^&VDZG-J&K>3_;? MB7Q/XBO=:UG5?*#"(76H:A--:G_9Q^$?[5GQ"_;4\#>#KFV^(7Q1L+"S\8:M)JUQ)%QPQ^:B*LF$_>*,-D4 ?0E%)'&L4:Q*6(50 68D_B3R M?J:6@ HHHH **** "BBB@ HHHH Q_ __ "")?^OV;_T*MBL?P/\ \@B7_K]F M_P#0JV* "BBB@ HHHH **** "BBB@ K'LO\ D=[W_KRB_F:V*Q[+_D=[W_KR MB_F: -BBBB@ HHHH **** "BBB@ HHHH Q_$O_(7T?\ Z_3_ .@FMBL?Q+_R M%]'_ .OT_P#H)K8H **** "BBB@ HHHH **** "LWQC_ ,BQ>_\ 7 UI5F^, M?^18O?\ K@: +FG?\@^#_KBO\A4U0Z=_R#X/^N*_R%34 %%%% !1110 4444 M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5\<_\$0O^33? M$?\ V5/6_P"<-?8U?'/_ 1"_P"33?$?_94];_G#0!]C4444 %%%% !1110 M4444 %%%% &/9?\ ([WO_7E%_,UL5CV7_([WO_7E%_,UL4 %%%% !1110 44 M44 %%%% !6/9?\CO>_\ 7E%_,UL5CV7_ ".][_UY1?S- &Q1110 4444 %%% M% !1110 4444 8_B7_D+Z/\ ]?I_]!-;%8_B7_D+Z/\ ]?I_]!-;% !1110 M4444 %%%% !1110 5F^,?^18O?\ K@:TJS?&/_(L7O\ UP- %S3O^0?!_P!< M5_D*FJ'3O^0?!_UQ7^0J:@ HHHH **** "BBB@ HHHH *Q_ _P#R")?^OV;_ M -"K8K'\#_\ ((E_Z_9O_0J -BBBB@ HHHH **** "BBB@ HHHH Q_ __((E M_P"OV;_T*MBL?P/_ ,@B7_K]F_\ 0JV* "BBB@ HHHH **** "BBB@ K'LO^ M1WO?^O*+^9K8K'LO^1WO?^O*+^9H V**** "BBB@ HHHH **** "BBB@#'\2 M_P#(7T?_ *_3_P"@FMBL?Q+_ ,A?1_\ K]/_ *":V* "BBB@ HHHH **** " MBBB@ K-\8_\ (L7O_7 UI5F^,?\ D6+W_K@: +FG?\@^#_KBO\A4U0Z=_P @ M^#_KBO\ (5-0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% ! M1110 4444 %%%% !7\OGBS_@I[^WA^RC\2_%WPE_9[_:*U3PSX=C\37-VFEV MEA:2()I N]\RPNV3@=\<5_4'7\@7[6?_ "NKU/DN,\17PV5PE2FXOG2NFU]F78]P_X?H_\ !6'_ M */+UW_P4Z=_\C4?\/T?^"L/_1Y>N_\ @IT[_P"1J^3**_H;_5OAW_H#I?\ M@N'^1^9_VIF?_/\ G_X%+_,^L_\ A^C_ ,%8?^CR]=_\%.G?_(U'_#]'_@K# M_P!'EZ[_ ."G3O\ Y&KY,HH_U;X=_P"@.E_X+A_D']J9G_S_ )_^!2_S/K/_ M (?H_P#!6'_H\O7?_!3IW_R-1_P_1_X*P_\ 1Y>N_P#@IT[_ .1J^3**/]6^ M'?\ H#I?^"X?Y!_:F9_\_P"?_@4O\SZS_P"'Z/\ P5A_Z/+UW_P4Z=_\C4?\ M/T?^"L/_ $>7KO\ X*=._P#D:ODRBC_5OAW_ * Z7_@N'^0?VIF?_/\ G_X% M+_,^L_\ A^C_ ,%8?^CR]=_\%.G?_(U'_#]'_@K#_P!'EZ[_ ."G3O\ Y&KY M,HH_U;X=_P"@.E_X+A_D']J9G_S_ )_^!2_S/JY/^"X?_!5>.\>_3]L77!-( M@5W_ +)T_D#H/^/>I?\ A^C_ ,%8?^CR]=_\%.G?_(U?)E%'^K?#O_0'2_\ M!7KO_ (*=._\ D:C_ (?H_P#! M6'_H\O7?_!3IW_R-7R911_JWP[_T!TO_ 7#_(/[4S/_ )_S_P# I?YGUG_P M_1_X*P_]'EZ[_P""G3O_ )&H_P"'Z/\ P5A_Z/+UW_P4Z=_\C5\F44?ZM\._ M] =+_P %P_R#^U,S_P"?\_\ P*7^9]9_\/T?^"L/_1Y>N_\ @IT[_P"1J/\ MA^C_ ,%8?^CR]=_\%.G?_(U?)E%'^K?#O_0'2_\ !7KO_ (*=._\ D:C_ (?H_P#!6'_H\O7?_!3IW_R-7R91 M1_JWP[_T!TO_ 7#_(/[4S/_ )_S_P# I?YGUG_P_1_X*P_]'EZ[_P""G3O_ M )&J)/\ @N'_ ,%5X[Q[]/VQ=<$TB!7?^R=/Y Z#_CWKY1HH_P!6^'?^@.E_ MX+A_D']J9G_S_G_X%+_,^L_^'Z/_ 5A_P"CR]=_\%.G?_(U'_#]'_@K#_T> M7KO_ (*=._\ D:ODRBC_ %;X=_Z Z7_@N'^0?VIF?_/^?_@4O\SZS_X?H_\ M!6'_ */+UW_P4Z=_\C4?\/T?^"L/_1Y>N_\ @IT[_P"1J^3**/\ 5OAW_H#I M?^"X?Y!_:F9_\_Y_^!2_S/K/_A^C_P %8?\ H\O7?_!3IW_R-1_P_1_X*P_] M'EZ[_P""G3O_ )&KY,HH_P!6^'?^@.E_X+A_D']J9G_S_G_X%+_,^L_^'Z/_ M 5A_P"CR]=_\%.G?_(U'_#]'_@K#_T>7KO_ (*=._\ D:ODRBC_ %;X=_Z MZ7_@N'^0?VIF?_/^?_@4O\SZS_X?H_\ !6'_ */+UW_P4Z=_\C4?\/T?^"L/ M_1Y>N_\ @IT[_P"1J^3**/\ 5OAW_H#I?^"X?Y!_:F9_\_Y_^!2_S/JZX_X+ MA_\ !5>ZEBFN/VQ=<9H'W1$Z3I_RGU_X]ZE_X?H_\%8?^CR]=_\ !3IW_P C M5\F44?ZM\._] =+_ ,%P_P @_M3,_P#G_/\ \"E_F?6?_#]'_@K#_P!'EZ[_ M ."G3O\ Y&H_X?H_\%8?^CR]=_\ !3IW_P C5\F44?ZM\._] =+_ ,%P_P @ M_M3,_P#G_/\ \"E_F?6?_#]'_@K#_P!'EZ[_ ."G3O\ Y&H_X?H_\%8?^CR] M=_\ !3IW_P C5\F44?ZM\._] =+_ ,%P_P @_M3,_P#G_/\ \"E_F?6?_#]' M_@K#_P!'EZ[_ ."G3O\ Y&H_X?H_\%8?^CR]=_\ !3IW_P C5\F44?ZM\._] M =+_ ,%P_P @_M3,_P#G_/\ \"E_F?6?_#]'_@K#_P!'EZ[_ ."G3O\ Y&H_ MX?H_\%8?^CR]=_\ !3IW_P C5\F44?ZM\._] =+_ ,%P_P @_M3,_P#G_/\ M\"E_F?6?_#]'_@K#_P!'EZ[_ ."G3O\ Y&J.[_X+C_\ !5F^MGM+K]L?7'CD M&'4Z3I_(_P# >OE"BC_5OAW_ * Z7_@N'^0?VIF?_/\ G_X%+_,^LH_^"YW_ M 5>B18H_P!LK70J@!1_9.G<#_P&I?\ A^C_ ,%8?^CR]=_\%.G?_(U?)E%' M^K?#O_0'2_\ !7KO_ (*=._\ MD:C_ (?H_P#!6'_H\O7?_!3IW_R-7R911_JWP[_T!TO_ 7#_(/[4S/_ )_S M_P# I?YGUG_P_1_X*P_]'EZ[_P""G3O_ )&H_P"'Z/\ P5A_Z/+UW_P4Z=_\ MC5\F44?ZM\._] =+_P %P_R#^U,S_P"?\_\ P*7^9]9_\/T?^"L/_1Y>N_\ M@IT[_P"1J/\ A^C_ ,%8?^CR]=_\%.G?_(U?)E%'^K?#O_0'2_\ !7KO_ (*=._\ D:C_ (?H_P#!6'_H\O7? M_!3IW_R-7R911_JWP[_T!TO_ 7#_(/[4S/_ )_S_P# I?YGUG_P_1_X*P_] M'EZ[_P""G3O_ )&J*S_X+A_\%5]/B,-G^V+KB*7+$#2=/ZGJ?^/>OE&BC_5O MAW_H#I?^"X?Y!_:F9_\ /^?_ (%+_,^L_P#A^C_P5A_Z/+UW_P %.G?_ "-1 M_P /T?\ @K#_ -'EZ[_X*=._^1J^3**/]6^'?^@.E_X+A_D']J9G_P _Y_\ M@4O\SZS_ .'Z/_!6'_H\O7?_ 4Z=_\ (U'_ _1_P""L/\ T>7KO_@IT[_Y M&KY,HH_U;X=_Z Z7_@N'^0?VIF?_ #_G_P"!2_S/K/\ X?H_\%8?^CR]=_\ M!3IW_P C4?\ #]'_ (*P_P#1Y>N_^"G3O_D:ODRBC_5OAW_H#I?^"X?Y!_:F M9_\ /^?_ (%+_,^L_P#A^C_P5A_Z/+UW_P %.G?_ "-1_P /T?\ @K#_ -'E MZ[_X*=._^1J^3**/]6^'?^@.E_X+A_D']J9G_P _Y_\ @4O\SZS_ .'Z/_!6 M'_H\O7?_ 4Z=_\ (U'_ _1_P""L/\ T>7KO_@IT[_Y&KY,HH_U;X=_Z Z7 M_@N'^0?VIF?_ #_G_P"!2_S/JZS_ ."X?_!5?3XC#9_MBZXBERQ TG3^IZG_ M (]ZE_X?H_\ !6'_ */+UW_P4Z=_\C5\F44?ZM\._P#0'2_\%P_R#^U,S_Y_ MS_\ I?YGUG_ ,/T?^"L/_1Y>N_^"G3O_D:C_A^C_P %8?\ H\O7?_!3IW_R M-7R911_JWP[_ - =+_P7#_(/[4S/_G_/_P "E_F?6?\ P_1_X*P_]'EZ[_X* M=._^1J/^'Z/_ 5A_P"CR]=_\%.G?_(U?)E%'^K?#O\ T!TO_!7KO_@IT[_Y&H_X?H_\ !6'_ */+UW_P4Z=_ M\C5\F44?ZM\._P#0'2_\%P_R#^U,S_Y_S_\ I?YGUG_ ,/T?^"L/_1Y>N_^ M"G3O_D:C_A^C_P %8?\ H\O7?_!3IW_R-7R911_JWP[_ - =+_P7#_(/[4S/ M_G_/_P "E_F?6?\ P_1_X*P_]'EZ[_X*=._^1JB3_@N'_P %5X[Q[]/VQ=<$ MTB!7?^R=/Y Z#_CWKY1HH_U;X=_Z Z7_ (+A_D']J9G_ ,_Y_P#@4O\ ,^L_ M^'Z/_!6'_H\O7?\ P4Z=_P#(U'_#]'_@K#_T>7KO_@IT[_Y&KY,HH_U;X=_Z M Z7_ (+A_D']J9G_ ,_Y_P#@4O\ ,^L_^'Z/_!6'_H\O7?\ P4Z=_P#(U'_# M]'_@K#_T>7KO_@IT[_Y&KY,HH_U;X=_Z Z7_ (+A_D']J9G_ ,_Y_P#@4O\ M,^L_^'Z/_!6'_H\O7?\ P4Z=_P#(U'_#]'_@K#_T>7KO_@IT[_Y&KY,HH_U; MX=_Z Z7_ (+A_D']J9G_ ,_Y_P#@4O\ ,^L_^'Z/_!6'_H\O7?\ P4Z=_P#( MU'_#]'_@K#_T>7KO_@IT[_Y&KY,HH_U;X=_Z Z7_ (+A_D']J9G_ ,_Y_P#@ M4O\ ,^L_^'Z/_!6'_H\O7?\ P4Z=_P#(U'_#]'_@K#_T>7KO_@IT[_Y&KY,H MH_U;X=_Z Z7_ (+A_D']J9G_ ,_Y_P#@4O\ ,^KKC_@N'_P57NI8IKC]L77& M:!]T1.DZ?\I]?^/>I?\ A^C_ ,%8?^CR]=_\%.G?_(U?)E%'^K?#O_0'2_\ M!7KO_ (*=._\ D:C_ (?H_P#! M6'_H\O7?_!3IW_R-7R911_JWP[_T!TO_ 7#_(/[4S/_ )_S_P# I?YGUG_P M_1_X*P_]'EZ[_P""G3O_ )&H_P"'Z/\ P5A_Z/+UW_P4Z=_\C5\F44?ZM\._ M] =+_P %P_R#^U,S_P"?\_\ P*7^9]9_\/T?^"L/_1Y>N_\ @IT[_P"1J/\ MA^C_ ,%8?^CR]=_\%.G?_(U?)E%'^K?#O_0'2_\ !-OAW^UY\#OV$/A5X@T;PUK_ ,9AKMY+XQU^P-VEC9:5 M;1S26]I;^9&LU[.95"&1C'$D,HO\ A3\'Q"\-^-;+2%L+JV@_M,Z=-I]_%&S1 M/(TA66&:-8@R+*IC)CWMD?'S]NKQ]\3?VG-;_8#_ &(-!T;5?%GA/2+?4OBY MX_\ $<4D^B^!K:XYMK4P0R1R7VI3J"R6PDA1$!D>0[3'0!]9:=_R#X/^N*_R M%35S_P ,/#WBCPQX,M-,\9?$"[\2ZAL#SZG=V-O;9) ^1(X$550=@=S<\NU> M"_M^?MG^+/V?OBU\"_V8/AKJ6B:+XF^/'C>[T.Q\7>)[-KFQT2WM+-KJ9A D MD9GNYCY5O;QEU0RSAFW!/+< ^FJ*^6/#'[2OQQ^#7_!13PS^PA\6O%MCX]TK MQ[\-M3\4:!XFM]%2QU/1IM/N8(9X;V.%O)EMI5N$\J9$B99(VC82;@R_4] ! M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %% M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5_( M%^UG_P G(>,?^PU)_(5_7[7\G_Q\_97_ &GOB9\;/%/C/X;_ +./CWQ!H]UK MW=M,4;8X66*)E;:RLIP>""#R*_5?""O0P_$M:562BO8RU;2^W3 M[GQ_&U.I5RJ"@FWSK;7[,CY_HKU+_AAK]MC_ *,]^*?_ (;[4O\ XQ1_PPU^ MVQ_T9[\4_P#PWVI?_&*_HW^T\M_Y_P /_ H_YGY?]4Q7_/N7W,\MHKU+_AAK M]MC_ *,]^*?_ (;[4O\ XQ1_PPU^VQ_T9[\4_P#PWVI?_&*/[3RW_G_#_P " MC_F'U3%?\^Y?_%/_ M ,-]J7_QBC^T\M_Y_P /_ H_YA]4Q7_/N7W,\MHKU+_AAK]MC_HSWXI_^&^U M+_XQ1_PPU^VQ_P!&>_%/_P -]J7_ ,8H_M/+?^?\/_ H_P"8?5,5_P ^Y?_%/_PWVI?_ !BC^T\M M_P"?\/\ P*/^8?5,5_S[E]S/+:*]2_X8;_;6SM_X8^^*6?3_ (5_J7_QFC_A MAK]MC_HSWXI_^&^U+_XQ1_:>6_\ /^'_ (%'_,/JF*_Y]R^YGEM%>I?\,-?M ML?\ 1GOQ3_\ #?:E_P#&*/\ AAK]MC_HSWXI_P#AOM2_^,4?VGEO_/\ A_X% M'_,/JF*_Y]R^YGEM%>I?\,-?ML?]&>_%/_PWVI?_ !BC_AAK]MC_ *,]^*?_ M (;[4O\ XQ1_:>6_\_X?^!1_S#ZIBO\ GW+[F>6T5ZE_PPU^VQ_T9[\4_P#P MWVI?_&*/^&&OVV/^C/?BG_X;[4O_ (Q1_:>6_P#/^'_@4?\ ,/JF*_Y]R^YG MEM%>I?\ ##7[;'_1GOQ3_P##?:E_\8H_X8:_;8_Z,]^*?_AOM2_^,4?VGEO_ M #_A_P"!1_S#ZIBO^?_%/_ ,-]J7_QBC^T\M_Y_P /_ H_ MYA]4Q7_/N7W,\MHKU+_AAK]MC_HSWXI_^&^U+_XQ1_PPU^VQ_P!&>_%/_P - M]J7_ ,8H_M/+?^?\/_ H_P"8?5,5_P ^Y?_%/_PWVI?_ !BC^T\M_P"?\/\ P*/^8?5,5_S[E]S/ M+:*]2_X8:_;8_P"C/?BG_P"&^U+_ .,4?\,-?ML?]&>_%/\ \-]J7_QBC^T\ MM_Y_P_\ H_YA]4Q7_/N7W,\MHKU+_AAK]MC_HSWXI_^&^U+_P",4?\ ##7[ M;'_1GOQ3_P##?:E_\8H_M/+?^?\ #_P*/^8?5,5_S[E]S/+:*]2/[#?[:P(! M_8^^*7/3_BW^I?\ QFC_ (8:_;8_Z,]^*?\ X;[4O_C%']IY;_S_ (?^!1_S M#ZIBO^?I?\,-?ML?]&>_%/\ \-]J M7_QBC_AAK]MC_HSWXI_^&^U+_P",4?VGEO\ S_A_X%'_ ##ZIBO^?6T5ZE_PPU^VQ_P!&>_%/_P -]J7_ ,8H_P"&&OVV M/^C/?BG_ .&^U+_XQ1_:>6_\_P"'_@4?\P^J8K_GW+[F>6T5ZE_PPU^VQ_T9 M[\4__#?:E_\ &*#^PW^VN!D_L??%(#W^'VI?_&:/[3RW_G_#_P "C_F'U3%? M\^Y?_%/_PWVI?_ !BC M^T\M_P"?\/\ P*/^8?5,5_S[E]S/+:*]2_X8:_;8_P"C/?BG_P"&^U+_ .,4 M?\,-?ML?]&>_%/\ \-]J7_QBC^T\M_Y_P_\ H_YA]4Q7_/N7W,\MHKU+_AA MK]MC_HSWXI_^&^U+_P",4?\ ##7[;'_1GOQ3_P##?:E_\8H_M/+?^?\ #_P* M/^8?5,5_S[E]S/+:*]2_X8:_;8_Z,]^*?_AOM2_^,4?\,-?ML?\ 1GOQ3_\ M#?:E_P#&*/[3RW_G_#_P*/\ F'U3%?\ /N7W,\MHKU+_ (8:_;8_Z,]^*?\ MX;[4O_C%'_##7[;'_1GOQ3_\-]J7_P 8H_M/+?\ G_#_ ,"C_F'U3%?\^Y?< MSRVBO4O^&&OVV/\ HSWXI_\ AOM2_P#C% _8;_;6897]C[XI'Z?#_4O_ (S1 M_:>6_P#/^'_@4?\ ,/JF*_Y]R^YGEM%>I?\ ##7[;'_1GOQ3_P##?:E_\8H_ MX8:_;8_Z,]^*?_AOM2_^,4?VGEO_ #_A_P"!1_S#ZIBO^?I?\,-?ML?]&>_%/\ M\-]J7_QBC_AAK]MC_HSWXI_^&^U+_P",4?VGEO\ S_A_X%'_ ##ZIBO^?6T5ZD/V&_P!M9AE?V/OBD?I\/]2_^,T?\,-? MML?]&>_%/_PWVI?_ !BC^T\M_P"?\/\ P*/^8?5,5_S[E]S/+:*]2_X8:_;8 M_P"C/?BG_P"&^U+_ .,4?\,-?ML?]&>_%/\ \-]J7_QBC^T\M_Y_P_\ H_Y MA]4Q7_/N7W,\MHKU+_AAK]MC_HSWXI_^&^U+_P",4?\ ##7[;'_1GOQ3_P## M?:E_\8H_M/+?^?\ #_P*/^8?5,5_S[E]S/+:*]2_X8:_;8_Z,]^*?_AOM2_^ M,4S_ (8D_;._Z-%^)_\ X0.H_P#QFFLRRZ6U:'_@2_S$\+BEO!_845Z?_ ,,2?MG?]&B_$_\ \('4?_C--'[%7[9#2F!? MV2_B:7499!X#U'('KCR:/[0P'_/V/_@2_P P^K8G^1_ MO;77P^@T]8Y;[6FDC(=TP(HDM05^T3&+$D)B\^+[_KY]_:J_8DU3XQ?M!?#3 M]L7X,?$.T\*?$_X7)J%EIMUJVDM?:9K6D7T82ZTZ\A26*0 E$DBFCD#0R L5 MD!*'^&C^@CY'_P""-_Q=^-7P$_;4^)O_ 3U_P""BGP\@G_:&U#2QXHM/C=! M/)/'\3?#\$OV>!@\G^H%L) B6T0CB4>=^Z2197E\4_X(7?LE>+?VOO\ @GI\ M9/VE/%G[4WQ2\%^//BE\8_$FI:Q>^#/$":=)8ZDCHBR2F./S;G:Q8^1-(\(# M':B%F8_I;\/_ -D?Q1JG[6%M^VQ^T1XMT;5?&&C>"I_"WA'2/#.ERVUAHMC< M7$=Q=R%YI))+JXF>&(>81$D<:;%CRSR/YSX5_8&^+W[(/BSXM:Q^Q7\7/"^B M^"/BQKT_B?4O!OB[PQ<7L?AOQ!.BI=WVGM;W4.^"?9&[V/, _$6O6T"Q+K$NG^25NBJ *& M*3JC%0 S1EL#=BJ?_!-[SP^MQ9W[7=F+/5+:[LHY8 MO]'O(AAA%*CQ$(R,=I5@#XY_X)9^._V@/V,_^"D6O_L#?\%+]!_X2_XN>.?# M37'PJ_:1::6=O&_A[38]W]E,)6;[');H'F>&/:'D\R2422.ES.?B/^U-X*_:[_:?\6^']0UOX9Z'JUA\/O#_ (3TJ:"TTR;4TABOKV:>>5Y+ MF5X8$A10L21(\N1(SJR>_4 %%%% !1110 4444 %%%% !1110 4444 %%%% M!1110 4444 %%?EO_P ' UMXE\/?M-?L;:=X'^+?Q"\+V_Q._:,TCPIXZM_! M_P 1]8TB/5M)N+FSAEMW6SNHPA*%@)$"NNYB&!)-?0'[4/\ P3 \=0_"S4?$ MO_!/G]KWXQ_#+XGZ1:/=>%Y=4^+NM^(M%U.Z0%H[6_L-;NKN!XI"-AD5%=-P M8[U7RV /LBBOAW_@DC_P6"\'?MI_\$X[_P#:X_:BU31/ &M?#?4;K0_B]-?7 M M+"POK5(V:X7S&S''+'-$P0DD2,\2EBH)^@?A5^WM^RO\9/BY'\ _"/Q!O[ M/QK'>!@YQ@T >PT5XY\"O MV_OV2OVE_BOXC^!WP1^*+/![[/%NB+XI45Y/\./VW/V!]8T6YO+"%HUENH5U"T@\V%6EC4NN5RX&$OA_X9O?&GCO MQ/I^BZ/IMN9]1U75KU+>VM8AU>220A44>I(% &C17Q[^Q%\7_P#@E3^QG^P/ M<_$W]GC]IO3+?X)6GB[6)6\9^*O%-Q/#+J4EU(]S%%/>8><^8'"+&&\S:67S M&9G;K9O^"PW_ 31M_&7@3P!/^UQX=75?B5:Z9<>#X3;W6RY&HP1W%C'-+Y/ MEV4LT,T4B0W+12%9%.WYA0!]*T45\M:5J'_!.;Q;_P %7+KQGX=^.%MJ?[1& M@_"2ZT;5?#.F^)YYX=.T"&_BEF:YMXR;>"99YXQMD*N0V=AV[@ ?4M%?->N? M\%A/^"9F@:3XOURX_;%\)W=KX%U.'3O$9&B_? MF&%FML2J8CYP3;)^[.'(6@#V^BO,+[]LC]G73/V:X_VP+_QS=1?#>72TU-/% M#^'=0\O[ Z[EO#'Y'FBW*$.)BGEE"'W;2#5OQ]^U7\#_ (9>%M!\5^+_ !%J M<7_"4P&;PYHEEX6U*\UG4D6-9',.EV]N]\_EHRM(!#F,,-^W(H ]$HKQ'PK_ M ,%(_P!A3QC\!M9_::TK]J#PK;^"/#FHRZ=XBUK6+PZ>=)OHOOV=U!=+'-;W M(_YX2(LAR,*%F>VN_+D6]1 M7M/M$GD[+ RHRNBW1B9E(8#'- 'TY17Q]^W?_P %=[WCQU^UU M^S]\./#?A7Q)XI\;7 /CBU6X\'Z+I^@7U[J^L1F%9F:WTRV@DO9=D;J\@6$F M($>9MH ])HKRWX0_MK_LJ?'3P!XA^)WPW^.&BSZ/X0O9;/QC+JDCZ;-X>N(_ M]9#J%O>+%-8R*.2DZ(<=J\LC_P""U_\ P2SNG\*PZ7^V1X'KTV6M7UEH][%;VET ";=I9X43S@&4F($NH8$@ @UN_ G]IKX M+?M*V^O7?P8\476JQ^%]=FT77VN-"O;+['J,)*S6C"ZACS-&PQ(@RT9(#!21 MD [VBBL_Q7XK\.>!O#EWXM\6ZO#8:;80F6\O)SA(DZ;CCMS0!H5^?'[ O_)K M>B_]AK7?_3S>U]8?\-S_ +(__1>M!_[_ #__ !-?)G_!/Z>*Y_94T*Y@D#)) MJ^N,C#H0=8O2#0![-1110 4444 %%%% !1110 4444 %%%% !1110 4444 % M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% !7U)7RW7TE_PF/AC_H-0?]]4 :5<+X&_ M:8^ _P 4/'%_\._AA\3-/\2ZGI,\D&L#P[OOK?3IX_OP7-S K0V\PZ>5(ZOG MC;FO@O\ X+\5^)]-_X7'>3ZG\5=;\"V5S/K%OX3 MM S365G]G4R12WIBFA,_"Q*AWD([,OOG[#W[?W[#VM^-[O\ X)]?"?X<:W\( M/$WPXT&&2Q^%OB[PRFE2#21M5+FR\F26&YARP#.DC-N8EAR30!])_$WXK?## MX*^#KGXA_ Z)X6T&S*BZUGQ!JD5G;1,QVJIDE95#,2 !G)) &2:R_AE\0 MO"WQ0U*X\7^#+B[GTZ>U06]Q=Z7<6GG '[Z+/&C.ASPX!5NQ-?E#^SK_ ,%$ M/!W[77[6_P 7?^"E_P =?@M\3OB+\//@MXIN_#7P(\*>#/"#ZA8Z%;6B9OO$ MS+,\4-Q?SAE"&(R7$$6]=@4HY_2[]EO]KW]GC]KWX?:;^TG^S_\ $>UUWPAX MDTU7TW44C>-@Z.R20R1N \4J.&5D8 @CZ&@#US5-5TS0],N-:UO4H+.SM(6F MN[NZF6.*&-02SNS$!5 !)). !7/?!SXV_"+]H7P'!\4O@9\2-'\6^&[NZN;: MTU[0+Y+JTN)+>=X)A'*A*R!98W37KUCD4J3R<'&17P=_P:R^)-"T__@B#\)+2]U.*.1=0\1[D M8\C.O7YH _1VBLW_ (3'PQ_T&H/^^J/^$Q\,?]!J#_OJ@#2HK-_X3'PQ_P!! MJ#_OJC_A,?#'_0:@_P"^J -*BLW_ (3'PQ_T&H/^^J/^$Q\,?]!J#_OJ@#2H MK-_X3'PQ_P!!J#_OJC_A,?#'_0:@_P"^J (?$O\ R%]'_P"OT_\ H)K8KF=> M\2Z#(A$4\DT ;FG?\@^#_KBO\A4U9%CXN\-1V4,;ZS"&6)003T.*E_X3'PQ_P!! MJ#_OJ@#2HK-_X3'PQ_T&H/\ OJC_ (3'PQ_T&H/^^J -*BLW_A,?#'_0:@_[ MZJQI^MZ3JKM'IU_',R#+!#T% %JBBB@ HHHH **** "BBB@ HHHH **** "B MBB@ HHHH _,'_@X7_P"3IO\ @GS_ -G@>'?_ $NLJ_0W]H'X]_"C]EWX+^)/ MV@?CAXOM="\*^%-*EO\ 6-2NI H2-!D(@)&^1VPB1CYG=U502P%>++&U MG7.)DL]9O[FW$@S]_P O=[\4 ?DK^P9X ^$_P&_X(4?%3]HW_@HQ^S]J^NZ! M^TC\=[77?!GPS@U2;2Y]4DGO+8Z2'N59&M8I+J&28RL2OV>-7 DWJC?67[0. MD_&_3?\ @O;^P[X@_:"\<>%[O7-2\+?$C.B^$M,D@L](A31$;RA-/(TUX=S/ MF=UA5O+!6"+Y@?O/]JO]D/\ 9X_;7^ ^J?LU?M)_#FW\0^#M6$)GTPSR6[1/ M$X>*6&6%E>%T900R,#C(.5)!\>;_ ((J_P#!.:Z\0?#_ ,8:[\$K_6-;^&TU MS)H&O:YXRU6]O[D3Q)%)%?7$URTE_!LC5!!<,\*H6C5!&[HP!\_?\% O$>B_ M\$HO^"IO@'_@J)>S#3/A+\:=.3X<_M 7"0DQ6&H1(TNBZU(%!)8"-K9W/"11 M]V<5W]W^REI/[1O_ 2N\?Z=^TOX[O/ASXD_:;U>'Q%X@UX1EKG0-1U2\LX= M!LG7(+&TACT>Q9-RAC _SH&+#.^+_P"TM\/O^"MGCO5O^";_ (6_9:^(\>B^ M%_BI:#XP>(OB#X$%GHT.F:-?K>%;6>1V$\E[<6L%O$H59/(GFFP@C!/V1^T5 M^SO\)/VK?@SK/[/_ ,=/#4NK^$_$"P+JVFP:E<6;3+#/'<(!-;/'+'B2)#E' M4\=: /@G]EK]JK]O+X!_\% ?A;^PK_P5L^#'A;Q3XE\2:3KMM\$_VB? 4CQP M:P(+1+F^MKVT(7R9GAMXVZ30.DD;?[2,".QH _&G]@:WMQ_P & MI?[0EN($\M/#_P 4MB;1A=K7I&!VQ@8],4__ (*+^%/"_AK_ (-*O@O)X=\. MV5@T'@3X6:G UG:I$8[V_,T:2ACYB(ZK)G+ MAC4OQ"_X)3_L-_%;]E71?V(_B'\,_$&J_"SP]';1:3X1N/B9XA$445N$%O"T MJWXFEBB\N/RXW=DCV#:%H ^B:_.[5H8H_P#@ZNTQXXE4R?L),TA5<%C_ ,)= M,,GU. !] *_0/PQX=T_PEX?L_#.E3WTMM8P+%#)J>J3WMPRCH9)[AWEE;U9V M9CW->3W7_!/_ /99O/VN(_VZ[CP?KY^*<6B?V-'XF7X@:VJKIOF&7[$+07GV M7[/YA,GD^5LWG=MSS0!\C_\ !)+PKX8_X>W_ /!07Q5_PCMC_:(OC-X^\/7FFQJ D5C/,(F2(8Q'M#DK@?*V".17V9\&_^"=?[*'[/_P 2 M?'OQ?^$?A3Q/I/B3XG7*W'CO5#\3-?N'U:=0X25EGOG5)$$CA'C"L@.%( & MG^R/^PQ^S+^PMX8U?P7^S!X+U70-*UW69M6U2POO&>K:K'+?2X\VX U"ZG\M MWV@L4V[B,G)H _//_@E_\4_B'\6_@_X<_P"")?QLN7N?&OP$^)ESHWQ0DD4J M+WP3H$T%WI4X'(\F\EETJS6-C^]M8[H\@$5Z/XF^*%P/^#BKQ/\ WXB_M": M_P##R]\1_L\:*GPFFTZ+2]NJQQZA=2W]I"=1L[E3*\O[PK$%=UL_FW")"]5!MK1(S]M?5M,:2YRH'[URS[GZMO;).37Z3?#C_@F M)^Q=\*/V5M=_8S\$?"^^LO GBQ+D>+[>#Q9J<5_KS7$7DW#7FH1W"W*/^"4_[#7C7]D*S_8+\5?##7[[X26 @2V\&3?$KQ!Y(CAEC MEAA:47_G/#')%&Z1-(8T9 54$4 ?-7_!2N9Y?^"LO_!-V>XE+._B+QN7=VR6 M)T*TY)/4DTGP>^).J7/_ <^?%CP1\5YT4G]FK25^$37#_++I8O()=0$&>"[ M7AFW;>2MKSD1_+]2_'__ ()H?L@?M.> _ 7P^^,?@?7-2M_ACJ:WW@;58O'6 MKPZMI'X?+$3007-JZ/Y#1C8T#[HV4G*GK0!\G^$_!>O>"?^ M#I?Q5?\ P@@,'A_Q9^R?8ZO\6$M^()M435Y;.QDE X^T>1;Q!"?F\OS<<%JI M?\&S_P +/AIJ/_!/[7=;U/X?Z-=7B_M ^*=02ZNM-BDDCNH+PQP3JS*2DD:? M*C#!4$XQDY^X?A-^R/\ !7X,:;XGB\':=K#:KXVF27QCXLU#Q+>W&MZO)'%Y M432Z@TOVA1&F5B2-T2$$B-4!-8W[)O["_P"RY_P3]\#ZSX4_9;\!ZYH6BZE? MSZKJ.DS>,=8UE);MP#+-''?W4^V63:-QCP7(&\U.]_P"VU[/<2@'H M' [5\J_"3]HWP%_P6C^,_P +O%GA#]EWX@^'OA_\%/&<_C'6=:^*W@I=+EE\ M16]O/9Z;8689W,C1MA?^"B'_P")KX4_8#54_99T1$4 #6== M ' ']L7M?H17\^OA_\ X.(_V7/V%HK[]E;XE?!7Q_JNL^%M;U#[5J.AQ6+6 MTPN;N6\39YMPC\+<*IRO53C(H _6:BORH_XBV?V(?^C=/BK_ . VF_\ R91_ MQ%L_L0_]&Z?%7_P&TW_Y,H _5>BORH_XBV?V(?\ HW3XJ_\ @-IO_P F4?\ M$6S^Q#_T;I\5?_ ;3?\ Y,H _5>BORH_XBV?V(?^C=/BK_X#:;_\F4?\1;/[ M$/\ T;I\5?\ P&TW_P"3* /U7HK\J/\ B+9_8A_Z-T^*O_@-IO\ \F4?\1;/ M[$/_ $;I\5?_ &TW_Y,H _5>BORH_XBV?V(?^C=/BK_ . VF_\ R91_Q%L_ ML0_]&Z?%7_P&TW_Y,H _5>BORH_XBV?V(L_\FY_%7'_7OIO_ ,ET?\1;/[$/ M_1NGQ5_\!M-_^3* /U7HK\J/^(MG]B'_ *-T^*O_ (#:;_\ )E'_ !%L_L0_ M]&Z?%7_P&TW_ .3* /U7HK\J/^(MG]B'_HW3XJ_^ VF__)E'_$6S^Q#_ -&Z M?%7_ ,!M-_\ DR@#]5Z*_*C_ (BV?V(?^C=/BK_X#:;_ /)E'_$6S^Q#_P!& MZ?%7_P !M-_^3* /U7HK\J/^(MG]B'_HW3XJ_P#@-IO_ ,F4?\1;/[$/_1NG MQ5_\!M-_^3* /U7HK\J/^(MG]B'_ *-T^*O_ (#:;_\ )E'_ !%L_L19_P"3 M<_BKC_KWTW_Y+H _5>BORH_XBV?V(?\ HW3XJ_\ @-IO_P F4?\ $6S^Q#_T M;I\5?_ ;3?\ Y,H _5>BORH_XBV?V(?^C=/BK_X#:;_\F4?\1;/[$/\ T;I\ M5?\ P&TW_P"3* /U7HK\J/\ B+9_8A_Z-T^*O_@-IO\ \F4?\1;/[$/_ $;I M\5?_ &TW_Y,H _5>BORH_XBV?V(?^C=/BK_ . VF_\ R91_Q%L_L0_]&Z?% M7_P&TW_Y,H _5>BORH_XBV?V(?\ HW3XJ_\ @-IO_P F4?\ $6S^Q#_T;I\5 M?_ ;3?\ Y,H _5>BORH/_!VS^Q%D8_9S^*OO_H^F_P#R71_Q%L_L0_\ 1NGQ M5_\ ;3?_DR@#]5Z*_*C_B+9_8A_Z-T^*O\ X#:;_P#)E'_$6S^Q#_T;I\5? M_ ;3?_DR@#]5Z*_*C_B+9_8A_P"C=/BK_P" VF__ "91_P 1;/[$/_1NGQ5_ M\!M-_P#DR@#]5Z*_*C_B+9_8A_Z-T^*O_@-IO_R91_Q%L_L0_P#1NGQ5_P# M;3?_ ),H _5>BORH_P"(MG]B'_HW3XJ_^ VF_P#R91_Q%L_L0_\ 1NGQ5_\ M ;3?_DR@#]5Z*_*C_B+9_8A_Z-T^*O\ X#:;_P#)E!_X.V?V(L_L[3_\ GQA_[]"OQP_X)\_\' '[,7_!1;]KWPC^QM\*_@]X\T37O&/V_P"P M:GX@@LELX?LFGW-\_F&&X=^8[9U&%/S,N<#)'[*T ?G%^WYX B_9E_X+7?L\ M?\%+/B#9QP?"V[\#:C\,O&7B24 6GA:]GDN9].N[MC\L,$\]R;-?A3X?\ VI?^"_\ \)/VC_@'>:=JV@?!;X1:U:_$OQ/H\B3V37.H":+3 MM':>,E'N5%Q/=F'),<>QVV^;'N_0J]LK/4K.73]1M(KBWGC*3031ATD4C!5E M/!!'8U#HF@Z'X9TN+1/#FC6FGV4 (@M+&W6**,9SA44 #D]A0!^9_P#P0XU+ MX7_\$U_@K\7/^"?G[6WC/0O!/B;X5?$G6-8@NO%>H16D>O>&+LI+9ZW;23%1 M/ P62-RI8Q/'LDVL0M97_!*'6OAU_P $B?\ @F/\1/VH?VP++4O!G@'6_B=J MGB_1-'GT"XDO-(T74[^"STN%K15,D32*L,OED HMP-X4A@/U!U?PIX7U^]L] M2U[PW87MQI\OFV%Q=V:2/;/_ 'HV8$H>!R,'BLVZT;2/$'B74]&U_2K:^L[B MQB6>TO(%EBD&[.&5@01D#J.U %6[^*7P=TOX7V_QJU[Q=HVE>%+G2X=137M9 ME2SMUMI45XY':?;Y8*LIPV#S@C/%? ?_ :D>*_ 'B+_ ((O_#?PEI7B/2+[ M6-$U+7UUK3+>[BDN; R:W?21B:,$M%NC977/'9Q*PA."L8!%:]9OC'_D6+W_ *X&@";3]/L&L(";*$DPKDF,>@J;^SM/ M_P"?&'_OT*-._P"0?!_UQ7^0J:@"'^SM/_Y\8?\ OT*/[.T__GQA_P"_0J:B M@"'^SM/_ .?&'_OT*?%;6T!)@MT0GJ40#-/HH **** "BBB@ HHHH **** " MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ** M** "BBB@ HHHH **** "BBB@ HHHH *_AU_X*5_\GS_$;_L-)_Z3Q5_<57\. MO_!2O_D^?XC?]AI/_2>*@#PVBBB@ HHHH **** "BBB@ HHHH **** "BBB@ M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** " MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ** M** "BBB@ HHHH **** "BBB@ HHHH **** /O_\ X-]GM-!$+RC4&@M+4*6EN9H,O M<>_\ !M=:?!JE[G>(/C#I%CK.H/XJO'U62.2\U<7TB+#//YUR MI:)XCY<:!?.=8]X_3KX0_$?PI\8M*TKXN> [\W6A^*O"NGZQHUTR;3-:7,2S M0OCME'4X]Z .#^-'[;>D>!OVA=._9#^#WPSU+XA_$Z]\-2>(]0\/Z9J%O9VV MAZ.LHA6\OKJ=@L(EE/EQ1(LDDC*QVJBM(.@_9-_:X^&?[7W@C5O$W@:SU'2= M6\+>)+OPYXW\(Z['&FH^'-9M6"SV5RL3O&6&5=9(W>.2-T=&8-7Q!_P2&UC5 M/B1_P6?_ ."A_P 1_%\CRZEI?B[PEX>TT2Y_T>PMK;4(D5,]%=8(FP."1GDG M-._X)W:]J?AO_@XH_;T^%6A,R^'[W1_ VMW%NI)C34#HUKO<=E9SJ?_ !^@ M#^26BOZVO^(3K_@B=_T;YXD_\.'JG_Q^C_B$Z_X(G?\ 1OGB3_PX>J?_ !^@ M#^26BOZVO^(3K_@B=_T;YXD_\.'JG_Q^C_B$Z_X(G?\ 1OGB3_PX>J?_ !^@ M#^26BOZVO^(3K_@B=_T;YXD_\.'JG_Q^C_B$Z_X(G?\ 1OGB3_PX>J?_ !^@ M#^26BOZVO^(3K_@B=_T;YXD_\.'JG_Q^C_B$Z_X(G?\ 1OGB3_PX>J?_ !^@ M#^26BOZVO^(3K_@B=_T;YXD_\.'JG_Q^LVV_X-2_^"+,OB>ZTQ_V?_$?DQ6R M.B_\+!U3@D\\^=0!_)O17];7_$)U_P $3O\ HWSQ)_X)/\ PX>J?_'Z/^(3K_@B=_T;YXD_\.'JG_Q^ M@#^26BOZVO\ B$Z_X(G?]&^>)/\ PX>J?_'Z/^(3K_@B=_T;YXD_\.'JG_Q^ M@#^26BOZVO\ B$Z_X(G?]&^>)/\ PX>J?_'Z/^(3K_@B=_T;YXD_\.'JG_Q^ M@#^26BOZVO\ B$Z_X(G?]&^>)/\ PX>J?_'Z/^(3K_@B=_T;YXD_\.'JG_Q^ M@#^26BOZVO\ B$Z_X(G?]&^>)/\ PX>J?_'ZH^(_^#4;_@BMIVAW-]:_L_>( MUDBB+(3\0M4.#_W_ * /Y,Z*_K5L_P#@T^_X(HS6D4TG[/OB,LT:EC_PL+5. MI'_7>I?^(3K_ ((G?]&^>)/_ X>J?\ Q^@#^26BOZVO^(3K_@B=_P!&^>)/ M_#AZI_\ 'Z/^(3K_ ((G?]&^>)/_ X>J?\ Q^@#^26BOZVO^(3K_@B=_P!& M^>)/_#AZI_\ 'Z/^(3K_ ((G?]&^>)/_ X>J?\ Q^@#^26BOZVO^(3K_@B= M_P!&^>)/_#AZI_\ 'Z/^(3K_ ((G?]&^>)/_ X>J?\ Q^@#^26BOZVO^(3K M_@B=_P!&^>)/_#AZI_\ 'Z/^(3K_ ((G?]&^>)/_ X>J?\ Q^@#^26BOZVO M^(3K_@B=_P!&^>)/_#AZI_\ 'ZS?"_\ P:E_\$6=3T][B\_9_P#$;,MS(@(^ M(.J#@-@?\MJ /Y-Z*_K:_P"(3K_@B=_T;YXD_P##AZI_\?H_XA.O^")W_1OG MB3_PX>J?_'Z /Y):*_K:_P"(3K_@B=_T;YXD_P##AZI_\?H_XA.O^")W_1OG MB3_PX>J?_'Z /Y):*_K:_P"(3K_@B=_T;YXD_P##AZI_\?H_XA.O^")W_1OG MB3_PX>J?_'Z /Y):*_K:_P"(3K_@B=_T;YXD_P##AZI_\?H_XA.O^")W_1OG MB3_PX>J?_'Z /Y):*_K:_P"(3K_@B=_T;YXD_P##AZI_\?H_XA.O^")W_1OG MB3_PX>J?_'Z /Y):*_K(\+_\&I?_ 19U/3WN+S]G_Q&S+_:D_9T^#NMZ5XR\+_:_P"Q M[^[\97]W'%]IM)K27,4LK(^8;B5>0<$@CD"OMJ@#X8^"G[./QC_X)T?\%!/C MC\5O!/P=USQW\(OVA=2M?%+R^$_LTFH>%O$\:NEY#/;S31--;7?F&5)X]WE. MFR154B0\SX7_ ."/FH_M!? +]KP_M&0?\(EXG_:YU[[:VD17$5XWA6TL8]NB MK<-"[137,8WZ&T4 ?GAXY^&W[/;U=47\S0!\?C]FOXH_L1_P#!3KXE M_MO_ D^$FM^-_A_\?/"6EP?$#0_"1MFU/1O$6E*T5I>+!<30K-:SV\LB,8V M:1)OF9=CLZ=#_P $UOV+_B'\(/B]\=OVX/V@="CTCXA_M ^-(-1G\-K>Q7+^ M'="L(6MM+T^::%GBDN5B9GF:%FBWLJ*SB,.WUO10 4444 %%%% !1110 444 M4 8_B7_D+Z/_ -?I_P#036Q6/XE_Y"^C_P#7Z?\ T$UL4 %%%% !1110 444 M4 %%%% !6;XQ_P"18O?^N!K2K-\8_P#(L7O_ %P- %S3O^0?!_UQ7^0J:H=. M_P"0?!_UQ7^0J:@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *** M* "BBB@ HHHH **** "OCG_@B%_R:;XC_P"RIZW_ #AK[&K\F/\ @GI_P6*_ M8/\ V)OA3XG^!_[0GQ)U32_$47Q#U2]>UM/#5W=((9?**'S(HV7)VGC.17;@ M_Z+7KO_A$:C_\:H_XB0_^ M"3W_ $6O7?\ PB-1_P#C5'^J'%7_ $ U?_!_Z+7KO_ (1&H_\ QJC_ %0XJ_Z M:O\ X+E_D']M91_T$0_\"7^9]VT5\)?\1(?_ 2>_P"BUZ[_ .$1J/\ \:H_ MXB0_^"3W_1:]=_\ "(U'_P"-4?ZH<5?] -7_ ,%R_P @_MK*/^@B'_@2_P S M[MHKX2_XB0_^"3W_ $6O7?\ PB-1_P#C5'_$2'_P2>_Z+7KO_A$:C_\ &J/] M4.*O^@&K_P""Y?Y!_;64?]!$/_ E_F?:ME_R.][_ ->47\S6Q7P!;?\ !QE_ MP2HB\3W6IO\ &C7/)EMD1&_X0K4.2#SQY5:7_$2'_P $GO\ HM>N_P#A$:C_ M /&J/]4.*O\ H!J_^"Y?Y!_;64?]!$/_ )?YGW;17PE_P 1(?\ P2>_Z+7K MO_A$:C_\:H_XB0_^"3W_ $6O7?\ PB-1_P#C5'^J'%7_ $ U?_!_Z+7KO_ (1& MH_\ QJC_ %0XJ_Z :O\ X+E_D']M91_T$0_\"7^9]VT5\)?\1(?_ 2>_P"B MUZ[_ .$1J/\ \:H_XB0_^"3W_1:]=_\ "(U'_P"-4?ZH<5?] -7_ ,%R_P @ M_MK*/^@B'_@2_P S[MHKX2_XB0_^"3W_ $6O7?\ PB-1_P#C5'_$2'_P2>_Z M+7KO_A$:C_\ &J/]4.*O^@&K_P""Y?Y!_;64?]!$/_ E_F?=M8]E_P CO>_] M>47\S7Q5_P 1(?\ P2>_Z+7KO_A$:C_\:K-MO^#C+_@E1%XGNM3?XT:YY,ML MB(W_ A6HN_P#A$:C_ /&J/^(D/_@D]_T6O7?_ B-1_\ C5'^J'%7 M_0#5_P#!4GP5J P,8_P">7-:7_$2'_P $GO\ HM>N_P#A M$:C_ /&J/]4.*O\ H!J_^"Y?Y!_;64?]!$/_ )?YGW;17PE_P 1(?\ P2>_ MZ+7KO_A$:C_\:H_XB0_^"3W_ $6O7?\ PB-1_P#C5'^J'%7_ $ U?_!_Z+7KO_ M (1&H_\ QJC_ %0XJ_Z :O\ X+E_D']M91_T$0_\"7^9]VT5\)?\1(?_ 2> M_P"BUZ[_ .$1J/\ \:H_XB0_^"3W_1:]=_\ "(U'_P"-4?ZH<5?] -7_ ,%R M_P @_MK*/^@B'_@2_P S[MHKX2_XB0_^"3W_ $6O7?\ PB-1_P#C5'_$2'_P M2>_Z+7KO_A$:C_\ &J/]4.*O^@&K_P""Y?Y!_;64?]!$/_ E_F?=M9OC'_D6 M+W_K@:^)/^(D/_@D]_T6O7?_ B-1_\ C54O$?\ P<;?\$IM1T.YL;7XT:XT MDL15 ?!6H#)_[]4?ZH<5?] -7_P7+_(/[:RC_H(A_P"!+_,^]-._Y!\'_7%? MY"IJ^#K/_@X__P""4,-I%#)\:M=#+&H8?\(3J/4#_KE4G_$2'_P2>_Z+7KO_ M (1&H_\ QJC_ %0XJ_Z :O\ X+E_D']M91_T$0_\"7^9]VT5\)?\1(?_ 2> M_P"BUZ[_ .$1J/\ \:H_XB0_^"3W_1:]=_\ "(U'_P"-4?ZH<5?] -7_ ,%R M_P @_MK*/^@B'_@2_P S[MHKX2_XB0_^"3W_ $6O7?\ PB-1_P#C5'_$2'_P M2>_Z+7KO_A$:C_\ &J/]4.*O^@&K_P""Y?Y!_;64?]!$/_ E_F?=M%?"7_$2 M'_P2>_Z+7KO_ (1&H_\ QJC_ (B0_P#@D]_T6O7?_"(U'_XU1_JAQ5_T U?_ M 7+_(/[:RC_ *"(?^!+_,^[:*^$O^(D/_@D]_T6O7?_ B-1_\ C5'_ !$A M_P#!)[_HM>N_^$1J/_QJC_5#BK_H!J_^"Y?Y!_;64?\ 01#_ ,"7^9]VUC^! M_P#D$2_]?LW_ *%7Q5_Q$A_\$GO^BUZ[_P"$1J/_ ,:K-\+_ /!QE_P2HTS3 MWM[SXT:XK-_Z+7KO_ (1&H_\ QJC_ (B0_P#@D]_T6O7?_"(U'_XU1_JA MQ5_T U?_ 7+_(/[:RC_ *"(?^!+_,^[:*^$O^(D/_@D]_T6O7?_ B-1_\ MC5'_ !$A_P#!)[_HM>N_^$1J/_QJC_5#BK_H!J_^"Y?Y!_;64?\ 01#_ ,"7 M^9]VT5\)?\1(?_!)[_HM>N_^$1J/_P :KZR_9G_:1^$_[7/P1T3]H;X':W/J M/A;Q#]I_LN\N;&2V>3R+F6VDS'( RXEAD'(Y R."*XL=D6=97157&8:=.+=D MY1:5]7:[6]D_N-\/F& Q<^2A5C)[V33T^1W=%%%>4=@4444 8_@?_D$2_P#7 M[-_Z%6Q6/X'_ .01+_U^S?\ H5;% !1110 4444 %%%% !1110 5CV7_ ".] M[_UY1?S-;%8]E_R.][_UY1?S- &Q1110 4444 %%%% !1110 4444 8_B7_D M+Z/_ -?I_P#036Q6/XE_Y"^C_P#7Z?\ T$UL4 %%%% !1110 4444 %%%% ! M6;XQ_P"18O?^N!K2K-\8_P#(L7O_ %P- %S3O^0?!_UQ7^0J:H=._P"0?!_U MQ7^0J:@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ MHHHH **** "OY OVL_\ DY#QC_V&I/Y"OZ_:_D"_:S_Y.0\8_P#8:D_D*_6O M!K_DIZW_ %YE_P"ETSXSCG_D4P_QK_TF1YY1117]+'Y4%%%% !1110 4444 M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4 M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11 M10 4444 %%%% !1110 5_3A_P;U?\H?_ (0_]Q__ -2#4J_F/K^G#_@WJ_Y0 M_P#PA_[C_P#ZD&I5^2^,O_),4?\ K]'_ -(J'V? W_(VG_@?_I43[0KQ"R_X M*7?\$\-2^*:? [3OVX?A3<>,I=>_L2+PK!X]L'U!]2\[R/L8@$N\S>;^[\L# M=NXQFMK]N"Z_:- MQX8TK4H_%DEM#B2>VUM(/-:]90S,YFE:1M^Z42N(V_FD_53]2?C%\;?@[^SS MX!N_BI\>?BEX?\&^&;&2*.\U_P 3ZO#8V<#R.(XU:69E4%G95 )Y) %8'[/W M[87[*7[6"ZJ_[,7[1_@CX@KH1A&M-X-\36VI"Q,V_P H2F!V\O?Y,? 7B#7K)3JN MKRJUO"ZV-PLGVIK6V,YC7R9J?\$;_ -H3_@G]^TQ^SCJ?Q&_8 M0_9N\._"-H=>?3OB-\/M*\&6>AWVCZU @5X;R&UC19&"D;)2.5R/E97C0 ^H M? __ "")?^OV;_T*N>^)/[2WP(^$?BO3_A_X\^)FG6WB75H#-I/A:U+7>K7L M0.UI8;&W5[B6,'@NL94$@$C->-_\%'?VXK+_ ()R_P#!._XE?M+P[IUQGR[K5+FX2VM$< @F,32H[@$'RT?!%?+'[!'[7/[/W_!.GX3^!?%' M[='A/XI:7\1/C_?V=S\0?VA/'W@B6WTS5/$5U'YD>F2W4A$]E:VZDV]M')!# M;K%"TBX0N] 'ZAHP= Z@X(R,@@_D>E+110 4444 %%%% !1110 5CV7_ ".] M[_UY1?S-;%8]E_R.][_UY1?S- &Q1110 4444 %%%% !1110 4444 8_B7_D M+Z/_ -?I_P#036Q6/XE_Y"^C_P#7Z?\ T$UL4 %%%% !1110 4444 %%%% ! M6;XQ_P"18O?^N!K2K-\8_P#(L7O_ %P- %S3O^0?!_UQ7^0J:H=._P"0?!_U MQ7^0J:@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ MHHHH **** "OY OVL_\ DY#QC_V&I/Y"OZ_:_#KX2?\ !%K]F']K/PA)^T%\ M2/B!X]LM8\0:WJ?VJUT34K**VC$%]/;)M66TD;E85)RQY)Q@<5]]X<\0Y;PU MG=3%8UM0E3<597U?_@##_4W._P"6/_@2/Q>HK]H?^(<_ M]B?_ **G\4__ =:;_\ *^C_ (AS_P!B?_HJ?Q3_ /!UIO\ \KZ/^(L<'_SS M_P# &'^IN=_RQ_\ D?B]17[0_\ $.?^Q/\ ]%3^*?\ X.M-_P#E?1_Q#G_L M3_\ 14_BG_X.M-_^5]'_ !%C@_\ GG_X P_U-SO^6/\ X$C\7J*_:'_B'/\ MV)_^BI_%/_P=:;_\KZ/^(<_]B?\ Z*G\4_\ P=:;_P#*^C_B+'!_\\__ !A M_J;G?\L?_ D?B]17[0?\0Y_[%.?^2J?%+'_89TW_ .0*7_B'/_8G_P"BI_%/ M_P '6F__ "OH_P"(L<'_ ,\__ &'^IN=_P L?_ D?B]17[0_\0Y_[$__ $5/ MXI_^#K3?_E?1_P 0Y_[$_P#T5/XI_P#@ZTW_ .5]'_$6.#_YY_\ @##_ %-S MO^6/_@2/Q>HK]H?^(<_]B?\ Z*G\4_\ P=:;_P#*^C_B'/\ V)_^BI_%/_P= M:;_\KZ/^(L<'_P \_P#P!A_J;G?\L?\ P)'XO45^T/\ Q#G_ +$__14_BG_X M.M-_^5]'_$.?^Q/_ -%3^*?_ (.M-_\ E?1_Q%C@_P#GG_X P_U-SO\ EC_X M$C\7J*_:'_B'/_8G_P"BI_%/_P '6F__ "OH_P"(<_\ 8G_Z*G\4_P#P=:;_ M /*^C_B+'!_\\_\ P!A_J;G?\L?_ )'XO45^T/_ !#G_L3_ /14_BG_ .#K M3?\ Y7TG_$.?^Q3G_DJGQ2Q_V&=-_P#D"C_B+'!_\\__ !A_J;G?\L?_ D? MB_17[0_\0Y_[$_\ T5/XI_\ @ZTW_P"5]'_$.?\ L3_]%3^*?_@ZTW_Y7T?\ M18X/_GG_ . ,/]3<[_EC_P"!(_%ZBOVA_P"(<_\ 8G_Z*G\4_P#P=:;_ /*^ MC_B'/_8G_P"BI_%/_P '6F__ "OH_P"(L<'_ ,\__ &'^IN=_P L?_ D?B]1 M7[0_\0Y_[$__ $5/XI_^#K3?_E?1_P 0Y_[$_P#T5/XI_P#@ZTW_ .5]'_$6 M.#_YY_\ @##_ %-SO^6/_@2/Q>HK]H?^(<_]B?\ Z*G\4_\ P=:;_P#*^C_B M'/\ V)_^BI_%/_P=:;_\KZ/^(L<'_P \_P#P!A_J;G?\L?\ P)'XO45^T/\ MQ#G_ +$__14_BG_X.M-_^5]'_$.?^Q/_ -%3^*?_ (.M-_\ E?1_Q%C@_P#G MG_X P_U-SO\ EC_X$C\7J*_: _\ !N?^Q3D8^*GQ2]_^)SIO_P @4O\ Q#G_ M +$__14_BG_X.M-_^5]'_$6.#_YY_P#@##_4W._Y8_\ @2/Q>HK]H?\ B'/_ M &)_^BI_%/\ \'6F_P#ROH_XAS_V)_\ HJ?Q3_\ !UIO_P KZ/\ B+'!_P#/ M/_P!A_J;G?\ +'_P)'XO45^T/_$.?^Q/_P!%3^*?_@ZTW_Y7T?\ $.?^Q/\ M]%3^*?\ X.M-_P#E?1_Q%C@_^>?_ ( P_P!3<[_EC_X$C\7J*_:'_B'/_8G_ M .BI_%/_ ,'6F_\ ROH_XAS_ -B?_HJ?Q3_\'6F__*^C_B+'!_\ //\ \ 8? MZFYW_+'_ ,"1^+U%?M#_ ,0Y_P"Q/_T5/XI_^#K3?_E?1_Q#G_L3_P#14_BG M_P"#K3?_ )7T?\18X/\ YY_^ ,/]3<[_ )8_^!(_%ZBOVA_XAS_V)_\ HJ?Q M3_\ !UIO_P KZ0_\&Y_[%&./BI\4L^^M:;_\@4?\18X/_GG_ . ,/]3<[_EC M_P"!(_%^BOV@_P"(<_\ 8H[_ !3^*7_@ZTW_ .0*7_B'/_8G_P"BI_%/_P ' M6F__ "OH_P"(L<'_ ,\__ &'^IN=_P L?_ D?B]17[0_\0Y_[$__ $5/XI_^ M#K3?_E?1_P 0Y_[$_P#T5/XI_P#@ZTW_ .5]'_$6.#_YY_\ @##_ %-SO^6/ M_@2/Q>HK]H?^(<_]B?\ Z*G\4_\ P=:;_P#*^C_B'/\ V)_^BI_%/_P=:;_\ MKZ/^(L<'_P \_P#P!A_J;G?\L?\ P)'XO45^T/\ Q#G_ +$__14_BG_X.M-_ M^5]'_$.?^Q/_ -%3^*?_ (.M-_\ E?1_Q%C@_P#GG_X P_U-SO\ EC_X$C\7 MJ*_:'_B'/_8G_P"BI_%/_P '6F__ "OKT[_B$Y_8Q_Z.-^)__?S3O_D6FO%? M@Y_\O)K_ +<8GP=GB^RO_ D?@A17[W_\0G/[&/\ T<;\3_\ OYIW_P BU0\/ M?\&IW[&^L6+W4_[1'Q-4K.\8"2:=C"G'_/K5?\16X._Y^R_\ D+_ %.SS^1? M^!(_!^BOWO\ ^(3G]C'_ *.-^)__ '\T[_Y%H_XA.?V,?^CC?B?_ -_-._\ MD6C_ (BMP=_S]E_X!(/]3L\_D7_@2/P0HK][_P#B$Y_8Q_Z.-^)__?S3O_D6 MC_B$Y_8Q_P"CC?B?_P!_-._^1:/^(K<'?\_9?^ 2#_4[//Y%_P"!(_!"OZK_E#_ /"'_N/_ /J0:E7S]_Q"<_L8_P#1QOQ/_P"_FG?_ "+7W[^Q/^R; MX+_8;_9C\,_LM_#WQ'JFKZ/X7^V_8]0UDQFYE^TWL]V^_P I57A[AE&%'RJ, MY.37Y_XC\;9!Q)D=/#8&;+6BC-=?-H^DX7R',0TZP@G=[&2^@9HQ<7DS6L(LPQD*!Y70+#FON75-*TO7-.FTC6]- MM[RTN$*7%K=0K)'*IZJRL"&'L:31M%T;P[ID.B^'])MK&SMUVV]I9P+%%$OH MJJ %'T%?BQ]X>"_$S_@JK_P3X^"/[2&J_LF_'/\ :E\,>!?&VD:/:ZI/8^-K MEM)M9[>X!,9@O+H1V]PQ_N1R,VTDO[?2=,,$^L_9W >);NYFN&3\;L"R?@16C0!^8/_ 44/A'_ (+J M?\$)?B'K?_!/[5;[Q7,-;.H>';)]+GM)]2N=+ODEGM%BF57:1X1)Y8P=[M&O M!)Q)_P %;?C7\%O^"I__ 1RB^#7[-FJZ3XE^(GQGO?#EKX%\#VMRCZEIVJ) MJEG->K<0@^99BRACNASMDOKADM[ M2!8T4M(68A5 )8DGU))K2T_PIX7TG6+OQ#I?ANPMK^_Q]NOK>S1)KC'3S' MW/CW)H A\">';KPAX'T;PG?:H]]/I>E6]I->R9W7#1Q*AD.23EBN>O>M6BB@ M HHHH **** "BBB@ K'LO^1WO?\ KRB_F:V*Q[+_ )'>]_Z\HOYF@#8HHHH M**** "BBB@ HHHH **** ,?Q+_R%]'_Z_3_Z":V*Q_$O_(7T?_K]/_H)K8H M**** "BBB@ HHHH **** "LWQC_R+%[_ -<#6E6;XQ_Y%B]_ZX&@"YIW_(/@ M_P"N*_R%35#IW_(/@_ZXK_(5-0 4444 %%%% !1110 4444 %%%% 'SU_P % M(?\ @H9X3_X)G?L_WW[3WQ4^"OB_Q/X.TB>UAUF^\(R6#2V37%PMO$6BNKF% MF4R/&I*;L>8., DGZU-=E AW-Y<3LH!W*,&O'?\ @ZG_ .4'/Q=_["'AO_T_ MV%?<'[/?_) _ _\ V)^F?^DL= &/^RE^UO\ L\?MN_!33/VA/V7_ (G6/BOP MIJI9(;^S#(\$R8WP3Q2!9()ER-TE?LT^*_B_^U-I.N?$_P"('Q4\-^&_CI\ CH^C M267AFWUD2%UMI;"(W5G+;%0D9N;J=9SN;Y@I% 'ZJ45\&?M:?M+?M<_LG?\ M!5WX&>#?'OQ^DA_9U^-6I7&AV\:>%].$^E>*$B+VFF37;0E_LUV=JQD#S=PD M7> N\>O3?%7X[^*?V]?'NA?#OX@:A??#[X5?#JSF\1>#K;2;(G4_%%XD\\%A M%._B6WR0MQ-/<>;'$X7$KJ$ M_1^42F)A"ZJY4[&9<@'L2,C(]LB@#RWX&?'#XU?$WXR_%+X=_$C]EK6/ WA_ MP1K=G9^#/&.HZU!

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end XML 20 ivc-20200930_htm.xml IDEA: XBRL DOCUMENT 0000742112 2020-01-01 2020-09-30 0000742112 us-gaap:CommonStockMember 2020-10-27 0000742112 us-gaap:CommonClassBMember 2020-10-27 0000742112 2020-07-01 2020-09-30 0000742112 2019-07-01 2019-09-30 0000742112 2019-01-01 2019-09-30 0000742112 2020-09-30 0000742112 2019-12-31 0000742112 us-gaap:CommonStockMember 2020-09-30 0000742112 us-gaap:CommonStockMember 2019-12-31 0000742112 us-gaap:CommonClassBMember 2020-09-30 0000742112 us-gaap:CommonClassBMember 2019-12-31 0000742112 2018-12-31 0000742112 us-gaap:CarryingReportedAmountFairValueDisclosureMember 2020-09-30 0000742112 2019-09-30 0000742112 us-gaap:CommonStockMember 2020-06-30 0000742112 us-gaap:CommonClassBMember 2020-06-30 0000742112 us-gaap:AdditionalPaidInCapitalMember 2020-06-30 0000742112 us-gaap:RetainedEarningsMember 2020-06-30 0000742112 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-06-30 0000742112 us-gaap:TreasuryStockMember 2020-06-30 0000742112 2020-06-30 0000742112 us-gaap:CommonStockMember 2020-07-01 2020-09-30 0000742112 us-gaap:AdditionalPaidInCapitalMember 2020-07-01 2020-09-30 0000742112 us-gaap:TreasuryStockMember 2020-07-01 2020-09-30 0000742112 us-gaap:RetainedEarningsMember 2020-07-01 2020-09-30 0000742112 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-07-01 2020-09-30 0000742112 us-gaap:CommonStockMember 2020-09-30 0000742112 us-gaap:AdditionalPaidInCapitalMember 2020-09-30 0000742112 us-gaap:RetainedEarningsMember 2020-09-30 0000742112 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-09-30 0000742112 us-gaap:TreasuryStockMember 2020-09-30 0000742112 us-gaap:CommonStockMember 2019-06-30 0000742112 us-gaap:CommonClassBMember 2019-06-30 0000742112 us-gaap:AdditionalPaidInCapitalMember 2019-06-30 0000742112 us-gaap:RetainedEarningsMember 2019-06-30 0000742112 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-06-30 0000742112 us-gaap:TreasuryStockMember 2019-06-30 0000742112 2019-06-30 0000742112 us-gaap:CommonStockMember 2019-07-01 2019-09-30 0000742112 us-gaap:AdditionalPaidInCapitalMember 2019-07-01 2019-09-30 0000742112 us-gaap:TreasuryStockMember 2019-07-01 2019-09-30 0000742112 us-gaap:RetainedEarningsMember 2019-07-01 2019-09-30 0000742112 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-07-01 2019-09-30 0000742112 us-gaap:CommonStockMember 2019-09-30 0000742112 us-gaap:CommonClassBMember 2019-09-30 0000742112 us-gaap:AdditionalPaidInCapitalMember 2019-09-30 0000742112 us-gaap:RetainedEarningsMember 2019-09-30 0000742112 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-09-30 0000742112 us-gaap:TreasuryStockMember 2019-09-30 0000742112 us-gaap:CommonStockMember 2019-12-31 0000742112 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0000742112 us-gaap:RetainedEarningsMember 2019-12-31 0000742112 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-12-31 0000742112 us-gaap:TreasuryStockMember 2019-12-31 0000742112 us-gaap:CommonStockMember 2020-01-01 2020-09-30 0000742112 us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-09-30 0000742112 us-gaap:TreasuryStockMember 2020-01-01 2020-09-30 0000742112 us-gaap:RetainedEarningsMember 2020-01-01 2020-09-30 0000742112 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-01-01 2020-09-30 0000742112 us-gaap:CommonStockMember 2018-12-31 0000742112 us-gaap:CommonClassBMember 2018-12-31 0000742112 us-gaap:AdditionalPaidInCapitalMember 2018-12-31 0000742112 us-gaap:RetainedEarningsMember 2018-12-31 0000742112 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-12-31 0000742112 us-gaap:TreasuryStockMember 2018-12-31 0000742112 us-gaap:CommonStockMember 2019-01-01 2019-09-30 0000742112 us-gaap:AdditionalPaidInCapitalMember 2019-01-01 2019-09-30 0000742112 us-gaap:TreasuryStockMember 2019-01-01 2019-09-30 0000742112 us-gaap:RetainedEarningsMember 2019-01-01 2019-09-30 0000742112 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-01-01 2019-09-30 0000742112 2020-01-01 2020-03-07 0000742112 2019-01-01 2019-12-31 0000742112 2020-03-07 0000742112 us-gaap:RiskLevelLowMember 2020-01-01 2020-09-30 0000742112 us-gaap:RiskLevelMediumMember 2020-01-01 2020-09-30 0000742112 us-gaap:RiskLevelHighMember 2020-01-01 2020-09-30 0000742112 country:US 2020-09-30 0000742112 country:US 2020-01-01 2020-09-30 0000742112 country:CA 2020-09-30 0000742112 country:CA 2020-01-01 2020-09-30 0000742112 country:US 2019-12-31 0000742112 country:US 2019-01-01 2019-12-31 0000742112 country:CA 2019-12-31 0000742112 country:CA 2019-01-01 2019-12-31 0000742112 us-gaap:MachineryAndEquipmentMember 2020-09-30 0000742112 us-gaap:MachineryAndEquipmentMember 2019-12-31 0000742112 us-gaap:LandBuildingsAndImprovementsMember 2020-09-30 0000742112 us-gaap:LandBuildingsAndImprovementsMember 2019-12-31 0000742112 ivc:CapitalizedSoftwareMember 2020-09-30 0000742112 ivc:CapitalizedSoftwareMember 2019-12-31 0000742112 us-gaap:FurnitureAndFixturesMember 2020-09-30 0000742112 us-gaap:FurnitureAndFixturesMember 2019-12-31 0000742112 us-gaap:LeaseholdImprovementsMember 2020-09-30 0000742112 us-gaap:LeaseholdImprovementsMember 2019-12-31 0000742112 2018-07-01 2018-09-30 0000742112 2020-04-01 2020-06-30 0000742112 us-gaap:CustomerListsMember 2020-09-30 0000742112 us-gaap:CustomerListsMember 2019-12-31 0000742112 us-gaap:TrademarksMember 2020-09-30 0000742112 us-gaap:TrademarksMember 2019-12-31 0000742112 us-gaap:DevelopedTechnologyRightsMember 2020-09-30 0000742112 us-gaap:DevelopedTechnologyRightsMember 2019-12-31 0000742112 us-gaap:PatentsMember 2020-09-30 0000742112 us-gaap:PatentsMember 2019-12-31 0000742112 us-gaap:LicensingAgreementsMember 2020-09-30 0000742112 us-gaap:LicensingAgreementsMember 2019-12-31 0000742112 us-gaap:OtherIntangibleAssetsMember 2020-09-30 0000742112 us-gaap:OtherIntangibleAssetsMember 2019-12-31 0000742112 srt:MinimumMember 2020-01-01 2020-09-30 0000742112 srt:MaximumMember 2020-01-01 2020-09-30 0000742112 srt:WeightedAverageMember 2020-01-01 2020-09-30 0000742112 ivc:ConvertibleSeniorNotesat5.00February2021Member us-gaap:ConvertibleSubordinatedDebtMember 2020-09-30 0000742112 ivc:ConvertibleSeniorNotesat5.00February2021Member us-gaap:ConvertibleSubordinatedDebtMember 2019-12-31 0000742112 ivc:ConvertibleSeniorNotesat4.50February2022Domain us-gaap:ConvertibleSubordinatedDebtMember 2020-09-30 0000742112 ivc:ConvertibleSeniorNotesat4.50February2022Domain us-gaap:ConvertibleSubordinatedDebtMember 2019-12-31 0000742112 ivc:ConvertibleSeniorNotesat5.00November2024Domain us-gaap:ConvertibleSubordinatedDebtMember 2020-09-30 0000742112 ivc:ConvertibleSeniorNotesat5.00November2024Domain us-gaap:ConvertibleSubordinatedDebtMember 2019-12-31 0000742112 ivc:SeriesIIConvertibleSeniorNotesAt500November2024Domain us-gaap:ConvertibleSubordinatedDebtMember 2020-09-30 0000742112 ivc:SeriesIIConvertibleSeniorNotesAt500November2024Domain us-gaap:ConvertibleSubordinatedDebtMember 2019-12-31 0000742112 ivc:OtherNotesandCapitalLeaseObligationsMember 2020-09-30 0000742112 ivc:OtherNotesandCapitalLeaseObligationsMember 2019-12-31 0000742112 ivc:ConvertibleSeniorSubordinatedDebenturesat5.00February2021Domain us-gaap:ConvertibleSubordinatedDebtMember 2020-01-01 2020-09-30 0000742112 us-gaap:LetterOfCreditMember 2020-09-30 0000742112 us-gaap:LetterOfCreditMember 2019-12-31 0000742112 us-gaap:RevolvingCreditFacilityMember ivc:RevolvingCreditandSecurityAgreementNewCreditAgreementMember us-gaap:LineOfCreditMember 2020-09-30 0000742112 currency:EUR us-gaap:RevolvingCreditFacilityMember ivc:RevolvingCreditandSecurityAgreementNewCreditAgreementMember us-gaap:LineOfCreditMember 2020-09-30 0000742112 currency:GBP us-gaap:RevolvingCreditFacilityMember ivc:RevolvingCreditandSecurityAgreementNewCreditAgreementMember us-gaap:LineOfCreditMember 2020-09-30 0000742112 us-gaap:RevolvingCreditFacilityMember us-gaap:LineOfCreditMember 2020-09-30 0000742112 us-gaap:RevolvingCreditFacilityMember us-gaap:LineOfCreditMember 2019-12-31 0000742112 us-gaap:LetterOfCreditMember ivc:RevolvingCreditandSecurityAgreementNewCreditAgreementMember us-gaap:LineOfCreditMember 2020-09-30 0000742112 us-gaap:RevolvingCreditFacilityMember ivc:RevolvingCreditandSecurityAgreementNewCreditAgreementMember us-gaap:LineOfCreditMember 2020-01-01 2020-09-30 0000742112 srt:MinimumMember us-gaap:RevolvingCreditFacilityMember ivc:RevolvingCreditandSecurityAgreementNewCreditAgreementMember us-gaap:LineOfCreditMember us-gaap:LondonInterbankOfferedRateLIBORMember 2020-01-01 2020-09-30 0000742112 srt:MaximumMember us-gaap:RevolvingCreditFacilityMember ivc:RevolvingCreditandSecurityAgreementNewCreditAgreementMember us-gaap:LineOfCreditMember us-gaap:LondonInterbankOfferedRateLIBORMember 2020-01-01 2020-09-30 0000742112 srt:MinimumMember us-gaap:RevolvingCreditFacilityMember ivc:RevolvingCreditandSecurityAgreementNewCreditAgreementMember us-gaap:LineOfCreditMember us-gaap:BaseRateMember 2020-01-01 2020-09-30 0000742112 srt:MaximumMember us-gaap:RevolvingCreditFacilityMember ivc:RevolvingCreditandSecurityAgreementNewCreditAgreementMember us-gaap:LineOfCreditMember us-gaap:BaseRateMember 2020-01-01 2020-09-30 0000742112 srt:MinimumMember us-gaap:RevolvingCreditFacilityMember ivc:RevolvingCreditandSecurityAgreementNewCreditAgreementMember us-gaap:LineOfCreditMember 2020-01-01 2020-09-30 0000742112 srt:MaximumMember us-gaap:RevolvingCreditFacilityMember ivc:RevolvingCreditandSecurityAgreementNewCreditAgreementMember us-gaap:LineOfCreditMember 2020-01-01 2020-09-30 0000742112 us-gaap:RevolvingCreditFacilityMember ivc:RevolvingCreditandSecurityAgreementEuropeCreditAgreementMemberDomain us-gaap:LineOfCreditMember 2020-09-30 0000742112 us-gaap:LetterOfCreditMember ivc:RevolvingCreditandSecurityAgreementEuropeCreditAgreementMemberDomain us-gaap:LineOfCreditMember 2020-09-30 0000742112 ivc:SwingLineLoansDomain ivc:RevolvingCreditandSecurityAgreementEuropeCreditAgreementMemberDomain us-gaap:LineOfCreditMember 2020-09-30 0000742112 ivc:AmountAvailabletoInvacareLimitedandInvacarePoirierSASDomain ivc:RevolvingCreditandSecurityAgreementEuropeCreditAgreementMemberDomain us-gaap:LineOfCreditMember 2020-09-30 0000742112 us-gaap:RevolvingCreditFacilityMember ivc:RevolvingCreditandSecurityAgreementEuropeCreditAgreementMemberDomain us-gaap:LineOfCreditMember 2020-01-01 2020-09-30 0000742112 srt:MinimumMember us-gaap:RevolvingCreditFacilityMember ivc:RevolvingCreditandSecurityAgreementEuropeCreditAgreementMemberDomain us-gaap:LineOfCreditMember us-gaap:LondonInterbankOfferedRateLIBORMember 2020-01-01 2020-09-30 0000742112 srt:MaximumMember us-gaap:RevolvingCreditFacilityMember ivc:RevolvingCreditandSecurityAgreementEuropeCreditAgreementMemberDomain us-gaap:LineOfCreditMember us-gaap:LondonInterbankOfferedRateLIBORMember 2020-01-01 2020-09-30 0000742112 srt:MinimumMember us-gaap:RevolvingCreditFacilityMember ivc:RevolvingCreditandSecurityAgreementEuropeCreditAgreementMemberDomain us-gaap:LineOfCreditMember us-gaap:BaseRateMember 2020-01-01 2020-09-30 0000742112 srt:MaximumMember us-gaap:RevolvingCreditFacilityMember ivc:RevolvingCreditandSecurityAgreementEuropeCreditAgreementMemberDomain us-gaap:LineOfCreditMember us-gaap:BaseRateMember 2020-01-01 2020-09-30 0000742112 srt:MinimumMember us-gaap:RevolvingCreditFacilityMember ivc:RevolvingCreditandSecurityAgreementEuropeCreditAgreementMemberDomain us-gaap:LineOfCreditMember 2020-01-01 2020-09-30 0000742112 srt:MaximumMember us-gaap:RevolvingCreditFacilityMember ivc:RevolvingCreditandSecurityAgreementEuropeCreditAgreementMemberDomain us-gaap:LineOfCreditMember 2020-01-01 2020-09-30 0000742112 ivc:ConvertibleSeniorNotesat5.00February2021Member us-gaap:ConvertibleSubordinatedDebtMember 2016-03-31 0000742112 ivc:ConvertibleSeniorNotesat5.00February2021Member us-gaap:ConvertibleSubordinatedDebtMember 2019-09-30 0000742112 ivc:ConvertibleSeniorNotesat5.00February2021Member us-gaap:ConvertibleSubordinatedDebtMember 2020-01-01 2020-09-30 0000742112 ivc:ConvertibleSeniorNotesat5.00February2021Member us-gaap:ConvertibleSubordinatedDebtMember 2019-01-01 2019-09-30 0000742112 2016-01-01 2016-03-31 0000742112 ivc:ConvertibleSeniorNotesat5.00February2021Member us-gaap:ConvertibleSubordinatedDebtMember 2016-12-31 0000742112 ivc:ConvertibleSeniorNotesat5.00February2021Member us-gaap:ConvertibleSubordinatedDebtMember 2016-01-01 2016-03-31 0000742112 ivc:ConvertibleSeniorNotesat5.00February2021Member us-gaap:ConvertibleSubordinatedDebtMember 2020-07-01 2020-09-30 0000742112 ivc:ConvertibleSeniorNotesat5.00February2021Member us-gaap:ConvertibleSubordinatedDebtMember 2019-07-01 2019-09-30 0000742112 ivc:ConvertibleSeniorNotesat4.50February2022Domain us-gaap:ConvertibleSubordinatedDebtMember 2017-06-30 0000742112 ivc:ConvertibleSeniorNotesat4.50February2022Domain us-gaap:ConvertibleSubordinatedDebtMember 2020-01-01 2020-09-30 0000742112 ivc:ConvertibleSeniorNotesat4.50February2022Domain us-gaap:ConvertibleSubordinatedDebtMember 2019-01-01 2019-09-30 0000742112 ivc:ConvertibleSeniorNotesat4.50February2022Domain us-gaap:ConvertibleSubordinatedDebtMember 2017-04-01 2017-06-30 0000742112 ivc:ConvertibleSeniorNotesat4.50February2022Domain us-gaap:ConvertibleSubordinatedDebtMember 2020-07-01 2020-09-30 0000742112 ivc:ConvertibleSeniorNotesat4.50February2022Domain us-gaap:ConvertibleSubordinatedDebtMember 2019-07-01 2019-09-30 0000742112 ivc:ConvertibleSeniorNotesat5.00February2021Member us-gaap:ConvertibleSubordinatedDebtMember 2019-10-01 2019-12-31 0000742112 ivc:ConvertibleSeniorNotesat5.00November2024Member us-gaap:ConvertibleSubordinatedDebtMember 2019-12-31 0000742112 ivc:ConvertibleSeniorNotesat5.00November2024Member us-gaap:ConvertibleSubordinatedDebtMember 2020-09-30 0000742112 ivc:ConvertibleSeniorNotesat5.00November2024Member us-gaap:ConvertibleSubordinatedDebtMember 2020-01-01 2020-09-30 0000742112 ivc:ConvertibleSeniorNotesat5.00November2024Domain us-gaap:ConvertibleSubordinatedDebtMember 2020-01-01 2020-09-30 0000742112 ivc:ConvertibleSeniorNotesat5.00November2024Member us-gaap:ConvertibleSubordinatedDebtMember 2019-10-01 2019-12-31 0000742112 ivc:ConvertibleSeniorNotesat5.00November2024Member us-gaap:ConvertibleSubordinatedDebtMember 2020-07-01 2020-09-30 0000742112 ivc:ConvertibleSeniorNotesat5.00February2021Member us-gaap:ConvertibleSubordinatedDebtMember 2020-04-01 2020-06-30 0000742112 ivc:ConvertibleSeniorNotesat4.50February2022Domain us-gaap:ConvertibleSubordinatedDebtMember 2020-04-01 2020-06-30 0000742112 ivc:SeriesIIConvertibleSeniorNotesAt500November2024Member us-gaap:ConvertibleSubordinatedDebtMember 2020-04-01 2020-06-30 0000742112 ivc:SeriesIIConvertibleSeniorNotesAt500November2024Member us-gaap:ConvertibleSubordinatedDebtMember 2020-09-30 0000742112 ivc:SeriesIIConvertibleSeniorNotesAt500November2024Member us-gaap:ConvertibleSubordinatedDebtMember 2020-01-01 2020-09-30 0000742112 ivc:SeriesIIConvertibleSeniorNotesAt500November2024Domain us-gaap:ConvertibleSubordinatedDebtMember 2020-01-01 2020-09-30 0000742112 ivc:SeriesIIConvertibleSeniorNotesAt500November2024Member us-gaap:ConvertibleSubordinatedDebtMember 2020-06-30 0000742112 ivc:SeriesIIConvertibleSeniorNotesAt500November2024Member us-gaap:ConvertibleSubordinatedDebtMember 2020-07-01 2020-09-30 0000742112 ivc:CARESActLoanMember 2020-05-15 0000742112 ivc:CARESActLoanMember 2020-09-30 0000742112 2015-04-23 0000742112 2015-04-01 2015-06-30 0000742112 2015-04-22 2015-04-23 0000742112 2020-07-01 0000742112 us-gaap:ProductMember srt:EuropeMember 2020-07-01 2020-09-30 0000742112 ivc:ServicesMember srt:EuropeMember 2020-07-01 2020-09-30 0000742112 srt:EuropeMember 2020-07-01 2020-09-30 0000742112 us-gaap:ProductMember srt:NorthAmericaMember 2020-07-01 2020-09-30 0000742112 ivc:ServicesMember srt:NorthAmericaMember 2020-07-01 2020-09-30 0000742112 srt:NorthAmericaMember 2020-07-01 2020-09-30 0000742112 us-gaap:ProductMember srt:AsiaPacificMember 2020-07-01 2020-09-30 0000742112 ivc:ServicesMember srt:AsiaPacificMember 2020-07-01 2020-09-30 0000742112 srt:AsiaPacificMember 2020-07-01 2020-09-30 0000742112 us-gaap:ProductMember 2020-07-01 2020-09-30 0000742112 ivc:ServicesMember 2020-07-01 2020-09-30 0000742112 us-gaap:ProductMember srt:EuropeMember 2020-01-01 2020-09-30 0000742112 ivc:ServicesMember srt:EuropeMember 2020-01-01 2020-09-30 0000742112 srt:EuropeMember 2020-01-01 2020-09-30 0000742112 us-gaap:ProductMember srt:NorthAmericaMember 2020-01-01 2020-09-30 0000742112 ivc:ServicesMember srt:NorthAmericaMember 2020-01-01 2020-09-30 0000742112 srt:NorthAmericaMember 2020-01-01 2020-09-30 0000742112 us-gaap:ProductMember srt:AsiaPacificMember 2020-01-01 2020-09-30 0000742112 ivc:ServicesMember srt:AsiaPacificMember 2020-01-01 2020-09-30 0000742112 srt:AsiaPacificMember 2020-01-01 2020-09-30 0000742112 us-gaap:ProductMember 2020-01-01 2020-09-30 0000742112 ivc:ServicesMember 2020-01-01 2020-09-30 0000742112 us-gaap:ProductMember srt:EuropeMember 2019-07-01 2019-09-30 0000742112 ivc:ServicesMember srt:EuropeMember 2019-07-01 2019-09-30 0000742112 srt:EuropeMember 2019-07-01 2019-09-30 0000742112 us-gaap:ProductMember srt:NorthAmericaMember 2019-07-01 2019-09-30 0000742112 ivc:ServicesMember srt:NorthAmericaMember 2019-07-01 2019-09-30 0000742112 srt:NorthAmericaMember 2019-07-01 2019-09-30 0000742112 us-gaap:ProductMember srt:AsiaPacificMember 2019-07-01 2019-09-30 0000742112 ivc:ServicesMember srt:AsiaPacificMember 2019-07-01 2019-09-30 0000742112 srt:AsiaPacificMember 2019-07-01 2019-09-30 0000742112 us-gaap:ProductMember 2019-07-01 2019-09-30 0000742112 ivc:ServicesMember 2019-07-01 2019-09-30 0000742112 us-gaap:ProductMember srt:EuropeMember 2019-01-01 2019-09-30 0000742112 ivc:ServicesMember srt:EuropeMember 2019-01-01 2019-09-30 0000742112 srt:EuropeMember 2019-01-01 2019-09-30 0000742112 us-gaap:ProductMember srt:NorthAmericaMember 2019-01-01 2019-09-30 0000742112 ivc:ServicesMember srt:NorthAmericaMember 2019-01-01 2019-09-30 0000742112 srt:NorthAmericaMember 2019-01-01 2019-09-30 0000742112 us-gaap:ProductMember srt:AsiaPacificMember 2019-01-01 2019-09-30 0000742112 ivc:ServicesMember srt:AsiaPacificMember 2019-01-01 2019-09-30 0000742112 srt:AsiaPacificMember 2019-01-01 2019-09-30 0000742112 us-gaap:ProductMember 2019-01-01 2019-09-30 0000742112 ivc:ServicesMember 2019-01-01 2019-09-30 0000742112 ivc:GeneralTermsandConditionsMember 2020-01-01 2020-09-30 0000742112 ivc:LargeNationalCustomersMember 2020-01-01 2020-09-30 0000742112 ivc:GovernmentTendersMember 2020-01-01 2020-09-30 0000742112 ivc:OtherCustomersMember 2020-01-01 2020-09-30 0000742112 us-gaap:CommonClassBMember 2020-01-01 2020-09-30 0000742112 us-gaap:CommonStockMember 2020-01-01 2020-09-30 0000742112 us-gaap:EmployeeStockOptionMember 2020-09-30 0000742112 ivc:A2018PlanMember 2020-01-01 2020-09-30 0000742112 ivc:A2018PlanMember 2020-04-01 2020-06-30 0000742112 ivc:A2013PlanMember 2020-09-30 0000742112 ivc:RestrictedStockandRestrictedStockUnitsRSUsMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2020-01-01 2020-09-30 0000742112 ivc:RestrictedStockandRestrictedStockUnitsRSUsMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2019-01-01 2019-09-30 0000742112 us-gaap:PerformanceSharesMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2020-01-01 2020-09-30 0000742112 us-gaap:PerformanceSharesMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2019-01-01 2019-09-30 0000742112 us-gaap:EmployeeStockOptionMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2020-01-01 2020-09-30 0000742112 us-gaap:EmployeeStockOptionMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2019-01-01 2019-09-30 0000742112 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2020-01-01 2020-09-30 0000742112 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2019-01-01 2019-09-30 0000742112 ivc:RestrictedStockandRestrictedStockUnitsRSUsMember 2020-09-30 0000742112 us-gaap:PerformanceSharesMember 2020-09-30 0000742112 us-gaap:EmployeeStockOptionMember 2020-01-01 2020-09-30 0000742112 ivc:RangeOfExercisePriceOneMember 2020-01-01 2020-09-30 0000742112 ivc:RangeOfExercisePriceFourMember 2020-01-01 2020-09-30 0000742112 us-gaap:RestrictedStockMember 2020-01-01 2020-09-30 0000742112 us-gaap:PerformanceSharesMember 2020-01-01 2020-09-30 0000742112 srt:MinimumMember ivc:RangeOfExercisePriceOneMember 2020-01-01 2020-09-30 0000742112 srt:MaximumMember ivc:RangeOfExercisePriceOneMember 2020-01-01 2020-09-30 0000742112 us-gaap:EmployeeStockOptionMember ivc:RangeOfExercisePriceOneMember 2020-09-30 0000742112 us-gaap:EmployeeStockOptionMember ivc:RangeOfExercisePriceOneMember 2020-01-01 2020-09-30 0000742112 srt:MinimumMember ivc:RangeOfExercisePriceTwoMember 2020-01-01 2020-09-30 0000742112 srt:MaximumMember ivc:RangeOfExercisePriceTwoMember 2020-01-01 2020-09-30 0000742112 us-gaap:EmployeeStockOptionMember ivc:RangeOfExercisePriceTwoMember 2020-09-30 0000742112 us-gaap:EmployeeStockOptionMember ivc:RangeOfExercisePriceTwoMember 2020-01-01 2020-09-30 0000742112 srt:MinimumMember ivc:RangeOfExercisePriceThreeMember 2020-01-01 2020-09-30 0000742112 srt:MaximumMember ivc:RangeOfExercisePriceThreeMember 2020-01-01 2020-09-30 0000742112 us-gaap:EmployeeStockOptionMember ivc:RangeOfExercisePriceThreeMember 2020-09-30 0000742112 us-gaap:EmployeeStockOptionMember ivc:RangeOfExercisePriceThreeMember 2020-01-01 2020-09-30 0000742112 srt:MinimumMember ivc:RangeOfExercisePriceFourMember 2020-01-01 2020-09-30 0000742112 srt:MaximumMember ivc:RangeOfExercisePriceFourMember 2020-01-01 2020-09-30 0000742112 us-gaap:EmployeeStockOptionMember ivc:RangeOfExercisePriceFourMember 2020-09-30 0000742112 us-gaap:EmployeeStockOptionMember ivc:RangeOfExercisePriceFourMember 2020-01-01 2020-09-30 0000742112 ivc:RestrictedStockandRestrictedStockUnitsRSUsMember 2019-12-31 0000742112 ivc:RestrictedStockandRestrictedStockUnitsRSUsMember 2020-01-01 2020-09-30 0000742112 us-gaap:PerformanceSharesMember 2019-12-31 0000742112 srt:WeightedAverageMember us-gaap:PerformanceSharesMember 2020-01-01 2020-09-30 0000742112 us-gaap:AccumulatedTranslationAdjustmentMember 2020-06-30 0000742112 ivc:AccumulatedLongTermNotesAdjustmentMember 2020-06-30 0000742112 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2020-06-30 0000742112 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2020-06-30 0000742112 us-gaap:AccumulatedTranslationAdjustmentMember 2020-07-01 2020-09-30 0000742112 ivc:AccumulatedLongTermNotesAdjustmentMember 2020-07-01 2020-09-30 0000742112 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2020-07-01 2020-09-30 0000742112 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2020-07-01 2020-09-30 0000742112 us-gaap:AccumulatedTranslationAdjustmentMember 2020-09-30 0000742112 ivc:AccumulatedLongTermNotesAdjustmentMember 2020-09-30 0000742112 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2020-09-30 0000742112 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2020-09-30 0000742112 us-gaap:AccumulatedTranslationAdjustmentMember 2019-12-31 0000742112 ivc:AccumulatedLongTermNotesAdjustmentMember 2019-12-31 0000742112 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2019-12-31 0000742112 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2019-12-31 0000742112 us-gaap:AccumulatedTranslationAdjustmentMember 2020-01-01 2020-09-30 0000742112 ivc:AccumulatedLongTermNotesAdjustmentMember 2020-01-01 2020-09-30 0000742112 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2020-01-01 2020-09-30 0000742112 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2020-01-01 2020-09-30 0000742112 us-gaap:AccumulatedTranslationAdjustmentMember 2019-06-30 0000742112 ivc:AccumulatedLongTermNotesAdjustmentMember 2019-06-30 0000742112 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2019-06-30 0000742112 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2019-06-30 0000742112 us-gaap:AccumulatedTranslationAdjustmentMember 2019-07-01 2019-09-30 0000742112 ivc:AccumulatedLongTermNotesAdjustmentMember 2019-07-01 2019-09-30 0000742112 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2019-07-01 2019-09-30 0000742112 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2019-07-01 2019-09-30 0000742112 us-gaap:AccumulatedTranslationAdjustmentMember 2019-09-30 0000742112 ivc:AccumulatedLongTermNotesAdjustmentMember 2019-09-30 0000742112 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2019-09-30 0000742112 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2019-09-30 0000742112 us-gaap:AccumulatedTranslationAdjustmentMember 2018-12-31 0000742112 ivc:AccumulatedLongTermNotesAdjustmentMember 2018-12-31 0000742112 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2018-12-31 0000742112 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2018-12-31 0000742112 us-gaap:AccumulatedTranslationAdjustmentMember 2019-01-01 2019-09-30 0000742112 ivc:AccumulatedLongTermNotesAdjustmentMember 2019-01-01 2019-09-30 0000742112 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2019-01-01 2019-09-30 0000742112 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2019-01-01 2019-09-30 0000742112 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2020-07-01 2020-09-30 0000742112 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2019-07-01 2019-09-30 0000742112 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2020-01-01 2020-09-30 0000742112 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2019-01-01 2019-09-30 0000742112 us-gaap:ForeignExchangeForwardMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2020-07-01 2020-09-30 0000742112 us-gaap:ForeignExchangeForwardMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2019-07-01 2019-09-30 0000742112 us-gaap:ForeignExchangeForwardMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2020-01-01 2020-09-30 0000742112 us-gaap:ForeignExchangeForwardMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2019-01-01 2019-09-30 0000742112 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2020-07-01 2020-09-30 0000742112 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2019-07-01 2019-09-30 0000742112 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2020-01-01 2020-09-30 0000742112 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2019-01-01 2019-09-30 0000742112 us-gaap:AllOtherSegmentsMember 2020-01-01 2020-09-30 0000742112 us-gaap:EmployeeSeveranceMember srt:EuropeMember 2020-01-01 2020-09-30 0000742112 us-gaap:ContractTerminationMember srt:EuropeMember 2020-01-01 2020-09-30 0000742112 us-gaap:EmployeeSeveranceMember srt:EuropeMember 2019-01-01 2019-09-30 0000742112 us-gaap:EmployeeSeveranceMember us-gaap:AllOtherSegmentsMember 2019-01-01 2019-09-30 0000742112 us-gaap:EmployeeSeveranceMember srt:NorthAmericaMember 2019-01-01 2019-09-30 0000742112 us-gaap:ContractTerminationMember srt:NorthAmericaMember 2019-01-01 2019-09-30 0000742112 us-gaap:EmployeeSeveranceMember srt:NorthAmericaMember 2019-12-31 0000742112 us-gaap:ContractTerminationMember srt:NorthAmericaMember 2019-12-31 0000742112 srt:NorthAmericaMember 2019-12-31 0000742112 us-gaap:EmployeeSeveranceMember srt:EuropeMember 2019-12-31 0000742112 us-gaap:ContractTerminationMember srt:EuropeMember 2019-12-31 0000742112 srt:EuropeMember 2019-12-31 0000742112 us-gaap:EmployeeSeveranceMember us-gaap:AllOtherSegmentsMember 2019-12-31 0000742112 us-gaap:ContractTerminationMember us-gaap:AllOtherSegmentsMember 2019-12-31 0000742112 us-gaap:AllOtherSegmentsMember 2019-12-31 0000742112 us-gaap:EmployeeSeveranceMember 2019-12-31 0000742112 us-gaap:ContractTerminationMember 2019-12-31 0000742112 us-gaap:EmployeeSeveranceMember srt:NorthAmericaMember 2020-01-01 2020-03-31 0000742112 us-gaap:ContractTerminationMember srt:NorthAmericaMember 2020-01-01 2020-03-31 0000742112 srt:NorthAmericaMember 2020-01-01 2020-03-31 0000742112 us-gaap:EmployeeSeveranceMember srt:EuropeMember 2020-01-01 2020-03-31 0000742112 us-gaap:ContractTerminationMember srt:EuropeMember 2020-01-01 2020-03-31 0000742112 srt:EuropeMember 2020-01-01 2020-03-31 0000742112 us-gaap:EmployeeSeveranceMember us-gaap:AllOtherSegmentsMember 2020-01-01 2020-03-31 0000742112 us-gaap:ContractTerminationMember us-gaap:AllOtherSegmentsMember 2020-01-01 2020-03-31 0000742112 us-gaap:AllOtherSegmentsMember 2020-01-01 2020-03-31 0000742112 us-gaap:EmployeeSeveranceMember 2020-01-01 2020-03-31 0000742112 us-gaap:ContractTerminationMember 2020-01-01 2020-03-31 0000742112 2020-01-01 2020-03-31 0000742112 us-gaap:EmployeeSeveranceMember srt:NorthAmericaMember 2020-03-31 0000742112 us-gaap:ContractTerminationMember srt:NorthAmericaMember 2020-03-31 0000742112 srt:NorthAmericaMember 2020-03-31 0000742112 us-gaap:EmployeeSeveranceMember srt:EuropeMember 2020-03-31 0000742112 us-gaap:ContractTerminationMember srt:EuropeMember 2020-03-31 0000742112 srt:EuropeMember 2020-03-31 0000742112 us-gaap:EmployeeSeveranceMember us-gaap:AllOtherSegmentsMember 2020-03-31 0000742112 us-gaap:ContractTerminationMember us-gaap:AllOtherSegmentsMember 2020-03-31 0000742112 us-gaap:AllOtherSegmentsMember 2020-03-31 0000742112 us-gaap:EmployeeSeveranceMember 2020-03-31 0000742112 us-gaap:ContractTerminationMember 2020-03-31 0000742112 2020-03-31 0000742112 us-gaap:EmployeeSeveranceMember srt:NorthAmericaMember 2020-04-01 2020-06-30 0000742112 us-gaap:ContractTerminationMember srt:NorthAmericaMember 2020-04-01 2020-06-30 0000742112 srt:NorthAmericaMember 2020-04-01 2020-06-30 0000742112 us-gaap:EmployeeSeveranceMember srt:EuropeMember 2020-04-01 2020-06-30 0000742112 us-gaap:ContractTerminationMember srt:EuropeMember 2020-04-01 2020-06-30 0000742112 srt:EuropeMember 2020-04-01 2020-06-30 0000742112 us-gaap:EmployeeSeveranceMember us-gaap:AllOtherSegmentsMember 2020-04-01 2020-06-30 0000742112 us-gaap:ContractTerminationMember us-gaap:AllOtherSegmentsMember 2020-04-01 2020-06-30 0000742112 us-gaap:AllOtherSegmentsMember 2020-04-01 2020-06-30 0000742112 us-gaap:EmployeeSeveranceMember 2020-04-01 2020-06-30 0000742112 us-gaap:ContractTerminationMember 2020-04-01 2020-06-30 0000742112 us-gaap:EmployeeSeveranceMember srt:NorthAmericaMember 2020-06-30 0000742112 us-gaap:ContractTerminationMember srt:NorthAmericaMember 2020-06-30 0000742112 srt:NorthAmericaMember 2020-06-30 0000742112 us-gaap:EmployeeSeveranceMember srt:EuropeMember 2020-06-30 0000742112 us-gaap:ContractTerminationMember srt:EuropeMember 2020-06-30 0000742112 srt:EuropeMember 2020-06-30 0000742112 us-gaap:EmployeeSeveranceMember us-gaap:AllOtherSegmentsMember 2020-06-30 0000742112 us-gaap:ContractTerminationMember us-gaap:AllOtherSegmentsMember 2020-06-30 0000742112 us-gaap:AllOtherSegmentsMember 2020-06-30 0000742112 us-gaap:EmployeeSeveranceMember 2020-06-30 0000742112 us-gaap:ContractTerminationMember 2020-06-30 0000742112 us-gaap:EmployeeSeveranceMember srt:NorthAmericaMember 2020-07-01 2020-09-30 0000742112 us-gaap:ContractTerminationMember srt:NorthAmericaMember 2020-07-01 2020-09-30 0000742112 us-gaap:EmployeeSeveranceMember srt:EuropeMember 2020-07-01 2020-09-30 0000742112 us-gaap:ContractTerminationMember srt:EuropeMember 2020-07-01 2020-09-30 0000742112 us-gaap:EmployeeSeveranceMember us-gaap:AllOtherSegmentsMember 2020-07-01 2020-09-30 0000742112 us-gaap:ContractTerminationMember us-gaap:AllOtherSegmentsMember 2020-07-01 2020-09-30 0000742112 us-gaap:AllOtherSegmentsMember 2020-07-01 2020-09-30 0000742112 us-gaap:EmployeeSeveranceMember 2020-07-01 2020-09-30 0000742112 us-gaap:ContractTerminationMember 2020-07-01 2020-09-30 0000742112 us-gaap:EmployeeSeveranceMember srt:NorthAmericaMember 2020-09-30 0000742112 us-gaap:ContractTerminationMember srt:NorthAmericaMember 2020-09-30 0000742112 srt:NorthAmericaMember 2020-09-30 0000742112 us-gaap:EmployeeSeveranceMember srt:EuropeMember 2020-09-30 0000742112 us-gaap:ContractTerminationMember srt:EuropeMember 2020-09-30 0000742112 srt:EuropeMember 2020-09-30 0000742112 us-gaap:EmployeeSeveranceMember us-gaap:AllOtherSegmentsMember 2020-09-30 0000742112 us-gaap:ContractTerminationMember us-gaap:AllOtherSegmentsMember 2020-09-30 0000742112 us-gaap:AllOtherSegmentsMember 2020-09-30 0000742112 us-gaap:EmployeeSeveranceMember 2020-09-30 0000742112 us-gaap:ContractTerminationMember 2020-09-30 0000742112 us-gaap:EmployeeStockOptionMember 2020-01-01 2020-09-30 0000742112 us-gaap:EmployeeStockOptionMember 2020-09-30 0000742112 us-gaap:EmployeeStockOptionMember 2020-07-01 2020-09-30 0000742112 us-gaap:EmployeeStockOptionMember 2019-01-01 2019-09-30 0000742112 us-gaap:EmployeeStockOptionMember 2019-09-30 0000742112 us-gaap:EmployeeStockOptionMember 2019-07-01 2019-09-30 0000742112 us-gaap:ForeignExchangeForwardMember 2020-01-01 2020-09-30 0000742112 us-gaap:ForeignExchangeForwardMember 2019-01-01 2019-09-30 0000742112 ivc:ForeignExchangeForwardUSDAUDMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-09-30 0000742112 ivc:ForeignExchangeForwardUSDAUDMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-01-01 2020-09-30 0000742112 ivc:ForeignExchangeForwardUSDAUDMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-12-31 0000742112 ivc:ForeignExchangeForwardUSDAUDMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-01-01 2019-12-31 0000742112 ivc:ForeignExchangeForwardUSDCADMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-09-30 0000742112 ivc:ForeignExchangeForwardUSDCADMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-01-01 2020-09-30 0000742112 ivc:ForeignExchangeForwardUSDCADMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-12-31 0000742112 ivc:ForeignExchangeForwardUSDCADMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-01-01 2019-12-31 0000742112 ivc:ForeignExchangeForwardUSDEURMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-09-30 0000742112 ivc:ForeignExchangeForwardUSDEURMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-01-01 2020-09-30 0000742112 ivc:ForeignExchangeForwardUSDEURMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-12-31 0000742112 ivc:ForeignExchangeForwardUSDEURMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-01-01 2019-12-31 0000742112 ivc:ForeignExchangeForwardUSDGBPMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-09-30 0000742112 ivc:ForeignExchangeForwardUSDGBPMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-01-01 2020-09-30 0000742112 ivc:ForeignExchangeForwardUSDGBPMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-12-31 0000742112 ivc:ForeignExchangeForwardUSDGBPMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-01-01 2019-12-31 0000742112 ivc:ForeignExchangeForwardUSDNZDMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-09-30 0000742112 ivc:ForeignExchangeForwardUSDNZDMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-01-01 2020-09-30 0000742112 ivc:ForeignExchangeForwardUSDNZDMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-12-31 0000742112 ivc:ForeignExchangeForwardUSDNZDMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-01-01 2019-12-31 0000742112 ivc:ForeignExchangeForwardUSDSEKMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-09-30 0000742112 ivc:ForeignExchangeForwardUSDSEKMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-01-01 2020-09-30 0000742112 ivc:ForeignExchangeForwardUSDSEKMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-12-31 0000742112 ivc:ForeignExchangeForwardUSDSEKMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-01-01 2019-12-31 0000742112 ivc:ForeignExchangeForwardUSDMXPMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-09-30 0000742112 ivc:ForeignExchangeForwardUSDMXPMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-01-01 2020-09-30 0000742112 ivc:ForeignExchangeForwardUSDMXPMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-12-31 0000742112 ivc:ForeignExchangeForwardUSDMXPMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-01-01 2019-12-31 0000742112 ivc:ForeignExchangeForwardEURCADMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-09-30 0000742112 ivc:ForeignExchangeForwardEURCADMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-01-01 2020-09-30 0000742112 ivc:ForeignExchangeForwardEURCADMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-12-31 0000742112 ivc:ForeignExchangeForwardEURCADMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-01-01 2019-12-31 0000742112 ivc:ForeignExchangeForwardEURCHFMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-09-30 0000742112 ivc:ForeignExchangeForwardEURCHFMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-01-01 2020-09-30 0000742112 ivc:ForeignExchangeForwardEURCHFMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-12-31 0000742112 ivc:ForeignExchangeForwardEURCHFMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-01-01 2019-12-31 0000742112 ivc:ForeignExchangeForwardEURGBPMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-09-30 0000742112 ivc:ForeignExchangeForwardEURGBPMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-01-01 2020-09-30 0000742112 ivc:ForeignExchangeForwardEURGBPMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-12-31 0000742112 ivc:ForeignExchangeForwardEURGBPMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-01-01 2019-12-31 0000742112 ivc:ForeignExchangeForwardEURSEKMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-09-30 0000742112 ivc:ForeignExchangeForwardEURSEKMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-01-01 2020-09-30 0000742112 ivc:ForeignExchangeForwardEURSEKMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-12-31 0000742112 ivc:ForeignExchangeForwardEURSEKMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-01-01 2019-12-31 0000742112 ivc:ForeignExchangeForwardEURNOKMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-09-30 0000742112 ivc:ForeignExchangeForwardEURNOKMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-01-01 2020-09-30 0000742112 ivc:ForeignExchangeForwardEURNOKMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-12-31 0000742112 ivc:ForeignExchangeForwardEURNOKMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-01-01 2019-12-31 0000742112 ivc:ForeignExchangeForwardDKKSEKMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-09-30 0000742112 ivc:ForeignExchangeForwardDKKSEKMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-01-01 2020-09-30 0000742112 ivc:ForeignExchangeForwardDKKSEKMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-12-31 0000742112 ivc:ForeignExchangeForwardDKKSEKMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-01-01 2019-12-31 0000742112 ivc:ForeignExchangeForwardNOKSEKMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-09-30 0000742112 ivc:ForeignExchangeForwardNOKSEKMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-01-01 2020-09-30 0000742112 ivc:ForeignExchangeForwardNOKSEKMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-12-31 0000742112 ivc:ForeignExchangeForwardNOKSEKMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-01-01 2019-12-31 0000742112 us-gaap:DesignatedAsHedgingInstrumentMember 2020-09-30 0000742112 us-gaap:DesignatedAsHedgingInstrumentMember 2020-01-01 2020-09-30 0000742112 us-gaap:DesignatedAsHedgingInstrumentMember 2019-12-31 0000742112 us-gaap:DesignatedAsHedgingInstrumentMember 2019-01-01 2019-12-31 0000742112 ivc:ForeignExchangeForwardAUDUSDMember us-gaap:NondesignatedMember 2020-09-30 0000742112 ivc:ForeignExchangeForwardAUDUSDMember us-gaap:NondesignatedMember 2020-01-01 2020-09-30 0000742112 ivc:ForeignExchangeForwardAUDUSDMember us-gaap:NondesignatedMember 2019-12-31 0000742112 ivc:ForeignExchangeForwardAUDUSDMember us-gaap:NondesignatedMember 2019-01-01 2019-12-31 0000742112 ivc:ForeignExchangeForwardCADUSDMember us-gaap:NondesignatedMember 2020-09-30 0000742112 ivc:ForeignExchangeForwardCADUSDMember us-gaap:NondesignatedMember 2020-01-01 2020-09-30 0000742112 ivc:ForeignExchangeForwardCADUSDMember us-gaap:NondesignatedMember 2019-12-31 0000742112 ivc:ForeignExchangeForwardCADUSDMember us-gaap:NondesignatedMember 2019-01-01 2019-12-31 0000742112 ivc:ForeignExchangeForwardEURUSDMember us-gaap:NondesignatedMember 2020-09-30 0000742112 ivc:ForeignExchangeForwardEURUSDMember us-gaap:NondesignatedMember 2020-01-01 2020-09-30 0000742112 ivc:ForeignExchangeForwardEURUSDMember us-gaap:NondesignatedMember 2019-12-31 0000742112 ivc:ForeignExchangeForwardEURUSDMember us-gaap:NondesignatedMember 2019-01-01 2019-12-31 0000742112 ivc:ForeignExchangeForwardDKKUSDMember us-gaap:NondesignatedMember 2020-09-30 0000742112 ivc:ForeignExchangeForwardDKKUSDMember us-gaap:NondesignatedMember 2020-01-01 2020-09-30 0000742112 ivc:ForeignExchangeForwardDKKUSDMember us-gaap:NondesignatedMember 2019-12-31 0000742112 ivc:ForeignExchangeForwardDKKUSDMember us-gaap:NondesignatedMember 2019-01-01 2019-12-31 0000742112 ivc:ForeignExchangeForwardGBPUSDMember us-gaap:NondesignatedMember 2020-09-30 0000742112 ivc:ForeignExchangeForwardGBPUSDMember us-gaap:NondesignatedMember 2020-01-01 2020-09-30 0000742112 ivc:ForeignExchangeForwardGBPUSDMember us-gaap:NondesignatedMember 2019-12-31 0000742112 ivc:ForeignExchangeForwardGBPUSDMember us-gaap:NondesignatedMember 2019-01-01 2019-12-31 0000742112 ivc:ForeignExchangeForwardNOKUSDMember us-gaap:NondesignatedMember 2020-09-30 0000742112 ivc:ForeignExchangeForwardNOKUSDMember us-gaap:NondesignatedMember 2020-01-01 2020-09-30 0000742112 ivc:ForeignExchangeForwardNOKUSDMember us-gaap:NondesignatedMember 2019-12-31 0000742112 ivc:ForeignExchangeForwardNOKUSDMember us-gaap:NondesignatedMember 2019-01-01 2019-12-31 0000742112 ivc:ForeignExchangeForwardNZDUSDMember us-gaap:NondesignatedMember 2020-09-30 0000742112 ivc:ForeignExchangeForwardNZDUSDMember us-gaap:NondesignatedMember 2020-01-01 2020-09-30 0000742112 ivc:ForeignExchangeForwardNZDUSDMember us-gaap:NondesignatedMember 2019-12-31 0000742112 ivc:ForeignExchangeForwardNZDUSDMember us-gaap:NondesignatedMember 2019-01-01 2019-12-31 0000742112 ivc:ForeignExchangeForwardEURCADMember us-gaap:NondesignatedMember 2020-09-30 0000742112 ivc:ForeignExchangeForwardEURCADMember us-gaap:NondesignatedMember 2020-01-01 2020-09-30 0000742112 ivc:ForeignExchangeForwardEURCADMember us-gaap:NondesignatedMember 2019-12-31 0000742112 ivc:ForeignExchangeForwardEURCADMember us-gaap:NondesignatedMember 2019-01-01 2019-12-31 0000742112 ivc:ForeignExchangeForwardEURGBPMember us-gaap:NondesignatedMember 2020-09-30 0000742112 ivc:ForeignExchangeForwardEURGBPMember us-gaap:NondesignatedMember 2020-01-01 2020-09-30 0000742112 ivc:ForeignExchangeForwardEURGBPMember us-gaap:NondesignatedMember 2019-12-31 0000742112 ivc:ForeignExchangeForwardEURGBPMember us-gaap:NondesignatedMember 2019-01-01 2019-12-31 0000742112 ivc:ForeignExchangeForwardAUDNZDMember us-gaap:NondesignatedMember 2020-09-30 0000742112 ivc:ForeignExchangeForwardAUDNZDMember us-gaap:NondesignatedMember 2020-01-01 2020-09-30 0000742112 ivc:ForeignExchangeForwardAUDNZDMember us-gaap:NondesignatedMember 2019-12-31 0000742112 ivc:ForeignExchangeForwardAUDNZDMember us-gaap:NondesignatedMember 2019-01-01 2019-12-31 0000742112 ivc:ForeignExchangeForwardEURNOKMember us-gaap:NondesignatedMember 2020-09-30 0000742112 ivc:ForeignExchangeForwardEURNOKMember us-gaap:NondesignatedMember 2020-01-01 2020-09-30 0000742112 ivc:ForeignExchangeForwardEURNOKMember us-gaap:NondesignatedMember 2019-12-31 0000742112 ivc:ForeignExchangeForwardEURNOKMember us-gaap:NondesignatedMember 2019-01-01 2019-12-31 0000742112 us-gaap:NondesignatedMember 2020-09-30 0000742112 us-gaap:NondesignatedMember 2020-01-01 2020-09-30 0000742112 us-gaap:NondesignatedMember 2019-12-31 0000742112 us-gaap:NondesignatedMember 2019-01-01 2019-12-31 0000742112 us-gaap:OtherCurrentAssetsMember us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-09-30 0000742112 us-gaap:AccruedLiabilitiesMember us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-09-30 0000742112 us-gaap:OtherCurrentAssetsMember us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-12-31 0000742112 us-gaap:AccruedLiabilitiesMember us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-12-31 0000742112 us-gaap:OtherCurrentAssetsMember us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember 2020-09-30 0000742112 us-gaap:AccruedLiabilitiesMember us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember 2020-09-30 0000742112 us-gaap:OtherCurrentAssetsMember us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember 2019-12-31 0000742112 us-gaap:AccruedLiabilitiesMember us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember 2019-12-31 0000742112 us-gaap:OtherCurrentAssetsMember 2020-09-30 0000742112 us-gaap:AccruedLiabilitiesMember 2020-09-30 0000742112 us-gaap:OtherCurrentAssetsMember 2019-12-31 0000742112 us-gaap:AccruedLiabilitiesMember 2019-12-31 0000742112 us-gaap:ForeignExchangeForwardMember us-gaap:CashFlowHedgingMember 2020-07-01 2020-09-30 0000742112 us-gaap:ForeignExchangeForwardMember us-gaap:CashFlowHedgingMember 2020-01-01 2020-09-30 0000742112 us-gaap:ForeignExchangeForwardMember us-gaap:CashFlowHedgingMember 2019-07-01 2019-09-30 0000742112 us-gaap:ForeignExchangeForwardMember us-gaap:CashFlowHedgingMember 2019-01-01 2019-09-30 0000742112 us-gaap:ForeignExchangeForwardMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2020-07-01 2020-09-30 0000742112 us-gaap:ForeignExchangeForwardMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2020-01-01 2020-09-30 0000742112 us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember 2019-07-01 2019-09-30 0000742112 us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember 2019-01-01 2019-09-30 0000742112 us-gaap:CashFlowHedgingMember us-gaap:SalesMember 2020-07-01 2020-09-30 0000742112 us-gaap:CashFlowHedgingMember us-gaap:SalesMember 2020-01-01 2020-09-30 0000742112 us-gaap:CashFlowHedgingMember us-gaap:CostOfSalesMember 2020-07-01 2020-09-30 0000742112 us-gaap:CashFlowHedgingMember us-gaap:CostOfSalesMember 2020-01-01 2020-09-30 0000742112 us-gaap:CashFlowHedgingMember 2020-07-01 2020-09-30 0000742112 us-gaap:CashFlowHedgingMember 2020-01-01 2020-09-30 0000742112 us-gaap:CashFlowHedgingMember us-gaap:SalesMember 2019-07-01 2019-09-30 0000742112 us-gaap:CashFlowHedgingMember us-gaap:SalesMember 2019-01-01 2019-09-30 0000742112 us-gaap:CashFlowHedgingMember us-gaap:CostOfSalesMember 2019-07-01 2019-09-30 0000742112 us-gaap:CashFlowHedgingMember us-gaap:CostOfSalesMember 2019-01-01 2019-09-30 0000742112 us-gaap:CashFlowHedgingMember 2019-07-01 2019-09-30 0000742112 us-gaap:CashFlowHedgingMember 2019-01-01 2019-09-30 0000742112 us-gaap:ForeignExchangeForwardMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2019-07-01 2019-09-30 0000742112 us-gaap:ForeignExchangeForwardMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2019-01-01 2019-09-30 0000742112 ivc:ConvertibleDebt2021ConversionFeatureMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2020-09-30 0000742112 ivc:ConvertibleDebt2022ConversionFeatureDomain us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2020-09-30 0000742112 ivc:ConvertibleDebtBondHedgeMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2020-09-30 0000742112 us-gaap:ForeignExchangeForwardMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2020-09-30 0000742112 us-gaap:ForeignExchangeForwardMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2020-09-30 0000742112 us-gaap:ForeignExchangeForwardMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2020-09-30 0000742112 us-gaap:ForeignExchangeForwardMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000742112 us-gaap:ForeignExchangeForwardMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000742112 us-gaap:ForeignExchangeForwardMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000742112 us-gaap:EstimateOfFairValueFairValueDisclosureMember 2020-09-30 0000742112 us-gaap:CarryingReportedAmountFairValueDisclosureMember 2019-12-31 0000742112 us-gaap:EstimateOfFairValueFairValueDisclosureMember 2019-12-31 0000742112 us-gaap:OtherCurrentAssetsMember us-gaap:ForeignExchangeForwardMember us-gaap:CarryingReportedAmountFairValueDisclosureMember 2020-09-30 0000742112 us-gaap:OtherCurrentAssetsMember us-gaap:ForeignExchangeForwardMember us-gaap:EstimateOfFairValueFairValueDisclosureMember 2020-09-30 0000742112 us-gaap:OtherCurrentAssetsMember us-gaap:ForeignExchangeForwardMember us-gaap:CarryingReportedAmountFairValueDisclosureMember 2019-12-31 0000742112 us-gaap:OtherCurrentAssetsMember us-gaap:ForeignExchangeForwardMember us-gaap:EstimateOfFairValueFairValueDisclosureMember 2019-12-31 0000742112 us-gaap:AccountsPayableAndAccruedLiabilitiesMember us-gaap:ForeignExchangeForwardMember us-gaap:CarryingReportedAmountFairValueDisclosureMember 2020-09-30 0000742112 us-gaap:AccountsPayableAndAccruedLiabilitiesMember us-gaap:ForeignExchangeForwardMember us-gaap:EstimateOfFairValueFairValueDisclosureMember 2020-09-30 0000742112 us-gaap:AccountsPayableAndAccruedLiabilitiesMember us-gaap:ForeignExchangeForwardMember us-gaap:CarryingReportedAmountFairValueDisclosureMember 2019-12-31 0000742112 us-gaap:AccountsPayableAndAccruedLiabilitiesMember us-gaap:ForeignExchangeForwardMember us-gaap:EstimateOfFairValueFairValueDisclosureMember 2019-12-31 0000742112 us-gaap:IntersegmentEliminationMember srt:EuropeMember 2020-07-01 2020-09-30 0000742112 us-gaap:IntersegmentEliminationMember srt:EuropeMember 2019-07-01 2019-09-30 0000742112 us-gaap:IntersegmentEliminationMember srt:EuropeMember 2020-01-01 2020-09-30 0000742112 us-gaap:IntersegmentEliminationMember srt:EuropeMember 2019-01-01 2019-09-30 0000742112 us-gaap:IntersegmentEliminationMember srt:NorthAmericaMember 2020-07-01 2020-09-30 0000742112 us-gaap:IntersegmentEliminationMember srt:NorthAmericaMember 2019-07-01 2019-09-30 0000742112 us-gaap:IntersegmentEliminationMember srt:NorthAmericaMember 2020-01-01 2020-09-30 0000742112 us-gaap:IntersegmentEliminationMember srt:NorthAmericaMember 2019-01-01 2019-09-30 0000742112 us-gaap:IntersegmentEliminationMember srt:AsiaPacificMember 2020-07-01 2020-09-30 0000742112 us-gaap:IntersegmentEliminationMember srt:AsiaPacificMember 2019-07-01 2019-09-30 0000742112 us-gaap:IntersegmentEliminationMember srt:AsiaPacificMember 2020-01-01 2020-09-30 0000742112 us-gaap:IntersegmentEliminationMember srt:AsiaPacificMember 2019-01-01 2019-09-30 0000742112 us-gaap:IntersegmentEliminationMember 2020-07-01 2020-09-30 0000742112 us-gaap:IntersegmentEliminationMember 2019-07-01 2019-09-30 0000742112 us-gaap:IntersegmentEliminationMember 2020-01-01 2020-09-30 0000742112 us-gaap:IntersegmentEliminationMember 2019-01-01 2019-09-30 0000742112 us-gaap:AllOtherSegmentsMember 2019-07-01 2019-09-30 0000742112 us-gaap:AllOtherSegmentsMember 2019-01-01 2019-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:LifestyleProductsDomain srt:EuropeMember 2020-07-01 2020-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:LifestyleProductsDomain srt:EuropeMember 2019-07-01 2019-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:LifestyleProductsDomain srt:EuropeMember 2020-01-01 2020-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:LifestyleProductsDomain srt:EuropeMember 2019-01-01 2019-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:MobilityandSeatingDomain srt:EuropeMember 2020-07-01 2020-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:MobilityandSeatingDomain srt:EuropeMember 2019-07-01 2019-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:MobilityandSeatingDomain srt:EuropeMember 2020-01-01 2020-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:MobilityandSeatingDomain srt:EuropeMember 2019-01-01 2019-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:RespiratoryTherapyDomain srt:EuropeMember 2020-07-01 2020-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:RespiratoryTherapyDomain srt:EuropeMember 2019-07-01 2019-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:RespiratoryTherapyDomain srt:EuropeMember 2020-01-01 2020-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:RespiratoryTherapyDomain srt:EuropeMember 2019-01-01 2019-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:OtherDomain srt:EuropeMember 2020-07-01 2020-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:OtherDomain srt:EuropeMember 2019-07-01 2019-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:OtherDomain srt:EuropeMember 2020-01-01 2020-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:OtherDomain srt:EuropeMember 2019-01-01 2019-09-30 0000742112 us-gaap:OperatingSegmentsMember srt:EuropeMember 2020-07-01 2020-09-30 0000742112 us-gaap:OperatingSegmentsMember srt:EuropeMember 2019-07-01 2019-09-30 0000742112 us-gaap:OperatingSegmentsMember srt:EuropeMember 2020-01-01 2020-09-30 0000742112 us-gaap:OperatingSegmentsMember srt:EuropeMember 2019-01-01 2019-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:LifestyleProductsDomain srt:NorthAmericaMember 2020-07-01 2020-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:LifestyleProductsDomain srt:NorthAmericaMember 2019-07-01 2019-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:LifestyleProductsDomain srt:NorthAmericaMember 2020-01-01 2020-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:LifestyleProductsDomain srt:NorthAmericaMember 2019-01-01 2019-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:MobilityandSeatingDomain srt:NorthAmericaMember 2020-07-01 2020-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:MobilityandSeatingDomain srt:NorthAmericaMember 2019-07-01 2019-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:MobilityandSeatingDomain srt:NorthAmericaMember 2020-01-01 2020-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:MobilityandSeatingDomain srt:NorthAmericaMember 2019-01-01 2019-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:RespiratoryTherapyDomain srt:NorthAmericaMember 2020-07-01 2020-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:RespiratoryTherapyDomain srt:NorthAmericaMember 2019-07-01 2019-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:RespiratoryTherapyDomain srt:NorthAmericaMember 2020-01-01 2020-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:RespiratoryTherapyDomain srt:NorthAmericaMember 2019-01-01 2019-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:OtherDomain srt:NorthAmericaMember 2020-07-01 2020-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:OtherDomain srt:NorthAmericaMember 2019-07-01 2019-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:OtherDomain srt:NorthAmericaMember 2020-01-01 2020-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:OtherDomain srt:NorthAmericaMember 2019-01-01 2019-09-30 0000742112 us-gaap:OperatingSegmentsMember srt:NorthAmericaMember 2020-07-01 2020-09-30 0000742112 us-gaap:OperatingSegmentsMember srt:NorthAmericaMember 2019-07-01 2019-09-30 0000742112 us-gaap:OperatingSegmentsMember srt:NorthAmericaMember 2020-01-01 2020-09-30 0000742112 us-gaap:OperatingSegmentsMember srt:NorthAmericaMember 2019-01-01 2019-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:MobilityandSeatingDomain srt:AsiaPacificMember 2020-07-01 2020-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:MobilityandSeatingDomain srt:AsiaPacificMember 2019-07-01 2019-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:MobilityandSeatingDomain srt:AsiaPacificMember 2020-01-01 2020-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:MobilityandSeatingDomain srt:AsiaPacificMember 2019-01-01 2019-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:LifestyleProductsDomain srt:AsiaPacificMember 2020-07-01 2020-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:LifestyleProductsDomain srt:AsiaPacificMember 2019-07-01 2019-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:LifestyleProductsDomain srt:AsiaPacificMember 2020-01-01 2020-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:LifestyleProductsDomain srt:AsiaPacificMember 2019-01-01 2019-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:RespiratoryTherapyDomain srt:AsiaPacificMember 2020-07-01 2020-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:RespiratoryTherapyDomain srt:AsiaPacificMember 2019-07-01 2019-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:RespiratoryTherapyDomain srt:AsiaPacificMember 2020-01-01 2020-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:RespiratoryTherapyDomain srt:AsiaPacificMember 2019-01-01 2019-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:OtherDomain srt:AsiaPacificMember 2020-07-01 2020-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:OtherDomain srt:AsiaPacificMember 2019-07-01 2019-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:OtherDomain srt:AsiaPacificMember 2020-01-01 2020-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:OtherDomain srt:AsiaPacificMember 2019-01-01 2019-09-30 0000742112 us-gaap:OperatingSegmentsMember srt:AsiaPacificMember 2020-07-01 2020-09-30 0000742112 us-gaap:OperatingSegmentsMember srt:AsiaPacificMember 2019-07-01 2019-09-30 0000742112 us-gaap:OperatingSegmentsMember srt:AsiaPacificMember 2020-01-01 2020-09-30 0000742112 us-gaap:OperatingSegmentsMember srt:AsiaPacificMember 2019-01-01 2019-09-30 shares iso4217:USD iso4217:USD shares pure ivc:payment ivc:votes 0000742112 --12-31 2020 Q3 false P5Y P5Y P5Y P5Y P3Y P3Y 10-Q true 2020-09-30 false 001-15103 INVACARE CORPORATION OH 95-2680965 One Invacare Way, Elyria, OH 44035 440 329-6000 Common Shares, without par value IVC NYSE Yes Yes Accelerated Filer false false false 34411688 6357 211906000 235774000 626646000 695051000 151866000 168189000 446968000 500945000 60040000 67585000 179678000 194106000 55530000 63539000 174672000 197035000 0 0 9790000 0 1580000 1628000 4657000 3641000 2930000 2418000 10139000 -6570000 0 0 0 -1197000 -761000 -280000 -7360000 -280000 7402000 6992000 21132000 22027000 7000 113000 90000 361000 -5226000 -4741000 -18263000 -27319000 2050000 3300000 4900000 7325000 -7276000 -8041000 -23163000 -34644000 0 0.0125 0.0125 0.0375 -0.21 -0.24 -0.68 -1.03 34419000 33660000 34213000 33571000 -0.21 -0.24 -0.68 -1.03 34530000 33668000 34313000 33581000 -7276000 -8041000 -23163000 -34644000 35944000 -9057000 36859000 -13041000 -193000 -201000 -362000 -276000 -9000 -38000 -25000 -54000 -9000 -38000 -25000 -54000 -2047000 -315000 -1159000 861000 -285000 -12000 -171000 127000 33989000 -9561000 35509000 -12583000 26713000 -17602000 12346000 -47227000 1.000 1.000 1.000 1.000 0.717 0.713 0.713 0.721 0.283 0.287 0.287 0.279 0.262 0.269 0.279 0.283 0 0 -0.016 0 0.007 0.007 0.007 0.005 0.014 0.010 0.016 -0.009 0 0 0 -0.002 0.004 0.001 0.012 0.0004 0.035 0.030 0.034 0.032 0 0 0 -0.001 -0.025 -0.020 -0.029 -0.039 0.010 0.014 0.008 0.011 -0.034 -0.034 -0.037 -0.050 86825000 80063000 108957000 116669000 261000 736000 145452000 120500000 37635000 37909000 379130000 355877000 3991000 4216000 27770000 26447000 53112000 46607000 65108000 26900000 13075000 18676000 401665000 373403000 943851000 852126000 93160000 88003000 124666000 120947000 2197000 345000 3352000 2514000 5843000 6790000 4062000 58000 233280000 218657000 238202000 219464000 63950000 26480000 7182000 12060000 70748000 66949000 300000 300000 0 0 0 0 150000000 150000000 38596000 37609000 9815000 9588000 12000000 12000000 6000 6000 2000 2000 324409000 312650000 63655000 87475000 38637000 3128000 4184000 3953000 106029000 104327000 330489000 308516000 943851000 852126000 -23163000 -34644000 9790000 0 10360000 11800000 5284000 6927000 554000 923000 111000 -232000 -594000 -837000 6965000 5873000 1066000 -186000 -7360000 -280000 8629000 9429000 1329000 1860000 0 -1197000 -6160000 -1501000 -532000 -405000 22021000 -3173000 -1691000 2099000 5903000 -1226000 1616000 -7749000 -226000 -779000 822000 -4732000 16824000 7177000 396000 73000 14563000 0 -67000 72000 2176000 0 -3974000 -7176000 72551000 0 59483000 16339000 1307000 0 414000 1234000 5593000 0 1702000 860000 4052000 -18433000 5862000 -1526000 6762000 -31867000 80063000 116907000 86825000 85040000 9815000 2000 322770000 70931000 4648000 -106020000 302146000 0 818000 0 818000 0 821000 -9000 812000 -7276000 -7276000 35944000 35944000 -1762000 -1762000 -193000 -193000 26713000 9815000 2000 324409000 63655000 38637000 -106029000 330489000 9588000 2000 301833000 115025000 9771000 -104293000 331926000 0 649000 0 649000 123000 123000 0 798000 798000 -8041000 -8041000 -9057000 -9057000 -303000 -303000 -201000 -201000 -17602000 415000 415000 9588000 2000 303403000 106569000 210000 -104293000 315479000 9588000 2000 312650000 87475000 3128000 -104327000 308516000 90000 90000 1121000 1121000 2494000 2494000 137000 4334000 -581000 3890000 -23163000 -23163000 36859000 36859000 -988000 -988000 -362000 -362000 12346000 5021000 5021000 414000 414000 243000 243000 9815000 2000 324409000 63655000 38637000 -106029000 330489000 9419000 2000 297919000 142447000 12793000 -103433000 359147000 29000 1619000 -348000 1300000 334000 334000 140000 3751000 -512000 3379000 -34644000 -34644000 -13041000 -13041000 734000 734000 -276000 -276000 -47227000 220000 220000 1234000 1234000 9588000 2000 303403000 106569000 210000 -104293000 315479000 Accounting Policies<div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Principles of Consolidation:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  The condensed consolidated financial statements include the accounts of the company and its wholly owned subsidiaries and include all adjustments, which were of a normal recurring nature, necessary to present fairly the financial position of the company as of September 30, 2020 and the results of its operations and changes in its cash flow for the nine months ended September 30, 2020 and 2019, respectively. Certain foreign subsidiaries, represented by the European segment, are consolidated using an August 31 quarter end to meet filing deadlines. No material subsequent events have occurred related to the European segment, which would require disclosure or adjustment to the company's financial statements. All significant intercompany transactions are eliminated. The results of operations for the three and nine months ended September 30, 2020 are not necessarily indicative of the results to be expected for the full year.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Use of Estimates: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The condensed consolidated financial statements are prepared in conformity with accounting principles generally accepted in the United States, which require management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results may differ from these estimates.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recent Accounting Pronouncements (Already Adopted):</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, the FASB issued ASU 2016-13, "Measurement of Credit Losses on Financial Statements." ASU 2016-13 requires a new credit loss standard for most financial assets and certain other instruments. For example, entities are required to use an "expected loss" model that will generally require earlier recognition of allowances for losses for trade receivables. The standard also requires additional disclosures, including disclosures regarding how an entity tracks credit quality. The company adopted ASU 2016-13, effective on January 1, 2020, which resulted in an increase for credit losses of $243,000 with the offsetting impact recorded to retained earnings.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2017, the FASB issued ASU 2017-04, "Intangibles - Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment." The guidance in ASU 2017-04 eliminates the requirement to determine the fair value of individual assets and liabilities of a reporting unit to measure goodwill impairment. Under the amendments in the new ASU, goodwill impairment testing will be performed by comparing the fair value of the reporting unit with its carrying amount and recognizing an impairment charge for the amount by which the carrying amount exceeds the reporting unit’s fair </span></div>value. The company adopted ASU 2017-04 as of January 1, 2020 with no impact to the company's financial statements upon adoption. In December 2019, the FASB issued ASU 2019-12, "Income Taxes (Topic 740) - Simplifying the Accounting for Income Taxes," which simplifies the accounting for income taxes by removing certain exceptions to the general principles in Topic 740. ASU 2019-12 removes the following exceptions: 1) exception to the incremental approach for intraperiod tax allocation when there is a loss from continuing operations and income or a gain from other items (for example, discontinued operations or other comprehensive income), 2) exception to the requirement to recognize a deferred tax liability for equity method investments when a foreign subsidiary becomes an equity method investment, 3) exception to the ability not to recognize a deferred tax liability for a foreign subsidiary when a foreign subsidiary becomes a subsidiary and 4) the exception to the general methodology for calculating income taxes in an interim period when a year-to-date loss exceeds the anticipated loss for the year. The ASU also simplifies other areas of Topic 740 by clarifying and amending existing guidance. The amendments in the ASU will be applied using different approaches depending on what the specific amendments relate to. The company early adopted ASU 2019-12 on a prospective basis as of January 1, 2020 with no impact to the company's financial statements upon adoption. <span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Principles of Consolidation:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  The condensed consolidated financial statements include the accounts of the company and its wholly owned subsidiaries and include all adjustments, which were of a normal recurring nature, necessary to present fairly the financial position of the company as of September 30, 2020 and the results of its operations and changes in its cash flow for the nine months ended September 30, 2020 and 2019, respectively. Certain foreign subsidiaries, represented by the European segment, are consolidated using an August 31 quarter end to meet filing deadlines. No material subsequent events have occurred related to the European segment, which would require disclosure or adjustment to the company's financial statements. All significant intercompany transactions are eliminated. The results of operations for the three and nine months ended September 30, 2020 are not necessarily indicative of the results to be expected for the full year.</span> <span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Use of Estimates: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The condensed consolidated financial statements are prepared in conformity with accounting principles generally accepted in the United States, which require management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results may differ from these estimates.</span> <div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recent Accounting Pronouncements (Already Adopted):</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, the FASB issued ASU 2016-13, "Measurement of Credit Losses on Financial Statements." ASU 2016-13 requires a new credit loss standard for most financial assets and certain other instruments. For example, entities are required to use an "expected loss" model that will generally require earlier recognition of allowances for losses for trade receivables. The standard also requires additional disclosures, including disclosures regarding how an entity tracks credit quality. The company adopted ASU 2016-13, effective on January 1, 2020, which resulted in an increase for credit losses of $243,000 with the offsetting impact recorded to retained earnings.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2017, the FASB issued ASU 2017-04, "Intangibles - Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment." The guidance in ASU 2017-04 eliminates the requirement to determine the fair value of individual assets and liabilities of a reporting unit to measure goodwill impairment. Under the amendments in the new ASU, goodwill impairment testing will be performed by comparing the fair value of the reporting unit with its carrying amount and recognizing an impairment charge for the amount by which the carrying amount exceeds the reporting unit’s fair </span></div>value. The company adopted ASU 2017-04 as of January 1, 2020 with no impact to the company's financial statements upon adoption. In December 2019, the FASB issued ASU 2019-12, "Income Taxes (Topic 740) - Simplifying the Accounting for Income Taxes," which simplifies the accounting for income taxes by removing certain exceptions to the general principles in Topic 740. ASU 2019-12 removes the following exceptions: 1) exception to the incremental approach for intraperiod tax allocation when there is a loss from continuing operations and income or a gain from other items (for example, discontinued operations or other comprehensive income), 2) exception to the requirement to recognize a deferred tax liability for equity method investments when a foreign subsidiary becomes an equity method investment, 3) exception to the ability not to recognize a deferred tax liability for a foreign subsidiary when a foreign subsidiary becomes a subsidiary and 4) the exception to the general methodology for calculating income taxes in an interim period when a year-to-date loss exceeds the anticipated loss for the year. The ASU also simplifies other areas of Topic 740 by clarifying and amending existing guidance. The amendments in the ASU will be applied using different approaches depending on what the specific amendments relate to. The company early adopted ASU 2019-12 on a prospective basis as of January 1, 2020 with no impact to the company's financial statements upon adoption. 243000 <div style="text-align:center"><span style="color:#003399;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">Divested Businesses</span></div><div style="margin-bottom:8pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"/></tr></table></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:46.666%"><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 7, 2020, the company, completed the sale (the “Transaction”) of its indirect subsidiary, Dynamic Controls, a New Zealand incorporated unlimited company (“Dynamic Controls”), to Allied Motion Christchurch Limited, a New Zealand limited company (the “Purchaser”), pursuant to a Securities Purchase Agreement among the company, Invacare Holdings New Zealand, a New Zealand incorporated unlimited company, and the Purchaser, dated March 6, 2020 (the “Purchase Agreement”). Dynamic Controls is a producer of electronic control systems for powered medical mobility devices, including systems incorporating the LiNX™ technology platform. Dynamic Controls was a component of the All Other Segment.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dynamic Controls is a supplier of power mobility products and respiratory components to the company as well as supplying power mobility products to external customers. Sales in 2020 through the date of disposition were $5,331,000, including intercompany sales of $2,532,000, compared to sales for the full year of 2019 of $30,261,000, including intercompany sales of $13,087,000. Income before income taxes was approximately $445,000 in 2020, through the date of disposition, compared to $853,000 in 2019, inclusive of intercompany profits on sales to the company. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The transaction was the result of considering options for the products sold by Dynamic Controls which resulted in selling the business to a third-party which can provide access to further technological innovations to further differentiate the company’s power mobility products. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The gross proceeds from the Transaction were $14,563,000, net of taxes and expenses. The company realized a pre-tax gain of $9,790,000 and recorded expenses related to the sale of the business totaling $2,150,000, of which $1,789,000 have been paid as of September 30, 2020.</span></div><div style="margin-bottom:3pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Purchase Agreement contains customary indemnification obligations of each party with respect to breaches of their respective representations, warranties and covenants, and certain other specified matters, which are subject to certain exceptions, terms and limitations described further in the Purchase Agreement.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="margin-bottom:3pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At the closing of the Transaction, the parties entered into a supply agreement pursuant to which Dynamic Controls will supply certain electronic components as required by the company for a five-year period following the Transaction, including ongoing supply and support of the LiNX™ electronic control system with informatics technology, continued contract manufacturing of certain electronic components for the company’s respiratory products and </span></div></div><div style="display:inline-block;max-width:6.666%;min-width:5.666%;vertical-align:top"/><div style="display:inline-block;vertical-align:top;width:46.668%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">continued infrastructure and applications support for the informatics solution for the company’s respiratory products. The estimated continued inflows and outflows following the disposal with the Purchaser are not expected to be material to the company.</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The assets and liabilities of Dynamic Controls as of March 7, 2020 and December 31, 2019 consisted of the following (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.816%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.900%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.883%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.901%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">March 7, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Trade receivables, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4,129 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,804 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Inventories, net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3,082 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3,008 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">855 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">933 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">600 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">707 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Operating lease assets, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,127 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,870 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total assets</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">10,793 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">8,322 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Accounts payable</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4,692 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4,501 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,473 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,108 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current taxes payable</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">41 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">92 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Current portion of operating lease obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">366 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">393 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Long-term obligations</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,019 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,754 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">8,591 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">8,848 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trade receivables as of March 7, 2020 includes receivables previously classified as intercompany related to product sold by Dynamic Controls to other Invacare entities.</span></div></div></div> 5331000 2532000 30261000 13087000 445000 853000 14563000 9790000 2150000 1789000 <div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The assets and liabilities of Dynamic Controls as of March 7, 2020 and December 31, 2019 consisted of the following (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.816%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.900%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.883%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.901%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">March 7, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Trade receivables, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4,129 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,804 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Inventories, net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3,082 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3,008 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">855 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">933 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">600 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">707 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Operating lease assets, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,127 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,870 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total assets</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">10,793 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">8,322 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Accounts payable</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4,692 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4,501 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,473 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,108 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current taxes payable</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">41 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">92 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Current portion of operating lease obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">366 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">393 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Long-term obligations</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,019 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,754 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">8,591 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">8,848 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 4129000 1804000 3082000 3008000 855000 933000 600000 707000 2127000 1870000 10793000 8322000 4692000 4501000 2473000 2108000 41000 92000 366000 393000 1019000 1754000 8591000 8848000 <div style="display:inline-block;vertical-align:top;width:46.666%"><div><span style="color:#003399;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Receivables</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Receivables consist of the following (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:48.602%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.007%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.288%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.603%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Accounts receivable, gross</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">132,809 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">141,732 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Customer rebate reserve</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(13,075)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(13,922)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Cash discount reserves</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(5,290)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,326)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Allowance for doubtful accounts</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(4,697)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,804)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other, principally returns and allowances reserves</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(790)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,011)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Accounts receivable, net</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">108,957 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">116,669 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reserves for customer rebates and cash discounts are recorded as a reduction in revenue and netted against gross accounts receivable. Customer rebates in excess of a given customer's accounts receivable balance are classified in Accrued Expenses. Customer rebates and cash discounts are estimated based on the most likely amount principle as well as historical experience and anticipated performance. In addition, customers have the right to return product within the company’s normal terms policy, and as such, the company estimates the expected returns based on an analysis of historical experience and adjusts revenue accordingly. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts receivable are reduced by an allowance for amounts that may become uncollectible in the future. Substantially all the company’s receivables are due from health care, medical equipment providers and long-term care facilities predominantly located throughout the United States, Australia, Canada, New Zealand, China and Europe. A significant portion of products sold to providers, both foreign and domestic, are ultimately funded through government reimbursement programs such as Medicare and Medicaid in the U.S. As a consequence, changes in these programs can have an adverse impact on dealer liquidity and profitability.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company adopted ASU 2016-13, "Measurement of Credit Losses on Financial Statements" on January 1, 2020. Accordingly, the company is now applying an "expected loss" model that will generally require earlier recognition of allowances for losses for trade receivables. In addition, the company expects more variability in its allowance for doubtful accounts as it previously provided for bad debts based on a specific reserve methodology while the new expected loss methodology requires companies to provide for estimated losses beginning at the time of sale. The adoption of the new standard resulted in an increase in credit losses of $243,000 as </span></div></div><div style="display:inline-block;max-width:6.666%;min-width:5.666%;vertical-align:top"/><div style="display:inline-block;vertical-align:top;width:46.668%"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">disclosed in the Condensed Consolidated Statement of Shareholders' Equity.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company's approach is to separate its receivables into good-standing and collection receivables. Good-standing receivables are assigned to risk pools of high, medium and low. The risk pools are driven by the specifics associated with the geography of origination. Expected loss percentages are calculated and assigned to each risk pool, driven primarily by historical experience. The historical loss percentages are calculated for each risk pool and then judgmentally revised to consider current risk factors as well as consideration of the impact of forecasted events, as applicable. The expected loss percentages are then applied to receivables balances each period to determine the allowance for doubtful accounts.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In North America, excluding Canada, good-standing receivables are assigned to the low risk pool and assigned an expected loss percentage of 1.0% as these receivables are deemed to share the same risk profile and collections efforts are the same. Installment receivables in North America are characterized as collection receivables and thus reserves based on specific analysis of each customer. In Canada, good-standing receivables and installment receivables are deemed low risk and assigned a loss percentage of 0.2%.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In Europe, expected losses are determined by each location in each region. Most locations have a majority of their receivables assigned to the low risk pool, which has an average expected loss percentage of 0.3%. About half of the locations have a portion of their receivables assigned as medium risk with an average expected loss percentage of 0.9%. Only a few locations have any receivables characterized as high risk and the average credit loss percentage for those locations is 2.7%. Collection risk is generally low as payment terms in certain key markets, such as Germany, are immediate and in many locations the ultimate customer is the government. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the Asia Pacific region, receivables are characterized as low risk, which have an average expected loss percentage of 0.3%. Historical losses are low in this region where the use of credit insurance is often customary.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div></div><div style="display:inline-block;vertical-align:top;width:46.666%"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The movement in the trade receivables allowance for doubtful accounts was as follows (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.054%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:30.746%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Nine Months Ended <br/>September 30, 2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Balance as of beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4,804 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Current period provision</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">522 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Direct write-offs charged against the allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(629)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Balance as of end of period</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4,697 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The current period provision includes the immaterial impact of the adoption of ASU 2016-03. The company did not make any material changes to the assignment of receivables to the different risk pools or to the expected loss reserves in the quarter. The company is monitoring the impacts of the COVID-19 pandemic and the possibility for an impact on collections,</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> but to date this has not materially impacted 2020. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For collections receivables, the estimated allowance for uncollectible amounts is based primarily on management’s evaluation of the financial condition of each customer. In addition, as a result of the company's financing arrangement with DLL, a third-party financing company which the company has worked with since 2000, management monitors the collection status of these contracts in accordance with the company’s limited recourse obligations and provides amounts necessary for estimated losses in the allowance for doubtful accounts and establishes reserves for specific customers as needed. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company writes off uncollectible trade accounts receivable after such receivables are moved to collection status and legal remedies are exhausted. See Concentration of Credit Risk in the Notes to the Condensed Consolidated Financial Statements for a description of the financing arrangement. Long-term installment receivables are included in “Other Assets” on the condensed consolidated balance sheet.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon adoption of ASU 2016-03, the company recorded a new contingent liability in the amount of $306,000 related to the contingent aspect of the company's guarantee associated with its arrangement with DLL. The contingent liability is recorded applying the same expected loss model used for the trade and installment receivables recorded on the company's books. Specifically, historical loss history is used to determine the expected loss percentage, which is then adjusted judgmentally to consider other factors, as needed.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company’s U.S. customers electing to finance their purchases can do so using DLL. In addition, the company, prior to 2020, provided financing directly for its Canadian customers for which DLL is not an option, as DLL typically </span></div></div><div style="display:inline-block;max-width:6.666%;min-width:5.666%;vertical-align:top"/><div style="display:inline-block;vertical-align:top;width:46.668%"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">provides financing to Canadian customers only on a limited basis. The installment receivables recorded on the books of the company represent a single portfolio segment of finance receivables to the independent provider channel and long-term care customers. The portfolio segment is comprised of two classes of receivables distinguished by geography and credit quality. The U.S. installment receivables are the first class and represent installment receivables repurchased from DLL because the customers were in default. Default with DLL is defined as a customer being delinquent by three payments. The Canadian installment receivables represent the second class of installment receivables which were originally financed by the company because third party financing was not available to the HME providers. The Canadian installment receivables were typically financed for twelve months and historically have had a very low risk of default. </span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated allowance for uncollectible amounts and evaluation for both classes of installment receivables is based on the company’s quarterly review of the financial condition of each individual customer with the allowance for doubtful accounts adjusted accordingly. Installments are individually and not collectively reviewed. The company assesses the bad debt reserve levels based upon the status of the customer’s adherence to a legally negotiated payment schedule and the company’s ability to enforce judgments, liens, etc.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For purposes of granting or extending credit, the company utilizes a scoring model to generate a composite score that considers each customer’s consumer credit score and/or D&amp;B credit rating, payment history, security collateral and time in business. Additional analysis is performed for most customers desiring credit greater than $250,000, which generally includes a detailed review of the customer’s financial statements as well as consideration of other factors such as exposure to changing reimbursement laws.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest income is recognized on installment receivables based on the terms of the installment agreements. Installment accounts are monitored and if a customer defaults on payments and is moved to collection, interest income is no longer recognized. Subsequent payments received once an account is put on non-accrual status are generally first applied to the principal balance and then to the interest. Accruing of interest on collection accounts would only be restarted if the account became current again.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All installment accounts are accounted for using the same methodology regardless of the duration of the installment agreements. When an account is placed in collection status, the company goes through a legal process for pursuing collection of outstanding amounts, the length of which typically approximates eighteen months. Any write-offs are made after the legal process has been completed. </span></div></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Installment receivables consist of the following (in thousands): </span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.722%"><tr><td style="width:1.0%"/><td style="width:28.565%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.042%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.042%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.042%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.042%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.042%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.045%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"> </span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Current</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Long-<br/>Term</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Current</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Long-<br/>Term</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Installment receivables</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">555 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">228 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">783 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,192 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,257 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,449 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Less: Unearned interest</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(3)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(3)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(22)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(22)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">552 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">228 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">780 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,170 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,257 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,427 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Allowance for doubtful accounts</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(291)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(164)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(455)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(434)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(1,080)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(1,514)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Installment receivables, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">261 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">64 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">325 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">736 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">177 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">913 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:46.666%"><div><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Installment receivables purchased from DLL during the nine months ended September 30, 2020 increased the gross installment receivables balance by $343,000, which will be part of the company's 2020 class of installment receivables. No sales of installment receivables were made by the company </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div></div><div style="display:inline-block;max-width:6.666%;min-width:5.666%;vertical-align:top"/><div style="display:inline-block;vertical-align:top;width:46.668%"><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">during the quarter. There was no impact on the allowance for doubtful accounts for installment receivables as a result of the adoption of ASU 2016-03 as the installment receivables in the U.S. are specifically reserved for by account and no adjustment was needed to the allowance for doubtful accounts for Canada installment receivables.</span></div></div></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The movement in the installment receivables allowance for doubtful accounts was as follows (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.483%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.761%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.762%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Nine Months Ended <br/>September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Year Ended December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Balance as of beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,514 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,542 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Current period provision</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">32 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">479 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Direct write-offs charged against the allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(1,091)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(507)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Balance as of end of period</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">455 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,514 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:46.666%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span></div></div><div style="display:inline-block;max-width:6.666%;min-width:5.666%;vertical-align:top"/><div style="display:inline-block;vertical-align:top;width:46.668%"/></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Installment receivables by class as of September 30, 2020 consist of the following (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.861%"><tr><td style="width:1.0%"/><td style="width:41.041%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.808%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.947%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.808%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.811%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Total<br/>Installment<br/>Receivables</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Unpaid<br/>Principal<br/>Balance</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Related<br/>Allowance for<br/>Doubtful<br/>Accounts</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Interest<br/>Income<br/>Recognized</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Impaired installment receivables with a related allowance recorded</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">649 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">649 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">453 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Canada</span></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Non-Impaired installment receivables with no related allowance recorded</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">132 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">129 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">26 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Impaired installment receivables with a related allowance recorded</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total Canadian installment receivables</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">134 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">131 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">26 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Non-Impaired installment receivables with no related allowance recorded</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">132 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">129 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">26 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Impaired installment receivables with a related allowance recorded</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">651 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">651 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">455 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total installment receivables</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">783 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">780 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">455 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">26 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Installment receivables by class as of December 31, 2019 consist of the following (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.861%"><tr><td style="width:1.0%"/><td style="width:41.180%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.808%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.808%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.808%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.811%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Total<br/>Installment<br/>Receivables</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Unpaid<br/>Principal<br/>Balance</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Related<br/>Allowance for<br/>Doubtful<br/>Accounts</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Interest<br/>Income<br/>Recognized</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Impaired installment receivables with a related allowance recorded</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,762 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,762 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,497 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Canada</span></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Non-Impaired installment receivables with no related allowance recorded</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">670 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">648 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">92 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Impaired installment receivables with a related allowance recorded</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">17 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">17 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">17 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total Canadian installment receivables</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">687 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">665 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">17 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">92 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Non-Impaired installment receivables with no related allowance recorded</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">670 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">648 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">92 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Impaired installment receivables with a related allowance recorded</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,779 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,779 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,514 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total installment receivables</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,449 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,427 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,514 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">92 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:46.666%"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Installment receivables with a related allowance recorded as noted in the table above represent those installment receivables on a non-accrual basis in accordance with ASU 2010-20. As of September 30, 2020, the company had no U.S. installment receivables past due of 90 days or more for which the company is still accruing interest. Individually, all U.S. installment receivables are assigned a specific allowance for doubtful accounts based on management’s review when the </span></div></div><div style="display:inline-block;max-width:6.666%;min-width:5.666%;vertical-align:top"/><div style="display:inline-block;vertical-align:top;width:46.668%"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">company does not expect to receive both the contractual principal and interest payments as specified in the loan agreement. In Canada, the company had an immaterial amount of Canadian installment receivables which were past due of 90 days or more as of December 31, 2019 for which the company was still accruing interest.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div></div></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The aging of the company’s installment receivables was as follows (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.722%"><tr><td style="width:1.0%"/><td style="width:27.451%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.042%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.042%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.042%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.610%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.042%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.042%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.045%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S.</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Canada</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S.</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Canada</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">659 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">659 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0-30 Days Past Due</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31-60 Days Past Due</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61-90 Days Past Due</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90+ Days Past Due</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">651 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">649 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,784 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,762 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">783 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">649 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,449 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,762 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">687 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> <div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Receivables consist of the following (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:48.602%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.007%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.288%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.603%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Accounts receivable, gross</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">132,809 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">141,732 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Customer rebate reserve</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(13,075)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(13,922)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Cash discount reserves</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(5,290)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,326)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Allowance for doubtful accounts</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(4,697)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,804)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other, principally returns and allowances reserves</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(790)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,011)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Accounts receivable, net</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">108,957 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">116,669 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 132809000 141732000 13075000 13922000 5290000 5326000 4697000 4804000 790000 1011000 108957000 116669000 243000 0.010 0.002 0.003 0.009 0.027 0.003 <div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The movement in the trade receivables allowance for doubtful accounts was as follows (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.054%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:30.746%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Nine Months Ended <br/>September 30, 2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Balance as of beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4,804 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Current period provision</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">522 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Direct write-offs charged against the allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(629)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Balance as of end of period</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4,697 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div> 4804000 522000 629000 4697000 306000 3 P12M 250000 P18M <div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Installment receivables consist of the following (in thousands): </span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.722%"><tr><td style="width:1.0%"/><td style="width:28.565%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.042%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.042%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.042%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.042%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.042%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.045%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"> </span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Current</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Long-<br/>Term</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Current</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Long-<br/>Term</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Installment receivables</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">555 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">228 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">783 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,192 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,257 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,449 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Less: Unearned interest</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(3)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(3)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(22)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(22)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">552 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">228 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">780 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,170 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,257 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,427 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Allowance for doubtful accounts</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(291)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(164)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(455)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(434)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(1,080)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(1,514)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Installment receivables, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">261 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">64 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">325 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">736 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">177 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">913 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 555000 228000 783000 1192000 1257000 2449000 3000 0 3000 22000 0 22000 552000 228000 780000 1170000 1257000 2427000 291000 164000 455000 434000 1080000 1514000 261000 64000 325000 736000 177000 913000 343000 <div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The movement in the installment receivables allowance for doubtful accounts was as follows (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.483%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.761%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.762%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Nine Months Ended <br/>September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Year Ended December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Balance as of beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,514 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,542 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Current period provision</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">32 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">479 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Direct write-offs charged against the allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(1,091)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(507)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Balance as of end of period</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">455 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,514 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 1514000 1542000 32000 479000 1091000 507000 455000 1514000 <div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Installment receivables by class as of September 30, 2020 consist of the following (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.861%"><tr><td style="width:1.0%"/><td style="width:41.041%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.808%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.947%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.808%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.811%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Total<br/>Installment<br/>Receivables</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Unpaid<br/>Principal<br/>Balance</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Related<br/>Allowance for<br/>Doubtful<br/>Accounts</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Interest<br/>Income<br/>Recognized</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Impaired installment receivables with a related allowance recorded</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">649 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">649 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">453 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Canada</span></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Non-Impaired installment receivables with no related allowance recorded</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">132 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">129 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">26 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Impaired installment receivables with a related allowance recorded</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total Canadian installment receivables</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">134 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">131 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">26 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Non-Impaired installment receivables with no related allowance recorded</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">132 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">129 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">26 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Impaired installment receivables with a related allowance recorded</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">651 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">651 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">455 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total installment receivables</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">783 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">780 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">455 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">26 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Installment receivables by class as of December 31, 2019 consist of the following (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.861%"><tr><td style="width:1.0%"/><td style="width:41.180%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.808%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.808%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.808%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.811%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Total<br/>Installment<br/>Receivables</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Unpaid<br/>Principal<br/>Balance</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Related<br/>Allowance for<br/>Doubtful<br/>Accounts</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Interest<br/>Income<br/>Recognized</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Impaired installment receivables with a related allowance recorded</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,762 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,762 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,497 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Canada</span></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Non-Impaired installment receivables with no related allowance recorded</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">670 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">648 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">92 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Impaired installment receivables with a related allowance recorded</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">17 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">17 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">17 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total Canadian installment receivables</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">687 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">665 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">17 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">92 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Non-Impaired installment receivables with no related allowance recorded</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">670 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">648 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">92 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Impaired installment receivables with a related allowance recorded</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,779 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,779 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,514 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total installment receivables</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,449 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,427 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,514 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">92 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> <div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Installment receivables by class as of September 30, 2020 consist of the following (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.861%"><tr><td style="width:1.0%"/><td style="width:41.041%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.808%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.947%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.808%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.811%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Total<br/>Installment<br/>Receivables</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Unpaid<br/>Principal<br/>Balance</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Related<br/>Allowance for<br/>Doubtful<br/>Accounts</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Interest<br/>Income<br/>Recognized</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Impaired installment receivables with a related allowance recorded</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">649 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">649 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">453 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Canada</span></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Non-Impaired installment receivables with no related allowance recorded</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">132 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">129 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">26 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Impaired installment receivables with a related allowance recorded</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total Canadian installment receivables</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">134 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">131 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">26 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Non-Impaired installment receivables with no related allowance recorded</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">132 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">129 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">26 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Impaired installment receivables with a related allowance recorded</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">651 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">651 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">455 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total installment receivables</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">783 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">780 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">455 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">26 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Installment receivables by class as of December 31, 2019 consist of the following (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.861%"><tr><td style="width:1.0%"/><td style="width:41.180%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.808%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.808%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.808%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.811%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Total<br/>Installment<br/>Receivables</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Unpaid<br/>Principal<br/>Balance</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Related<br/>Allowance for<br/>Doubtful<br/>Accounts</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Interest<br/>Income<br/>Recognized</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Impaired installment receivables with a related allowance recorded</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,762 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,762 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,497 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Canada</span></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Non-Impaired installment receivables with no related allowance recorded</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">670 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">648 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">92 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Impaired installment receivables with a related allowance recorded</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">17 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">17 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">17 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total Canadian installment receivables</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">687 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">665 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">17 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">92 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Non-Impaired installment receivables with no related allowance recorded</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">670 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">648 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">92 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Impaired installment receivables with a related allowance recorded</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,779 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,779 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,514 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total installment receivables</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,449 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,427 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,514 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">92 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 649000 649000 453000 0 132000 129000 0 26000 2000 2000 2000 0 134000 131000 2000 26000 132000 129000 0 26000 651000 651000 455000 0 783000 780000 455000 26000 1762000 1762000 1497000 0 670000 648000 0 92000 17000 17000 17000 0 687000 665000 17000 92000 670000 648000 0 92000 1779000 1779000 1514000 0 2449000 2427000 1514000 92000 <div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The aging of the company’s installment receivables was as follows (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.722%"><tr><td style="width:1.0%"/><td style="width:27.451%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.042%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.042%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.042%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.610%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.042%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.042%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.045%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S.</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Canada</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S.</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Canada</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">659 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">659 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0-30 Days Past Due</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31-60 Days Past Due</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61-90 Days Past Due</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90+ Days Past Due</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">651 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">649 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,784 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,762 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">783 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">649 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,449 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,762 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">687 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 132000 0 132000 659000 0 659000 0 0 0 2000 0 2000 0 0 0 4000 0 4000 0 0 0 0 0 0 651000 649000 2000 1784000 1762000 22000 783000 649000 134000 2449000 1762000 687000 <div><span style="color:#003399;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Inventories, Net</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories consist of the following (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.038%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.983%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.985%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68,599 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,064 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,093 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,638 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,760 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,798 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories, net</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145,452 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120,500 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> <div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories consist of the following (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.038%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.983%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.985%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68,599 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,064 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,093 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,638 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,760 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,798 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories, net</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145,452 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120,500 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 68599000 54064000 66093000 54638000 10760000 11798000 145452000 120500000 <div><span style="color:#003399;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Current Assets</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other current assets consist of the following (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.038%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.983%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.985%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax receivables principally value added taxes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,188 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,049 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivable due from information technology provider</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,402 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,262 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid inventory</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,392 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">684 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives (foreign currency forward exchange contracts)</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">599 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">838 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">446 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,013 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid insurance</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">341 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,918 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred financing fees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">209 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">207 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid social charges</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,216 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recoverable income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">297 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid and other current assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,913 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,425 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Current Assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,635 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,909 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>In the fourth quarter of 2019, the company entered into an agreement to outsource substantially all of the company’s information technology ("IT") business service activities, including, among other things, support, rationalization and upgrading of the company’s legacy information technology systems and implementation of a global enterprise resource planning system. The agreement provides for reimbursement by the IT provider of IT expenses incurred by the company which are shown as Receivable due from IT provider above. The amount of pass through charges will diminish as IT expenses are recorded directly by the IT provider. In addition, a corresponding current payable is due to the IT provider. See "Accrued Expenses" in the notes to the Condensed Consolidated Financial Statements included elsewhere in this report. <div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other current assets consist of the following (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.038%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.983%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.985%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax receivables principally value added taxes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,188 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,049 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivable due from information technology provider</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,402 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,262 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid inventory</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,392 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">684 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives (foreign currency forward exchange contracts)</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">599 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">838 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">446 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,013 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid insurance</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">341 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,918 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred financing fees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">209 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">207 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid social charges</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,216 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recoverable income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">297 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid and other current assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,913 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,425 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Current Assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,635 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,909 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 23188000 16049000 2402000 6262000 1392000 684000 599000 838000 446000 2013000 341000 2918000 209000 207000 95000 1216000 50000 297000 8913000 7425000 37635000 37909000 <div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:46.666%"><div><span style="color:#003399;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Long-Term Assets</span></div></div><div style="display:inline-block;max-width:6.666%;min-width:5.666%;vertical-align:top"/><div style="display:inline-block;vertical-align:top;width:46.668%"><div><span><br/></span></div></div></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other long-term assets consist of the following (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.038%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.983%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.985%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash surrender value of life insurance policies</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,224 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,124 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,032 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">928 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred financing fees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">461 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">602 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Installment receivables</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">177 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Long-Term Assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,991 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,216 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> <div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other long-term assets consist of the following (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.038%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.983%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.985%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash surrender value of life insurance policies</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,224 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,124 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,032 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">928 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred financing fees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">461 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">602 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Installment receivables</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">177 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Long-Term Assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,991 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,216 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 2224000 2124000 1032000 928000 461000 602000 85000 85000 64000 177000 125000 300000 3991000 4216000 Property and Equipment<div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment consist of the following (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.038%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.983%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.985%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">291,902 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">296,078 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land, buildings and improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,088 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,054 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized software</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,787 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,509 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,866 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,898 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,087 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,023 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and Equipment, gross</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">351,730 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">351,562 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(298,618)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(304,955)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and Equipment, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,112 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,607 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:46.666%"><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Machinery and equipment includes demonstration units placed in provider locations which are depreciated to their estimated recoverable values over their estimated useful lives. In the fourth quarter of 2019, the company initiated the first stage of an Enterprise Resource Planning ("ERP") software implementation. As a result of the initiation of the ERP project, the company capitalized certain costs in accordance with ASC 350 as shown in capitalized software above. </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div></div><div style="display:inline-block;max-width:6.666%;min-width:5.666%;vertical-align:top"/><div style="display:inline-block;vertical-align:top;width:46.668%"><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the third quarter of 2018, the company agreed to sell its Isny, Germany location with a net book value at the signing of the agreement of approximately $2,900,000, which is included in Land, buildings and improvements in the table above as of December 31, 2019. In accordance with the agreement, control transferred to the buyer in April 2020. The company recorded a gain on the transaction of $971,000.</span></div><div style="text-align:justify"><span><br/></span></div></div></div> <div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment consist of the following (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.038%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.983%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.985%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">291,902 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">296,078 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land, buildings and improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,088 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,054 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized software</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,787 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,509 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,866 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,898 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,087 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,023 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and Equipment, gross</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">351,730 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">351,562 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(298,618)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(304,955)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and Equipment, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,112 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,607 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 291902000 296078000 28088000 33054000 13787000 3509000 9866000 9898000 8087000 9023000 351730000 351562000 298618000 304955000 53112000 46607000 2900000 971000 <div><span style="color:#003399;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Goodwill</span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The change in goodwill from December 31, 2019 to September 30, 2020 was due to foreign currency translation. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangibles—Goodwill and Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, ASC 350, goodwill is tested annually for impairment. The company first estimates the fair value of each reporting unit and compares the calculated fair value to the carrying value of each reporting unit. A reporting unit is defined as an operating segment or one level below. The company has determined that its reporting units are North America / HME, Europe, Institutional Products Group and Asia Pacific.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In consideration of the negative impact of COVID-19 on the global economy, the company performed an interim test of </span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">goodwill for impairment in the first quarter of 202</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0 and no impairment was recorded. For the second and third</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> quarters of 2020</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the company concluded that the facts and circumstances driving the conclusions from the first quarter review had not changed materially. While the</span>re was no indication of impairment in the second or third quarter of 2020 related to goodwill for the Europe or Institutional Products Group reporting units, a future potential impairment is possible for these reporting units should actual results differ materially from the company's current forecasted results or market inputs used to determine the discount rate change significantly. Please refer to Goodwill in the company's Annual Report on Form 10-K for the period ending December 31, 2019 for further disclosure regarding the company's impairment analysis review methodology. <div style="margin-top:9pt"><span style="color:#003399;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Intangibles</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company's intangibles consist of the following (in thousands):</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:2pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.861%"><tr><td style="width:1.0%"/><td style="width:41.180%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.808%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.808%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.808%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.811%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Historical<br/>Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Historical<br/>Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer lists</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,267 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,267 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,108 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,108 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,019 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,479 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technology</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,918 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,150 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,483 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,642 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patents</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,514 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,514 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,521 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,521 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">License agreements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,864 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">891 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,884 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">770 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,161 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,151 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,163 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,150 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangibles</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96,743 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68,973 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91,638 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,191 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:46.666%"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All the company’s intangible assets have been assigned definite lives and continue to be amortized over their useful lives, except for trademarks shown above, which have indefinite lives. The changes in intangible balances reflected on the balance sheet from December 31, 2019 to September 30, 2020 were the result of foreign currency translation and amortization.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company evaluates the carrying value of definite-lived assets annually in the fourth quarter and whenever events or circumstances indicate possible impairment. In consideration of the negative impact of COVID-19 on the g</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">lobal economy, the company performed a review of intangibles for impairment in the first quarter of 2020 and concluded there was no</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> impairment to be recorded. For the second and third quarters</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of 2020, the company concluded that the facts and circumstances driving the conclusions from the first quarter review had not changed materially. Definite-lived assets are determined to be impaired if the future undiscounted cash </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">flows expected to be generated by the asset are less than the carrying value. Actual impairment amounts for definite-</span></div></div><div style="display:inline-block;max-width:6.666%;min-width:5.666%;vertical-align:top"/><div style="display:inline-block;vertical-align:top;width:46.668%"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">lived assets are then calculated using a discounted cash flow calculation. </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any impairment amounts for indefinite-lived assets are calculated as the difference between the future discounted cash flows expected to be generated by the asset less than the carrying value for the asset. </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense related to intangibles was $276,000 in the first nine months of 2020 and is expected to be $419,000 in 2020, $390,000 in 2021, $390,000 in 2022, $389,000 in 2023, $355,000 in 2024 and $212,000 in 2025. Amortized intangibles are being amortized on a straight-line basis over remaining lives of 1 to 10 years with most of the intangibles being amortized over an average remaining life of approximately 8 years.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div></div></div> <div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company's intangibles consist of the following (in thousands):</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:2pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.861%"><tr><td style="width:1.0%"/><td style="width:41.180%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.808%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.808%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.808%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.811%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Historical<br/>Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Historical<br/>Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer lists</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,267 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,267 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,108 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,108 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,019 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,479 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technology</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,918 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,150 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,483 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,642 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patents</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,514 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,514 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,521 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,521 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">License agreements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,864 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">891 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,884 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">770 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,161 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,151 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,163 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,150 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangibles</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96,743 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68,973 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91,638 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,191 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> <div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company's intangibles consist of the following (in thousands):</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:2pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.861%"><tr><td style="width:1.0%"/><td style="width:41.180%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.808%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.808%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.808%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.811%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Historical<br/>Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Historical<br/>Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer lists</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,267 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,267 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,108 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,108 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,019 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,479 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technology</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,918 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,150 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,483 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,642 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patents</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,514 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,514 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,521 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,521 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">License agreements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,864 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">891 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,884 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">770 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,161 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,151 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,163 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,150 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangibles</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96,743 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68,973 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91,638 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,191 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 54267000 54267000 51108000 51108000 25019000 23479000 7918000 7150000 7483000 6642000 5514000 5514000 5521000 5521000 2864000 891000 2884000 770000 1161000 1151000 1163000 1150000 96743000 68973000 91638000 65191000 276000 419000 390000 390000 389000 355000 212000 P1Y P10Y P8Y <div><span style="color:#003399;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accrued Expenses</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued expenses consist of accruals for the following (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.038%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.983%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.985%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Salaries and wages</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,612 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,725 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Taxes other than income taxes, primarily Value Added Taxes</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,830 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,194 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warranty</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,144 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,626 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Professional</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,481 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,869 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,988 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,023 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,663 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,608 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rebates</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,146 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,743 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IT service contracts</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,790 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,125 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Freight</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,710 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,744 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,436 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,173 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative liabilities (foreign currency forward exchange contracts)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,824 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">905 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product liability, current portion</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,810 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,736 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Insurance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">781 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">699 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rent</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">568 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">415 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Supplemental Executive Retirement Program liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">391 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">391 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Advance payment on sale of land &amp; buildings</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,471 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IT licenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,114 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other items, principally trade accruals</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,492 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,386 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued Expenses</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124,666 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120,947 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:46.666%"><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Generally, the company's products are covered by warranties against defects in material and workmanship for various periods depending on the product from the date of sales to the customer. Certain components carry a lifetime warranty. A provision for estimated warranty cost is recorded at the time of sale based upon actual experience. In addition, the company has sold extended warranties that, while immaterial, require the company to defer the revenue associated with those warranties until earned. The company has established procedures to appropriate defer such revenue. The company continuously assesses the adequacy of its product warranty accrual and makes adjustments as needed. Historical analysis is primarily used to determine the company's warranty reserves. Claims history is reviewed and provisions are adjusted as needed. However, the company does consider other events, such as a product field action and recalls, which could require additional warranty reserve provision.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div></div><div style="display:inline-block;max-width:6.666%;min-width:5.666%;vertical-align:top"/><div style="display:inline-block;vertical-align:top;width:46.668%"><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued rebates relate to several volume incentive programs the company offers its customers. The company accounts for these rebates as a reduction of revenue when the products are sold. Rebates are netted against gross accounts receivables. If rebates are in excess of such receivables, they are then classified as accrued expenses. The reduction in accrued rebates from December 31, 2019 to September 30, 2020 primarily relates to payments principally made in the first quarter each year.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the fourth quarter of 2019, the company entered into an agreement with an IT provider to outsource substantially all of the company’s information technology business service activities, including, among other things, support, rationalization and upgrading of the company’s legacy information technology systems and implementation of a global enterprise resource planning (“ERP”) system. Accrued expenses related to IT outsourcing are reflected in IT service contracts. Separately, the company entered into licenses for a new ERP system which are shown as IT licenses.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div></div></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of the changes in accrued warranty costs for the reporting period (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:78.661%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.139%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1, 2020</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,626 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warranties provided during the period</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,311 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements made during the period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,926)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in liability for pre-existing warranties during the period, including expirations</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,133 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of September 30, 2020</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,144 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>Warranty reserves are subject to adjustment in future periods as new developments change the company's estimate of the total cost. In the third quarter of 2020, warranty expense includes a provision of $768,000 for a product recall which was related to a component on a respiratory product, recorded in the North America segment. <div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued expenses consist of accruals for the following (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.038%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.983%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.985%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Salaries and wages</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,612 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,725 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Taxes other than income taxes, primarily Value Added Taxes</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,830 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,194 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warranty</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,144 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,626 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Professional</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,481 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,869 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,988 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,023 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,663 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,608 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rebates</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,146 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,743 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IT service contracts</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,790 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,125 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Freight</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,710 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,744 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,436 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,173 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative liabilities (foreign currency forward exchange contracts)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,824 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">905 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product liability, current portion</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,810 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,736 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Insurance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">781 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">699 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rent</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">568 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">415 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Supplemental Executive Retirement Program liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">391 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">391 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Advance payment on sale of land &amp; buildings</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,471 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IT licenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,114 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other items, principally trade accruals</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,492 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,386 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued Expenses</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124,666 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120,947 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 34612000 29725000 29830000 22194000 11144000 11626000 8481000 6869000 5988000 7023000 4663000 3608000 4146000 10743000 3790000 6125000 3710000 3744000 3436000 3173000 2824000 905000 2810000 2736000 781000 699000 568000 415000 391000 391000 0 3471000 0 2114000 7492000 5386000 124666000 120947000 <div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of the changes in accrued warranty costs for the reporting period (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:78.661%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.139%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1, 2020</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,626 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warranties provided during the period</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,311 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements made during the period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,926)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in liability for pre-existing warranties during the period, including expirations</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,133 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of September 30, 2020</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,144 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 11626000 4311000 5926000 1133000 11144000 768000 <div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Debt consists of the following (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.816%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.094%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.096%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Convertible senior notes at 5.00%, due in February 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,224 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,628 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Convertible senior notes at 4.50%, due in June 2022</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,652 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101,815 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Convertible senior notes Series I at 5.00%, due in November 2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,443 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,817 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Convertible senior notes Series II at 5.00%, due November 2024</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,556 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,389 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">262 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">242,264 </span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">219,522 </span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less current maturities of long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,062)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(58)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-Term Debt</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">238,202 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">219,464 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:46.666%"><div><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 30, 2015, the company entered into an Amended and Restated Revolving Credit and Security Agreement, which was subsequently amended (the “Credit Agreement”) and which matures on January 16, 2024. The Credit Agreement was entered into by and among the company, certain of the company’s direct and indirect U.S. and Canadian subsidiaries and certain of the company’s European subsidiaries (together with the company, the “Borrowers”), certain other of the company’s direct and indirect U.S., Canadian and European subsidiaries (the “Guarantors”), and PNC Bank, National Association (“PNC”), JPMorgan Chase Bank, N.A., J.P. Morgan Europe Limited, KeyBank National Association, and Citizens Bank, National Association (the “Lenders”). PNC is the administrative agent (the “Administrative Agent”) and J.P. Morgan Europe Limited is the European agent (the “European Agent”) under the Credit Agreement. In connection with entering into the company's Credit Agreement, the company incurred fees which were capitalized and are being amortized as interest expense. As of September 30, 2020, debt fees yet to be amortized through January 2024 totaled $670,000. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company had outstanding letters of credit of $7,740,000 and $8,011,000 as of September 30, 2020 and December 31, 2019, respectively. Outstanding letters of credit and other reserves impacting borrowing capacity were $7,653,000 and $8,827,000 as of September 30, 2020 and December 31, 2019, respectively. The company had outstanding borrowings of $23,700,000 under its U.S. and Canadian Credit Facility as of September 30, 2020. The company had outstanding borrowings of $6,322,000 (€5,300,000) under its French Credit Facility and $2,138,000 (£1,600,000) under its UK Credit Facility as of September 30, 2020, together referred to as the European Credit Facility. The company had no borrowings under the Credit Facilities as of December 31, 2019. The weighted average interest rate on all borrowings, excluding financing leases, was 4.63% for the </span></div></div><div style="display:inline-block;max-width:6.666%;min-width:5.666%;vertical-align:top"/><div style="display:inline-block;vertical-align:top;width:46.668%"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">nine months ended September 30, 2020 and 4.78% for the year ended December 31, 2019.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">U.S. and Canadian Borrowers Credit Facility</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the company's U.S. and Canadian Borrowers, the Credit Agreement provides for an asset-based-lending senior secured revolving credit facility which is secured by substantially all the company’s U.S. and Canadian assets, other than real estate. The Credit Agreement provides the company and the other Borrowers with a credit facility in an aggregate principal amount of $60,000,000, subject to availability based on a borrowing base formula, under a senior secured revolving credit, letter of credit and swing line loan facility (the “U.S. and Canadian Credit Facility”). Up to $20,000,000 of the U.S. and Canadian Credit Facility will be available for issuance of letters of credit. The aggregate principal amount of the U.S. and Canadian Credit Facility may be increased by up to $25,000,000 to the extent requested by the company and agreed to by any Lender or new financial institution approved by the Administrative Agent. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The aggregate borrowing availability under the U.S. and Canadian Credit Facility is determined based on a borrowing base formula. The aggregate usage under the U.S. and Canadian Credit Facility may not exceed an amount equal to the sum of (a) 85% of eligible U.S. accounts receivable </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">plus</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (b) the lesser of (i) 70% of eligible U.S. inventory and eligible foreign in-transit inventory and (ii) 85% of the net orderly liquidation value of eligible U.S. inventory and eligible foreign in-transit inventory (not to exceed $4,000,000), </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">plus</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (c) the lesser of (i) 85% of the net orderly liquidation value of U.S. eligible machinery and equipment and (ii) $0 as of September 30, 2020 (subject to reduction as provided in the Credit Agreement), </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">plus</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (d) 85% of eligible Canadian accounts receivable, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">plus</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (e) the lesser of (i) 70% of eligible Canadian inventory and (ii) 85% of the net orderly liquidation value of eligible Canadian inventory, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">less</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (f) swing loans </span></div></div></div><div style="display:inline-block;vertical-align:top;width:46.666%"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">outstanding under the U.S. and Canadian Credit Facility, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">less</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (g) letters of credit issued and undrawn under the U.S. and Canadian Credit Facility, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">less</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (h) a $3,000,000 minimum availability reserve, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">less</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (i) other reserves required by the Administrative Agent, and in each case subject to the definitions and limitations in the Credit Agreement. As of September 30, 2020, the company was in compliance with all covenant requirements. As of September 30, 2020, the company had gross borrowing availability of $23,700,000 under the U.S. and Canadian Credit Facility under the Credit Agreement, considering the minimum availability reserve, then-outstanding letters of credit, other reserves and the $7,500,000 dominion trigger amount described below. Borrowings under the U.S. and Canadian Credit Facility are secured by substantially all of the company’s U.S. and Canadian assets, other than real estate.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest will accrue on outstanding indebtedness under the Credit Agreement at the LIBOR rate, plus a margin ranging from 2.25% to 2.75%, or at the alternate base rate, plus a margin ranging from 1.25% to 1.75%, as selected by the company. Borrowings under the U.S. and Canadian Credit Facility are subject to commitment fees of 0.25% or 0.375% per year, depending on utilization. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Credit Agreement contains customary representations, warranties and covenants. Exceptions to the operating covenants in the Credit Agreement provide the company with flexibility to, among other things, enter into or undertake certain sale and leaseback transactions, dispositions of assets, additional credit facilities, sales of receivables, additional indebtedness and intercompany indebtedness, all subject to limitations set forth in the Credit Agreement, as amended. The Credit Agreement also contains a covenant requiring the company to maintain minimum availability under the U.S. and Canadian Credit Facility of not less than the greater of (i) 11.25% of the maximum amount that may be drawn under the U.S. and Canadian Credit Facility for five (5) consecutive business days, or (ii) $6,000,000 on any business day. The company also is subject to dominion triggers under the U.S. and Canadian Credit Facility requiring the company to maintain borrowing capacity of not less than $7,500,000 on any business day in order to avoid triggering full control by an agent for the Lenders of the company's cash receipts for application to the company’s obligations under the agreement.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Credit Agreement contains customary default provisions, with certain grace periods and exceptions, which provide for events of default that include, among other things, failure to pay amounts due, breach of covenants, representations or warranties, bankruptcy, the occurrence of a material adverse effect, exclusion from any medical reimbursement program, and an interruption of any material manufacturing facilities for more than 10 consecutive days. </span></div></div><div style="display:inline-block;max-width:6.666%;min-width:5.666%;vertical-align:top"/><div style="display:inline-block;vertical-align:top;width:46.668%"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There was $23,700,000 outstanding under the U.S. and Canadian Credit Facility at September 30, 2020.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">European Credit Facility</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Credit Agreement also provides for a revolving credit, letter of credit and swing line loan facility which gives the company and the European Borrowers the ability to borrow up to an aggregate principal amount of $30,000,000, with a $5,000,000 sublimit for letters of credit and a $2,000,000 sublimit for swing line loans (the “European Credit Facility”). Up to $15,000,000 of the European Credit Facility will be available to each of Invacare Limited (the “UK Borrower”) and Invacare Poirier SAS (the “French Borrower” and, together with the UK Borrower, the “European Borrowers”). The European Credit Facility matures in January 2024, together with the U.S. and Canadian Credit Facility. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The aggregate borrowing availability for each European Borrower under the European Credit Facility is determined based on a borrowing base formula. The aggregate borrowings of each of the European Borrowers under the European Credit Facility may not exceed an amount equal to (a) 85% of the European Borrower’s eligible accounts receivable, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">less </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) the European Borrower’s borrowings and swing line loans outstanding under the European Credit Facility, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">less </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c) the European Borrower’s letters of credit issued and undrawn under the European Credit Facility, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">less </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d) a $3,000,000 minimum availability reserve, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">less </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e) other reserves required by the European Agent, and in each case subject to the definitions and limitations in the Credit Agreement. As of September 30, 2020, the gross borrowing availability to the European Borrowers under the European Credit Facility was $8,564,000, considering the $3,000,000 minimum availability reserve and the $3,750,000 dominion trigger amount described below.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The aggregate principal amount of the European Credit Facility may be increased by up to $10,000,000 to the extent requested by the company and agreed to by any Lender or Lenders that wish to increase their lending participation or, if not agreed to by any Lender, a new financial institution that agrees to join the European Credit Facility and that is approved by the Administrative Agent and the European Agent.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest will accrue on outstanding indebtedness under the European Credit Facility at the LIBOR rate, plus a margin ranging from 2.50% to 3.00%, or for swing line loans, at the overnight LIBOR rate, plus a margin ranging from 2.50% to 3.00%, as selected by the company. The margin that will be adjusted quarterly based on utilization. Borrowings under the European Credit Facility are subject to commitment fees of 0.25% or 0.375% per year, depending on utilization. </span></div></div><div style="display:inline-block;vertical-align:top;width:46.666%"><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The European Credit Facility is secured by substantially all the personal property assets of the UK Borrower and its in-country subsidiaries, and all the receivables of the French Borrower and its in-country subsidiaries. The UK and French facilities (which comprise the European Credit Facility) are cross collateralized, and the US personal property assets previously pledged under the U.S. and Canadian Credit Facility also serve as collateral for the European Credit Facility. </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The European Credit Facility is subject to customary representations, warranties and covenants generally consistent with those applicable to the U.S. and Canadian Credit Facility. Exceptions to the operating covenants in the Credit Agreement provide the company with flexibility to, among other things, enter into or undertake certain sale/leaseback transactions, dispositions of assets, additional credit facilities, sales of receivables, additional indebtedness and intercompany indebtedness, all subject to limitations set forth in the Credit Agreement. The Credit Agreement also contains a covenant requiring the European Borrowers to maintain undrawn availability under the European Credit Facility of not less than the greater of (i) 11.25% of the maximum amount that may be drawn under the European Credit Facility for five (5) consecutive business days, or (ii) $3,000,000 on any business day. The European Borrowers also are subject to cash dominion triggers under the European Credit Facility requiring the European Borrower to maintain borrowing capacity of not less than $3,750,000 on any business day in order to avoid triggering full control by an agent for the Lenders of the European Borrower’s cash receipts for application to its obligations under the European Credit Facility. </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The European Credit Facility is subject to customary default provisions, with certain grace periods and exceptions, consistent with those applicable to the U.S. and Canadian Credit Facility, which provide that events of default include, among other things, failure to pay amounts due, breach of covenants, representations or warranties, cross-default, bankruptcy, the occurrence of a material adverse effect, exclusion from any medical reimbursement program, and an interruption in the operations of any material manufacturing facility for more than 10 consecutive days. The proceeds of the European Credit Facility will be used to finance the working capital and other business needs of the company. As of September 30, 2020, the company had borrowings of $6,322,000 (€5,300,000) under its French Credit Facility and $2,138,000 (£1,600,000) under its UK Credit Facility as of September 30, 2020, together referred to as the European Credit Facility.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Convertible senior notes due 2021</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of 2016, the company issued $150,000,000 aggregate principal amount of 5.00% </span></div></div><div style="display:inline-block;max-width:6.666%;min-width:5.666%;vertical-align:top"/><div style="display:inline-block;vertical-align:top;width:46.668%"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Convertible Senior Notes due 2021 (the “2021 notes”) in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act. The 2021 notes bear interest at a rate of 5.00% per year payable semi-annually in arrears on February 15 and August 15 of each year, beginning August 15, 2016. The 2021 notes will mature on February 15, 2021, unless repurchased or converted in accordance with their terms prior to such date. Prior to August 15, 2020, the 2021 notes were convertible only upon satisfaction of certain conditions and during certain periods, and thereafter, at any time until the close of business on the second scheduled trading day immediately preceding the maturity date. Prior to May 16, 2019, the 2021 notes were convertible, subject to certain conditions, into cash only. On May 16, 2019, the company obtained shareholder approval under applicable New York Stock Exchange rules such that conversion of the 2021 notes may be settled in cash, the company’s common shares or a combination of cash and the company’s common shares, at the company’s election. At September 30, 2020, $1,250,000 aggregate principal amount of the 2021 Notes remained outstanding, following the repurchase of $16,000,000 aggregate principal amount of 2021 Notes for cash in the third quarter of 2019, the exchange transactions completed in the fourth quarter of 2019 and the second quarter of 2020, as further discussed below, and the repurchases of $24,466,000 aggregate principal amount in the third quarter of 2020. The $24,466,000 repurchases in the third quarter of 2020, resulted in a $761,000 loss on debt extinguishment. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders of the 2021 notes may convert their 2021 notes at their option at any time prior to the close of business on the business day immediately preceding August 15, 2020 only under the following circumstances: (1) during any fiscal quarter commencing after March 31, 2016 (and only during such fiscal quarter), if the last reported sale price of the company’s Common Shares for at least 20 trading days (whether or not consecutive) during the period of 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding fiscal quarter is greater than or equal to 130% of the applicable conversion price for the 2021 notes on each applicable trading day; (2) during the <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmVkMzM0M2I5YTc1ZDRkMGRhNDRlMjIzZWQxZWY4NDc2L3NlYzplZDMzNDNiOWE3NWQ0ZDBkYTQ0ZTIyM2VkMWVmODQ3Nl8xMjEvZnJhZzoxNGU3YzQxYjcxZjE0NDFjODAyMmZhNzdmYTdlMTIxMC90ZXh0cmVnaW9uOjE0ZTdjNDFiNzFmMTQ0MWM4MDIyZmE3N2ZhN2UxMjEwXzE0MTA3_fb4f0cf7-f12c-4495-97d8-eb8a305dd81b">five</span> business day period after any 10 consecutive trading day period (the “measurement period”) in which the “trading price” (as defined in the Indenture) per one thousand U.S. dollar principal amount of 2021 notes for each trading day of such measurement period was less than 98% of the product of the last reported sale price of the company’s Common Shares and the applicable conversion rate for the 2021 notes on each such trading day; or (3) upon the occurrence of specified corporate events described in the Indenture. On or after August 15, 2020 until the close of business on the second scheduled trading day immediately preceding the maturity of the 2021 Notes, holders may convert their 2021 Notes, at the option of the holder, regardless of the foregoing circumstances. </span></div></div><div style="display:inline-block;vertical-align:top;width:46.666%"><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders of the 2021 notes will have the right to require the company to repurchase all or some of their 2021 notes at 100% of their principal, plus any accrued and unpaid interest, upon the occurrence of certain fundamental changes. The initial conversion rate is 60.0492 common shares per $1,000 principal amount of 2021 notes (equivalent to an initial conversion price of approximately $16.65 per common share). Until the company received shareholder approval on May 16, 2019 authorizing it to elect to settle future conversions of the 2021 Notes in common shares, the company separately accounted for the conversion features as a derivative. The derivative was capitalized on the balance sheet as a long-term liability with adjustment to reflect fair value each quarter until the change to the conversion features as a result of the shareholder approval received on May 16, 2019 resulted in the termination of the derivative. The fair value of the convertible debt conversion liability at issuance was $34,480,000. The company recognized a loss of $2,210,000 for the nine months ended September 30, 2019 related to the convertible debt conversion liability. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the offering of the 2021 notes, the company entered into privately negotiated convertible note hedge transactions with two financial institutions (the “option counterparties”). These transactions cover, subject to customary anti-dilution adjustments, the number of the company’s common shares that will initially underlie the 2021 notes, and are expected generally to reduce the potential equity dilution, and/or offset any cash payments in excess of the principal amount due, as the case may be, upon conversion of the 2021 notes. The company evaluated the note hedges under the applicable accounting literature, including </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivatives and Hedging</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, ASC 815, and determined that the note hedges should be accounted for as derivatives. These derivatives were capitalized on the balance sheet as long-term assets and will be adjusted to reflect fair value each quarter. The fair value of the convertible note hedge assets at issuance was $27,975,000. The company recognized a gain of $2,852,000 for the nine months ended September 30, 2019 related to the convertible note hedge asset. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company entered into separate, privately negotiated warrant transactions with the option counterparties at a higher strike price relating to the same number of the company’s common shares, subject to customary anti-dilution adjustments, pursuant to which the company sold warrants to the option counterparties. The warrants could have a dilutive effect on the company’s outstanding common shares and the company’s earnings per share to the extent that the price of the company’s common shares exceeds the strike price of those warrants. The initial strike price of the warrants is $22.4175 per share and is subject to certain adjustments under the terms of the warrant transactions. The company evaluated the warrants under the applicable accounting literature, including </span></div></div><div style="display:inline-block;max-width:6.666%;min-width:5.666%;vertical-align:top"/><div style="display:inline-block;vertical-align:top;width:46.668%"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivatives and Hedging</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, ASC 815, and determined that the warrants meet the definition of a derivative, are indexed to the company's own stock and should be classified in shareholder's equity. The amount paid for the warrants and capitalized in shareholder's equity was $12,376,000.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The net proceeds from the offering of the 2021 notes were approximately $144,034,000, after deducting fees and offering expenses of $5,966,000, which were paid in 2016. These debt issuance costs were capitalized and are being amortized as interest expense through February 2021. Debt issuance costs are presented on the balance sheet as a direct deduction from the carrying amount of the related debt liability. Approximately $5,000,000 of the net proceeds from the offering were used to repurchase the company’s common shares from purchasers of 2021 notes in the offering in privately negotiated transactions. A portion of the net proceeds from the offering were used to pay the cost of the convertible note hedge transactions (after such cost is partially offset by the proceeds to the company from the warrant transactions), with a net cost of $15,600,000.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The liability components of the 2021 notes consist of the following (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.702%"><tr><td style="width:1.0%"/><td style="width:44.273%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.467%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.292%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.468%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Principal amount of liability component</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,250 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,091 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized discount</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,916)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt fees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(547)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net carrying amount of liability component</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,224 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,628 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unamortized discount of $22,000 is to be amortized through February 2021. The effective interest rate on the liability component was 11.1%. Non-cash interest expense of $261,000 and $1,767,000 was recognized for the three and nine months ended September 30, 2020, respectively, compared to $1,444,000 and $5,391,000 for the three and nine months ended September 30, 2019, respectively. Actual interest expense accrued was $241,000 and $1,617,000 for the three and nine months ended September 30, 2020, respectively, compared to $1,834,000 and $5,584,000 for the three and nine months ended September 30, 2019, respectively, based on the stated coupon rate of 5.0%. The 2021 notes were not convertible as of September 30, 2020 nor was the applicable conversion threshold met.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Convertible senior notes due 2022</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the second quarter of 2017, the company issued $120,000,000 aggregate principal amount of 4.50% Convertible Senior Notes due 2022 (the “2022 notes”) in a private offering to qualified institutional buyers pursuant to </span></div></div><div style="display:inline-block;vertical-align:top;width:46.666%"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Rule 144A under the Securities Act. The 2022 notes bear interest at a rate of 4.50% per year payable semi-annually in arrears on June 1 and December 1 of each year, beginning December 1, 2017. The 2022 notes will mature on June 1, 2022, unless repurchased or converted in accordance with their terms prior to such date. Prior to December 1, 2021, the 2022 notes will be convertible only upon satisfaction of certain conditions and during certain periods, and thereafter, at any time until the close of business on the second scheduled trading day immediately preceding the maturity date. Prior to May 16, 2019, the 2022 notes were convertible, subject to certain conditions, into cash only. On May 16, 2019, the company obtained shareholder approval under applicable New York Stock Exchange rules such that conversion of the 2022 notes may be settled in cash, the company’s common shares or a combination of cash and the company’s common shares, at the company’s election. At September 30, 2020, $81,500,000 aggregate principal amount of the 2022 Notes remained outstanding, following the exchange transactions completed in the second quarter of 2020, as further discussed below.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders of the 2022 notes may convert their 2022 notes at their option at any time prior to the close of business on the business day immediately preceding December 1, 2021 only under the following circumstances: (1) during any fiscal quarter commencing after September 30, 2017 (and only during such fiscal quarter), if the last reported sale price of the company’s Common Shares for at least 20 trading days (whether or not consecutive) during the period of 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding fiscal quarter is greater than or equal to 130% of the applicable conversion price for the 2022 notes on each applicable trading day; (2) during the <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmVkMzM0M2I5YTc1ZDRkMGRhNDRlMjIzZWQxZWY4NDc2L3NlYzplZDMzNDNiOWE3NWQ0ZDBkYTQ0ZTIyM2VkMWVmODQ3Nl8xMjEvZnJhZzoxNGU3YzQxYjcxZjE0NDFjODAyMmZhNzdmYTdlMTIxMC90ZXh0cmVnaW9uOjE0ZTdjNDFiNzFmMTQ0MWM4MDIyZmE3N2ZhN2UxMjEwXzIxNjE0_86fa8e5c-2388-4669-a40b-926a1b6bf284">five</span> business day period after any 10 consecutive trading day period (the “measurement period”) in which the “trading price” (as defined in the Indenture) per one thousand U.S. dollar principal amount of 2022 notes for each trading day of such measurement period was less than 98% of the product of the last reported sale price of the company’s Common Shares and the applicable conversion rate for the 2022 notes on each such trading day; or (3) upon the occurrence of specified corporate events described in the Indenture. On or after December 1, 2021 until the close of business on the second scheduled trading day immediately preceding the maturity of the 2022 Notes, holders may convert their 2022 Notes, at the option of the holder, regardless of the foregoing circumstances.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders of the 2022 notes will have the right to require the company to repurchase all or some of their 2022 notes at 100% of their principal, plus any accrued and unpaid interest, upon the occurrence of certain fundamental changes. The initial conversion rate is 61.6095 common shares per $1,000 principal amount of 2022 notes (equivalent to an initial conversion price of approximately $16.23 per common share). </span></div></div><div style="display:inline-block;max-width:6.666%;min-width:5.666%;vertical-align:top"/><div style="display:inline-block;vertical-align:top;width:46.668%"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Until the company received shareholder approval on May 16, 2019 authorizing it to elect to settle future conversions of the 2022 Notes in common shares, the company separately accounted for the conversion features as a derivative. The derivative was capitalized on the balance sheet as a long-term liability with adjustment to reflect fair value each quarter until the change to the conversion features as a result of the shareholder approval received on May 16, 2019 resulted in the termination of the derivative. The fair value of the convertible debt conversion liability at issuance was $28,859,000. The company recognized a loss of $6,193,000 for the nine months ended September 30, 2019 related to the convertible debt conversion liability. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the offering of the 2022 notes, the company entered into privately negotiated convertible note hedge transactions with one financial institution (the “option counterparty”). These transactions cover, subject to customary anti-dilution adjustments, the number of the company’s common shares that will initially underlie the 2022 notes, and are expected generally to reduce the potential equity dilution, and/or offset any cash payments in excess of the principal amount due, as the case may be, upon conversion of the 2022 notes. The company evaluated the note hedges under the applicable accounting literature, including </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivatives and Hedging</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, ASC 815, and determined that the note hedges should be accounted for as derivatives. These derivatives were capitalized on the balance sheet as long-term assets and will be adjusted to reflect fair value each quarter. The fair value of the convertible note hedge assets at issuance was $24,780,000. The company recognized a gain of $6,748,000 for the nine months ended September 30, 2019 related to the convertible note hedge asset. </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company entered into separate, privately negotiated warrant transactions with the option counterparty at a higher strike price relating to the same number of the company’s common shares, subject to customary anti-dilution adjustments, pursuant to which the company sold warrants to the option counterparties. The warrants could have a dilutive effect on the company’s outstanding common shares and the company’s earnings per share to the extent that the price of the company’s common shares exceeds the strike price of those warrants. The initial strike price of the warrants is $21.4375 per share and is subject to certain adjustments under the terms of the warrant transactions. The company evaluated the warrants under the applicable accounting literature, including </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivatives and Hedging</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, ASC 815, and determined that the warrants meet the definition of a derivative, are indexed to the company's own shares and should be classified in shareholder's equity. The amount paid for the warrants and capitalized in shareholder's equity was $14,100,000. </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The net proceeds from the offering of the 2022 notes were approximately $115,289,000, after deducting fees and offering </span></div></div><div style="display:inline-block;vertical-align:top;width:46.666%"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">expenses of $4,711,000, which were paid in 2017. These debt issuance costs were capitalized and are being amortized as interest expense through June 2022. Debt issuance costs are presented on the balance sheet as a direct deduction from the carrying amount of the related debt liability. A portion of the net proceeds from the offering were used to pay the cost of the convertible note hedge transactions (after such cost is partially offset by the proceeds to the company from the warrant transactions), which net cost was $10,680,000.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The liability components of the 2022 notes consist of the following (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.245%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.983%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.288%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.984%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Principal amount of liability component</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81,500 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120,000 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized discount</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,837)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16,027)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt fees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,011)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,158)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net carrying amount of liability component</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,652 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101,815 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unamortized discount of $7,837,000 is to be amortized through June 2022. The effective interest rate on the liability component was 10.9%. Non-cash interest expense of $1,046,000 and $3,829,000 was recognized for the three and nine months ended September 30, 2020, respectively, compared to $1,320,000 and $4,038,000 for the three and nine months ended September 30, 2019, respectively. Actual interest expense accrued of $917,000 and $3,487,000 for the three and nine months ended September 30, 2020, respectively, compared to $1,350,000 and $4,050,000 for the three and nine months ended September 30, 2019, respectively, based on the stated coupon rate of 4.5%. The 2022 notes were not convertible as of September 30, 2020 nor was the applicable conversion threshold met. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Convertible senior notes Series I due 2024</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of 2019, the company entered into separate privately negotiated agreements with certain holders of its 2021 Notes to exchange $72,909,000 in aggregate principal amount of 2021 Notes for aggregate consideration of $72,909,000 in aggregate principal amount of new 5.00% Convertible Senior Exchange Notes due 2024 (the “2024 Notes”) of the company and $6,928,000 in cash. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The notes bear interest at a rate of 5.00% per year payable semi-annually in arrears on May 15 and November 15 of each year, beginning May 15, 2020. The notes will mature on November 15, 2024, unless repurchased, redeemed or converted in accordance with their terms prior to such date. Prior to May 15, 2024, the 2024 notes will be convertible only upon satisfaction of certain conditions and during certain periods, and thereafter, at any time until the close of business </span></div></div><div style="display:inline-block;max-width:6.666%;min-width:5.666%;vertical-align:top"/><div style="display:inline-block;vertical-align:top;width:46.668%"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">on the second scheduled trading day immediately preceding the maturity date. The 2024 notes may be settled in cash, the company’s common shares or a combination of cash and the company’s common shares, at the company’s election. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to the maturity of the 2024 Notes, the company may, at its election, redeem for cash all or part of the 2024 Notes if the last reported sale price of the company’s common shares equals or exceeds 130% of the conversion price then in effect for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading day period (including the last trading day of such period) ending on, and including, the trading day immediately preceding the date on which the company provides notice of redemption. The redemption price will be equal to 100% of the principal amount of the 2024 Notes to be redeemed, plus accrued and unpaid interest to, but excluding, the redemption date (subject to certain limited exceptions). No sinking fund is provided for the 2024 Notes, which means the company is not required to redeem or retire the 2024 Notes periodically.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders of the 2024 notes may convert their 2024 notes at their option at any time prior to the close of business on the business day immediately preceding May 15, 2024 only under the following circumstances: (1) during any calendar quarter commencing after the calendar quarter ending December 31, 2019 (and only during such calendar quarter), if the last reported sale price of the company’s Common Shares for at least 20 trading days (whether or not consecutive) during the period of 30 consecutive trading days ending on the last trading day of the immediately preceding calendar quarter is greater than or equal to 130% of the conversion price for the 2024 notes on each applicable trading day; (2) during the <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmVkMzM0M2I5YTc1ZDRkMGRhNDRlMjIzZWQxZWY4NDc2L3NlYzplZDMzNDNiOWE3NWQ0ZDBkYTQ0ZTIyM2VkMWVmODQ3Nl8xMjEvZnJhZzoxNGU3YzQxYjcxZjE0NDFjODAyMmZhNzdmYTdlMTIxMC90ZXh0cmVnaW9uOjE0ZTdjNDFiNzFmMTQ0MWM4MDIyZmE3N2ZhN2UxMjEwXzI5NTQy_70f06642-56aa-4163-949e-f6985d3867b0">five</span> business day period after any 10 consecutive trading day period (the “measurement period”) in which the “trading price” (as defined in the Indenture) per one thousand U.S. dollar principal amount of 2024 notes for each trading day of such measurement period was less than 98% of the product of the last reported sale price of the company’s Common Shares and the applicable conversion rate for the 2024 notes on each such trading day; (3) upon the occurrence of specified corporate events described in the Indenture; or (4) if the company calls the 2024 Notes for redemption pursuant to the terms of the Indenture. Holders of the 2024 notes will have the right to require the company to repurchase all or some of their 2024 notes at 100% of their principal, plus any accrued and unpaid interest, upon the occurrence of certain fundamental changes. The initial conversion rate is 67.6819 common shares per $1,000 principal amount of 2024 notes (equivalent to an initial conversion price of approximately $14.78 per common share). On or after May 15, 2024 until the close of business on the second scheduled trading day immediately preceding the maturity of the 2024 Notes, holders may convert their 2024 Notes, at the option of the holder, regardless of the foregoing circumstances.</span></div></div><div style="display:inline-block;vertical-align:top;width:46.666%"><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A loss of $5,885,000 was recorded a part of the exchange transaction, which included the write-off of fees related to the portion of the 2021 note exchanged. Debt issuance costs of $1,394,000 were capitalized and are being amortized as interest expense through November 15. Debt issuance costs are presented on the balance sheet as a direct deduction from the carrying amount of the related debt liability. </span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The liability components of the 2024 notes consist of the following (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.245%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.983%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.288%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.984%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Principal amount of liability component</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">72,909 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">72,909 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unamortized discount</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9,363)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(10,733)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Debt fees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,103)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,359)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net carrying amount of liability component</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">62,443 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60,817 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unamortized discount of $9,363,000 is to be amortized through November 15, 2024. The effective interest rate on the liability component was 8.77%. Non-cash interest expense of $468,000 and $1,370,000 was recognized for the three and nine months ended September 30, 2020, respectively. Actual interest expense accrued $912,000 and $2,735,000 for the three and nine months ended September 30, 2020, respectively, based on the stated coupon rate of 5.0%. The 2024 notes were not convertible as of September 30, 2020 nor was the applicable conversion threshold met.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:4.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Convertible senior notes Series II due 2024</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the second quarter of 2020, the company entered into separate, privately negotiated agreements with certain holders of its 2021 Notes and certain holders of its 2022 Notes to exchange $35,375,000 in aggregate principal amount of 2021 Notes and $38,500,000 in aggregate principal amount of 2022 notes, for aggregate consideration of $73,875,000 in aggregate principal amount of new 5.00% Series II Convertible Senior Exchange Notes due 2024 (the “Series II Notes”) of the company and $5,593,000 in cash. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The notes bear interest at a rate of 5.00% per year, payable semi-annually in arrears on May 15 and November 15 of each year, beginning November 15, 2020. The notes will mature on November 15, 2024, unless repurchased, redeemed or converted in accordance with their terms prior to such date. Prior to May 15, 2024, the Series II Notes will be convertible only upon satisfaction of certain conditions and during certain periods, and thereafter, at any time until the close of business on the second scheduled trading day immediately preceding the maturity date. The Series II Notes may be settled in cash, </span></div></div><div style="display:inline-block;max-width:6.666%;min-width:5.666%;vertical-align:top"/><div style="display:inline-block;vertical-align:top;width:46.668%"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the company’s common shares or a combination of cash and the company’s common shares, at the company’s election. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to the maturity of the Series II Notes, the company may, at its election, redeem for cash all or part of the Series II Notes, if the last reported sale price of the company’s common shares equals or exceeds 130% of the conversion price then in effect for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading day period (including the last trading day of such period) ending on, and including, the trading day immediately preceding the date on which the company provides notice of redemption. The redemption price will be equal to 100% of the accreted principal amount of the Series II Notes to be redeemed, plus any accrued and unpaid interest, if any, on the original principal amount of the New Notes redeemed to, but excluding, the redemption date (subject to certain limited exceptions). No sinking fund is provided for the Series II Notes, which means the company is not required to redeem or retire the Series II Notes periodically.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders of the Series II notes may convert their Series II notes at their option at any time prior to the close of business on the business day immediately preceding May 15, 2024 only under the following circumstances: (1) during any calendar quarter commencing after the calendar quarter ending June 30, 2020 (and only during such calendar quarter), if the last reported sale price of the company’s Common Shares for at least 20 trading days (whether or not consecutive) during the period of 30 consecutive trading days ending on the last trading day of the immediately preceding calendar quarter is greater than 130% of the conversion price for the Series II notes on each applicable trading day; (2) during the <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmVkMzM0M2I5YTc1ZDRkMGRhNDRlMjIzZWQxZWY4NDc2L3NlYzplZDMzNDNiOWE3NWQ0ZDBkYTQ0ZTIyM2VkMWVmODQ3Nl8xMjEvZnJhZzoxNGU3YzQxYjcxZjE0NDFjODAyMmZhNzdmYTdlMTIxMC90ZXh0cmVnaW9uOjE0ZTdjNDFiNzFmMTQ0MWM4MDIyZmE3N2ZhN2UxMjEwXzM0NjIy_3bbee2ce-5a36-4929-8fbc-2af55cbdbaa2">five</span> business day period after any 10 consecutive trading day period (the “measurement period”) in which the “trading price” (as defined in the Indenture) per one thousand U.S. dollar principal amount of Series II notes for each trading day of such measurement period was less than 98% of the product of the last reported sale price of the company’s Common Shares and the applicable conversion rate for the Series II notes on each such trading day; (3) upon the occurrence of specified corporate events described in the Indenture; or (4) if the company calls the Series II Notes for redemption pursuant to the terms of the Indenture. Holders of the Series II notes will have the right to require the company to repurchase all or some of their Series II at 100% of the accreted principal amount, plus any accrued and unpaid interest, upon the occurrence of certain fundamental changes. The initial conversion rate is 67.6819 common shares per $1,000 principal amount of Series II Notes (equivalent to an initial conversion price of approximately $14.78 per common share). On or after May 15, 2024 until the close of business on the second scheduled trading day immediately preceding the maturity of the Series II, holders may convert their Series II, at </span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the option of the holder, regardless of the foregoing circumstances.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The principal amount of the Series II Notes also will accrete at a rate of approximately 4.7% per year commencing June 4, 2020, compounding on a semi-annual basis. The accreted portion of the principal is payable in cash upon maturity but does not bear interest and is not convertible into the company’s common shares. The amount accreted as of September 30, 2020 was $1,016,000.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A loss of $6,599,000 was recorded a part of the exchange transaction, which included the write-off of fees related to portions of the 2021 and 2022 note exchanged. Debt issuance costs of $1,518,000 were capitalized and are being amortized as interest expense through November 2024. Debt issuance costs are presented on the balance sheet as a direct deduction from the carrying amount of the related debt liability. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The liability components of the Series II Notes consist of the following (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.816%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.984%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Principal amount of liability component - including accretion</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">74,891 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unamortized discount</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9,967)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Debt fees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,368)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net carrying amount of liability component</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">63,556 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unamortized discount of $9,967,000 is to be amortized through November 15, 2024. The effective interest rate on the liability component was 8.99%. Non-cash interest expense, including accretion, of $1,260,000 and $1,663,000 was recognized for the three and nine months ended September 30, 2020, respectively. Actual interest expense accrued of $923,000 and $1,200,000 for the three and nine months ended September 30, 2020, respectively, based on the stated coupon rate of 5.0%. The 2024 notes were not convertible as of June 30, 2020 nor was the applicable conversion threshold met.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">CARES Act Loan</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 15, 2020 the company entered into an unsecured loan agreement in the aggregate amount of $10,000,000 pursuant to sections 1102 and 1106 of the Coronavirus Aid, Relief and Economic Security, "CARES," Act which was evidenced by a promissory note, dated May 13, 2020, and bears interest at a fixed rate of 1.00%, payable in monthly payments commencing on December 13, 2020. Payments were subsequently deferred to commence on March 13, 2021. This loan may be forgivable, partially or in full, if certain conditions are met, principally based on having been disbursed </span></div>for permissible purposes and based on average levels of employment over a designated period of time. No assurance can be given that the company will be granted forgiveness of the loan in whole or in part. The company has recorded $2,816,000 of the amount borrowed in current maturities of long term debt. <div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Debt consists of the following (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.816%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.094%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.096%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Convertible senior notes at 5.00%, due in February 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,224 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,628 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Convertible senior notes at 4.50%, due in June 2022</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,652 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101,815 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Convertible senior notes Series I at 5.00%, due in November 2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,443 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,817 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Convertible senior notes Series II at 5.00%, due November 2024</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,556 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,389 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">262 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">242,264 </span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">219,522 </span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less current maturities of long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,062)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(58)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-Term Debt</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">238,202 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">219,464 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 1224000 56628000 72652000 101815000 62443000 60817000 63556000 0 42389000 262000 242264000 219522000 4062000 58000 238202000 219464000 670000 7740000 8011000 7653000 8827000 23700000 6322000 5300000 2138000 1600000 0.0463 0.0478 60000000 20000000 25000000 0.85 0.70 0.85 4000000 0.85 0 0.85 0.70 0.85 3000000 23700000 7500000 0.0225 0.0275 0.0125 0.0175 0.0025 0.00375 0.1125 P5D 6000000 7500000 P10D 23700000 30000000 5000000 2000000 15000000 0.85 3000000 8564000 3000000 3750000 10000000 0.0250 0.0300 0.0250 0.0300 0.0025 0.00375 0.1125 P5D 3000000 3750000 P10D 6322000 5300000 2138000 1600000 150000000 0.0500 0.0500 1250000 16000000 24466000 24466000 -761000 P20D 30 1.30 10 0.98 1 60.0492 1000 16.65 34480000 -2210000 27975000 2852000 22.4175 12376000 144034000 5966000 5000000 -15600000 <div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The liability components of the 2021 notes consist of the following (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.702%"><tr><td style="width:1.0%"/><td style="width:44.273%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.467%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.292%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.468%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Principal amount of liability component</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,250 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,091 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized discount</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,916)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt fees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(547)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net carrying amount of liability component</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,224 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,628 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 1250000 61091000 22000 3916000 -4000 -547000 1224000 56628000 22000 0.111 261000 1767000 1444000 5391000 241000 1617000 1834000 5584000 0.050 120000000 0.0450 0.0450 81500000 P20D 30 1.30 10 0.98 1 61.6095 1000 16.23 28859000 -6193000 24780000 6748000 21.4375 14100000 115289000 4711000 -10680000 <div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The liability components of the 2022 notes consist of the following (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.245%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.983%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.288%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.984%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Principal amount of liability component</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81,500 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120,000 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized discount</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,837)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16,027)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt fees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,011)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,158)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net carrying amount of liability component</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,652 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101,815 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div> 81500000 120000000 7837000 16027000 -1011000 -2158000 72652000 101815000 7837000 0.109 1046000 3829000 1320000 4038000 917000 3487000 1350000 4050000 0.045 72909000 72909000 0.0500 6928000 0.0500 1.30 P20D 30 1 P20D 30 1.30 10 0.98 1 67.6819 1000 14.78 5885000 1394000 <div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The liability components of the 2024 notes consist of the following (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.245%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.983%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.288%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.984%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Principal amount of liability component</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">72,909 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">72,909 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unamortized discount</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9,363)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(10,733)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Debt fees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,103)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,359)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net carrying amount of liability component</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">62,443 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60,817 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div> 72909000 72909000 9363000 10733000 -1103000 -1359000 62443000 60817000 9363000 0.0877 468000 1370000 912000 2735000 0.050 35375000 38500000 73875000 0.0500 5593000 0.0500 1.30 P20D 30 1 P20D 30 1.30 10 0.98 1 67.6819 1000 14.78 0.047 1016000 6599000 1518000 <div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The liability components of the Series II Notes consist of the following (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.816%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.984%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Principal amount of liability component - including accretion</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">74,891 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unamortized discount</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9,967)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Debt fees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,368)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net carrying amount of liability component</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">63,556 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div> 74891000 9967000 -1368000 63556000 9967000 0.0899 1260000 1663000 923000 1200000 0.050 10000000 0.0100 2816000 <div style="text-align:center"><span style="color:#003399;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">Other Long-Term Obligations</span></div><div style="margin-bottom:8pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"/></tr></table></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:46.666%"><div><span><br/></span></div></div><div style="display:inline-block;max-width:6.666%;min-width:5.666%;vertical-align:top"/><div style="display:inline-block;vertical-align:top;width:46.668%"><div><span><br/></span></div></div></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other long-term obligations consist of the following (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.038%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.983%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.985%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,223 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,376 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,545 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,414 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,586 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,006 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred gain on sale leaseback</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,582 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,819 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,318 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,354 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Supplemental Executive Retirement Plan liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,245 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,433 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Uncertain tax obligation including interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,660 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,612 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,589 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,935 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Long-Term Obligations</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70,748 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,949 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:46.666%"><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 23, 2015, the company entered into a real estate sale leaseback transaction which resulted in the company recording an initial deferred gain of $7,414,000, the majority of which is included in Other Long-Term Obligations and will be recognized over the 20-year life of the leases. The gains realized were $77,000 and $228,000 for the for the three and nine months ended September 30, 2020, respectively, compared to $74,000 and $220,000 for the three and nine months ended September 30, 2019, respectively.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div></div><div style="display:inline-block;max-width:6.666%;min-width:5.666%;vertical-align:top"/><div style="display:inline-block;vertical-align:top;width:46.668%"/></div> <div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other long-term obligations consist of the following (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.038%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.983%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.985%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,223 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,376 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,545 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,414 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,586 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,006 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred gain on sale leaseback</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,582 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,819 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,318 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,354 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Supplemental Executive Retirement Plan liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,245 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,433 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Uncertain tax obligation including interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,660 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,612 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,589 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,935 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Long-Term Obligations</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70,748 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,949 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 24223000 23376000 13545000 13414000 7586000 7006000 5582000 5819000 5318000 5354000 5245000 5433000 2660000 2612000 6589000 3935000 70748000 66949000 7414000 77000 228000 74000 220000 <div style="text-align:center"><span style="color:#003399;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">Leases and Commitments</span></div><div style="margin-bottom:8pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"/></tr></table></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:46.666%"><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company reviews new contracts in accordance with ASU 2016-02, "Leases" to determine if the contracts include a lease. To the extent a lease agreement includes an extension option that is reasonably certain to be exercised, the company has recognized those amounts as part of the right-of-use assets and lease liabilities. The company combines lease and non-lease components, such as common area maintenance, in the calculation of the lease assets and related liabilities. As most lease agreements do not provide an implicit rate, the company uses an incremental borrowing rate (IBR) based on information available at commencement date in determining the present value of lease payments and to help classify the lease as operating or financing. The company calculates its IBR based on the secured rates of the company's recent debt issuances, the credit rating of the company, changes in currencies, lease repayment timing as well as other publicly available data.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company leases a portion of its facilities, transportation equipment, data processing equipment and certain other equipment. These leases have terms from 1 to 20 years and provide for renewal options. Generally, the company is required to pay taxes and normal expenses associated with operating the facilities and equipment. As of September 30, 2020, the company is committed under non-cancelable operating leases, which have initial or remaining terms in excess of one year and expire on various dates through 2035. </span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 23, 2015, the company </span><span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">sold and leased back, under four separate lease agreements, four properties located in Ohio and one property in Florida for net proceeds of $23,000,000, which were used to reduce debt under the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. and Canadian Credit Facility</span><span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The initial total annual rent for the properties was $2,275,000 and can increase annually over the 20-year term of the leases based on the applicable geographical consumer price index (CPI). Each of the four lease agreements contains three 10-year renewals with the rent for each option term based on the greater of the then-current fair market rent for each property or the then- current rate and increasing annually by the applicable CPI. Under the terms of the lease agreements, the company is responsible for all taxes, insurance and utilities. The company is permitted to sublet the properties; however, the properties are currently being utilized exclusively by the company and there is no current subletting. The company is required to adequately maintain each of the properties and any leasehold improvements will be amortized over the lesser of the lives of the improvements or the remaining lease lives, consistent with any other company leases. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div></div><div style="display:inline-block;max-width:6.666%;min-width:5.666%;vertical-align:top"/><div style="display:inline-block;vertical-align:top;width:46.668%"><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the transaction, the requirements for sale lease-back accounting were met. Accordingly, the company recorded the sale of the properties, removed the related property and equipment from the company's balance sheet, recognized an initial deferred gain of $7,414,000 and an immediate loss of $257,000 related to one property and recorded new lease liabilities. Specifically, the company recorded four capital leases totaling $32,339,000 and one operating lease related to leased land, which was not a material component of the transaction. The gains on the sales of the properties were required to be deferred and recognized over the life of the leases as the property sold is being leased back. The deferred gain is classified under Other Long-Term Obligations on the condensed consolidated balance sheet. The gains realized were $77,000 and $228,000 for the three and nine months ended September 30, 2020, respectively, compared to $74,000 and $220,000 for the three and nine months ended September 30, 2019, respectively. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2018, the company entered into a 20-year lease agreement in Germany. The lease commenced in July 2020. The lease increased the company's financing lease obligations by $36,916,000.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lease expense for the three and nine months ended September 30, 2020 and September 30, 2019, respectively, were as follows (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:30.447%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.180%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.078%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.288%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.078%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.180%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.078%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.288%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,926 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,696 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,210 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,175 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Variable and short-term leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,077 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">894 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,936 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,974 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total operating leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,003 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,590 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,146 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,149 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance lease interest cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">829 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">346 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,483 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">977 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance lease depreciation</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">980 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">706 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,346 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,957 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,809 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,052 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,829 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,934 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div></div></div><div style="display:inline-block;vertical-align:top;width:46.666%"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future minimum operating and finance lease commitments, as of September 30, 2020, are as follows (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.721%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.245%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.288%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.246%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Finance <br/>Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating Leases</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,873 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,842 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2021</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,416 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,027 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,487 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,466 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,421 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,407 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,365 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">890 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">84,251 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">786 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total future minimum lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">112,813 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,418 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amounts representing interest</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(45,511)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,393)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Present value of minimum lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">67,302 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,025 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: current maturities of lease obligations</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,352)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,843)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term lease obligations</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">63,950 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,182 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental cash flow amounts for the nine months ended September 30, 2020 were as follows (in thousands): </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.138%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.883%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:26.579%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash Activity: Cash paid in measurement of amounts for lease liabilities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating Leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,407 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Financing Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,429 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,836 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-Cash Activity: Right-of-use assets obtained in exchange for lease obligations</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating Leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,789 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Financing Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39,942 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">42,731 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr></table></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div></div><div style="display:inline-block;max-width:6.666%;min-width:5.666%;vertical-align:top"/><div style="display:inline-block;vertical-align:top;width:46.668%"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted-average remaining lease terms and discount rates for finance and operating leases are as follows as of September 30, 2020: </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.221%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:26.579%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted-average remaining lease term - finance leases</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17.2 years</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted-average remaining lease term - operating leases</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.2 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted-average discount rate - finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.32%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted-average discount rate - operating leases</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.74%</span></td></tr></table></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span><br/></span></div></div> P1Y P20Y 23000000 2275000 Each of the four lease agreements contains three 10-year renewals with the rent for each option term based on the greater of the then-current fair market rent for each property or the then- current rate and increasing annually by the applicable CPI. Under the terms of the lease agreements, the company is responsible for all taxes, insurance and utilities. The company is permitted to sublet the properties; however, the properties are currently being utilized exclusively by the company and there is no current subletting. The company is required to adequately maintain each of the properties and any leasehold improvements will be amortized over the lesser of the lives of the improvements or the remaining lease lives, consistent with any other company leases. 7414000 257000 32339000 77000 228000 74000 220000 36916000 <div style="margin-top:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lease expense for the three and nine months ended September 30, 2020 and September 30, 2019, respectively, were as follows (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:30.447%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.180%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.078%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.288%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.078%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.180%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.078%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.288%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,926 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,696 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,210 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,175 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Variable and short-term leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,077 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">894 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,936 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,974 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total operating leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,003 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,590 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,146 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,149 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance lease interest cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">829 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">346 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,483 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">977 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance lease depreciation</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">980 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">706 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,346 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,957 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,809 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,052 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,829 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,934 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr></table></div> 1926000 2696000 6210000 8175000 1077000 894000 2936000 1974000 3003000 3590000 9146000 10149000 829000 346000 1483000 977000 980000 706000 2346000 1957000 1809000 1052000 3829000 2934000 <div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future minimum operating and finance lease commitments, as of September 30, 2020, are as follows (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.721%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.245%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.288%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.246%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Finance <br/>Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating Leases</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,873 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,842 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2021</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,416 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,027 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,487 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,466 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,421 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,407 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,365 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">890 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">84,251 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">786 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total future minimum lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">112,813 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,418 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amounts representing interest</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(45,511)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,393)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Present value of minimum lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">67,302 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,025 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: current maturities of lease obligations</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,352)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,843)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term lease obligations</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">63,950 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,182 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> <div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future minimum operating and finance lease commitments, as of September 30, 2020, are as follows (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.721%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.245%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.288%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.246%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Finance <br/>Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating Leases</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,873 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,842 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2021</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,416 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,027 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,487 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,466 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,421 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,407 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,365 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">890 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">84,251 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">786 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total future minimum lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">112,813 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,418 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amounts representing interest</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(45,511)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,393)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Present value of minimum lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">67,302 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,025 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: current maturities of lease obligations</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,352)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,843)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term lease obligations</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">63,950 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,182 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 1873000 1842000 7416000 6027000 6487000 3466000 6421000 1407000 6365000 890000 84251000 786000 112813000 14418000 45511000 1393000 67302000 13025000 3352000 5843000 63950000 7182000 <div style="margin-top:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental cash flow amounts for the nine months ended September 30, 2020 were as follows (in thousands): </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.138%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.883%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:26.579%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash Activity: Cash paid in measurement of amounts for lease liabilities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating Leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,407 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Financing Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,429 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,836 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-Cash Activity: Right-of-use assets obtained in exchange for lease obligations</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating Leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,789 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Financing Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39,942 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">42,731 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr></table></div> 9407000 3429000 12836000 2789000 39942000 42731000 <div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted-average remaining lease terms and discount rates for finance and operating leases are as follows as of September 30, 2020: </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.221%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:26.579%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted-average remaining lease term - finance leases</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17.2 years</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted-average remaining lease term - operating leases</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.2 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted-average discount rate - finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.32%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted-average discount rate - operating leases</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.74%</span></td></tr></table></div> P17Y2M12D P3Y2M12D 0.0632 0.0774 <div style="text-align:center"><span style="color:#003399;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">Revenue</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"/></tr></table></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:46.666%"><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company has two revenue streams: products and services. Services include repair, refurbishment, preventive maintenance and rental of product. Services for the North America segment include maintenance and repair of product. Services for the Europe segment include repair, refurbishment and preventive maintenance services. Services in All Other, are in the Asia Pacific region, and include rental and repair of product. The following tables disaggregate the company’s revenues by major source and by reportable segment for the three and nine months ended September 30, 2020 and September 30, 2019 (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.404%"><tr><td style="width:1.0%"/><td style="width:36.025%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.297%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.361%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.297%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.361%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.297%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.362%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Product</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Service</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">113,043 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,242 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">116,285 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">North America</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">87,821 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">234 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">88,055 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other (Asia/Pacific)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,428 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,138 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,566 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">207,292 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,614 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">211,906 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">% Split</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">98%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.404%"><tr><td style="width:1.0%"/><td style="width:36.025%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.297%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.361%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.297%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.361%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.297%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.362%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Product</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Service</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">329,943 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,204 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">339,147 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">North America</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">260,999 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">596 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">261,595 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other (Asia/Pacific)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,565 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,339 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25,904 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">613,507 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,139 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">626,646 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">% Split</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">98%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.404%"><tr><td style="width:1.0%"/><td style="width:36.025%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.297%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.361%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.297%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.361%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.297%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.362%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Product</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Service</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">133,839 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,532 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">137,371 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">North America</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">86,761 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">357 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">87,118 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other (Asia/Pacific)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,047 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,238 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,285 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">230,647 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,127 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">235,774 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">% Split</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">98%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.404%"><tr><td style="width:1.0%"/><td style="width:36.025%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.297%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.361%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.297%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.361%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.297%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.362%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Product</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Service</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">386,007 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,199 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">396,206 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">North America</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">261,707 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,208 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">262,915 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other (Asia/Pacific)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,242 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,688 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35,930 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">679,956 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,095 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">695,051 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">% Split</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">98%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div></div><div style="display:inline-block;max-width:6.666%;min-width:5.666%;vertical-align:top"/><div style="display:inline-block;vertical-align:top;width:46.668%"><div style="padding-right:4.5pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company's revenues are principally related to the sale of products, approximately 98%, with the remaining 2% related to services including repair, refurbishment, preventive maintenance and rental of product. While the company has a significant amount of contract types, the sales split by contract type is as follows: general terms and conditions (31%), large national customers (26%), governments, principally pursuant to tender contracts (20%) and other customers including buying groups and independent customers (23%). </span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All product and substantially all service revenues are recognized at a point in time. The remaining service revenue, recognized over time, are reflected in the Europe segment and include multiple performance obligations. For such contracts, the company allocates revenue to each performance obligation based on its relative standalone selling price. The company generally determines the standalone selling price based on the expected cost-plus margin methodology.    </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is recognized when obligations under the terms of a contract with the customer are satisfied; generally, this occurs with the transfer of control of the company’s products and services. Revenue is measured as the amount of consideration expected to be received in exchange for transferring product or providing services. The amount of consideration received and revenue recognized by the company can vary as a result of variable consideration terms included in the contracts related to customer rebates, cash discounts and return policies. Customer rebates and cash discounts are estimated based on the most likely amount principle and these estimates are based on historical experience and anticipated performance. In addition, customers have the right to return product within the company’s normal terms policy, and as such the company estimates the expected returns based on an analysis of historical experience. The company adjusts its estimate of revenue at the earlier of when the most likely amount of consideration it expects to receive changes or when the consideration becomes fixed. The company generally does not expect that there will be significant changes to its estimates of variable consideration (see “Receivables” and "Accrued Expenses" in the Notes to the Condensed Consolidated Financial Statements include elsewhere in this report for more detail). </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depending on the terms of the contract, the company may defer the recognition of a portion of the revenue at the end of a reporting period to align with transfer of control of the company’s products to the customer. In addition, to the extent performance obligations are satisfied over time, the company defers revenue recognition until the performance obligations </span></div></div></div>are satisfied. As of September 30, 2020 and December 31, 2019, the company had deferred revenue of $3,436,000 and $3,173,000, respectively, related to outstanding performance obligations. The following tables disaggregate the company’s revenues by major source and by reportable segment for the three and nine months ended September 30, 2020 and September 30, 2019 (in thousands):<div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.404%"><tr><td style="width:1.0%"/><td style="width:36.025%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.297%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.361%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.297%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.361%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.297%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.362%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Product</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Service</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">113,043 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,242 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">116,285 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">North America</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">87,821 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">234 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">88,055 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other (Asia/Pacific)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,428 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,138 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,566 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">207,292 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,614 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">211,906 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">% Split</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">98%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.404%"><tr><td style="width:1.0%"/><td style="width:36.025%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.297%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.361%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.297%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.361%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.297%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.362%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Product</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Service</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">329,943 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,204 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">339,147 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">North America</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">260,999 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">596 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">261,595 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other (Asia/Pacific)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,565 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,339 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25,904 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">613,507 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,139 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">626,646 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">% Split</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">98%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.404%"><tr><td style="width:1.0%"/><td style="width:36.025%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.297%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.361%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.297%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.361%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.297%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.362%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Product</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Service</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">133,839 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,532 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">137,371 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">North America</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">86,761 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">357 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">87,118 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other (Asia/Pacific)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,047 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,238 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,285 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">230,647 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,127 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">235,774 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">% Split</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">98%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.404%"><tr><td style="width:1.0%"/><td style="width:36.025%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.297%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.361%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.297%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.361%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.297%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.362%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Product</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Service</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">386,007 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,199 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">396,206 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">North America</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">261,707 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,208 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">262,915 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other (Asia/Pacific)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,242 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,688 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35,930 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">679,956 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,095 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">695,051 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">% Split</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">98%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div> 113043000 3242000 116285000 87821000 234000 88055000 6428000 1138000 7566000 207292000 4614000 211906000 0.98 0.02 1 329943000 9204000 339147000 260999000 596000 261595000 22565000 3339000 25904000 613507000 13139000 626646000 0.98 0.02 1 133839000 3532000 137371000 86761000 357000 87118000 10047000 1238000 11285000 230647000 5127000 235774000 0.98 0.02 1 386007000 10199000 396206000 261707000 1208000 262915000 32242000 3688000 35930000 679956000 15095000 695051000 0.98 0.02 1 0.98 0.02 0.31 0.26 0.20 0.23 3436000 3173000 <div style="text-align:center"><span style="color:#003399;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">Equity Compensation</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"/></tr></table></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:46.666%"><div><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company’s Common Shares have a $0.25 stated value. The Common Shares and the Class B Common Shares generally have identical rights, terms and conditions and vote together as a single class on most issues, except that the Class B Common Shares have ten votes per share, carry a 10% lower cash dividend rate and, in general, can only be transferred to family members or for estate planning purposes. Holders of Class B Common Shares are entitled to convert their shares into Common Shares at any time on a share-for-share basis. When Class B Common Shares are transferred out of a familial relationship, they automatically convert to Common Shares. The Board of Directors suspended further dividends on the Common Shares and the Class B Common Shares.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 30, 2020, 6,357 Class B Common Shares remained outstanding. Prior conversions of Class B Common Shares have substantially diminished the significance of the company’s dual class voting structure. As of September 30, 2020, the holders of the Common Shares represented approximately 99.9% of the company’s total outstanding voting power.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Equity Compensation Plan</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 17, 2018, the shareholders of the company approved the Invacare Corporation 2018 Equity Compensation Plan (the “2018 Plan”), which was adopted on March 27, 2018 by the company's Board of Directors (the “Board”). The company’s Board adopted the 2018 Plan in order to authorize additional Common Shares for grant as equity compensation, and to reflect changes to Section 162(m) of the Internal Revenue Code (the “Code”) resulting from the U.S. Tax Cuts and Jobs Act of 2017. </span></div><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following shareholder approval of the 2018 Plan, all of the Common Shares then-remaining available for issuance under the Invacare Corporation 2013 Equity Compensation Plan (the “2013 Plan”) and all of the Common Shares that were forfeited or remained unpurchased or undistributed upon termination or expiration of awards under the 2013 Plan and under the Invacare Corporation 2003 Performance Plan (the “2003 Plan”), become available for issuance under the 2018 Plan. Awards granted previously under the 2013 Plan and 2003 Plan will remain in effect under their original terms.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2018 Plan uses a fungible share-counting method, under which each Common Share underlying an award of share options or share appreciation rights ("SAR") will count against the number of total shares available under the 2018 Plan as one share; and each Common Share underlying any award other than a share option or a SAR will count against </span></div></div><div style="display:inline-block;max-width:6.666%;min-width:5.666%;vertical-align:top"/><div style="display:inline-block;vertical-align:top;width:46.668%"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the number of total shares available under the 2018 Plan as two shares. Shares underlying awards made under the 2003 Plan or 2013 Plan that are forfeited or remain unpurchased or undistributed upon termination or expiration of the awards will become available under the 2018 Plan for use in future awards. Any Common Shares that are added back to the 2018 Plan as the result of forfeiture, termination or expiration of an award granted under the 2018 Plan or the 2013 Plan will be added back in the same manner such shares were originally counted against the total number of shares available under the 2018 Plan or 2013 Plan, as applicable. Each Common Share that is added back to the 2018 Plan due to a forfeiture, termination or expiration of an award granted under the 2003 Plan will be added back as one Common Share. </span></div><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Compensation and Management Development Committee of the Board (the “Compensation Committee”), in its discretion, may grant an award under the 2018 Plan to any director or employee of the company or an affiliate. As of September 30, 2020, 3,513,468 Common Shares were available for future issuance under the 2018 Plan in connection with the following types of awards with respect to the company's Common Shares: incentive share options, nonqualified share options, SARs, restricted shares, restricted share units, unrestricted shares and performance shares. The Compensation Committee also may grant performance units that are payable in cash. The Compensation Committee has the authority to determine which participants will receive awards, the amount of the awards and the other terms and conditions of the awards. The Common Shares authorized for issuance under the 2018 Plan includes an additional 1,400,000 Common Shares that were approved by shareholders at the company’s 2020 annual meeting on May 21, 2020.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the second quarter of 2020 the company transferred a total of 1,004,079 shares into the 2018 Plan from the 2003 and 2013 Plans. At September 30, 2020, an aggregate of 328,274 Common Shares underlie awards which were forfeited or expired unexercised under the 2003 and 2013 Plans and thus are available to be transferred into the 2018 Plan.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2018 Plan provides that shares granted come from the company's authorized but unissued Common Shares or treasury shares. In addition, the company's equity compensation plans allow employee participants to exchange shares for minimum withholding taxes, which results in the company acquiring treasury shares. </span></div></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:46.666%"><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amounts of equity-based compensation expense recognized as part of SG&amp;A expenses in All Other in business segments were as follows (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:61.697%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.757%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.288%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.758%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restricted share / units</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,471 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,891 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Performance shares / units</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,494 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,648 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-qualified and performance share options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">334 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total share-based compensation expense</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,965 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,873 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span><br/></span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 30, 2020, unrecognized compensation expense related to equity-based compensation arrangements granted under the company's 2018 Plan and previous plans, which is related to non-vested shares, was as follows (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.411%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.389%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restricted share and restricted share units</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,443 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Performance shares and performance share units</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,144 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total unrecognized share-based compensation expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,587 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div></div><div style="display:inline-block;max-width:6.666%;min-width:5.666%;vertical-align:top"/><div style="display:inline-block;vertical-align:top;width:46.668%"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total unrecognized compensation cost will be adjusted for future changes in actual and estimated forfeitures and for updated vesting assumptions for the performance share awards (see "Share Options" and "Performance Shares and Performance Share Units" below). No tax benefits for share-based compensation were realized during the three and nine months ended September 30, 2020 and 2019, respectively, due to a valuation allowance against deferred tax assets. In accordance with ASC 718, any tax benefits resulting from tax deductions in excess of the compensation expense recognized is classified as a component of financing cash flows.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Share Options</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Generally, non-qualified share option awards have a term of ten years and were granted with an exercise price per share equal to the fair market value of one of the company’s Common Shares on the date of grant. Share option awards granted in 2017 were performance-based awards and became exercisable based upon achievement of performance goals established by the Compensation Committee and achieved over the <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmVkMzM0M2I5YTc1ZDRkMGRhNDRlMjIzZWQxZWY4NDc2L3NlYzplZDMzNDNiOWE3NWQ0ZDBkYTQ0ZTIyM2VkMWVmODQ3Nl8xMzMvZnJhZzphMTkwNDc4NDhiZTc0YWMyYmE3NGI0ZWVjMzJiM2FhYi90ZXh0cmVnaW9uOmExOTA0Nzg0OGJlNzRhYzJiYTc0YjRlZWMzMmIzYWFiXzYzNDI_294fd665-8f49-46ea-b292-98a7e818c659">three</span>-year period ended in 2019 and were subject to the Compensation Committee's exercise of negative discretion to reduce the number of options vested based on the progress towards the company's transformation. The company recognized the compensation expense over a weighted-average period of approximately two years. </span></div></div></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes information about share option activity for the nine months ended September 30, 2020:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.038%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.261%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.438%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.763%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted Average<br/>Exercise Price</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Options outstanding at January 1, 2020</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,441,202 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18.26 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Canceled</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(354,006)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24.88</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Options outstanding at September 30, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,087,196 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16.12 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Options exercise price range at September 30, 2020</span></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12.15 </span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">to</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33.36 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Options exercisable at September 30, 2020</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,087,196 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shares available for grant at September 30, 2020*</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,513,468 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">________</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> *    Shares available for grant under the 2018 Plan as of September 30, 2020 reduced by net restricted share and restricted share unit award activity of 696,058 shares and performance share and performance share unit award activity of 1,859,054 shares.</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes information about stock options outstanding at September 30, 2020:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.722%"><tr><td style="width:1.0%"/><td style="width:21.044%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.827%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.638%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.638%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.827%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.642%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Options Outstanding</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Options Exercisable</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Exercise Prices</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number<br/>Outstanding at<br/>September 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted Average<br/>Remaining<br/>Contractual Life (Years)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted Average<br/>Exercise Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number<br/>Exercisable at<br/>September 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted Average<br/>Exercise Price</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$12.15 – $20.00</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">777,159 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12.74 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">777,159 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12.73 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$20.01 – $25.00</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">300,149 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.9</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24.45 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">300,149 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24.45 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$25.01 – $30.00</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,392 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27.82 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,392 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27.82 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$30.01 – $33.36</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,496 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.6</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33.36 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,496 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33.36 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,087,196 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.9</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16.12 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,087,196 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16.12 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:46.666%"><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2018 Plan provides for a one-year minimum vesting period for share options and, generally, options must be exercised within ten years from the date granted. No share options were issued in 2020 or 2019. The performance-based options issued in 2017 vested after the conclusion of the three-year performance period ending December 31, 2019. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restricted Share and Restricted Share Units</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes information about restricted shares and restricted share units (primarily for non-U.S. recipients):</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:48.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.197%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.883%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.520%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted Average Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shares / Units unvested at<br/>January 1, 2020</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">965,085 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11.32 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">764,012 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.11 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(452,922)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11.47 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Canceled</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(94,993)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.19 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shares / Units unvested at<br/>September 30, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,181,182 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8.63 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2018 Plan provides for a one-year minimum vesting period for restricted share awards, the outstanding restricted share awards generally vest ratably over the three years after the award date. Unearned restricted share compensation, determined as the market value of the shares at the date of grant, is being amortized on a straight-line basis over the vesting period. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div></div><div style="display:inline-block;max-width:6.666%;min-width:5.666%;vertical-align:top"/><div style="display:inline-block;vertical-align:top;width:46.668%"><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Performance Shares and Performance Share Units</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes information about performance shares and performance share units (for non-U.S. recipients):</span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.081%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.716%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.877%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.826%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted Average Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shares / Units unvested at January 1, 2020</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">753,272 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11.82 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 6pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">523,329 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.08 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Canceled</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(65,976)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.48 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shares / Units unvested at <br/>September 30, 2020</span></td><td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,210,625 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.90 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine months ended September 30, 2020, performance shares and performance share units (for non-U.S. recipients) were granted as performance awards with a <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmVkMzM0M2I5YTc1ZDRkMGRhNDRlMjIzZWQxZWY4NDc2L3NlYzplZDMzNDNiOWE3NWQ0ZDBkYTQ0ZTIyM2VkMWVmODQ3Nl8xMzMvZnJhZzphMTkwNDc4NDhiZTc0YWMyYmE3NGI0ZWVjMzJiM2FhYi90ZXh0cmVnaW9uOmExOTA0Nzg0OGJlNzRhYzJiYTc0YjRlZWMzMmIzYWFiXzgyOTU_b56c6de6-3f5d-414c-a0b4-74c53a03a21c">three</span>-year performance period with payouts based on achievement of certain performance goals. The awards are classified as equity awards as they will be settled in Common Shares upon vesting. The number of shares earned will be determined at the end of the three-year performance period based on achievement of performance criteria for January 1, 2020 through December 31, 2022 established by the Compensation Committee at the time of grant. Recipients will be entitled to receive a number of Common Shares equal to the number of performance shares that vest based upon the levels of achievement which may range between 0% and 150% of the target number of shares with the target being 100% of the initial grant. </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the performance awards is based on the share price on the date of grant discounted for the estimated value of dividends foregone as the awards are not eligible for dividends except to the extent vested. The company assesses the probability that the performance targets will be met with expense recognized whenever it is probable that at least the minimum performance criteria will be achieved. Depending upon the company's assessment of the probability of achievement of the goals, the company may not recognize any expense associated with performance awards in a given </span></div></div></div>period, may reverse prior expense recorded or record additional expense to make up for expense not recorded in a prior period. Performance award compensation expense is generally expected to be recognized over three years. Expense is being recognized for the 2018, 2019 and 2020 awards as it is considered probable that the performance goals for those awards will be met. 0.25 10 0.10 6357 0.999 The 2018 Plan uses a fungible share-counting method, under which each Common Share underlying an award of share options or share appreciation rights ("SAR") will count against the number of total shares available under the 2018 Plan as one share; and each Common Share underlying any award other than a share option or a SAR will count against the number of total shares available under the 2018 Plan as two shares. Shares underlying awards made under the 2003 Plan or 2013 Plan that are forfeited or remain unpurchased or undistributed upon termination or expiration of the awards will become available under the 2018 Plan for use in future awards. Any Common Shares that are added back to the 2018 Plan as the result of forfeiture, termination or expiration of an award granted under the 2018 Plan or the 2013 Plan will be added back in the same manner such shares were originally counted against the total number of shares available under the 2018 Plan or 2013 Plan, as applicable. Each Common Share that is added back to the 2018 Plan due to a forfeiture, termination or expiration of an award granted under the 2003 Plan will be added back as one Common Share. 3513468 1400000 1004079 328274 <div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amounts of equity-based compensation expense recognized as part of SG&amp;A expenses in All Other in business segments were as follows (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:61.697%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.757%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.288%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.758%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restricted share / units</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,471 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,891 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Performance shares / units</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,494 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,648 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-qualified and performance share options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">334 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total share-based compensation expense</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,965 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,873 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 4471000 3891000 2494000 1648000 0 334000 6965000 5873000 <div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 30, 2020, unrecognized compensation expense related to equity-based compensation arrangements granted under the company's 2018 Plan and previous plans, which is related to non-vested shares, was as follows (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.411%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.389%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restricted share and restricted share units</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,443 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Performance shares and performance share units</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,144 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total unrecognized share-based compensation expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,587 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 8443000 11144000 19587000 P10Y <div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes information about share option activity for the nine months ended September 30, 2020:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.038%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.261%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.438%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.763%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted Average<br/>Exercise Price</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Options outstanding at January 1, 2020</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,441,202 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18.26 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Canceled</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(354,006)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24.88</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Options outstanding at September 30, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,087,196 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16.12 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Options exercise price range at September 30, 2020</span></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12.15 </span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">to</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33.36 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Options exercisable at September 30, 2020</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,087,196 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shares available for grant at September 30, 2020*</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,513,468 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">________</span></div> *    Shares available for grant under the 2018 Plan as of September 30, 2020 reduced by net restricted share and restricted share unit award activity of 696,058 shares and performance share and performance share unit award activity of 1,859,054 shares 1441202 18.26 354006 24.88 1087196 16.12 12.15 33.36 1087196 3513468 696058 1859054 <div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes information about stock options outstanding at September 30, 2020:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.722%"><tr><td style="width:1.0%"/><td style="width:21.044%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.827%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.638%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.638%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.827%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.642%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Options Outstanding</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Options Exercisable</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Exercise Prices</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number<br/>Outstanding at<br/>September 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted Average<br/>Remaining<br/>Contractual Life (Years)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted Average<br/>Exercise Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number<br/>Exercisable at<br/>September 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted Average<br/>Exercise Price</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$12.15 – $20.00</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">777,159 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12.74 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">777,159 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12.73 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$20.01 – $25.00</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">300,149 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.9</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24.45 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">300,149 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24.45 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$25.01 – $30.00</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,392 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27.82 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,392 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27.82 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$30.01 – $33.36</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,496 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.6</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33.36 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,496 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33.36 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,087,196 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.9</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16.12 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,087,196 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16.12 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 12.15 20.00 777159 P5Y1M6D 12.74 777159 12.73 20.01 25.00 300149 P0Y10M24D 24.45 300149 24.45 25.01 30.00 5392 P0Y2M12D 27.82 5392 27.82 30.01 33.36 4496 P0Y7M6D 33.36 4496 33.36 1087196 P3Y10M24D 16.12 1087196 16.12 <div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes information about restricted shares and restricted share units (primarily for non-U.S. recipients):</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:48.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.197%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.883%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.520%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted Average Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shares / Units unvested at<br/>January 1, 2020</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">965,085 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11.32 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">764,012 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.11 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(452,922)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11.47 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Canceled</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(94,993)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.19 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shares / Units unvested at<br/>September 30, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,181,182 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8.63 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 965085 11.32 764012 7.11 452922 11.47 94993 10.19 1181182 8.63 <div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes information about performance shares and performance share units (for non-U.S. recipients):</span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.081%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.716%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.877%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.826%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted Average Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shares / Units unvested at January 1, 2020</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">753,272 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11.82 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 6pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">523,329 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.08 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Canceled</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(65,976)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.48 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shares / Units unvested at <br/>September 30, 2020</span></td><td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,210,625 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.90 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 753272 11.82 523329 7.08 65976 9.48 1210625 9.90 0 1.50 1 P3Y <div style="text-align:center"><span style="color:#003399;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">Accumulated Other Comprehensive Income (Loss) by Component</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"/></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in accumulated other comprehensive income ("OCI") (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.583%"><tr><td style="width:1.0%"/><td style="width:44.506%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.497%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.497%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.497%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.497%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.497%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.085%"/><td style="width:0.1%"/></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Long-Term Notes</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Defined Benefit Plans</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,455 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,133)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,468)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">794 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,648 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OCI before reclassifications</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,231 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">713 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">281 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,501)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,724 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount reclassified from accumulated OCI</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(474)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">739 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">265 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current-period OCI</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,231 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">713 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(193)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,762)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,989 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,686 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,420)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,661)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(968)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,637 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.583%"><tr><td style="width:1.0%"/><td style="width:44.506%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.497%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.497%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.497%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.497%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.497%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.085%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Long-Term Notes</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Defined Benefit Plans</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,898 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,491)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,299)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,128 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OCI before reclassifications</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,788 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,929)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,340)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,641 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount reclassified from accumulated OCI</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(484)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">352 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(132)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current-period OCI</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,788 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,929)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(362)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(988)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,509 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,686 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,420)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,661)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(968)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,637 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.583%"><tr><td style="width:1.0%"/><td style="width:44.506%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.497%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.497%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.497%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.497%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.497%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.085%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Long-Term Notes</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Defined Benefit Plans</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,122 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,200)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,778)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,627 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,771 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OCI before reclassifications</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,729)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,328)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(504)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">557 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,004)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount reclassified from accumulated OCI</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">303 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(860)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(557)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current-period OCI</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,729)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,328)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(201)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(303)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,561)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,393 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,528)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,979)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,324 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.583%"><tr><td style="width:1.0%"/><td style="width:44.506%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.497%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.497%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.497%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.497%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.497%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.085%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Long-Term Notes</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Defined Benefit Plans</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,244 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,662 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,703)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">590 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,793 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OCI before reclassifications</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,851)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,190)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(922)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,179 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,784)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount reclassified from accumulated OCI</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">646 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,445)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(799)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current-period OCI</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,851)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,190)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(276)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">734 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,583)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,393 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,528)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,979)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,324 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr></table></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reclassifications out of accumulated OCI were as follows (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:24.316%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.161%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.205%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.205%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.050%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.205%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.205%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:27.655%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount reclassified from OCI</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Affected line item in the Statement of Comprehensive (Income) Loss</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Three Months Ended September 30,</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Nine Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Defined Benefit Plans</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service and interest costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(474)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">303 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(484)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">646 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expenses</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax provision</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total after tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(474)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">303 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(484)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">646 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forward contracts hedging sales</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(481)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(197)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(692)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(189)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forward contracts hedging purchases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,259 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(747)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,029 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,375)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total loss (income) before tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">778 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(944)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">337 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,564)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax provision (benefit)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total after tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">739 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(860)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">352 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,445)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr></table></div> <div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in accumulated other comprehensive income ("OCI") (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.583%"><tr><td style="width:1.0%"/><td style="width:44.506%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.497%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.497%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.497%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.497%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.497%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.085%"/><td style="width:0.1%"/></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Long-Term Notes</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Defined Benefit Plans</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,455 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,133)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,468)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">794 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,648 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OCI before reclassifications</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,231 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">713 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">281 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,501)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,724 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount reclassified from accumulated OCI</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(474)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">739 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">265 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current-period OCI</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,231 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">713 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(193)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,762)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,989 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,686 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,420)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,661)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(968)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,637 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.583%"><tr><td style="width:1.0%"/><td style="width:44.506%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.497%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.497%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.497%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.497%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.497%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.085%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Long-Term Notes</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Defined Benefit Plans</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,898 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,491)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,299)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,128 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OCI before reclassifications</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,788 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,929)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,340)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,641 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount reclassified from accumulated OCI</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(484)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">352 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(132)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current-period OCI</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,788 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,929)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(362)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(988)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,509 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,686 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,420)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,661)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(968)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,637 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.583%"><tr><td style="width:1.0%"/><td style="width:44.506%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.497%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.497%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.497%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.497%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.497%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.085%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Long-Term Notes</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Defined Benefit Plans</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,122 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,200)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,778)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,627 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,771 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OCI before reclassifications</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,729)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,328)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(504)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">557 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,004)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount reclassified from accumulated OCI</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">303 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(860)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(557)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current-period OCI</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,729)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,328)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(201)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(303)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,561)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,393 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,528)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,979)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,324 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.583%"><tr><td style="width:1.0%"/><td style="width:44.506%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.497%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.497%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.497%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.497%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.497%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.085%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Long-Term Notes</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Defined Benefit Plans</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,244 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,662 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,703)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">590 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,793 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OCI before reclassifications</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,851)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,190)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(922)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,179 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,784)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount reclassified from accumulated OCI</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">646 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,445)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(799)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current-period OCI</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,851)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,190)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(276)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">734 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,583)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,393 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,528)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,979)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,324 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr></table></div> 16455000 -9133000 -3468000 794000 4648000 35231000 713000 281000 -2501000 33724000 0 0 474000 -739000 -265000 35231000 713000 -193000 -1762000 33989000 51686000 -8420000 -3661000 -968000 38637000 8898000 -2491000 -3299000 20000 3128000 42788000 -5929000 122000 -1340000 35641000 0 0 484000 -352000 132000 42788000 -5929000 -362000 -988000 35509000 51686000 -8420000 -3661000 -968000 38637000 13122000 -2200000 -2778000 1627000 9771000 -5729000 -3328000 -504000 557000 -9004000 0 0 -303000 860000 557000 -5729000 -3328000 -201000 -303000 -9561000 7393000 -5528000 -2979000 1324000 210000 12244000 2662000 -2703000 590000 12793000 -4851000 -8190000 -922000 2179000 -11784000 0 0 -646000 1445000 799000 -4851000 -8190000 -276000 734000 -12583000 7393000 -5528000 -2979000 1324000 210000 <div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reclassifications out of accumulated OCI were as follows (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:24.316%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.161%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.205%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.205%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.050%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.205%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.205%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:27.655%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount reclassified from OCI</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Affected line item in the Statement of Comprehensive (Income) Loss</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Three Months Ended September 30,</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Nine Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Defined Benefit Plans</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service and interest costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(474)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">303 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(484)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">646 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expenses</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax provision</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total after tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(474)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">303 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(484)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">646 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forward contracts hedging sales</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(481)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(197)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(692)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(189)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forward contracts hedging purchases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,259 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(747)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,029 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,375)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total loss (income) before tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">778 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(944)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">337 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,564)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax provision (benefit)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total after tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">739 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(860)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">352 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,445)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr></table></div> 474000 -303000 484000 -646000 0 0 0 0 -474000 303000 -484000 646000 481000 197000 692000 189000 -1259000 747000 -1029000 1375000 778000 -944000 337000 -1564000 39000 -84000 -15000 -119000 739000 -860000 352000 -1445000 <div style="text-align:center"><span style="color:#003399;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">Charges Related to Restructuring Activities</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"/></tr></table></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:46.666%"><div style="text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company's restructuring charges were originally necessitated primarily by continued declines in Medicare and Medicaid reimbursement by the U.S. government, as well as similar healthcare reimbursement pressures abroad, which negatively affect the company's customers (e.g. home health care providers) and continued pricing pressures faced by the company due to the outsourcing by competitors to lower cost locations. Restructuring decisions were also the result of reduced profitability in North America and Asia Pacific. In addition, as a result of the company's transformation strategy, additional restructuring actions were implemented in 2017 and have continued into 2020.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the nine months ended September 30, 2020, charges totaled $4,657,000 which were related to North America of $865,000, Europe of $3,674,000 and All Other of $118,000. In North America and All Other, costs were incurred related to severance. The European charges were for severance costs of $3,328,000 and contract terminations of $346,000 primarily related to the closure of a German manufacturing facility. Payments for the nine months ended September 30, 2020 were $5,692,000 and the cash payments were funded with the company's cash on hand. The 2020 charges are expected to be paid out within twelve months.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the nine months ended September 30, 2019, charges totaled $3,641,000 which were related to North America of </span></div></div><div style="display:inline-block;max-width:6.666%;min-width:5.666%;vertical-align:top"/><div style="display:inline-block;vertical-align:top;width:46.668%"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$1,539,000, Europe of $1,903,000 and All Other of $199,000. In North America, costs were incurred related to severance of $1,495,000 and contract terminations of $44,000. The European and All Other charges were for severance costs. Payments for the nine months ended September 30, 2019 were $4,152,000 and the cash payments were funded with company's cash on hand. Most of the 2019 charges have been paid out.</span></div><div style="margin-top:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no material changes in accrued balances related to the charges, either as a result of revisions to the plans or changes in estimates. In addition, the savings anticipated as a result of the company's restructuring plans have been or are expected to be achieved, primarily resulting in reduced salary and benefit costs principally impacting Selling, General and Administrative expenses, and to a lesser extent, Costs of Products Sold. To date, the company's liquidity has not been materially impacted by the restructuring plans. Please refer to Charges Related to Restructuring Activities of company's Annual Report on Form 10-K for the period ending December 31, 2019 for disclosure of restructuring activity prior to 2020. </span></div></div></div><div style="margin-top:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A progression by reporting segment of the accruals recorded as a result of the restructuring for the nine months ended September 30, 2020 is as follows (in thousands): </span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.861%"><tr><td style="width:1.0%"/><td style="width:45.770%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.146%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:16.146%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:16.148%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Severance</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Contract Terminations</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019 Balances</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">211 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">211 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,406 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,410 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">406 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">406 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,023 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,027 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charges</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America </span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">691 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">691 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">592 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">665 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All Other</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total </span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,319 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,392 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(562)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(562)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe </span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(959)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(73)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,032)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(276)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(276)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total </span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,797)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(73)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,870)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2020 Balances</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">340 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">340 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,039 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,043 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All Other</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,545 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,549 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charges </span></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,302 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">273 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,575 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,412 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">273 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,685 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(265)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(265)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,596)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(273)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,869)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All Other</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(82)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(82)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,943)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(273)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,216)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2020 Balances</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,745 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,749 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,014 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,018 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charges</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">146 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">146 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,434 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,434 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All Other</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,580 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,580 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(151)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(151)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,455)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,455)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,606)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,606)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.861%"><tr><td style="width:1.0%"/><td style="width:45.770%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.146%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:16.146%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:16.148%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Severance</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Contract Terminations</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2020 Balances</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,724 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,728 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All Other</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,988 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,992 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr></table> 4657000 865000 3674000 118000 3328000 346000 5692000 P12M 3641000 1539000 1903000 199000 1495000 44000 4152000 <div style="margin-top:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A progression by reporting segment of the accruals recorded as a result of the restructuring for the nine months ended September 30, 2020 is as follows (in thousands): </span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.861%"><tr><td style="width:1.0%"/><td style="width:45.770%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.146%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:16.146%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:16.148%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Severance</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Contract Terminations</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019 Balances</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">211 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">211 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,406 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,410 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">406 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">406 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,023 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,027 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charges</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America </span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">691 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">691 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">592 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">665 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All Other</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total </span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,319 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,392 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(562)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(562)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe </span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(959)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(73)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,032)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(276)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(276)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total </span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,797)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(73)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,870)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2020 Balances</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">340 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">340 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,039 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,043 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All Other</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,545 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,549 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charges </span></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,302 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">273 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,575 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,412 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">273 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,685 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(265)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(265)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,596)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(273)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,869)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All Other</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(82)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(82)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,943)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(273)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,216)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2020 Balances</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,745 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,749 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,014 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,018 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charges</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">146 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">146 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,434 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,434 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All Other</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,580 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,580 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(151)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(151)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,455)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,455)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,606)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,606)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.861%"><tr><td style="width:1.0%"/><td style="width:45.770%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.146%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:16.146%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:16.148%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Severance</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Contract Terminations</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2020 Balances</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,724 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,728 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All Other</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,988 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,992 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr></table> 211000 0 211000 6406000 4000 6410000 406000 0 406000 7023000 4000 7027000 691000 0 691000 592000 73000 665000 36000 0 36000 1319000 73000 1392000 562000 0 562000 959000 73000 1032000 276000 0 276000 1797000 73000 1870000 340000 0 340000 6039000 4000 6043000 166000 0 166000 6545000 4000 6549000 28000 0 28000 1302000 273000 1575000 82000 0 82000 1412000 273000 1685000 265000 0 265000 1596000 273000 1869000 82000 0 82000 1943000 273000 2216000 103000 0 103000 5745000 4000 5749000 166000 0 166000 6014000 4000 6018000 146000 0 146000 1434000 0 1434000 0 0 0 1580000 0 1580000 151000 0 151000 1455000 0 1455000 0 0 0 1606000 0 1606000 98000 0 98000 5724000 4000 5728000 166000 0 166000 5988000 4000 5992000 <div style="text-align:center"><span style="color:#003399;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">Income Taxes</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"/></tr></table></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:46.666%"><div><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company had an effective tax rate of 39.2% and 26.8% on losses before tax for the three and nine months ended September 30, 2020, respectively, compared to an expected benefit of 21.0% on the pre-tax loss for each period. The company had an effective tax rate of 69.6% and 26.8% on losses before tax for the three and nine months ended and September 30, 2019, respectively, compared to an expected benefit for the three and nine months ended September 30, 2019 of 21.0% on the pre-tax loss for each period. The company's effective tax rate for the three and nine months ended September 30, 2020 and September 30, 2019 were unfavorable as compared to the U.S. federal statutory rate expected benefit, principally due to the negative impact of the company not being able to record tax benefits related to the significant losses in countries which had tax valuation allowances. The effective tax rate was increased for the three and nine months ended September 30, 2020 and September 30, 2019 by certain taxes outside the United States, excluding countries with tax valuation allowances, that were at an effective rate higher than the U.S. statutory rate, except for the gain on the disposition of Dynamic Controls which was not taxable locally</span><span style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the company had accrued withholding taxes on earnings of its Chinese subsidiary based on the expectation of not permanently reinvesting those earnings. The sale of this entity, without such distribution resulted in the reversal of this accrual in the amount of $988,000 for the nine months ended September 30, 2020.</span></div><div style="text-align:justify"><span><br/></span></div></div><div style="display:inline-block;max-width:6.666%;min-width:5.666%;vertical-align:top"/><div style="display:inline-block;vertical-align:top;width:46.668%"/></div> -0.392 -0.268 0.210 -0.696 -0.268 0.210 988000 Loss Per Common Share<div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the computation of basic and diluted net loss per common share for the periods indicated.</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.038%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.455%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.050%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.455%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.455%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.459%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(In thousands except per share data)</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basic</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,419 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,660 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,213 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,571 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,276)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,041)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23,163)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34,644)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss per common share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.21)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.24)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.68)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.03)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Diluted</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,419 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,660 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,213 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,571 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share options and awards</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares assuming dilution</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,530 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,668 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,313 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,581 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,276)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,041)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23,163)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34,644)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss per common share *</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.21)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.24)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.68)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.03)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">________</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">* Net loss per common share assuming dilution calculated utilizing weighted average shares outstanding-basic for the periods in which there was a net loss.</span></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:46.666%"><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September 30, 2020, 300,149 shares associated with shares options were excluded from the average common shares assuming dilution for the three and nine months ended September 30, 2020 as they were anti-dilutive. At September 30, 2020, the majority of the anti-dilutive shares were granted at an exercise price of $24.45, which was higher than the average fair market value price of $6.93 and $7.12 for the three and nine months ended September 30, 2020.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September 30, 2019, 326,799 shares associated with share options were excluded from the average common shares assuming dilution for the three and nine months ended September 30, 2019 as they were anti-dilutive. At September 30, 2019, the majority of the anti-dilutive shares were granted at an exercise price of $25.24, which was higher than the average fair market value price of $5.61 and $6.43 for the three and nine months ended September 30, 2019.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div></div><div style="display:inline-block;max-width:6.666%;min-width:5.666%;vertical-align:top"/><div style="display:inline-block;vertical-align:top;width:46.668%"><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three and nine months ended September 30, 2020 and September 30, 2019, respectively, no shares were included in the common shares assuming dilution related to the company's issued warrants as the average market price of the company shares for these periods did not exceed the strike price of the warrants.</span></div><div style="text-indent:24.75pt"><span><br/></span></div></div></div> <div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the computation of basic and diluted net loss per common share for the periods indicated.</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.038%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.455%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.050%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.455%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.455%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.459%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(In thousands except per share data)</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basic</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,419 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,660 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,213 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,571 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,276)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,041)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23,163)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34,644)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss per common share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.21)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.24)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.68)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.03)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Diluted</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,419 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,660 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,213 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,571 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share options and awards</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares assuming dilution</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,530 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,668 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,313 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,581 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,276)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,041)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23,163)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34,644)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss per common share *</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.21)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.24)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.68)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.03)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">________</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">* Net loss per common share assuming dilution calculated utilizing weighted average shares outstanding-basic for the periods in which there was a net loss.</span></div> 34419000 33660000 34213000 33571000 -7276000 -8041000 -23163000 -34644000 -0.21 -0.24 -0.68 -1.03 34419000 33660000 34213000 33571000 111000 8000 100000 10000 34530000 33668000 34313000 33581000 -7276000 -8041000 -23163000 -34644000 -0.21 -0.24 -0.68 -1.03 300149 24.45 6.93 7.12 326799 25.24 5.61 6.43 <div style="text-align:center"><span style="color:#003399;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">Concentration of Credit Risk</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"/></tr></table></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:46.666%"><div><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company manufactures and distributes durable medical equipment to the home health care, retail and extended care markets. The company performs credit evaluations of its customers’ financial condition. The company utilizes De Lage Landen, Inc. (“DLL”), a third-party financing company, to provide lease financing to Invacare's U.S. customers. The DLL agreement provides for direct leasing between DLL and the Invacare customer. The company retains a recourse obligation of $2,682,000 at September 30, 2020 to DLL for events of default under the contracts, which total $8,262,000 at September 30, 2020. Guarantees, ASC 460, requires the company to record a guarantee liability as it relates to the limited recourse obligation. The company's recourse is reevaluated by DLL biannually, considers activity between the biannual dates and excludes any receivables purchased by the company from DLL. The company monitors the collections status of these contracts and has provided amounts for estimated losses in its allowances for doubtful accounts in accordance with </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Receivables,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> ASC 310-10-05-4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Credit losses are provided for in the financial statements.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div></div><div style="display:inline-block;max-width:6.666%;min-width:5.666%;vertical-align:top"/><div style="display:inline-block;vertical-align:top;width:46.668%"><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Substantially all the company’s receivables are due from health care, medical equipment providers and long-term care facilities located throughout the United States, Australia, Canada, New Zealand and Europe. A significant portion of products sold to dealers, both foreign and domestic, is ultimately funded through government reimbursement programs such as Medicare and Medicaid. The company has also seen a significant shift in reimbursement to customers from managed care entities. As a consequence, changes in these programs can have an adverse impact on dealer liquidity and profitability. In addition, reimbursement guidelines in the home health care industry have a substantial impact on the nature and type of equipment an end user can obtain as well as the timing of reimbursement and, thus, affect the product mix, pricing and payment patterns of the company’s customers.</span></div><div style="text-indent:24.75pt"><span><br/></span></div></div></div> 2682000 8262000 <div style="text-align:center"><span style="color:#003399;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">Derivatives</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"/></tr></table></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:46.666%"><div><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASC 815 requires companies to recognize all derivative instruments as either assets or liabilities at fair value. The accounting for changes in fair value of a derivative is dependent upon whether or not the derivative has been designated and qualifies for hedge accounting treatment and the type of hedging relationship. For derivatives designated and qualifying as hedging instruments, the company must designate the hedging instrument, based upon the exposure being hedged, as a fair value hedge, cash flow hedge, or a hedge of a net investment in a foreign operation.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Cash Flow Hedging Strategy</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company uses derivative instruments in an attempt to manage its exposure to transactional foreign currency exchange risk. Foreign forward exchange contracts are used to manage the price risk associated with forecasted sales denominated in foreign currencies and the price risk associated with forecasted purchases of inventory over the next twelve months.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company recognizes its derivative instruments as assets or liabilities measured at fair value. A majority of the company’s derivative instruments are designated and qualify as cash flow hedges. Accordingly, the effective portion of the gain or loss on the derivative instrument is reported as a component of other comprehensive income and reclassified into earnings in the same period or periods during which the hedged transaction affects earnings. The remaining gain or loss on the derivative instrument in excess of the cumulative change in the fair value of the hedged item, if any, is recognized in current earnings during the period of change.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div></div><div style="display:inline-block;max-width:6.666%;min-width:5.666%;vertical-align:top"/><div style="display:inline-block;vertical-align:top;width:46.668%"><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To protect against increases/decreases in forecasted foreign currency cash flows resulting from inventory purchases/sales over the next year, the company utilizes foreign currency forward contracts to hedge portions of its forecasted purchases/sales denominated in foreign currencies. The gains and losses are included in cost of products sold and selling, general and administrative expenses on the condensed consolidated statement of comprehensive income (loss). If it is later determined that a hedged forecasted transaction is unlikely to occur, any prospective gains or losses on the forward contracts would be recognized in earnings. The company does not expect any material amount of hedge ineffectiveness related to forward contract cash flow hedges during the next twelve months.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company has historically not recognized any material amount of ineffectiveness related to forward contract cash flow hedges because the company generally limits its hedges to between 50% and 90% of total forecasted transactions for a given entity’s exposure to currency rate changes and the transactions hedged are recurring in nature. Furthermore, most of the hedged transactions are related to intercompany sales and purchases for which settlement occurs on a specific day each month. Forward contracts with a total notional amount in USD of $155,783,000 and $110,373,000 matured for the nine months ended September 30, 2020 and September 30, 2019, respectively.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div></div></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outstanding foreign currency forward exchange contracts qualifying and designated for hedge accounting treatment were as follows (in thousands USD):</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.861%"><tr><td style="width:1.0%"/><td style="width:41.180%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.808%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.808%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.808%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.811%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Notional<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized<br/>Net Gain<br/>(Loss)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Notional<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized<br/>Net Gain<br/>(Loss)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USD / AUD</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">960 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,840 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(106)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USD / CAD</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,138 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,888 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USD / EUR</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,468 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,061)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110,905 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USD / GBP</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">387 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,972 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USD / NZD</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">290 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,760 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(166)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USD / SEK</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">876 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(88)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,062 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USD / MXN</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,901 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(58)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,763 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">346 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EUR / CAD</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">915 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,151 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EUR / CHF</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,703 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,821 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EUR / GBP</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,325 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,824 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(216)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EUR / SEK</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,330 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(72)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,493 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EUR / NOK</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,490 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,797 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DKK / SEK</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,402 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,936 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NOK / SEK</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,490 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,151 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,675 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,148)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">207,363 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Derivatives Not Qualifying or Designated for Hedge Accounting Treatment</span></div><div><span><br/></span></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:46.666%"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company utilizes foreign currency forward contracts that are not designated as hedges in accordance with ASC 815. These contracts are entered into to eliminate the risk associated with the settlement of short-term intercompany trading receivables and payables between Invacare Corporation and its foreign subsidiaries. The currency forward contracts are entered into at the same time as the intercompany </span></div></div><div style="display:inline-block;max-width:6.666%;min-width:5.666%;vertical-align:top"/><div style="display:inline-block;vertical-align:top;width:46.668%"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">receivables or payables are created so that upon settlement, the gain/loss on the settlement is offset by the gain/loss on the foreign currency forward contract. No material net gain or loss was realized by the company in 2020 or 2019 related to these contracts and the associated short-term intercompany trading receivables and payables.</span></div></div></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Foreign currency forward exchange contracts not qualifying or designated for hedge accounting treatment, as well as ineffective hedges, entered into in 2020 and 2019, respectively, and outstanding were as follows (in thousands USD):</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.861%"><tr><td style="width:1.0%"/><td style="width:52.307%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.026%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.026%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.026%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.030%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Notional<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Gain<br/>(Loss)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Notional<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Gain<br/>(Loss)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">AUD / USD</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">6,149 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">96 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">10,000 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(94)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">CAD / USD</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">8,321 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">88 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">8,000 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(50)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">EUR / USD</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">11,735 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(745)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">10,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">104 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">DKK / USD</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">15,081 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(137)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">GBP / USD</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">650 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">7,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">40 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">NOK / USD</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">8,986 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(427)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">NZD / USD</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">309 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4,500 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(101)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">EUR / CAD</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">130 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(6)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">EUR / GBP</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,086 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">59 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">AUD / NZD</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">6,438 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">21 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">7,900 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">23 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">EUR / NOK</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">80 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">59,965 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(1,077)</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">47,400 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(78)</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair values of the company’s derivative instruments were as follows (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.372%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.013%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Liabilities</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline">Derivatives designated as hedging instruments under ASC 815</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Foreign currency forward exchange contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">334 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,482 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">668 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">657 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline">Derivatives not designated as hedging instruments under ASC 815</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Foreign currency forward exchange contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">265 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,342 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">170 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">248 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total derivatives</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">599 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,824 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">838 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">905 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair values of the company’s foreign currency forward exchange contract assets and liabilities are included in Other Current Assets and Accrued Expenses, respectively in the condensed consolidated balance sheets. </span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effect of derivative instruments on Accumulated Other Comprehensive Income (OCI) and the Statement of Comprehensive Income (Loss) and was as follows (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.861%"><tr><td style="width:1.0%"/><td style="width:39.372%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.172%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.510%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.156%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Derivatives in ASC 815 cash flow hedge<br/>relationships</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Amount of Gain<br/>(Loss) Recognized  in Accumulated OCI on Derivatives<br/>(Effective Portion)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Amount of Gain (Loss)<br/>Reclassified from<br/>Accumulated  OCI into<br/>Income (Effective<br/>Portion)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Amount of Gain (Loss)<br/>Recognized in Income on<br/>Derivatives (Ineffective  Portion and Amount Excluded from<br/>Effectiveness Testing)</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline">Three months ended September 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Foreign currency forward exchange contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(2,501)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(739)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(662)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline">Nine months ended September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Foreign currency forward exchange contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(1,340)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(352)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(718)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline">Three months ended September 30, 2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Foreign currency forward exchange contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">557 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">860 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline">Nine months ended September 30, 2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Foreign currency forward exchange contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,179 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,445 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">50 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Derivatives not designated as hedging<br/>instruments under ASC 815</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Amount of Gain (Loss)<br/>Recognized in Income on Derivatives</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline">Three months ended September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="12" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Foreign currency forward exchange contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(1,320)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline">Nine months ended September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="12" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Foreign currency forward exchange contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(1,077)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline">Three months ended September 30, 2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="12" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Foreign currency forward exchange contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">317 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline">Nine months ended September 30, 2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="12" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Foreign currency forward exchange contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">103 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:46.666%"><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The gains or losses recognized as the result of the settlement of cash flow hedge foreign currency forward contracts are recognized in net sales for hedges of inventory sales and in cost of product sold for hedges of inventory purchases. For the three and nine months ended September 30, 2020, net sales were increased by $481,000 and $692,000 while cost of product sold was increased by $1,259,000 and $1,029,000 for net pre-tax realized loss of $778,000 and $337,000, respectively. For the three and nine months ended September 30, 2019, net sales were increased by $197,000 and $189,000 while cost of product sold was decreased by $747,000 and $1,375,000 for net realized pre-tax gains of $944,000 and $1,564,000, respectively.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Losses of $1,320,000 and $1,077,000 were recognized in selling, general and administrative (SG&amp;A) expenses for the three and nine months ended September 30, 2020 compared to gains of $317,000 and $103,000 for the three and nine months ended September 30, 2019 related to forward contracts not designated as hedging instruments. The forward contracts were entered into to offset gains/losses that were also recorded in SG&amp;A expenses on intercompany trade receivables or payables. The gains/losses on the non-designated hedging </span></div></div><div style="display:inline-block;max-width:6.666%;min-width:5.666%;vertical-align:top"/><div style="display:inline-block;vertical-align:top;width:46.668%"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">instruments were substantially offset by gains/losses on intercompany trade payables.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company's derivative agreements provide the counterparties with a right of set off in the event of a default. The right of set off would enable the counterparty to offset any net payment due by the counterparty to the company under the applicable agreement by any amount due by the company to the counterparty under any other agreement. For example, the terms of the agreement would permit a counterparty to a derivative contract that is also a lender under the company's Credit Agreement to reduce any derivative settlement amounts owed to the company under the derivative contract by any amounts owed to the counterparty by the company under the Credit Agreement. In addition, the agreements contain cross-default provisions that could trigger a default by the company under the agreement in the event of a default by the company under another agreement with the same counterparty. The company does not present any derivatives on a net basis in its financial statements, other than the conversion and bond hedge derivatives which are presented net on the condensed consolidated statement of comprehensive income (loss), and </span></div></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:46.666%"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">all derivative balances presented are subject to provisions that are similar to master netting agreements.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2016, the company entered into privately negotiated convertible 2021 note hedges and 2021 warrants in connection with its sale of $150,000,000 in aggregate principal amount of the company’s 5.00% Convertible Senior Notes due 2021. The 2021 warrants, which increased paid in capital by $12,376,000, are clearly and closely related to the convertible 2021 notes and thus classified as equity. The 2021 note hedge asset and 2021 convertible debt conversion liability were recorded, based on initial fair values, as an asset of $27,975,000 and a liability of $34,480,000, respectively, with the offset to the income statement. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the second quarter of 2017, the company entered into privately negotiated convertible 2022 note hedges and </span></div></div><div style="display:inline-block;max-width:6.666%;min-width:5.666%;vertical-align:top"/><div style="display:inline-block;vertical-align:top;width:46.668%"><div style="margin-top:9pt;text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">warrants in connection with its sale of $120,000,000 in aggregate principal amount of the company’s 4.50% Convertible Senior Notes due 2022. The 2022 warrants, which increased paid in capital by $14,100,000, are clearly and closely related to the convertible 2022 notes and thus classified as equity. The 2022 note hedge assets and 2022 convertible debt conversion liability were recorded, based on initial fair values, as an asset of $24,780,000 and a liability of $28,859,000, respectively, with the offset to the income statement. See "Long-Term Debt" in the Notes to the Condensed Consolidated Financial Statements included elsewhere in this report for more detail. </span></div></div></div><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair values of the outstanding convertible note derivatives as of September 30, 2020 and their effect on the Statement of Comprehensive Income (Loss) were as follows (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:27.511%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.911%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.050%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.911%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.050%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.235%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Gain (Loss)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Gain (Loss)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">September 30, 2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">September 30, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Convertible 2021 debt conversion long-term liability</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(2,210)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Convertible 2022 debt conversion long-term liability</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(6,193)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Convertible 2021 note hedge long-term asset</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,852 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Convertible 2022 note hedge long-term asset</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">6,748 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net fair value and net gain on convertible debt derivatives</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,197 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:46.666%"><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2021 and 2022 convertible debt conversion liability amounts and the 2021 and 2022 note hedge asset amounts are included in Other Long-Term Obligations and Other Long-Term Assets, respectively, in the company's condensed consolidated balance sheets. The 2019 year-to-date changes in the fair values of the convertible debt conversion liabilities and note hedge derivatives were significantly impacted by the change in the company's share price. </span></div><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 16, 2019, the company received shareholder approval authorizing it to elect to settle future conversions of convertible notes in common shares. As a result of the shareholder approval, the note hedge assets and conversion liabilities may no longer be bifurcated and accounted for as separate derivatives and thus were eliminated together with a corresponding offset to additional paid-in-capital.</span></div></div><div style="display:inline-block;max-width:6.666%;min-width:5.666%;vertical-align:top"/><div style="display:inline-block;vertical-align:top;width:46.668%"/></div> 0.50 0.90 155783000 110373000 <div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outstanding foreign currency forward exchange contracts qualifying and designated for hedge accounting treatment were as follows (in thousands USD):</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.861%"><tr><td style="width:1.0%"/><td style="width:41.180%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.808%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.808%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.808%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.811%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Notional<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized<br/>Net Gain<br/>(Loss)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Notional<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized<br/>Net Gain<br/>(Loss)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USD / AUD</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">960 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,840 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(106)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USD / CAD</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,138 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,888 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USD / EUR</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,468 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,061)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110,905 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USD / GBP</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">387 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,972 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USD / NZD</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">290 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,760 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(166)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USD / SEK</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">876 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(88)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,062 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USD / MXN</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,901 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(58)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,763 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">346 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EUR / CAD</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">915 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,151 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EUR / CHF</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,703 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,821 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EUR / GBP</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,325 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,824 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(216)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EUR / SEK</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,330 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(72)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,493 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EUR / NOK</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,490 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,797 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DKK / SEK</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,402 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,936 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NOK / SEK</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,490 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,151 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,675 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,148)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">207,363 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 960000 -41000 3840000 -106000 1138000 -2000 3888000 32000 17468000 -1061000 110905000 122000 387000 -11000 3972000 -8000 290000 -13000 2760000 -166000 876000 -88000 5062000 -38000 3901000 -58000 6763000 346000 915000 -42000 4151000 24000 2703000 -45000 9821000 10000 6325000 178000 29824000 -216000 2330000 -72000 9493000 -46000 1490000 14000 5797000 15000 1402000 40000 5936000 24000 1490000 53000 5151000 18000 41675000 -1148000 207363000 11000 <div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Foreign currency forward exchange contracts not qualifying or designated for hedge accounting treatment, as well as ineffective hedges, entered into in 2020 and 2019, respectively, and outstanding were as follows (in thousands USD):</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.861%"><tr><td style="width:1.0%"/><td style="width:52.307%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.026%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.026%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.026%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.030%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Notional<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Gain<br/>(Loss)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Notional<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Gain<br/>(Loss)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">AUD / USD</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">6,149 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">96 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">10,000 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(94)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">CAD / USD</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">8,321 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">88 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">8,000 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(50)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">EUR / USD</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">11,735 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(745)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">10,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">104 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">DKK / USD</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">15,081 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(137)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">GBP / USD</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">650 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">7,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">40 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">NOK / USD</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">8,986 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(427)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">NZD / USD</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">309 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4,500 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(101)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">EUR / CAD</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">130 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(6)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">EUR / GBP</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,086 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">59 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">AUD / NZD</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">6,438 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">21 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">7,900 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">23 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">EUR / NOK</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">80 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">59,965 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(1,077)</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">47,400 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(78)</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 6149000 96000 10000000 -94000 8321000 88000 8000000 -50000 11735000 -745000 10000000 104000 15081000 -137000 0 0 650000 -18000 7000000 40000 8986000 -427000 0 0 309000 -9000 4500000 -101000 130000 -6000 0 0 2086000 59000 0 0 6438000 21000 7900000 23000 80000 1000 0 0 59965000 -1077000 47400000 -78000 <div style="text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair values of the company’s derivative instruments were as follows (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.372%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.013%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Liabilities</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline">Derivatives designated as hedging instruments under ASC 815</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Foreign currency forward exchange contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">334 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,482 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">668 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">657 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline">Derivatives not designated as hedging instruments under ASC 815</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Foreign currency forward exchange contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">265 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,342 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">170 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">248 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total derivatives</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">599 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,824 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">838 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">905 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 334000 1482000 668000 657000 265000 1342000 170000 248000 599000 2824000 838000 905000 <div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effect of derivative instruments on Accumulated Other Comprehensive Income (OCI) and the Statement of Comprehensive Income (Loss) and was as follows (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.861%"><tr><td style="width:1.0%"/><td style="width:39.372%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.172%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.510%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.156%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Derivatives in ASC 815 cash flow hedge<br/>relationships</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Amount of Gain<br/>(Loss) Recognized  in Accumulated OCI on Derivatives<br/>(Effective Portion)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Amount of Gain (Loss)<br/>Reclassified from<br/>Accumulated  OCI into<br/>Income (Effective<br/>Portion)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Amount of Gain (Loss)<br/>Recognized in Income on<br/>Derivatives (Ineffective  Portion and Amount Excluded from<br/>Effectiveness Testing)</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline">Three months ended September 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Foreign currency forward exchange contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(2,501)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(739)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(662)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline">Nine months ended September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Foreign currency forward exchange contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(1,340)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(352)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(718)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline">Three months ended September 30, 2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Foreign currency forward exchange contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">557 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">860 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline">Nine months ended September 30, 2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Foreign currency forward exchange contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,179 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,445 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">50 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Derivatives not designated as hedging<br/>instruments under ASC 815</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Amount of Gain (Loss)<br/>Recognized in Income on Derivatives</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline">Three months ended September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="12" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Foreign currency forward exchange contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(1,320)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline">Nine months ended September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="12" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Foreign currency forward exchange contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(1,077)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline">Three months ended September 30, 2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="12" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Foreign currency forward exchange contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">317 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline">Nine months ended September 30, 2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="12" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Foreign currency forward exchange contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">103 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> -2501000 -739000 -662000 -1340000 -352000 -718000 557000 860000 -2000 2179000 1445000 50000 1320000 1077000 317000 103000 481000 692000 1259000 1029000 778000 337000 197000 189000 747000 1375000 -944000 -1564000 1320000 1077000 317000 103000 150000000 0.0500 12376000 27975000 34480000 120000000 0.0450 14100000 24780000 28859000 <div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair values of the outstanding convertible note derivatives as of September 30, 2020 and their effect on the Statement of Comprehensive Income (Loss) were as follows (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:27.511%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.911%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.050%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.911%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.050%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.235%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Gain (Loss)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Gain (Loss)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">September 30, 2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">September 30, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Convertible 2021 debt conversion long-term liability</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(2,210)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Convertible 2022 debt conversion long-term liability</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(6,193)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Convertible 2021 note hedge long-term asset</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,852 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Convertible 2022 note hedge long-term asset</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">6,748 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net fair value and net gain on convertible debt derivatives</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,197 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 0 0 0 0 -2210000 0 0 0 0 -6193000 0 0 0 0 2852000 0 0 0 0 6748000 0 0 0 0 1197000 <div style="text-align:center"><span style="color:#003399;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">Fair Values</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"/></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:46.666%"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to ASC 820, the inputs used to derive the fair value of assets and liabilities are analyzed and assigned a level I, II or III priority, with level I being the highest and level III being the lowest in the hierarchy. Level I inputs are quoted prices in active markets for identical assets or liabilities. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div></div><div style="display:inline-block;max-width:6.666%;min-width:5.666%;vertical-align:top"/><div style="display:inline-block;vertical-align:top;width:46.668%"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level II inputs are quoted prices for similar assets or liabilities in active markets: quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations in which all significant inputs are observable in active markets. Level III inputs are based on valuations derived from valuation techniques in which one or more significant inputs are unobservable. </span></div></div></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a summary of the company’s assets and liabilities that are measured on a recurring basis (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.861%"><tr><td style="width:1.0%"/><td style="width:46.048%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:19.623%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.616%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.923%"/><td style="width:0.1%"/></tr><tr style="height:14pt"><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Basis for Fair Value Measurements at Reporting Date</span></td></tr><tr style="height:32pt"><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Quoted Prices in Active<br/>Markets for Identical<br/>Assets / (Liabilities)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Significant Other<br/>Observable<br/>Inputs</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Significant Other<br/>Unobservable<br/>Inputs</span></td></tr><tr style="height:14pt"><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level I</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level II</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level III</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">September 30, 2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Forward exchange contracts—net</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">—</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,225)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">—</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">December 31, 2019</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Forward exchange contracts—net</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">—</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(67)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">—</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:46.666%"><div style="text-align:justify"><span><br/></span></div></div><div style="display:inline-block;max-width:6.666%;min-width:5.666%;vertical-align:top"/><div style="display:inline-block;vertical-align:top;width:46.668%"/></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying values and fair values of the company’s financial instruments are as follows (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.722%"><tr><td style="width:1.0%"/><td style="width:58.370%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.510%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.510%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.510%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.512%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86,825 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86,825 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80,063 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80,063 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other investments</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Installment receivables, net of reserves</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">325 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">325 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">913 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">913 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt (including current maturities of long-term debt) *</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(242,264)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(218,231)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(219,522)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(207,193)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward contracts in Other Current Assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">599 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">599 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">838 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">838 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward contracts in Accrued Expenses</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,824)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,824)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(905)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(905)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">________</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">* The company's total debt is shown net of discount and fees associated with the Convertible Senior Notes due in 2021, 2022 and 2024 on the company's condensed consolidated balance sheet. Accordingly, the fair values of the Convertible Senior Notes due in 2021, 2022 and 2024 are included in the long-term debt presented in this table are also shown net of the discount and fees. Total debt amounts exclude operating and financing leases obligations.</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company, in estimating its fair value disclosures for financial instruments, used the following methods and assumptions:</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash, cash equivalents:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The carrying value reported in the balance sheet for cash, cash equivalents equals its fair value.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other investments:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The company has made an investment in a limited partnership, which is accounted for using the cost method, adjusted for any estimated declines in value. The investment was acquired in private placement and there is no quoted market price or stated rate of return. The company does not have the ability to easily sell the investment. The company completes an evaluation of the residual value related to such investments in the fourth quarter each year.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Installment receivables:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The carrying value reported in the balance sheet for installment receivables approximates its fair value. The interest rates associated with these receivables have not varied significantly since inception. Management believes that after consideration of the credit risk, the net book value of the installment receivables approximates market value.</span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Total debt:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Fair value for the company’s convertible debt is based on quoted market-based estimates as of the end of the period, while the revolving credit facility fair value is based upon an estimate of the market for similar borrowing arrangements. The fair values are deemed to be categorized as Level 2 in the fair value hierarchy.</span>Forward contracts: The company operates internationally, and as a result, is exposed to foreign currency fluctuations. Specifically, the exposure includes intercompany loans and third-party sales or payments. In an attempt to reduce this exposure, foreign currency forward contracts are utilized and accounted for as hedging instruments. The forward contracts are used to hedge the following currencies: AUD, CAD, CHF, DKK, EUR, GBP, MXN, NOK, NZD, SEK and USD. The company does not use derivative financial instruments for speculative purposes. Fair values for the company’s foreign exchange forward contracts are based on quoted market prices for contracts with similar maturities. The company’s forward contracts are included in Other Current Assets or Accrued Expenses in the condensed consolidated balance sheets. <div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a summary of the company’s assets and liabilities that are measured on a recurring basis (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.861%"><tr><td style="width:1.0%"/><td style="width:46.048%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:19.623%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.616%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.923%"/><td style="width:0.1%"/></tr><tr style="height:14pt"><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Basis for Fair Value Measurements at Reporting Date</span></td></tr><tr style="height:32pt"><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Quoted Prices in Active<br/>Markets for Identical<br/>Assets / (Liabilities)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Significant Other<br/>Observable<br/>Inputs</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Significant Other<br/>Unobservable<br/>Inputs</span></td></tr><tr style="height:14pt"><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level I</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level II</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level III</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">September 30, 2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Forward exchange contracts—net</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">—</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,225)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">—</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">December 31, 2019</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Forward exchange contracts—net</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">—</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(67)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">—</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div> 0 -2225000 0 0 -67000 0 <div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying values and fair values of the company’s financial instruments are as follows (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.722%"><tr><td style="width:1.0%"/><td style="width:58.370%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.510%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.510%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.510%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.512%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86,825 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86,825 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80,063 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80,063 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other investments</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Installment receivables, net of reserves</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">325 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">325 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">913 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">913 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt (including current maturities of long-term debt) *</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(242,264)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(218,231)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(219,522)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(207,193)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward contracts in Other Current Assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">599 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">599 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">838 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">838 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward contracts in Accrued Expenses</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,824)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,824)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(905)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(905)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">________</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">* The company's total debt is shown net of discount and fees associated with the Convertible Senior Notes due in 2021, 2022 and 2024 on the company's condensed consolidated balance sheet. Accordingly, the fair values of the Convertible Senior Notes due in 2021, 2022 and 2024 are included in the long-term debt presented in this table are also shown net of the discount and fees. Total debt amounts exclude operating and financing leases obligations.</span></div> 86825000 86825000 80063000 80063000 85000 85000 85000 85000 325000 325000 913000 913000 242264000 218231000 219522000 207193000 599000 599000 838000 838000 2824000 2824000 905000 905000 <div style="margin-bottom:6pt;text-align:center"><span style="color:#003399;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">Business Segments</span></div><div style="margin-bottom:11pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"/></tr></table></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:46.666%"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company operates in two primary business segments: North America and Europe with each selling the company's primary product categories, which include: lifestyle, mobility and seating and respiratory therapy products. Sales in Asia Pacific are reported in All Other and include products similar to those sold in North America and Europe. The accounting policies of each segment are the same as those described in the summary of significant accounting policies for the company's consolidated financial statements. Intersegment sales and transfers are based on the costs to manufacture plus a reasonable profit element. </span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Segment performance is measured and resources are allocated based on a number of factors, with the primary profit or loss measure being segment operating profit (loss). Segment operating profit (loss) represents net sales less cost of products sold less selling general and administrative expenses. Segment operating profit (loss) excludes unallocated corporate </span></div></div><div style="display:inline-block;max-width:6.666%;min-width:5.666%;vertical-align:top"/><div style="display:inline-block;vertical-align:top;width:46.668%"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">general and administrative expenses not allocated to the segments and intersegment sales and profit eliminations, which are included in All Other. In addition, segment operating profit (loss) further excludes charges related to restructuring activities, asset impairments and gain on sale of business (as applicable).</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This performance measure, segment operating income (loss), is used by the Chief Operating Decision Maker (CODM) for purposes of making decisions about allocating resources to a segment and assessing its performance. In addition, this metric is reviewed by the company's Board of Directors regarding segment performance and is a key metric in the performance management assessment of the company's employees. </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:46.666%"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information by segment is as follows (in thousands):</span></div></div><div style="display:inline-block;max-width:6.666%;min-width:5.666%;vertical-align:top"/><div style="display:inline-block;vertical-align:top;width:46.668%"/></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.205%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.150%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.150%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.455%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.458%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">For the Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">For the Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Revenues from external customers</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Europe</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">116,285 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">137,371 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">339,147 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">396,206 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">North America</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">88,055 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">87,118 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">261,595 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">262,915 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">All Other (Asia Pacific)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">7,566 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">11,285 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">25,904 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">35,930 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Consolidated</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">211,906 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">235,774 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">626,646 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">695,051 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Intersegment revenues</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Europe</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">6,027 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3,124 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">14,438 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">10,396 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">North America</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">23,625 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">21,130 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">66,356 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">61,109 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">All Other (Asia Pacific)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,116 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3,904 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3,645 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">9,776 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Consolidated</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">30,768 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">28,158 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">84,439 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">81,281 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Restructuring charges before income taxes</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Europe</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,434 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,263 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3,674 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,903 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">North America</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">146 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">331 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">865 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,539 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">All Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">34 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">118 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">199 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Consolidated</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,580 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,628 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4,657 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3,641 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Operating income (loss)</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Europe</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">7,600 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">11,365 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">16,624 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">22,617 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">North America</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,992 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(1,694)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">5,759 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(7,316)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">All Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(6,082)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(5,625)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(17,377)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(18,230)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Charge expense related to restructuring activities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(1,580)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(1,628)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(4,657)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(3,641)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Gain on sale of business</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">9,790 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Consolidated operating income (loss)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,930 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,418 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">10,139 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(6,570)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net gain on convertible debt derivatives</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,197 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Loss on debt extinguishment including debt finance charges and associated fees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(761)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(280)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(7,360)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(280)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(7,395)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(6,879)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(21,042)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(21,666)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Loss before income taxes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(5,226)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(4,741)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(18,263)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(27,319)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net sales by product, are as follows (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.205%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.150%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.150%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.455%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.458%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">For the Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">For the Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Lifestyle</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">50,307 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">59,403 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">160,628 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">182,103 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 18pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Mobility and Seating</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">54,851 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">68,286 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">147,275 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">184,819 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Respiratory Therapy</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">6,070 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4,919 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">16,680 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">14,875 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 18pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other(1)</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">5,057 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4,763 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">14,564 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">14,409 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">116,285 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">137,371 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">339,147 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">396,206 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">North America</span></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Lifestyle</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">41,845 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">43,401 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">124,888 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">131,259 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 18pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Mobility and Seating</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">26,572 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">31,252 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">82,485 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">89,638 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Respiratory Therapy</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">19,405 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">12,108 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">53,626 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">40,811 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 18pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other(1)</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">233 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">357 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">596 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,207 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">88,055 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">87,118 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">261,595 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">262,915 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">All Other (Asia Pacific)</span></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Mobility and Seating</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,670 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">6,645 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">10,757 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">21,986 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 18pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Lifestyle</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3,375 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3,001 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">10,176 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">8,261 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Respiratory Therapy</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">195 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">175 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,043 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,063 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 18pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other(1)</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,326 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,464 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3,928 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4,620 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">7,566 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">11,285 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">25,904 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">35,930 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total Consolidated</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">211,906 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">235,774 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">626,646 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">695,051 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  ________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Includes various services, including repair services, equipment rentals and external contracting.</span></div> <div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:46.666%"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information by segment is as follows (in thousands):</span></div></div><div style="display:inline-block;max-width:6.666%;min-width:5.666%;vertical-align:top"/><div style="display:inline-block;vertical-align:top;width:46.668%"/></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.205%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.150%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.150%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.455%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.458%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">For the Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">For the Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Revenues from external customers</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Europe</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">116,285 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">137,371 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">339,147 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">396,206 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">North America</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">88,055 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">87,118 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">261,595 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">262,915 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">All Other (Asia Pacific)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">7,566 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">11,285 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">25,904 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">35,930 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Consolidated</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">211,906 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">235,774 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">626,646 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">695,051 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Intersegment revenues</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Europe</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">6,027 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3,124 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">14,438 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">10,396 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">North America</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">23,625 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">21,130 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">66,356 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">61,109 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">All Other (Asia Pacific)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,116 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3,904 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3,645 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">9,776 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Consolidated</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">30,768 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">28,158 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">84,439 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">81,281 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Restructuring charges before income taxes</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Europe</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,434 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,263 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3,674 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,903 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">North America</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">146 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">331 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">865 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,539 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">All Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">34 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">118 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">199 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Consolidated</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,580 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,628 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4,657 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3,641 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Operating income (loss)</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Europe</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">7,600 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">11,365 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">16,624 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">22,617 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">North America</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,992 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(1,694)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">5,759 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(7,316)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">All Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(6,082)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(5,625)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(17,377)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(18,230)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Charge expense related to restructuring activities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(1,580)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(1,628)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(4,657)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(3,641)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Gain on sale of business</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">9,790 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Consolidated operating income (loss)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,930 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,418 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">10,139 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(6,570)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net gain on convertible debt derivatives</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,197 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Loss on debt extinguishment including debt finance charges and associated fees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(761)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(280)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(7,360)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(280)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(7,395)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(6,879)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(21,042)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(21,666)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Loss before income taxes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(5,226)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(4,741)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(18,263)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(27,319)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div> 116285000 137371000 339147000 396206000 88055000 87118000 261595000 262915000 7566000 11285000 25904000 35930000 211906000 235774000 626646000 695051000 6027000 3124000 14438000 10396000 23625000 21130000 66356000 61109000 1116000 3904000 3645000 9776000 30768000 28158000 84439000 81281000 1434000 1263000 3674000 1903000 146000 331000 865000 1539000 0 34000 118000 199000 1580000 1628000 4657000 3641000 7600000 11365000 16624000 22617000 2992000 -1694000 5759000 -7316000 -6082000 -5625000 -17377000 -18230000 1580000 1628000 4657000 3641000 0 0 9790000 0 2930000 2418000 10139000 -6570000 0 0 0 -1197000 -761000 -280000 -7360000 -280000 -7395000 -6879000 -21042000 -21666000 -5226000 -4741000 -18263000 -27319000 <div style="text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net sales by product, are as follows (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.205%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.150%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.150%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.455%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.458%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">For the Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">For the Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Lifestyle</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">50,307 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">59,403 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">160,628 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">182,103 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 18pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Mobility and Seating</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">54,851 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">68,286 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">147,275 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">184,819 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Respiratory Therapy</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">6,070 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4,919 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">16,680 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">14,875 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 18pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other(1)</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">5,057 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4,763 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">14,564 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">14,409 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">116,285 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">137,371 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">339,147 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">396,206 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">North America</span></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Lifestyle</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">41,845 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">43,401 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">124,888 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">131,259 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 18pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Mobility and Seating</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">26,572 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">31,252 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">82,485 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">89,638 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Respiratory Therapy</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">19,405 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">12,108 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">53,626 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">40,811 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 18pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other(1)</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">233 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">357 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">596 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,207 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">88,055 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">87,118 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">261,595 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">262,915 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">All Other (Asia Pacific)</span></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Mobility and Seating</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,670 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">6,645 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">10,757 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">21,986 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 18pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Lifestyle</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3,375 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3,001 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">10,176 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">8,261 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Respiratory Therapy</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">195 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">175 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,043 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,063 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 18pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other(1)</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,326 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,464 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3,928 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4,620 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">7,566 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">11,285 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">25,904 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">35,930 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total Consolidated</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">211,906 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">235,774 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">626,646 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">695,051 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  ________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Includes various services, including repair services, equipment rentals and external contracting.</span></div> 50307000 59403000 160628000 182103000 54851000 68286000 147275000 184819000 6070000 4919000 16680000 14875000 5057000 4763000 14564000 14409000 116285000 137371000 339147000 396206000 41845000 43401000 124888000 131259000 26572000 31252000 82485000 89638000 19405000 12108000 53626000 40811000 233000 357000 596000 1207000 88055000 87118000 261595000 262915000 2670000 6645000 10757000 21986000 3375000 3001000 10176000 8261000 195000 175000 1043000 1063000 1326000 1464000 3928000 4620000 7566000 11285000 25904000 35930000 211906000 235774000 626646000 695051000 <div style="text-align:center"><span style="color:#003399;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">Contingencies</span></div><div style="margin-bottom:11pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"/></tr></table></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:46.666%"><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">General</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the ordinary course of its business, the company is a defendant in a number of lawsuits, primarily product liability actions in which various plaintiffs seek damages for injuries allegedly caused by defective products. All the product liability lawsuits that the company faces in the United States have been referred to the company's captive insurance company and/or excess insurance carriers while all non-U.S. lawsuits have been referred to the company's commercial insurance carriers. All such lawsuits are generally contested vigorously. The coverage territory of the company's insurance is worldwide with the exception of those countries with respect to which, at the time the product is sold for use or at the time a claim is made, the U.S. government has suspended or prohibited diplomatic or trade relations. The amount recorded for identified contingent liabilities is based on estimates. Amounts recorded are reviewed periodically and adjusted to reflect additional technical and legal information that becomes available. Actual costs to be incurred in future periods may vary from the estimates, given the inherent uncertainties in evaluating certain exposures.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a medical device manufacturer, the company is subject to extensive government regulation, including numerous laws directed at preventing fraud and abuse and laws regulating reimbursement under various government programs. The marketing, invoicing, documenting, developing, testing, manufacturing, labeling, promoting, distributing and other practices of health care suppliers and medical device manufacturers are all subject to government scrutiny. Most of the company's facilities are subject to inspection at any time by the FDA or similar medical device regulatory agencies in other jurisdictions. Violations of law or regulations can result in administrative, civil and criminal penalties and sanctions, which could have a material adverse effect on the company's business.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Medical Device Regulatory Matters</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FDA in the United States and comparable medical device regulatory authorities in other jurisdictions regulate virtually all aspects of the marketing, invoicing, documenting, development, testing, manufacturing, labeling, promotion, distribution and other practices regarding medical devices. The company and its products are subject to the laws and regulations of the FDA and other regulatory bodies in the various jurisdictions where the company's products are manufactured or sold. The company's failure to comply with the regulatory requirements of the FDA and other applicable medical device regulatory requirements can subject the company to administrative or judicially imposed sanctions or </span></div></div><div style="display:inline-block;max-width:6.666%;min-width:5.666%;vertical-align:top"/><div style="display:inline-block;vertical-align:top;width:46.668%"><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">enforcement actions. These sanctions include injunctions, consent decrees, warning letters, civil penalties, criminal penalties, product seizure or detention, product recalls and total or partial suspension of production.</span></div><div style="margin-top:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2012, the company became subject to a consent decree of injunction filed by FDA with respect to the company's Corporate facility and its Taylor Street manufacturing facility in Elyria, Ohio. The consent decree initially limited the company's (i) manufacture and distribution of power and manual wheelchairs, wheelchair components and wheelchair sub-assemblies at or from its Taylor Street manufacturing facility, except in verified cases of medical necessity, (ii) design activities related to wheelchairs and power beds that take place at the impacted Elyria facilities and (iii) replacement, service and repair of products already in use from the Taylor Street manufacturing facility. Under the terms of the consent decree, in order to resume full operations, the company had to successfully complete independent, third-party expert certification audits at the impacted Elyria facilities, comprising three distinct certification reports separately submitted to, and subject to acceptance by, FDA; submit its own report to the FDA; and successfully complete a reinspection by FDA of the company's Corporate and Taylor Street facilities.</span></div><div style="margin-top:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 24, 2017, following its June 2017 reinspection of the Corporate and Taylor Street facilities, FDA notified the company that it is in substantial compliance with the FDA Act, FDA regulations and the terms of the consent decree and, that the company was permitted to resume full operations at those facilities including the resumption of unrestricted sales of products made in those facilities.</span></div><div style="margin-top:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consent decree will continue in effect for at least five years from July 2017, during which time the company's Corporate and Taylor Street facilities must complete two semi-annual audits in the first year and then four annual audits in the next four years performed by a company-retained expert firm. The expert audit firm will determine whether the facilities remain in continuous compliance with the FDA Act, FDA regulations and the terms of the consent decree. The FDA has the authority to inspect these facilities and any other FDA registered facility, at any time. </span></div><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FDA has continued to actively inspect the company's facilities, other than through the processes established under the consent decree. The company expects that the FDA will, from time to time, inspect substantially all the company's domestic and foreign FDA-registered facilities.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The results of regulatory claims, proceedings, investigations, or litigation are difficult to predict. An </span></div></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">unfavorable resolution or outcome of any FDA warning letters or inspectional observations, or other FDA enforcement related to company facilities, could materially and adversely affect the company's business, financial condition, and results of operations.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The limitations previously imposed by the FDA consent decree negatively affected net sales in the North America segment and, to a certain extent, the Asia Pacific region beginning in 2012. The limitations led to delays in new product introductions. Further, uncertainty regarding how long the limitations would be in effect limited the company's ability to renegotiate and bid on certain customer contracts and otherwise led to a decline in customer orders.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although the company has been permitted to resume full operations at the Corporate and Taylor Street facilities, the negative effect of the consent decree on customer orders and net sales in the North America segment and Asia Pacific region has been considerable, and it is uncertain as to whether, or how quickly, the company will be able to rebuild net sales to more typical historical levels, irrespective of market conditions. Accordingly, when compared to the company's 2010 results, the previous limitations in the consent decree had, and likely may continue to have, a material adverse effect on the company's business, financial condition and results of operations. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Warranty Matters</span></div><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company's warranty reserves are subject to adjustment in future periods based on historical analysis of warranty claims and as new developments occur that may change the company's estimates related to specific product recalls. See Current Liabilities in the Notes to the Condensed Consolidated Financial Statements for the total provision amounts and a reconciliation of the changes in the warranty accrual.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any of the above contingencies could have an adverse impact on the company's financial condition or results of operations. </span></div><div style="margin-top:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For additional information regarding the consent decree, other regulatory matters, and risks and trends that may impact the company’s financial condition or results of operations, please see the following sections of the company's Annual Report on Form 10-K for the year ended December 31, 2019: Item 1. Business - Government Regulation and Item 1A. Risk Factors; Item 3. Legal Proceedings; and Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations - Liquidity and Capital Resources.</span></div> Net loss per common share assuming dilution calculated utilizing weighted average shares outstanding-basic for the periods in which there was a net loss.  *    Shares available for grant under the 2018 Plan as of September 30, 2020 reduced by net restricted share and restricted share unit award activity of 696,058 shares and performance share and performance share unit award activity of 1,859,054 shares. XML 21 R1.htm IDEA: XBRL DOCUMENT v3.20.2
DEI Document - shares
 9 Months Ended
Sep. 30, 2020
Oct. 27, 2020
Entity Information [Line Items]    
Document Type 10-Q  
Document Quarterly Report true  
Document Period End Date Sep. 30, 2020  
Document Transition Report false  
Entity File Number 001-15103  
Entity Registrant Name INVACARE CORPORATION  
Entity Incorporation, State or Country Code OH  
Entity Tax Identification Number 95-2680965  
Entity Address, Address Line One One Invacare Way,  
Entity Address, City or Town Elyria,  
Entity Address, State or Province OH  
Entity Address, Postal Zip Code 44035  
City Area Code 440  
Local Phone Number 329-6000  
Title of 12(b) Security Common Shares, without par value  
Trading Symbol IVC  
Security Exchange Name NYSE  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Accelerated Filer  
Entity Small Business false  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Central Index Key 0000742112  
Current Fiscal Year End Date --12-31  
Document Fiscal Year Focus 2020  
Document Fiscal Period Focus Q3  
Amendment Flag false  
Common Shares [Member]    
Entity Information [Line Items]    
Entity Common Stock, Shares Outstanding   34,411,688
Class B Common Shares [Member]    
Entity Information [Line Items]    
Entity Common Stock, Shares Outstanding   6,357

XML 22 R2.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Consolidated Statement of Comprehensive Income (Loss) - USD ($)
shares in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Statement of Comprehensive Income [Abstract]        
Net Sales $ 211,906,000 $ 235,774,000 $ 626,646,000 $ 695,051,000
Cost of products sold 151,866,000 168,189,000 446,968,000 500,945,000
Gross Profit 60,040,000 67,585,000 179,678,000 194,106,000
Selling, general and administrative expenses 55,530,000 63,539,000 174,672,000 197,035,000
Gain on sale of business 0 0 9,790,000 0
Charges related to restructuring activities 1,580,000 1,628,000 4,657,000 3,641,000
Operating Income (Loss) 2,930,000 2,418,000 10,139,000 (6,570,000)
Net gain on convertible debt derivatives 0 0 0 (1,197,000)
Loss on debt extinguishment including debt finance charges and fees 761,000 280,000 7,360,000 280,000
Interest expense 7,402,000 6,992,000 21,132,000 22,027,000
Interest Income, Other 7,000 113,000 90,000 361,000
Loss Before Income Taxes (5,226,000) (4,741,000) (18,263,000) (27,319,000)
Income tax provision 2,050,000 3,300,000 4,900,000 7,325,000
Net Loss $ (7,276,000) $ (8,041,000) $ (23,163,000) $ (34,644,000)
Dividends Declared per Common Share $ 0 $ 0.0125 $ 0.0125 $ 0.0375
Net Loss per Share—Basic        
Net Loss per Share—Basic $ (0.21) $ (0.24) $ (0.68) $ (1.03)
Weighted Average Shares Outstanding—Basic 34,419 33,660 34,213 33,571
Net Loss per Share—Assuming Dilution        
Net Loss per Share—Assuming Dilution [1] $ (0.21) $ (0.24) $ (0.68) $ (1.03)
Weighted Average Shares Outstanding—Assuming Dilution 34,530 33,668 34,313 33,581
Other comprehensive income (loss):        
Foreign currency translation adjustments $ 35,944,000 $ (9,057,000) $ 36,859,000 $ (13,041,000)
Defined Benefit Plans:        
Amortization of prior service costs and unrecognized losses (193,000) (201,000) (362,000) (276,000)
Deferred tax adjustment resulting from defined benefit plan activity 9,000 38,000 25,000 54,000
Valuation reserve associated with defined benefit plan activity (9,000) (38,000) (25,000) (54,000)
Current period (loss) gain on cash flow hedges (2,047,000) (315,000) (1,159,000) 861,000
Deferred tax benefit (provision) related to gain on cash flow hedges 285,000 12,000 171,000 (127,000)
Other Comprehensive Income (Loss) 33,989,000 (9,561,000) 35,509,000 (12,583,000)
Comprehensive Income (Loss) $ 26,713,000 $ (17,602,000) $ 12,346,000 $ (47,227,000)
Net Sales, as a Percent of Net Sales 100.00% 100.00% 100.00% 100.00%
Cost of Products Sold, as a Percent of Net Sales 71.70% 71.30% 71.30% 72.10%
Gross Profit, as a Percent of Net Sales 28.30% 28.70% 28.70% 27.90%
Selling, general and administrative expenses, as a Percent of Net Sales 26.20% 26.90% 27.90% 28.30%
Gain on sale of business, as a Percent of Net Sales 0.00% 0.00% (1.60%) 0.00%
Charges related to restructuring activities, as a Percent of Net Sales 0.70% 0.70% 0.70% 0.50%
Operating Gain (Loss), as a Percent of Net Sales 1.40% 1.00% 1.60% (0.90%)
Net loss (gain) on convertible debt derivatives, as a Percent of Net Sales 0.00% 0.00% 0.00% (0.20%)
Interest expense, as a Percent of Net Sales 3.50% 3.00% 3.40% 3.20%
Interest income, as a Percent of Net Sales 0.00% 0.00% 0.00% (0.10%)
Gain (loss) Before Income Taxes, as a Percent of Net Sales (2.50%) (2.00%) (2.90%) (3.90%)
Income Tax Provision, as a Percent of Net Sales 1.00% 1.40% 0.80% 1.10%
Net Gain (Loss), as a percent of Net Sales (3.40%) (3.40%) (3.70%) (5.00%)
Net loss (gain) on debt extinguishment, as a Percent of Net Sales [Line Items] 0.40% 0.10% 1.20% 0.04%
[1] Net loss per common share assuming dilution calculated utilizing weighted average shares outstanding-basic for the periods in which there was a net loss.
XML 23 R3.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2020
Dec. 31, 2019
Current Assets    
Cash and cash equivalents $ 86,825 $ 80,063
Trade receivables, net 108,957 116,669
Installment receivables, net 261 736
Inventories, net 145,452 120,500
Other current assets 37,635 37,909
Total Current Assets 379,130 355,877
Other Assets 3,991 4,216
Intangibles 27,770 26,447
Property and Equipment, net 53,112 46,607
Finance Lease, Right-of-Use Asset 65,108 26,900
Operating Lease, Right-of-Use Asset 13,075 18,676
Goodwill 401,665 373,403
Total Assets 943,851 852,126
Current Liabilities    
Accounts payable 93,160 88,003
Accrued expenses 124,666 120,947
Current taxes payable 2,197 345
Current portion of financing lease obligations 3,352 2,514
Current portion of operating lease obligations 5,843 6,790
Short-term debt and current maturities of long-term obligations 4,062 58
Total Current Liabilities 233,280 218,657
Long-Term Debt 238,202 219,464
Finance Lease Long-Term Obligations 63,950 26,480
Operating Leases Long-Term Obligations 7,182 12,060
Other Long-Term Obligations 70,748 66,949
Shareholders’ Equity    
Preferred Shares (Authorized 300 shares; none outstanding) 0 0
Additional paid-in-capital 324,409 312,650
Retained earnings 63,655 87,475
Accumulated other comprehensive income 38,637 3,128
Treasury Shares (4,184 and 3,953 shares at September 30, 2020 and December 31, 2019, respectively) (106,029) (104,327)
Total Shareholders’ Equity 330,489 308,516
Total Liabilities and Shareholders’ Equity 943,851 852,126
Common Shares [Member]    
Shareholders’ Equity    
Common Shares 9,815 9,588
Class B Common Shares [Member]    
Shareholders’ Equity    
Common Shares 2 2
Total Shareholders’ Equity $ 2 $ 2
XML 24 R4.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Consolidated Balance Sheets (Parentheticals) - shares
shares in Thousands
Sep. 30, 2020
Dec. 31, 2019
Preferred Stock, Shares Authorized 300 300
Preferred Stock, Shares Outstanding 0 0
Treasury Stock, Shares 4,184 3,953
Common Shares [Member]    
Common Stock, Shares Authorized 150,000 150,000
Common Stock, Shares, Issued 38,596 37,609
Class B Common Shares [Member]    
Common Stock, Shares Authorized 12,000 12,000
Common Stock, Shares, Issued 6 6
XML 25 R5.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Consolidated Statement Of Cash Flows - USD ($)
 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Operating Activities    
Net loss $ (23,163,000) $ (34,644,000)
Adjustments to reconcile net loss to net cash used by operating activities:    
Gain on sale of business 9,790,000 0
Depreciation and amortization 10,360,000 11,800,000
Amortization of operating lease right of use assets 5,284,000 6,927,000
Provision for losses on trade and installment receivables 554,000 923,000
(Provision) benefit for deferred income taxes 111,000 (232,000)
Provision for other deferred liabilities 594,000 837,000
Provision for equity compensation 6,965,000 5,873,000
Loss (gain) on disposals of property and equipment (1,066,000) 186,000
Loss on debt extinguishment including debt finance charges and fees 7,360,000 280,000
Amortization of convertible debt discount 8,629,000 9,429,000
Amortization of debt fees 1,329,000 1,860,000
Gain on convertible debt derivatives 0 1,197,000
Changes in operating assets and liabilities:    
Trade receivables 6,160,000 1,501,000
Installment sales contracts, net 532,000 405,000
Inventories, net (22,021,000) 3,173,000
Other current assets 1,691,000 (2,099,000)
Accounts payable 5,903,000 (1,226,000)
Accrued expenses 1,616,000 (7,749,000)
Other long-term liabilities (226,000) (779,000)
Net Cash Provided by (Used in) Operating Activities 822,000 (4,732,000)
Investing Activities    
Purchases of property and equipment (16,824,000) (7,177,000)
Proceeds from sale of property and equipment 396,000 73,000
Proceeds from sale of business 14,563,000 0
Change in other long-term assets 67,000 (72,000)
Other 2,176,000 0
Net Cash Used by Investing Activities (3,974,000) (7,176,000)
Financing Activities    
Proceeds from revolving lines of credit and long-term borrowings 72,551,000 0
Repurchases of convertible debt, payments on revolving lines of credit and financing leases (59,483,000) (16,339,000)
Payment of financing costs (1,307,000) 0
Payment of dividends (414,000) (1,234,000)
Payments to debt holders (5,593,000) 0
Purchase of treasury shares (1,702,000) (860,000)
Net Cash Provided (Used) by Financing Activities 4,052,000 (18,433,000)
Effect of exchange rate changes on cash 5,862,000 (1,526,000)
Cash, Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 6,762,000 (31,867,000)
Cash and cash equivalents at beginning of year 80,063,000 116,907,000
Cash and cash equivalents at end of period $ 86,825,000 $ 85,040,000
XML 26 R6.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Consolidated Statement of Shareholders' Equity Statement - USD ($)
Total
Class B Common Shares [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
Treasury Stock [Member]
Total Shareholders’ Equity at Dec. 31, 2018 $ 359,147,000 $ 2,000 $ 9,419,000 $ 297,919,000 $ 142,447,000 $ 12,793,000 $ (103,433,000)
Allocated Share-based Compensation Expense 1,300,000   29,000 1,619,000     (348,000)
Adjustments to Additional Paid in Capital, Share-based Compensation, Stock Options, Requisite Service Period Recognition 334,000     334,000      
Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures 3,379,000   140,000 3,751,000     (512,000)
Net Loss (34,644,000)       (34,644,000)    
Foreign currency translation adjustments (13,041,000)            
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax (13,041,000)            
Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, Net of Tax 734,000         734,000  
Amortization of prior service costs and unrecognized losses (276,000)            
Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), Reclassification Adjustment from AOCI, after Tax (276,000)            
Comprehensive Income (Loss), Net of Tax, Attributable to Parent (47,227,000)            
Convertible Debt Derivative Adjustments (220,000)     (220,000)      
Payments of Ordinary Dividends, Common Stock (1,234,000)            
Dividends, Common Stock, Cash (1,234,000)            
Total Shareholders’ Equity at Sep. 30, 2019 315,479,000 2,000 9,588,000 303,403,000 106,569,000 210,000 (104,293,000)
Total Shareholders’ Equity at Jun. 30, 2019 331,926,000 2,000 9,588,000 301,833,000 115,025,000 9,771,000 (104,293,000)
Allocated Share-based Compensation Expense 649,000   0 649,000     0
Adjustments to Additional Paid in Capital, Share-based Compensation, Stock Options, Requisite Service Period Recognition 123,000     123,000      
Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures 798,000   0 798,000    
Net Loss (8,041,000)       (8,041,000)    
Foreign currency translation adjustments (9,057,000)            
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax (9,057,000)            
Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, Net of Tax (303,000)         (303,000)  
Amortization of prior service costs and unrecognized losses (201,000)            
Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), Reclassification Adjustment from AOCI, after Tax (201,000)            
Comprehensive Income (Loss), Net of Tax, Attributable to Parent (17,602,000)            
Payments of Ordinary Dividends, Common Stock (415,000)            
Dividends, Common Stock, Cash (415,000)            
Total Shareholders’ Equity at Sep. 30, 2019 315,479,000 2,000 9,588,000 303,403,000 106,569,000 210,000 (104,293,000)
Total Shareholders’ Equity at Dec. 31, 2019 308,516,000 2,000 9,588,000 312,650,000 87,475,000 3,128,000 (104,327,000)
Stock Issued During Period, Value, Stock Options Exercised (1,121,000)   (90,000) (90,000)     (1,121,000)
Allocated Share-based Compensation Expense 2,494,000     2,494,000      
Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures 3,890,000   137,000 4,334,000     (581,000)
Net Loss (23,163,000)       (23,163,000)    
Foreign currency translation adjustments 36,859,000            
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax 36,859,000            
Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, Net of Tax (988,000)         (988,000)  
Amortization of prior service costs and unrecognized losses (362,000)            
Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), Reclassification Adjustment from AOCI, after Tax (362,000)            
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12,346,000            
Exchange of Convertible Notes 5,021,000     5,021,000      
Payments of Ordinary Dividends, Common Stock (414,000)            
Dividends, Common Stock, Cash (414,000)            
Adoption of Credit Loss Standard (243,000)            
Total Shareholders’ Equity at Sep. 30, 2020 330,489,000 2,000 9,815,000 324,409,000 63,655,000 38,637,000 (106,029,000)
Total Shareholders’ Equity at Jun. 30, 2020 302,146,000 2,000 9,815,000 322,770,000 70,931,000 4,648,000 (106,020,000)
Allocated Share-based Compensation Expense 818,000   0 818,000     0
Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures 812,000   0 821,000     (9,000)
Net Loss (7,276,000)       (7,276,000)    
Foreign currency translation adjustments 35,944,000            
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax 35,944,000            
Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, Net of Tax (1,762,000)         (1,762,000)  
Amortization of prior service costs and unrecognized losses (193,000)            
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 26,713,000            
Total Shareholders’ Equity at Sep. 30, 2020 $ 330,489,000 $ 2,000 $ 9,815,000 $ 324,409,000 $ 63,655,000 $ 38,637,000 $ (106,029,000)
XML 27 R7.htm IDEA: XBRL DOCUMENT v3.20.2
Accounting Policies
 9 Months Ended
Sep. 30, 2020
Accounting Policies [Abstract]  
Accounting Policies Accounting Policies
Principles of Consolidation:  The condensed consolidated financial statements include the accounts of the company and its wholly owned subsidiaries and include all adjustments, which were of a normal recurring nature, necessary to present fairly the financial position of the company as of September 30, 2020 and the results of its operations and changes in its cash flow for the nine months ended September 30, 2020 and 2019, respectively. Certain foreign subsidiaries, represented by the European segment, are consolidated using an August 31 quarter end to meet filing deadlines. No material subsequent events have occurred related to the European segment, which would require disclosure or adjustment to the company's financial statements. All significant intercompany transactions are eliminated. The results of operations for the three and nine months ended September 30, 2020 are not necessarily indicative of the results to be expected for the full year.

Use of Estimates:  The condensed consolidated financial statements are prepared in conformity with accounting principles generally accepted in the United States, which require management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results may differ from these estimates.

Recent Accounting Pronouncements (Already Adopted): 
In June 2016, the FASB issued ASU 2016-13, "Measurement of Credit Losses on Financial Statements." ASU 2016-13 requires a new credit loss standard for most financial assets and certain other instruments. For example, entities are required to use an "expected loss" model that will generally require earlier recognition of allowances for losses for trade receivables. The standard also requires additional disclosures, including disclosures regarding how an entity tracks credit quality. The company adopted ASU 2016-13, effective on January 1, 2020, which resulted in an increase for credit losses of $243,000 with the offsetting impact recorded to retained earnings.

In January 2017, the FASB issued ASU 2017-04, "Intangibles - Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment." The guidance in ASU 2017-04 eliminates the requirement to determine the fair value of individual assets and liabilities of a reporting unit to measure goodwill impairment. Under the amendments in the new ASU, goodwill impairment testing will be performed by comparing the fair value of the reporting unit with its carrying amount and recognizing an impairment charge for the amount by which the carrying amount exceeds the reporting unit’s fair
value. The company adopted ASU 2017-04 as of January 1, 2020 with no impact to the company's financial statements upon adoption. In December 2019, the FASB issued ASU 2019-12, "Income Taxes (Topic 740) - Simplifying the Accounting for Income Taxes," which simplifies the accounting for income taxes by removing certain exceptions to the general principles in Topic 740. ASU 2019-12 removes the following exceptions: 1) exception to the incremental approach for intraperiod tax allocation when there is a loss from continuing operations and income or a gain from other items (for example, discontinued operations or other comprehensive income), 2) exception to the requirement to recognize a deferred tax liability for equity method investments when a foreign subsidiary becomes an equity method investment, 3) exception to the ability not to recognize a deferred tax liability for a foreign subsidiary when a foreign subsidiary becomes a subsidiary and 4) the exception to the general methodology for calculating income taxes in an interim period when a year-to-date loss exceeds the anticipated loss for the year. The ASU also simplifies other areas of Topic 740 by clarifying and amending existing guidance. The amendments in the ASU will be applied using different approaches depending on what the specific amendments relate to. The company early adopted ASU 2019-12 on a prospective basis as of January 1, 2020 with no impact to the company's financial statements upon adoption.
XML 28 R8.htm IDEA: XBRL DOCUMENT v3.20.2
Divested Businesses (Notes)
 9 Months Ended
Sep. 30, 2020
Divested Businesses [Abstract]  
Divested Businesses
Divested Businesses
On March 7, 2020, the company, completed the sale (the “Transaction”) of its indirect subsidiary, Dynamic Controls, a New Zealand incorporated unlimited company (“Dynamic Controls”), to Allied Motion Christchurch Limited, a New Zealand limited company (the “Purchaser”), pursuant to a Securities Purchase Agreement among the company, Invacare Holdings New Zealand, a New Zealand incorporated unlimited company, and the Purchaser, dated March 6, 2020 (the “Purchase Agreement”). Dynamic Controls is a producer of electronic control systems for powered medical mobility devices, including systems incorporating the LiNX™ technology platform. Dynamic Controls was a component of the All Other Segment.
Dynamic Controls is a supplier of power mobility products and respiratory components to the company as well as supplying power mobility products to external customers. Sales in 2020 through the date of disposition were $5,331,000, including intercompany sales of $2,532,000, compared to sales for the full year of 2019 of $30,261,000, including intercompany sales of $13,087,000. Income before income taxes was approximately $445,000 in 2020, through the date of disposition, compared to $853,000 in 2019, inclusive of intercompany profits on sales to the company.
The transaction was the result of considering options for the products sold by Dynamic Controls which resulted in selling the business to a third-party which can provide access to further technological innovations to further differentiate the company’s power mobility products.
The gross proceeds from the Transaction were $14,563,000, net of taxes and expenses. The company realized a pre-tax gain of $9,790,000 and recorded expenses related to the sale of the business totaling $2,150,000, of which $1,789,000 have been paid as of September 30, 2020.
The Purchase Agreement contains customary indemnification obligations of each party with respect to breaches of their respective representations, warranties and covenants, and certain other specified matters, which are subject to certain exceptions, terms and limitations described further in the Purchase Agreement.

At the closing of the Transaction, the parties entered into a supply agreement pursuant to which Dynamic Controls will supply certain electronic components as required by the company for a five-year period following the Transaction, including ongoing supply and support of the LiNX™ electronic control system with informatics technology, continued contract manufacturing of certain electronic components for the company’s respiratory products and
continued infrastructure and applications support for the informatics solution for the company’s respiratory products. The estimated continued inflows and outflows following the disposal with the Purchaser are not expected to be material to the company.
The assets and liabilities of Dynamic Controls as of March 7, 2020 and December 31, 2019 consisted of the following (in thousands):
March 7, 2020December 31, 2019
Trade receivables, net$4,129 $1,804 
Inventories, net3,082 3,008 
Other assets855 933 
Property and equipment, net600 707 
Operating lease assets, net2,127 1,870 
Total assets$10,793 $8,322 
Accounts payable$4,692 $4,501 
Accrued expenses2,473 2,108 
Current taxes payable41 92 
Current portion of operating lease obligations366 393 
Long-term obligations1,019 1,754 
Total liabilities$8,591 $8,848 

Trade receivables as of March 7, 2020 includes receivables previously classified as intercompany related to product sold by Dynamic Controls to other Invacare entities.
XML 29 R9.htm IDEA: XBRL DOCUMENT v3.20.2
Receivables
 9 Months Ended
Sep. 30, 2020
Receivables [Abstract]  
Receivables
Receivables

Receivables consist of the following (in thousands):
September 30, 2020December 31, 2019
Accounts receivable, gross$132,809 $141,732 
Customer rebate reserve(13,075)(13,922)
Cash discount reserves(5,290)(5,326)
Allowance for doubtful accounts(4,697)(4,804)
Other, principally returns and allowances reserves(790)(1,011)
Accounts receivable, net$108,957 $116,669 

Reserves for customer rebates and cash discounts are recorded as a reduction in revenue and netted against gross accounts receivable. Customer rebates in excess of a given customer's accounts receivable balance are classified in Accrued Expenses. Customer rebates and cash discounts are estimated based on the most likely amount principle as well as historical experience and anticipated performance. In addition, customers have the right to return product within the company’s normal terms policy, and as such, the company estimates the expected returns based on an analysis of historical experience and adjusts revenue accordingly.

Accounts receivable are reduced by an allowance for amounts that may become uncollectible in the future. Substantially all the company’s receivables are due from health care, medical equipment providers and long-term care facilities predominantly located throughout the United States, Australia, Canada, New Zealand, China and Europe. A significant portion of products sold to providers, both foreign and domestic, are ultimately funded through government reimbursement programs such as Medicare and Medicaid in the U.S. As a consequence, changes in these programs can have an adverse impact on dealer liquidity and profitability.

The company adopted ASU 2016-13, "Measurement of Credit Losses on Financial Statements" on January 1, 2020. Accordingly, the company is now applying an "expected loss" model that will generally require earlier recognition of allowances for losses for trade receivables. In addition, the company expects more variability in its allowance for doubtful accounts as it previously provided for bad debts based on a specific reserve methodology while the new expected loss methodology requires companies to provide for estimated losses beginning at the time of sale. The adoption of the new standard resulted in an increase in credit losses of $243,000 as
disclosed in the Condensed Consolidated Statement of Shareholders' Equity.

The company's approach is to separate its receivables into good-standing and collection receivables. Good-standing receivables are assigned to risk pools of high, medium and low. The risk pools are driven by the specifics associated with the geography of origination. Expected loss percentages are calculated and assigned to each risk pool, driven primarily by historical experience. The historical loss percentages are calculated for each risk pool and then judgmentally revised to consider current risk factors as well as consideration of the impact of forecasted events, as applicable. The expected loss percentages are then applied to receivables balances each period to determine the allowance for doubtful accounts.

In North America, excluding Canada, good-standing receivables are assigned to the low risk pool and assigned an expected loss percentage of 1.0% as these receivables are deemed to share the same risk profile and collections efforts are the same. Installment receivables in North America are characterized as collection receivables and thus reserves based on specific analysis of each customer. In Canada, good-standing receivables and installment receivables are deemed low risk and assigned a loss percentage of 0.2%.

In Europe, expected losses are determined by each location in each region. Most locations have a majority of their receivables assigned to the low risk pool, which has an average expected loss percentage of 0.3%. About half of the locations have a portion of their receivables assigned as medium risk with an average expected loss percentage of 0.9%. Only a few locations have any receivables characterized as high risk and the average credit loss percentage for those locations is 2.7%. Collection risk is generally low as payment terms in certain key markets, such as Germany, are immediate and in many locations the ultimate customer is the government.

In the Asia Pacific region, receivables are characterized as low risk, which have an average expected loss percentage of 0.3%. Historical losses are low in this region where the use of credit insurance is often customary.

The movement in the trade receivables allowance for doubtful accounts was as follows (in thousands):
 Nine Months Ended
September 30, 2020
Balance as of beginning of period$4,804 
Current period provision522 
Direct write-offs charged against the allowance(629)
Balance as of end of period$4,697 

The current period provision includes the immaterial impact of the adoption of ASU 2016-03. The company did not make any material changes to the assignment of receivables to the different risk pools or to the expected loss reserves in the quarter. The company is monitoring the impacts of the COVID-19 pandemic and the possibility for an impact on collections, but to date this has not materially impacted 2020.

For collections receivables, the estimated allowance for uncollectible amounts is based primarily on management’s evaluation of the financial condition of each customer. In addition, as a result of the company's financing arrangement with DLL, a third-party financing company which the company has worked with since 2000, management monitors the collection status of these contracts in accordance with the company’s limited recourse obligations and provides amounts necessary for estimated losses in the allowance for doubtful accounts and establishes reserves for specific customers as needed.

The company writes off uncollectible trade accounts receivable after such receivables are moved to collection status and legal remedies are exhausted. See Concentration of Credit Risk in the Notes to the Condensed Consolidated Financial Statements for a description of the financing arrangement. Long-term installment receivables are included in “Other Assets” on the condensed consolidated balance sheet.

Upon adoption of ASU 2016-03, the company recorded a new contingent liability in the amount of $306,000 related to the contingent aspect of the company's guarantee associated with its arrangement with DLL. The contingent liability is recorded applying the same expected loss model used for the trade and installment receivables recorded on the company's books. Specifically, historical loss history is used to determine the expected loss percentage, which is then adjusted judgmentally to consider other factors, as needed.

The company’s U.S. customers electing to finance their purchases can do so using DLL. In addition, the company, prior to 2020, provided financing directly for its Canadian customers for which DLL is not an option, as DLL typically
provides financing to Canadian customers only on a limited basis. The installment receivables recorded on the books of the company represent a single portfolio segment of finance receivables to the independent provider channel and long-term care customers. The portfolio segment is comprised of two classes of receivables distinguished by geography and credit quality. The U.S. installment receivables are the first class and represent installment receivables repurchased from DLL because the customers were in default. Default with DLL is defined as a customer being delinquent by three payments. The Canadian installment receivables represent the second class of installment receivables which were originally financed by the company because third party financing was not available to the HME providers. The Canadian installment receivables were typically financed for twelve months and historically have had a very low risk of default.

The estimated allowance for uncollectible amounts and evaluation for both classes of installment receivables is based on the company’s quarterly review of the financial condition of each individual customer with the allowance for doubtful accounts adjusted accordingly. Installments are individually and not collectively reviewed. The company assesses the bad debt reserve levels based upon the status of the customer’s adherence to a legally negotiated payment schedule and the company’s ability to enforce judgments, liens, etc.

For purposes of granting or extending credit, the company utilizes a scoring model to generate a composite score that considers each customer’s consumer credit score and/or D&B credit rating, payment history, security collateral and time in business. Additional analysis is performed for most customers desiring credit greater than $250,000, which generally includes a detailed review of the customer’s financial statements as well as consideration of other factors such as exposure to changing reimbursement laws.

Interest income is recognized on installment receivables based on the terms of the installment agreements. Installment accounts are monitored and if a customer defaults on payments and is moved to collection, interest income is no longer recognized. Subsequent payments received once an account is put on non-accrual status are generally first applied to the principal balance and then to the interest. Accruing of interest on collection accounts would only be restarted if the account became current again.

All installment accounts are accounted for using the same methodology regardless of the duration of the installment agreements. When an account is placed in collection status, the company goes through a legal process for pursuing collection of outstanding amounts, the length of which typically approximates eighteen months. Any write-offs are made after the legal process has been completed.
Installment receivables consist of the following (in thousands):
 September 30, 2020December 31, 2019
 CurrentLong-
Term		TotalCurrentLong-
Term		Total
Installment receivables$555 $228 $783 $1,192 $1,257 $2,449 
Less: Unearned interest(3)— (3)(22)— (22)
552 228 780 1,170 1,257 2,427 
Allowance for doubtful accounts(291)(164)(455)(434)(1,080)(1,514)
Installment receivables, net$261 $64 $325 $736 $177 $913 

Installment receivables purchased from DLL during the nine months ended September 30, 2020 increased the gross installment receivables balance by $343,000, which will be part of the company's 2020 class of installment receivables. No sales of installment receivables were made by the company


during the quarter. There was no impact on the allowance for doubtful accounts for installment receivables as a result of the adoption of ASU 2016-03 as the installment receivables in the U.S. are specifically reserved for by account and no adjustment was needed to the allowance for doubtful accounts for Canada installment receivables.

The movement in the installment receivables allowance for doubtful accounts was as follows (in thousands):
 Nine Months Ended
September 30, 2020		Year Ended December 31, 2019
Balance as of beginning of period$1,514 $1,542 
Current period provision32 479 
Direct write-offs charged against the allowance(1,091)(507)
Balance as of end of period$455 $1,514 
 
Installment receivables by class as of September 30, 2020 consist of the following (in thousands):
 Total
Installment
Receivables		Unpaid
Principal
Balance		Related
Allowance for
Doubtful
Accounts		Interest
Income
Recognized
U.S.
Impaired installment receivables with a related allowance recorded$649 $649 $453 $— 
Canada
Non-Impaired installment receivables with no related allowance recorded132 129 — 26 
Impaired installment receivables with a related allowance recorded2 2 2 — 
Total Canadian installment receivables134 131 2 26 
Total
Non-Impaired installment receivables with no related allowance recorded132 129 — 26 
Impaired installment receivables with a related allowance recorded651 651 455 — 
Total installment receivables$783 $780 $455 $26 
Installment receivables by class as of December 31, 2019 consist of the following (in thousands):
 Total
Installment
Receivables		Unpaid
Principal
Balance		Related
Allowance for
Doubtful
Accounts		Interest
Income
Recognized
U.S.
Impaired installment receivables with a related allowance recorded$1,762 $1,762 $1,497 $— 
Canada
Non-Impaired installment receivables with no related allowance recorded670 648 — 92 
Impaired installment receivables with a related allowance recorded17 17 17 — 
Total Canadian installment receivables687 665 17 92 
Total
Non-Impaired installment receivables with no related allowance recorded670 648 — 92 
Impaired installment receivables with a related allowance recorded1,779 1,779 1,514 — 
Total installment receivables$2,449 $2,427 $1,514 $92 

Installment receivables with a related allowance recorded as noted in the table above represent those installment receivables on a non-accrual basis in accordance with ASU 2010-20. As of September 30, 2020, the company had no U.S. installment receivables past due of 90 days or more for which the company is still accruing interest. Individually, all U.S. installment receivables are assigned a specific allowance for doubtful accounts based on management’s review when the
company does not expect to receive both the contractual principal and interest payments as specified in the loan agreement. In Canada, the company had an immaterial amount of Canadian installment receivables which were past due of 90 days or more as of December 31, 2019 for which the company was still accruing interest.


The aging of the company’s installment receivables was as follows (in thousands):
September 30, 2020December 31, 2019
TotalU.S.CanadaTotalU.S.Canada
Current$132 $— $132 $659 $— $659 
0-30 Days Past Due— — — 2 — 2 
31-60 Days Past Due— — — 4 — 4 
61-90 Days Past Due— — — — — — 
90+ Days Past Due651 649 2 1,784 1,762 22 
$783 $649 $134 $2,449 $1,762 $687 
XML 30 R10.htm IDEA: XBRL DOCUMENT v3.20.2
Inventories
 9 Months Ended
Sep. 30, 2020
Inventory Disclosure [Abstract]  
Inventories
Inventories, Net

Inventories consist of the following (in thousands):
September 30, 2020December 31, 2019
Finished goods$68,599 $54,064 
Raw materials66,093 54,638 
Work in process10,760 11,798 
Inventories, net$145,452 $120,500 
XML 31 R11.htm IDEA: XBRL DOCUMENT v3.20.2
Other Current Assets
 9 Months Ended
Sep. 30, 2020
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]  
Other Current Assets
Other Current Assets


Other current assets consist of the following (in thousands):
September 30, 2020December 31, 2019
Tax receivables principally value added taxes$23,188 $16,049 
Receivable due from information technology provider2,402 6,262 
Prepaid inventory1,392 684 
Derivatives (foreign currency forward exchange contracts)599 838 
Service contracts446 2,013 
Prepaid insurance341 2,918 
Deferred financing fees209 207 
Prepaid social charges95 1,216 
Recoverable income taxes50 297 
Prepaid and other current assets8,913 7,425 
Other Current Assets$37,635 $37,909 
In the fourth quarter of 2019, the company entered into an agreement to outsource substantially all of the company’s information technology ("IT") business service activities, including, among other things, support, rationalization and upgrading of the company’s legacy information technology systems and implementation of a global enterprise resource planning system. The agreement provides for reimbursement by the IT provider of IT expenses incurred by the company which are shown as Receivable due from IT provider above. The amount of pass through charges will diminish as IT expenses are recorded directly by the IT provider. In addition, a corresponding current payable is due to the IT provider. See "Accrued Expenses" in the notes to the Condensed Consolidated Financial Statements included elsewhere in this report.
XML 32 R12.htm IDEA: XBRL DOCUMENT v3.20.2
Other Long-Term Assets
 9 Months Ended
Sep. 30, 2020
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]  
Other Long-Term Assets
Other Long-Term Assets


Other long-term assets consist of the following (in thousands):
September 30, 2020December 31, 2019
Cash surrender value of life insurance policies$2,224 $2,124 
Deferred income taxes1,032 928 
Deferred financing fees461 602 
Investments85 85 
Installment receivables64 177 
Other125 300 
Other Long-Term Assets$3,991 $4,216 
XML 33 R13.htm IDEA: XBRL DOCUMENT v3.20.2
Property And Equipment
 9 Months Ended
Sep. 30, 2020
Property, Plant and Equipment [Abstract]  
Property And Equipment Property and Equipment
Property and equipment consist of the following (in thousands):
September 30, 2020December 31, 2019
Machinery and equipment$291,902 $296,078 
Land, buildings and improvements28,088 33,054 
Capitalized software13,787 3,509 
Furniture and fixtures9,866 9,898 
Leasehold improvements8,087 9,023 
Property and Equipment, gross351,730 351,562 
Accumulated depreciation(298,618)(304,955)
Property and Equipment, net$53,112 $46,607 

Machinery and equipment includes demonstration units placed in provider locations which are depreciated to their estimated recoverable values over their estimated useful lives. In the fourth quarter of 2019, the company initiated the first stage of an Enterprise Resource Planning ("ERP") software implementation. As a result of the initiation of the ERP project, the company capitalized certain costs in accordance with ASC 350 as shown in capitalized software above.













In the third quarter of 2018, the company agreed to sell its Isny, Germany location with a net book value at the signing of the agreement of approximately $2,900,000, which is included in Land, buildings and improvements in the table above as of December 31, 2019. In accordance with the agreement, control transferred to the buyer in April 2020. The company recorded a gain on the transaction of $971,000.
XML 34 R14.htm IDEA: XBRL DOCUMENT v3.20.2
Goodwill
 9 Months Ended
Sep. 30, 2020
Goodwill and Intangible Assets Disclosure [Abstract]  
Goodwill
Goodwill
The change in goodwill from December 31, 2019 to September 30, 2020 was due to foreign currency translation.

In accordance with Intangibles—Goodwill and Other, ASC 350, goodwill is tested annually for impairment. The company first estimates the fair value of each reporting unit and compares the calculated fair value to the carrying value of each reporting unit. A reporting unit is defined as an operating segment or one level below. The company has determined that its reporting units are North America / HME, Europe, Institutional Products Group and Asia Pacific.

In consideration of the negative impact of COVID-19 on the global economy, the company performed an interim test of
goodwill for impairment in the first quarter of 2020 and no impairment was recorded. For the second and third quarters of 2020, the company concluded that the facts and circumstances driving the conclusions from the first quarter review had not changed materially. While there was no indication of impairment in the second or third quarter of 2020 related to goodwill for the Europe or Institutional Products Group reporting units, a future potential impairment is possible for these reporting units should actual results differ materially from the company's current forecasted results or market inputs used to determine the discount rate change significantly. Please refer to Goodwill in the company's Annual Report on Form 10-K for the period ending December 31, 2019 for further disclosure regarding the company's impairment analysis review methodology.
XML 35 R15.htm IDEA: XBRL DOCUMENT v3.20.2
Intangibles
 9 Months Ended
Sep. 30, 2020
Goodwill and Intangible Assets Disclosure [Abstract]  
Other Intangibles
Intangibles

The company's intangibles consist of the following (in thousands):
 
 September 30, 2020December 31, 2019
 Historical
Cost		Accumulated
Amortization		Historical
Cost		Accumulated
Amortization
Customer lists$54,267 $54,267 $51,108 $51,108 
Trademarks25,019 — 23,479 — 
Developed technology7,918 7,150 7,483 6,642 
Patents5,514 5,514 5,521 5,521 
License agreements2,864 891 2,884 770 
Other1,161 1,151 1,163 1,150 
Intangibles$96,743 $68,973 $91,638 $65,191 

All the company’s intangible assets have been assigned definite lives and continue to be amortized over their useful lives, except for trademarks shown above, which have indefinite lives. The changes in intangible balances reflected on the balance sheet from December 31, 2019 to September 30, 2020 were the result of foreign currency translation and amortization.

The company evaluates the carrying value of definite-lived assets annually in the fourth quarter and whenever events or circumstances indicate possible impairment. In consideration of the negative impact of COVID-19 on the global economy, the company performed a review of intangibles for impairment in the first quarter of 2020 and concluded there was no impairment to be recorded. For the second and third quarters of 2020, the company concluded that the facts and circumstances driving the conclusions from the first quarter review had not changed materially. Definite-lived assets are determined to be impaired if the future undiscounted cash flows expected to be generated by the asset are less than the carrying value. Actual impairment amounts for definite-
lived assets are then calculated using a discounted cash flow calculation.

Any impairment amounts for indefinite-lived assets are calculated as the difference between the future discounted cash flows expected to be generated by the asset less than the carrying value for the asset.

Amortization expense related to intangibles was $276,000 in the first nine months of 2020 and is expected to be $419,000 in 2020, $390,000 in 2021, $390,000 in 2022, $389,000 in 2023, $355,000 in 2024 and $212,000 in 2025. Amortized intangibles are being amortized on a straight-line basis over remaining lives of 1 to 10 years with most of the intangibles being amortized over an average remaining life of approximately 8 years.
XML 36 R16.htm IDEA: XBRL DOCUMENT v3.20.2
Accrued Expenses
 9 Months Ended
Sep. 30, 2020
Payables and Accruals [Abstract]  
Accrued Expenses
Accrued Expenses

Accrued expenses consist of accruals for the following (in thousands):
September 30, 2020December 31, 2019
Salaries and wages$34,612 $29,725 
Taxes other than income taxes, primarily Value Added Taxes29,830 22,194 
Warranty11,144 11,626 
Professional8,481 6,869 
Severance5,988 7,023 
Interest4,663 3,608 
Rebates4,146 10,743 
IT service contracts3,790 6,125 
Freight3,710 3,744 
Deferred revenue3,436 3,173 
Derivative liabilities (foreign currency forward exchange contracts)2,824 905 
Product liability, current portion2,810 2,736 
Insurance781 699 
Rent568 415 
Supplemental Executive Retirement Program liability391 391 
Advance payment on sale of land & buildings— 3,471 
IT licenses— 2,114 
Other items, principally trade accruals7,492 5,386 
Accrued Expenses$124,666 $120,947 

Generally, the company's products are covered by warranties against defects in material and workmanship for various periods depending on the product from the date of sales to the customer. Certain components carry a lifetime warranty. A provision for estimated warranty cost is recorded at the time of sale based upon actual experience. In addition, the company has sold extended warranties that, while immaterial, require the company to defer the revenue associated with those warranties until earned. The company has established procedures to appropriate defer such revenue. The company continuously assesses the adequacy of its product warranty accrual and makes adjustments as needed. Historical analysis is primarily used to determine the company's warranty reserves. Claims history is reviewed and provisions are adjusted as needed. However, the company does consider other events, such as a product field action and recalls, which could require additional warranty reserve provision.





Accrued rebates relate to several volume incentive programs the company offers its customers. The company accounts for these rebates as a reduction of revenue when the products are sold. Rebates are netted against gross accounts receivables. If rebates are in excess of such receivables, they are then classified as accrued expenses. The reduction in accrued rebates from December 31, 2019 to September 30, 2020 primarily relates to payments principally made in the first quarter each year.

In the fourth quarter of 2019, the company entered into an agreement with an IT provider to outsource substantially all of the company’s information technology business service activities, including, among other things, support, rationalization and upgrading of the company’s legacy information technology systems and implementation of a global enterprise resource planning (“ERP”) system. Accrued expenses related to IT outsourcing are reflected in IT service contracts. Separately, the company entered into licenses for a new ERP system which are shown as IT licenses.


The following is a reconciliation of the changes in accrued warranty costs for the reporting period (in thousands):
Balance as of January 1, 2020$11,626 
Warranties provided during the period4,311 
Settlements made during the period(5,926)
Changes in liability for pre-existing warranties during the period, including expirations1,133 
Balance as of September 30, 2020$11,144 
Warranty reserves are subject to adjustment in future periods as new developments change the company's estimate of the total cost. In the third quarter of 2020, warranty expense includes a provision of $768,000 for a product recall which was related to a component on a respiratory product, recorded in the North America segment.
XML 37 R17.htm IDEA: XBRL DOCUMENT v3.20.2
Long-Term Debt
 9 Months Ended
Sep. 30, 2020
Debt Disclosure [Abstract]  
Debt and Capital Leases Disclosures
Debt consists of the following (in thousands):
September 30, 2020December 31, 2019
Convertible senior notes at 5.00%, due in February 2021$1,224 $56,628 
Convertible senior notes at 4.50%, due in June 202272,652 101,815 
Convertible senior notes Series I at 5.00%, due in November 202462,443 60,817 
Convertible senior notes Series II at 5.00%, due November 202463,556 — 
Other obligations42,389 262 
242,264 219,522 
Less current maturities of long-term debt(4,062)(58)
Long-Term Debt$238,202 $219,464 

On September 30, 2015, the company entered into an Amended and Restated Revolving Credit and Security Agreement, which was subsequently amended (the “Credit Agreement”) and which matures on January 16, 2024. The Credit Agreement was entered into by and among the company, certain of the company’s direct and indirect U.S. and Canadian subsidiaries and certain of the company’s European subsidiaries (together with the company, the “Borrowers”), certain other of the company’s direct and indirect U.S., Canadian and European subsidiaries (the “Guarantors”), and PNC Bank, National Association (“PNC”), JPMorgan Chase Bank, N.A., J.P. Morgan Europe Limited, KeyBank National Association, and Citizens Bank, National Association (the “Lenders”). PNC is the administrative agent (the “Administrative Agent”) and J.P. Morgan Europe Limited is the European agent (the “European Agent”) under the Credit Agreement. In connection with entering into the company's Credit Agreement, the company incurred fees which were capitalized and are being amortized as interest expense. As of September 30, 2020, debt fees yet to be amortized through January 2024 totaled $670,000.

The company had outstanding letters of credit of $7,740,000 and $8,011,000 as of September 30, 2020 and December 31, 2019, respectively. Outstanding letters of credit and other reserves impacting borrowing capacity were $7,653,000 and $8,827,000 as of September 30, 2020 and December 31, 2019, respectively. The company had outstanding borrowings of $23,700,000 under its U.S. and Canadian Credit Facility as of September 30, 2020. The company had outstanding borrowings of $6,322,000 (€5,300,000) under its French Credit Facility and $2,138,000 (£1,600,000) under its UK Credit Facility as of September 30, 2020, together referred to as the European Credit Facility. The company had no borrowings under the Credit Facilities as of December 31, 2019. The weighted average interest rate on all borrowings, excluding financing leases, was 4.63% for the
nine months ended September 30, 2020 and 4.78% for the year ended December 31, 2019.

U.S. and Canadian Borrowers Credit Facility

For the company's U.S. and Canadian Borrowers, the Credit Agreement provides for an asset-based-lending senior secured revolving credit facility which is secured by substantially all the company’s U.S. and Canadian assets, other than real estate. The Credit Agreement provides the company and the other Borrowers with a credit facility in an aggregate principal amount of $60,000,000, subject to availability based on a borrowing base formula, under a senior secured revolving credit, letter of credit and swing line loan facility (the “U.S. and Canadian Credit Facility”). Up to $20,000,000 of the U.S. and Canadian Credit Facility will be available for issuance of letters of credit. The aggregate principal amount of the U.S. and Canadian Credit Facility may be increased by up to $25,000,000 to the extent requested by the company and agreed to by any Lender or new financial institution approved by the Administrative Agent.

The aggregate borrowing availability under the U.S. and Canadian Credit Facility is determined based on a borrowing base formula. The aggregate usage under the U.S. and Canadian Credit Facility may not exceed an amount equal to the sum of (a) 85% of eligible U.S. accounts receivable plus (b) the lesser of (i) 70% of eligible U.S. inventory and eligible foreign in-transit inventory and (ii) 85% of the net orderly liquidation value of eligible U.S. inventory and eligible foreign in-transit inventory (not to exceed $4,000,000), plus (c) the lesser of (i) 85% of the net orderly liquidation value of U.S. eligible machinery and equipment and (ii) $0 as of September 30, 2020 (subject to reduction as provided in the Credit Agreement), plus (d) 85% of eligible Canadian accounts receivable, plus (e) the lesser of (i) 70% of eligible Canadian inventory and (ii) 85% of the net orderly liquidation value of eligible Canadian inventory, less (f) swing loans
outstanding under the U.S. and Canadian Credit Facility, less (g) letters of credit issued and undrawn under the U.S. and Canadian Credit Facility, less (h) a $3,000,000 minimum availability reserve, less (i) other reserves required by the Administrative Agent, and in each case subject to the definitions and limitations in the Credit Agreement. As of September 30, 2020, the company was in compliance with all covenant requirements. As of September 30, 2020, the company had gross borrowing availability of $23,700,000 under the U.S. and Canadian Credit Facility under the Credit Agreement, considering the minimum availability reserve, then-outstanding letters of credit, other reserves and the $7,500,000 dominion trigger amount described below. Borrowings under the U.S. and Canadian Credit Facility are secured by substantially all of the company’s U.S. and Canadian assets, other than real estate.

Interest will accrue on outstanding indebtedness under the Credit Agreement at the LIBOR rate, plus a margin ranging from 2.25% to 2.75%, or at the alternate base rate, plus a margin ranging from 1.25% to 1.75%, as selected by the company. Borrowings under the U.S. and Canadian Credit Facility are subject to commitment fees of 0.25% or 0.375% per year, depending on utilization.

The Credit Agreement contains customary representations, warranties and covenants. Exceptions to the operating covenants in the Credit Agreement provide the company with flexibility to, among other things, enter into or undertake certain sale and leaseback transactions, dispositions of assets, additional credit facilities, sales of receivables, additional indebtedness and intercompany indebtedness, all subject to limitations set forth in the Credit Agreement, as amended. The Credit Agreement also contains a covenant requiring the company to maintain minimum availability under the U.S. and Canadian Credit Facility of not less than the greater of (i) 11.25% of the maximum amount that may be drawn under the U.S. and Canadian Credit Facility for five (5) consecutive business days, or (ii) $6,000,000 on any business day. The company also is subject to dominion triggers under the U.S. and Canadian Credit Facility requiring the company to maintain borrowing capacity of not less than $7,500,000 on any business day in order to avoid triggering full control by an agent for the Lenders of the company's cash receipts for application to the company’s obligations under the agreement.

The Credit Agreement contains customary default provisions, with certain grace periods and exceptions, which provide for events of default that include, among other things, failure to pay amounts due, breach of covenants, representations or warranties, bankruptcy, the occurrence of a material adverse effect, exclusion from any medical reimbursement program, and an interruption of any material manufacturing facilities for more than 10 consecutive days.
There was $23,700,000 outstanding under the U.S. and Canadian Credit Facility at September 30, 2020.

European Credit Facility

The Credit Agreement also provides for a revolving credit, letter of credit and swing line loan facility which gives the company and the European Borrowers the ability to borrow up to an aggregate principal amount of $30,000,000, with a $5,000,000 sublimit for letters of credit and a $2,000,000 sublimit for swing line loans (the “European Credit Facility”). Up to $15,000,000 of the European Credit Facility will be available to each of Invacare Limited (the “UK Borrower”) and Invacare Poirier SAS (the “French Borrower” and, together with the UK Borrower, the “European Borrowers”). The European Credit Facility matures in January 2024, together with the U.S. and Canadian Credit Facility.

The aggregate borrowing availability for each European Borrower under the European Credit Facility is determined based on a borrowing base formula. The aggregate borrowings of each of the European Borrowers under the European Credit Facility may not exceed an amount equal to (a) 85% of the European Borrower’s eligible accounts receivable, less (b) the European Borrower’s borrowings and swing line loans outstanding under the European Credit Facility, less (c) the European Borrower’s letters of credit issued and undrawn under the European Credit Facility, less (d) a $3,000,000 minimum availability reserve, less (e) other reserves required by the European Agent, and in each case subject to the definitions and limitations in the Credit Agreement. As of September 30, 2020, the gross borrowing availability to the European Borrowers under the European Credit Facility was $8,564,000, considering the $3,000,000 minimum availability reserve and the $3,750,000 dominion trigger amount described below.

The aggregate principal amount of the European Credit Facility may be increased by up to $10,000,000 to the extent requested by the company and agreed to by any Lender or Lenders that wish to increase their lending participation or, if not agreed to by any Lender, a new financial institution that agrees to join the European Credit Facility and that is approved by the Administrative Agent and the European Agent.

Interest will accrue on outstanding indebtedness under the European Credit Facility at the LIBOR rate, plus a margin ranging from 2.50% to 3.00%, or for swing line loans, at the overnight LIBOR rate, plus a margin ranging from 2.50% to 3.00%, as selected by the company. The margin that will be adjusted quarterly based on utilization. Borrowings under the European Credit Facility are subject to commitment fees of 0.25% or 0.375% per year, depending on utilization.
The European Credit Facility is secured by substantially all the personal property assets of the UK Borrower and its in-country subsidiaries, and all the receivables of the French Borrower and its in-country subsidiaries. The UK and French facilities (which comprise the European Credit Facility) are cross collateralized, and the US personal property assets previously pledged under the U.S. and Canadian Credit Facility also serve as collateral for the European Credit Facility.

The European Credit Facility is subject to customary representations, warranties and covenants generally consistent with those applicable to the U.S. and Canadian Credit Facility. Exceptions to the operating covenants in the Credit Agreement provide the company with flexibility to, among other things, enter into or undertake certain sale/leaseback transactions, dispositions of assets, additional credit facilities, sales of receivables, additional indebtedness and intercompany indebtedness, all subject to limitations set forth in the Credit Agreement. The Credit Agreement also contains a covenant requiring the European Borrowers to maintain undrawn availability under the European Credit Facility of not less than the greater of (i) 11.25% of the maximum amount that may be drawn under the European Credit Facility for five (5) consecutive business days, or (ii) $3,000,000 on any business day. The European Borrowers also are subject to cash dominion triggers under the European Credit Facility requiring the European Borrower to maintain borrowing capacity of not less than $3,750,000 on any business day in order to avoid triggering full control by an agent for the Lenders of the European Borrower’s cash receipts for application to its obligations under the European Credit Facility.

The European Credit Facility is subject to customary default provisions, with certain grace periods and exceptions, consistent with those applicable to the U.S. and Canadian Credit Facility, which provide that events of default include, among other things, failure to pay amounts due, breach of covenants, representations or warranties, cross-default, bankruptcy, the occurrence of a material adverse effect, exclusion from any medical reimbursement program, and an interruption in the operations of any material manufacturing facility for more than 10 consecutive days. The proceeds of the European Credit Facility will be used to finance the working capital and other business needs of the company. As of September 30, 2020, the company had borrowings of $6,322,000 (€5,300,000) under its French Credit Facility and $2,138,000 (£1,600,000) under its UK Credit Facility as of September 30, 2020, together referred to as the European Credit Facility.

Convertible senior notes due 2021

In the first quarter of 2016, the company issued $150,000,000 aggregate principal amount of 5.00%
Convertible Senior Notes due 2021 (the “2021 notes”) in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act. The 2021 notes bear interest at a rate of 5.00% per year payable semi-annually in arrears on February 15 and August 15 of each year, beginning August 15, 2016. The 2021 notes will mature on February 15, 2021, unless repurchased or converted in accordance with their terms prior to such date. Prior to August 15, 2020, the 2021 notes were convertible only upon satisfaction of certain conditions and during certain periods, and thereafter, at any time until the close of business on the second scheduled trading day immediately preceding the maturity date. Prior to May 16, 2019, the 2021 notes were convertible, subject to certain conditions, into cash only. On May 16, 2019, the company obtained shareholder approval under applicable New York Stock Exchange rules such that conversion of the 2021 notes may be settled in cash, the company’s common shares or a combination of cash and the company’s common shares, at the company’s election. At September 30, 2020, $1,250,000 aggregate principal amount of the 2021 Notes remained outstanding, following the repurchase of $16,000,000 aggregate principal amount of 2021 Notes for cash in the third quarter of 2019, the exchange transactions completed in the fourth quarter of 2019 and the second quarter of 2020, as further discussed below, and the repurchases of $24,466,000 aggregate principal amount in the third quarter of 2020. The $24,466,000 repurchases in the third quarter of 2020, resulted in a $761,000 loss on debt extinguishment.

Holders of the 2021 notes may convert their 2021 notes at their option at any time prior to the close of business on the business day immediately preceding August 15, 2020 only under the following circumstances: (1) during any fiscal quarter commencing after March 31, 2016 (and only during such fiscal quarter), if the last reported sale price of the company’s Common Shares for at least 20 trading days (whether or not consecutive) during the period of 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding fiscal quarter is greater than or equal to 130% of the applicable conversion price for the 2021 notes on each applicable trading day; (2) during the five business day period after any 10 consecutive trading day period (the “measurement period”) in which the “trading price” (as defined in the Indenture) per one thousand U.S. dollar principal amount of 2021 notes for each trading day of such measurement period was less than 98% of the product of the last reported sale price of the company’s Common Shares and the applicable conversion rate for the 2021 notes on each such trading day; or (3) upon the occurrence of specified corporate events described in the Indenture. On or after August 15, 2020 until the close of business on the second scheduled trading day immediately preceding the maturity of the 2021 Notes, holders may convert their 2021 Notes, at the option of the holder, regardless of the foregoing circumstances.

Holders of the 2021 notes will have the right to require the company to repurchase all or some of their 2021 notes at 100% of their principal, plus any accrued and unpaid interest, upon the occurrence of certain fundamental changes. The initial conversion rate is 60.0492 common shares per $1,000 principal amount of 2021 notes (equivalent to an initial conversion price of approximately $16.65 per common share). Until the company received shareholder approval on May 16, 2019 authorizing it to elect to settle future conversions of the 2021 Notes in common shares, the company separately accounted for the conversion features as a derivative. The derivative was capitalized on the balance sheet as a long-term liability with adjustment to reflect fair value each quarter until the change to the conversion features as a result of the shareholder approval received on May 16, 2019 resulted in the termination of the derivative. The fair value of the convertible debt conversion liability at issuance was $34,480,000. The company recognized a loss of $2,210,000 for the nine months ended September 30, 2019 related to the convertible debt conversion liability.

In connection with the offering of the 2021 notes, the company entered into privately negotiated convertible note hedge transactions with two financial institutions (the “option counterparties”). These transactions cover, subject to customary anti-dilution adjustments, the number of the company’s common shares that will initially underlie the 2021 notes, and are expected generally to reduce the potential equity dilution, and/or offset any cash payments in excess of the principal amount due, as the case may be, upon conversion of the 2021 notes. The company evaluated the note hedges under the applicable accounting literature, including Derivatives and Hedging, ASC 815, and determined that the note hedges should be accounted for as derivatives. These derivatives were capitalized on the balance sheet as long-term assets and will be adjusted to reflect fair value each quarter. The fair value of the convertible note hedge assets at issuance was $27,975,000. The company recognized a gain of $2,852,000 for the nine months ended September 30, 2019 related to the convertible note hedge asset.

The company entered into separate, privately negotiated warrant transactions with the option counterparties at a higher strike price relating to the same number of the company’s common shares, subject to customary anti-dilution adjustments, pursuant to which the company sold warrants to the option counterparties. The warrants could have a dilutive effect on the company’s outstanding common shares and the company’s earnings per share to the extent that the price of the company’s common shares exceeds the strike price of those warrants. The initial strike price of the warrants is $22.4175 per share and is subject to certain adjustments under the terms of the warrant transactions. The company evaluated the warrants under the applicable accounting literature, including
Derivatives and Hedging, ASC 815, and determined that the warrants meet the definition of a derivative, are indexed to the company's own stock and should be classified in shareholder's equity. The amount paid for the warrants and capitalized in shareholder's equity was $12,376,000.

The net proceeds from the offering of the 2021 notes were approximately $144,034,000, after deducting fees and offering expenses of $5,966,000, which were paid in 2016. These debt issuance costs were capitalized and are being amortized as interest expense through February 2021. Debt issuance costs are presented on the balance sheet as a direct deduction from the carrying amount of the related debt liability. Approximately $5,000,000 of the net proceeds from the offering were used to repurchase the company’s common shares from purchasers of 2021 notes in the offering in privately negotiated transactions. A portion of the net proceeds from the offering were used to pay the cost of the convertible note hedge transactions (after such cost is partially offset by the proceeds to the company from the warrant transactions), with a net cost of $15,600,000.
The liability components of the 2021 notes consist of the following (in thousands):
September 30, 2020December 31, 2019
Principal amount of liability component$1,250 $61,091 
Unamortized discount(22)(3,916)
Debt fees(4)(547)
Net carrying amount of liability component$1,224 $56,628 

The unamortized discount of $22,000 is to be amortized through February 2021. The effective interest rate on the liability component was 11.1%. Non-cash interest expense of $261,000 and $1,767,000 was recognized for the three and nine months ended September 30, 2020, respectively, compared to $1,444,000 and $5,391,000 for the three and nine months ended September 30, 2019, respectively. Actual interest expense accrued was $241,000 and $1,617,000 for the three and nine months ended September 30, 2020, respectively, compared to $1,834,000 and $5,584,000 for the three and nine months ended September 30, 2019, respectively, based on the stated coupon rate of 5.0%. The 2021 notes were not convertible as of September 30, 2020 nor was the applicable conversion threshold met.

Convertible senior notes due 2022

In the second quarter of 2017, the company issued $120,000,000 aggregate principal amount of 4.50% Convertible Senior Notes due 2022 (the “2022 notes”) in a private offering to qualified institutional buyers pursuant to
Rule 144A under the Securities Act. The 2022 notes bear interest at a rate of 4.50% per year payable semi-annually in arrears on June 1 and December 1 of each year, beginning December 1, 2017. The 2022 notes will mature on June 1, 2022, unless repurchased or converted in accordance with their terms prior to such date. Prior to December 1, 2021, the 2022 notes will be convertible only upon satisfaction of certain conditions and during certain periods, and thereafter, at any time until the close of business on the second scheduled trading day immediately preceding the maturity date. Prior to May 16, 2019, the 2022 notes were convertible, subject to certain conditions, into cash only. On May 16, 2019, the company obtained shareholder approval under applicable New York Stock Exchange rules such that conversion of the 2022 notes may be settled in cash, the company’s common shares or a combination of cash and the company’s common shares, at the company’s election. At September 30, 2020, $81,500,000 aggregate principal amount of the 2022 Notes remained outstanding, following the exchange transactions completed in the second quarter of 2020, as further discussed below.

Holders of the 2022 notes may convert their 2022 notes at their option at any time prior to the close of business on the business day immediately preceding December 1, 2021 only under the following circumstances: (1) during any fiscal quarter commencing after September 30, 2017 (and only during such fiscal quarter), if the last reported sale price of the company’s Common Shares for at least 20 trading days (whether or not consecutive) during the period of 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding fiscal quarter is greater than or equal to 130% of the applicable conversion price for the 2022 notes on each applicable trading day; (2) during the five business day period after any 10 consecutive trading day period (the “measurement period”) in which the “trading price” (as defined in the Indenture) per one thousand U.S. dollar principal amount of 2022 notes for each trading day of such measurement period was less than 98% of the product of the last reported sale price of the company’s Common Shares and the applicable conversion rate for the 2022 notes on each such trading day; or (3) upon the occurrence of specified corporate events described in the Indenture. On or after December 1, 2021 until the close of business on the second scheduled trading day immediately preceding the maturity of the 2022 Notes, holders may convert their 2022 Notes, at the option of the holder, regardless of the foregoing circumstances.

Holders of the 2022 notes will have the right to require the company to repurchase all or some of their 2022 notes at 100% of their principal, plus any accrued and unpaid interest, upon the occurrence of certain fundamental changes. The initial conversion rate is 61.6095 common shares per $1,000 principal amount of 2022 notes (equivalent to an initial conversion price of approximately $16.23 per common share).
Until the company received shareholder approval on May 16, 2019 authorizing it to elect to settle future conversions of the 2022 Notes in common shares, the company separately accounted for the conversion features as a derivative. The derivative was capitalized on the balance sheet as a long-term liability with adjustment to reflect fair value each quarter until the change to the conversion features as a result of the shareholder approval received on May 16, 2019 resulted in the termination of the derivative. The fair value of the convertible debt conversion liability at issuance was $28,859,000. The company recognized a loss of $6,193,000 for the nine months ended September 30, 2019 related to the convertible debt conversion liability.

In connection with the offering of the 2022 notes, the company entered into privately negotiated convertible note hedge transactions with one financial institution (the “option counterparty”). These transactions cover, subject to customary anti-dilution adjustments, the number of the company’s common shares that will initially underlie the 2022 notes, and are expected generally to reduce the potential equity dilution, and/or offset any cash payments in excess of the principal amount due, as the case may be, upon conversion of the 2022 notes. The company evaluated the note hedges under the applicable accounting literature, including Derivatives and Hedging, ASC 815, and determined that the note hedges should be accounted for as derivatives. These derivatives were capitalized on the balance sheet as long-term assets and will be adjusted to reflect fair value each quarter. The fair value of the convertible note hedge assets at issuance was $24,780,000. The company recognized a gain of $6,748,000 for the nine months ended September 30, 2019 related to the convertible note hedge asset.

The company entered into separate, privately negotiated warrant transactions with the option counterparty at a higher strike price relating to the same number of the company’s common shares, subject to customary anti-dilution adjustments, pursuant to which the company sold warrants to the option counterparties. The warrants could have a dilutive effect on the company’s outstanding common shares and the company’s earnings per share to the extent that the price of the company’s common shares exceeds the strike price of those warrants. The initial strike price of the warrants is $21.4375 per share and is subject to certain adjustments under the terms of the warrant transactions. The company evaluated the warrants under the applicable accounting literature, including Derivatives and Hedging, ASC 815, and determined that the warrants meet the definition of a derivative, are indexed to the company's own shares and should be classified in shareholder's equity. The amount paid for the warrants and capitalized in shareholder's equity was $14,100,000.

The net proceeds from the offering of the 2022 notes were approximately $115,289,000, after deducting fees and offering
expenses of $4,711,000, which were paid in 2017. These debt issuance costs were capitalized and are being amortized as interest expense through June 2022. Debt issuance costs are presented on the balance sheet as a direct deduction from the carrying amount of the related debt liability. A portion of the net proceeds from the offering were used to pay the cost of the convertible note hedge transactions (after such cost is partially offset by the proceeds to the company from the warrant transactions), which net cost was $10,680,000.

The liability components of the 2022 notes consist of the following (in thousands):
September 30, 2020December 31, 2019
Principal amount of liability component$81,500 $120,000 
Unamortized discount(7,837)(16,027)
Debt fees(1,011)(2,158)
Net carrying amount of liability component$72,652 $101,815 

The unamortized discount of $7,837,000 is to be amortized through June 2022. The effective interest rate on the liability component was 10.9%. Non-cash interest expense of $1,046,000 and $3,829,000 was recognized for the three and nine months ended September 30, 2020, respectively, compared to $1,320,000 and $4,038,000 for the three and nine months ended September 30, 2019, respectively. Actual interest expense accrued of $917,000 and $3,487,000 for the three and nine months ended September 30, 2020, respectively, compared to $1,350,000 and $4,050,000 for the three and nine months ended September 30, 2019, respectively, based on the stated coupon rate of 4.5%. The 2022 notes were not convertible as of September 30, 2020 nor was the applicable conversion threshold met.

Convertible senior notes Series I due 2024

During the fourth quarter of 2019, the company entered into separate privately negotiated agreements with certain holders of its 2021 Notes to exchange $72,909,000 in aggregate principal amount of 2021 Notes for aggregate consideration of $72,909,000 in aggregate principal amount of new 5.00% Convertible Senior Exchange Notes due 2024 (the “2024 Notes”) of the company and $6,928,000 in cash.

The notes bear interest at a rate of 5.00% per year payable semi-annually in arrears on May 15 and November 15 of each year, beginning May 15, 2020. The notes will mature on November 15, 2024, unless repurchased, redeemed or converted in accordance with their terms prior to such date. Prior to May 15, 2024, the 2024 notes will be convertible only upon satisfaction of certain conditions and during certain periods, and thereafter, at any time until the close of business
on the second scheduled trading day immediately preceding the maturity date. The 2024 notes may be settled in cash, the company’s common shares or a combination of cash and the company’s common shares, at the company’s election.

Prior to the maturity of the 2024 Notes, the company may, at its election, redeem for cash all or part of the 2024 Notes if the last reported sale price of the company’s common shares equals or exceeds 130% of the conversion price then in effect for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading day period (including the last trading day of such period) ending on, and including, the trading day immediately preceding the date on which the company provides notice of redemption. The redemption price will be equal to 100% of the principal amount of the 2024 Notes to be redeemed, plus accrued and unpaid interest to, but excluding, the redemption date (subject to certain limited exceptions). No sinking fund is provided for the 2024 Notes, which means the company is not required to redeem or retire the 2024 Notes periodically.

Holders of the 2024 notes may convert their 2024 notes at their option at any time prior to the close of business on the business day immediately preceding May 15, 2024 only under the following circumstances: (1) during any calendar quarter commencing after the calendar quarter ending December 31, 2019 (and only during such calendar quarter), if the last reported sale price of the company’s Common Shares for at least 20 trading days (whether or not consecutive) during the period of 30 consecutive trading days ending on the last trading day of the immediately preceding calendar quarter is greater than or equal to 130% of the conversion price for the 2024 notes on each applicable trading day; (2) during the five business day period after any 10 consecutive trading day period (the “measurement period”) in which the “trading price” (as defined in the Indenture) per one thousand U.S. dollar principal amount of 2024 notes for each trading day of such measurement period was less than 98% of the product of the last reported sale price of the company’s Common Shares and the applicable conversion rate for the 2024 notes on each such trading day; (3) upon the occurrence of specified corporate events described in the Indenture; or (4) if the company calls the 2024 Notes for redemption pursuant to the terms of the Indenture. Holders of the 2024 notes will have the right to require the company to repurchase all or some of their 2024 notes at 100% of their principal, plus any accrued and unpaid interest, upon the occurrence of certain fundamental changes. The initial conversion rate is 67.6819 common shares per $1,000 principal amount of 2024 notes (equivalent to an initial conversion price of approximately $14.78 per common share). On or after May 15, 2024 until the close of business on the second scheduled trading day immediately preceding the maturity of the 2024 Notes, holders may convert their 2024 Notes, at the option of the holder, regardless of the foregoing circumstances.

A loss of $5,885,000 was recorded a part of the exchange transaction, which included the write-off of fees related to the portion of the 2021 note exchanged. Debt issuance costs of $1,394,000 were capitalized and are being amortized as interest expense through November 15. Debt issuance costs are presented on the balance sheet as a direct deduction from the carrying amount of the related debt liability.
The liability components of the 2024 notes consist of the following (in thousands):
September 30, 2020December 31, 2019
Principal amount of liability component$72,909 $72,909 
Unamortized discount(9,363)(10,733)
Debt fees(1,103)(1,359)
Net carrying amount of liability component$62,443 $60,817 

The unamortized discount of $9,363,000 is to be amortized through November 15, 2024. The effective interest rate on the liability component was 8.77%. Non-cash interest expense of $468,000 and $1,370,000 was recognized for the three and nine months ended September 30, 2020, respectively. Actual interest expense accrued $912,000 and $2,735,000 for the three and nine months ended September 30, 2020, respectively, based on the stated coupon rate of 5.0%. The 2024 notes were not convertible as of September 30, 2020 nor was the applicable conversion threshold met.


Convertible senior notes Series II due 2024

During the second quarter of 2020, the company entered into separate, privately negotiated agreements with certain holders of its 2021 Notes and certain holders of its 2022 Notes to exchange $35,375,000 in aggregate principal amount of 2021 Notes and $38,500,000 in aggregate principal amount of 2022 notes, for aggregate consideration of $73,875,000 in aggregate principal amount of new 5.00% Series II Convertible Senior Exchange Notes due 2024 (the “Series II Notes”) of the company and $5,593,000 in cash.

The notes bear interest at a rate of 5.00% per year, payable semi-annually in arrears on May 15 and November 15 of each year, beginning November 15, 2020. The notes will mature on November 15, 2024, unless repurchased, redeemed or converted in accordance with their terms prior to such date. Prior to May 15, 2024, the Series II Notes will be convertible only upon satisfaction of certain conditions and during certain periods, and thereafter, at any time until the close of business on the second scheduled trading day immediately preceding the maturity date. The Series II Notes may be settled in cash,
the company’s common shares or a combination of cash and the company’s common shares, at the company’s election.

Prior to the maturity of the Series II Notes, the company may, at its election, redeem for cash all or part of the Series II Notes, if the last reported sale price of the company’s common shares equals or exceeds 130% of the conversion price then in effect for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading day period (including the last trading day of such period) ending on, and including, the trading day immediately preceding the date on which the company provides notice of redemption. The redemption price will be equal to 100% of the accreted principal amount of the Series II Notes to be redeemed, plus any accrued and unpaid interest, if any, on the original principal amount of the New Notes redeemed to, but excluding, the redemption date (subject to certain limited exceptions). No sinking fund is provided for the Series II Notes, which means the company is not required to redeem or retire the Series II Notes periodically.

Holders of the Series II notes may convert their Series II notes at their option at any time prior to the close of business on the business day immediately preceding May 15, 2024 only under the following circumstances: (1) during any calendar quarter commencing after the calendar quarter ending June 30, 2020 (and only during such calendar quarter), if the last reported sale price of the company’s Common Shares for at least 20 trading days (whether or not consecutive) during the period of 30 consecutive trading days ending on the last trading day of the immediately preceding calendar quarter is greater than 130% of the conversion price for the Series II notes on each applicable trading day; (2) during the five business day period after any 10 consecutive trading day period (the “measurement period”) in which the “trading price” (as defined in the Indenture) per one thousand U.S. dollar principal amount of Series II notes for each trading day of such measurement period was less than 98% of the product of the last reported sale price of the company’s Common Shares and the applicable conversion rate for the Series II notes on each such trading day; (3) upon the occurrence of specified corporate events described in the Indenture; or (4) if the company calls the Series II Notes for redemption pursuant to the terms of the Indenture. Holders of the Series II notes will have the right to require the company to repurchase all or some of their Series II at 100% of the accreted principal amount, plus any accrued and unpaid interest, upon the occurrence of certain fundamental changes. The initial conversion rate is 67.6819 common shares per $1,000 principal amount of Series II Notes (equivalent to an initial conversion price of approximately $14.78 per common share). On or after May 15, 2024 until the close of business on the second scheduled trading day immediately preceding the maturity of the Series II, holders may convert their Series II, at
the option of the holder, regardless of the foregoing circumstances.

The principal amount of the Series II Notes also will accrete at a rate of approximately 4.7% per year commencing June 4, 2020, compounding on a semi-annual basis. The accreted portion of the principal is payable in cash upon maturity but does not bear interest and is not convertible into the company’s common shares. The amount accreted as of September 30, 2020 was $1,016,000.

A loss of $6,599,000 was recorded a part of the exchange transaction, which included the write-off of fees related to portions of the 2021 and 2022 note exchanged. Debt issuance costs of $1,518,000 were capitalized and are being amortized as interest expense through November 2024. Debt issuance costs are presented on the balance sheet as a direct deduction from the carrying amount of the related debt liability.

The liability components of the Series II Notes consist of the following (in thousands):
September 30, 2020
Principal amount of liability component - including accretion$74,891 
Unamortized discount(9,967)
Debt fees(1,368)
Net carrying amount of liability component$63,556 

The unamortized discount of $9,967,000 is to be amortized through November 15, 2024. The effective interest rate on the liability component was 8.99%. Non-cash interest expense, including accretion, of $1,260,000 and $1,663,000 was recognized for the three and nine months ended September 30, 2020, respectively. Actual interest expense accrued of $923,000 and $1,200,000 for the three and nine months ended September 30, 2020, respectively, based on the stated coupon rate of 5.0%. The 2024 notes were not convertible as of June 30, 2020 nor was the applicable conversion threshold met.

CARES Act Loan

On May 15, 2020 the company entered into an unsecured loan agreement in the aggregate amount of $10,000,000 pursuant to sections 1102 and 1106 of the Coronavirus Aid, Relief and Economic Security, "CARES," Act which was evidenced by a promissory note, dated May 13, 2020, and bears interest at a fixed rate of 1.00%, payable in monthly payments commencing on December 13, 2020. Payments were subsequently deferred to commence on March 13, 2021. This loan may be forgivable, partially or in full, if certain conditions are met, principally based on having been disbursed
for permissible purposes and based on average levels of employment over a designated period of time. No assurance can be given that the company will be granted forgiveness of the loan in whole or in part. The company has recorded $2,816,000 of the amount borrowed in current maturities of long term debt.
XML 38 R18.htm IDEA: XBRL DOCUMENT v3.20.2
Other Long-Term Obligations
 9 Months Ended
Sep. 30, 2020
Other Liabilities Disclosure [Abstract]  
Other Long-Term Obligations
Other Long-Term Obligations


Other long-term obligations consist of the following (in thousands):
September 30, 2020December 31, 2019
Deferred income taxes$24,223 $23,376 
Product liability13,545 13,414 
Pension 7,586 7,006 
Deferred gain on sale leaseback5,582 5,819 
Deferred compensation5,318 5,354 
Supplemental Executive Retirement Plan liability5,245 5,433 
Uncertain tax obligation including interest2,660 2,612 
Other6,589 3,935 
Other Long-Term Obligations$70,748 $66,949 

On April 23, 2015, the company entered into a real estate sale leaseback transaction which resulted in the company recording an initial deferred gain of $7,414,000, the majority of which is included in Other Long-Term Obligations and will be recognized over the 20-year life of the leases. The gains realized were $77,000 and $228,000 for the for the three and nine months ended September 30, 2020, respectively, compared to $74,000 and $220,000 for the three and nine months ended September 30, 2019, respectively.
XML 39 R19.htm IDEA: XBRL DOCUMENT v3.20.2
Leases and Commitments (Notes)
 9 Months Ended
Sep. 30, 2020
Leases [Abstract]  
Leases of Lessee Disclosure [Text Block]
Leases and Commitments

The company reviews new contracts in accordance with ASU 2016-02, "Leases" to determine if the contracts include a lease. To the extent a lease agreement includes an extension option that is reasonably certain to be exercised, the company has recognized those amounts as part of the right-of-use assets and lease liabilities. The company combines lease and non-lease components, such as common area maintenance, in the calculation of the lease assets and related liabilities. As most lease agreements do not provide an implicit rate, the company uses an incremental borrowing rate (IBR) based on information available at commencement date in determining the present value of lease payments and to help classify the lease as operating or financing. The company calculates its IBR based on the secured rates of the company's recent debt issuances, the credit rating of the company, changes in currencies, lease repayment timing as well as other publicly available data.

The company leases a portion of its facilities, transportation equipment, data processing equipment and certain other equipment. These leases have terms from 1 to 20 years and provide for renewal options. Generally, the company is required to pay taxes and normal expenses associated with operating the facilities and equipment. As of September 30, 2020, the company is committed under non-cancelable operating leases, which have initial or remaining terms in excess of one year and expire on various dates through 2035.

On April 23, 2015, the company sold and leased back, under four separate lease agreements, four properties located in Ohio and one property in Florida for net proceeds of $23,000,000, which were used to reduce debt under the U.S. and Canadian Credit Facility. The initial total annual rent for the properties was $2,275,000 and can increase annually over the 20-year term of the leases based on the applicable geographical consumer price index (CPI). Each of the four lease agreements contains three 10-year renewals with the rent for each option term based on the greater of the then-current fair market rent for each property or the then- current rate and increasing annually by the applicable CPI. Under the terms of the lease agreements, the company is responsible for all taxes, insurance and utilities. The company is permitted to sublet the properties; however, the properties are currently being utilized exclusively by the company and there is no current subletting. The company is required to adequately maintain each of the properties and any leasehold improvements will be amortized over the lesser of the lives of the improvements or the remaining lease lives, consistent with any other company leases.



In connection with the transaction, the requirements for sale lease-back accounting were met. Accordingly, the company recorded the sale of the properties, removed the related property and equipment from the company's balance sheet, recognized an initial deferred gain of $7,414,000 and an immediate loss of $257,000 related to one property and recorded new lease liabilities. Specifically, the company recorded four capital leases totaling $32,339,000 and one operating lease related to leased land, which was not a material component of the transaction. The gains on the sales of the properties were required to be deferred and recognized over the life of the leases as the property sold is being leased back. The deferred gain is classified under Other Long-Term Obligations on the condensed consolidated balance sheet. The gains realized were $77,000 and $228,000 for the three and nine months ended September 30, 2020, respectively, compared to $74,000 and $220,000 for the three and nine months ended September 30, 2019, respectively.

In December 2018, the company entered into a 20-year lease agreement in Germany. The lease commenced in July 2020. The lease increased the company's financing lease obligations by $36,916,000.
Lease expense for the three and nine months ended September 30, 2020 and September 30, 2019, respectively, were as follows (in thousands):
For the Three Months Ended September 30,For the Nine Months Ended September 30,
2020201920202019
Operating leases$1,926 $2,696 $6,210 $8,175 
Variable and short-term leases1,077 894 2,936 1,974 
Total operating leases$3,003 $3,590 $9,146 $10,149 
Finance lease interest cost$829 $346 $1,483 $977 
Finance lease depreciation980 706 2,346 1,957 
Total finance leases$1,809 $1,052 $3,829 $2,934 





Future minimum operating and finance lease commitments, as of September 30, 2020, are as follows (in thousands):
Finance 
Leases		Operating Leases
2020$1,873 $1,842 
20217,416 6,027 
20226,487 3,466 
20236,421 1,407 
20246,365 890 
Thereafter84,251 786 
Total future minimum lease payments112,813 14,418 
Amounts representing interest(45,511)(1,393)
Present value of minimum lease payments67,302 13,025 
Less: current maturities of lease obligations(3,352)(5,843)
Long-term lease obligations$63,950 $7,182 
Supplemental cash flow amounts for the nine months ended September 30, 2020 were as follows (in thousands):
Cash Activity: Cash paid in measurement of amounts for lease liabilitiesSeptember 30, 2020
Operating Leases$9,407 
Financing Leases3,429 
Total$12,836 
Non-Cash Activity: Right-of-use assets obtained in exchange for lease obligationsSeptember 30, 2020
Operating Leases$2,789 
Financing Leases39,942 
Total$42,731 



















Weighted-average remaining lease terms and discount rates for finance and operating leases are as follows as of September 30, 2020:
September 30, 2020
Weighted-average remaining lease term - finance leases17.2 years
Weighted-average remaining lease term - operating leases3.2 years
Weighted-average discount rate - finance leases6.32%
Weighted-average discount rate - operating leases7.74%
XML 40 R20.htm IDEA: XBRL DOCUMENT v3.20.2
Revenue Revenue
 9 Months Ended
Sep. 30, 2020
Revenue [Abstract]  
Revenue Recognition, Deferred Revenue [Policy Text Block]
Revenue

The company has two revenue streams: products and services. Services include repair, refurbishment, preventive maintenance and rental of product. Services for the North America segment include maintenance and repair of product. Services for the Europe segment include repair, refurbishment and preventive maintenance services. Services in All Other, are in the Asia Pacific region, and include rental and repair of product. The following tables disaggregate the company’s revenues by major source and by reportable segment for the three and nine months ended September 30, 2020 and September 30, 2019 (in thousands):
Three Months Ended September 30, 2020
ProductServiceTotal
Europe$113,043 $3,242 $116,285 
North America87,821 234 88,055 
Other (Asia/Pacific)6,428 1,138 7,566 
Total$207,292 $4,614 $211,906 
% Split98%2%100%
Nine Months Ended September 30, 2020
ProductServiceTotal
Europe$329,943 $9,204 $339,147 
North America260,999 596 261,595 
Other (Asia/Pacific)22,565 3,339 25,904 
Total$613,507 $13,139 $626,646 
% Split98%2%100%
Three Months Ended September 30, 2019
ProductServiceTotal
Europe$133,839 $3,532 $137,371 
North America86,761 357 87,118 
Other (Asia/Pacific)10,047 1,238 11,285 
Total$230,647 $5,127 $235,774 
% Split98%2%100%
Nine Months Ended September 30, 2019
ProductServiceTotal
Europe$386,007 $10,199 $396,206 
North America261,707 1,208 262,915 
Other (Asia/Pacific)32,242 3,688 35,930 
Total$679,956 $15,095 $695,051 
% Split98%2%100%
The company's revenues are principally related to the sale of products, approximately 98%, with the remaining 2% related to services including repair, refurbishment, preventive maintenance and rental of product. While the company has a significant amount of contract types, the sales split by contract type is as follows: general terms and conditions (31%), large national customers (26%), governments, principally pursuant to tender contracts (20%) and other customers including buying groups and independent customers (23%).

All product and substantially all service revenues are recognized at a point in time. The remaining service revenue, recognized over time, are reflected in the Europe segment and include multiple performance obligations. For such contracts, the company allocates revenue to each performance obligation based on its relative standalone selling price. The company generally determines the standalone selling price based on the expected cost-plus margin methodology.    

Revenue is recognized when obligations under the terms of a contract with the customer are satisfied; generally, this occurs with the transfer of control of the company’s products and services. Revenue is measured as the amount of consideration expected to be received in exchange for transferring product or providing services. The amount of consideration received and revenue recognized by the company can vary as a result of variable consideration terms included in the contracts related to customer rebates, cash discounts and return policies. Customer rebates and cash discounts are estimated based on the most likely amount principle and these estimates are based on historical experience and anticipated performance. In addition, customers have the right to return product within the company’s normal terms policy, and as such the company estimates the expected returns based on an analysis of historical experience. The company adjusts its estimate of revenue at the earlier of when the most likely amount of consideration it expects to receive changes or when the consideration becomes fixed. The company generally does not expect that there will be significant changes to its estimates of variable consideration (see “Receivables” and "Accrued Expenses" in the Notes to the Condensed Consolidated Financial Statements include elsewhere in this report for more detail).

Depending on the terms of the contract, the company may defer the recognition of a portion of the revenue at the end of a reporting period to align with transfer of control of the company’s products to the customer. In addition, to the extent performance obligations are satisfied over time, the company defers revenue recognition until the performance obligations
are satisfied. As of September 30, 2020 and December 31, 2019, the company had deferred revenue of $3,436,000 and $3,173,000, respectively, related to outstanding performance obligations.
XML 41 R21.htm IDEA: XBRL DOCUMENT v3.20.2
Equity Compensation
 9 Months Ended
Sep. 30, 2020
Share-based Payment Arrangement [Abstract]  
Shareholders' Equity Transactions
Equity Compensation

The company’s Common Shares have a $0.25 stated value. The Common Shares and the Class B Common Shares generally have identical rights, terms and conditions and vote together as a single class on most issues, except that the Class B Common Shares have ten votes per share, carry a 10% lower cash dividend rate and, in general, can only be transferred to family members or for estate planning purposes. Holders of Class B Common Shares are entitled to convert their shares into Common Shares at any time on a share-for-share basis. When Class B Common Shares are transferred out of a familial relationship, they automatically convert to Common Shares. The Board of Directors suspended further dividends on the Common Shares and the Class B Common Shares.

As of September 30, 2020, 6,357 Class B Common Shares remained outstanding. Prior conversions of Class B Common Shares have substantially diminished the significance of the company’s dual class voting structure. As of September 30, 2020, the holders of the Common Shares represented approximately 99.9% of the company’s total outstanding voting power.

Equity Compensation Plan

On May 17, 2018, the shareholders of the company approved the Invacare Corporation 2018 Equity Compensation Plan (the “2018 Plan”), which was adopted on March 27, 2018 by the company's Board of Directors (the “Board”). The company’s Board adopted the 2018 Plan in order to authorize additional Common Shares for grant as equity compensation, and to reflect changes to Section 162(m) of the Internal Revenue Code (the “Code”) resulting from the U.S. Tax Cuts and Jobs Act of 2017.
Following shareholder approval of the 2018 Plan, all of the Common Shares then-remaining available for issuance under the Invacare Corporation 2013 Equity Compensation Plan (the “2013 Plan”) and all of the Common Shares that were forfeited or remained unpurchased or undistributed upon termination or expiration of awards under the 2013 Plan and under the Invacare Corporation 2003 Performance Plan (the “2003 Plan”), become available for issuance under the 2018 Plan. Awards granted previously under the 2013 Plan and 2003 Plan will remain in effect under their original terms.
The 2018 Plan uses a fungible share-counting method, under which each Common Share underlying an award of share options or share appreciation rights ("SAR") will count against the number of total shares available under the 2018 Plan as one share; and each Common Share underlying any award other than a share option or a SAR will count against
the number of total shares available under the 2018 Plan as two shares. Shares underlying awards made under the 2003 Plan or 2013 Plan that are forfeited or remain unpurchased or undistributed upon termination or expiration of the awards will become available under the 2018 Plan for use in future awards. Any Common Shares that are added back to the 2018 Plan as the result of forfeiture, termination or expiration of an award granted under the 2018 Plan or the 2013 Plan will be added back in the same manner such shares were originally counted against the total number of shares available under the 2018 Plan or 2013 Plan, as applicable. Each Common Share that is added back to the 2018 Plan due to a forfeiture, termination or expiration of an award granted under the 2003 Plan will be added back as one Common Share.
The Compensation and Management Development Committee of the Board (the “Compensation Committee”), in its discretion, may grant an award under the 2018 Plan to any director or employee of the company or an affiliate. As of September 30, 2020, 3,513,468 Common Shares were available for future issuance under the 2018 Plan in connection with the following types of awards with respect to the company's Common Shares: incentive share options, nonqualified share options, SARs, restricted shares, restricted share units, unrestricted shares and performance shares. The Compensation Committee also may grant performance units that are payable in cash. The Compensation Committee has the authority to determine which participants will receive awards, the amount of the awards and the other terms and conditions of the awards. The Common Shares authorized for issuance under the 2018 Plan includes an additional 1,400,000 Common Shares that were approved by shareholders at the company’s 2020 annual meeting on May 21, 2020.

In the second quarter of 2020 the company transferred a total of 1,004,079 shares into the 2018 Plan from the 2003 and 2013 Plans. At September 30, 2020, an aggregate of 328,274 Common Shares underlie awards which were forfeited or expired unexercised under the 2003 and 2013 Plans and thus are available to be transferred into the 2018 Plan.
The 2018 Plan provides that shares granted come from the company's authorized but unissued Common Shares or treasury shares. In addition, the company's equity compensation plans allow employee participants to exchange shares for minimum withholding taxes, which results in the company acquiring treasury shares.
The amounts of equity-based compensation expense recognized as part of SG&A expenses in All Other in business segments were as follows (in thousands):
For the Nine Months Ended September 30,
20202019
Restricted share / units$4,471 $3,891 
Performance shares / units2,494 1,648 
Non-qualified and performance share options— 334 
Total share-based compensation expense$6,965 $5,873 

As of September 30, 2020, unrecognized compensation expense related to equity-based compensation arrangements granted under the company's 2018 Plan and previous plans, which is related to non-vested shares, was as follows (in thousands):
September 30, 2020
Restricted share and restricted share units$8,443 
Performance shares and performance share units11,144 
Total unrecognized share-based compensation expense$19,587 



Total unrecognized compensation cost will be adjusted for future changes in actual and estimated forfeitures and for updated vesting assumptions for the performance share awards (see "Share Options" and "Performance Shares and Performance Share Units" below). No tax benefits for share-based compensation were realized during the three and nine months ended September 30, 2020 and 2019, respectively, due to a valuation allowance against deferred tax assets. In accordance with ASC 718, any tax benefits resulting from tax deductions in excess of the compensation expense recognized is classified as a component of financing cash flows.

Share Options

Generally, non-qualified share option awards have a term of ten years and were granted with an exercise price per share equal to the fair market value of one of the company’s Common Shares on the date of grant. Share option awards granted in 2017 were performance-based awards and became exercisable based upon achievement of performance goals established by the Compensation Committee and achieved over the three-year period ended in 2019 and were subject to the Compensation Committee's exercise of negative discretion to reduce the number of options vested based on the progress towards the company's transformation. The company recognized the compensation expense over a weighted-average period of approximately two years.
The following table summarizes information about share option activity for the nine months ended September 30, 2020:
Weighted Average
Exercise Price
Options outstanding at January 1, 20201,441,202 $18.26 
Canceled(354,006)24.88
Options outstanding at September 30, 20201,087,196 $16.12 
Options exercise price range at September 30, 2020$12.15 to$33.36 
Options exercisable at September 30, 20201,087,196 
Shares available for grant at September 30, 2020*3,513,468 
________
 *    Shares available for grant under the 2018 Plan as of September 30, 2020 reduced by net restricted share and restricted share unit award activity of 696,058 shares and performance share and performance share unit award activity of 1,859,054 shares.
The following table summarizes information about stock options outstanding at September 30, 2020:
 Options OutstandingOptions Exercisable
Exercise PricesNumber
Outstanding at
September 30, 2020		Weighted Average
Remaining
Contractual Life (Years)		Weighted Average
Exercise Price		Number
Exercisable at
September 30, 2020		Weighted Average
Exercise Price
$12.15 – $20.00
777,159 5.1$12.74 777,159 $12.73 
$20.01 – $25.00
300,149 0.924.45 300,149 24.45 
$25.01 – $30.00
5,392 0.227.82 5,392 27.82 
$30.01 – $33.36
4,496 0.633.36 4,496 33.36 
Total1,087,196 3.9$16.12 1,087,196 $16.12 

The 2018 Plan provides for a one-year minimum vesting period for share options and, generally, options must be exercised within ten years from the date granted. No share options were issued in 2020 or 2019. The performance-based options issued in 2017 vested after the conclusion of the three-year performance period ending December 31, 2019.

Restricted Share and Restricted Share Units

The following table summarizes information about restricted shares and restricted share units (primarily for non-U.S. recipients):
Weighted Average Fair Value
Shares / Units unvested at
January 1, 2020		965,085 $11.32 
Granted764,012 7.11 
Vested(452,922)11.47 
Canceled(94,993)10.19 
Shares / Units unvested at
September 30, 2020		1,181,182 $8.63 

The 2018 Plan provides for a one-year minimum vesting period for restricted share awards, the outstanding restricted share awards generally vest ratably over the three years after the award date. Unearned restricted share compensation, determined as the market value of the shares at the date of grant, is being amortized on a straight-line basis over the vesting period.












Performance Shares and Performance Share Units

The following table summarizes information about performance shares and performance share units (for non-U.S. recipients):
 Weighted Average Fair Value
Shares / Units unvested at January 1, 2020753,272 $11.82 
Granted523,329 7.08 
Canceled(65,976)9.48 
Shares / Units unvested at
September 30, 2020		1,210,625 $9.90 

During the nine months ended September 30, 2020, performance shares and performance share units (for non-U.S. recipients) were granted as performance awards with a three-year performance period with payouts based on achievement of certain performance goals. The awards are classified as equity awards as they will be settled in Common Shares upon vesting. The number of shares earned will be determined at the end of the three-year performance period based on achievement of performance criteria for January 1, 2020 through December 31, 2022 established by the Compensation Committee at the time of grant. Recipients will be entitled to receive a number of Common Shares equal to the number of performance shares that vest based upon the levels of achievement which may range between 0% and 150% of the target number of shares with the target being 100% of the initial grant.

The fair value of the performance awards is based on the share price on the date of grant discounted for the estimated value of dividends foregone as the awards are not eligible for dividends except to the extent vested. The company assesses the probability that the performance targets will be met with expense recognized whenever it is probable that at least the minimum performance criteria will be achieved. Depending upon the company's assessment of the probability of achievement of the goals, the company may not recognize any expense associated with performance awards in a given
period, may reverse prior expense recorded or record additional expense to make up for expense not recorded in a prior period. Performance award compensation expense is generally expected to be recognized over three years. Expense is being recognized for the 2018, 2019 and 2020 awards as it is considered probable that the performance goals for those awards will be met.
XML 42 R22.htm IDEA: XBRL DOCUMENT v3.20.2
Accumulated Other Comprehensive Income (Loss) by Component
 9 Months Ended
Sep. 30, 2020
Equity [Abstract]  
Accumulated Other Comprehensive Income (Loss) by Component
Accumulated Other Comprehensive Income (Loss) by Component

Changes in accumulated other comprehensive income ("OCI") (in thousands):
Foreign CurrencyLong-Term NotesDefined Benefit PlansDerivativesTotal
June 30, 2020$16,455 $(9,133)$(3,468)$794 $4,648 
OCI before reclassifications35,231 713 281 (2,501)33,724 
Amount reclassified from accumulated OCI— — (474)739 265 
Net current-period OCI35,231 713 (193)(1,762)33,989 
September 30, 2020$51,686 $(8,420)$(3,661)$(968)$38,637 
Foreign CurrencyLong-Term NotesDefined Benefit PlansDerivativesTotal
December 31, 2019$8,898 $(2,491)$(3,299)$20 $3,128 
OCI before reclassifications42,788 (5,929)122 (1,340)35,641 
Amount reclassified from accumulated OCI— — (484)352 (132)
Net current-period OCI42,788 (5,929)(362)(988)35,509 
September 30, 2020$51,686 $(8,420)$(3,661)$(968)$38,637 
Foreign CurrencyLong-Term NotesDefined Benefit PlansDerivativesTotal
June 30, 2019$13,122 $(2,200)$(2,778)$1,627 $9,771 
OCI before reclassifications(5,729)(3,328)(504)557 (9,004)
Amount reclassified from accumulated OCI— — 303 (860)(557)
Net current-period OCI(5,729)(3,328)(201)(303)(9,561)
September 30, 2019$7,393 $(5,528)$(2,979)$1,324 $210 
Foreign CurrencyLong-Term NotesDefined Benefit PlansDerivativesTotal
December 31, 2018$12,244 $2,662 $(2,703)$590 $12,793 
OCI before reclassifications(4,851)(8,190)(922)2,179 (11,784)
Amount reclassified from accumulated OCI— — 646 (1,445)(799)
Net current-period OCI(4,851)(8,190)(276)734 (12,583)
September 30, 2019$7,393 $(5,528)$(2,979)$1,324 $210 
Reclassifications out of accumulated OCI were as follows (in thousands):
Amount reclassified from OCIAffected line item in the Statement of Comprehensive (Income) Loss
For the Three Months Ended September 30,For the Nine Months Ended September 30,
2020201920202019
Defined Benefit Plans 
Service and interest costs$(474)$303 $(484)$646 Selling, general and administrative expenses
Tax— — — — Income tax provision
Total after tax$(474)$303 $(484)$646 
Derivatives
Foreign currency forward contracts hedging sales$(481)$(197)$(692)$(189)Net sales
Foreign currency forward contracts hedging purchases1,259 (747)1,029 (1,375)Cost of products sold
Total loss (income) before tax778 (944)337 (1,564)
Tax(39)84 15 119 Income tax provision (benefit)
Total after tax$739 $(860)$352 $(1,445)
XML 43 R23.htm IDEA: XBRL DOCUMENT v3.20.2
Charges Related To Restructuring Activities
 9 Months Ended
Sep. 30, 2020
Restructuring and Related Activities [Abstract]  
Charges Related To Restructuring Activities
Charges Related to Restructuring Activities

The company's restructuring charges were originally necessitated primarily by continued declines in Medicare and Medicaid reimbursement by the U.S. government, as well as similar healthcare reimbursement pressures abroad, which negatively affect the company's customers (e.g. home health care providers) and continued pricing pressures faced by the company due to the outsourcing by competitors to lower cost locations. Restructuring decisions were also the result of reduced profitability in North America and Asia Pacific. In addition, as a result of the company's transformation strategy, additional restructuring actions were implemented in 2017 and have continued into 2020.

For the nine months ended September 30, 2020, charges totaled $4,657,000 which were related to North America of $865,000, Europe of $3,674,000 and All Other of $118,000. In North America and All Other, costs were incurred related to severance. The European charges were for severance costs of $3,328,000 and contract terminations of $346,000 primarily related to the closure of a German manufacturing facility. Payments for the nine months ended September 30, 2020 were $5,692,000 and the cash payments were funded with the company's cash on hand. The 2020 charges are expected to be paid out within twelve months.
For the nine months ended September 30, 2019, charges totaled $3,641,000 which were related to North America of
$1,539,000, Europe of $1,903,000 and All Other of $199,000. In North America, costs were incurred related to severance of $1,495,000 and contract terminations of $44,000. The European and All Other charges were for severance costs. Payments for the nine months ended September 30, 2019 were $4,152,000 and the cash payments were funded with company's cash on hand. Most of the 2019 charges have been paid out.
There have been no material changes in accrued balances related to the charges, either as a result of revisions to the plans or changes in estimates. In addition, the savings anticipated as a result of the company's restructuring plans have been or are expected to be achieved, primarily resulting in reduced salary and benefit costs principally impacting Selling, General and Administrative expenses, and to a lesser extent, Costs of Products Sold. To date, the company's liquidity has not been materially impacted by the restructuring plans. Please refer to Charges Related to Restructuring Activities of company's Annual Report on Form 10-K for the period ending December 31, 2019 for disclosure of restructuring activity prior to 2020.
A progression by reporting segment of the accruals recorded as a result of the restructuring for the nine months ended September 30, 2020 is as follows (in thousands):
SeveranceContract TerminationsTotal
December 31, 2019 Balances
North America$211 $— $211 
Europe6,406 4 6,410 
All Other406 — 406 
Total7,023 4 7,027 
Charges
North America 691 — 691 
Europe592 73 665 
All Other36 — 36 
Total 1,319 73 1,392 
Payments
North America (562)— (562)
Europe (959)(73)(1,032)
All Other(276)— (276)
Total (1,797)(73)(1,870)
March 31, 2020 Balances
North America340 — 340 
Europe6,039 4 6,043 
All Other166 — 166 
Total$6,545 $4 $6,549 
Charges
North America$28 $— $28 
Europe1,302 273 1,575 
All Other82 — 82 
Total1,412 273 1,685 
Payments
North America(265)— (265)
Europe(1,596)(273)(1,869)
All Other(82)— (82)
Total(1,943)(273)(2,216)
June 30, 2020 Balances
North America103 — 103 
Europe5,745 4 5,749 
All Other166 — 166 
Total$6,014 $4 $6,018 
Charges
North America146 — 146 
Europe1,434 — 1,434 
All Other— — — 
Total1,580 — 1,580 
Payments
North America(151)— (151)
Europe(1,455)— (1,455)
All Other— — — 
Total(1,606)— (1,606)
SeveranceContract TerminationsTotal
September 30, 2020 Balances
North America98 — 98 
Europe5,724 4 5,728 
All Other166 — 166 
Total$5,988 $4 $5,992 
XML 44 R24.htm IDEA: XBRL DOCUMENT v3.20.2
Income Taxes
 9 Months Ended
Sep. 30, 2020
Income Tax Disclosure [Abstract]  
Income Taxes
Income Taxes

The company had an effective tax rate of 39.2% and 26.8% on losses before tax for the three and nine months ended September 30, 2020, respectively, compared to an expected benefit of 21.0% on the pre-tax loss for each period. The company had an effective tax rate of 69.6% and 26.8% on losses before tax for the three and nine months ended and September 30, 2019, respectively, compared to an expected benefit for the three and nine months ended September 30, 2019 of 21.0% on the pre-tax loss for each period. The company's effective tax rate for the three and nine months ended September 30, 2020 and September 30, 2019 were unfavorable as compared to the U.S. federal statutory rate expected benefit, principally due to the negative impact of the company not being able to record tax benefits related to the significant losses in countries which had tax valuation allowances. The effective tax rate was increased for the three and nine months ended September 30, 2020 and September 30, 2019 by certain taxes outside the United States, excluding countries with tax valuation allowances, that were at an effective rate higher than the U.S. statutory rate, except for the gain on the disposition of Dynamic Controls which was not taxable locally. In addition, the company had accrued withholding taxes on earnings of its Chinese subsidiary based on the expectation of not permanently reinvesting those earnings. The sale of this entity, without such distribution resulted in the reversal of this accrual in the amount of $988,000 for the nine months ended September 30, 2020.
XML 45 R25.htm IDEA: XBRL DOCUMENT v3.20.2
Net Earnings (Loss) Per Common Share
 9 Months Ended
Sep. 30, 2020
Earnings Per Share [Abstract]  
Net Earnings (Loss) Per Common Share Loss Per Common Share
The following table sets forth the computation of basic and diluted net loss per common share for the periods indicated.
(In thousands except per share data)For the Three Months Ended September 30,For the Nine Months Ended September 30,
2020201920202019
Basic
Weighted average common shares outstanding34,419 33,660 34,213 33,571 
Net loss$(7,276)$(8,041)$(23,163)$(34,644)
Net loss per common share$(0.21)$(0.24)$(0.68)$(1.03)
Diluted
Weighted average common shares outstanding34,419 33,660 34,213 33,571 
Share options and awards111 8 100 10 
Weighted average common shares assuming dilution34,530 33,668 34,313 33,581 
Net loss$(7,276)$(8,041)$(23,163)$(34,644)
Net loss per common share *$(0.21)$(0.24)$(0.68)$(1.03)
________
* Net loss per common share assuming dilution calculated utilizing weighted average shares outstanding-basic for the periods in which there was a net loss.

At September 30, 2020, 300,149 shares associated with shares options were excluded from the average common shares assuming dilution for the three and nine months ended September 30, 2020 as they were anti-dilutive. At September 30, 2020, the majority of the anti-dilutive shares were granted at an exercise price of $24.45, which was higher than the average fair market value price of $6.93 and $7.12 for the three and nine months ended September 30, 2020.

At September 30, 2019, 326,799 shares associated with share options were excluded from the average common shares assuming dilution for the three and nine months ended September 30, 2019 as they were anti-dilutive. At September 30, 2019, the majority of the anti-dilutive shares were granted at an exercise price of $25.24, which was higher than the average fair market value price of $5.61 and $6.43 for the three and nine months ended September 30, 2019.










For the three and nine months ended September 30, 2020 and September 30, 2019, respectively, no shares were included in the common shares assuming dilution related to the company's issued warrants as the average market price of the company shares for these periods did not exceed the strike price of the warrants.
XML 46 R26.htm IDEA: XBRL DOCUMENT v3.20.2
Concentration Of Credit Risk
 9 Months Ended
Sep. 30, 2020
Risks and Uncertainties [Abstract]  
Concentration Of Credit Risk
Concentration of Credit Risk

The company manufactures and distributes durable medical equipment to the home health care, retail and extended care markets. The company performs credit evaluations of its customers’ financial condition. The company utilizes De Lage Landen, Inc. (“DLL”), a third-party financing company, to provide lease financing to Invacare's U.S. customers. The DLL agreement provides for direct leasing between DLL and the Invacare customer. The company retains a recourse obligation of $2,682,000 at September 30, 2020 to DLL for events of default under the contracts, which total $8,262,000 at September 30, 2020. Guarantees, ASC 460, requires the company to record a guarantee liability as it relates to the limited recourse obligation. The company's recourse is reevaluated by DLL biannually, considers activity between the biannual dates and excludes any receivables purchased by the company from DLL. The company monitors the collections status of these contracts and has provided amounts for estimated losses in its allowances for doubtful accounts in accordance with Receivables, ASC 310-10-05-4. Credit losses are provided for in the financial statements.

































Substantially all the company’s receivables are due from health care, medical equipment providers and long-term care facilities located throughout the United States, Australia, Canada, New Zealand and Europe. A significant portion of products sold to dealers, both foreign and domestic, is ultimately funded through government reimbursement programs such as Medicare and Medicaid. The company has also seen a significant shift in reimbursement to customers from managed care entities. As a consequence, changes in these programs can have an adverse impact on dealer liquidity and profitability. In addition, reimbursement guidelines in the home health care industry have a substantial impact on the nature and type of equipment an end user can obtain as well as the timing of reimbursement and, thus, affect the product mix, pricing and payment patterns of the company’s customers.
XML 47 R27.htm IDEA: XBRL DOCUMENT v3.20.2
Derivatives
 9 Months Ended
Sep. 30, 2020
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Derivatives
Derivatives

ASC 815 requires companies to recognize all derivative instruments as either assets or liabilities at fair value. The accounting for changes in fair value of a derivative is dependent upon whether or not the derivative has been designated and qualifies for hedge accounting treatment and the type of hedging relationship. For derivatives designated and qualifying as hedging instruments, the company must designate the hedging instrument, based upon the exposure being hedged, as a fair value hedge, cash flow hedge, or a hedge of a net investment in a foreign operation.

Cash Flow Hedging Strategy

The company uses derivative instruments in an attempt to manage its exposure to transactional foreign currency exchange risk. Foreign forward exchange contracts are used to manage the price risk associated with forecasted sales denominated in foreign currencies and the price risk associated with forecasted purchases of inventory over the next twelve months.

The company recognizes its derivative instruments as assets or liabilities measured at fair value. A majority of the company’s derivative instruments are designated and qualify as cash flow hedges. Accordingly, the effective portion of the gain or loss on the derivative instrument is reported as a component of other comprehensive income and reclassified into earnings in the same period or periods during which the hedged transaction affects earnings. The remaining gain or loss on the derivative instrument in excess of the cumulative change in the fair value of the hedged item, if any, is recognized in current earnings during the period of change.





















To protect against increases/decreases in forecasted foreign currency cash flows resulting from inventory purchases/sales over the next year, the company utilizes foreign currency forward contracts to hedge portions of its forecasted purchases/sales denominated in foreign currencies. The gains and losses are included in cost of products sold and selling, general and administrative expenses on the condensed consolidated statement of comprehensive income (loss). If it is later determined that a hedged forecasted transaction is unlikely to occur, any prospective gains or losses on the forward contracts would be recognized in earnings. The company does not expect any material amount of hedge ineffectiveness related to forward contract cash flow hedges during the next twelve months.

The company has historically not recognized any material amount of ineffectiveness related to forward contract cash flow hedges because the company generally limits its hedges to between 50% and 90% of total forecasted transactions for a given entity’s exposure to currency rate changes and the transactions hedged are recurring in nature. Furthermore, most of the hedged transactions are related to intercompany sales and purchases for which settlement occurs on a specific day each month. Forward contracts with a total notional amount in USD of $155,783,000 and $110,373,000 matured for the nine months ended September 30, 2020 and September 30, 2019, respectively.






Outstanding foreign currency forward exchange contracts qualifying and designated for hedge accounting treatment were as follows (in thousands USD):
 September 30, 2020December 31, 2019
 Notional
Amount		Unrealized
Net Gain
(Loss)		Notional
Amount		Unrealized
Net Gain
(Loss)
USD / AUD$960 $(41)$3,840 $(106)
USD / CAD1,138 (2)3,888 32 
USD / EUR17,468 (1,061)110,905 122 
USD / GBP387 (11)3,972 (8)
USD / NZD290 (13)2,760 (166)
USD / SEK876 (88)5,062 (38)
USD / MXN3,901 (58)6,763 346 
EUR / CAD915 (42)4,151 24 
EUR / CHF2,703 (45)9,821 10 
EUR / GBP6,325 178 29,824 (216)
EUR / SEK2,330 (72)9,493 (46)
EUR / NOK1,490 14 5,797 15 
DKK / SEK1,402 40 5,936 24 
NOK / SEK1,490 53 5,151 18 
$41,675 $(1,148)$207,363 $11 

Derivatives Not Qualifying or Designated for Hedge Accounting Treatment

The company utilizes foreign currency forward contracts that are not designated as hedges in accordance with ASC 815. These contracts are entered into to eliminate the risk associated with the settlement of short-term intercompany trading receivables and payables between Invacare Corporation and its foreign subsidiaries. The currency forward contracts are entered into at the same time as the intercompany
receivables or payables are created so that upon settlement, the gain/loss on the settlement is offset by the gain/loss on the foreign currency forward contract. No material net gain or loss was realized by the company in 2020 or 2019 related to these contracts and the associated short-term intercompany trading receivables and payables.
Foreign currency forward exchange contracts not qualifying or designated for hedge accounting treatment, as well as ineffective hedges, entered into in 2020 and 2019, respectively, and outstanding were as follows (in thousands USD):
 September 30, 2020December 31, 2019
 Notional
Amount		Gain
(Loss)		Notional
Amount		Gain
(Loss)
AUD / USD$6,149 $96 $10,000 $(94)
CAD / USD8,321 88 8,000 (50)
EUR / USD11,735 (745)10,000 104 
DKK / USD15,081 (137)— — 
GBP / USD650 (18)7,000 40 
NOK / USD8,986 (427)— — 
NZD / USD309 (9)4,500 (101)
EUR / CAD130 (6)— — 
EUR / GBP2,086 59 — — 
AUD / NZD6,438 21 7,900 23 
EUR / NOK80 1 — — 
$59,965 $(1,077)$47,400 $(78)

The fair values of the company’s derivative instruments were as follows (in thousands):
 September 30, 2020December 31, 2019
 AssetsLiabilitiesAssetsLiabilities
Derivatives designated as hedging instruments under ASC 815
Foreign currency forward exchange contracts$334 $1,482 $668 $657 
Derivatives not designated as hedging instruments under ASC 815
Foreign currency forward exchange contracts265 1,342 170 248 
Total derivatives$599 $2,824 $838 $905 

The fair values of the company’s foreign currency forward exchange contract assets and liabilities are included in Other Current Assets and Accrued Expenses, respectively in the condensed consolidated balance sheets.
The effect of derivative instruments on Accumulated Other Comprehensive Income (OCI) and the Statement of Comprehensive Income (Loss) and was as follows (in thousands):
Derivatives in ASC 815 cash flow hedge
relationships		Amount of Gain
(Loss) Recognized  in Accumulated OCI on Derivatives
(Effective Portion)		Amount of Gain (Loss)
Reclassified from
Accumulated  OCI into
Income (Effective
Portion)		Amount of Gain (Loss)
Recognized in Income on
Derivatives (Ineffective  Portion and Amount Excluded from
Effectiveness Testing)
Three months ended September 30, 2020
Foreign currency forward exchange contracts$(2,501)$(739)$(662)
Nine months ended September 30, 2020
Foreign currency forward exchange contracts$(1,340)$(352)$(718)
Three months ended September 30, 2019
Foreign currency forward exchange contracts$557 $860 $(2)
Nine months ended September 30, 2019
Foreign currency forward exchange contracts$2,179 $1,445 $50 
Derivatives not designated as hedging
instruments under ASC 815		  Amount of Gain (Loss)
Recognized in Income on Derivatives
Three months ended September 30, 2020
Foreign currency forward exchange contracts$(1,320)
Nine months ended September 30, 2020
Foreign currency forward exchange contracts$(1,077)
Three months ended September 30, 2019
Foreign currency forward exchange contracts$317 
Nine months ended September 30, 2019
Foreign currency forward exchange contracts$103 
The gains or losses recognized as the result of the settlement of cash flow hedge foreign currency forward contracts are recognized in net sales for hedges of inventory sales and in cost of product sold for hedges of inventory purchases. For the three and nine months ended September 30, 2020, net sales were increased by $481,000 and $692,000 while cost of product sold was increased by $1,259,000 and $1,029,000 for net pre-tax realized loss of $778,000 and $337,000, respectively. For the three and nine months ended September 30, 2019, net sales were increased by $197,000 and $189,000 while cost of product sold was decreased by $747,000 and $1,375,000 for net realized pre-tax gains of $944,000 and $1,564,000, respectively.

Losses of $1,320,000 and $1,077,000 were recognized in selling, general and administrative (SG&A) expenses for the three and nine months ended September 30, 2020 compared to gains of $317,000 and $103,000 for the three and nine months ended September 30, 2019 related to forward contracts not designated as hedging instruments. The forward contracts were entered into to offset gains/losses that were also recorded in SG&A expenses on intercompany trade receivables or payables. The gains/losses on the non-designated hedging
instruments were substantially offset by gains/losses on intercompany trade payables.

The company's derivative agreements provide the counterparties with a right of set off in the event of a default. The right of set off would enable the counterparty to offset any net payment due by the counterparty to the company under the applicable agreement by any amount due by the company to the counterparty under any other agreement. For example, the terms of the agreement would permit a counterparty to a derivative contract that is also a lender under the company's Credit Agreement to reduce any derivative settlement amounts owed to the company under the derivative contract by any amounts owed to the counterparty by the company under the Credit Agreement. In addition, the agreements contain cross-default provisions that could trigger a default by the company under the agreement in the event of a default by the company under another agreement with the same counterparty. The company does not present any derivatives on a net basis in its financial statements, other than the conversion and bond hedge derivatives which are presented net on the condensed consolidated statement of comprehensive income (loss), and
all derivative balances presented are subject to provisions that are similar to master netting agreements.

During the first quarter of 2016, the company entered into privately negotiated convertible 2021 note hedges and 2021 warrants in connection with its sale of $150,000,000 in aggregate principal amount of the company’s 5.00% Convertible Senior Notes due 2021. The 2021 warrants, which increased paid in capital by $12,376,000, are clearly and closely related to the convertible 2021 notes and thus classified as equity. The 2021 note hedge asset and 2021 convertible debt conversion liability were recorded, based on initial fair values, as an asset of $27,975,000 and a liability of $34,480,000, respectively, with the offset to the income statement.
During the second quarter of 2017, the company entered into privately negotiated convertible 2022 note hedges and

warrants in connection with its sale of $120,000,000 in aggregate principal amount of the company’s 4.50% Convertible Senior Notes due 2022. The 2022 warrants, which increased paid in capital by $14,100,000, are clearly and closely related to the convertible 2022 notes and thus classified as equity. The 2022 note hedge assets and 2022 convertible debt conversion liability were recorded, based on initial fair values, as an asset of $24,780,000 and a liability of $28,859,000, respectively, with the offset to the income statement. See "Long-Term Debt" in the Notes to the Condensed Consolidated Financial Statements included elsewhere in this report for more detail.
The fair values of the outstanding convertible note derivatives as of September 30, 2020 and their effect on the Statement of Comprehensive Income (Loss) were as follows (in thousands):
 Gain (Loss)Gain (Loss)
 Fair ValueThree Months EndedNine Months Ended
September 30, 2020September 30, 2020September 30, 2019September 30, 2020September 30, 2019
Convertible 2021 debt conversion long-term liability$— $— $— $— $(2,210)
Convertible 2022 debt conversion long-term liability— — — — (6,193)
Convertible 2021 note hedge long-term asset— — — — 2,852 
Convertible 2022 note hedge long-term asset— — — — 6,748 
Net fair value and net gain on convertible debt derivatives$— $— $— $— $1,197 
The 2021 and 2022 convertible debt conversion liability amounts and the 2021 and 2022 note hedge asset amounts are included in Other Long-Term Obligations and Other Long-Term Assets, respectively, in the company's condensed consolidated balance sheets. The 2019 year-to-date changes in the fair values of the convertible debt conversion liabilities and note hedge derivatives were significantly impacted by the change in the company's share price.
On May 16, 2019, the company received shareholder approval authorizing it to elect to settle future conversions of convertible notes in common shares. As a result of the shareholder approval, the note hedge assets and conversion liabilities may no longer be bifurcated and accounted for as separate derivatives and thus were eliminated together with a corresponding offset to additional paid-in-capital.
XML 48 R28.htm IDEA: XBRL DOCUMENT v3.20.2
Fair Values
 9 Months Ended
Sep. 30, 2020
Fair Value Disclosures [Abstract]  
Fair Value of Financial Instruments
Fair Values

Pursuant to ASC 820, the inputs used to derive the fair value of assets and liabilities are analyzed and assigned a level I, II or III priority, with level I being the highest and level III being the lowest in the hierarchy. Level I inputs are quoted prices in active markets for identical assets or liabilities.



Level II inputs are quoted prices for similar assets or liabilities in active markets: quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations in which all significant inputs are observable in active markets. Level III inputs are based on valuations derived from valuation techniques in which one or more significant inputs are unobservable.
The following table provides a summary of the company’s assets and liabilities that are measured on a recurring basis (in thousands):
 Basis for Fair Value Measurements at Reporting Date
Quoted Prices in Active
Markets for Identical
Assets / (Liabilities)		Significant Other
Observable
Inputs		Significant Other
Unobservable
Inputs
Level ILevel IILevel III
September 30, 2020
Forward exchange contracts—net—$(2,225)—
December 31, 2019
Forward exchange contracts—net—$(67)—

The carrying values and fair values of the company’s financial instruments are as follows (in thousands):
 September 30, 2020December 31, 2019
 Carrying ValueFair ValueCarrying ValueFair Value
Cash and cash equivalents$86,825 $86,825 $80,063 $80,063 
Other investments85 85 85 85 
Installment receivables, net of reserves325 325 913 913 
Total debt (including current maturities of long-term debt) *(242,264)(218,231)(219,522)(207,193)
Forward contracts in Other Current Assets599 599 838 838 
Forward contracts in Accrued Expenses(2,824)(2,824)(905)(905)
________
* The company's total debt is shown net of discount and fees associated with the Convertible Senior Notes due in 2021, 2022 and 2024 on the company's condensed consolidated balance sheet. Accordingly, the fair values of the Convertible Senior Notes due in 2021, 2022 and 2024 are included in the long-term debt presented in this table are also shown net of the discount and fees. Total debt amounts exclude operating and financing leases obligations.
The company, in estimating its fair value disclosures for financial instruments, used the following methods and assumptions:

Cash, cash equivalents: The carrying value reported in the balance sheet for cash, cash equivalents equals its fair value.

Other investments: The company has made an investment in a limited partnership, which is accounted for using the cost method, adjusted for any estimated declines in value. The investment was acquired in private placement and there is no quoted market price or stated rate of return. The company does not have the ability to easily sell the investment. The company completes an evaluation of the residual value related to such investments in the fourth quarter each year.

Installment receivables: The carrying value reported in the balance sheet for installment receivables approximates its fair value. The interest rates associated with these receivables have not varied significantly since inception. Management believes that after consideration of the credit risk, the net book value of the installment receivables approximates market value.
Total debt: Fair value for the company’s convertible debt is based on quoted market-based estimates as of the end of the period, while the revolving credit facility fair value is based upon an estimate of the market for similar borrowing arrangements. The fair values are deemed to be categorized as Level 2 in the fair value hierarchy.Forward contracts: The company operates internationally, and as a result, is exposed to foreign currency fluctuations. Specifically, the exposure includes intercompany loans and third-party sales or payments. In an attempt to reduce this exposure, foreign currency forward contracts are utilized and accounted for as hedging instruments. The forward contracts are used to hedge the following currencies: AUD, CAD, CHF, DKK, EUR, GBP, MXN, NOK, NZD, SEK and USD. The company does not use derivative financial instruments for speculative purposes. Fair values for the company’s foreign exchange forward contracts are based on quoted market prices for contracts with similar maturities. The company’s forward contracts are included in Other Current Assets or Accrued Expenses in the condensed consolidated balance sheets.
XML 49 R29.htm IDEA: XBRL DOCUMENT v3.20.2
Business Segments
 9 Months Ended
Sep. 30, 2020
Segment Reporting [Abstract]  
Business Segments
Business Segments
The company operates in two primary business segments: North America and Europe with each selling the company's primary product categories, which include: lifestyle, mobility and seating and respiratory therapy products. Sales in Asia Pacific are reported in All Other and include products similar to those sold in North America and Europe. The accounting policies of each segment are the same as those described in the summary of significant accounting policies for the company's consolidated financial statements. Intersegment sales and transfers are based on the costs to manufacture plus a reasonable profit element.

Segment performance is measured and resources are allocated based on a number of factors, with the primary profit or loss measure being segment operating profit (loss). Segment operating profit (loss) represents net sales less cost of products sold less selling general and administrative expenses. Segment operating profit (loss) excludes unallocated corporate
general and administrative expenses not allocated to the segments and intersegment sales and profit eliminations, which are included in All Other. In addition, segment operating profit (loss) further excludes charges related to restructuring activities, asset impairments and gain on sale of business (as applicable).

This performance measure, segment operating income (loss), is used by the Chief Operating Decision Maker (CODM) for purposes of making decisions about allocating resources to a segment and assessing its performance. In addition, this metric is reviewed by the company's Board of Directors regarding segment performance and is a key metric in the performance management assessment of the company's employees.


The information by segment is as follows (in thousands):
 For the Three Months Ended September 30,For the Nine Months Ended September 30,
2020201920202019
Revenues from external customers
Europe$116,285 $137,371 $339,147 $396,206 
North America88,055 87,118 261,595 262,915 
All Other (Asia Pacific)7,566 11,285 25,904 35,930 
Consolidated$211,906 $235,774 $626,646 $695,051 
Intersegment revenues
Europe$6,027 $3,124 $14,438 $10,396 
North America23,625 21,130 66,356 61,109 
All Other (Asia Pacific)1,116 3,904 3,645 9,776 
Consolidated$30,768 $28,158 $84,439 $81,281 
Restructuring charges before income taxes
Europe$1,434 $1,263 $3,674 $1,903 
North America146 331 865 1,539 
All Other— 34 118 199 
Consolidated$1,580 $1,628 $4,657 $3,641 
Operating income (loss)
Europe$7,600 $11,365 $16,624 $22,617 
North America2,992 (1,694)5,759 (7,316)
All Other(6,082)(5,625)(17,377)(18,230)
Charge expense related to restructuring activities(1,580)(1,628)(4,657)(3,641)
Gain on sale of business— — 9,790 — 
Consolidated operating income (loss)2,930 2,418 10,139 (6,570)
Net gain on convertible debt derivatives— — — 1,197 
Loss on debt extinguishment including debt finance charges and associated fees(761)(280)(7,360)(280)
Net Interest expense(7,395)(6,879)(21,042)(21,666)
Loss before income taxes$(5,226)$(4,741)$(18,263)$(27,319)
Net sales by product, are as follows (in thousands):
For the Three Months Ended September 30,For the Nine Months Ended September 30,
2020201920202019
Europe
Lifestyle$50,307 $59,403 $160,628 $182,103 
Mobility and Seating54,851 68,286 147,275 184,819 
Respiratory Therapy6,070 4,919 16,680 14,875 
Other(1)5,057 4,763 14,564 14,409 
$116,285 $137,371 $339,147 $396,206 
North America
Lifestyle$41,845 $43,401 $124,888 $131,259 
Mobility and Seating26,572 31,252 82,485 89,638 
Respiratory Therapy19,405 12,108 53,626 40,811 
Other(1)233 357 596 1,207 
$88,055 $87,118 $261,595 $262,915 
All Other (Asia Pacific)
Mobility and Seating$2,670 $6,645 $10,757 $21,986 
Lifestyle3,375 3,001 10,176 8,261 
Respiratory Therapy195 175 1,043 1,063 
Other(1)1,326 1,464 3,928 4,620 
$7,566 $11,285 $25,904 $35,930 
Total Consolidated$211,906 $235,774 $626,646 $695,051 
   ________________________
(1)Includes various services, including repair services, equipment rentals and external contracting.
XML 50 R30.htm IDEA: XBRL DOCUMENT v3.20.2
Contingencies
 9 Months Ended
Sep. 30, 2020
Commitments and Contingencies Disclosure [Abstract]  
Contingencies
Contingencies
General

In the ordinary course of its business, the company is a defendant in a number of lawsuits, primarily product liability actions in which various plaintiffs seek damages for injuries allegedly caused by defective products. All the product liability lawsuits that the company faces in the United States have been referred to the company's captive insurance company and/or excess insurance carriers while all non-U.S. lawsuits have been referred to the company's commercial insurance carriers. All such lawsuits are generally contested vigorously. The coverage territory of the company's insurance is worldwide with the exception of those countries with respect to which, at the time the product is sold for use or at the time a claim is made, the U.S. government has suspended or prohibited diplomatic or trade relations. The amount recorded for identified contingent liabilities is based on estimates. Amounts recorded are reviewed periodically and adjusted to reflect additional technical and legal information that becomes available. Actual costs to be incurred in future periods may vary from the estimates, given the inherent uncertainties in evaluating certain exposures.

As a medical device manufacturer, the company is subject to extensive government regulation, including numerous laws directed at preventing fraud and abuse and laws regulating reimbursement under various government programs. The marketing, invoicing, documenting, developing, testing, manufacturing, labeling, promoting, distributing and other practices of health care suppliers and medical device manufacturers are all subject to government scrutiny. Most of the company's facilities are subject to inspection at any time by the FDA or similar medical device regulatory agencies in other jurisdictions. Violations of law or regulations can result in administrative, civil and criminal penalties and sanctions, which could have a material adverse effect on the company's business.

Medical Device Regulatory Matters
The FDA in the United States and comparable medical device regulatory authorities in other jurisdictions regulate virtually all aspects of the marketing, invoicing, documenting, development, testing, manufacturing, labeling, promotion, distribution and other practices regarding medical devices. The company and its products are subject to the laws and regulations of the FDA and other regulatory bodies in the various jurisdictions where the company's products are manufactured or sold. The company's failure to comply with the regulatory requirements of the FDA and other applicable medical device regulatory requirements can subject the company to administrative or judicially imposed sanctions or
enforcement actions. These sanctions include injunctions, consent decrees, warning letters, civil penalties, criminal penalties, product seizure or detention, product recalls and total or partial suspension of production.
In December 2012, the company became subject to a consent decree of injunction filed by FDA with respect to the company's Corporate facility and its Taylor Street manufacturing facility in Elyria, Ohio. The consent decree initially limited the company's (i) manufacture and distribution of power and manual wheelchairs, wheelchair components and wheelchair sub-assemblies at or from its Taylor Street manufacturing facility, except in verified cases of medical necessity, (ii) design activities related to wheelchairs and power beds that take place at the impacted Elyria facilities and (iii) replacement, service and repair of products already in use from the Taylor Street manufacturing facility. Under the terms of the consent decree, in order to resume full operations, the company had to successfully complete independent, third-party expert certification audits at the impacted Elyria facilities, comprising three distinct certification reports separately submitted to, and subject to acceptance by, FDA; submit its own report to the FDA; and successfully complete a reinspection by FDA of the company's Corporate and Taylor Street facilities.
On July 24, 2017, following its June 2017 reinspection of the Corporate and Taylor Street facilities, FDA notified the company that it is in substantial compliance with the FDA Act, FDA regulations and the terms of the consent decree and, that the company was permitted to resume full operations at those facilities including the resumption of unrestricted sales of products made in those facilities.
The consent decree will continue in effect for at least five years from July 2017, during which time the company's Corporate and Taylor Street facilities must complete two semi-annual audits in the first year and then four annual audits in the next four years performed by a company-retained expert firm. The expert audit firm will determine whether the facilities remain in continuous compliance with the FDA Act, FDA regulations and the terms of the consent decree. The FDA has the authority to inspect these facilities and any other FDA registered facility, at any time.
The FDA has continued to actively inspect the company's facilities, other than through the processes established under the consent decree. The company expects that the FDA will, from time to time, inspect substantially all the company's domestic and foreign FDA-registered facilities.
The results of regulatory claims, proceedings, investigations, or litigation are difficult to predict. An
unfavorable resolution or outcome of any FDA warning letters or inspectional observations, or other FDA enforcement related to company facilities, could materially and adversely affect the company's business, financial condition, and results of operations.
The limitations previously imposed by the FDA consent decree negatively affected net sales in the North America segment and, to a certain extent, the Asia Pacific region beginning in 2012. The limitations led to delays in new product introductions. Further, uncertainty regarding how long the limitations would be in effect limited the company's ability to renegotiate and bid on certain customer contracts and otherwise led to a decline in customer orders.
Although the company has been permitted to resume full operations at the Corporate and Taylor Street facilities, the negative effect of the consent decree on customer orders and net sales in the North America segment and Asia Pacific region has been considerable, and it is uncertain as to whether, or how quickly, the company will be able to rebuild net sales to more typical historical levels, irrespective of market conditions. Accordingly, when compared to the company's 2010 results, the previous limitations in the consent decree had, and likely may continue to have, a material adverse effect on the company's business, financial condition and results of operations.
Warranty Matters
The company's warranty reserves are subject to adjustment in future periods based on historical analysis of warranty claims and as new developments occur that may change the company's estimates related to specific product recalls. See Current Liabilities in the Notes to the Condensed Consolidated Financial Statements for the total provision amounts and a reconciliation of the changes in the warranty accrual.
Any of the above contingencies could have an adverse impact on the company's financial condition or results of operations.
For additional information regarding the consent decree, other regulatory matters, and risks and trends that may impact the company’s financial condition or results of operations, please see the following sections of the company's Annual Report on Form 10-K for the year ended December 31, 2019: Item 1. Business - Government Regulation and Item 1A. Risk Factors; Item 3. Legal Proceedings; and Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations - Liquidity and Capital Resources.
XML 51 R31.htm IDEA: XBRL DOCUMENT v3.20.2
Accounting Policies (Policies)
 9 Months Ended
Sep. 30, 2020
Accounting Policies [Abstract]  
Principles of Consolidation Principles of Consolidation:  The condensed consolidated financial statements include the accounts of the company and its wholly owned subsidiaries and include all adjustments, which were of a normal recurring nature, necessary to present fairly the financial position of the company as of September 30, 2020 and the results of its operations and changes in its cash flow for the nine months ended September 30, 2020 and 2019, respectively. Certain foreign subsidiaries, represented by the European segment, are consolidated using an August 31 quarter end to meet filing deadlines. No material subsequent events have occurred related to the European segment, which would require disclosure or adjustment to the company's financial statements. All significant intercompany transactions are eliminated. The results of operations for the three and nine months ended September 30, 2020 are not necessarily indicative of the results to be expected for the full year.
Use of Estimates Use of Estimates:  The condensed consolidated financial statements are prepared in conformity with accounting principles generally accepted in the United States, which require management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results may differ from these estimates.
Recent Accounting Pronouncements
Recent Accounting Pronouncements (Already Adopted): 
In June 2016, the FASB issued ASU 2016-13, "Measurement of Credit Losses on Financial Statements." ASU 2016-13 requires a new credit loss standard for most financial assets and certain other instruments. For example, entities are required to use an "expected loss" model that will generally require earlier recognition of allowances for losses for trade receivables. The standard also requires additional disclosures, including disclosures regarding how an entity tracks credit quality. The company adopted ASU 2016-13, effective on January 1, 2020, which resulted in an increase for credit losses of $243,000 with the offsetting impact recorded to retained earnings.

In January 2017, the FASB issued ASU 2017-04, "Intangibles - Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment." The guidance in ASU 2017-04 eliminates the requirement to determine the fair value of individual assets and liabilities of a reporting unit to measure goodwill impairment. Under the amendments in the new ASU, goodwill impairment testing will be performed by comparing the fair value of the reporting unit with its carrying amount and recognizing an impairment charge for the amount by which the carrying amount exceeds the reporting unit’s fair
value. The company adopted ASU 2017-04 as of January 1, 2020 with no impact to the company's financial statements upon adoption. In December 2019, the FASB issued ASU 2019-12, "Income Taxes (Topic 740) - Simplifying the Accounting for Income Taxes," which simplifies the accounting for income taxes by removing certain exceptions to the general principles in Topic 740. ASU 2019-12 removes the following exceptions: 1) exception to the incremental approach for intraperiod tax allocation when there is a loss from continuing operations and income or a gain from other items (for example, discontinued operations or other comprehensive income), 2) exception to the requirement to recognize a deferred tax liability for equity method investments when a foreign subsidiary becomes an equity method investment, 3) exception to the ability not to recognize a deferred tax liability for a foreign subsidiary when a foreign subsidiary becomes a subsidiary and 4) the exception to the general methodology for calculating income taxes in an interim period when a year-to-date loss exceeds the anticipated loss for the year. The ASU also simplifies other areas of Topic 740 by clarifying and amending existing guidance. The amendments in the ASU will be applied using different approaches depending on what the specific amendments relate to. The company early adopted ASU 2019-12 on a prospective basis as of January 1, 2020 with no impact to the company's financial statements upon adoption.
XML 52 R32.htm IDEA: XBRL DOCUMENT v3.20.2
Divested Businesses (Tables)
 2 Months Ended
Mar. 07, 2020
Divested Businesses [Abstract]  
Assets and Liabilities of Divested Business [Table Text Block]
The assets and liabilities of Dynamic Controls as of March 7, 2020 and December 31, 2019 consisted of the following (in thousands):
March 7, 2020December 31, 2019
Trade receivables, net$4,129 $1,804 
Inventories, net3,082 3,008 
Other assets855 933 
Property and equipment, net600 707 
Operating lease assets, net2,127 1,870 
Total assets$10,793 $8,322 
Accounts payable$4,692 $4,501 
Accrued expenses2,473 2,108 
Current taxes payable41 92 
Current portion of operating lease obligations366 393 
Long-term obligations1,019 1,754 
Total liabilities$8,591 $8,848 
XML 53 R33.htm IDEA: XBRL DOCUMENT v3.20.2
Receivables (Tables)
 9 Months Ended
Sep. 30, 2020
Receivables [Abstract]  
Schedule of Accounts Receivable
Receivables consist of the following (in thousands):
September 30, 2020December 31, 2019
Accounts receivable, gross$132,809 $141,732 
Customer rebate reserve(13,075)(13,922)
Cash discount reserves(5,290)(5,326)
Allowance for doubtful accounts(4,697)(4,804)
Other, principally returns and allowances reserves(790)(1,011)
Accounts receivable, net$108,957 $116,669 
Schedule for Allowance for Credit Losses
The movement in the trade receivables allowance for doubtful accounts was as follows (in thousands):
 Nine Months Ended
September 30, 2020
Balance as of beginning of period$4,804 
Current period provision522 
Direct write-offs charged against the allowance(629)
Balance as of end of period$4,697 
Schedule of Installment Receivables
Installment receivables consist of the following (in thousands):
 September 30, 2020December 31, 2019
 CurrentLong-
Term		TotalCurrentLong-
Term		Total
Installment receivables$555 $228 $783 $1,192 $1,257 $2,449 
Less: Unearned interest(3)— (3)(22)— (22)
552 228 780 1,170 1,257 2,427 
Allowance for doubtful accounts(291)(164)(455)(434)(1,080)(1,514)
Installment receivables, net$261 $64 $325 $736 $177 $913 
Schedule of Installment Receivables Allowance for Doubtful Accounts
The movement in the installment receivables allowance for doubtful accounts was as follows (in thousands):
 Nine Months Ended
September 30, 2020		Year Ended December 31, 2019
Balance as of beginning of period$1,514 $1,542 
Current period provision32 479 
Direct write-offs charged against the allowance(1,091)(507)
Balance as of end of period$455 $1,514 
Schedule of Installment Receivables by Class
Installment receivables by class as of September 30, 2020 consist of the following (in thousands):
 Total
Installment
Receivables		Unpaid
Principal
Balance		Related
Allowance for
Doubtful
Accounts		Interest
Income
Recognized
U.S.
Impaired installment receivables with a related allowance recorded$649 $649 $453 $— 
Canada
Non-Impaired installment receivables with no related allowance recorded132 129 — 26 
Impaired installment receivables with a related allowance recorded2 2 2 — 
Total Canadian installment receivables134 131 2 26 
Total
Non-Impaired installment receivables with no related allowance recorded132 129 — 26 
Impaired installment receivables with a related allowance recorded651 651 455 — 
Total installment receivables$783 $780 $455 $26 
Installment receivables by class as of December 31, 2019 consist of the following (in thousands):
 Total
Installment
Receivables		Unpaid
Principal
Balance		Related
Allowance for
Doubtful
Accounts		Interest
Income
Recognized
U.S.
Impaired installment receivables with a related allowance recorded$1,762 $1,762 $1,497 $— 
Canada
Non-Impaired installment receivables with no related allowance recorded670 648 — 92 
Impaired installment receivables with a related allowance recorded17 17 17 — 
Total Canadian installment receivables687 665 17 92 
Total
Non-Impaired installment receivables with no related allowance recorded670 648 — 92 
Impaired installment receivables with a related allowance recorded1,779 1,779 1,514 — 
Total installment receivables$2,449 $2,427 $1,514 $92 
Schedule of Financing Receivables
Installment receivables by class as of September 30, 2020 consist of the following (in thousands):
 Total
Installment
Receivables		Unpaid
Principal
Balance		Related
Allowance for
Doubtful
Accounts		Interest
Income
Recognized
U.S.
Impaired installment receivables with a related allowance recorded$649 $649 $453 $— 
Canada
Non-Impaired installment receivables with no related allowance recorded132 129 — 26 
Impaired installment receivables with a related allowance recorded2 2 2 — 
Total Canadian installment receivables134 131 2 26 
Total
Non-Impaired installment receivables with no related allowance recorded132 129 — 26 
Impaired installment receivables with a related allowance recorded651 651 455 — 
Total installment receivables$783 $780 $455 $26 
Installment receivables by class as of December 31, 2019 consist of the following (in thousands):
 Total
Installment
Receivables		Unpaid
Principal
Balance		Related
Allowance for
Doubtful
Accounts		Interest
Income
Recognized
U.S.
Impaired installment receivables with a related allowance recorded$1,762 $1,762 $1,497 $— 
Canada
Non-Impaired installment receivables with no related allowance recorded670 648 — 92 
Impaired installment receivables with a related allowance recorded17 17 17 — 
Total Canadian installment receivables687 665 17 92 
Total
Non-Impaired installment receivables with no related allowance recorded670 648 — 92 
Impaired installment receivables with a related allowance recorded1,779 1,779 1,514 — 
Total installment receivables$2,449 $2,427 $1,514 $92 
Schedule of Aging of Installment Receivables
The aging of the company’s installment receivables was as follows (in thousands):
September 30, 2020December 31, 2019
TotalU.S.CanadaTotalU.S.Canada
Current$132 $— $132 $659 $— $659 
0-30 Days Past Due— — — 2 — 2 
31-60 Days Past Due— — — 4 — 4 
61-90 Days Past Due— — — — — — 
90+ Days Past Due651 649 2 1,784 1,762 22 
$783 $649 $134 $2,449 $1,762 $687 
XML 54 R34.htm IDEA: XBRL DOCUMENT v3.20.2
Inventories (Tables)
 9 Months Ended
Sep. 30, 2020
Inventory Disclosure [Abstract]  
Schedule of Inventory
Inventories consist of the following (in thousands):
September 30, 2020December 31, 2019
Finished goods$68,599 $54,064 
Raw materials66,093 54,638 
Work in process10,760 11,798 
Inventories, net$145,452 $120,500 
XML 55 R35.htm IDEA: XBRL DOCUMENT v3.20.2
Other Current Assets (Tables)
 9 Months Ended
Sep. 30, 2020
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]  
Schedule of Other Current Assets
Other current assets consist of the following (in thousands):
September 30, 2020December 31, 2019
Tax receivables principally value added taxes$23,188 $16,049 
Receivable due from information technology provider2,402 6,262 
Prepaid inventory1,392 684 
Derivatives (foreign currency forward exchange contracts)599 838 
Service contracts446 2,013 
Prepaid insurance341 2,918 
Deferred financing fees209 207 
Prepaid social charges95 1,216 
Recoverable income taxes50 297 
Prepaid and other current assets8,913 7,425 
Other Current Assets$37,635 $37,909 
XML 56 R36.htm IDEA: XBRL DOCUMENT v3.20.2
Other Long-Term Assets (Tables)
 9 Months Ended
Sep. 30, 2020
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]  
Schedule of Other Assets, Noncurrent
Other long-term assets consist of the following (in thousands):
September 30, 2020December 31, 2019
Cash surrender value of life insurance policies$2,224 $2,124 
Deferred income taxes1,032 928 
Deferred financing fees461 602 
Investments85 85 
Installment receivables64 177 
Other125 300 
Other Long-Term Assets$3,991 $4,216 
XML 57 R37.htm IDEA: XBRL DOCUMENT v3.20.2
Property And Equipment (Tables)
 9 Months Ended
Sep. 30, 2020
Property, Plant and Equipment [Abstract]  
Property, Plant and Equipment
Property and equipment consist of the following (in thousands):
September 30, 2020December 31, 2019
Machinery and equipment$291,902 $296,078 
Land, buildings and improvements28,088 33,054 
Capitalized software13,787 3,509 
Furniture and fixtures9,866 9,898 
Leasehold improvements8,087 9,023 
Property and Equipment, gross351,730 351,562 
Accumulated depreciation(298,618)(304,955)
Property and Equipment, net$53,112 $46,607 
XML 58 R38.htm IDEA: XBRL DOCUMENT v3.20.2
Intangibles (Tables)
 9 Months Ended
Sep. 30, 2020
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule of Indefinite-Lived Intangible Assets
The company's intangibles consist of the following (in thousands):
 
 September 30, 2020December 31, 2019
 Historical
Cost		Accumulated
Amortization		Historical
Cost		Accumulated
Amortization
Customer lists$54,267 $54,267 $51,108 $51,108 
Trademarks25,019 — 23,479 — 
Developed technology7,918 7,150 7,483 6,642 
Patents5,514 5,514 5,521 5,521 
License agreements2,864 891 2,884 770 
Other1,161 1,151 1,163 1,150 
Intangibles$96,743 $68,973 $91,638 $65,191 
Schedule of Finite-Lived Intangible Assets
The company's intangibles consist of the following (in thousands):
 
 September 30, 2020December 31, 2019
 Historical
Cost		Accumulated
Amortization		Historical
Cost		Accumulated
Amortization
Customer lists$54,267 $54,267 $51,108 $51,108 
Trademarks25,019 — 23,479 — 
Developed technology7,918 7,150 7,483 6,642 
Patents5,514 5,514 5,521 5,521 
License agreements2,864 891 2,884 770 
Other1,161 1,151 1,163 1,150 
Intangibles$96,743 $68,973 $91,638 $65,191 
XML 59 R39.htm IDEA: XBRL DOCUMENT v3.20.2
Accrued Expenses (Tables)
 9 Months Ended
Sep. 30, 2020
Payables and Accruals [Abstract]  
Schedule of Accrued Expenses
Accrued expenses consist of accruals for the following (in thousands):
September 30, 2020December 31, 2019
Salaries and wages$34,612 $29,725 
Taxes other than income taxes, primarily Value Added Taxes29,830 22,194 
Warranty11,144 11,626 
Professional8,481 6,869 
Severance5,988 7,023 
Interest4,663 3,608 
Rebates4,146 10,743 
IT service contracts3,790 6,125 
Freight3,710 3,744 
Deferred revenue3,436 3,173 
Derivative liabilities (foreign currency forward exchange contracts)2,824 905 
Product liability, current portion2,810 2,736 
Insurance781 699 
Rent568 415 
Supplemental Executive Retirement Program liability391 391 
Advance payment on sale of land & buildings— 3,471 
IT licenses— 2,114 
Other items, principally trade accruals7,492 5,386 
Accrued Expenses$124,666 $120,947 
Schedule of Product Warranty Liability
The following is a reconciliation of the changes in accrued warranty costs for the reporting period (in thousands):
Balance as of January 1, 2020$11,626 
Warranties provided during the period4,311 
Settlements made during the period(5,926)
Changes in liability for pre-existing warranties during the period, including expirations1,133 
Balance as of September 30, 2020$11,144 
XML 60 R40.htm IDEA: XBRL DOCUMENT v3.20.2
Long-Term Debt (Tables)
 9 Months Ended
Sep. 30, 2020
Debt Disclosure [Abstract]  
Schedule of Long-term Debt Instruments
Debt consists of the following (in thousands):
September 30, 2020December 31, 2019
Convertible senior notes at 5.00%, due in February 2021$1,224 $56,628 
Convertible senior notes at 4.50%, due in June 202272,652 101,815 
Convertible senior notes Series I at 5.00%, due in November 202462,443 60,817 
Convertible senior notes Series II at 5.00%, due November 202463,556 — 
Other obligations42,389 262 
242,264 219,522 
Less current maturities of long-term debt(4,062)(58)
Long-Term Debt$238,202 $219,464 
Liability Components of Convertible 2021 Note
The liability components of the 2021 notes consist of the following (in thousands):
September 30, 2020December 31, 2019
Principal amount of liability component$1,250 $61,091 
Unamortized discount(22)(3,916)
Debt fees(4)(547)
Net carrying amount of liability component$1,224 $56,628 
Liability Components of Convertible 2022 Note
The liability components of the 2022 notes consist of the following (in thousands):
September 30, 2020December 31, 2019
Principal amount of liability component$81,500 $120,000 
Unamortized discount(7,837)(16,027)
Debt fees(1,011)(2,158)
Net carrying amount of liability component$72,652 $101,815 
Liability Components of Convertible 2024 Note
The liability components of the 2024 notes consist of the following (in thousands):
September 30, 2020December 31, 2019
Principal amount of liability component$72,909 $72,909 
Unamortized discount(9,363)(10,733)
Debt fees(1,103)(1,359)
Net carrying amount of liability component$62,443 $60,817 
Liability Components of Convertible Series II 2024 Note
The liability components of the Series II Notes consist of the following (in thousands):
September 30, 2020
Principal amount of liability component - including accretion$74,891 
Unamortized discount(9,967)
Debt fees(1,368)
Net carrying amount of liability component$63,556 
XML 61 R41.htm IDEA: XBRL DOCUMENT v3.20.2
Other Long-Term Obligations (Tables)
 9 Months Ended
Sep. 30, 2020
Other Liabilities Disclosure [Abstract]  
Other Noncurrent Liabilities
Other long-term obligations consist of the following (in thousands):
September 30, 2020December 31, 2019
Deferred income taxes$24,223 $23,376 
Product liability13,545 13,414 
Pension 7,586 7,006 
Deferred gain on sale leaseback5,582 5,819 
Deferred compensation5,318 5,354 
Supplemental Executive Retirement Plan liability5,245 5,433 
Uncertain tax obligation including interest2,660 2,612 
Other6,589 3,935 
Other Long-Term Obligations$70,748 $66,949 
XML 62 R42.htm IDEA: XBRL DOCUMENT v3.20.2
Leases and Commitments (Tables)
 9 Months Ended
Sep. 30, 2020
Leases [Abstract]  
Lease, Cost [Table]
Lease expense for the three and nine months ended September 30, 2020 and September 30, 2019, respectively, were as follows (in thousands):
For the Three Months Ended September 30,For the Nine Months Ended September 30,
2020201920202019
Operating leases$1,926 $2,696 $6,210 $8,175 
Variable and short-term leases1,077 894 2,936 1,974 
Total operating leases$3,003 $3,590 $9,146 $10,149 
Finance lease interest cost$829 $346 $1,483 $977 
Finance lease depreciation980 706 2,346 1,957 
Total finance leases$1,809 $1,052 $3,829 $2,934 
Schedule of Future Minimum Rental Payments for Operating Leases [Table]
Future minimum operating and finance lease commitments, as of September 30, 2020, are as follows (in thousands):
Finance 
Leases		Operating Leases
2020$1,873 $1,842 
20217,416 6,027 
20226,487 3,466 
20236,421 1,407 
20246,365 890 
Thereafter84,251 786 
Total future minimum lease payments112,813 14,418 
Amounts representing interest(45,511)(1,393)
Present value of minimum lease payments67,302 13,025 
Less: current maturities of lease obligations(3,352)(5,843)
Long-term lease obligations$63,950 $7,182 
Schedule of Future Minimum Lease Payments for Capital Leases [Table]
Future minimum operating and finance lease commitments, as of September 30, 2020, are as follows (in thousands):
Finance 
Leases		Operating Leases
2020$1,873 $1,842 
20217,416 6,027 
20226,487 3,466 
20236,421 1,407 
20246,365 890 
Thereafter84,251 786 
Total future minimum lease payments112,813 14,418 
Amounts representing interest(45,511)(1,393)
Present value of minimum lease payments67,302 13,025 
Less: current maturities of lease obligations(3,352)(5,843)
Long-term lease obligations$63,950 $7,182 
Schedule of Cash Flow, Supplemental Disclosures [Table]
Supplemental cash flow amounts for the nine months ended September 30, 2020 were as follows (in thousands):
Cash Activity: Cash paid in measurement of amounts for lease liabilitiesSeptember 30, 2020
Operating Leases$9,407 
Financing Leases3,429 
Total$12,836 
Non-Cash Activity: Right-of-use assets obtained in exchange for lease obligationsSeptember 30, 2020
Operating Leases$2,789 
Financing Leases39,942 
Total$42,731 
Weighted-Average Remaining Lease Terms and Discount Rates [Table]
Weighted-average remaining lease terms and discount rates for finance and operating leases are as follows as of September 30, 2020:
September 30, 2020
Weighted-average remaining lease term - finance leases17.2 years
Weighted-average remaining lease term - operating leases3.2 years
Weighted-average discount rate - finance leases6.32%
Weighted-average discount rate - operating leases7.74%
XML 63 R43.htm IDEA: XBRL DOCUMENT v3.20.2
Revenue (Tables)
 9 Months Ended
Sep. 30, 2020
Revenue Recognition, Multiple-deliverable Arrangements [Line Items]  
Revenue Recognition, Multiple-deliverable Arrangements The following tables disaggregate the company’s revenues by major source and by reportable segment for the three and nine months ended September 30, 2020 and September 30, 2019 (in thousands):
Three Months Ended September 30, 2020
ProductServiceTotal
Europe$113,043 $3,242 $116,285 
North America87,821 234 88,055 
Other (Asia/Pacific)6,428 1,138 7,566 
Total$207,292 $4,614 $211,906 
% Split98%2%100%
Nine Months Ended September 30, 2020
ProductServiceTotal
Europe$329,943 $9,204 $339,147 
North America260,999 596 261,595 
Other (Asia/Pacific)22,565 3,339 25,904 
Total$613,507 $13,139 $626,646 
% Split98%2%100%
Three Months Ended September 30, 2019
ProductServiceTotal
Europe$133,839 $3,532 $137,371 
North America86,761 357 87,118 
Other (Asia/Pacific)10,047 1,238 11,285 
Total$230,647 $5,127 $235,774 
% Split98%2%100%
Nine Months Ended September 30, 2019
ProductServiceTotal
Europe$386,007 $10,199 $396,206 
North America261,707 1,208 262,915 
Other (Asia/Pacific)32,242 3,688 35,930 
Total$679,956 $15,095 $695,051 
% Split98%2%100%
XML 64 R44.htm IDEA: XBRL DOCUMENT v3.20.2
Equity Compensation (Tables)
 9 Months Ended
Sep. 30, 2020
Share-based Payment Arrangement [Abstract]  
Schedule of Compensation Cost for Share-based Payment Arrangements, Allocation of Share-based Compensation Costs by Plan
The amounts of equity-based compensation expense recognized as part of SG&A expenses in All Other in business segments were as follows (in thousands):
For the Nine Months Ended September 30,
20202019
Restricted share / units$4,471 $3,891 
Performance shares / units2,494 1,648 
Non-qualified and performance share options— 334 
Total share-based compensation expense$6,965 $5,873 
Schedule of Unrecognized Compensation Cost, Nonvested Awards
As of September 30, 2020, unrecognized compensation expense related to equity-based compensation arrangements granted under the company's 2018 Plan and previous plans, which is related to non-vested shares, was as follows (in thousands):
September 30, 2020
Restricted share and restricted share units$8,443 
Performance shares and performance share units11,144 
Total unrecognized share-based compensation expense$19,587 
Schedule of Share-based Compensation, Stock Options, Activity
The following table summarizes information about share option activity for the nine months ended September 30, 2020:
Weighted Average
Exercise Price
Options outstanding at January 1, 20201,441,202 $18.26 
Canceled(354,006)24.88
Options outstanding at September 30, 20201,087,196 $16.12 
Options exercise price range at September 30, 2020$12.15 to$33.36 
Options exercisable at September 30, 20201,087,196 
Shares available for grant at September 30, 2020*3,513,468 
________
 *    Shares available for grant under the 2018 Plan as of September 30, 2020 reduced by net restricted share and restricted share unit award activity of 696,058 shares and performance share and performance share unit award activity of 1,859,054 shares
Schedule of Share-based Compensation, Stock Options Outstanding
The following table summarizes information about stock options outstanding at September 30, 2020:
 Options OutstandingOptions Exercisable
Exercise PricesNumber
Outstanding at
September 30, 2020		Weighted Average
Remaining
Contractual Life (Years)		Weighted Average
Exercise Price		Number
Exercisable at
September 30, 2020		Weighted Average
Exercise Price
$12.15 – $20.00
777,159 5.1$12.74 777,159 $12.73 
$20.01 – $25.00
300,149 0.924.45 300,149 24.45 
$25.01 – $30.00
5,392 0.227.82 5,392 27.82 
$30.01 – $33.36
4,496 0.633.36 4,496 33.36 
Total1,087,196 3.9$16.12 1,087,196 $16.12 
Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity
The following table summarizes information about restricted shares and restricted share units (primarily for non-U.S. recipients):
Weighted Average Fair Value
Shares / Units unvested at
January 1, 2020		965,085 $11.32 
Granted764,012 7.11 
Vested(452,922)11.47 
Canceled(94,993)10.19 
Shares / Units unvested at
September 30, 2020		1,181,182 $8.63 
Share-based Compensation, Performance Shares Award Unvested Activity
The following table summarizes information about performance shares and performance share units (for non-U.S. recipients):
 Weighted Average Fair Value
Shares / Units unvested at January 1, 2020753,272 $11.82 
Granted523,329 7.08 
Canceled(65,976)9.48 
Shares / Units unvested at
September 30, 2020		1,210,625 $9.90 
XML 65 R45.htm IDEA: XBRL DOCUMENT v3.20.2
Accumulated Other Comprehensive Income (Loss) by Component (Tables)
 9 Months Ended
Sep. 30, 2020
Equity [Abstract]  
Schedule of Accumulated Other Comprehensive Income (Loss)
Changes in accumulated other comprehensive income ("OCI") (in thousands):
Foreign CurrencyLong-Term NotesDefined Benefit PlansDerivativesTotal
June 30, 2020$16,455 $(9,133)$(3,468)$794 $4,648 
OCI before reclassifications35,231 713 281 (2,501)33,724 
Amount reclassified from accumulated OCI— — (474)739 265 
Net current-period OCI35,231 713 (193)(1,762)33,989 
September 30, 2020$51,686 $(8,420)$(3,661)$(968)$38,637 
Foreign CurrencyLong-Term NotesDefined Benefit PlansDerivativesTotal
December 31, 2019$8,898 $(2,491)$(3,299)$20 $3,128 
OCI before reclassifications42,788 (5,929)122 (1,340)35,641 
Amount reclassified from accumulated OCI— — (484)352 (132)
Net current-period OCI42,788 (5,929)(362)(988)35,509 
September 30, 2020$51,686 $(8,420)$(3,661)$(968)$38,637 
Foreign CurrencyLong-Term NotesDefined Benefit PlansDerivativesTotal
June 30, 2019$13,122 $(2,200)$(2,778)$1,627 $9,771 
OCI before reclassifications(5,729)(3,328)(504)557 (9,004)
Amount reclassified from accumulated OCI— — 303 (860)(557)
Net current-period OCI(5,729)(3,328)(201)(303)(9,561)
September 30, 2019$7,393 $(5,528)$(2,979)$1,324 $210 
Foreign CurrencyLong-Term NotesDefined Benefit PlansDerivativesTotal
December 31, 2018$12,244 $2,662 $(2,703)$590 $12,793 
OCI before reclassifications(4,851)(8,190)(922)2,179 (11,784)
Amount reclassified from accumulated OCI— — 646 (1,445)(799)
Net current-period OCI(4,851)(8,190)(276)734 (12,583)
September 30, 2019$7,393 $(5,528)$(2,979)$1,324 $210 
Schedule of Amounts Recognized in Other Comprehensive Income (Loss)
Reclassifications out of accumulated OCI were as follows (in thousands):
Amount reclassified from OCIAffected line item in the Statement of Comprehensive (Income) Loss
For the Three Months Ended September 30,For the Nine Months Ended September 30,
2020201920202019
Defined Benefit Plans 
Service and interest costs$(474)$303 $(484)$646 Selling, general and administrative expenses
Tax— — — — Income tax provision
Total after tax$(474)$303 $(484)$646 
Derivatives
Foreign currency forward contracts hedging sales$(481)$(197)$(692)$(189)Net sales
Foreign currency forward contracts hedging purchases1,259 (747)1,029 (1,375)Cost of products sold
Total loss (income) before tax778 (944)337 (1,564)
Tax(39)84 15 119 Income tax provision (benefit)
Total after tax$739 $(860)$352 $(1,445)
XML 66 R46.htm IDEA: XBRL DOCUMENT v3.20.2
Charges Related To Restructuring Activities (Tables)
 9 Months Ended
Sep. 30, 2020
Restructuring and Related Activities [Abstract]  
Schedule of Restructuring and Related Costs
A progression by reporting segment of the accruals recorded as a result of the restructuring for the nine months ended September 30, 2020 is as follows (in thousands):
SeveranceContract TerminationsTotal
December 31, 2019 Balances
North America$211 $— $211 
Europe6,406 4 6,410 
All Other406 — 406 
Total7,023 4 7,027 
Charges
North America 691 — 691 
Europe592 73 665 
All Other36 — 36 
Total 1,319 73 1,392 
Payments
North America (562)— (562)
Europe (959)(73)(1,032)
All Other(276)— (276)
Total (1,797)(73)(1,870)
March 31, 2020 Balances
North America340 — 340 
Europe6,039 4 6,043 
All Other166 — 166 
Total$6,545 $4 $6,549 
Charges
North America$28 $— $28 
Europe1,302 273 1,575 
All Other82 — 82 
Total1,412 273 1,685 
Payments
North America(265)— (265)
Europe(1,596)(273)(1,869)
All Other(82)— (82)
Total(1,943)(273)(2,216)
June 30, 2020 Balances
North America103 — 103 
Europe5,745 4 5,749 
All Other166 — 166 
Total$6,014 $4 $6,018 
Charges
North America146 — 146 
Europe1,434 — 1,434 
All Other— — — 
Total1,580 — 1,580 
Payments
North America(151)— (151)
Europe(1,455)— (1,455)
All Other— — — 
Total(1,606)— (1,606)
SeveranceContract TerminationsTotal
September 30, 2020 Balances
North America98 — 98 
Europe5,724 4 5,728 
All Other166 — 166 
Total$5,988 $4 $5,992 
XML 67 R47.htm IDEA: XBRL DOCUMENT v3.20.2
Net Earnings (Loss) Per Common Share (Tables)
 9 Months Ended
Sep. 30, 2020
Earnings Per Share [Abstract]  
Schedule of Earnings Per Share, Basic and Diluted
The following table sets forth the computation of basic and diluted net loss per common share for the periods indicated.
(In thousands except per share data)For the Three Months Ended September 30,For the Nine Months Ended September 30,
2020201920202019
Basic
Weighted average common shares outstanding34,419 33,660 34,213 33,571 
Net loss$(7,276)$(8,041)$(23,163)$(34,644)
Net loss per common share$(0.21)$(0.24)$(0.68)$(1.03)
Diluted
Weighted average common shares outstanding34,419 33,660 34,213 33,571 
Share options and awards111 8 100 10 
Weighted average common shares assuming dilution34,530 33,668 34,313 33,581 
Net loss$(7,276)$(8,041)$(23,163)$(34,644)
Net loss per common share *$(0.21)$(0.24)$(0.68)$(1.03)
________
* Net loss per common share assuming dilution calculated utilizing weighted average shares outstanding-basic for the periods in which there was a net loss.
XML 68 R48.htm IDEA: XBRL DOCUMENT v3.20.2
Derivatives (Tables)
 9 Months Ended
Sep. 30, 2020
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Schedule of Notional Amounts of Outstanding Derivative Positions
Outstanding foreign currency forward exchange contracts qualifying and designated for hedge accounting treatment were as follows (in thousands USD):
 September 30, 2020December 31, 2019
 Notional
Amount		Unrealized
Net Gain
(Loss)		Notional
Amount		Unrealized
Net Gain
(Loss)
USD / AUD$960 $(41)$3,840 $(106)
USD / CAD1,138 (2)3,888 32 
USD / EUR17,468 (1,061)110,905 122 
USD / GBP387 (11)3,972 (8)
USD / NZD290 (13)2,760 (166)
USD / SEK876 (88)5,062 (38)
USD / MXN3,901 (58)6,763 346 
EUR / CAD915 (42)4,151 24 
EUR / CHF2,703 (45)9,821 10 
EUR / GBP6,325 178 29,824 (216)
EUR / SEK2,330 (72)9,493 (46)
EUR / NOK1,490 14 5,797 15 
DKK / SEK1,402 40 5,936 24 
NOK / SEK1,490 53 5,151 18 
$41,675 $(1,148)$207,363 $11 
Schedule of Other Derivatives Not Designated as Hedging Instruments, Statements of Financial Performance and Financial Position, Location
Foreign currency forward exchange contracts not qualifying or designated for hedge accounting treatment, as well as ineffective hedges, entered into in 2020 and 2019, respectively, and outstanding were as follows (in thousands USD):
 September 30, 2020December 31, 2019
 Notional
Amount		Gain
(Loss)		Notional
Amount		Gain
(Loss)
AUD / USD$6,149 $96 $10,000 $(94)
CAD / USD8,321 88 8,000 (50)
EUR / USD11,735 (745)10,000 104 
DKK / USD15,081 (137)— — 
GBP / USD650 (18)7,000 40 
NOK / USD8,986 (427)— — 
NZD / USD309 (9)4,500 (101)
EUR / CAD130 (6)— — 
EUR / GBP2,086 59 — — 
AUD / NZD6,438 21 7,900 23 
EUR / NOK80 1 — — 
$59,965 $(1,077)$47,400 $(78)
Schedule of Derivatives Instruments Statements of Financial Position, Fair Value
The fair values of the company’s derivative instruments were as follows (in thousands):
 September 30, 2020December 31, 2019
 AssetsLiabilitiesAssetsLiabilities
Derivatives designated as hedging instruments under ASC 815
Foreign currency forward exchange contracts$334 $1,482 $668 $657 
Derivatives not designated as hedging instruments under ASC 815
Foreign currency forward exchange contracts265 1,342 170 248 
Total derivatives$599 $2,824 $838 $905 
Schedule of Derivative Instruments, Effect on Other Comprehensive Income (Loss)
The effect of derivative instruments on Accumulated Other Comprehensive Income (OCI) and the Statement of Comprehensive Income (Loss) and was as follows (in thousands):
Derivatives in ASC 815 cash flow hedge
relationships		Amount of Gain
(Loss) Recognized  in Accumulated OCI on Derivatives
(Effective Portion)		Amount of Gain (Loss)
Reclassified from
Accumulated  OCI into
Income (Effective
Portion)		Amount of Gain (Loss)
Recognized in Income on
Derivatives (Ineffective  Portion and Amount Excluded from
Effectiveness Testing)
Three months ended September 30, 2020
Foreign currency forward exchange contracts$(2,501)$(739)$(662)
Nine months ended September 30, 2020
Foreign currency forward exchange contracts$(1,340)$(352)$(718)
Three months ended September 30, 2019
Foreign currency forward exchange contracts$557 $860 $(2)
Nine months ended September 30, 2019
Foreign currency forward exchange contracts$2,179 $1,445 $50 
Derivatives not designated as hedging
instruments under ASC 815		  Amount of Gain (Loss)
Recognized in Income on Derivatives
Three months ended September 30, 2020
Foreign currency forward exchange contracts$(1,320)
Nine months ended September 30, 2020
Foreign currency forward exchange contracts$(1,077)
Three months ended September 30, 2019
Foreign currency forward exchange contracts$317 
Nine months ended September 30, 2019
Foreign currency forward exchange contracts$103 
Schedule of Fair Value Hedging Instruments, Statements of Financial Performance and Financial Position, Location
The fair values of the outstanding convertible note derivatives as of September 30, 2020 and their effect on the Statement of Comprehensive Income (Loss) were as follows (in thousands):
 Gain (Loss)Gain (Loss)
 Fair ValueThree Months EndedNine Months Ended
September 30, 2020September 30, 2020September 30, 2019September 30, 2020September 30, 2019
Convertible 2021 debt conversion long-term liability$— $— $— $— $(2,210)
Convertible 2022 debt conversion long-term liability— — — — (6,193)
Convertible 2021 note hedge long-term asset— — — — 2,852 
Convertible 2022 note hedge long-term asset— — — — 6,748 
Net fair value and net gain on convertible debt derivatives$— $— $— $— $1,197 
XML 69 R49.htm IDEA: XBRL DOCUMENT v3.20.2
Fair Values (Tables)
 9 Months Ended
Sep. 30, 2020
Fair Value Disclosures [Abstract]  
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis
The following table provides a summary of the company’s assets and liabilities that are measured on a recurring basis (in thousands):
 Basis for Fair Value Measurements at Reporting Date
Quoted Prices in Active
Markets for Identical
Assets / (Liabilities)		Significant Other
Observable
Inputs		Significant Other
Unobservable
Inputs
Level ILevel IILevel III
September 30, 2020
Forward exchange contracts—net—$(2,225)—
December 31, 2019
Forward exchange contracts—net—$(67)—
Fair Value, by Balance Sheet Grouping
The carrying values and fair values of the company’s financial instruments are as follows (in thousands):
 September 30, 2020December 31, 2019
 Carrying ValueFair ValueCarrying ValueFair Value
Cash and cash equivalents$86,825 $86,825 $80,063 $80,063 
Other investments85 85 85 85 
Installment receivables, net of reserves325 325 913 913 
Total debt (including current maturities of long-term debt) *(242,264)(218,231)(219,522)(207,193)
Forward contracts in Other Current Assets599 599 838 838 
Forward contracts in Accrued Expenses(2,824)(2,824)(905)(905)
________
* The company's total debt is shown net of discount and fees associated with the Convertible Senior Notes due in 2021, 2022 and 2024 on the company's condensed consolidated balance sheet. Accordingly, the fair values of the Convertible Senior Notes due in 2021, 2022 and 2024 are included in the long-term debt presented in this table are also shown net of the discount and fees. Total debt amounts exclude operating and financing leases obligations.
XML 70 R50.htm IDEA: XBRL DOCUMENT v3.20.2
Business Segments (Tables)
 9 Months Ended
Sep. 30, 2020
Segment Reporting [Abstract]  
Schedule of Segment Reporting Information, by Segment
The information by segment is as follows (in thousands):
 For the Three Months Ended September 30,For the Nine Months Ended September 30,
2020201920202019
Revenues from external customers
Europe$116,285 $137,371 $339,147 $396,206 
North America88,055 87,118 261,595 262,915 
All Other (Asia Pacific)7,566 11,285 25,904 35,930 
Consolidated$211,906 $235,774 $626,646 $695,051 
Intersegment revenues
Europe$6,027 $3,124 $14,438 $10,396 
North America23,625 21,130 66,356 61,109 
All Other (Asia Pacific)1,116 3,904 3,645 9,776 
Consolidated$30,768 $28,158 $84,439 $81,281 
Restructuring charges before income taxes
Europe$1,434 $1,263 $3,674 $1,903 
North America146 331 865 1,539 
All Other— 34 118 199 
Consolidated$1,580 $1,628 $4,657 $3,641 
Operating income (loss)
Europe$7,600 $11,365 $16,624 $22,617 
North America2,992 (1,694)5,759 (7,316)
All Other(6,082)(5,625)(17,377)(18,230)
Charge expense related to restructuring activities(1,580)(1,628)(4,657)(3,641)
Gain on sale of business— — 9,790 — 
Consolidated operating income (loss)2,930 2,418 10,139 (6,570)
Net gain on convertible debt derivatives— — — 1,197 
Loss on debt extinguishment including debt finance charges and associated fees(761)(280)(7,360)(280)
Net Interest expense(7,395)(6,879)(21,042)(21,666)
Loss before income taxes$(5,226)$(4,741)$(18,263)$(27,319)
Revenue from External Customer [Line Items]  
Revenue from External Customers by Products and Services [Table Text Block]
Net sales by product, are as follows (in thousands):
For the Three Months Ended September 30,For the Nine Months Ended September 30,
2020201920202019
Europe
Lifestyle$50,307 $59,403 $160,628 $182,103 
Mobility and Seating54,851 68,286 147,275 184,819 
Respiratory Therapy6,070 4,919 16,680 14,875 
Other(1)5,057 4,763 14,564 14,409 
$116,285 $137,371 $339,147 $396,206 
North America
Lifestyle$41,845 $43,401 $124,888 $131,259 
Mobility and Seating26,572 31,252 82,485 89,638 
Respiratory Therapy19,405 12,108 53,626 40,811 
Other(1)233 357 596 1,207 
$88,055 $87,118 $261,595 $262,915 
All Other (Asia Pacific)
Mobility and Seating$2,670 $6,645 $10,757 $21,986 
Lifestyle3,375 3,001 10,176 8,261 
Respiratory Therapy195 175 1,043 1,063 
Other(1)1,326 1,464 3,928 4,620 
$7,566 $11,285 $25,904 $35,930 
Total Consolidated$211,906 $235,774 $626,646 $695,051 
   ________________________
(1)Includes various services, including repair services, equipment rentals and external contracting.
XML 71 R51.htm IDEA: XBRL DOCUMENT v3.20.2
Divested Businesses (Details) - USD ($)
 2 Months Ended 3 Months Ended 9 Months Ended 12 Months Ended
Mar. 07, 2020
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Dec. 31, 2019
Divested Businesses [Abstract]            
Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net $ 4,129,000         $ 1,804,000
Disposal Group, Including Discontinued Operation, Revenue 5,331,000         30,261,000
Disposal Group, Including Discontinued Operation, Inter-Company Revenue 2,532,000         13,087,000
Disposal Group, Including Discontinued Operation, Earnings Before Taxes 445,000         853,000
Proceeds from sale of business       $ 14,563,000 $ 0  
Gain on sale of business   $ 0 $ 0 9,790,000 $ 0  
Disposal Group, Including Discontinued Operation, Payments for Divestiture Costs       1,789,000    
Disposal Group, Including Discontinued Operation, Divestiture Costs Incurred       $ 2,150,000    
Disposal Group, Including Discontinued Operation, Inventory 3,082,000         3,008,000
Disposal Group, Including Discontinued Operation, Other Assets 855,000         933,000
Disposal Group, Including Discontinued Operation, Property, Plant and Equipment 600,000         707,000
Disposal Group, Including Discontinued Operation, Operating Lease Right-of-Use Asset 2,127,000         1,870,000
ERROR in label resolution. 10,793,000         8,322,000
Disposal Group, Including Discontinued Operation, Accounts Payable 4,692,000         4,501,000
Disposal Group, Including Discontinued Operation, Accrued Liabilities 2,473,000         2,108,000
Disposal Group, Including Discontinued Operation, Accrued Income Tax Payable 41,000         92,000
Disposal Group, Including Discontinued Operation, Operating Lease, Liability, Current 366,000         393,000
Disposal Group, Including Discontinued Operation, Operating Lease, Liability, NonCurrent 1,019,000         1,754,000
Disposal Group, Including Discontinued Operation, Liabilities $ 8,591,000         $ 8,848,000
XML 72 R52.htm IDEA: XBRL DOCUMENT v3.20.2
Receivables (Narrative) (Details)
 9 Months Ended
Sep. 30, 2020
USD ($)
payment
Accounts, Notes, Loans and Financing Receivable [Line Items]  
Adoption of Credit Loss Standard $ (243,000)
Contingent Liability, Guarantee $ 306,000
Number of missed payments before delinquent | payment 3
Typical financing period 12 months
Credit amount requiring additional analysis $ 250,000
Average period of adjudication 18 months
Installment receivable purchased from DLL $ 343,000
Risk Level, Low  
Accounts, Notes, Loans and Financing Receivable [Line Items]  
Receivables, Expected Loss Percentage, North America excluding Canada 1.00%
Receivables, Expected Loss Percentage, Canada 0.20%
Receivables, Expected Loss Percentage, Europe 0.30%
Receivables, Expected Loss Percentage, AsiaPac 0.30%
Risk Level, Medium  
Accounts, Notes, Loans and Financing Receivable [Line Items]  
Receivables, Expected Loss Percentage, Europe 0.90%
Risk Level, High  
Accounts, Notes, Loans and Financing Receivable [Line Items]  
Receivables, Expected Loss Percentage, Europe 2.70%
XML 73 R53.htm IDEA: XBRL DOCUMENT v3.20.2
Receivables (Schedule of Accounts Receivable) (Details) - USD ($)
$ in Thousands
Sep. 30, 2020
Dec. 31, 2019
Schedule of Accounts Receivable [Abstract]    
Accounts receivable, gross $ 132,809 $ 141,732
Customer rebate reserve (13,075) (13,922)
Cash discount reserves (5,290) (5,326)
Allowance for doubtful accounts (4,697) (4,804)
Other, principally returns and allowances reserves (790) (1,011)
Accounts Receivable, Net $ 108,957 $ 116,669
XML 74 R54.htm IDEA: XBRL DOCUMENT v3.20.2
Receivables Schedule for Allowance for Credit Losses (Details) - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2020
Dec. 31, 2019
Financing Receivable, Allowance for Credit Losses [Line Items]    
Allowance for Credit Losses $ 4,697 $ 4,804
Allowance for Loan and Lease Losses, Adjustments, Other 522  
Financing Receivable, Allowance for Credit Losses, Write-downs $ (629)  
XML 75 R55.htm IDEA: XBRL DOCUMENT v3.20.2
Receivables (Installment Recevables) (Details) - USD ($)
Sep. 30, 2020
Dec. 31, 2019
Dec. 31, 2018
Receivables [Abstract]      
Non-Impaired Financing Receivable, Related Allowance $ 0 $ 0  
Installment Receivables, Current 555,000 1,192,000  
Installment Receivables, Long-Term 228,000 1,257,000  
Total Installment Receivables 783,000 2,449,000  
Unearned Interest 3,000 22,000  
Unearned Interest - Noncurrent 0 0  
Total Unearned Interest (3,436,000) (3,173,000)  
Unearned Interest 3,000 22,000  
Installment Receivables Net of Unearned Interest Current 552,000 1,170,000  
Installment Receivables Net of Unearned Interest Noncurrent 228,000 1,257,000  
Installment Receivables, Net of Unearned Interest 780,000 2,427,000  
Allowance for doubtful accounts, current (291,000) (434,000)  
Allowance for doubtful accounts, long-term (164,000) (1,080,000)  
Allowance for doubtful accounts (455,000) (1,514,000) $ (1,542,000)
Installment receivables, net 261,000 736,000  
Installment receivables, net, long-term 64,000 177,000  
Installment receivables, net $ 325,000 $ 913,000  
XML 76 R56.htm IDEA: XBRL DOCUMENT v3.20.2
Receivables (Rollforward of Allowance for Doubtful Accounts) (Details) - USD ($)
$ in Thousands
 9 Months Ended 12 Months Ended
Sep. 30, 2020
Dec. 31, 2019
Allowance for Doubtful Accounts [Roll Forward]    
Balance as of beginning of period $ 1,514 $ 1,542
Current period provision 32 479
Direct write-offs charged against the allowance (1,091) (507)
Balance as of end of period $ 455 $ 1,514
XML 77 R57.htm IDEA: XBRL DOCUMENT v3.20.2
Receivables (Installment Receivables by Class) (Details) - USD ($)
$ in Thousands
 9 Months Ended 12 Months Ended
Sep. 30, 2020
Dec. 31, 2019
Total Installment Receivables    
Non-Impaired installment receivables with no related allowance recorded $ 132 $ 670
Impaired installment receivables with a related allowance recorded 651 1,779
Total installment receivables 783 2,449
Unpaid Principal Balance    
Non-Impaired installment receivables with no related allowance recorded 129 648
Impaired installment receivables with a related allowance recorded 651 1,779
Total installment receivables 780 2,427
Non-Impaired Financing Receivable, Related Allowance 0 0
Related Allowance for Doubtful Accounts    
Impaired installment receivables with a related allowance recorded 455 1,514
Interest Income Recognized    
Non-Impaired installment receivables with no related allowance recorded 26 92
Impaired installment receivables with a related allowance recorded 0 0
Total installment receivables 26 92
U.S.    
Total Installment Receivables    
Impaired installment receivables with a related allowance recorded 649 1,762
Unpaid Principal Balance    
Impaired installment receivables with a related allowance recorded 649 1,762
Related Allowance for Doubtful Accounts    
Impaired installment receivables with a related allowance recorded 453 1,497
Interest Income Recognized    
Impaired installment receivables with a related allowance recorded 0 0
CANADA    
Total Installment Receivables    
Non-Impaired installment receivables with no related allowance recorded 132 670
Impaired installment receivables with a related allowance recorded 2 17
Total installment receivables 134 687
Unpaid Principal Balance    
Non-Impaired installment receivables with no related allowance recorded 129 648
Impaired installment receivables with a related allowance recorded 2 17
Total installment receivables 131 665
Non-Impaired Financing Receivable, Related Allowance 0 0
Related Allowance for Doubtful Accounts    
Impaired installment receivables with a related allowance recorded 2 17
Interest Income Recognized    
Non-Impaired installment receivables with no related allowance recorded 26 92
Impaired installment receivables with a related allowance recorded 0 0
Total installment receivables $ 26 $ 92
XML 78 R58.htm IDEA: XBRL DOCUMENT v3.20.2
Receivables (Aging of Installment Receivables) (Details) - USD ($)
$ in Thousands
Sep. 30, 2020
Dec. 31, 2019
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Current $ 132 $ 659
0-30 Days Past Due 0 2
31-60 Days Past Due 0 4
61-90 Days Past Due 0 0
90+ Days Past Due 651 1,784
Total Installment Receivables Past Due 783 2,449
U.S.    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Current 0 0
0-30 Days Past Due 0 0
31-60 Days Past Due 0 0
61-90 Days Past Due 0 0
90+ Days Past Due 649 1,762
Total Installment Receivables Past Due 649 1,762
CANADA    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Current 132 659
0-30 Days Past Due 0 2
31-60 Days Past Due 0 4
61-90 Days Past Due 0 0
90+ Days Past Due 2 22
Total Installment Receivables Past Due $ 134 $ 687
XML 79 R59.htm IDEA: XBRL DOCUMENT v3.20.2
Inventories (Details) - USD ($)
$ in Thousands
Sep. 30, 2020
Dec. 31, 2019
Inventory Disclosure [Abstract]    
Finished goods $ 68,599 $ 54,064
Raw materials 66,093 54,638
Work in process 10,760 11,798
Inventory, net $ 145,452 $ 120,500
XML 80 R60.htm IDEA: XBRL DOCUMENT v3.20.2
Other Current Assets Components of Other Current Assets (Details) - USD ($)
$ in Thousands
Sep. 30, 2020
Dec. 31, 2019
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]    
Tax receivables principally value added taxes $ 23,188 $ 16,049
Receivable due from information technology provider 2,402 6,262
Prepaid inventory 1,392 684
Derivatives (foreign currency forward exchange contracts) 599 838
Service contracts 446 2,013
Prepaid insurance 341 2,918
Deferred financing fees 209 207
Prepaid social charges 95 1,216
Recoverable income taxes 50 297
Prepaid and other current assets 8,913 7,425
Other current assets $ 37,635 $ 37,909
XML 81 R61.htm IDEA: XBRL DOCUMENT v3.20.2
Other Long-Term Assets Components of Other Long-Term Assets (Details) - USD ($)
$ in Thousands
Sep. 30, 2020
Dec. 31, 2019
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]    
Cash surrender value of life insurance policies $ 2,224 $ 2,124
Deferred income taxes 1,032 928
Deferred financing fees 461 602
Investments 85 85
Installment receivables 64 177
Other 125 300
Other Long-Term Assets $ 3,991 $ 4,216
XML 82 R62.htm IDEA: XBRL DOCUMENT v3.20.2
Property And Equipment (Details) - USD ($)
$ in Thousands
 3 Months Ended
Jun. 30, 2020
Sep. 30, 2018
Sep. 30, 2020
Dec. 31, 2019
Property, Plant and Equipment [Line Items]        
Property and equipment, gross     $ 351,730 $ 351,562
Less allowance for depreciation     (298,618) (304,955)
Property and equipment, net     53,112 46,607
Advance Payment from Sale of Property   $ 2,900    
Gain (Loss) on Sale of Properties $ 971      
Machinery and equipment        
Property, Plant and Equipment [Line Items]        
Property and equipment, gross     291,902 296,078
Land, buildings and improvements        
Property, Plant and Equipment [Line Items]        
Property and equipment, gross     28,088 33,054
Furniture and fixtures        
Property, Plant and Equipment [Line Items]        
Property and equipment, gross     9,866 9,898
Leasehold improvements        
Property, Plant and Equipment [Line Items]        
Property and equipment, gross     8,087 9,023
Capitalized Software [Member]        
Property, Plant and Equipment [Line Items]        
Property and equipment, gross     $ 13,787 $ 3,509
XML 83 R63.htm IDEA: XBRL DOCUMENT v3.20.2
Intangibles (Narrative) (Details)
 9 Months Ended
Sep. 30, 2020
USD ($)
Finite-Lived Intangible Assets [Line Items]  
Amortization expense $ 276,000
Minimum  
Finite-Lived Intangible Assets [Line Items]  
Finite-Lived intangible assets, useful life 1 year
Maximum  
Finite-Lived Intangible Assets [Line Items]  
Finite-Lived intangible assets, useful life 10 years
Weighted Average  
Finite-Lived Intangible Assets [Line Items]  
Finite-Lived intangible assets, useful life 8 years
XML 84 R64.htm IDEA: XBRL DOCUMENT v3.20.2
Intangibles (Intangible Table) (Details) - USD ($)
$ in Thousands
Sep. 30, 2020
Dec. 31, 2019
Finite-Lived and Indefinite-Lived Intangible Assets [Line Items]    
Historical Cost $ 96,743 $ 91,638
Accumulated Amortization 68,973 65,191
Customer lists    
Finite-Lived and Indefinite-Lived Intangible Assets [Line Items]    
Historical Cost 54,267 51,108
Accumulated Amortization 54,267 51,108
Developed technology    
Finite-Lived and Indefinite-Lived Intangible Assets [Line Items]    
Historical Cost 7,918 7,483
Accumulated Amortization 7,150 6,642
Patents    
Finite-Lived and Indefinite-Lived Intangible Assets [Line Items]    
Historical Cost 5,514 5,521
Accumulated Amortization 5,514 5,521
License agreements    
Finite-Lived and Indefinite-Lived Intangible Assets [Line Items]    
Historical Cost 2,864 2,884
Accumulated Amortization 891 770
Other    
Finite-Lived and Indefinite-Lived Intangible Assets [Line Items]    
Historical Cost 1,161 1,163
Accumulated Amortization 1,151 1,150
Trademarks    
Finite-Lived and Indefinite-Lived Intangible Assets [Line Items]    
Historical Cost $ 25,019 $ 23,479
XML 85 R65.htm IDEA: XBRL DOCUMENT v3.20.2
Intangibles (Finite-Lived Intangible Asset Future Amortization Expense) (Details)
Sep. 30, 2020
USD ($)
Goodwill and Intangible Assets Disclosure [Abstract]  
Future amortization expense, remainder of fiscal year $ 419,000
Future amortization expense, 2021 390,000
Future amortization expense, 2022 390,000
Future amortization expense, 2023 389,000
Future amortization expense, 2024 355,000
Future amortization expense, 2025 $ 212,000
XML 86 R66.htm IDEA: XBRL DOCUMENT v3.20.2
Accrued Expenses Components of Accrued Expenses (Details) - USD ($)
$ in Thousands
Sep. 30, 2020
Dec. 31, 2019
Payables and Accruals [Abstract]    
Salaries and wages $ 34,612 $ 29,725
Taxes other than income taxes, primarily Value Added Taxes 29,830 22,194
Warranty 11,144 11,626
Professional 8,481 6,869
Severance 5,988 7,023
Interest 4,663 3,608
Rebates 4,146 10,743
IT service contracts 3,790 6,125
Freight 3,710 3,744
Deferred revenue 3,436 3,173
Derivative liabilities (foreign currency forward exchange contracts) 2,824 905
Product liability, current portion 2,810 2,736
Insurance 781 699
Rent 568 415
Supplemental Executive Retirement Program liability 391 391
Advance payment on sale of land & buildings 0 3,471
IT licenses 0 2,114
Other items, principally trade accruals 7,492 5,386
Accrued expenses $ 124,666 $ 120,947
XML 87 R67.htm IDEA: XBRL DOCUMENT v3.20.2
Accrued Expenses Warranty Schedule (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2020
Product Liability Contingency    
Balance as of January 1, 2020   $ 11,626
Warranties provided during the period   4,311
Settlements made during the period   (5,926)
Changes in liability for pre-existing warranties during the period, including expirations   1,133
Balance as of September 30, 2020 $ 11,144 $ 11,144
Extended Product Warranty Accrual, Increase for Warranties Issued $ 768  
XML 88 R68.htm IDEA: XBRL DOCUMENT v3.20.2
Long-Term Debt (Details) - USD ($)
 9 Months Ended
Sep. 30, 2020
Dec. 31, 2019
Jun. 30, 2017
Mar. 31, 2016
Debt Instrument [Line Items]        
Long-term debt $ 242,264,000 $ 219,522,000    
Long-term Debt and Capital Lease Obligations, Current (4,062,000) (58,000)    
Long-term debt net of current maturities 238,202,000 219,464,000    
Accretion Expense $ 1,016,000      
Accretion Rate 4.70%      
CARES Act Loan [Member]        
Debt Instrument [Line Items]        
Interest rate (as a percent) 1.00%      
Convertible Subordinated Debt | Convertible Senior Notes at 5.00% February 2021 [Member]        
Debt Instrument [Line Items]        
Debt Instrument, Face Amount $ 1,250,000 61,091,000   $ 150,000,000
Long-term debt 1,224,000 56,628,000    
Debt Instrument, Unamortized Discount (22,000) (3,916,000)    
Debt Instrument, Fee Amount (4,000) (547,000)    
Debt Instrument, Net Carrying Amount $ 1,224,000 56,628,000    
Interest rate (as a percent) 5.00%      
Convertible Subordinated Debt | Convertible Senior Notes at 4.50% February 2022 [Domain]        
Debt Instrument [Line Items]        
Debt Instrument, Face Amount $ 81,500,000 120,000,000 $ 120,000,000  
Long-term debt 72,652,000 101,815,000    
Debt Instrument, Unamortized Discount (7,837,000) (16,027,000)    
Debt Instrument, Fee Amount (1,011,000) (2,158,000)    
Debt Instrument, Net Carrying Amount $ 72,652,000 101,815,000    
Interest rate (as a percent) 4.50%      
Convertible Subordinated Debt | Convertible Senior Notes at 5.00% November 2024 [Domain]        
Debt Instrument [Line Items]        
Long-term debt $ 62,443,000 60,817,000    
Convertible Subordinated Debt | Series II Convertible Senior Notes at 5.00% November 2024 [Domain]        
Debt Instrument [Line Items]        
Long-term debt 63,556,000 0    
Other Notes and Capital Lease Obligations        
Debt Instrument [Line Items]        
Long-term debt $ 42,389,000 $ 262,000    
XML 89 R69.htm IDEA: XBRL DOCUMENT v3.20.2
Long-Term Debt Components of Convertible Debt (Details) - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2020
Dec. 31, 2019
Sep. 30, 2019
Jun. 30, 2017
Mar. 31, 2016
Sep. 30, 2020
Sep. 30, 2019
Debt Instrument [Line Items]              
Issuance of warrants         $ 12,376,000    
Long-term debt $ 242,264,000 $ 219,522,000       $ 242,264,000  
Convertible Subordinated Debt | Convertible Senior Notes at 5.00% February 2021 [Member]              
Debt Instrument [Line Items]              
Debt Instrument, Increase, Accrued Interest 241,000   $ 1,834,000     1,617,000 $ 5,584,000
Debt Instrument, Face Amount $ 1,250,000 61,091,000     $ 150,000,000 $ 1,250,000  
Interest rate (as a percent) 5.00%         5.00%  
Unamortized discount $ (22,000) (3,916,000)       $ (22,000)  
Long-term debt 1,224,000 56,628,000       1,224,000  
Debt fees (4,000) (547,000)       (4,000)  
Debt Instrument, Net Carrying Amount 1,224,000 56,628,000       1,224,000  
Convertible Subordinated Debt | Convertible Senior Notes at 4.50% February 2022 [Domain]              
Debt Instrument [Line Items]              
Debt Instrument, Increase, Accrued Interest 917,000   $ 1,350,000     3,487,000 $ 4,050,000
Debt Instrument, Face Amount $ 81,500,000 120,000,000   $ 120,000,000   $ 81,500,000  
Issuance of warrants       $ 14,100,000      
Interest rate (as a percent) 4.50%         4.50%  
Unamortized discount $ (7,837,000) (16,027,000)       $ (7,837,000)  
Long-term debt 72,652,000 101,815,000       72,652,000  
Debt fees (1,011,000) (2,158,000)       (1,011,000)  
Debt Instrument, Net Carrying Amount 72,652,000 101,815,000       72,652,000  
Convertible Subordinated Debt | Convertible Senior Notes at 5.00% November 2024 [Domain]              
Debt Instrument [Line Items]              
Long-term debt 62,443,000 60,817,000       62,443,000  
Convertible Subordinated Debt | Convertible Senior Notes at 5.00% November 2024 [Member]              
Debt Instrument [Line Items]              
Debt Instrument, Increase, Accrued Interest 912,000         2,735,000  
Debt Instrument, Loss on Exchange   5,885,000          
Debt Instrument, Face Amount $ 72,909,000 $ 72,909,000       $ 72,909,000  
Interest rate (as a percent) 5.00% 5.00%       5.00%  
Unamortized discount $ (9,363,000) $ (10,733,000)       $ (9,363,000)  
Debt fees (1,103,000) (1,359,000)       (1,103,000)  
Debt Instrument, Net Carrying Amount $ 62,443,000 $ 60,817,000       $ 62,443,000  
XML 90 R70.htm IDEA: XBRL DOCUMENT v3.20.2
Long-Term Debt Narrative (Details) - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2020
Jun. 30, 2020
Dec. 31, 2019
Sep. 30, 2019
Jun. 30, 2017
Mar. 31, 2016
Sep. 30, 2020
Sep. 30, 2019
May 15, 2020
Dec. 31, 2016
Debt Instrument [Line Items]                    
Issuance of warrants           $ 12,376,000        
Payments for Repurchase of Common Stock             $ 1,702,000 $ 860,000    
Amortization of debt fees             1,329,000 1,860,000    
Loss on debt extinguishment including debt finance charges and fees $ 761,000     $ 280,000     $ 7,360,000 280,000    
CARES Act Loan [Member]                    
Debt Instrument [Line Items]                    
Interest rate (as a percent) 1.00%           1.00%      
Unsecured Debt                 $ 10,000,000  
Unsecured Debt, Current $ 2,816,000           $ 2,816,000      
Convertible Subordinated Debt | Convertible Senior Notes at 5.00% November 2024 [Domain]                    
Debt Instrument [Line Items]                    
Debt Instrument, Convertible, Threshold Trading Days             10      
Convertible Subordinated Debt | Convertible Senior Notes at 5.00% November 2024 [Member]                    
Debt Instrument [Line Items]                    
Debt Instrument, Fee Amount     $ 1,394,000              
Debt Instrument, Face Amount $ 72,909,000   $ 72,909,000       $ 72,909,000      
Interest rate (as a percent) 5.00%   5.00%       5.00%      
Debt Instrument Repurchase Amount, Cash Paid     $ 6,928,000              
Last Reported Sales Price Period, Common Stock             20 days      
Debt Instrument, Convertible, Threshold Consecutive Trading Days             30      
Percent of the Applicable Conversion Price 130.00%           130.00%      
Business Day Period             5 years      
Percent of the Product of the Last Reported Sale Price, Common Shares 98.00%           98.00%      
Convertible Senior Notes, Percentage of Principal Required for Repurchase 100.00%           100.00%      
Convertible Preferred Stock, Shares Issued upon Conversion 67.6819           67.6819      
Convertible Debt, Conversion Rate of Commmon Shares, Principal $ 1,000           $ 1,000      
Debt Instrument, Convertible, Conversion Price $ 14.78           $ 14.78      
Debt Instrument, Net Carrying Amount $ 62,443,000   60,817,000       $ 62,443,000      
Debt Instrument, Fee Amount (1,103,000)   (1,359,000)       (1,103,000)      
Debt Instrument, Unamortized Discount $ (9,363,000)   (10,733,000)       $ (9,363,000)      
Debt Instrument, Interest Rate, Effective Percentage 8.77%           8.77%      
Debt Instrument, Non-Cash Interest Expense Recognized in the Period $ 468,000           $ 1,370,000      
Debt Instrument, Increase, Accrued Interest 912,000           2,735,000      
Debt Instrument, Loss on Exchange     5,885,000              
Convertible Subordinated Debt | Convertible Senior Notes at 5.00% February 2021 [Member]                    
Debt Instrument [Line Items]                    
Debt Instrument, Fee Amount                   $ 5,966,000
Debt Instrument, Face Amount $ 1,250,000   61,091,000     $ 150,000,000 $ 1,250,000      
Interest rate (as a percent) 5.00%           5.00%      
Debt Instrument Exchange Amount   $ 35,375,000 72,909,000              
Debt Instrument, Repurchase Amount $ 24,466,000     16,000,000     $ 24,466,000 16,000,000    
Last Reported Sales Price Period, Common Stock             20 days      
Debt Instrument, Convertible, Threshold Consecutive Trading Days             30      
Percent of the Applicable Conversion Price 130.00%           130.00%      
Business Day Period             5 years      
Debt Instrument, Convertible, Threshold Trading Days             10      
Percent of the Product of the Last Reported Sale Price, Common Shares 98.00%           98.00%      
Convertible Senior Notes, Percentage of Principal Required for Repurchase 100.00%           100.00%      
Convertible Preferred Stock, Shares Issued upon Conversion 60.0492           60.0492      
Convertible Debt, Conversion Rate of Commmon Shares, Principal $ 1,000           $ 1,000      
Debt Instrument, Convertible, Conversion Price $ 16.65           $ 16.65      
Convertible Debt Conversion Feature, Fair Value at Issuance $ 34,480,000           $ 34,480,000      
Convertible Debt Conversion Feature Gain (Loss) 0     0     0 2,210,000    
Convertible due 2021 - Bond Hedge, Fair Value at Issuance 27,975,000           27,975,000      
Convertible Debt Note Hedge Gain (Loss) 0     0     0 2,852,000    
Derivative, Price Risk Option Strike Price           $ 22.4175        
Debt Instrument, Net Proceeds                   144,034,000
Debt Instrument, Net Carrying Amount 1,224,000   56,628,000       1,224,000      
Debt Instrument, Fee Amount (4,000)   (547,000)       (4,000)      
Payments for Repurchase of Common Stock           $ 5,000,000        
Derivative, Amount of Hedged Item                   $ (15,600,000)
Debt Instrument, Unamortized Discount $ (22,000)   (3,916,000)       $ (22,000)      
Debt Instrument, Interest Rate, Effective Percentage 11.10%           11.10%      
Debt Instrument, Non-Cash Interest Expense Recognized in the Period $ 261,000     1,444,000     $ 1,767,000 5,391,000    
Debt Instrument, Increase, Accrued Interest 241,000     1,834,000     1,617,000 5,584,000    
Convertible Subordinated Debt | Convertible Senior Notes at 4.50% February 2022 [Domain]                    
Debt Instrument [Line Items]                    
Debt Instrument, Fee Amount         $ 4,711,000          
Debt Instrument, Face Amount $ 81,500,000   120,000,000   120,000,000   $ 81,500,000      
Interest rate (as a percent) 4.50%           4.50%      
Debt Instrument Exchange Amount   38,500,000                
Last Reported Sales Price Period, Common Stock             20 days      
Debt Instrument, Convertible, Threshold Consecutive Trading Days             30      
Percent of the Applicable Conversion Price 130.00%           130.00%      
Business Day Period             5 years      
Debt Instrument, Convertible, Threshold Trading Days             10      
Percent of the Product of the Last Reported Sale Price, Common Shares 98.00%           98.00%      
Convertible Senior Notes, Percentage of Principal Required for Repurchase 100.00%           100.00%      
Convertible Preferred Stock, Shares Issued upon Conversion 61.6095           61.6095      
Convertible Debt, Conversion Rate of Commmon Shares, Principal $ 1,000           $ 1,000      
Debt Instrument, Convertible, Conversion Price $ 16.23           $ 16.23      
Convertible Debt Conversion Feature, Fair Value at Issuance         28,859,000          
Convertible Debt Conversion Feature Gain (Loss) $ 0     0     $ 0 6,193,000    
Convertible due 2022 - Bond Hedge, Fair Value at Issuance 24,780,000       $ 24,780,000   24,780,000      
Convertible Debt Note Hedge Gain (Loss) 0     0     0 6,748,000    
Derivative, Price Risk Option Strike Price         $ 21.4375          
Issuance of warrants         $ 14,100,000          
Debt Instrument, Net Proceeds         115,289,000          
Debt Instrument, Net Carrying Amount 72,652,000   101,815,000       72,652,000      
Debt Instrument, Fee Amount (1,011,000)   (2,158,000)       (1,011,000)      
Derivative, Amount of Hedged Item         $ (10,680,000)          
Debt Instrument, Unamortized Discount $ (7,837,000)   $ (16,027,000)       $ (7,837,000)      
Debt Instrument, Interest Rate, Effective Percentage 10.90%           10.90%      
Debt Instrument, Non-Cash Interest Expense Recognized in the Period $ 1,046,000     1,320,000     $ 3,829,000 4,038,000    
Debt Instrument, Increase, Accrued Interest 917,000     $ 1,350,000     3,487,000 $ 4,050,000    
Convertible Subordinated Debt | Convertible Senior Subordinated Debentures at 5.00% February 2021 [Domain]                    
Debt Instrument [Line Items]                    
Unamortized Financing Costs             670,000      
Convertible Subordinated Debt | Series II Convertible Senior Notes at 5.00% November 2024 [Member]                    
Debt Instrument [Line Items]                    
Debt Instrument, Fee Amount   1,518,000                
Debt Instrument, Face Amount $ 74,891,000           $ 74,891,000      
Interest rate (as a percent) 5.00%           5.00%      
Debt Instrument Exchange Amount   73,875,000                
Debt Instrument Repurchase Amount, Cash Paid $ 5,593,000           $ 5,593,000      
Last Reported Sales Price Period, Common Stock             20 days      
Debt Instrument, Convertible, Threshold Consecutive Trading Days             30      
Percent of the Applicable Conversion Price 130.00%           130.00%      
Debt Instrument, Convertible, Threshold Trading Days             10      
Percent of the Product of the Last Reported Sale Price, Common Shares 98.00%           98.00%      
Convertible Senior Notes, Percentage of Principal Required for Repurchase 100.00%           100.00%      
Convertible Preferred Stock, Shares Issued upon Conversion 67.6819           67.6819      
Convertible Debt, Conversion Rate of Commmon Shares, Principal $ 1,000           $ 1,000      
Debt Instrument, Convertible, Conversion Price $ 14.78           $ 14.78      
Debt Instrument, Net Carrying Amount $ 63,556,000           $ 63,556,000      
Debt Instrument, Fee Amount (1,368,000)           (1,368,000)      
Debt Instrument, Unamortized Discount $ (9,967,000)           $ (9,967,000)      
Debt Instrument, Interest Rate, Effective Percentage 8.99%           8.99%      
Debt Instrument, Non-Cash Interest Expense Recognized in the Period $ 1,260,000           $ 1,663,000      
Debt Instrument, Increase, Accrued Interest $ 923,000           $ 1,200,000      
Debt Instrument, Loss on Exchange   $ 6,599,000                
Convertible Subordinated Debt | Series II Convertible Senior Notes at 5.00% November 2024 [Domain]                    
Debt Instrument [Line Items]                    
Business Day Period             5 years      
Revolving Credit Facility | Line of Credit                    
Debt Instrument [Line Items]                    
Weighted average interest rate (as a percent) 4.63%   4.78%       4.63%      
Revolving Credit Facility | Line of Credit | Revolving Credit and Security Agreement (Europe Credit Agreement)                    
Debt Instrument [Line Items]                    
Borrowing capacity $ 30,000,000           $ 30,000,000      
Line of Credit, Covenant Compliance, Maximum Borrowing Capacity, Trade Receivables, Europe, Percent             85.00%      
Minimum availability reserve 3,000,000           $ 3,000,000      
Line of Credit Facility, Covenant Feature, Dominion Trigger 3,750,000           3,750,000      
Line of Credit Facility, Remaining Borrowing Capacity 8,564,000           8,564,000      
Remaining borrowing capacity $ 10,000,000           $ 10,000,000      
Minimum required undrawn balance (as a percent) 11.25%           11.25%      
Consecutive business days for minimum undrawn balance             5 days      
Required undrawn balance, minimum $ 3,000,000           $ 3,000,000      
Interruption of material manufacturing facilities, period             10 days      
Revolving Credit Facility | Line of Credit | Revolving Credit and Security Agreement (New Credit Agreement)                    
Debt Instrument [Line Items]                    
Line of Credit Facility, Fair Value of Amount Outstanding 23,700,000           $ 23,700,000      
Borrowing capacity 60,000,000           60,000,000      
Additional increase in borrowing capacity available 25,000,000           $ 25,000,000      
Percentage of domestic accounts receivable             85.00%      
Percentage of eligible domestic inventory and in-transit inventory             70.00%      
Percentage of net orderly liquidation value of domestic inventory             85.00%      
Maximum value of net orderly liquidation value domestic inventory and in-transit inventory 4,000,000           $ 4,000,000      
Net orderly liquidation value of domestic eligible machinery and equipment             85.00%      
Additional amount of machinery and equipment 0           $ 0      
Percentage of eligible Canadian accounts receivable             85.00%      
Percentage of eligible Canadian inventory             70.00%      
Percentage of net orderly liquidation value of eligible Canadian inventory             85.00%      
Minimum availability reserve 3,000,000           $ 3,000,000      
Line of Credit Facility, Current Borrowing Capacity 23,700,000           23,700,000      
Line of Credit Facility, Covenant Feature, Dominion Trigger $ 7,500,000           $ 7,500,000      
Minimum required undrawn balance (as a percent) 11.25%           11.25%      
Line of Credit, Covenant Compliance, Consecutive Business Days for Undrawn_Balance             5 days      
Required undrawn balance, minimum $ 6,000,000           $ 6,000,000      
Interruption of material manufacturing facilities, period             10 days      
Line of Credit Facility, Foreign Currency Fair Value of Amount Outstanding (France) 6,322,000           $ 6,322,000      
Line of Credit Facility, Foreign Currency Fair Value of Amount Outstanding (UK) 2,138,000           2,138,000      
Revolving Credit Facility | Line of Credit | Revolving Credit and Security Agreement (New Credit Agreement) | Euro Member Countries, Euro                    
Debt Instrument [Line Items]                    
Line of Credit Facility, Foreign Currency Fair Value of Amount Outstanding (France) 5,300,000           5,300,000      
Revolving Credit Facility | Line of Credit | Revolving Credit and Security Agreement (New Credit Agreement) | United Kingdom, Pounds                    
Debt Instrument [Line Items]                    
Line of Credit Facility, Foreign Currency Fair Value of Amount Outstanding (UK) 1,600,000           1,600,000      
Letter of Credit                    
Debt Instrument [Line Items]                    
Line of Credit Facility, Fair Value of Amount Outstanding 7,653,000   $ 8,827,000       7,653,000      
Letters of Credit Outstanding, Amount 7,740,000   $ 8,011,000       7,740,000      
Letter of Credit | Line of Credit | Revolving Credit and Security Agreement (Europe Credit Agreement)                    
Debt Instrument [Line Items]                    
Borrowing capacity 5,000,000           5,000,000      
Letter of Credit | Line of Credit | Revolving Credit and Security Agreement (New Credit Agreement)                    
Debt Instrument [Line Items]                    
Borrowing capacity 20,000,000           20,000,000      
Swing Line Loans | Line of Credit | Revolving Credit and Security Agreement (Europe Credit Agreement)                    
Debt Instrument [Line Items]                    
Borrowing capacity 2,000,000           2,000,000      
Amount Available to Invacare Limited and Invacare Poirier SAS | Line of Credit | Revolving Credit and Security Agreement (Europe Credit Agreement)                    
Debt Instrument [Line Items]                    
Borrowing capacity $ 15,000,000           $ 15,000,000      
Minimum | Revolving Credit Facility | Line of Credit | Revolving Credit and Security Agreement (Europe Credit Agreement)                    
Debt Instrument [Line Items]                    
Commitment fee percentage             0.25%      
Minimum | Revolving Credit Facility | Line of Credit | Revolving Credit and Security Agreement (New Credit Agreement)                    
Debt Instrument [Line Items]                    
Commitment fee percentage             0.25%      
Minimum | London Interbank Offered Rate (LIBOR) | Revolving Credit Facility | Line of Credit | Revolving Credit and Security Agreement (Europe Credit Agreement)                    
Debt Instrument [Line Items]                    
Basis spread on variable rate             2.50%      
Minimum | London Interbank Offered Rate (LIBOR) | Revolving Credit Facility | Line of Credit | Revolving Credit and Security Agreement (New Credit Agreement)                    
Debt Instrument [Line Items]                    
Basis spread on variable rate             2.25%      
Minimum | Base Rate | Revolving Credit Facility | Line of Credit | Revolving Credit and Security Agreement (Europe Credit Agreement)                    
Debt Instrument [Line Items]                    
Basis spread on variable rate             2.50%      
Minimum | Base Rate | Revolving Credit Facility | Line of Credit | Revolving Credit and Security Agreement (New Credit Agreement)                    
Debt Instrument [Line Items]                    
Basis spread on variable rate             1.25%      
Maximum | Revolving Credit Facility | Line of Credit | Revolving Credit and Security Agreement (Europe Credit Agreement)                    
Debt Instrument [Line Items]                    
Commitment fee percentage             0.375%      
Maximum | Revolving Credit Facility | Line of Credit | Revolving Credit and Security Agreement (New Credit Agreement)                    
Debt Instrument [Line Items]                    
Commitment fee percentage             0.375%      
Maximum | London Interbank Offered Rate (LIBOR) | Revolving Credit Facility | Line of Credit | Revolving Credit and Security Agreement (Europe Credit Agreement)                    
Debt Instrument [Line Items]                    
Basis spread on variable rate             3.00%      
Maximum | London Interbank Offered Rate (LIBOR) | Revolving Credit Facility | Line of Credit | Revolving Credit and Security Agreement (New Credit Agreement)                    
Debt Instrument [Line Items]                    
Basis spread on variable rate             2.75%      
Maximum | Base Rate | Revolving Credit Facility | Line of Credit | Revolving Credit and Security Agreement (Europe Credit Agreement)                    
Debt Instrument [Line Items]                    
Basis spread on variable rate             3.00%      
Maximum | Base Rate | Revolving Credit Facility | Line of Credit | Revolving Credit and Security Agreement (New Credit Agreement)                    
Debt Instrument [Line Items]                    
Basis spread on variable rate             1.75%      
XML 91 R71.htm IDEA: XBRL DOCUMENT v3.20.2
Long-Term Debt Sale Leaseback Transactions (Details)
Apr. 23, 2015
USD ($)
Sale Leaseback Transaction [Line Items]  
Sale Leaseback Transaction, Deferred Gain, Gross $ 7,414,000
XML 92 R72.htm IDEA: XBRL DOCUMENT v3.20.2
Other Long-Term Obligations (Details) - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Dec. 31, 2019
Apr. 23, 2015
Other Liabilities Disclosure [Abstract]            
Deferred income taxes $ 24,223,000   $ 24,223,000   $ 23,376,000  
Product liability 13,545,000   13,545,000   13,414,000  
Pension 7,586,000   7,586,000   7,006,000  
Deferred gain on sale leaseback 5,582,000   5,582,000   5,819,000  
Deferred compensation 5,318,000   5,318,000   5,354,000  
Supplemental Executive Retirement Plan liability 5,245,000   5,245,000   5,433,000  
Uncertain tax obligation including interest 2,660,000   2,660,000   2,612,000  
Other 6,589,000   6,589,000   3,935,000  
Other Long-Term Obligations 70,748,000   70,748,000   $ 66,949,000  
Sale Leaseback Transaction, Deferred Gain, Gross           $ 7,414,000
Sale Leaseback Transaction, Current Period Gain Recognized $ 77,000 $ 74,000 $ 228,000 $ 220,000    
XML 93 R73.htm IDEA: XBRL DOCUMENT v3.20.2
Leases and Commitments (Details) - USD ($)
 3 Months Ended 9 Months Ended
Apr. 23, 2015
Sep. 30, 2020
Sep. 30, 2019
Jun. 30, 2015
Sep. 30, 2020
Sep. 30, 2019
Jul. 01, 2020
Lessee, Lease, Description [Line Items]              
Finance Lease, Liability             $ 36,916,000
Sale Leaseback Transaction, Net Proceeds, Investing Activities       $ 23,000,000      
Sale Leaseback Transaction, Annual Rental Payments         $ 2,275,000    
Sale Leaseback Transaction, Lease Terms         Each of the four lease agreements contains three 10-year renewals with the rent for each option term based on the greater of the then-current fair market rent for each property or the then- current rate and increasing annually by the applicable CPI. Under the terms of the lease agreements, the company is responsible for all taxes, insurance and utilities. The company is permitted to sublet the properties; however, the properties are currently being utilized exclusively by the company and there is no current subletting. The company is required to adequately maintain each of the properties and any leasehold improvements will be amortized over the lesser of the lives of the improvements or the remaining lease lives, consistent with any other company leases.    
Sale Leaseback Transaction, Deferred Gain, Gross $ 7,414,000            
Sale Leaseback Transaction, Immediate Loss Recognized 257,000            
Capital Lease Obligations $ 32,339,000            
Sale Leaseback Transaction, Current Period Gain Recognized   $ 77,000 $ 74,000   $ 228,000 $ 220,000  
Minimum              
Lessee, Lease, Description [Line Items]              
General Lease Term         1 year    
Maximum              
Lessee, Lease, Description [Line Items]              
General Lease Term         20 years    
XML 94 R74.htm IDEA: XBRL DOCUMENT v3.20.2
Leases and Commitments Lease Expenses (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Leases [Abstract]        
Operating Lease, Expense $ 1,926 $ 2,696 $ 6,210 $ 8,175
Short-term Lease, Cost 1,077 894 2,936 1,974
Operating Lease, Cost 3,003 3,590 9,146 10,149
Finance Lease, Interest Expense 829 346 1,483 977
Finance Lease, Right-of-Use Asset, Amortization 980 706 2,346 1,957
Financing Lease, Cost $ 1,809 $ 1,052 $ 3,829 $ 2,934
XML 95 R75.htm IDEA: XBRL DOCUMENT v3.20.2
Leases and Commitments Future Minimum Operating and Financing Lease Commitments (Details) - USD ($)
$ in Thousands
Sep. 30, 2020
Dec. 31, 2019
Leases [Abstract]    
Finance Lease, Liability, Payments, Due Next Twelve Months $ 1,873  
Operating Leases, Future Minimum Payments Due, Next Twelve Months 1,842  
Finance Lease, Liability, Payments, Due Year Two 7,416  
Operating Leases, Future Minimum Payments, Due in Two Years 6,027  
Finance Lease, Liability, Payments, Due Year Three 6,487  
Operating Leases, Future Minimum Payments, Due in Three Years 3,466  
Finance Lease, Liability, Payments, Due Year Four 6,421  
Operating Leases, Future Minimum Payments, Due in Four Years 1,407  
Finance Lease, Liability, Payments, Due Year Five 6,365  
Operating Leases, Future Minimum Payments, Due in Five Years 890  
Finance Lease, Liability, Payments, Due after Year Five 84,251  
Operating Leases, Future Minimum Payments, Due Thereafter 786  
Finance Lease, Liability, Payments, Due 112,813  
Operating Leases, Future Minimum Payments Due 14,418  
Financing Leases, Future Minimum Payments, Interest Included in Payments (45,511)  
Operating Leases, Future Minimum Payments, Interest Included in Payments (1,393)  
Financing Leases, Future Minimum Payments, Present Value of Net Minimum Payments 67,302  
Operating Leases, Future Minimum Payments, Present Value of Net Minimum Payments 13,025  
Finance Lease, Liability, Current (3,352) $ (2,514)
Operating Lease, Liability, Current (5,843) (6,790)
Financing Lease Liability, non-current 63,950  
Operating Leases Long-Term Obligations $ 7,182 $ 12,060
XML 96 R76.htm IDEA: XBRL DOCUMENT v3.20.2
Leases and Commitments Supplemental Cash Flow Information (Details)
$ in Thousands
 9 Months Ended
Sep. 30, 2020
USD ($)
Leases [Abstract]  
Operating Leases, Cash Paid in Measurement of Amounts for Lease Liabilities $ 9,407
Financing Leases, Cash Paid in Measurement of Amounts for Lease Liabilities 3,429
Total Cash Paid in Measurement of Amounts for Lease Liabilities 12,836
Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 2,789
Right-of-Use Asset Obtained in Exchange for Finance Lease Liability 39,942
Right-of-Use Asset Obtained in Exchange for Total Lease Liability $ 42,731
XML 97 R77.htm IDEA: XBRL DOCUMENT v3.20.2
Leases and Commitments Weighted-Average Remaining Lease Terms and Discount Rates (Details)
Sep. 30, 2020
Leases [Abstract]  
Finance Lease, Weighted Average Remaining Lease Term 17 years 2 months 12 days
Operating Lease, Weighted Average Remaining Lease Term 3 years 2 months 12 days
Finance Lease, Weighted Average Discount Rate, Percent 6.32%
Operating Lease, Weighted Average Discount Rate, Percent 7.74%
XML 98 R78.htm IDEA: XBRL DOCUMENT v3.20.2
Revenue (Details) - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Dec. 31, 2019
Revenue Recognition, Multiple-deliverable Arrangements [Line Items]          
Net Sales $ 211,906,000 $ 235,774,000 $ 626,646,000 $ 695,051,000  
Net Revenue 100.00% 100.00% 100.00% 100.00%  
Deferred Revenue $ 3,436,000   $ 3,436,000   $ 3,173,000
Product          
Revenue Recognition, Multiple-deliverable Arrangements [Line Items]          
Net Sales $ 207,292,000 $ 230,647,000 $ 613,507,000 $ 679,956,000  
Net Revenue 98.00% 98.00% 98.00% 98.00%  
Service          
Revenue Recognition, Multiple-deliverable Arrangements [Line Items]          
Net Sales $ 4,614,000 $ 5,127,000 $ 13,139,000 $ 15,095,000  
Net Revenue 2.00% 2.00% 2.00% 2.00%  
Europe          
Revenue Recognition, Multiple-deliverable Arrangements [Line Items]          
Net Sales $ 116,285,000 $ 137,371,000 $ 339,147,000 $ 396,206,000  
Europe | Product          
Revenue Recognition, Multiple-deliverable Arrangements [Line Items]          
Net Sales 113,043,000 133,839,000 329,943,000 386,007,000  
Europe | Service          
Revenue Recognition, Multiple-deliverable Arrangements [Line Items]          
Net Sales 3,242,000 3,532,000 9,204,000 10,199,000  
North America          
Revenue Recognition, Multiple-deliverable Arrangements [Line Items]          
Net Sales 88,055,000 87,118,000 261,595,000 262,915,000  
North America | Product          
Revenue Recognition, Multiple-deliverable Arrangements [Line Items]          
Net Sales 87,821,000 86,761,000 260,999,000 261,707,000  
North America | Service          
Revenue Recognition, Multiple-deliverable Arrangements [Line Items]          
Net Sales 234,000 357,000 596,000 1,208,000  
Asia/Pacific          
Revenue Recognition, Multiple-deliverable Arrangements [Line Items]          
Net Sales 7,566,000 11,285,000 25,904,000 35,930,000  
Asia/Pacific | Product          
Revenue Recognition, Multiple-deliverable Arrangements [Line Items]          
Net Sales 6,428,000 10,047,000 22,565,000 32,242,000  
Asia/Pacific | Service          
Revenue Recognition, Multiple-deliverable Arrangements [Line Items]          
Net Sales $ 1,138,000 $ 1,238,000 $ 3,339,000 $ 3,688,000  
General Terms and Conditions          
Revenue Recognition, Multiple-deliverable Arrangements [Line Items]          
Contract Type Sales Split     31.00%    
Large National Customers          
Revenue Recognition, Multiple-deliverable Arrangements [Line Items]          
Contract Type Sales Split     26.00%    
Government Tenders          
Revenue Recognition, Multiple-deliverable Arrangements [Line Items]          
Contract Type Sales Split     20.00%    
Other Customers          
Revenue Recognition, Multiple-deliverable Arrangements [Line Items]          
Contract Type Sales Split     23.00%    
XML 99 R79.htm IDEA: XBRL DOCUMENT v3.20.2
Equity Compensation (Narrative) (Details)
 3 Months Ended 9 Months Ended
Jun. 30, 2020
shares
Sep. 30, 2020
votes
$ / shares
shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Common Stock, Par or Stated Value Per Share | $ / shares   $ 0.25
Share Based Compensation Arrangement By Share Based Payment Award Performance Period   3 years
Share-based Compensation Arrangement by Share-based Payment Award, Description   The 2018 Plan uses a fungible share-counting method, under which each Common Share underlying an award of share options or share appreciation rights ("SAR") will count against the number of total shares available under the 2018 Plan as one share; and each Common Share underlying any award other than a share option or a SAR will count against the number of total shares available under the 2018 Plan as two shares. Shares underlying awards made under the 2003 Plan or 2013 Plan that are forfeited or remain unpurchased or undistributed upon termination or expiration of the awards will become available under the 2018 Plan for use in future awards. Any Common Shares that are added back to the 2018 Plan as the result of forfeiture, termination or expiration of an award granted under the 2018 Plan or the 2013 Plan will be added back in the same manner such shares were originally counted against the total number of shares available under the 2018 Plan or 2013 Plan, as applicable. Each Common Share that is added back to the 2018 Plan due to a forfeiture, termination or expiration of an award granted under the 2003 Plan will be added back as one Common Share.
Restricted Stock    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Net award activity (in shares)   696,058
Performance Shares    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Net award activity (in shares)   1,859,054
Award requisite service period   3 years
Performance achievement level, lower range   0.00%
Performance achievement level, upper range   150.00%
Performance achievement level, target range   100.00%
Stock Options    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Expiration period   10 years
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant [1]   3,513,468
2013 Plan [Member]    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Share-based Compensation Arrangement by Share-based Payment Award, Number of Share Awards Underlying from 2003 Plan   328,274
2018 Plan [Member]    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized   1,400,000
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Transferred from Prior Plans 1,004,079  
Weighted Average | Performance Shares    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Period for recognition of unrecognized compensation costs   3 years
Class B Common Shares [Member]    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Common Stock, Number of Votes | votes   10
Common Stock, Difference in Dividend Rate   10.00%
Common Stock, Shares, Issued   6,357
Common Stock [Member]    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Common Stock, Holders Percentage of Total Outstanding   99.90%
[1]  *    Shares available for grant under the 2018 Plan as of September 30, 2020 reduced by net restricted share and restricted share unit award activity of 696,058 shares and performance share and performance share unit award activity of 1,859,054 shares.
XML 100 R80.htm IDEA: XBRL DOCUMENT v3.20.2
Equity Compensation Share-based Compensation Expense (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]        
Allocated Share-based Compensation Expense $ 818 $ 649 $ 2,494 $ 1,300
Selling, General and Administrative Expenses        
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]        
Allocated Share-based Compensation Expense     6,965 5,873
Restricted Stock and Restricted Stock Units (RSUs) | Selling, General and Administrative Expenses        
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]        
Allocated Share-based Compensation Expense     4,471 3,891
Performance Shares | Selling, General and Administrative Expenses        
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]        
Allocated Share-based Compensation Expense     2,494 1,648
Stock Options | Selling, General and Administrative Expenses        
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]        
Allocated Share-based Compensation Expense     $ 0 $ 334
XML 101 R81.htm IDEA: XBRL DOCUMENT v3.20.2
Equity Compensation Unrecognized Compensation Expense (Details)
$ in Thousands
Sep. 30, 2020
USD ($)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized $ 19,587
Performance Shares  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized 11,144
Restricted Stock and Restricted Stock Units (RSUs)  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized $ 8,443
XML 102 R82.htm IDEA: XBRL DOCUMENT v3.20.2
Equity Compensation (Options Activity) (Details)
 9 Months Ended
Sep. 30, 2020
$ / shares
shares
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]  
Options outstanding at beginning of period (in shares) | shares 1,441,202
Canceled (in shares) | shares (354,006)
Options outstanding at end of period (in shares) | shares 1,087,196
Weighted Average Exercise Price  
Options outstanding at beginning of period - Weighted Average Exercise Price (in dollars per share) $ 18.26
Canceled - Weighted Average Exercise Price (in dollars per share) 24.88
Options outstanding at end of period - Weighted Average Exercise Price (in dollars per share) $ 16.12
Options exercisable at end of period (in shares) | shares 1,087,196
Stock Options  
Weighted Average Exercise Price  
Options outstanding at end of period - Weighted Average Exercise Price (in dollars per share) $ 16.12
Options available for grant at end of period (in shares) | shares 3,513,468 [1]
$12.15 – $20.00  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Exercise price range, lower limit (in dollars per share) $ 12.15
$12.15 – $20.00 | Stock Options  
Weighted Average Exercise Price  
Options outstanding at end of period - Weighted Average Exercise Price (in dollars per share) 12.74
$30.01 – $33.36  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Exercise price range, upper limit (in dollars per share) 33.36
$30.01 – $33.36 | Stock Options  
Weighted Average Exercise Price  
Options outstanding at end of period - Weighted Average Exercise Price (in dollars per share) $ 33.36
[1]  *    Shares available for grant under the 2018 Plan as of September 30, 2020 reduced by net restricted share and restricted share unit award activity of 696,058 shares and performance share and performance share unit award activity of 1,859,054 shares.
XML 103 R83.htm IDEA: XBRL DOCUMENT v3.20.2
Equity Compensation (Stock Options Outstanding by Exercise Price) (Details) - $ / shares
 9 Months Ended
Sep. 30, 2020
Dec. 31, 2019
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]    
Options Outstanding - Weighted Average Exercise Price (in dollars per share) $ 16.12 $ 18.26
$12.15 – $20.00    
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]    
Exercise price range, lower limit (in dollars per share) 12.15  
$12.15 – $20.00 | Minimum    
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]    
Exercise price range, upper limit (in dollars per share) 12.15  
$12.15 – $20.00 | Maximum    
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]    
Exercise price range, upper limit (in dollars per share) 20.00  
$20.01 – $25.00 | Minimum    
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]    
Exercise price range, upper limit (in dollars per share) 20.01  
$20.01 – $25.00 | Maximum    
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]    
Exercise price range, upper limit (in dollars per share) 25.00  
$25.01 – $30.00 | Minimum    
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]    
Exercise price range, lower limit (in dollars per share) 25.01  
$25.01 – $30.00 | Maximum    
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]    
Exercise price range, lower limit (in dollars per share) 30.00  
$30.01 – $33.36    
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]    
Exercise price range, upper limit (in dollars per share) 33.36  
$30.01 – $33.36 | Minimum    
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]    
Exercise price range, upper limit (in dollars per share) 30.01  
$30.01 – $33.36 | Maximum    
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]    
Exercise price range, upper limit (in dollars per share) $ 33.36  
Stock Options    
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]    
Options Outstanding - Number Outstanding at end of period (in shares) 1,087,196  
Options Outstanding - Weighted Average Remaining Contractual Life 3 years 10 months 24 days  
Options Outstanding - Weighted Average Exercise Price (in dollars per share) $ 16.12  
Options Exercisable - Number Exercisable At end of period (in shares) 1,087,196  
Options Exercisable - Weighted Average Exercise Price (in dollars per share) $ 16.12  
Stock Options | $12.15 – $20.00    
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]    
Options Outstanding - Number Outstanding at end of period (in shares) 777,159  
Options Outstanding - Weighted Average Remaining Contractual Life 5 years 1 month 6 days  
Options Outstanding - Weighted Average Exercise Price (in dollars per share) $ 12.74  
Options Exercisable - Number Exercisable At end of period (in shares) 777,159  
Options Exercisable - Weighted Average Exercise Price (in dollars per share) $ 12.73  
Stock Options | $20.01 – $25.00    
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]    
Options Outstanding - Number Outstanding at end of period (in shares) 300,149  
Options Outstanding - Weighted Average Remaining Contractual Life 10 months 24 days  
Options Outstanding - Weighted Average Exercise Price (in dollars per share) $ 24.45  
Options Exercisable - Number Exercisable At end of period (in shares) 300,149  
Options Exercisable - Weighted Average Exercise Price (in dollars per share) $ 24.45  
Stock Options | $25.01 – $30.00    
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]    
Options Outstanding - Number Outstanding at end of period (in shares) 5,392  
Options Outstanding - Weighted Average Remaining Contractual Life 2 months 12 days  
Options Outstanding - Weighted Average Exercise Price (in dollars per share) $ 27.82  
Options Exercisable - Number Exercisable At end of period (in shares) 5,392  
Options Exercisable - Weighted Average Exercise Price (in dollars per share) $ 27.82  
Stock Options | $30.01 – $33.36    
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]    
Options Outstanding - Number Outstanding at end of period (in shares) 4,496  
Options Outstanding - Weighted Average Remaining Contractual Life 7 months 6 days  
Options Outstanding - Weighted Average Exercise Price (in dollars per share) $ 33.36  
Options Exercisable - Number Exercisable At end of period (in shares) 4,496  
Options Exercisable - Weighted Average Exercise Price (in dollars per share) $ 33.36  
XML 104 R84.htm IDEA: XBRL DOCUMENT v3.20.2
Equity Compensation Restricted Stock Activity (Details) - Restricted Stock and Restricted Stock Units (RSUs)
 9 Months Ended
Sep. 30, 2020
$ / shares
shares
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number, Beginning Balance | shares 965,085
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period | shares 764,012
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period | shares (452,922)
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period | shares (94,993)
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number, Ending Balance | shares 1,181,182
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value, Beginning Balance | $ / shares $ 11.32
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value | $ / shares 7.11
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value | $ / shares 11.47
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value | $ / shares 10.19
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value, Ending Balance | $ / shares $ 8.63
XML 105 R85.htm IDEA: XBRL DOCUMENT v3.20.2
Equity Compensation Performance Share Activity (Details) - Performance Shares - $ / shares
 9 Months Ended
Sep. 30, 2020
Dec. 31, 2019
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number 1,210,625 753,272
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value $ 9.90 $ 11.82
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 523,329  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value $ 7.08  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period (65,976)  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value $ 9.48  
XML 106 R86.htm IDEA: XBRL DOCUMENT v3.20.2
Accumulated Other Comprehensive Income (Loss) by Component (Changes in Accumulated Other Comprehensive Income) (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]        
Beginning Balance $ 4,648 $ 9,771 $ 3,128 $ 12,793
OCI before reclassifications 33,724 (9,004) 35,641 (11,784)
Amount reclassified from accumulated OCI 265 (557) (132) (799)
Other Comprehensive Income (Loss) 33,989 (9,561) 35,509 (12,583)
Ending Balance 38,637 210 38,637 210
Accumulated Translation Adjustment [Member]        
Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]        
Beginning Balance 16,455 13,122 8,898 12,244
OCI before reclassifications 35,231 (5,729) 42,788 (4,851)
Amount reclassified from accumulated OCI 0 0 0 0
Other Comprehensive Income (Loss) 35,231 (5,729) 42,788 (4,851)
Ending Balance 51,686 7,393 51,686 7,393
Accumulated Long-Term Notes Adjustment [Member]        
Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]        
Beginning Balance (9,133) (2,200) (2,491) 2,662
OCI before reclassifications 713 (3,328) (5,929) (8,190)
Amount reclassified from accumulated OCI 0 0 0 0
Other Comprehensive Income (Loss) 713 (3,328) (5,929) (8,190)
Ending Balance (8,420) (5,528) (8,420) (5,528)
Accumulated Defined Benefit Plans Adjustment [Member]        
Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]        
Beginning Balance (3,468) (2,778) (3,299) (2,703)
OCI before reclassifications 281 (504) 122 (922)
Amount reclassified from accumulated OCI (474) 303 (484) 646
Other Comprehensive Income (Loss) (193) (201) (362) (276)
Ending Balance (3,661) (2,979) (3,661) (2,979)
Accumulated Net Gain (Loss) from Designated or Qualifying Cash Flow Hedges [Member]        
Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]        
Beginning Balance 794 1,627 20 590
OCI before reclassifications (2,501) 557 (1,340) 2,179
Amount reclassified from accumulated OCI 739 (860) 352 (1,445)
Other Comprehensive Income (Loss) (1,762) (303) (988) 734
Ending Balance $ (968) $ 1,324 $ (968) $ 1,324
XML 107 R87.htm IDEA: XBRL DOCUMENT v3.20.2
Accumulated Other Comprehensive Income (Loss) by Component (Reclassified Out of Accumulated Other Comprehensive Income) (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]        
Cost of Products Sold $ (151,866) $ (168,189) $ (446,968) $ (500,945)
Amortization of prior service costs and unrecognized gains (55,530) (63,539) (174,672) (197,035)
Income tax provision (2,050) (3,300) (4,900) (7,325)
Net Sales (211,906) (235,774) (626,646) (695,051)
Accumulated Defined Benefit Plans Adjustment [Member] | Reclassification out of Accumulated Other Comprehensive Income        
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]        
Amortization of prior service costs and unrecognized gains (474) 303 (484) 646
Income tax provision 0 0 0 0
Net loss from Continuing Operations (474) 303 (484) 646
Accumulated Net Gain (Loss) from Designated or Qualifying Cash Flow Hedges [Member] | Reclassification out of Accumulated Other Comprehensive Income        
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]        
Income (Loss) from Continuing Operations before Income Taxes 778 (944) 337 (1,564)
Income tax provision (39) 84 15 119
Net loss from Continuing Operations 739 (860) 352 (1,445)
Accumulated Net Gain (Loss) from Designated or Qualifying Cash Flow Hedges [Member] | Reclassification out of Accumulated Other Comprehensive Income | Foreign currency forward contracts        
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]        
Cost of Products Sold 1,259 (747) 1,029 (1,375)
Net Sales $ (481) $ (197) $ (692) $ (189)
XML 108 R88.htm IDEA: XBRL DOCUMENT v3.20.2
Charges Related To Restructuring Activities (Details) - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2020
Jun. 30, 2020
Mar. 31, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Restructuring Reserve [Roll Forward]            
Beginning Balance $ 6,018,000 $ 6,549,000 $ 7,027,000   $ 7,027,000  
Charges 1,580,000 1,685,000 1,392,000 $ 1,628,000 4,657,000 $ 3,641,000
Payments (1,606,000) (2,216,000) (1,870,000)   (5,692,000) (4,152,000)
Ending Balance 5,992,000 6,018,000 6,549,000   5,992,000  
Severance            
Restructuring Reserve [Roll Forward]            
Beginning Balance 6,014,000 6,545,000 7,023,000   7,023,000  
Charges 1,580,000 1,412,000 1,319,000      
Payments (1,606,000) (1,943,000) (1,797,000)      
Ending Balance 5,988,000 6,014,000 6,545,000   5,988,000  
Contract Termination            
Restructuring Reserve [Roll Forward]            
Beginning Balance 4,000 4,000 4,000   4,000  
Charges 0 273,000 73,000      
Payments 0 (273,000) (73,000)      
Ending Balance 4,000 4,000 4,000   4,000  
All Other            
Restructuring Reserve [Roll Forward]            
Beginning Balance 166,000 166,000 406,000   406,000  
Charges 0 82,000 36,000 34,000 118,000 199,000
Payments 0 (82,000) (276,000)      
Ending Balance 166,000 166,000 166,000   166,000  
All Other | Severance            
Restructuring Reserve [Roll Forward]            
Beginning Balance 166,000 166,000 406,000   406,000  
Charges 0 82,000 36,000     199,000
Payments 0 (82,000) (276,000)      
Ending Balance 166,000 166,000 166,000   166,000  
All Other | Contract Termination            
Restructuring Reserve [Roll Forward]            
Beginning Balance 0 0 0   0  
Charges 0 0 0      
Payments 0 0 0      
Ending Balance 0 0 0   0  
Europe            
Restructuring Reserve [Roll Forward]            
Beginning Balance 5,749,000 6,043,000 6,410,000   6,410,000  
Charges 1,434,000 1,575,000 665,000 1,263,000 3,674,000 1,903,000
Payments (1,455,000) (1,869,000) (1,032,000)      
Ending Balance 5,728,000 5,749,000 6,043,000   5,728,000  
Europe | Severance            
Restructuring Reserve [Roll Forward]            
Beginning Balance 5,745,000 6,039,000 6,406,000   6,406,000  
Charges 1,434,000 1,302,000 592,000   3,328,000 1,903,000
Payments (1,455,000) (1,596,000) (959,000)      
Ending Balance 5,724,000 5,745,000 6,039,000   5,724,000  
Europe | Contract Termination            
Restructuring Reserve [Roll Forward]            
Beginning Balance 4,000 4,000 4,000   4,000  
Charges 0 273,000 73,000   346,000  
Payments 0 (273,000) (73,000)      
Ending Balance 4,000 4,000 4,000   4,000  
North America            
Restructuring Reserve [Roll Forward]            
Beginning Balance 103,000 340,000 211,000   211,000  
Charges 146,000 28,000 691,000 $ 331,000 865,000 1,539,000
Restructuring Reserve, Accrual Adjustment 146,000       865,000  
Payments (151,000) (265,000) (562,000)      
Ending Balance 98,000 103,000 340,000   98,000  
North America | Severance            
Restructuring Reserve [Roll Forward]            
Beginning Balance 103,000 340,000 211,000   211,000  
Charges 146,000 28,000 691,000     1,495,000
Payments (151,000) (265,000) (562,000)      
Ending Balance 98,000 103,000 340,000   98,000  
North America | Contract Termination            
Restructuring Reserve [Roll Forward]            
Beginning Balance 0 0 0   0  
Charges           $ 44,000
Restructuring Reserve, Accrual Adjustment 0 0 0      
Payments 0 0 0      
Ending Balance $ 0 $ 0 $ 0   $ 0  
XML 109 R89.htm IDEA: XBRL DOCUMENT v3.20.2
Charges Related To Restructuring Activities Narrative (Details) - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2020
Jun. 30, 2020
Mar. 31, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Restructuring Cost and Reserve [Line Items]            
Charges $ 1,580,000 $ 1,685,000 $ 1,392,000 $ 1,628,000 $ 4,657,000 $ 3,641,000
Restructuring and Related Activities, Expected Payout Period         12 months  
Payments (1,606,000) (2,216,000) (1,870,000)   $ (5,692,000) (4,152,000)
Severance            
Restructuring Cost and Reserve [Line Items]            
Charges 1,580,000 1,412,000 1,319,000      
Payments (1,606,000) (1,943,000) (1,797,000)      
Contract Termination            
Restructuring Cost and Reserve [Line Items]            
Charges 0 273,000 73,000      
Payments 0 (273,000) (73,000)      
North America            
Restructuring Cost and Reserve [Line Items]            
Charges 146,000 28,000 691,000 331,000 865,000 1,539,000
Restructuring Reserve, Accrual Adjustment 146,000       865,000  
Payments (151,000) (265,000) (562,000)      
North America | Severance            
Restructuring Cost and Reserve [Line Items]            
Charges 146,000 28,000 691,000     1,495,000
Payments (151,000) (265,000) (562,000)      
North America | Contract Termination            
Restructuring Cost and Reserve [Line Items]            
Charges           44,000
Restructuring Reserve, Accrual Adjustment 0 0 0      
Payments 0 0 0      
Europe            
Restructuring Cost and Reserve [Line Items]            
Charges 1,434,000 1,575,000 665,000 1,263,000 3,674,000 1,903,000
Payments (1,455,000) (1,869,000) (1,032,000)      
Europe | Severance            
Restructuring Cost and Reserve [Line Items]            
Charges 1,434,000 1,302,000 592,000   3,328,000 1,903,000
Payments (1,455,000) (1,596,000) (959,000)      
Europe | Contract Termination            
Restructuring Cost and Reserve [Line Items]            
Charges 0 273,000 73,000   346,000  
Payments 0 (273,000) (73,000)      
All Other            
Restructuring Cost and Reserve [Line Items]            
Charges 0 82,000 36,000 $ 34,000 $ 118,000 199,000
Payments 0 (82,000) (276,000)      
All Other | Severance            
Restructuring Cost and Reserve [Line Items]            
Charges 0 82,000 36,000     $ 199,000
Payments 0 (82,000) (276,000)      
All Other | Contract Termination            
Restructuring Cost and Reserve [Line Items]            
Charges 0 0 0      
Payments $ 0 $ 0 $ 0      
XML 110 R90.htm IDEA: XBRL DOCUMENT v3.20.2
Income Taxes (Narrative) (Details) - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Valuation Allowance [Line Items]        
Reversal of Accrued Withholding Taxes on Earnings     $ 988,000  
Effective income tax rate, continuing operations (39.20%) (69.60%) (26.80%) (26.80%)
U.S. statutory income tax rate     21.00% 21.00%
Effective income tax rate, continuing operations (39.20%) (69.60%) (26.80%) (26.80%)
U.S. statutory income tax rate     21.00% 21.00%
XML 111 R91.htm IDEA: XBRL DOCUMENT v3.20.2
Net Earnings (Loss) Per Common Share Computation of Basic and Diluted Net Earnings (Loss) Per Common Share (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Net Loss per Share—Basic        
Average common shares outstanding 34,419 33,660 34,213 33,571
Net Loss $ (7,276) $ (8,041) $ (23,163) $ (34,644)
Net earnings (loss) per common share $ (0.21) $ (0.24) $ (0.68) $ (1.03)
Net Loss per Share—Assuming Dilution        
Average common shares outstanding 34,419 33,660 34,213 33,571
Stock options and awards 111 8 100 10
Average common shares assuming dilution 34,530 33,668 34,313 33,581
Net Loss $ (7,276) $ (8,041) $ (23,163) $ (34,644)
Net earnings (loss) per per common share—assuming dilution (in dollars per share) [1] $ (0.21) $ (0.24) $ (0.68) $ (1.03)
[1] Net loss per common share assuming dilution calculated utilizing weighted average shares outstanding-basic for the periods in which there was a net loss.
XML 112 R92.htm IDEA: XBRL DOCUMENT v3.20.2
Net Earnings (Loss) Per Common Share Textuals (Details) - Stock Options - $ / shares
 3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Antidilutive securities excluded from computation of earnings per share, amount     300,149 326,799
Antidilutive share granted, average exercise price $ 24.45 $ 25.24 $ 24.45 $ 25.24
Fair value stock price $ 6.93 $ 5.61 $ 7.12 $ 6.43
XML 113 R93.htm IDEA: XBRL DOCUMENT v3.20.2
Concentration Of Credit Risk (Details)
Sep. 30, 2020
USD ($)
Risks and Uncertainties [Abstract]  
Retained Recourse Obligation For Events Of Default Under Contracts $ 2,682,000
Events of Default Under Contract by Third Party $ 8,262,000
XML 114 R94.htm IDEA: XBRL DOCUMENT v3.20.2
Derivatives Notional Amounts - Designated as Hedges (Details) - USD ($)
$ in Thousands
 9 Months Ended 12 Months Ended
Sep. 30, 2020
Dec. 31, 2019
Not Designated as Hedging Instrument [Member]    
Derivative [Line Items]    
Notional Amount $ 59,965 $ 47,400
Gain (Loss) (1,077) (78)
Designated as Hedging Instrument [Member]    
Derivative [Line Items]    
Notional Amount 41,675 207,363
Unrealized Gain (Loss) (1,148) 11
USD / AUD | Designated as Hedging Instrument [Member]    
Derivative [Line Items]    
Notional Amount 960 3,840
Unrealized Gain (Loss) (41) (106)
USD / CAD | Designated as Hedging Instrument [Member]    
Derivative [Line Items]    
Notional Amount 1,138 3,888
Unrealized Gain (Loss) (2) 32
USD / EUR | Designated as Hedging Instrument [Member]    
Derivative [Line Items]    
Notional Amount 17,468 110,905
Unrealized Gain (Loss) (1,061) 122
USD / GBP | Designated as Hedging Instrument [Member]    
Derivative [Line Items]    
Notional Amount 387 3,972
Unrealized Gain (Loss) (11) (8)
USD / NZD | Designated as Hedging Instrument [Member]    
Derivative [Line Items]    
Notional Amount 290 2,760
Unrealized Gain (Loss) (13) (166)
USD / SEK | Designated as Hedging Instrument [Member]    
Derivative [Line Items]    
Notional Amount 876 5,062
Unrealized Gain (Loss) (88) (38)
USD / MXN | Designated as Hedging Instrument [Member]    
Derivative [Line Items]    
Notional Amount 3,901 6,763
Unrealized Gain (Loss) (58) 346
EUR / CAD | Not Designated as Hedging Instrument [Member]    
Derivative [Line Items]    
Notional Amount 130 0
Gain (Loss) (6) 0
EUR / CAD | Designated as Hedging Instrument [Member]    
Derivative [Line Items]    
Notional Amount 915 4,151
Unrealized Gain (Loss) (42) 24
EUR / CHF | Designated as Hedging Instrument [Member]    
Derivative [Line Items]    
Notional Amount 2,703 9,821
Unrealized Gain (Loss) (45) 10
EUR / GBP | Not Designated as Hedging Instrument [Member]    
Derivative [Line Items]    
Notional Amount 2,086 0
Gain (Loss) 59 0
EUR / GBP | Designated as Hedging Instrument [Member]    
Derivative [Line Items]    
Notional Amount 6,325 29,824
Unrealized Gain (Loss) 178 (216)
EUR / SEK | Designated as Hedging Instrument [Member]    
Derivative [Line Items]    
Notional Amount 2,330 9,493
Unrealized Gain (Loss) (72) (46)
EUR / NOK | Not Designated as Hedging Instrument [Member]    
Derivative [Line Items]    
Notional Amount 80 0
Gain (Loss) 1 0
EUR / NOK | Designated as Hedging Instrument [Member]    
Derivative [Line Items]    
Notional Amount 1,490 5,797
Unrealized Gain (Loss) 14 15
DKK / SEK | Designated as Hedging Instrument [Member]    
Derivative [Line Items]    
Notional Amount 1,402 5,936
Unrealized Gain (Loss) 40 24
NOK / SEK | Designated as Hedging Instrument [Member]    
Derivative [Line Items]    
Notional Amount 1,490 5,151
Unrealized Gain (Loss) $ 53 $ 18
XML 115 R95.htm IDEA: XBRL DOCUMENT v3.20.2
Derivatives Notional Amounts - Not Designated as Hedges (Details) - Not Designated as Hedging Instrument [Member] - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Dec. 31, 2019
Derivative [Line Items]        
Notional Amount   $ 59,965   $ 47,400
Gain (Loss)   (1,077)   (78)
Forward exchange contracts—net        
Derivative [Line Items]        
Gain (Loss) $ 317   $ 103  
AUD / USD        
Derivative [Line Items]        
Notional Amount   6,149   10,000
Gain (Loss)   96   (94)
CAD / USD        
Derivative [Line Items]        
Notional Amount   8,321   8,000
Gain (Loss)   88   (50)
EUR / USD        
Derivative [Line Items]        
Notional Amount   11,735   10,000
Gain (Loss)   (745)   104
DKK / USD        
Derivative [Line Items]        
Notional Amount   15,081   0
Gain (Loss)   (137)   0
GBP / USD        
Derivative [Line Items]        
Notional Amount   650   7,000
Gain (Loss)   (18)   40
NOK / USD        
Derivative [Line Items]        
Notional Amount   8,986   0
Gain (Loss)   (427)   0
NZD / USD        
Derivative [Line Items]        
Notional Amount   309   4,500
Gain (Loss)   (9)   (101)
EUR / CAD        
Derivative [Line Items]        
Notional Amount   130   0
Gain (Loss)   (6)   0
EUR / GBP        
Derivative [Line Items]        
Notional Amount   2,086   0
Gain (Loss)   59   0
AUD / NZD        
Derivative [Line Items]        
Notional Amount   6,438   7,900
Gain (Loss)   21   23
EUR / NOK        
Derivative [Line Items]        
Notional Amount   80   0
Gain (Loss)   $ 1   $ 0
XML 116 R96.htm IDEA: XBRL DOCUMENT v3.20.2
Derivatives Balance Sheet Location (Details) - USD ($)
$ in Thousands
Sep. 30, 2020
Dec. 31, 2019
Other Current Assets    
Derivatives, Fair Value [Line Items]    
Derivative assets $ 599 $ 838
Other Current Assets | Foreign currency forward contracts | Designated as Hedging Instrument [Member]    
Derivatives, Fair Value [Line Items]    
Derivative assets 334 668
Other Current Assets | Foreign currency forward contracts | Not Designated as Hedging Instrument [Member]    
Derivatives, Fair Value [Line Items]    
Derivative assets 265 170
Accrued Expenses    
Derivatives, Fair Value [Line Items]    
Derivative liabilities 2,824 905
Accrued Expenses | Foreign currency forward contracts | Designated as Hedging Instrument [Member]    
Derivatives, Fair Value [Line Items]    
Derivative liabilities 1,482 657
Accrued Expenses | Foreign currency forward contracts | Not Designated as Hedging Instrument [Member]    
Derivatives, Fair Value [Line Items]    
Derivative liabilities $ 1,342 $ 248
XML 117 R97.htm IDEA: XBRL DOCUMENT v3.20.2
Derivatives Gain (Loss) in Statement of Finacial Position (Details) - USD ($)
 3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Dec. 31, 2019
Derivative Instruments, Gain (Loss) [Line Items]          
Current period (loss) gain on cash flow hedges $ (2,047,000) $ (315,000) $ (1,159,000) $ 861,000  
Cash Flow Hedging [Member]          
Derivative Instruments, Gain (Loss) [Line Items]          
Gain (Loss) 778,000 (944,000) 337,000 (1,564,000)  
Foreign currency forward contracts | Cash Flow Hedging [Member]          
Derivative Instruments, Gain (Loss) [Line Items]          
Current period (loss) gain on cash flow hedges (2,501,000) 557,000 (1,340,000) 2,179,000  
Amount of Gain (Loss) Reclassified from Accumulated OCI into Income (Effective Portion) (739,000) 860,000 (352,000) 1,445,000  
Amount of Gain (Loss) Recognized in Income on Derivatives (Ineffective Portion and Amount Excluded from Effectiveness Testing) $ (662,000) (2,000) (718,000) 50,000  
Not Designated as Hedging Instrument [Member]          
Derivative Instruments, Gain (Loss) [Line Items]          
Gain (Loss)     $ (1,077,000)   $ (78,000)
Not Designated as Hedging Instrument [Member] | Foreign currency forward contracts          
Derivative Instruments, Gain (Loss) [Line Items]          
Gain (Loss)   $ 317,000   $ 103,000  
XML 118 R98.htm IDEA: XBRL DOCUMENT v3.20.2
Derivatives Narrative (Details) - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Jun. 30, 2017
Mar. 31, 2016
Sep. 30, 2020
Sep. 30, 2019
Dec. 31, 2019
Derivative [Line Items]              
Convertible Debt 2022 Conversion Feature, Initial Fair Value $ 28,859,000       $ 28,859,000    
Proceeds from Issuance of Warrants       $ 12,376,000      
Foreign currency forward contracts              
Derivative [Line Items]              
Notional amount of derivatives, matured during period         155,783,000 $ 110,373,000  
Selling, General and Administrative Expenses | Foreign currency forward contracts              
Derivative [Line Items]              
Loss on derivative (1,320,000) $ (317,000)     $ (1,077,000) (103,000)  
Minimum              
Derivative [Line Items]              
Derivative, percentage of forcasted transactions with currency rate exposure         50.00%    
Maximum              
Derivative [Line Items]              
Derivative, percentage of forcasted transactions with currency rate exposure         90.00%    
Cash Flow Hedging [Member]              
Derivative [Line Items]              
Gain (Loss) (778,000) 944,000     $ (337,000) 1,564,000  
Cash Flow Hedging [Member] | Sales [Member]              
Derivative [Line Items]              
Gain recognized in income   197,000       189,000  
Loss on derivative (481,000)       (692,000)    
Cash Flow Hedging [Member] | Cost of Sales [Member]              
Derivative [Line Items]              
Gain recognized in income   $ 747,000       $ 1,375,000  
Loss on derivative (1,259,000)       (1,029,000)    
Convertible Subordinated Debt | Convertible Senior Notes at 5.00% February 2021 [Member]              
Derivative [Line Items]              
Convertible due 2021 - Bond Hedge, Initial Fair Value 27,975,000       27,975,000    
Convertible Debt Conversion Feature, Initial Fair Value (34,480,000)       (34,480,000)    
Debt Instrument, Face Amount $ 1,250,000     $ 150,000,000 $ 1,250,000   $ 61,091,000
Interest rate (as a percent) 5.00%       5.00%    
Convertible Subordinated Debt | Convertible Senior Notes at 4.50% February 2022 [Domain]              
Derivative [Line Items]              
Proceeds from Issuance of Warrants     $ 14,100,000        
Convertible due 2022 - Bond Hedge, Fair Value at Issuance $ 24,780,000   24,780,000   $ 24,780,000    
Debt Instrument, Face Amount $ 81,500,000   $ 120,000,000   $ 81,500,000   $ 120,000,000
Interest rate (as a percent) 4.50%       4.50%    
XML 119 R99.htm IDEA: XBRL DOCUMENT v3.20.2
Derivatives Fair Value of Convertible Debt Hedges (Details) - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Derivative Instruments and Hedging Activities Disclosures [Line Items]        
Fair Values Convertible Debt Hedges, Net $ 0   $ 0  
Fair Values Convertible Debt Hedges, Gain (Loss) 0 $ 0    
Fair Value, Inputs, Level 2 | Convertible Debt Conversion Feature | Fair Value, Measurements, Recurring        
Derivative Instruments and Hedging Activities Disclosures [Line Items]        
Convertible 2021 debt conversion liability 0   0  
Fair Value, Inputs, Level 2 | Convertible Debt 2022 Conversion Feature | Fair Value, Measurements, Recurring        
Derivative Instruments and Hedging Activities Disclosures [Line Items]        
Convertible Debt Conversion Feature 0   0  
Fair Value, Inputs, Level 2 | Convertible Debt Bond Hedge | Fair Value, Measurements, Recurring        
Derivative Instruments and Hedging Activities Disclosures [Line Items]        
Convertible 2021 note hedge asset 0   0  
Convertible 2022 note hedge asset 0   0  
Convertible Subordinated Debt | Convertible Senior Notes at 4.50% February 2022 [Domain]        
Derivative Instruments and Hedging Activities Disclosures [Line Items]        
Convertible Debt Conversion Feature Gain (Loss) 0 0 0 $ (6,193,000)
Convertible Debt Note Hedge Gain (Loss) 0 0 0 6,748,000
Convertible Subordinated Debt | Convertible Senior Notes at 5.00% February 2021 [Member]        
Derivative Instruments and Hedging Activities Disclosures [Line Items]        
Convertible Debt Conversion Feature Gain (Loss) 0 0 0 (2,210,000)
Convertible Debt Note Hedge Gain (Loss) $ 0 $ 0 0 2,852,000
Fair Values Convertible Debt Hedges, Gain (Loss)     $ 0 $ 1,197,000
XML 120 R100.htm IDEA: XBRL DOCUMENT v3.20.2
Fair Values (Assets and Liabilities Measured at Fair Value on a Recurring Basis) (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Dec. 31, 2019
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]          
Fair Values Convertible Debt Hedges, Gain (Loss) $ 0 $ 0      
Convertible Senior Notes at 5.00% February 2021 [Member] | Convertible Subordinated Debt          
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]          
Fair Values Convertible Debt Hedges, Gain (Loss)     $ 0 $ 1,197  
Convertible Debt Bond Hedge | Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 2          
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]          
Convertible 2021 note hedge asset 0   0    
Forward exchange contracts—net | Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 1 [Member]          
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]          
Derivative assets (liabilities), at fair value, net 0   0   $ 0
Forward exchange contracts—net | Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 2          
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]          
Derivative assets (liabilities), at fair value, net (2,225)   (2,225)   (67)
Forward exchange contracts—net | Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 3 [Member]          
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]          
Derivative assets (liabilities), at fair value, net $ 0   $ 0   $ 0
XML 121 R101.htm IDEA: XBRL DOCUMENT v3.20.2
Fair Values (Details of Book Value and Fair Value of Financial Instruments) (Details) - USD ($)
$ in Thousands
Sep. 30, 2020
Dec. 31, 2019
Sep. 30, 2019
Dec. 31, 2018
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]        
Cash and cash equivalents $ 86,825 $ 80,063 $ 85,040 $ 116,907
Carrying Value        
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]        
Cash and cash equivalents 86,825 80,063    
Other investments 85 85    
Installment receivables, net of reserves 325 913    
Total debt (including current maturities of long-term debt) * (242,264) (219,522)    
Fair Value        
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]        
Cash and cash equivalents 86,825 80,063    
Other investments 85 85    
Installment receivables, net of reserves 325 913    
Total debt (including current maturities of long-term debt) * (218,231) (207,193)    
Foreign currency forward contracts | Other Current Assets | Carrying Value        
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]        
Derivative assets 599 838    
Foreign currency forward contracts | Other Current Assets | Fair Value        
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]        
Derivative assets 599 838    
Foreign currency forward contracts | Accrued Expenses | Carrying Value        
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]        
Derivative liabilities (2,824) (905)    
Foreign currency forward contracts | Accrued Expenses | Fair Value        
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]        
Derivative liabilities (2,824) (905)    
Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 1 [Member] | Foreign currency forward contracts        
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]        
Derivative assets (liabilities), at fair value, net 0 0    
Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 2 | Convertible Debt 2022 Conversion Feature        
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]        
Convertible Debt Conversion Feature 0      
Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 2 | Foreign currency forward contracts        
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]        
Derivative assets (liabilities), at fair value, net (2,225) (67)    
Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 2 | Convertible Debt Conversion Feature        
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]        
Convertible 2021 debt conversion liability 0      
Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 2 | Convertible Debt Bond Hedge        
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]        
Convertible due 2021 - Bond Hedge 0      
Convertible 2022 note hedge asset 0      
Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 3 [Member] | Foreign currency forward contracts        
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]        
Derivative assets (liabilities), at fair value, net $ 0 $ 0    
XML 122 R102.htm IDEA: XBRL DOCUMENT v3.20.2
Business Segments (Information by Segment) (Details) - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2020
Jun. 30, 2020
Mar. 31, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Dec. 31, 2019
Segment Reporting Information [Line Items]              
Net Sales $ 211,906,000     $ 235,774,000 $ 626,646,000 $ 695,051,000  
Restructuring Reserve 5,992,000 $ 6,018,000 $ 6,549,000   5,992,000   $ 7,027,000
Charges (1,580,000) (1,685,000) (1,392,000) (1,628,000) (4,657,000) (3,641,000)  
Gain on sale of business 0     0 9,790,000 0  
Operating Income (Loss) 2,930,000     2,418,000 10,139,000 (6,570,000)  
Net gain on convertible debt derivatives 0     0 0 1,197,000  
Interest Revenue (Expense), Net (7,395,000)     (6,879,000) (21,042,000) (21,666,000)  
Earnings (loss) before income taxes (5,226,000)     (4,741,000) (18,263,000) (27,319,000)  
Loss on debt extinguishment including debt finance charges and fees (761,000)     (280,000) (7,360,000) (280,000)  
Asia/Pacific              
Segment Reporting Information [Line Items]              
Net Sales 7,566,000     11,285,000 25,904,000 35,930,000  
All Other              
Segment Reporting Information [Line Items]              
Restructuring Reserve 166,000 166,000 166,000   166,000   406,000
Charges 0 (82,000) (36,000) (34,000) (118,000) (199,000)  
Operating Income (Loss) (6,082,000)     (5,625,000) (17,377,000) (18,230,000)  
Europe              
Segment Reporting Information [Line Items]              
Net Sales 116,285,000     137,371,000 339,147,000 396,206,000  
Restructuring Reserve 5,728,000 5,749,000 6,043,000   5,728,000   6,410,000
Charges (1,434,000) (1,575,000) (665,000) (1,263,000) (3,674,000) (1,903,000)  
Operating Income (Loss) 7,600,000     11,365,000 16,624,000 22,617,000  
North America              
Segment Reporting Information [Line Items]              
Net Sales 88,055,000     87,118,000 261,595,000 262,915,000  
Restructuring Reserve 98,000 103,000 340,000   98,000   211,000
Restructuring Reserve, Accrual Adjustment 146,000       865,000    
Charges (146,000) (28,000) (691,000) (331,000) (865,000) (1,539,000)  
Operating Income (Loss) 2,992,000     (1,694,000) 5,759,000 (7,316,000)  
Operating Segments [Member] | Asia/Pacific              
Segment Reporting Information [Line Items]              
Net Sales 7,566,000     11,285,000 25,904,000 35,930,000  
Operating Segments [Member] | Europe              
Segment Reporting Information [Line Items]              
Net Sales 116,285,000     137,371,000 339,147,000 396,206,000  
Operating Segments [Member] | North America              
Segment Reporting Information [Line Items]              
Net Sales 88,055,000     87,118,000 261,595,000 262,915,000  
Intersegment revenues              
Segment Reporting Information [Line Items]              
Net Sales 30,768,000     28,158,000 84,439,000 81,281,000  
Intersegment revenues | Asia/Pacific              
Segment Reporting Information [Line Items]              
Net Sales 1,116,000     3,904,000 3,645,000 9,776,000  
Intersegment revenues | Europe              
Segment Reporting Information [Line Items]              
Net Sales 6,027,000     3,124,000 14,438,000 10,396,000  
Intersegment revenues | North America              
Segment Reporting Information [Line Items]              
Net Sales 23,625,000     21,130,000 66,356,000 61,109,000  
Severance              
Segment Reporting Information [Line Items]              
Restructuring Reserve 5,988,000 6,014,000 6,545,000   5,988,000   7,023,000
Charges (1,580,000) (1,412,000) (1,319,000)        
Severance | All Other              
Segment Reporting Information [Line Items]              
Restructuring Reserve 166,000 166,000 166,000   166,000   406,000
Charges 0 (82,000) (36,000)     (199,000)  
Severance | Europe              
Segment Reporting Information [Line Items]              
Restructuring Reserve 5,724,000 5,745,000 6,039,000   5,724,000   6,406,000
Charges (1,434,000) (1,302,000) (592,000)   (3,328,000) (1,903,000)  
Severance | North America              
Segment Reporting Information [Line Items]              
Restructuring Reserve 98,000 103,000 340,000   98,000   211,000
Charges (146,000) (28,000) (691,000)     (1,495,000)  
Contract Termination              
Segment Reporting Information [Line Items]              
Restructuring Reserve 4,000 4,000 4,000   4,000   4,000
Charges 0 (273,000) (73,000)        
Contract Termination | All Other              
Segment Reporting Information [Line Items]              
Restructuring Reserve 0 0 0   0   0
Charges 0 0 0        
Contract Termination | Europe              
Segment Reporting Information [Line Items]              
Restructuring Reserve 4,000 4,000 4,000   4,000   4,000
Charges 0 (273,000) (73,000)   (346,000)    
Contract Termination | North America              
Segment Reporting Information [Line Items]              
Restructuring Reserve 0 0 0   0   $ 0
Restructuring Reserve, Accrual Adjustment 0 $ 0 $ 0        
Charges           (44,000)  
Lifestyle Products [Domain] | Operating Segments [Member] | Asia/Pacific              
Segment Reporting Information [Line Items]              
Net Sales 3,375,000     3,001,000 10,176,000 8,261,000  
Lifestyle Products [Domain] | Operating Segments [Member] | Europe              
Segment Reporting Information [Line Items]              
Net Sales 50,307,000     59,403,000 160,628,000 182,103,000  
Lifestyle Products [Domain] | Operating Segments [Member] | North America              
Segment Reporting Information [Line Items]              
Net Sales 41,845,000     43,401,000 124,888,000 131,259,000  
Mobility and Seating [Domain] | Operating Segments [Member] | Asia/Pacific              
Segment Reporting Information [Line Items]              
Net Sales 2,670,000     6,645,000 10,757,000 21,986,000  
Mobility and Seating [Domain] | Operating Segments [Member] | Europe              
Segment Reporting Information [Line Items]              
Net Sales 54,851,000     68,286,000 147,275,000 184,819,000  
Mobility and Seating [Domain] | Operating Segments [Member] | North America              
Segment Reporting Information [Line Items]              
Net Sales 26,572,000     31,252,000 82,485,000 89,638,000  
Respiratory Therapy [Domain] | Operating Segments [Member] | Asia/Pacific              
Segment Reporting Information [Line Items]              
Net Sales 195,000     175,000 1,043,000 1,063,000  
Respiratory Therapy [Domain] | Operating Segments [Member] | Europe              
Segment Reporting Information [Line Items]              
Net Sales 6,070,000     4,919,000 16,680,000 14,875,000  
Respiratory Therapy [Domain] | Operating Segments [Member] | North America              
Segment Reporting Information [Line Items]              
Net Sales 19,405,000     12,108,000 53,626,000 40,811,000  
Other [Domain] | Operating Segments [Member] | Asia/Pacific              
Segment Reporting Information [Line Items]              
Net Sales 1,326,000     1,464,000 3,928,000 4,620,000  
Other [Domain] | Operating Segments [Member] | Europe              
Segment Reporting Information [Line Items]              
Net Sales 5,057,000     4,763,000 14,564,000 14,409,000  
Other [Domain] | Operating Segments [Member] | North America              
Segment Reporting Information [Line Items]              
Net Sales $ 233,000     $ 357,000 $ 596,000 $ 1,207,000  
EXCEL 123 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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how.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 125 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 126 FilingSummary.xml IDEA: XBRL DOCUMENT 3.20.2 html 658 621 1 true 122 0 false 6 false false R1.htm 000010001 - Document - DEI Document Sheet http://www.invacare.com/role/DEIDocument DEI Document Cover 1 false false R2.htm 100010002 - Statement - Condensed Consolidated Statement of Comprehensive Income (Loss) Sheet http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss Condensed Consolidated Statement of Comprehensive Income (Loss) Statements 2 false false R3.htm 100020003 - Statement - Condensed Consolidated Balance Sheets Sheet http://www.invacare.com/role/CondensedConsolidatedBalanceSheets Condensed Consolidated Balance Sheets Statements 3 false false R4.htm 100030004 - Statement - Condensed Consolidated Balance Sheets (Parentheticals) Sheet http://www.invacare.com/role/CondensedConsolidatedBalanceSheetsParentheticals Condensed Consolidated Balance Sheets (Parentheticals) Statements 4 false false R5.htm 100040005 - Statement - Condensed Consolidated Statement Of Cash Flows Sheet http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows Condensed Consolidated Statement Of Cash Flows Statements 5 false false R6.htm 100050006 - Statement - Condensed Consolidated Statement of Shareholders' Equity Statement Sheet http://www.invacare.com/role/CondensedConsolidatedStatementofShareholdersEquityStatement Condensed Consolidated Statement of Shareholders' Equity Statement Statements 6 false false R7.htm 210011001 - Disclosure - Accounting Policies Sheet http://www.invacare.com/role/AccountingPolicies Accounting Policies Notes 7 false false R8.htm 210041002 - Disclosure - Divested Businesses (Notes) Notes http://www.invacare.com/role/DivestedBusinessesNotes Divested Businesses (Notes) Notes 8 false false R9.htm 210071003 - Disclosure - Receivables Sheet http://www.invacare.com/role/Receivables Receivables Notes 9 false false R10.htm 210161004 - Disclosure - Inventories Sheet http://www.invacare.com/role/Inventories Inventories Notes 10 false false R11.htm 210191005 - Disclosure - Other Current Assets Sheet http://www.invacare.com/role/OtherCurrentAssets Other Current Assets Notes 11 false false R12.htm 210221006 - Disclosure - Other Long-Term Assets Sheet http://www.invacare.com/role/OtherLongTermAssets Other Long-Term Assets Notes 12 false false R13.htm 210261007 - Disclosure - Property And Equipment Sheet http://www.invacare.com/role/PropertyAndEquipment Property And Equipment Notes 13 false false R14.htm 210291008 - Disclosure - Goodwill Sheet http://www.invacare.com/role/Goodwill Goodwill Notes 14 false false R15.htm 210311009 - Disclosure - Intangibles Sheet http://www.invacare.com/role/Intangibles Intangibles Notes 15 false false R16.htm 210361010 - Disclosure - Accrued Expenses Sheet http://www.invacare.com/role/AccruedExpenses Accrued Expenses Notes 16 false false R17.htm 210401011 - Disclosure - Long-Term Debt Sheet http://www.invacare.com/role/LongTermDebt Long-Term Debt Notes 17 false false R18.htm 210471012 - Disclosure - Other Long-Term Obligations Sheet http://www.invacare.com/role/OtherLongTermObligations Other Long-Term Obligations Notes 18 false false R19.htm 210501013 - Disclosure - Leases and Commitments (Notes) Notes http://www.invacare.com/role/LeasesandCommitmentsNotes Leases and Commitments (Notes) Notes 19 false false R20.htm 210571014 - Disclosure - Revenue Revenue Sheet http://www.invacare.com/role/RevenueRevenue Revenue Revenue Notes 20 false false R21.htm 210601015 - Disclosure - Equity Compensation Sheet http://www.invacare.com/role/EquityCompensation Equity Compensation Notes 21 false false R22.htm 210701016 - Disclosure - Accumulated Other Comprehensive Income (Loss) by Component Sheet http://www.invacare.com/role/AccumulatedOtherComprehensiveIncomeLossbyComponent Accumulated Other Comprehensive Income (Loss) by Component Notes 22 false false R23.htm 210741017 - Disclosure - Charges Related To Restructuring Activities Sheet http://www.invacare.com/role/ChargesRelatedToRestructuringActivities Charges Related To Restructuring Activities Notes 23 false false R24.htm 210781018 - Disclosure - Income Taxes Sheet http://www.invacare.com/role/IncomeTaxes Income Taxes Notes 24 false false R25.htm 210801019 - Disclosure - Net Earnings (Loss) Per Common Share Sheet http://www.invacare.com/role/NetEarningsLossPerCommonShare Net Earnings (Loss) Per Common Share Notes 25 false false R26.htm 210841020 - Disclosure - Concentration Of Credit Risk Sheet http://www.invacare.com/role/ConcentrationOfCreditRisk Concentration Of Credit Risk Notes 26 false false R27.htm 210861021 - Disclosure - Derivatives Sheet http://www.invacare.com/role/Derivatives Derivatives Notes 27 false false R28.htm 210941022 - Disclosure - Fair Values Sheet http://www.invacare.com/role/FairValues Fair Values Notes 28 false false R29.htm 210981023 - Disclosure - Business Segments Sheet http://www.invacare.com/role/BusinessSegments Business Segments Notes 29 false false R30.htm 211011024 - Disclosure - Contingencies Sheet http://www.invacare.com/role/Contingencies Contingencies Notes 30 false false R31.htm 220022001 - Disclosure - Accounting Policies (Policies) Sheet http://www.invacare.com/role/AccountingPoliciesPolicies Accounting Policies (Policies) Policies http://www.invacare.com/role/AccountingPolicies 31 false false R32.htm 230053001 - Disclosure - Divested Businesses (Tables) Sheet http://www.invacare.com/role/DivestedBusinessesTables Divested Businesses (Tables) Tables http://www.invacare.com/role/DivestedBusinessesNotes 32 false false R33.htm 230083002 - Disclosure - Receivables (Tables) Sheet http://www.invacare.com/role/ReceivablesTables Receivables (Tables) Tables http://www.invacare.com/role/Receivables 33 false false R34.htm 230173003 - Disclosure - Inventories (Tables) Sheet http://www.invacare.com/role/InventoriesTables Inventories (Tables) Tables http://www.invacare.com/role/Inventories 34 false false R35.htm 230203004 - Disclosure - Other Current Assets (Tables) Sheet http://www.invacare.com/role/OtherCurrentAssetsTables Other Current Assets (Tables) Tables http://www.invacare.com/role/OtherCurrentAssets 35 false false R36.htm 230233005 - Disclosure - Other Long-Term Assets (Tables) Sheet http://www.invacare.com/role/OtherLongTermAssetsTables Other Long-Term Assets (Tables) Tables http://www.invacare.com/role/OtherLongTermAssets 36 false false R37.htm 230273006 - Disclosure - Property And Equipment (Tables) Sheet http://www.invacare.com/role/PropertyAndEquipmentTables Property And Equipment (Tables) Tables http://www.invacare.com/role/PropertyAndEquipment 37 false false R38.htm 230323007 - Disclosure - Intangibles (Tables) Sheet http://www.invacare.com/role/IntangiblesTables Intangibles (Tables) Tables http://www.invacare.com/role/Intangibles 38 false false R39.htm 230373008 - Disclosure - Accrued Expenses (Tables) Sheet http://www.invacare.com/role/AccruedExpensesTables Accrued Expenses (Tables) Tables http://www.invacare.com/role/AccruedExpenses 39 false false R40.htm 230413009 - Disclosure - Long-Term Debt (Tables) Sheet http://www.invacare.com/role/LongTermDebtTables Long-Term Debt (Tables) Tables http://www.invacare.com/role/LongTermDebt 40 false false R41.htm 230483010 - Disclosure - Other Long-Term Obligations (Tables) Sheet http://www.invacare.com/role/OtherLongTermObligationsTables Other Long-Term Obligations (Tables) Tables http://www.invacare.com/role/OtherLongTermObligations 41 false false R42.htm 230513011 - Disclosure - Leases and Commitments (Tables) Sheet http://www.invacare.com/role/LeasesandCommitmentsTables Leases and Commitments (Tables) Tables http://www.invacare.com/role/LeasesandCommitmentsNotes 42 false false R43.htm 230583012 - Disclosure - Revenue (Tables) Sheet http://www.invacare.com/role/RevenueTables Revenue (Tables) Tables http://www.invacare.com/role/RevenueRevenue 43 false false R44.htm 230613013 - Disclosure - Equity Compensation (Tables) Sheet http://www.invacare.com/role/EquityCompensationTables Equity Compensation (Tables) Tables http://www.invacare.com/role/EquityCompensation 44 false false R45.htm 230713014 - Disclosure - Accumulated Other Comprehensive Income (Loss) by Component (Tables) Sheet http://www.invacare.com/role/AccumulatedOtherComprehensiveIncomeLossbyComponentTables Accumulated Other Comprehensive Income (Loss) by Component (Tables) Tables http://www.invacare.com/role/AccumulatedOtherComprehensiveIncomeLossbyComponent 45 false false R46.htm 230753015 - Disclosure - Charges Related To Restructuring Activities (Tables) Sheet http://www.invacare.com/role/ChargesRelatedToRestructuringActivitiesTables Charges Related To Restructuring Activities (Tables) Tables http://www.invacare.com/role/ChargesRelatedToRestructuringActivities 46 false false R47.htm 230813016 - Disclosure - Net Earnings (Loss) Per Common Share (Tables) Sheet http://www.invacare.com/role/NetEarningsLossPerCommonShareTables Net Earnings (Loss) Per Common Share (Tables) Tables http://www.invacare.com/role/NetEarningsLossPerCommonShare 47 false false R48.htm 230873017 - Disclosure - Derivatives (Tables) Sheet http://www.invacare.com/role/DerivativesTables Derivatives (Tables) Tables http://www.invacare.com/role/Derivatives 48 false false R49.htm 230953018 - Disclosure - Fair Values (Tables) Sheet http://www.invacare.com/role/FairValuesTables Fair Values (Tables) Tables http://www.invacare.com/role/FairValues 49 false false R50.htm 230993019 - Disclosure - Business Segments (Tables) Sheet http://www.invacare.com/role/BusinessSegmentsTables Business Segments (Tables) Tables http://www.invacare.com/role/BusinessSegments 50 false false R51.htm 240064002 - Disclosure - Divested Businesses (Details) Sheet http://www.invacare.com/role/DivestedBusinessesDetails Divested Businesses (Details) Details http://www.invacare.com/role/DivestedBusinessesTables 51 false false R52.htm 240094003 - Disclosure - Receivables (Narrative) (Details) Sheet http://www.invacare.com/role/ReceivablesNarrativeDetails Receivables (Narrative) (Details) Details http://www.invacare.com/role/ReceivablesTables 52 false false R53.htm 240104004 - Disclosure - Receivables (Schedule of Accounts Receivable) (Details) Sheet http://www.invacare.com/role/ReceivablesScheduleofAccountsReceivableDetails Receivables (Schedule of Accounts Receivable) (Details) Details http://www.invacare.com/role/ReceivablesTables 53 false false R54.htm 240114005 - Disclosure - Receivables Schedule for Allowance for Credit Losses (Details) Sheet http://www.invacare.com/role/ReceivablesScheduleforAllowanceforCreditLossesDetails Receivables Schedule for Allowance for Credit Losses (Details) Details 54 false false R55.htm 240124006 - Disclosure - Receivables (Installment Recevables) (Details) Sheet http://www.invacare.com/role/ReceivablesInstallmentRecevablesDetails Receivables (Installment Recevables) (Details) Details http://www.invacare.com/role/ReceivablesTables 55 false false R56.htm 240134007 - Disclosure - Receivables (Rollforward of Allowance for Doubtful Accounts) (Details) Sheet http://www.invacare.com/role/ReceivablesRollforwardofAllowanceforDoubtfulAccountsDetails Receivables (Rollforward of Allowance for Doubtful Accounts) (Details) Details http://www.invacare.com/role/ReceivablesTables 56 false false R57.htm 240144008 - Disclosure - Receivables (Installment Receivables by Class) (Details) Sheet http://www.invacare.com/role/ReceivablesInstallmentReceivablesbyClassDetails Receivables (Installment Receivables by Class) (Details) Details http://www.invacare.com/role/ReceivablesTables 57 false false R58.htm 240154009 - Disclosure - Receivables (Aging of Installment Receivables) (Details) Sheet http://www.invacare.com/role/ReceivablesAgingofInstallmentReceivablesDetails Receivables (Aging of Installment Receivables) (Details) Details http://www.invacare.com/role/ReceivablesTables 58 false false R59.htm 240184010 - Disclosure - Inventories (Details) Sheet http://www.invacare.com/role/InventoriesDetails Inventories (Details) Details http://www.invacare.com/role/InventoriesTables 59 false false R60.htm 240214011 - Disclosure - Other Current Assets Components of Other Current Assets (Details) Sheet http://www.invacare.com/role/OtherCurrentAssetsComponentsofOtherCurrentAssetsDetails Other Current Assets Components of Other Current Assets (Details) Details 60 false false R61.htm 240244012 - Disclosure - Other Long-Term Assets Components of Other Long-Term Assets (Details) Sheet http://www.invacare.com/role/OtherLongTermAssetsComponentsofOtherLongTermAssetsDetails Other Long-Term Assets Components of Other Long-Term Assets (Details) Details 61 false false R62.htm 240284014 - Disclosure - Property And Equipment (Details) Sheet http://www.invacare.com/role/PropertyAndEquipmentDetails Property And Equipment (Details) Details http://www.invacare.com/role/PropertyAndEquipmentTables 62 false false R63.htm 240334016 - Disclosure - Intangibles (Narrative) (Details) Sheet http://www.invacare.com/role/IntangiblesNarrativeDetails Intangibles (Narrative) (Details) Details http://www.invacare.com/role/IntangiblesTables 63 false false R64.htm 240344017 - Disclosure - Intangibles (Intangible Table) (Details) Sheet http://www.invacare.com/role/IntangiblesIntangibleTableDetails Intangibles (Intangible Table) (Details) Details http://www.invacare.com/role/IntangiblesTables 64 false false R65.htm 240354018 - Disclosure - Intangibles (Finite-Lived Intangible Asset Future Amortization Expense) (Details) Sheet http://www.invacare.com/role/IntangiblesFiniteLivedIntangibleAssetFutureAmortizationExpenseDetails Intangibles (Finite-Lived Intangible Asset Future Amortization Expense) (Details) Details http://www.invacare.com/role/IntangiblesTables 65 false false R66.htm 240384019 - Disclosure - Accrued Expenses Components of Accrued Expenses (Details) Sheet http://www.invacare.com/role/AccruedExpensesComponentsofAccruedExpensesDetails Accrued Expenses Components of Accrued Expenses (Details) Details 66 false false R67.htm 240394020 - Disclosure - Accrued Expenses Warranty Schedule (Details) Sheet http://www.invacare.com/role/AccruedExpensesWarrantyScheduleDetails Accrued Expenses Warranty Schedule (Details) Details 67 false false R68.htm 240424021 - Disclosure - Long-Term Debt (Details) Sheet http://www.invacare.com/role/LongTermDebtDetails Long-Term Debt (Details) Details http://www.invacare.com/role/LongTermDebtTables 68 false false R69.htm 240444023 - Disclosure - Long-Term Debt Components of Convertible Debt (Details) Sheet http://www.invacare.com/role/LongTermDebtComponentsofConvertibleDebtDetails Long-Term Debt Components of Convertible Debt (Details) Details 69 false false R70.htm 240454024 - Disclosure - Long-Term Debt Narrative (Details) Sheet http://www.invacare.com/role/LongTermDebtNarrativeDetails Long-Term Debt Narrative (Details) Details 70 false false R71.htm 240464025 - Disclosure - Long-Term Debt Sale Leaseback Transactions (Details) Sheet http://www.invacare.com/role/LongTermDebtSaleLeasebackTransactionsDetails Long-Term Debt Sale Leaseback Transactions (Details) Details 71 false false R72.htm 240494026 - Disclosure - Other Long-Term Obligations (Details) Sheet http://www.invacare.com/role/OtherLongTermObligationsDetails Other Long-Term Obligations (Details) Details http://www.invacare.com/role/OtherLongTermObligationsTables 72 false false R73.htm 240524027 - Disclosure - Leases and Commitments (Details) Sheet http://www.invacare.com/role/LeasesandCommitmentsDetails Leases and Commitments (Details) Details http://www.invacare.com/role/LeasesandCommitmentsTables 73 false false R74.htm 240534028 - Disclosure - Leases and Commitments Lease Expenses (Details) Sheet http://www.invacare.com/role/LeasesandCommitmentsLeaseExpensesDetails Leases and Commitments Lease Expenses (Details) Details 74 false false R75.htm 240544029 - Disclosure - Leases and Commitments Future Minimum Operating and Financing Lease Commitments (Details) Sheet http://www.invacare.com/role/LeasesandCommitmentsFutureMinimumOperatingandFinancingLeaseCommitmentsDetails Leases and Commitments Future Minimum Operating and Financing Lease Commitments (Details) Details 75 false false R76.htm 240554030 - Disclosure - Leases and Commitments Supplemental Cash Flow Information (Details) Sheet http://www.invacare.com/role/LeasesandCommitmentsSupplementalCashFlowInformationDetails Leases and Commitments Supplemental Cash Flow Information (Details) Details 76 false false R77.htm 240564031 - Disclosure - Leases and Commitments Weighted-Average Remaining Lease Terms and Discount Rates (Details) Sheet http://www.invacare.com/role/LeasesandCommitmentsWeightedAverageRemainingLeaseTermsandDiscountRatesDetails Leases and Commitments Weighted-Average Remaining Lease Terms and Discount Rates (Details) Details 77 false false R78.htm 240594032 - Disclosure - Revenue (Details) Sheet http://www.invacare.com/role/RevenueDetails Revenue (Details) Details http://www.invacare.com/role/RevenueTables 78 false false R79.htm 240624033 - Disclosure - Equity Compensation (Narrative) (Details) Sheet http://www.invacare.com/role/EquityCompensationNarrativeDetails Equity Compensation (Narrative) (Details) Details http://www.invacare.com/role/EquityCompensationTables 79 false false R80.htm 240634034 - Disclosure - Equity Compensation Share-based Compensation Expense (Details) Sheet http://www.invacare.com/role/EquityCompensationSharebasedCompensationExpenseDetails Equity Compensation Share-based Compensation Expense (Details) Details 80 false false R81.htm 240644035 - Disclosure - Equity Compensation Unrecognized Compensation Expense (Details) Sheet http://www.invacare.com/role/EquityCompensationUnrecognizedCompensationExpenseDetails Equity Compensation Unrecognized Compensation Expense (Details) Details 81 false false R82.htm 240654036 - Disclosure - Equity Compensation (Options Activity) (Details) Sheet http://www.invacare.com/role/EquityCompensationOptionsActivityDetails Equity Compensation (Options Activity) (Details) Details http://www.invacare.com/role/EquityCompensationTables 82 false false R83.htm 240664037 - Disclosure - Equity Compensation (Stock Options Outstanding by Exercise Price) (Details) Sheet http://www.invacare.com/role/EquityCompensationStockOptionsOutstandingbyExercisePriceDetails Equity Compensation (Stock Options Outstanding by Exercise Price) (Details) Details http://www.invacare.com/role/EquityCompensationTables 83 false false R84.htm 240674038 - Disclosure - Equity Compensation Restricted Stock Activity (Details) Sheet http://www.invacare.com/role/EquityCompensationRestrictedStockActivityDetails Equity Compensation Restricted Stock Activity (Details) Details 84 false false R85.htm 240684039 - Disclosure - Equity Compensation Performance Share Activity (Details) Sheet http://www.invacare.com/role/EquityCompensationPerformanceShareActivityDetails Equity Compensation Performance Share Activity (Details) Details 85 false false R86.htm 240724041 - Disclosure - Accumulated Other Comprehensive Income (Loss) by Component (Changes in Accumulated Other Comprehensive Income) (Details) Sheet http://www.invacare.com/role/AccumulatedOtherComprehensiveIncomeLossbyComponentChangesinAccumulatedOtherComprehensiveIncomeDetails Accumulated Other Comprehensive Income (Loss) by Component (Changes in Accumulated Other Comprehensive Income) (Details) Details http://www.invacare.com/role/AccumulatedOtherComprehensiveIncomeLossbyComponentTables 86 false false R87.htm 240734042 - Disclosure - Accumulated Other Comprehensive Income (Loss) by Component (Reclassified Out of Accumulated Other Comprehensive Income) (Details) Sheet http://www.invacare.com/role/AccumulatedOtherComprehensiveIncomeLossbyComponentReclassifiedOutofAccumulatedOtherComprehensiveIncomeDetails Accumulated Other Comprehensive Income (Loss) by Component (Reclassified Out of Accumulated Other Comprehensive Income) (Details) Details http://www.invacare.com/role/AccumulatedOtherComprehensiveIncomeLossbyComponentTables 87 false false R88.htm 240764043 - Disclosure - Charges Related To Restructuring Activities (Details) Sheet http://www.invacare.com/role/ChargesRelatedToRestructuringActivitiesDetails Charges Related To Restructuring Activities (Details) Details http://www.invacare.com/role/ChargesRelatedToRestructuringActivitiesTables 88 false false R89.htm 240774044 - Disclosure - Charges Related To Restructuring Activities Narrative (Details) Sheet http://www.invacare.com/role/ChargesRelatedToRestructuringActivitiesNarrativeDetails Charges Related To Restructuring Activities Narrative (Details) Details http://www.invacare.com/role/ChargesRelatedToRestructuringActivitiesTables 89 false false R90.htm 240794045 - Disclosure - Income Taxes (Narrative) (Details) Sheet http://www.invacare.com/role/IncomeTaxesNarrativeDetails Income Taxes (Narrative) (Details) Details http://www.invacare.com/role/IncomeTaxes 90 false false R91.htm 240824046 - Disclosure - Net Earnings (Loss) Per Common Share Computation of Basic and Diluted Net Earnings (Loss) Per Common Share (Details) Sheet http://www.invacare.com/role/NetEarningsLossPerCommonShareComputationofBasicandDilutedNetEarningsLossPerCommonShareDetails Net Earnings (Loss) Per Common Share Computation of Basic and Diluted Net Earnings (Loss) Per Common Share (Details) Details http://www.invacare.com/role/NetEarningsLossPerCommonShareTables 91 false false R92.htm 240834047 - Disclosure - Net Earnings (Loss) Per Common Share Textuals (Details) Sheet http://www.invacare.com/role/NetEarningsLossPerCommonShareTextualsDetails Net Earnings (Loss) Per Common Share Textuals (Details) Details http://www.invacare.com/role/NetEarningsLossPerCommonShareTables 92 false false R93.htm 240854048 - Disclosure - Concentration Of Credit Risk (Details) Sheet http://www.invacare.com/role/ConcentrationOfCreditRiskDetails Concentration Of Credit Risk (Details) Details http://www.invacare.com/role/ConcentrationOfCreditRisk 93 false false R94.htm 240884049 - Disclosure - Derivatives Notional Amounts - Designated as Hedges (Details) Sheet http://www.invacare.com/role/DerivativesNotionalAmountsDesignatedasHedgesDetails Derivatives Notional Amounts - Designated as Hedges (Details) Details 94 false false R95.htm 240894050 - Disclosure - Derivatives Notional Amounts - Not Designated as Hedges (Details) Sheet http://www.invacare.com/role/DerivativesNotionalAmountsNotDesignatedasHedgesDetails Derivatives Notional Amounts - Not Designated as Hedges (Details) Details 95 false false R96.htm 240904051 - Disclosure - Derivatives Balance Sheet Location (Details) Sheet http://www.invacare.com/role/DerivativesBalanceSheetLocationDetails Derivatives Balance Sheet Location (Details) Details 96 false false R97.htm 240914052 - Disclosure - Derivatives Gain (Loss) in Statement of Finacial Position (Details) Sheet http://www.invacare.com/role/DerivativesGainLossinStatementofFinacialPositionDetails Derivatives Gain (Loss) in Statement of Finacial Position (Details) Details 97 false false R98.htm 240924053 - Disclosure - Derivatives Narrative (Details) Sheet http://www.invacare.com/role/DerivativesNarrativeDetails Derivatives Narrative (Details) Details 98 false false R99.htm 240934054 - Disclosure - Derivatives Fair Value of Convertible Debt Hedges (Details) Sheet http://www.invacare.com/role/DerivativesFairValueofConvertibleDebtHedgesDetails Derivatives Fair Value of Convertible Debt Hedges (Details) Details 99 false false R100.htm 240964055 - Disclosure - Fair Values (Assets and Liabilities Measured at Fair Value on a Recurring Basis) (Details) Sheet http://www.invacare.com/role/FairValuesAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails Fair Values (Assets and Liabilities Measured at Fair Value on a Recurring Basis) (Details) Details http://www.invacare.com/role/FairValuesTables 100 false false R101.htm 240974056 - Disclosure - Fair Values (Details of Book Value and Fair Value of Financial Instruments) (Details) Sheet http://www.invacare.com/role/FairValuesDetailsofBookValueandFairValueofFinancialInstrumentsDetails Fair Values (Details of Book Value and Fair Value of Financial Instruments) (Details) Details http://www.invacare.com/role/FairValuesTables 101 false false R102.htm 241004057 - Disclosure - Business Segments (Information by Segment) (Details) Sheet http://www.invacare.com/role/BusinessSegmentsInformationbySegmentDetails Business Segments (Information by Segment) (Details) Details http://www.invacare.com/role/BusinessSegmentsTables 102 false false All Reports Book All Reports ivc-20200930.htm ivc-20200930.xsd ivc-20200930_cal.xml ivc-20200930_def.xml ivc-20200930_lab.xml ivc-20200930_pre.xml q32020ivcex311.htm q32020ivcex312.htm q32020ivcex321.htm q32020ivcex322.htm ivc-20200930_g1.jpg ivc-20200930_g2.jpg ivc-20200930_g3.jpg ivc-20200930_g4.jpg ivc-20200930_g5.jpg ivc-20200930_g6.jpg ivc-20200930_g7.jpg ivc-20200930_g8.jpg ivc-20200930_g9.jpg http://fasb.org/srt/2020-01-31 http://fasb.org/us-gaap/2020-01-31 http://xbrl.sec.gov/country/2020-01-31 http://xbrl.sec.gov/dei/2019-01-31 http://xbrl.sec.gov/currency/2020-01-31 true true JSON 129 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "ivc-20200930.htm": { "axisCustom": 2, "axisStandard": 28, "contextCount": 658, "dts": { "calculationLink": { "local": [ "ivc-20200930_cal.xml" ] }, "definitionLink": { "local": [ "ivc-20200930_def.xml" ], "remote": [ "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-eedm-def-2020-01-31.xml", "http://xbrl.fasb.org/srt/2020/elts/srt-eedm1-def-2020-01-31.xml" ] }, "inline": { "local": [ "ivc-20200930.htm" ] }, "labelLink": { "local": [ "ivc-20200930_lab.xml" ], "remote": [ "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml", "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-doc-2020-01-31.xml" ] }, "presentationLink": { "local": [ "ivc-20200930_pre.xml" ] }, "referenceLink": { "remote": [ "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-ref-2020-01-31.xml", "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml" ] }, "schema": { "local": [ "ivc-20200930.xsd" ], "remote": [ "http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd", "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd", "http://xbrl.fasb.org/srt/2020/elts/srt-roles-2020-01-31.xsd", "https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd", "https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd", "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "http://xbrl.fasb.org/us-gaap/2020/elts/us-parts-codification-2020-01-31.xsd", "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd" ] } }, "elementCount": 915, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2020-01-31": 1, "http://www.invacare.com/20200930": 5, "http://xbrl.sec.gov/dei/2019-01-31": 5, "total": 11 }, "keyCustom": 163, "keyStandard": 458, "memberCustom": 56, "memberStandard": 64, "nsprefix": "ivc", "nsuri": "http://www.invacare.com/20200930", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i2c8a6c816e3b4e3fa7215fe88ee54f26_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "000010001 - Document - DEI Document", "role": "http://www.invacare.com/role/DEIDocument", "shortName": "DEI Document", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i2c8a6c816e3b4e3fa7215fe88ee54f26_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i2c8a6c816e3b4e3fa7215fe88ee54f26_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InventoryDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "210161004 - Disclosure - Inventories", "role": "http://www.invacare.com/role/Inventories", "shortName": "Inventories", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i2c8a6c816e3b4e3fa7215fe88ee54f26_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InventoryDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R100": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "ibf18eeed95914bb380235dabb0fc48f3_D20200701-20200930", "decimals": "-3", "first": true, "lang": "en-US", "name": "ivc:FairValuesConvertibleDebtHedgesGainLoss", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240964055 - Disclosure - Fair Values (Assets and Liabilities Measured at Fair Value on a Recurring Basis) (Details)", "role": "http://www.invacare.com/role/FairValuesAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "shortName": "Fair Values (Assets and Liabilities Measured at Fair Value on a Recurring Basis) (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R101": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i08b1d1438dd2406ab77dd82937638abf_I20200930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240974056 - Disclosure - Fair Values (Details of Book Value and Fair Value of Financial Instruments) (Details)", "role": "http://www.invacare.com/role/FairValuesDetailsofBookValueandFairValueofFinancialInstrumentsDetails", "shortName": "Fair Values (Details of Book Value and Fair Value of Financial Instruments) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:FairValueByBalanceSheetGroupingTextBlock", "us-gaap:FairValueDisclosuresTextBlock", "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i362d1f8c2bdb45f1b9ea67fc7f9932b2_I20200930", "decimals": "-3", "lang": "en-US", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R102": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "ibf18eeed95914bb380235dabb0fc48f3_D20200701-20200930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:Revenues", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "241004057 - Disclosure - Business Segments (Information by Segment) (Details)", "role": "http://www.invacare.com/role/BusinessSegmentsInformationbySegmentDetails", "shortName": "Business Segments (Information by Segment) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "ibf18eeed95914bb380235dabb0fc48f3_D20200701-20200930", "decimals": "-3", "lang": "en-US", "name": "us-gaap:InterestRevenueExpenseNet", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i2c8a6c816e3b4e3fa7215fe88ee54f26_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OtherCurrentAssetsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "210191005 - Disclosure - Other Current Assets", "role": "http://www.invacare.com/role/OtherCurrentAssets", "shortName": "Other Current Assets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i2c8a6c816e3b4e3fa7215fe88ee54f26_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OtherCurrentAssetsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i2c8a6c816e3b4e3fa7215fe88ee54f26_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OtherAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "210221006 - Disclosure - Other Long-Term Assets", "role": "http://www.invacare.com/role/OtherLongTermAssets", "shortName": "Other Long-Term Assets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i2c8a6c816e3b4e3fa7215fe88ee54f26_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OtherAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "span", "div", "div", "div", "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i2c8a6c816e3b4e3fa7215fe88ee54f26_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "210261007 - Disclosure - Property And Equipment", "role": "http://www.invacare.com/role/PropertyAndEquipment", "shortName": "Property And Equipment", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "div", "div", "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i2c8a6c816e3b4e3fa7215fe88ee54f26_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i2c8a6c816e3b4e3fa7215fe88ee54f26_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:GoodwillDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "210291008 - Disclosure - Goodwill", "role": "http://www.invacare.com/role/Goodwill", "shortName": "Goodwill", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i2c8a6c816e3b4e3fa7215fe88ee54f26_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:GoodwillDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i2c8a6c816e3b4e3fa7215fe88ee54f26_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "210311009 - Disclosure - Intangibles", "role": "http://www.invacare.com/role/Intangibles", "shortName": "Intangibles", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i2c8a6c816e3b4e3fa7215fe88ee54f26_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i2c8a6c816e3b4e3fa7215fe88ee54f26_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "210361010 - Disclosure - Accrued Expenses", "role": "http://www.invacare.com/role/AccruedExpenses", "shortName": "Accrued Expenses", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i2c8a6c816e3b4e3fa7215fe88ee54f26_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i2c8a6c816e3b4e3fa7215fe88ee54f26_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtAndCapitalLeasesDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "210401011 - Disclosure - Long-Term Debt", "role": "http://www.invacare.com/role/LongTermDebt", "shortName": "Long-Term Debt", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i2c8a6c816e3b4e3fa7215fe88ee54f26_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtAndCapitalLeasesDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i2c8a6c816e3b4e3fa7215fe88ee54f26_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OtherLiabilitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "210471012 - Disclosure - Other Long-Term Obligations", "role": "http://www.invacare.com/role/OtherLongTermObligations", "shortName": "Other Long-Term Obligations", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i2c8a6c816e3b4e3fa7215fe88ee54f26_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OtherLiabilitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i2c8a6c816e3b4e3fa7215fe88ee54f26_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LeasesOfLesseeDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "210501013 - Disclosure - Leases and Commitments (Notes)", "role": "http://www.invacare.com/role/LeasesandCommitmentsNotes", "shortName": "Leases and Commitments (Notes)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i2c8a6c816e3b4e3fa7215fe88ee54f26_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LeasesOfLesseeDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "ibf18eeed95914bb380235dabb0fc48f3_D20200701-20200930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:Revenues", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "100010002 - Statement - Condensed Consolidated Statement of Comprehensive Income (Loss)", "role": "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss", "shortName": "Condensed Consolidated Statement of Comprehensive Income (Loss)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "ibf18eeed95914bb380235dabb0fc48f3_D20200701-20200930", "decimals": "-3", "lang": "en-US", "name": "us-gaap:GrossProfit", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i2c8a6c816e3b4e3fa7215fe88ee54f26_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RevenueRecognitionDeferredRevenue", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "210571014 - Disclosure - Revenue Revenue", "role": "http://www.invacare.com/role/RevenueRevenue", "shortName": "Revenue Revenue", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i2c8a6c816e3b4e3fa7215fe88ee54f26_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RevenueRecognitionDeferredRevenue", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i2c8a6c816e3b4e3fa7215fe88ee54f26_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "210601015 - Disclosure - Equity Compensation", "role": "http://www.invacare.com/role/EquityCompensation", "shortName": "Equity Compensation", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i2c8a6c816e3b4e3fa7215fe88ee54f26_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i2c8a6c816e3b4e3fa7215fe88ee54f26_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ComprehensiveIncomeNoteTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "210701016 - Disclosure - Accumulated Other Comprehensive Income (Loss) by Component", "role": "http://www.invacare.com/role/AccumulatedOtherComprehensiveIncomeLossbyComponent", "shortName": "Accumulated Other Comprehensive Income (Loss) by Component", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i2c8a6c816e3b4e3fa7215fe88ee54f26_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ComprehensiveIncomeNoteTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i2c8a6c816e3b4e3fa7215fe88ee54f26_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "210741017 - Disclosure - Charges Related To Restructuring Activities", "role": "http://www.invacare.com/role/ChargesRelatedToRestructuringActivities", "shortName": "Charges Related To Restructuring Activities", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i2c8a6c816e3b4e3fa7215fe88ee54f26_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i2c8a6c816e3b4e3fa7215fe88ee54f26_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "210781018 - Disclosure - Income Taxes", "role": "http://www.invacare.com/role/IncomeTaxes", "shortName": "Income Taxes", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i2c8a6c816e3b4e3fa7215fe88ee54f26_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i2c8a6c816e3b4e3fa7215fe88ee54f26_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "210801019 - Disclosure - Net Earnings (Loss) Per Common Share", "role": "http://www.invacare.com/role/NetEarningsLossPerCommonShare", "shortName": "Net Earnings (Loss) Per Common Share", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i2c8a6c816e3b4e3fa7215fe88ee54f26_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i2c8a6c816e3b4e3fa7215fe88ee54f26_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ConcentrationRiskDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "210841020 - Disclosure - Concentration Of Credit Risk", "role": "http://www.invacare.com/role/ConcentrationOfCreditRisk", "shortName": "Concentration Of Credit Risk", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i2c8a6c816e3b4e3fa7215fe88ee54f26_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ConcentrationRiskDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i2c8a6c816e3b4e3fa7215fe88ee54f26_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "210861021 - Disclosure - Derivatives", "role": "http://www.invacare.com/role/Derivatives", "shortName": "Derivatives", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i2c8a6c816e3b4e3fa7215fe88ee54f26_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i2c8a6c816e3b4e3fa7215fe88ee54f26_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "210941022 - Disclosure - Fair Values", "role": "http://www.invacare.com/role/FairValues", "shortName": "Fair Values", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i2c8a6c816e3b4e3fa7215fe88ee54f26_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i2c8a6c816e3b4e3fa7215fe88ee54f26_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "210981023 - Disclosure - Business Segments", "role": "http://www.invacare.com/role/BusinessSegments", "shortName": "Business Segments", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i2c8a6c816e3b4e3fa7215fe88ee54f26_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i08b1d1438dd2406ab77dd82937638abf_I20200930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "100020003 - Statement - Condensed Consolidated Balance Sheets", "role": "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets", "shortName": "Condensed Consolidated Balance Sheets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i08b1d1438dd2406ab77dd82937638abf_I20200930", "decimals": "-3", "lang": "en-US", "name": "us-gaap:AccountsReceivableNetCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i2c8a6c816e3b4e3fa7215fe88ee54f26_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LossContingencyDisclosures", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "211011024 - Disclosure - Contingencies", "role": "http://www.invacare.com/role/Contingencies", "shortName": "Contingencies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i2c8a6c816e3b4e3fa7215fe88ee54f26_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LossContingencyDisclosures", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "div", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i2c8a6c816e3b4e3fa7215fe88ee54f26_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ConsolidationPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "220022001 - Disclosure - Accounting Policies (Policies)", "role": "http://www.invacare.com/role/AccountingPoliciesPolicies", "shortName": "Accounting Policies (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i2c8a6c816e3b4e3fa7215fe88ee54f26_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ConsolidationPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "div", "div", "us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock", "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "ie184bff37eda4b88b8302d9c7fdb60d7_D20200101-20200307", "decimals": null, "first": true, "lang": "en-US", "name": "ivc:AssetsandLiabilitiesofDivestedBusinessTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "230053001 - Disclosure - Divested Businesses (Tables)", "role": "http://www.invacare.com/role/DivestedBusinessesTables", "shortName": "Divested Businesses (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "div", "us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock", "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "ie184bff37eda4b88b8302d9c7fdb60d7_D20200101-20200307", "decimals": null, "first": true, "lang": "en-US", "name": "ivc:AssetsandLiabilitiesofDivestedBusinessTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "div", "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock", "div", "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i2c8a6c816e3b4e3fa7215fe88ee54f26_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "ivc:ScheduleofAccountsReceivableTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "230083002 - Disclosure - Receivables (Tables)", "role": "http://www.invacare.com/role/ReceivablesTables", "shortName": "Receivables (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock", "div", "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i2c8a6c816e3b4e3fa7215fe88ee54f26_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "ivc:ScheduleofAccountsReceivableTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i2c8a6c816e3b4e3fa7215fe88ee54f26_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "230173003 - Disclosure - Inventories (Tables)", "role": "http://www.invacare.com/role/InventoriesTables", "shortName": "Inventories (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i2c8a6c816e3b4e3fa7215fe88ee54f26_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "us-gaap:OtherCurrentAssetsTextBlock", "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i2c8a6c816e3b4e3fa7215fe88ee54f26_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "230203004 - Disclosure - Other Current Assets (Tables)", "role": "http://www.invacare.com/role/OtherCurrentAssetsTables", "shortName": "Other Current Assets (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:OtherCurrentAssetsTextBlock", "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i2c8a6c816e3b4e3fa7215fe88ee54f26_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "us-gaap:OtherAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i2c8a6c816e3b4e3fa7215fe88ee54f26_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfOtherAssetsNoncurrentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "230233005 - Disclosure - Other Long-Term Assets (Tables)", "role": "http://www.invacare.com/role/OtherLongTermAssetsTables", "shortName": "Other Long-Term Assets (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:OtherAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i2c8a6c816e3b4e3fa7215fe88ee54f26_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfOtherAssetsNoncurrentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i2c8a6c816e3b4e3fa7215fe88ee54f26_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "230273006 - Disclosure - Property And Equipment (Tables)", "role": "http://www.invacare.com/role/PropertyAndEquipmentTables", "shortName": "Property And Equipment (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i2c8a6c816e3b4e3fa7215fe88ee54f26_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i2c8a6c816e3b4e3fa7215fe88ee54f26_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "230323007 - Disclosure - Intangibles (Tables)", "role": "http://www.invacare.com/role/IntangiblesTables", "shortName": "Intangibles (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i2c8a6c816e3b4e3fa7215fe88ee54f26_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i2c8a6c816e3b4e3fa7215fe88ee54f26_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "230373008 - Disclosure - Accrued Expenses (Tables)", "role": "http://www.invacare.com/role/AccruedExpensesTables", "shortName": "Accrued Expenses (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i2c8a6c816e3b4e3fa7215fe88ee54f26_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i08b1d1438dd2406ab77dd82937638abf_I20200930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:PreferredStockSharesAuthorized", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "100030004 - Statement - Condensed Consolidated Balance Sheets (Parentheticals)", "role": "http://www.invacare.com/role/CondensedConsolidatedBalanceSheetsParentheticals", "shortName": "Condensed Consolidated Balance Sheets (Parentheticals)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i08b1d1438dd2406ab77dd82937638abf_I20200930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:PreferredStockSharesAuthorized", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R40": { "firstAnchor": { "ancestors": [ "us-gaap:DebtAndCapitalLeasesDisclosuresTextBlock", "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i2c8a6c816e3b4e3fa7215fe88ee54f26_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "230413009 - Disclosure - Long-Term Debt (Tables)", "role": "http://www.invacare.com/role/LongTermDebtTables", "shortName": "Long-Term Debt (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:DebtAndCapitalLeasesDisclosuresTextBlock", "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i2c8a6c816e3b4e3fa7215fe88ee54f26_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R41": { "firstAnchor": { "ancestors": [ "us-gaap:OtherLiabilitiesDisclosureTextBlock", "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i2c8a6c816e3b4e3fa7215fe88ee54f26_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OtherNoncurrentLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "230483010 - Disclosure - Other Long-Term Obligations (Tables)", "role": "http://www.invacare.com/role/OtherLongTermObligationsTables", "shortName": "Other Long-Term Obligations (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:OtherLiabilitiesDisclosureTextBlock", "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i2c8a6c816e3b4e3fa7215fe88ee54f26_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OtherNoncurrentLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R42": { "firstAnchor": { "ancestors": [ "div", "div", "us-gaap:LeasesOfLesseeDisclosureTextBlock", "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i2c8a6c816e3b4e3fa7215fe88ee54f26_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LeaseCostTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "230513011 - Disclosure - Leases and Commitments (Tables)", "role": "http://www.invacare.com/role/LeasesandCommitmentsTables", "shortName": "Leases and Commitments (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "div", "us-gaap:LeasesOfLesseeDisclosureTextBlock", "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i2c8a6c816e3b4e3fa7215fe88ee54f26_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LeaseCostTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R43": { "firstAnchor": { "ancestors": [ "span", "div", "div", "div", "us-gaap:RevenueRecognitionDeferredRevenue", "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i2c8a6c816e3b4e3fa7215fe88ee54f26_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RevenueRecognitionMultipleDeliverableArrangementsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "230583012 - Disclosure - Revenue (Tables)", "role": "http://www.invacare.com/role/RevenueTables", "shortName": "Revenue (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "span", "div", "div", "div", "us-gaap:RevenueRecognitionDeferredRevenue", "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i2c8a6c816e3b4e3fa7215fe88ee54f26_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RevenueRecognitionMultipleDeliverableArrangementsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R44": { "firstAnchor": { "ancestors": [ "div", "div", "ix:continuation", "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i2c8a6c816e3b4e3fa7215fe88ee54f26_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "230613013 - Disclosure - Equity Compensation (Tables)", "role": "http://www.invacare.com/role/EquityCompensationTables", "shortName": "Equity Compensation (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "div", "ix:continuation", "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i2c8a6c816e3b4e3fa7215fe88ee54f26_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R45": { "firstAnchor": { "ancestors": [ "us-gaap:ComprehensiveIncomeNoteTextBlock", "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i2c8a6c816e3b4e3fa7215fe88ee54f26_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "230713014 - Disclosure - Accumulated Other Comprehensive Income (Loss) by Component (Tables)", "role": "http://www.invacare.com/role/AccumulatedOtherComprehensiveIncomeLossbyComponentTables", "shortName": "Accumulated Other Comprehensive Income (Loss) by Component (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:ComprehensiveIncomeNoteTextBlock", "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i2c8a6c816e3b4e3fa7215fe88ee54f26_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R46": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i2c8a6c816e3b4e3fa7215fe88ee54f26_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "230753015 - Disclosure - Charges Related To Restructuring Activities (Tables)", "role": "http://www.invacare.com/role/ChargesRelatedToRestructuringActivitiesTables", "shortName": "Charges Related To Restructuring Activities (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i2c8a6c816e3b4e3fa7215fe88ee54f26_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R47": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i2c8a6c816e3b4e3fa7215fe88ee54f26_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "230813016 - Disclosure - Net Earnings (Loss) Per Common Share (Tables)", "role": "http://www.invacare.com/role/NetEarningsLossPerCommonShareTables", "shortName": "Net Earnings (Loss) Per Common Share (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i2c8a6c816e3b4e3fa7215fe88ee54f26_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R48": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i2c8a6c816e3b4e3fa7215fe88ee54f26_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "230873017 - Disclosure - Derivatives (Tables)", "role": "http://www.invacare.com/role/DerivativesTables", "shortName": "Derivatives (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i2c8a6c816e3b4e3fa7215fe88ee54f26_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R49": { "firstAnchor": { "ancestors": [ "us-gaap:FairValueDisclosuresTextBlock", "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i2c8a6c816e3b4e3fa7215fe88ee54f26_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "230953018 - Disclosure - Fair Values (Tables)", "role": "http://www.invacare.com/role/FairValuesTables", "shortName": "Fair Values (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:FairValueDisclosuresTextBlock", "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i2c8a6c816e3b4e3fa7215fe88ee54f26_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i2c8a6c816e3b4e3fa7215fe88ee54f26_D20200101-20200930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "100040005 - Statement - Condensed Consolidated Statement Of Cash Flows", "role": "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows", "shortName": "Condensed Consolidated Statement Of Cash Flows", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i2c8a6c816e3b4e3fa7215fe88ee54f26_D20200101-20200930", "decimals": "-3", "lang": "en-US", "name": "us-gaap:DepreciationDepletionAndAmortization", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R50": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i2c8a6c816e3b4e3fa7215fe88ee54f26_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "230993019 - Disclosure - Business Segments (Tables)", "role": "http://www.invacare.com/role/BusinessSegmentsTables", "shortName": "Business Segments (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i2c8a6c816e3b4e3fa7215fe88ee54f26_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R51": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ivc:AssetsandLiabilitiesofDivestedBusinessTableTextBlock", "div", "div", "us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock", "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i92041a2bd4554593873e5518517c1318_I20200307", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240064002 - Disclosure - Divested Businesses (Details)", "role": "http://www.invacare.com/role/DivestedBusinessesDetails", "shortName": "Divested Businesses (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ivc:AssetsandLiabilitiesofDivestedBusinessTableTextBlock", "div", "div", "us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock", "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i92041a2bd4554593873e5518517c1318_I20200307", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R52": { "firstAnchor": { "ancestors": [ "span", "div", "div", "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock", "div", "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i2c8a6c816e3b4e3fa7215fe88ee54f26_D20200101-20200930", "decimals": "0", "first": true, "lang": "en-US", "name": "ivc:AdoptionofCreditLossStandard", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240094003 - Disclosure - Receivables (Narrative) (Details)", "role": "http://www.invacare.com/role/ReceivablesNarrativeDetails", "shortName": "Receivables (Narrative) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i2c8a6c816e3b4e3fa7215fe88ee54f26_D20200101-20200930", "decimals": "0", "lang": "en-US", "name": "ivc:ContingentLiabilityGuarantee", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R53": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ivc:ScheduleofAccountsReceivableTableTextBlock", "div", "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock", "div", "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i08b1d1438dd2406ab77dd82937638abf_I20200930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:AccountsReceivableGross", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240104004 - Disclosure - Receivables (Schedule of Accounts Receivable) (Details)", "role": "http://www.invacare.com/role/ReceivablesScheduleofAccountsReceivableDetails", "shortName": "Receivables (Schedule of Accounts Receivable) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ivc:ScheduleofAccountsReceivableTableTextBlock", "div", "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock", "div", "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i08b1d1438dd2406ab77dd82937638abf_I20200930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:AccountsReceivableGross", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R54": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ivc:AllowanceforCreditLossesTableTextBlock", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i08b1d1438dd2406ab77dd82937638abf_I20200930", "decimals": "-3", "first": true, "lang": "en-US", "name": "ivc:AllowanceforCreditLosses", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240114005 - Disclosure - Receivables Schedule for Allowance for Credit Losses (Details)", "role": "http://www.invacare.com/role/ReceivablesScheduleforAllowanceforCreditLossesDetails", "shortName": "Receivables Schedule for Allowance for Credit Losses (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ivc:AllowanceforCreditLossesTableTextBlock", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i08b1d1438dd2406ab77dd82937638abf_I20200930", "decimals": "-3", "first": true, "lang": "en-US", "name": "ivc:AllowanceforCreditLosses", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R55": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ivc:FinancingReceivablesTableTextBlock", "us-gaap:ImpairedFinancingReceivablesTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i08b1d1438dd2406ab77dd82937638abf_I20200930", "decimals": "-3", "first": true, "lang": "en-US", "name": "ivc:NonImpairedFinancingReceivableRelatedAllowance", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240124006 - Disclosure - Receivables (Installment Recevables) (Details)", "role": "http://www.invacare.com/role/ReceivablesInstallmentRecevablesDetails", "shortName": "Receivables (Installment Recevables) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i08b1d1438dd2406ab77dd82937638abf_I20200930", "decimals": "-3", "lang": "en-US", "name": "us-gaap:NotesAndLoansReceivableGrossCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R56": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i617027d6fa504e1cbb5d2fbc0742e6a0_I20191231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:FinancingReceivableAllowanceForCreditLosses", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240134007 - Disclosure - Receivables (Rollforward of Allowance for Doubtful Accounts) (Details)", "role": "http://www.invacare.com/role/ReceivablesRollforwardofAllowanceforDoubtfulAccountsDetails", "shortName": "Receivables (Rollforward of Allowance for Doubtful Accounts) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i2c8a6c816e3b4e3fa7215fe88ee54f26_D20200101-20200930", "decimals": "-3", "lang": "en-US", "name": "us-gaap:AllowanceForLoanAndLeaseLossesAdjustmentsNet", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R57": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ivc:FinancingReceivablesTableTextBlock", "us-gaap:ImpairedFinancingReceivablesTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i08b1d1438dd2406ab77dd82937638abf_I20200930", "decimals": "-3", "first": true, "lang": "en-US", "name": "ivc:FinancingReceivablewithNoRelatedAllowanceRecordedInvestment", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240144008 - Disclosure - Receivables (Installment Receivables by Class) (Details)", "role": "http://www.invacare.com/role/ReceivablesInstallmentReceivablesbyClassDetails", "shortName": "Receivables (Installment Receivables by Class) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ivc:FinancingReceivablesTableTextBlock", "us-gaap:ImpairedFinancingReceivablesTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i08b1d1438dd2406ab77dd82937638abf_I20200930", "decimals": "-3", "first": true, "lang": "en-US", "name": "ivc:FinancingReceivablewithNoRelatedAllowanceRecordedInvestment", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R58": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:PastDueFinancingReceivablesTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i08b1d1438dd2406ab77dd82937638abf_I20200930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:FinancingReceivableRecordedInvestmentCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240154009 - Disclosure - Receivables (Aging of Installment Receivables) (Details)", "role": "http://www.invacare.com/role/ReceivablesAgingofInstallmentReceivablesDetails", "shortName": "Receivables (Aging of Installment Receivables) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:PastDueFinancingReceivablesTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i08b1d1438dd2406ab77dd82937638abf_I20200930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:FinancingReceivableRecordedInvestmentCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R59": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i08b1d1438dd2406ab77dd82937638abf_I20200930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:InventoryFinishedGoodsNetOfReserves", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240184010 - Disclosure - Inventories (Details)", "role": "http://www.invacare.com/role/InventoriesDetails", "shortName": "Inventories (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i08b1d1438dd2406ab77dd82937638abf_I20200930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:InventoryFinishedGoodsNetOfReserves", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i10058c7782d74f799253a7422638945e_I20181231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "100050006 - Statement - Condensed Consolidated Statement of Shareholders' Equity Statement", "role": "http://www.invacare.com/role/CondensedConsolidatedStatementofShareholdersEquityStatement", "shortName": "Condensed Consolidated Statement of Shareholders' Equity Statement", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i10058c7782d74f799253a7422638945e_I20181231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R60": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock", "us-gaap:OtherCurrentAssetsTextBlock", "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i08b1d1438dd2406ab77dd82937638abf_I20200930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:ValueAddedTaxReceivableCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240214011 - Disclosure - Other Current Assets Components of Other Current Assets (Details)", "role": "http://www.invacare.com/role/OtherCurrentAssetsComponentsofOtherCurrentAssetsDetails", "shortName": "Other Current Assets Components of Other Current Assets (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock", "us-gaap:OtherCurrentAssetsTextBlock", "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i08b1d1438dd2406ab77dd82937638abf_I20200930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:ValueAddedTaxReceivableCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R61": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfOtherAssetsNoncurrentTextBlock", "us-gaap:OtherAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i08b1d1438dd2406ab77dd82937638abf_I20200930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:CashSurrenderValueOfLifeInsurance", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240244012 - Disclosure - Other Long-Term Assets Components of Other Long-Term Assets (Details)", "role": "http://www.invacare.com/role/OtherLongTermAssetsComponentsofOtherLongTermAssetsDetails", "shortName": "Other Long-Term Assets Components of Other Long-Term Assets (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfOtherAssetsNoncurrentTextBlock", "us-gaap:OtherAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i08b1d1438dd2406ab77dd82937638abf_I20200930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:CashSurrenderValueOfLifeInsurance", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R62": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:PropertyPlantAndEquipmentTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i08b1d1438dd2406ab77dd82937638abf_I20200930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentGross", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240284014 - Disclosure - Property And Equipment (Details)", "role": "http://www.invacare.com/role/PropertyAndEquipmentDetails", "shortName": "Property And Equipment (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:PropertyPlantAndEquipmentTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i08b1d1438dd2406ab77dd82937638abf_I20200930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentGross", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R63": { "firstAnchor": { "ancestors": [ "span", "div", "div", "div", "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i2c8a6c816e3b4e3fa7215fe88ee54f26_D20200101-20200930", "decimals": "0", "first": true, "lang": "en-US", "name": "us-gaap:AmortizationOfIntangibleAssets", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240334016 - Disclosure - Intangibles (Narrative) (Details)", "role": "http://www.invacare.com/role/IntangiblesNarrativeDetails", "shortName": "Intangibles (Narrative) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "div", "div", "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i2c8a6c816e3b4e3fa7215fe88ee54f26_D20200101-20200930", "decimals": "0", "first": true, "lang": "en-US", "name": "us-gaap:AmortizationOfIntangibleAssets", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R64": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock", "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i08b1d1438dd2406ab77dd82937638abf_I20200930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:FiniteLivedIntangibleAssetsGross", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240344017 - Disclosure - Intangibles (Intangible Table) (Details)", "role": "http://www.invacare.com/role/IntangiblesIntangibleTableDetails", "shortName": "Intangibles (Intangible Table) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock", "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i08b1d1438dd2406ab77dd82937638abf_I20200930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:FiniteLivedIntangibleAssetsGross", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R65": { "firstAnchor": { "ancestors": [ "span", "div", "div", "div", "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i08b1d1438dd2406ab77dd82937638abf_I20200930", "decimals": "0", "first": true, "lang": "en-US", "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240354018 - Disclosure - Intangibles (Finite-Lived Intangible Asset Future Amortization Expense) (Details)", "role": "http://www.invacare.com/role/IntangiblesFiniteLivedIntangibleAssetFutureAmortizationExpenseDetails", "shortName": "Intangibles (Finite-Lived Intangible Asset Future Amortization Expense) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "div", "div", "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i08b1d1438dd2406ab77dd82937638abf_I20200930", "decimals": "0", "first": true, "lang": "en-US", "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R66": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i08b1d1438dd2406ab77dd82937638abf_I20200930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:AccruedSalariesCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240384019 - Disclosure - Accrued Expenses Components of Accrued Expenses (Details)", "role": "http://www.invacare.com/role/AccruedExpensesComponentsofAccruedExpensesDetails", "shortName": "Accrued Expenses Components of Accrued Expenses (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i08b1d1438dd2406ab77dd82937638abf_I20200930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:AccruedSalariesCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R67": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i617027d6fa504e1cbb5d2fbc0742e6a0_I20191231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:ProductWarrantyAccrualClassifiedCurrent", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240394020 - Disclosure - Accrued Expenses Warranty Schedule (Details)", "role": "http://www.invacare.com/role/AccruedExpensesWarrantyScheduleDetails", "shortName": "Accrued Expenses Warranty Schedule (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i2c8a6c816e3b4e3fa7215fe88ee54f26_D20200101-20200930", "decimals": "-3", "lang": "en-US", "name": "us-gaap:ProductWarrantyAccrualWarrantiesIssued", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R68": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "us-gaap:DebtAndCapitalLeasesDisclosuresTextBlock", "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i08b1d1438dd2406ab77dd82937638abf_I20200930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240424021 - Disclosure - Long-Term Debt (Details)", "role": "http://www.invacare.com/role/LongTermDebtDetails", "shortName": "Long-Term Debt (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "us-gaap:DebtAndCapitalLeasesDisclosuresTextBlock", "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i08b1d1438dd2406ab77dd82937638abf_I20200930", "decimals": "-3", "lang": "en-US", "name": "us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R69": { "firstAnchor": { "ancestors": [ "span", "div", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i75456f6803e643e18a3e8897535128c1_D20160101-20160331", "decimals": "0", "first": true, "lang": "en-US", "name": "us-gaap:ProceedsFromIssuanceOfWarrants", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240444023 - Disclosure - Long-Term Debt Components of Convertible Debt (Details)", "role": "http://www.invacare.com/role/LongTermDebtComponentsofConvertibleDebtDetails", "shortName": "Long-Term Debt Components of Convertible Debt (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R7": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i2c8a6c816e3b4e3fa7215fe88ee54f26_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "210011001 - Disclosure - Accounting Policies", "role": "http://www.invacare.com/role/AccountingPolicies", "shortName": "Accounting Policies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i2c8a6c816e3b4e3fa7215fe88ee54f26_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R70": { "firstAnchor": { "ancestors": [ "span", "div", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i75456f6803e643e18a3e8897535128c1_D20160101-20160331", "decimals": "0", "first": true, "lang": "en-US", "name": "us-gaap:ProceedsFromIssuanceOfWarrants", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240454024 - Disclosure - Long-Term Debt Narrative (Details)", "role": "http://www.invacare.com/role/LongTermDebtNarrativeDetails", "shortName": "Long-Term Debt Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "id778babb82b04757affb9ee9a9ef62aa_I20200515", "decimals": "-6", "lang": "en-US", "name": "us-gaap:UnsecuredDebt", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R71": { "firstAnchor": { "ancestors": [ "span", "div", "div", "div", "us-gaap:LeasesOfLesseeDisclosureTextBlock", "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "ie583e311e02344bd993a9966729ee002_I20150423", "decimals": "0", "first": true, "lang": "en-US", "name": "us-gaap:SaleLeasebackTransactionDeferredGainGross", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240464025 - Disclosure - Long-Term Debt Sale Leaseback Transactions (Details)", "role": "http://www.invacare.com/role/LongTermDebtSaleLeasebackTransactionsDetails", "shortName": "Long-Term Debt Sale Leaseback Transactions (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R72": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:OtherNoncurrentLiabilitiesTableTextBlock", "us-gaap:OtherLiabilitiesDisclosureTextBlock", "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i08b1d1438dd2406ab77dd82937638abf_I20200930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240494026 - Disclosure - Other Long-Term Obligations (Details)", "role": "http://www.invacare.com/role/OtherLongTermObligationsDetails", "shortName": "Other Long-Term Obligations (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:OtherNoncurrentLiabilitiesTableTextBlock", "us-gaap:OtherLiabilitiesDisclosureTextBlock", "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i617027d6fa504e1cbb5d2fbc0742e6a0_I20191231", "decimals": "-3", "lang": "en-US", "name": "us-gaap:DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R73": { "firstAnchor": { "ancestors": [ "span", "div", "div", "div", "us-gaap:LeasesOfLesseeDisclosureTextBlock", "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "iea0bc40717f44c07912ca4251c71b160_I20200701", "decimals": "0", "first": true, "lang": "en-US", "name": "us-gaap:FinanceLeaseLiability", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240524027 - Disclosure - Leases and Commitments (Details)", "role": "http://www.invacare.com/role/LeasesandCommitmentsDetails", "shortName": "Leases and Commitments (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "div", "div", "us-gaap:LeasesOfLesseeDisclosureTextBlock", "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "iea0bc40717f44c07912ca4251c71b160_I20200701", "decimals": "0", "first": true, "lang": "en-US", "name": "us-gaap:FinanceLeaseLiability", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R74": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:LeaseCostTableTextBlock", "div", "div", "us-gaap:LeasesOfLesseeDisclosureTextBlock", "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "ibf18eeed95914bb380235dabb0fc48f3_D20200701-20200930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeaseExpense", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240534028 - Disclosure - Leases and Commitments Lease Expenses (Details)", "role": "http://www.invacare.com/role/LeasesandCommitmentsLeaseExpensesDetails", "shortName": "Leases and Commitments Lease Expenses (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:LeaseCostTableTextBlock", "div", "div", "us-gaap:LeasesOfLesseeDisclosureTextBlock", "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "ibf18eeed95914bb380235dabb0fc48f3_D20200701-20200930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeaseExpense", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R75": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfFutureMinimumLeasePaymentsForCapitalLeasesTableTextBlock", "us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i08b1d1438dd2406ab77dd82937638abf_I20200930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240544029 - Disclosure - Leases and Commitments Future Minimum Operating and Financing Lease Commitments (Details)", "role": "http://www.invacare.com/role/LeasesandCommitmentsFutureMinimumOperatingandFinancingLeaseCommitmentsDetails", "shortName": "Leases and Commitments Future Minimum Operating and Financing Lease Commitments (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfFutureMinimumLeasePaymentsForCapitalLeasesTableTextBlock", "us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i08b1d1438dd2406ab77dd82937638abf_I20200930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R76": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i08b1d1438dd2406ab77dd82937638abf_I20200930", "decimals": "-3", "first": true, "lang": "en-US", "name": "ivc:OperatingLeasesCashPaidinMeasurementofAmountsforLeaseLiabilities", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240554030 - Disclosure - Leases and Commitments Supplemental Cash Flow Information (Details)", "role": "http://www.invacare.com/role/LeasesandCommitmentsSupplementalCashFlowInformationDetails", "shortName": "Leases and Commitments Supplemental Cash Flow Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i08b1d1438dd2406ab77dd82937638abf_I20200930", "decimals": "-3", "first": true, "lang": "en-US", "name": "ivc:OperatingLeasesCashPaidinMeasurementofAmountsforLeaseLiabilities", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R77": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ivc:WeightedAverageRemainingLeaseTermsandDiscountRatesTableTextBlock", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i08b1d1438dd2406ab77dd82937638abf_I20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240564031 - Disclosure - Leases and Commitments Weighted-Average Remaining Lease Terms and Discount Rates (Details)", "role": "http://www.invacare.com/role/LeasesandCommitmentsWeightedAverageRemainingLeaseTermsandDiscountRatesDetails", "shortName": "Leases and Commitments Weighted-Average Remaining Lease Terms and Discount Rates (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ivc:WeightedAverageRemainingLeaseTermsandDiscountRatesTableTextBlock", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i08b1d1438dd2406ab77dd82937638abf_I20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R78": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "ibf18eeed95914bb380235dabb0fc48f3_D20200701-20200930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:Revenues", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240594032 - Disclosure - Revenue (Details)", "role": "http://www.invacare.com/role/RevenueDetails", "shortName": "Revenue (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "div", "div", "us-gaap:RevenueRecognitionDeferredRevenue", "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "ibf18eeed95914bb380235dabb0fc48f3_D20200701-20200930", "decimals": "2", "lang": "en-US", "name": "ivc:NetRevenue", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" } }, "R79": { "firstAnchor": { "ancestors": [ "span", "div", "div", "div", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i08b1d1438dd2406ab77dd82937638abf_I20200930", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:CommonStockParOrStatedValuePerShare", "reportCount": 1, "unique": true, "unitRef": "usdPerShare", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240624033 - Disclosure - Equity Compensation (Narrative) (Details)", "role": "http://www.invacare.com/role/EquityCompensationNarrativeDetails", "shortName": "Equity Compensation (Narrative) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "div", "div", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i08b1d1438dd2406ab77dd82937638abf_I20200930", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:CommonStockParOrStatedValuePerShare", "reportCount": 1, "unique": true, "unitRef": "usdPerShare", "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i2c8a6c816e3b4e3fa7215fe88ee54f26_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "210041002 - Disclosure - Divested Businesses (Notes)", "role": "http://www.invacare.com/role/DivestedBusinessesNotes", "shortName": "Divested Businesses (Notes)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i2c8a6c816e3b4e3fa7215fe88ee54f26_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R80": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "ibf18eeed95914bb380235dabb0fc48f3_D20200701-20200930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:AllocatedShareBasedCompensationExpense", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240634034 - Disclosure - Equity Compensation Share-based Compensation Expense (Details)", "role": "http://www.invacare.com/role/EquityCompensationSharebasedCompensationExpenseDetails", "shortName": "Equity Compensation Share-based Compensation Expense (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock", "div", "div", "ix:continuation", "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i6f5fb46953bd41e48c9562fde678f712_D20200101-20200930", "decimals": "-3", "lang": "en-US", "name": "us-gaap:AllocatedShareBasedCompensationExpense", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R81": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock", "div", "div", "ix:continuation", "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i08b1d1438dd2406ab77dd82937638abf_I20200930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240644035 - Disclosure - Equity Compensation Unrecognized Compensation Expense (Details)", "role": "http://www.invacare.com/role/EquityCompensationUnrecognizedCompensationExpenseDetails", "shortName": "Equity Compensation Unrecognized Compensation Expense (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock", "div", "div", "ix:continuation", "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i08b1d1438dd2406ab77dd82937638abf_I20200930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R82": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i617027d6fa504e1cbb5d2fbc0742e6a0_I20191231", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240654036 - Disclosure - Equity Compensation (Options Activity) (Details)", "role": "http://www.invacare.com/role/EquityCompensationOptionsActivityDetails", "shortName": "Equity Compensation (Options Activity) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i617027d6fa504e1cbb5d2fbc0742e6a0_I20191231", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R83": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i08b1d1438dd2406ab77dd82937638abf_I20200930", "decimals": "2", "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "reportCount": 1, "unitRef": "usdPerShare", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240664037 - Disclosure - Equity Compensation (Stock Options Outstanding by Exercise Price) (Details)", "role": "http://www.invacare.com/role/EquityCompensationStockOptionsOutstandingbyExercisePriceDetails", "shortName": "Equity Compensation (Stock Options Outstanding by Exercise Price) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "td", "tr", "table", "div", "us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "if40a30a97f3d4fb7a19e1b6fe170adaf_D20200101-20200930", "decimals": "2", "lang": "en-US", "name": "us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit", "reportCount": 1, "unique": true, "unitRef": "usdPerShare", "xsiNil": "false" } }, "R84": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock", "div", "div", "ix:continuation", "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i2d428cd1ad6f42259774be4af4dd3ead_I20191231", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240674038 - Disclosure - Equity Compensation Restricted Stock Activity (Details)", "role": "http://www.invacare.com/role/EquityCompensationRestrictedStockActivityDetails", "shortName": "Equity Compensation Restricted Stock Activity (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock", "div", "div", "ix:continuation", "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i2d428cd1ad6f42259774be4af4dd3ead_I20191231", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R85": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock", "div", "div", "ix:continuation", "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i2a2219ced110443eb927cd2279847ec8_I20200930", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240684039 - Disclosure - Equity Compensation Performance Share Activity (Details)", "role": "http://www.invacare.com/role/EquityCompensationPerformanceShareActivityDetails", "shortName": "Equity Compensation Performance Share Activity (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock", "div", "div", "ix:continuation", "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i2a2219ced110443eb927cd2279847ec8_I20200930", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R86": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "us-gaap:ComprehensiveIncomeNoteTextBlock", "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i4f0cdcc3ae2f4e38825236cc947dd299_I20200630", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240724041 - Disclosure - Accumulated Other Comprehensive Income (Loss) by Component (Changes in Accumulated Other Comprehensive Income) (Details)", "role": "http://www.invacare.com/role/AccumulatedOtherComprehensiveIncomeLossbyComponentChangesinAccumulatedOtherComprehensiveIncomeDetails", "shortName": "Accumulated Other Comprehensive Income (Loss) by Component (Changes in Accumulated Other Comprehensive Income) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "us-gaap:ComprehensiveIncomeNoteTextBlock", "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i4f0cdcc3ae2f4e38825236cc947dd299_I20200630", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R87": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "ibf18eeed95914bb380235dabb0fc48f3_D20200701-20200930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:CostOfRevenue", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240734042 - Disclosure - Accumulated Other Comprehensive Income (Loss) by Component (Reclassified Out of Accumulated Other Comprehensive Income) (Details)", "role": "http://www.invacare.com/role/AccumulatedOtherComprehensiveIncomeLossbyComponentReclassifiedOutofAccumulatedOtherComprehensiveIncomeDetails", "shortName": "Accumulated Other Comprehensive Income (Loss) by Component (Reclassified Out of Accumulated Other Comprehensive Income) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i0c164637fbf748d5834a6c0b4496beca_D20200701-20200930", "decimals": "-3", "lang": "en-US", "name": "us-gaap:SellingGeneralAndAdministrativeExpense", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R88": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i4f0cdcc3ae2f4e38825236cc947dd299_I20200630", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:RestructuringReserve", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240764043 - Disclosure - Charges Related To Restructuring Activities (Details)", "role": "http://www.invacare.com/role/ChargesRelatedToRestructuringActivitiesDetails", "shortName": "Charges Related To Restructuring Activities (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R89": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "ibf18eeed95914bb380235dabb0fc48f3_D20200701-20200930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:RestructuringCharges", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240774044 - Disclosure - Charges Related To Restructuring Activities Narrative (Details)", "role": "http://www.invacare.com/role/ChargesRelatedToRestructuringActivitiesNarrativeDetails", "shortName": "Charges Related To Restructuring Activities Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "div", "div", "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock", "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i2c8a6c816e3b4e3fa7215fe88ee54f26_D20200101-20200930", "decimals": null, "lang": "en-US", "name": "ivc:RestructuringAndRelatedActivitiesExpectedPayoutPeriod", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i2c8a6c816e3b4e3fa7215fe88ee54f26_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "210071003 - Disclosure - Receivables", "role": "http://www.invacare.com/role/Receivables", "shortName": "Receivables", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i2c8a6c816e3b4e3fa7215fe88ee54f26_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R90": { "firstAnchor": { "ancestors": [ "span", "div", "div", "div", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i2c8a6c816e3b4e3fa7215fe88ee54f26_D20200101-20200930", "decimals": "0", "first": true, "lang": "en-US", "name": "ivc:ReversalofAccruedWithholdingTaxesonEarnings", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240794045 - Disclosure - Income Taxes (Narrative) (Details)", "role": "http://www.invacare.com/role/IncomeTaxesNarrativeDetails", "shortName": "Income Taxes (Narrative) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "div", "div", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i2c8a6c816e3b4e3fa7215fe88ee54f26_D20200101-20200930", "decimals": "0", "first": true, "lang": "en-US", "name": "ivc:ReversalofAccruedWithholdingTaxesonEarnings", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R91": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "ibf18eeed95914bb380235dabb0fc48f3_D20200701-20200930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:WeightedAverageNumberOfSharesOutstandingBasic", "reportCount": 1, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240824046 - Disclosure - Net Earnings (Loss) Per Common Share Computation of Basic and Diluted Net Earnings (Loss) Per Common Share (Details)", "role": "http://www.invacare.com/role/NetEarningsLossPerCommonShareComputationofBasicandDilutedNetEarningsLossPerCommonShareDetails", "shortName": "Net Earnings (Loss) Per Common Share Computation of Basic and Diluted Net Earnings (Loss) Per Common Share (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "ibf18eeed95914bb380235dabb0fc48f3_D20200701-20200930", "decimals": "-3", "lang": "en-US", "name": "us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R92": { "firstAnchor": { "ancestors": [ "span", "div", "div", "div", "ix:continuation", "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "id0021b6ca7a04d4982afd3ec4237fc36_D20200101-20200930", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240834047 - Disclosure - Net Earnings (Loss) Per Common Share Textuals (Details)", "role": "http://www.invacare.com/role/NetEarningsLossPerCommonShareTextualsDetails", "shortName": "Net Earnings (Loss) Per Common Share Textuals (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "div", "div", "ix:continuation", "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "id0021b6ca7a04d4982afd3ec4237fc36_D20200101-20200930", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R93": { "firstAnchor": { "ancestors": [ "span", "div", "div", "div", "us-gaap:ConcentrationRiskDisclosureTextBlock", "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i08b1d1438dd2406ab77dd82937638abf_I20200930", "decimals": "0", "first": true, "lang": "en-US", "name": "ivc:ConcentrationRiskRetainedRecourseObligationForDefaultofCustomerLeaseObligationsUnderContract", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240854048 - Disclosure - Concentration Of Credit Risk (Details)", "role": "http://www.invacare.com/role/ConcentrationOfCreditRiskDetails", "shortName": "Concentration Of Credit Risk (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "div", "div", "us-gaap:ConcentrationRiskDisclosureTextBlock", "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i08b1d1438dd2406ab77dd82937638abf_I20200930", "decimals": "0", "first": true, "lang": "en-US", "name": "ivc:ConcentrationRiskRetainedRecourseObligationForDefaultofCustomerLeaseObligationsUnderContract", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R94": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i522371c692cb44bebeaaabbc4be69a49_I20200930", "decimals": "-3", "first": true, "lang": "en-US", "name": "ivc:NotionalAmountDerivative", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240884049 - Disclosure - Derivatives Notional Amounts - Designated as Hedges (Details)", "role": "http://www.invacare.com/role/DerivativesNotionalAmountsDesignatedasHedgesDetails", "shortName": "Derivatives Notional Amounts - Designated as Hedges (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "ib450a291cb334bbe8ca18d8f697ca24e_I20200930", "decimals": "-3", "lang": "en-US", "name": "ivc:NotionalAmountDerivative", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R95": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i522371c692cb44bebeaaabbc4be69a49_I20200930", "decimals": "-3", "first": true, "lang": "en-US", "name": "ivc:NotionalAmountDerivative", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240894050 - Disclosure - Derivatives Notional Amounts - Not Designated as Hedges (Details)", "role": "http://www.invacare.com/role/DerivativesNotionalAmountsNotDesignatedasHedgesDetails", "shortName": "Derivatives Notional Amounts - Not Designated as Hedges (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i5b0912276aca42049a9a7e8ce61ad2be_I20200930", "decimals": "-3", "lang": "en-US", "name": "ivc:NotionalAmountDerivative", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R96": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "ib09b9275caf742f2be4fcc1612750d6d_I20200930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:DerivativeFairValueOfDerivativeAsset", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240904051 - Disclosure - Derivatives Balance Sheet Location (Details)", "role": "http://www.invacare.com/role/DerivativesBalanceSheetLocationDetails", "shortName": "Derivatives Balance Sheet Location (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "ib09b9275caf742f2be4fcc1612750d6d_I20200930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:DerivativeFairValueOfDerivativeAsset", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R97": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "ibf18eeed95914bb380235dabb0fc48f3_D20200701-20200930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240914052 - Disclosure - Derivatives Gain (Loss) in Statement of Finacial Position (Details)", "role": "http://www.invacare.com/role/DerivativesGainLossinStatementofFinacialPositionDetails", "shortName": "Derivatives Gain (Loss) in Statement of Finacial Position (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i1ef8b001278e4672bdf0bc8842c073d0_D20200701-20200930", "decimals": "-3", "lang": "en-US", "name": "us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R98": { "firstAnchor": { "ancestors": [ "span", "div", "div", "div", "ix:continuation", "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i08b1d1438dd2406ab77dd82937638abf_I20200930", "decimals": "0", "first": true, "lang": "en-US", "name": "ivc:ConvertibleDebt2022ConversionFeatureInitialFairValue", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240924053 - Disclosure - Derivatives Narrative (Details)", "role": "http://www.invacare.com/role/DerivativesNarrativeDetails", "shortName": "Derivatives Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "div", "div", "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i1f1b642f9aa44b52a7715267189985f8_D20200101-20200930", "decimals": "0", "lang": "en-US", "name": "ivc:NotionalAmountOfDerivativesMaturedDuringPeriod", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R99": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ivc-20200930.htm", "contextRef": "i08b1d1438dd2406ab77dd82937638abf_I20200930", "decimals": "-3", "first": true, "lang": "en-US", "name": "ivc:FairValuesConvertibleDebtHedgesNet", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240934054 - Disclosure - Derivatives Fair Value of Convertible Debt Hedges (Details)", "role": "http://www.invacare.com/role/DerivativesFairValueofConvertibleDebtHedgesDetails", "shortName": "Derivatives Fair Value of Convertible Debt Hedges (Details)", "subGroupType": "details", "uniqueAnchor": null } }, "segmentCount": 122, "tag": { "country_CA": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "CANADA", "terseLabel": "CANADA" } } }, "localname": "CA", "nsuri": "http://xbrl.sec.gov/country/2020-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesAgingofInstallmentReceivablesDetails", "http://www.invacare.com/role/ReceivablesInstallmentReceivablesbyClassDetails" ], "xbrltype": "domainItemType" }, "country_US": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "UNITED STATES", "terseLabel": "U.S." } } }, "localname": "US", "nsuri": "http://xbrl.sec.gov/country/2020-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesAgingofInstallmentReceivablesDetails", "http://www.invacare.com/role/ReceivablesInstallmentReceivablesbyClassDetails" ], "xbrltype": "domainItemType" }, "currency_AllCurrenciesDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "All Currencies [Domain]", "terseLabel": "All Currencies [Domain]" } } }, "localname": "AllCurrenciesDomain", "nsuri": "http://xbrl.sec.gov/currency/2020-01-31", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "currency_EUR": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Euro Member Countries, Euro", "terseLabel": "Euro Member Countries, Euro" } } }, "localname": "EUR", "nsuri": "http://xbrl.sec.gov/currency/2020-01-31", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "currency_GBP": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "United Kingdom, Pounds", "terseLabel": "United Kingdom, Pounds" } } }, "localname": "GBP", "nsuri": "http://xbrl.sec.gov/currency/2020-01-31", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.invacare.com/role/DEIDocument" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.invacare.com/role/DEIDocument" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]", "terseLabel": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date", "terseLabel": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.invacare.com/role/DEIDocument" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus", "terseLabel": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.invacare.com/role/DEIDocument" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus", "terseLabel": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.invacare.com/role/DEIDocument" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.invacare.com/role/DEIDocument" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r664" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report", "terseLabel": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.invacare.com/role/DEIDocument" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r665" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report", "terseLabel": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.invacare.com/role/DEIDocument" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.invacare.com/role/DEIDocument" ], "xbrltype": "submissionTypeItemType" }, "dei_EntitiesTable": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Container to assemble all relevant information about each entity associated with the document instance", "label": "Entities [Table]", "terseLabel": "Entities [Table]" } } }, "localname": "EntitiesTable", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.invacare.com/role/DEIDocument" ], "xbrltype": "stringItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.invacare.com/role/DEIDocument" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.invacare.com/role/DEIDocument" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.invacare.com/role/DEIDocument" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.invacare.com/role/DEIDocument" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r666" ], "lang": { "en-US": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.invacare.com/role/DEIDocument" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding", "terseLabel": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.invacare.com/role/DEIDocument" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status", "terseLabel": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.invacare.com/role/DEIDocument" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r666" ], "lang": { "en-US": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.invacare.com/role/DEIDocument" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.invacare.com/role/DEIDocument" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r666" ], "lang": { "en-US": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category", "terseLabel": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.invacare.com/role/DEIDocument" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.invacare.com/role/DEIDocument" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInformationLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Entity Information [Line Items]", "terseLabel": "Entity Information [Line Items]" } } }, "localname": "EntityInformationLineItems", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.invacare.com/role/DEIDocument" ], "xbrltype": "stringItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r667" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current", "terseLabel": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.invacare.com/role/DEIDocument" ], "xbrltype": "yesNoItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r666" ], "lang": { "en-US": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.invacare.com/role/DEIDocument" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r666" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company", "terseLabel": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.invacare.com/role/DEIDocument" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r666" ], "lang": { "en-US": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business", "terseLabel": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.invacare.com/role/DEIDocument" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r666" ], "lang": { "en-US": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.invacare.com/role/DEIDocument" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.invacare.com/role/DEIDocument" ], "xbrltype": "normalizedStringItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r662" ], "lang": { "en-US": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.invacare.com/role/DEIDocument" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r663" ], "lang": { "en-US": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.invacare.com/role/DEIDocument" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.invacare.com/role/DEIDocument" ], "xbrltype": "tradingSymbolItemType" }, "ivc_A2013PlanMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "2013 Plan [Member]", "label": "2013 Plan [Member]", "terseLabel": "2013 Plan [Member]" } } }, "localname": "A2013PlanMember", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/EquityCompensationNarrativeDetails" ], "xbrltype": "domainItemType" }, "ivc_A2018PlanMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "2018 Plan", "label": "2018 Plan [Member]", "terseLabel": "2018 Plan [Member]" } } }, "localname": "A2018PlanMember", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/EquityCompensationNarrativeDetails" ], "xbrltype": "domainItemType" }, "ivc_AccretionRate": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Accretion Rate", "label": "Accretion Rate", "terseLabel": "Accretion Rate" } } }, "localname": "AccretionRate", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/LongTermDebtDetails" ], "xbrltype": "percentItemType" }, "ivc_AccruedFreightExpenseCurrent": { "auth_ref": [], "calculation": { "http://www.invacare.com/role/AccruedExpensesComponentsofAccruedExpensesDetails": { "order": 7.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Freight Accrual, Current [Line Items]", "label": "Accrued Freight Expense, Current", "terseLabel": "Freight" } } }, "localname": "AccruedFreightExpenseCurrent", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/AccruedExpensesComponentsofAccruedExpensesDetails" ], "xbrltype": "monetaryItemType" }, "ivc_AccumulatedLongTermNotesAdjustmentMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Accumulated Long-Term Notes Adjustment [Member]", "label": "Accumulated Long-Term Notes Adjustment [Member]", "terseLabel": "Accumulated Long-Term Notes Adjustment [Member]" } } }, "localname": "AccumulatedLongTermNotesAdjustmentMember", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/AccumulatedOtherComprehensiveIncomeLossbyComponentChangesinAccumulatedOtherComprehensiveIncomeDetails" ], "xbrltype": "domainItemType" }, "ivc_AdoptionofCreditLossStandard": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Adoption of Credit Loss Standard", "label": "Adoption of Credit Loss Standard", "negatedTerseLabel": "Adoption of Credit Loss Standard" } } }, "localname": "AdoptionofCreditLossStandard", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofShareholdersEquityStatement", "http://www.invacare.com/role/ReceivablesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ivc_AdvancePaymentfromSaleofProperty": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Advance Payment from Sale of Property", "label": "Advance Payment from Sale of Property", "terseLabel": "Advance Payment from Sale of Property" } } }, "localname": "AdvancePaymentfromSaleofProperty", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/PropertyAndEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "ivc_AdvancePaymentonSaleofLand": { "auth_ref": [], "calculation": { "http://www.invacare.com/role/AccruedExpensesComponentsofAccruedExpensesDetails": { "order": 17.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Advance Payment on Sale of Land", "label": "Advance Payment on Sale of Land", "terseLabel": "Advance payment on sale of land & buildings" } } }, "localname": "AdvancePaymentonSaleofLand", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/AccruedExpensesComponentsofAccruedExpensesDetails" ], "xbrltype": "monetaryItemType" }, "ivc_AllowanceforCreditLosses": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Allowance for Credit Losses", "label": "Allowance for Credit Losses", "terseLabel": "Allowance for Credit Losses" } } }, "localname": "AllowanceforCreditLosses", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/ReceivablesScheduleforAllowanceforCreditLossesDetails" ], "xbrltype": "monetaryItemType" }, "ivc_AllowanceforCreditLossesTableTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Allowance for Credit Losses", "label": "Allowance for Credit Losses [Table Text Block]", "terseLabel": "Schedule for Allowance for Credit Losses" } } }, "localname": "AllowanceforCreditLossesTableTextBlock", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/ReceivablesTables" ], "xbrltype": "textBlockItemType" }, "ivc_AllowanceforCreditLossesWritedowns": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Allowance for Credit Losses, Write-downs", "label": "Allowance for Credit Losses, Write-downs", "negatedTerseLabel": "Financing Receivable, Allowance for Credit Losses, Write-downs" } } }, "localname": "AllowanceforCreditLossesWritedowns", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/ReceivablesScheduleforAllowanceforCreditLossesDetails" ], "xbrltype": "monetaryItemType" }, "ivc_AllowanceforLossesAdjustmentsOther": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Allowance for Losses, Adjustments, Other", "label": "Allowance for Losses, Adjustments, Other", "terseLabel": "Allowance for Loan and Lease Losses, Adjustments, Other" } } }, "localname": "AllowanceforLossesAdjustmentsOther", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/ReceivablesScheduleforAllowanceforCreditLossesDetails" ], "xbrltype": "monetaryItemType" }, "ivc_AmountAvailabletoInvacareLimitedandInvacarePoirierSASDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Invacare Limited and Invacare Poirier SAS", "label": "Amount Available to Invacare Limited and Invacare Poirier SAS [Domain]", "terseLabel": "Amount Available to Invacare Limited and Invacare Poirier SAS" } } }, "localname": "AmountAvailabletoInvacareLimitedandInvacarePoirierSASDomain", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "ivc_AssetsandLiabilitiesofDivestedBusinessTableTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Assets and Liabilities of Divested Business", "label": "Assets and Liabilities of Divested Business [Table Text Block]", "terseLabel": "Assets and Liabilities of Divested Business [Table Text Block]" } } }, "localname": "AssetsandLiabilitiesofDivestedBusinessTableTextBlock", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/DivestedBusinessesTables" ], "xbrltype": "textBlockItemType" }, "ivc_AverageFairValueStockPrice": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Average Fair Value Stock Price", "label": "Average Fair Value Stock Price", "terseLabel": "Fair value stock price" } } }, "localname": "AverageFairValueStockPrice", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/NetEarningsLossPerCommonShareTextualsDetails" ], "xbrltype": "perShareItemType" }, "ivc_BusinessDayPeriod": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Business Day Period", "label": "Business Day Period", "terseLabel": "Business Day Period" } } }, "localname": "BusinessDayPeriod", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "durationItemType" }, "ivc_CARESActLoanMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "CARES Act Loan", "label": "CARES Act Loan [Member]", "terseLabel": "CARES Act Loan [Member]" } } }, "localname": "CARESActLoanMember", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/LongTermDebtDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "ivc_CapitalizedSoftwareMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Capitalized Software [Member]", "label": "Capitalized Software [Member]", "terseLabel": "Capitalized Software [Member]" } } }, "localname": "CapitalizedSoftwareMember", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/PropertyAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "ivc_CashDiscountReserves": { "auth_ref": [], "calculation": { "http://www.invacare.com/role/ReceivablesScheduleofAccountsReceivableDetails": { "order": 3.0, "parentTag": "us-gaap_AccountsReceivableNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Cash Discount Reserves", "label": "Cash Discount Reserves", "negatedTerseLabel": "Cash discount reserves" } } }, "localname": "CashDiscountReserves", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/ReceivablesScheduleofAccountsReceivableDetails" ], "xbrltype": "monetaryItemType" }, "ivc_ChargesrelatedtorestructuringactivitiesasaPercentofNetSales": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Charges related to restructuring activities, as a Percent of Net Sales", "label": "Charges related to restructuring activities, as a Percent of Net Sales", "terseLabel": "Charges related to restructuring activities, as a Percent of Net Sales" } } }, "localname": "ChargesrelatedtorestructuringactivitiesasaPercentofNetSales", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss" ], "xbrltype": "percentItemType" }, "ivc_CommonStockDifferenceinDividendRate": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Common Stock, Difference in Dividend Rate", "label": "Common Stock, Difference in Dividend Rate", "terseLabel": "Common Stock, Difference in Dividend Rate" } } }, "localname": "CommonStockDifferenceinDividendRate", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/EquityCompensationNarrativeDetails" ], "xbrltype": "percentItemType" }, "ivc_CommonStockHoldersPercentageofTotalOutstanding": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Common Stock, Holders Percentage of Total Outstanding", "label": "Common Stock, Holders Percentage of Total Outstanding", "terseLabel": "Common Stock, Holders Percentage of Total Outstanding" } } }, "localname": "CommonStockHoldersPercentageofTotalOutstanding", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/EquityCompensationNarrativeDetails" ], "xbrltype": "percentItemType" }, "ivc_CommonStockNumberofVotes": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Common Stock, Number of Votes", "label": "Common Stock, Number of Votes", "terseLabel": "Common Stock, Number of Votes" } } }, "localname": "CommonStockNumberofVotes", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/EquityCompensationNarrativeDetails" ], "xbrltype": "integerItemType" }, "ivc_ConcentrationRiskRecourseforCustomerLeaseObligationUnderDefault": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Concentration Risk, Recourse for Customer Lease Obligation Under Default", "label": "Concentration Risk, Recourse for Customer Lease Obligation Under Default", "terseLabel": "Events of Default Under Contract by Third Party" } } }, "localname": "ConcentrationRiskRecourseforCustomerLeaseObligationUnderDefault", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/ConcentrationOfCreditRiskDetails" ], "xbrltype": "monetaryItemType" }, "ivc_ConcentrationRiskRetainedRecourseObligationForDefaultofCustomerLeaseObligationsUnderContract": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Concentration Risk, Retained Recourse Obligation For Default of Customer Lease Obligations Under Contract", "label": "Concentration Risk, Retained Recourse Obligation For Default of Customer Lease Obligations Under Contract", "terseLabel": "Retained Recourse Obligation For Events Of Default Under Contracts" } } }, "localname": "ConcentrationRiskRetainedRecourseObligationForDefaultofCustomerLeaseObligationsUnderContract", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/ConcentrationOfCreditRiskDetails" ], "xbrltype": "monetaryItemType" }, "ivc_ContingentLiabilityGuarantee": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Contingent Liability, Guarantee", "label": "Contingent Liability, Guarantee", "terseLabel": "Contingent Liability, Guarantee" } } }, "localname": "ContingentLiabilityGuarantee", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/ReceivablesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ivc_ContractTypeAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Contract Type [Axis]", "label": "Contract Type [Axis]", "terseLabel": "Contract Type [Axis]" } } }, "localname": "ContractTypeAxis", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/RevenueDetails" ], "xbrltype": "stringItemType" }, "ivc_ContractTypeDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "[Domain] for Contract Type [Axis]", "label": "Contract Type [Domain]", "terseLabel": "Contract Type [Domain]" } } }, "localname": "ContractTypeDomain", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/RevenueDetails" ], "xbrltype": "domainItemType" }, "ivc_ContractTypeSalesSplit": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Contract Type Sales Split", "label": "Contract Type Sales Split", "terseLabel": "Contract Type Sales Split" } } }, "localname": "ContractTypeSalesSplit", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/RevenueDetails" ], "xbrltype": "percentItemType" }, "ivc_ConvertibleDebt2021ConversionFeatureFairValue": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Convertible Debt 2021 Conversion Feature, Fair Value", "label": "Convertible Debt 2021 Conversion Feature, Fair Value", "terseLabel": "Convertible 2021 debt conversion liability" } } }, "localname": "ConvertibleDebt2021ConversionFeatureFairValue", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/DerivativesFairValueofConvertibleDebtHedgesDetails", "http://www.invacare.com/role/FairValuesDetailsofBookValueandFairValueofFinancialInstrumentsDetails", "http://www.invacare.com/role/LongTermDebtComponentsofConvertibleDebtDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ivc_ConvertibleDebt2021ConversionFeatureInitialFairValue": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Convertible Debt 2021 Conversion Feature, Initial Fair Value", "label": "Convertible Debt 2021 Conversion Feature, Initial Fair Value", "negatedTerseLabel": "Convertible Debt Conversion Feature, Initial Fair Value" } } }, "localname": "ConvertibleDebt2021ConversionFeatureInitialFairValue", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/DerivativesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ivc_ConvertibleDebt2021ConversionFeatureMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Convertible Debt 2021 Conversion Feature", "label": "Convertible Debt 2021 Conversion Feature [Member]", "terseLabel": "Convertible Debt Conversion Feature" } } }, "localname": "ConvertibleDebt2021ConversionFeatureMember", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/DerivativesFairValueofConvertibleDebtHedgesDetails", "http://www.invacare.com/role/FairValuesAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.invacare.com/role/FairValuesDetailsofBookValueandFairValueofFinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "ivc_ConvertibleDebt2022ConversionFeatureDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Convertible Debt 2022 Conversion Feature [Domain]", "label": "Convertible Debt 2022 Conversion Feature [Domain]", "terseLabel": "Convertible Debt 2022 Conversion Feature" } } }, "localname": "ConvertibleDebt2022ConversionFeatureDomain", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/DerivativesFairValueofConvertibleDebtHedgesDetails", "http://www.invacare.com/role/FairValuesDetailsofBookValueandFairValueofFinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "ivc_ConvertibleDebt2022ConversionFeatureFairValue": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Convertible Debt 2022 Conversion Feature, Fair Value", "label": "Convertible Debt 2022 Conversion Feature, Fair Value", "negatedTerseLabel": "Convertible Debt Conversion Feature", "terseLabel": "Convertible Debt 2022 Conversion Feature, Fair Value" } } }, "localname": "ConvertibleDebt2022ConversionFeatureFairValue", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/DerivativesFairValueofConvertibleDebtHedgesDetails", "http://www.invacare.com/role/FairValuesDetailsofBookValueandFairValueofFinancialInstrumentsDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ivc_ConvertibleDebt2022ConversionFeatureInitialFairValue": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Convertible Debt 2022 Conversion Feature, Initial Fair Value", "label": "Convertible Debt 2022 Conversion Feature, Initial Fair Value", "terseLabel": "Convertible Debt 2022 Conversion Feature, Initial Fair Value" } } }, "localname": "ConvertibleDebt2022ConversionFeatureInitialFairValue", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/DerivativesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ivc_ConvertibleDebtBondHedgeMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Convertible Debt Bond Hedge", "label": "Convertible Debt Bond Hedge [Member]", "terseLabel": "Convertible Debt Bond Hedge" } } }, "localname": "ConvertibleDebtBondHedgeMember", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/DerivativesFairValueofConvertibleDebtHedgesDetails", "http://www.invacare.com/role/FairValuesAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.invacare.com/role/FairValuesDetailsofBookValueandFairValueofFinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "ivc_ConvertibleDebtConversionFeatureFairValueatIssuance": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Convertible Debt Conversion Feature, Fair Value at Issuance", "label": "Convertible Debt Conversion Feature, Fair Value at Issuance", "terseLabel": "Convertible Debt Conversion Feature, Fair Value at Issuance" } } }, "localname": "ConvertibleDebtConversionFeatureFairValueatIssuance", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ivc_ConvertibleDebtConversionFeatureGainLoss": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Convertible Debt Conversion Feature Gain (Loss)", "label": "Convertible Debt Conversion Feature Gain (Loss)", "negatedTerseLabel": "Convertible Debt Conversion Feature Gain (Loss)", "terseLabel": "Convertible Debt Conversion Feature Gain (Loss)" } } }, "localname": "ConvertibleDebtConversionFeatureGainLoss", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/DerivativesFairValueofConvertibleDebtHedgesDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ivc_ConvertibleDebtConversionRateofCommmonSharesPrincipal": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Convertible Debt, Conversion Rate of Commmon Shares, Principal", "label": "Convertible Debt, Conversion Rate of Commmon Shares, Principal", "terseLabel": "Convertible Debt, Conversion Rate of Commmon Shares, Principal" } } }, "localname": "ConvertibleDebtConversionRateofCommmonSharesPrincipal", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ivc_ConvertibleDebtDerivativeAdjustments": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Convertible Debt Derivative Adjustments", "label": "Convertible Debt Derivative Adjustments", "negatedTerseLabel": "Convertible Debt Derivative Adjustments" } } }, "localname": "ConvertibleDebtDerivativeAdjustments", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofShareholdersEquityStatement" ], "xbrltype": "monetaryItemType" }, "ivc_ConvertibleDebtNoteHedgeGainLoss": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Convertible Debt Note Hedge Gain (Loss)", "label": "Convertible Debt Note Hedge Gain (Loss)", "terseLabel": "Convertible Debt Note Hedge Gain (Loss)" } } }, "localname": "ConvertibleDebtNoteHedgeGainLoss", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/DerivativesFairValueofConvertibleDebtHedgesDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ivc_ConvertibleSeniorNotesPercentageofPrincipalRequiredforRepurchase": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Convertible Senior Notes, Percentage of Principal Required for Repurchase", "label": "Convertible Senior Notes, Percentage of Principal Required for Repurchase", "terseLabel": "Convertible Senior Notes, Percentage of Principal Required for Repurchase" } } }, "localname": "ConvertibleSeniorNotesPercentageofPrincipalRequiredforRepurchase", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "percentItemType" }, "ivc_ConvertibleSeniorNotesat4.50February2022Domain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Convertible Senior Notes at 4.50% February 2022", "label": "Convertible Senior Notes at 4.50% February 2022 [Domain]", "terseLabel": "Convertible Senior Notes at 4.50% February 2022 [Domain]" } } }, "localname": "ConvertibleSeniorNotesat4.50February2022Domain", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/DerivativesFairValueofConvertibleDebtHedgesDetails", "http://www.invacare.com/role/DerivativesNarrativeDetails", "http://www.invacare.com/role/LongTermDebtComponentsofConvertibleDebtDetails", "http://www.invacare.com/role/LongTermDebtDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "ivc_ConvertibleSeniorNotesat5.00February2021Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Convertible Senior Notes at 5.00% February 2021 [Member]", "label": "Convertible Senior Notes at 5.00% February 2021 [Member]", "terseLabel": "Convertible Senior Notes at 5.00% February 2021 [Member]" } } }, "localname": "ConvertibleSeniorNotesat5.00February2021Member", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/DerivativesFairValueofConvertibleDebtHedgesDetails", "http://www.invacare.com/role/DerivativesNarrativeDetails", "http://www.invacare.com/role/FairValuesAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.invacare.com/role/LongTermDebtComponentsofConvertibleDebtDetails", "http://www.invacare.com/role/LongTermDebtDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "ivc_ConvertibleSeniorNotesat5.00November2024Domain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Convertible Senior Notes at 5.00% November 2024 [Domain]", "label": "Convertible Senior Notes at 5.00% November 2024 [Domain]", "terseLabel": "Convertible Senior Notes at 5.00% November 2024 [Domain]" } } }, "localname": "ConvertibleSeniorNotesat5.00November2024Domain", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/LongTermDebtComponentsofConvertibleDebtDetails", "http://www.invacare.com/role/LongTermDebtDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "ivc_ConvertibleSeniorNotesat5.00November2024Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Convertible Senior Subordinated Debentures at 4.125% February 2027 [Member]", "label": "Convertible Senior Notes at 5.00% November 2024 [Member]", "terseLabel": "Convertible Senior Notes at 5.00% November 2024 [Member]" } } }, "localname": "ConvertibleSeniorNotesat5.00November2024Member", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/LongTermDebtComponentsofConvertibleDebtDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "ivc_ConvertibleSeniorSubordinatedDebenturesat5.00February2021Domain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Convertible Senior Subordinated Debentures at 5.00% February 2021", "label": "Convertible Senior Subordinated Debentures at 5.00% February 2021 [Domain]", "terseLabel": "Convertible Senior Subordinated Debentures at 5.00% February 2021 [Domain]" } } }, "localname": "ConvertibleSeniorSubordinatedDebenturesat5.00February2021Domain", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "ivc_Convertibledue2021BondHedgeFairValue": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Convertible due 2021 - Bond Hedge, Fair Value", "label": "Convertible due 2021 - Bond Hedge, Fair Value", "terseLabel": "Convertible 2021 note hedge asset", "verboseLabel": "Convertible due 2021 - Bond Hedge" } } }, "localname": "Convertibledue2021BondHedgeFairValue", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/DerivativesFairValueofConvertibleDebtHedgesDetails", "http://www.invacare.com/role/FairValuesAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.invacare.com/role/FairValuesDetailsofBookValueandFairValueofFinancialInstrumentsDetails", "http://www.invacare.com/role/LongTermDebtComponentsofConvertibleDebtDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ivc_Convertibledue2021BondHedgeFairValueatIssuance": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Convertible due 2021 - Bond Hedge, Fair Value at Issuance", "label": "Convertible due 2021 - Bond Hedge, Fair Value at Issuance", "terseLabel": "Convertible due 2021 - Bond Hedge, Fair Value at Issuance" } } }, "localname": "Convertibledue2021BondHedgeFairValueatIssuance", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ivc_Convertibledue2021BondHedgeInitialFairValue": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Convertible due 2021 - Bond Hedge, Initial Fair Value", "label": "Convertible due 2021 - Bond Hedge, Initial Fair Value", "terseLabel": "Convertible due 2021 - Bond Hedge, Initial Fair Value" } } }, "localname": "Convertibledue2021BondHedgeInitialFairValue", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/DerivativesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ivc_Convertibledue2022BondHedgeFairValue": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Convertible due 2022 - Bond Hedge, Fair Value", "label": "Convertible due 2022 - Bond Hedge, Fair Value", "terseLabel": "Convertible 2022 note hedge asset" } } }, "localname": "Convertibledue2022BondHedgeFairValue", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/DerivativesFairValueofConvertibleDebtHedgesDetails", "http://www.invacare.com/role/FairValuesDetailsofBookValueandFairValueofFinancialInstrumentsDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ivc_Convertibledue2022BondHedgeFairValueatIssuance": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Convertible due 2022 - Bond Hedge, Fair Value at Issuance", "label": "Convertible due 2022 - Bond Hedge, Fair Value at Issuance", "terseLabel": "Convertible due 2022 - Bond Hedge, Fair Value at Issuance" } } }, "localname": "Convertibledue2022BondHedgeFairValueatIssuance", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/DerivativesNarrativeDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ivc_CostofProductsSoldasaPercentofNetSales": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Cost of Products Sold, as a Percent of Net Sales", "label": "Cost of Products Sold, as a Percent of Net Sales", "terseLabel": "Cost of Products Sold, as a Percent of Net Sales" } } }, "localname": "CostofProductsSoldasaPercentofNetSales", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss" ], "xbrltype": "percentItemType" }, "ivc_CustomerRebateReserve": { "auth_ref": [], "calculation": { "http://www.invacare.com/role/ReceivablesScheduleofAccountsReceivableDetails": { "order": 2.0, "parentTag": "us-gaap_AccountsReceivableNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Customer Rebate Reserve", "label": "Customer Rebate Reserve", "negatedTerseLabel": "Customer rebate reserve" } } }, "localname": "CustomerRebateReserve", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/ReceivablesScheduleofAccountsReceivableDetails" ], "xbrltype": "monetaryItemType" }, "ivc_DebtInstrumentExchangeAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Debt Instrument Exchange Amount", "label": "Debt Instrument Exchange Amount", "terseLabel": "Debt Instrument Exchange Amount" } } }, "localname": "DebtInstrumentExchangeAmount", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ivc_DebtInstrumentFeeAmountNetBalanceShownasaLiability": { "auth_ref": [], "calculation": { "http://www.invacare.com/role/LongTermDebtComponentsofConvertibleDebtDetails": { "order": 1.0, "parentTag": "ivc_DebtInstrumentNetCarryingAmount", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Debt Instrument, Fee Amount, Net Balance Shown as a Liability", "label": "Debt Instrument, Fee Amount, Net Balance Shown as a Liability", "terseLabel": "Debt Instrument, Fee Amount", "verboseLabel": "Debt fees" } } }, "localname": "DebtInstrumentFeeAmountNetBalanceShownasaLiability", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/LongTermDebtComponentsofConvertibleDebtDetails", "http://www.invacare.com/role/LongTermDebtDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ivc_DebtInstrumentLossonExchange": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Debt Instrument, Loss on Exchange", "label": "Debt Instrument, Loss on Exchange", "terseLabel": "Debt Instrument, Loss on Exchange" } } }, "localname": "DebtInstrumentLossonExchange", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/LongTermDebtComponentsofConvertibleDebtDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ivc_DebtInstrumentNetCarryingAmount": { "auth_ref": [], "calculation": { "http://www.invacare.com/role/LongTermDebtComponentsofConvertibleDebtDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Debt Instrument, Net Carrying Amount", "label": "Debt Instrument, Net Carrying Amount", "terseLabel": "Debt Instrument, Net Carrying Amount", "totalLabel": "Debt Instrument, Net Carrying Amount" } } }, "localname": "DebtInstrumentNetCarryingAmount", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/LongTermDebtComponentsofConvertibleDebtDetails", "http://www.invacare.com/role/LongTermDebtDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ivc_DebtInstrumentNetProceeds": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Debt Instrument, Net Proceeds", "label": "Debt Instrument, Net Proceeds", "terseLabel": "Debt Instrument, Net Proceeds" } } }, "localname": "DebtInstrumentNetProceeds", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ivc_DebtInstrumentNonCashInterestExpenseRecognizedinthePeriod": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Debt Instrument, Non-Cash Interest Expense Recognized in the Period", "label": "Debt Instrument, Non-Cash Interest Expense Recognized in the Period", "terseLabel": "Debt Instrument, Non-Cash Interest Expense Recognized in the Period" } } }, "localname": "DebtInstrumentNonCashInterestExpenseRecognizedinthePeriod", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ivc_DebtInstrumentRepurchaseAmountCashPaid": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Debt Instrument Repurchase Amount, Cash Paid", "label": "Debt Instrument Repurchase Amount, Cash Paid", "terseLabel": "Debt Instrument Repurchase Amount, Cash Paid" } } }, "localname": "DebtInstrumentRepurchaseAmountCashPaid", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ivc_DerivativeInstrumentsandHedgingActivitiesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Derivative Instruments and Hedging Activities [Abstract]", "label": "Derivative Instruments and Hedging Activities [Abstract]", "terseLabel": "Derivative Instruments and Hedging Activities [Abstract]" } } }, "localname": "DerivativeInstrumentsandHedgingActivitiesAbstract", "nsuri": "http://www.invacare.com/20200930", "xbrltype": "stringItemType" }, "ivc_DerivativePercentageOfForcastedTransactionsWithCurrencyRateExposure": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Derivative, Percentage of Forcasted Transactions With Currency Rate Exposure", "label": "Derivative, Percentage of Forcasted Transactions With Currency Rate Exposure", "terseLabel": "Derivative, percentage of forcasted transactions with currency rate exposure" } } }, "localname": "DerivativePercentageOfForcastedTransactionsWithCurrencyRateExposure", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/DerivativesNarrativeDetails" ], "xbrltype": "percentItemType" }, "ivc_DisposalGroupIncludingDiscontinuedOperationDivestitureCostsIncurred": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Disposal Group, Including Discontinued Operation, Divestiture Costs Incurred", "label": "Disposal Group, Including Discontinued Operation, Divestiture Costs Incurred", "terseLabel": "Disposal Group, Including Discontinued Operation, Divestiture Costs Incurred" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationDivestitureCostsIncurred", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/DivestedBusinessesDetails" ], "xbrltype": "monetaryItemType" }, "ivc_DisposalGroupIncludingDiscontinuedOperationEarningsBeforeTaxes": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Disposal Group, Including Discontinued Operation, Earnings Before Taxes", "label": "Disposal Group, Including Discontinued Operation, Earnings Before Taxes", "terseLabel": "Disposal Group, Including Discontinued Operation, Earnings Before Taxes" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationEarningsBeforeTaxes", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/DivestedBusinessesDetails" ], "xbrltype": "monetaryItemType" }, "ivc_DisposalGroupIncludingDiscontinuedOperationInterCompanyRevenue": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Disposal Group, Including Discontinued Operation, Inter-Company Revenue", "label": "Disposal Group, Including Discontinued Operation, Inter-Company Revenue", "terseLabel": "Disposal Group, Including Discontinued Operation, Inter-Company Revenue" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationInterCompanyRevenue", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/DivestedBusinessesDetails" ], "xbrltype": "monetaryItemType" }, "ivc_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Disposal Group, Including Discontinued Operation, Operating Lease, Liability, Current", "label": "Disposal Group, Including Discontinued Operation, Operating Lease, Liability, Current", "terseLabel": "Disposal Group, Including Discontinued Operation, Operating Lease, Liability, Current" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/DivestedBusinessesDetails" ], "xbrltype": "monetaryItemType" }, "ivc_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNonCurrent": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Disposal Group, Including Discontinued Operation, Operating Lease, Liability, NonCurrent", "label": "Disposal Group, Including Discontinued Operation, Operating Lease, Liability, NonCurrent", "terseLabel": "Disposal Group, Including Discontinued Operation, Operating Lease, Liability, NonCurrent" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNonCurrent", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/DivestedBusinessesDetails" ], "xbrltype": "monetaryItemType" }, "ivc_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightofUseAsset": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Disposal Group, Including Discontinued Operation, Operating Lease Right-of-Use Asset", "label": "Disposal Group, Including Discontinued Operation, Operating Lease Right-of-Use Asset", "terseLabel": "Disposal Group, Including Discontinued Operation, Operating Lease Right-of-Use Asset" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightofUseAsset", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/DivestedBusinessesDetails" ], "xbrltype": "monetaryItemType" }, "ivc_DisposalGroupIncludingDiscontinuedOperationPaymentsforDivestitureCosts": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Disposal Group, Including Discontinued Operation, Payments for Divestiture Costs", "label": "Disposal Group, Including Discontinued Operation, Payments for Divestiture Costs", "terseLabel": "Disposal Group, Including Discontinued Operation, Payments for Divestiture Costs" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationPaymentsforDivestitureCosts", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/DivestedBusinessesDetails" ], "xbrltype": "monetaryItemType" }, "ivc_DivestedBusinessesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Divested Businesses [Abstract]", "label": "Divested Businesses [Abstract]", "terseLabel": "Divested Businesses [Abstract]" } } }, "localname": "DivestedBusinessesAbstract", "nsuri": "http://www.invacare.com/20200930", "xbrltype": "stringItemType" }, "ivc_ExchangeOfConvertibleNotes": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Exchange of Convertible Notes", "label": "Exchange of Convertible Notes", "terseLabel": "Exchange of Convertible Notes" } } }, "localname": "ExchangeOfConvertibleNotes", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofShareholdersEquityStatement" ], "xbrltype": "monetaryItemType" }, "ivc_FairValuesConvertibleDebtHedgesGainLoss": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Fair Values Convertible Debt Hedges, Gain (Loss)", "label": "Fair Values Convertible Debt Hedges, Gain (Loss)", "terseLabel": "Fair Values Convertible Debt Hedges, Gain (Loss)" } } }, "localname": "FairValuesConvertibleDebtHedgesGainLoss", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/DerivativesFairValueofConvertibleDebtHedgesDetails", "http://www.invacare.com/role/FairValuesAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "xbrltype": "monetaryItemType" }, "ivc_FairValuesConvertibleDebtHedgesNet": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Fair Values Convertible Debt Hedges, Net", "label": "Fair Values Convertible Debt Hedges, Net", "terseLabel": "Fair Values Convertible Debt Hedges, Net" } } }, "localname": "FairValuesConvertibleDebtHedgesNet", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/DerivativesFairValueofConvertibleDebtHedgesDetails" ], "xbrltype": "monetaryItemType" }, "ivc_FinancingLeaseCost": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Financing Lease, Cost", "label": "Financing Lease, Cost", "terseLabel": "Financing Lease, Cost" } } }, "localname": "FinancingLeaseCost", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsLeaseExpensesDetails" ], "xbrltype": "monetaryItemType" }, "ivc_FinancingLeaseLiabilitynoncurrent": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Financing Lease Liability, non-current", "label": "Financing Lease Liability, non-current", "terseLabel": "Financing Lease Liability, non-current" } } }, "localname": "FinancingLeaseLiabilitynoncurrent", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsFutureMinimumOperatingandFinancingLeaseCommitmentsDetails" ], "xbrltype": "monetaryItemType" }, "ivc_FinancingLeasesCashPaidinMeasurementofAmountsforLeaseLiabilities": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Financing Leases, Cash Paid in Measurement of Amounts for Lease Liabilities", "label": "Financing Leases, Cash Paid in Measurement of Amounts for Lease Liabilities", "terseLabel": "Financing Leases, Cash Paid in Measurement of Amounts for Lease Liabilities" } } }, "localname": "FinancingLeasesCashPaidinMeasurementofAmountsforLeaseLiabilities", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsSupplementalCashFlowInformationDetails" ], "xbrltype": "monetaryItemType" }, "ivc_FinancingLeasesFutureMinimumPaymentsInterestIncludedinPayments": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Financing Leases, Future Minimum Payments, Interest Included in Payments", "label": "Financing Leases, Future Minimum Payments, Interest Included in Payments", "negatedTerseLabel": "Financing Leases, Future Minimum Payments, Interest Included in Payments" } } }, "localname": "FinancingLeasesFutureMinimumPaymentsInterestIncludedinPayments", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsFutureMinimumOperatingandFinancingLeaseCommitmentsDetails" ], "xbrltype": "monetaryItemType" }, "ivc_FinancingLeasesFutureMinimumPaymentsPresentValueofNetMinimumPayments": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Financing Leases, Future Minimum Payments, Present Value of Net Minimum Payments", "label": "Financing Leases, Future Minimum Payments, Present Value of Net Minimum Payments", "terseLabel": "Financing Leases, Future Minimum Payments, Present Value of Net Minimum Payments" } } }, "localname": "FinancingLeasesFutureMinimumPaymentsPresentValueofNetMinimumPayments", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsFutureMinimumOperatingandFinancingLeaseCommitmentsDetails" ], "xbrltype": "monetaryItemType" }, "ivc_FinancingReceivableCreditLimit": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Financing Receivable Credit Limit", "label": "Financing Receivable Credit Limit", "terseLabel": "Credit amount requiring additional analysis" } } }, "localname": "FinancingReceivableCreditLimit", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/ReceivablesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ivc_FinancingReceivableInterestIncomeAccrualMethod": { "auth_ref": [], "calculation": { "http://www.invacare.com/role/ReceivablesInstallmentReceivablesbyClassDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Financing Receivable, Interest Income, Accrual Method", "label": "Financing Receivable, Interest Income, Accrual Method", "totalLabel": "Total installment receivables" } } }, "localname": "FinancingReceivableInterestIncomeAccrualMethod", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/ReceivablesInstallmentReceivablesbyClassDetails" ], "xbrltype": "monetaryItemType" }, "ivc_FinancingReceivableRecordedInvestment": { "auth_ref": [], "calculation": { "http://www.invacare.com/role/ReceivablesInstallmentReceivablesbyClassDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Financing Receivable, Recorded Investment", "label": "Financing Receivable, Recorded Investment", "totalLabel": "Total installment receivables" } } }, "localname": "FinancingReceivableRecordedInvestment", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/ReceivablesInstallmentReceivablesbyClassDetails" ], "xbrltype": "monetaryItemType" }, "ivc_FinancingReceivableUnpaidPrincipalBalance": { "auth_ref": [], "calculation": { "http://www.invacare.com/role/ReceivablesInstallmentReceivablesbyClassDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Financing Receivable, Unpaid Principal Balance", "label": "Financing Receivable, Unpaid Principal Balance", "totalLabel": "Total installment receivables" } } }, "localname": "FinancingReceivableUnpaidPrincipalBalance", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/ReceivablesInstallmentReceivablesbyClassDetails" ], "xbrltype": "monetaryItemType" }, "ivc_FinancingReceivablesTableTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Financing Receivables [Table Text Block]", "label": "Financing Receivables [Table Text Block]", "terseLabel": "Schedule of Financing Receivables" } } }, "localname": "FinancingReceivablesTableTextBlock", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/ReceivablesTables" ], "xbrltype": "textBlockItemType" }, "ivc_FinancingReceivablewithNoRelatedAllowanceInterestIncomeAccrualMethod": { "auth_ref": [], "calculation": { "http://www.invacare.com/role/ReceivablesInstallmentReceivablesbyClassDetails": { "order": 1.0, "parentTag": "ivc_FinancingReceivableInterestIncomeAccrualMethod", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Financing Receivable, with No Related Allowance, Interest Income, Accrual Method", "label": "Financing Receivable, with No Related Allowance, Interest Income, Accrual Method", "terseLabel": "Non-Impaired installment receivables with no related allowance recorded" } } }, "localname": "FinancingReceivablewithNoRelatedAllowanceInterestIncomeAccrualMethod", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/ReceivablesInstallmentReceivablesbyClassDetails" ], "xbrltype": "monetaryItemType" }, "ivc_FinancingReceivablewithNoRelatedAllowanceRecordedInvestment": { "auth_ref": [], "calculation": { "http://www.invacare.com/role/ReceivablesInstallmentReceivablesbyClassDetails": { "order": 1.0, "parentTag": "ivc_FinancingReceivableRecordedInvestment", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Financing Receivable, with No Related Allowance, Recorded Investment", "label": "Financing Receivable, with No Related Allowance, Recorded Investment", "terseLabel": "Non-Impaired installment receivables with no related allowance recorded" } } }, "localname": "FinancingReceivablewithNoRelatedAllowanceRecordedInvestment", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/ReceivablesInstallmentReceivablesbyClassDetails" ], "xbrltype": "monetaryItemType" }, "ivc_FinancingReceivablewithNoRelatedAllowanceUnpaidPrincipalBalance": { "auth_ref": [], "calculation": { "http://www.invacare.com/role/ReceivablesInstallmentReceivablesbyClassDetails": { "order": 1.0, "parentTag": "ivc_FinancingReceivableUnpaidPrincipalBalance", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Financing Receivable, with No Related Allowance, Unpaid Principal Balance", "label": "Financing Receivable, with No Related Allowance, Unpaid Principal Balance", "terseLabel": "Non-Impaired installment receivables with no related allowance recorded" } } }, "localname": "FinancingReceivablewithNoRelatedAllowanceUnpaidPrincipalBalance", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/ReceivablesInstallmentReceivablesbyClassDetails" ], "xbrltype": "monetaryItemType" }, "ivc_FiniteLivedandIndefiniteLivedIntangibleAssetsLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "[Line Items] for Schedule of Finite-Lived and Indefinite-Lived Intangible Assets [Table]", "label": "Finite-Lived and Indefinite-Lived Intangible Assets [Line Items]", "terseLabel": "Finite-Lived and Indefinite-Lived Intangible Assets [Line Items]" } } }, "localname": "FiniteLivedandIndefiniteLivedIntangibleAssetsLineItems", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/IntangiblesIntangibleTableDetails" ], "xbrltype": "stringItemType" }, "ivc_ForeignExchangeForwardAUDNZDMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Foreign Exchange Forward AUD / NZD [Member]", "label": "Foreign Exchange Forward AUD / NZD [Member]", "terseLabel": "AUD / NZD" } } }, "localname": "ForeignExchangeForwardAUDNZDMember", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/DerivativesNotionalAmountsNotDesignatedasHedgesDetails" ], "xbrltype": "domainItemType" }, "ivc_ForeignExchangeForwardAUDUSDMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Foreign Exchange Forward AUD / USD [Member]", "label": "Foreign Exchange Forward AUD / USD [Member]", "terseLabel": "AUD / USD" } } }, "localname": "ForeignExchangeForwardAUDUSDMember", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/DerivativesNotionalAmountsNotDesignatedasHedgesDetails" ], "xbrltype": "domainItemType" }, "ivc_ForeignExchangeForwardCADUSDMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Foreign Exchange Forward CAD / USD [Member]", "label": "Foreign Exchange Forward CAD / USD [Member]", "terseLabel": "CAD / USD" } } }, "localname": "ForeignExchangeForwardCADUSDMember", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/DerivativesNotionalAmountsNotDesignatedasHedgesDetails" ], "xbrltype": "domainItemType" }, "ivc_ForeignExchangeForwardContractsByExchangeAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Foreign Exchange Forward Contracts, by Exchange [Axis]", "label": "Foreign Exchange Forward Contracts, by Exchange [Axis]", "terseLabel": "Foreign Exchange Forward Contracts, by Exchange [Axis]" } } }, "localname": "ForeignExchangeForwardContractsByExchangeAxis", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/DerivativesNotionalAmountsNotDesignatedasHedgesDetails" ], "xbrltype": "stringItemType" }, "ivc_ForeignExchangeForwardContractsByExchangeDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Foreign Exchange Forward Contracts, by Exchange [Domain]", "label": "Foreign Exchange Forward Contracts, by Exchange [Domain]", "terseLabel": "Foreign Exchange Forward Contracts, by Exchange [Domain]" } } }, "localname": "ForeignExchangeForwardContractsByExchangeDomain", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/DerivativesNotionalAmountsNotDesignatedasHedgesDetails" ], "xbrltype": "domainItemType" }, "ivc_ForeignExchangeForwardDKKSEKMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Foreign Exchange Forward DKK / SEK [Member]", "label": "Foreign Exchange Forward DKK / SEK [Member]", "terseLabel": "DKK / SEK" } } }, "localname": "ForeignExchangeForwardDKKSEKMember", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/DerivativesNotionalAmountsDesignatedasHedgesDetails" ], "xbrltype": "domainItemType" }, "ivc_ForeignExchangeForwardDKKUSDMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Foreign Exchange Forward DKK / USD [Member]", "label": "Foreign Exchange Forward DKK / USD [Member]", "terseLabel": "DKK / USD" } } }, "localname": "ForeignExchangeForwardDKKUSDMember", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/DerivativesNotionalAmountsNotDesignatedasHedgesDetails" ], "xbrltype": "domainItemType" }, "ivc_ForeignExchangeForwardEURCADMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Foreign Exchange Forward EUR / CAD [Member]", "label": "Foreign Exchange Forward EUR / CAD [Member]", "terseLabel": "EUR / CAD" } } }, "localname": "ForeignExchangeForwardEURCADMember", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/DerivativesNotionalAmountsDesignatedasHedgesDetails", "http://www.invacare.com/role/DerivativesNotionalAmountsNotDesignatedasHedgesDetails" ], "xbrltype": "domainItemType" }, "ivc_ForeignExchangeForwardEURCHFMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Foreign Exchange Forward EUR / CHF [Member]", "label": "Foreign Exchange Forward EUR / CHF [Member]", "terseLabel": "EUR / CHF" } } }, "localname": "ForeignExchangeForwardEURCHFMember", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/DerivativesNotionalAmountsDesignatedasHedgesDetails" ], "xbrltype": "domainItemType" }, "ivc_ForeignExchangeForwardEURGBPMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Foreign Exchange Forward EUR / GBP [Member]", "label": "Foreign Exchange Forward EUR / GBP [Member]", "terseLabel": "EUR / GBP" } } }, "localname": "ForeignExchangeForwardEURGBPMember", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/DerivativesNotionalAmountsDesignatedasHedgesDetails", "http://www.invacare.com/role/DerivativesNotionalAmountsNotDesignatedasHedgesDetails" ], "xbrltype": "domainItemType" }, "ivc_ForeignExchangeForwardEURNOKMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Foreign Exchange Forward EUR / NOK [Member]", "label": "Foreign Exchange Forward EUR / NOK [Member]", "terseLabel": "EUR / NOK" } } }, "localname": "ForeignExchangeForwardEURNOKMember", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/DerivativesNotionalAmountsDesignatedasHedgesDetails", "http://www.invacare.com/role/DerivativesNotionalAmountsNotDesignatedasHedgesDetails" ], "xbrltype": "domainItemType" }, "ivc_ForeignExchangeForwardEURSEKMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Foreign Exchange Forward EUR / SEK [Member]", "label": "Foreign Exchange Forward EUR / SEK [Member]", "terseLabel": "EUR / SEK" } } }, "localname": "ForeignExchangeForwardEURSEKMember", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/DerivativesNotionalAmountsDesignatedasHedgesDetails" ], "xbrltype": "domainItemType" }, "ivc_ForeignExchangeForwardEURUSDMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Foreign Exchange Forward EUR / USD [Member]", "label": "Foreign Exchange Forward EUR / USD [Member]", "terseLabel": "EUR / USD" } } }, "localname": "ForeignExchangeForwardEURUSDMember", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/DerivativesNotionalAmountsNotDesignatedasHedgesDetails" ], "xbrltype": "domainItemType" }, "ivc_ForeignExchangeForwardGBPUSDMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Foreign Exchange Forward GBP / USD [Member]", "label": "Foreign Exchange Forward GBP / USD [Member]", "terseLabel": "GBP / USD" } } }, "localname": "ForeignExchangeForwardGBPUSDMember", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/DerivativesNotionalAmountsNotDesignatedasHedgesDetails" ], "xbrltype": "domainItemType" }, "ivc_ForeignExchangeForwardNOKSEKMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Foreign Exchange Forward NOK / SEK [Member]", "label": "Foreign Exchange Forward NOK / SEK [Member]", "terseLabel": "NOK / SEK" } } }, "localname": "ForeignExchangeForwardNOKSEKMember", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/DerivativesNotionalAmountsDesignatedasHedgesDetails" ], "xbrltype": "domainItemType" }, "ivc_ForeignExchangeForwardNOKUSDMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Foreign Exchange Forward NOK / USD [Member]", "label": "Foreign Exchange Forward NOK / USD [Member]", "terseLabel": "NOK / USD" } } }, "localname": "ForeignExchangeForwardNOKUSDMember", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/DerivativesNotionalAmountsNotDesignatedasHedgesDetails" ], "xbrltype": "domainItemType" }, "ivc_ForeignExchangeForwardNZDUSDMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Foreign Exchange Forward NZD / USD [Member]", "label": "Foreign Exchange Forward NZD / USD [Member]", "terseLabel": "NZD / USD" } } }, "localname": "ForeignExchangeForwardNZDUSDMember", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/DerivativesNotionalAmountsNotDesignatedasHedgesDetails" ], "xbrltype": "domainItemType" }, "ivc_ForeignExchangeForwardUSDAUDMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Foreign Exchange Forward USD / AUD [Member]", "label": "Foreign Exchange Forward USD / AUD [Member]", "terseLabel": "USD / AUD" } } }, "localname": "ForeignExchangeForwardUSDAUDMember", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/DerivativesNotionalAmountsDesignatedasHedgesDetails" ], "xbrltype": "domainItemType" }, "ivc_ForeignExchangeForwardUSDCADMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Foreign Exchange Forward USD / CAD [Member]", "label": "Foreign Exchange Forward USD / CAD [Member]", "terseLabel": "USD / CAD" } } }, "localname": "ForeignExchangeForwardUSDCADMember", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/DerivativesNotionalAmountsDesignatedasHedgesDetails" ], "xbrltype": "domainItemType" }, "ivc_ForeignExchangeForwardUSDEURMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Foreign Exchange Forward USD / EUR [Member]", "label": "Foreign Exchange Forward USD / EUR [Member]", "terseLabel": "USD / EUR" } } }, "localname": "ForeignExchangeForwardUSDEURMember", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/DerivativesNotionalAmountsDesignatedasHedgesDetails" ], "xbrltype": "domainItemType" }, "ivc_ForeignExchangeForwardUSDGBPMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Foreign Exchange Forward USD / GBP [Member]", "label": "Foreign Exchange Forward USD / GBP [Member]", "terseLabel": "USD / GBP" } } }, "localname": "ForeignExchangeForwardUSDGBPMember", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/DerivativesNotionalAmountsDesignatedasHedgesDetails" ], "xbrltype": "domainItemType" }, "ivc_ForeignExchangeForwardUSDMXPMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Foreign Exchange Forward USD / MXP [Member]", "label": "Foreign Exchange Forward USD / MXP [Member]", "terseLabel": "USD / MXN" } } }, "localname": "ForeignExchangeForwardUSDMXPMember", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/DerivativesNotionalAmountsDesignatedasHedgesDetails" ], "xbrltype": "domainItemType" }, "ivc_ForeignExchangeForwardUSDNZDMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Foreign Exchange Forward USD / NZD [Member]", "label": "Foreign Exchange Forward USD / NZD [Member]", "terseLabel": "USD / NZD" } } }, "localname": "ForeignExchangeForwardUSDNZDMember", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/DerivativesNotionalAmountsDesignatedasHedgesDetails" ], "xbrltype": "domainItemType" }, "ivc_ForeignExchangeForwardUSDSEKMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Foreign Exchange Forward USD / SEK [Member]", "label": "Foreign Exchange Forward USD / SEK [Member]", "terseLabel": "USD / SEK" } } }, "localname": "ForeignExchangeForwardUSDSEKMember", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/DerivativesNotionalAmountsDesignatedasHedgesDetails" ], "xbrltype": "domainItemType" }, "ivc_GainlossBeforeIncomeTaxesasaPercentofNetSales": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Gain (loss) Before Income Taxes, as a Percent of Net Sales", "label": "Gain (loss) Before Income Taxes, as a Percent of Net Sales", "terseLabel": "Gain (loss) Before Income Taxes, as a Percent of Net Sales" } } }, "localname": "GainlossBeforeIncomeTaxesasaPercentofNetSales", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss" ], "xbrltype": "percentItemType" }, "ivc_GainonsaleofbusinessasaPercentofNetSales": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Gain on sale of business, as a Percent of Net Sales", "label": "Gain on sale of business, as a Percent of Net Sales", "terseLabel": "Gain on sale of business, as a Percent of Net Sales" } } }, "localname": "GainonsaleofbusinessasaPercentofNetSales", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss" ], "xbrltype": "percentItemType" }, "ivc_GeneralLeaseTerm": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "General Lease Term", "label": "General Lease Term", "terseLabel": "General Lease Term" } } }, "localname": "GeneralLeaseTerm", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsDetails" ], "xbrltype": "durationItemType" }, "ivc_GeneralTermsandConditionsMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "General Terms and Conditions [Member]", "label": "General Terms and Conditions [Member]", "terseLabel": "General Terms and Conditions" } } }, "localname": "GeneralTermsandConditionsMember", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/RevenueDetails" ], "xbrltype": "domainItemType" }, "ivc_GovernmentTendersMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Government Tenders [Member]", "label": "Government Tenders [Member]", "terseLabel": "Government Tenders" } } }, "localname": "GovernmentTendersMember", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/RevenueDetails" ], "xbrltype": "domainItemType" }, "ivc_GrossProfitasaPercentofNetSales": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Gross Profit, as a Percent of Net Sales", "label": "Gross Profit, as a Percent of Net Sales", "terseLabel": "Gross Profit, as a Percent of Net Sales" } } }, "localname": "GrossProfitasaPercentofNetSales", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss" ], "xbrltype": "percentItemType" }, "ivc_ITLicenses": { "auth_ref": [], "calculation": { "http://www.invacare.com/role/AccruedExpensesComponentsofAccruedExpensesDetails": { "order": 18.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "IT Licenses", "label": "IT Licenses", "terseLabel": "IT licenses" } } }, "localname": "ITLicenses", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/AccruedExpensesComponentsofAccruedExpensesDetails" ], "xbrltype": "monetaryItemType" }, "ivc_ITServiceContract": { "auth_ref": [], "calculation": { "http://www.invacare.com/role/AccruedExpensesComponentsofAccruedExpensesDetails": { "order": 3.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "IT Service Contract", "label": "IT Service Contract", "terseLabel": "IT service contracts" } } }, "localname": "ITServiceContract", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/AccruedExpensesComponentsofAccruedExpensesDetails" ], "xbrltype": "monetaryItemType" }, "ivc_ImpairedFinancingReceivableRelatedAllowanceAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Impaired Financing Receivable, Related Allowance [Abstract]", "label": "Impaired Financing Receivable, Related Allowance [Abstract]", "terseLabel": "Related Allowance for Doubtful Accounts" } } }, "localname": "ImpairedFinancingReceivableRelatedAllowanceAbstract", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/ReceivablesInstallmentReceivablesbyClassDetails" ], "xbrltype": "stringItemType" }, "ivc_IncomeTaxProvisionasaPercentofNetSales": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Income Tax Provision, as a Percent of Net Sales", "label": "Income Tax Provision, as a Percent of Net Sales", "terseLabel": "Income Tax Provision, as a Percent of Net Sales" } } }, "localname": "IncomeTaxProvisionasaPercentofNetSales", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss" ], "xbrltype": "percentItemType" }, "ivc_InstallmentReceivable1to29DaysPastDue": { "auth_ref": [], "calculation": { "http://www.invacare.com/role/ReceivablesAgingofInstallmentReceivablesDetails": { "order": 2.0, "parentTag": "us-gaap_FinancingReceivableRecordedInvestmentPastDue", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Installment Receivable, 1 to 29 Days Past Due", "label": "Installment Receivable, 1 to 29 Days Past Due", "terseLabel": "0-30 Days Past Due" } } }, "localname": "InstallmentReceivable1to29DaysPastDue", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/ReceivablesAgingofInstallmentReceivablesDetails" ], "xbrltype": "monetaryItemType" }, "ivc_InstallmentReceivable30to59DaysPastDue": { "auth_ref": [], "calculation": { "http://www.invacare.com/role/ReceivablesAgingofInstallmentReceivablesDetails": { "order": 3.0, "parentTag": "us-gaap_FinancingReceivableRecordedInvestmentPastDue", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Installment Receivable, 30 to 59 Days Past Due", "label": "Installment Receivable, 30 to 59 Days Past Due", "terseLabel": "31-60 Days Past Due" } } }, "localname": "InstallmentReceivable30to59DaysPastDue", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/ReceivablesAgingofInstallmentReceivablesDetails" ], "xbrltype": "monetaryItemType" }, "ivc_InstallmentReceivableGreaterThan90DaysPastDue": { "auth_ref": [], "calculation": { "http://www.invacare.com/role/ReceivablesAgingofInstallmentReceivablesDetails": { "order": 5.0, "parentTag": "us-gaap_FinancingReceivableRecordedInvestmentPastDue", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Installment Receivable, Greater than 90 Days Past Due", "label": "Installment Receivable, Greater than 90 Days Past Due", "terseLabel": "90+ Days Past Due" } } }, "localname": "InstallmentReceivableGreaterThan90DaysPastDue", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/ReceivablesAgingofInstallmentReceivablesDetails" ], "xbrltype": "monetaryItemType" }, "ivc_InstallmentSales60to89DaysPastDue": { "auth_ref": [], "calculation": { "http://www.invacare.com/role/ReceivablesAgingofInstallmentReceivablesDetails": { "order": 4.0, "parentTag": "us-gaap_FinancingReceivableRecordedInvestmentPastDue", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Installment Sales, 60 to 89 Days Past Due", "label": "Installment Sales, 60 to 89 Days Past Due", "terseLabel": "61-90 Days Past Due" } } }, "localname": "InstallmentSales60to89DaysPastDue", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/ReceivablesAgingofInstallmentReceivablesDetails" ], "xbrltype": "monetaryItemType" }, "ivc_InterestexpenseasaPercentofNetSales": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Interest expense, as a Percent of Net Sales", "label": "Interest expense, as a Percent of Net Sales", "terseLabel": "Interest expense, as a Percent of Net Sales" } } }, "localname": "InterestexpenseasaPercentofNetSales", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss" ], "xbrltype": "percentItemType" }, "ivc_InterestincomeasaPercentofNetSales": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Interest income, as a Percent of Net Sales", "label": "Interest income, as a Percent of Net Sales", "terseLabel": "Interest income, as a Percent of Net Sales" } } }, "localname": "InterestincomeasaPercentofNetSales", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss" ], "xbrltype": "percentItemType" }, "ivc_LargeNationalCustomersMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Large National Customers [Member]", "label": "Large National Customers [Member]", "terseLabel": "Large National Customers" } } }, "localname": "LargeNationalCustomersMember", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/RevenueDetails" ], "xbrltype": "domainItemType" }, "ivc_LastReportedSalesPricePeriodCommonStock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Last Reported Sales Price Period, Common Stock", "label": "Last Reported Sales Price Period, Common Stock", "terseLabel": "Last Reported Sales Price Period, Common Stock" } } }, "localname": "LastReportedSalesPricePeriodCommonStock", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "durationItemType" }, "ivc_LiabilityComponentsOfConvertibleSeriesII2024NoteTableTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Liability Components of Convertible Series II 2024 Note", "label": "Liability Components of Convertible Series II 2024 Note [Table Text Block]", "terseLabel": "Liability Components of Convertible Series II 2024 Note" } } }, "localname": "LiabilityComponentsOfConvertibleSeriesII2024NoteTableTextBlock", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/LongTermDebtTables" ], "xbrltype": "textBlockItemType" }, "ivc_LiabilityComponentsofConvertible2021NoteTableTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "[Table Text Block] for Liability Components of Convertible 2021 Note", "label": "Liability Components of Convertible 2021 Note [Table Text Block]", "terseLabel": "Liability Components of Convertible 2021 Note" } } }, "localname": "LiabilityComponentsofConvertible2021NoteTableTextBlock", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/LongTermDebtTables" ], "xbrltype": "textBlockItemType" }, "ivc_LiabilityComponentsofConvertible2022NoteTableTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Liability Components of Convertible 2022 Note [Table Text Block] [Table Text Block]", "label": "Liability Components of Convertible 2022 Note [Table Text Block]", "terseLabel": "Liability Components of Convertible 2022 Note" } } }, "localname": "LiabilityComponentsofConvertible2022NoteTableTextBlock", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/LongTermDebtTables" ], "xbrltype": "textBlockItemType" }, "ivc_LiabilityComponentsofConvertible2024NoteTableTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Liability Components of Convertible 2024 Note", "label": "Liability Components of Convertible 2024 Note [Table Text Block]", "terseLabel": "Liability Components of Convertible 2024 Note" } } }, "localname": "LiabilityComponentsofConvertible2024NoteTableTextBlock", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/LongTermDebtTables" ], "xbrltype": "textBlockItemType" }, "ivc_LifestyleProductsDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Lifestyle Products", "label": "Lifestyle Products [Domain]", "terseLabel": "Lifestyle Products [Domain]" } } }, "localname": "LifestyleProductsDomain", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/BusinessSegmentsInformationbySegmentDetails" ], "xbrltype": "domainItemType" }, "ivc_LineOfCreditFacilityForeignCurrencyFairValueOfAmountOutstandingFrance": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Line of Credit Facility, Foreign Currency Fair Value of Amount Outstanding (France)", "label": "Line of Credit Facility, Foreign Currency Fair Value of Amount Outstanding (France)", "terseLabel": "Line of Credit Facility, Foreign Currency Fair Value of Amount Outstanding (France)" } } }, "localname": "LineOfCreditFacilityForeignCurrencyFairValueOfAmountOutstandingFrance", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/LongTermDebtDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ivc_LineOfCreditFacilityForeignCurrencyFairValueOfAmountOutstandingUK": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Line of Credit Facility, Foreign Currency Fair Value of Amount Outstanding (UK)", "label": "Line of Credit Facility, Foreign Currency Fair Value of Amount Outstanding (UK)", "terseLabel": "Line of Credit Facility, Foreign Currency Fair Value of Amount Outstanding (UK)" } } }, "localname": "LineOfCreditFacilityForeignCurrencyFairValueOfAmountOutstandingUK", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/LongTermDebtDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ivc_LineofCreditCovenantComplianceConsecutiveBusinessDaysforUndrawnBalance": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line of Credit, Covenant Compliance, Consecutive Business Days for Undrawn Balance", "label": "Line of Credit, Covenant Compliance, Consecutive Business Days for Undrawn Balance", "terseLabel": "Consecutive business days for minimum undrawn balance" } } }, "localname": "LineofCreditCovenantComplianceConsecutiveBusinessDaysforUndrawnBalance", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "durationItemType" }, "ivc_LineofCreditCovenantComplianceConsecutiveBusinessDaysforUndrawn_Balance": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line of Credit, Covenant Compliance, Consecutive Business Days for Undrawn_Balance", "label": "Line of Credit, Covenant Compliance, Consecutive Business Days for Undrawn_Balance", "terseLabel": "Line of Credit, Covenant Compliance, Consecutive Business Days for Undrawn_Balance" } } }, "localname": "LineofCreditCovenantComplianceConsecutiveBusinessDaysforUndrawn_Balance", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "durationItemType" }, "ivc_LineofCreditCovenantComplianceInterruptionofManufacturingFacilitiesPeriod": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line of Credit, Covenant Compliance, Interruption of Manufacturing Facilities Period", "label": "Line of Credit, Covenant Compliance, Interruption of Manufacturing Facilities Period", "terseLabel": "Interruption of material manufacturing facilities, period" } } }, "localname": "LineofCreditCovenantComplianceInterruptionofManufacturingFacilitiesPeriod", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "durationItemType" }, "ivc_LineofCreditCovenantComplianceMaximumBorrowingCapacityAdditionalLongLivedAssetAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Line of Credit, Covenant Compliance, Maximum Borrowing Capacity, Additional Long-Lived Asset Amount", "label": "Line of Credit, Covenant Compliance, Maximum Borrowing Capacity, Additional Long-Lived Asset Amount", "terseLabel": "Additional amount of machinery and equipment" } } }, "localname": "LineofCreditCovenantComplianceMaximumBorrowingCapacityAdditionalLongLivedAssetAmount", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ivc_LineofCreditCovenantComplianceMaximumBorrowingCapacityAvailabilityReserveMinimum": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Line of Credit, Covenant Compliance, Maximum Borrowing Capacity, Availability Reserve, Minimum", "label": "Line of Credit, Covenant Compliance, Maximum Borrowing Capacity, Availability Reserve, Minimum", "terseLabel": "Minimum availability reserve" } } }, "localname": "LineofCreditCovenantComplianceMaximumBorrowingCapacityAvailabilityReserveMinimum", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ivc_LineofCreditCovenantComplianceMaximumBorrowingCapacityInventoriesDomesticPercent": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line of Credit, Covenant Compliance, Maximum Borrowing Capacity, Inventories, Domestic, Percent", "label": "Line of Credit, Covenant Compliance, Maximum Borrowing Capacity, Inventories, Domestic, Percent", "terseLabel": "Percentage of eligible domestic inventory and in-transit inventory" } } }, "localname": "LineofCreditCovenantComplianceMaximumBorrowingCapacityInventoriesDomesticPercent", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "percentItemType" }, "ivc_LineofCreditCovenantComplianceMaximumBorrowingCapacityInventoriesForeignLiquidationValuePercent": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line of Credit, Covenant Compliance, Maximum Borrowing Capacity, Inventories, Foreign, Liquidation Value, Percent", "label": "Line of Credit, Covenant Compliance, Maximum Borrowing Capacity, Inventories, Foreign, Liquidation Value, Percent", "terseLabel": "Percentage of net orderly liquidation value of eligible Canadian inventory" } } }, "localname": "LineofCreditCovenantComplianceMaximumBorrowingCapacityInventoriesForeignLiquidationValuePercent", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "percentItemType" }, "ivc_LineofCreditCovenantComplianceMaximumBorrowingCapacityInventoriesForeignPercent": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line of Credit, Covenant Compliance, Maximum Borrowing Capacity, Inventories, Foreign, Percent", "label": "Line of Credit, Covenant Compliance, Maximum Borrowing Capacity, Inventories, Foreign, Percent", "terseLabel": "Percentage of eligible Canadian inventory" } } }, "localname": "LineofCreditCovenantComplianceMaximumBorrowingCapacityInventoriesForeignPercent", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "percentItemType" }, "ivc_LineofCreditCovenantComplianceMaximumBorrowingCapacityInventoriesLiquidationValueAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Line of Credit, Covenant Compliance, Maximum Borrowing Capacity, Inventories, Liquidation Value, Amount", "label": "Line of Credit, Covenant Compliance, Maximum Borrowing Capacity, Inventories, Liquidation Value, Amount", "terseLabel": "Maximum value of net orderly liquidation value domestic inventory and in-transit inventory" } } }, "localname": "LineofCreditCovenantComplianceMaximumBorrowingCapacityInventoriesLiquidationValueAmount", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ivc_LineofCreditCovenantComplianceMaximumBorrowingCapacityInventoriesLiquidationValuePercent": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line of Credit, Covenant Compliance, Maximum Borrowing Capacity, Inventories, Liquidation Value, Percent", "label": "Line of Credit, Covenant Compliance, Maximum Borrowing Capacity, Inventories, Liquidation Value, Percent", "terseLabel": "Percentage of net orderly liquidation value of domestic inventory" } } }, "localname": "LineofCreditCovenantComplianceMaximumBorrowingCapacityInventoriesLiquidationValuePercent", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "percentItemType" }, "ivc_LineofCreditCovenantComplianceMaximumBorrowingCapacityPropertyPlantandEquipmentLiquidationValuePercent": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line of Credit, Covenant Compliance, Maximum Borrowing Capacity, Property, Plant and Equipment, Liquidation Value, Percent", "label": "Line of Credit, Covenant Compliance, Maximum Borrowing Capacity, Property, Plant and Equipment, Liquidation Value, Percent", "terseLabel": "Net orderly liquidation value of domestic eligible machinery and equipment" } } }, "localname": "LineofCreditCovenantComplianceMaximumBorrowingCapacityPropertyPlantandEquipmentLiquidationValuePercent", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "percentItemType" }, "ivc_LineofCreditCovenantComplianceMaximumBorrowingCapacityTradeReceivablesDomesticPercent": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line of Credit, Covenant Compliance, Maximum Borrowing Capacity, Trade Receivables, Domestic, Percent", "label": "Line of Credit, Covenant Compliance, Maximum Borrowing Capacity, Trade Receivables, Domestic, Percent", "terseLabel": "Percentage of domestic accounts receivable" } } }, "localname": "LineofCreditCovenantComplianceMaximumBorrowingCapacityTradeReceivablesDomesticPercent", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "percentItemType" }, "ivc_LineofCreditCovenantComplianceMaximumBorrowingCapacityTradeReceivablesEuropePercent": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line of Credit, Covenant Compliance, Maximum Borrowing Capacity, Trade Receivables, Europe, Percent", "label": "Line of Credit, Covenant Compliance, Maximum Borrowing Capacity, Trade Receivables, Europe, Percent", "terseLabel": "Line of Credit, Covenant Compliance, Maximum Borrowing Capacity, Trade Receivables, Europe, Percent" } } }, "localname": "LineofCreditCovenantComplianceMaximumBorrowingCapacityTradeReceivablesEuropePercent", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "percentItemType" }, "ivc_LineofCreditCovenantComplianceMaximumBorrowingCapacityTradeReceivablesForeignPercent": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line of Credit, Covenant Compliance, Maximum Borrowing Capacity, Trade Receivables, Foreign, Percent", "label": "Line of Credit, Covenant Compliance, Maximum Borrowing Capacity, Trade Receivables, Foreign, Percent", "terseLabel": "Percentage of eligible Canadian accounts receivable" } } }, "localname": "LineofCreditCovenantComplianceMaximumBorrowingCapacityTradeReceivablesForeignPercent", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "percentItemType" }, "ivc_LineofCreditCovenantComplianceRequiredUndrawnBalanceAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Line of Credit, Covenant Compliance, Required Undrawn Balance, Amount", "label": "Line of Credit, Covenant Compliance, Required Undrawn Balance, Amount", "terseLabel": "Required undrawn balance, minimum" } } }, "localname": "LineofCreditCovenantComplianceRequiredUndrawnBalanceAmount", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ivc_LineofCreditCovenantComplianceRequiredUndrawnBalanceMinimumPercent": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line of Credit, Covenant Compliance, Required Undrawn Balance, Minimum, Percent", "label": "Line of Credit, Covenant Compliance, Required Undrawn Balance, Minimum, Percent", "terseLabel": "Minimum required undrawn balance (as a percent)" } } }, "localname": "LineofCreditCovenantComplianceRequiredUndrawnBalanceMinimumPercent", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "percentItemType" }, "ivc_LineofCreditFacilityAdditionalBorrowingCapacity": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Line of Credit Facility, Additional Borrowing Capacity", "label": "Line of Credit Facility, Additional Borrowing Capacity", "terseLabel": "Additional increase in borrowing capacity available" } } }, "localname": "LineofCreditFacilityAdditionalBorrowingCapacity", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ivc_LineofCreditFacilityCovenantFeatureDominionTrigger": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Line of Credit Facility, Covenant Feature, Dominion Trigger", "label": "Line of Credit Facility, Covenant Feature, Dominion Trigger", "terseLabel": "Line of Credit Facility, Covenant Feature, Dominion Trigger" } } }, "localname": "LineofCreditFacilityCovenantFeatureDominionTrigger", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/LongTermDebtDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ivc_LineofCreditFacilityCovenantFeatureIncreaseLimit": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Line of Credit Facility, Covenant Feature, Increase Limit", "label": "Line of Credit Facility, Covenant Feature, Increase Limit", "terseLabel": "Remaining borrowing capacity" } } }, "localname": "LineofCreditFacilityCovenantFeatureIncreaseLimit", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ivc_LossgainonConvertibleDebtDerivatives": { "auth_ref": [], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows": { "order": 12.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss": { "order": 5.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Gain (loss) on Convertible Debt Derivatives", "label": "Loss (gain) on Convertible Debt Derivatives", "negatedLabel": "Gain on convertible debt derivatives", "negatedTerseLabel": "Net gain on convertible debt derivatives", "terseLabel": "Net gain on convertible debt derivatives" } } }, "localname": "LossgainonConvertibleDebtDerivatives", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/BusinessSegmentsInformationbySegmentDetails", "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows", "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "ivc_MobilityandSeatingDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Mobility and Seating", "label": "Mobility and Seating [Domain]", "terseLabel": "Mobility and Seating [Domain]" } } }, "localname": "MobilityandSeatingDomain", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/BusinessSegmentsInformationbySegmentDetails" ], "xbrltype": "domainItemType" }, "ivc_NetGainLossasapercentofNetSales": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Net Gain (Loss), as a percent of Net Sales", "label": "Net Gain (Loss), as a percent of Net Sales", "terseLabel": "Net Gain (Loss), as a percent of Net Sales" } } }, "localname": "NetGainLossasapercentofNetSales", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss" ], "xbrltype": "percentItemType" }, "ivc_NetLossGainOnDebtExtinguishmentAsAPercentOfNetSales": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Net loss (gain) on debt extinguishment, as a Percent of Net Sales", "label": "Net loss (gain) on debt extinguishment, as a Percent of Net Sales", "terseLabel": "Net loss (gain) on debt extinguishment, as a Percent of Net Sales [Line Items]" } } }, "localname": "NetLossGainOnDebtExtinguishmentAsAPercentOfNetSales", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss" ], "xbrltype": "percentItemType" }, "ivc_NetRevenue": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Net Revenue", "label": "Net Revenue", "terseLabel": "Net Revenue" } } }, "localname": "NetRevenue", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/RevenueDetails" ], "xbrltype": "percentItemType" }, "ivc_NetSalesasaPercentofNetSales": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Net Sales, as a Percent of Net Sales", "label": "Net Sales, as a Percent of Net Sales", "terseLabel": "Net Sales, as a Percent of Net Sales" } } }, "localname": "NetSalesasaPercentofNetSales", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss" ], "xbrltype": "percentItemType" }, "ivc_NetlossgainonconvertibledebtderivativesasaPercentofNetSales": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Net loss (gain) on convertible debt derivatives, as a Percent of Net Sales", "label": "Net loss (gain) on convertible debt derivatives, as a Percent of Net Sales", "terseLabel": "Net loss (gain) on convertible debt derivatives, as a Percent of Net Sales" } } }, "localname": "NetlossgainonconvertibledebtderivativesasaPercentofNetSales", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss" ], "xbrltype": "percentItemType" }, "ivc_NonImpairedFinancingReceivableRelatedAllowance": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Non-Impaired Financing Receivable, Related Allowance", "label": "Non-Impaired Financing Receivable, Related Allowance", "terseLabel": "Non-Impaired Financing Receivable, Related Allowance" } } }, "localname": "NonImpairedFinancingReceivableRelatedAllowance", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/ReceivablesInstallmentReceivablesbyClassDetails", "http://www.invacare.com/role/ReceivablesInstallmentRecevablesDetails" ], "xbrltype": "monetaryItemType" }, "ivc_NotesLoansAndFinancingReceivableNetOfUnearnedInterest": { "auth_ref": [], "calculation": { "http://www.invacare.com/role/ReceivablesInstallmentRecevablesDetails": { "order": 1.0, "parentTag": "us-gaap_NotesReceivableNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Notes, Loans and Financing Receivable, Net of Unearned Interest", "label": "Notes, Loans and Financing Receivable, Net of Unearned Interest", "totalLabel": "Installment Receivables, Net of Unearned Interest" } } }, "localname": "NotesLoansAndFinancingReceivableNetOfUnearnedInterest", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/ReceivablesInstallmentRecevablesDetails" ], "xbrltype": "monetaryItemType" }, "ivc_NotesLoansAndFinancingReceivableNetOfUnearnedInterestCurrent": { "auth_ref": [], "calculation": { "http://www.invacare.com/role/ReceivablesInstallmentRecevablesDetails": { "order": 1.0, "parentTag": "us-gaap_NotesAndLoansReceivableNetCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Notes Loans and Financing Receivable Net of Unearned Interest Current", "label": "Notes Loans and Financing Receivable Net of Unearned Interest Current", "totalLabel": "Installment Receivables Net of Unearned Interest Current" } } }, "localname": "NotesLoansAndFinancingReceivableNetOfUnearnedInterestCurrent", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/ReceivablesInstallmentRecevablesDetails" ], "xbrltype": "monetaryItemType" }, "ivc_NotesLoansAndFinancingReceivableNetOfUnearnedInterestNoncurrent": { "auth_ref": [], "calculation": { "http://www.invacare.com/role/ReceivablesInstallmentRecevablesDetails": { "order": 1.0, "parentTag": "us-gaap_NotesAndLoansReceivableNetNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Notes Loans and Financing Receivable Net of Unearned Interest Noncurrent", "label": "Notes Loans and Financing Receivable Net of Unearned Interest Noncurrent", "totalLabel": "Installment Receivables Net of Unearned Interest Noncurrent" } } }, "localname": "NotesLoansAndFinancingReceivableNetOfUnearnedInterestNoncurrent", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/ReceivablesInstallmentRecevablesDetails" ], "xbrltype": "monetaryItemType" }, "ivc_NotesLoansAndFinancingReceivablesAverageFinancingPeriod": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Notes, Loans and Financing Receivables, Average Financing Period", "label": "Notes, Loans and Financing Receivables, Average Financing Period", "terseLabel": "Typical financing period" } } }, "localname": "NotesLoansAndFinancingReceivablesAverageFinancingPeriod", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/ReceivablesNarrativeDetails" ], "xbrltype": "durationItemType" }, "ivc_NotesLoansAndFinancingReceivablesNumberOfMissedPaymentsBeforeDelinquent": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Notes, Loans, and Financing Receivables, Number of Missed Payments before Delinquent", "label": "Notes, Loans, and Financing Receivables, Number of Missed Payments before Delinquent", "terseLabel": "Number of missed payments before delinquent" } } }, "localname": "NotesLoansAndFinancingReceivablesNumberOfMissedPaymentsBeforeDelinquent", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/ReceivablesNarrativeDetails" ], "xbrltype": "integerItemType" }, "ivc_NotesLoansAndFinancingReceivablesPurchaseOfFinanceReceivables": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Notes, Loans and Financing Receivables, Purchase of Finance Receivables", "label": "Notes, Loans and Financing Receivables, Purchase of Finance Receivables", "terseLabel": "Installment receivable purchased from DLL" } } }, "localname": "NotesLoansAndFinancingReceivablesPurchaseOfFinanceReceivables", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/ReceivablesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ivc_NotesLoansFinancingReceivableAveragePeriodOfAdjudication": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Notes, Loans, Financing Receivable, Average Period of Adjudication", "label": "Notes, Loans, Financing Receivable, Average Period of Adjudication", "terseLabel": "Average period of adjudication" } } }, "localname": "NotesLoansFinancingReceivableAveragePeriodOfAdjudication", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/ReceivablesNarrativeDetails" ], "xbrltype": "durationItemType" }, "ivc_NotionalAmountDerivative": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Notional Amount, Derivative", "label": "Notional Amount, Derivative", "terseLabel": "Notional Amount" } } }, "localname": "NotionalAmountDerivative", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/BusinessSegmentsInformationbySegmentDetails", "http://www.invacare.com/role/DerivativesNotionalAmountsDesignatedasHedgesDetails", "http://www.invacare.com/role/DerivativesNotionalAmountsNotDesignatedasHedgesDetails" ], "xbrltype": "monetaryItemType" }, "ivc_NotionalAmountOfDerivativesMaturedDuringPeriod": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Notional Amount of Derivatives, Matured During Period", "label": "Notional Amount of Derivatives, Matured During Period", "terseLabel": "Notional amount of derivatives, matured during period" } } }, "localname": "NotionalAmountOfDerivativesMaturedDuringPeriod", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/DerivativesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ivc_OperatingGainLossasaPercentofNetSales": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Operating Gain (Loss), as a Percent of Net Sales", "label": "Operating Gain (Loss), as a Percent of Net Sales", "terseLabel": "Operating Gain (Loss), as a Percent of Net Sales" } } }, "localname": "OperatingGainLossasaPercentofNetSales", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss" ], "xbrltype": "percentItemType" }, "ivc_OperatingLeaseRightofUseAmortization": { "auth_ref": [], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Operating Lease, Right-of-Use, Amortization", "label": "Operating Lease, Right-of-Use, Amortization", "terseLabel": "Amortization of operating lease right of use assets" } } }, "localname": "OperatingLeaseRightofUseAmortization", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ivc_OperatingLeasesCashPaidinMeasurementofAmountsforLeaseLiabilities": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Operating Leases, Cash Paid in Measurement of Amounts for Lease Liabilities", "label": "Operating Leases, Cash Paid in Measurement of Amounts for Lease Liabilities", "terseLabel": "Operating Leases, Cash Paid in Measurement of Amounts for Lease Liabilities" } } }, "localname": "OperatingLeasesCashPaidinMeasurementofAmountsforLeaseLiabilities", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsSupplementalCashFlowInformationDetails" ], "xbrltype": "monetaryItemType" }, "ivc_OperatingLeasesFutureMinimumPaymentsInterestIncludedinPayments": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Operating Leases, Future Minimum Payments, Interest Included in Payments", "label": "Operating Leases, Future Minimum Payments, Interest Included in Payments", "negatedTerseLabel": "Operating Leases, Future Minimum Payments, Interest Included in Payments" } } }, "localname": "OperatingLeasesFutureMinimumPaymentsInterestIncludedinPayments", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsFutureMinimumOperatingandFinancingLeaseCommitmentsDetails" ], "xbrltype": "monetaryItemType" }, "ivc_OperatingLeasesFutureMinimumPaymentsPresentValueofNetMinimumPayments": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Operating Leases, Future Minimum Payments, Present Value of Net Minimum Payments", "label": "Operating Leases, Future Minimum Payments, Present Value of Net Minimum Payments", "terseLabel": "Operating Leases, Future Minimum Payments, Present Value of Net Minimum Payments" } } }, "localname": "OperatingLeasesFutureMinimumPaymentsPresentValueofNetMinimumPayments", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsFutureMinimumOperatingandFinancingLeaseCommitmentsDetails" ], "xbrltype": "monetaryItemType" }, "ivc_OtherComprehensiveIncomeLossDeferredTaxValuationReserve": { "auth_ref": [], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss": { "order": 4.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Other Comprehensive Income (Loss), Deferred Tax Valuation Reserve", "label": "Other Comprehensive Income (Loss), Deferred Tax Valuation Reserve", "terseLabel": "Valuation reserve associated with defined benefit plan activity" } } }, "localname": "OtherComprehensiveIncomeLossDeferredTaxValuationReserve", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "ivc_OtherCustomersMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Other Customers [Member]", "label": "Other Customers [Member]", "terseLabel": "Other Customers" } } }, "localname": "OtherCustomersMember", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/RevenueDetails" ], "xbrltype": "domainItemType" }, "ivc_OtherDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Other", "label": "Other [Domain]", "terseLabel": "Other [Domain]" } } }, "localname": "OtherDomain", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/BusinessSegmentsInformationbySegmentDetails" ], "xbrltype": "domainItemType" }, "ivc_OtherNotesandCapitalLeaseObligationsMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Other Notes and Capital Lease Obligations [Member]", "label": "Other Notes and Capital Lease Obligations [Member]", "terseLabel": "Other Notes and Capital Lease Obligations" } } }, "localname": "OtherNotesandCapitalLeaseObligationsMember", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/LongTermDebtDetails" ], "xbrltype": "domainItemType" }, "ivc_PaymentsToDebtHolders": { "auth_ref": [], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Payments to Debt Holders", "label": "Payments to Debt Holders", "negatedTerseLabel": "Payments to debt holders" } } }, "localname": "PaymentsToDebtHolders", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ivc_PercentoftheApplicableConversionPrice": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Percent of the Applicable Conversion Price", "label": "Percent of the Applicable Conversion Price", "terseLabel": "Percent of the Applicable Conversion Price" } } }, "localname": "PercentoftheApplicableConversionPrice", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "percentItemType" }, "ivc_PercentoftheProductoftheLastReportedSalePriceCommonShares": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Percent of the Product of the Last Reported Sale Price, Common Shares", "label": "Percent of the Product of the Last Reported Sale Price, Common Shares", "terseLabel": "Percent of the Product of the Last Reported Sale Price, Common Shares" } } }, "localname": "PercentoftheProductoftheLastReportedSalePriceCommonShares", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "percentItemType" }, "ivc_PrepaidDebtFees": { "auth_ref": [], "calculation": { "http://www.invacare.com/role/OtherCurrentAssetsComponentsofOtherCurrentAssetsDetails": { "order": 6.0, "parentTag": "us-gaap_OtherAssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Prepaid Debt Fees", "label": "Prepaid Debt Fees", "terseLabel": "Deferred financing fees" } } }, "localname": "PrepaidDebtFees", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/OtherCurrentAssetsComponentsofOtherCurrentAssetsDetails" ], "xbrltype": "monetaryItemType" }, "ivc_PrepaidInventory": { "auth_ref": [], "calculation": { "http://www.invacare.com/role/OtherCurrentAssetsComponentsofOtherCurrentAssetsDetails": { "order": 7.0, "parentTag": "us-gaap_OtherAssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Prepaid Inventory", "label": "Prepaid Inventory", "terseLabel": "Prepaid inventory" } } }, "localname": "PrepaidInventory", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/OtherCurrentAssetsComponentsofOtherCurrentAssetsDetails" ], "xbrltype": "monetaryItemType" }, "ivc_PrepaidServiceContracts": { "auth_ref": [], "calculation": { "http://www.invacare.com/role/OtherCurrentAssetsComponentsofOtherCurrentAssetsDetails": { "order": 5.0, "parentTag": "us-gaap_OtherAssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Prepaid Service Contracts", "label": "Prepaid Service Contracts", "terseLabel": "Service contracts" } } }, "localname": "PrepaidServiceContracts", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/OtherCurrentAssetsComponentsofOtherCurrentAssetsDetails" ], "xbrltype": "monetaryItemType" }, "ivc_PrepaidSocialCharges": { "auth_ref": [], "calculation": { "http://www.invacare.com/role/OtherCurrentAssetsComponentsofOtherCurrentAssetsDetails": { "order": 10.0, "parentTag": "us-gaap_OtherAssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Prepaid Social Charges", "label": "Prepaid Social Charges", "terseLabel": "Prepaid social charges" } } }, "localname": "PrepaidSocialCharges", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/OtherCurrentAssetsComponentsofOtherCurrentAssetsDetails" ], "xbrltype": "monetaryItemType" }, "ivc_ProductLiabilityCurrent": { "auth_ref": [], "calculation": { "http://www.invacare.com/role/AccruedExpensesComponentsofAccruedExpensesDetails": { "order": 9.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Product Liability, Current", "label": "Product Liability, Current", "terseLabel": "Product liability, current portion" } } }, "localname": "ProductLiabilityCurrent", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/AccruedExpensesComponentsofAccruedExpensesDetails" ], "xbrltype": "monetaryItemType" }, "ivc_ProductLiabilityNoncurrent": { "auth_ref": [], "calculation": { "http://www.invacare.com/role/OtherLongTermObligationsDetails": { "order": 2.0, "parentTag": "us-gaap_OtherLiabilitiesNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Product Liability, Noncurrent", "label": "Product Liability, Noncurrent", "terseLabel": "Product liability" } } }, "localname": "ProductLiabilityNoncurrent", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/OtherLongTermObligationsDetails" ], "xbrltype": "monetaryItemType" }, "ivc_RangeOfExercisePriceFourMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Range of Exercise Price Four [Member]", "label": "Range of Exercise Price Four [Member]", "terseLabel": "$30.01 \u2013 $33.36" } } }, "localname": "RangeOfExercisePriceFourMember", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/EquityCompensationOptionsActivityDetails", "http://www.invacare.com/role/EquityCompensationStockOptionsOutstandingbyExercisePriceDetails" ], "xbrltype": "domainItemType" }, "ivc_RangeOfExercisePriceOneMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Range of Exercise Price One [Member]", "label": "Range of Exercise Price One [Member]", "terseLabel": "$12.15 \u2013 $20.00" } } }, "localname": "RangeOfExercisePriceOneMember", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/EquityCompensationOptionsActivityDetails", "http://www.invacare.com/role/EquityCompensationStockOptionsOutstandingbyExercisePriceDetails" ], "xbrltype": "domainItemType" }, "ivc_RangeOfExercisePriceThreeMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Range of Exercise Price Three [Member]", "label": "Range of Exercise Price Three [Member]", "terseLabel": "$25.01 \u2013 $30.00" } } }, "localname": "RangeOfExercisePriceThreeMember", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/EquityCompensationStockOptionsOutstandingbyExercisePriceDetails" ], "xbrltype": "domainItemType" }, "ivc_RangeOfExercisePriceTwoMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Range of Exercise Price Two [Member]", "label": "Range of Exercise Price Two [Member]", "terseLabel": "$20.01 \u2013 $25.00" } } }, "localname": "RangeOfExercisePriceTwoMember", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/EquityCompensationStockOptionsOutstandingbyExercisePriceDetails" ], "xbrltype": "domainItemType" }, "ivc_ReceivableDueFromInformationTechnologyProvider": { "auth_ref": [], "calculation": { "http://www.invacare.com/role/OtherCurrentAssetsComponentsofOtherCurrentAssetsDetails": { "order": 2.0, "parentTag": "us-gaap_OtherAssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Receivable Due From Information Technology Provider", "label": "Receivable Due From Information Technology Provider", "terseLabel": "Receivable due from information technology provider" } } }, "localname": "ReceivableDueFromInformationTechnologyProvider", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/OtherCurrentAssetsComponentsofOtherCurrentAssetsDetails" ], "xbrltype": "monetaryItemType" }, "ivc_ReceivablesExpectedLossPercentageAsiaPac": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Receivables, Expected Loss Percentage, AsiaPac", "label": "Receivables, Expected Loss Percentage, AsiaPac", "terseLabel": "Receivables, Expected Loss Percentage, AsiaPac" } } }, "localname": "ReceivablesExpectedLossPercentageAsiaPac", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/ReceivablesNarrativeDetails" ], "xbrltype": "percentItemType" }, "ivc_ReceivablesExpectedLossPercentageCanada": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Receivables, Expected Loss Percentage, Canada", "label": "Receivables, Expected Loss Percentage, Canada", "terseLabel": "Receivables, Expected Loss Percentage, Canada" } } }, "localname": "ReceivablesExpectedLossPercentageCanada", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/ReceivablesNarrativeDetails" ], "xbrltype": "percentItemType" }, "ivc_ReceivablesExpectedLossPercentageEurope": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Receivables, Expected Loss Percentage, Europe", "label": "Receivables, Expected Loss Percentage, Europe", "terseLabel": "Receivables, Expected Loss Percentage, Europe" } } }, "localname": "ReceivablesExpectedLossPercentageEurope", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/ReceivablesNarrativeDetails" ], "xbrltype": "percentItemType" }, "ivc_ReceivablesExpectedLossPercentageNorthAmericaexcludingCanada": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Receivables, Expected Loss Percentage, North America excluding Canada", "label": "Receivables, Expected Loss Percentage, North America excluding Canada", "terseLabel": "Receivables, Expected Loss Percentage, North America excluding Canada" } } }, "localname": "ReceivablesExpectedLossPercentageNorthAmericaexcludingCanada", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/ReceivablesNarrativeDetails" ], "xbrltype": "percentItemType" }, "ivc_RespiratoryTherapyDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Respiratory Therapy", "label": "Respiratory Therapy [Domain]", "terseLabel": "Respiratory Therapy [Domain]" } } }, "localname": "RespiratoryTherapyDomain", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/BusinessSegmentsInformationbySegmentDetails" ], "xbrltype": "domainItemType" }, "ivc_RestrictedStockandRestrictedStockUnitsRSUsMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Restricted Stock and Restricted Stock Units (RSUs) [Member]", "label": "Restricted Stock and Restricted Stock Units (RSUs) [Member]", "terseLabel": "Restricted Stock and Restricted Stock Units (RSUs)" } } }, "localname": "RestrictedStockandRestrictedStockUnitsRSUsMember", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/EquityCompensationRestrictedStockActivityDetails", "http://www.invacare.com/role/EquityCompensationSharebasedCompensationExpenseDetails", "http://www.invacare.com/role/EquityCompensationUnrecognizedCompensationExpenseDetails" ], "xbrltype": "domainItemType" }, "ivc_RestructuringAndRelatedActivitiesExpectedPayoutPeriod": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Restructuring and Related Activities, Expected Payout Period", "label": "Restructuring and Related Activities, Expected Payout Period", "terseLabel": "Restructuring and Related Activities, Expected Payout Period" } } }, "localname": "RestructuringAndRelatedActivitiesExpectedPayoutPeriod", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/ChargesRelatedToRestructuringActivitiesNarrativeDetails" ], "xbrltype": "durationItemType" }, "ivc_ReturnsandAllowancesReserve": { "auth_ref": [], "calculation": { "http://www.invacare.com/role/ReceivablesScheduleofAccountsReceivableDetails": { "order": 5.0, "parentTag": "us-gaap_AccountsReceivableNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Returns and Allowances Reserve", "label": "Returns and Allowances Reserve", "negatedTerseLabel": "Other, principally returns and allowances reserves" } } }, "localname": "ReturnsandAllowancesReserve", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/ReceivablesScheduleofAccountsReceivableDetails" ], "xbrltype": "monetaryItemType" }, "ivc_RevenueAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Revenue [Abstract]", "label": "Revenue [Abstract]", "terseLabel": "Revenue [Abstract]" } } }, "localname": "RevenueAbstract", "nsuri": "http://www.invacare.com/20200930", "xbrltype": "stringItemType" }, "ivc_ReversalofAccruedWithholdingTaxesonEarnings": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Reversal of Accrued Withholding Taxes on Earnings", "label": "Reversal of Accrued Withholding Taxes on Earnings", "terseLabel": "Reversal of Accrued Withholding Taxes on Earnings" } } }, "localname": "ReversalofAccruedWithholdingTaxesonEarnings", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ivc_RevolvingCreditandSecurityAgreementEuropeCreditAgreementMemberDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Revolving Credit and Security Agreement (Europe Credit Agreement) [Member] [Domain]", "label": "Revolving Credit and Security Agreement (Europe Credit Agreement) [Member] [Domain]", "terseLabel": "Revolving Credit and Security Agreement (Europe Credit Agreement)" } } }, "localname": "RevolvingCreditandSecurityAgreementEuropeCreditAgreementMemberDomain", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "ivc_RevolvingCreditandSecurityAgreementNewCreditAgreementMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Revolving Credit and Security Agreement (New Credit Agreement) [Member]", "label": "Revolving Credit and Security Agreement (New Credit Agreement) [Member]", "terseLabel": "Revolving Credit and Security Agreement (New Credit Agreement)" } } }, "localname": "RevolvingCreditandSecurityAgreementNewCreditAgreementMember", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "ivc_RightofUseAssetObtainedinExchangeforTotalLeaseLiability": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Right-of-Use Asset Obtained in Exchange for Total Lease Liability", "label": "Right-of-Use Asset Obtained in Exchange for Total Lease Liability", "terseLabel": "Right-of-Use Asset Obtained in Exchange for Total Lease Liability" } } }, "localname": "RightofUseAssetObtainedinExchangeforTotalLeaseLiability", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsSupplementalCashFlowInformationDetails" ], "xbrltype": "monetaryItemType" }, "ivc_RiskFactorAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Risk Factor", "label": "Risk Factor [Axis]", "terseLabel": "Risk Factor [Axis]" } } }, "localname": "RiskFactorAxis", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/ReceivablesNarrativeDetails" ], "xbrltype": "stringItemType" }, "ivc_RiskFactorDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "[Domain] for Risk Factor", "label": "Risk Factor [Domain]", "terseLabel": "Risk Factor [Domain]" } } }, "localname": "RiskFactorDomain", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/ReceivablesNarrativeDetails" ], "xbrltype": "domainItemType" }, "ivc_SaleLeasebackTransactionImmediateLossRecognized": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Sale Leaseback Transaction, Immediate Loss Recognized", "label": "Sale Leaseback Transaction, Immediate Loss Recognized", "terseLabel": "Sale Leaseback Transaction, Immediate Loss Recognized" } } }, "localname": "SaleLeasebackTransactionImmediateLossRecognized", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsDetails" ], "xbrltype": "monetaryItemType" }, "ivc_SaleLeasebackTransactionsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Sale Leaseback Transactions [Abstract]", "label": "Sale Leaseback Transactions [Abstract]", "terseLabel": "Sale Leaseback Transactions [Abstract]" } } }, "localname": "SaleLeasebackTransactionsAbstract", "nsuri": "http://www.invacare.com/20200930", "xbrltype": "stringItemType" }, "ivc_ScheduleforAllowanceforCreditLossesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Schedule for Allowance for Credit Losses [Abstract]", "label": "Schedule for Allowance for Credit Losses [Abstract]", "terseLabel": "Schedule for Allowance for Credit Losses [Abstract]" } } }, "localname": "ScheduleforAllowanceforCreditLossesAbstract", "nsuri": "http://www.invacare.com/20200930", "xbrltype": "stringItemType" }, "ivc_ScheduleofAccountsReceivableAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Schedule of Accounts Receivable [Abstract]", "label": "Schedule of Accounts Receivable [Abstract]", "terseLabel": "Schedule of Accounts Receivable [Abstract]" } } }, "localname": "ScheduleofAccountsReceivableAbstract", "nsuri": "http://www.invacare.com/20200930", "xbrltype": "stringItemType" }, "ivc_ScheduleofAccountsReceivableTableTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "[Table Text Block] for Schedule of Accounts Receivable [Table]", "label": "Schedule of Accounts Receivable [Table Text Block]", "terseLabel": "Schedule of Accounts Receivable" } } }, "localname": "ScheduleofAccountsReceivableTableTextBlock", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/ReceivablesTables" ], "xbrltype": "textBlockItemType" }, "ivc_ScheduleofFiniteLivedandIndefiniteLivedIntangibleAssetsTable": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Schedule of Finite-Lived and Indefinite-Lived Intangible Assets [Table]", "label": "Schedule of Finite-Lived and Indefinite-Lived Intangible Assets [Table]", "terseLabel": "Schedule of Finite-Lived and Indefinite-Lived Intangible Assets [Table]" } } }, "localname": "ScheduleofFiniteLivedandIndefiniteLivedIntangibleAssetsTable", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/IntangiblesIntangibleTableDetails" ], "xbrltype": "stringItemType" }, "ivc_SellinggeneralandadministrativeexpensesasaPercentofNetSales": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Selling, general and administrative expenses, as a Percent of Net Sales", "label": "Selling, general and administrative expenses, as a Percent of Net Sales", "terseLabel": "Selling, general and administrative expenses, as a Percent of Net Sales" } } }, "localname": "SellinggeneralandadministrativeexpensesasaPercentofNetSales", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss" ], "xbrltype": "percentItemType" }, "ivc_SeriesIIConvertibleSeniorNotesAt500November2024Domain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Series II Convertible Senior Notes at 5.00% November 2024", "label": "Series II Convertible Senior Notes at 5.00% November 2024 [Domain]", "terseLabel": "Series II Convertible Senior Notes at 5.00% November 2024 [Domain]" } } }, "localname": "SeriesIIConvertibleSeniorNotesAt500November2024Domain", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/LongTermDebtDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "ivc_SeriesIIConvertibleSeniorNotesAt500November2024Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Series II Convertible Senior Notes at 5.00% November 2024", "label": "Series II Convertible Senior Notes at 5.00% November 2024 [Member]", "terseLabel": "Series II Convertible Senior Notes at 5.00% November 2024 [Member]" } } }, "localname": "SeriesIIConvertibleSeniorNotesAt500November2024Member", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "ivc_ServicesMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Services [Member]", "label": "Services [Member]", "terseLabel": "Service" } } }, "localname": "ServicesMember", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/RevenueDetails" ], "xbrltype": "domainItemType" }, "ivc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfShareAwardsUnderlyingFrom2003And2013Plans": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Share Awards Underlying from 2003 and 2013 Plans", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Share Awards Underlying from 2003 and 2013 Plans", "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Share Awards Underlying from 2003 Plan" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfShareAwardsUnderlyingFrom2003And2013Plans", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/EquityCompensationNarrativeDetails" ], "xbrltype": "sharesItemType" }, "ivc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesTransferredFromPriorPlans": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Transferred from Prior Plans", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Transferred from Prior Plans", "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Transferred from Prior Plans" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesTransferredFromPriorPlans", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/EquityCompensationNarrativeDetails" ], "xbrltype": "sharesItemType" }, "ivc_ShareBasedCompensationArrangementByShareBasedPaymentAwardPerformancePeriod": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Share Based Compensation Arrangement By Share Based Payment Award Performance Period", "label": "Share Based Compensation Arrangement By Share Based Payment Award Performance Period", "terseLabel": "Share Based Compensation Arrangement By Share Based Payment Award Performance Period" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardPerformancePeriod", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/EquityCompensationNarrativeDetails" ], "xbrltype": "durationItemType" }, "ivc_SharebasedCompensationArrangementbySharebasedPaymentAwardNonOptionEquityInstrumentsPerformanceAwardTargetAcheivementLowerRangePercentage": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Performance Award Target Acheivement, Lower Range, Percentage", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Performance Award Target Acheivement, Lower Range, Percentage", "terseLabel": "Performance achievement level, lower range" } } }, "localname": "SharebasedCompensationArrangementbySharebasedPaymentAwardNonOptionEquityInstrumentsPerformanceAwardTargetAcheivementLowerRangePercentage", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/EquityCompensationNarrativeDetails" ], "xbrltype": "percentItemType" }, "ivc_SharebasedCompensationArrangementbySharebasedPaymentAwardNonOptionEquityInstrumentsPerformanceAwardTargetAcheivementPercentage": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Level of Performance Award Achievement, Target", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Performance Award Target Acheivement, Percentage", "terseLabel": "Performance achievement level, target range" } } }, "localname": "SharebasedCompensationArrangementbySharebasedPaymentAwardNonOptionEquityInstrumentsPerformanceAwardTargetAcheivementPercentage", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/EquityCompensationNarrativeDetails" ], "xbrltype": "percentItemType" }, "ivc_SharebasedCompensationArrangementbySharebasedPaymentAwardNonOptionEquityInstrumentsPerformanceAwardTargetAcheivementUpperRangePercentage": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Performance Award Target Acheivement, Upper Range, Percentage", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Performance Award Target Acheivement, Upper Range, Percentage", "terseLabel": "Performance achievement level, upper range" } } }, "localname": "SharebasedCompensationArrangementbySharebasedPaymentAwardNonOptionEquityInstrumentsPerformanceAwardTargetAcheivementUpperRangePercentage", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/EquityCompensationNarrativeDetails" ], "xbrltype": "percentItemType" }, "ivc_SwingLineLoansDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Swing Line Loans [Domain]", "label": "Swing Line Loans [Domain]", "terseLabel": "Swing Line Loans" } } }, "localname": "SwingLineLoansDomain", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "ivc_TotalCashPaidinMeasurementofAmountsforLeaseLiabilities": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Total Cash Paid in Measurement of Amounts for Lease Liabilities", "label": "Total Cash Paid in Measurement of Amounts for Lease Liabilities", "terseLabel": "Total Cash Paid in Measurement of Amounts for Lease Liabilities" } } }, "localname": "TotalCashPaidinMeasurementofAmountsforLeaseLiabilities", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsSupplementalCashFlowInformationDetails" ], "xbrltype": "monetaryItemType" }, "ivc_UnamortizedFinancingCosts": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Unamortized Financing Costs", "label": "Unamortized Financing Costs", "terseLabel": "Unamortized Financing Costs" } } }, "localname": "UnamortizedFinancingCosts", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ivc_UnearnedInterest": { "auth_ref": [], "calculation": { "http://www.invacare.com/role/ReceivablesInstallmentRecevablesDetails": { "order": 2.0, "parentTag": "ivc_NotesLoansAndFinancingReceivableNetOfUnearnedInterest", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Unearned Interest", "label": "Unearned Interest", "totalLabel": "Unearned Interest" } } }, "localname": "UnearnedInterest", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/ReceivablesInstallmentRecevablesDetails" ], "xbrltype": "monetaryItemType" }, "ivc_UnearnedInterestCurrent": { "auth_ref": [], "calculation": { "http://www.invacare.com/role/ReceivablesInstallmentRecevablesDetails": { "order": 2.0, "parentTag": "ivc_NotesLoansAndFinancingReceivableNetOfUnearnedInterestCurrent", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Unearned Interest - Current", "label": "Unearned Interest - Current", "terseLabel": "Unearned Interest" } } }, "localname": "UnearnedInterestCurrent", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/ReceivablesInstallmentRecevablesDetails" ], "xbrltype": "monetaryItemType" }, "ivc_UnearnedInterestNoncurrent": { "auth_ref": [], "calculation": { "http://www.invacare.com/role/ReceivablesInstallmentRecevablesDetails": { "order": 2.0, "parentTag": "ivc_UnearnedInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Unearned Interest - Noncurrent", "label": "Unearned Interest - Noncurrent", "terseLabel": "Unearned Interest - Noncurrent" } } }, "localname": "UnearnedInterestNoncurrent", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/ReceivablesInstallmentRecevablesDetails" ], "xbrltype": "monetaryItemType" }, "ivc_WeightedAverageRemainingLeaseTermsandDiscountRatesTableTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Weighted-Average Remaining Lease Terms and Discount Rates [Table Text Block]", "label": "Weighted-Average Remaining Lease Terms and Discount Rates [Table Text Block]", "terseLabel": "Weighted-Average Remaining Lease Terms and Discount Rates [Table]" } } }, "localname": "WeightedAverageRemainingLeaseTermsandDiscountRatesTableTextBlock", "nsuri": "http://www.invacare.com/20200930", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsTables" ], "xbrltype": "textBlockItemType" }, "srt_AsiaPacificMember": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Asia Pacific [Member]", "terseLabel": "Asia/Pacific" } } }, "localname": "AsiaPacificMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.invacare.com/role/BusinessSegmentsInformationbySegmentDetails", "http://www.invacare.com/role/RevenueDetails" ], "xbrltype": "domainItemType" }, "srt_ConsolidationItemsAxis": { "auth_ref": [ "r192", "r205", "r206", "r207", "r208", "r210", "r212", "r216" ], "lang": { "en-US": { "role": { "label": "Consolidation Items [Axis]", "terseLabel": "Consolidation Items [Axis]" } } }, "localname": "ConsolidationItemsAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.invacare.com/role/BusinessSegmentsInformationbySegmentDetails", "http://www.invacare.com/role/GoodwillGoodwillDetailsDetails", "http://www.invacare.com/role/ReceivablesNarrativeDetails" ], "xbrltype": "stringItemType" }, "srt_ConsolidationItemsDomain": { "auth_ref": [ "r192", "r205", "r206", "r207", "r208", "r210", "r212", "r216" ], "lang": { "en-US": { "role": { "label": "Consolidation Items [Domain]", "terseLabel": "Consolidation Items [Domain]" } } }, "localname": "ConsolidationItemsDomain", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.invacare.com/role/BusinessSegmentsInformationbySegmentDetails", "http://www.invacare.com/role/GoodwillGoodwillDetailsDetails", "http://www.invacare.com/role/ReceivablesNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_CounterpartyNameAxis": { "auth_ref": [ "r75", "r132" ], "lang": { "en-US": { "role": { "label": "Counterparty Name [Axis]", "terseLabel": "Counterparty Name [Axis]" } } }, "localname": "CounterpartyNameAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesNarrativeDetails" ], "xbrltype": "stringItemType" }, "srt_CurrencyAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Currency [Axis]", "terseLabel": "Currency [Axis]" } } }, "localname": "CurrencyAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "stringItemType" }, "srt_EuropeMember": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Europe [Member]", "terseLabel": "Europe" } } }, "localname": "EuropeMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.invacare.com/role/AccruedExpensesWarrantyScheduleDetails", "http://www.invacare.com/role/BusinessSegmentsInformationbySegmentDetails", "http://www.invacare.com/role/ChargesRelatedToRestructuringActivitiesDetails", "http://www.invacare.com/role/ChargesRelatedToRestructuringActivitiesNarrativeDetails", "http://www.invacare.com/role/RevenueDetails" ], "xbrltype": "domainItemType" }, "srt_MaximumMember": { "auth_ref": [ "r378", "r381", "r560", "r561", "r562", "r563", "r564", "r565", "r585", "r632", "r635" ], "lang": { "en-US": { "role": { "label": "Maximum [Member]", "terseLabel": "Maximum" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.invacare.com/role/DerivativesNarrativeDetails", "http://www.invacare.com/role/EquityCompensationStockOptionsOutstandingbyExercisePriceDetails", "http://www.invacare.com/role/IntangiblesNarrativeDetails", "http://www.invacare.com/role/LeasesandCommitmentsDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [ "r378", "r381", "r560", "r561", "r562", "r563", "r564", "r565", "r585", "r632", "r635" ], "lang": { "en-US": { "role": { "label": "Minimum [Member]", "terseLabel": "Minimum" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.invacare.com/role/DerivativesNarrativeDetails", "http://www.invacare.com/role/EquityCompensationStockOptionsOutstandingbyExercisePriceDetails", "http://www.invacare.com/role/IntangiblesNarrativeDetails", "http://www.invacare.com/role/LeasesandCommitmentsDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_NorthAmericaMember": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "North America [Member]", "terseLabel": "North America", "verboseLabel": "North America" } } }, "localname": "NorthAmericaMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.invacare.com/role/AccruedExpensesWarrantyScheduleDetails", "http://www.invacare.com/role/BusinessSegmentsInformationbySegmentDetails", "http://www.invacare.com/role/ChargesRelatedToRestructuringActivitiesDetails", "http://www.invacare.com/role/ChargesRelatedToRestructuringActivitiesNarrativeDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails", "http://www.invacare.com/role/RevenueDetails" ], "xbrltype": "domainItemType" }, "srt_ProductOrServiceAxis": { "auth_ref": [ "r218", "r359", "r360", "r586", "r631", "r633" ], "lang": { "en-US": { "role": { "label": "Product and Service [Axis]", "terseLabel": "Product and Service [Axis]" } } }, "localname": "ProductOrServiceAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.invacare.com/role/BusinessSegmentsInformationbySegmentDetails", "http://www.invacare.com/role/BusinessSegmentsTables", "http://www.invacare.com/role/ReceivablesNarrativeDetails", "http://www.invacare.com/role/RevenueDetails", "http://www.invacare.com/role/RevenueTables" ], "xbrltype": "stringItemType" }, "srt_ProductsAndServicesDomain": { "auth_ref": [ "r218", "r359", "r360", "r586", "r631", "r633" ], "lang": { "en-US": { "role": { "label": "Product and Service [Domain]", "terseLabel": "Product and Service [Domain]" } } }, "localname": "ProductsAndServicesDomain", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.invacare.com/role/BusinessSegmentsInformationbySegmentDetails", "http://www.invacare.com/role/BusinessSegmentsTables", "http://www.invacare.com/role/ReceivablesNarrativeDetails", "http://www.invacare.com/role/RevenueDetails", "http://www.invacare.com/role/RevenueTables" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [ "r367", "r378", "r381", "r560", "r561", "r562", "r563", "r564", "r565", "r585", "r632", "r635" ], "lang": { "en-US": { "role": { "label": "Statistical Measurement [Axis]", "terseLabel": "Range [Axis]" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.invacare.com/role/DerivativesNarrativeDetails", "http://www.invacare.com/role/EquityCompensationNarrativeDetails", "http://www.invacare.com/role/EquityCompensationPerformanceShareActivityDetails", "http://www.invacare.com/role/EquityCompensationStockOptionsOutstandingbyExercisePriceDetails", "http://www.invacare.com/role/EquityCompensationUnrecognizedCompensationExpenseDetails", "http://www.invacare.com/role/GoodwillGoodwillDetailsDetails", "http://www.invacare.com/role/IntangiblesNarrativeDetails", "http://www.invacare.com/role/LeasesandCommitmentsDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [ "r367", "r378", "r381", "r560", "r561", "r562", "r563", "r564", "r565", "r585", "r632", "r635" ], "lang": { "en-US": { "role": { "label": "Statistical Measurement [Domain]", "terseLabel": "Range [Domain]" } } }, "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.invacare.com/role/DerivativesNarrativeDetails", "http://www.invacare.com/role/EquityCompensationNarrativeDetails", "http://www.invacare.com/role/EquityCompensationPerformanceShareActivityDetails", "http://www.invacare.com/role/EquityCompensationStockOptionsOutstandingbyExercisePriceDetails", "http://www.invacare.com/role/EquityCompensationUnrecognizedCompensationExpenseDetails", "http://www.invacare.com/role/GoodwillGoodwillDetailsDetails", "http://www.invacare.com/role/IntangiblesNarrativeDetails", "http://www.invacare.com/role/LeasesandCommitmentsDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_RepurchaseAgreementCounterpartyNameDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Counterparty Name [Domain]", "terseLabel": "Counterparty Name [Domain]" } } }, "localname": "RepurchaseAgreementCounterpartyNameDomain", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_RestatementAxis": { "auth_ref": [ "r138", "r139", "r140", "r141", "r142", "r143", "r146", "r147", "r148", "r150", "r151", "r152", "r153", "r154", "r171", "r248", "r249", "r417", "r433", "r638", "r639", "r640", "r641", "r642", "r643", "r644", "r645", "r646", "r647" ], "lang": { "en-US": { "role": { "label": "Revision of Prior Period [Axis]", "terseLabel": "Restatement [Axis]" } } }, "localname": "RestatementAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofShareholdersEquityStatement" ], "xbrltype": "stringItemType" }, "srt_RestatementDomain": { "auth_ref": [ "r138", "r139", "r140", "r141", "r142", "r143", "r146", "r147", "r148", "r150", "r151", "r152", "r153", "r154", "r171", "r248", "r249", "r417", "r433", "r638", "r639", "r640", "r641", "r642", "r643", "r644", "r645", "r646", "r647" ], "lang": { "en-US": { "role": { "label": "Revision of Prior Period [Domain]", "terseLabel": "Restatement [Domain]" } } }, "localname": "RestatementDomain", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofShareholdersEquityStatement" ], "xbrltype": "domainItemType" }, "srt_ScenarioUnspecifiedDomain": { "auth_ref": [ "r379" ], "lang": { "en-US": { "role": { "label": "Scenario [Domain]", "terseLabel": "Scenario, Unspecified [Domain]" } } }, "localname": "ScenarioUnspecifiedDomain", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows", "http://www.invacare.com/role/LongTermDebtLeverageRatiosDetails" ], "xbrltype": "domainItemType" }, "srt_SegmentGeographicalDomain": { "auth_ref": [ "r219", "r220", "r359", "r361", "r634", "r653", "r654", "r655", "r656", "r657", "r658", "r659", "r660" ], "lang": { "en-US": { "role": { "label": "Geographical [Domain]", "terseLabel": "Geographical [Domain]" } } }, "localname": "SegmentGeographicalDomain", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_StatementGeographicalAxis": { "auth_ref": [ "r219", "r220", "r359", "r361", "r634", "r649", "r653", "r654", "r655", "r656", "r657", "r658", "r659", "r660", "r661" ], "lang": { "en-US": { "role": { "label": "Geographical [Axis]", "terseLabel": "Geographical [Axis]" } } }, "localname": "StatementGeographicalAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesNarrativeDetails" ], "xbrltype": "stringItemType" }, "srt_StatementScenarioAxis": { "auth_ref": [ "r324", "r379", "r553" ], "lang": { "en-US": { "role": { "label": "Scenario [Axis]", "terseLabel": "Scenario [Axis]" } } }, "localname": "StatementScenarioAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows", "http://www.invacare.com/role/LongTermDebtLeverageRatiosDetails" ], "xbrltype": "stringItemType" }, "srt_WeightedAverageMember": { "auth_ref": [ "r560", "r562", "r565" ], "lang": { "en-US": { "role": { "label": "Weighted Average [Member]", "terseLabel": "Weighted Average" } } }, "localname": "WeightedAverageMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationNarrativeDetails", "http://www.invacare.com/role/IntangiblesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AOCIAttributableToParentNetOfTaxRollForward": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "AOCI Attributable to Parent, Net of Tax [Roll Forward]", "terseLabel": "Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]" } } }, "localname": "AOCIAttributableToParentNetOfTaxRollForward", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/AccumulatedOtherComprehensiveIncomeLossbyComponentChangesinAccumulatedOtherComprehensiveIncomeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Accounting Policies [Abstract]", "terseLabel": "Accounting Policies [Abstract]" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_AccountsNotesAndLoansReceivableLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Accounts, Notes, Loans and Financing Receivable [Line Items]", "terseLabel": "Accounts, Notes, Loans and Financing Receivable [Line Items]" } } }, "localname": "AccountsNotesAndLoansReceivableLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis": { "auth_ref": [ "r67" ], "lang": { "en-US": { "role": { "documentation": "Information by type of receivable.", "label": "Receivable Type [Axis]", "terseLabel": "Receivable Type [Axis]" } } }, "localname": "AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AccountsNotesLoansAndFinancingReceivablesByBillingStatusTypeAxis": { "auth_ref": [ "r67" ], "lang": { "en-US": { "role": { "documentation": "Information by billing status of receivables.", "label": "Billing Status, Type [Axis]", "terseLabel": "Billing Status, Type [Axis]" } } }, "localname": "AccountsNotesLoansAndFinancingReceivablesByBillingStatusTypeAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AccountsNotesLoansAndFinancingReceivablesByIndustryOfCounterpartyTypeAxis": { "auth_ref": [ "r67" ], "lang": { "en-US": { "role": { "documentation": "Information by industry of counterparty. A counterparty is the other party that participates in a financial transaction.", "label": "Industry of Counterparty, Type [Axis]", "terseLabel": "Industry of Counterparty, Type [Axis]" } } }, "localname": "AccountsNotesLoansAndFinancingReceivablesByIndustryOfCounterpartyTypeAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AccountsNotesLoansAndFinancingReceivablesByLegalEntityOfCounterpartyTypeAxis": { "auth_ref": [ "r67" ], "lang": { "en-US": { "role": { "documentation": "Information by legal entity of counterparty. A counterparty is the other party that participates in a financial transaction.", "label": "Legal Entity of Counterparty, Type [Axis]", "terseLabel": "Legal Entity of Counterparty, Type [Axis]" } } }, "localname": "AccountsNotesLoansAndFinancingReceivablesByLegalEntityOfCounterpartyTypeAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as current at the end of the reporting period.", "label": "Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block]", "terseLabel": "Accrued Expenses" } } }, "localname": "AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/AccruedExpenses" ], "xbrltype": "textBlockItemType" }, "us-gaap_AccountsPayableAndAccruedLiabilitiesMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Primary financial statement caption encompassing accounts payable and accrued liabilities.", "label": "Accounts Payable and Accrued Liabilities [Member]", "terseLabel": "Accrued Expenses" } } }, "localname": "AccountsPayableAndAccruedLiabilitiesMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/FairValuesDetailsofBookValueandFairValueofFinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccountsPayableCurrent": { "auth_ref": [ "r53" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts Payable, Current", "terseLabel": "Accounts payable" } } }, "localname": "AccountsPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableGross": { "auth_ref": [ "r224" ], "calculation": { "http://www.invacare.com/role/ReceivablesScheduleofAccountsReceivableDetails": { "order": 1.0, "parentTag": "us-gaap_AccountsReceivableNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount, before allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business.", "label": "Accounts Receivable, before Allowance for Credit Loss", "terseLabel": "Accounts receivable, gross" } } }, "localname": "AccountsReceivableGross", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesScheduleofAccountsReceivableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableNet": { "auth_ref": [ "r33", "r613" ], "calculation": { "http://www.invacare.com/role/ReceivablesScheduleofAccountsReceivableDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business.", "label": "Accounts Receivable, after Allowance for Credit Loss", "totalLabel": "Accounts Receivable, Net" } } }, "localname": "AccountsReceivableNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesScheduleofAccountsReceivableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableNetCurrent": { "auth_ref": [ "r10", "r33", "r224", "r225" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.", "label": "Accounts Receivable, after Allowance for Credit Loss, Current", "terseLabel": "Trade receivables, net" } } }, "localname": "AccountsReceivableNetCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccretionExpense": { "auth_ref": [ "r308", "r309" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount recognized for the passage of time, typically for liabilities, that have been discounted to their net present values. Excludes accretion associated with asset retirement obligations.", "label": "Accretion Expense", "terseLabel": "Accretion Expense" } } }, "localname": "AccretionExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LongTermDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent": { "auth_ref": [ "r19", "r56", "r420" ], "calculation": { "http://www.invacare.com/role/AccruedExpensesComponentsofAccruedExpensesDetails": { "order": 2.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for real and property taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrual for Taxes Other than Income Taxes, Current", "terseLabel": "Taxes other than income taxes, primarily Value Added Taxes" } } }, "localname": "AccrualForTaxesOtherThanIncomeTaxesCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/AccruedExpensesComponentsofAccruedExpensesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedInsuranceCurrent": { "auth_ref": [ "r18", "r19", "r56" ], "calculation": { "http://www.invacare.com/role/AccruedExpensesComponentsofAccruedExpensesDetails": { "order": 10.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable to insurance entities to mitigate potential loss from various risks or to satisfy a promise to provide certain coverage's to employees. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued Insurance, Current", "terseLabel": "Insurance" } } }, "localname": "AccruedInsuranceCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/AccruedExpensesComponentsofAccruedExpensesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedLiabilitiesCurrent": { "auth_ref": [ "r56" ], "calculation": { "http://www.invacare.com/role/AccruedExpensesComponentsofAccruedExpensesDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued Liabilities, Current", "terseLabel": "Accrued expenses", "totalLabel": "Accrued expenses" } } }, "localname": "AccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/AccruedExpensesComponentsofAccruedExpensesDetails", "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedLiabilitiesMember": { "auth_ref": [ "r56" ], "lang": { "en-US": { "role": { "documentation": "This item represents obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered.", "label": "Accrued Liabilities [Member]", "terseLabel": "Accrued Expenses" } } }, "localname": "AccruedLiabilitiesMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/DerivativesBalanceSheetLocationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccruedMarketingCostsCurrent": { "auth_ref": [], "calculation": { "http://www.invacare.com/role/AccruedExpensesComponentsofAccruedExpensesDetails": { "order": 5.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for the marketing, trade and selling of the entity's goods and services. Marketing costs would include expenditures for planning and executing the conception, pricing, promotion, and distribution of ideas, goods, and services; costs of public relations and corporate promotions; and obligations incurred and payable for sales discounts, rebates, price protection programs, etc. offered to customers and under government programs. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued Marketing Costs, Current", "terseLabel": "Rebates" } } }, "localname": "AccruedMarketingCostsCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/AccruedExpensesComponentsofAccruedExpensesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedProfessionalFeesCurrent": { "auth_ref": [ "r18", "r19", "r56" ], "calculation": { "http://www.invacare.com/role/AccruedExpensesComponentsofAccruedExpensesDetails": { "order": 8.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued Professional Fees, Current", "terseLabel": "Professional" } } }, "localname": "AccruedProfessionalFeesCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/AccruedExpensesComponentsofAccruedExpensesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedRentCurrent": { "auth_ref": [ "r18", "r19", "r56" ], "calculation": { "http://www.invacare.com/role/AccruedExpensesComponentsofAccruedExpensesDetails": { "order": 13.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for contractual rent under lease arrangements. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued Rent, Current", "terseLabel": "Rent" } } }, "localname": "AccruedRentCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/AccruedExpensesComponentsofAccruedExpensesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedSalariesCurrent": { "auth_ref": [ "r18", "r19", "r56" ], "calculation": { "http://www.invacare.com/role/AccruedExpensesComponentsofAccruedExpensesDetails": { "order": 1.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Carrying value as of the balance sheet date of the obligations incurred through that date and payable for employees' services provided. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued Salaries, Current", "terseLabel": "Salaries and wages" } } }, "localname": "AccruedSalariesCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/AccruedExpensesComponentsofAccruedExpensesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember": { "auth_ref": [ "r80", "r85", "r88", "r458" ], "lang": { "en-US": { "role": { "documentation": "Accumulated other comprehensive (income) loss related to defined benefit plans attributable to the parent.", "label": "Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]", "terseLabel": "Accumulated Defined Benefit Plans Adjustment [Member]" } } }, "localname": "AccumulatedDefinedBenefitPlansAdjustmentMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/AccumulatedOtherComprehensiveIncomeLossbyComponentChangesinAccumulatedOtherComprehensiveIncomeDetails", "http://www.invacare.com/role/AccumulatedOtherComprehensiveIncomeLossbyComponentReclassifiedOutofAccumulatedOtherComprehensiveIncomeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": { "auth_ref": [ "r51", "r301" ], "calculation": { "http://www.invacare.com/role/PropertyAndEquipmentDetails": { "order": 2.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.", "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment", "negatedTerseLabel": "Less allowance for depreciation" } } }, "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/PropertyAndEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember": { "auth_ref": [ "r79", "r85", "r88", "r457" ], "lang": { "en-US": { "role": { "documentation": "Accumulated other comprehensive income (loss) resulting from gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges, attributable to the parent.", "label": "Accumulated Net Gain (Loss) from Cash Flow Hedges Attributable to Parent [Member]", "terseLabel": "Accumulated Net Gain (Loss) from Designated or Qualifying Cash Flow Hedges [Member]" } } }, "localname": "AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/AccumulatedOtherComprehensiveIncomeLossbyComponentChangesinAccumulatedOtherComprehensiveIncomeDetails", "http://www.invacare.com/role/AccumulatedOtherComprehensiveIncomeLossbyComponentReclassifiedOutofAccumulatedOtherComprehensiveIncomeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]", "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Line Items]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/AccumulatedOtherComprehensiveIncomeLossbyComponentChangesinAccumulatedOtherComprehensiveIncomeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": { "auth_ref": [ "r36", "r82", "r84", "r85", "r619", "r643", "r647" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.", "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax", "periodEndLabel": "Ending Balance", "periodStartLabel": "Beginning Balance", "terseLabel": "Accumulated other comprehensive income" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/AccumulatedOtherComprehensiveIncomeLossbyComponentChangesinAccumulatedOtherComprehensiveIncomeDetails", "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": { "auth_ref": [ "r513", "r514", "r515", "r516", "r517", "r519" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss).", "label": "Accumulated Other Comprehensive Income (Loss) [Table]", "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Table]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/AccumulatedOtherComprehensiveIncomeLossbyComponentChangesinAccumulatedOtherComprehensiveIncomeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "auth_ref": [ "r81", "r85", "r88", "r138", "r139", "r141", "r458", "r638", "r639" ], "lang": { "en-US": { "role": { "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.", "label": "AOCI Attributable to Parent [Member]", "terseLabel": "AOCI Attributable to Parent [Member]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofShareholdersEquityStatement" ], "xbrltype": "domainItemType" }, "us-gaap_AccumulatedTranslationAdjustmentMember": { "auth_ref": [ "r78", "r85", "r88", "r458", "r514", "r515", "r516", "r517", "r519" ], "lang": { "en-US": { "role": { "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to the parent.", "label": "Accumulated Foreign Currency Adjustment Attributable to Parent [Member]", "terseLabel": "Accumulated Translation Adjustment [Member]" } } }, "localname": "AccumulatedTranslationAdjustmentMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/AccumulatedOtherComprehensiveIncomeLossbyComponentChangesinAccumulatedOtherComprehensiveIncomeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AdditionalPaidInCapital": { "auth_ref": [ "r34", "r417" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.", "label": "Additional Paid in Capital", "terseLabel": "Additional paid-in-capital" } } }, "localname": "AdditionalPaidInCapital", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r138", "r139", "r141", "r414", "r415", "r416" ], "lang": { "en-US": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]", "terseLabel": "Additional Paid-in Capital [Member]" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofShareholdersEquityStatement" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsForChangeInAccountingPrincipleAxis": { "auth_ref": [ "r142", "r143", "r144", "r145" ], "lang": { "en-US": { "role": { "documentation": "Information by type of change in accounting principle. Excludes change from amendment to accounting standards.", "label": "Change in Accounting Principle, Type [Axis]", "terseLabel": "Adjustments for Change in Accounting Principle [Axis]" } } }, "localname": "AdjustmentsForChangeInAccountingPrincipleAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofShareholdersEquityStatement" ], "xbrltype": "stringItemType" }, "us-gaap_AdjustmentsForErrorCorrectionDomain": { "auth_ref": [ "r140", "r146", "r147", "r150", "r151", "r153", "r154" ], "lang": { "en-US": { "role": { "documentation": "Type of error correction.", "label": "Error Correction, Type [Domain]", "terseLabel": "Adjustments for Error Correction [Domain]" } } }, "localname": "AdjustmentsForErrorCorrectionDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofShareholdersEquityStatement" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsForNewAccountingPronouncementsAxis": { "auth_ref": [ "r142", "r143", "r144", "r145", "r244", "r245", "r246", "r247", "r248", "r249", "r410", "r411", "r412", "r413", "r414", "r415", "r416", "r417", "r430", "r431", "r432", "r433", "r588", "r589", "r590", "r636", "r637", "r638", "r639", "r640", "r641", "r642", "r643", "r644", "r645", "r646", "r647" ], "lang": { "en-US": { "role": { "documentation": "Information by amendment to accounting standards.", "label": "Accounting Standards Update [Axis]", "terseLabel": "Adjustments for New Accounting Pronouncements [Axis]" } } }, "localname": "AdjustmentsForNewAccountingPronouncementsAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofShareholdersEquityStatement" ], "xbrltype": "stringItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for option under share-based payment arrangement.", "label": "APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition", "terseLabel": "Adjustments to Additional Paid in Capital, Share-based Compensation, Stock Options, Requisite Service Period Recognition" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofShareholdersEquityStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Adjustments to reconcile net loss to net cash used by operating activities:" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_AllOtherSegmentsMember": { "auth_ref": [ "r188", "r205", "r206", "r207", "r208", "r210" ], "lang": { "en-US": { "role": { "documentation": "Operating segments classified as other. Excludes intersegment elimination and reconciling items.", "label": "Other Segments [Member]", "terseLabel": "All Other" } } }, "localname": "AllOtherSegmentsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/BusinessSegmentsInformationbySegmentDetails", "http://www.invacare.com/role/ChargesRelatedToRestructuringActivitiesDetails", "http://www.invacare.com/role/ChargesRelatedToRestructuringActivitiesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AllocatedShareBasedCompensationExpense": { "auth_ref": [ "r383", "r407", "r418" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.", "label": "Share-based Payment Arrangement, Expense", "terseLabel": "Allocated Share-based Compensation Expense" } } }, "localname": "AllocatedShareBasedCompensationExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofShareholdersEquityStatement", "http://www.invacare.com/role/EquityCompensationSharebasedCompensationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock": { "auth_ref": [ "r228", "r256" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of allowance for credit loss on financing receivable.", "label": "Financing Receivable, Allowance for Credit Loss [Table Text Block]", "terseLabel": "Schedule of Installment Receivables Allowance for Doubtful Accounts" } } }, "localname": "AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_AllowanceForDoubtfulAccountsReceivable": { "auth_ref": [ "r235", "r250", "r252", "r255" ], "calculation": { "http://www.invacare.com/role/ReceivablesScheduleofAccountsReceivableDetails": { "order": 4.0, "parentTag": "us-gaap_AccountsReceivableNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of allowance for credit loss on accounts receivable.", "label": "Accounts Receivable, Allowance for Credit Loss", "negatedTerseLabel": "Allowance for doubtful accounts" } } }, "localname": "AllowanceForDoubtfulAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesScheduleofAccountsReceivableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllowanceForLoanAndLeaseLossesAdjustmentsNet": { "auth_ref": [ "r233" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of other addition (reduction) in allowance reserve for credit loss.", "label": "Allowance for Loan and Lease Losses, Adjustments, Other", "terseLabel": "Current period provision" } } }, "localname": "AllowanceForLoanAndLeaseLossesAdjustmentsNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesRollforwardofAllowanceforDoubtfulAccountsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllowanceForNotesAndLoansReceivableCurrent": { "auth_ref": [ "r40", "r235", "r250" ], "calculation": { "http://www.invacare.com/role/ReceivablesInstallmentRecevablesDetails": { "order": 2.0, "parentTag": "us-gaap_NotesAndLoansReceivableNetCurrent", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of allowance for credit loss on financing receivable, classified as current.", "label": "Financing Receivable, Allowance for Credit Loss, Current", "negatedLabel": "Allowance for doubtful accounts, current" } } }, "localname": "AllowanceForNotesAndLoansReceivableCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesInstallmentRecevablesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllowanceForNotesAndLoansReceivableNoncurrent": { "auth_ref": [ "r40", "r235", "r250" ], "calculation": { "http://www.invacare.com/role/ReceivablesInstallmentRecevablesDetails": { "order": 2.0, "parentTag": "us-gaap_NotesAndLoansReceivableNetNoncurrent", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of allowance for credit loss on financing receivable, classified as noncurrent.", "label": "Financing Receivable, Allowance for Credit Loss, Noncurrent", "negatedLabel": "Allowance for doubtful accounts, long-term" } } }, "localname": "AllowanceForNotesAndLoansReceivableNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesInstallmentRecevablesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfDebtDiscountPremium": { "auth_ref": [ "r109", "r125", "r521" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.", "label": "Amortization of Debt Discount (Premium)", "terseLabel": "Amortization of convertible debt discount" } } }, "localname": "AmortizationOfDebtDiscountPremium", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfFinancingCosts": { "auth_ref": [ "r104", "r125", "r523" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of amortization expense attributable to debt issuance costs.", "label": "Amortization of Debt Issuance Costs", "terseLabel": "Amortization of debt fees" } } }, "localname": "AmortizationOfFinancingCosts", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfIntangibleAssets": { "auth_ref": [ "r125", "r286", "r293" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.", "label": "Amortization of Intangible Assets", "terseLabel": "Amortization expense" } } }, "localname": "AmortizationOfIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/IntangiblesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "auth_ref": [ "r168" ], "lang": { "en-US": { "role": { "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount", "terseLabel": "Antidilutive securities excluded from computation of earnings per share, amount" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/NetEarningsLossPerCommonShareTextualsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": { "auth_ref": [ "r168" ], "lang": { "en-US": { "role": { "documentation": "Information by type of antidilutive security.", "label": "Antidilutive Securities [Axis]", "terseLabel": "Antidilutive Securities [Axis]" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/NetEarningsLossPerCommonShareTextualsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]", "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/NetEarningsLossPerCommonShareTextualsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AntidilutiveSecuritiesNameDomain": { "auth_ref": [ "r168" ], "lang": { "en-US": { "role": { "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.", "label": "Antidilutive Securities, Name [Domain]", "terseLabel": "Antidilutive Securities, Name [Domain]" } } }, "localname": "AntidilutiveSecuritiesNameDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/NetEarningsLossPerCommonShareTextualsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ArrangementsAndNonarrangementTransactionsMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]", "terseLabel": "Arrangements and Non-arrangement Transactions [Domain]" } } }, "localname": "ArrangementsAndNonarrangementTransactionsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/RevenueDetails", "http://www.invacare.com/role/RevenueTables" ], "xbrltype": "domainItemType" }, "us-gaap_Assets": { "auth_ref": [ "r130", "r200", "r207", "r214", "r243", "r454", "r460", "r511", "r595", "r615" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "totalLabel": "Total Assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Assets [Abstract]", "terseLabel": "Assets" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r14", "r16", "r70", "r130", "r243", "r454", "r460", "r511" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Current", "totalLabel": "Total Current Assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Assets, Current [Abstract]", "terseLabel": "Current Assets" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation": { "auth_ref": [ "r0", "r1", "r4", "r5", "r6", "r305" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount classified as assets attributable to disposal group held for sale or disposed of.", "label": "Disposal Group, Including Discontinued Operation, Assets", "terseLabel": "ERROR in label resolution." } } }, "localname": "AssetsOfDisposalGroupIncludingDiscontinuedOperation", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/DivestedBusinessesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AwardDateAxis": { "auth_ref": [ "r384", "r409" ], "lang": { "en-US": { "role": { "documentation": "Information by date or year award under share-based payment arrangement is granted.", "label": "Award Date [Axis]", "terseLabel": "Award Date [Axis]" } } }, "localname": "AwardDateAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationPerformanceShareActivityDetails", "http://www.invacare.com/role/EquityCompensationUnrecognizedCompensationExpenseDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AwardDateDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Date or year award under share-based payment arrangement is granted.", "label": "Award Date [Domain]", "terseLabel": "Award Date [Domain]" } } }, "localname": "AwardDateDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationPerformanceShareActivityDetails", "http://www.invacare.com/role/EquityCompensationUnrecognizedCompensationExpenseDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AwardTypeAxis": { "auth_ref": [ "r384", "r409" ], "lang": { "en-US": { "role": { "documentation": "Information by type of award under share-based payment arrangement.", "label": "Award Type [Axis]", "terseLabel": "Award Type [Axis]" } } }, "localname": "AwardTypeAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationNarrativeDetails", "http://www.invacare.com/role/EquityCompensationOptionsActivityDetails", "http://www.invacare.com/role/EquityCompensationPerformanceShareActivityDetails", "http://www.invacare.com/role/EquityCompensationRestrictedStockActivityDetails", "http://www.invacare.com/role/EquityCompensationSharebasedCompensationExpenseDetails", "http://www.invacare.com/role/EquityCompensationStockOptionsOutstandingbyExercisePriceDetails", "http://www.invacare.com/role/EquityCompensationUnrecognizedCompensationExpenseDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BalanceSheetLocationAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Information by location on balance sheet (statement of financial position).", "label": "Balance Sheet Location [Axis]", "terseLabel": "Balance Sheet Location [Axis]" } } }, "localname": "BalanceSheetLocationAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/DerivativesBalanceSheetLocationDetails", "http://www.invacare.com/role/EquityCompensationSharebasedCompensationExpenseDetails", "http://www.invacare.com/role/FairValuesDetailsofBookValueandFairValueofFinancialInstrumentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BalanceSheetLocationDomain": { "auth_ref": [ "r471", "r476" ], "lang": { "en-US": { "role": { "documentation": "Location in the balance sheet (statement of financial position).", "label": "Balance Sheet Location [Domain]", "terseLabel": "Balance Sheet Location [Domain]" } } }, "localname": "BalanceSheetLocationDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/DerivativesBalanceSheetLocationDetails", "http://www.invacare.com/role/EquityCompensationSharebasedCompensationExpenseDetails", "http://www.invacare.com/role/FairValuesDetailsofBookValueandFairValueofFinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BaseRateMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Minimum rate investor will accept.", "label": "Base Rate [Member]", "terseLabel": "Base Rate" } } }, "localname": "BaseRateMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CapitalLeaseObligations": { "auth_ref": [ "r27", "r529", "r618" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount equal to the present value (the principal) at the beginning of the lease term of minimum lease payments during the lease term (excluding that portion of the payments representing executory costs such as insurance, maintenance, and taxes to be paid by the lessor, together with any profit thereon) net of payments or other amounts applied to the principal through the balance sheet date.", "label": "Capital Lease Obligations", "terseLabel": "Capital Lease Obligations" } } }, "localname": "CapitalLeaseObligations", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CarryingReportedAmountFairValueDisclosureMember": { "auth_ref": [ "r507", "r508" ], "lang": { "en-US": { "role": { "documentation": "Measured as reported on the statement of financial position (balance sheet).", "label": "Reported Value Measurement [Member]", "terseLabel": "Carrying Value" } } }, "localname": "CarryingReportedAmountFairValueDisclosureMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/FairValuesDetailsofBookValueandFairValueofFinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r8", "r48", "r127" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash and Cash Equivalents, at Carrying Value", "periodEndLabel": "Cash and cash equivalents at end of period", "periodStartLabel": "Cash and cash equivalents at beginning of year", "terseLabel": "Cash and cash equivalents" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets", "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows", "http://www.invacare.com/role/FairValuesDetailsofBookValueandFairValueofFinancialInstrumentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsFairValueDisclosure": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash and Cash Equivalents, Fair Value Disclosure", "terseLabel": "Cash and cash equivalents" } } }, "localname": "CashAndCashEquivalentsFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/FairValuesDetailsofBookValueandFairValueofFinancialInstrumentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "auth_ref": [ "r122", "r512" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "totalLabel": "Cash, Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashFlowHedgingMember": { "auth_ref": [ "r468" ], "lang": { "en-US": { "role": { "documentation": "Hedge of the exposure to variability in the cash flows of a recognized asset or liability, or of a forecasted transaction, that is attributable to a particular risk.", "label": "Cash Flow Hedging [Member]", "terseLabel": "Cash Flow Hedging [Member]" } } }, "localname": "CashFlowHedgingMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/DerivativesGainLossinStatementofFinacialPositionDetails", "http://www.invacare.com/role/DerivativesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CashSurrenderValueOfLifeInsurance": { "auth_ref": [ "r17", "r52" ], "calculation": { "http://www.invacare.com/role/OtherLongTermAssetsComponentsofOtherLongTermAssetsDetails": { "order": 1.0, "parentTag": "us-gaap_OtherAssetsNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Carrying amount as of the balance sheet date of amounts which could be received based on the terms of the insurance contract upon surrendering life policies owned by the entity.", "label": "Cash Surrender Value of Life Insurance", "terseLabel": "Cash surrender value of life insurance policies" } } }, "localname": "CashSurrenderValueOfLifeInsurance", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/OtherLongTermAssetsComponentsofOtherLongTermAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ChangeInAccountingPrincipleMember": { "auth_ref": [ "r142", "r143", "r144", "r145" ], "lang": { "en-US": { "role": { "documentation": "Change in accounting principle. Excludes change from amendment to accounting standards.", "label": "Change in Accounting Principle, Type [Domain]", "terseLabel": "Adjustments for Change in Accounting Principle [Domain]" } } }, "localname": "ChangeInAccountingPrincipleMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofShareholdersEquityStatement" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfFinancingReceivableTypeOfBorrowerAxis": { "auth_ref": [ "r263" ], "lang": { "en-US": { "role": { "documentation": "Information by type of borrower determined on the basis of initial measurement attribute, risk characteristics and method of monitoring and assessing credit risk.", "label": "Type of Borrower [Axis]", "terseLabel": "Class of Financing Receivable, Type of Borrower [Axis]" } } }, "localname": "ClassOfFinancingReceivableTypeOfBorrowerAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesNarrativeDetails", "http://www.invacare.com/role/ReceivablesScheduleforAllowanceforCreditLossesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfFinancingReceivableTypeOfBorrowerDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Category of entity or individual who borrows funds.", "label": "Class of Financing Receivable, Type of Borrower [Domain]", "terseLabel": "Class of Financing Receivable, Type of Borrower [Domain]" } } }, "localname": "ClassOfFinancingReceivableTypeOfBorrowerDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesNarrativeDetails", "http://www.invacare.com/role/ReceivablesScheduleforAllowanceforCreditLossesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [ "r129", "r130", "r158", "r162", "r163", "r165", "r167", "r175", "r176", "r177", "r243", "r511" ], "lang": { "en-US": { "role": { "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.", "label": "Class of Stock [Domain]", "terseLabel": "Class of Stock [Domain]" } } }, "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets", "http://www.invacare.com/role/CondensedConsolidatedBalanceSheetsParentheticals", "http://www.invacare.com/role/CondensedConsolidatedStatementofShareholdersEquityStatement", "http://www.invacare.com/role/DEIDocument", "http://www.invacare.com/role/EquityCompensationNarrativeDetails", "http://www.invacare.com/role/EquityCompensationPerformanceShareActivityDetails", "http://www.invacare.com/role/EquityCompensationUnrecognizedCompensationExpenseDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": { "auth_ref": [ "r351" ], "lang": { "en-US": { "role": { "documentation": "Exercise price per share or per unit of warrants or rights outstanding.", "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights", "terseLabel": "Derivative, Price Risk Option Strike Price" } } }, "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_CollateralAxis": { "auth_ref": [ "r266" ], "lang": { "en-US": { "role": { "documentation": "Information by category of collateral or no collateral, from lender's perspective.", "label": "Collateral Held [Axis]", "terseLabel": "Collateral [Axis]" } } }, "localname": "CollateralAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesNarrativeDetails", "http://www.invacare.com/role/ReceivablesScheduleforAllowanceforCreditLossesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CollateralDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Category of collateral or no collateral, from lender's perspective.", "label": "Collateral Held [Domain]", "terseLabel": "Collateral [Domain]" } } }, "localname": "CollateralDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesNarrativeDetails", "http://www.invacare.com/role/ReceivablesScheduleforAllowanceforCreditLossesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]", "terseLabel": "Commitments and Contingencies Disclosure [Abstract]" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_CommonClassBMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Classification of common stock that has different rights than Common Class A, representing ownership interest in a corporation.", "label": "Common Class B [Member]", "terseLabel": "Class B Common Shares [Member]", "verboseLabel": "Class B Common Shares [Member]" } } }, "localname": "CommonClassBMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets", "http://www.invacare.com/role/CondensedConsolidatedBalanceSheetsParentheticals", "http://www.invacare.com/role/CondensedConsolidatedStatementofShareholdersEquityStatement", "http://www.invacare.com/role/DEIDocument", "http://www.invacare.com/role/EquityCompensationNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockDividendsPerShareDeclared": { "auth_ref": [ "r356" ], "lang": { "en-US": { "role": { "documentation": "Aggregate dividends declared during the period for each share of common stock outstanding.", "label": "Common Stock, Dividends, Per Share, Declared", "terseLabel": "Dividends Declared per Common Share" } } }, "localname": "CommonStockDividendsPerShareDeclared", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r138", "r139" ], "lang": { "en-US": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]", "terseLabel": "Common Stock [Member]", "verboseLabel": "Common Shares [Member]" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets", "http://www.invacare.com/role/CondensedConsolidatedBalanceSheetsParentheticals", "http://www.invacare.com/role/CondensedConsolidatedStatementofShareholdersEquityStatement", "http://www.invacare.com/role/DEIDocument", "http://www.invacare.com/role/EquityCompensationNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r31" ], "lang": { "en-US": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common Stock, Par or Stated Value Per Share", "terseLabel": "Common Stock, Par or Stated Value Per Share" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationNarrativeDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r31" ], "lang": { "en-US": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common Stock, Shares Authorized", "terseLabel": "Common Stock, Shares Authorized" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedBalanceSheetsParentheticals" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r31" ], "lang": { "en-US": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common Stock, Shares, Issued", "terseLabel": "Common Stock, Shares, Issued" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedBalanceSheetsParentheticals" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r31", "r350" ], "lang": { "en-US": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common Stock, Shares, Outstanding", "terseLabel": "Common Stock, Shares, Issued" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValueOutstanding": { "auth_ref": [ "r31" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Value of all classes of common stock held by shareholders. May be all or portion of the number of common shares authorized. These shares exclude common shares repurchased by the entity and held as treasury shares.", "label": "Common Stock, Value, Outstanding", "terseLabel": "Common Shares" } } }, "localname": "CommonStockValueOutstanding", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomeNetOfTax": { "auth_ref": [ "r91", "r93", "r94", "r101", "r606", "r627" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent", "terseLabel": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent", "totalLabel": "Comprehensive Income (Loss)" } } }, "localname": "ComprehensiveIncomeNetOfTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss", "http://www.invacare.com/role/CondensedConsolidatedStatementofShareholdersEquityStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomeNoteTextBlock": { "auth_ref": [ "r100", "r110", "r605", "r626" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.", "label": "Comprehensive Income (Loss) Note [Text Block]", "terseLabel": "Accumulated Other Comprehensive Income (Loss) by Component" } } }, "localname": "ComprehensiveIncomeNoteTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/AccumulatedOtherComprehensiveIncomeLossbyComponent" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConcentrationRiskBenchmarkDomain": { "auth_ref": [ "r182", "r183", "r222", "r509", "r510" ], "lang": { "en-US": { "role": { "documentation": "The denominator in a calculation of a disclosed concentration risk percentage.", "label": "Concentration Risk Benchmark [Domain]", "terseLabel": "Concentration Risk Benchmark [Domain]" } } }, "localname": "ConcentrationRiskBenchmarkDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ConcentrationRiskByBenchmarkAxis": { "auth_ref": [ "r182", "r183", "r222", "r509", "r510", "r648" ], "lang": { "en-US": { "role": { "documentation": "Information by benchmark of concentration risk.", "label": "Concentration Risk Benchmark [Axis]", "terseLabel": "Concentration Risk Benchmark [Axis]" } } }, "localname": "ConcentrationRiskByBenchmarkAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskByTypeAxis": { "auth_ref": [ "r182", "r183", "r222", "r509", "r510", "r648" ], "lang": { "en-US": { "role": { "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.", "label": "Concentration Risk Type [Axis]", "terseLabel": "Concentration Risk Type [Axis]" } } }, "localname": "ConcentrationRiskByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskDisclosureTextBlock": { "auth_ref": [ "r187" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date.", "label": "Concentration Risk Disclosure [Text Block]", "terseLabel": "Concentration Of Credit Risk" } } }, "localname": "ConcentrationRiskDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/ConcentrationOfCreditRisk" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConcentrationRiskTypeDomain": { "auth_ref": [ "r182", "r183", "r222", "r509", "r510" ], "lang": { "en-US": { "role": { "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration.", "label": "Concentration Risk Type [Domain]", "terseLabel": "Concentration Risk Type [Domain]" } } }, "localname": "ConcentrationRiskTypeDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ConsolidationPolicyTextBlock": { "auth_ref": [ "r128", "r456" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.", "label": "Consolidation, Policy [Policy Text Block]", "terseLabel": "Principles of Consolidation" } } }, "localname": "ConsolidationPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/AccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ContractTerminationMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Termination of a contract associated with exit from or disposal of business activities or restructurings pursuant to a plan.", "label": "Contract Termination [Member]", "terseLabel": "Contract Termination" } } }, "localname": "ContractTerminationMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/BusinessSegmentsInformationbySegmentDetails", "http://www.invacare.com/role/ChargesRelatedToRestructuringActivitiesDetails", "http://www.invacare.com/role/ChargesRelatedToRestructuringActivitiesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion": { "auth_ref": [ "r29", "r30", "r351", "r352" ], "lang": { "en-US": { "role": { "documentation": "Number of shares issued for each share of convertible preferred stock that is converted.", "label": "Convertible Preferred Stock, Shares Issued upon Conversion", "terseLabel": "Convertible Preferred Stock, Shares Issued upon Conversion" } } }, "localname": "ConvertiblePreferredStockSharesIssuedUponConversion", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ConvertibleSubordinatedDebtMember": { "auth_ref": [ "r344" ], "lang": { "en-US": { "role": { "documentation": "Debt that places a lender in a lien position behind debt having a higher priority of repayment in liquidation of the entity's assets which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.", "label": "Convertible Subordinated Debt [Member]", "terseLabel": "Convertible Subordinated Debt" } } }, "localname": "ConvertibleSubordinatedDebtMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/DerivativesFairValueofConvertibleDebtHedgesDetails", "http://www.invacare.com/role/DerivativesNarrativeDetails", "http://www.invacare.com/role/FairValuesAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.invacare.com/role/LongTermDebtComponentsofConvertibleDebtDetails", "http://www.invacare.com/role/LongTermDebtDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CostMethodInvestmentsFairValueDisclosure": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Fair value portion of investments accounted under the cost method.", "label": "Cost Method Investments, Fair Value Disclosure", "terseLabel": "Other investments" } } }, "localname": "CostMethodInvestmentsFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/FairValuesDetailsofBookValueandFairValueofFinancialInstrumentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostOfRevenue": { "auth_ref": [ "r107", "r130", "r243", "r511" ], "calculation": { "http://www.invacare.com/role/AccumulatedOtherComprehensiveIncomeLossbyComponentReclassifiedOutofAccumulatedOtherComprehensiveIncomeDetails": { "order": 2.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "weight": -1.0 }, "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss": { "order": 2.0, "parentTag": "us-gaap_GrossProfit", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period.", "label": "Cost of Revenue", "negatedLabel": "Cost of Products Sold", "terseLabel": "Cost of products sold" } } }, "localname": "CostOfRevenue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/AccumulatedOtherComprehensiveIncomeLossbyComponentReclassifiedOutofAccumulatedOtherComprehensiveIncomeDetails", "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostOfSalesMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Primary financial statement caption encompassing cost of sales.", "label": "Cost of Sales [Member]", "terseLabel": "Cost of Sales [Member]" } } }, "localname": "CostOfSalesMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/DerivativesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CreditFacilityAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.", "label": "Credit Facility [Axis]", "terseLabel": "Credit Facility [Axis]" } } }, "localname": "CreditFacilityAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LongTermDebtDetails", "http://www.invacare.com/role/LongTermDebtLeverageRatiosDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CreditFacilityDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.", "label": "Credit Facility [Domain]", "terseLabel": "Credit Facility [Domain]" } } }, "localname": "CreditFacilityDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LongTermDebtDetails", "http://www.invacare.com/role/LongTermDebtLeverageRatiosDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CreditLossStatusAxis": { "auth_ref": [ "r240", "r270", "r275" ], "lang": { "en-US": { "role": { "documentation": "Information by credit loss status of financial asset.", "label": "Credit Loss Status [Axis]", "terseLabel": "Credit Loss Status [Axis]" } } }, "localname": "CreditLossStatusAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesScheduleforAllowanceforCreditLossesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CreditLossStatusDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Credit loss status of financial asset.", "label": "Credit Loss Status [Domain]", "terseLabel": "Credit Loss Status [Domain]" } } }, "localname": "CreditLossStatusDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesScheduleforAllowanceforCreditLossesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CustomerListsMember": { "auth_ref": [ "r446" ], "lang": { "en-US": { "role": { "documentation": "Information about customers such as their name and contact information; it may also be an extensive database that includes other information about the customers such as their order history and demographic information.", "label": "Customer Lists [Member]", "verboseLabel": "Customer lists" } } }, "localname": "CustomerListsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/IntangiblesIntangibleTableDetails", "http://www.invacare.com/role/IntangiblesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtAndCapitalLeasesDisclosuresTextBlock": { "auth_ref": [ "r349", "r536" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for debt and capital lease obligations can be reported. Information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants. Also includes descriptions and amounts of capital leasing arrangements that consist of direct financing, sales type and leveraged leases. Disclosure may include the effect on the balance sheet and the income statement resulting from a change in lease classification for leases that at inception would have been classified differently had guidance been in effect at the inception of the original lease.", "label": "Debt and Capital Leases Disclosures [Text Block]", "terseLabel": "Debt and Capital Leases Disclosures" } } }, "localname": "DebtAndCapitalLeasesDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LongTermDebt" ], "xbrltype": "textBlockItemType" }, "us-gaap_DebtDisclosureAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Debt Disclosure [Abstract]", "terseLabel": "Debt Disclosure [Abstract]" } } }, "localname": "DebtDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentAxis": { "auth_ref": [ "r25", "r26", "r27", "r596", "r598", "r612" ], "lang": { "en-US": { "role": { "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.", "label": "Debt Instrument [Axis]", "terseLabel": "Debt Instrument [Axis]" } } }, "localname": "DebtInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/DerivativesFairValueofConvertibleDebtHedgesDetails", "http://www.invacare.com/role/DerivativesNarrativeDetails", "http://www.invacare.com/role/FairValuesAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.invacare.com/role/LongTermDebtComponentsofConvertibleDebtDetails", "http://www.invacare.com/role/LongTermDebtDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.", "label": "Debt Instrument, Basis Spread on Variable Rate", "terseLabel": "Basis spread on variable rate" } } }, "localname": "DebtInstrumentBasisSpreadOnVariableRate1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentConvertibleConversionPrice1": { "auth_ref": [ "r345" ], "lang": { "en-US": { "role": { "documentation": "The price per share of the conversion feature embedded in the debt instrument.", "label": "Debt Instrument, Convertible, Conversion Price", "terseLabel": "Debt Instrument, Convertible, Conversion Price" } } }, "localname": "DebtInstrumentConvertibleConversionPrice1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Threshold period of specified consecutive trading days within which common stock price to conversion price of convertible debt instrument must exceed threshold percentage for specified number of trading days to trigger conversion feature.", "label": "Debt Instrument, Convertible, Threshold Consecutive Trading Days", "terseLabel": "Debt Instrument, Convertible, Threshold Consecutive Trading Days" } } }, "localname": "DebtInstrumentConvertibleThresholdConsecutiveTradingDays1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "integerItemType" }, "us-gaap_DebtInstrumentConvertibleThresholdTradingDays": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Threshold number of specified trading days that common stock price to conversion price of convertible debt instruments must exceed threshold percentage within a specified consecutive trading period to trigger conversion feature.", "label": "Debt Instrument, Convertible, Threshold Trading Days", "terseLabel": "Debt Instrument, Convertible, Threshold Trading Days" } } }, "localname": "DebtInstrumentConvertibleThresholdTradingDays", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "integerItemType" }, "us-gaap_DebtInstrumentFaceAmount": { "auth_ref": [ "r522", "r524" ], "calculation": { "http://www.invacare.com/role/LongTermDebtComponentsofConvertibleDebtDetails": { "order": 3.0, "parentTag": "ivc_DebtInstrumentNetCarryingAmount", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Face (par) amount of debt instrument at time of issuance.", "label": "Debt Instrument, Face Amount", "terseLabel": "Debt Instrument, Face Amount" } } }, "localname": "DebtInstrumentFaceAmount", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows", "http://www.invacare.com/role/DerivativesNarrativeDetails", "http://www.invacare.com/role/LongTermDebtComponentsofConvertibleDebtDetails", "http://www.invacare.com/role/LongTermDebtDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentFairValue": { "auth_ref": [ "r506" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.", "label": "Debt Instrument, Fair Value Disclosure", "negatedTerseLabel": "Total debt (including current maturities of long-term debt) *" } } }, "localname": "DebtInstrumentFairValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/FairValuesDetailsofBookValueandFairValueofFinancialInstrumentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentFeeAmount": { "auth_ref": [ "r60" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of the fee that accompanies borrowing money under the debt instrument.", "label": "Debt Instrument, Fee Amount", "terseLabel": "Debt Instrument, Fee Amount" } } }, "localname": "DebtInstrumentFeeAmount", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentIncreaseAccruedInterest": { "auth_ref": [ "r134" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Increase for accrued, but unpaid interest on the debt instrument for the period.", "label": "Debt Instrument, Increase, Accrued Interest", "terseLabel": "Debt Instrument, Increase, Accrued Interest" } } }, "localname": "DebtInstrumentIncreaseAccruedInterest", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LongTermDebtComponentsofConvertibleDebtDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentInterestRateEffectivePercentage": { "auth_ref": [ "r59", "r346", "r522" ], "lang": { "en-US": { "role": { "documentation": "Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.", "label": "Debt Instrument, Interest Rate, Effective Percentage", "terseLabel": "Debt Instrument, Interest Rate, Effective Percentage" } } }, "localname": "DebtInstrumentInterestRateEffectivePercentage", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentInterestRateStatedPercentage": { "auth_ref": [ "r59" ], "lang": { "en-US": { "role": { "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.", "label": "Debt Instrument, Interest Rate, Stated Percentage", "terseLabel": "Interest rate (as a percent)" } } }, "localname": "DebtInstrumentInterestRateStatedPercentage", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/DerivativesNarrativeDetails", "http://www.invacare.com/role/LongTermDebtComponentsofConvertibleDebtDetails", "http://www.invacare.com/role/LongTermDebtDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Debt Instrument [Line Items]", "terseLabel": "Debt Instrument [Line Items]" } } }, "localname": "DebtInstrumentLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LongTermDebtComponentsofConvertibleDebtDetails", "http://www.invacare.com/role/LongTermDebtDetails", "http://www.invacare.com/role/LongTermDebtLeverageRatiosDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentNameDomain": { "auth_ref": [ "r61" ], "lang": { "en-US": { "role": { "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.", "label": "Debt Instrument, Name [Domain]", "terseLabel": "Debt Instrument, Name [Domain]" } } }, "localname": "DebtInstrumentNameDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/DerivativesFairValueofConvertibleDebtHedgesDetails", "http://www.invacare.com/role/DerivativesNarrativeDetails", "http://www.invacare.com/role/FairValuesAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.invacare.com/role/LongTermDebtComponentsofConvertibleDebtDetails", "http://www.invacare.com/role/LongTermDebtDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtInstrumentRepurchaseAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Fair value amount of debt instrument that was repurchased.", "label": "Debt Instrument, Repurchase Amount", "terseLabel": "Debt Instrument, Repurchase Amount" } } }, "localname": "DebtInstrumentRepurchaseAmount", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentTable": { "auth_ref": [ "r61", "r133", "r351", "r353", "r354", "r355", "r521", "r522", "r524", "r611" ], "lang": { "en-US": { "role": { "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Schedule of Long-term Debt Instruments [Table]", "terseLabel": "Schedule of Long-term Debt Instruments [Table]" } } }, "localname": "DebtInstrumentTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LongTermDebtComponentsofConvertibleDebtDetails", "http://www.invacare.com/role/LongTermDebtDetails", "http://www.invacare.com/role/LongTermDebtLeverageRatiosDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentUnamortizedDiscount": { "auth_ref": [ "r521", "r524" ], "calculation": { "http://www.invacare.com/role/LongTermDebtComponentsofConvertibleDebtDetails": { "order": 2.0, "parentTag": "ivc_DebtInstrumentNetCarryingAmount", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount, after accumulated amortization, of debt discount.", "label": "Debt Instrument, Unamortized Discount", "negatedLabel": "Unamortized discount", "negatedTerseLabel": "Debt Instrument, Unamortized Discount" } } }, "localname": "DebtInstrumentUnamortizedDiscount", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LongTermDebtComponentsofConvertibleDebtDetails", "http://www.invacare.com/role/LongTermDebtDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredCompensationCashBasedArrangementsLiabilityCurrent": { "auth_ref": [ "r362", "r363" ], "calculation": { "http://www.invacare.com/role/AccruedExpensesComponentsofAccruedExpensesDetails": { "order": 6.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Aggregate carrying value as of the balance sheet date of the liabilities for deferred compensation arrangements payable within one year (or the normal operating cycle, if longer). Represents currently earned compensation under cash arrangements (such as a profit-sharing plan, rabbi trust, and employee contract--excluding equity-based arrangements) that is not actually paid until a later date.", "label": "Deferred Compensation Cash-based Arrangements, Liability, Current", "terseLabel": "Supplemental Executive Retirement Program liability" } } }, "localname": "DeferredCompensationCashBasedArrangementsLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/AccruedExpensesComponentsofAccruedExpensesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredCompensationCashbasedArrangementsLiabilityClassifiedNoncurrent": { "auth_ref": [], "calculation": { "http://www.invacare.com/role/OtherLongTermObligationsDetails": { "order": 8.0, "parentTag": "us-gaap_OtherLiabilitiesNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Aggregate carrying value as of the balance sheet date of the liabilities for deferred compensation arrangements payable after one year (or the normal operating cycle, if longer). Represents currently earned compensation under cash arrangements (such as a profit-sharing plan, rabbi trust, and employee contract--excluding equity-based arrangements) that is not actually paid until a later date.", "label": "Deferred Compensation Cash-based Arrangements, Liability, Classified, Noncurrent", "terseLabel": "Supplemental Executive Retirement Plan liability" } } }, "localname": "DeferredCompensationCashbasedArrangementsLiabilityClassifiedNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/OtherLongTermObligationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent": { "auth_ref": [], "calculation": { "http://www.invacare.com/role/OtherLongTermObligationsDetails": { "order": 3.0, "parentTag": "us-gaap_OtherLiabilitiesNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Aggregate carrying value as of the balance sheet date of the liabilities for all deferred compensation arrangements payable beyond one year (or the operating cycle, if longer).", "label": "Deferred Compensation Liability, Classified, Noncurrent", "terseLabel": "Deferred compensation" } } }, "localname": "DeferredCompensationLiabilityClassifiedNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/OtherLongTermObligationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]", "terseLabel": "Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]" } } }, "localname": "DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_DeferredFinanceCostsNoncurrentNet": { "auth_ref": [ "r52", "r523" ], "calculation": { "http://www.invacare.com/role/OtherLongTermAssetsComponentsofOtherLongTermAssetsDetails": { "order": 2.0, "parentTag": "us-gaap_OtherAssetsNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount, after accumulated amortization, of debt issuance costs classified as noncurrent. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.", "label": "Debt Issuance Costs, Noncurrent, Net", "terseLabel": "Deferred financing fees" } } }, "localname": "DeferredFinanceCostsNoncurrentNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/OtherLongTermAssetsComponentsofOtherLongTermAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxExpenseBenefit": { "auth_ref": [ "r125", "r131", "r429", "r436", "r437", "r438" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Deferred Income Tax Expense (Benefit)", "terseLabel": "(Provision) benefit for deferred income taxes" } } }, "localname": "DeferredIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent": { "auth_ref": [], "calculation": { "http://www.invacare.com/role/OtherLongTermObligationsDetails": { "order": 7.0, "parentTag": "us-gaap_OtherLiabilitiesNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences, after deferred tax asset, and other tax liabilities expected to be paid after one year or operating cycle, if longer.", "label": "Deferred Income Taxes and Other Tax Liabilities, Noncurrent", "terseLabel": "Deferred income taxes" } } }, "localname": "DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/OtherLongTermObligationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredRevenue": { "auth_ref": [ "r41" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.", "label": "Deferred Revenue", "negatedTerseLabel": "Total Unearned Interest", "terseLabel": "Deferred Revenue" } } }, "localname": "DeferredRevenue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesInstallmentRecevablesDetails", "http://www.invacare.com/role/RevenueDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredRevenueCurrent": { "auth_ref": [ "r41" ], "calculation": { "http://www.invacare.com/role/AccruedExpensesComponentsofAccruedExpensesDetails": { "order": 12.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.", "label": "Deferred Revenue, Current", "terseLabel": "Deferred revenue" } } }, "localname": "DeferredRevenueCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/AccruedExpensesComponentsofAccruedExpensesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsTaxDeferredExpense": { "auth_ref": [ "r427", "r428" ], "calculation": { "http://www.invacare.com/role/OtherLongTermAssetsComponentsofOtherLongTermAssetsDetails": { "order": 5.0, "parentTag": "us-gaap_OtherAssetsNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount, before allocation of valuation allowances, of deferred tax asset attributable to deductible differences from reserves and accruals, compensation and benefit costs, and other provisions, reserves, and allowances.", "label": "Deferred Tax Assets, Tax Deferred Expense", "terseLabel": "Deferred income taxes" } } }, "localname": "DeferredTaxAssetsTaxDeferredExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/OtherLongTermAssetsComponentsofOtherLongTermAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent": { "auth_ref": [ "r28", "r364", "r365", "r366" ], "calculation": { "http://www.invacare.com/role/OtherLongTermObligationsDetails": { "order": 1.0, "parentTag": "us-gaap_OtherLiabilitiesNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of liability, recognized in statement of financial position, for defined benefit pension plan, classified as noncurrent. Excludes other postretirement benefit plan.", "label": "Liability, Defined Benefit Pension Plan, Noncurrent", "terseLabel": "Pension" } } }, "localname": "DefinedBenefitPensionPlanLiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/OtherLongTermObligationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepreciationDepletionAndAmortization": { "auth_ref": [ "r125", "r195" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.", "label": "Depreciation, Depletion and Amortization", "terseLabel": "Depreciation and amortization" } } }, "localname": "DepreciationDepletionAndAmortization", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeAmountOfHedgedItem": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Amount of hedged item in hedging relationship. Excludes hedged asset or liability.", "label": "Derivative, Amount of Hedged Item", "terseLabel": "Derivative, Amount of Hedged Item" } } }, "localname": "DerivativeAmountOfHedgedItem", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeAssets": { "auth_ref": [ "r73", "r74", "r506" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.", "label": "Derivative Asset", "verboseLabel": "Derivative assets" } } }, "localname": "DerivativeAssets", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/FairValuesDetailsofBookValueandFairValueofFinancialInstrumentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeAssetsCurrent": { "auth_ref": [ "r73" ], "calculation": { "http://www.invacare.com/role/OtherCurrentAssetsComponentsofOtherCurrentAssetsDetails": { "order": 4.0, "parentTag": "us-gaap_OtherAssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.", "label": "Derivative Asset, Current", "terseLabel": "Derivatives (foreign currency forward exchange contracts)" } } }, "localname": "DerivativeAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/OtherCurrentAssetsComponentsofOtherCurrentAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet": { "auth_ref": [ "r463" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Fair values as of the balance sheet date of the net amount of all assets and liabilities resulting from contracts that meet the criteria of being accounted for as derivative instruments.", "label": "Derivative Assets (Liabilities), at Fair Value, Net", "terseLabel": "Derivative assets (liabilities), at fair value, net" } } }, "localname": "DerivativeAssetsLiabilitiesAtFairValueNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/FairValuesAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.invacare.com/role/FairValuesDetailsofBookValueandFairValueofFinancialInstrumentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeContractTypeDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.", "label": "Derivative Contract [Domain]", "terseLabel": "Derivative Contract [Domain]" } } }, "localname": "DerivativeContractTypeDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/AccumulatedOtherComprehensiveIncomeLossbyComponentReclassifiedOutofAccumulatedOtherComprehensiveIncomeDetails", "http://www.invacare.com/role/DerivativesBalanceSheetLocationDetails", "http://www.invacare.com/role/DerivativesFairValueofConvertibleDebtHedgesDetails", "http://www.invacare.com/role/DerivativesGainLossinStatementofFinacialPositionDetails", "http://www.invacare.com/role/DerivativesNarrativeDetails", "http://www.invacare.com/role/DerivativesNotionalAmountsDesignatedasHedgesDetails", "http://www.invacare.com/role/DerivativesNotionalAmountsNotDesignatedasHedgesDetails", "http://www.invacare.com/role/FairValuesAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.invacare.com/role/FairValuesDetailsofBookValueandFairValueofFinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DerivativeFairValueOfDerivativeAsset": { "auth_ref": [ "r72", "r76", "r474", "r567" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.", "label": "Derivative Asset, Fair Value, Gross Asset", "verboseLabel": "Derivative assets" } } }, "localname": "DerivativeFairValueOfDerivativeAsset", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/DerivativesBalanceSheetLocationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeFairValueOfDerivativeLiability": { "auth_ref": [ "r72", "r76", "r474", "r567" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.", "label": "Derivative Liability, Fair Value, Gross Liability", "terseLabel": "Derivative liabilities" } } }, "localname": "DerivativeFairValueOfDerivativeLiability", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/DerivativesBalanceSheetLocationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeGainLossOnDerivativeNet": { "auth_ref": [ "r473" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.", "label": "Derivative, Gain (Loss) on Derivative, Net", "negatedLabel": "Gain (Loss)", "terseLabel": "Gain (Loss)", "verboseLabel": "Gain (Loss)" } } }, "localname": "DerivativeGainLossOnDerivativeNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/BusinessSegmentsInformationbySegmentDetails", "http://www.invacare.com/role/DerivativesGainLossinStatementofFinacialPositionDetails", "http://www.invacare.com/role/DerivativesNarrativeDetails", "http://www.invacare.com/role/DerivativesNotionalAmountsDesignatedasHedgesDetails", "http://www.invacare.com/role/DerivativesNotionalAmountsNotDesignatedasHedgesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeGainOnDerivative": { "auth_ref": [ "r473" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of increase in the fair value of derivatives recognized in the income statement.", "label": "Derivative, Gain on Derivative", "terseLabel": "Gain recognized in income" } } }, "localname": "DerivativeGainOnDerivative", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/DerivativesGainLossinStatementofFinacialPositionDetails", "http://www.invacare.com/role/DerivativesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeInstrumentRiskAxis": { "auth_ref": [ "r472", "r475", "r483", "r486" ], "lang": { "en-US": { "role": { "documentation": "Information by type of derivative contract.", "label": "Derivative Instrument [Axis]", "terseLabel": "Derivative Instrument [Axis]" } } }, "localname": "DerivativeInstrumentRiskAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/AccumulatedOtherComprehensiveIncomeLossbyComponentReclassifiedOutofAccumulatedOtherComprehensiveIncomeDetails", "http://www.invacare.com/role/DerivativesBalanceSheetLocationDetails", "http://www.invacare.com/role/DerivativesFairValueofConvertibleDebtHedgesDetails", "http://www.invacare.com/role/DerivativesGainLossinStatementofFinacialPositionDetails", "http://www.invacare.com/role/DerivativesNarrativeDetails", "http://www.invacare.com/role/DerivativesNotionalAmountsDesignatedasHedgesDetails", "http://www.invacare.com/role/DerivativesNotionalAmountsNotDesignatedasHedgesDetails", "http://www.invacare.com/role/FairValuesAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.invacare.com/role/FairValuesDetailsofBookValueandFairValueofFinancialInstrumentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]", "terseLabel": "Derivative Instruments and Hedging Activities Disclosure [Abstract]" } } }, "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": { "auth_ref": [ "r495" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.", "label": "Derivative Instruments and Hedging Activities Disclosure [Text Block]", "terseLabel": "Derivatives" } } }, "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/Derivatives" ], "xbrltype": "textBlockItemType" }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Derivative Instruments and Hedging Activities Disclosures [Line Items]", "terseLabel": "Derivative Instruments and Hedging Activities Disclosures [Line Items]" } } }, "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/DerivativesFairValueofConvertibleDebtHedgesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Disclosure of information about derivatives and hedging activities.", "label": "Derivative Instruments and Hedging Activities Disclosures [Table]", "terseLabel": "Derivative Instruments and Hedging Activities Disclosures [Table]" } } }, "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/DerivativesFairValueofConvertibleDebtHedgesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis": { "auth_ref": [ "r469", "r472", "r483" ], "lang": { "en-US": { "role": { "documentation": "Information by type of hedging relationship.", "label": "Hedging Relationship [Axis]", "terseLabel": "Hedging Relationship [Axis]" } } }, "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/DerivativesFairValueofConvertibleDebtHedgesDetails", "http://www.invacare.com/role/DerivativesGainLossinStatementofFinacialPositionDetails", "http://www.invacare.com/role/DerivativesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable": { "auth_ref": [ "r469", "r472", "r483", "r486", "r487", "r491", "r493" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of information about the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.", "label": "Derivative Instruments, Gain (Loss) [Table]", "terseLabel": "Derivative Instruments, Gain (Loss) by Hedging Relationship, by Income Statement Location, by Derivative Instrument Risk [Table]" } } }, "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/DerivativesGainLossinStatementofFinacialPositionDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsGainLossLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Derivative Instruments, Gain (Loss) [Line Items]", "terseLabel": "Derivative Instruments, Gain (Loss) [Line Items]" } } }, "localname": "DerivativeInstrumentsGainLossLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/DerivativesGainLossinStatementofFinacialPositionDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet": { "auth_ref": [ "r480", "r485" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The effective portion of net gain (loss) reclassified from accumulated other comprehensive income into income on derivative instruments designated and qualifying as hedging instruments.", "label": "Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net", "terseLabel": "Amount of Gain (Loss) Reclassified from Accumulated OCI into Income (Effective Portion)" } } }, "localname": "DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/DerivativesGainLossinStatementofFinacialPositionDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet": { "auth_ref": [ "r481", "r492" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The portion of gains and losses (net) on derivative instruments designated and qualifying as hedging instruments representing (a) the amount of the hedge ineffectiveness and (b) the amount, if any, excluded from the assessment of hedge effectiveness.", "label": "Derivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net", "terseLabel": "Amount of Gain (Loss) Recognized in Income on Derivatives (Ineffective Portion and Amount Excluded from Effectiveness Testing)" } } }, "localname": "DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/DerivativesGainLossinStatementofFinacialPositionDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeLiabilities": { "auth_ref": [ "r73", "r74", "r506" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.", "label": "Derivative Liability", "negatedLabel": "Derivative liabilities" } } }, "localname": "DerivativeLiabilities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/FairValuesDetailsofBookValueandFairValueofFinancialInstrumentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeLiabilitiesCurrent": { "auth_ref": [ "r73" ], "calculation": { "http://www.invacare.com/role/AccruedExpensesComponentsofAccruedExpensesDetails": { "order": 16.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.", "label": "Derivative Liability, Current", "terseLabel": "Derivative liabilities (foreign currency forward exchange contracts)" } } }, "localname": "DerivativeLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/AccruedExpensesComponentsofAccruedExpensesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Derivative [Line Items]", "terseLabel": "Derivative [Line Items]" } } }, "localname": "DerivativeLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/DerivativesNarrativeDetails", "http://www.invacare.com/role/DerivativesNotionalAmountsDesignatedasHedgesDetails", "http://www.invacare.com/role/DerivativesNotionalAmountsNotDesignatedasHedgesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeLossOnDerivative": { "auth_ref": [ "r473" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of decrease in the fair value of derivatives recognized in the income statement.", "label": "Derivative, Loss on Derivative", "negatedLabel": "Loss on derivative", "terseLabel": "Derivative, Loss on Derivative" } } }, "localname": "DerivativeLossOnDerivative", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/DerivativesGainLossinStatementofFinacialPositionDetails", "http://www.invacare.com/role/DerivativesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeTable": { "auth_ref": [ "r464", "r466", "r467", "r469", "r470", "r477", "r483", "r489", "r490", "r493" ], "lang": { "en-US": { "role": { "documentation": "Schedule that describes and identifies a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.", "label": "Derivative [Table]", "terseLabel": "Derivative [Table]" } } }, "localname": "DerivativeTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/DerivativesNarrativeDetails", "http://www.invacare.com/role/DerivativesNotionalAmountsDesignatedasHedgesDetails", "http://www.invacare.com/role/DerivativesNotionalAmountsNotDesignatedasHedgesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativesFairValueLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Derivatives, Fair Value [Line Items]", "terseLabel": "Derivatives, Fair Value [Line Items]" } } }, "localname": "DerivativesFairValueLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/DerivativesBalanceSheetLocationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DesignatedAsHedgingInstrumentMember": { "auth_ref": [ "r469" ], "lang": { "en-US": { "role": { "documentation": "Derivative instrument designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).", "label": "Designated as Hedging Instrument [Member]", "terseLabel": "Designated as Hedging Instrument [Member]" } } }, "localname": "DesignatedAsHedgingInstrumentMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/DerivativesBalanceSheetLocationDetails", "http://www.invacare.com/role/DerivativesNotionalAmountsDesignatedasHedgesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DevelopedTechnologyRightsMember": { "auth_ref": [ "r448" ], "lang": { "en-US": { "role": { "documentation": "Rights to developed technology, which can include the right to develop, use, market, sell, or offer for sale products, compounds, or intellectual property.", "label": "Developed Technology Rights [Member]", "terseLabel": "Developed technology" } } }, "localname": "DevelopedTechnologyRightsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/IntangiblesIntangibleTableDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": { "auth_ref": [ "r419" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for share-based payment arrangement.", "label": "Share-based Payment Arrangement [Text Block]", "terseLabel": "Shareholders' Equity Transactions" } } }, "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensation" ], "xbrltype": "textBlockItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Share-based Payment Arrangement [Abstract]", "terseLabel": "Disclosure of Compensation Related Costs, Share-based Payments [Abstract]" } } }, "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet": { "auth_ref": [ "r0", "r1", "r4", "r305" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount classified as accounts, notes and loans receivable attributable to disposal group held for sale or disposed of.", "label": "Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net", "terseLabel": "Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/DivestedBusinessesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable": { "auth_ref": [ "r0", "r1", "r4", "r305" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount classified as accounts payable attributable to disposal group held for sale or disposed of.", "label": "Disposal Group, Including Discontinued Operation, Accounts Payable", "terseLabel": "Disposal Group, Including Discontinued Operation, Accounts Payable" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationAccountsPayable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/DivestedBusinessesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedIncomeTaxPayable": { "auth_ref": [ "r0", "r1", "r4", "r305" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount classified as income tax obligations attributable to disposal group held for sale or disposed of.", "label": "Disposal Group, Including Discontinued Operation, Accrued Income Tax Payable", "terseLabel": "Disposal Group, Including Discontinued Operation, Accrued Income Tax Payable" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationAccruedIncomeTaxPayable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/DivestedBusinessesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities": { "auth_ref": [ "r0", "r1", "r4", "r305" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount classified as accrued liabilities attributable to disposal group held for sale or disposed of.", "label": "Disposal Group, Including Discontinued Operation, Accrued Liabilities", "terseLabel": "Disposal Group, Including Discontinued Operation, Accrued Liabilities" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/DivestedBusinessesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1": { "auth_ref": [ "r0", "r1", "r4", "r305" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount classified as inventory attributable to disposal group held for sale or disposed of.", "label": "Disposal Group, Including Discontinued Operation, Inventory", "terseLabel": "Disposal Group, Including Discontinued Operation, Inventory" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationInventory1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/DivestedBusinessesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets": { "auth_ref": [ "r0", "r1", "r4", "r305" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount classified as other assets attributable to disposal group held for sale or disposed of.", "label": "Disposal Group, Including Discontinued Operation, Other Assets", "terseLabel": "Disposal Group, Including Discontinued Operation, Other Assets" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationOtherAssets", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/DivestedBusinessesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment": { "auth_ref": [ "r0", "r1", "r4", "r305" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount classified as property, plant and equipment attributable to disposal group held for sale or disposed of.", "label": "Disposal Group, Including Discontinued Operation, Property, Plant and Equipment", "terseLabel": "Disposal Group, Including Discontinued Operation, Property, Plant and Equipment" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/DivestedBusinessesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue": { "auth_ref": [ "r3", "r6" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of revenue attributable to disposal group, including, but not limited to, discontinued operation.", "label": "Disposal Group, Including Discontinued Operation, Revenue", "terseLabel": "Disposal Group, Including Discontinued Operation, Revenue" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationRevenue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/DivestedBusinessesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain": { "auth_ref": [ "r377", "r380" ], "lang": { "en-US": { "role": { "documentation": "Name of disposal group.", "label": "Disposal Group Name [Domain]", "terseLabel": "Disposal Groups, Including Discontinued Operations, Name [Domain]" } } }, "localname": "DisposalGroupsIncludingDiscontinuedOperationsNameDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/GoodwillGoodwillDetailsDetails", "http://www.invacare.com/role/PropertyAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DividendsCommonStockCash": { "auth_ref": [ "r356" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of paid and unpaid common stock dividends declared with the form of settlement in cash.", "label": "Dividends, Common Stock, Cash", "negatedTerseLabel": "Dividends, Common Stock, Cash" } } }, "localname": "DividendsCommonStockCash", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofShareholdersEquityStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_EarningsPerShareAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Earnings Per Share [Abstract]", "terseLabel": "Earnings Per Share [Abstract]" } } }, "localname": "EarningsPerShareAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareBasic": { "auth_ref": [ "r102", "r146", "r147", "r148", "r149", "r150", "r156", "r158", "r165", "r166", "r167", "r171", "r172", "r607", "r628" ], "lang": { "en-US": { "role": { "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.", "label": "Earnings Per Share, Basic", "terseLabel": "Net Loss per Share\u2014Basic", "verboseLabel": "Net earnings (loss) per common share" } } }, "localname": "EarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss", "http://www.invacare.com/role/NetEarningsLossPerCommonShareComputationofBasicandDilutedNetEarningsLossPerCommonShareDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareBasicAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Earnings Per Share, Basic [Abstract]", "terseLabel": "Net Loss per Share\u2014Basic" } } }, "localname": "EarningsPerShareBasicAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss", "http://www.invacare.com/role/NetEarningsLossPerCommonShareComputationofBasicandDilutedNetEarningsLossPerCommonShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareDiluted": { "auth_ref": [ "r102", "r146", "r147", "r148", "r149", "r150", "r158", "r165", "r166", "r167", "r171", "r172", "r607", "r628" ], "lang": { "en-US": { "role": { "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Earnings Per Share, Diluted", "terseLabel": "Net earnings (loss) per per common share\u2014assuming dilution (in dollars per share)", "verboseLabel": "Net Loss per Share\u2014Assuming Dilution" } } }, "localname": "EarningsPerShareDiluted", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss", "http://www.invacare.com/role/NetEarningsLossPerCommonShareComputationofBasicandDilutedNetEarningsLossPerCommonShareDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareDilutedAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Earnings Per Share, Diluted [Abstract]", "terseLabel": "Net Loss per Share\u2014Assuming Dilution" } } }, "localname": "EarningsPerShareDilutedAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss", "http://www.invacare.com/role/NetEarningsLossPerCommonShareComputationofBasicandDilutedNetEarningsLossPerCommonShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareTextBlock": { "auth_ref": [ "r168", "r169", "r170", "r173" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for earnings per share.", "label": "Earnings Per Share [Text Block]", "terseLabel": "Net Earnings (Loss) Per Common Share" } } }, "localname": "EarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/NetEarningsLossPerCommonShare" ], "xbrltype": "textBlockItemType" }, "us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents": { "auth_ref": [ "r512" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of increase (decrease) from the effect of exchange rate changes on cash and cash equivalent balances held in foreign currencies.", "label": "Effect of Exchange Rate on Cash and Cash Equivalents", "terseLabel": "Effect of exchange rate changes on cash" } } }, "localname": "EffectOfExchangeRateOnCashAndCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_EffectiveIncomeTaxRateContinuingOperations": { "auth_ref": [ "r422" ], "lang": { "en-US": { "role": { "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Effective Income Tax Rate Reconciliation, Percent", "terseLabel": "Effective income tax rate, continuing operations" } } }, "localname": "EffectiveIncomeTaxRateContinuingOperations", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": { "auth_ref": [ "r422", "r439" ], "lang": { "en-US": { "role": { "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).", "label": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent", "terseLabel": "U.S. statutory income tax rate" } } }, "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]", "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]" } } }, "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationSharebasedCompensationExpenseDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": { "auth_ref": [ "r408" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement.", "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount", "terseLabel": "Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationUnrecognizedCompensationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": { "auth_ref": [ "r408" ], "lang": { "en-US": { "role": { "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition", "terseLabel": "Period for recognition of unrecognized compensation costs" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_EmployeeSeveranceMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Termination of an employee associated with exit from or disposal of business activities or restructurings pursuant to a plan.", "label": "Employee Severance [Member]", "terseLabel": "Severance" } } }, "localname": "EmployeeSeveranceMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/BusinessSegmentsInformationbySegmentDetails", "http://www.invacare.com/role/ChargesRelatedToRestructuringActivitiesDetails", "http://www.invacare.com/role/ChargesRelatedToRestructuringActivitiesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EmployeeStockOptionMember": { "auth_ref": [ "r405" ], "lang": { "en-US": { "role": { "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.", "label": "Share-based Payment Arrangement, Option [Member]", "terseLabel": "Stock Options" } } }, "localname": "EmployeeStockOptionMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationNarrativeDetails", "http://www.invacare.com/role/EquityCompensationOptionsActivityDetails", "http://www.invacare.com/role/EquityCompensationSharebasedCompensationExpenseDetails", "http://www.invacare.com/role/EquityCompensationStockOptionsOutstandingbyExercisePriceDetails", "http://www.invacare.com/role/EquityCompensationUnrecognizedCompensationExpenseDetails", "http://www.invacare.com/role/NetEarningsLossPerCommonShareTextualsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Revenue from External Customer [Line Items]", "terseLabel": "Revenue from External Customer [Line Items]" } } }, "localname": "EntityWideInformationRevenueFromExternalCustomerLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/BusinessSegmentsTables" ], "xbrltype": "stringItemType" }, "us-gaap_EquityAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Equity [Abstract]", "terseLabel": "Equity [Abstract]" } } }, "localname": "EquityAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r138", "r139", "r141", "r143", "r151", "r154", "r174", "r247", "r350", "r356", "r414", "r415", "r416", "r432", "r433", "r513", "r514", "r515", "r516", "r517", "r519", "r638", "r639", "r640" ], "lang": { "en-US": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.", "label": "Equity Component [Domain]", "terseLabel": "Equity Component [Domain]" } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/AccumulatedOtherComprehensiveIncomeLossbyComponentChangesinAccumulatedOtherComprehensiveIncomeDetails", "http://www.invacare.com/role/AccumulatedOtherComprehensiveIncomeLossbyComponentReclassifiedOutofAccumulatedOtherComprehensiveIncomeDetails", "http://www.invacare.com/role/CondensedConsolidatedStatementofShareholdersEquityStatement" ], "xbrltype": "domainItemType" }, "us-gaap_EquitySecuritiesByIndustryAxis": { "auth_ref": [ "r265" ], "lang": { "en-US": { "role": { "documentation": "Information by industry sector, examples include but are not limited to, commercial, industrial, agricultural, financial services, technology, healthcare and real estate.", "label": "Industry Sector [Axis]", "terseLabel": "Industry Sector [Axis]" } } }, "localname": "EquitySecuritiesByIndustryAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesNarrativeDetails", "http://www.invacare.com/role/ReceivablesScheduleforAllowanceforCreditLossesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EquitySecuritiesIndustryMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Industry sector consisting of government, private and corporate entities engaged in business activities, including but not limited to, commercial, industrial, agricultural, financial services, technology, healthcare and real estate.", "label": "Industry Sector [Domain]", "terseLabel": "Industry Sector [Domain]" } } }, "localname": "EquitySecuritiesIndustryMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesNarrativeDetails", "http://www.invacare.com/role/ReceivablesScheduleforAllowanceforCreditLossesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis": { "auth_ref": [ "r140", "r146", "r147", "r150", "r151", "r153", "r154" ], "lang": { "en-US": { "role": { "documentation": "Information by type of error correction.", "label": "Error Correction, Type [Axis]", "terseLabel": "Adjustments for Error Corrections [Axis]" } } }, "localname": "ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofShareholdersEquityStatement" ], "xbrltype": "stringItemType" }, "us-gaap_EstimateOfFairValueFairValueDisclosureMember": { "auth_ref": [ "r506" ], "lang": { "en-US": { "role": { "documentation": "Measured as an estimate of fair value.", "label": "Estimate of Fair Value Measurement [Member]", "verboseLabel": "Fair Value" } } }, "localname": "EstimateOfFairValueFairValueDisclosureMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/FairValuesDetailsofBookValueandFairValueofFinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ExtendedProductWarrantyAccrualWarrantiesIssued": { "auth_ref": [ "r341" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of increase in the extended product warranty accrual from warranties issued. Excludes standard product warranties.", "label": "Extended Product Warranty Accrual, Increase for Warranties Issued", "terseLabel": "Extended Product Warranty Accrual, Increase for Warranties Issued" } } }, "localname": "ExtendedProductWarrantyAccrualWarrantiesIssued", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/AccruedExpensesWarrantyScheduleDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]", "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/FairValuesAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": { "auth_ref": [ "r496", "r497", "r498", "r502" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.", "label": "Fair Value, Recurring and Nonrecurring [Table]", "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Table]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/FairValuesAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]", "terseLabel": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]" } } }, "localname": "FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/FairValuesDetailsofBookValueandFairValueofFinancialInstrumentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByBalanceSheetGroupingTable": { "auth_ref": [ "r496", "r507", "r508" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of information about the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.", "label": "Fair Value, by Balance Sheet Grouping [Table]", "terseLabel": "Fair Value, by Balance Sheet Grouping [Table]" } } }, "localname": "FairValueByBalanceSheetGroupingTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/FairValuesDetailsofBookValueandFairValueofFinancialInstrumentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByBalanceSheetGroupingTextBlock": { "auth_ref": [ "r496", "r507" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.", "label": "Fair Value, by Balance Sheet Grouping [Table Text Block]", "terseLabel": "Fair Value, by Balance Sheet Grouping" } } }, "localname": "FairValueByBalanceSheetGroupingTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/FairValuesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "auth_ref": [ "r368", "r369", "r370", "r371", "r372", "r373", "r374", "r376", "r497", "r557", "r558", "r559" ], "lang": { "en-US": { "role": { "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.", "label": "Fair Value Hierarchy and NAV [Axis]", "terseLabel": "Fair Value Hierarchy and NAV [Axis]" } } }, "localname": "FairValueByFairValueHierarchyLevelAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/DerivativesFairValueofConvertibleDebtHedgesDetails", "http://www.invacare.com/role/FairValuesAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.invacare.com/role/FairValuesDetailsofBookValueandFairValueofFinancialInstrumentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByMeasurementBasisAxis": { "auth_ref": [ "r496", "r503" ], "lang": { "en-US": { "role": { "documentation": "Information by measurement basis.", "label": "Measurement Basis [Axis]", "terseLabel": "Measurement Basis [Axis]" } } }, "localname": "FairValueByMeasurementBasisAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/FairValuesDetailsofBookValueandFairValueofFinancialInstrumentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByMeasurementFrequencyAxis": { "auth_ref": [ "r496", "r497", "r499", "r500", "r504" ], "lang": { "en-US": { "role": { "documentation": "Information by measurement frequency.", "label": "Measurement Frequency [Axis]", "terseLabel": "Measurement Frequency [Axis]" } } }, "localname": "FairValueByMeasurementFrequencyAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/DerivativesFairValueofConvertibleDebtHedgesDetails", "http://www.invacare.com/role/FairValuesAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.invacare.com/role/FairValuesDetailsofBookValueandFairValueofFinancialInstrumentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosureItemAmountsDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Measurement basis, for example, but not limited to, reported value, fair value, portion at fair value, portion at other than fair value.", "label": "Fair Value Measurement [Domain]", "terseLabel": "Fair Value Measurement [Domain]" } } }, "localname": "FairValueDisclosureItemAmountsDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/FairValuesDetailsofBookValueandFairValueofFinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueDisclosuresAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Fair Value Disclosures [Abstract]", "terseLabel": "Fair Value Disclosures [Abstract]" } } }, "localname": "FairValueDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresTextBlock": { "auth_ref": [ "r501" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.", "label": "Fair Value Disclosures [Text Block]", "terseLabel": "Fair Value of Financial Instruments" } } }, "localname": "FairValueDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/FairValues" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueInputsLevel1Member": { "auth_ref": [ "r368", "r369", "r374", "r376", "r497", "r557" ], "lang": { "en-US": { "role": { "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.", "label": "Fair Value, Inputs, Level 1 [Member]", "terseLabel": "Fair Value, Inputs, Level 1 [Member]" } } }, "localname": "FairValueInputsLevel1Member", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/FairValuesAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.invacare.com/role/FairValuesDetailsofBookValueandFairValueofFinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel2Member": { "auth_ref": [ "r368", "r369", "r374", "r376", "r497", "r558" ], "lang": { "en-US": { "role": { "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.", "label": "Fair Value, Inputs, Level 2 [Member]", "terseLabel": "Fair Value, Inputs, Level 2" } } }, "localname": "FairValueInputsLevel2Member", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/DerivativesFairValueofConvertibleDebtHedgesDetails", "http://www.invacare.com/role/FairValuesAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.invacare.com/role/FairValuesDetailsofBookValueandFairValueofFinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel3Member": { "auth_ref": [ "r368", "r369", "r370", "r371", "r372", "r373", "r374", "r376", "r497", "r559" ], "lang": { "en-US": { "role": { "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Inputs, Level 3 [Member]", "terseLabel": "Fair Value, Inputs, Level 3 [Member]" } } }, "localname": "FairValueInputsLevel3Member", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/FairValuesAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.invacare.com/role/FairValuesDetailsofBookValueandFairValueofFinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementFrequencyDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Measurement frequency.", "label": "Measurement Frequency [Domain]", "terseLabel": "Fair Value, Measurement Frequency [Domain]" } } }, "localname": "FairValueMeasurementFrequencyDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/DerivativesFairValueofConvertibleDebtHedgesDetails", "http://www.invacare.com/role/FairValuesAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.invacare.com/role/FairValuesDetailsofBookValueandFairValueofFinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "auth_ref": [ "r368", "r369", "r370", "r371", "r372", "r373", "r374", "r376", "r557", "r558", "r559" ], "lang": { "en-US": { "role": { "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.", "label": "Fair Value Hierarchy and NAV [Domain]", "terseLabel": "Fair Value Hierarchy and NAV [Domain]" } } }, "localname": "FairValueMeasurementsFairValueHierarchyDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/DerivativesFairValueofConvertibleDebtHedgesDetails", "http://www.invacare.com/role/FairValuesAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.invacare.com/role/FairValuesDetailsofBookValueandFairValueofFinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementsRecurringMember": { "auth_ref": [ "r501", "r504" ], "lang": { "en-US": { "role": { "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.", "label": "Fair Value, Recurring [Member]", "terseLabel": "Fair Value, Measurements, Recurring" } } }, "localname": "FairValueMeasurementsRecurringMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/DerivativesFairValueofConvertibleDebtHedgesDetails", "http://www.invacare.com/role/FairValuesAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.invacare.com/role/FairValuesDetailsofBookValueandFairValueofFinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable": { "auth_ref": [ "r471", "r477", "r491" ], "lang": { "en-US": { "role": { "documentation": "Schedule that discloses the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.", "label": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]", "terseLabel": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]" } } }, "localname": "FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/DerivativesBalanceSheetLocationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FinanceLeaseInterestExpense": { "auth_ref": [ "r539", "r542", "r550" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of interest expense on finance lease liability.", "label": "Finance Lease, Interest Expense", "terseLabel": "Finance Lease, Interest Expense" } } }, "localname": "FinanceLeaseInterestExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsLeaseExpensesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiability": { "auth_ref": [ "r538", "r549" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease.", "label": "Finance Lease, Liability", "terseLabel": "Finance Lease, Liability" } } }, "localname": "FinanceLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityCurrent": { "auth_ref": [ "r538" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.", "label": "Finance Lease, Liability, Current", "negatedTerseLabel": "Finance Lease, Liability, Current", "terseLabel": "Current portion of financing lease obligations" } } }, "localname": "FinanceLeaseLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets", "http://www.invacare.com/role/LeasesandCommitmentsFutureMinimumOperatingandFinancingLeaseCommitmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityNoncurrent": { "auth_ref": [ "r538" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets": { "order": 6.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.", "label": "Finance Lease, Liability, Noncurrent", "terseLabel": "Finance Lease Long-Term Obligations" } } }, "localname": "FinanceLeaseLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityPaymentsDue": { "auth_ref": [ "r549" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments for finance lease.", "label": "Finance Lease, Liability, Payment, Due", "terseLabel": "Finance Lease, Liability, Payments, Due" } } }, "localname": "FinanceLeaseLiabilityPaymentsDue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsFutureMinimumOperatingandFinancingLeaseCommitmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive": { "auth_ref": [ "r549" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finance Lease, Liability, to be Paid, after Year Five", "terseLabel": "Finance Lease, Liability, Payments, Due after Year Five" } } }, "localname": "FinanceLeaseLiabilityPaymentsDueAfterYearFive", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsFutureMinimumOperatingandFinancingLeaseCommitmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths": { "auth_ref": [ "r549" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finance Lease, Liability, to be Paid, Year One", "terseLabel": "Finance Lease, Liability, Payments, Due Next Twelve Months" } } }, "localname": "FinanceLeaseLiabilityPaymentsDueNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsFutureMinimumOperatingandFinancingLeaseCommitmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive": { "auth_ref": [ "r549" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finance Lease, Liability, to be Paid, Year Five", "terseLabel": "Finance Lease, Liability, Payments, Due Year Five" } } }, "localname": "FinanceLeaseLiabilityPaymentsDueYearFive", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsFutureMinimumOperatingandFinancingLeaseCommitmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour": { "auth_ref": [ "r549" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finance Lease, Liability, to be Paid, Year Four", "terseLabel": "Finance Lease, Liability, Payments, Due Year Four" } } }, "localname": "FinanceLeaseLiabilityPaymentsDueYearFour", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsFutureMinimumOperatingandFinancingLeaseCommitmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree": { "auth_ref": [ "r549" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finance Lease, Liability, to be Paid, Year Three", "terseLabel": "Finance Lease, Liability, Payments, Due Year Three" } } }, "localname": "FinanceLeaseLiabilityPaymentsDueYearThree", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsFutureMinimumOperatingandFinancingLeaseCommitmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo": { "auth_ref": [ "r549" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finance Lease, Liability, to be Paid, Year Two", "terseLabel": "Finance Lease, Liability, Payments, Due Year Two" } } }, "localname": "FinanceLeaseLiabilityPaymentsDueYearTwo", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsFutureMinimumOperatingandFinancingLeaseCommitmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseRightOfUseAsset": { "auth_ref": [ "r537" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount, after accumulated amortization, of right-of-use asset from finance lease.", "label": "Finance Lease, Right-of-Use Asset, after Accumulated Amortization", "terseLabel": "Finance Lease, Right-of-Use Asset" } } }, "localname": "FinanceLeaseRightOfUseAsset", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseRightOfUseAssetAmortization": { "auth_ref": [ "r539", "r542", "r550" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of amortization expense attributable to right-of-use asset from finance lease.", "label": "Finance Lease, Right-of-Use Asset, Amortization", "terseLabel": "Finance Lease, Right-of-Use Asset, Amortization" } } }, "localname": "FinanceLeaseRightOfUseAssetAmortization", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsLeaseExpensesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent": { "auth_ref": [ "r547", "r550" ], "lang": { "en-US": { "role": { "documentation": "Weighted average discount rate for finance lease calculated at point in time.", "label": "Finance Lease, Weighted Average Discount Rate, Percent", "terseLabel": "Finance Lease, Weighted Average Discount Rate, Percent" } } }, "localname": "FinanceLeaseWeightedAverageDiscountRatePercent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsWeightedAverageRemainingLeaseTermsandDiscountRatesDetails" ], "xbrltype": "percentItemType" }, "us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1": { "auth_ref": [ "r546", "r550" ], "lang": { "en-US": { "role": { "documentation": "Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Finance Lease, Weighted Average Remaining Lease Term", "terseLabel": "Finance Lease, Weighted Average Remaining Lease Term" } } }, "localname": "FinanceLeaseWeightedAverageRemainingLeaseTerm1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsWeightedAverageRemainingLeaseTermsandDiscountRatesDetails" ], "xbrltype": "durationItemType" }, "us-gaap_FinancialInstrumentAxis": { "auth_ref": [ "r241", "r242", "r251", "r256", "r257", "r258", "r260", "r271", "r272", "r273", "r274", "r554", "r555", "r556", "r557", "r558", "r559", "r560", "r561", "r562", "r563", "r564", "r565", "r566", "r568", "r569", "r570", "r571", "r572", "r573", "r574", "r575", "r576", "r577", "r578", "r579", "r580", "r581", "r582", "r583", "r584" ], "lang": { "en-US": { "role": { "documentation": "Information by type of financial instrument.", "label": "Financial Instrument [Axis]", "terseLabel": "Financial Instrument [Axis]" } } }, "localname": "FinancialInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/FairValuesAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.invacare.com/role/FairValuesDetailsofBookValueandFairValueofFinancialInstrumentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FinancingReceivableAllowanceForCreditLosses": { "auth_ref": [ "r226", "r250", "r252", "r255", "r600" ], "calculation": { "http://www.invacare.com/role/ReceivablesInstallmentRecevablesDetails": { "order": 2.0, "parentTag": "us-gaap_NotesReceivableNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of allowance for credit loss on financing receivable. Excludes allowance for financing receivable covered under loss sharing agreement.", "label": "Financing Receivable, Allowance for Credit Loss", "negatedTotalLabel": "Allowance for doubtful accounts", "periodEndLabel": "Balance as of end of period", "periodStartLabel": "Balance as of beginning of period" } } }, "localname": "FinancingReceivableAllowanceForCreditLosses", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesInstallmentRecevablesDetails", "http://www.invacare.com/role/ReceivablesRollforwardofAllowanceforDoubtfulAccountsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinancingReceivableAllowanceForCreditLossesLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Financing Receivable, Allowance for Credit Loss [Line Items]", "terseLabel": "Financing Receivable, Allowance for Credit Losses [Line Items]" } } }, "localname": "FinancingReceivableAllowanceForCreditLossesLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesScheduleforAllowanceforCreditLossesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FinancingReceivableAllowanceForCreditLossesRollForward": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Financing Receivable, Allowance for Credit Loss [Roll Forward]", "terseLabel": "Allowance for Doubtful Accounts [Roll Forward]" } } }, "localname": "FinancingReceivableAllowanceForCreditLossesRollForward", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesRollforwardofAllowanceforDoubtfulAccountsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FinancingReceivableAllowanceForCreditLossesWriteOffs": { "auth_ref": [ "r227", "r254", "r268" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of writeoff of financing receivable, charged against allowance for credit loss.", "label": "Financing Receivable, Allowance for Credit Loss, Writeoff", "negatedTerseLabel": "Direct write-offs charged against the allowance" } } }, "localname": "FinancingReceivableAllowanceForCreditLossesWriteOffs", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesRollforwardofAllowanceforDoubtfulAccountsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinancingReceivableImpairedLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Financing Receivable, Impaired [Line Items]", "terseLabel": "Financing Receivable, Impaired [Line Items]" } } }, "localname": "FinancingReceivableImpairedLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesInstallmentReceivablesbyClassDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FinancingReceivablePortfolioSegmentAxis": { "auth_ref": [ "r251", "r256", "r261" ], "lang": { "en-US": { "role": { "documentation": "Information by the level at which an entity develops and documents a systematic methodology to determine its allowance for credit losses.", "label": "Financing Receivable Portfolio Segment [Axis]", "terseLabel": "Financing Receivable Portfolio Segment [Axis]" } } }, "localname": "FinancingReceivablePortfolioSegmentAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesNarrativeDetails", "http://www.invacare.com/role/ReceivablesScheduleforAllowanceforCreditLossesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FinancingReceivablePortfolioSegmentDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Level at which an entity develops and documents a systematic methodology to determine its allowance for credit losses.", "label": "Financing Receivable Portfolio Segment [Domain]", "terseLabel": "Financing Receivable Portfolio Segment" } } }, "localname": "FinancingReceivablePortfolioSegmentDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesNarrativeDetails", "http://www.invacare.com/role/ReceivablesScheduleforAllowanceforCreditLossesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis": { "auth_ref": [ "r234", "r236", "r237", "r257", "r258", "r260", "r262", "r264", "r268", "r269" ], "lang": { "en-US": { "role": { "documentation": "Information by class of financing receivable determined on the basis of initial measurement attribute, risk characteristics and method of monitoring and assessing credit risk.", "label": "Class of Financing Receivable [Axis]", "terseLabel": "Class of Financing Receivable, Type [Axis]" } } }, "localname": "FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesNarrativeDetails", "http://www.invacare.com/role/ReceivablesScheduleforAllowanceforCreditLossesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FinancingReceivableRecordedInvestmentClassOfFinancingReceivableDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Financing receivables determined on the basis of initial measurement attribute, risk characteristics and method of monitoring and assessing credit risk.", "label": "Class of Financing Receivable [Domain]", "terseLabel": "Class of Financing Receivable, Type" } } }, "localname": "FinancingReceivableRecordedInvestmentClassOfFinancingReceivableDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesNarrativeDetails", "http://www.invacare.com/role/ReceivablesScheduleforAllowanceforCreditLossesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FinancingReceivableRecordedInvestmentCurrent": { "auth_ref": [ "r237", "r257", "r269" ], "calculation": { "http://www.invacare.com/role/ReceivablesAgingofInstallmentReceivablesDetails": { "order": 1.0, "parentTag": "us-gaap_FinancingReceivableRecordedInvestmentPastDue", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of financing receivable not past due.", "label": "Financing Receivable, Not Past Due", "terseLabel": "Current" } } }, "localname": "FinancingReceivableRecordedInvestmentCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesAgingofInstallmentReceivablesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinancingReceivableRecordedInvestmentPastDue": { "auth_ref": [ "r237", "r257", "r269" ], "calculation": { "http://www.invacare.com/role/ReceivablesAgingofInstallmentReceivablesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of financing receivable past due.", "label": "Financing Receivable, Past Due", "totalLabel": "Total Installment Receivables Past Due" } } }, "localname": "FinancingReceivableRecordedInvestmentPastDue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesAgingofInstallmentReceivablesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinancingReceivableRecordedInvestmentPastDueLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Financing Receivable, Past Due [Line Items]", "terseLabel": "Financing Receivable, Recorded Investment, Past Due [Line Items]" } } }, "localname": "FinancingReceivableRecordedInvestmentPastDueLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesAgingofInstallmentReceivablesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetUsefulLife": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Finite-Lived Intangible Asset, Useful Life", "terseLabel": "Finite-Lived intangible assets, useful life" } } }, "localname": "FiniteLivedIntangibleAssetUsefulLife", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/IntangiblesNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": { "auth_ref": [ "r292" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Accumulated Amortization", "terseLabel": "Accumulated Amortization" } } }, "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/IntangiblesIntangibleTableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": { "auth_ref": [ "r294" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One", "terseLabel": "Future amortization expense, 2021" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/IntangiblesFiniteLivedIntangibleAssetFutureAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in remainder of current fiscal year.", "label": "Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year", "terseLabel": "Future amortization expense, remainder of fiscal year" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/IntangiblesFiniteLivedIntangibleAssetFutureAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": { "auth_ref": [ "r294" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Five", "terseLabel": "Future amortization expense, 2025" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/IntangiblesFiniteLivedIntangibleAssetFutureAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": { "auth_ref": [ "r294" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four", "terseLabel": "Future amortization expense, 2024" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/IntangiblesFiniteLivedIntangibleAssetFutureAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": { "auth_ref": [ "r294" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three", "terseLabel": "Future amortization expense, 2023" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/IntangiblesFiniteLivedIntangibleAssetFutureAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": { "auth_ref": [ "r294" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two", "terseLabel": "Future amortization expense, 2022" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/IntangiblesFiniteLivedIntangibleAssetFutureAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": { "auth_ref": [ "r287", "r289", "r292", "r296", "r587", "r591" ], "lang": { "en-US": { "role": { "documentation": "Information by major type or class of finite-lived intangible assets.", "label": "Finite-Lived Intangible Assets by Major Class [Axis]", "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]" } } }, "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/IntangiblesIntangibleTableDetails", "http://www.invacare.com/role/IntangiblesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsGross": { "auth_ref": [ "r292", "r591" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Gross", "terseLabel": "Historical Cost" } } }, "localname": "FiniteLivedIntangibleAssetsGross", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/IntangiblesIntangibleTableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Finite-Lived Intangible Assets [Line Items]", "terseLabel": "Finite-Lived Intangible Assets [Line Items]" } } }, "localname": "FiniteLivedIntangibleAssetsLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/IntangiblesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": { "auth_ref": [ "r287", "r291" ], "lang": { "en-US": { "role": { "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.", "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]", "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]" } } }, "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/IntangiblesIntangibleTableDetails", "http://www.invacare.com/role/IntangiblesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ForeignExchangeForwardMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Foreign exchange forward traded on an exchange (examples include but are not limited to the International Securities Exchange, Philadelphia Stock Exchange, or the Chicago Mercantile Exchange) for options or future contracts to buy or sell a certain currency, at a specified date, at a fixed exercise exchange rate.", "label": "Foreign Exchange Forward [Member]", "terseLabel": "Forward exchange contracts\u2014net", "verboseLabel": "Foreign currency forward contracts" } } }, "localname": "ForeignExchangeForwardMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/AccumulatedOtherComprehensiveIncomeLossbyComponentReclassifiedOutofAccumulatedOtherComprehensiveIncomeDetails", "http://www.invacare.com/role/DerivativesBalanceSheetLocationDetails", "http://www.invacare.com/role/DerivativesGainLossinStatementofFinacialPositionDetails", "http://www.invacare.com/role/DerivativesNarrativeDetails", "http://www.invacare.com/role/DerivativesNotionalAmountsNotDesignatedasHedgesDetails", "http://www.invacare.com/role/FairValuesAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.invacare.com/role/FairValuesDetailsofBookValueandFairValueofFinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FurnitureAndFixturesMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.", "label": "Furniture and Fixtures [Member]", "terseLabel": "Furniture and fixtures" } } }, "localname": "FurnitureAndFixturesMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/PropertyAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_GainLossOnSaleOfBusiness": { "auth_ref": [ "r125", "r459" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 }, "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss": { "order": 2.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of gain (loss) from sale and disposal of integrated set of activities and assets capable of being conducted and managed for purpose of providing return in form of dividend, lower cost, or other economic benefit to investor, owner, member and participant.", "label": "Gain (Loss) on Disposition of Business", "terseLabel": "Gain on sale of business" } } }, "localname": "GainLossOnSaleOfBusiness", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/BusinessSegmentsInformationbySegmentDetails", "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows", "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss", "http://www.invacare.com/role/DivestedBusinessesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GainLossOnSaleOfProperties": { "auth_ref": [ "r125", "r299", "r303" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The difference between the carrying value and the sale price of real estate or properties that were intended to be sold or held for capital appreciation or rental income. This element refers to the gain (loss) included in earnings and not to the cash proceeds of the sale. This element is a noncash adjustment to net income when calculating net cash generated by operating activities using the indirect method.", "label": "Gain (Loss) on Sale of Properties", "terseLabel": "Gain (Loss) on Sale of Properties" } } }, "localname": "GainLossOnSaleOfProperties", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/PropertyAndEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GainLossOnSaleOfPropertyPlantEquipment": { "auth_ref": [ "r125" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.", "label": "Gain (Loss) on Disposition of Property Plant Equipment", "negatedLabel": "Loss (gain) on disposals of property and equipment" } } }, "localname": "GainLossOnSaleOfPropertyPlantEquipment", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_GainsLossesOnExtinguishmentOfDebt": { "auth_ref": [ "r125", "r347", "r348" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows": { "order": 20.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 }, "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss": { "order": 3.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.", "label": "Gain (Loss) on Extinguishment of Debt", "negatedTerseLabel": "Loss on debt extinguishment including debt finance charges and fees", "terseLabel": "Loss on debt extinguishment including debt finance charges and fees" } } }, "localname": "GainsLossesOnExtinguishmentOfDebt", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/BusinessSegmentsInformationbySegmentDetails", "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows", "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GeographicDistributionAxis": { "auth_ref": [ "r267", "r609", "r610" ], "lang": { "en-US": { "role": { "documentation": "Information by geographic distribution of business activity identified as either domestic or foreign. Excludes names of countries, states and provinces, and cities.", "label": "Geographic Distribution [Axis]", "terseLabel": "Geographic Distribution [Axis]" } } }, "localname": "GeographicDistributionAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesNarrativeDetails", "http://www.invacare.com/role/ReceivablesScheduleforAllowanceforCreditLossesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_GeographicDistributionDomain": { "auth_ref": [ "r609", "r610" ], "lang": { "en-US": { "role": { "documentation": "Allocation of business activity identified as domestic or foreign. Excludes names of countries, states and provinces, and cities.", "label": "Geographic Distribution [Domain]", "terseLabel": "Geographic Distribution [Domain]" } } }, "localname": "GeographicDistributionDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesNarrativeDetails", "http://www.invacare.com/role/ReceivablesScheduleforAllowanceforCreditLossesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_Goodwill": { "auth_ref": [ "r280", "r281", "r593" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets": { "order": 7.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill", "terseLabel": "Goodwill" } } }, "localname": "Goodwill", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Goodwill and Intangible Assets Disclosure [Abstract]", "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]" } } }, "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_GoodwillDisclosureTextBlock": { "auth_ref": [ "r284" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for goodwill.", "label": "Goodwill Disclosure [Text Block]", "terseLabel": "Goodwill" } } }, "localname": "GoodwillDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/Goodwill" ], "xbrltype": "textBlockItemType" }, "us-gaap_GoodwillLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Goodwill [Line Items]", "terseLabel": "Goodwill [Line Items]" } } }, "localname": "GoodwillLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/GoodwillGoodwillDetailsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_GrossProfit": { "auth_ref": [ "r105", "r130", "r200", "r206", "r210", "r213", "r216", "r243", "r511" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss": { "order": 4.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.", "label": "Gross Profit", "totalLabel": "Gross Profit" } } }, "localname": "GrossProfit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_HedgingDesignationAxis": { "auth_ref": [ "r469", "r487" ], "lang": { "en-US": { "role": { "documentation": "Information by designation of purpose of derivative instrument.", "label": "Hedging Designation [Axis]", "terseLabel": "Hedging Designation [Axis]" } } }, "localname": "HedgingDesignationAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/DerivativesBalanceSheetLocationDetails", "http://www.invacare.com/role/DerivativesFairValueofConvertibleDebtHedgesDetails", "http://www.invacare.com/role/DerivativesGainLossinStatementofFinacialPositionDetails", "http://www.invacare.com/role/DerivativesNotionalAmountsDesignatedasHedgesDetails", "http://www.invacare.com/role/DerivativesNotionalAmountsNotDesignatedasHedgesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_HedgingDesignationDomain": { "auth_ref": [ "r469" ], "lang": { "en-US": { "role": { "documentation": "Designation of purpose of derivative instrument.", "label": "Hedging Designation [Domain]", "terseLabel": "Hedging Designation [Domain]" } } }, "localname": "HedgingDesignationDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/DerivativesBalanceSheetLocationDetails", "http://www.invacare.com/role/DerivativesFairValueofConvertibleDebtHedgesDetails", "http://www.invacare.com/role/DerivativesGainLossinStatementofFinacialPositionDetails", "http://www.invacare.com/role/DerivativesNotionalAmountsDesignatedasHedgesDetails", "http://www.invacare.com/role/DerivativesNotionalAmountsNotDesignatedasHedgesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_HedgingRelationshipDomain": { "auth_ref": [ "r469" ], "lang": { "en-US": { "role": { "documentation": "Nature or intent of a hedge.", "label": "Hedging Relationship [Domain]", "terseLabel": "Hedging Relationship [Domain]" } } }, "localname": "HedgingRelationshipDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/DerivativesFairValueofConvertibleDebtHedgesDetails", "http://www.invacare.com/role/DerivativesGainLossinStatementofFinacialPositionDetails", "http://www.invacare.com/role/DerivativesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ImpairedFinancingReceivableInterestIncomeAccrualMethodAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Impaired Financing Receivable, Interest Income, Accrual Method [Abstract]", "terseLabel": "Interest Income Recognized" } } }, "localname": "ImpairedFinancingReceivableInterestIncomeAccrualMethodAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesInstallmentReceivablesbyClassDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ImpairedFinancingReceivableRecordedInvestmentAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Impaired Financing Receivable, Recorded Investment [Abstract]", "terseLabel": "Total Installment Receivables" } } }, "localname": "ImpairedFinancingReceivableRecordedInvestmentAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesInstallmentReceivablesbyClassDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ImpairedFinancingReceivableRelatedAllowance": { "auth_ref": [ "r230" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of allowance for credit losses related to recorded investment.", "label": "Impaired Financing Receivable, Related Allowance", "terseLabel": "Impaired installment receivables with a related allowance recorded" } } }, "localname": "ImpairedFinancingReceivableRelatedAllowance", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesInstallmentReceivablesbyClassDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ImpairedFinancingReceivableUnpaidPrincipalBalanceAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Impaired Financing Receivable, Unpaid Principal Balance [Abstract]", "terseLabel": "Unpaid Principal Balance" } } }, "localname": "ImpairedFinancingReceivableUnpaidPrincipalBalanceAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesInstallmentReceivablesbyClassDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ImpairedFinancingReceivableWithRelatedAllowanceInterestIncomeAccrualMethod": { "auth_ref": [ "r232" ], "calculation": { "http://www.invacare.com/role/ReceivablesInstallmentReceivablesbyClassDetails": { "order": 2.0, "parentTag": "ivc_FinancingReceivableInterestIncomeAccrualMethod", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of interest income, recognized on accrual basis, on financing receivables, for which there is a related allowance for credit losses and are recognized as impaired.", "label": "Impaired Financing Receivable, with Related Allowance, Interest Income, Accrual Method", "terseLabel": "Impaired installment receivables with a related allowance recorded" } } }, "localname": "ImpairedFinancingReceivableWithRelatedAllowanceInterestIncomeAccrualMethod", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesInstallmentReceivablesbyClassDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ImpairedFinancingReceivableWithRelatedAllowanceRecordedInvestment": { "auth_ref": [ "r229" ], "calculation": { "http://www.invacare.com/role/ReceivablesInstallmentReceivablesbyClassDetails": { "order": 2.0, "parentTag": "ivc_FinancingReceivableRecordedInvestment", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of investment in impaired financing receivables for which there is a related allowance for credit losses.", "label": "Impaired Financing Receivable, with Related Allowance, Recorded Investment", "terseLabel": "Impaired installment receivables with a related allowance recorded" } } }, "localname": "ImpairedFinancingReceivableWithRelatedAllowanceRecordedInvestment", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesInstallmentReceivablesbyClassDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ImpairedFinancingReceivableWithRelatedAllowanceUnpaidPrincipalBalance": { "auth_ref": [ "r231" ], "calculation": { "http://www.invacare.com/role/ReceivablesInstallmentReceivablesbyClassDetails": { "order": 2.0, "parentTag": "ivc_FinancingReceivableUnpaidPrincipalBalance", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Unpaid principal balance of impaired financing receivables for which there is a related allowance for credit losses.", "label": "Impaired Financing Receivable, with Related Allowance, Unpaid Principal Balance", "terseLabel": "Impaired installment receivables with a related allowance recorded" } } }, "localname": "ImpairedFinancingReceivableWithRelatedAllowanceUnpaidPrincipalBalance", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesInstallmentReceivablesbyClassDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ImpairedFinancingReceivablesTableTextBlock": { "auth_ref": [ "r233" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of impaired financing receivables.", "label": "Impaired Financing Receivables [Table Text Block]", "terseLabel": "Schedule of Installment Receivables by Class" } } }, "localname": "ImpairedFinancingReceivablesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeLossFromContinuingOperations": { "auth_ref": [ "r106", "r126", "r146", "r147", "r148", "r149", "r164", "r167", "r451" ], "calculation": { "http://www.invacare.com/role/AccumulatedOtherComprehensiveIncomeLossbyComponentReclassifiedOutofAccumulatedOtherComprehensiveIncomeDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount after tax of income (loss) from continuing operations attributable to the parent.", "label": "Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent", "terseLabel": "Net loss from continuing operations", "totalLabel": "Net loss from Continuing Operations" } } }, "localname": "IncomeLossFromContinuingOperations", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/AccumulatedOtherComprehensiveIncomeLossbyComponentReclassifiedOutofAccumulatedOtherComprehensiveIncomeDetails", "http://www.invacare.com/role/NetEarningsLossPerCommonShareComputationofBasicandDilutedNetEarningsLossPerCommonShareDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "auth_ref": [ "r98", "r200", "r206", "r210", "r213", "r216", "r592", "r603", "r610", "r629" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.", "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest", "terseLabel": "Earnings (loss) before income taxes", "totalLabel": "Loss Before Income Taxes" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/BusinessSegmentsInformationbySegmentDetails", "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments": { "auth_ref": [ "r135", "r200", "r206", "r210", "r213", "r216" ], "calculation": { "http://www.invacare.com/role/AccumulatedOtherComprehensiveIncomeLossbyComponentReclassifiedOutofAccumulatedOtherComprehensiveIncomeDetails": { "order": 3.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperations", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.", "label": "Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest", "totalLabel": "Income (Loss) from Continuing Operations before Income Taxes" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/AccumulatedOtherComprehensiveIncomeLossbyComponentReclassifiedOutofAccumulatedOtherComprehensiveIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis": { "auth_ref": [ "r377", "r380" ], "lang": { "en-US": { "role": { "documentation": "Information by name of disposal group.", "label": "Disposal Group Name [Axis]", "terseLabel": "Disposal Group Name [Axis]" } } }, "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/GoodwillGoodwillDetailsDetails", "http://www.invacare.com/role/PropertyAndEquipmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationAxis": { "auth_ref": [ "r304" ], "lang": { "en-US": { "role": { "documentation": "Information by location in the income statement.", "label": "Income Statement Location [Axis]", "terseLabel": "Income Statement Location [Axis]" } } }, "localname": "IncomeStatementLocationAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/DerivativesNarrativeDetails", "http://www.invacare.com/role/EquityCompensationSharebasedCompensationExpenseDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Location in the income statement.", "label": "Income Statement Location [Domain]", "terseLabel": "Income Statement Location [Domain]" } } }, "localname": "IncomeStatementLocationDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/DerivativesNarrativeDetails", "http://www.invacare.com/role/EquityCompensationSharebasedCompensationExpenseDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeTaxDisclosureAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Income Tax Disclosure [Abstract]", "terseLabel": "Income Tax Disclosure [Abstract]" } } }, "localname": "IncomeTaxDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureTextBlock": { "auth_ref": [ "r423", "r424", "r426", "r434", "r440", "r442", "r443", "r444" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.", "label": "Income Tax Disclosure [Text Block]", "terseLabel": "Income Taxes" } } }, "localname": "IncomeTaxDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/IncomeTaxes" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxExpenseBenefit": { "auth_ref": [ "r131", "r153", "r154", "r198", "r421", "r435", "r441", "r630" ], "calculation": { "http://www.invacare.com/role/AccumulatedOtherComprehensiveIncomeLossbyComponentReclassifiedOutofAccumulatedOtherComprehensiveIncomeDetails": { "order": 2.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperations", "weight": -1.0 }, "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Income Tax Expense (Benefit)", "negatedTerseLabel": "Income tax provision", "terseLabel": "Income tax provision" } } }, "localname": "IncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/AccumulatedOtherComprehensiveIncomeLossbyComponentReclassifiedOutofAccumulatedOtherComprehensiveIncomeDetails", "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxesReceivable": { "auth_ref": [ "r65", "r602", "r624" ], "calculation": { "http://www.invacare.com/role/OtherCurrentAssetsComponentsofOtherCurrentAssetsDetails": { "order": 3.0, "parentTag": "us-gaap_OtherAssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Carrying amount due within one year of the balance sheet date (or one operating cycle, if longer) from tax authorities as of the balance sheet date representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes.", "label": "Income Taxes Receivable, Current", "terseLabel": "Recoverable income taxes" } } }, "localname": "IncomeTaxesReceivable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/OtherCurrentAssetsComponentsofOtherCurrentAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayable": { "auth_ref": [ "r124" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows": { "order": 17.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.", "label": "Increase (Decrease) in Accounts Payable", "terseLabel": "Accounts payable" } } }, "localname": "IncreaseDecreaseInAccountsPayable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "auth_ref": [ "r124" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows": { "order": 13.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.", "label": "Increase (Decrease) in Accounts Receivable", "negatedLabel": "Trade receivables" } } }, "localname": "IncreaseDecreaseInAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccruedLiabilities": { "auth_ref": [ "r124" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows": { "order": 18.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.", "label": "Increase (Decrease) in Accrued Liabilities", "terseLabel": "Accrued expenses" } } }, "localname": "IncreaseDecreaseInAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInFinanceReceivables": { "auth_ref": [ "r124" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows": { "order": 14.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The increase (decrease) during the reporting period in outstanding loans including accrued interest.", "label": "Increase (Decrease) in Finance Receivables", "negatedLabel": "Installment sales contracts, net" } } }, "localname": "IncreaseDecreaseInFinanceReceivables", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInInventories": { "auth_ref": [ "r124" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows": { "order": 15.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.", "label": "Increase (Decrease) in Inventories", "negatedLabel": "Inventories, net" } } }, "localname": "IncreaseDecreaseInInventories", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Increase (Decrease) in Operating Capital [Abstract]", "terseLabel": "Changes in operating assets and liabilities:" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInOtherDeferredLiability": { "auth_ref": [ "r124" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows": { "order": 19.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of increase (decrease) in deferred obligations classified as other.", "label": "Increase (Decrease) in Other Deferred Liability", "terseLabel": "Other long-term liabilities" } } }, "localname": "IncreaseDecreaseInOtherDeferredLiability", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOtherOperatingAssets": { "auth_ref": [ "r124" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows": { "order": 16.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of increase (decrease) in operating assets classified as other.", "label": "Increase (Decrease) in Other Operating Assets", "negatedLabel": "Other current assets" } } }, "localname": "IncreaseDecreaseInOtherOperatingAssets", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": { "auth_ref": [ "r159", "r160", "r161", "r167" ], "calculation": { "http://www.invacare.com/role/NetEarningsLossPerCommonShareComputationofBasicandDilutedNetEarningsLossPerCommonShareDetails": { "order": 2.0, "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0 } }, "lang": { "en-US": { "role": { "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.", "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements", "terseLabel": "Stock options and awards" } } }, "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/NetEarningsLossPerCommonShareComputationofBasicandDilutedNetEarningsLossPerCommonShareDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis": { "auth_ref": [ "r288", "r295" ], "lang": { "en-US": { "role": { "documentation": "Information by type or class of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.", "label": "Indefinite-lived Intangible Assets [Axis]", "terseLabel": "Indefinite-lived Intangible Assets by Major Class [Axis]" } } }, "localname": "IndefiniteLivedIntangibleAssetsByMajorClassAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/IntangiblesIntangibleTableDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill": { "auth_ref": [ "r295" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.", "label": "Indefinite-lived Intangible Assets (Excluding Goodwill)", "terseLabel": "Historical Cost" } } }, "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/IntangiblesIntangibleTableDetails", "http://www.invacare.com/role/IntangiblesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain": { "auth_ref": [ "r288", "r295" ], "lang": { "en-US": { "role": { "documentation": "The major class of indefinite-lived intangible asset (for example, trade names, etc. but not all-inclusive), excluding goodwill. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of the company.", "label": "Indefinite-lived Intangible Assets, Major Class Name [Domain]", "terseLabel": "Indefinite-lived Intangible Assets, Major Class Name [Domain]" } } }, "localname": "IndefiniteLivedIntangibleAssetsMajorClassNameDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/IntangiblesIntangibleTableDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IndustryOfCounterpartyDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The industry of the party or parties having primary responsibility to meet the obligations of the arrangement with the entity.", "label": "Industry of Counterparty [Domain]", "terseLabel": "Industry of Counterparty [Domain]" } } }, "localname": "IndustryOfCounterpartyDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IntangibleAssetsDisclosureTextBlock": { "auth_ref": [ "r298" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for all or part of the information related to intangible assets.", "label": "Intangible Assets Disclosure [Text Block]", "terseLabel": "Other Intangibles" } } }, "localname": "IntangibleAssetsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/Intangibles" ], "xbrltype": "textBlockItemType" }, "us-gaap_IntangibleAssetsNetExcludingGoodwill": { "auth_ref": [ "r285", "r290" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.", "label": "Intangible Assets, Net (Excluding Goodwill)", "terseLabel": "Intangibles" } } }, "localname": "IntangibleAssetsNetExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpense": { "auth_ref": [ "r96", "r194", "r520", "r523", "r608" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss": { "order": 2.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.", "label": "Interest Expense", "terseLabel": "Interest expense" } } }, "localname": "InterestExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestIncomeOther": { "auth_ref": [], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss": { "order": 4.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of interest income earned from interest bearing assets classified as other.", "label": "Interest Income, Other", "terseLabel": "Interest Income, Other" } } }, "localname": "InterestIncomeOther", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPayableCurrent": { "auth_ref": [ "r19", "r20", "r56" ], "calculation": { "http://www.invacare.com/role/AccruedExpensesComponentsofAccruedExpensesDetails": { "order": 11.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Interest Payable, Current", "terseLabel": "Interest" } } }, "localname": "InterestPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/AccruedExpensesComponentsofAccruedExpensesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestRevenueExpenseNet": { "auth_ref": [ "r200" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of interest revenue (income derived from investments in debt securities and on cash and cash equivalents) net of interest expense (cost of borrowed funds accounted for as interest).", "label": "Interest Revenue (Expense), Net", "terseLabel": "Interest Revenue (Expense), Net" } } }, "localname": "InterestRevenueExpenseNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/BusinessSegmentsInformationbySegmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IntersegmentEliminationMember": { "auth_ref": [ "r192", "r205", "r206", "r207", "r208", "r210", "r212", "r216" ], "lang": { "en-US": { "role": { "documentation": "Eliminating entries used in operating segment consolidation.", "label": "Intersegment Eliminations [Member]", "terseLabel": "Intersegment revenues" } } }, "localname": "IntersegmentEliminationMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/BusinessSegmentsInformationbySegmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_InventoryDisclosureAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Inventory Disclosure [Abstract]", "terseLabel": "Inventory Disclosure [Abstract]" } } }, "localname": "InventoryDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_InventoryDisclosureTextBlock": { "auth_ref": [ "r277" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.", "label": "Inventory Disclosure [Text Block]", "terseLabel": "Inventories" } } }, "localname": "InventoryDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/Inventories" ], "xbrltype": "textBlockItemType" }, "us-gaap_InventoryFinishedGoodsNetOfReserves": { "auth_ref": [ "r42", "r276" ], "calculation": { "http://www.invacare.com/role/InventoriesDetails": { "order": 1.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.", "label": "Inventory, Finished Goods, Net of Reserves", "terseLabel": "Finished goods" } } }, "localname": "InventoryFinishedGoodsNetOfReserves", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/InventoriesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryNet": { "auth_ref": [ "r9", "r68" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 }, "http://www.invacare.com/role/InventoriesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.", "label": "Inventory, Net", "terseLabel": "Inventories, net", "totalLabel": "Inventory, net" } } }, "localname": "InventoryNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets", "http://www.invacare.com/role/InventoriesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryRawMaterialsNetOfReserves": { "auth_ref": [ "r44", "r276" ], "calculation": { "http://www.invacare.com/role/InventoriesDetails": { "order": 2.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.", "label": "Inventory, Raw Materials, Net of Reserves", "terseLabel": "Raw materials" } } }, "localname": "InventoryRawMaterialsNetOfReserves", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/InventoriesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryWorkInProcessNetOfReserves": { "auth_ref": [ "r43", "r276" ], "calculation": { "http://www.invacare.com/role/InventoriesDetails": { "order": 3.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.", "label": "Inventory, Work in Process, Net of Reserves", "terseLabel": "Work in process" } } }, "localname": "InventoryWorkInProcessNetOfReserves", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/InventoriesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LandBuildingsAndImprovementsMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Real estate held and additions or improvements to real estate held and structures used in the conduct of business.", "label": "Land, Buildings and Improvements [Member]", "terseLabel": "Land, buildings and improvements" } } }, "localname": "LandBuildingsAndImprovementsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/PropertyAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LeaseCostTableTextBlock": { "auth_ref": [ "r548" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.", "label": "Lease, Cost [Table Text Block]", "terseLabel": "Lease, Cost [Table]" } } }, "localname": "LeaseCostTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_LeaseholdImprovementsMember": { "auth_ref": [ "r300" ], "lang": { "en-US": { "role": { "documentation": "Additions or improvements to assets held under a lease arrangement.", "label": "Leasehold Improvements [Member]", "terseLabel": "Leasehold improvements" } } }, "localname": "LeaseholdImprovementsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/PropertyAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LeasesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Leases [Abstract]", "terseLabel": "Leases [Abstract]" } } }, "localname": "LeasesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_LeasesOfLesseeDisclosureTextBlock": { "auth_ref": [ "r536" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for lessee entity's leasing arrangements including, but not limited to, all of the following: (a.) The basis on which contingent rental payments are determined, (b.) The existence and terms of renewal or purchase options and escalation clauses, (c.) Restrictions imposed by lease agreements, such as those concerning dividends, additional debt, and further leasing.", "label": "Leases of Lessee Disclosure [Text Block]", "terseLabel": "Leases of Lessee Disclosure [Text Block]" } } }, "localname": "LeasesOfLesseeDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsNotes" ], "xbrltype": "textBlockItemType" }, "us-gaap_LegalEntityTypeOfCounterpartyDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Nature of the other party participating in a financial transaction.", "label": "Legal Entity Type of Counterparty [Domain]", "terseLabel": "Legal Entity Type of Counterparty [Domain]" } } }, "localname": "LegalEntityTypeOfCounterpartyDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LesseeLeaseDescriptionLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Lessee, Lease, Description [Line Items]", "terseLabel": "Lessee, Lease, Description [Line Items]" } } }, "localname": "LesseeLeaseDescriptionLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LesseeLeaseDescriptionTable": { "auth_ref": [ "r541" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of information about lessee's leases.", "label": "Lessee, Lease, Description [Table]", "terseLabel": "Lessee, Lease, Description [Table]" } } }, "localname": "LesseeLeaseDescriptionTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LetterOfCreditMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "A document typically issued by a financial institution which acts as a guarantee of payment to a beneficiary, or as the source of payment for a specific transaction (for example, wiring funds to a foreign exporter if and when specified merchandise is accepted pursuant to the terms of the letter of credit).", "label": "Letter of Credit [Member]", "terseLabel": "Letter of Credit" } } }, "localname": "LetterOfCreditMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LettersOfCreditOutstandingAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The total amount of the contingent obligation under letters of credit outstanding as of the reporting date.", "label": "Letters of Credit Outstanding, Amount", "terseLabel": "Letters of Credit Outstanding, Amount" } } }, "localname": "LettersOfCreditOutstandingAmount", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r39", "r130", "r243", "r511", "r599", "r621" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "Total Liabilities and Shareholders\u2019 Equity" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Liabilities and Equity [Abstract]", "terseLabel": "Liabilities and Shareholders\u2019 Equity" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r58", "r130", "r243", "r455", "r460", "r461", "r511" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "totalLabel": "Total Current Liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Liabilities, Current [Abstract]", "terseLabel": "Current Liabilities" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation": { "auth_ref": [ "r0", "r1", "r4", "r5", "r6", "r305" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount classified as liabilities attributable to disposal group held for sale or disposed of.", "label": "Disposal Group, Including Discontinued Operation, Liabilities", "terseLabel": "Disposal Group, Including Discontinued Operation, Liabilities" } } }, "localname": "LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/DivestedBusinessesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilityForUncertainTaxPositionsNoncurrent": { "auth_ref": [ "r62" ], "calculation": { "http://www.invacare.com/role/OtherLongTermObligationsDetails": { "order": 4.0, "parentTag": "us-gaap_OtherLiabilitiesNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount recognized for uncertainty in income taxes classified as noncurrent.", "label": "Liability for Uncertainty in Income Taxes, Noncurrent", "terseLabel": "Uncertain tax obligation including interest" } } }, "localname": "LiabilityForUncertainTaxPositionsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/OtherLongTermObligationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LicensingAgreementsMember": { "auth_ref": [ "r447" ], "lang": { "en-US": { "role": { "documentation": "Rights, generally of limited duration, under a license arrangement (for example, to sell or otherwise utilize specified products or processes in a specified territory).", "label": "Licensing Agreements [Member]", "verboseLabel": "License agreements" } } }, "localname": "LicensingAgreementsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/IntangiblesIntangibleTableDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity": { "auth_ref": [ "r54" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of current borrowing capacity under the credit facility considering any current restrictions on the amount that could be borrowed (for example, borrowings may be limited by the amount of current assets), but without considering any amounts currently outstanding under the facility.", "label": "Line of Credit Facility, Current Borrowing Capacity", "terseLabel": "Line of Credit Facility, Current Borrowing Capacity" } } }, "localname": "LineOfCreditFacilityCurrentBorrowingCapacity", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding": { "auth_ref": [ "r506" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Fair value of the amount outstanding under the credit facility.", "label": "Line of Credit Facility, Fair Value of Amount Outstanding", "terseLabel": "Line of Credit Facility, Fair Value of Amount Outstanding" } } }, "localname": "LineOfCreditFacilityFairValueOfAmountOutstanding", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LongTermDebtDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": { "auth_ref": [ "r54" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.", "label": "Line of Credit Facility, Maximum Borrowing Capacity", "terseLabel": "Borrowing capacity" } } }, "localname": "LineOfCreditFacilityMaximumBorrowingCapacity", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity": { "auth_ref": [ "r54" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding).", "label": "Line of Credit Facility, Remaining Borrowing Capacity", "terseLabel": "Line of Credit Facility, Remaining Borrowing Capacity" } } }, "localname": "LineOfCreditFacilityRemainingBorrowingCapacity", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The fee, expressed as a percentage of the line of credit facility, for available but unused credit capacity under the credit facility.", "label": "Line of Credit Facility, Unused Capacity, Commitment Fee Percentage", "terseLabel": "Commitment fee percentage" } } }, "localname": "LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_LineOfCreditMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars.", "label": "Line of Credit [Member]", "terseLabel": "Line of Credit" } } }, "localname": "LineOfCreditMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LongTermDebtDetails", "http://www.invacare.com/role/LongTermDebtLeverageRatiosDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock": { "auth_ref": [ "r239" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for claims held for amounts due a entity, excluding financing receivables. Examples include, but are not limited to, trade accounts receivables, notes receivables, loans receivables. Includes disclosure for allowance for credit losses.", "label": "Loans, Notes, Trade and Other Receivables Disclosure [Text Block]", "terseLabel": "Receivables" } } }, "localname": "LoansNotesTradeAndOtherReceivablesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/Receivables" ], "xbrltype": "textBlockItemType" }, "us-gaap_LondonInterbankOfferedRateLIBORMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Interest rate at which a bank borrows funds from other banks in the London interbank market.", "label": "London Interbank Offered Rate (LIBOR) [Member]", "terseLabel": "London Interbank Offered Rate (LIBOR)" } } }, "localname": "LondonInterbankOfferedRateLIBORMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LongTermDebtAndCapitalLeaseObligations": { "auth_ref": [ "r27" ], "calculation": { "http://www.invacare.com/role/LongTermDebtDetails": { "order": 1.0, "parentTag": "us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of long-term debt and lease obligation, classified as noncurrent.", "label": "Long-term Debt and Lease Obligation", "verboseLabel": "Long-term debt net of current maturities" } } }, "localname": "LongTermDebtAndCapitalLeaseObligations", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LongTermDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent": { "auth_ref": [ "r56" ], "calculation": { "http://www.invacare.com/role/LongTermDebtDetails": { "order": 2.0, "parentTag": "us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of long-term debt and lease obligation, classified as current.", "label": "Long-term Debt and Lease Obligation, Current", "negatedTerseLabel": "Long-term Debt and Capital Lease Obligations, Current" } } }, "localname": "LongTermDebtAndCapitalLeaseObligationsCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LongTermDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities": { "auth_ref": [], "calculation": { "http://www.invacare.com/role/LongTermDebtDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of long-term debt and lease obligation, including portion classified as current.", "label": "Long-term Debt and Lease Obligation, Including Current Maturities", "terseLabel": "Long-term debt", "totalLabel": "Long-term debt" } } }, "localname": "LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LongTermDebtComponentsofConvertibleDebtDetails", "http://www.invacare.com/role/LongTermDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtCurrent": { "auth_ref": [ "r55" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets": { "order": 6.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.", "label": "Long-term Debt, Current Maturities", "terseLabel": "Short-term debt and current maturities of long-term obligations" } } }, "localname": "LongTermDebtCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtNoncurrent": { "auth_ref": [ "r61" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.", "label": "Long-term Debt, Excluding Current Maturities", "terseLabel": "Long-Term Debt" } } }, "localname": "LongTermDebtNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermInvestments": { "auth_ref": [ "r49" ], "calculation": { "http://www.invacare.com/role/OtherLongTermAssetsComponentsofOtherLongTermAssetsDetails": { "order": 3.0, "parentTag": "us-gaap_OtherAssetsNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The total amount of investments that are intended to be held for an extended period of time (longer than one operating cycle).", "label": "Long-term Investments", "terseLabel": "Investments" } } }, "localname": "LongTermInvestments", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/OtherLongTermAssetsComponentsofOtherLongTermAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongtermDebtTypeAxis": { "auth_ref": [ "r61" ], "lang": { "en-US": { "role": { "documentation": "Information by type of long-term debt.", "label": "Long-term Debt, Type [Axis]", "terseLabel": "Long-term Debt, Type [Axis]" } } }, "localname": "LongtermDebtTypeAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/DerivativesFairValueofConvertibleDebtHedgesDetails", "http://www.invacare.com/role/DerivativesNarrativeDetails", "http://www.invacare.com/role/FairValuesAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.invacare.com/role/LongTermDebtComponentsofConvertibleDebtDetails", "http://www.invacare.com/role/LongTermDebtDetails", "http://www.invacare.com/role/LongTermDebtLeverageRatiosDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LongtermDebtTypeDomain": { "auth_ref": [ "r61", "r343" ], "lang": { "en-US": { "role": { "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Long-term Debt, Type [Domain]", "terseLabel": "Long-term Debt, Type [Domain]" } } }, "localname": "LongtermDebtTypeDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/DerivativesFairValueofConvertibleDebtHedgesDetails", "http://www.invacare.com/role/DerivativesNarrativeDetails", "http://www.invacare.com/role/FairValuesAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.invacare.com/role/LongTermDebtComponentsofConvertibleDebtDetails", "http://www.invacare.com/role/LongTermDebtDetails", "http://www.invacare.com/role/LongTermDebtLeverageRatiosDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LongtermDebtWeightedAverageInterestRate": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Weighted average interest rate of long-term debt outstanding calculated at point in time.", "label": "Long-term Debt, Weighted Average Interest Rate, at Point in Time", "terseLabel": "Weighted average interest rate (as a percent)" } } }, "localname": "LongtermDebtWeightedAverageInterestRate", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_LossContingenciesByNatureOfContingencyAxis": { "auth_ref": [ "r323", "r324", "r325", "r326", "r327", "r328", "r329", "r334", "r335" ], "lang": { "en-US": { "role": { "documentation": "Information by type of existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur.", "label": "Loss Contingency Nature [Axis]", "terseLabel": "Loss Contingency Nature [Axis]" } } }, "localname": "LossContingenciesByNatureOfContingencyAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/AccruedExpensesWarrantyScheduleDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LossContingencyDisclosures": { "auth_ref": [ "r331", "r332" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for loss and gain contingencies. Describes any existing condition, situation, or set of circumstances involving uncertainty as of the balance sheet date (or prior to issuance of the financial statements) as to a probable or reasonably possible loss incurred by an entity that will ultimately be resolved when one or more future events occur or fail to occur, and typically discloses the amount of loss recorded or a range of possible loss, or an assertion that no reasonable estimate can be made.", "label": "Contingencies Disclosure [Text Block]", "terseLabel": "Contingencies" } } }, "localname": "LossContingencyDisclosures", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/Contingencies" ], "xbrltype": "textBlockItemType" }, "us-gaap_LossContingencyNatureDomain": { "auth_ref": [ "r323", "r324", "r325", "r326", "r327", "r328", "r329", "r334", "r335" ], "lang": { "en-US": { "role": { "documentation": "An existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur. Resolution of the uncertainty may confirm the incurrence of a loss or impairment of an asset or the incurrence of a liability.", "label": "Loss Contingency, Nature [Domain]", "terseLabel": "Loss Contingency, Nature [Domain]" } } }, "localname": "LossContingencyNatureDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/AccruedExpensesWarrantyScheduleDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MachineryAndEquipmentMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment.", "label": "Machinery and Equipment [Member]", "terseLabel": "Machinery and equipment" } } }, "localname": "MachineryAndEquipmentMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/PropertyAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock": { "auth_ref": [ "r7", "r449" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for business combinations, including leverage buyout transactions (as applicable), and divestitures. This may include a description of a business combination or divestiture (or series of individually immaterial business combinations or divestitures) completed during the period, including background, timing, and assets and liabilities recognized and reclassified or sold. This element does not include fixed asset sales and plant closings.", "label": "Mergers, Acquisitions and Dispositions Disclosures [Text Block]", "terseLabel": "Divested Businesses" } } }, "localname": "MergersAcquisitionsAndDispositionsDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/DivestedBusinessesNotes" ], "xbrltype": "textBlockItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r122" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net Cash Provided (Used) by Financing Activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]", "terseLabel": "Financing Activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r122" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "Net Cash Used by Investing Activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]", "terseLabel": "Investing Activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r122", "r123", "r126" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-US": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Net Cash Provided by (Used in) Operating Activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Operating Activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Net Cash Provided by (Used in) Operating Activities, Continuing Operations [Abstract]", "terseLabel": "Adjustments to reconcile net loss to net cash used by operating activities:" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r6", "r89", "r92", "r99", "r126", "r130", "r142", "r146", "r147", "r148", "r149", "r153", "r154", "r164", "r200", "r206", "r210", "r213", "r216", "r243", "r511", "r604", "r625" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss": { "order": 1.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net Income (Loss) Attributable to Parent", "terseLabel": "Net Loss", "totalLabel": "Net Loss", "verboseLabel": "Net loss" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows", "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss", "http://www.invacare.com/role/CondensedConsolidatedStatementofShareholdersEquityStatement", "http://www.invacare.com/role/NetEarningsLossPerCommonShareComputationofBasicandDilutedNetEarningsLossPerCommonShareDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "New Accounting Pronouncements, Policy [Policy Text Block]", "terseLabel": "Recent Accounting Pronouncements" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/AccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_NondesignatedMember": { "auth_ref": [ "r469" ], "lang": { "en-US": { "role": { "documentation": "Derivative instrument not designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).", "label": "Not Designated as Hedging Instrument [Member]", "terseLabel": "Not Designated as Hedging Instrument [Member]" } } }, "localname": "NondesignatedMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/DerivativesBalanceSheetLocationDetails", "http://www.invacare.com/role/DerivativesGainLossinStatementofFinacialPositionDetails", "http://www.invacare.com/role/DerivativesNotionalAmountsDesignatedasHedgesDetails", "http://www.invacare.com/role/DerivativesNotionalAmountsNotDesignatedasHedgesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_NotesAndLoansReceivableGrossCurrent": { "auth_ref": [ "r10", "r11", "r66", "r225" ], "calculation": { "http://www.invacare.com/role/ReceivablesInstallmentRecevablesDetails": { "order": 1.0, "parentTag": "ivc_NotesLoansAndFinancingReceivableNetOfUnearnedInterestCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount, before allowance for credit loss, of financing receivable, classified as current.", "label": "Financing Receivable, before Allowance for Credit Loss, Current", "terseLabel": "Installment Receivables, Current" } } }, "localname": "NotesAndLoansReceivableGrossCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesInstallmentRecevablesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NotesAndLoansReceivableGrossNoncurrent": { "auth_ref": [ "r224" ], "calculation": { "http://www.invacare.com/role/ReceivablesInstallmentRecevablesDetails": { "order": 2.0, "parentTag": "us-gaap_NotesReceivableGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount, before allowance for credit loss, of financing receivable, classified as noncurrent.", "label": "Financing Receivable, before Allowance for Credit Loss, Noncurrent", "terseLabel": "Installment Receivables, Long-Term" } } }, "localname": "NotesAndLoansReceivableGrossNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesInstallmentRecevablesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NotesAndLoansReceivableNetCurrent": { "auth_ref": [ "r10", "r11", "r32", "r224", "r225", "r601" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 }, "http://www.invacare.com/role/ReceivablesInstallmentRecevablesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount, after allowance for credit loss, of financing receivable, classified as current. Includes, but is not limited to, notes and loan receivable.", "label": "Financing Receivable, after Allowance for Credit Loss, Current", "terseLabel": "Installment receivables, net", "totalLabel": "Installment receivables, net" } } }, "localname": "NotesAndLoansReceivableNetCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets", "http://www.invacare.com/role/ReceivablesInstallmentRecevablesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NotesAndLoansReceivableNetNoncurrent": { "auth_ref": [ "r33" ], "calculation": { "http://www.invacare.com/role/OtherLongTermAssetsComponentsofOtherLongTermAssetsDetails": { "order": 4.0, "parentTag": "us-gaap_OtherAssetsNoncurrent", "weight": 1.0 }, "http://www.invacare.com/role/ReceivablesInstallmentRecevablesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount, after allowance for credit loss, of financing receivable, classified as noncurrent.", "label": "Financing Receivable, after Allowance for Credit Loss, Noncurrent", "terseLabel": "Installment receivables", "totalLabel": "Installment receivables, net, long-term" } } }, "localname": "NotesAndLoansReceivableNetNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/OtherLongTermAssetsComponentsofOtherLongTermAssetsDetails", "http://www.invacare.com/role/ReceivablesInstallmentRecevablesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NotesReceivableGross": { "auth_ref": [ "r259", "r268", "r269" ], "calculation": { "http://www.invacare.com/role/ReceivablesInstallmentRecevablesDetails": { "order": 1.0, "parentTag": "ivc_NotesLoansAndFinancingReceivableNetOfUnearnedInterest", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount, before allowance for credit loss, of financing receivable.", "label": "Financing Receivable, before Allowance for Credit Loss", "totalLabel": "Total Installment Receivables" } } }, "localname": "NotesReceivableGross", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesInstallmentRecevablesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NotesReceivableNet": { "auth_ref": [ "r33", "r224", "r259" ], "calculation": { "http://www.invacare.com/role/ReceivablesInstallmentRecevablesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount, after allowance for credit loss, of financing receivable. Excludes financing receivable covered under loss sharing agreement.", "label": "Financing Receivable, after Allowance for Credit Loss", "totalLabel": "Installment receivables, net" } } }, "localname": "NotesReceivableNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesInstallmentRecevablesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r200", "r206", "r210", "r213", "r216" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss": { "order": 1.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating Income (Loss)", "terseLabel": "Operating Income (Loss)", "totalLabel": "Operating Income (Loss)" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/BusinessSegmentsInformationbySegmentDetails", "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseCost": { "auth_ref": [ "r543", "r550" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.", "label": "Operating Lease, Cost", "terseLabel": "Operating Lease, Cost" } } }, "localname": "OperatingLeaseCost", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsLeaseExpensesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseExpense": { "auth_ref": [ "r540" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of operating lease expense. Excludes sublease income.", "label": "Operating Lease, Expense", "terseLabel": "Operating Lease, Expense" } } }, "localname": "OperatingLeaseExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsLeaseExpensesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityCurrent": { "auth_ref": [ "r538" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.", "label": "Operating Lease, Liability, Current", "negatedTerseLabel": "Operating Lease, Liability, Current", "terseLabel": "Current portion of operating lease obligations" } } }, "localname": "OperatingLeaseLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets", "http://www.invacare.com/role/LeasesandCommitmentsFutureMinimumOperatingandFinancingLeaseCommitmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "auth_ref": [ "r538" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.", "label": "Operating Lease, Liability, Noncurrent", "terseLabel": "Operating Leases Long-Term Obligations" } } }, "localname": "OperatingLeaseLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets", "http://www.invacare.com/role/LeasesandCommitmentsFutureMinimumOperatingandFinancingLeaseCommitmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAsset": { "auth_ref": [ "r537" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets": { "order": 6.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of lessee's right to use underlying asset under operating lease.", "label": "Operating Lease, Right-of-Use Asset", "terseLabel": "Operating Lease, Right-of-Use Asset" } } }, "localname": "OperatingLeaseRightOfUseAsset", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": { "auth_ref": [ "r547", "r550" ], "lang": { "en-US": { "role": { "documentation": "Weighted average discount rate for operating lease calculated at point in time.", "label": "Operating Lease, Weighted Average Discount Rate, Percent", "terseLabel": "Operating Lease, Weighted Average Discount Rate, Percent" } } }, "localname": "OperatingLeaseWeightedAverageDiscountRatePercent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsWeightedAverageRemainingLeaseTermsandDiscountRatesDetails" ], "xbrltype": "percentItemType" }, "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": { "auth_ref": [ "r546", "r550" ], "lang": { "en-US": { "role": { "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Operating Lease, Weighted Average Remaining Lease Term", "terseLabel": "Operating Lease, Weighted Average Remaining Lease Term" } } }, "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsWeightedAverageRemainingLeaseTermsandDiscountRatesDetails" ], "xbrltype": "durationItemType" }, "us-gaap_OperatingLeasesFutureMinimumPaymentsDue": { "auth_ref": [ "r526", "r527" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of required minimum rental payments for leases having an initial or remaining non-cancelable letter-terms in excess of one year.", "label": "Operating Leases, Future Minimum Payments Due", "terseLabel": "Operating Leases, Future Minimum Payments Due" } } }, "localname": "OperatingLeasesFutureMinimumPaymentsDue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsFutureMinimumOperatingandFinancingLeaseCommitmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent": { "auth_ref": [ "r526", "r527" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Operating Leases, Future Minimum Payments Due, Next Twelve Months", "terseLabel": "Operating Leases, Future Minimum Payments Due, Next Twelve Months" } } }, "localname": "OperatingLeasesFutureMinimumPaymentsDueCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsFutureMinimumOperatingandFinancingLeaseCommitmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears": { "auth_ref": [ "r526", "r527" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Operating Leases, Future Minimum Payments, Due in Five Years", "terseLabel": "Operating Leases, Future Minimum Payments, Due in Five Years" } } }, "localname": "OperatingLeasesFutureMinimumPaymentsDueInFiveYears", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsFutureMinimumOperatingandFinancingLeaseCommitmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears": { "auth_ref": [ "r526", "r527" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Operating Leases, Future Minimum Payments, Due in Four Years", "terseLabel": "Operating Leases, Future Minimum Payments, Due in Four Years" } } }, "localname": "OperatingLeasesFutureMinimumPaymentsDueInFourYears", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsFutureMinimumOperatingandFinancingLeaseCommitmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears": { "auth_ref": [ "r526", "r527" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Operating Leases, Future Minimum Payments, Due in Three Years", "terseLabel": "Operating Leases, Future Minimum Payments, Due in Three Years" } } }, "localname": "OperatingLeasesFutureMinimumPaymentsDueInThreeYears", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsFutureMinimumOperatingandFinancingLeaseCommitmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears": { "auth_ref": [ "r526", "r527" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Operating Leases, Future Minimum Payments, Due in Two Years", "terseLabel": "Operating Leases, Future Minimum Payments, Due in Two Years" } } }, "localname": "OperatingLeasesFutureMinimumPaymentsDueInTwoYears", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsFutureMinimumOperatingandFinancingLeaseCommitmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter": { "auth_ref": [ "r526", "r527" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due after the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Operating Leases, Future Minimum Payments, Due Thereafter", "terseLabel": "Operating Leases, Future Minimum Payments, Due Thereafter" } } }, "localname": "OperatingLeasesFutureMinimumPaymentsDueThereafter", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsFutureMinimumOperatingandFinancingLeaseCommitmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingSegmentsMember": { "auth_ref": [ "r205", "r206", "r207", "r208", "r210", "r216" ], "lang": { "en-US": { "role": { "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.", "label": "Operating Segments [Member]", "terseLabel": "Operating Segments [Member]" } } }, "localname": "OperatingSegmentsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/BusinessSegmentsInformationbySegmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock": { "auth_ref": [ "r137", "r155", "r187", "r462" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for the general note to the financial statements for the reporting entity which may include, descriptions of the basis of presentation, business description, significant accounting policies, consolidations, reclassifications, new pronouncements not yet adopted and changes in accounting principles.", "label": "Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block]", "terseLabel": "Accounting Policies" } } }, "localname": "OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/AccountingPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherAccruedLiabilitiesCurrent": { "auth_ref": [ "r18", "r19", "r20", "r56" ], "calculation": { "http://www.invacare.com/role/AccruedExpensesComponentsofAccruedExpensesDetails": { "order": 15.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.", "label": "Other Accrued Liabilities, Current", "terseLabel": "Other items, principally trade accruals" } } }, "localname": "OtherAccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/AccruedExpensesComponentsofAccruedExpensesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAssetsCurrent": { "auth_ref": [ "r69" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 }, "http://www.invacare.com/role/OtherCurrentAssetsComponentsofOtherCurrentAssetsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of current assets classified as other.", "label": "Other Assets, Current", "terseLabel": "Other current assets", "totalLabel": "Other current assets" } } }, "localname": "OtherAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets", "http://www.invacare.com/role/OtherCurrentAssetsComponentsofOtherCurrentAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAssetsDisclosureTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for other assets. This disclosure includes other current assets and other noncurrent assets.", "label": "Other Assets Disclosure [Text Block]", "terseLabel": "Other Long-Term Assets" } } }, "localname": "OtherAssetsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/OtherLongTermAssets" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherAssetsNoncurrent": { "auth_ref": [ "r52" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 }, "http://www.invacare.com/role/OtherLongTermAssetsComponentsofOtherLongTermAssetsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of noncurrent assets classified as other.", "label": "Other Assets, Noncurrent", "terseLabel": "Other Assets", "totalLabel": "Other Long-Term Assets" } } }, "localname": "OtherAssetsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets", "http://www.invacare.com/role/OtherLongTermAssetsComponentsofOtherLongTermAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentBeforeTaxPortionAttributableToParentAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, before Tax, after Reclassification Adjustment, Attributable to Parent [Abstract]", "terseLabel": "Defined Benefit Plans:" } } }, "localname": "OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentBeforeTaxPortionAttributableToParentAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss" ], "xbrltype": "stringItemType" }, "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax": { "auth_ref": [ "r83" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss": { "order": 3.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of tax expense (benefit) for (increase) decrease in value of benefit obligation for change in actuarial assumptions and increase (decrease) in value of plan assets from experience different from that assumed of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.", "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, Tax", "negatedTerseLabel": "Deferred tax adjustment resulting from defined benefit plan activity" } } }, "localname": "OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent": { "auth_ref": [ "r452", "r453", "r457" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss": { "order": 1.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.", "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent", "terseLabel": "Foreign currency translation adjustments" } } }, "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss", "http://www.invacare.com/role/CondensedConsolidatedStatementofShareholdersEquityStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax": { "auth_ref": [ "r82", "r86", "r87", "r375" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss": { "order": 2.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount, before tax, of reclassification adjustment from accumulated other comprehensive (income) loss for prior service cost (credit) of defined benefit plan.", "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), Reclassification Adjustment from AOCI, before Tax", "terseLabel": "Amortization of prior service costs and unrecognized losses" } } }, "localname": "OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss", "http://www.invacare.com/role/CondensedConsolidatedStatementofShareholdersEquityStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax": { "auth_ref": [ "r82", "r86", "r87", "r375" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount, after tax, of reclassification adjustment from accumulated other comprehensive (income) loss for prior service cost (credit) of defined benefit plan.", "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), Reclassification Adjustment from AOCI, after Tax", "terseLabel": "Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), Reclassification Adjustment from AOCI, after Tax" } } }, "localname": "OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofShareholdersEquityStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax": { "auth_ref": [ "r85", "r95", "r513", "r515", "r519" ], "calculation": { "http://www.invacare.com/role/AccumulatedOtherComprehensiveIncomeLossbyComponentChangesinAccumulatedOtherComprehensiveIncomeDetails": { "order": 1.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount after tax, before reclassification adjustments of other comprehensive income (loss).", "label": "Other Comprehensive Income (Loss), before Reclassifications, Net of Tax", "terseLabel": "OCI before reclassifications" } } }, "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/AccumulatedOtherComprehensiveIncomeLossbyComponentChangesinAccumulatedOtherComprehensiveIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": { "auth_ref": [ "r77" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.", "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax", "terseLabel": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax" } } }, "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofShareholdersEquityStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossNetOfTax": { "auth_ref": [ "r90", "r93", "r95", "r100", "r350", "r513", "r518", "r519", "r605", "r626" ], "calculation": { "http://www.invacare.com/role/AccumulatedOtherComprehensiveIncomeLossbyComponentChangesinAccumulatedOtherComprehensiveIncomeDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss": { "order": 2.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).", "label": "Other Comprehensive Income (Loss), Net of Tax", "totalLabel": "Other Comprehensive Income (Loss)" } } }, "localname": "OtherComprehensiveIncomeLossNetOfTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/AccumulatedOtherComprehensiveIncomeLossbyComponentChangesinAccumulatedOtherComprehensiveIncomeDetails", "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]", "terseLabel": "Other comprehensive income (loss):" } } }, "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss" ], "xbrltype": "stringItemType" }, "us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax": { "auth_ref": [ "r79", "r82", "r494" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss": { "order": 5.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount before tax of increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's increase (decrease) in deferred hedging gain (loss).", "label": "Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, before Tax", "terseLabel": "Current period (loss) gain on cash flow hedges" } } }, "localname": "OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss", "http://www.invacare.com/role/DerivativesGainLossinStatementofFinacialPositionDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax": { "auth_ref": [ "r79", "r82", "r494" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount after tax of increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's increase (decrease) in deferred hedging gain (loss).", "label": "Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, Net of Tax", "terseLabel": "Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, Net of Tax" } } }, "localname": "OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofShareholdersEquityStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodTax": { "auth_ref": [ "r79", "r83" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss": { "order": 6.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of tax expense (benefit), before reclassification adjustments, related to increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's increase (decrease) in deferred hedging gain (loss).", "label": "Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, Tax", "negatedTerseLabel": "Deferred tax benefit (provision) related to gain on cash flow hedges" } } }, "localname": "OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherCurrentAssetsMember": { "auth_ref": [ "r471", "r491" ], "lang": { "en-US": { "role": { "documentation": "Primary financial statement caption encompassing other current assets.", "label": "Other Current Assets [Member]", "terseLabel": "Other Current Assets" } } }, "localname": "OtherCurrentAssetsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/DerivativesBalanceSheetLocationDetails", "http://www.invacare.com/role/FairValuesDetailsofBookValueandFairValueofFinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherCurrentAssetsTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for other current assets.", "label": "Other Current Assets [Text Block]", "terseLabel": "Other Current Assets" } } }, "localname": "OtherCurrentAssetsTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/OtherCurrentAssets" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherEmployeeRelatedLiabilitiesCurrent": { "auth_ref": [ "r56" ], "calculation": { "http://www.invacare.com/role/AccruedExpensesComponentsofAccruedExpensesDetails": { "order": 14.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of obligations incurred for employer-related costs classified as other, payable within one year or the normal operating cycle, if longer.", "label": "Other Employee-related Liabilities, Current", "terseLabel": "Severance" } } }, "localname": "OtherEmployeeRelatedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/AccruedExpensesComponentsofAccruedExpensesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherIntangibleAssetsMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Intangible assets classified as other.", "label": "Other Intangible Assets [Member]", "terseLabel": "Other" } } }, "localname": "OtherIntangibleAssetsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/IntangiblesIntangibleTableDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherLiabilitiesDisclosureAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Other Liabilities Disclosure [Abstract]", "terseLabel": "Other Liabilities Disclosure [Abstract]" } } }, "localname": "OtherLiabilitiesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_OtherLiabilitiesDisclosureTextBlock": { "auth_ref": [ "r57" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for other liabilities.", "label": "Other Liabilities Disclosure [Text Block]", "terseLabel": "Other Long-Term Obligations" } } }, "localname": "OtherLiabilitiesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/OtherLongTermObligations" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherLiabilitiesNoncurrent": { "auth_ref": [ "r62" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 }, "http://www.invacare.com/role/OtherLongTermObligationsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.", "label": "Other Liabilities, Noncurrent", "terseLabel": "Other Long-Term Obligations", "totalLabel": "Other Long-Term Obligations" } } }, "localname": "OtherLiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets", "http://www.invacare.com/role/OtherLongTermObligationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNoncashIncomeExpense": { "auth_ref": [ "r126" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.", "label": "Other Noncash Income (Expense)", "negatedTerseLabel": "Provision for other deferred liabilities" } } }, "localname": "OtherNoncashIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNoncurrentLiabilitiesTableTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of other noncurrent liabilities.", "label": "Other Noncurrent Liabilities [Table Text Block]", "terseLabel": "Other Noncurrent Liabilities" } } }, "localname": "OtherNoncurrentLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/OtherLongTermObligationsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherPrepaidExpenseCurrent": { "auth_ref": [ "r12", "r15", "r279" ], "calculation": { "http://www.invacare.com/role/OtherCurrentAssetsComponentsofOtherCurrentAssetsDetails": { "order": 9.0, "parentTag": "us-gaap_OtherAssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of asset related to consideration paid in advance for other costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.", "label": "Other Prepaid Expense, Current", "terseLabel": "Prepaid and other current assets" } } }, "localname": "OtherPrepaidExpenseCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/OtherCurrentAssetsComponentsofOtherCurrentAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherSundryLiabilitiesNoncurrent": { "auth_ref": [ "r28", "r597", "r616" ], "calculation": { "http://www.invacare.com/role/OtherLongTermObligationsDetails": { "order": 5.0, "parentTag": "us-gaap_OtherLiabilitiesNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Obligations not otherwise itemized or categorized in the footnotes to the financial statements that are expected to be paid after one year (or the normal operating cycle, if longer), from the balance sheet date.", "label": "Other Sundry Liabilities, Noncurrent", "terseLabel": "Other" } } }, "localname": "OtherSundryLiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/OtherLongTermObligationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PastDueFinancingReceivablesTableTextBlock": { "auth_ref": [ "r236", "r237", "r257", "r269" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of aging analysis for financing receivable.", "label": "Financing Receivable, Past Due [Table Text Block]", "terseLabel": "Schedule of Aging of Installment Receivables" } } }, "localname": "PastDueFinancingReceivablesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_PatentsMember": { "auth_ref": [ "r448" ], "lang": { "en-US": { "role": { "documentation": "Exclusive legal right granted by the government to the owner of the patent to exploit an invention or a process for a period of time specified by law.", "label": "Patents [Member]", "terseLabel": "Patents" } } }, "localname": "PatentsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/IntangiblesIntangibleTableDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PayablesAndAccrualsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Payables and Accruals [Abstract]", "terseLabel": "Payables and Accruals [Abstract]" } } }, "localname": "PayablesAndAccrualsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_PaymentsForProceedsFromLongtermInvestments": { "auth_ref": [ "r136" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The net amount paid (received) by the reporting entity through acquisition or sale and maturities of long-term investments which qualify for treatment as an investing activity based on management's intention and intended by management to be liquidated, if necessary, beyond the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the long-term.", "label": "Payments for (Proceeds from) Long-term Investments", "negatedLabel": "Change in other long-term assets" } } }, "localname": "PaymentsForProceedsFromLongtermInvestments", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsForProceedsFromOtherInvestingActivities": { "auth_ref": [ "r113", "r115", "r136" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of cash (inflow) outflow from investing activities classified as other.", "label": "Payments for (Proceeds from) Other Investing Activities", "terseLabel": "Other" } } }, "localname": "PaymentsForProceedsFromOtherInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsForRepurchaseOfCommonStock": { "auth_ref": [ "r118" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The cash outflow to reacquire common stock during the period.", "label": "Payments for Repurchase of Common Stock", "negatedTerseLabel": "Purchase of treasury shares", "terseLabel": "Payments for Repurchase of Common Stock" } } }, "localname": "PaymentsForRepurchaseOfCommonStock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsForRestructuring": { "auth_ref": [ "r121", "r311" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation.", "label": "Payments for Restructuring", "negatedTerseLabel": "Payments" } } }, "localname": "PaymentsForRestructuring", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/ChargesRelatedToRestructuringActivitiesDetails", "http://www.invacare.com/role/ChargesRelatedToRestructuringActivitiesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfDividendsCommonStock": { "auth_ref": [ "r118" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.", "label": "Payments of Ordinary Dividends, Common Stock", "negatedLabel": "Payment of dividends", "negatedTerseLabel": "Payments of Ordinary Dividends, Common Stock" } } }, "localname": "PaymentsOfDividendsCommonStock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows", "http://www.invacare.com/role/CondensedConsolidatedStatementofShareholdersEquityStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfFinancingCosts": { "auth_ref": [ "r120" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The cash outflow for loan and debt issuance costs.", "label": "Payments of Financing Costs", "negatedTerseLabel": "Payment of financing costs" } } }, "localname": "PaymentsOfFinancingCosts", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "auth_ref": [ "r114" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.", "label": "Payments to Acquire Property, Plant, and Equipment", "negatedLabel": "Purchases of property and equipment" } } }, "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PerformanceSharesMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Share-based payment arrangement awarded for meeting performance target.", "label": "Performance Shares [Member]", "terseLabel": "Performance Shares" } } }, "localname": "PerformanceSharesMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationNarrativeDetails", "http://www.invacare.com/role/EquityCompensationPerformanceShareActivityDetails", "http://www.invacare.com/role/EquityCompensationSharebasedCompensationExpenseDetails", "http://www.invacare.com/role/EquityCompensationUnrecognizedCompensationExpenseDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PlanNameAxis": { "auth_ref": [ "r384", "r409" ], "lang": { "en-US": { "role": { "documentation": "Information by plan name for share-based payment arrangement.", "label": "Plan Name [Axis]", "terseLabel": "Plan Name [Axis]" } } }, "localname": "PlanNameAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationNarrativeDetails", "http://www.invacare.com/role/EquityCompensationPerformanceShareActivityDetails", "http://www.invacare.com/role/EquityCompensationUnrecognizedCompensationExpenseDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PlanNameDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Plan name for share-based payment arrangement.", "label": "Plan Name [Domain]", "terseLabel": "Plan Name [Domain]" } } }, "localname": "PlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationNarrativeDetails", "http://www.invacare.com/role/EquityCompensationPerformanceShareActivityDetails", "http://www.invacare.com/role/EquityCompensationUnrecognizedCompensationExpenseDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PortionAtFairValueFairValueDisclosureMember": { "auth_ref": [ "r505" ], "lang": { "en-US": { "role": { "documentation": "Measured at fair value for financial reporting purposes.", "label": "Portion at Fair Value Measurement [Member]", "terseLabel": "Portion at Fair Value Measurement" } } }, "localname": "PortionAtFairValueFairValueDisclosureMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/FairValuesDetailsofBookValueandFairValueofFinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r30" ], "lang": { "en-US": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred Stock, Shares Authorized", "terseLabel": "Preferred Stock, Shares Authorized" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedBalanceSheetsParentheticals" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesOutstanding": { "auth_ref": [ "r30" ], "lang": { "en-US": { "role": { "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.", "label": "Preferred Stock, Shares Outstanding", "terseLabel": "Preferred Stock, Shares Outstanding" } } }, "localname": "PreferredStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedBalanceSheetsParentheticals" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r30" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets": { "order": 6.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Preferred Stock, Value, Issued", "terseLabel": "Preferred Shares (Authorized 300\u00a0shares; none outstanding)" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidExpenseAndOtherAssetsNoncurrent": { "auth_ref": [ "r24", "r594", "r614" ], "calculation": { "http://www.invacare.com/role/OtherLongTermAssetsComponentsofOtherLongTermAssetsDetails": { "order": 6.0, "parentTag": "us-gaap_OtherAssetsNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed after one year or the normal operating cycle, if longer.", "label": "Prepaid Expense and Other Assets, Noncurrent", "terseLabel": "Other" } } }, "localname": "PrepaidExpenseAndOtherAssetsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/OtherLongTermAssetsComponentsofOtherLongTermAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidInsurance": { "auth_ref": [ "r13", "r15", "r278", "r279" ], "calculation": { "http://www.invacare.com/role/OtherCurrentAssetsComponentsofOtherCurrentAssetsDetails": { "order": 8.0, "parentTag": "us-gaap_OtherAssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of asset related to consideration paid in advance for insurance that provides economic benefits within a future period of one year or the normal operating cycle, if longer.", "label": "Prepaid Insurance", "terseLabel": "Prepaid insurance" } } }, "localname": "PrepaidInsurance", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/OtherCurrentAssetsComponentsofOtherCurrentAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested": { "auth_ref": [ "r111" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "This element represents the cash inflow during the period from the sale of a component of the entity.", "label": "Proceeds from Divestiture of Businesses, Net of Cash Divested", "terseLabel": "Proceeds from sale of business" } } }, "localname": "ProceedsFromDivestitureOfBusinessesNetOfCashDivested", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows", "http://www.invacare.com/role/DivestedBusinessesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfLongTermDebt": { "auth_ref": [ "r117" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.", "label": "Proceeds from Issuance of Long-term Debt", "terseLabel": "Proceeds from revolving lines of credit and long-term borrowings" } } }, "localname": "ProceedsFromIssuanceOfLongTermDebt", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfWarrants": { "auth_ref": [ "r116" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt).", "label": "Proceeds from Issuance of Warrants", "terseLabel": "Issuance of warrants", "verboseLabel": "Proceeds from Issuance of Warrants" } } }, "localname": "ProceedsFromIssuanceOfWarrants", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/DerivativesNarrativeDetails", "http://www.invacare.com/role/LongTermDebtComponentsofConvertibleDebtDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment": { "auth_ref": [ "r112" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.", "label": "Proceeds from Sale of Property, Plant, and Equipment", "terseLabel": "Proceeds from sale of property and equipment" } } }, "localname": "ProceedsFromSaleOfPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProductLiabilityContingencyLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Product Liability Contingency [Line Items]", "terseLabel": "Product Liability Contingency" } } }, "localname": "ProductLiabilityContingencyLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/AccruedExpensesWarrantyScheduleDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ProductLiabilityContingencyTable": { "auth_ref": [ "r323", "r325", "r326", "r327", "r328", "r329", "r330" ], "lang": { "en-US": { "role": { "documentation": "Information and financial data about the reasonably possible loss or the recognized and additional reasonably possible loss from product liability related to an individual product.", "label": "Product Liability Contingency [Table]", "terseLabel": "Product Liability Contingency [Table]" } } }, "localname": "ProductLiabilityContingencyTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/AccruedExpensesWarrantyScheduleDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ProductMember": { "auth_ref": [ "r360" ], "lang": { "en-US": { "role": { "documentation": "Article or substance produced by nature, labor or machinery.", "label": "Product [Member]", "terseLabel": "Product" } } }, "localname": "ProductMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/RevenueDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ProductWarrantyAccrualClassifiedCurrent": { "auth_ref": [ "r56", "r333", "r337" ], "calculation": { "http://www.invacare.com/role/AccruedExpensesComponentsofAccruedExpensesDetails": { "order": 4.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for estimated claims under standard and extended warranty protection rights granted to customers. For classified balance sheets, represents the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Product Warranty Accrual, Current", "periodEndLabel": "Balance as of September 30, 2020", "periodStartLabel": "Balance as of January 1, 2020", "terseLabel": "Warranty" } } }, "localname": "ProductWarrantyAccrualClassifiedCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/AccruedExpensesComponentsofAccruedExpensesDetails", "http://www.invacare.com/role/AccruedExpensesWarrantyScheduleDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProductWarrantyAccrualPayments": { "auth_ref": [ "r338" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of decrease in the standard and extended product warranty accrual from payments made in cash or in kind to satisfy claims under the terms of the standard and extended product warranty.", "label": "Standard and Extended Product Warranty Accrual, Decrease for Payments", "negatedTerseLabel": "Settlements made during the period" } } }, "localname": "ProductWarrantyAccrualPayments", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/AccruedExpensesWarrantyScheduleDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProductWarrantyAccrualPreexistingIncreaseDecrease": { "auth_ref": [ "r340" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of increase (decrease) in the standard and extended product warranty accrual from changes in estimates attributable to preexisting product warranties.", "label": "Standard and Extended Product Warranty Accrual, Increase (Decrease) for Preexisting Warranties", "terseLabel": "Changes in liability for pre-existing warranties during the period, including expirations" } } }, "localname": "ProductWarrantyAccrualPreexistingIncreaseDecrease", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/AccruedExpensesWarrantyScheduleDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProductWarrantyAccrualWarrantiesIssued": { "auth_ref": [ "r339" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of increase in the standard and extended product warranty accrual from warranties issued.", "label": "Standard and Extended Product Warranty Accrual, Increase for Warranties Issued", "terseLabel": "Warranties provided during the period" } } }, "localname": "ProductWarrantyAccrualWarrantiesIssued", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/AccruedExpensesWarrantyScheduleDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Property, Plant and Equipment [Abstract]", "terseLabel": "Property, Plant and Equipment [Abstract]" } } }, "localname": "PropertyPlantAndEquipmentAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "auth_ref": [ "r51", "r302" ], "lang": { "en-US": { "role": { "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.", "label": "Long-Lived Tangible Asset [Axis]", "terseLabel": "Property, Plant and Equipment by Type [Axis]" } } }, "localname": "PropertyPlantAndEquipmentByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/PropertyAndEquipmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": { "auth_ref": [ "r307", "r650", "r651", "r652" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.", "label": "Property, Plant and Equipment Disclosure [Text Block]", "terseLabel": "Property And Equipment" } } }, "localname": "PropertyPlantAndEquipmentDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/PropertyAndEquipment" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentGross": { "auth_ref": [ "r50", "r300" ], "calculation": { "http://www.invacare.com/role/PropertyAndEquipmentDetails": { "order": 1.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, Plant and Equipment, Gross", "terseLabel": "Property and equipment, gross" } } }, "localname": "PropertyPlantAndEquipmentGross", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/PropertyAndEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Property, Plant and Equipment [Line Items]", "terseLabel": "Property, Plant and Equipment [Line Items]" } } }, "localname": "PropertyPlantAndEquipmentLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/PropertyAndEquipmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentNet": { "auth_ref": [ "r22", "r23", "r302", "r623" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_Assets", "weight": 1.0 }, "http://www.invacare.com/role/PropertyAndEquipmentDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, Plant and Equipment, Net", "terseLabel": "Property and Equipment, net", "totalLabel": "Property and equipment, net" } } }, "localname": "PropertyPlantAndEquipmentNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets", "http://www.invacare.com/role/PropertyAndEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentTextBlock": { "auth_ref": [ "r22", "r302" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Property, Plant and Equipment [Table Text Block]", "terseLabel": "Property, Plant and Equipment" } } }, "localname": "PropertyPlantAndEquipmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/PropertyAndEquipmentTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "auth_ref": [ "r22", "r300" ], "lang": { "en-US": { "role": { "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.", "label": "Long-Lived Tangible Asset [Domain]", "terseLabel": "Property, Plant and Equipment, Type [Domain]" } } }, "localname": "PropertyPlantAndEquipmentTypeDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/PropertyAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ProvisionForDoubtfulAccounts": { "auth_ref": [ "r103", "r253" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable.", "label": "Accounts Receivable, Credit Loss Expense (Reversal)", "verboseLabel": "Provision for losses on trade and installment receivables" } } }, "localname": "ProvisionForDoubtfulAccounts", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ReceivableTypeDomain": { "auth_ref": [ "r67" ], "lang": { "en-US": { "role": { "documentation": "Financing arrangement representing a contractual right to receive money either on demand or on fixed and determinable dates.", "label": "Receivable [Domain]", "terseLabel": "Receivable [Domain]" } } }, "localname": "ReceivableTypeDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ReceivablesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Receivables [Abstract]", "terseLabel": "Receivables [Abstract]" } } }, "localname": "ReceivablesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_ReceivablesBillingStatusDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Amounts due from customers (or dealers) within the next year (or operating cycle, if longer) for goods or services that have been delivered or used, but not yet paid.", "label": "Receivables Billing Status [Domain]", "terseLabel": "Receivables Billing Status [Domain]" } } }, "localname": "ReceivablesBillingStatusDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ReceivablesFairValueDisclosure": { "auth_ref": [ "r40", "r71", "r601", "r622" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Fair value portion of receivables, including, but not limited to, trade account receivables, note receivables, and loan receivables.", "label": "Receivables, Fair Value Disclosure", "terseLabel": "Installment receivables, net of reserves" } } }, "localname": "ReceivablesFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/FairValuesDetailsofBookValueandFairValueofFinancialInstrumentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]", "terseLabel": "Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]" } } }, "localname": "ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/AccumulatedOtherComprehensiveIncomeLossbyComponentReclassifiedOutofAccumulatedOtherComprehensiveIncomeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax": { "auth_ref": [ "r85", "r88", "r95", "r513", "r517", "r519" ], "calculation": { "http://www.invacare.com/role/AccumulatedOtherComprehensiveIncomeLossbyComponentChangesinAccumulatedOtherComprehensiveIncomeDetails": { "order": 2.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount after tax of reclassification adjustments of other comprehensive income (loss).", "label": "Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax", "negatedTerseLabel": "Amount reclassified from accumulated OCI" } } }, "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/AccumulatedOtherComprehensiveIncomeLossbyComponentChangesinAccumulatedOtherComprehensiveIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Information by item reclassified out of accumulated other comprehensive income (loss).", "label": "Reclassification out of Accumulated Other Comprehensive Income [Axis]", "terseLabel": "Reclassification out of Accumulated Other Comprehensive Income [Axis]" } } }, "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/AccumulatedOtherComprehensiveIncomeLossbyComponentReclassifiedOutofAccumulatedOtherComprehensiveIncomeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Item reclassified out of accumulated other comprehensive income (loss).", "label": "Reclassification out of Accumulated Other Comprehensive Income [Domain]", "terseLabel": "Reclassification out of Accumulated Other Comprehensive Income [Domain]" } } }, "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/AccumulatedOtherComprehensiveIncomeLossbyComponentReclassifiedOutofAccumulatedOtherComprehensiveIncomeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Identifies item reclassified out of accumulated other comprehensive income (loss).", "label": "Reclassification out of Accumulated Other Comprehensive Income [Member]", "terseLabel": "Reclassification out of Accumulated Other Comprehensive Income" } } }, "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/AccumulatedOtherComprehensiveIncomeLossbyComponentReclassifiedOutofAccumulatedOtherComprehensiveIncomeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Disclosure of information about items reclassified out of accumulated other comprehensive income (loss).", "label": "Reclassification out of Accumulated Other Comprehensive Income [Table]", "terseLabel": "Reclassification out of Accumulated Other Comprehensive Income [Table]" } } }, "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/AccumulatedOtherComprehensiveIncomeLossbyComponentReclassifiedOutofAccumulatedOtherComprehensiveIncomeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RepaymentsOfLongTermDebt": { "auth_ref": [ "r119" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.", "label": "Repayments of Long-term Debt", "negatedLabel": "Repurchases of convertible debt, payments on revolving lines of credit and financing leases" } } }, "localname": "RepaymentsOfLongTermDebt", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestrictedStockMember": { "auth_ref": [ "r168" ], "lang": { "en-US": { "role": { "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met.", "label": "Restricted Stock [Member]", "terseLabel": "Restricted Stock" } } }, "localname": "RestrictedStockMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RestructuringAndRelatedActivitiesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Restructuring and Related Activities [Abstract]", "terseLabel": "Restructuring and Related Activities [Abstract]" } } }, "localname": "RestructuringAndRelatedActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock": { "auth_ref": [ "r322" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.", "label": "Restructuring and Related Activities Disclosure [Text Block]", "terseLabel": "Charges Related To Restructuring Activities" } } }, "localname": "RestructuringAndRelatedActivitiesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/ChargesRelatedToRestructuringActivities" ], "xbrltype": "textBlockItemType" }, "us-gaap_RestructuringCharges": { "auth_ref": [ "r125", "r310", "r315", "r320" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss": { "order": 1.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.", "label": "Restructuring Charges", "negatedTerseLabel": "Charges", "terseLabel": "Charges", "verboseLabel": "Charges related to restructuring activities" } } }, "localname": "RestructuringCharges", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/BusinessSegmentsInformationbySegmentDetails", "http://www.invacare.com/role/ChargesRelatedToRestructuringActivitiesDetails", "http://www.invacare.com/role/ChargesRelatedToRestructuringActivitiesNarrativeDetails", "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestructuringCostAndReserveAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Information by type of restructuring cost.", "label": "Restructuring Type [Axis]", "terseLabel": "Restructuring Cost and Reserve [Axis]" } } }, "localname": "RestructuringCostAndReserveAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/BusinessSegmentsInformationbySegmentDetails", "http://www.invacare.com/role/ChargesRelatedToRestructuringActivitiesDetails", "http://www.invacare.com/role/ChargesRelatedToRestructuringActivitiesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RestructuringCostAndReserveLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Restructuring Cost and Reserve [Line Items]", "terseLabel": "Restructuring Cost and Reserve [Line Items]" } } }, "localname": "RestructuringCostAndReserveLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/ChargesRelatedToRestructuringActivitiesDetails", "http://www.invacare.com/role/ChargesRelatedToRestructuringActivitiesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RestructuringReserve": { "auth_ref": [ "r311", "r317" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.", "label": "Restructuring Reserve", "periodEndLabel": "Ending Balance", "periodStartLabel": "Beginning Balance", "terseLabel": "Restructuring Reserve" } } }, "localname": "RestructuringReserve", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/BusinessSegmentsInformationbySegmentDetails", "http://www.invacare.com/role/ChargesRelatedToRestructuringActivitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestructuringReserveAccrualAdjustment1": { "auth_ref": [ "r310", "r316" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of expense (reversal of expense) which increases (decreases) the restructuring reserve from an adjustment to a previously accrued restructuring liability.", "label": "Restructuring Reserve, Accrual Adjustment", "terseLabel": "Restructuring Reserve, Accrual Adjustment" } } }, "localname": "RestructuringReserveAccrualAdjustment1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/BusinessSegmentsInformationbySegmentDetails", "http://www.invacare.com/role/ChargesRelatedToRestructuringActivitiesDetails", "http://www.invacare.com/role/ChargesRelatedToRestructuringActivitiesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestructuringReserveRollForward": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Restructuring Reserve [Roll Forward]", "terseLabel": "Restructuring Reserve [Roll Forward]" } } }, "localname": "RestructuringReserveRollForward", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/ChargesRelatedToRestructuringActivitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r35", "r356", "r417", "r620", "r642", "r647" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings (Accumulated Deficit)", "terseLabel": "Retained earnings" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r138", "r139", "r141", "r143", "r151", "r154", "r247", "r414", "r415", "r416", "r432", "r433", "r638", "r640" ], "lang": { "en-US": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings [Member]", "terseLabel": "Retained Earnings [Member]" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofShareholdersEquityStatement" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueRecognitionDeferredRevenue": { "auth_ref": [ "r128" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for recognizing unearned income or deferred revenue related to transactions involving the sale of a product or performance of services.", "label": "Revenue Recognition, Deferred Revenue [Policy Text Block]", "terseLabel": "Revenue Recognition, Deferred Revenue [Policy Text Block]" } } }, "localname": "RevenueRecognitionDeferredRevenue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/RevenueRevenue" ], "xbrltype": "textBlockItemType" }, "us-gaap_RevenueRecognitionMultipleDeliverableArrangementsLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Revenue Recognition, Multiple-deliverable Arrangements [Line Items]", "terseLabel": "Revenue Recognition, Multiple-deliverable Arrangements [Line Items]" } } }, "localname": "RevenueRecognitionMultipleDeliverableArrangementsLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/RevenueDetails", "http://www.invacare.com/role/RevenueTables" ], "xbrltype": "stringItemType" }, "us-gaap_RevenueRecognitionMultipleDeliverableArrangementsTable": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Summarization of information required and determined to be disclosed concerning the recognition of revenue arrangements under which the entity does or will perform multiple revenue-generating activities, categorized by type of arrangement, including certain revenue arrangements that include software elements. This item does not include multiple-deliverable arrangements for industries that prepare disclosures under specific requirements (for instance, construction-type and production-type contracts) otherwise provided for in the taxonomy.", "label": "Revenue Recognition, Multiple-deliverable Arrangements [Table]", "terseLabel": "Revenue Recognition, Multiple-deliverable Arrangements [Table]" } } }, "localname": "RevenueRecognitionMultipleDeliverableArrangementsTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/RevenueDetails", "http://www.invacare.com/role/RevenueTables" ], "xbrltype": "stringItemType" }, "us-gaap_RevenueRecognitionMultipleDeliverableArrangementsTableTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the recognition of revenue arrangements under which the entity does or will perform multiple revenue-generating activities, categorized by type of arrangement. This item includes certain revenue arrangements that include software elements. This item does not include multiple-deliverable arrangements for industries that prepare disclosures under specific requirements (for instance, construction-type and production-type contracts) otherwise provided for in the taxonomy.", "label": "Revenue Recognition, Multiple-deliverable Arrangements [Table Text Block]", "terseLabel": "Revenue Recognition, Multiple-deliverable Arrangements" } } }, "localname": "RevenueRecognitionMultipleDeliverableArrangementsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/RevenueTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_Revenues": { "auth_ref": [ "r97", "r130", "r191", "r192", "r205", "r211", "r212", "r218", "r219", "r222", "r243", "r511", "r610" ], "calculation": { "http://www.invacare.com/role/AccumulatedOtherComprehensiveIncomeLossbyComponentReclassifiedOutofAccumulatedOtherComprehensiveIncomeDetails": { "order": 1.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "weight": 1.0 }, "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss": { "order": 1.0, "parentTag": "us-gaap_GrossProfit", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).", "label": "Revenues", "negatedTerseLabel": "Net Sales", "terseLabel": "Net Sales" } } }, "localname": "Revenues", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/AccumulatedOtherComprehensiveIncomeLossbyComponentReclassifiedOutofAccumulatedOtherComprehensiveIncomeDetails", "http://www.invacare.com/role/BusinessSegmentsInformationbySegmentDetails", "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss", "http://www.invacare.com/role/RevenueDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevolvingCreditFacilityMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.", "label": "Revolving Credit Facility [Member]", "terseLabel": "Revolving Credit Facility", "verboseLabel": "Senior secured revolving credit facility, due in October 2015" } } }, "localname": "RevolvingCreditFacilityMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LongTermDebtDetails", "http://www.invacare.com/role/LongTermDebtLeverageRatiosDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability": { "auth_ref": [ "r545", "r550" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of increase in right-of-use asset obtained in exchange for finance lease liability.", "label": "Right-of-Use Asset Obtained in Exchange for Finance Lease Liability", "terseLabel": "Right-of-Use Asset Obtained in Exchange for Finance Lease Liability" } } }, "localname": "RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsSupplementalCashFlowInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": { "auth_ref": [ "r545", "r550" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.", "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability", "terseLabel": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability" } } }, "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsSupplementalCashFlowInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RiskLevelHighMember": { "auth_ref": [ "r336", "r488" ], "lang": { "en-US": { "role": { "documentation": "An entity's internal risk assessment as having high risk.", "label": "Risk Level, High [Member]", "terseLabel": "Risk Level, High" } } }, "localname": "RiskLevelHighMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RiskLevelLowMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "An entity's internal risk assessment as having low risk.", "label": "Risk Level, Low [Member]", "terseLabel": "Risk Level, Low" } } }, "localname": "RiskLevelLowMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RiskLevelMediumMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "An entity's internal risk assessment as having medium risk.", "label": "Risk Level, Medium [Member]", "terseLabel": "Risk Level, Medium" } } }, "localname": "RiskLevelMediumMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RisksAndUncertaintiesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Risks and Uncertainties [Abstract]", "terseLabel": "Risks and Uncertainties [Abstract]" } } }, "localname": "RisksAndUncertaintiesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_SaleLeasebackTransactionAnnualRentalPayments": { "auth_ref": [ "r525", "r532" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The yearly payments due under the lease entered into in connection with the transaction involving the sale of property to another party and the lease of the property back to the seller.", "label": "Sale Leaseback Transaction, Annual Rental Payments", "terseLabel": "Sale Leaseback Transaction, Annual Rental Payments" } } }, "localname": "SaleLeasebackTransactionAnnualRentalPayments", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SaleLeasebackTransactionCurrentPeriodGainRecognized": { "auth_ref": [ "r531" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The portion of the deferred gain that was recognized in the current period.", "label": "Sale Leaseback Transaction, Current Period Gain Recognized", "terseLabel": "Sale Leaseback Transaction, Current Period Gain Recognized" } } }, "localname": "SaleLeasebackTransactionCurrentPeriodGainRecognized", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsDetails", "http://www.invacare.com/role/OtherLongTermObligationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SaleLeasebackTransactionDeferredGainGross": { "auth_ref": [ "r530" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The amount of the gain recorded in connection with the transaction involving the sale of property to another party and the lease of the property back to the seller to be recognized in future periods.", "label": "Sale Leaseback Transaction, Deferred Gain, Gross", "terseLabel": "Sale Leaseback Transaction, Deferred Gain, Gross" } } }, "localname": "SaleLeasebackTransactionDeferredGainGross", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsDetails", "http://www.invacare.com/role/LongTermDebtSaleLeasebackTransactionsDetails", "http://www.invacare.com/role/OtherLongTermObligationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SaleLeasebackTransactionDeferredGainNet": { "auth_ref": [ "r531" ], "calculation": { "http://www.invacare.com/role/OtherLongTermObligationsDetails": { "order": 6.0, "parentTag": "us-gaap_OtherLiabilitiesNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The portion of the gain that will be recorded as income or a reduction in rent expense in future periods less amounts recognized in the current period.", "label": "Sale Leaseback Transaction, Deferred Gain, Net", "terseLabel": "Deferred gain on sale leaseback" } } }, "localname": "SaleLeasebackTransactionDeferredGainNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/OtherLongTermObligationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SaleLeasebackTransactionDescriptionAxis": { "auth_ref": [ "r532", "r552" ], "lang": { "en-US": { "role": { "documentation": "Information pertinent to a sale and leaseback transaction, by transaction.", "label": "Sale Leaseback Transaction, Description [Axis]", "terseLabel": "Sale Leaseback Transaction, Description [Axis]" } } }, "localname": "SaleLeasebackTransactionDescriptionAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LongTermDebtSaleLeasebackTransactionsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SaleLeasebackTransactionLeaseTerms": { "auth_ref": [ "r532", "r551" ], "lang": { "en-US": { "role": { "documentation": "A description of the terms of the lease(s) related to the assets being leased-back in connection with the transaction involving the sale of property to another party and the lease of the property back to the seller.", "label": "Sale Leaseback Transaction, Lease Terms", "terseLabel": "Sale Leaseback Transaction, Lease Terms" } } }, "localname": "SaleLeasebackTransactionLeaseTerms", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SaleLeasebackTransactionLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Sale Leaseback Transaction [Line Items]", "terseLabel": "Sale Leaseback Transaction [Line Items]" } } }, "localname": "SaleLeasebackTransactionLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LongTermDebtSaleLeasebackTransactionsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SaleLeasebackTransactionNameDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The name of the significant provisions of the transaction involving the sale of property to another party and the lease of the property back to the seller.", "label": "Sale Leaseback Transaction, Name [Domain]", "terseLabel": "Sale Leaseback Transaction, Name [Domain]" } } }, "localname": "SaleLeasebackTransactionNameDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LongTermDebtSaleLeasebackTransactionsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SaleLeasebackTransactionNetProceedsInvestingActivities": { "auth_ref": [ "r533", "r534", "r535" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of cash inflow after closing and debt issuance costs received by a seller-lessee in a sale-leaseback recognized in investing activities.", "label": "Sale Leaseback Transaction, Net Proceeds, Investing Activities", "terseLabel": "Sale Leaseback Transaction, Net Proceeds, Investing Activities" } } }, "localname": "SaleLeasebackTransactionNetProceedsInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SaleLeasebackTransactionTable": { "auth_ref": [ "r525", "r532", "r552" ], "lang": { "en-US": { "role": { "documentation": "A summary of the elements of a transaction involving the entity's sale of property to another party and the lease of the property back to the entity.", "label": "Sale Leaseback Transaction [Table]", "terseLabel": "Sale Leaseback Transaction [Table]" } } }, "localname": "SaleLeasebackTransactionTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LongTermDebtSaleLeasebackTransactionsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SalesMember": { "auth_ref": [ "r485" ], "lang": { "en-US": { "role": { "documentation": "Primary financial statement caption encompassing revenue from sale of goods and services rendered in the normal course of business.", "label": "Sales [Member]", "terseLabel": "Sales [Member]" } } }, "localname": "SalesMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/DerivativesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable": { "auth_ref": [ "r67" ], "lang": { "en-US": { "role": { "documentation": "Schedule itemizing specific types of trade accounts and notes receivable, and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.", "label": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table]", "terseLabel": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table]" } } }, "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock": { "auth_ref": [ "r67" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.", "label": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]", "terseLabel": "Schedule of Installment Receivables" } } }, "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the components of accrued liabilities.", "label": "Schedule of Accrued Liabilities [Table Text Block]", "terseLabel": "Schedule of Accrued Expenses" } } }, "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/AccruedExpensesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": { "auth_ref": [ "r85", "r518", "r519" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).", "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]", "terseLabel": "Schedule of Accumulated Other Comprehensive Income (Loss)" } } }, "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/AccumulatedOtherComprehensiveIncomeLossbyComponentTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock": { "auth_ref": [ "r375" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the net gain (loss) and net prior service cost or credit recognized in other comprehensive income (loss) for the period for pension plans and/or other employee benefit plans, and reclassification adjustments of other comprehensive income (loss) for the period, as those amounts, including amortization of the net transition asset or obligation, are recognized as components of net periodic benefit cost.", "label": "Schedule of Amounts Recognized in Other Comprehensive Income (Loss) [Table Text Block]", "terseLabel": "Schedule of Amounts Recognized in Other Comprehensive Income (Loss)" } } }, "localname": "ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/AccumulatedOtherComprehensiveIncomeLossbyComponentTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": { "auth_ref": [ "r168" ], "lang": { "en-US": { "role": { "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.", "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]", "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]" } } }, "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/NetEarningsLossPerCommonShareTextualsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of supplemental cash flow information for the periods presented.", "label": "Schedule of Cash Flow, Supplemental Disclosures [Table Text Block]", "terseLabel": "Schedule of Cash Flow, Supplemental Disclosures [Table]" } } }, "localname": "ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock": { "auth_ref": [ "r406" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of cost recognized for award under share-based payment arrangement by plan. Includes, but is not limited to, related tax benefit.", "label": "Share-based Payment Arrangement, Cost by Plan [Table Text Block]", "terseLabel": "Schedule of Compensation Cost for Share-based Payment Arrangements, Allocation of Share-based Compensation Costs by Plan" } } }, "localname": "ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDebtInstrumentsTextBlock": { "auth_ref": [ "r61", "r133", "r351", "r353", "r354", "r355", "r521", "r522", "r524", "r611" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.", "label": "Schedule of Long-term Debt Instruments [Table Text Block]", "terseLabel": "Schedule of Long-term Debt Instruments" } } }, "localname": "ScheduleOfDebtInstrumentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LongTermDebtTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock": { "auth_ref": [ "r479" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the effective portion of the gains and losses on derivative instruments designated (and non-derivative instruments) designated and qualifying in cash flow hedges and net investment hedges that was recognized in other comprehensive income (loss) during the current period.", "label": "Schedule of Derivative Instruments, Effect on Other Comprehensive Income (Loss) [Table Text Block]", "terseLabel": "Schedule of Derivative Instruments, Effect on Other Comprehensive Income (Loss)" } } }, "localname": "ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/DerivativesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock": { "auth_ref": [ "r477" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.", "label": "Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]", "terseLabel": "Schedule of Derivatives Instruments Statements of Financial Position, Fair Value" } } }, "localname": "ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/DerivativesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "auth_ref": [ "r167" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.", "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]", "terseLabel": "Schedule of Earnings Per Share, Basic and Diluted" } } }, "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/NetEarningsLossPerCommonShareTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable": { "auth_ref": [ "r383", "r406", "r418" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of information about amount recognized for award under share-based payment arrangement. Includes, but is not limited to, amount expensed in statement of income or comprehensive income, amount capitalized in statement of financial position, and corresponding reporting line item in financial statements.", "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]", "terseLabel": "Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table]" } } }, "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationSharebasedCompensationExpenseDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable": { "auth_ref": [ "r218" ], "lang": { "en-US": { "role": { "documentation": "Tabular presentation of the description and amount of revenues from a product or service, or a group of similar products or similar services, reported from external customers during the period, if the information is not provided as part of the reportable operating segment information.", "label": "Revenue from External Customers by Products and Services [Table]", "terseLabel": "Revenue from External Customers by Products and Services [Table]" } } }, "localname": "ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/BusinessSegmentsTables" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock": { "auth_ref": [ "r218" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of entity-wide revenues from external customers for each product or service or each group of similar products or services if the information is not provided as part of the reportable operating segment information.", "label": "Revenue from External Customers by Products and Services [Table Text Block]", "terseLabel": "Revenue from External Customers by Products and Services [Table Text Block]" } } }, "localname": "ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/BusinessSegmentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": { "auth_ref": [ "r496", "r497" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).", "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]", "terseLabel": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis" } } }, "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/FairValuesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock": { "auth_ref": [ "r478" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure for fair value hedging instruments of (a) the location and amount of gains and losses reported in the statement of financial performance and (b) the location and fair value amounts of the instruments reported in the statement of financial position.", "label": "Schedule of Fair Value Hedging Instruments, Statements of Financial Performance and Financial Position, Location [Table Text Block]", "terseLabel": "Schedule of Fair Value Hedging Instruments, Statements of Financial Performance and Financial Position, Location" } } }, "localname": "ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/DerivativesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfFinancingReceivableAllowanceForCreditLossesTable": { "auth_ref": [ "r256" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of information about allowance for credit loss on financing receivable.", "label": "Financing Receivable, Allowance for Credit Loss [Table]", "terseLabel": "Schedule of Financing Receivable, Allowance for Credit Losses [Table]" } } }, "localname": "ScheduleOfFinancingReceivableAllowanceForCreditLossesTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesScheduleforAllowanceforCreditLossesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfFinancingReceivablesPastDueTable": { "auth_ref": [ "r257", "r269" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of information about aging analysis for financing receivable.", "label": "Financing Receivable, Past Due [Table]", "terseLabel": "Schedule of Financing Receivables Past Due [Table]" } } }, "localname": "ScheduleOfFinancingReceivablesPastDueTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesAgingofInstallmentReceivablesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": { "auth_ref": [ "r287", "r291", "r587" ], "lang": { "en-US": { "role": { "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Schedule of Finite-Lived Intangible Assets [Table]", "terseLabel": "Schedule of Finite-Lived Intangible Assets by Major Class [Table]" } } }, "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/IntangiblesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": { "auth_ref": [ "r287", "r291" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.", "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]", "terseLabel": "Schedule of Finite-Lived Intangible Assets" } } }, "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/IntangiblesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfFutureMinimumLeasePaymentsForCapitalLeasesTableTextBlock": { "auth_ref": [ "r529" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of future minimum lease payments as of the date of the latest balance sheet presented, in aggregate and for each of the five years succeeding fiscal years, with separate deductions from the total for the amount representing executor costs, including any profit thereon, included in the minimum lease payments and for the amount of the imputed interest necessary to reduce the net minimum lease payments to present value.", "label": "Schedule of Future Minimum Lease Payments for Capital Leases [Table Text Block]", "terseLabel": "Schedule of Future Minimum Lease Payments for Capital Leases [Table]" } } }, "localname": "ScheduleOfFutureMinimumLeasePaymentsForCapitalLeasesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock": { "auth_ref": [ "r528" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of future minimum payments required in the aggregate and for each of the five succeeding fiscal years for operating leases having initial or remaining noncancelable lease terms in excess of one year and the total minimum rentals to be received in the future under noncancelable subleases as of the balance sheet date.", "label": "Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block]", "terseLabel": "Schedule of Future Minimum Rental Payments for Operating Leases [Table]" } } }, "localname": "ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfGoodwillTable": { "auth_ref": [ "r282", "r283" ], "lang": { "en-US": { "role": { "documentation": "Schedule of goodwill and the changes during the year due to acquisition, sale, impairment or for other reasons.", "label": "Schedule of Goodwill [Table]", "terseLabel": "Schedule of Goodwill [Table]" } } }, "localname": "ScheduleOfGoodwillTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/GoodwillGoodwillDetailsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfImpairedFinancingReceivableTable": { "auth_ref": [ "r233" ], "lang": { "en-US": { "role": { "documentation": "Schedule of the recorded investment, unpaid principal balance, associated allowance, average recorded investment, accounting policies, and interest income recognized on the accrual and cash basis for impaired financing receivables by class of financing receivable.", "label": "Schedule of Impaired Financing Receivable [Table]", "terseLabel": "Schedule of Impaired Financing Receivable [Table]" } } }, "localname": "ScheduleOfImpairedFinancingReceivableTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesInstallmentReceivablesbyClassDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock": { "auth_ref": [ "r295", "r297" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance and exist in perpetuity, by either major class or business segment.", "label": "Schedule of Indefinite-Lived Intangible Assets [Table Text Block]", "terseLabel": "Schedule of Indefinite-Lived Intangible Assets" } } }, "localname": "ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/IntangiblesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": { "auth_ref": [ "r21", "r45", "r46", "r47" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.", "label": "Schedule of Inventory, Current [Table Text Block]", "terseLabel": "Schedule of Inventory" } } }, "localname": "ScheduleOfInventoryCurrentTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/InventoriesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock": { "auth_ref": [ "r465" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the notional amounts of outstanding derivative positions.", "label": "Schedule of Notional Amounts of Outstanding Derivative Positions [Table Text Block]", "terseLabel": "Schedule of Notional Amounts of Outstanding Derivative Positions" } } }, "localname": "ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/DerivativesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock": { "auth_ref": [ "r52" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of noncurrent assets.", "label": "Schedule of Other Assets, Noncurrent [Table Text Block]", "terseLabel": "Schedule of Other Assets, Noncurrent" } } }, "localname": "ScheduleOfOtherAssetsNoncurrentTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/OtherLongTermAssetsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the carrying amounts of other current assets.", "label": "Schedule of Other Current Assets [Table Text Block]", "terseLabel": "Schedule of Other Current Assets" } } }, "localname": "ScheduleOfOtherCurrentAssetsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/OtherCurrentAssetsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock": { "auth_ref": [ "r482", "r484" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of derivative instrument not designated or qualifying as hedging instrument.", "label": "Derivatives Not Designated as Hedging Instruments [Table Text Block]", "terseLabel": "Schedule of Other Derivatives Not Designated as Hedging Instruments, Statements of Financial Performance and Financial Position, Location" } } }, "localname": "ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/DerivativesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock": { "auth_ref": [ "r342" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the changes in the guarantor's aggregate product warranty liability, including the beginning balance of the aggregate product warranty liability, the aggregate reductions in that liability for payments made (in cash or in kind) under the warranty, the aggregate changes in the liability for accruals related to product warranties issued during the reporting period, the aggregate changes in the liability for accruals related to preexisting warranties (including adjustments related to changes in estimates), and the ending balance of the aggregate product warranty liability.", "label": "Schedule of Product Warranty Liability [Table Text Block]", "terseLabel": "Schedule of Product Warranty Liability" } } }, "localname": "ScheduleOfProductWarrantyLiabilityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/AccruedExpensesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": { "auth_ref": [ "r51", "r302" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Property, Plant and Equipment [Table]", "terseLabel": "Schedule of Property, Plant and Equipment [Table]" } } }, "localname": "ScheduleOfPropertyPlantAndEquipmentTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/PropertyAndEquipmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": { "auth_ref": [ "r313", "r314", "r318" ], "lang": { "en-US": { "role": { "documentation": "Table presenting the description of the restructuring costs, such as the expected cost; the costs incurred during the period; the cumulative costs incurred as of the balance sheet date; the income statement caption within which the restructuring charges recognized for the period are included; and the amount of and periodic changes to an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost by type of restructuring.", "label": "Schedule of Restructuring and Related Costs [Table]", "terseLabel": "Schedule of Restructuring and Related Costs [Table]" } } }, "localname": "ScheduleOfRestructuringAndRelatedCostsTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/ChargesRelatedToRestructuringActivitiesDetails", "http://www.invacare.com/role/ChargesRelatedToRestructuringActivitiesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock": { "auth_ref": [ "r311", "r319" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost. This element may also include a description of any reversal and other adjustment made during the period to the amount of an accrued liability for restructuring activities. This element may be used to encapsulate the roll forward presentations of an entity's restructuring reserve by type of cost and in total, and explanation of changes that occurred in the period.", "label": "Schedule of Restructuring Reserve by Type of Cost [Table Text Block]", "terseLabel": "Schedule of Restructuring and Related Costs" } } }, "localname": "ScheduleOfRestructuringReserveByTypeOfCostTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/ChargesRelatedToRestructuringActivitiesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": { "auth_ref": [ "r200", "r203", "r209", "r282" ], "lang": { "en-US": { "role": { "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.", "label": "Schedule of Segment Reporting Information, by Segment [Table]", "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]" } } }, "localname": "ScheduleOfSegmentReportingInformationBySegmentTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/BusinessSegmentsInformationbySegmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": { "auth_ref": [ "r200", "r203", "r209", "r282" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.", "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]", "terseLabel": "Schedule of Segment Reporting Information, by Segment" } } }, "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/BusinessSegmentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": { "auth_ref": [ "r384", "r409" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of information about share-based payment arrangement.", "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]", "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]" } } }, "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationNarrativeDetails", "http://www.invacare.com/role/EquityCompensationOptionsActivityDetails", "http://www.invacare.com/role/EquityCompensationPerformanceShareActivityDetails", "http://www.invacare.com/role/EquityCompensationRestrictedStockActivityDetails", "http://www.invacare.com/role/EquityCompensationUnrecognizedCompensationExpenseDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable": { "auth_ref": [ "r409" ], "lang": { "en-US": { "role": { "documentation": "Details comprising a table providing supplementary information on outstanding and exercisable share awards as of the balance sheet date which stratifies outstanding options by ranges of exercise prices.", "label": "Share-based Payment Arrangement, Option, Exercise Price Range [Table]", "terseLabel": "Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range [Table]" } } }, "localname": "ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationStockOptionsOutstandingbyExercisePriceDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock": { "auth_ref": [ "r409" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms.", "label": "Share-based Payment Arrangement, Option, Exercise Price Range [Table Text Block]", "terseLabel": "Schedule of Share-based Compensation, Stock Options Outstanding" } } }, "localname": "ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": { "auth_ref": [ "r390", "r401", "r402" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.", "label": "Share-based Payment Arrangement, Option, Activity [Table Text Block]", "terseLabel": "Schedule of Share-based Compensation, Stock Options, Activity" } } }, "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year.", "label": "Share-based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block]", "terseLabel": "Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity" } } }, "localname": "ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock": { "auth_ref": [ "r408" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of cost not yet recognized and weighted-average period over which cost is expected to be recognized for nonvested award under share-based payment arrangement.", "label": "Share-based Payment Arrangement, Nonvested Award, Cost [Table Text Block]", "terseLabel": "Schedule of Unrecognized Compensation Cost, Nonvested Awards" } } }, "localname": "ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SegmentDomain": { "auth_ref": [ "r188", "r191", "r192", "r193", "r194", "r195", "r196", "r197", "r198", "r199", "r200", "r201", "r202", "r205", "r206", "r207", "r208", "r210", "r211", "r212", "r213", "r214", "r216", "r222", "r631" ], "lang": { "en-US": { "role": { "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.", "label": "Segments [Domain]", "terseLabel": "Segments [Domain]" } } }, "localname": "SegmentDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/AccruedExpensesWarrantyScheduleDetails", "http://www.invacare.com/role/BusinessSegmentsInformationbySegmentDetails", "http://www.invacare.com/role/ChargesRelatedToRestructuringActivitiesDetails", "http://www.invacare.com/role/ChargesRelatedToRestructuringActivitiesNarrativeDetails", "http://www.invacare.com/role/GoodwillGoodwillDetailsDetails", "http://www.invacare.com/role/IntangiblesNarrativeDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails", "http://www.invacare.com/role/ReceivablesAgingofInstallmentReceivablesDetails", "http://www.invacare.com/role/ReceivablesInstallmentReceivablesbyClassDetails", "http://www.invacare.com/role/ReceivablesNarrativeDetails", "http://www.invacare.com/role/RevenueDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SegmentReportingAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Segment Reporting [Abstract]", "terseLabel": "Segment Reporting [Abstract]" } } }, "localname": "SegmentReportingAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_SegmentReportingDisclosureTextBlock": { "auth_ref": [ "r188", "r189", "r190", "r200", "r204", "r210", "r214", "r215", "r216", "r217", "r218", "r221", "r222", "r223" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.", "label": "Segment Reporting Disclosure [Text Block]", "terseLabel": "Business Segments" } } }, "localname": "SegmentReportingDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/BusinessSegments" ], "xbrltype": "textBlockItemType" }, "us-gaap_SegmentReportingInformationLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Segment Reporting Information [Line Items]", "terseLabel": "Segment Reporting Information [Line Items]" } } }, "localname": "SegmentReportingInformationLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/BusinessSegmentsInformationbySegmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SellingGeneralAndAdministrativeExpense": { "auth_ref": [ "r108" ], "calculation": { "http://www.invacare.com/role/AccumulatedOtherComprehensiveIncomeLossbyComponentReclassifiedOutofAccumulatedOtherComprehensiveIncomeDetails": { "order": 1.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperations", "weight": -1.0 }, "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss": { "order": 3.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.", "label": "Selling, General and Administrative Expense", "negatedLabel": "Amortization of prior service costs and unrecognized gains", "terseLabel": "Selling, general and administrative expenses" } } }, "localname": "SellingGeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/AccumulatedOtherComprehensiveIncomeLossbyComponentReclassifiedOutofAccumulatedOtherComprehensiveIncomeDetails", "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_SellingGeneralAndAdministrativeExpensesMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Primary financial statement caption encompassing selling, general and administrative expense.", "label": "Selling, General and Administrative Expenses [Member]", "terseLabel": "Selling, General and Administrative Expenses" } } }, "localname": "SellingGeneralAndAdministrativeExpensesMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/DerivativesNarrativeDetails", "http://www.invacare.com/role/EquityCompensationSharebasedCompensationExpenseDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensation": { "auth_ref": [ "r124" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of noncash expense for share-based payment arrangement.", "label": "Share-based Payment Arrangement, Noncash Expense", "terseLabel": "Provision for equity compensation" } } }, "localname": "ShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1": { "auth_ref": [ "r386" ], "lang": { "en-US": { "role": { "documentation": "Estimated period over which an employee is required to provide service in exchange for the equity-based payment award, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Requisite Service Period", "terseLabel": "Award requisite service period" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription": { "auth_ref": [ "r382", "r385" ], "lang": { "en-US": { "role": { "documentation": "Description of terms of share-based payment arrangement. Includes, but is not limited to, type of award or grantee and reason for issuance.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Description", "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Description" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": { "auth_ref": [ "r394" ], "lang": { "en-US": { "role": { "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period", "negatedTerseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationPerformanceShareActivityDetails", "http://www.invacare.com/role/EquityCompensationRestrictedStockActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": { "auth_ref": [ "r399" ], "lang": { "en-US": { "role": { "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value", "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationPerformanceShareActivityDetails", "http://www.invacare.com/role/EquityCompensationRestrictedStockActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": { "auth_ref": [ "r397" ], "lang": { "en-US": { "role": { "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period", "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationPerformanceShareActivityDetails", "http://www.invacare.com/role/EquityCompensationRestrictedStockActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r397" ], "lang": { "en-US": { "role": { "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value", "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationPerformanceShareActivityDetails", "http://www.invacare.com/role/EquityCompensationRestrictedStockActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": { "auth_ref": [ "r395" ], "lang": { "en-US": { "role": { "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number", "periodEndLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number, Ending Balance", "periodStartLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number, Beginning Balance", "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationPerformanceShareActivityDetails", "http://www.invacare.com/role/EquityCompensationRestrictedStockActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]", "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationRestrictedStockActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": { "auth_ref": [ "r395" ], "lang": { "en-US": { "role": { "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value", "periodEndLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value, Ending Balance", "periodStartLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value, Beginning Balance", "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationPerformanceShareActivityDetails", "http://www.invacare.com/role/EquityCompensationRestrictedStockActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]", "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationRestrictedStockActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPeriodIncreaseDecrease": { "auth_ref": [ "r396" ], "lang": { "en-US": { "role": { "documentation": "The net total number of shares (or other type of equity) under an equity-based award plan, other than a stock option plan, that were granted, vested and forfeited during the reporting period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Period Increase (Decrease)", "terseLabel": "Net award activity (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPeriodIncreaseDecrease", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": { "auth_ref": [ "r398" ], "lang": { "en-US": { "role": { "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period", "negatedTerseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationRestrictedStockActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r398" ], "lang": { "en-US": { "role": { "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value", "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationRestrictedStockActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]", "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationNarrativeDetails", "http://www.invacare.com/role/EquityCompensationOptionsActivityDetails", "http://www.invacare.com/role/EquityCompensationPerformanceShareActivityDetails", "http://www.invacare.com/role/EquityCompensationRestrictedStockActivityDetails", "http://www.invacare.com/role/EquityCompensationUnrecognizedCompensationExpenseDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Number of additional shares authorized for issuance under share-based payment arrangement.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized", "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": { "auth_ref": [ "r409" ], "lang": { "en-US": { "role": { "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant", "terseLabel": "Options available for grant at end of period (in shares)", "verboseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationNarrativeDetails", "http://www.invacare.com/role/EquityCompensationOptionsActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": { "auth_ref": [ "r393" ], "lang": { "en-US": { "role": { "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number", "terseLabel": "Options exercisable at end of period (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationOptionsActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": { "auth_ref": [ "r393" ], "lang": { "en-US": { "role": { "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price", "terseLabel": "Antidilutive share granted, average exercise price" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/NetEarningsLossPerCommonShareTextualsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": { "auth_ref": [ "r394" ], "lang": { "en-US": { "role": { "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period", "negatedTerseLabel": "Canceled (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationOptionsActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": { "auth_ref": [ "r392", "r409" ], "lang": { "en-US": { "role": { "documentation": "Number of options outstanding, including both vested and non-vested options.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number", "periodEndLabel": "Options outstanding at end of period (in shares)", "periodStartLabel": "Options outstanding at beginning of period (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationOptionsActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]", "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationOptionsActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": { "auth_ref": [ "r391" ], "lang": { "en-US": { "role": { "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price", "periodEndLabel": "Options outstanding at end of period - Weighted Average Exercise Price (in dollars per share)", "periodStartLabel": "Options outstanding at beginning of period - Weighted Average Exercise Price (in dollars per share)", "terseLabel": "Options Outstanding - Weighted Average Exercise Price (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationOptionsActivityDetails", "http://www.invacare.com/role/EquityCompensationStockOptionsOutstandingbyExercisePriceDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "auth_ref": [ "r382", "r388" ], "lang": { "en-US": { "role": { "documentation": "Award under share-based payment arrangement.", "label": "Award Type [Domain]", "terseLabel": "Equity Award [Domain]" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationNarrativeDetails", "http://www.invacare.com/role/EquityCompensationOptionsActivityDetails", "http://www.invacare.com/role/EquityCompensationPerformanceShareActivityDetails", "http://www.invacare.com/role/EquityCompensationRestrictedStockActivityDetails", "http://www.invacare.com/role/EquityCompensationSharebasedCompensationExpenseDetails", "http://www.invacare.com/role/EquityCompensationStockOptionsOutstandingbyExercisePriceDetails", "http://www.invacare.com/role/EquityCompensationUnrecognizedCompensationExpenseDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.", "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price", "terseLabel": "Canceled - Weighted Average Exercise Price (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationOptionsActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock": { "auth_ref": [ "r389" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of number and weighted-average grant date fair value for nonvested performance shares.", "label": "Share-based Payment Arrangement, Performance Shares, Activity [Table Text Block]", "terseLabel": "Share-based Compensation, Performance Shares Award Unvested Activity" } } }, "localname": "ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis": { "auth_ref": [ "r404" ], "lang": { "en-US": { "role": { "documentation": "Information by range of option prices pertaining to options granted.", "label": "Exercise Price Range [Axis]", "terseLabel": "Exercise Price Range [Axis]" } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationOptionsActivityDetails", "http://www.invacare.com/role/EquityCompensationStockOptionsOutstandingbyExercisePriceDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain": { "auth_ref": [ "r405" ], "lang": { "en-US": { "role": { "documentation": "Supplementary information on outstanding and exercisable share awards as of the balance sheet date which stratifies outstanding options by ranges of exercise prices.", "label": "Exercise Price Range [Domain]", "terseLabel": "Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Domain]" } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationOptionsActivityDetails", "http://www.invacare.com/role/EquityCompensationStockOptionsOutstandingbyExercisePriceDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]", "terseLabel": "Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]" } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationStockOptionsOutstandingbyExercisePriceDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit": { "auth_ref": [ "r405" ], "lang": { "en-US": { "role": { "documentation": "The floor of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.", "label": "Share-based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit", "terseLabel": "Exercise price range, lower limit (in dollars per share)" } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationOptionsActivityDetails", "http://www.invacare.com/role/EquityCompensationStockOptionsOutstandingbyExercisePriceDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions": { "auth_ref": [ "r400" ], "lang": { "en-US": { "role": { "documentation": "The number of shares reserved for issuance pertaining to the outstanding exercisable stock options as of the balance sheet date in the customized range of exercise prices for which the market and performance vesting condition has been satisfied.", "label": "Share-based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable", "terseLabel": "Options Exercisable - Number Exercisable At end of period (in shares)" } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationStockOptionsOutstandingbyExercisePriceDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions": { "auth_ref": [ "r392" ], "lang": { "en-US": { "role": { "documentation": "The number of shares reserved for issuance pertaining to the outstanding stock options as of the balance sheet date for all option plans in the customized range of exercise prices.", "label": "Share-based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding", "terseLabel": "Options Outstanding - Number Outstanding at end of period (in shares)" } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationStockOptionsOutstandingbyExercisePriceDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit": { "auth_ref": [ "r405" ], "lang": { "en-US": { "role": { "documentation": "The ceiling of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.", "label": "Share-based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit", "terseLabel": "Exercise price range, upper limit (in dollars per share)" } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationOptionsActivityDetails", "http://www.invacare.com/role/EquityCompensationStockOptionsOutstandingbyExercisePriceDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": { "auth_ref": [ "r387" ], "lang": { "en-US": { "role": { "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period", "terseLabel": "Expiration period" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]", "terseLabel": "Weighted Average Exercise Price" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationOptionsActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1": { "auth_ref": [ "r393" ], "lang": { "en-US": { "role": { "documentation": "Weighted average exercise price as of the balance sheet date for those equity-based payment arrangements exercisable and outstanding.", "label": "Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price", "terseLabel": "Options Exercisable - Weighted Average Exercise Price (in dollars per share)" } } }, "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationStockOptionsOutstandingbyExercisePriceDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2": { "auth_ref": [ "r403" ], "lang": { "en-US": { "role": { "documentation": "Weighted average remaining contractual term of outstanding stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Share-based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Remaining Contractual Term", "verboseLabel": "Options Outstanding - Weighted Average Remaining Contractual Life" } } }, "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationStockOptionsOutstandingbyExercisePriceDetails" ], "xbrltype": "durationItemType" }, "us-gaap_ShortTermLeaseCost": { "auth_ref": [ "r544", "r550" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of short-term lease cost, excluding expense for lease with term of one month or less.", "label": "Short-term Lease, Cost", "terseLabel": "Short-term Lease, Cost" } } }, "localname": "ShortTermLeaseCost", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsLeaseExpensesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StatementBusinessSegmentsAxis": { "auth_ref": [ "r2", "r188", "r191", "r192", "r193", "r194", "r195", "r196", "r197", "r198", "r199", "r200", "r201", "r202", "r205", "r206", "r207", "r208", "r210", "r211", "r212", "r213", "r214", "r216", "r222", "r282", "r306", "r312", "r321", "r631" ], "lang": { "en-US": { "role": { "documentation": "Information by business segments.", "label": "Segments [Axis]", "terseLabel": "Segments [Axis]" } } }, "localname": "StatementBusinessSegmentsAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/AccruedExpensesWarrantyScheduleDetails", "http://www.invacare.com/role/BusinessSegmentsInformationbySegmentDetails", "http://www.invacare.com/role/ChargesRelatedToRestructuringActivitiesDetails", "http://www.invacare.com/role/ChargesRelatedToRestructuringActivitiesNarrativeDetails", "http://www.invacare.com/role/GoodwillGoodwillDetailsDetails", "http://www.invacare.com/role/IntangiblesNarrativeDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails", "http://www.invacare.com/role/ReceivablesAgingofInstallmentReceivablesDetails", "http://www.invacare.com/role/ReceivablesInstallmentReceivablesbyClassDetails", "http://www.invacare.com/role/ReceivablesNarrativeDetails", "http://www.invacare.com/role/RevenueDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [ "r29", "r30", "r31", "r129", "r130", "r158", "r162", "r163", "r165", "r167", "r175", "r176", "r177", "r243", "r350", "r511" ], "lang": { "en-US": { "role": { "documentation": "Information by the different classes of stock of the entity.", "label": "Class of Stock [Axis]", "terseLabel": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets", "http://www.invacare.com/role/CondensedConsolidatedBalanceSheetsParentheticals", "http://www.invacare.com/role/CondensedConsolidatedStatementofShareholdersEquityStatement", "http://www.invacare.com/role/DEIDocument", "http://www.invacare.com/role/EquityCompensationNarrativeDetails", "http://www.invacare.com/role/EquityCompensationPerformanceShareActivityDetails", "http://www.invacare.com/role/EquityCompensationUnrecognizedCompensationExpenseDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r64", "r138", "r139", "r141", "r143", "r151", "r154", "r174", "r247", "r350", "r356", "r414", "r415", "r416", "r432", "r433", "r513", "r514", "r515", "r516", "r517", "r519", "r638", "r639", "r640" ], "lang": { "en-US": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]", "terseLabel": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/AccumulatedOtherComprehensiveIncomeLossbyComponentChangesinAccumulatedOtherComprehensiveIncomeDetails", "http://www.invacare.com/role/AccumulatedOtherComprehensiveIncomeLossbyComponentReclassifiedOutofAccumulatedOtherComprehensiveIncomeDetails", "http://www.invacare.com/role/CondensedConsolidatedStatementofShareholdersEquityStatement" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]", "terseLabel": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets", "http://www.invacare.com/role/CondensedConsolidatedBalanceSheetsParentheticals", "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows", "http://www.invacare.com/role/CondensedConsolidatedStatementofShareholdersEquityStatement" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Statement of Cash Flows [Abstract]", "terseLabel": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Statement of Financial Position [Abstract]", "terseLabel": "Statement of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Statement of Comprehensive Income [Abstract]", "terseLabel": "Statement of Comprehensive Income [Abstract]" } } }, "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Statement of Stockholders' Equity [Abstract]", "terseLabel": "Statement of Stockholders' Equity [Abstract]" } } }, "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r138", "r139", "r141", "r174", "r586" ], "lang": { "en-US": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]", "terseLabel": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets", "http://www.invacare.com/role/CondensedConsolidatedBalanceSheetsParentheticals", "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows", "http://www.invacare.com/role/CondensedConsolidatedStatementofShareholdersEquityStatement" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures": { "auth_ref": [ "r350", "r356" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Value of stock related to Restricted Stock Awards issued during the period, net of the stock value of such awards forfeited.", "label": "Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures", "terseLabel": "Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures" } } }, "localname": "StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofShareholdersEquityStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": { "auth_ref": [ "r64", "r350", "r356" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Value of stock issued as a result of the exercise of stock options.", "label": "Stock Issued During Period, Value, Stock Options Exercised", "negatedTerseLabel": "Stock Issued During Period, Value, Stock Options Exercised" } } }, "localname": "StockIssuedDuringPeriodValueStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofShareholdersEquityStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r31", "r37", "r38", "r130", "r238", "r243", "r511" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Stockholders' Equity Attributable to Parent", "periodEndLabel": "Total Shareholders\u2019 Equity", "periodStartLabel": "Total Shareholders\u2019 Equity", "totalLabel": "Total Shareholders\u2019 Equity" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets", "http://www.invacare.com/role/CondensedConsolidatedStatementofShareholdersEquityStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Stockholders' Equity Attributable to Parent [Abstract]", "terseLabel": "Shareholders\u2019 Equity" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_SubsegmentsAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Information by business subsegments.", "label": "Subsegments [Axis]", "terseLabel": "Subsegments [Axis]" } } }, "localname": "SubsegmentsAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsegmentsDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Divisions of a component of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.", "label": "Subsegments [Domain]", "terseLabel": "Subsegments [Domain]" } } }, "localname": "SubsegmentsDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TaxPeriodAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Information about the period subject to enacted tax laws.", "label": "Tax Period [Axis]", "terseLabel": "Tax Period [Axis]" } } }, "localname": "TaxPeriodAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_TaxPeriodDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Identified tax period.", "label": "Tax Period [Domain]", "terseLabel": "Tax Period [Domain]" } } }, "localname": "TaxPeriodDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TaxesPayableCurrent": { "auth_ref": [ "r55" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Taxes Payable, Current", "terseLabel": "Current taxes payable" } } }, "localname": "TaxesPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_TrademarksMember": { "auth_ref": [ "r445" ], "lang": { "en-US": { "role": { "documentation": "Rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style.", "label": "Trademarks [Member]", "terseLabel": "Trademarks" } } }, "localname": "TrademarksMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/IntangiblesIntangibleTableDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": { "auth_ref": [ "r241", "r242", "r554", "r555", "r556", "r557", "r558", "r559", "r560", "r561", "r562", "r563", "r564", "r565", "r566", "r568", "r569", "r570", "r571", "r572", "r573", "r574", "r575", "r576", "r577", "r578", "r579", "r580", "r581", "r582", "r583", "r584" ], "lang": { "en-US": { "role": { "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.", "label": "Financial Instruments [Domain]", "terseLabel": "Financial Instruments [Domain]" } } }, "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/FairValuesAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.invacare.com/role/FairValuesDetailsofBookValueandFairValueofFinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TreasuryStockMember": { "auth_ref": [ "r63", "r357" ], "lang": { "en-US": { "role": { "documentation": "Shares of an entity that have been repurchased by the entity. This stock has no voting rights and receives no dividends. Note that treasury stock may be recorded at its total cost or separately as par (or stated) value and additional paid in capital. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.", "label": "Treasury Stock [Member]", "terseLabel": "Treasury Stock [Member]" } } }, "localname": "TreasuryStockMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofShareholdersEquityStatement" ], "xbrltype": "domainItemType" }, "us-gaap_TreasuryStockShares": { "auth_ref": [ "r63", "r357" ], "lang": { "en-US": { "role": { "documentation": "Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.", "label": "Treasury Stock, Shares", "terseLabel": "Treasury Stock, Shares" } } }, "localname": "TreasuryStockShares", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedBalanceSheetsParentheticals" ], "xbrltype": "sharesItemType" }, "us-gaap_TreasuryStockValue": { "auth_ref": [ "r63", "r357", "r358" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_StockholdersEquity", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.", "label": "Treasury Stock, Value", "negatedLabel": "Treasury Shares (4,184 and 3,953 shares at September 30, 2020 and December 31, 2019, respectively)" } } }, "localname": "TreasuryStockValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_TypeOfAdoptionMember": { "auth_ref": [ "r142", "r143", "r144", "r145", "r244", "r245", "r246", "r247", "r248", "r249", "r410", "r411", "r412", "r413", "r414", "r415", "r416", "r417", "r430", "r431", "r432", "r433", "r588", "r589", "r590", "r636", "r637", "r638", "r639", "r640", "r641", "r642", "r643", "r644", "r645", "r646", "r647" ], "lang": { "en-US": { "role": { "documentation": "Amendment to accounting standards.", "label": "Accounting Standards Update [Domain]", "terseLabel": "Type of Adoption [Domain]" } } }, "localname": "TypeOfAdoptionMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofShareholdersEquityStatement" ], "xbrltype": "domainItemType" }, "us-gaap_TypeOfArrangementAxis": { "auth_ref": [ "r450" ], "lang": { "en-US": { "role": { "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]", "terseLabel": "Type of Arrangement and Non-arrangement Transactions [Axis]" } } }, "localname": "TypeOfArrangementAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/RevenueDetails", "http://www.invacare.com/role/RevenueTables" ], "xbrltype": "stringItemType" }, "us-gaap_TypeOfRestructuringDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Identification of the types of restructuring costs.", "label": "Type of Restructuring [Domain]", "terseLabel": "Type of Restructuring [Domain]" } } }, "localname": "TypeOfRestructuringDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/BusinessSegmentsInformationbySegmentDetails", "http://www.invacare.com/role/ChargesRelatedToRestructuringActivitiesDetails", "http://www.invacare.com/role/ChargesRelatedToRestructuringActivitiesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_UnrealizedGainLossOnDerivatives": { "auth_ref": [ "r125" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The net change in the difference between the fair value and the carrying value, or in the comparative fair values, of derivative instruments, including options, swaps, futures, and forward contracts, held at each balance sheet date, that was included in earnings for the period.", "label": "Unrealized Gain (Loss) on Derivatives", "terseLabel": "Unrealized Gain (Loss)" } } }, "localname": "UnrealizedGainLossOnDerivatives", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/DerivativesNotionalAmountsDesignatedasHedgesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnsecuredDebt": { "auth_ref": [ "r27", "r598", "r618" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Including the current and noncurrent portions, carrying value as of the balance sheet date of uncollateralized debt obligations (with maturities initially due after one year or beyond the operating cycle if longer).", "label": "Unsecured Debt", "terseLabel": "Unsecured Debt" } } }, "localname": "UnsecuredDebt", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnsecuredDebtCurrent": { "auth_ref": [ "r25", "r596", "r617" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Carrying value as of the balance sheet date of the portion of long-term, uncollateralized debt obligations due within one year or the normal operating cycle, if longer.", "label": "Unsecured Debt, Current", "terseLabel": "Unsecured Debt, Current" } } }, "localname": "UnsecuredDebtCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r178", "r179", "r180", "r181", "r184", "r185", "r186" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "Use of Estimates, Policy [Policy Text Block]", "terseLabel": "Use of Estimates" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/AccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ValuationAllowanceLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Valuation Allowance [Line Items]", "terseLabel": "Valuation Allowance [Line Items]" } } }, "localname": "ValuationAllowanceLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ValuationAllowanceTable": { "auth_ref": [ "r425" ], "lang": { "en-US": { "role": { "documentation": "A listing of an entity's valuation allowances to reduce deferred tax assets to amounts which it is more likely than not will not be realized, including a description of the deferred tax assets for which the valuation allowance has been recorded and the amount of the valuation allowance.", "label": "Valuation Allowance [Table]", "terseLabel": "Valuation Allowance [Table]" } } }, "localname": "ValuationAllowanceTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ValueAddedTaxReceivableCurrent": { "auth_ref": [ "r69" ], "calculation": { "http://www.invacare.com/role/OtherCurrentAssetsComponentsofOtherCurrentAssetsDetails": { "order": 1.0, "parentTag": "us-gaap_OtherAssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Carrying amount as of the balance sheet date of value added taxes due either from customers arising from sales on credit terms, or as previously overpaid to tax authorities. For classified balance sheets, represents the current amount receivable, that is amounts expected to be collected within one year or the normal operating cycle, if longer.", "label": "Value Added Tax Receivable, Current", "terseLabel": "Tax receivables principally value added taxes" } } }, "localname": "ValueAddedTaxReceivableCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/OtherCurrentAssetsComponentsofOtherCurrentAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_VariableRateAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Information by type of variable rate.", "label": "Variable Rate [Axis]", "terseLabel": "Variable Rate [Axis]" } } }, "localname": "VariableRateAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_VariableRateDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.", "label": "Variable Rate [Domain]", "terseLabel": "Variable Rate [Domain]" } } }, "localname": "VariableRateDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_VestingAxis": { "auth_ref": [ "r409" ], "lang": { "en-US": { "role": { "documentation": "Information by vesting schedule of award under share-based payment arrangement.", "label": "Vesting [Axis]", "terseLabel": "Vesting [Axis]" } } }, "localname": "VestingAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationPerformanceShareActivityDetails", "http://www.invacare.com/role/EquityCompensationUnrecognizedCompensationExpenseDetails" ], "xbrltype": "stringItemType" }, "us-gaap_VestingDomain": { "auth_ref": [ "r409" ], "lang": { "en-US": { "role": { "documentation": "Vesting schedule of award under share-based payment arrangement.", "label": "Vesting [Domain]", "terseLabel": "Vesting [Domain]" } } }, "localname": "VestingDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationPerformanceShareActivityDetails", "http://www.invacare.com/role/EquityCompensationUnrecognizedCompensationExpenseDetails" ], "xbrltype": "domainItemType" }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "auth_ref": [ "r157", "r167" ], "calculation": { "http://www.invacare.com/role/NetEarningsLossPerCommonShareComputationofBasicandDilutedNetEarningsLossPerCommonShareDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "lang": { "en-US": { "role": { "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.", "label": "Weighted Average Number of Shares Outstanding, Diluted", "terseLabel": "Weighted Average Shares\u00a0Outstanding\u2014Assuming Dilution", "totalLabel": "Average common shares assuming dilution" } } }, "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss", "http://www.invacare.com/role/NetEarningsLossPerCommonShareComputationofBasicandDilutedNetEarningsLossPerCommonShareDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "auth_ref": [ "r156", "r167" ], "calculation": { "http://www.invacare.com/role/NetEarningsLossPerCommonShareComputationofBasicandDilutedNetEarningsLossPerCommonShareDetails": { "order": 1.0, "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0 } }, "lang": { "en-US": { "role": { "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.", "label": "Weighted Average Number of Shares Outstanding, Basic", "terseLabel": "Weighted Average Shares\u00a0Outstanding\u2014Basic", "verboseLabel": "Average common shares outstanding" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss", "http://www.invacare.com/role/NetEarningsLossPerCommonShareComputationofBasicandDilutedNetEarningsLossPerCommonShareDetails" ], "xbrltype": "sharesItemType" } }, "unitCount": 6 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=d3e1107-107759" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721533-107759" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(21))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(24))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(25))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(5))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(8))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.1,2)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.13)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.2)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.8)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765" }, "r110": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "220", "URI": "http://asc.fasb.org/topic&trid=2134417" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3179-108585" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3179-108585" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3179-108585" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3367-108585" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3521-108585" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3044-108585" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18780-107790" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(d))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)(1)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(m)(1)(iii))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08.(e),(f))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08.(f))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08.(h)(1)(i))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-04(a))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690" }, "r137": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "http://asc.fasb.org/topic&trid=2122369" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21914-107793" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21930-107793" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "27", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e22044-107793" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21711-107793" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(4)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22583-107794" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22595-107794" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6787-107765" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22658-107794" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22663-107794" }, "r155": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "250", "URI": "http://asc.fasb.org/topic&trid=2122394" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1448-109256" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1505-109256" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1252-109256" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1707-109256" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6801-107765" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1757-109256" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "28A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1500-109256" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1278-109256" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "55", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e2626-109256" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1337-109256" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3630-109257" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6812-107765" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=120380238&loc=d3e3842-109258" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=120380238&loc=d3e4984-109258" }, "r173": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "260", "URI": "http://asc.fasb.org/topic&trid=2144383" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=6828210&loc=d3e70191-108054" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=6828210&loc=d3e70229-108054" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6911-107765" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592" }, "r187": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "275", "URI": "http://asc.fasb.org/topic&trid=2134479" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8657-108599" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6935-107765" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(j)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e7018-107765" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "26", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8844-108599" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "34", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8981-108599" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9031-108599" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(13))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9054-108599" }, "r223": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "280", "URI": "http://asc.fasb.org/topic&trid=2134510" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4428-111522" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4531-111522" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "11B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=SL6953423-111524" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "11B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(3)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=SL6953423-111524" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "11B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=SL6953423-111524" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "14A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=SL6953550-111524" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(14))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=d3e5212-111524" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(4)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=d3e5212-111524" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=d3e5212-111524" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=d3e5212-111524" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=d3e5066-111524" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=d3e5074-111524" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=d3e5111-111524" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=SL6953401-111524" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707" }, "r239": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/subtopic&trid=2196772" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(17))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r240": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "30", "Topic": "310", "URI": "http://asc.fasb.org/subtopic&trid=2196854" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27232-111563" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=SL120269820-111563" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(3)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(4)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(19))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121599878&loc=SL82895884-210446" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919244-210447" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919249-210447" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919249-210447" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919249-210447" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919249-210447" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919249-210447" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919253-210447" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919258-210447" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919230-210447" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(20))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919230-210447" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121647567&loc=SL82921830-210448" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121647567&loc=SL82921833-210448" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121647567&loc=SL82921835-210448" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121647567&loc=SL82921835-210448" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121647567&loc=SL82921835-210448" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121647567&loc=SL82921835-210448" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121647567&loc=SL82921835-210448" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "79", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121647567&loc=SL82922352-210448" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "80", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121647567&loc=SL82922355-210448" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r270": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/subtopic&trid=82887181" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922888-210455" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922895-210455" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922900-210455" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456" }, "r275": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/subtopic&trid=82887182" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.BB)", "Topic": "330", "URI": "http://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729" }, "r277": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "330", "URI": "http://asc.fasb.org/topic&trid=2126998" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "340", "URI": "http://asc.fasb.org/extlink&oid=68074540&loc=d3e5879-108316" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "340", "URI": "http://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(24))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267" }, "r284": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/subtopic&trid=2144439" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "((a)(1),(b))", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(2)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(3)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b),(d)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275" }, "r298": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "350", "URI": "http://asc.fasb.org/topic&trid=2144416" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226348&loc=d3e2443-110228" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230" }, "r307": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "360", "URI": "http://asc.fasb.org/topic&trid=2155823" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "410", "URI": "http://asc.fasb.org/extlink&oid=6392676&loc=d3e7480-110848" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=6394232&loc=d3e17558-110866" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 5.P.3)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.3)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 5.P.4(b)(2))", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 5.P.4(b))", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 5.P.4)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(b)(2))", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(3)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(b))", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(d))", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747" }, "r322": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "420", "URI": "http://asc.fasb.org/topic&trid=2175745" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14394-108349" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14453-108349" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14472-108349" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751" }, "r331": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/subtopic&trid=2127163" }, "r332": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "30", "Topic": "450", "URI": "http://asc.fasb.org/subtopic&trid=2127197" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=68070138&loc=d3e11281-110244" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=121555522&loc=d3e12021-110248" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=121555522&loc=d3e12053-110248" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=121555522&loc=d3e12069-110248" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=68068213&loc=d3e12524-110249" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "((c)(2))", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=68068213&loc=d3e12565-110249" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "((c)(3))", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=68068213&loc=d3e12565-110249" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "((c)(4))", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=68068213&loc=d3e12565-110249" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(3)", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=68068213&loc=d3e12565-110249" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=68068213&loc=d3e12565-110249" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=6802200&loc=SL6230698-112601" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=109126253&loc=d3e4875-112606" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6031898-161870" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6036836-161870" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "40", "SubTopic": "50", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=117329964&loc=d3e12317-112629" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "40", "SubTopic": "50", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=117329964&loc=d3e12355-112629" }, "r349": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "470", "URI": "http://asc.fasb.org/topic&trid=2208564" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644" }, "r351": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644" }, "r353": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21521-112644" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21538-112644" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770" }, "r357": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655" }, "r358": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656" }, "r359": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130545-203045" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(4))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r360": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046" }, "r361": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "710", "URI": "http://asc.fasb.org/extlink&oid=75028277&loc=d3e19793-108362" }, "r363": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "30", "SubTopic": "10", "Topic": "710", "URI": "http://asc.fasb.org/extlink&oid=6409875&loc=d3e20028-108363" }, "r364": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=109237824&loc=d3e1703-114919" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=109237824&loc=d3e1731-114919" }, "r366": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(i)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r368": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r369": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r370": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r371": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(A)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r372": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(B)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r373": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(C)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r374": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(03)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r375": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(i)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r376": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118257860&loc=d3e4179-114921" }, "r377": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947" }, "r378": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(d)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r379": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(f)(3)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r380": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947" }, "r381": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "80", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948" }, "r382": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r383": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r384": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r385": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r386": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r387": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r388": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a),(g)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r389": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r390": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r391": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r392": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)-(ii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r393": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r394": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(3)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r395": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(i)-(ii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r396": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r397": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r398": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r399": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(3)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(4))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r400": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(iii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r401": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r402": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r403": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r404": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r405": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r406": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r407": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r408": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r409": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(5))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r410": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r411": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r412": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r413": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r414": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r415": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r416": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r417": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(g)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r418": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.F)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809" }, "r419": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "718", "URI": "http://asc.fasb.org/topic&trid=2228938" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r420": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "720", "URI": "http://asc.fasb.org/extlink&oid=6419918&loc=d3e35281-107843" }, "r421": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32672-109319" }, "r422": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32687-109319" }, "r423": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32705-109319" }, "r424": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32809-109319" }, "r425": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319" }, "r426": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32857-109319" }, "r427": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32621-109319" }, "r428": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32632-109319" }, "r429": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r430": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740" }, "r431": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740" }, "r432": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740" }, "r433": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740" }, "r434": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817" }, "r435": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.7)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817" }, "r436": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.7)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817" }, "r437": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.1)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817" }, "r438": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.2)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817" }, "r439": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.4)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(4))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r440": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.C)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330215-122817" }, "r441": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=120385591&loc=d3e38679-109324" }, "r442": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "270", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338" }, "r443": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331" }, "r444": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "740", "URI": "http://asc.fasb.org/topic&trid=2144680" }, "r445": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5263-128473" }, "r446": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5333-128473" }, "r447": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5419-128473" }, "r448": { "Name": "Accounting Standards Codification", "Paragraph": "38", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5504-128473" }, "r449": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "805", "URI": "http://asc.fasb.org/topic&trid=2303972" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r450": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "808", "URI": "http://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434" }, "r451": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4613673-111683" }, "r452": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569616-111683" }, "r453": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569643-111683" }, "r454": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r455": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r456": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684" }, "r457": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(3)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r458": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c),(3)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r459": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4582445-111684" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r460": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685" }, "r461": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685" }, "r462": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "810", "URI": "http://asc.fasb.org/topic&trid=2197479" }, "r463": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=117331979&loc=d3e41228-113958" }, "r464": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5579240-113959" }, "r465": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5579245-113959" }, "r466": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5579245-113959" }, "r467": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5580258-113959" }, "r468": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)(ii)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41620-113959" }, "r469": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41620-113959" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(c))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r470": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41638-113959" }, "r471": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5618551-113959" }, "r472": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5618551-113959" }, "r473": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(1)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5618551-113959" }, "r474": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a),(c)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959" }, "r475": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959" }, "r476": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959" }, "r477": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959" }, "r478": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624171-113959" }, "r479": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624171-113959" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.1)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r480": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624171-113959" }, "r481": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624171-113959" }, "r482": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624171-113959" }, "r483": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624171-113959" }, "r484": { "Name": "Accounting Standards Codification", "Paragraph": "4CC", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL109998890-113959" }, "r485": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624177-113959" }, "r486": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624177-113959" }, "r487": { "Name": "Accounting Standards Codification", "Paragraph": "4E", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624181-113959" }, "r488": { "Name": "Accounting Standards Codification", "Paragraph": "4K", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5708775-113959" }, "r489": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41641-113959" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.12)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r490": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41678-113959" }, "r491": { "Name": "Accounting Standards Codification", "Paragraph": "182", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121582272&loc=SL5629052-113961" }, "r492": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "25", "Subparagraph": "(a)(1),(2)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986" }, "r493": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "25", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986" }, "r494": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121558989&loc=d3e80720-113993" }, "r495": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "815", "URI": "http://asc.fasb.org/topic&trid=2229140" }, "r496": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r497": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r498": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r499": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(1)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "5C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(2)", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.13)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r500": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(2)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r501": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r502": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19279-110258" }, "r503": { "Name": "Accounting Standards Codification", "Paragraph": "6A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=SL6742756-110258" }, "r504": { "Name": "Accounting Standards Codification", "Paragraph": "6A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=SL6742756-110258" }, "r505": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=116690757&loc=d3e13220-108610" }, "r506": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13433-108611" }, "r507": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13467-108611" }, "r508": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13476-108611" }, "r509": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13531-108611" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.14)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r510": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13537-108611" }, "r511": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612" }, "r512": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=98513438&loc=d3e33268-110906" }, "r513": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900" }, "r514": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r515": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r516": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r517": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r518": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r519": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.17)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r520": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391" }, "r521": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28541-108399" }, "r522": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28551-108399" }, "r523": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28555-108399" }, "r524": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400" }, "r525": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "840", "URI": "http://asc.fasb.org/extlink&oid=121549808&loc=d3e36991-112694" }, "r526": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(Note 3)", "Topic": "840", "URI": "http://asc.fasb.org/extlink&oid=121580752&loc=d3e38371-112697" }, "r527": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "840", "URI": "http://asc.fasb.org/extlink&oid=121573735&loc=d3e41502-112717" }, "r528": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "840", "URI": "http://asc.fasb.org/extlink&oid=121573735&loc=d3e41502-112717" }, "r529": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "840", "URI": "http://asc.fasb.org/extlink&oid=121616839&loc=d3e45280-112737" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r530": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "25", "SubTopic": "40", "Topic": "840", "URI": "http://asc.fasb.org/extlink&oid=121596030&loc=d3e49567-112750" }, "r531": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "35", "SubTopic": "40", "Topic": "840", "URI": "http://asc.fasb.org/extlink&oid=121616360&loc=d3e50609-112754" }, "r532": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "840", "URI": "http://asc.fasb.org/extlink&oid=121586228&loc=d3e50796-112755" }, "r533": { "Name": "Accounting Standards Codification", "Paragraph": "50", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "840", "URI": "http://asc.fasb.org/extlink&oid=121602674&loc=d3e51831-112757" }, "r534": { "Name": "Accounting Standards Codification", "Paragraph": "51", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "840", "URI": "http://asc.fasb.org/extlink&oid=121602674&loc=d3e51840-112757" }, "r535": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "840", "URI": "http://asc.fasb.org/extlink&oid=121602674&loc=d3e51843-112757" }, "r536": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "840", "URI": "http://asc.fasb.org/topic&trid=2208923" }, "r537": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918627-209977" }, "r538": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918627-209977" }, "r539": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918638-209977" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(b),22(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r540": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918638-209977" }, "r541": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918673-209980" }, "r542": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980" }, "r543": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980" }, "r544": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980" }, "r545": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(2)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980" }, "r546": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(3)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980" }, "r547": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(4)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980" }, "r548": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980" }, "r549": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918701-209980" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19,20)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r550": { "Name": "Accounting Standards Codification", "Paragraph": "53", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121568110&loc=SL77918982-209971" }, "r551": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121606570&loc=SL77919786-209982" }, "r552": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121606570&loc=SL77919786-209982" }, "r553": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662" }, "r554": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)(i)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r555": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)(ii)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r556": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r557": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r558": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r559": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r560": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r561": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r562": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r563": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r564": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r565": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r566": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r567": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=SL51823488-111719" }, "r568": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728" }, "r569": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20,24)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r570": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746" }, "r571": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746" }, "r572": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746" }, "r573": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(4)(i)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746" }, "r574": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746" }, "r575": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746" }, "r576": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746" }, "r577": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(4)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746" }, "r578": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(5)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746" }, "r579": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(6)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r580": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(7)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746" }, "r581": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(b)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746" }, "r582": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746" }, "r583": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746" }, "r584": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746" }, "r585": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "910", "URI": "http://asc.fasb.org/extlink&oid=119991564&loc=SL119991595-234733" }, "r586": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856" }, "r587": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "926", "URI": "http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959" }, "r588": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "926", "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079" }, "r589": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "926", "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r590": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "926", "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079" }, "r591": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "340", "Topic": "928", "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004" }, "r592": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "940", "URI": "http://asc.fasb.org/extlink&oid=68072869&loc=d3e41242-110953" }, "r593": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(10)(1))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r594": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(10))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r595": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r596": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(13))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r597": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(15))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r598": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(16))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r599": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r600": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(7)(2))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r601": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(7))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r602": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.10)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r603": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(15))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r604": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r605": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(23))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r606": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(26))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r607": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(27))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r608": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.9)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r609": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(1))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r610": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884" }, "r611": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823" }, "r612": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(16))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r613": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(5))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r614": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(10))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r615": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r616": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(15))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r617": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(16)(a)(1))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r618": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(16))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r619": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.24)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r620": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r621": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r622": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(5))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r623": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r624": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.5(c))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r625": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r626": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(19))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r627": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(22))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r628": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(23))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r629": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(8))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29,30)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r630": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(9))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r631": { "Name": "Accounting Standards Codification", "Paragraph": "4H", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438" }, "r632": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121643868&loc=SL117782755-158439" }, "r633": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441" }, "r634": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(b)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441" }, "r635": { "Name": "Accounting Standards Codification", "Paragraph": "29F", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117819544-158441" }, "r636": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r637": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(b)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r638": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r639": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r640": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r641": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(1)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r642": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r643": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(ii)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r644": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(iii)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r645": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(iv)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r646": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(1)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r647": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r648": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=99380617&loc=SL75241803-196195" }, "r649": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "310", "Subparagraph": "(SX 210.12-29(Footnote 4))", "Topic": "948", "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.3(a)(4))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r650": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Subparagraph": "(d)", "Topic": "958", "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99779-112916" }, "r651": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99893-112916" }, "r652": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=SL120174063-112916" }, "r653": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column B))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r654": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column C))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r655": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column D))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r656": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column E))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r657": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column F))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r658": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column G))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r659": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column H))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.3(a),(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r660": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column I))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r661": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Footnote 2))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r662": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r663": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r664": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-13" }, "r665": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1-" }, "r666": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r667": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.3,4)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.6(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.8)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r7": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/subtopic&trid=2122178" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.9)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13728-122682" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226008-175313" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226024-175313" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226000-175313" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a),(b),(c)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(i),(j),(k)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e637-108580" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e640-108580" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e681-108580" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "14A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669686-108580" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e689-108580" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "17A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL34724391-108580" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "17B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL34724394-108580" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e557-108580" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121640130&loc=d3e1436-108581" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(210.5-03(11))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(1))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(10))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" } }, "version": "2.1" } ZIP 130 0000742112-20-000109-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0000742112-20-000109-xbrl.zip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ŞUZ15W"6!( M,9*AZNA=U_4 X55;R:7[]KN\QC!2V3BG+,J7BE0JBV42I&>XF61M;9:.LB;Z M

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

3/-^,>_XY>14X(B0N.8+10C:&4= R1:&W$AG M+(AV9Y%K+S\5Q@>(= /)@S;)+J. G\:+!)/_%V%^E:/*(P;TY"T*44CS="X, M- *SUI>BL\I%M,@PN._]SY[J)H+=P/:@7;2K)-6OJ'ZBGRQ& 8WR4=?,5"R, M("$+-='%&, D"M>J"=GWO/[9<]U"K!NH'K2==AO31?[Y)2H=02=(+.>:D$R! M O,&%#.9XGV9M'.YA6M^+X 3HWM?T6X@?- NVBN"E%>P)O!A%(0INEX\=I(C MTU'1*F.*8D7% $: S++%[9Q;+WWVQ.XOP@UD#M\8&^/B-X@3'*68K4ZTA'A; M]W"RR"R2JE'(1SIE.8#W+SZ1+_6/XXP:HR?_EV@1^^WE'=G?;S!?L \&FT2E:J#WH]@<7B M75E%!J_^&"]&4?J@53%,&B2%1%$O ;K$C">#(LAM=&%#YL@5,P46<47/Y8N^ MJY=LO\/) ?O"MA-/#^L%L*M M$(W6;M:W5(&[D%HN]O?5!OC*?&/.9ET$?B!5R-Y:RRD\#+8FLA$\R%PQ*"E9 MLD]8](;LT.>C K?*+1Q3 W:0/J%+L2O(SF*GG6V!\FVX?WZVX!6H_S^"I&+R%$! ^<6[KW3NY__6Y-(N2^_F/?&BFO9]-,2R!F^F(QFXQS MK4%UO=C-2CT=F./'NDI^QGI;[0S?SA:+VR"WJJ>R[YL:U%YI,LBU.BTNYN0= M!6,Q.6TCABS1^ZA0! H89!HU&&\#*K^'2:V4]>M'Q&4SUFX_M!=!#T!?X\)F MARJH4H^JM"C<2YY*]"[Y4"1%T)NYN/W\1M'3UU"21RE+72NLX+2V<^]8B$K7 M]#8 FZ!L3"AI =0QEJ)EXM%B2A5['>4T[+D41E:-V+3-A #H^K%>94$,QE M0;Z0\-QN.HD;/K#;, YO'@9RO&X>!DBU@RMP@>;R]. :5*;Y1$Z)8X7K6B60 MS)\O]&WDP)';8%9SL!?5:V@.S_@0BC:R/42^/9Q]6'Q\-(!4*>@&5(_E& C24$AM-\%\HID#U0P WK0VTM^GDW3):@@ M"JH4,[-UNUK;+%E,9%&R-T*I5&L'RQS_2Y+QF _]U-LN_CR>348!88B(#4U/%ZV9X5]SH= /6N-:";M#G[?3^-IW3=_B[# 7VHGDG?E[XL+S1TE MDK-.4K" GI2TJ$A?24>\@<]2\I3Z;!@^@.E9ZT$K67?P!=^1@D*]RKT1'%?" M.Y5QJZ4I96)#<,8Y*@W; K>\2\#V(ZEFK0CMY=W :KZV4-<$)[02+1II: M3T>SH'.M76FY+"H1L"X^PDGX 7M)L6'QS]M#&CD'.H,BPY*!UVBD9BL@*58. M-ON4A=O4:J%5?/>LF=Q#@@V+>EZA>#N&.)ZL\E;)AUCEM7R<3>C9B^I/++]< M#S4%;S"0@@5>(M.9-"_$>K$[*:6B09_$AGJ^PYG>%N"S/^SMPD2'4YX;..]N M<.0LDDTU+JVER4MB()5ER63KM8Y*;.K4T%1'CGX@W(?&^W5E" <=SP#?PY=Z MUG"U8>62=4YJSJ0PM=:'5;3>Q=7U(Y]4"LY"EUW?S7".JA6#"+OG\&^ M/OH MP/P<\]TQCU)25B(!L_6JN$Y(_@H'SX0V.7H9@6.7/(%[$9V2)C20>8=MP]_@ M#US7S^ADB/1R%E ],2DM^KZF-974!EE4LX*/,Y%'WW@9:!W4RRM!,\CW.A&]M4MQ! MY[P)Q=^4$,D:]H..R6 MPJ/$8IA3-83A63%R5A,+0%^(YQ3W488+OL.$<-&Y^4&O.(L&B\< MR]4R:1T4"TK35Q3LAF0Y3YL*B'3R'$]>1UJRT2'&N,>?N0$P"^YJ&6$FT1.L M0%_1@;:BZD]PV3,Y]RYZL\-PLAAN%, 6B8-P602J>*3@+BC.T M.J4H>*VRV$,%'L!T,JK02NX=(I57.:]D"I/W,,YOIJ_ATW@)DQ&DHB6M?TQE MD.0)"\MBYK5'\J[_(S+=^4W^&.4 \]0]_BX)>])U^YT@ A,&!L+@"S)=%&:'7&> MC ;UY*=#I/+;G +L\_F7&RY2B(YB:.X9U[5+&M2RSF #LX@FE%*@\BZ74/%0 +;*RD7?1@L> G>@N15,^.NC+=7[R M94%BXS*&PEE,.=9C0T5H(+/$!3BOHM>ZRW6;VS!Z%^^^\]:W39*S!\CRZ5?O MQF2MK;?)3:AZ2FX+38>DF J2--0;BJ2[).<^F>K=+5C>NH3W+M(^3-WF;1"] M[!+>.W'V> 'G?01^&%4(01 TEQG]-KDXI1Z^9"-9""4;Y;(V?5)NGGP)[\8: ML(N<#U+"NT30*KK$$AAR?P(Y0CYH(+Z*JM%.%'VV+)]F">^=Z'FTA/: GOX73O+=TCEO"^5=SX/=3# M]X^X'">8]*D"O?:*@]2$?FA8:Q6BDU9>RY",1*XM0E .4RX14^!&!]RB0O3: MVYK7BXYHHO96,ZXCD$.J@$4)ECF1P%N3$6.G;9[6]:)OG^]>=!=]=;[\.)N/ M_QOSR&D3<]UA4]HJIIVT##("32/DQ44N7.ERGOHPK"=QQ7@7'7CX5'V0U#O8 MJ4WH;A[V*BN]5-HQ#$G2R(.J">H4SG,PE@M- ^^2R/<(KI/4BGWEWM=7O:NQ M!,2AC PYY^19!2";G2*3Q9@$6/6V2]^Q!S ]>W5H)>\.^19WH+U9+,X)ELW> M!!"V7E.J/5.,9='9NEL32$6M3""[;&W>@^?T5& /.7?(L[AU%'DY# M80A>,%J++ O%1$:(@@^<\*8N124B;4=62N%T2X*TKB:P*%1 MLNB+)5]%\5A[*J;8Q05X,F<80^@=(,NG?X9!,3H6R!3"2U?;I%FR3!X4JQ&\ METY;WRLW^VF?8>S$\M9G&+M(^S ;U]L@>MEG&#MQ]O@.]CX"/] 9AK16644L M117(2_&:G%2@KR)$:6*20?;9W'SJ9QB--6 7.1_D#"-(3V:0 E51%*UPD@<& M%A-+(?N$RB@*3U[0&<8N]#QZAK&+; ]SAA%!9^%RO?QN29N3T P<>:;9/1F\_NWFKTWH&L'5<4)P76 M@CVR*"T4?>E]0 X2G4TQAD>:B]Y\3?N^EE(9+DMDRM06)+;4//M=;B*?0"K33(3+UVIB7Y4+6B/G-6%\$Q M"LF[\/YD=B"&<#Q EL?>@5C,EU_A_YIP"O/Q;.55ZXC9F"19MK5!>X3,@DR) M>1]U/3D)0FRC$?2"&]I WZUKPKT(GLA.PTYLSEI*M6%PL0)TB>/OT\4G3.,R MQGSI8VT#:H=-ANTHOP_-8?<7&C$UZR7F@^E )M;[H?E_IZ-A4-2OXMTGT+8,2NKB#S\MNZAR0Z#70M6 M (2&5(*J502-X%Z(G(!GX$HE4/Z18.7A%S?;$L!.$8$01)V)2DZS2XXU\+&\CU M%E<$=Y%NEV"%$%TF*;;2"6I M8\U-5IYGIHV5+%KM:#&W3B25@Y==]DQW1GH:VM*-FQYE_">KWZ%UN"Z^W\-J M=3[[1,LT5* __E&_Q!%'K06WG"51>T@'Y1CX0H*A^!!CT,[F+E=&MH/W[-6F M PM=*N'\Y_EB64>]^&UV3YF6S0.XJ?J_(*VBB_$2?\7YYW'"BQGR"Z;9APO6 M1LHJ&A]YA0H]30GR,1EY%(%BSI)B2+H$V4?9#C.^YZ^M3U /.F2B/;26_X*+ MY7RE0SY:38O.%Z>U[0JKS*@XZENEM3.#,4R#UJ0VU!<]L$( M4?J5$AP _-DKZ$&9ZY 01WB^5J(9%:AHC&;.%%DW8S.+Q@(SJ&W(V:/N$ZG< M0O'L=6)_F?;HF7I/Y2'201Q_F%Y4;4]??IL#+9QI)>=I7GTW6:VC7U?@JSI% M[V?SU0=+4NYXOJR;M;_-+JXJC;#(6+CQK$2^ZACM690U4:R =$ACY[E?P=M# MC?+9*^C3U8D.Y8T>*KVU_X!'4!QX&6I/M%KSP]3V%J 2\S9#+L&XV,=S[#.< MDU7I [+3.?:/Z^W2.,*E7:/Y*LJYC?#?]@1R/SS2.S[AX-2=O=_KAID-R M/2(2L5&"&V9<+1V44[US$1RYNYEKFS/$<- 5>O^AG*S.'HC=#MU_'YJ%K\ZJ MC?COM9GV$PGYU;O7;]Y?'!K1A%P]X_V,7&= I!#;8)DF&,LM;@SUUVN M\3P5 9SLW'C2FG1W1H5G/J.N%Q:E@(<,%)P67N]]Z%H-.7AFK2^B&,A6=KD9 M^T3&_\_Y= 0]VG &T2+Q>UT$U]ALPJ2X2[^(: M/8#IV>M=*WEOT(6]#Z3&GU--$/B,I/44J-9,T:_NU8T=YQ%7*85$ _=8"RVM M>I99"@:\$]Q;5$66M=R<.PD8V[[KV1+=19@;V-[[2*D"_/&/]!&F'_!=N0'U MY]D2:'4C1F-,P+AV3?;0Q)F%IR=0N.[W_#LV:VD> V\#GXS.0] M?%DIUKORP_CS..,T+VY<,QH5*Z5U,C 0)3-=JS9'H!5&B2QX5E*;/FW:'H;U M;)6A@]0W*,7@XXQ-H.K%E%%2-FMR+T@])=340L.B1L5L20Y5HJ!9=U&'^P ] M>T5H(ND-*K#W@4==KE[EV>K$=U8NW,[JW?Y:ZP[!/(]X*;;X[)C"1,"L<;1@ MV4)6*,JB;(QYO6#UQI7^H7<\6U:;"F\#JSV:%("/)B+0K-/U7 &,J&@X,Q9T M\L[G8KKLP#^6>3CX3E#*Z*)-F@&&6B-%%.9#JOT@''G*PG(?L<_ GLB=H&$' M\GO+\BG<":HY Y<#6*7$0W):Y5"84J)>CUK=C#+(DG+HD@9?_#:UU+>Z'K#V M[B=R#V@G!F=M)-GX]L<-*)?W$K8!T_KFSQT4A[_Q,XB3S=P.$&AWEHWD@G/M M275S;4R<"@-#3I&2T5L?+,%$L9YJBWUKV.3(G/43G#/?8I7W\@ZB>\=K=7NH=\I/7,%W= M-ML"5,^B41M1';ENU'#V9KU$WV&IV PNH-84/V6F4Z#@*:&EX$DA\[%XF:PP MMD\AH0/JP[9%I ZD#KM(_""UI)SWQJDDF0J&U]X_FD51N]"CE#*E8GCN8B6> M0"VI!@P]6DYJ%_%VN"=WS\V$2W!&U'[")A*D6BE1DTL4HT<*;+-UR86$L0OW M#Z(Z!3UH)_8.:\!Z_^!+5.00:^-)286K+<:S3"R6G)E0)8;"4]!>]%"&S7!. M00L:"+K'#;;'F_]> N4F<.MK9JFN)9%E G*2160I">YXE,GWZ>6]-<)34)(^ M=/0N2GX)27DP%.C*VEC_ L2WZG MR&J4H%*P@460N9YRD#I*CBP9[7,..BCLDGCWU M1-]E:&"3M#I-_0QW.;1"] M[$+4.W'V>!GB?01^F$+4UF %H!B*9)B.@<+D$!13QJ*-"KDU?6+(IUZ(NK$& M["+G;IL'MZKG.J6+2](R!2D1(E5SYURD:%=8XTQR*+J<"#_1VL0[$?1X;>)= MI-ME\^ Z27*50OT[^:JU4FF]W3.?3>G+M%+[B[TR$-(7FSC+D.M>61;,UU:3 M+HDL'*!"TR5)>2>4)^ C]&.E@_OX&_W>NW*5P'.IUMM@ZNDY; )U'-^A(Y?K MH44K(CK8E8W8>$JH%,],\'H?(Q*V:$$PE%I)A\G&TL6R'$XY'O$JCJP;N\B_ M1TVN6Z-_O746]*)!P0U WTLN^_W+CF\M?G.:+/A$KB=E:9MZ9S&BYKHG(I?8F M)6,=O)&%@D/E2Y>CF1Z#.0&[>'2..Y0GNCV%UT9XM=^Q!<2>!G0+C,;9+H!\VXB_:'6*5MB M_OY\,9[B8H&+BU((NPOTOB[)!I3LDF*UE.O/84UQ4L7A'88)4?4 MHRWP#A7ERH]N(\O+1W41YB:8:](D510&8XZF<"V@=IR,L6A1G#(VNDW2O(MX MJ#CWG^SW/ZN+0+>9[#JH(@"Y3IBT0 $>;"+5U"&X !8V2'3P9/\%$XX_[ZN4 M-_]U ['="V9-4*I$)"']V#:V_1[#UK[SZCK9BV MF*=@;9'!(=BH-3FKP%4P2+%[".@DQM&#&/<6V<\PGZ_*".T_11]Z6ELQ/@QV M7?N4$E)8+J*,VH'REFRT"\HI,(Z'-'KHP8/SDJNUOS!+%(B\G4%MD'#UNK?7 ME_!-23R[*%G6H299*,."\X[Q7 NU80;=IU#LM@"[U0D10F0I##">:D7^0 ./ M11B6$TC,TBN-ZA&U>WIU0KK0OG7UD%U$VC##IN*Z,9-J;YO:C:%"HT \4=0, M'_#GV7SY\=49!>8)\(\T.<_D";^&*608>:,I,C>1V2P5T]I%%A$%RT[6S#*1 MP.4M5&$(AA-4E8-1TG#7;"O;D*LH>@&U[QV0KBC^?SV2<< ><&O4=FM2!U+2JR(-$QM");'WT*:9NB4UN^ M[B7JPAZ";IBYOQ7$5XLQO(3V-=S]E MN'S?2]2&?43=,"'SLAIJW4Q;5;2".)Z,EU_^>@YSF"X11T+5D6O!"M!P-<; M@)8P5JR-REECO'=;J,!#[SA!VIN)M&'^4\6U&O!JM#3JG\93F":">3-X.Z^2 M>U?^-EXL,%\5S[RH+O\#TB/_ZYQ^,!+< EDNQV@)*S4+$!B8E&HY9)>,"V3? M_!9:T0C."2K0,8AJF"RPU1!>?<8YK8#7'UV<-8Y<\>"$(\B*U^/%3(;10&)) M><^YD\Y:V4*W-K_^)>I2 R(:]A*JD#>@O(S2QV?CY4@AQ5%"^=I6NG:_+(9Y ME2A:-Q:= /*FXS8['@^_Y00UH:%8&S;CN:VC&S!>ZN>%6M:,]/^D #NMVC^, MI+ N)JT8H27,(E(T)6VJ0] N.:QM&G9:+79[_PDJR4&H:-AY9JLE[OWY/'V$ M!;XK%Y_BC<]&R$U&](;Q8,@AJ MFMQ5VP[)V;&++J]V%<:+?_P$B7YAE9 7,&G/A6+%R5H!1A@&GDOF=1$.OM^FLDUS5C'L>R.8WZ$7Z/D0(]5-8;*1L@J-[D M&5 4-I'I0B\#TU8@BTHAX[P 2/ A(SP9TNY)(^[)V2[RZ5'MCO"\Q<\X>3O[ M_?)"D%91A>(#*\EX\C.$8& H!M)%%^X\#T)UN:IU%\KAG,'AU*P7MQLFUP[E M*JX1_8TBW?.S2U (3GNC'44G-8G=2,<\8*RE.$4P-FL53%>R;Z(Y!;[WEF[/ MR?V_QA\^7A4U@,RC+9JI5&B0.D5:L[ABT22EHR2/LT]=L@U83H'N/27;H7#E M!H_P_6R^++/)>/;KA:^]LEQ:6S)=(3 :/@64PF<6HN#,D1&++IKHUJ/\-@JP M);Z7X&_WI.PXFG4YI;8!VO/"X]9(CW/ML0O?N^O4 +(Z&*GM 1<.9$RM9T70 MG-8.$HN@+9-"B)(PQ5B.M7(=\6[CTU*J73@ZC#+15_7I^!]XLE'J;9IWM5"TW=&_< /:F>X.Q6.W M&L3]0[@J?[K%( YL>G[^X(/$LUWH7Y+F5\)[7=P!PF%VY3*5[&:!E(&VNN M.F=0E&(^<14").%+E^M4MV&\)*,^@( .)5J_HKD*F[; T[4JWAJ@X]C,(23= MR_< "7=="*YZE=8B;)9PF>P]TYZ61C!%,%0N<(248Z<:=@=A_!'KTI/P703; M@>B_XNS#'#Y]'*LRS$49!?A]VL4LVGA7!4<_WXV MG\]^QXMT$T0RJ"ER1G$1F5NRKRRZ ,R5:&@1S5G$+IUH=P'YDBQ3-_(Z5"K= M%NM5V<$MT!Z@<=66<(\4_72C?T\]&\#=$9>V2]3* &*4@1EE-=-!TPI?0F%< MH>A_:&=SJO!K(9 MW546]Q;8>AK@A\ =J>/&<7B?=2:MP\+X($8)PJ!0@05>M]F4%PQ\\DP4&X*U MP:. TU"HQ]IO/'U]VH6KXQK8M_@!)C].E^/E?4)*Y"@(721+&"F"MUHS4%B8 MUW6W6"LD]^3(-O;10?S3S!Z _(:7Z:_&<@/@A2.[8:YM [&GP=T"XY.WNXT5 M8788%CNLG-M ==[5 A.)F>B!:1-K*B:M\#*KI+Q$;_OT@CV:HK6SQ\?7LUW( M:ZA?B_ER=!/-SW!V,5YCC7+:5O^@EJ?)%EBP)3,!)G,N>-%VFR-*>OX-1:+O MUI7H/@ OP3(V$7[#6A\5SR_XZ;)NQ*L/<[QHL+X&\>JBTQ8@=[!O6VG*UN@. M:]G:$#D[% N-UX\=P$8445)<8XNTM(CR6I53^CI=DDXF0,G-%I4CJ\H]MNF8 MFK*#\!MKR/OY+)^GY;OYKSC_/$X7(P:;E5!Z1;*<,F "_%P@P6?LOZ/S< U<%>0EI%-R'"F[M+>2,I] M%H0-X- '8T)*#+VO!8J"8 %482"YY25(GF";VWA/D?H'3,*!F-]%N,V#C.EB M-AGG53&[52VJU1@%DM7)9(4LC8GI4 A,B)&98FTA3.).=XTA8<8F""_%##0@ M8(-*--:)2SW=!E1K.W ?F&-$$L.9>I#X 5+NOBIMP"_ZCIW>=?[8K0F2$VF#5G,]0I MM('%"(H)9T"&@"5@GPJ/#Z%Z"4:B/3T;=&=PU9#;=0&V0=/SC.4)5/]H2->Z M(@P6=8_%XW9=B.!4U'6;Q.E:;,E%%GC1S#M:RJQ'@YD_4]X?.=PX%.V[2+@' MW>=Q<7-@%H(VCL(AKS+! 8\,A-)116J"[4]":FJV5J"U2MMX[N17/XO:-& M=,UZB;KU(G$O.) Y:*T% ^[J5G>M*1"$9URAU5+%$ODVV:%/D?\'=I .2?\N M$CYN+O'WXPD]Y4,5SOGB.J/+(G!ALR$1D%G3)9(P/)#-+(%SKJ,(V+^C^1[ M7X+E.0K)&Y1T<$6'FQ!O KQ:0K> US-R>1C>DT\/;L#Y>@7N]GSUJ,#^,$H/ MEB952(QK7SO-U1+DT=3BX5FQ#&TJ5T.\,&5:1>:CFA O_]R^];N M2BS91&.%4(S'BCVFS#QW@5G!K55.QA"ZE!@9 OJ?AK,#N1L4N9P-YZ6H2;V#CT6E>2_M(@XYI);'6XD&6I-$B9BB@ MNI1V/YRN-#)_AU&57>CHH"(__M?Y>/GE5TSGHSN+S".KPK<%==F;: U]- /0SO M.*:J):./*$L#-@ZPYJRAC,7$HDUAOGC--*VI#%+M":X5IP71&%FZ'& M,57'4Y5=2.A2$'B:<+JP?P?%[73C4D$I# E PW="ZJ+,SDKR&+"79)J:DK1!B097)+@+\ K>51N'+0#V+3#^,,!C M%1QOR>NC2M. DX.L0&LX@Q=@,T8FO:Z.N\LLQE"8U"DD*8TO?;JN'T=G'BU9 M?DR5V86*PQBKZWC1J1!2"IY19*B8]C7U)&!-.L3L<_9"ZB[;S@]@>N$F:B]J M-FC-WA4%[L5V8U=@&VP'-4S'WM]K1N1C"C*0A$,L+S<@"E-,25D2C[EN1RG. M0%O+#%JA? ;,^3!&Z,A[>L=0CUUD?Z]:_.MW:V)Z2]^N/EC]O(KA%RS?U+__ M_LN;:Y']_OOO?QI//T.".?XIS/F66UK0?DCXQQ*GN1Y%CC,-ACP! MF25DKX < TU!LBE" EIKHQ!)C/8?W6":RFS^:C*9_4X6L'[]>HYYO'P[6RQP MT92M+=[3A[1=![C&70 NLA)HD@2=; K!1V]502/(T?,;N=OBEJVX2B3 ^Q"+*QH)YD6NK"H+?FJ0@7N+(C4)P]A'["#\]*O/;X=WG[A M] $:QW7A3*7:W%:"HGC!&H::)JM*06O?Y91J?\@-[1Y,)O>;NNY:=R<#_C L M;C*1WU01Y>6?TV2V0%H'EO-S_/K#V71)R\2/DU5R)ZV)%UF9!VB2?5&/-G ; M@D"&N4!-]33,UPH2'$R6KJ -*AQH(F_"=_PHKZ^V[-XV>V?6.OCR6\"\VM/8 M NB!FPP?LA/['HV$A_.]=ROV?<@ZJG;9((33R%E6OM!4BY%YK0*+P+FCR28] M%R>H5;NW]3VB4NW"T6&4:8\>QU):Y)@XD^1E,)V=9R%1D)QE &+0Q]C:#.+#U?2JMT?>PS+VUJ$MO]'U4X%C+\*.# M\=HECE&Q(%=[H%RSF+5G7(HB;2)+(KKT_7K">KR[+_ LU7@7YKL<7MSJ9>VB M"X:+S(RMY1LE%#)/(%B4-D@(LE9<['-><1/&"[/K SBXJQY7<:4F^#9Z^ M9YV'Z/G^^ 'G_B0]UO1]'PEW70NN4WV<5EI%6I$"*;6J3>V#0L93R-IF'I!W M2N([!../'EGV(WP7P?8@>I=6FK7J(L3D63&Q!M.>,PJ?/_Y<,:C%[\W=6UO2N>[(KUJD##%FC_V7*Y%_W#.N'NP]T15[>KO>'L70H* M&/C:*C@; MF$%JQ,U=K1E2JH&,N MTPS1Z#T+07G&LRY8A,R@NKB]A]>01\S/411D!^'W"+FOE\J+8F$7W8=E$D+0 M. $+UMICR#SGBBE>=#6-VH?2);#> .:%&9O!?-S5D<&52-8Q7?4JWP)5UPV_ MC;".M+$WF+9']&" S ^P:EP=CL3D"]>T2 :B2XM5M5Z/3!@MM>;6N4ZG3@?4 MA,59N7MKZ878>E^5\YFUR$*K!]AQ2QJBDRB4[@P6FC'8(Y4 [A'7!#786K!VZ5<_YU]&?MKE.R=Y=W6L(V2>3W\?+CS[-?L";PY.M%^2[\4?)&*4OZX @R MT]X8%K0++!B@*"Y;'K)_9-$<".'P&G0 @F>'9Z=#J/. H/Z#AK#% %RQ$&U) MC-Q &H 6B?EB/$N)YJ>VW'K1I=+K8.2GK)7'H;?AK9Q[IM4&@"*K)*+)K&C@ M3)N860R$TD70P5)0XG3<;WE[62K31^(=\L ?$,G?I_11?C\?T\\_P>1[F%2M MOA9+\8I\ TOL"Z](+$ZQ($1@WH1:8XX$IKL4/=H;\:$# UM;/RHI0RXM7;#-,)[4ZM62['U)1W')7J:6'H_J_N[9/2!+PJR-!19% M!II9]2JA(1\RF.0#R9#[Q/=;_EZF"O63?D-WK8+\>39]T(&]K>*C'"2'"*%V M1#;D5Y!SX84I+$5E4I%H@MU&3W9[ZPGY6)U%WGC]V 'F]6QQ);C@G& Q 4F% M!\\BKAH7N"!RRB69;?:R]GCUB:E);^$?-NZ[H]8H9(KT,I2(6,8[!-:SH[ 8\/KJ#L%K0^, M8R0,R^_#?$04IE-= X- M,R)3P!-+83%0T.U-*0@.15%VOV7RI:M59S(Z1!1?D^ ?$-=ETGO(.<08690B MUIX-D84<@67.,7I1N,I=BHUL#_&(9<3;^G&=6'DJ9<)KGO/JB=^?+TA>B\5E M\=:+7&H4V?ND,S-<.::SX"QR75@P-J&R-+@^.>8/HCK^)96VFK"N<,T8Z>"> MW2[MNPV8GI=2GD ![X9LK>O!8%%WYS]:;2 )S;@F%TN#=S51S#'/$]:&)A)] MER8@QR^Q?2C:=Y%P0[I7^?/S+Z.__TJ^%RF5MIHA&L^T0L$@.2@0N.68?*V2*D=AO*7 QB[?6KY\S:CC([^"VO5Q_(S9B5S9H-;>^?[#ZH.[>_ '02 ,*CCER1SZ5R=C&AI#6^E[)Q;HOE M3(8?X,OB4B0CK4PB47B&(9.92,JPP%5B07JR&\$J$[?9<]OJ9:>L'7TDWCA7 M=B- Q9I%,-DWCK9 MYRO"7X',OR5P_A8XE,(:12HK-05NNB3! KI(?KR/6=%766^5VO/8BUZ0+C20 M=..$P(V*^M W@68C**:0IK:^$$R[6HU<2\U(6XOCCILLMTF; MW^FE+T@]&C/0H4;W+J(9A9B,#Y'4VD9%:EU3&16YFMQ)Y%'DT.F(9A>0IZQ= MW4GK4._VP3)85[/@XH1!"AZ=D*IH7;D05I$B^79DE@02I=[KMM#/.() M8&>5ZD33\S@2E$%@1 KJ5"W+ITT!\MIT9!R40D$2M;%+^8PG?B385A-V.A+< MA9'N1T+;@'G11X([L?7@V= ^HNY_)!P$* N.%;^ZC:T=BY@SBQ3C0P2?R(8^ M4]X''0FVHWT7"?RU:'RX=_TAP)['? M/1+<169]C@1)_4"8(E@T-,EK3+I.+U;Q^CMAER>9WXD.(2U'65VF"/! MZM).B>LQ[G/<=_-?-SC*NQ?,VC&=T398:3G]18Y.E*!X+LY+K93S0>+H'EQ[ MBV;E<@T4T.4SVHII$[#U,TV;C4!'X6:A4,3;D+P)Q65K59#<7YYWO5HL M<+F/V#8\I('8'H-V9V8JC^"+L9[LD^5DAGCB3D7GA>1!CQY&.51L>\_3>Q_5 M181;S%H;9:')*4(@_>,8 )(R#G,(25E5\@9!#IV\=Y_X>G;V:3:M/N>LW/UT M_QF^[YNZD+''(->XB@924MHEPY-&%:)(QA=5DBD)DI0;N-IYO'M0^78V_? ; MSL^&K2AK3VE%P4/@UM<4#\5'F:7015LC(TJO.81(?X$*EU/A?IR#13=L5=GX MK#YBW&)= 1_ >%%*SD4[39Z %5DCJ$P>J#-JDS";+"RW'WE'_V]_/'!IV>M= M?2C99Z!KE,E"# 4(7G"M Y< UG&@&!^UEZ;H393M/N;!E/X,\SDLQY^Q*7EW MGMJ'IH?!KWO43L=BT/*BHXY>!N2!QI!*1EJ?3-A$R$/CV$WT[^>S3SA??GDU MS;4MVJ?5%OWNLM[XF ;"?1S>FC2S-\*B#T'4HY)22^W7Y&8P+H<8/(X>0SI< M?'LO\ \\K),HMUCB.:T/0CJ+P62=I?<12\C&:\\E!8-\HT"'KO&;GKG_0O#0 MTSH)=JOR] 30H*H50J3VS@*0NR=,M"(ZTEJQ4;)M4H&OGOQ^ N0EWGC\V^LC MR#I?;.&925,[%W'(#+SR+&JI8^+2)=NE_N?CT(8>"=S[AK_.9XO%J,CD0HBU M?PH'1M$Z9X Y,9Y V%*OSIDNJ1$/PSK\5F5C'5D_-FC(0L,=Z2MTKU(Z/SM? MW>G_ 3_-,8UAU:@-:;59B7V:7YW-YLOQ?Z]^?N]@1@DD.NX$XY@RC4-(1B:^ M,)\Q11')[&.7.ZJM!G!R>G<49CL<;-X+[&=PY<*IHJEYK;.RA7>44[&%5V@#EHP MG55@ >@K%P.HY UW6Y7U>.P])T-X%%AG<]Q\?T7^N;3; $3\OO//RWH$9/S/)Y^J+]# M*,?3<\SO2% K;^PB6\F$P*/WA63AR/-*5?Y:!Y:L!!]E]"GT:4UQD.$=/UNT MI6:NEU%[>AK2P3??"?#/<(97#<"W@-TS/75/W,=)9'V*JC0[GAX\(35V6+* M8)F4/C&M"D7&]#US'(SGX"@."B>OOH_DXYZP]NY"_R$W1K[_\AL]8B46+5.( MHM8\=5E5VX+;"=M_EMSTW#GY%&(%>"EAF\#L:>= MW@+C<6QRE.$]=#.71 M].<1H_@4U&<73CJHS=\@?1Q/<7[KT/=OJ]VMD=4<>#&.I;K\:FWD[!3>]L_G4VR[^/OQZ)[9!8>?U/&V11;H:QEC*)(#47V5F; MI2XY@/="*RTD)NZ-"Z--B/83Q]7?EPF7^V>?/O+ AJ+;!O*=VP#*(G>E^*)T MCN"MRSKY"%88GQ(?/?+L@4D+EP_]>K2:DB^ 4K/(>:YM] *+/CK&DS")EKYB M[(;+^PUR%=:1M#MWOWKTQ>Z9Q20@&D,CBI9IFP/S+F46C0RHM7!E4^GKEL?L MM_ F>^_ M:3Y $8]S1+Z+0CRAL\5M8/_SB/P)JU*C0\9]]. )J;'7VB>+D@E:'&HK<5&S M13T#S[D-)8&27;9RGY3Z/HTC\F-H[R[T-]3:Q7PY>DU(9I-Q7F%:N6(K*<22 MA=4Z4GR;R6*A#2Q4LZ4I)!5DQ3A?+Q^\42'I#3>4D;Y;5\3[(9R"#6\DX(8[ M?IL17;6DV0+3#L9T3_*/82%;$?4@[P.DW'W27QV6:^X$!?\,#4BFBZ;%SX%@ MN\FWLT!-D_A[CD%&"V>PCC=8GBL3!,FEH MD;-%!)1]\OV?=J7<=G%<._%WN"YTNP[A-F!>=%G[V-@T=9="%4OC,J,A*[6"N7)8VP6?W=G M\0'?NRV)NTCM4!60EX1OO'>!WZ__NDF5VGO W"DYR5$I'F6)7$,44:TJ$!DM ML):6SJ-[<.TMF@$5D->?T59,6Q3$"C9R"SY(D4UM!!>SB$5:([4*UKHR>A#C MWB)K4!#OH:>U%>-.!?!,PBR=U[D(U#(F;VQ2J(WV6B67U>BA!P_NF35>XEMZ M7O[ZDHL2>V^O3ZJ5(UR A:58^Z472QZ#4<"<<4* C2Z9+@EQVX ;?OI\R?;F M]_SXQ^6.]I4/-=+6"F&+9MRLFL=;8,"E8#);6H*SEGN MP7!'KGK4T+I11NE=68<[BLYHK@*PI'P@4;A"HN!DP)7GUM+:DER7:?4PK!/4 MFX8\],A1OW?X?U]@.9^\'1<<%6TDHK?,$R:F18P,BB!IQE5V,8[;K@$ M?P5W@AK3G),.*>RWFIO=)XZ+D%\(\B)B[?1=4WEUXJ[V<$7&?0P@32P:NVC/ M]A /V(VPK^9T8N6I).L],*COO_P-_G,V?SV!Q<7F8>V_DRDD91I4JF?\G(4$ M@I$MECG+1/]UR;C; >/Q]^;::LG6R]@PM@YJ!1=?@=Y((-D&;L\3FQWQ'N=, MIQO_V^M9,_*>@,Z9DJ23 "P[^D-+R\DN6,\H6@^:FZ)#Z=(\\4GHVB/G2$]5 MU7;AK(.*O3Y?+&=G.'\[7EQ?;Y/1HM16,9DLN1="UMU;\!1O2%&\-\&X+FJT M =ZUK/KX(+ L)BO[CJ8@3 MS%+ILLKO+]F&.8?KA_;;P#C1Q)6=&+@GYV$?\75,7/%.9;#.L!A"AM%L(D_&Q:W2EQI0>(N4FM,WM](4F?G9U<9-*"MH"6$)>-KCKHM+&A: M\M&(5, D!+'->>Y6]-UZ\^%BKT&RG[407,-(:@4$_K@)Q$;M!;V>USOTVDC% M0%39QY@5.(-0L!F#-]_\#!G<6W"-Y^!_X/C#QR7F5Y]Q#E]7=B]EMDJP"-Y3 ML(_(0'G+(%/$[I-0Q31C&[;V2@O\^N7*KVN2SG7/,]LF=6T# M_$Z]'B.!YZB,TCH*2VNF,S+$' 3/*J31XX_?OYC5#8\:IOF1[)FWU\>?09)Y M3^"9"8G"*6E(%66QS#BP*2H?4(='F-G_[1WW]"_ZZM&2YTKPP+RA(:Y*6$9. M\X-S$81R21N]C;O62I)(T],K [^0$F%1^UELR8()GF MW%%4Q /+V@DCBJ7/MPD#6QO68R>/'59W=K.Q@SCL8&(?@;LYU6 +R#V/5_? M?*RJ:AUU83>]:T;D$]%!7Z(J(@463'1,:S(GH<3 3!18,DBP_AA+WY-),WOJ MJK<+?QU4[KRU-(KZWCLDE&T#N3P MB6;=V9LU%'V'[8Q=$C*!@]#@.5-!UC(?(K,H;:IX'5HCE7==NL$]X4S]HSI; MO;CKD*&V:S[G-G#_F;??B_^!R=3[D/<$\O:E00C.".:3#4Q[M"QJ6N 3+?86 M?9 ^_S-O_XFIVBZ<'2AOWQ<=@BBUVZ/5ACK?:FX6(6F(8M7"T=&5) MJ%1A2FF9@-8SJ;I4&7H TVEK22LR#M.R[D;6V/U"^NE\U7KSQD'TCW]\HJG0 M)N-NP'O;9N6U$L!ZYIZ+QDM(*4C47F:O8@!P$;D!#/Y6E;LVLMA-!5ZE-#_' M?/FX?M1]V+:HP1@%F%)X"6BM%B5[3MJIG/(00[$0UH4WM [CVN->S\X^S:;5E,[* MVD?[+RZ[OZ.]Z'<=V!HM@E,D&JT- K,V 2,:9\F/*,9X2"&NT[+;& =1]A^U M<.1T^>5J4[L93_<]N#TY6PUAC9$2N-':.U^L(H\@1EU$= YBBW/>. M@:'@?);/T_+M&.)X,EY^>;UJCO0!I^G+V^M\(B,(F5#(3$(*6$(N+#A= Q:' M-F<)%KHTI-@&W.!8^.(=5])="1TF*P=N7,:87Y_/YS0-1MIQXJ889JJ7I9-% M!B%'IKDH)HJZ24[LEOJ,T:6ZK.7>"Y@[,=-B VPSS\MLQ+MXL%C2+1SQ' MD]$;%DNID@!@$6)FR0OZJ2TH^J2.;0?OQ:C/(%YZ;,5M1/D>OJRV T8>O.8. M"P,)N581R"QHK0A=B0)5).7NLB/S,*P7HRU[\=!AR^X>='/$/\:+*H@WTS1' MJ,';Q=\C*Z6E"+$P#(%D49(C!8?$7$ZJI!B\0G- Q;D?Z(;:SPK MP5BF34P,'(>:DR6,C8)SB_.O)T=W*91I-KDS@N\K&"C3DZ+QE* MN=KL#RQ$+QC/M;VA4U)C.'!T==#*QX=:C]LP\%2NKCQ<>*I@"3)(R;BO.F]# M9"$Y&J 5'A7(6@.\ATX]R7I];?G?J4K?+CQTK]*V#9@77:5O)[8>+->VCZC[ M]Y*48&+AH?:/(#7W-><74V12ILAM%A#[=+9_ZE7ZVM&^BX0;UZWY>39??GQU MAO-Q@NL\?P"M4+,"$)A6,C&O?6#HI8Z>QZ1BLZ:2=U]_>,=S !>S9H)L7%#J MQ_/Y[--U*9X8N38$H3BY*IZC&6@R6\$%P\%: UL%]5L1>O/%SY7*O87782E^ M.ULLOCH>%)U\_^5GJ$?P[\H-?V2U'@4.SLBLF>$E,QTELBAT)G9(TX*1$427 MJU';0SQ)3ZX30STR^&XAO41Y.5>V@=;3R7L VW%<13? +:L@L5A^F<^W8V_? ; MSL]^P+BFGUNE9=SZYPV2+^Z'LY9BD:SE4IH0N0*=2'X&C.4Z9+!*..5&]R'; M7SQ[IW!M>$AC46V1O"6#+19$Y@Y11S20C72Y-AW#F)V&T<,H]Q?;_CD_FY[2 M6'#;9//H5'PND;3,*^TY18S>!@ +-&6M@CS:],"A-W_B\LUTL9R?5U?YZU9I M :\2.L-"R12M0&T2)Z1A*H,*M$)1Y-+ESO0]>(9?5YC6Q7>.>;S\"=+*[_L) MQO/_#9-S^N#5V>Q\NGQWOEPL85IKJ8V"(*$;E,SG5/?[K6>1W$$&1G*?#,4* ML:\YM);"\P' MKVP*M.)@E]VQ^P"=AGHT$7=#7[A63Z@CFZVI[.O99YP"(<0K5XS$/9O^-A]_ M^% O[,404U'U;C'73&L:O2<]93851_]SD8M_Q%#M]^;GK04'D':7\/JKJ7XU MS:_ATW@)D[R+9,&$R[K$ M)"% E_( V\%[27JS$Q4=\I1NC_SO4[BX&HCYA_$BK5PVCIY<= 0:?J(_HM&, M?+7"G- 11G8::M"7@KH;8(3[SFA^/EV[\S[C\'B8P3?CKQ]GO M4UC ]=G,2$MA>2*TUI7$=!5(E#RRHNA+'IQ,Z]UD-_K,N[_Y>:O# :1]5S=< M.]T@D*]A/O]2ZQIK6-C*>7>V>$(31C^WR;?&:4V-] MF!SO4NR'ALQW=GEFC"8YZ\NA^?DKE*%(RK5W_]]I$-MV"X+4T8@TTD#"YR<)^L2 ME(PZ:*G[*]3?__W%*]..7&S8T!N\L5O3__%&'8M1"2!XK9KCK2"+J A5O6W- M #'D(A1%85WNSJT#>=[*T42\&_@>M(-[#>876!*2$K27]0*P=H+I[ T#FSU3 MP?AHK9&2;],6[-9#GS=IPV2T@:W!>ZJW1_=FNL0Y+I85VBHW-[_'>:(/X .. M1$1G ] P)=2-$R"+%(QBPAIAA \H?)?TM^TA/F_EZ$S)!NT9O"5Z&^I%JI]S MF=!PR7( P[3DM22Z-0PQ:?/_L_=FS6TE2;K@7[G6[UX=^S(V]T&Y5:>-.I6F MS*RV>8)Y;!*F*4(-D,K,^^O' P0D$CPDS\$Y@86DE153(BF$AW]?1+A'^,*X MC[Y-,F*'+(?*E&K/@N&J/95\J+NFRSI *_.82PH>HO"*+!)DM7R^@QAMY,H9 MFWF3'.C[HAPK7G8TN+OU;\Q1_$=H M^V!,$#XC>2 00[TVE=*"S\*",#K%[&6VI4GEHL,QX(EXUH,08("2&P#_/G]9 M7'RI+[EWA-ND?=B8>'8R :]I 62Z1$"G)(AB>0S")O(!6C#@4:D.;T".!V[1 M2NL-@KSJB]O5-DR5_LV:]XQK:4PP$'6N+A *\,YER(%GPQ./B36+RM@5YKD8 M!*,5W2A\Y[9,&[+WD:IM8DR76,?*B1D+VQ,\&*'S)HDOG=)9;;F1Y-4R(PS0 MR6? U;;>T6CEG A,8Y.(ST,RX7E5BQ__=AWH4^>7 M]8:C"KFMR8^2N5($N*(+**_(F6:203(&4YTTLTV*L#PIV>%-A2D@W#4;)]5_ M"X/AUO/'1B)!OR6\<"11,;4UMH+ 2RT,:)#SD(UH4RWAOBC/@@(C-3QQ"/BZ MJ/XOBZN\P@<#LC92!ILD-8?7AY\-QD1+.P_/D2320D#0.9!CA#F;HC'%)OTM[HOR7'R$D4IN M$&&]$VCSK4]''[E:^@@/"78<+V$L<(_R8*36&QB)#\I74G:JT*Y41+)5/@1, M]"76AAM6>.YSD]+-AV7#$Y["H<@P1-D3&P6WK=1\.5]LSK K_0_&?LIA>8W+ MOPDJOFW25*(5M0FS<#[1GNA)4F8<,&5RBHF<)U5Z& ;#1CWVT_.^2"T.HN8) M/8/')%7_T+E3Z\ MV&OP9T"/]DJ?T.=8\_G-^Q]_>Q.OWB[P_O@V56^T-=HH:\'SVIO DZWH2"8H MR2>R%#%EW>1UMU'5FZY+&#*$6:SA&IB< I5# !=E33".16G/M,<#^*$G$?$X M!.T^$8]#5'OLB,=:V?1K0>/?8K[$Y7RQ=L@CYRDY1]NB8J7&X M\")%UZ<60*_ZL)T2G-*5Y2!(%U.J=N+*SELY_KA*<"2!%5]"FSN/L<^1*"VO?9["=2 MY@S1XRO=R@]B& ]8IIWD/;APIJMY$@ A#5-V" /6JZ,;',:G&[, M\B"0GHY9'J+A!VV 9@]1WR\^?5YJW*) MBNE@6)99A:1]EB))&WQTP7+A9P/':M2R0:7,"VU.A:5026JA]K&"%%E"Q95* ML4GVR4$>K[;=SM?]F7/:%AJ9H2@AJE)S/,(V]CM@!.V%D\9DD\H!"G@\(-VQ MG]'WX\93)5[& S%QA-W.I!>K52TP%3_B9:TZ8PH9[\5!0ETKBA4!Z&KO1,$^JP7:AJF-5R;;^O=4=X.+C%^7"[*7T^HGTL+/J]5U+4+ZKOP7+I=(=M=, M.NFML(Q D_4LX@CH)8(SRC#44EG9Y&[[<;&>!R4F5/V$#0MV-K)TG>L^]MWB M,OU'3A]N[5^6",MTJ57G:EJZ= $P60>6!7+A.=>J5SWQ/F.=-]Y---J\X\"C M!0@)@HP))42L[_"N5C=W5@&S.JC,I76R216?LZP).:'#,!$D$S8CZ):TJUM" M2(8I60O48M1 2BG@8TQ@)..,?E0L.X!=<=KM*B:CRE@ )FQ)@Q7[;$S.!Y_J+;9LWI)&]=YBAX->.$CA%@X+\B- M4"\RHF<0P+TB>@8H^G#Q&WVD>MD1/4-@ZQG1LX?.#UBF4N3@==(@)-;$92]H MIR0YK53*%XTA^29E[$\^HF=Z(@Q1]5'*5,80$(624$(DN]5S#DXZ YD'X;W3 M)K3I+'U&92J'0#BX3.40_3<( >XHPF229\4'!JEX3K:NK&:N4:!883QG:[)[ M@?7JQA@+(Y7<_.GT5H6%/G*]Z'IU@X#K6Z)L'ZT?LEZ=8TEK&QEXK/$\WA8( MEKY8EG7.(B%+!VB@=7KUZIJ088BRCUNOSG#E(BH#+IM<)VUI3ZR=QH/FW/IH MPVZ75])-WN9)-FLX);8'0_*: M)97\4@/$KN9?\C0I)/<^;N*$DRE=YCKWK[(?_$U&_>RF[<7N5K]WE'VDG3ZX: M,[*(#%I$F[ MQ7*Y^+/& ^%G^LG5W[-DI?>9SE7DT=,97C,>D@ZDHI -Y\7&T*0%Z! AGR^- M)H%E8B.XRKG8R/D]66.7>+E._;R8UV"AAR3^?8F)+*B8YU_J%?/JQ^OEXG/> M!,3.,M-2F!Q!94Z^/NH:Z\C)A*._.VF3%B;TL)0;B';>W#H%O":N!GU[.E]K M&*6T!@4O[J\4R4(R+@LHKHHJZ]42^0L0BM$\9V0L][FW&SCL\Z+-U'J>./]E M&H:3TYI75_.XY3@S16F:#"2;4JV!(P MYYT>LXF$V8 MDK/_A'Z^I-^D#YW?GXOU2DG##4TCUWI9DH/7D8/FB@492-6F3R3KU'*]5.I- MA-2$N3R3S.7M_'^NYVF=#;#V5[9SDL4'GI!#)CK1">\LF9K6@\XF!):3XKN! M$6W8]X!\KRRLOKB\G7_)ZN%K*]5 I.B%@'!4=%WHPV2';F M@D$CBIA RIHN5V( STNN=^;<)JFX%'T*9$TLUDLEWC0X=7#N".\:]^?RD%%1 M#RR//4]OJH;=Y,.@ T'4R:[ GB >)O"WF_G7^:DYLK$S(A M&7!57_!B9K7KH0%K@M)T3,:DS0'*93XLX'ES MIRD<';S9^SK^L=WOC\OK54[;'8\,>R+X)F;\5I'/S%'DPCQHZ6/M?ZK %6- M:A=,*A:-;%,"<5^)GP>S#@-81UCMQ!4J;I4=M]KI'(NKZJ"]$ZT#-/5Y("3: M3&7*AA^@]-DI5GF?,-]C/W5W\&#BX@2/%A+F/-)YJB-D4:],?8C@LT?P(CBI MD/P]Q=LSXSQJ.T_'E&^.\P9Y4@QW0CKK\O2O8^_SY>DFRK3:B?8^KC[_B/,T,]Q%K M@[YX$[S@ @2G.' 3E+;!:&1^,,@/C?;58^^I*!Y*4@4'0'M2FV/;C8ITW.QJHOH,9XRY5<54%6BSI /H-+_+JU^4\ M5H-VODC5QEU<_G:UB/\]RX%.'FW(KBVT8RF>:CD-9D$6J8Q513/;Z^VQWW#G M#7LKO79@/W$;AUMU$WXG%%4JQ^N:=U_C/>:7'W[ OU=\9K(,Q40& MPD9>+V,$./)^0*6BDCT2Q7*^+?S,9CI%E(3E[/ :JF/"'E M>=.D/3 =F=:C H%O;U&_+A?I.M[\>=IJ-?-.2Y5,AI@=UG1N#X[[&O.FG-+)UT94/;:1!PT\_^N$Q+_/-RTV5J$^?XM<*("R5H8X%+&6@7,W0"LE1 RX!18N+1 MCP],[2/)^7/DP&ATD*EA=8];[O(M&WQ5%LO-A&:;&MR=.^YV\Y[WL5@R?9RZT)*12E F4AU M02'GP8FHQ^<)/2;!WUY_;E"L2C_B9?7!6-MUWKY81/D M-,^KS>63M-IK.I$?-L@Q,LC(TJ'640,^=4JVPZ6#8J"O= M[LK:WT)7%N57DCG./^/%=I70OOKMR7,632I:\@1(/ZG);Y(6BE-@E8XU)\D4 MW+_I07\YSI]/!T6B@T:C[Y=O3>!7 IKHG]/Z4?3F&NKGU>J:MMC/B\MO3QKU M:HJEJ"6H5"_&0\@0@@J0-*T)J]#K-FEA>\AZW@P[%$@=A1RG:L%2U?%-JGI) M1=OOXM.WB\ZOZV.F+5-9B0B9U\NK6E39I1I^E\EW4%D6+_MD]^\U^'GSY# Z M[V#)Q!&RM^:P\X+*R;]T-A@GP1CGR?CWMA;:KMFSEFDAR2/ T&+3Z2WA>5.H M+2 =U)FJ@\M=LF\REK[6;<>KNCFN_<@4O# E,"@> ^V*H0:#RPR>!XPI,A_R M0)NG[]#GS8Q#Z+N#'Z-NKG?DK7VH'I9YQE%ZS)H3D\NZARXYB\%R$IQK2?9\ M$6)@QZ>G!WUVG)A0QQUL&'7U?%]2_HBD/DE,Q1>PGI%C%YR 8(B\";U@M38( MG8M[L>&109\C&Z;2<0<;1ET6/[67_9/4]W:Q6LV$3->Y[EK?+2[3?^3TH?,4H^D* M'PRI(:F:!"]J?W4I@"LG0J0#CK&!NT&/49\5%:;6<@PSULL ?Y!&.R"?ZO[T1D#^*#NM,8PI,E8$ MR01*D^T2>+)@M- I,*ZY']@ LL>HSY &TVFY@Q"CRO7V$75F Z+7UH A9Q>4 MRQS(7,D04S*2&PPB#'03'ASK98 _2*,=?3ZFO*.L]_9KZ;X9*3'6HN<6(@I' M&Y2JZ;\V0K)1DZ0L2,:'FW_WQGE64(_79 ?,HR\9O[_ U>I=^:_:N?3RZMWR M?0V@_/&OO(SSU4WD[= =/.&2P"I>W3!N7! U)]3SS[>W[Y81-SA,HAHBH0 M@J%]*'$-&)D$DXURWDN#NR]4_7"].\PS1'>$'CLP'G4Y^$#K:!)R$U_VV\?% MGY>XPK?S37W?&B:A,<\ M+=IY,Z81!!TLV?L^\=NTE_,O6&.;-VW#R]HC2G7R,U7(O64F0%060>D:ENIX M)D2SS2DH*7,3Q^(QH9X',R93>PBOCZX?Y*JX/OF"*C:;09B:KA5-4 M N<1P9G$K5!9*WF ZH =DCT7=DP)0 =%)D[VOYW9^6,MZUZ)?;O*I9;,%NM MLZQ!R<3(N\D6I/)!2A:1"=^>+D](^1RI,R4P'8UD1UUK[AC7B\M:^FPK\(]_ M?EW!&3:"^,P^3*\X-P M E/O^TV,RVLZ/3;FY%PW57I7=C+6;12Q*&U ."-!11_ :2Y( M&T7%0-1FOLE]YV-"/0]R3*;V#DY,>-=9WWP6E]N*JS,6>"->_/MKR,:[LKE9 MN;Y:U1[<-3-VN0[?*9X)*YB'6)PAE7!9;^TUA*R-X9',$]VW>,)H830.Q MZZ,O3&DNTJF917KTCP^B*I+J>KSY6];PKZ].3V*S)Z/4@?:H2IIJ)1D:2 M0YN<-2SPV*3;TY.2G3=]V@#009'Q_9WR%;G'JRW/;_%W6^%=DL^<2H H:\6& M@ *P, DZ:YU=0&=]FU:#3PCV/ @RJ?KO\\-.W)3I]UJF>:86@U7;4>[-_H132]=_5_Q8K'*Z7__ M&WUX_O;-Q>55_NOJQXM'^6N^FFEE'&UD M""2HK40-$+Q ,&A4+%H%LYOWU4D*^M!;A*"_[9+ASJ@3PO^19KN,UR$#?3=? MKLM@]*3#'M MQJJP"_RQ./[G>@/L)<:,=(W7%U>3(GHS_I0;^Q9)V!'W&Z(C M$-C%<(3Z&J(I4'COM 63.*L%!\B;2;17B5!*$IQ%TZO7Q6F@N#ZH#P'B$*U- M#-ZF^NA&$&F+8TX*,+86M-;*0Z@]A;E)OJ"2*N8^O8UZP7=GY,/95Z-TOYA" M1P->.X\B5UG$Z!&^/?(8([JVX M"=?@]HQ?=S9<=^?=%-K\[<9<6JTW&9-#%%DGD)IF1YL,T4\XN904JIDKZR'6&]SE8\9O*WY^)RYK)UP=C?>:__3_/[PA[_T&H'% M8C)%3FB?;>?U+US.ZSE5HQ'7A,V&AT0G%' I:L%LK10R#]QA+<&?HAZ&P#^=G&9%I?K^,^ E__] MKI2\S*G*]_;G[]Z]W][799]5U+7=$R,AZ^.;+U*#HOFJ8FQ)LL_%]? 'KC[2 M'?[ 'POC_1Y<$V/0P!CX#E?K^6ZDR<%;M*C(=G7UL+,2/%M'&<5@BBF!*]6" M$7?%.'OH1VBUP69P-XYCO=M95J(1V0#)13Z*R A>U8*K27,A4#BO> N<[XOR M7(R^D4KN*% U+>P;5O>1J:7AUR74<4R_L8 ]BO\(;3?? #:R!3)IDLJYUM+" M6D*QU%>" EG4?A)&FXA-DG,.QX G3,!#$&"(DAL _SY_65Q\J2D?=X3;'$LV M>5.\"1"*I.W.R@!(1@<$SFBVQJ/+32KD/RK5X<_^\< M6FF]@<%W$W:UC;K: MR&1TC!B8!RG(X%%<<,"H))!39'/)+#C;) 6K2YAG0(#1.IYP*ZCAO+_]261\ M.[_,;Q=XN=I>: KR=),MH&0@A]B5@6A%M 6=U&(G.J(S6KKKL\\8PDG4 M->'36Y7G)A[RS1><7U0S]6KQ\^47C+C,;^>?YE;@/]._V9M MXLBH:*N1!33W)%-D ;STM>\AVAQ%C':W^M3T[=>WPCP7WV^THCMJ@TP-_H:2 M?:1JZ?]UBW4<#W \;$_P8(3.V]P)=TFGI2XR, :6UU@C5VJ[W,@ A=7%,S); M>*M+X(,QX0E/\%!$&*+J%@2XE=6UO7V.P=!^5R!9LZZA3L)PC"112L4DCLB: MY&;?%^7P9L(4(.WB/D[##=R]V_U&KP-]ZOP2KVY2B3<"ABA%1I(-L>9Q)"?! MU0Z0"0FZVO2Q-"I;_91DSX(1T^J_P:9PUQ:Z"6!B(K$8)"09R5/5V0*Y-QED M3"5H25_:W O=%^6Y&(@CE=R1_3@M[+_@IRW9^\C5TD!\2+#CF(AC@7N4!R.U MWGPSN"5?<"@R#%'VQ#>% M.U?7>)E^J[5'ZOO(AV5>Q[S^>+U0Y=BITONBNC@B)!-:H0]WO,>2SMI,_I9C4>C=I/NGNNCT&/49T*2AFB?>8_I*^M6! M$I89%*#1T!9;;V]]-@P$FHPRQFQ4GQOL8:.^($+LH>:)WS=Z['"_Y#\[M[=9 M]"I8K1%X\+':XO5VW2#86H YY)A"Z=-N.IQC^4P[+:US^ M71O);23E]$==FT!@D;6CM"ZU$T0$CI%%%,$P-K K8X]1GP$[&JIYPJBWQR15 M_]"W)17;>WG+9,XVU-I#-4\Z>_!H1QN/?1!A.@>]1D38@(U3_@0 MUBGISAT-ZV<7E[0,N'7XLL02\2))?\@A.DX:L\=&[@):%/J5H1XKQ'"G3 M$(@);\O6T2!Y.<^KGW_N9OV;*]UI3@6N0I&1 Q>YU@$0""XELJZ2\1B4H!^Q M'LS9:_!GP)?V2N^H JIWGS_L??WL2K&C*T/0B#SD[& -G6YB#.<@A!92AT M#"8B="BL]-D\[GWR,\!WI+KN@S>JO?= MFWFSHPKLJ !J4OUF.H3CN'D0I?L M/8_2&]'']=AK\&= @?9*O\^2O6M&UDSN;>73F^@ 3"0@<=1&XVK#,$]L9070 M*AU=[4C?*VJB5S+\[8'/_45LE"(GW+/C1H;9FXN+C3S$QJW%VD.FA]_ 5ENE MKW+\QX?%EW_?CG6#]/9ONT@_)M'A"\/MC]&BD8(GO(5\5#;'A-8F^!JEN?99 M.#AI'029,N/%,;9;E_RL0'^DCEQ;S(?HM076/_[Q?N8\1Q4L0C2UYXGB"H*( M$8H-,:FL;;(=Z:UCL:61#W=>3X?!+JA#%3CA.])7&?[YW:\S+873AB,HJRP9 MBH$FX:*'S#E&&0NZW7;84X!((S\'$(_A]Q\>G?U^JH@5>_;P*O?L.+_+8VL0H8__OW M)5ZN,-;/7_V0KW!^L;HKV6K^Z?/%4V;VH(__]V^3N#NYS1AW )YZ.OFOJWR9 MN%)V>.M/Z!A>,HGU9\YM>PT45R[E6PJRQ[(GGJ,--+T/3(LRG@^(>>M2KX^$36N[/BGBD0J^MD"X)XM&PG,<(G%F0S;.@1&TB)0I M#&C'=D 6;>:I!&=-DP2C8Q'HJS+MP,?^P[EJ[ MC[?WX$=-X-GU$W/'BY.B=G!75K(4%$/C4+)H32S>N9RRF/61>!IUKL^X*96Z M^<"&JNT2>4?!0N<8DN;2E*BL\XXQHK'D*H2HE;?^KBJ<^L:&B M^UQ(^.PURXS)*(C0)2'WJ#5FK8P(,H0'-=TA_\ KHKJCK? R?;_X]&E^M2ZW MO7XIW.<^Z,'/FN+RIY^@.XIUVNI8F-29?!K,WDLA=0S:>>&RE''62^;Q*MU[ M@WCDPQHIM>N5]T"$JG6+JU.K83:'K,T?<73[R:8T4 MVVDN/"MKF&?$*N,0$J_\R7>8D7Z\^N&^O,,163]QX4 MDZZ6)%+DKUH#! JZH*+,V">6>?=SCY!R/2&8MZ-+1FFLP?7?3_/+VF%Y+<_; M.89U::*9ST)(FRV8(@(HE3AXKLC@-S[9I%0M/MV"JIW2/ _PIU-XBPH;?17 MF(^,7'C0V1=0V=9G#1[!D/,>;2RBE&E;&Q[SPG8R"#M;CPY1Y<1-=FXWCNLC MQC-M/3H(@0>Z5NZCOI9H1G+G. L@2]&5E@S0D3B>H7:916]$GWH)IX%BK]:C MDX X0&L3@W>W@V8P)EJ>!?! ,BCM#- I(T %+HU@,@0MIH+O1%J/#M+]@ZU' MARAN0BO[?@?-8G(2$@U$AK54(22J]NEI=4ZM1_=&<&_%3;P& M[\2?,F>3L9G5D'(#*FJ:2. %#(]!&A:+=I,!> H!]BV,G+T5.F&"_Z.AC'UD M>DF!]H,PZA-TO8^"#Q5H'PWC/*(&FV*MC"C(H2N)_BJM$CEI$T)'S-/9@-XW MT'YRS(?HM56@?58B9/+6P;&L:S615)WU!-$&1.6,]S9/C^WI!-H/PJ KT'Z( M A\TI*:-T>ZXT%]_[\>_/A/G\\1O')T?W>C!X^EI[+Q^)&],B=%)9YQ"#"ZH MP,CL52DD6K&E\_7CJ1F-A^.GZYI%O['(WY'Q@5?SRP_T.S>7H;6K0?U7S=ZE M]A^_$; 3*60'?6-CU%BX="(J'80/4GFOBY3>>;+5.M&?1#?C*?+;]>?/-S>2 M>/$]KC[^=+'X\^?+LEA^PILXI"GYT'.P1N#O,]4=I(MFEC/K$JJDI([D &56 M.X66FO*J9"?2PV<]'M;_RO,/'Z]R>O.%B/6!/JR>0EM.U?>O^OL_S%>Q-K.H MG0DG7OG[C]\(_(D4LL,'K31990&U$36N**),+B:E66$UU*![WY]$-\,H\CY_ MR9?7>?.?/3#>^8 )0'I,I!TM6TY&DRO*^BB4\BYP;S!*Q5E-, QI]K!T>ZEI M[YB7N_]^.B7UB&QA5B3M%!D=,2A3BM/%)R-UEE8P%&QV]Z-&MY&[T7=XH\0<^]82.O(?J=\/V./N:_9ZR>-]IH<%E84+6:L"LAUG)9 M@HL2I0A-^G&,E/OPT0,'8F5'=[^#X=L@$&4_\6?2&(ZB!(B^&%#)BIOZ?J9Z MLC&FI$*3H*K]Q#U4X,)947 0AL<.=]A.M;;A>%=NS65]9R9"L2BD :U=+2GH M&;CD)7 ED&;"A)1-^E5V2G.L%X-#L& Q-1H-@JIN3_'-9?IE<8G?OG,[#W[S MPM5'W):Y;0/E/4ZBVP1(+PX/TPFPR^ILF+4, M;,+K?\+2^_S.--U PW-B/9?,!2J=G&*D'@ M6D$(7.J$I63;)^^_URMWEP OX.R:1/<3/HC?DJ=2=B/1]N&HCU!3AP$^*,WA M7\/' W4?]8FTW&8[Z! N: MQ ^$_!#E'B;S>;,5[G\?O_,!TUU#]KD1CR%BBBBLXTXY;EUVAJ'"HIFT7G^] MJYTF]6N$O\VB9RKK!-S6$C*ALB@%#\Z$HDLT6725_GL&%Y&KF97!"BXR,-+ M3?_Z=0TDGHPI@I?L8LNI'Z'FU(%X\L"]S#"-3]QNZY=\M1%CQH)54BH-QG+: MZ[B-@$9$FAFGUS"F&Q E71 T0/2[D]_$?!.H-@)G8%OY;5ORM5MF>>E ML#0QA&)$S5;-NOK$&GA1*?JH2LI]\KOVZ+=Y1XYGSX@I]#]A5ZN1[G$,SFOI M+9G+->HP&P=>![*>!;*HHDG:-6G<_&P?:28P!EIB>.Q'FMW]=.VSD8,E,ZL5 MI=8Z0R2?S?A 7S 6YA5MI&G@$76&-U6#8'S@>!JLSH8VR+9M: ]INJ^GG@3Y M&%=.XS7^ '0CU-4>1!\U5Y%Y,FX4F;6".2"C!P&+4#8%F=7N,7%4\!ZX-&J- MW1 M38S9IGC)-C:0A$OSVZ\8FB1CFAF0QI.Q&NA$1L4E6)3"R,!MX7VVV">& M.9SQ-P4"]VN_3**^B;WSM[C\D']9QP'CQ??7JZO%I[S9$$(;!;U*$3UL?&.%M,)U/+SMDR*U]Y%'LG*$++:&ZPVMM,& M F:4= 2F/%UXQ>V!C]!Y9W_]+R90WL3U?7Y9+*\^OB'38QYQ:WP8&YA,#+2T MODY)@R?W'RQCR3%7'/=]'K9[07E_^',%=*0B)UZ;;U9S_!7CO,SC1IBDN0E) M!S#!DS?'66UMIQUDXAZ36I'!P:9"]=[HYPKJ.#4V,*^Z8WV55LH9)6I@1 V_ M4C0]API,T8IQ;ER6?;!]D8D;8RSQ\6@T<-Z&!F_W$?!Z002 M-[3V+$L44*Q!4$@[+V:A@;;=)$R)WMHF(1&3%7A]!HD;^YQ=D^C^/A=4FZC]/D*]M,2-04#U M"M_?1\L'2]PHM/LYE+'>D-2@L2B(Y"0F&=N^H!"U9_J90C\T<6-ZY(*PU8:G@B9Q51JG?AA M?CNGK0VKN"Z*!1#&DB0B,0CUVE,%C(P;9$KU"9V_^ZGG#-A('1TFE>K'_[F> M7_W]_>)3K;&XCA6X.WZO=*J.#YD@I>HIT78;ER7&6"R,I]HXTC'/M2M:\ERX MS-*FV>-2CE7;WA6Q'ORH)BKL42>K>)6SU)H'39Y*DCYK+B7*4DMX*BXZ%#FV M_]O]3_RE^C979!WOG^37XT.;J/AQT7?+X^E:#5-)+1.YAEJCQR)%X$+D8@I3 M'YY8]\]_>W7_D5_U[[LG_B,KW]UFO>1)-UJ3T+ M+*M?R%6))8$V5L2<+5K;)(A^O.AC;9Q:LW!Q^=O5(O[WK[@D@ZZ^#*9_X<5U M_C4OUX//7*@%%"*9<[4SNM+(P$OI0;ED>?'%9M>D.ED/V8YP=7]8MNT:3U/C MU:#:V%J(\+2&PJZ&?OSK\WRY_F6:RGR19CF2;1&] H-&WP1M!F81HF*\J)JD MT89XD\W@Q='S.-A/'-^YMPY)]'7)W\N8-[,0GAOA'8*S.9'9G3B@MA(B#\Y8 M[G0ROH]/,9E$+X:11P2RP>..=4_LE\7EE[RJ58?K'%:_+VHQ MZEL__WZQNOIE2PTWPQ:^$,6-0B3GA?9=]X+#]?KJZ6U^OWC'44].\?\?+= MND'3ZF:Z/U_&Y4WKIIO_SFPA!&I[65/3CU0N#H)0 5QDY-%GVC2ZFML99KV:7VVWF9LY\AF234/GI "_[E5GE(* 0H+E MQI*QY[79[5]^Y.7QV&Q>U\#!.7&?Z'JTE?^8JQ(><%7H@+Q9O?=6]RVS?UE_Y-O%GWFY[M](OQKI&_@ASS0SP6G%H-AZDRZ4A^#H3S:Y MJ"QF:Y+KZR.S,HX):4/(M']A63.;2']\?GS?1V4;,JZ@ ^S,I.]B;2M MY!@!A3?%&V-SZ?6 =R+S>5U(ITZB^PO)GMM"NC7SH&L?8"R0LJ4/ M\R_SE"]3;:56@U0L2[% 1$9;./G0$)CPM)ESI2/I F49QH&'AGJI=)A$]1VO M-J/?'F_)N%;#ZMWUU>H*+]/\\L,L,4Q(TP.GI025&0>?:-/RR$J(,B?I^\1O MCWG'OB?4BV'0Y AUT&=DT:RO@OW'XJ+6*?EVU"W*^AK\MJ@66>)9"K#1D2*\ MT$#^%CE<7]1H MM)\6RW_2O[V:,1N]DRH#DY8FEL@W<4HA%+*O)(_DIJ@F;=A:3>C%D/BDF-%! M^;U?V$:]K=^9U,T;XQ^U+-3%W[2*?R+L:(>4;RZ38%S^>H&7JQG*I)V3&@QC MM0I!E("9_(Q45-*^D&5A>CNF!Y'XQ3#\A(G0P??CO8MMI_HFW50EQ(O-DKZ^ M^KA8UA?TF54LL,P$Y,!(_1@X."33AQ:R1ZX*:?^T'H^?GM.+60:GQH\.[N_] M5#9Z;C_D55S.U[=-LY1MXD(I*,4K4,[3 F9%@71.*Y>54+Q)9^@IA']E%^++-K,@DHR MB2*;1G?VE//%,/?D0.]@]-XO1%]U&S_F='V1-Y(^-M750W.]2= OF3F5R7,( M020RIVJKFU@XE&B%Y49[WBMW>?AN/-4,#M5-XM@;\5$0/W:CB7NU"K^_P-6* M=% OA-8)YV@D+S)ED%$:4(J3^VN]@V2$X][;F&1LPM^')#I6@8XC$>2ARJ^C M@&J0QW];GDTZ=!^)6I:5NB_2D>N_CL-L]XY_&H4?A@K)6"XB"D@\T/9L?:A= MP!(8YEA ;;S5;5Z%#D2!OJ5@6S-@B)Y;(+]^35C+]=VFF$$4B#:J CI)K$71 MR:46QD(HVA=CB]6I26'"^Z(VFV0A7KK]6C;;\ %G9#GFDQ8 M.T;H G2<%3!.R9 *DSXTB3^_)\DS07M?W4YL#)&(5PTD)6HC8"4 M)1L[(P@968DJ)BU$#X![U6+Z.NK+M/GV5_R$R9%?A=B0L(\84Y=CNS7^X0NP M[8G +H8CU-=B+6^K/V;'HJI7+)$I4"0=A)0$6.6\J%7(LYJLLEIS%!^II38M MB$.T-C%X_Y7G'S[6O-%:$?*K0"DX'@V/$+G5H)*L?=H\_54Y2^=-HF],5GJ_ M4X+#5N#:&XO%E(IL8$_5R\]?\-,-4X.F4T*@!*E+K2966P)$AF"9524E;15O M$I)R6XB7>?".AJ-!HO56EHUEV4>:EGU IN%,8&3[5_Z&-XGB?03UR>M@!ZBTHG+W[S9!MQL#IY2 M"QVAX,8UZ)BY@6D5Q MMT3QJ$7AW-)L!!DPVEIA2G)*L9Y(N6>"U+[J:=&<8'WR;[L6QU!M M0#KR>2KAYOXE)$'<\6B45)9A]BWVS#M2O&P;:G] CE%SXT%%?)O&9=I9.7WF MU+3#88-)'<>@&\&5H6%5AP*Z17_%%G,K-#)]RC7(UO"LZ5PI"#X:!CQJ MKX5,C SZ%J3KE.8$ _B: [V8&J46=V+?DN5OH@:WAJ:*$G-,@%:34<(% BJ# M8*Q%D8SQ439Y:7Q GE?Z3()4@[WG:T'&RNF;B@S;!U6>O#<^@]>\UAOE$E#6 M$EG2BLPM+S'V:7,ZF$(/2O1*HHG0>O !M'%;C.YB(3_^5?\X:9."7@,U:5PP M?(J[+3B,9H& LR5D)45 I27S$;6VPA>G.YH9]!KS ,5_WURL/XC^]*[L%F:M M)5M7;[_&(CLE8R^C[D9B2R*3D$V M$,XD[0FSF' VA\KD."7R M'I\6IY+BL7-!(26S!3UXB0Z4)CO-"\= ,L>Y52X8W<1[.K&;\:.1XO%;\@'@ MG,L%8Y\YO=Z2[W%+/H0K![DEWP/HM^?[L&I*I YZ>UZ"-CJ$!$4@@K)6@]/90O*R*%XL5ZP)A9[[ M[?D8$DV#5H/>:C]?QL6G_#4/]NW&H5J; 4:F4B/KH>A 6V3T 5"3]U0L*HDJ M:^:;-(9]1*97SW1JX ['JF.XSE.AF4_CHP HL%!]KB0TMML MG=& UM4$6U[W6Y(YQ<"9$DZZW*3,R1%8\H2+=AR2#-%_B]N"?$$_^O#/?)F7 M>$%G\IOTB91-ECW6'NJ;-XZM2::80B&R !V4 >54 2PQ0?0NRYB$M+W2[89? M PR1\O#6T(0([SK[S>!IX')]AQ/M2+R[!,XG@LHS+1ZE#5@DJ:_ M1,DY-C&8'Q+HUP6L]1CU0I M^NW7L KMHI.(!DK@]6)1<$ D,RD8+W@,FI9!&RMVM.B3W6E.W:)]AK+P8J4! M9H(')0."8\X"+UK4C2$4Z5KHM-F,3O!.=5IF/WB#>E1N- V0&YL.JIB0Q44/ M3-=TT)(<:58BR,1E8-DQ=*\EC4^ RL=!_%3BW>X4C9 EZ%QX!(-.@W+6@XNH M(3FK@\\J6JU;4/9YU=(91(/':ND,@:-]994^TKRH6CJ#X'F\Q,H^NFV/>)*8 ML[(.A*@]O0RG#56B N^CM39GP=IT>SN!"*Q60 ]1::NZ'S_@U:9&$/J4BO9@ MM+>@HA'@C*\^N#+61I]Y;A?=O)7B9>_W^P/2X*7XJS#;"E\]Q&FYX^_(<\0X MXOT0>@CK$>IMN2=L VN*U2YY ;9@[1'B"GA##AA*I9-0Z%5HXK<8%GT*.MLAH(>N:&>QJW0TO LV3IU@$4UF&I[(,XLHAT@'V ?I<4EFBDE;67EF,,0-DN!<(W!8H0BBA0I'< MM[G$.QOR#DIE.3GN#L'WH&'CJE;DEIK<0\\9G2V!@[>&D[T0)9TZ1KC<)*7Z MN8>-#P*\=]CX$+0.F+Z2#&>:9P7.BUIJ5#I IP-A;P/6.J;HFE3N>=[I*V,H M- 52QTZI"RYG9]""9IA)5DX>$8H,T67G4%EOPDZ7LM>4NG'L:0Y3@\NDAYNY M:1.$2UC#31D9 2IY"#9R*,DH6@:A>-ZFO?SS[94YQA.=!J@&98@[.H7UD>AE M]\HD/G&2\V\8*VR5OUR??* MG)@!0_0\(?)WVU$5KP.79%JG) LH$VE\Y DR*NU$#-SY/A7J7UH[O7V.A?T5 M?Q]]/54#MCYB/--V>H,0>* 3VS[J:[&6MR5*LT1.8P,I/1 M:\N$Q 1HQQ@: M3S\T?0S TT"Q5SN]*4 Q8-SGA9F(%]LLYA["M#30[TAS'-M\;VRZ,1ZAV':[ MP-<:'"G9F"64' RHI!QX+B6$S(KF-@;%6NX#1S2_VX \1)_'2HJZN?=>O8E7 M\R_THRF3H![XZ"9)3WVFL9/D5+BWJ)E+SJ1:"P9%D>3TP"A' M3VI*PF!M_0H8)/F(A8P2C\@A:^D-2NVE:N(\'S^IJ5N"F[OX-]=7'Q?+FH7R M!\&^O/7,4^]P5S_^16;"?)5_7Y^!"S*#X1(#;1,FJB:-U%I.Z@2OW:?E=[]WYB,PI$5VTY1S^^/SYSMSDBUFV/\W?75Z@HO M$QEL[Q<7%S\MEO6',VV2-%ID<*YV,0L^0_"60T NK*+_V](DF[7-=%X9?WA6 MM'A^G6Y6OURO[Y^8="+7KE2!9@:*IP@.M0!NLM')V*!#DVR1R6=R1@R?D&+M M6+\'/TYPEECR_NJ9S[N?+F[))LVA*L"X52-G4!(#, 6O0OE::-*\8L_JT M:C\\/)=7TI\ 1\YBG[>Z,&65AJ"0%*Q, 60&P>I<6UGR*$Z3]$_L\WNJ]EX[ MM?L"A0<$^EK^XK_R_,/'6@;C2U[BA_Q/^H"KFAKT$\Z7_\*+Z_PFU!I]\6I6 M/+%&:P\\UI@MFQQX4;^H'$I.J:C4II'2P:=Z1OO1A&;FZ;+I&%E%_1?TSISO M>)HSSCS71BDH6&-G:Z#Y'6FEG#!5VYFRD_'LI/*; M'K9>'ITO'?I),1,AU[*P2DD!+G-7'[=<]#+15WZ4=37Q1%\7V-@%=DSFG;9- M_>@TK4:!DDQKJ;4#)2)63#)PGFF;R%AV A3@VTVKHW/UDNF M.21F!"D<'6#6#*ST3&9:!=JG4U3XO9F\3.OY:%QHD-RP]X1NQ-^$GZW>?,'Y M19T5;;'KW7_FC/$1N0"+@=/>B19"R!FDDCK;VBP'3XOC3TSHE>K'8,:$L=S3 M1TYZ7T2*T@!JRVCINIJ-$.BO,4AI0^2J46.)%UA94SI\#:%12**X$ M@R",R:!,LN"#%\"LTP93Y#+WJA?RV""GXB4>$,)%"_U/&'/\D& _+:Z7&\E$ M0!89DV"*7:>J"PB%<_!.,?(MN8,F^23O;,RI*.\4OV!^08[S#[U%_J,Z?7LJ3#RY(.XLHA2CON M _1)/=L_,C<>$ZUE(\GBU :4%[3$':UX6O>*N9(MYN/$Z)T,>0>5)3TY[@[! M]Z!E20./I*P2@9MZMB2GP16NP#.NC=0LA=SD=>FYER4=!'COLJ1#T'K0\F^< M3WY+ZMN!!>&NVSUEFOFP$9MDGX^8]$Y2NHG:*R>*LDQ5= MG3>'#7Y"EV'?7J6"(;\%F:$-&U.]>['@>*&-0\2 /B3GR@%#/L=.YZ1N''GM 4V.:29W*H7'0=7#0//?Q"S3SL&2LA!#?;\1M6F*S0A)H)0P>: MW^N2.5$NMLXU&RTBY_ MYTB3?EUMG Y?3B7=Z&Y$ ^>N&"DRZ)))N9*^A(P<7-#26!M"YDT"QL\B ME.Z0['@TOFX(2F<3FM1C3J_Q=;"%:^ V MDP>010!70@"O:%DY99AT:4]B?!WDE1C3Z/\ .\;OA/&6LYS1O!@W9$QSFG"J M/98Y^8K<9)\U2ANMW9<:WX9Y)<=4&$SH3_0HED 'KL-$GKXSM08#2Q*"$(7^ M6JQ+VM(6Y_9DQW,K5S$E.?9$8,+PPYUF[D(A,TF1!49?E-,T-R5=;>M>4$0? ME.YS.=R_??WK9<8=GNR/1@M*;*\">X@QX,J@/SFFWS6>=N]'(+"+X0CU36@; MW!.'"\$*[3.2#AW:OFP&QW@&3[N,+='*;.79H/B D]H Q %:FQB\_R1-?;K^ MM!%$AURDCAID#)8LS,0 F92URK<*/'/+?)][BU[PW1GY<(?W*-TOIE#JTTIHXJ#D^,=J0\F[??PON$<5E+!;;4/HV9T8$B90:6N/.)\>#= M::70O&U;CJ&'!#<@_WQ)P%ZO'[K?77W,R]\_XN5NWY_;#3AH#"DC<1CJY MK0%G8P0;$I%*9\?9<6)5)IWFJ;C%S=; 9.E)[5ETL%"&26>[[?NBK L>-9CL MZ)CU5@-R2X:NUT$+(VNUKS-=+F?7&^@ 5#W\JMJ#9Z?4#OO)B:Z;R7SK?VS) M02SH!1BM:VQ?T>!\D> 2^1(!C3%6G]=ZNCO!U^5TE.4T@F6GU!'PR7G^:XW' MUWDB"U$YR6I"/8)B.4-]$@-.D^?:IB0$GM=JNCO!U]5TE-4T@F6G5,7AR7EN M&HW>FJJ*SA7,#+C">H\E;(TZ]\ ,3Z+&RB1Y9N;>O3F^KJFCK*EQ7#NEEI*# M;=M:3CZ:X,"R2!9MTA%\"0*L*"9FH[)HU(#O.#[424+Q9.OGVRO(R1 T*PJ2 M4<1,SV(M<,W!"PS6)FD\/U? ANCAC';*L[E$:L;#LW**^ZMC%J3*EF4')99Z M'1 EZ< (X+;8%(K+!?L\;9WE6CRC!7@**^ $5_,@^I[5$KY[X_"T(E1QI F/ M$(I(H$R($#R34*3"@K(D7\[,LQBH@=?%?)J+N261S_AN[6E%L"PB1VYK[$1- M$A89G"9M6!E]?+O%O/K&M?XRZZ5!"4 MU1Q4C6MT12!HP66(60M9^@1QGM!R'C+]U[5\FFNY&87/\T:QQV8F TS4553S'7$/#@[2@>%3@5;"00G0^ M'Q>H<# #F74G%]YO1:[W"/>H=#N'*0>H=[ 'TN)$XR^FA<3%;O M?_MCM\+(OE)[R,>:W(%IEF3XW1)-5LT,1V&.WJR&9T;)9IN@ M+VM4E-K3@K>)O-(H"@0M);D!07)A,G/\S-X[SS=Q9C_F'R\99@AWSC.[K$?@ MA(I!H4/P7/O:[Z* 8T$""Y;IR+UK=!MQ"I-_75JGSK@S#M69266K;>O!:JU M69G(W5(),N<^81"8_)E%MYYM"MJIKYX1S#FKT)>A,4!%9A=C4<"T,;6JK ;G MM ,C)1-.8$[AS()2GV\PVWFML6FY=X[1*KF09"CGME*%=+*8:!1& M=2V:$D_VGB^M<*%F<,B"-:"J:,!2'!2?E'.,CM[=!Y;7 M4)ZC\/XHB)]**,_V7>NFZ05R;[W(P),LI$:F(423:E"G*Z;&1;HF]_NWA3C_ M0)Y!-%A,!$>#BZ6=)\\^TK2,P#F%V)G]X7D YQ&Z/0#B41J>#&VH6$NE)L_ M9T-$%KR6/47/?),F=2<0:-(,Z $J;0#P>I>J]M9Z7MZCUY9S\FLX2:1I]*LP&[+V$:?ECK\CSQ'#)?=#Z"&L1ZBW MY9ZP[2D24U;1)6!92-JG=*;=3DNPQO-L!^ASB=C7S"2#2'L^EU@S0P.$DA&*2\&7%)3E\663=U#$_LEQ M=PB^+1SNG8C?;=2W%(9;I1"BJ[XBM[5MHXD@'"_*:ATT;^-Y=\MS@F\AS<'> M]>,G0*I%R.45F9AU[M]?X&I%)LVZ24E=:MK5%'8GP:1J<'+A:=I1D(42N2Y% MJV+;]*MX2**7;>]- U2#Q^;;\FS720^)6EIN]T4ZCMTU$6:+)@IO3LUDZ1D@YLXVC+9+3NN)(^ZJB(\4VBJ0]%@:H4( [16H,C MN):@FU]^N)F.R:$8F6E?T30=3Q-S,A30'(//J$)F39S 6S*\S,UY+!CW>6$F MXL4V^[R',"T-]#O2',G;**0L?'-BF<\)3X.[42 MLD>9+>IB4U3>N.6@F/SV28^M_$>/WI^H)=+^KW\=K%:A;4 B\L:=3DABYCD*4T0K<8941Y&H)+[0Q1B7' MO;1*V))BE-$[$?=@U3XBC@R5Z2?CVZ_)!RG:S#F+D(NK33-CAJ"R 2LX8T+X M@*9)HL=004?'$+W[_N;B^JFO]]\6OQ+_+JU_RU;OR._YUNR@TYT)P MGSSP6"(H9A*YXBR!=8A*Y.*M;Y+H/$#&PS]J-F76O0"C1F@U>,3LJ9>MY+,L M B<#,8*O+?$42@[H5 "##IFR16)HDI@X4,XC$*P5YKO<:@A8 W?Z,1F_RV6Q M)"LEUC>9>9E'O"G_LA4]J!=(R!RRC[Z^759$W>>E?YX+>R2 T\2;54@Z2&.0$3B M/ C1)$]ORDD\7Y8>#>H&D<&]MO?HA.&2:<@,%:BB'2TR)#?**D\"*J]3$V/O M91_"DT/3(+AHJ*' HD*3*[V#KZV=VG:]!(:9=DU4\O-"Y80 M*M%"%\#(@ZY=Y#4$E(8LJ&B$39*Y7N^XK71RT%(!A_6@6J%T*KG_7Z.;OEVO MK^]<5IOJZK*P3"M0!..!M@NL-3@,N**4\\K'S)I8OH]*=:P'Z79<>"A.=#0F M#1RI'9F^=FQX6JB6K]&=4ATY8G0\>HM6JC\8+^BT-H)<*S#95Z\?:^M36A6< M/"V3@O#1X)GSH6_XZ('H,$3C+9),OVV2OR_QEY]^65SEU3T9O13:&Q20;2"/('L/^/^W]V;-;23)FNC[_2\^%OOR M,F92E:I/65=+=4O=T]?."\UCDS"' C0 6: $J1@<82&<-*A*&TRR*-CT)>L%\R.Z5>N MKQ;EQ/):#L%WE/R6T02ZE>>26#)1DZ8+:U3PR7MT"9E%;DIT.@W(C@^VJ)EV_FZ4WZ0DRLKI8DHS_SN[]JG6I 7T-'*O[PZ4:4#\MYE>S^37!_O U+S<9 M$9M$B1*9]SDQN""=?X>M7]5!6I@1=YMX2;=_C&X[V0 MP1D1ZGEA:Z$0=QPPHP6A9*TE%1QED\-[#Y[7KHN'$=0@.>;Y5^0B$PP=D@:C ML,Z&2P*\\P6*P8(Q&\]RDVF>ST-[[=HT&FT-TF9N#-;510I&)AD%)%:[2SFR M(Q!Y!IMRY"H+P]JX#[< 7J^2#**@P3R2;7ETE<(F$\':Y%/B!)D4ECP> N^R M%5"*-5KKXG.;]CT'H9XJF>AT5&TJBE]&XI$RM:S4T*G.%)F$S"&XDA"*U3%J M;H74;>:,GF+BT83*T2L3J0])DV6<= 'U(Q.I+WN=4D^&B'ZZ3*3,4Z%]&)11 M]!HPVJD$?8MH6I@Z_F2Z>%;2E=ATN]'+)Y,$Q;< JI[.W MV2;56KE>?GK!."HW#8D-]K.A5N!Z=W>*14=YRL M$49G@N*U3M%+!M&291(#E[+-;-]3U-1G/(^7JJA]*#XA!;VQ5U0PMHAD0?M: M]VB8K'6/'K3.V?%H.;;Q> ^#??SKAI9*,I)^#F"X@6OTB]D0FM;:-]3H%Z?13D:10VNSN^QU?O7 M)<:K.K+G=AA"!VPM[<&GP!W'VAN/RKTZ,A(/#8[")S$R+G6P18$UM.\JICF$ M8@)PVG]CR;'HU.2@FUY'GK&SCJ,B?<3?0#5^62SS[-/\W5]QW2;RIJW*;%053CD390Q:R6/'OAF@3>G@(UO84S'GV+1K+?:YV,6H[STV=< M?LJK/_*F+';Q1ZYO2;RZ7M8.XY$$1(\8U!RXZR>/4 (S:!%;Q2M%)N%M4%:[ MJ*(13MMLBJ.= (MU'B\&K*<)%8.[-??[_.EHZ="7F67%4*+6,G/%BO+TIQC( MG0C,H"^I*SF'-F/N^)CAU6<]'S =25WJOU22*EJ7/+*DD#O4ML8F4)7(/;>^ M*TMC%7 ]^/!:\?)FGNAG>?GG@P2E$IU/BFO@* RH(#,XH1,XZPW*E&,V38;) M= %W>*SDP3-N/OQAES43"Q.JU.)V ;7,:(= M(VO*XYC&>$PT"%KL@G<1HY-D 4L('-,F^0%--95C+L$@9F$GTXXCJ\2AC'70 MAE[B;A)7??@*;+;IBZ"DM"(F$*F(VF23#-68+#@4&A5C*<0FGL(N,&>L D/$ MW>2V\O%ZW\2XO,;+^P043BZ,"LF@AI)5;6D@.'@L$JIY5HS2RN0F[:NZP3MC M-1F'D@9!RYOI +]!+'E1UGG6I0\"] $1)JEVB")I^AK))0_I]@,Y+ M.481>Y,JG1W'&SEP@00>*Y(,2F\O5Z1P%:KCYO/O6F;Z(S $#C$VLA7<4MOO50@\Q6R*RC96V;E.FKA=W_!,>C!,9FE<,L)T,0 Z#;9_^."72.E!PAOQ MW:TXWB^65Y_??,G+6<3;:V+-8S)9U3II6E*DQ3GG!(3DA!>\H%)E+"H?/_ZE M$GJ@(%N'U+YW>=9G#W/&"X$:F"%25!:.3$\90'A70N362-G$9G\&U[E;[6/2 MTD!K:B+*E@AN\U(Z &MIP^]%=JQBCQ%Y7+0DH8&YMQ]@H8U-Q6@@2E4-DE# M)V: TZF&WM=&YDW2C"?6CF<++(ZA''UDWZ+._\O7R\6WG#_F/_,2Y_'6O!'& MQ.)-!LE$J,U8-#B> GA9Z!ST.>38Q G8@V=Z"V,DQK:+_$<0=X/[_+N,QKS\ M,INOT^MOJR-<0*7)N&7!U\3&Z,"9(B%QIM$4)WEI5>41KHA1-C(+)$]UNLRF,]2P'(R!YE*"< M$. 4#]6IQ&2X#:Q-O^@33%X90R6P[TB4$&A]I-P?'8JXHZ6 . MDCQ)I[1RR +RR3+;3BZ#I;FNC,/+B+9SG0^U)]YPOV77#KN1?O([?EM1F=2 HRZ)C58A)KS3/AMM+)$0P?&,R?DX(>?D9I,0T"#0,W>#)Q01 X< M'9A .X'2J,B25 *RE%D([7DJ37+D3C3QJ<6>,HKL&R3#]8EA:A2B3L8!%FL/ M7>,,!,@0?6G%R\M(#K+D'3%'.Z-EPM&*+ <7@H5H MLE%ZW4:L[=#JEYHB4']:&D>7)(%S"O.CFH%UM/9HD,$75S_EW15AKK M0-@ZFKTH">3&:3"&SE*RQCD9K"^4]X.2@\:CO8^$VR<82%&LXAX!UWT;362 MN=#B?"DQH!3>=4G'?J$)!KVX>#K!H(\@6R;_\$"N=1_J9 RX8LCHY25KT^2N MYC03]X80/:* CY <%(POLB0&N9!JJJ@5!$86;A:<<2.\R*UZU;WXY*!#K/8Q M:9DT.:@+L!_)0<-X[)S_,82$29.#=*AFJRR ZY;A@1OPA794IJ-4*()WI4D9 MP,M*#FJC''UD/V%RD U()RDG)R?4*E'''81,7YCB3 =CD[==LHW/,3FH%V,= MDX/ZB'O2Y"!OHDXI"C"W=D#"S\/?'B&)9R^8K<0^K1Q1=9.)+N7SSUP8?M3/\++Z\W$PW;U^?/B,M&&LQ;M8OX.EW/Z;G5!*E,')7J0%A4H11N%%S: ,#(4 M9;7 (I[1M9Z/G'[?'8OZ[U,*VLBXP9G\KI07MVDHT1WBR]>>QK2T,.UW(OTCQ\4\SBYG&^%<_9+I M:7A9KSRNZ?.^??>/+T@<,;%H('NI:J)R@-H$F4P3G:,0UO#09+[H"-C/7>7: M$=D@0O58-)N@G-,A:TNV;G(%:WLS#Q@P0O1%*8M),CO1$3YI9DLK31E#S*>2 MO$*:N\GH6P=?$C/*:!]!:D8.LA6%#F,7P7N=4+,2HVUR\?$=BF.%N4>A=3LB M-5B\+4*3MV!N'.LN<)J&K;_'/Z /%.P'K07A;4JDXPK7=OR,#' M+( %;2T3"KEHDH,_"=O/!)_;D=U'JM.$D][GJULGJXX7_7T]T^?+8O[Q,_VS M 5&3IS]OA+A)#\!;D1-O=4I"A\"45%H&3T>X-2(P$:R)GE]TQCZBB :N9X?%KHAXX#>/+#Z_"JZZOU6;XH M;W$UBSA//\\NKS<3=_?_XO"88EL\K>D>5V#;LPFX,D*6J&)FJC94#LD*JSTR MF3!I][2BC"F[,=]N6N0U7AXP;Z+7QS=_WY]:SA:?B.3%TEE7VQLK;:(+6I,O MA88K+H51S[SX6T\Z,(%K?C5+51G(;_^8X_7RIF(I7EX3X#I2^X'^?"BWL C2 M&LR]/^@MKZ,R:GYI]=Q=*H"L)'",R:R#]+2X)BE?(RW@X$RXPW"\^;*XGE_5 M.D)AR2N"&)@'9;@ ;[2NPP%CDIJL(-7$MAP%_?2AK*-H[Z,4OT8NL[[!\PO.EC7.E3]>+>)_;5"EX*6EZX3K3O&PL=3]9MX%$W>B(9K.G[AP?2:.JZ5/)K&M"B"VHGL/7ZYF[K= 5_+>Z+G M ![GXNAD-**3IAY(YS'4+LHBN"X2N*Y]AJ,5X')VD'B2Q3GDDC5)CC^.NCUS M<_5BM:T/BRTK+ZH!OG'7;A/ 798%701'1A,Y8S*!=Z'0N8#9)IN%]$UR'?8B M.A4W:2AY^XHP#I+\WEC1N'TY%_.8:Z7 YNWY:9G3[.J/V>J_!L3U]W_6&+TU MNP'=SBR7+&7%DZM)^B7X$+A@VB6M/1?9F(M.F$<2Z0$]39_[R)8"[G(SD@3: MP*QTV>?:K-1SJY4(+)?$769ZOYP/OJSZ.2]G?ZXK H9(]N%OCR#$O6"V[^UU M#CYBCBQ:99)RAI33I:#J!;XTXF(/KL&B&7PG__@SQA53A_MV89%+F)\Z]^SJO9IWDM^L;5?^3T:<]X^KY" M[?R4<<4^;'%;Q&3K8I8Q1L>5XB8$XV7,PO @$B-#ZF+( P^S>NZ?^"!DQ')4 MR7 (O"A0G,Y?>MD,T'DN9%%*I-(DR7P'ED,"V=]+\/[#+W1.PM%6"UZ'7.<( M90C2)R@84@V*>9[T,PKYU.=/;YT=2N+#>/0H4FMP;W>/Y&\DDIHM\&%^_[/W M^>JB:"<0@Z5U1G).ZC1=5TC+R'Z)'%-1=,:V5=L]R%ZN0K01?@/G[5_S9<;+ MV?_-:1? U47,G#P4\E13-N1(!*%A/4_0H)%>69<+-M&-9W"]?,T84_ -[K#N MH6P"NRPXE"QZB*XVGC4J @KTX$M(,COND#7>(R:]16JW#_07YZG@L6R&K& K ."4E$ N6:TH&P+G7!D0/,F[16> G6L.Y6#R-ZK M. <*O<'9<8_MK@<$_>9M)] .V%K>:#P%[CBW&>-1N5='1N)A^=J^4-"RR5NB%?O:^*X8PLNM0M;!Z7S^2<>T M*0]E9=%,I"-ZI$^B^^G-+3I3.#0CA=T\Z M=\*'B72J-_S=O_ZX0<WO]^@RSYK[8J$B,)L.@/X&.K@ZI25,ZJPK XA_.Y)YT[X,)&. M.!CF273O__-V_Z$-Q@OK.!11@UR))4 M,FCIR(.6LGXYA/"[)YT[X<-$^IAP MU83PC^_^?GO@2)]D3;EVF=N:=:!JQR &5G&5K??,I7((X7=/.G?"AXGT,>&Z M">'_^/_N]A\1N8N$J>AJ4IJB !DKM/]DXWT.PILN?=R>?]*Y$SY,I(\)-^,3 M3N;%O4E9@@H^80"TM<;"1*P#H"7(;%A!E902.)CPAT\Z:\('B_0QX;8-X?_Q MRVUGWX36R%0#F'6.A V9U-&G:G!H'S/)Q0WWPQ\^Z>P)'R32QX2[)H3?FY1* M&QV"M1#K='?E50)24%H]&NX\J6=PP[?TAT\Z=\*'B?0QX;X)X?<6AL+$63*T MTER[0,MHP)N"8*(K7'NEBN]2I?C\D\Z=\&$BW1%X:1!J(WCO/]S"]_OU=(RPJG4T=! MD#J10F8)/D0'GJ%3G@F;\O!W_.&3SIKQP2+=P7B#8!MIXST\[UQTEEDB$3W! MLV1DR#IE2@GAM>'2;7>^[<'XPR>=->.#1;J#\8/',-<\UCJ\X2:UMH[I1^2ZX M6N9<[ -VG'R+,"27KC4'FH'3*$$1A]8I(6%M[ M+/LFQ\,.+-.;"N,0M1A7RDVR_6_QO%G=K/D^E>@&(FIK"W,:1"H.%$O55C4) M;!&&-8@M?,<-H%,H^*/5&;]N0SQR]/4P2*J3HK(SIR5IS7@$44TNA$ MFY(KOF3;YKV?ICP-G50V<*>3QU;LRKRT"RYG[;*/)HV/S=T&_U9OO]W^ MS=JQXYGI=8I42#4)DH<$H4@%5D95A'!6:]OA/.CUT%.)>O5B]MGHYQ@2GB2O M> ?06W.^ ]3=L;'#E.(8$;#&1 Y1EP-8.++BA$CG'+TS$+7)M0^H@R!3 .D" M9Q&M)OPO16'V!,A.5U_Z"+^I^;&C'LM%*2RG16>L%=JU'@M3\E"B3"@2\Z*U M.W6Z):]#CI_1A=ZT+'['C6,7;#]*7H=1V:>><0@/4Y>\EA LSTZ PCKQD'90 M[#O#QTJH?):\-5:2/^!NHQNYC\"8P'$5)]0 %YET 92W!8HF#T,E' MGGUBN4F\XRE0)Y;;T8N^12/93U(9^^9?/]>B@)NZ76DMUKF'REA#:U>\=M=F M=>V")^>#L7ZP*?KP2=/3/1XKSUJ;@T4ZC2/RY@&ZS$NLRP.NF015> (R@368 M$I YITI2:;CO\>:5$#Y8I)-4QK[[UQ_WZ)1RNBC:TW+A=1!R0@A:14BR".^4 M1%:>NUSK]J2S)GRP2">IC/WY[W]_H([2BE!O7S2:4H\S$1D0^ M/$;Y\$EG3?A@D4Y2&?NWM[\_4,<8G.>*=AWA21V%HS_)D "Q%,>44NR =B8/ MGW36A \6Z225L>\_/%!'G5/F@CP7*VH("RV"BY8,<&V9+5+F[+LT37W^26=- M^&"13E(9^_X_'UH8'A,/7H*I2JCJS"COT$,*EDB547EQ0,+]?[X2HVVP2">K MC+VKVT4E&<\!H7:(!!6"@8 I MF6KD@"Z.-P*_VXI=#3&FW#1#I]96Q2*JDB M/:"0I(XQ&\# /5@GO?<\VLR&^^''K8R=EO!A(IVD,O;-OQXT6\%DC3CMB_9MK RS"1'J$R-B0GU2&J(Y*>LFC.Z&,_H MC.*U8%0)249)0@,F2,9^N!QBYTZ+V&KN,D4&TL4F?PQJQSY8&286\MM8::V*ONNN.FI9XR5 M2;/Z!6?+_X67UP\2XM$YJ\ACA%BD.,-(:9&/=HMN]FPH;1Y+7II:*9RBJ7K\+,A9= M*A$XO2;.1E](N$VRV9HM:?KBK['5\D3H/G9%V:TX=JU\[>/$4%(R-3G(:%V; MJC,(:$6]CZA%D%XDTZ3:Q=L'VHXYU&)5]BA2'\#!U':LI6:O"%3B5:E*'"8"*#D\K%(]H MN4G;/;=>JHX<4L?:3$7ZB'_J.E8N!"_>25IJ;G $AA?.>#E+#4JHSZQQXK14D@\X@G;/T/IQ_JM6) MFBLC<#9EUE877*\^:ZL7>5V3=(9(?LJL+8\\,!419$+:^Z2AET"Q3&>OR<(5 MU-+AR]>(85E;312BC\";V*?/-ULNM>XSUBPERR,=M.MR4"8A,^6R1QU-,6W, MU)?4\KH7D0-:7O=AH8%5LBOQC*QOJ8-U-?',@;)DACE6FVM:50@4EM0FCG+: MZ7V'*,*A4IZ\U_EMZ]O9_.,58:[ZNBB_S.889WCY^V(U&RW?K]>3QDT '+[( MK8Q Z27/R!GCA30DL=I+02C'@J%OE9(70Q\Z?K#T[OF_W65-D#?$(F>UO"47 M4!K)$3=D(#O2]Z(#ETPU3GYZ"MXXMTB++U^7^7.U$^K32!GRO^;+C)>S_YO3 MKC;/JS?+V:IN ]=+^OH[_7R1WN9"[N4_\:\+G7/)Z!UH0\)2,43P0DF0Z+UG M,4?;9G),@[418/^/WQ;*27)N91T/RS,F $;R.]$@(WB@/VI;%?PZSUMK>#-/F^$-[_Z*E]=I M(X"[A<[S:O7/O+JBU[DN5EB=0O!U6GPDBPM]@B#6":5,6^-]$G&R^\%FJWR5 M^G\\/6EZ#UE7^/"$NN L2!5L!AMJB5% 021Y-XY*?;4AGKAL',3!B MD[7=6KMK<(TA)$(&";P( JB(3*_00@E"Q)1YMF6"[>/$I@9-M(L(3=HZ MR>#N0NV/?+D.@ZT^S[Z^_;8Y8.]"%[NNY;Z_Z]]PU%JXR4VO49"DU M9')48]!1JMBD)<]IW]?V(JK#?6T?*4]T 7"72TNNI;->*?!.*L(F&802/42K M;>*E%F=,=H5W[,J'%V*!C,;GU)407;#]J(081F6?-/=48*PAH-*WM/.["R@\T8'RX7?'J?](I5F@(UT/)WI04D#7?D)5Y]_ MN5S\]PW FW/;*1\SSP&X-QZ4I*W7J2 AF\3I+SAGKLDMVDXT1POU',K68FQ1 M3]Y\]STNE^L_C9*!_^C3QLVR?QKL5B:]YZ5$@RHYZ54@N"H4GHO+R46=K+YX MZH-'2ZVYNT5-0B96QROE7)-^120?C14/-D=M0ZJ&>).QPSNP'#+;@WR+/_/R M:D9&V\\Y7-%#Q>9'=5_^)>/5]9+V7*(9+^\*<2]BB"X5>HEX88+>@,(V==C> MF.@*+YYS^8R2#7WV,?VP8>0_'/O17-HCNF05[_W:?R_?5UL:+E7) SBI&1F*0RY*JB*'0( M1P%9I)A2B<5T&N@W I27K3M3'Q147 M,84<(D$31I,#25L]( D(3/#61T&G]W;*Q$ZMZ??4EZT@#24\;2ISD#I+% &* M(XM=E6C!94U6?%0B9QV"%XU#PZ>4RGR88HPL[FGSEC.KJ=.J@I*UWXNE0R\8 M!SJ5@CE;DU*382*GF;<\MB(<).ZC)"F3M<.P" DA6@05'?ERLM#BR4#*06AF MMT?%OH(DY1;[PZ'";Y"1_/MR$7-.JUJ=\^MJ=5W;_WPH_ZZ.WOQJ=9'I^5PG M!RX&LFQD36J-](5,9.V9T"[&)N[8T[!>OEZ,*/;'2G'0:.D'OE2ZSM65>KN8 MIQJJN9\>@5>WF"\P2(.1+!VF]7IDD@%$JR QG[SRS*#N8E#V>^K+Y;^QA!_K MPD%3IQ\AY7=('[G3QF *GMSI[!S!Y*)V?:M3M!1+(0E/^Q@?H@C['WEF6C"2 M;!^KP$%SJ!^'5OCSH14="M,1-?G#08*R+$((UD(THI!13 Y2IT'%0YY]-DK1 M1MJ/M6/PT.K[]8>K^^NC7S#FC:=\$;P7:#T#K*$1I8VHT_0R%..,M@*)[";E M&?L O5S5&%74.P)0(^27/ 3VZ_PJ+_/JJL;(UBD.Z3ZT=A&X\J9X"UH%03M8 M\A X*F!)!XE,^.(FT(JG()Z;GHQ&QP[-&3&9<9/AHHTLA5QB\%+5GE^2@<.D M0* F-)%<(M?X_N=(M85C^YO]Q7DJU7Z_+>:?2&._5"VNN7F;@2LR&^8L60G< MUF9 C*Q@'R(==R[J+$1QNDG5S2XPQT\T&T#N8F0A-TC!V,9T.RVI ZJ6B5Z[ M81TGR^MPVI[1@P-D/IU&,)W()2)T+M>I@](HJ!80I,!JPTBFM&Z2R3RE)CR3 MNC65(O01=8NLK'N'Z.-UH$^=K0O$*LB;M"'&HG88"S"9::6)7* @4H&4C*C= M/EE)30Z&9Y%-;T:.0>%VJM:H\F^2V?[0U%V_!:YDJ7BB([4&2A293>!4<#(4#!=SDBOLAHO?XY5;1N^!J6R>W&]BQ$L(/(^Y)/3A0 MZDVJXO;@DTF5:%3M*,<)7]$64.0 13H78N;,R49=NJ;4AF>SQ?+]XBJO\$K_#\9^R6%YCL8*,8*8I^Y_^T3)"]G.!;D&F4HBU,X# M!IO DN6;L\EU)$';L.3+JH0E#R63EBCJS4N@_2,8S(.L> M(3CO(;HZZ#.%X%*3R]63+U?LQ5:G(;,3/[#L2MC]0! M1@_3H#N;X[^GSQL !S"PS>$!XAMQ1]Z&HQTS/GD-*G)%Q\VZU8L,8+//+CFA M!.]R(7$:+.XYD<;KC\B#9+\80W,@'XC_PKP= LI#%!*V@<$GV'N,2@@\5H##Y\\@MD<+#@&IBT>WHBK;>84K3@R!F95\[169\*H%(61$23M G> MR29].)[ ])+-H+%%WJ P:0^TVT9M'<"UC*8\B>XX$971N.RF(P<0,=W><0M2 ML1RBX5 DUNY[F7PU%B0@STF9P@AEDRDL1]"29T(H1U*2'O)OH!P?\3*O;LXX M(S%FQLEM9[48U](AZ;-U0*<;\YK9J$V3_.('&*:/BXS(SF(4'4VCDW4R1&F ,RG(TRH1, @/W,849!:!M@<)?<1*^,?8=G2+[H+M1U_^853V:;H^A(>I^_+;S'QBCC!BM/2"U$O( M&J:)01IKDXC1L_/0D4/Z\C=3D3[BG[XOO_-*&D^OE]*@G),0-*]%'+)D'@NR M3A'GWJKQ@OKR]Z*O7U_^[K*?O.GL78G_HFPU!EBWB5B-THNVZT/&;5$[:&E; MG6MC$2:)I+4PJ&S)(7#R,K5S(?GDB[H8\+P&R85O-ET]R 9^4T>?D]SH<;-5 MK:B]7N8' T23LU9RK\'2"D )+>LX= [9&4W&5)02&\\*'H"Z=6^1^S87F4F9 M9'%00JH]#A@#7YN@$/N2NQ!B<<^I?>^'GLB4Y"8JU+?OR# FIAIF\HR(-EX* M2HNAAC23% 1!=6K;H+0B[9N MM>]#9#Z=1@BFE"F) ?+J$_G"P3-;YZ22RVR#+B(VR0D_]28(#12ACZB/T@3! M&$3+:.O#C)'\8SJ!L113Z^V*3,QZD9K,(WXY31!Z4=B["4(?^4_3!,$$CX[O28(4YH4!U(Q9;N$+KA>=;N$7L1UK9 ? M(O4IVR5PK@4G+8=@4("R0I%S[Q)@<%K1;HG89K3]J;=+:*(,?80]4;N$/67; MW+O$BJTS;4PM=T(-+M/&Z 394^3@"^>W!B:>5W5\+Z:&5\?W$?-$[1+V-':P M2@KI$,$77]\'&0&%RA"3*D6DB&P[I_*\^F>,K1 CB+G%Q>5MT/?MM[L__LK,FJJFT"[ZK%9+AV&#PGQZO)%68G>*_+ FU M68-&"7?0_I&Q+GPMF\=X;UZV+F!;FJJ]T!['?FU!^S[-:L99RQVL$^C(F(PL M2V 8-"C:R0ETUL"<2R6C%R$T21D^ 05[QB0^.?WJ0U5+O?IU_O7Z:K66@+@Y MM(4P+AFRXIQV$E3.) 0N+40G,3$?%6L3CGL"T_264T,V]^G-@51,=%=]E^U6 M0E&Z* 9"HP-5#;Q@N8/@$GJ6"LM\LH2/TTDHGC9:-Q(](W:'Z)00UP7;C]3C M853VR2L=PL/4JCXC6')SL!7M Y2<:<-\;$XK:;)@S.KCO)#.->+/7, MG!L@XG:QO1N4XA'*VUYX+#AA5 &L;5J54!I0TNF*&&,4V22IY2!%V/?$LU6$ M443<=D>X&SEXVT<$T98D"F1F?;W'1D"2!K@H)2M>E11U?_*WGG*>A!\BR@:W MO@_<]0?^UR_+_'^N\SQ^6Q]YBBD3F=1@@S&DAX8VI, +F"AT,(&A;3.@KP.V MU^6&C$U6@W8LN[SY.X W;U(7B%-':;+N];LEJC MC++, $^U?UDI=>21"9 4FERDU2ZU*:3L .XTXJ\'L=HE6G\()0W"KS?']L]Y M-?LTO^]T%)RD=Z/>IWLLH'1M56B]@IRS8EEXCZ+)S+#=<%Z7K3,")0WZ/#Q& M==<:_GE<$[3M?P3L.(;,&.0]JP\'2+Y=4_['^ @;*ILT!!G)P6-6@R>'#SCG MQ6:=K7!-+OFFU8AG3),I%:*/P$]GPF38XY]_3R!!N)ITQ@[Z8A)F! M+@I!V5+'I 0%P3I7O([9ER;1P+.8,=-&9_I0LE=71NU.<^?T#>DZ\^"71^@F MLP_*5I<8P9E/&)T1PBFE%2)A(@O"2&^L4^)B-ZJA8ED?2H<)Y^8C1A71+EA; M@BI61?3>-#$:4X$2,WPFCK+YY".%1<;U:K?+7">?IMAF%VN3[B;^() M":_NN_;,\2ZR\!97LP-:'XWW[%$)&E40V\SZ&'7D4GLIE-#&,<++2K3"!L&% MOA@/QDA1O@V,-SMA?)C?/9K^P?O%?/D=DM_NVI)8D61![2 F\C\48Z5>[%D@ M+X*C0!]SF\&_HZYB/*]E@^8!E#?W?+[/5Q96WMJB<$"%6[A$<; MP#%M(#NGBS:6SIJ>;;SV/NLU*DP3'D9.0KD_;G;VXKNUMB^P".0L"0(6,QG5 M@0,R'<#H9"+/V5G/.ZA*Q\>]5FUIP4;+A)8#A+6)&-'&6-9SIVVB+ZIZ;2Y' M!5$Z058.8R:?K%TP:5>XX^OG<!IK^8\&M"F=DMF M/H(/J"!%:6)(.=O\_',6 M: ] M9V!9D,6X8G(0_5S>DZNM.1ZKPVIQ^E#2MA9GNVX O0I9>04&903E X/ 18!< M^UH&)9///?OJG$0)QBDJR"&BGRC!Y*X\T7N/67 -I>9GJLP\.",*>=]8G+$L MQ=PX.GLZM>*G8?"/1E>3GH]/%#QUP?:C=GP8E7T*@X?P,'7M>+9>,67IW0A2 MUBYG!D*J_YF1Q]1-JB1>'(^E@]>T,H2:,8=K3MJPE:[(D3'O3/) MV-2DR?P+FDTV1"M&E_WQG-ND)>H2(O@D\DW#+RLM2!MU**@$;8(OW+F=8E,8 M2\3'*B5/0GCC+#C4!-&2Z^23)[LZ,)>U"24UNHHXW5+RT_!2QB9OHE:@CZJ7 M.T#\45H^!K]#2LL'D'.DTG(GD5MN Y!9I4'1RP/>: W.%AY#82)LMSEZX?HS M1FEY8_7IP\G12LM]*B;' *Q6UBLO'/A"3 M,/!56 F--PF\OM[2\%ZN#2LM[ M4-+";>K6#[>HJ'.@Q9<4R#R4JD @@""3C8IILOIXD[O'T^Z,?G*VT5@4-N@# MVJ^/;A>P/SJECT[[09VLAW!V]$[IM3K(*PS 8YU4@CF SU8#MS'5N"=M\VVS M*%]ZI_0)]:L'51-U2K\=;X*U.Y$G:-;7J4I>!@A:,;!*1RV**60L--6BQYA. MPYP:BZFGX7 =2TZ"SZ=X) M;UUPO>KYJ+V(ZSH28T.J9U$;[.%Y>>D/(,(9 W)TR=1:]40M&SK/EEC+K\9>1:=YL(RX(Z0*,$4!%!IU%MS'=OB\=4+4T+G;#.HYI<3AMS^C! 3)O8%KL0:>4<3;D>E^5X+CG*EZX)SY@54RE"'U$W4("'9]YUH$^=S?$JIPKRUG^V0@6K M:@2N BPFT$'*/!13G*ECJ5B;7CS/(IO>XAB#PD5+^>\U,QHUWKMIM;4H;Q>+ M_UK_".?IOC/7[KJI$=JE'?+<45NEC2: K39IR*JKDEQ(2BIE90BTM7CZ(HKT M(?*+<2",E7: E_2(_/%SSE=_6RZNOY(9=??8CU>DT/6I/^'7=4_)W^[:<,@L MDDW!0N"2WAY%7T)6#F1$)!-+Y53:#DD8"'R"QE3>!A8-))[K?9RVM=%T!.8S MHA>&^\3Z>7"GV)AJ"K49T(NJN^C;5N/N'-MV#U1S%I!9!2@3>;FBEFH$'J%$ MYYDSC+-M5V_P<+Q7KBPCD]'"BL/59W)CZ__>_9_KV9]XN>Y93N)8+K^1H#8@ M@_4^N,S(=*BS_I#P!?J>-D@9,(2(.C:YX.Z$[I6H5CO&&MQ=[09Y)[?[_O<7 M6%1,GE3?.%@X.*GQ8HN0@QM-J^. %^;@K7@K4'&ZA\Y M9E+_VB-\%SJ.RO B"W"LD[;)UZXI)!:BD$*1(9B]:A(O?QK6*].E$3EJ?B=_ M;_))'S5&4AS 0X,Y2?=X'MQ%7DAC?$ G MH>3B:AM:!]XB0BF%T<%H6,(F'0UVHGFU&C*4D<=JXJ:;D&"$$#HE!D$'TF<7 M"V D*UZ4I(VP3A944^PKIS@AX10VG'&8>ZQBOG4KC?NC%'5!DS0'864 E0JO MD= ,Q4=Z'91)PFX-E1S<3>.U63%MR=@18!QWEH;8$3>/J))#KH"%$DD,M(7([5IZ0+Q1[N?,?@=T*]E"#G'TB,3 MC+6& T^.$]12P+&0 (U+2BB4](:=E?Z,T.ZGN?KTX.18[7X"4RD$:<'%5.^ M78 0M0!C!6)6VBO3-DGJQ;7[Z<7JD'8_?2@Y7KL?4[36B8[M%/A-;JK'0%Y" M898;I14WK[G=SP1FSUCLM&RDV:DVNPO8'YU\1J?]H$XK0S@[?BLD92&]=[6(>2 B) M]G"=)8LY9V7;:M$+[.33A\T>G7SZ4#%Q)Y]<"DH>-225R8KS40!*>E44TQYU M\#SFMOU77V GGY&U9 @5$W?RD9D%&;@$&2PY$\Z3%:BMA-J%EFD3E7!-$CA> M?D;5D"!4M3.8]$PB+$[9VFZ*5UN:OQ=&1Z\C=+%'II$E]';;91TYT]&TS MQVH$^3?(8!YUFER7M?R8:CMDJFTO+6DY)W0(Q0W.O%'7Q),*.>0,A<"#JEU0 M0F0&M&6T0RM=LFIRN7OZZCIPJNW):&L?9IL/_GE<@7>#4D8>0S8: B_K_NL( MF R'G(O/C&LMV( )8$\\\84/+>W%:L^BR &4M*VCW9YQ9J331L0,-M8$/*8E M!'(Y@-!9X5W)RW+$6A=L/P;6#J.RSS32(3PTW5%V8+0, M4>9(VUMMVJ,"-^"%JK5(RC'CM%>^\9SLES"PMIF*]!'_\4Q7)/O(>,V!:Z5 MH180+*\'KTE,*>E&JSJT)4B; 2.B8&R+H'7 M.D#2PFK/Z""];S'Y2H?:#M&0T67??(/8.W'5LR1C8AJD9A:4C K0D0I;%@BM MD8E^/E(9SMG0WU#$(UXL='"8%.\3"G5XSN8F^@$!^N/N?E3]?+9;TO6M>;WPZB M92EK3B>FX4[3N!*U:B$E0!\BZ.R0OJLU\P^X0 MST9;&K'2,O7MNRJL]0R,]?X9HS3.90[%DD.D3.+@BA'@DBFT@2J&IDF7JV=P MG:V1.B8?#?I;_;Y8KL5\W])D1\>V&\WN K6E\=H#Z]%+1@[G>C$M42VWHGN MM>O!FR_KK?2VJL7[Y$NT("2=M*ID!">2 AV2+L66%'3;_>@)<,>N"QE=B49G MI('6]%'TH+0U&378;*LS(!1@IJ/71(6Z^*"2;.(L'6DGZIG;/1K)!VQ%?1AJ M8$W?=M_^(W\ET#EMA+ ?KC569&Z)K$.5ZN/FZY*0P8L/?J($68E/0UK:^Q1DNM]7CO- MI7(Q>3)7! IA# F5)7[Q%,+#Q+5VW<80VLT'-1#=+HA; K2Z<,:3,PFUBI)[ M2Z)SJ6YQ@0?A'@GPYC,/W-WF5[.K;_^>I?SKO"R67]9AE#_RGWE.KQ"]R.\( MY'*.ES]=KZX67_+RM[N&9D6;R$W@$*PSH&2A;;D("TQ9IDP)]*PFEU^#$1]Z M$'R,GW.ZOJ1-IB^$U=MOOR\7Z3I>W6?XYM4_20'>T@/^Z\*F0)M/0,A1DJ$? M:JA*T#$7L\JT)X5HV^2O-EO1]$?,-'J\?>Z?),-+NW AR[1^5J>75QLY /RYMEK,,R MJ(3WY.M""K)FO>H(+AL!(1FI44@56)>+.OK\!QI,WVUK[SX QPJ@GX!*+$:D M9D17\0&>APN\S6'M *I',+V/WCQ&,VVX?!RB'K,^DI0G4P&3-9)W1,ZL81F4 MR)I[9/AV\\/ALY3[?'H# M5[;S8K;\6Z^T=RJEPF12F2'R&"07B04;LXCRD7_[U(,.M&XW'[8)0,[FGQX\ MZ=YZBDDQX\CX-M%;4#X+\#5/)"D74// 1&D2RNL"[O#1:NNS>G4A=3"B8*27 MI4ZI9$D )J? .V.Y+$%DU\0BOP4PO:,X.O>/1Z(-D&T#%^Z/7.NUXM7U0*D9RQ$)P5 62B+TH2)&^5!%3.9YVL-JY- M%OMC+&>H"8=*?,02J%JV5Y__B02SF&\5\-T7":XN BNEV.R!>U:GE%LZP(I4 M4 0K.LJ@M-X:=[BS#K++L\Z(\2;B;9!5_.O\*B_IO+KQ>M[]]37/5^MAB1(5 MV2Z$2?),B43 ^-JO*^F@B'W"H35(KB0A"ZRC6(U6]-9JN9I:$"#4;_5'EO5E64R MR0@T0;N>K3Y7>7XH=7^^R%'ILHYO9TM?R$:K@C,02LG2&1]TF]R89Y&=H:*- MR\;(8WO?+^I"R:-?ISK>G]L7F]M R++0_ASHV/:90_):<><+,O_44F2D0:QV\6NYQ2I[YNZ-#[S?80[ MXM?;N5Q2U$O1MY*AZ\#EOL]_Z5R.(K>1VX.NVT[= MP%#11*$+^1X\D2O"=2:/D];E$WV5(G+CN]#WX"-?.F-#I=,@M>'[=(O%ZHI6 M>9N/L^YR'I(0-@8(HL[$BS6%KV"]:W.ZE**LCDTB.,_@.G=/J04]#1*D:O?; M#^4[D+=S#CH :SH0;A^RX[1,&I7'[;E9HY+08F3;7H#",!$Q2-!8Q_74\0G! M60_1%!]<-,GK-O/7IM6.9UHA'41+U\O%]]R_IC_))ME'N]ZFFEY XP)3'6]=?8V([NH7EE:)\%&H73"K&6;!L%[$9V+)HPC\I%#< 1J MM;BN$U^BU*9+-^@39/Z)B/Q4Q/<1;HOV\+<9WK=5L#<'$Q83Z&!*4(JM MQ82> R8Z[HHT0FJ6N..ZA2VP!\^TX:=QR-J72W^ I!N8@^LDQYO;_7>7LRW[ M!!4W>MVV3HI"MBJ2K5K'3&N/!3DG6R4TJ;9Y$M49*,-X4F^P)WR\PJM-:^"M M"OF-:XRI6%X"8%QWH9>)#.%D $40R;.41 DM5.))5.=N,XY/38/ZK-N>"3>1 ML Y@6H8COT-SG!#DB&QMZ\'!HFZQ;WP'2D61:J$8X5&TDV&4X+PGK6<8Z;@3 M:$23:,($O#\37)R*]CX2'ME7>+.:X>\89V46;\XL;0TSRGO:RY#59)7:/)YL M&6Z]2-DSS[;+[H8["8^>?K37ZYO2+1O5((HLR )A6DM0 MA4ZKD%P Z;1$+3V7KDD)U&XX+Y'M$04\\JO\[GJY^'HWWR-HG4N,Y-Y&4K]" M;HE/"H$59VW)CK/89=/N]!8_?/!+I/0@X8UX,UQQO">C\_.;+WDYBWCK1'"K MK*HZ)$CN*BL'0<8ZR=2Z[+T*RG6YU>E$Y>/'OU1"#Q3DWJ#LJ/W>-M6-G_(\ MS@;U(?_^]T?HV?8$H*VN;)IIEPU+DB,GCFH/"5&X1.+=%K#C;+6+P%7^7_^ M/_\_4$L#!!0 ( *N%75&.2S YW"(! (9$ 0 3 :79C+3(P,C P.3,P M7V#L #/J=Y3@, =QBX#NSI:\6?A4VZETZ>O__X^5X^ M$=$C8N+2IV1DY>155-74+UR\=/V&MH[N33U]4S-S"\N[5M8.#QR=G%UGK[^@<&?PP1Q\8G?DU.3<_,SM&65U;7UC?HC,TMNWB G3S_//^G M=@F"=NW8M6OGKCU;=O'L\-FJ(+B+]_C9W8>N&N^YYW'XQ+EGOPE=BTXK_KQ7 MZKS)DO#]Q]U\(B=5QJ1I6Z9M6_8_9MCS_TN6_],[E:?65!Z4]ETM,ME$V^\V@+ MW>'1%A9*$&S:R#3_L->E8!8_+ZNUVI_@-=&I-LRQOK/'0/N1*$;D"1-54U[5 MS@6BU+XO#DL# <)G_U0>Q6&\!(@\A[V'DCF;1=!)"[A;RP7,][>C/MWD/&'8_! HR:3I8$1' MD_(Z)PJ5E!EN,+'6"=PADGHK4IG%IRT9G%VZJ*$WKLY8EY.LD6]AR3VXGS?-6!#V^7CG9MA_CDXR]V\ %W/9RXC >A4:LX!// M4"03A/:+1LT/39W'IHFF@2Z]]SG2^9Z!3SX:C5O3RPWA9!]JH/':\D_HA-FO M017"!$VZ'54#0 ;*[^XS(.[#( YLM0HH,V*XX&\;$0\-H2;3N0!9E?8F:3VL M8FI0V:J&8FS^B[8GE O,*.:AR 8+B 8KX:.Q/\Q-1VV-&*-QHR7$##G0M0&=EP=9&4(WH@J"ZF@W<+3X/077R K-- D<)A4 M"IJO;3CV3K\4S+ -E66T;B\7](P)#^HJEV)G/.P"#2R&4 3_X *-A(W.P.OL MM+$*9.S=OC@4D8C*NEEAO5-=?&T9Q]07SV"J"]5_8A=J38]T<[Y?0@1-65<) MM+C)<584 T\59I534F53@H0_<('YONC\P!H-LT+.ZBZ4=>?/L_P+9]:C%X,H M LTIQV#C8*NF3A$8PQ6VHV4_E55"4RWU=Q^!-A?(TY^A^A 6IJCAQ]"L!TMQ M@S\<5Y2F9W9!#Y6YHB;'<=H3;B=@-8_PC(VCHV[P4=*'TBKSC.&2-!/G338V\G+)(4K="F^(3%#L)&?["_840=X9ZL!G/:I#P.!%% M.9YERV;CO]]E/?J^6+_B]D% +[U* ?HZ29),JARV'N#(]RRB^DF* *+;/*.^ M(F'Q5B$7V)$7]X(]\&%/M[808/S_JW(VT6M(D\U M>?Y4AL5CC?)M;-B,=Y:O$+ C]^4EW*$1?QP^5?\2G#>!#\FL4CY0T6+$S*IRNYZB[7&OM'@-.D6YED6?M!H MKWU.PR';&!)&&TZ6B%9W2T11\R>\E"-CVCKR3DVMV@X^(P?>[KW/<%L(G.*L M#B'G[U9@1/ HAI,"KE]V"G M*B95&'ZZ)J>V' _;='U\GK$#\/#]GZ+F5'0FIBP9#%GO;NYP"=4 MA7LQ=1.+*Y_&Y^ISTD4"G 6EF>#$7J*XLJ$&'BU-:6'7G<,SFRCF% M_ MP8Z)LTV NIYN@'JD:@*[SDV&OPM\GK;$(_G-&S+E2.29[7ONVP@-=#8Q) M+]Q2<2,;R9S+0.3!.-;J[+4[U(T,5)U+S"G*VM&>RUS@L'$EN$+)A-'P79<] M35W2G_+)IO_)*V1\9;MH)6I??DKI["=GN<8>.YOCUH(+R+\EI7DETSX$Q M'I(W^F]59Q'9PR!FU^>G"%59WLL>--6''H0+!@WG0:GY>($W>!M4C9Q5Q M(-S^FW*:[;+=[1+RN%,-<@-Y$FP5Z7*=%F 5P7;PPU ];56%WWWLRZHUAN.U M^U;O8_0@UOKUM\B.G(+')\V&/A*F8?G5Z>F MUY\!\6F3I)H&KOLY!\8+T^M>8WLY4VD!",SZ"RX0XJ@U6_X8LRFBT#!P#>.5?Y-:=()9 M>F[P:(F\P)B;>('G'-H["BD^5+$XP;P&3IO$GV0N<-7!4HK^>D)1 DE4882V>VAA1&0UT1*V$@M_&?J55:L6M0E3>-%<11%+'^HY+6U MMN-"A[87T8AB[B%"6D%---<'H"D!XC%2:=V>< &<6 M.T;W0NZR5^^4)"6C>L7.L47NWHME/[DZ)0= M'ZQUS71#EK:?V&P)XY@W71(^3M-F=W2K;&(RS\QY)T#FBDX@Z0>Q\I_K*<'> M/UC>M -OAMU%?-?72&+"0RXHO#FI1K[UO,5.K8GT^C^^$65X*PRGX#]^$FV\&K")SK1D2U0NXPA_>*N(H9X@24 MY B/V7+9_^\5A^K\12>B@AK3]GG_H\BJN@!+Y5SZVZ\=^Y)S=^96#QZ/F#1* M'OV(5!VG;& 3*@?>%"[CS6W"XG)W^KO=)=#,$.?;^O='8:0;@HBS9:1=% O' M#_N&;2Y*%[9K"K&G"GFC1K] $^.+UXS$;(84Y$N^[U[U7K)1[BS/(_N&]W0& M.^'.#M9+B8SD2?MUO:H_?E*_T\-/2('3:_$V1ZY&V^YUS;'.@L!;SWD==8KV M6-.S3A:TO>FTYQ]7CA2WPY[[+#,,P60]\L]IWF]J0I*L9J=(3++)PG,];5BS M 6LI&6O^O-7=Q1,&Y1:NB_&DRXS(KLF!2CN;<9TXQYK.VGA:RY+N)U87W3)\ M!)ZP&>&>.F[1Q=3)B&HDC#*P@SGO>L*:%^_/JQ>/PF&B]6[E%O!ZM(S,&DA] M:5-5N8L6U2[=A!!?2)9YF*X/1[SJP L9U@I\=4P_1-JE2:SUFTWI 3VEQ>0G MI>=1G_*P.0G,_L'K8U5J7 +3PR$@GZ_'T$QD7GWRQ)D(TZAO8@23H,7K,9L MJI>5KUFXB7[[:ZH7-520C)6,&S:$JPUHI<$57+I,I/<]!^C+^1A7/ST4+OMA M!UCV=!-&$[4!**I.J$V69]5TZY5;Z6 :/H0:;J;(D(61!\__NL;3K[ MSK12(#U16Y1G%2N50W*RC@J_8AMF4?MBT?8C<-;\N8-_'YVZK)O#!(1ZLQK5QD>EHHLZ!2+" M7S%PU"'$Q MFJVTC%S,DZJ.5ZZ2 J5#+3'QU#'8_N[>HT\&9C9^&VRN5AN,8,M=EO#KYP)7 M/#5RC8AR])1;X8V3P,"@R\(QNKG'P2/SL*81<4RA K]M>PYQB\P5(N M2=G]?4]L'-VI? O0/[$6-+J1"6PU2'_:R)LCPFCR,W_\QA!:ZIE_(?SQ$";8 M!54F\BQ?GNI6@"CM9?EDP,/KS<=9Y%%JMGG\S7XTTYSL M"J*UII5E6QW:TYMT15)3V%[BJU+"$]/3+]CQV/_5S/ ^?/1X5*?8_O%CTY/N!O-&+6OXKRI9;"FQ]NI$"[&CU\^%T-@93L.( M!S[J47&,#9HF2D,^2UAV!JO09POH43HW*EW^6+7 7:SL4U)^X!RO$YW,[%\[ M\C ::<5"7\I64[CI'F 93G IO,;1.WS;O,+(_!?':VHS+$+5T-TI("+O09== MIVV'5Y83036(5T-5GN][9)2RVR6T!<+JBZ-;YXKE50=G3J?S[,=!8P>!=N.+ MY_,%KR(<.)U>XI#0!X1H8ZF13L/N)X2R6]CRNODQY L3*RD?-!W;CH,--946 MG:WZ1D?][$BX@RUSXP*! [V!QYG*K&)<9EG0@=&!?G,'ZQR<]6>AT\,6]0'S MO>^BHFZ@4U%CL*Q\5C<+'YOGZ\Z/JL;/$@>RCMK$(;K6*":J%@QL>8I>^V-K M704UC,B ';YE/C[OL!IQ1E7QL8H%L;]YCO@QKG[-_TD?SE/NH7-'PU2!W=40 MZ\I:X; @OPULM>##+T;714WNK5A"'Y'/6^!7A^=%G'#ZOZWDGZOQRLR$ZX_\ MDM16B_4"M,*=YM3O[)S)=L_PNOQT4ZYL3HE'6\CX$9]A7YDYD)PWG"?[@9>D M,Z?_;WLEL5X2N3PNF:3;I"M[M97F] '9]/#M$@S"GSJS%\3%;09Z+AP(^C\@ MI01[ADP%,1:Y\6]I]'&Q474?479'?WV>#WPXO=*1"SRSO)K%NC6X&@^3WX2! MC$M!VUG^47R,3O3[C%+-$Y"(O:AE.-$P,=L.YP'E= MS\PV5+C81CIGWUXVHLT%=ZG(*A1;JSCS1%?40J9$=ZP/A;E!.VEY[+7Z(HP1 M;2VRV1(9>'&EP//KZQ5D2.UG+A U57M;8C["FW%J:R06ZPDT?JL>SF3?F_ID M; OV[>?YVQ:7CZ.-QG5K0&B('UQU%99)K+^=5FJ/'T,1Z?7]M=$V@UZ!.4B: MR>B:-YQH*YJ:]6XG([Q.LN6E*F'MD%%F.V>=ANFP?&TIVV@Z9+L0>N+]NC-9 M2Y*=5K;?TKML?9SVZJ=;EUL\H18X%62CVS(KC\ M"ZBO_>VP5_:GEUX.N\SG]29&A_94Q%L:<_@#+EUP 7GC>A%AQJP;-O%8LMJHHW#*#$5)1]+!L MJS9W8)W^4OU**;W*KOMFB<"ZC0K/_;]3X/\K)2-&.U(LL3QWSB7F1KB:CUO^ MI:1Q#>/Q#^&?;> 'GC]5\HUHTCM4(N5FQ.:KK6@\=H;95G@W6)Z6T-%68HDA M(8R\9$8_' A?L0W(TUJ[VT-QK(LI84$SV_-NU9@G>UI6^$(^!3A8QFMBKPBQ M%'X.)B#.#699S2ZYBG !]5&LP5%QN_I^AO<@_P3UE;A/R,*#ZC[W>"'SDX.!LXCF;YC'6;_4$%S5_P*E:Q?S#]8Y,ONEF9&#YM M$8-0/&&D1/:P:^_'3DN:6M?T3[FZGW05JX=OOA>Y/4D=&"[^;".2-RO9I4\/ MHY7\(GGY=HN/;'Z5)Y MY=7!/0Y>Y=7[H2;# M%5-%?-$/5_-:C\W^U#QI=ZY=AH1[LC1:[):A@ZVR= LDC!%>1<]ZUTA0^9)6 MQM^5E%//3^(.%!WS^ 4H_6]@O[:"50D!3#F7!7D2.#MLF4K"^TMX?%K MJ%[6-J>M0KAKSEZKLIK9ZUYP/-Z*%#E@H1G;B#DD./2Q?]J_(C+5&YE4RYEO M%% ([+$(3"KFK 6H+.7+3L>9?2L!7U6F6=@U%Q+HV)18$] E\UMS47B[Z!P' MT3LCE7W84W-,+W.29LM(9%*1%5W7JE_,@O^B&-HP'Z'=+MEA$SMTI$)48NY- MC&6)K\^Z%8WZ:KU,?#\QC7-1:KEWY2'?*OD Y].H3#61&-D4E7JY():*9#T2 MW!PP;1ES=95+U\)9! G$S%J(01:QJD&,].!/29*Y%GVJ0]*:/?R!P5F$+)]J MZ(+7THI!@R:>0ELLO0V U.(*Q^NSQHH )'2A^X\'&\Y3#_SM1@C>I&3.3LM" MEDR^;5"[%8H:"\.*.W^"\;@>84)#"_=*3CK%ZYF=%4/9>8G0*$HIWZ_E)]'M<*K:$+K^F/8M7:AAC*U_ MBPMT7=836!;>K#J*..2F;6[\77E'9I.G ;2 <^2DZYJ\\R0%LQ!!VSV/65#X MP07F,QVAJ0J/!]>/T<.@K 9SU&C5*Y0:KN=ASZ!&:8NKH&MT,_E^#L98^CQ_I4R$P6F65HEK"^@_;XO:[7_5$.B@M8$ZZL MZ&C#UIN5JYDA:W"C-,:8S(+HQ,N',D,GP6XH"FS$N8EU"7K(CLDG_?G\!5904U,@V27!8.;:R?H$>AJCAG"QM13.FPS@W!C2G%VIHN[N\ MJ0?@MX0?ZQ-OZFA]L)Q#3>A.V)Q>.5BMW @SS0R^"0O<3PM-J?G6C71H@9TC M7F4UW1\)A Y0K.(6?IEJU<30;6I8*_ /F[8[UU:F^$"-[^7S8*+F)7IQFJZ M1PX46E+*X!"^;*+8I>AV+O#]9M$KV@ZFV5=?X1[=7YXV;01_4!S5PS74-Q!K MUXW9<5H2,)RXA#6SX1$78)Y5;9V#%>]Y2MT9E#IA7.$P?^("V(6VEZY6FO)K ME0=+YV:Z.ML4J)I&G+V,3(.J@MIK7TGQ"*,YB4U+T0+49ZVU'Q&JH=CL$65' MUY,Z;#/T0,WQ]_>DUPLW_JR5O!'X3#M(L""X$7*P0.R-^&,['6BXQ)]=LV]1 M^N.JZ*&*%N(I:IDOTH2/T++N)+6R4WAXG[=X3H/J1J+!?@M- :5,DLW@*._ M@EA\@)B#(T._)-K*TU4]'C1=<1)&W^\E_]$_^_Z8=+7\8H;7Q0PO9EN[GO5! MI3EU$^-;O"2]?]'>4W. M9RZ:<6='<8&U9%]P#MC;4#(>%NJ2;!GW]W9N<'\ M2[MIA3L* 9MR[[88C_$548H7HN842:BC!D4LPNK2BPMF$9,JG2I["DP>2RRI M-FZS& ?Y.YC&2"F31W2K.?X)G "LRS8/5'Q;BV^2Y#S(KP..<96,"9NZE3] M(KBX5X(($4:W?$O=R).JC#DU$G-N,-9&MJ&_7P$J57)DJ% Z;R&Z=9S 7U)K M[]C(WV/CK0357]!09NHADO:%Q[8JM_=;1?K>CIT@P70O.3XA/S"^2KLCT!- M&J9A<[-H."0RF9T&2[TSRSDRJ.6F;N&FYCTK/"C'!8(.H/2+#R2/U^W96$?- M?A=([BQ]>PMZ?"4X;LS\\T ZY4*9MURS=79PJO6@DDE>I(47Z3;<"DP*>L+Q6X8.V<4 CWP1??H"JZM$EES10(B M4 LHID6Y.N#N1%U82"-&X"U2]LDAQ=.5^JV78$3E]3A'LK&E4TXS.BK)J*%&+.X7V&E*L?(2&[&R,1[6' EK M(;[KZ?*2>4JE/PS'/T,OK4<_Y8F3BZR+[>N;.^-X&A7:K8XJ! M!K&340U)URA5R1Y9V<;VK=/H3))A^K.[WG/JIBX?3M\LM)"*R<>:QN6*%2*] M2LK2^D"P$/;$2M^J$(Z-_/;J6\N=:C OJ^(=V'/3P;U40T1^U'4C>&>KJA1[ M#G(D)^[0.SELZ] NVZF% M*$=2M1WEQA ]LQ$*9=N2U M7&+&4Y%,BKWP0[*@Z5A@[ES4,<$9W\%0J",4H'LY*.>TY[9=PG?\*;:II-"K M@MKK4G_T2K53K+-#U/J2/*1CW\ WXAF%MA1XG-9%-?<8F]VR+'D\B5+W4E&S MHWOX2]V#Q.?RG%.5=<@)HQOA=*\607"Z0_2@1%#!. M.[F 9-&<[SY#PP].TT<6NTI+Y-6\S._;N$@:!C^9)Y=;OJ*V0H9%"W+H]Z+_ MF.<"MG%&\_8!A<'?Q8N*AG-(3\BCU='9(*RWXJZE&KQ*:$J+:.Q!FZ[.F]"H MH66/OS!AO6Y6_ID)'J<J3I(HXF7;SWD?CX-UV$KW3L&C]Z@'"F2$L1<6YQ M.?&>*1?0H'/,MTZVG>:IHWH@8(@OAFJS>L[Z$A$/@A/F('B9EP\]2\BFE:O# M^UR@M WKJ37(L(1N.6D]2$3/H_=;W4TN\!;.&D]N%-V !,]9@"K*W+N^$EEW M7IW%5ST1;6Q3*A-E=R+X*3EXV(4P]Z2='Y6Z)E *.?D[Q7<+RB* M-"]/_!94^CLD*_!2[^6@*;C[!'MN]**:I/N;T4MVZ!(DU"W%:Q,>/\ D3$?& ML B&C0.&@Q3,N)/3T+A>?Y#(E^'--%S,3%%(W#W+(:EYO$!.$?0A]&#[L6;: M@;1%R_;KC!#AV]3U\H$B4>3ZMX_8P0V?@K"5([ADET(1FU".27"-V:8T 4[Q M="=3"I%L*D4,U9P/TIC;<^15"9H YT 1BEZ]Q"?/!4I!AMS..+S65M<%\I+0 ME'[4C/HXA"5IRP5H3U -1O^Y 8C SO>XP#NM*LNJU7TH_.ZB-P75HX1*5,#= M2JEE10O"&%8UATD<*"V M$-3@QD3"&^\EZWIP 4/%K/V@+&ZU&4"5U[XA$\IZ?G&!(K<3P4>GZH$1UU$$ M%_";O_C@A_-W JZK!*KS$/60*>9=4'U2BR+)!5;/@ER-7,PN#+QX@-F#.#*B7"/3H8^S"S8!P7^&+W$W,HO2 I-3(P)WVD50+2BE7; /ML MP!S.<&X@WF#,KVL+@A]1HK!RB#Q>7B%*3NZ K5=QO J=:0WF>.0:@K-,8V&5 M%ZR_T^7OXL/3-[26!U .Z##K$HS\-ZH1=)5Z08H+'-M=2[4'*3%JUI*O,XO^ MHETS9GR8"SA9<.)6%F.9)HAJ)[+\W"+$=W$2PE3UMM:EI.&LA97S[%HIZ@F_ M@_CP[OO'JCCEYUG? VYI&K;BJ3\@3>L/F[],&!'L1V\Q);@ 9$J COF+]F^B1UJEU V=VQZT)DS8L.F M6R%61P6( B"WCQ"^WW_:)\.#D[COO,R*S&I^@KTP_?C$'\.%3WZ\_&B=\Z>HH-\'XQQ.NXF$_6L >7O M.VD%?8@+?(;BOZIK16.M[',>//S"!:*/L!'EJ1ZAJ8NCN5/Q?.D_&#O"UV%" MP6VP@QK*53G?%W_=F%NG,5H9V=I^J6D_298&T3$!%\T3)H^_"U]->YUE^3/& M626W+VJF.1TC75 <1!^"2_;W>XH4;&UP!8EN;5Q5\IZ:LY:MW L2Q#)SH"87 MY(^ TIS^/QL/(OG MXAE5MX79VK3^T<]C%KRE ML?)_"7<^A!]@R M5DEZ90RCF]F_G.?M]8RBG%]72)T;C(/)-PR2K!B2;YO-HM"F0R*#3<=$8657 MI0S=ZTY5Q)ZH,=K#Z;&>#LN,=$ZR,)]?L7PQP[G4OWI1N' QRX[04#EHAZ I M& Q8M@VL_GE2<3EQC#V"^9.37O^X7L]$O,='-VV?W18K_+ID1'&]E\OP(+,G M6.84+4EZ7!H]1AH1D&6!'(.S1M -_O:%3)* ]5TRE1_1]9:]4\F381X1Y-FD M]5NB%6OMM?_-JK,5K-\\['EM5:T/]$LYX/4,S(+3=4^T55F,R*TM^3Q#P2FF M>BX3M4XQ9]E3N/3 PTS]&7NI2).Q>#$!KWNV3<>ZM9U=J]>B<.)UA7VF"MX6 M4V4N_Y-O;86[[C(NK8 #70-K/,[NGR!_KN$$Z<_&?^&CM%EX*ZY8A#527R6%H36N M>@3X>9SNH%26JB$B2+ T1[KLF!R)=8MV5G6$?-I;)-RPSQUG/PV4;3ORIW^V M7M-__JUYC!]!"*.1G-4VN6>@7C(S1QKUNJLJA(3S.CEE,HLS1U]%/N[$!SL5 M37SB GQ>9 G8=:2C@T:SSB?!/&F"_#KU*;G$C@N\>1#%!4S1"]4NS;._["6& M=&GBS&2PA8"*HD&:;]=Z?,/3#3UC86<(!NH/^4F$,T=7BX(]/>TB1?LB\.93X MT)RFJ\(OA?OYXY)S^B DS.G(R[<>R&3)9W'2W+*&-9M(C=[ELQN9B5].<$[5 M.K>@\,@0C9,%\;>([QOHA/X61G0LP^+)K%D!Q=#6+:MJ$:#-VE)?U:+&R'P* M*/@B=8)#].>4UBM<+B]]!2;PRQK-T#,^D,;!Y_,P M8=5.QV2O7IU(3)SOO/WDOGB\(?SRT=@FT]#DTE719@@>3/-EJM$J,^*4P%_;,ED M(9.M2HI"R7G;\ 1G:)@9._HKHYD+_PR8\+5HDYE^F/NS\ JU(J/]5T1_ODH1=T9@O,V(\P(&:2BPMV&W MA\+HPG!K^K 9GEFQKS^I?=Z$(VRY,KBB/*\R3;NQCA0.;@Z^_#U>[^%J_\#O M,(9K]K=2+C!1"^5[W1:T_IR'# MUMD1MGVG!YD?1SY"7GU3^*["!89EFM#NY=5E ]9K?\Z[8:U.OB+; D;3-CIW MYVRRE#_'MH>E?FOYMFS5+DJ.C$^$:=L'&M$1XTP_:#F+URUGM,;#Z\.W@;PC MZV\6C7JJ"FT^0P_@4[K2Z.E4PZ#:JX76#YQ[.R(PK#"[,TV:^5=Q+>J65N/(,)]42 4BJ[*DOG1B8Z "Y!@3D:^A-.(O1,GA-_WCWZRN?AZ* M IW"3?C!]A\A@-*W&1X.Q(>#_\[);9V&"Z0G@DES\2]G$N59-=;^*Z'^G4K_ M.B7:ZT:5KGB8^:;0SOL%[;I%=[U.[+<7B^_<=13>I!>G7#"SB*E6B=2[/N:, M':9'?!D]!2KS8>]>]V2.]?!J5T^!S^ MK&QZ.!PVM? M)2Y-"\(9/&-[^A'\85V"I^77:E33 X+Y"_O2%R9&H(:BBLXT)/79"=P8+&]/ MFS-$@&P\ =',N<4;V"PEWWBG7\GQE[_9_)?L#O:))7+3_IV-Q0HVL!M%J)"D M:OS;2XL6(] A7#LV"-%T;&>EA5.JL*28C2SY%>X!/8!I#;>VT15F=9X,V@CL MGR@;7P#MMU;HT#A,FV[@*(:JGC]]KH0C/+.^86RO@]L5<0(R;GWE[O^,/%B M/ CC#W"R(S=8=PQ;>OF1T7AT";%S!;7W@X DO7C\\Z[SRHFPD_0:VR"33:/D M29)](NU%TVZK4]K(.GL9*1$G)^H5T;++AU&YUP_:#2?5+[!36#OBO<^2#"!M M6#!U"BS5S*?^'EF^:-? &)S)>;GZI%O%)L#+CJ"LPI/EXR,<4I!PN*1EG[Y5 M8B4?;S"3\^LYU^"KKN5C=I-3I\6 M_AA(X-0%.\$MNU!^)Q>'_\0'.1F^(%!_U0E<%K6,?ER4:69FMKFYTK2%9X"7 M$-&P#]C\RQ\S_^)NZB9]FT%ODN+Z'MVH24QV4\0[Z&^>F I+&T$D1'_>]; I M&=D.0W(Z827X&JOA^6J6X;I%@_;.1\XL_Q".5S)3/K@K&GXHTM2T F2I7J61 MPPGLP(R4%^QH%BPNJ/BHZR[XJ_S<#$ 9X(%!$J<,*W1BUYRKPAKR7?5MWE14 MA+>-7O@C\GZH*K&XN9)OSQ^\=UNR)+'M]8J! 4O4+U@]D2FOFK[^8)L+PSG, M:7Q@A]RW@JH_BKX-]/2G1J)R;5SC>VSM;77=W-^7E9ZY 6L<[(()HQ[:\7\Q MD"X**]_\&4AP2;XLQ%0VI8_7WZ2W,(U D740F6GZN!TNL?'H2^.)(%[?D*DT MS86M8Z).F/'+UO@8W,9180^/J+?]J4TTA?5W-($H]\2IVGAMCF3G%S;P"1+B MI[B.]\O]VJ71T8$B%K!!!I&3HY,B[*+3$G>I-(]VUB431(#9JE=E)NXY[ND_ M)?*&_YU)R/YS?\54-AO$@D4P9UP*5]_:6?VWRR_I_W;H:R$) @11EG^K&<^] M55.Y5=XP8\/T9P>V\>2?Q4Q/U@;[<;N4__,4N*+=VVEIZQ#:[*FQMO ?_Y:; M>.:/&U7WGQC5QS3=,=8?W+5@Q?F>@%":(@:;WJ%N9!MK%Z@-C_R3M;*/,]E; M>[Q;G[VU[:LT![H0"=2XJX"QSG:=[SQ;Q]%;[#_G$42O.EG[][^&RS.<2S), M?PJYG9O[8:]+;MXJ,!>H;O)I.$;'(G?K.M#M%KR%&YJB-% M21)=_'1\Q6G,CXHP9FT#)L?87K?Z?8FP6_OR8/*K3W<:E?TOI;RCF!F"8(T.?- MEE;;!C;V8=FDYAH$2M07U410RG,O5X]<9F[#0GK7O2-6ZH)L3')64*#\Y7;5S%+Y.(D;-P@$$OF60SG J^-5+SH3== M<+QT3^:=V6/2-\?[3H;O]96HL"QW)3:E%O*UNWH<_1J M;BN_'_C\@H/[X1; M"/831QF!<:Y(]$'MQ3T>R%PNL,+^PD193S55VI&_N.R<(AR%-W,!L]@I!B+1 M?'08WK3:/#ZG)]M[CZF]*L>>$N)9JUA(_ME].N+)_'*1>'T=[G=V\JI@%MVH M0<*\H>'RJ]:F@B"^-_2 MHY-&Q33^#"NAP32H&X4X"7@7EAZ^[.TVY'GW,G9U1%5:Y]T?U1!U^\"5A['; M=!LDX7:G=N;^[6];%RFVPN:OZP[:GX("D M<8&D )>3[PJ@B"KJ*':K-M4LX M<6;WU#OFB3>#Z)E+ ?"DS#/R:W#V879D+;]P853.N.XK $,[72K#Q(8FMC [ MBU&4.#^Q>)D?QMZDU/@#"2KO1[]N0AKJ(:5+Y9'.6;,TAG=\KN >[[63&R>7 M#1\ZO.].14P*$+O6DXWV7/<8"]HQP=:85%9R<'?@ O=NA*7G[,@<]5M]L'E_;P#VMM9J(U&WRV8(L M/:G+(I>3-1$R%OU%J@%Y,JDZ3MZD%7-Q]IX]SW)>1L87+,W?E]1U_+C%2!5Z M+[3TYLL';<7W%IDH2\X%@4$=#"+(%J:#,CLSY\X.$&LR_VT?7V[K_6U]D_-H MZP^ESW:GU^6MZR1*_YSCB/)L!S_P.2_OW MI\(8#/$=V\/Z&Y'N6\N5W3D.LN)_X\E.<];8IW-;UV!V@"\H"MF"\)#^$R3) M-T'&; &B4O+VU1>=.<#Z[_'^ XY;0R)3_[H/^"\,W,(+R7]NO5R\BR-E;Y\I M >XNP6?Z5L7B*(O2MJ@#6]DKH\AJR8;HO*K0V.Y*SU@+; M:W"P4.6):>/MU(YU.0WE(&?(\!.#IKY"RRF2P"'9#5.V0A$=Q;R"X.ROCG2L MC(N6B'/"[>D.-$:EW\*YG5>"$E7)5O3YFS23 G$2+M9C0WOD@@!]<[!UO$3O MRW+Z8LTQ_&E;FIR KF/&=)>#10G9VA2M@SHA/[M>?&V3@GU17/''ED M/+QCT2C9+#BBVUYS:7H]O%O#\:BKQXGA$77F=>'Y1R.ZGD=BY$1N:(KY%30; M;G^[ZK]6=D,B3BZ7)2!7>NJ/TBGY[C&.I(U2UCP%3HK<"^M>J9N M-6*-\X1G@K*!]?QR>N>)^$D4]FYLG5@^W9I]F9(/^ M?VIN+T3[_-;5J:W\0C*XP@]FFZVC2>/JQ-L?#E#'#/.U\E0GV#^DE&M&#BBL MJ?]$AH6%:AVB6[>XMUHW*3E!5@=@HP2.!@66 !.P;%OZ5BS/7CERAVPAO+F& M>!CO_?&SJ&#C,]&9W;R![EYJD\)L5RYP(&BWB%HFQK,5Z@I[\Y%U8NGHRE7Y M(KQ_ML)5$K1.AK5'(V!P,N>UQE7/\?TFXW/C.M&3;XL5YQ _4 A_HN*?RU\I8*R^[V'U@0'E/N<-)F"EXR 2;$5JQ!9:FH.JPSV[ M^Z9#A4FOW"I@FE=V!X337K\/>V6SNZ^$&=\"0^Z/[?#<0HVL]+>-VSH6I+]R M($V047EJ+76[!_D@N0G2?9B(L#.8;V[E][SKRK%_*C"*_J MI##WLF[7\_7\&+;*XP*I@QXHZ?MPTO3"89H\R5/(V])P5I(HP/XM?(+S_4L. MTJ5^!8GMXYA.M2D0\>0?7& \-.38;.!YST=[6(P24..DM^+.#VH(%-'A8Q_Z MRFJ2+UKF&XI=9XC/YKS.L/R9A%)QEC=%-[X1EW64';;R!F>K>M^U+8#;_M[& M-KKQ-6PC&\^]X3R7]*/92;W"#4ZO=K?[X)8&Q_^]Y4_V?3,'>%R%S]XBX3?=IDJN-9]>RIY MZSLB^C,[,)5;4X>DHYJMT6%%(@8!H;:60<[CA3N;:RS-0IX,]$*>O.BH8^\/ M#F2Y(.E)ZLP64#)!T:;!+TZ [A+'6*.52%:7HFI1*8"?HQ<7X!MVCE!$S7_@ M>'VUU%WB3"S4GRI%_H5)Z71GCC8;RJD,9UAR^';D, 7TN8 '(25(]V?R,Z\Q M.]46UK+P"H$REIV, WZ,4)@Q"^R]N.O*WHV?OA5]=)XB"0TP._5@Z1C5>UM1 M>'J;!6-C+H$!J&[\2')KS;=YK^C.WGH)SD:#?XPR4XP+$)X3C#AGZ0V<@]27 MJ5*#'V+;8Q1$EB',$BU! ?9J.RP!L\=)S[VH@$08P"W_S@7TF0'K>8,IA =, M.5../:=U'^9Y#,H,%]N1MS*>EU.*^A6P*OU0<_#Z2IA)M7I%K'YG583X\T3" M:/AF92J_CX]#;:.>*(J$*XM!SWB8K_5+>6ALJTM>J$/[N9Y\DVGF/ M_J$7L2,;2+H#+@2RJJ3.X6WG DW&7&"?UU(&)P3DCY^J4/3\]5IF-\:?(5 X M#DUA3R-/!AR3^Z=**1=X9L(%:&:H!DF6+!=(0W*!4UE@\&*)*U0]C+]6Q2N. MST;8R0"()*<753+=T+6+=7Q00S?=53EGSMO(;5)O/4]2*^#/B3_,7TM*YG=] M4AXZ_T6\Y654QOAE&[?[-I&AN_%5?PAZ?/.>2%I%#C^96+]'2V .0#?MD+9< M8$$A=P06J%AC]@P9&U#G0L(VP]K0VQP+"KUP$UOZ!DN &K-H6:!%\=.X/O* M9!]P@9T5AW1N9.>7*!D\!L3NPX=3VAP4Q_/>88WVC^'>%44 MN^'IUGY5EAFC_)WSWO*7#SI0,#_P$LT[8XQM3U[8&##Y\SV*W_^"9L,![:!0 M\\C-)JBS.E6YZ9B.//ID548IJT,2I(39ZB3X1M3.6KKZV-U:O_%Y.QF*R,#R M39)[\EXV8A5VFQT5?$3;<8>=+^I;I6!^NPQQDI%\-/4W*BP!LA\I4T)["-&D'VKN^+A0KLE*I1:=EZ0AFIZ"EN$"H M)MV<"UP;1OVT);#,(4LM&#[4OR8+AV"YX$3G?='3*#\'IZ&V7&FL]UA(.+A0D<&NA'G*!GV9_]4[>6@HH75AY:^+[ MM97!VM,3S(882;0P.!:M[;&,@9WG@9U#Q]#UPJCOE:@E>7"9Z_+#43:-J*Z6 M;=\[S[K-?L/B\?H9Y%HF*6(@Z7193[HTYO)KR$:X.B]1#Z)V%I9L&4]%>*GL MWX@.QWPAN*\T*RS#UK.7E%F@%9&I)SY&095Z7#G]R-G)UI6G6HE-0<<,(U+T MVN+T[!:+_.AMKMIZ4JV@J(%9>7Z%V%DV0/81(C7,'3*;)AD;YU["SN?("'_M M&'9PPCUFA]9"9"(X&JZ/,4F#MTR#E%D[XT")T6:Y6UUP0>ZBXC>6M+")97S+ ML+7R@MM23[M^:>C&=?6$UX=.][*SC:_[)] ;<]6@(ZK)Q4& MT+9G?^&Q;O$X^3_/GR[K[,87W*9(%X?78-OQC0VVEVK;[0G_N2Y,DM-#Y@M4 M'H-%^B-# ^6[3W:U2-^L]BR^V'PJ>U6>?JDQ4O!=C)0'7R1JJ WX- M3F.>4B;I&\S[+0&G&"KS$@E]SJMW)RYJ:S65*[/XZHZ*G"IYG"=7GEX3,WO- MPA!RDVZTKD[W>GXD69VA&H7[==FZH^('S!KVC(6\:9;S4-U[W1G1GT-2M M>WYUXPTB+EHBFH=OYL>MBE(*ES8X!PD1%0D6H*JTCHFH+%^=I@I\KK#L\MK4 M$<_'Z:N*F@6R[P96<@%=OO*6-!&ZQ"9+NOG8/8CY8VA MPM-S0<"BH?/%9OZDVU\KFSJ'CJR7EY!NYATJ/?\$EU//SVD8E::5V,P%GWQ+ M]]0/O*"7WMF70=128]LLJZ[F+*PQI6=0>]T*UPRM+WBAA0")3L<.M1Q.XHL^ M+E"&VF?Y/;M>5^Q]:\4^+1(7^+HV>T_(*[5@F1S&!4K#GFH=U1;K+3OBCCO, M@>'ZC)1T/2K=8/3?A.=@^K9\M^O75L[G74(GN5,[J'J*!^=DTS]\*&!;7N]= M:W=PR[.R@8M,%Z@;GW[-.*.:ILUO^)1!'7=>N/<3=K3A=+5C\=+4!_*9@'O5 MI[1FC"!+AQ3&D6^@I3(16H=&-"J\,?!>@\"$@2I?]$240#&NOVL@;TY-C5B8 M65[Q5M<3<6XA1NS=N0N:KU3GQSSUZG:DA11684W/7_X6P!_ZW)=X4; \#LX,5%** MES_Z'275A-4Q2ZTY:+*8O9A5-/]^?#$'N;4OMLU^5V'/(7N\4&]2E<+T>AV& M#W'6Y^:TV2."SKS)FP?6(I=JQN*+:99- _['T+L94P];%9S;GY_=2/DZDTXP MK3\0^'MW_7[Z-?*-GFC[6WMJ:A\T)IS;\%Y?E<1^ZB@5#D67YM#.]S2,5=7- M+G@D.2]X+-4WMQUQ[#Y9&WU0P4BZXUFF5!7?%5;^-.NXS06< M5_C$U-XK2Z6>AZ4_F*H7IA\_3Z!T%BE1$Q828(H^8\7F[!2;S@6#K-W]W:N0 MK3%V;8H:_84I?PV@E!/2^SJN$&KK;ZYKV'#$^,>8"UW-0 M#7);@)RF V'Q5W*!B;CY1*$'9FPGP@JA#@3Z8[K@"+!;*><(:DEI@@M$F7D& MMY+Y'EA EEXW9V[85'&!@K@%(9/-3C#A!QRXNZYQWH0=67\$-LS0RS!R(J_T M\,*W9VA=B6F\FZ#=G MCXT$9U.]8.<$V&\3U.L.G].25"O-O8D%_9MV/Y6'H&,I&\_+^-M3]A:YNS^A MGXI'XMM72G6.I/YV-!86OSE@X3*XR/IL&-P3"%*R&)N?"UZ<9I"I=>^UO=CO M7S9B=G* *7E!W^/75/$75,.)0(6_>=ODWVMRXQ^OVF9(I=TPU;_6D/(+[= , M'8O6 K/O]PHN$/OX+^;WGWO #LUD_"NS3$"6OF+XN,",#1=H_8L#/("%H%:5 MN,"O+2\,T!0*0@J"=$KTY.5C(&KO>[WE/^#*/=ONFP"VYH=N-]YV#_]_W./M M0F D\PJG;52@1^-WY<#+H#LYC]SHG%)/ZJIT0-<:!@H$"0PA3T4P(\L)-L$7 M4%\C?3CSX#!.$4[57N4"Q[%=FS/]ZQ<5X7&NK8:C+8F1;\R3M.7ERN8V#5+O M).??=#]9X?9UV(:=Y"A4L8L!QD4#]' 6/FQ!O R1=_?8Q\ZN7_[H+]5Z&I<1 MV(9ULH"=N_&*Q$6)C8A5S?D6>4XLSFYFD%^QMJ- PLOO2&UYO+0ZXOSWC(A' M/3;'9I?^&VWO&=#4MJX+QX6*HH@*B( 0%;!0;8!*R4($1$0$A$B-BM0($>D0 M$A7I(@(J"D*4(IU([XF"]"8EA!X2>D\H(9#V35QK[>_N<_UE MZ4@[S-K7L7[0,5(^M:(GW]S>OMF(8KG:SC_X?UE"?*[:"IR8>@,_G8[<1UOY M69]Y@[0(GH9]'IQ N4;F(8V8UYV88HYFVQ&E51V;7TN:S=E6^(U'X([,LM$, MW2%I<\XB"(5AB1!V9XVIG>*OB+F&:8*>95HZ088PO.O\.15Y$_IZ*YR22*84 MXY-+LG!">^*4#O^FNVWC>-1.W]1:_Z_OT9-3N[5(R8024>;5&(S#J?QJ&3E]"@;/.W MN;/%=XY(; 0Y#(V8OPQM9>X!C)%"K+QY-@\+(^5M&D2(KC"-&!]3LX XBJ'>1FSR 4+[^\/-MJ$QQU_W\2\[*V=2(A@]N=OI(RIZ M*(ACB&Z +/>C9[UJ )7Y!F'%\>MQ<'%_UP0#V]" 7^^&L/= %_,!:'+;>=BX_=(1,#@Y3Y2A*C#.-SU7K M 3)QY(= >P?F"1=TJQJ=#.-L8LN*ZOT@BZIC7K3E']&'[LD'+"F0F8]%-225 M/HS/)3:.VWP0&VT\M'=M?J;-I3&9'QRKECER.^&B4+=4X*1K<0O[/%AE[3@N M[I'7Q@9+$/$=/8 [2..-./7*+[XP_9, Z6'4\N9[(^84'F)Y,<#OV+Z-I%+B M@N,"@&E+&&@JNK92LSU.)L'P\O)4,[.Q\U>IW,1JPN!3Q8R:EZ$*:AL:DA%G ML'%JVW5Y J?87Y%/<3P,G5P;^62;^FYVK""'"QK=KJ2&1J%_:"+W/$:>Q?IV MS$'6HAY.+] 71I!IDV%T!\CF@0K,$+$A#HXZV54MG+&4<+>_70A99'!:Z_EB M*:Z$83.6B9) :OQ25P59._=E";Z;Z?:*P8O(PW_%+WUKT;#'-AGD7-TZDU)- M"_Y[5 KX'&J$)$#\B><_03P9[=7P[H0YX"+4215;YV#,.;P*9]P5.V@DRG M'V5 S;OR539]^CH/W'MT5FH2\GP*+X%T_=Q)Q@BZB'G]=#WV[:9Q#/YE$,PQ MACB5(6N4,>%WN=_EZ\.N6^DP8*^Z*Z3S.R^%2% MJW07.J?7[*V1LPZF>[$QETC/.4=T[ WPAVU.LBO9?HUH6?4UK:WD0-"J0+_/ MV&%?[3IWWVF+[01W1Q9XZX\;^$M'VEGH90@GB$/#YG['OF@KZ*@>N0SQDF3S MR;Y%-AKK"%,DM/Y+K/T/P6[<'78VVEX.)GIOF)%8VY=SH$#2OK+XU7WK ^EO MT0&]/EOK6_AC4'X:A**;-,9_6-]-T5PM2R@L=5A5@)Z#W6>>)YM]M^SB)[O+ M@WH3N]9?O1EQ =65*E(7>S M*';C3J7[L7/7*A0-49]1[?@B'(8*J;O?7#C_LRPS+\!7")G$^M"YL6-^SF^M M,>Z#W7APJ+Q7G-JY?I1/NT)4]#,,SR7,"\F#-IIM"ATY3S.W@KD@OS2>E*V3 MTY/"\\4^^S1I&)J%T02 F&V\ MV<:36=@>UC[ 2$T3T?/=&TD!UT"Q LQ'=_&F>M9-;%N3EMSF(9@> M\O1OU+3,Y &PZ@T/;"V$19\Z5+? M8*!]X_8=GTB-+\5J H>&V&5UW:YOSSK+6U287-F$?V8@:)%6#)]LV=RVS*CB M5#2_KV9<_C88T2B.$I=SV[2LT3:@J<2--]F5]9;.;L5BFY$Y*P5U.R%@$ONLOX&'FLB9%BCC50C_5QJV[=15U$)5;%U%U9F674?#NS2,M,N MEN/V^MYJH=8$@J]YUGC6MJ$,I93A>0AJVXKMBUKIJ9D#XQJH=V* MAIJ*KK-"+$MN_)]:FOF(D;@CEIO1XQNAG"[')T/HE\1>$\5UK RCX$ODB"8B MGF$(0KG/'4P,:)9R:S<;2O>"'2SV2)^/4QS)AL>AUG:LA2Z$CFNE^28N/&TN MD:YEC;*@(RU#1"^4"4N#MC/Y&$TYJ5ME^,;%3>(L\1E2!QQ>K>3H'U7QT;NL M[QGD*MH5$[I,C@Y/".XU7BRK>O D%''4S6@>=I$X!UY,I;:KVU.93,L]/C;] M*J)5FXXL?M0#F%7-N]X8U98?. P5-TDQ& M"Z8P "Z0^HT+N"#J;:/-O8P@3G7/9B-,-1&Y?^,;I,YQY*VQ#M*]=[M*T5=U M$0^@UZ K5B6;T?G M!23^ 8#]B=WH&>4A\(8C1ZE+J-1Q^V[NAX7^[A'TVVC !(L!< /DHBF!&Q)O MP;GF=6@ZG88!5.P7$SH!>U4ME\F0^NG_/C1[J"2/_1:[OZLL>\L_J)^XB!F' M@5&C:!"$+$^=]V5>+R%ES\;8&4@+(V ,7@ ]\0BVL8T"@E&#,^B570"_G!^%L'="*7IUI$W1>$XE0/R^ M1+#+?@&T8IM>$JO16WLRVU'*J^P#+>BZ\"\Z0M"0.R:2;XM#TT%(1Z8XZX82 M3:DA6;P\\4E%3?(];56:?'3C9"6N=3Z!]9;A,]Y;-O(:# NN"&)>"\:U]F M$Z'N%I;M[FI[R,'[JI(C0,W*CNK$: Y!4A7&@SS:-ZVO7I78RSP&HT)J &X= MDIW!>R4S/\4?K, Z5AP_WKCH[DX1SQQ86Y1UZ$U4#Y9%>^*#A%A'\']^_X%] MSP7=A^U(XB5';80OI0[Y88??F[1VQAV2A:A>@/96Y'^ZNYG]-"_U,_T7\%LJ M_C4GX]8J+!%=%EU71\:&Y^7^D!RR,=[5 /VZ6@>@[SKE+5T_42P&[0H)36W@ M@O9\K7D-OK"L']=A2FI%O,/336V3K6#]#T^.=NIZ$$,U5*);&UPC;0N8BLA3 MD*,H>>=*U[;'@SK8+;?/1BS:-4TCAK@PC"'LQS]^]&,,CCH/ _2%:H0-E2/# M7FYHGDHXJ53"?&$6#3LIGQU=S^ID>>-2+_UDRBK*>3\9FT6H!!KNW.O*5W\X MU_TX7V;.L\^>(#, F[W4N+_MNW;MI.2,COS(&&QV=S]9MQ->D51Y1IB6L;WD[<$%.SS?YQI=* M7'7-1^A9&VBBMNW$4S_+%0>T14IQ!=,, +FB3LFRKW QV8-S?%?#[/?K]7KE MU;6CSC#TQGG#U46R]-SA6=:#+5$5TB'7Y):-!CKIW26T2,L9G&+L943ZYHE> M8>^TT&]HHSP_ E7YS%R)JG4A-$BS8H.899]C^-<=J?)S7 M#Y,'9;:Y@>R4AQ7DJXQA99RHY^8*LDW2EW44TKT&JYE:_KMZP:8\?YQ18:YGPNJ&.=Q_B=$%G:!U3KXVNQ&F%%2E@?D0= MT;""ALAA1$8REA^1W[<+L JUY]E3+%X)5)"$4X-:-RV"Q];!@P,F'M M0,;(FK'.D]__T-4N(1?.:*6HD?8BS]-VYV5<(ZJ6]@VEA%LY/[QW !^%U((2C*]"F4"%[HW(\-YG^3ZF<+247MH@:'12+ET1N@MM$KCG6>&1Y9R MDODP7FK/G$BZF H#HS;;O/B ^?CL2'(829KQOT!G&.BQHYG2N MY2F%%/B!#[ 4!#8NY9BQOMPL&@\_#.&% R?MLV"J-/72!+!DUS$ ,^W7!,R7 MCH(9>\@O5!L5<28+0'W:?^Y]KD<4WMQDWD ^I3F^K/;RA3-,//5V/&;3]=F"N*B#W@Y.4X!Y#O8O=Y6!R8VIVL"O@] M0B<;@)HLYSXNJ+CQM<*2%'HQ!Q,3A,Z-8\&-%BI3ID-7P8#.2SS:.P9/:B^3 M);7\'2VJZMR:@\]$BW#ZQ4A1+#7$ _2Q0ZUB0GX/3/9_7'IJB"3ZN=-SLM(Y M3#=L1LN3GKH?67D6$^.G12U.Z?R>CK:1[_< :BS;W Y0N:!1A= MK/B(#32(Y15 SDD?.OW1C23_IKGEG$:8,GF\L.FAR*5+,3-WZB\SB_JW4L<< M%Q5\R%E?OO5.K"K@EI>/$@C>O]<_]3 4"^5?V@4V51#+JZI)=@>(W4 M6>8"8@B,3[^\)7+X=F1W-3^.'3A"*_K!!2%ZEL1;.6*,Z)^6\%G_M*X+BX,- MSRZ:15PH9$]B2_&/P.'7.(W,PQ2CQ*2JQ!JD@4U\+5[48(PD9#DBG6CJQ1=C[G@!Y-_/NJB_FWI5Y/1JNKV>3X\B8T)_XA M"FMQNNA7;0G$61S\;LTLR=0HSJ Z=B\4OILCFP7S3UK7ZRQQ=+@:<5;5]&#Q M/Y6YV_/R#"H3*]\G?=^NZ$N)?%:5U0O(@) RNDHB<)4+VCG!!;W!A$'FVR&? MO*@J>1L/L3CTV"?,BA"-E^V7L?H:AU!FB"[?CU\:V+ 7,H9)>OWF'_Q,=W0S MUK>5S?Q/>*Z',PQ;@8]>X()0P.$:Y,U_8#\'@-('%\CZ&F:+W[N1#6"OR/\2 M"-I^09/W+#WP3=>)/;W+0O3I4N[[3"&[K&RE<'BP]^^!-GD<>:"UI?!G!=R28QXZKP!(XD,3Q(Q";M0 M)?_FILC4"_M):?!M3FK$;#'3P]D.P?.TZWK8#?K1_(22)-_&1$\-^5A%@&2W M'4_3..OT6:!>("Q.,Y165V^P8;8.ST63QF&9X$)H=.AKU*%^N>;*>2,[^.GV MN-?9Z PR[ .@XL'X 8ZB;ZPGLS7S)FGS(+$'0C7J#'_16+_B=-&PE-]>QM_'3.FP]LN(MDX ]!5V(5[VY6V8Z12G^>A4:C=<(%C*/N^ MM^9;BE=JJ5P08UZ0"]J!;6:F7QB6-]CX6$IN/L\R8$$+); MJ7]DK"DS9K^P+N&K&=/@(&E=JPD"NBB-#^_ULFKO%M^6>MFA5EW/R1[3!,^* M[ :]6=@"8NS!&.)9PA_J*)N&M SC1 [O,\PFOQWVB;+1[6]!^CV+CUWC6LI* MPT^$\U)37NW8Y"N_+3>=F%#LNURC7P&"%SG&I@1$'@ XZA!J/-[\CU*JLK;3/04[CACEZ-J V8P]1[M MW3#*/N1UH0T_Z8)\WLIU3&A;':<"ZB;\U.,NVI[7=*&3E^%"_($[VNVI=I$3 MG3'8^#B4.22T'^/15^:44E[6^SL0=9R=QCDWQ)*@ZI2LXI24]_TL*K/>^.$- MV6@YQ 7]D3]-WH@8HW4&78KRWVW^>FO 7LU_]TP=]3Z!FL$26JXW%3C$@-P. M'VKND0K(,)N=JL+"&'P"S+F:'#H/K64>S^_%OW=B5:8[']D$T("W05+K_+91 MMY1.B2G[U^B(>IRJ IMVZ0A/[Y=]G?/5:OZJ/2&JV^\]\?RE"RPD090D)2< MQ2^V7]4.+8X;;J+4#NUYJEN7F1*QTKH=+-"\R2[4/*>?:E4:9*_Z/@:[_-%J M^;QH(QF6O/4UZU2Z9W>5VS!A 5.B%Y'6A_1#Y@Z5=2RA!6W%M_L9O71?!A35 MU9L]C9?M#Q1JD>N[O&=)P83L74@05VO%'+"52[VH _BWOG?4](4BYP^QIC+AUK M)^>&J#&Q&&Q%NQ\[J-M]/#IT!#EDVJ:,B B5[55/X.U[_'5O8 M*2$'K/DY; 6Y-R[56?5%R6/O/;GB1QGZZ!,6#?+(I2.NO#%9&,_=L'74W]N6SB3Y =?UZ,+E^*"Z'!J[T;5VY%BXKE4]'[7$XU3VN"&:M4?&.KM M=@,S@NM76D.1\Y%H\= XH^Z!48OOG-U/A8YKIBIOJ,1_M70:M,]/>K#3N\\\ M1J'ZX/7R&^/&)7<%_MQ]UO%HB_)@L CZ/-GN)M>K9)>^]?. MD/:O5_@L>H<%LS3MMOB&&9X<=!UI7S.;K3B OVR.Y34"[N" ^R$2\+X3SO0^]=4+N:[HJWSE$SOWD4"N :I_;]A['$.&XP[YJ M#:;RE:30QUYG[TZH=RTIAW-!^TG45L[+&B4.&TS#WCK=%R?Y+CO/7+;E]FAN MO-!ZP12>V@YF.&"HOP=SM1+CF)7(36A ML@O($J8>IT/R8.2/A\M__EI8"\CQ]G8L,\3='_I%G+9?@]A7)R@MG;=D>S F M^JDR1&8>H"@ QZ?QLD*PD/E4Z,"C$L>KKOJCC?&O(LR=A3*_=L%N^&EG_O]% M[B"O4W,W?W=ZOH\ ;=?8O[VS&Q_*,O0ASS=-E\7$"\^9KU@@KY+?P7-2 MEGRO[N5@%J&19C5*=S$&E19C,>_>E2%+IBE43]J=R=C>A=0PSZ3D1AQ2B5&0 MS5+M2V5/1![67[T^( Y?Q@:3A(J7PP;5+_XXF==_S M^FF3S06.3!*WG@?X(,IN++7G)U]+M_9D:9_N0[E5UFTQ7XN56QLGE)5],9F> MT&3D&08V@Z7;-1Y[Q=B-H#LQLE&.U;J,IN$!&_9AG[^,I]NC4U#/-?5_N MY;C!JDL**'D'# 7OQIZRR2FG%,SP+ @,G!X_?#WG\]Q%5W-F56&P6" >B_O]HF\('[/MFT8&W7RP_Z(YCJ1:*+=@L9 ME>K5AN*:GGZX.=6[ 5E#[/D9@^T@@+Y()^7(%,G*8(;*T:34L@=^6HMDH$,@$8-PG N.0:+LA6GS6. M_=2.VAW0KT0N6FHYDX)3G]UV!^KB= I 1FQI\4SZ?TS.9;#+\1/$:GL..Y03 M;T4\S^0!*.&Y7O3\+&1-;#&:6<0%B M*4^6^H '_->4-HPYIK! $SY/J=DMJV&]OA1 MXM0=LH5E]JVL_X)K.3NEI&TG7'A?<0C):D8\K.,$ON;2^3M.YLGLTSU@]VR7H)K2P2 MD2^%..=7>+23R1/,_J,O@R782='ZQ9$9<"YJ:D5DU7IN\"XM\YSG2 <+_T)> M8[]#G6)$WZM,%A#0OZ2GAD:+M&^6/"'M@]C#HC1Y:.FX+^ @-_(-1;N*"$3Q MCV#9@85-;/%/ P'YDQFB>2(>KX/BBV-CA]D6*3E#Q7%6#=V-DS?O'C$<& QX M%5$ $_+>-L:B8J30W)+U(I%OX:A&+XD)WLJ;H;)Z*WG^?ZO^F^ZN/\'1F&+I MIU:LFX23<(@]/E?S,R*LZL-VV+H0LO"" M(QD $6,,_E+86DB\W>T 2Q DV+]%!S!SAO :E\_[EC\XT:ZP)94?S&LVL@!C M1Z,?=3*NQQ(;*8(LAQHI)7]NJ!QUCY(*X( 5()21HOF?A=J][!*@>N,=?2D'NNZ5A4,^/_:K1J!-$UGR&E5$=8#RA>*F7=) MTH6H9P!$ZA('G@O8)&N(1O-:)E_.-$[;/ M"+3.W,1^_6%1J+>A9Z^&*T03"KK?OS$AMB5M2_(?WM@@W$YT M\QI\.]0#\Z7_]79U'O,[\H,@$]9XEF4!!?\K((K59$Q3$J-WL12)RE4VM7#E M<"+"F#FQDZ.;@]S'J+&CQ7^GPH^TY?CL2PQH@G(L6FHXKZZ +?/UGZZN2117 MS-XUUKGQ8AL(22DW(@UH[/BZ3OYAF/6MG"LFQ\,3WR-@G_,+#2DJ9U0U+_/V MX:] X +A"0L<^>H2_*K"@/C#.M;YYX-5W^XA<@F3,Z^RC6)5'5]QNC"',VC$ M2-%!AQAU$@5AR;9DW$)3^AAJ?R,#FI'UQR4E*1_7MFX^=LZ__ZVG?2QK1>?Q M*^KJ=&3"O-JUQ0 M4[#7WS4]TLA_16D6GBJ]T(N/&A!R^FH,N^VW/;SP]MCO>*T M>Z63I#;/\+3#>S5WL\RK&($4.'05TI6@56-9C0M^F%?AQ+..J>6<*J+91O.S M/T6>O+HBPC#T\UD\394D NXM6-KWP5">E>*,#7KR\U+&%K23"RH"-^I1"6O^ MMU-5M^1S1::PY;F(D[VN=N7/JYO2;%K@-[UD;KH\&=F;+N, 6,6>'QNC GV* M\M@33K:G9,WB)?@]JG+6F/1O[(3[C/"T8?B@L/\O-M]!XZTAESI/9\%*7/(A;78 MGB_K]MOQGW\]\.;$K,$-_SN\XXA&+FA3#G4*P":SZ+4'6+D^*7;'.K-YE6]= M*9JT E4WX()@/8 J.E1/V:_:V6.[G7.Z#)HE]T^,6S3[:*:P7VK*8$-QQP#!^Q;W6(Z@&?#I!ZY8O<_)U*Q P#:1\E%-W!V M=7FEN3;,#8AI<_J/(HC*M(]1BOJK/AH3FREIK[,CSF"E_X5=L^9$J,[F(B(^ M"I-#=>(&4JK43%'EI]6J=#RMGZKW@ZUE7&OC@1\S6Q9=MJ0X=AH/V:=L\M./ #!_5\;^!]> MDON8%BP!]*OD/Y2^-D[!!VWMRW3FK\:LZJTO0;;6-YVSG,O$#"?ZRNX47VRH M%Y6V%I8*@I4_@CYG>;)CU95H25][4SN"*;OG_?B67@.8QE#P%<9]BU@3[R#' MSZS$"$P\H9SC$$=?3T\"4'7K=#T7]"VZ7N# \(W2JX_%)C-GE8-;5)89^Q;1 MW156D $PI6:R[GKR ;PY_ZNFE/-<4.#Y/W!Y=D]6H*8PO\E*8140^ U^F2ISJYJ^U'MA5V!AM1ISMXARHCEW)5J"[0SF:FTZ;S_ MPK[(]_0=**WU$084.$H^U&Y?[;&.A./4J82"X-17WBAK845@ MV5.BJ ^7QWL)$W6&@KM:XDPY-6T\DES\,"4W&-"5P_^)VNP$>^/V,P!P?;HS M'TU,)P1.:2XB1:E@CE&J+2#05ME+=4AA#9ZLC71 ]H__SG,3&]F7YDB[618N M.>7-CYYHU/' ,. "1,,/*IZ"H+M]<9^8J4S0*=:.,NLJM@3_+=3@R$F*X[$YAVZ4..:9%WM(A M^Q?V9T^JZNZ\'S$:[/Q@+CMFYGI*VB<+Q@.L54W^YX*KBS'2@SJH/N2I?Z]R M:8L>NCBV@-F/D]E\HTL:*&N?MFIFD[F@/FQ/]$O2B@%2G NZ#X>P#[Y;<"@Q M<^K)DOCX;D_ Y:=)@,VPW?%K>^.0BS0I>D4/#@PGBL'[&R_6GS!L/R$!X9N MD'&7\%N[?G!!Z&B&&28*4W"7)%2MQ=/:O!RQ* M+X:"^%I94JVU#0C'*^%AD1\(N$?2=KOQJE[A[P--9HE+Q<$Y,_A7^$*E,-SA M&>\-+FC(&'YDI2C5[_S;%>K%CD#X5/C;W%=Y&^\JL&FM9[LS#"M-IO1B(C^E M=;O4=MT:,;!MGHK\W;'\!^!N9(1 [%ZWKZ:9?Z<_#'M!?Z4#U+8[]?6VI^A= MNA3X,%!L12U,'+Y[Q+;FTAO?>7U.7]%@Y5LYSKL_N*#6/R%A 5O$,',N*(AE M# E5ON$8CC-S@PY6+[@=OISMJK$E\<%_*:ZH?RN(CF 0W,>B#VK;>9V:/XO2 MY832^!"=#KG> ]Z?-"!/:?$*GBSNBFVE4@W M9?2??JVQSR21<:VA?1Z6?#=#UO1)\LQ&7&6E9@F@7N>#_QN;)EK9\*F,OKBR MY&Z[@V9%7O!/SR55V9"6B-W*G;[16@;]%@14RC/(.:0SV8^ED7WK%?[4DEPB MM@!P:DHBU+99<#MG$1F/=?*8B8_5D7]<9?GLS."(ON.3PI]#-N)/[+$%$ ?( MX!YU]QG_:M*I8=T5U1%E6HUEC]?>M:K,I>,.43VI"B!4N9ZTS\&<5/FP^;H M:!.II'.A $Z!BT<+^OH3[,JOM]<7RVW@!X^RX3YT!#OE.&&1W%7B]\Z>+#Q0 MDS-+BJ5 R)Y>6R&[*\] DR5=GIPR-C5W)'\M21UV\NFVLM;MJE3I%BN:7XNG M9[!C\UA0>R\*F'^("\K8WZJKQF:2/<-^GVS2$8EG%9O^+@/B\X]G%6%_01BG3[-> MKB]OK1A-2Z"0<["5#KP6?CO[(TC$SS=#/GFM#F1\Y^C]/T4;?R5;GN/',KU/ MSBGM5*7)CBA-V6%C.'RL&S54O; \M^,?4Y,'_R3)H7-O340P!3E\[IR,'Q Z M;1L@#=4'6*161BZ?MF3N5Y QY15AN[EGCW84&3F@AI&G&%&.--7:(Y5YN1'= M%RAWP;6$P:!ZE#VJ@00V"JK603CZJ;)N+@W9A;@)); 52RI>KXQ>^>SEF[:# M0$SE@9T/2YEISP_U?%=B=<0I)6)*^I\B$983@\D%R7AL!R\@G%?*TP'L^5\X M"!?4;$-39:,!T)G*[T= Q6LSW-=@,:OKZ+ 66_<>+R8P<39C@9CK.L_2QXG%^+DB]'X2F6[+:"2=67;F@0>$U\ *<=IEQD7(J^LF*:]G' M^G1@B^UKT+0Y6I'L,:JWQN-CF^3F7K9#RH=<"1^E-GY-W*6Y?VB,8 U2CVD& M:Z4YCF.#.9(6-T;O>C3N_*KI_?Y$&H+!M\X%>>-:B.N1: &GLLJDYB&$,\^P M_IIQ J.3KMWMP(BFC=K@R,.:PO!N\QT0> _92>%H$=_4[Y&(;M74''::8I##+51 MQU#;S#T<_,C8#=2D=UIT#;O=VSE C68Q53D[!:AY4C<]H!%G=6J,4@O/-&$_ MX-4:7Z84Y#IB;N4L MXH.^C X.4*W#AHM!?K;OXJF]>B!5)K^AO+_>)_>[ M6V,IOR.ZSM77@!.(X8+^X&689T?IT0TF';LJA!Y!.V#4(=O#7! &@,W?GW.$ M_KXR\?>59H&VV)50*I;NBRH6U\ZWW^ ^,*"[HI&X>%V2-SL0V0B+> M4^;K$PJYH!Y36 '^$!%V;0:.(IP-<9U!@BPUDL?JD9GUG[;L&2C>Y35;&!&I;BBCVZN M;@\MOKS7U$[=GP4VA@6KMM!%C$=U6 J=W?@;D/M*4:V4:/[VL:AKXVW5W[0] M,BZ6M?T27 7@/\@N9H&T0-1T#B[#54K$AU[\=]*G#[AL8T?TU8C7KW64@GL]W MH?;S"X$O^=EQ>5:)[G<"C@/WR_RW*0%M'$UM@+L(+'6;#:O@5-&5\!4UVSL) M]13LB 4_JA+IQP7%\,VSB5S0+T.4#B.(HQW/!:WW$OL?H7=&*XD7GNFZE3X" M,_)HDM!1];H:^OI(-'.J]I-%K.?TE8_HX[97$_IC25][79[,GUW=6ZHJ],Y+ MK;;- MY, ;OJ1:+NAA3#Q3M]ZG;OZDC^5F+I%W46KQ]F4>771+CGJ1,'Q]*#7F M*1^Q0?*+R_]0-GM K7Y4!/"S[WQ.S'/:D5A:)/ERY6OGA]%3HM@2"S/"?H'@)WK2D,+$R(NX56,"\RNEZ W__9E:L>LB>OU35A>&6 MYPS0R1@_B?KJ*/%4MUU./.LM5PY3E&/$GX(_B&T&T#^Q8Q>0:+A7OB]JY 'A MRGLGL]+PRW,:K)U:?"GJB,[;/ AN/RRRH@5X031(S>2?';#;@Y& M.?_"J(M>B(@M@AQ$6HP!1GZOBZGEZ+6NIJCBD%P^-H+]&>^@(4*AQ[M[.>X_ MXD^%Q=I4F5A[/T9?9;4ROE#C+1@(K,T]%Y6\?=?ZL<4_QA^$FP_JQ5@&A>38 MO02\7<\5G>T'=@&0;'%[I+?DG"4H(PO=>I6]^^_*VVV"(,UQ)TXW?&$);PG\ M79_QKW@ ST4&N(G^#?9W\6UX]]_%MX"^G*H:AVP7W^+^0_$M8&.:\QF=V\6W M2O];L<8@?@3#P%\W&<#<,=81_GECNPP!,,Q"TVR]%^C%\:F !J=MVVW>\=.+.WZ[9$ ?__;).;_P3L"^1M90$%L[S M#5O]D[3/-#8CBPFE"C0TTWC(WI%9FR_T7]I>)RUCP:W",P2:"$N01+EFK9?) ML+70M$AEFI4CS.9XQ]"T0>:33]#OT(R%NQHY2/X@4IVKK)]]K\ZELQ:6J+)6[2;%49#$, M822;:3)GPGK(3F.IC:F=/?H#(6_^U)5SN/TCF,.#87GCYGL67-=RQ.%R]_K$ MK7S?'TVUC<@^!]K:84- ^UP3VJJYMR4"8!CR06,=W85#!N<'>4W_!.]!_[A> M;2@WYV^;N'/(KC!HRH@^_ )-^_6.2AJ0T MH&#=U6*XU5W7SGT1ELF:@.;)J*0T'-\=]_#9![(M/J\^,N$ZQMU>9Y239#LX M!%8K/#/6-Y'9]/T<)":'0..];ZQO\*?HUD@Q,<%LXLC2R>0;-@_12Q7@LZSY M.MP?G.XM]$_QK&J-/-5^I+;+E$*1^Y3PY>-<4#%_( B^4D?_WH70W(OJLGR? MZM ]-%LYI0QW/C'>&M.\JL=F'>C/KU8^0W1+)'WN,?!85]^A-PX3XG2B2]=+ M1O+R8\;WBFG7ZF4J2:/QL PZJE'1>P@M.K:[G974FGG8\[ MIYI$G,F]_D]Q^PG**\Q-Q,@$47 <'XF2I.Y.E.GXXIO^(O:PI@'8Q?WEUT5A M;]X'?CZ[,0CIC7'!%:,#"J%U*BD.KL(R80FJ]Y[68GA+5&ER1,8, 0 M>+M>0ZSUO=DB?<<,<'R+.9-D#6VM_%KBGGVK4_[5 &<]4)=7OLA,+K!1^/&U MD)AA[ZP\:]*HOEQ96_M=#@&2IZ-?B8ON-UWPP]S+&DY<--WJHF>Q721ZW3(6 MG.DB97]]1E"SRN*"RJ3,$>^R70FW21SM-UQ0C?7Z;,.Y2CUSL=Q)XU.=PXB= MZ*:/G_\IL(P8R14 /GA'7F;R @1FYHO5^F8/X^/\-KG;H[F(%*$*<(PPMG\5 MH_:4((6I(L![&/ >_J]02$6B6;I@ .=,>(2!;\WX]7<^/U;S\R%%Q3RO,PA]L 0<(GFU MQ\M@;W55U=F?!6BOT&L9 Z&["^:5[KY,E:<%KFWFC/[L-CO>8:T XQ9W?;2[WC!SW'97NK#8@ 'W9WE:634C#V4-/QPR M05S]WC0L\QVLCJ8JBTK.FJ?- ?=%2WCQ$$=CDMT43=;'89LV]DK:J MCTQ2$G4"ST_>\P)V]=Z9/+]JN0P8\>7WI$?[#RR?\" M%^1?:'%3I2\M(>#\0-[/E(BS$62#RMB(O2+;;:*?=XW<_GM8XJY[V\GH?0)Y MG;R,%PB!^8/#4JYU^_MV*VXLR&T4$]B9!TQYQ^9&E9Y+1>&<,Z MD+9)'($5B?RTIR%>IA:]-R0>7-N"?H<(>)V@P/:..G67SG^ ="ML^#]?%?@) MS4.UX33C:G'GRB+T11]Z#YKCKS8^X& M&C.T9\\:#6K=8 NF? YY5!YRQ6XS MIO?0FK*&W]27_PZ\&Q?FY/Q1]7Q.]N89GA>T^""[ZA!=L^&H[;!J"Q(JKWJQA'&EO^#41I\JW[\&ATJN+J[%/N$T1R;_ M(H7X(Y"'TA$EDY_J5C#BNJGX3G<=^UIS+Z?+$O-"Z4M9=;FS_,?2-\.OH,.: M>QC!Z;[3AB&46K+%@%^DC[+QV\^]*0L_"6N.D\1&[$"B+0.:JM2C>LO<3ZIQH3G1G_1Y(-N'WL5/S# M@/8=^5[H?;7$!._N*>7)\:UGF?D5 =*T*Q58W8W W% M$TXCXLXC%DSV_(P@+G,U :YKL#TX+RLL(RN0X,+DI:LQ>KZRSA(08./HCA4GS/A?=J&EBXB"<_'4 90@ M%Y2LP 6A0QG&7!!_/!FR22%M,-#!*!,T'/ MG3))7I-^$@=VIE\%K=T MI:/-*Q]&O\U.*4:'C KV7DJZ26IS_' SOW#'D&0(#MRG'%GC@1B2=OZ ]BLR M6W3+*+')'((C%OJS4>V']ELK&X)S(?^'=0%XWS^)G>?!GFMERI["6*;WLRT M/MA*Q;"HD.V+O)-Y&&QR-+C.TW4IM21YE])$Z_%6T(4GOMA&I44X9MDL!RSH MHL)?N3=!8\2[Q*#%M.N"K>R[8KU>4AFF/E(IC#@HD?Y63LP9]S!^57594>\; M9Q$9!?52<%F^:P\/%].%+9M)$);),]E"!.5?*]F=@P8?]]W-?[?H=H0B@'OG MX;7_2[PK_')6SOEK;I\J8M:P"P5,_4XJT5A+RF_0<^&(DVCI(K9(A-Y.C5-< M/H'_?0ZL#R'@HN8:3?,\@44K[#(TU$HQRL)#LK+!!#YJB]A]4O[[A4^" MT=UX,2X(D) :RX.,NKLOP&?=/IKV>,F\/=679B!R>U"<=%3Y)1%W$FX9H4BH MJ(B]4^.]]! >F6%MK=';+E&B05B+L2XPMA&0-$HP?)V]\6NS=-'4[0O. M/R.[Z'#7B&024Y5U%T/&1Q;7V(A:6EU!^PFJJ.KZ1[#Y2]C%R-,:E6I65XL4 M*;@GVWN0S+RLKYK-(OAYR0%\)Z<6&Y]=6*7QX>'L2KY]UE;1OZT:_&\[ IW4 MHZ=W;F1R>BLXZQY164,KG]6O\"9V+!L"A$ J7X8H.=]T]\Y85C AHQF,\'[H30-GXNM]A MFE9J!HN*8+(@M7A92(DBNN;W8G+ "Q_>K5=J1!,RT8\1>ULO-$X43N,_06I+ M4'+(@%_%$)[-4NB;86L7\V[Y^SY^R>QT&7?KF0IQ,O#;CO>S-U6D%-6+) M'8<0)'.)P M00)4;(N<17J)3=9*WCU.;R5G'X+5@ M%P!XKAPE5?_>WS#7%C:TEG5,],B?!KL;P>E((WB^[6#SE(Z4G'_>O5YUXTR7 M-YM0*/])0 6LR"LD.[.[N 9A]TN31U+*SKD^JNH^14)(N7*F7=:50B'%/F'5 MO![BEB0C>!&S4(7474U)B15"D[&W\X\('VD0*H@+B26 44B [+UX7DQKW%T# MW]4GY/;.RHYCQY(;K59C6OH*VH3?BG]JT12@(H$^SQ'>Y"OEF+H9O<=:SHO0 MT4\I7F8<83M;!>LL#?-03W?/=%SHPDA& \!F1Q5GUAF\17+H8(LX"A<4E#*/ MM4)_UP9/R-'ZB)0C1? -1 9;=A5YARCA7;*V_>@NJ!+]5B1]+0"3NT$JY@V2 M)T(&^579'D:TD^5@00Z1(]&M'>D="BA=%'77M;Z#/WL^X,2 9:WYU.Z1)LOM@R]#&K*ENCUPW[ MY[@T0.7=_NJX_6MPE$K2[DN]1TJNKT.6>WZF*_@ M_5R0*T9@F&';TL<%&<#%(\](E3V@?R:W?!8%GUG++^.(*]5B5G_\;4BSR\K? M$[PS6DI.TX,;-W*F)4T2*S70V]8 X.Z -)IR?%79'#!9CZ4""X9,!Z%)9. H M;-A?W-ESD&)%"*!\UP2V+Z]CP,>)(4AC#<&4Y#\,0+_6>/^1@"M3 ) M5TT)5$\EZ95F'3O+I57ZE#"F]3+R5P?1;137QS%I4TON:!,L@EQ[KBY M\4[T1S;\HMM4L0NKI;S@A_+@;[YE?V-4W8T O( HX 7LVR\.W^A6<[/KJ[EU8-]<^'S% M-$6N(;OX>EJ,3XZ">.:(;=9T%#4Z3!$I3C$(R+$**?&UU__RT?=\4X:LWJ\( MM@)59+$S!3XHSVO>@VK//"G;63CQV+M11ONF.CW(]Z M>EN7!?MO'\KFW^O[S,M<_Q8^G.S 0'D 9QML0 RM1Z8,>W^GX S_@&:1_D' M3 @40A.'RZ%/2Y<^S&L%M?.;P[VU.1Q,>]!C3M]AE[: -KW="CZ_\$@0?/XW M5D$GXONSN:M ]Q2!W6_)_F!WG/VJQG_Y#PR);9Q9[6$P/V)]O"K ^"X*TPW_ MKZ!P=FVX_/33HM,O9 _I'GV\L!S6DE)'4<#T>LQ=&[8!N0]"6,=W"B#00AL< MI-'Y6N"TTL$%#2^'OV6Z-^P+;Y_J+GJ+F;OIVLP^U9<2,Z%6[\:J\K6 MW(0G)"VJ!?ZQ]W3WB>X%_]>)GPLK]=S3O36PU>*S1ZX333K/O!,M!MLIGC=@ M)HTJ'PFZ3!6_7YXLUJ5HZ)S"!5 '#W!7"U4VC/-1OU=CS8(\N[EYXSX/T.>]BJ!%T5V5C_AI&SR@#EH; ME1@.J:S>/PJ6W\@=T\Y_X8'=6[B>G'$W[QN\?2-$QS#7ZM,]_Y/[JJRD4>;# MBXB;;U?U7G>_?;UY-HDSTY_[#.;]2W3Z'\\,XRL%2K,PU)9,<+:1Q"5$V";C M6Y ^$DS?> +J%Y^-?TUOBTA/'BS_8 DYO*8V0O]BEP#'AA"AY38&G-*10643 MH.I[8N\/=!>T=4K5/S'G8<_)HMFM59X9]PQ\O9=%Y[W' M2@/3]>\N!7=+0QGX[/QQG-&O":[_;/M!-AC] ST:_5*K91 TR0.$(W:.4U[H MW83Z#%4AY_IJ>\@:^W(/B>D,#>JMYP@M"S7:BE;15[O"V\M;!]3[ID +*<^& M=X]UI<>L@S7 ]8BSS/'1PJ$GWK(G4:6^Z\Y"CXO61]L:"Q$? IZB=S34&'&/ M=M>6.4@CE:@9[T0[P$^Q,F5XX/=FL4X%#7+P)% MH" ZLP$EG??Q!3GTQY_X M3X4[&Z U0+)UTL5$=9&J"=?-N1$<[5;\@?ILY /EH;ZCKR>E."@J1F*78F55\;S7(LK1' M8;RRM,(J#7,=!-5BB(YB'C$NWT0JNK8Z;MSY%*N7(!,L$OB'39.75N\C/(W7M@1A,]UT;AD4*_C M(:S[N1_C@,]+MQ6/5ST\<>=5[H(I/_7V2OC^,_?^1SK_[VSWK,7U7ZH=_\2; MHZ048^,K!]NW=@(9;M^?$OX"V>ZDG$&=#\%RL[>\);?]5)+>[I[YTU1JNT") M>N]9WY\2^ )5\'2!:G[,/X[,(!S__-N!.BKQWD+O9[<$_"V]Q= "<7SSNMJ? M!AWM.@U;T\G&?VW](('0_RLCH9EN<;%MBF*M7>X"H0G!=V[5MO\\"RE!X"7R M:P9ART+@GUJXM!%]RM OY6.!E.E_D@5A_\^0&<4*1I8&42_F-PNL;)8(^K0:5;))&31-Y& M_SHTI"S#K#+L6#TK=M[R.FOFFTS(WTG"25FW1D*$J MZQGOB6KRU^8S#^:.*F)G4H[XY=>M8R2[,@BDJ'0ONTPKCXYBT#RVW_!ZYVJA MG)Q&2[2IQS]=&0B%&:SKH6F?TM$CHE MR3Z47H_+"[+O4K- #+@DND61O9://!7B;B@C,K@$>B\9']Z9IE?YE'M@XRS+ M..@B%L#6[2JD:KWWSTSG ?Y: C6N0Z>A;+%#'UR\4V-;C_".+YGK4LL>2KE>9C"XH"&P/)LI<@#]_]TN#%9>+=SJTEJ\!%T M.[\UY:R;\I$TGUIS9#"84DLBQ 2UBF$>\ "E98^QMY8NK2P^6O(G=5%3ZC65 M)89SBHYX79S6/VKI DO3?LGY>W7<80PMZ_OYB^0JGCRWC%SSK$$BI*XO\T'F M*T6/UA]T@)@7SAY9?Y[SWP"D8&OK5GVF=G/M8P6FU?;J>%OHN:'&8WZ8U<#@ MJQ[(HUV!I^ M5X#)V(/:(FWW3L;TUPTK^K6NI6@]_1+3]+F.8J )']F%OQ=- M)D2+!A.6T0WXQ[D@_9-&-#0?'R=<@\YKD<,9Y51@HW7R"7K4Y)._/C/*VQ8M M=@ "P76(/FESNF+7.4.-!/2@=2++<+2M"2[:3/78@!HW>YNU M5;O8RGZEO0,0F>%1BW>BW97W(,\2CEK<<-]#/)X_A7B!*&YZQ#@Q-+:NI]/I M[3CE.*]WG.-AF;*3XOH1;R&MZ$#4$*Y^#>V44JJVQ\,*&V/KOD16;L (V19> M#JT['>5B+)S&VQH-'VK+,1UR#= Y+J5UJ2^ [N9A.5IS+??_&93RU#0=J99L M*C]HA53?/WREI4-GPG,:.9:"0[SWBBYLRAT%KSS;'J?>;_B:8@C;=%-WDDJF MP8$C?YG5>S^B:\_ZS$YKFH_ 3>N@'=9#?2W"LJCCKW!3-JN!SW-!Z8^R)1U# M!![T#?\JN_UE6I)BP$<3)2&B %R22"\CPNL%9B5U@KV9Q&DB\>6L\]CSH&:? M;>;89\FQI]92?+,&U*HGR'&EV4/A#F?FDOU_C])F%"C%F9N[^41?!3Y3FQTZ MS%B+#D2BLUWC&,%1&%.1+JQ+^8^E:R]E@"R[C\C#7XV[08FZ>^#>FJ'AFRK8 MAUP)1BRN7Q5U#2[^><%%<=U5'<3EUD[UX^Q*@Y%M;"O69;_^NC455T@F/UMP M_M1CVGY?TF?V7,KKYI@"J1T-G#&&>W33=BD2)GD][>Q(M.00O&^2N=CC< MVPH+";(_4?*RMZ**P"MNRS#.D8^/%3_-XFQ^8K, 9MVSV_\ZQ,=QYRT?E3_W MG$E[9,EOPK^+5>5N^;8(D)>/#[\E_?1/>71.4#QT7>#=-*\=OK4N23#1?7DK M, BL5-+&?L:GBGU;=G6",Z6]%LTV,S/ZK)X"[%>PNZ=<5!]'I:^N =?B"+MD:"L#XU YP4)46,/'L7P^FA746XEMWD M ;67Y^V_Q.J:8>QJ@(-PIWH>X%EBRD.UB,!^X>?WXN3V2JDWW_K1T.EM5PE/ M[ Z*FFZ]2E!,6/%NP[EK2[.WM[,O[TN5BQXW.-U@,F#C$E4I=^6B=$_D8Q?M M4RZ"149W,D>#G>I\$>X,][Q<9-YT?Y)ZQU[1R]&/)'VT\C:Y73([&:N1*GY3 MM20,(?\$36,^5>ZNULU&:#?8E0?8YP?22VS[('.XF#Y0JG2RBF@\]2+,M6L+L4_5,-L8RA#Z1%I)?Y4_D2A/OKI]B<;96:7H M8.*1+7E1:_^XI-Q+[05^NA\]'W=FZ7I;\;^_AF3 MA)P-:.M033(0OE7:Z7;/.O#R!9.A7:89'CE][X(!A0^K?*4=7]S;H D0?NFZ2=C'F@0PJ8GBI*UL7=A3CSAP M S,'(TY?Q3?Q .+*L45P>1Z@[3I[;J;$2N..\?(%CX@;7_*\=2A#;TDU;Y8* MM&.V6H?PK]8I\9-<;+O79>K\[GI.6HPW0#% ^4.ONM]L(S8D8Y(\Y1UP^D/W M\'B$^OS) A#_OMB&KH"?X>XRY?LU_66&-^8XR)44"&HSN K['K0<..(&=F;4 ME;!;)AD;/3,2B55NJ!YN0CB[?2%XM_L_\\W_[6:S0!R%!.O\D997S)6:SGDG MFE1S+$CV,?]-S_)EY1TF:^*-J ?G["('@M#0MNX)^CPM2?G M04W]SD(IH4Y$!R]4036U&C**;XYR^M!CS-W(>!A4Y2NU5 Y/"8A["-;#'.:V M2YV.0HV^&-,AD!P.;X2>MZWBT0DZ+]J([T76 <6.)UH0 MX&!CAPN),I'!C4% 1LR:!L.POE1QP(?B^EZD@5YN4A,OBLM$Z*5K;K[V/6I? MO.PM[F34X>Y5F:!TW+G7-7EV]="%M7;<_\LITU3#I)W/-]7?_C1;W3*XN[*; M]*9$;"-^(B/MH887\+"KM@SYQ=C766O_SH66O2%'L0=L6?3^M;(N561L,(RJ M>,V0U%-\DQJ?IY6%P[-%;&L5[+C6MD1 M9X;76X-0V7/Q 4CW\#NQ<\!]6!?T03\I!Y;62G&V='2E;G..V@=Z=\[<-73[ M[(M,BU@#.<(Y[@E,:\H!C.3SDSU!YP)%TIR\::0-ZL@^KIV#WACRRZ\)(=T: M2>[@FL;MJN M)YHY'6T??\7AKLP43A"B7UKVJ2->Y9L%YI>O__F>)LA]LA8RTD8%R_Q^[O/^ MY5GH:TID?;OYRS)0Z%?4DQ88%&T- .QV_LH\Q."TI($Z5/>Z-VM](Q/1R6%_PE] MU[=^CJ0 AU^9;EN9W8K"X6__/?1I;*7_N?VYL>GOG"_APKT#X:";96J"TY7VA^*H#?E%,V ;(I]2 MTCS/0-(E:X5%.IH]QJ*N*)!B/R^)X:KV !>4L(?:,CVQ)6'S,0YTW5HU&N:" M,AGI*7.X9^I%K:CEN-9W'N 05^@%!6)7<_Y<,PL[:,J$C@7^$2#3Z@GQZ#+6 M\7-RJ0]R(DL A=DZ%UEI_>C)#U@8VX-Q8\B]TFMXY1L/<(ECR"G6-$D^R@3[ M2B:46_>^/*85]D50S_JN)JF-G, #D)MJJDZ%Y'Z&MVG\L7;C M.7EPB\4+RM(C'L[^M.;;2@$%?"-G-S^EXQ. X44^%;%-I>N"2V?C):L+Q_Q] M@W?X"W+"->4P'VQOS8XN_&$,,M(Z/_AFVXS-'[/)7Y\F=(=":'EN3*>T6Y0LS7T$-O?(+8MLV^L?Q MCY>^Z\OV-Y>3XTW:!<9]G?($C[H1JS7,# M-]HA4F14K:Y-*+Z%'_#O4#5/>4CW#ZA_&]20VHP8Q=)0.SJ:D?G\@!W\>O+A M97 $HD3R<<1XVEA+W4OP3CY'UT>/JM M7!>T*EQ?H]*A:>Q>TFNK)ZM!=Y\D%-T-7Y (=Z9:)DVC^,K=JUQ?\V\H)8!:R3OI='KOA"1$AS6@L+J-#=)NT MQVIDF8VL@\S2#R\-/)R HVK+ M#?!G#]ZR)N335CYW_3:@+^2NZX!>0^9\PYQ$7MH;_LU6GQ#H7F3(/T8U.=+U MSJ6L8&/ZU!J5 0Z3NI#==?KEZFOJNX\#!0_L%D3??07R #)J=-]0 M[CEDLDRTS\!Y/H$J0PYI [F]B5DOVPN(+Z]W+IX#V8CN?)9:N+O*YY+Y+7/, M24?F''?W%.-ZW:2^UVLWLH$K.;2X8K><5H=!MG9+(ATH'G21H?%8J:8-[QP0 MBM.X3RYWA@1K;$-D8'9RRMP(.E%HB[[QKGJY'C8.MDI3'EM\Q/9TIL;[2K0= MH01T&D6*H7/NX;Z^;+;CQP4)R678[M%41;NVQB832N!$)KX'+X'YB-BE?>+* M,@]0=]'%0>%)1/5!0UF@CN$@#S!.&!$HJ#VVZ_UX,K[.5MG/FHDB^ F)-MUD M\ #OH.::'4_+WG9>S Q-_,[F ?CW:_-0T_#[^,:V7?XXB<>D51*V!27G$._; M?B&&!SB*/]1#EBYBFLS-D[[B C,'L&W2+8XA/(#<]NHST&S3D9=.FJEG%B*# MNVA=@YG:JXKN5ZJVAF3_U>$%ZV;\:U<\GOU(B,]H_5KMWMB*2A@#]!(3$0."C%_&0_P;D MW[,R077.O^=D6Z(1NW\J1X@7CB)V(6W5J,<[RA25IBRZY%A_PYK@7+*7S.H: MY<,B\[3I$W1^T.VJ#S87OGEM/+#NY7-8ZI7%/>-S-/S:EU]P9%9E:_YP%Z]+4&*U6KI/2JHE-FUGK'9$2\9]JPC]7I^S5 M% W.:5$I[&PRZ97.U\"/)N9<[7H9Z6OGWMR,($XUZG01*H*TD.K3;BI_*!O^ M.>X=9$@BX9\-*50PPI[CE9VB,UP$?(T+0:E*"F\0U"/O36T^2O_O75F>VM4)8GTXM1& M0A(J&$!R(71Z!>\[M4'IN54SE3UCBZ3'UZ>;]4@L\?%0IYPS']4OE+@I/ H. MG6+@(VOZ&*6@3\TM?35.&OBT#**6S4F%-S@\V F\)TJTCO&YG>84:5?]HH2L MD2D7E0[KRZ-]?P*&=>-CM?Z_N8W3]'2(7>;$HA[N$C5*;-N/(06F_=&.\GL# MA8/(#^Q@NBID\M+U96C?[=1XI%-4FB+ID7=X#+T2DV2HR3<6I-.K<,O015#Z&\^[JV]?J!Q\I+1T$A?DK2=VD(PR U3N$(R1*U MZC/8[JL69 4Y@COD;L'_X"9A=!CH/'2&""TA1R50GOBJ??MKCC/ARBZEXQM% MT'7+NM_@D/?8?;.;D%$*S7^I&9WO'NUGTGI%AL(XO^9(AS;D. :^U7);A!MN MZE".I!AWU*@PJUG;F6'U/( S^=LXMZ/45N_EL+9V[/I4"/>,LZU\"(PZ8][/ ME"(UWIVKQ#AHS96_4"$%&?3K&9EZBCEF7190@_OM!7:BS/7 QKKXDF\CCGDZI2^2B!$CA][%H$MO M:Q+9^_Y"#J4GFB;'JCJ)T=OF4Y+YG=DV87SQH3:(ON-'-&)FJ9[(:FF>LO7T M<%+,1\6I6^!A:K)J?J4OC%[YWC SUG&^PB>C^VKYR>0Q/B']US31/WJ.1K_\ M=O_UPHY^N,ED*U'GO%+??!DP4FHHBB U_O495N@!Z&%:3'C<=,57X]X40R9P MK8#-2C\5,0+.5]\A%.KN:I IKU,/AV=%7)QO,-'!U_-]:1H%.,[-?K,@>(G45 KK7+'6H5 MYEF8$_>RK?08#\"4TW[D.PD.#;(.SB::AYD\<@(:S)0"US\5R=8BRG^O"/P>9TCO^)P^P M%\_Q3[SD->M:T!:K">T*GY& M@&D;/L"6K22@=\RI%RM;)7Z^#@32'D)7B_9!K&C]R+K/+3W>/KH9W'] MW=__3(()4B;U\*U))>=?3X(OI?%97-K6[G5EP+SF(7I,$^* XQ)9;?0MQ()[ M2)&\UQZQGK* 'W-U,#D'C2DY*[=R\T<.OJ@&B*W58'L4^7OZY9MWLM7($6ZT'6MK[&GGR_&I%RV1*MH"E2OMYWCTM4FS5O/ MF+9K.TUPG6[\V1FW"4P"B];L]>L9RQSK9]K7$TDIK80B69S;N2E6A_H!["&$ M+?L4G]"XG2B#4O9[M_(Y3DF9#T?&$?C:G(U<")061JEW7$9"_&BH,7CNWC,' M]@< +HC_Y87?4X.$%?V]#AU??_N^KNY2]1W(!XI(T'EZ,P1^N?[2J>1HY$/I M>09[R;ZJLN7BNCWZ]"]!,G-!&,0_IT M]Z13-$Y=\W;?A>9O>SPB8DJNN/HE-93+B+4OJ!G<&D71CME4:6#O+2)>@PG MYOZ40DC]8\CV&K)N83BE<0\2,@L)]9+"Z9MZUPF;;[*Z>5HK] M2W\-RI=6A/G#6GD$.7E*W#5^W>[^QJF^-^631-D.PW77CNDI%F'!\XU\0FMA MOEF*@^N,I!YX,)UUG%(%Z1/M?3/<"TM'>L)E70BVD*,I]89O+NX+3LVQ0MHA MX;&ZSC[F68[C=A&*ZEG1KNHS%O?5P\]6Y8B'F4=(6RF[RX:?&K J[_9N*>_& MWV=>'_DS@E.*E9F.X9A@V_1HEM1"J3\]XYK*E%%MOG '3\U>X[&$+H>-&6YN?J860*A'GA@P:",&I[Z;I MTXEN/@REP?S6H!T!7ZOU-+K6[5Z91V?KB$$O_M?+"O_K[3>TU*TDN*^H;L%1 MZSKUGME^+$VX>V^*TVXK/(Y^A)V3.N/# WQ +OA&G3(H MJ@I+M]B7/2J-7+DLZ;+B"F!_9>RL[^=(Z7):5'B *IN"K3!N88%O%Y4(.OV8 M9@63H@]+!>W673Y\'#4\_VUG2U=>H_0#-F' +V(TF!LMZQ:5 .4DCKLK.!%0 M)4TMY0_5R>#Q0FA]#(B?'K:S+T<%KM=C^SZO0Y;N=EE_N<-ZW?-%S&CG3,H3 MS&4_;*-1,VGV C]/RF]7Q!\CXX(.G7R&?6ZMMG$^B_EX73_:=F@T_9YMY0BX MS]J&WBD/T7@=P9D%L%B6=&["F+ %LQ;6LZL^I6CSVTE!QN,$CTM#;-OW2' M;N>B=7@CD %>.\D(>]SG0IN_3R;81*OQTT0V:&H06;N9]?S\J>XWT26K Q7X MP:+#V%X\F-'V ?\[^_ICG6Y5OS@H#Q"WQK]XV,[PM;..)3 SV)&8>EU8.D.M MY"T4I>&->19DQ._)OE?_*K'QL]W(:G&76/]CYW*;VA*V0;0WK DCE&A8[J(A M'\'&V.I-@GHS(]*AH]'-\H>>C[-R!J'*98&MEW3U:7WJB$5%LZ)2:+: MKPNV?,A]]_^:N?]GG"K&^]2E7XG (3Z8;C67RZ)6,LJD+X3";&:I:4<4!\'MBI^MMH(1D5YAQI$@'F#X[I/- M'CPS<*VW]+XY8V>H$DT2J-;X]+$7^P5X19[]/G36VF?@I0J5FC0>90]Q<%8^ M[&$CKK)YGCJ3/X^CTY+5-D7RAIFK 3YAK+OL2]TO M6EI::-OM/^!,2QU.,PS&E_%WZ(L-P+W,"M%Y]'X74A)PA%"EAVV\^C%GK8)T MN;SZQHS. BZ$P*:#;-PM E=[B=J??>M M[5![MB%K5C-\Q-M0>$[JR)!%>N;@]Q9.R[/#HC^NX =)C\>&0#F1GC=B= =- M='9@9>%&K9,U9^3NTZ,#S],=TJ,Q2R4=4%I-,1WZ0?O8@+?H#F=)]X!/ #6M!+R*15LU_8DH-@9]KG:&$*^ZGX]/!QXC& M)(JQ-Y\Q2]95WR@FI, [#>^)#+BG"\W?=HW*^; M/]0,F7*+C2"18<>*=K6]7BRM.9'A=88$R1Y7#Z&E:87<:?[L-;M>#5D[Q&S) M/H]M/+N6,4^W[:]9./\-DM)1&059LV"69A8YT"4(QX535@)UDW*;Z8[EEN$J M?=+1O<:<=M8N? M01UE;;TI8UG%Q'DNH&?MS?YE2XB4>K#P0U!Q!^4>+G*SAHK83S*?M [M4;-4Y(6 M&+@?A+N[AP&Q[=O,7D.$V6E9+,WKRVD]/=X\9SL\LLB4@X8I7*,\)YOGN*+6 M(R]Y[79+6!E@?6*'!!=IOSI LQ$_KW!C+;9:9#PL6R;L;[_3:Z9,\Q'SJ++% MG2[KDL(\@+)4>!+QXR+KRT/,0VC!5=31 F&QBY&'K ME7VVZM/ M+[B_C)CG9L_U81 0K:,%]&CWX;=R.9_8UO^X#JQPU:S8@*.:>0K MF_?,>UDN>\KGKT5AEC'BXQ@53NK=DE =@D/Q,ZSTGRH:*^++X ;E/OD%'N#+ MXUKB^2GEBI?#IO"N]][R6E[74'J>,\KAP#*+I-%\*W"P](49=SP/D'H <8!M MQFPM"+K1=7+XO#_0^UIQ'KW!UQ;5%=F?-YDR^H"%@6WN^2/ 2YPZ MI9DUD?;]!VK%7^GDP/!Y-905\SZ%WO/.!2,Z2%SW[G;AB@"5%^;2S NN/9HH MYPKLD15F?V#$P8-X.R+]&1\TH1;2=:F2"U29@9KKC?WUI["A>:WOYKE2:Z V MT3SEP2*L4?LU]PW76.N(6!FH1SK_G192)S\JBP1(I-H=\FVQ&5S-,>@FQ7[R MT!/V1Y9ZVP]>A_ND[MK(3R(;P\_Y7G0LN/>%8'&KVHN@>VL:]J;M@;QADNKB MV%CUH5%L7=7P8=<#54WMO>FB*G"RW:M9W0,/XNHB;0;_7@P!BTPQ;'-*VZ3U M'"1;3R;Y-0;#1_C94TVF6C5Y/XT0%5M MI;D^)>PO%PE&FP)6O8]9X'-N[)0S^\R:BXE9-RD1+!)T0#1,]?M@>O_9&7CW M.0PLV-]Q]/^",/['Y!%E6$>-__S=W'1Z$.03#F LB@6!0F>LU>?:&"B\)"/^ MP_>)@4][UKE2K,.O5&CNL0G!HRSK1G2\"^>,T/*3AN%=:%6J8[AZ'[A7[<.P M,]'GH$J+M%(?1Y[/*2W=8RD/"FKR"#\P2DS0CHY/Y8/8Q40 \V4X_Z:(!XG& M#68XI_/3S&UJDY>:'Z-7RC?2'1'KSD+[AI8"+0;%(@NYK;XRXLS&(J:KSGU2 M["LLP4;A[T^'4-[]M]^)%K&%6/!+&QZNBI6!"_<05_R@X] P]NUB6H4EO.K\ M'G:]!6@=:0IAR*5F?,2C/4[Z\0"N#\%6B@NIY(B@@PKA@?F.J5U>55JPWT.7 MJ)=S<#ODC.I7\6V('=P.J:FPC"C;,0MC;G?P[A$^S@ =PGN7+W2%$$ MH71F".NDGVBS\9>9[*P$+QY@B2H^#KZU@1[38Q^B6)4<;'O7NH-]7>&@9A@[ M*KAME =X#@,^L[=XS##'T4OWS,HF7H0^4"G9+/3I:++(+"MR.J-KG AQMEK6?F,@; C*LO$S8/V58K]&K)ZS8KO,]E*[ ?I=6, M,*/YT8]&]9IX&;QG3/&:TB>IOWF V*#.<67!\)+;E_A$U!>_A?;$U=PQ%W/F M_0>?GXY_6X;)=T_&^-[M=PB)YPJ98UQGSA$>;Q7QW)P]\U.+<*?'BJF&(!]_ MM"54^:]BTUR75T:7#[8;FTX+9CSU26\;?HY6>PPD7LZU8_$)8"8N@H#\W2)\ MR;R?VVVWD.Y];QK4.M<[D)UKAHLN%+< (*3,6IC=S \5A^7Q' M?EPWZ5JZT:[*AK" S@;Z.DZ\P#%9(_"F3,4GSY(S$GP>LM!2F; >BC% MS?"9SP=L0_\5QGXM_+']-=HY1M /E_.<%[.)K!A^MO,A/\[OEB?S)2N*JH1P M >8DZM&J50.AUG2U/CS#,'/@>3-GR0P[;=X_G5*.J#>PBE5"+WJY6#.5Y_M7 MSRT""S&W+9DMT/<.SOA3< H-JN_$B+%Y;NZ41-/G]+ZZP-'Q:%/(5(RM<9P3 MWTD"VZF"P[G"#)#\#$:^0_FD>[2>/S"!!PB*J5HI(EA>"C6MD FE_%&(4;8T M7!J:+F]=!/(1>>4(U'QT.,K(11I;0BA$U]-ZW=!]YS:EQN/,V26L]@+7SL#S MJWU/$$FV1SGY9-1=<3?N<;4.;)O6G;ZS6/6[UJMXO78P"BS]03D@M#*!<6M)SF/C:X=^86^*"SHCU$ MS"ZR/?&:BA)9.1VAI.25#WKT]GMB+S"EP4*KIP[]&V*19?B$3]\IB_Y]-J)5 M<[%%=>%!'0L@&5]/EC;[7%4_Y8.,E'2 ?X#9V1Y.MWB2)TLYZ PI/I"Y\X8I M#W";5B[ZZ2]0MU]Z.,$BK<]P45)^WF^P9SZ,CIDUH(W M:RY"64YX%,>1A"6 M-%LJ43V*+.STI ?5,,*UN]U#X*IB5#G5B$ELH.3)0)E#/,#>ZW1#[M,<'H#N MX,\G*P('ZN/,TSS -3,L4X4LL-E=Z$T_D4(L9"\NWOLDT_R4!ZC?S^8?F"H/ M9A^VQ3)F2T7G7>B.0\_$M8%PE3-KJ]@$SOQ%V>^,%G3O MH1%.OKOA]IEYG_&#JD5@.4^8!*5T9UV2ND+R]O9]@?IN1S &B:N7S@:Z4KYP MUXX4S_O3\!^ H3[(_4+\]&A-?M+!M>P>Z;_=L+'9E^K M9,>1@E@=RW-6E9\6AH?,X^W>)B2 QCC68PTR]R,U^S\90J.K-AFM M#S;#&A1-. EVZ-)T[-X@K/QB=CR^[,O 2'G7)K8)46:1_2!29L/KNR&[F+@A MS0 'D"\WI$AE5"P?;/.*Q$8EDK_J5)!1G1\[-%CF=L,0X"!>-UGFK?;32U'3 M9=)YR,2L:EG5974JS:#XV^W"RAK7@=*.YG5D1L=*,:=O^H&QA:[%.2_*WL7^ MI1Z7#*99$*6J$'4: E1N@9?CTL/XKYZZE9DN"J%_W("BO"6T#P_RZ&K0-!POZ)PL"/W2B:)5O'IFH-1)?RW\4PA^DY2(WD&)KVK!>Y726\G"W$+7 MKC[%JJ:6B4+/P <%0=E%SG(]/A-%DA:E_:2:4&949J.0/L&"K&%;=QZ:J1OT M>1(E@RRPICD6@4T0U?"FRF,;^4^H>EOG=Z76YUG[E+#,EP1%'D>SH0.WD 1Y.Y?>F%S4O$ M+\<=U-3RZY[Z9WQ)OV,N$Q;//L4$!HX+9U94X#Z5WC[G8[H)_9Z\FXG<$4)6 M][&8.P*)I/%_0D\(1J99S*-V!ZE^^]W?S,>J ^MK#CPQB+(:AW"O5HH"T??KL!#Q_*2=O":[G7F61;IT.@KYQ1:0E &\% M_\\+,OZ'F_BM.0B1C!C26PXHA*<]O-!J_\$(GH\RC^'W?;P:0Z_N#R4B9K)Z M+37QCREX4=[PHM'.AF0%IFB5YTFU'YAC3 @VJU1%MQ^Y@C6B$S)GU;O[AJ)L MH,^T)?L'0>Y$A&#)2^CR=?)[5$E=B]5\)F8UN'(,]_BO.R4H(HP?VL6"]OII M-H4?+=LV\JKX"T/]AZ-%494ETY/_K2C6*="*P001Q-1HF M'-I'J;>M'J'T)9EUP%0KH@6#CB\N4S?X07#JS@8>V88\X! M2_G6PWH5/("P.FBI2#H7U>]EHD+PZ@,VM**O1\- GWQP:SE"JY:-S$ANK\7B-)Q]*,\V=04@,VY^5[*OW :SF=:CIF9(=! M#JT,E2<$;>(!2D[7\P"'FV6#0\IZ4YBT?MS'GJ_ _921-_&S'9#1N8_*,64F M^A.4V7.;/7TP_JE%;=R!NFNW- M:)Y/'T_941;EGSK8O)\+5GC%;A:?"(@/6=52TK6.L++OY[9B%MI<=G2ACK0K MY 041"0N+TI@VC!"C)<:_6RP6]'P4H?X=^RME9G)0A<3L$>K@JIM\UB@[LQZ M/$J%U6(318WW=.03J+BJ5^F* MIA<'[A-U;IU)R]D:^C7,,KZJ+IB'WRXH)K^R)9VQ?W-K^_MO/6K7?(LYGZSKD&\U)^O #T;CIYR:]H;Z987)5>'_,\6AI-]:N O@:/%4- -R)7XR MKLG:9S7TFCK7'W\L+?OEC@(=G:Y-O>M,.NDN8IX'^,,O0G_%$GV_?_//HBE] M3EZ0E?/.[S4G!XB ,5':9C&.1F26BTA(K>L\1^[[2:#-S*YO8C] MJ,VY9.ENK:)C9WF =T^+\@TXY4%WJS#=HZW[6%D&;Z?X6)=Z&3HY[]O9N.[H MP ,\,L]9G9NNF>C*YP&V%\C\'EGS6=6R9IJC]9Y#=-^#[P\2\LMOLNU8,=AT MXQ(J42QWO_M[;?V<&GP*AU$E&N"(0HS5]7&4X_""0,DJ6.H;D9F*KUU'9Z"9 MXG9+GPVSQTP:Z_/ YHI8-WX,[XP]-#"K?I$'2(F0W6!G4+M3:' Z:=5,5.RD MVV!FV5LP_#4'N10*C(1M^]G31=&V!+=2P;9$'>&C2 M:.HTA\JF[:!/+J/CQVCG'JAH?@JB<';MZ2QG5HY$5-= (U75G:8I?7^&LB,< M*<=[QL\O;*STZPYVDQ]9I#,_(9<6._@YX\,B<'1!LAE)'=9@ KZ+(GN,MJ3= MT#[>,2F+C_<_A)6%IO:HMF0,[TM%GL#ZRYF KR-PPHPG$*ZBFC]WCL]G88G@ MB$0-AN5'"LT_BJN6LF;-=5H7I^6N@^U&*\)'?754OJ3GZN[<,!N CI>P;;[Q M %-4+&MS>-Q4CV%_E4O[S /T7X>PE!"M3&RM5+[A!NZ[]IEQ*N5X*K,]\ZI4 MFD&.;D2[Q8.=R]GZC'Q(K)4MZNJK58LWT>QI;DO\,@9(O][7R;5?'<>YAD*> MW37HN%F,-_CZG>N](S] M:V64UQR/>)M.5(_*8XQ*]4=XI% M;-=8DBM9P(#98 *+>[K,_3R+P,^&5L35-JQ/-^_B 9X81G!_J^02[AB^@&)K MG=PH:U\L(N0-?3YM-LK,A>4?+B/P(4/$O&TYV,2%DN*7L%:X&I9M#=[>!,Z MY=",(U3A*<'*G!77R,153O,P*98R8DY^T =)%964B=:>I5*0A@?AOR\'P5&N M*0.E4<:4/RLYR(<]%.<+JRIUZPVPN!Q1\T1=T&8Q_I7$K)7U9'1BD36Q%7Z@ MSN1%RY(D]<>:'MDFR+%T8-B)Z *>2\>&.+4R/$TKX._UQ,YR^CV5EXE&A@W3]JH3SFZ9KL3U4VMLPIR,,+WE3GLIOL5F\0E;W5T.%\ FS,.TR# W9#DYL?N2K%D4 M#:@3_EEM WG/[)1]<\&-B/4\:=R!JY)#+\ESZE;?5!]9O%]M#;B\RWJRR->" ML4HH0)4;)I+CFU(.DJD.5B"8EX,,LG>:AI;EI0U&FQ%"=>#BU&S6&O].]>/M-\RWK] MB/-J]!AV+]:I6KGV?=.081\>7#,H4=W"3T$&G>#YC[56]=(85V(/.^ ME'K;';=*\S:R%KZ^>MDNH;#"0BF!U_*D"^U+>L#>A5KU087&=6T@"UEUB=$% M*4(9$V*!27*TBO?VVM]T @:(^V^\SO]OMSV^4JCJ#C8#WXU\V\460?L4$LSS MB](>:EHW '>/5 R^WIJ9_,PVIJM?-"]O%N@N]=Q.[7&!U^4,.L?U0):5^@#L M#<;IVL-W'9UCX[E"MM@\OYU&G584GR_Y_!@?[3HL.E)ET9?7_6%N>!=M00,S M^1"L[:ZZ0;-&-K4807NX)YF21ZK*ZVVA8Z*/5?H7[D?E"#6>I0]"W/M?ZB+6 MD7G=VD=G)?;VVZ,(7P=<--0+":.N@._MW&-(*=7P=KA&"[<=;T3'TRX6N(A( MM2R5]O6^&P=BXQ XA65Q8/7U0(F'S%*ZS?[\(MQZNBU$(Q= MP8NHI?*^KDZV<:Y+0>&.>OY?X0A6!BMWPX1S,MI8YCX4-T M:F0=EM X6--5$8T=,=NVNE \&@QL.&-JTEFH++:ZG/8;UWM"1H7S-U>&60NG ME/8;Q%;UC0-CA(R83FO)'6HZYA7.KX@L\^D^< --&&K>&WBPF =P+0NQZF0Z MW%--GOI8H\H#/$9?!R/ZDSL3^0WT(O/5V+?E+?"CQM;!L_9MB[WL@]'!TW MIU^%0Z^GJS4,^2',^'2Z]S.?U#I6B8TKFO[YZM31]E@=[9L.$8M-+<8+^2=A M9P4KRB3"X5VO_DU0S60A(^VAI*"V5R5\]WM!-:_$O],S>-X6H]K'B_G>0$1Q\K1*J+EE>P@F]:9"87B,=/%L IE^F*^]29X"$8:>=&>?\@-ZE E\$G94?4E[ M/LE5AYFK5> 6H>;Y.3+#Y*5V 4+"TL6#72(_5H+65M*-;)$.HBQ"/Q-3#F6G M+!I8>09=\>7SH%C0[NZP2]HY).:'SQ2%%.:J9T!VXPS0=Y'"F-TH1Q^]R:?9 MN3Q G;ZO7[^=A2-Z@=HB+&9XD=9';-Q]:I#5Q@ZHJ+9N-E1:'+*0"1M).>B7 MIF,=>+C7FI5OVSV"[=UIV7W8H;NWH).2T+.4=B=6W*=^R.GI@&M/8D;2W:@$ MW#HRAYY2"SSD1QWU@;4<,6"[98NO.3W!.@Z+,.'F-5][8HJD@]Z"Y5=!0)%: MAST9Q@5G*&?,BZ02PF&F.F=\M9WHHO-)6 MG6BU_,!3?4G(J&ZR,SS!/#^IHN<4"5UM&3FOIBQV&&/NVHRZ.N7:3+12DB*) M:$"4B1/O=BN@ABR*DB"='N5OLV:.@T-)H$"/@]^V(=U/P$K_$[.<_S\V,[14 MR6B\M[X.P!'NK!Z/"- BM,TF;R>2+/JE"#Y>1CN?(U-VH[('N3A;])CR(P:D M"D7JH=Y)Y5K N^\$R_2-8IS7ONVLY>>Z,G8#G_;U+7/L1U&T)/6/1(:X-TN>[P>JL'*;Z>-:>.'B0 //\:MKG2_](1 ML0XCEE&>P;[&M4S80I9X (+ENI3B('XX)"])=Z;;Y]O.$C_?M1<]JN7F@:$. ML%6<,+?'%$-SSQKD+O5\- MOQ- F' _[%I<.T&Q!JD,'BQB09@)J:[A54KE MI=")ZII,3]?ADU\H=/F!3LQQI)1G4+R((*\ <.X0NQ65XKV@>X;I\LF4BZK@ M/FFK3JN@3]+\"!'@%,H#($'/R@N6L,.WG87F P=5>DQP#H,%DOHSJO>:YVQ. M/],&!($9*L1^S?/W"X:;W6NL>(#FOT!/Z#P 33_;%F75!V;-5@O=8G:_<[V, M[1#WQ1+,#W\&"[\O\-<(I]Q- +8ND>"NVCO>SYE08Z'-E561PJL.%:6A MHX8(E3^[!_=VI#%COSB$/0'O7M0$Y?:J]Z*L/*Q*8%L5B12T6MNCFIV,/1I] M9+!3)>7%A;K$9> !3#U%=+6Z=7N;73,KKPC\=]''R;+AAL1S?K9?V%&34=V; M.F/*S-._IWA4E@VZ:@T^;4=QK?"G&1KL0_C&MER%T=7!R^E)H.QNR3799?(I$K!T^Y+*W13OI04&U MKZZ.5U/9Z=+S7I.D(W=F-2P(/2'>$(N-^0D$4\3ID[V'Y+!@@@/F*:N>.*U' M>AG]"C\$@[W_J8V?,7CEI^3!]G9]@1/&P?^ Y20);WEI2/PR3!<6'5[\/]/Z MW*Y]HW=L7_6=$8X!F45_,E\WC_Z:=%1L@'1>HY6\0^+CF$MGT)2^_&^S MUMCP2O,*M1-#4O'2B6??/@W@1W8[+>=L!E2*B&.KV8E75:!?2J"9(H;RH#?S MZ0S91K;9C*;Y:?9* 1Q<%S"4UF]7^K:4^ZEHN8X'*(V/"C(^$0&76;C- _@< M1$K*>U!OMWMJAYT^_3P#N^%BS@,03\4O++AN(FMY@/?@<.\#1Q+#"\-E"L\K M0>E?D?V:LJS?F8'Z>_J2_Q=[[QW51/?O"X^B(B!&1 1!R:."J(#8 *4D6 5 M$2ST$A51( (BTD,&045!1$1!0 B(]!(I(5(C74 $I 1""45Z2R@AD&1RA^?Y MG?7>>\YZU[KW7?>XM\\,K*_!9\@RV"456WLGLV_9H,9*DFOK 7(LV]KL0O.F>J6W:F$ E^=@%W?L7Y4OJ(CG?H_@6PUSD=N&;7N=(2?2;M!).CGF^ M$U72<"5CPP2-'/[E0]S##S_[O .QJ9QF\R)6?I_J$VF7P+FF8H>-98K*U::L MN.0RB@_6SH!!;Z0H>\2Z!!6X-NE(K=D&K> MIT_SY [1HXB6DY_E5S,7TC&E M.F+5,-0G_'^8L_^_<=E8V/7(8"79\FV/!S1DXS< AJQ4G M.D,,'BS&&R$O_/CZ8S%NJ2>W<)I* E F5)1P\EPO M*T!7-Q"+1:MQ6T2OQV MZ+=S&J>MRW \:-8%-47D"CD(+(Z;LC7=!-2Z>Z'57%/.T"R/V!]6@6%AES1O ML!^LLT*6&3(+MS_0AEYL";!WCYPK"YH_WZEGX'. TT;R3\G&B>OW%TGD2IJS MD63/_9; ZKL0ELW-P9]Y+KVRM%$/Q/.5*$Y1#O"(V7=9LB\BJC";>SV]I^C/ M-U?.1&DY&+:M;N7W5NCQ M@8HP;[_S#2M1,3I(&S;(*HSPS"Z T1O;=AI#"[U63LLO-%GE ["J%#7<]X?I MWQ#C(+!4;< >3<+,]I_,G6=EI18PQT)]*?)_<-31?F*HJB:FV$.!MVRSA<#$ M6GVUYP.7/A3!#*6#3#.>ZO)"/AX^M'ZY*R4".9=/PKM/H@M-B0_(N-_P.3#I M]'SF;"&! M9G>EI+<\*D"SW&JP)9!43G=B#! B.^HWIBU(5&$Q>?3J>(QGOVJ.%]BRFP_L MI5JD<5U;522\+I.AS59=%+%"36*I1U%1F--;]KW:>[CY'+!2&X<$2V=*GK%6 M)\?T[TH.QG19=3=U7\AC%V?BF_&JOWO*^G?/PL;05\"Z>:4*W&FNUO.DA\J; M^$'L<\RY'>^F=.('9:GM JC16,:X'X3/)DNK/NN9+ND!JTH.QC9E7UHK-*H. M#=\RQ:+@ZS"#G-BUU>@7QJ"5E/H#KHS+73BU0'%.( MO^,O0$*4Y$:KF;4_?GX^437@(=46#%BI>B@2TEXN17 <8$94S?_I@"XTZDS% M^[5AW ?@K5R=N++06931RKV#JR%59>O^R/N7\L -VN7)HE']Q0.%YE.(6?%E M'X(T[##\[ZQ?M%YA/W7JQ5>+NT"S/Q^LJMKUX:O '7?[^<#.(F=*_VTPQRGO MENWO\RSQ&5Q+25CGDGS]S$WF=OD6EM8L--7UD ![QAH)/O!Q'YW'5G4J5V!% MH!K]PT7[K_7;UM#S*6_ "03L(/#-9G&L.\SRDCEGV5%P-B*Y]R9TQ^\(2^M= MR#*&?9\N#;8>FH9XL>BA.)PC']")"^>PG,H+-<-[6O)&;YEE\H'J,][MT%.X M*GK!>:BYXK1G+R\:S>.<+L_6#"X@V#6F$^]@>ESK84]XW(\ %^XDSL2-]!*+ M/_<7T>?J'%A+?"!&I,/_:H%+QDCR MYM Y^EU'P).*W2UYB\\EEK7#9P28&T>3D3U3*6LN\?J+JJT6ZY](QCVB3]L5 MAO.F/[8LJ"(DS[F>5CWO'_[F,+'X(1\8C,/O!Y=78G'@_"6CA>8G)2!7W-:< MQ4NS;N=Q2>[<[]D#J$".KI)62PL,?Z0#O3_HGFK$W\TJD%!#4BUYUA=.ZE[- MNV"<\/1I>C?R>QO%.J5 =8!;B&J3I7F(9[-H*E<)7] MZ._XO>WBSKG!=Q"_^XT6)?)<'3=GS@9*#6$N=:@L9,O'H0O$,5D7N=GP46;4 M1\HQ6+5H+3W#?'/?I]^2?")*K:/,8NB M21\];H-XQST+!R2;,9:01X+2%Y'#ET8$EL\2KZW7%\[@G+-WG6&5P;"8\!.= M*#$C[F3:ZK\:53"G99'6RYLDF\GEF8R6A=VZT9WQF:O)H 8GW\IOG4FJUUO8 M01Y_3=5+E_ D-I)JZ;BK[;/0M)EZ!NX^.=0K6MY=;2#GO6_U<4Q9KU,V+85$ MH<=@OR\;A>F2G2.R(CHJCED;E3X,NX1(4=%ROH/E \H2E$&3IBF"1"*Y/U_7 MHKGO4VJKGA MFRF,.:>R3#'/Y[3# FHMNIF>ZY*MRVV[\OW^]\?_8Z;Z7:RL<+/^\!X/WI.)5B,B<+]I-= MRM1 5V<^L#Z-EC-MS#82F.,U/UZ+KNRFS]7K($5;$OMK5Y*=4KL>IPV$9\;FZC@U_L@ZF M]3O%:I\?4RD]I<(5+@TE/E\YX=_IU/"-(3J#66A.%U"CUUK&$_M+HJ&U'"SZ M%:V6V/\M$EK++BY3])/D%CBE'0KWD!P(2Q=H+82;&EN;V]]N +M+,\-4Z'?L M>QDO0Q7>LJULESL1WCZM#2M%!(Z191,9%T)G[+>1")\52^ES[FN"JQ7F3ELUM,_]Z+RK[;( MM]E8<%*76#)^5 1QPB8:D$9V3%<_S]ZA'1:_2Y/E5'*^ZE+I@ M1TD _N.%D9P#8.D3RDIK5@0[[EKT7#_<0DPL+&ND5$-A)V'91=E'\J:,I@#X M)ZC"-(BH01):"T1 MD3%!C$GBI1\$5YTEK(-9GYY6++49"[8EW (7F^%(DI;JG=>CK#3C^ !R]H0K M'] ^F!'->@^W-"$"_W[N^TIX@2X?T*)"J[O\8U56QR@K/X@B&-J57LA7]X;* M['Z8M;0/?)Y!/.(HH1=KP?D(_9[/<%D8,' A3#3;H=1H=1(Y>9T\N\]YO6[> MX5*!OK)T/C >"\?NZ='7"OTVI,$76^P6/4;K I+1--:=S<1N]\.V_?LM"C;#@];1_MD_514BRHV*I MUU4&(N"A7-T^PGKCQ0>BGV>7AM,.Z*^O)2+ROW0JB\]?I:QTFD76F(KY3S\G MAKB@'83HD)6I37V]00Q^YOT&UM+ Z?:[?""*SF9D<\)?6=Y#UL E<)INS! 6 MIJ23H%XSJP>6-.L@76QPM[^&SN7#?3J?YUIQQBJM/\)L@?CZ'C,JS8UK>)T/ M8)W<>6-.P%JI,9N!2^+_Z]]UTY4Q4^YJYSJ$55R^ +I='S+HD( M\PZ4JK5!ZJ=+9EP/ZX.K,5S$); M)H7UG$<=N)^;V5*I /F0GNQ&":(7?P5HC!OE0 M==/8DG/07(!60GV5"ZPQ; X1!JL7H+ERK"%#I*C_:P%(LM$-?ZKF3"]"=P5H M!1LQ,/V\_G64UF_BE"QQ,"(TJ^7^_=RL&S+>B7S 3)K(*=Q0[5@A!'Z(UR[ _3HU?#/7:.[-FQ2R].AR#F1M/_WS,K]+UN,265&7:I.L2% TJ%P M1Y6!-QF&0P9G?8F0YKKWV^_.@&B8DBQS,D%D,!HRS_$UW+5A1)(N!$=,@FH+ M'8<,6\&/502GQ^X"RS([-BSPQBL+_[5)!KDXC[&YG-;;M))D250(GH'%=92? M@\ PIR7(#O*?WKXX"+6LVF$>&0Z)G 77$;\%!LMLBH==(N*Y2X78>WAWU6@W M1JHN)X_:;X;<=A.;Y#K&8"2B!OZ-+EBEWD*IUUL5$):D:!6 M/8&/#I/"O3ZV M'GH\'-+40%714+Z35=B ],_EV/&N\=9HXD>Y7>[[0FO?X.K*5Z MV"QGYN.._*L2;]D&?\NP]C2FJM^7]1>OK!5;BNJ##; M6N2_-G:^A*3_&:H +;-?'73(4O6LV75PU:%S3HRK^D^O+<.'BO_I".!]I6<* MP36\>2P<3Z_IG+_.54?_W>ZLUG];2T00S*J]PKF&IDF,^&I895:\"/ZWXK9D MM@OXSQG3K![LP&<+KO;?=9TY(J"P(T-EK0A< MB>,>%JB<@9#AJ^-676B$%Z_;"RRU;=L=C=VZJCR"9.SE QJ%F9EJQ"8=68P= MH\MH=:476D'^(F=#LO5(NCUFQ2>W*P2H+&*$O=YG\H6G>&V?&@VQ_ BV2=^= M^O_K;@7\5R^WG*71 R9.[T* ISEW7/+@9 GH<$ZA40:>P[W>\)$FNBY'I .- MA+LI#)+S=9V]2PFB^4Y$A8 9.IO"I$TY)&X_;Q3V.20B3KL^=^1UPBR:J<9>GQW,!YA#M@1=P,<.I_!W MK#)2^4!5QOIJ8[EI"+ LDT$(6\^V79][ +$N';A+6$28*1@ M(;F<.Q8"C"2SW9W*[[5PMZ2%?]]]>>7+?;CC5!-=P+V-K6B$F5!+6 MFTH6E &GGL\!I^Q:LP],/J1D9!VYXRS93PX#!P]DM^EL,]EZQAHL-?J?>,7L M_[_\7[(0WU">$:]0E0:&Z3>E>PIX,ZY%YI[^L48E MT@?CZ0OM*3@Z'T#\Y .97BHW'$;O'WMY0G@6V2-SYTZ#3;UL:@98O8B>"@%'>_A WZT-:W!1$R)7 M\G#!;9QX WH9IHT5"7P$]P13K70$$5RRG3QLM!W.2_D<)[4L=[%WXI M>./RH/'F$L66)_1P^C;5G_ MV?<#!$94V$%L2S"_+B.;5CWF!&W_A#W^@3.@(W/,;'*4_!&<_H#?:;:L MDC/!PA]HFR\L99N.5;&$E'/WN[S3FS)YSSM''(L>2:N:;@FD2VG9#/HMS*J] M2F]RR*=L<7CZ\P;,:2.'Z8RCPT@5H:S,3A,3 ,-O];'^/XU9&$N;^F9TR MY?VY&(%ID6M&/'=+[GSN_"!8DT4,(DB6[1^QTGT0?:%CL-PA,EQ-_LX8+)$$ M#&%SNS$1,5D4DO1E*HHV%_T@O?LG6OBUEHJ.H/^ED6[PDEC!;$[D_$M MF*UI3\52IQNVF(8FO%5MP>*J2-,V[5$AOZAFO6 MO_51\6KU$\_6-_=B^$"/;@,ZVA)8&X>$3#BP9:X:9+]&R;/?M8#/<(J/*?=" M;O5%TUYNB/#O4LH.@ZA1&BY$&FT(0N 46_%"./76,O&AK.O8+XYJPU+LZL9^ M6[.#6:51]U>7E7%=G\"[ZU8+C3)6[LT,8.6A4=;8$#INW36-E]2/Q MJ?$P1&X*?:'\U^'V^L!"LW!D;7&.Q:L5)7."+\#$YGBQM AZOYVU[#EGO7N' MTEYXO+BT1)>8UE#JBIJ3/7[CG/N^:DVW1;>Q[6/EZ.]X.:;KC 234H46+=,= M-J!(XX28V8'MU=)C*?R\D-MU2NR\5*RPZ>Z[(1S1TL;R6=,Z_L/5+SD M X$Y$[Y>P:"=\^Y?&QO2-;&2:8)I8I,RK2U945AC$(XKA>-2X&"ZT" M1V^!/L.+=Y'+70'H!%\80-%^E,&/&$EPR!G?8"M=5!S7W(E3/C@A*1^NN1_H M94[^T3+@ QNBFA]\ OZH' M+9Q0C"<<'!?Y@-,37FS%5NO:+S8^*#7F7Y%&;57D%N#[8JX;+!8[7]!9 ZB. M#:O3<&MO\#+#ZS"A=D/04Z\Q-KJRO>Q&OII=:0=^)M_O)>00#='L7A"?9>H_ MGOG97!PNEU"]??RT"=@>V4L/J0&Y/Z1.\\EQT;VH M),)H!!^8_3CU@4'ABB-9E_C BR!V'A\0,GN9#0?Q1O8U\_%X.4P_W181JXCW MMD?ZUZ>VXGGXB=9_7/V#J9(N0I(%J2L%=$ZCO=FV75'XG; T,6.6 X85ON??-$=MC0 MD5&\Q$&JLL5'#K!,,\=8.9GF]5GTZ7NX_M47>;ZR+3AOK_'FQO\EKLP]9<&F M#!IMZY?QQ]15R/YV$7 ^07?Z>GYU^O4IA"4P,Y&+-&#W,%:LOW%0<2.4;5/B M3$Z6S=T!_?$TX;%2D]M3>ZX-^DH#_O_3U[!-_$)?YNQWO!]QY]79!Q$!PMH- MB2*[S 3]F-2AHAATA!=3I*JHP&,AM2LG(F])Q> .LVGH5\8I77NF0!7UW9LK M5M.F UT*>IOW,BC][PYM2Q/<*V8Z\=\-;'47UW&(#VS[ M8(.Q;G^2ZA*X-G<&7#IP6.!QR"*=[8!Y3EBZJ87D T'31M#9&SU<3[9S>M.H M!?<\(Z>CU.MAL&61>[BU8.)V5LBO=E*H\MW>EJ]EY(H@R+?WAYRMGF^&:O+_ MV#>)Y\,J4A.V8F2.7FGV)$UI+T$-FCLC"=Q;^.-K=A;+G!^*7ZZRZN5>9'RH MF:_2W5[L-%??+9B(T/F<5:GE=?Q+GD:#>$#C5,\VQ'E1\W\^YXX9EGQZNN55 MPF8J5S[GXN])R\[W79)'GPDN_#G_)>-L];8_2$MN@S/&F'V$D5;#!_+5Z\-L MC039X(V?MCO9$:PMI7GO.JRS>^6,J_>&S^/G\<@-M\A3R^X#QQGH8&B_P\F) MBD-MI_G CDGQ.U_R.F;?#>\^F$0;?/VF+@!UD927=RCD$N>NS- QYU8^_U!3?# V7U1&KS+V#H:$A9A60]-; M<^F#Z&JOP&$;3U9SCF (ZY_-^QK_\;4\^(S#EK\G:P2,LE6,X M5Q#/47L=*T7SA[N;M^N!HY&12'".2NYV9-%TWZMYJC$M+74"SR0&'H^H2PZ0 MT ,V!JC\9_OFFWLN9)C*/)TZ GO,Q7"./4X*#5 H_O#\ MKY_ 7EUBPQ0PAQ+%72IEHYD/JFQ5\_O:)WS?2]:IGCGY^:L*DBNJ#KL)WU(^ MT"O)>E_.2Z\X@T4=\V=,Y(&)$T6/P2:1TPKW]>\_MNCMSVLU>P9'G2=2&)+& M$J0J]CN@MC$ZR312_-U1Y\0+\5D)%GUO7F:*G)C9145B"I",R_0>24@B+8 R MA&7'UKN^*C,$I&^=)+8\2%.30A<8+I!Y[KV\L5T;6,B95<:%"[QX2-P!M:55 MW*,B7G)^+N9\>6>UN]+L7/.J:#(;V^Y W,[+AF%=5(!UDVWF-1QF+=^5=1;K MC+QL5FW;%_%6.\*WU%-V)C'@(1?DI90)LQ>YU0QYAO<@[E9-FOPVG)#[O8 M=2VC$66P;BUN2O8@574?GE>QW)7F)?\SA\#Z%&GN43!$$,+BU;MN_];2_H*9 M+LGF7K!+[=6N60!+7@JISD9"WY&%JA41O"\PH:AV%=5YZN5IP=YIU+SA[\MV MP1.V(*;6\#%6?!'C(D7,I4'S)9+HH;Z:$/ MHU\\SISUK?0X+)ET!*8[96VW8S-\P%]Q6-OJ4GDKZ>P2[]HO?PV(=F$OBWS] MX^BK8!/[VUO1EBVPX$X;G*_#"'%]&I M6D$S>N>VE*Y!ON = HU\G?=P>L8LQ>^Q6MW]Y:IN,:3&;'><88O#M2%E5/W;N MSP2QMM1(H]:0!+W:%'L>X.$8N.#T0(%1R/[IY?'A\CAA?,A>(%6 M+4SRJ\@K73-W*22K#T)_O='=5OI>/"AH&O-S,VB(!)8.#H%/P>U/[JH5Q0TU M:_P,^@3-=9V>;W$"EOX'%N7";B(P;!)UFBW/,6&G_FJJE9[-#)G&*,?%(A@4ER-:A"AAWJN&6Z91O&_PV3"OD? MNV0,:^F"DS6"/ \G@ N[EN?$$=>UO20^P)4VX@.U9B:,%M8K)J6:\A(OS=1A MHLCXTV%Z(ET%<3=BW@V)59]^*'([V/@6#]N8GHB8,CI'?5AFE#19\BON$=G2 M,\EY7W_A].]+\1>2$9FQG<0P]. 'PAZKX>B9K!1']4@A58S@KS6YI+ACMXUE M^_,F1RE1Z.D/_M$ZFW&P<-I\C)=D-8B>ZN)GJ^-;6MEGNQL"EX@^,G^<6ANV1+#J-8C;=A'Z ")(&9U88F*H$ M@:]BI8Y1 38M2"ZYQ#7!QQ_ON"LE)=@'S7ZBD[^+!&7WH.OQVRW[YP_YB&JMT;SFW1QE7>49MM^0# MD*@"'QC.ZN #KIA=2$FH&]RM\CJN+-[%$)T+CG0K%Z$1A\JV!&BP*XZPQWPV M*KS6.C\W+AR:\>NR K09\[L^$(=6>*&U)\GA]Y7VRVG=YQQ^7ZIM.JFWX]UE MN7%9$G< :K&5DE5G+S*FJ^=*DSNXNFFT2^C).&L]*4@D%OKX_^AC8@+%$=/K M/A0\4_RP"U+HE#%F'DST+CN;XAR[_!2I>$9.Z8J_]6M6/P:FOG;):*4$?W9JK995GMGO9!G?1WN1 M[+$_UJ\T8]N[*W_^%)RZ]\Y_0F 6'49AF-)?$W8>^D9B1/9P-=HL7EYL?VMM MF[^F71-$+'/XL"#Y&B7')@_OH]/*;@Z'V=5XR9!]8DE+(*3UE2$BVL?.(R0X&#ZP*89)#5'HYUYEJ.71IZ,["%,V.PMRP,/@FB^+UF\T3NSNEJ@6HPS^CIOI&% M\8Z$%>.WZARSQYG(.M4W :B"SR&KDJP97NEIUQ[]:OU+OT4K"IC(&\$>49_& MGWA>3T"UN84/39,T\E@-B0@G-IVCCT/QXLNT2BAON/JNR5]B.-JQ8P99GS5U MA4?C^D8$BB56DYDMD,C9X6:GX>'J(9,:NFAI./-(Z^"4G.)PJ0'K_?,$W90<$: MO29(W/O(CALV>NFQ56YT9J03#SP\T(.$-&V-E(A:K^=J_[A'V37(==SZ M>P@W-XE>F;Y<:A4GDY$])S[7[+I?'Y,DI;J2QMTY,B)8JR*-[[ 4#/9 R++# M31DYI+#1SK%(,,/0W>7Z[2=7Y9X'#NN_9H; KIG8%LX^0'A>RP?J$?O83U^, MMN-014'HJL4^O1Y9-OD.NU5PYCGN,LP?+LRQI,'P'LO#2^5ZX]?*.\O..=Z3 M)WVL/U3[QB)N\Z4SO!_-_F1,-(%A118;YN*8ZBCZEF5./J35>T"CU7S7Z>#!P7F4]0_ XZN+*/>M727ZM+ MJME*5Z!%N6=ZS&<++8QZ[UDS[I5^Q_$!*EK)'SO<6)SFN**1,Z,69;HP8-W8 M>S!PX.3<'Y;PV=, S\JB0^L<*,_*\'//L&WZ&:T>>3K_[,I]N=@D&\D0K4@OLD5X\AA%C? ML:AW+H3S91$I[7-F9_=_5A V6HG&^E'GR#-$SF4')$FE"JNRQRΰ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

?E Y@EI&S$:,N9901L: M=(D$B/((PNY3.3+T.+^442!AV9H@U[3.[V[ ^=4G/IF7:XAZYS13Z5U<2XC. MOH<3(9H("HCZQ81T+J3Q4__XX?DH2TI0E0J:BB$H+:9&3D,J[AB1%FC9%0@NE M8DZ1/>:=%D691"35)%O9)GLE(5O6F4'9F0GC,&?.^9VI>^^[Q?O>]_U][^?> MWLL?Y_&8\YKS.L_GZ[D_S^OU>KZ@PV3AY-8)-GC.!B>4+V-B9,%49!TG+C2S M+P7JE?1@VQW4X!@ZQ$@3=/W>\7H7*EQ_D9/,U_7$2>F08UO);& M7;EQ1JOJ[5)JX\2"#FX/7;%_8PMS\:%Z?>L\B&/'K"LN(G-(PX+T0<@O2AU] MZ],R&230*8JOYBB&Q ?;1ZV0WWQMST]F*O:A)##^2EW] 4$UX%5LXEG(X:,2 MDJT.D(NP$&H4!J0&%)6RP]CDN U:F]F?Q3GA3AEC[*6U0"IO,-')VB8:7""#W_L/R? MN&TN.4HIH44M+4L4]373DQMU&MJ.5H@N2 A+FG^;D(1*HC50%N4J"Z1[V9?JU%RZ]7:09L1+=YR M'**O(YA""P =(DD I9"B6JYOQ/$OWF]&>&3\_:9Q[Y^DV MJ\G#6R0T1HK&UP9Z[$&(3!\(:S!SB?"\\(N("7Z:1^V#>B*;U?(J9ACHA"TN AK#42IOOA^K Z4]5G\YVGAB O[8\$ M5&\12=KFHEU(YFPC!3(E(.?^*93G-%D,V"=UG%\4M;2#=. MQ17UA(?IUR<['E^0]MXL2UPYM()=>6KM.)Z4<-4E9164^X'X<;_*- QXC.>Z MHQ;QM9W,0E&%*O-3=D@;)CHNRWNWC5]0?&SQPK@Z]$UJV?GX9N7.ZTSG?79H^*6/I\G;"^AB?DY9#V MH'5G&6)$Y%:BH6?SR+!Z!@8H@BT*&!!*&SS1+*R?YKXWMM!'1('R\ 4& MA^2.ZGP%WW_TC\6FG\J'1&49] MX<+5;%TD.:A\ 8,P "ZY1Z^D?8?I$@R8"7:T"TO#>)^E#V3@KQ V6_!3E>'96BPMT-O%OXP"46_8D&#GZ/Z[T(&&0F $O3QD'[M$P1\C13=86R!QD#V.QD*SE'"@/)71#>&<'9XJTMX> MAFZ,A)A0;F+ M_C>QE^4A#>=I51^*AEL\J>C0,SW B7OB:>FT5<,.H6SV3^2 MUK>-R:T_$0%^+.TGPLO!5KIK_2G\?1I_JI'_SK2>)F34HQ6"^*]DOIO)^TMG M_B?O_N98<>]7PO,U0WXOHO=?%1W++'D,F/@ MK21.T]_LS.J?A%:J2%RVR&+RW#(K754O]JP_6:+YC*B9;J+?&F_3#[9(TF$- M;8&R7CZA;"O.Q\.CC?X!'[>HYY;(7:VUAUM?M MY:J5[?7$==UNI65:5Y8NX]8$"8)P'!9D\$U0IHFA),Y!XF]@D,N MP]9@BG7>8,C$G=>[=HA@P#BG!OT!;DN0()"*3L[&*7+^A;>QX(Z!PM3G4PVK MGA%A*;S_5#LHUQ#J8.7^_X/BQ_W63SSAW(O0@-NY&$U M#.BC9&FCLS(^%_BIR/=:<2BJ>O/66P24CQJ#8/XH7?^##"C6_F'SE[LKUO^;&BM>!/8RX@? 059/#B M3]QN,M3S6Q2]/K!M&1VV M=_^#GOH$#)@5"'7S7 42:5I*SV/30E3EBESGLG@CB0?_L5517QV5.-W:+^*Y M"J?U:<\C-0C4*K7,)(7&)@U@;7RD]K;/^&CT<;T7[;Z&U_8_GU"; M!W*V$R>0X7R>@B"*P:*#C_OB][;052BO>V.O'SFL7T28_N&(NUD9"IFOG3X>271&EA]Q#ZP716;8Q.SQWP=E>\1Z) M18INZ=R'A3R&UZ/.6IF=#=&KVT-?-:_HG7JOI3E7_/G$6.%91%T9PN(/>VGO M$E&)V7RPB4KTT.:=Y3)]]2VXTOEYE@L'XL*NG4GV;>M*8Y:75!<4_%_5=)ZM?-7RY(5'S_9!QN^EOB\Z&Z;G2* =R;@)SE M%MU@)6K/])3EO*9,KM+?>3+#Z]&SN8^8*:9..N_WWVHM>WVOT$^)>J5UT#6? M(LDYY;/5(VLV>\VR3;8)G@UW*X^HGOL) YJ=S[D8M$><"O25XH&IZ54_,+;GGLQ9;3Q!YV4[7&<BQ-\L788"P=&:]#RH1&=_% M.W,J;Z%3OJ+8A:R%K4HE%[SS"ZCQ#47N4EMFD ^_=)2]5.PZ\\U/QWM^CI'; M19K26&Y,C"A9P("%Z6UR(+A]\> MN81(95:H!:8Z&#VZ^^&5]^N$(X$OE4V'J>::PXAL)^I%(2(% MRS/"?9&9K51?&WJ0[L/EI!2CN'I;FUC+ETNHJ_6?S;2X\O%![H8R.;ZXQ>ZZ MG5W;PSI'0V*MI_[D.\_;(3\VR$/S.<=P4&?<1PSHS>9HL=61Z6*H>&Y+F3\D MD;53[CT]<+"& 3NW*DS?L"_8.N5RZ>.JA>\U%?(.A9C>(DJOZ[,(>KK_ YEC M0B BD"!%GW@, T3'"1X@4@:^+6V<:GJ^E^KFS+4/&'5;%]<, 3$!]0/6TC&S MWLB8I0_J=F% FDLZWF%W< L&^.F/XXMYB+ 5."K)T9M=6ZA*\(?1[MYFI9Q% MK\*GUJ][E;XDUMYN7^Z FNC,:/)-_J'G!.\<&<%-5!RV99'/MST-_XGS*' B MS=7=@]^WZ**#2.-/S&(=>L9.Y8]O>HHOKYW!3(4*M141@B"=[-,IXT'@QK$!]*O=R3ZELQ\9[Y%BRO&>RI($A:'K%^- MBOMRY'EQ7&*O:@*R#KY$*&2,[R;+],VQ38I%P,(W_.PU1UA626]C?,_[+;CW M+"-T]NS35?)$1O5Z;4GXL-(,G:>>J_==>UO67N*2%J!Z^M3$9FN%A4]%HIX! MY6(?2+WC^*:()%<;4;;C:WGXY;>$4J6R:W-!&5/%+OE];[>=C3V5MG%.I%/! M@.:UD)E6-_><.ZY%W,0]Y$-9A <*$'BX_P)$,-#VH*PY6\!\DDKU3[&FV@9K MW9^67J)D.V]#5M5)JQ*-E;.LN][+CH-[<>]^7_CI%BUEBH.LD(Q^1*:?%\HM M#,]GAF" .*+5XBKAQ)3,,KJN&]P0YJIV_H'S8OL<;>67E\8_F_QH0[U59!<) M7CY<;"#/A9!I\:RH6^RF#8V;[\!GSB[<3"F;,^F0?+I:\35S!9;/Q[:]5P95 M0<==L'9N;40#'#&0=^9 QI5K<36;UYE-JC]Y;BC@Q?H6_XQVE6I*34U-4R[H 2&'" VB#SG#P>!>&PVORH M:=QV[R';%_JV]]?OKQP4;*KI>[.B)3,#S$P-=>B;*ZEVU]+3\)1]%?$\XW!9 MG25O@P\JN9"_!#F.#W^#DXI**ASOQ9VP&SE2:3"]:]KFNU0QX"$$W;N;J#/= M><'!#3(GRU*RBTW=)S+VNNB4+N]MMGUH(&ZS8_)2G4L3M6=T^:M>-;BE!>89 M !QB/G_G T]1UBU58^\6RX4%J]9'RCTQF]W5HVH^XYE^E(/(QRE,GK<@A,&* MI'&LZ/7:; (B%\X:]N_U7,;U*9H*=[/E"UWE8#EW)Z6G]LE^2K=6E+9MXHQL MEIZE4/\@S*5>154] :VC<SA$?YA"/+.VUOS;7%8^@I3U,\Z*6I(3F M%S8K5*;NF'/=3%;QZI43=S8L%3G'.I>O'I55G=FTFE3U(+925TG!9>'=S6$- M95/=W DN'*CEJ(Z7ML.&^I5J#T6Y> M<^>FW=+)W,,[IM#3N/;9^4G ?67/V[[F:XL-.[:OC@X[H)Q[9S9 M'Q1R7VQN.MEV.?2&SK@18;6VO8)H Y&=:!V8WI=TFAN3E[0SG]N4ZJ@]M[:W M9MJ>QSJ;W;-R*B==FC'Y7._DQ5N.[<8#L FE<#&':BJLP&8PN\,FO:!I?/-H M"1LL"-'\^,IKMUR$)+^X1NIN0ZLY M\"QJ#\A-+, !?+::L]Q]X25U2X8M1A0]XS>]??),CP4MTX]W"JH:6=SO9J? M6UBC\ZGKZR(OSZVM91R$ZMM1\22^$Y1KEB7&-X?C48G5G))"QC1$CRU)F^RI MR5'W2RG)GC.I3SN9EWEKU.?&HKX/I,;B\3V3+H0\R9Q(-(%RU^<0T&:*!GR# M$]X:WN.^GT6;X0@1=!=NZB^$)ND?NU\2UP"'F06[>]=_T"H(W;:QU^>G_3M_ M+II<..+VT_%14L\0+FAU>AD&5_EXW)=KD"/M*5^N \ET1KSG1 M&OF?FXU$8PSC;0OW/5PP+;'QQF[2@@RU36_F7A3I/2P,EV :*E&" 7,OLP@" MORP3#(C+)1_Y=!37=O+( AH ]>BV: N62XP8K,& ,'E=#'A\& -&#YNFYM,^ MFK,PH+L7%"Q4(9G(6H]<@W:.633C=W:IW."K0"^+X%-H,YZBA1[FA^4H":A@ M6ZOG:@QPA49-=;U>DAMHZ\M&9A\#>3*@0-<8$2DDCV@X0K7W,*#SA$0IEXH$ MRS.&GM=<_<>V'Z?1JPF0ZT6H;0<>(3^: M^,B1^9'@@SZE?Y0CC;FX"(CXE6I'D[_9(_3U#J+_3$$EQDJ(Q6(&1,V#+>XB M,^'SK.Z .U5N E?KY?WZJ-#SEO6:O: *BOI%?>1E[C67F6T12!:N##5 M)&# G8>)B2(^>0<5ZG?LLM+=>G7C^F47PXY=.?#VRH&H$)UZQX[*Y#7*=[:& M.OL[UB7D8\ FT^<,#I=1;XI2!DG"[:&:5-B#V:N* > 9]4]%$.1V$TPHP7A2 MYI]''YVV%^1$";-T2N=0HRLB"$_ZF"+ZKKQ+&$#+EOF\.RV(+G:' M"E\PP%/[8''<-@PR1J:.]NFA%%QAQD,?SA9_UR$&5='C;\" LN; S[O("ZU] M*DR1=40)1H?)!0S(.X/GZUZGE'"H]AAP'AQ8T_I=#SR7)"@)8J'V?N//>U=; M$G,[8M#9!%_RX)P\B+U&&S4VR,3C =H3#'A.&XGB?M7X;E(__Z4@ G&T@?)\C+%818,2V M%DQZ3(-)GSZ9/&J%VGL8''7T4!81UJCM5=LP9]A$ 0/NF;=C@,J?E!+?/@ZR M6Z$4*B+HH FW#5MYK)&%"F9S$M$+.TB(^J?O5K7'& ,\,HQ+T++F;YXF?BWD M62I!8,M4V I7XP7JJ,RG;V[=3YDC?&T$E\X;_=\\+ER7HRB(#9RPNR.&."2A MC &MU7^>T8]E$8C<29Z:&! ]'0.9 ]RAYJYG.,XQE,_0*!:L\P?A MH3\E'7Y,8S"&G?O3TN)W9!K$4 E=_L9IY\_>H1Z[^UDG:C^)>(3V7SKQ/Y8# M B+KQ M3'3]LHM*ZZ3<) AD7!-2!\>?U$3^&'( <"WK]AHN23;)G0S0^RP$# MYRM2 ?WHYN!_+@5>2BQBWZT? R$]'&9B("(]SW]0 <76Y#^7ZWGO*Y([,FUE>\F149P]SV<7Y M>>)I89D6&W>_U.H_D*ER//4JB-M21E<]-S^JR>?JDQ/4X:8NMQJN4YH3QMC MD$! 1)49[^I(".R/CJ<^F8.+'1?*-=D;N)<4H$*L#P+P(6]ON(T!YRH9;(3) ML:".:J@0<=G=WB"L4!?B$,,7PU/.VQX02P-,>D(;X>)O)-I#^2,,5@QQT%P? MQ(GT,/U31:VQ1BS[#S3$>,LM,J<&N<4Q_> M:\ZIWG;^>DH#C9,,LB'8A\3 7[^?K\17[U'D6FM:Q9[ M.7$5&58@JPX:>4@;7H@!?5NSIFB\.IZUR,3FH>*2B^$+(S:"05H?];?,*5F* M&)"VW]6T^-P82+Q_Q<*$LI:RYW=8XT,=G;(= \*<.'0TWR8>#4JC5QZ&VU$) M7&O4[?GJ&%!G&3YB:[U%8=R_2#!<+W:;7@ZUX&RITD-)&%!/=$:SH"KPTV_:JVPYP;8]9R06KQ$E M1 MPY#FH/60Q?D.#?PYJ !7M'NNPLXIA*%6%+>#'R&T"K7JH'?%B)0+G\(-$"X8 MYDQA7P=B=[$ []&& 8($)+&"7(WC+'P. Z81T&@&WK<8@#?OH+Y+] =''GS)%C,%1O\]=UV+ ;K"+ M^)E#I/>[@]#[N.#ASU'A &A(ZG/G\]^(IRE\A=#K13R/ <1X###43?Y]H?]; MM4LNI,4<3!VDB"$4FF!"Q:\A?_2'1/X_HEG61;.@O"5G<5DW/]QW4XSGJ4P8 MTD)\_PGP^M^K6B?K[Q-#5.6S"$,3?XW\)59R @O'Y] A8;GFK8P7V][]0*SZ M#U$K@:R J_6DPGX1@6%BQE%B'>L@D?IR )B8BV"2<>OA_9E7WD"4JA><'$748<)R)OM<:LL3))8;<+A8C"@N23PE'&00PH3]SWGZF)/D;$]*Z:HX=,KVR9E\X)+B8"!AJP M2TV-EU%^LW:5NZ2&ZZ4(^6L:>]RG3+L:%#9Q[9YCC=8'[M=H(KBEL>EX&OW:_)=U[B=-F3K6[]41T(R' MA[MW3G':\>!='@_G(TW':",G0@636_O;<)?F(S]"#(,*SG+X(UT0*QT]U-4D M-[(13P/?"AXR.FXA*X6+^H6GO\^K^)7&J0K-(Y MN[X!#63FTQ!9,LXI9^+W+5R1%?R1^1C *D0-<:WKS^]O%Q[N&@LP6)J9*13@DY1,\U M4D[:-Q3LYO$GM"IC0%PU'::$]SIC@'$_NPR5T,95;SD5/G_3"[F"9S7[WB@"@?NBI159VA]O(P2[_)MH8K5\ GA.:UX%K(T%P046"\ M %O6P%[($,BQQ1/H(9<@)!9/^#LI-&/>.J6 M&XSXH*I,?V:9I7#?\ "XO8/^BC06!?[[1$E"S'"#Z$5$&234V^GCP/>=[ZSA_/*:)R.7?-^Z/MZRI&STGPGH@Y0?2$#_TMB_-/8OC?U+ M8W_'&GMYK%HZ%(LN,F>7=GW^ML?AI*>P%X>[U:J^4">2LY97VKN1@,CK\5*\ M9<\;J'BNFBVKH;Z1\49,D/-/@&3_1?7_M!C6_+*DB;&0\9W1\=F*CYI-J5&\ M>R'#JSB_WS\H[%'-_%BFMUB:ZS\S:K_D YJ'D6A_5#*2;V,HL99&,)@Y-4A6 M)I;9+H(R'7$[].>E_ \BBJ2QEK2-F"9 N4<93E);\^P,6G$K7;C1VDGVK6NN M2(->JAK(V<6L?SMIZP3X-*?C@OGM6_,P8 61Q_]5&$-_$?W_2 IW_I*8(VEC M11Z'I8('NF;B M;GRJ/Y,@-]?N@>5&Q@3"D>;:&C+'K+_A#\2%K_@HH]!0G1RUI/40*LL])64OMVS!D3T)EJF].LSLN7+Q MB::I^_!+CC]L;I4[H# YX2T#:G M@3B&"8-U#@,&MH-]^!_/%)'B(M+('Y!D.9.S&:[OLO,/8,!?KJ9V:O0!MNG3F<;)*_Y.01& M/9=^=&$I9P-K.!-;=A1 MNUX=#6X/@3@)F1C0>@7*WTBI ?)^DX8X+N9B0'*CQ8%,;L]Z",CVMG7O2PE M,<"@=5@U!0<<)K@#=>1XU&* 1"0#76F*Z(3WRF" R4 1 ][6A '<5RT=,7_K MZ5^]F#'0!QY?3?IM$ W2@S" %L9_]WN$:,3?0"GO,72E[M99T4F3;<)Y=DGC M^Y?MLI/UIW^)_M;#" MM(9+'OA(/DNXOQ=J;Z2TG:1QWI)32 +Y,D4,8%N>PH#B/P% ,,6_=TK!='BH MU2CT!G\=^DD;X5,;0RM113->(.XY1UK)B*8+!L#O MB=^]2ROX#O5A"Z.]+8='W):' 65/!2]Z078LPX$VJAVE*RSVV(\!H1;?(_\G MA5B.OB6FK)YJVUH;,F75H4(]3ZAMT_?OLI8W(=H60F4OO7H,$G"#2CO&OU3_ MO?K%?(_^,3>+H2QK! EOSN^Z3AX9)CZ;&?^]\OT9(!)Z9_.-DD1SUGB4M\9Y M6IXJ1HU_[P;R]P31M=Z(%[ W54A^GRJB["< 8KVJ?./SY[G]1;0_QB!_!(A& M%-RB&$D]Y'8775"Y#?^Z;A'J37F!(B*MS!#P=SC,'Q7B>D$LZ."G)#3HD]88 MJ9+E8-A%"/HU7W!;$ LY_+S8 M8 U<^;L;XH\+<2Q[GAU#J<& U$/^$WSRF2G, BW":M=(GK8BV80QH^CDJV47 M;WIM/MTKM[1@G[K*SLVI7:_\B(0MNRJ\22]5!_M1J5A! N18%H !'%O0.V>#1W+_5Z>S*>.9O ^U83 MX7D8D$L@=AG,XZJD/X)+V&)^[@SI;@-U[F9>XHFS7NYQ1B=TXLR>Q6IE[&Q; M;2TQ3F*BW-HV!BL' S[Z,>MET)<(L]'2)Z MJ$3Z/?3Y,",I/#!'"5&UP3@/IN7;+.?['EN+BMEHC&A( M6YEHUO#)M# [KP=%)9,K&E[WA6@]\%L;:Y^HCDY9 @>R&$$@QXA6OQ;>PM7N M'90RVO36I>^JT;K:M%$TO'V!\XL3LG>CCQNT/7[E+RJU!\I]R?Q(UP[!@!XB MJU^@[Y@RKI,FA@$'F? \4CXC>-4I1+:=12B0=X 7 D0\]96!' MK@K;TYG=H-'O3A6%(_-M0GT?V-8_&^="*4QH:'C#"7NE7[WNAKW2DWQP'I1[ ME+($#TK#<;.Q7WN:IS$!G3:-MI^[A$27."H\'6\^&U[ACP[@3O3"7DRKQ 3O,O)-:;%C>KPHGV<5V[9W*D M=]LY+F[HFJZ]__2: DO#^$[.Z7*UXV8:E]Y(K_?_T/@B5J0BE2HLYN]SVZDF M0R61NXJWPC7+6M[/37#:#V]4UJ!0\"NHY: MY,'M!4QX ?TYY ]Q+,^"[^0MO+9+>FFSFV,>P9FV&'#!TOS6=GCWSH8ZFX9) M>T_>.)G*OF9O*?UDO?=F=C5E296^*]\&RE7, 1QLAD-T,& *I9+\V&HXP*WT MQ%JN;D)8;0$Z*2FS>C:CLD]MMVC;DB:SR9=N3C\T2=)V? )Y??=;-2+'W>"R M3M\TD'V!V'[B?'%PG#IM;RG@M9/CP\, 05C.&N0H5ZRG@1/>$AO!"/64_&F[=J43E\Q:B1<9 .APR[2%U!,2!U?N=I7V M<%K7U"HI-6^-[8:GE:HW3JW-&YWK7[+T? :X:->KX-EV'70J%6+%9ER[A0$3 M7N!:=E6X1]T[K?[% HJ2I[$WZ$=,,>8NVI?N9_G!8;0QVA #+#5/;]UT>IJI MLM/KFP)5_D38U:X&/$200:N:]=_>3>'J%:_9U%]4RZO=L-UIYG(G-Q_3I*.G MU_ML\BZ4S1Z$E<@B?(PR9P MN'9P1#MKV1TX,J\^*JA^Z+Y4V?*;H[XI2[JF^8JFV^KX."P<7N_$[6>K%SB? M8),0Q?D<0O'X@:UI'!Q>R41]1,S6=:'S^9,8J@]X' M#QYL0W_VA 14R!ZJW^1Z'K?2\448T$ JIBQ)YI"I*5ZN[(E)\60'"\/3"9'1[7YSNP142.P"O:.&9)<*Z^%'P.$YB@3-;.X FIY.M MNG7#UNW)F9=\+KA8/17S(5]E<$Y]\^ M<&VYP+9Y>W">F5^HKLJNI>FO\_NFU0)H]N'F29S=V1[N4B?R%.UZ<\WCSF8; MK%0^7^YBKR[')2-RVGE1\AQFD>LY.ILI]6['C%3:U,#-5R.,=TDMN]@KLN(E MTEW0LNM-FEG^]<:\H"UNCMON7!.M%^D8=U MU14R71TWJKNN(7TXBRH?PEEAA@$QNXFP;0DS.:T@K$D6*')P M\\$T^KPTHPCB;&.,ZK)Q;YHC7%Z:*IA<88K\1)\!E2\B8L"X! PH$4%G;S'! M /"^%Q?O1&B/_*U("8\=NMJJ/2J:CP$L77!D#U0P_P6C?8B4 R+GD0$H_R+> MG@ -.N'_2WH1_K;D9 ;N>+9B0$>M/SI]%,=A7NW@,A,B=VF6/0:L?0HA$^,Q M8 $!]ETICZ )P\48\#,8Y0H?H^%,0$,\(+9K].?9A^]&B_HYQ'Q#)%S2IL;/ MP8.':@,8[R4V4(J;EF6X7M[%@ HZ 5DX" H7B7PW7G)YJ2Q4\(H;+AB/DXZC M2$,>@RVR;>2!T7@F$5V+GJ8B4RM1B6O@AUK&1U[YYP4KWZ((&>E88(",5A%Y M4!*G_?/#T,?G&!!@>0DJZZ)Y0B,B(Q_&(D?%&"C2.PX&@2WV'B7H^:-XG"E% M0G<0_^+^?X3[PF+B4B K83_J?!8#M)V%B#J-SKA#A6_L7HH!MW>!J(@E!EP3 M0];=#$:A;?Q6/((CENE]3Y._).#'EX#7$,N/QMF6A '+LS$@/,W_\U3H=XC^ M)0$_O 2(H9,F\07DF4G19;R%DJ)S[W*J?7VU!-D"E(?I@>F ME"0Y\T+$S%/]A[?7+MW4$!>E-F+>>G(+H 9M@#@UQ&2F0#820D1H&!!2F^?V MSPU77QGL1*CK1X,V,]!Q91A0U($!?H\%43A#8AMP=BEC .*2(_,O\#X)Y>^@ ME$YUQZDR!4#U; VF8S8DO)@OKR5L7F=L)P@_1 F(W1R:G]]][MHB\OBU@6++(+S*T)690T? ML]RZ*Z5=UZGT80L]KOA\H0K1?J6*B:W2^@>-T24'&IT?Q,QTEN5YE=V!V$LX MQ8*)>(*:@0=PNWV0"M!,"K[Q<]Q-U@'I6)>O#HNU19+A.6.U.B=?ZYH M?)LPXADNG,V(^,WKWP:@^G">&2S'=_"OA$U8U6?/OF[[OBEA$:RDE M;0H:THOIN?YNU]JW<1U5O<=-Q4*W>";GX2S9X/HN.5=E?#)LS7I&6>JH(E_9 M<^U-?OX9:\-922=[A1W[TZDVTV+W .-%@2G5@TVRXP8P()C!"@" M^TL([P@%9+%^6_;T6U3UW#2*;HWS_DB!5B^M4R;WY.4F*):V8N2MP8$1JGYU M?[T(*I[/5Z54,9.;;_ U$0J'%)!EQEHX=X^MU_C^%H-LA9OK4U;O=6&H@KJ\3OG]"-;Q7K6\)=0RLG)7LR>&]Q*=E7.$L["GB7%BVZT MA)SAFS^U5%#9E7#ZV.K&V(1SVZVNK%@Y^]E*-F,O"59C]*S$#>X'1I5N?QV5 M[?L^+NG>.RD#NQ.[:_N&S)X>,?*??G3-:RK/0^]^4NBLZ+IM:2V)U-A[MPD1 MGE)XOQL"J@$1 =_F2'0JNEYT-9C941^K>)6:;W>B>#0J.EKRWB';ZTV]CPY! M2W6?6D7V]!0Q7X_+>A#4"3I0875"CQ=_F^=Q3GSO3&XRVZT^/!B9&5\2[WCF M;ASC[(%%"]1.J+YK*G9>.KWG(58" M93G7%9&.R2,^Z2^X?.@N8IQVI M82OWKFAUX.<+="[6IZ'X(8N\5T9VS^WB2;I;NL4Z50FTMT\ MN\H]4D8J_Z4:]\YA>9GKEYIWSKPJX=UCVW]BMRM?>'HP@<&*9#ZF%FZ#2_CZ MGC)9*;4+2HMYDR.80=I#*]R6K-!:\B2HZ]"&F>57EIZSU]AYBGV=^-#A\S1< MCCIN;)_@CN< +((!>^G3H,['U@UR([VXP67!]W$V]*&2GENH1HJ7*G4?.@DF M-8X8.(2]T:"6I::UOBXS>IME,.]54EV_5.OQ1MG3B=8Q6V^JNM%7YED$93IJ MO;Q[\JV='97LWZZXDR=]O,XJCOEJPP<-^L\,=E<85"%!1N8S^!%4^$PL;7 = MKGP2KN@'>FL_?)6N#';L8' HN/>Y1JO$@(;3IP90 D*E._S3OC'H7*=BPNAT M;82(V];WT8+T< ADX?9PE!A].4!A";8B_6Z 3\)=9S>WE_!T(^0?']W<.].=OR/WK/>_] M".C^H8&2$+FMNYGC_P;G[H^/\.\9: +A*VK_>M?1'P/?/S#0SR:_F/@++[Y% M(M"&FX_Z!F. &)XPC3A SN^993#XT2#G3LZZ[U#\&HNOW+$_K]D.P0 \DU;M MKM=JT_X&Q]\*-OL/ #86Y%AM/%;\_+=1V?!;N'^YY?\+Z[_K&.??96S7#R)/ MOTNP1GBBL"U"_W/.?W0G0XT#6+6A@!=0(8H"+4PFTCWB.AP%I MZCT,-K5^%5D&](\L@)S?A*9Y=]@*HGAGR4.9,4V9+YJ&U^OMOWE 8,C71]^4 M(R+HNX]9-O7QO/2Z@8SBEQ^SZ,L$:6\\RX[L;\[NGYPUARMRP=,H?_^R77/B MMP3?CQ/WTXYU/LQ@/6,IQ'KO.C*/(8$!/;KWH8[$PX,?R2/* M>QG=;>!@[)D9)"1$ PH%1[>"J@XXUN?!(__S/:[_Y0N$&*Q Z.-%LA]Y6!$# M*JN'O*S(FKA:2./*HL"8S.C3Q8#XQ*[1^PQ:,GU$>1_4W88!@W$4]4CHQ5L& M_!X#[BZ^$Z3U6I]S)T@#P"^1;SB<]!7_/SWR_WS1 T'6@]UBG/ ">KTD;P^' M$#JHH;M&R1J^=,PIP7%XUO6^V?9IDT,N'C7Q2B<+O_=L8K3U, Y@ %_S. 9H M';[WRCSLBEU$W=49FZ2W!B>;QD#YB0Q6%'G0$97# (8TQ'7[KL5]4%2N3A!_ M RH;P0#65@Q8EL@WPE4;O/NIQ+H!A)L#:RA7G]%1*91"BAH&M'2,T=;=(:&! M5KYFM./F '>\UR&'_1C0/OBIQGD9WM35#ZN'"Q0A7ZB_@(;8$;]M\!IG0JP_ M'8[WIJ&BV@.$WLD0@GXN,XXCALZTPX )'S$@AL2A"^#+&! <,T8;_;9&#)^T M%'_' 8\OXON%413\9NWGTJ]TW#3\IOH(0LY?B /H! LRW@-IBS!@('1S]76 MVS$ =C^%R)2@(6 >8[B%A"ZB?MN0<^X.M5>_!(7P08\/'_'G^8$H9/:IV+EG M+1W*7<1@T:[51]V83'Q"][UZ,$-+,T!MQ*^91DD%V=5,#DE[5 >WGAC # 3A M#!X5E]<79%,,H'\J1_SN1QZ=L&[#E$?"CX(#!E0!M_!8A(D#\0ZQ5PCR+X7-<>)P^R M*A,5Q[5X/8U-YG/5,4#>]/LF\EH+4UZ4/?X*?.SGS9#\?RGYW=J[\<'80;G@ MPM0U2Q5 >[*D9JG;=JNI&P>DL@T$7O-WH',QX.< PPU/DU8A?^T,/\ MLRKXA^RSJ+@[#A1)JQI\L4=PU7-!HF[%SFV&ZJ^7#_*'$L82YA2/<'3=*"@0 MEI&N*?SAA_@'U_*=9X81Z6Y4?,0YH?/G7+XFO'.[TYTG][Q)UYT[A[L[-Q5S MM1'?06A4 (Z*_SJ9H[1_Z$'^F75\A4<,*NZ*]QE-Y@B:JND]">P#E^;,G;GG M\BR&C6ZCP7 8BTU66/WQJ.^-)O&^8<< 5=^^?\'S2J[9B*/+OI0W_B:;.$'([ M"4?ES$O[R52^AL>V9./8RQ-NWH086[\GG7N_S2]%$C?_.33F?RY!['_&YNI$ M(CR7BLC4F&D<@.J,\NY&S%6[KM;6*A@='KO*^:]1V_M_/Z>>V4I MV!/-WEHJ'?:3]/%CJ,!L+%IE_U(;4?RY>IP]V-8Q[Q]$\,N.2/,N0R9"%LS1E@TIQNWPEJO7)WY M$]EM ?_-DFML,KS NN"L-FY#Y:%#Q*",:Y$+WS/\/=V][I4ZBOB>OJ;PL/'. MY>=JDT^0W:W;31%EX>>J?A\&3[$&'+RF.+QBOZC_:SA!3R)7)0\@7&H*&^*0;XK,!E?,D]>@\9]HY2@/+?>QA7)&.9 @A>YH-H#2@&@2T2'J%QH:?'@-TA084@[CSPZ M*TH5!WJ3R"9?KQ(>CFB97S8Z,1R=C.NA&I&KG(4_??LZKJ<9$!(X>N);>FC\ MA6]WG9WZ<_K4>ZDW7SSO,O?,5RC>A%3=H7ZE5<(:\N]; M0,$$W B*5N("1:JD?8.%*0*&L[4%4TG3<)AO"!SZZ\/"0 MBANUWI5%">3FKRM?Y)9IY]IK8!72>/^C25MCB(=1GZ M2.T'H$9K#-B2?G7$.KA9Y2A=_&CU@H,[-^;%)JZ7>O9J=[?O^NI()X^'I)HL M):YJL$=^8/>>@4VOW%K76VYW?W']ZZ+OKFP][NDG??ND;ES16-R$\U[$*/9/&3$:! MB+%*I"1[_L.GWOVB[C#P2^G9;=53OCAFT?(/CL=_KO+,/[T8JT 6"QH1\YPI MG'W#<\S8Q[4=V10\&,EM8,H@ASA./$L.L8#F7Q^VLVO4)?44SRQPX5OSG /7 M+ RLW@R6E?=*85N?[?>NHLJ M'[BT:Z1X2NMB61O+AYMBYS3UW&2U1#YQJ3U3I^=R$4:#$!RP_VW*.]Q7F"\ M.89.G[<"?-O4/4I'YTGZ@.U%N,H!N$26D-IH$5"\\^W8L["TDRJF:A8^Q@GB"@= Y1BQFKZ&BDC=&YE"*-#%8]&S@OW?9AV MN&"#=6<05X@UNKZ^@DX0X9=W#$8O26"64' MG@^4@T>@48WI1'A6*@:TXNG MPT%N4T/+GJ?+4,]]($<"0E+ %KL5 M#:CW8CR9F$E"MU'B+NWC7# PP6$*$14'4 MALA==-,9MTH*$#(%)[LF:'F/7D*$SXCUXO;*9#P^R G3&8@+=8R6ZXLFX\&Y M A49C[NMA80Q1*@4XJPCU5NV,'HS<8-O#5OS%U,J1K/3TED,/ ER@8YT_KQS M;DPISYE@GNDO_5S:N*#VH<(SN.,O=B(!^VD>_CX1^\. MGF>E8\ B/,W\3$9:16U(+<+X.S/@4A/*:YP9,= >:%15#X0MNT"$0H7=7'MP M03(^B.==$EZFGP_M##S/8HP,D/\F;R:XC/06$_'$XQ\2UZHKQU\V%A8@NX+Q M&!1,BZ0A\X>(*(AK 4$43S$B<$;\C:B-Q_#,@?-WQBRS(">#G [F.R(:4%J& MRH[BI"0^*'5%Q=?PQ7=VK7+.9N1V^YH%AX51X8VI(I?2P0$F'@CN\=!&/6N_ M$+R3K50\(_F[%',_! ENX+?KT>>XR*YW@3CQ51 L('X+"%:D2*0W#20DW]P>.M/^P<.GJ:U7[T1NMM4__)%UE%1 MBF,++4AY35$C:"9R+G[[LI =I<^*YN]<=ZQSY>IFLW@O4B6BSHD/@)4"[K<. M2%RY*[[UBO2%V*9&MG;JI$0;[4>\\DZ'.T'(5-3GEV497QZ#L^_K4W%^95G& MEW,"N"?YXNZV5-"O+#!8YCE6FGN?,D99>/,)57\[%/G+2^X?'S;EHZ6K4D /5RJ'KXNZY_>('(_[ 2 BO_3 1-<2CS-H>YJ@<'I$):\A/ MTQ902C$@>GOAF%V^NK8I1MUR>N"8KKB9V;F\)%IYR(-9YVC/+,@WR!SC(GUKKRP:MS0@?7I/%'N M<%'_5,^=\"F.=>%V#DQL$0MRI30EV)Q^^X8>9T?>KW=<_9KUB3#VP_<]N9:] M="J4;MJ3R]?9W:5XJ) >()^TJZ/>INN,(.T\VXYD<]DDR;G!I;]V2]K-=PUI M+Y>7'GL?<]K5;_468(U+T( 3K4&$=RB8Y1?(-]WAN?=M*FFB1Y291]:2!QUS MAXB]">W[?FZHRS_\Q,Q]]=(G 7/67]9H=;%*\K\-Y1I"^[-/;.'&)7IQGY3E M5WBN3$NF%?L4*[HS_9F&9DE+TO0V)N2+K+.?NF';X@GG8B>OF@[P;+3>$Q1P M-WXQ3PV)R3(HZ_<#K9O,[N3;#LC2N[I]0=J-NO>FL[:J?ZQ MPGOZA'NEFW$"KZJ%6)%12^"]+/($2C.DLB!%2G.X.&-1.BO8>76AC.WNPQDW M90Y6OC1;=_!90,K-WJT^LX?G6[D#HW%!7,9%!L><\>XR[RS\+ X1AB2ZB./Z N1-:?O^9R02\V.#;],6G4;M ^PS5?SWABD)9H7MD%,\CF#LZW_ MG5(+E,LD(*=@5[[Q3B>4R#T4L$@'E)P7$L-L[%I5=!>8YV1KMVJ%5,_'.2$] M">(%'B<^3JT:-R@EU\K$3:4KM0YLH>739R DCGSA$;ECKWZ=3ML7WW8$[$?0R8#++BB)-=D6.W;9L[ M(RY$]#U;?B/&SL'ZZ,BJA8_NU*0]*3E:(;@5[_%Z$3?V@57LWHNS9XETG]'* M%6Z_BD+S>!%O+L63$0^_FOR"54P>Z(_8GKK=M1@^L:U*3W9Z6GUE0\BJTV:) MLS;T*5Q;;Q$6.\6G]51O*U\)+65*ZQ!],$"9X= O ;L6JLP]A+XH=Y?:2*E4 MK5@)D[J1LX&=K^VGTV?/-+IXH=ID]2CNV+#BI@VUTXOH>XD'?N MC)3P2%/**BCW _'C?A4\B'N,N^-1B_C:'CL*".6VU*NDMY#>)>=&J/N[G4WD M-X2XL P/V;N\+9DM\TY:3E;:8P)GE<3FV$>Y\YHN(7D6=J<0W(L74T?G4!;A MWL>E^W.(B -KF\"@3Q>.DUF+! M-% >8NNY_VUC+01S<2=)*F3"FYL@;H9!DM%(;;-/W3;4>E@Y1*X6R@<1#SQ" M5F_I1^;U,83Q5QD&J( =@3 > XEGTO&8^1.<\K.:M%=HZZ4[&?WP(=S9$@>- M$3L,N-!4^RD8_@[T:"&AG7R&8&\Y0FX\KF-M]_T W+Z'O2,:Z>XW[+D/:?%# MUP=U,]@T5!^JD.&>0F5.D84QW/>0NV7!6UX=:ZZ2WD/'7E38.<(BW,:IA%R2 M_(E*=+X0?;,Q('OM\Q^@9XL]24#H?2L5M1Y]3R?P6] /S%'WX=L\*_"JH%C5 MQ)WY/9G&X-I0$/%-SJ#*)P[Q35$I/,BZTHW@Z#S#DSN+$!L&O1[=PD2\P MY?3Q9$PT!Y[;0I)'EG$G7HVWA?(V\H(%9NNC)NUK8C^TLCZ1(;HK6?-BU$:1 M;,B&UF"C)Q!]"/6/XH"^)%RPCI5K[T,EU+N&,2R BJA?_OYB$(41FNF\FA \ ME'8B\U%&J^E7-U^PO*5T/_S+0A#<8W M?T4I(Y/M:'T%HV,AGIM M8C#5S=?BLC..XF0LP-S<#J>>S"Z45W]9?DG%"*: M[2\IQ<2,)[1HMFZ_TA2CANX[>M.J?J:)K%78UT[VRY4J7]^-Z5;EJ%^?!OG5 M[5JE7_/&!^%BU"28.49LIE] MW7-A"V.B1^76MX6W&G_N*MS\>OF)XIEM:@7W7FH^V]$67J+QQH;AI/V 777D M8&6?BE6H1X2>@[K'S8D*<^TF'=#GO#(4^]F0+@'CZ=*$,D$H=) 8@BX0Q%#$ M/>0+(D@7D=,GTWG#4E(H>U;15V47C"^D)%I&Q M&2;;'9\PER\V=IW21T;%K5MGFK:Z]IKR#WK*<+5[+5J8XI[K*AB.]*G-AU5D MDI++8\.&\Q^E\3*L6(I^MX[I7)*T]6 ]/Z&H:?*1'J'GY<,U0L49_)F(G2!> MI[]!KY \>4@+#%JU^^<,*\9%9&&K\WZCS+#7TL9XAGNPZ7FZUH#<'"O/>U:@ MYCUE^=Y ?-@X%[W=*8U,A0>@@W8H8Z*K: M=$2=*W;QX.:M;UQE&CIKYV' )M=%HJ%F>R>D!\\R/B$;>#QVR4[5A]IUVKQ< MN)7K6D1.L>ZYA/,7?Y4;>3Q:'D6$%RJCL[C$"_3=K<;<>+]6NW6KS>[I+5-8 M5WKV^/*P'2-OIN3/" (?90G7U/0++F,[7#?G71BESAO,>;IU)8E<9 M2'+E^D*6^YR5E5E[.5_W9L6+TO>-6Q0VO'DR8]<+Y:2R-5QK%JUG@*^*2,// MN+7;:QY]X,H'>LH= MU%,@TDJ U9D]7/Y*3^'G].W[.+4%VA,=G.YT,R9Z&B;"P19A%9*2_+T>^ZMF M98>O/_RE>D=,1*W"7(P!L0A1OZH5)S@HF7+H&5.,J$ S_Q?'G$U7&IZ MH#9\?''_\24'RC4PX$!+SCF<0[(H_G^R=3$95B/G:X_W7%NC;WW6P6T$9.]# M%M**TCF==,_TRO3PLW$C,26A=H&J#7MG/9V063SK4HF@E+\=S06?%/>FLIHD MV?V]JAP,,*]Q R=WI8U&^=]UI&A7NWDL=&%-,%QLMZH+*%78_SCMY*'WA8 G MGD2+FG.*_3W-A,X+1^-XO8>/46IV@!-1^E#=B?%/!YP'G<19%-,=[ZTND3B/ M)YRP:^^]X<5?!>NA$DI\/40%-N)(KGT&#ZM1%E6C2MVG:BT[1]5]%[@EHE>!2S M[[_0EWJD74BIB/5?YKG!, M;I0^S&YL[RWK+6 M8",^+F-'='X%R'I"XY@WJ1:KZ*36IAZH0F=$]FXI^T_V\G_NJKN[E>=[[O>_KOC_/ M'_/'Z71LO_7[.X[?[SC?CQW9WHI)16];3\)EUL&+\F?AV4S(V7)@-@U,V:KV M+M%01M.#-J>F!G&[A@;W3SMW/A7^7/LQTKVH%:MF=NE9FA)BIN5/-BH,>Y4/ MVP#!G&H3"#7WZS?&6=YV7O.=*+GK:[^EPM,G,]?%]5KT#H-TSW.[CC_,+U2] MD>/^T@_=0SL]A2N"$(P2J"9_*ECE!]N=33(OZ8D(C5,[]3;6 M8&Z6=.FF;I9MI>5'O(B*B:3W9!V!;)!M,N!EI($+451M,?2<6LZL;$Z+\;"^ M:*_.MGJ('J62\.;0WN&/J'D\9-YK=N+M3(*3)-V"JL3(N!!+XB1UDEJ/W#R' M=L\R)E[(HU/<%[Y$'GQ0-QFI/I/#5[58\?[=]EF$(PL Y?IFLFD7Z:?(R(;Y M""9?7XG)%OK1;BW":,+P41)'65I>E.)K>CFB0<#$AWSAZ+#-8H?>(@5/P*+&^MI/DD$K4% M/YRO7E2SOE'_ZV/Y9L1H J%4!4Z^$"F!5F"DRG:\*.K"\( 2>?0K:2W.'?J< M]3Y+"29)FRP_[Y#?D_^4O2TN3[O_G93/_"P$939)@4C:!O!)=1) R:]N"TM2 MJ:),#LS2-?'\FB**)2&SO?MUCJZ&MNQ/-]^\$E*G+'36JA0QFD@H\IV?(=(T MF^%A:-'T*:V#$#8-77:30&MW>43!G[CD.O>9>*J^HX4ICVE&\F$.>K^A.Y'"L0W"*VX;CMMWHO55BX^>O2SQT!UW;J3J M" ./=3!A1W.#_>23TS5KC7B/@=CU*#DGC-LR^*(FZ/:2Y*^V^ M\J0!VA.J)@MX2 M&:5<#$4+< ,6@$L@T'F<$43.3L3DQ H+V#!0NB=_MFZ5WO17_N$Y+Q;468I< M787&JBY-96[QE69BW+!DA6P["+W\M8;\YRZ1\Q)1F5]>-1UKWCH4S '+ %_CBH@\+N.^B_TTO%@W_G)87XR<#/:9M](V#CLP9)'W.CGUMISTX MV%E>_MW>(OMO-,K\CCZ?4OP.LH!OB!3Y#65SUTN1_@4MGU&4'A2W2'!\G=L1 MEM)1;P"[58_9E=/OK70J]N->JXE%!<$G8>E-I\I^]C5JX#H4ZOV97/!O*&6] M?AS[+9^_I7%/ 12S_/]O:0X7!(U.%[2[YA%?ERN(G_!;V:]/DD_/(?R6?@B< M+R3;QBC\:E;2.F&U6T[$.")&Z5OIB/WNT/-?OJ+?M;RMM9L<^\S^^;!-G;N' MU>$0MKD+D?7F"4J;OICU-\A?&KF68N;N\>F+Q<^#$E["_U"S_\]OF$I" M;G:*U>#K&5(7T4M]^%AR_"%=SZ/GMV"-.]:6IS.M*-3B367+B1>D+P6=:=]U MT/G-][+_Y:OYT3(ZU%<)=NWWV)']VE4Q3%] ZEB+ !A:=&WT[3[KPVFHA _% MI\XH)DCL(_SD0'T;6\(?VD;^V#)\U)PGU2"UY',J;B7[^O^7ZDI_Q&@I4H"N M3G[2@&?'2(%O,FPTZJS[-K58Z[UM>F87M4%$&J'\B.:0?XHV\I,:VV>?0:V= M8>\+O*@7(H?/?&R+S7@CKQ71VK_DD!'=';-_C._PW$L=1J<^% S6U6.O8]?X MG?'@GNA(T#MRIHT%Z+1:0NA T'*R5:B!!0@&$#D72 @R%'4Y8K59@.N$1-\0 M)@#[UUMNP]8_!W7HKR/I.UC "=U[LJP;].4.EU3G^K IY/9$.X.&0]I>DA M\P,+6!+OP9)-=V/0'?KT4[ '\):'$*K$,YYC_VT&V[L^!*85\%/-/3_)3%9J M4/I^=/G%B5 $Z2Q:BGE)G\G' F;9:5X'YJK&EG8P):77#WG;;T, I^;$+]^- MCM=R3&7NYJR%C==C1PG,=D39;?[I.80.GDA"%"$8G*I(^C9#_7_:2$@4MHZ' M?ILY 2E/ 3\Z_N($EAS(0H:N72)C)>CPBVHTPGQ*R^3ADIIDC=6,3)C-^;W M4&V;8A9OVU*J>F?Z;H\AP"O8".Q0!Z1AE[%@/((8R(1@YFTHG*ZYSP)(J)GW M\F,(DDVEUKPU%"LI,;57(\$0NO$ CKEA/4'SQ_;Y=VE":.>"UV6EB2J)?8=N MA(E\7GRTN- W$//=#J ^W:@L>'@:.PK)\SM.^@FF["P$@-FP]*@%)/T O@DQ MMQZ,'$#0C>'D6A8@S@+>I$+J7LT"**K4:Q#'*[Q]1\J8O$BZ'[;>A.3:#0TO MP@*:X:*0!GU/D2Y$T>1]3T(0GDLEI3T:[9U T8N+(D2X5Y_V(!8@*Y\ M>BJZRCSK. #HN>-12;\#WMR$4$*8=A0M(_5FYRO$+I?MGF^%YA3?89&*F'@32B_C"^0(0A M9!**!X]V85>1^G3=,)H MN,\"-FE@+?J+"!F>:UM;3X*JX(G;UW*7ZZ0FU=Z M3;=(P3MC2>+(3V',T(P&)%WB"YZ>G\K&WXR4K<$$;>%%F"H/ KS>BQ +USI'PF_Q*!:0F9ABTD9CURR5QK'Z3# M\\8L8-P7/EVE1U]/X]=EN#;36N800IGY S@P6(0*A;XI613(N'/>@SR[A058%V(6:)$-SO+4C)\M[7?K9WB]P\MX+_GA3,BL_(5B7Z1D3O#*ZR:HQB M%0F;MRJR"(DR&^S_G<>6RZ9( MX'>416+[&MWO>/E]](WL25BYF^_ILNJRJCSNC5.OF:AJ^:0^MVC[=7!A<(%[ M3TK5@57MWQG&'_\ ?/H+6(P=7H]?$(%D:GJ)!4S)ELK_\/QS /?_,)[Z3[-+ M,WX:K!K_+(_WFW37SN\BPV\,E7/P-]8N\S]['G_*H_X^2^?[')Z?9U'_=W\_ MN^6$)E:U&X)DK\"N.@0_PA'>']8THMQ=U?1BBB#@FJ\JC]_]>>%RN$(_X<:5 M9Z_8#I\UG)&WVB9OASH9OOW-&>,]#;*#+OTRL;EE*486'[+[D@.3]_6\2.5* M'Y?M--Q]9_ >].JMH-9 2I4'!&T+L34(_%059.RR7T(ZK0 G4TU N16&"(%> MXHEDZN6GL S[S9F( 1 >B*8!FN*H:M=3,EF%K"1 M"9D"&@N(S8-4^ETQMJX?,8HC+"&Q"ST]V%7AR&6Y1Y#L6Z_#9E7$*F3<;%_+ M,8.>8ND2ZWGZ6F$_G] ]]6KX0 L5R\C$EN")>B!$I=LTV#LF9%-"S(?+HB;O M)EG2T7J2,ZMFOD-C;H??M2FJ![Y.4*PS$@BK[LTXHU:9<-6_X'+_\E%T.T?#7_3L_[RQ1']3L]_2U\Q_7I"ZP?EG.8)_3J?KC?DS M-G+<\.T1\+GS&M^<(_]G3^.?=6$6Y%\#UJV2!-F+66?5Q(RN0Z8LKT*.A7/] MP/SHZ#PCJ"22L3NH"N>/_5S4@IW9% UC?D8MIN/U\*-^+ C$'O7@C1F]J-%E5 M ^=I@2P@(PN7!W])'LWZ:^Z"]]6>G&1:_E8449__FG[1%OG%0\^?%?WT_&CT-*I+- 2UXOM=L$Q1U/ZG!K(G7SZU5T MO@TL )8,N;]4CV 6P%WT7YYTR@T_-;R3!=3FK+M$]%$].$6H\CB$"%=]VR%C MH,O<*1>,6%(*)D .F1;VXZA4=2;? 4:Q R,?2\3>90'\Y^H@YQV)K94/C\\J M7Z2S@-G(M:L)=U:U5H<'(3QR2(C&8 $U.\Y&CAFIAG/WCN@'7Q*)NKZEZ?(!]PP+D?'H6^7E[C[-N>=0 MKAGSR]M,D6*^F7_F^5_)M_H+3/^Q>NV'9^#&7Y2O?^)8"3\#EN=^HB1^LC\% M_M\ 7:=O--1/\9O+ 71_*T+K_H^=1,H__")"]BAPE=)&C)QI(5O7LX!B6*.; MH/X+;^M:,96U]+),C=B#-8*Q.\_?FFOBSCQR_=K9S5*6'UA H4D#;I# Y!8E MFYQFY*H0'FHHU< V@>\_?87S:TK# \9Z/4.*,^1FRM82/RP^U#V3<-T:Y1UW M]9:BP^,G91]9P.B72!A(J$>03^2'"8#[CGRV-GK+/W\Q:$BPS5XRW[%3D-/\ M7.')I0O-FAOT>Y!D$V.'NI&=C/M57--)@DFB*BWY#S#BT36CC6U[OL32M-G3 M.;?//CK+&8GY@""?Q3]<\YIM7K]JCP6X,.1U"L T!V(/13+$VD2F\.%S?\;YP<+4P:^&:ATM8Z J< ],-AS$/T:^"R;0C:#A%[P5S M#WCE2KK<0Z7Q@%F+>$QRIMYM&;7.D]&-G9I.&V\9;O=8==#CSZUPFT32MTWJ M=J.1$-A0P-1K*-6]2W/Q.D,N+<.21!5"^/@C!&>4C_*;BUK,'3C#IE1\ZU,N M#)1NFWE".^SMP^0NH[D0IG";/5J<*CDI^G63M8=.7N4T5A=SJ7_RR^H;Q9D/ M#86&,BO/8<\1HR&XDN!9==H%- *DN=/.@S1CBG 9>9Z:1%&_7YSP%JX3=J8T M[$Q7;O%RN'2(NEK7_B?-SVPO(GR**S:=U>K.;\2!<2 M %HG^TLOHE2NOJ1#Q=I-T.;B1:>^[$T)X7IV)=[TZ>>GK]C>WM6XR6?U[E*O;RR3^LP^GP!F3.D9-BH05W,LV$NSL4GJU[! MVC3HB*M4]/@-!1=^JX5UPZK#!ZV>QND?]TZ@2C&3F+K1Q-_T(I%D#^V"@GHL4^.RE#'5K@\C3 M,KY;7<5EA_;=%Q0=T!&,.QCHI:0-+U@RTQ=K$*M/>V@."-N9D$SDOCHY OE- M)J!F'?.T?2V"*@;1Z)3*&N,HF$LT&6BSI-P>0\9U,UG>Y"$ MD##B$7$P,PUUN_JY$T_"RFZS7(*,+:\0C8<%=,2B95A G5L:"Z"$(HC^^"O8 MM4-M#W"@RQ*>>1#9AJ3,PR:) NX M 4UW/YV/+ *Y6-"@JHU1P0*X<$%VA31L/YT@W;I032CZF.!Z[VYX1#K>B+Q8 M_Z&L'IG#,'OPA<9OM%B2CSB6>YWZV6M9_[T[8C/I-;+?QSD*5SQ1DI^AI+C" M @1FMUD@/JVG,NI4*-$Y$&/ZWSX@T^![;IA"(-Z.@F=PS.#)V]=SPK]] /[& M:\D? LY+Z6]0I)ANCY[R'H7$@<\/12]+R;M\]469S-A"='\^',=DAU.>\X7* MP[_]0^H?Y.UW=^%]^RZG]59?@WSFEVS/E]9'2YJW'*K6MACL7FOGM-2S9X1! MHKVTHY %5-LS57R_>V(K^&._![Z[JO%6_'A^J*5IE\7T^5(O5+34-3^_W+*L MY5Q$@3>!&7 '"?)B&Z%P)P?[S7/DO_3=#['8MR^+5%N0V_)2TW-[LV[,];5]KYYC]8R^/H^&W M\@#X-^S,!&.[&K*>#Q^CYCI3N"*?AKCJ2']JY]3YYJ*%P&L.8[H. F$7BWC& M%=M=(K2;>M-H(N&08*A?8P%^3?3U0\>F[__RQWJ_P>UG.TCR.(I"1M@YG7*? M6:L>D@#\H."0OWY!MIH%1D7-?7M)PH$JLUF.3Y]Y?1W9[_RQU\=N]\V%&;!O M/=%YM)$3J;O=-8EF4>+]0/_#B3*IJ!E']N??["O4%A91DHL>-N3T!R[$.:HU M2=E/FS'^4-;T;[Y7_]D]'VT_D^R>!'F$V([#CZQ:GR+WW@FX<8M#JYBMX@^^ MO+_I;+XK:5:_[\4GIMTD-QO].7(E^_I_>V_S4*7GJ!LG_0S9(I\\1A()FEE. MY+3M&G+6V!5T4.UD4RNP&C!Z G:?NP-8C]6CQT;XK#; *ECV1--P#[QURT%)3/4Q[%:W?-%(?+RO() M/TF[N'FWVIW[?G=@^PO?CZ&C#VJZXS?C1Q,08EH;L37:6@>8O;C-6!2/#:*& M(#KOT8JL3]I40=88LI'-LG=NURNDS ,@'/SWP.B\#: M(4#9X";DIQ:B6Q,BF(HM<0BLU/.BI)).OAV+G#U2)31D+1OYTKF9]W9&M&HP M3:\\1]K.+;Q&)DXZ=/&M")-K!_&M-7,SG$@ =[LUP@>.&U\"81=\'8AM]00^ M;^.E<'W=[H;QGB'UZ\)O7U^TX?O<(9$O//74SY0BQ>!.\=,ZPHA@ 5>0X!YX M %H_91I//@L#][P#:QQ&*YM'9]F-R+M+(]T4ID)2(L]V?PY_5+;0&-%X..3\ MQ8/*(C'V'@,,__6+ T40]LB!'6.1C00A3&<\YZ/]&'6P&\29MN=@Q%O3M&*\ M2MIE+/FRAE:C9O9Q.2Z_K:EGL%G^@[-;,G#\$4VS$*9PC/HFD$^+[ $6INQ"?.$5DD0TW,E]55^%S<="K6"@D!.%J!748L 30>Q%,^U M@Z-*@S#J63"+U&+"1E=AO*B$Y4][,1T^%2?"ZZEE(LHSX2]\HU)C73(?-;'[ MO5@28N@NN;Q3'BH\DE/P]-0O3ZC"DQE[1D8&J!-&J&SJFU7.4!8PR\/UQ>>] M5B>UE\!!_;04NB<%GQ[9>/Q?DP'TO_E&_[:S^-?F&SU#D&^5T9\@ [%4L1[$ MDGG)O;M*](@#A.4%^)K9,=X,YLE?$$UPQEYX5+&I'E8;5_JGWGS-(<6%9OA+ M(OH0"WC=QWSFECUNM9;-Y(+"_;T:( 1>W/,9APB6"8G8=[BM+,!VD@6\* I0 M@W"X#98,M31T^-.^=5L&2>=?=:7:_U[A]F\^CW_6%6Y:^-%R+*^J=[_@?GSTJ%?U>?M&[W-6[;GG^&Q5L^BF3OGGY\+W]"1R M=V3SD;ILL\^OEWINZ4/?9 &I,>0,)K>K(PMXB*HZC.UX#YYC 9O45==,(9?8 M1I.&M/A>.W9^D0505+!UMYGO(.QH6PRGT5D W=A7:6VR'KY(P8Y"+)(FL "K M1?PD$N2&'A:1S)UY()$%Z,L33>C;UI-VOQL0M93*W(&C0NXC9?DY"R! VDN" M)A$TR8B"'/E;1\3**@L XQ%]6E(L !>V'H>NN_DWZ>\1B+@G-C.K1D0"*18==21W!=+)Z6T/*(==.J M)7URN3YZ)9WW=K^Q;]3?L<1KR+#;'XPWFV:9'FY68?046?CR3KNKN=D^RCKC MW&E\3+A-OWWYGOQ[!/$-"[B*75.R@C&86*9L).B*[8^>@U]2WLUNYHZJ*-HZL^%SSUL$=9P1+5R[R2U2;/LNH7=.EP2J M6?O?(EJ(HDP&$8]G5#G%:5#Z=*+&A 4DO:Z+O=I M4_-SF-TW>V@+"C^G5/H?2%O^P?WI_225H-*K 5\F,O-,/6A^5\!8>IATL0P_+;K(V[?71U MQ,SZ=:?3.BP W\8"ZGN]PK"N2OV'W/A&]#B;C(7U'0W.AP\_Q5T6@<0U[)M@ M,OM=\<\IE?#OJ%]_9W\B/P7T%((P'5D1V4H+")^?T3[XZP=%0>UJA6- MK2&#[XKLWWE#R@*D)/OOO!044R,.HSJR]SG^9U#D[X8"W\4R>2:C;>&:\F,$ MKN9\\.BE@+-%&C'U2,>R&WG+Z$.+0Y87_S'[!-[JLW>O.632KX!R5S*M]#2W M>I.NQHJF\D:D]Q=R:0K,VBY>(H0SMX'Z)-C#RB.D2(&ZHS:@M1EJ5J;NB-[% MT&V[@RF\DK^P(>C[YH.P2V>6E.C;="$=@0(,[@HBCK'U[?K%45O6#7"%'G % M6YNW?L_6I?3JG,NBVNX7&J,+__Z>QED0G1&=0@EFB)5H:8ZY6,'4V! M,V6?4_"U."ZZ#D4D6-.4=-@!A>=Q-O9]\=1A3_;!XP]>,7<&=):? FI90* - MN8T9,A((A4X/_U23^7T_98[/>95 L1V[9Y1X@.S-<./$$ZR8J^ MW_?A;/)^Q,/+2WG1?@?P/_ M\L=^<@?VL//\( *.OV/_<,J_OBM4/=X9R0:* MU8TIU:!0< ZG TV>8W?-)@Y[3,5<0Q8='*A6^J#\J:_#O!4D$$T>8*3 L+JD M/11QY1)"8(EL5>=IY5_,GR8?OX#=4O-%>RL+^/A [B+6LP!^380F"X MZ7MU*(@. M+V4:VETY'7UG >5%TJ^;YT>;DQ4SR/,-':?67'-O7*Z\L'O/^&;.( F84%JJ MDT4\?Z13\I>OM3SRCJ-^1Z\^T.-^<^PC\)P7_^]AN?Z^KA8(@_;$%3\/?+]1 MDT;0L]%PR1&2 M_ WM&N7?JZ;^[RBDCUE?7*U4<&CXB#V:,V)D1"6$K,TK#5 MIQKO5Z=,WPO">#4D(;DFXNI,@K?2#Y/IBW1$AP3A1+V?R[I# 0X:#S;F_ MHUBN\8Y3Q>T>/L8P$XLM%ZWU-[(-RNS:8]X\=W/3Q3\"5?['75%@?Y.<;N0V M8D9="%/<&W.7"9^*F$^Q4J[X_N-WW>F.HXO;:J;![Y@"^,B//F4:\2.O:VW MVE%\KB;]1$3PK87MBCKY;CDF(7!8Y1&*974YK@XOHB?_I;RDP)]R^9?47V0D MMWMH0G:E#A&$XY<#W8FKDR VY6A5B./'^;3C1ENYKSXI>V+].[)9Q:O%.#V? MHL9+)N5(%99&<+&7&IPXF_UD:)2[Z(]!F/^'SDCPOT72/,)?5V?"7Z>W16QX MFI6CQK'TX(QLKOVYJ?[ ;+3 MGV?5PYO\#O$ OYSO/=/N]*49V[^^A*WT?.\ M'IM^1,EC0)R-^L1V^A*AEK".#X\1^^E*HZ\=C(S"3Y'6=-R/1%5^P?G\FM0_ M==32\!\0"EG6(D'6YR5 MYE+]B6.7=>7#[-U+?O'/,0\>?@Y+0V^B.3.;\=NTI&$/\#"L(YS7F2D5C1M"/,UN@!:[H[^#85 MO.,S+9\PB$(UAYV^,>M?TMH?SG[(^KCHZ:)7 OIOO H_.Q#QH()#C36BWYK) MI8KR)-L*D5G 0ZS#!?2.7/31[AM1]K[R9[OF9W)/MW1-.%Y_8S''1#G<(?%K M%5!DO"V9W*(DMT$O:DSGU1(02T%19;I(9+T9RM%!WZSKZEY5D@^(9;;&U(?C M$6QQOVXMN+JG1AMA[.%K;T#ACT*18+"OL7V](KW-[M=\'#1:^.H5DZ-/>.ZV MN6BP\[Z4/U<.@1.M3T;4[\AU;JNQW5W:3:@K_Q!_IMAE>^$ 05_\EJ&K]0ZC MYS'LF^10@AF\.>N; J_$64")W$P)"]@8QTC$VB6TW+V!08 5M8Q^Y7DE]SHXU+/QNW+1A@" M>[WH6^N(L'JC^0?8;2S %1ZH)4$Y$W>K="TR6!4G><%Z9/#T^YR"9I[W$A>" MS+8]HM>^19"JO\6[K+YPZ.Z$3^()[7D7K]WU][M#$MX[2=L\/OE2FW-:OY$%#(11,8R$ ML4*W<(*0!Q[6G%ESV]T>Y3&SV+JI<+.BJ_#V.H,K@5Q.UP;'Z[>+7-OH4$"> M?$@_-@:'7? NJ[6:3[?$1(E>.%08S245 M$(#DH-^I,.EO8_)^,^O.R7'+"6EJE+@M0 MLQ]R&XH[3+Q>>"^[*-FQ7H;QOH*1R0*NPD!IKQD*36:Z?'\O'E[I\ +Y";0^ M2=E4<71*.!HY-(QU)!S_=#7@3-><0ECMH)$1U>=TSI,T .,'&I$0]^E>+U'E MZ@&51BY9E[P=+)@M?;$=80J)4T%[6RO4U%;#Q#N4]\CDD?EA0F6V/C1UD)T( MJX$!ULPV%L"#-G?+;"4&RMDXE1R>4]T1-ACL-*?D%IK8.#'A$'M7PF]D09FM M]9[0]W>6OP.+QN9KX!O0I\F$&NQV^D4R,X'$ K8;[O-&UO;=RS'*=$XZ;V8L MK>M6\<'#@!3UK'I ;>&6]C%/C#OD1O0PHNCU#_S01?2I[& 8D05P?+DC-E*4 MB]8+L^K97PRFX$PW$S^A\<4&+R7MGEU."!F0*.CU0^BI^B)/D9DQGOFH@<2W M,>$Q%4.V(\,?"AK#Y#IP]&%&/DLX+K2@)+5&_)D#3Q\ M@//A,H_-,56.PE>5C)G2,X-F"[LO\_9^(.P;TB^7U>10I6#IXN84N7J1)("1 MA+#+55RP]I6G!C!2Z:I$A.C33_=O)R>\;FW-%OC8+S$Z_/7AUUO;N[%D9-N. M(69S'*$0.YM+GK^>F.,-IS[JK%2]U?M2>BOH95'\)M*T8.=-WEN[7T@I:9M? MN)7BI]4!)M#LF2U8#K0GO,XD%"E./Y8\[5H:?BQF>0I9D#LTHI=ZZ?4F!>&[ M]T-EGSZ/J3F_7T?HBRU^RYS&\]EO42GNO2E&QKC%X#W MIQZ?&;[- G@5M43D O;3CY)O+>KZLA\/5,G>8<+?NG7@T^[R_:@;_KLL#HH% MV@3LT&;?4,[]75GO&-V3IDWG!^W'VGCI"F Q:%N#1%2Z>#M@MY+')PU4ZGJ M2>/^6,NU>5&&.[/A*5]VA,&[O%J\&F(T&PO39$_%UB!9P&7D0PV$OT>"L8\% M&$-R++&YWF<2<32[VUAV:%?KODRGXWX;YN0<1^VJ($CN']!$.S^":<1M43'Y M%%?WRAFYS=.&PQA1:^2>W6!76G3FA(F'["^!^D'JT><_ZD2K1&W%C+YOR)MR/VM$/5T7%.ZOX5P$<] M#YPP_@:VWVW4)"R%#&]@ 1$8.)F90^U=41YP%DDV3JQ<#/.6*[_,/:"[?_*] MX?4]$:OF=CI"JUV0E2@!>VCBWM+4:O+*S#G:16S-=J8D\P.\&!/W0K6OCN'< M5JMA/F2[.W2[Q/7XN@M!L(,9!_C(?E4[]'-BK*46UIA:@DN]ADGGS^;*'Y[62;D$"5XZZ$' MES^S+\\5:,'7_56#&V_^(Z8X&#MXH?-JY9N2,-,BN_86AQ#$F;H.[7Q*.JF>J]7CXW.EU*S%U4ZB/KXSST>RM M\GGT;KN:URN]'3=_8:/>B(_ \2<-%)>UY[ZLO8Z*_86K_K*KHG7ZT.VDI_F' MP6,T!\Q[7#$L]"K9I 8;B1&C2+XL-?'9E)20F5TRGG(X?"XWI+J\S')?NK=1 MH^@OPLVB]%1&L:K2@!OU&@L(<,=?1WP:).$>JMJH-R*W:QH338(Q^Z,O)AUM M11A4H<+2"^\@#AVRJMOT2UB?4Y3&]:H'4*,PNJX#31SS#LF!OX%\8'' T:JL MVNT1$_Z:3.FR6WAP[T2!D<6GO1K8+W7OH>B6S&71,04W^#SPVO#]K-W8%[?@6=IQ;Q15!^2#)'^XC&(\ M@:,$G =UDP?I9RBJ:=718S5K>B6_" ^$LX#X0UK]*B^I=Q[=LKH3/I2E/^;?'\G,^%1O?1AT='-I5=8 F&V'0?"G\ M79VFV&">Y6CO,[)/K>V& A!)UK 1/L9>0Z5,Q<;;!M^);DA7*-^G4.1B9QJE MO$31P,:O?,%ZSA MI8Y/->7#T@[<_U M60 I@^G"DDV40#F\/^+R?*B54A,BP%:HVR.D4CYG>D234EJ1.EB:C<5YA'K>C[ M?_4V,J)(K%G[AJ+>3#PQCB!F[#PW$ULT&!3R"MM16073AJ7@F-SK'W0G1Y*2 MP>V$,E@M#C3FP#."T'LT[U[VA,\B$.]H(OWU50ZX2L M& MP,.:O&_T5>S7:;;:MZ(M8>.!(@)V0]<=*']K#S[1]UX\K"ANG&5YF6TO@ M;1^JC1->R(EZEQS54;A=4F>CIU#XJ,E#"&DFIH^@$#"ZD4OVQ4_.*_=L>H83 MA$/<%*X[NNZ$/3H8<=Y[T$E*0^-)C!3:BZS IP008A7;C/+$/&F2_OFEO#A MY9.UX?O:&M8Z#0K;1GTE!SJWNRWOW3YW[K;D>%$IY\WHV=[3FF?/6'YE ??7 M8#61 !U1 !XC*TX:&,-J[G1,D;_$&Z^U,7#C>TQY7R@?B&/??VG>SNB@3+3V MT>_J%BBP2#C9+/\3#Q4)IEXC6U*#&/F5[*,L0(CPPDTX, \,W2X7+L,"+!8W MN&\H,WKT:H6"1PF>$T]CKZ8\N9 M[AXF0:+BP6L?2UH<:NN60I7=]5?]Q@V%5B$LN,D6Q&5C&@ADER9_C #F(U+" MGG(^:2\9_X I/H43*$YX2_EJX75@EXDG3[:XOFKQUI/X@_N>L/WJAX) 38!_ MI7P&LPE'-D3PH:\Q<+,I[26X_J)&K2T]6CO:4-LC9VSUAL0N!XPWS24-C(]% M(\J_&ES6 WS?4BJHKQGQ^.NT*15\!$*TV(1O:,BI\^NN$>;G^:!:N1.Q:^9G M3PL7%*6\_9!@=_RK:,VNMQSOJ6UF1<&F77FDUV6O0Z[Z>\OP1TOS9LOSZ;1/2GJ=4>/2AS_ M2CS1Y0TW* M2K>R1LWB_&NMNM"GG8.F)N&CM!]M[+<["2M P"KR:()B[+-_& M!OEK\P"#WKSB\.,^:@KBEJ5MXT,Z%=NO1VAW5'4>+]<0/W1@AV<#'8JJ:B*# M$+ <)A=Z2[=*5QJX;V.79&V;F?6S7!G3:$7KVT<2/Q5'=*+G9C[6Q\I6G/H. MME&4!GB8W(8T=N9[Q)89K:V83G@)P:]2A&1S2B6:H-='U^/=^L+U9O3[%TR2 MVB1,MN?P84TQ:MB.:0FS1@F3TY6A$P.DW;$CI,WL+S+K]KVO"]JX14=\"PH2 M8W!_%83E-W8QGB NYX=9X(HC ]%R$BL-?(CSUA>6C0^,.<OO&.B%U1VM"9T*(<%$Z!R3K.MX[:A %$.Q2<0MC2I/G:RI0 M2& ZU?Q$ER=MN6C03>K91^F210.V"W,7'N]<#03NC*S?C!N'K='4%* =5>/_A1E0.2*!=7"_' M+G)IR,4UP1]IJ ?+5;QZC0\=6+MUS5K>%^_XUD.[52+'NNO#ZYL%^F^]RC]; MCCO,B% 0HTHS1)HQ79T1A1W-Q9%/XMC0\F!;_M-@H.T=!QNK7OMW7>&7O+*9KGY!IA+W!='(@^Q>9W+F4KK&X67DW96_.)GRA MAY62GU)&R5V7>5<%5SGU>-Z-&VP7+)]=-SJ_:4)P7.C]@;.PCE9Y\\[E6<7! M2^W+\CZ#\H,>21\7.J]%[R5Y\D9+9^V,^<5_NR"75.@'LD,]EIU^XLD%$W9( MJ,Z)<92H166_314V\IDZ+GI9X9%R.CEG6V*>*+_H1?TZ1,%&0@E\I@?BW2O& MKRS@2D)Z?-W89"B=OU2MP/GF:J'WT5/A94/.7NX%A\5\7U#;98SKAM_FOAG( M^X"W9[9A>,&#Y&#B;$:UB?] SR]4#._#BR.#LIEQEE$?&UY$6S=NK+C4*FVH M$FVXV"P3,1M=W\[I^6T&M;EGZVT]9:UN/)YR3.63#RM<3HEQCQFCNS+NF0:42"G^]_EY4!Z8TJ,&D7.Z6!LGMO2Z>$NIFQ1'3 M9[KW*PH[*CZ/TFW:?VOGOJGWNAP;_;FD%I'/LBB7I_!D4RZ\&V' ZMTG]!&P M@,9[H8XH<9+$&?U107LH/=DG6;^&X^O5I"/VP?-#F_;=_W"5/Y^YN<>+9HII M)I -3/H'J1K=Q?TY50BPJM&J.VI,\'HO]I7'9V\ZI5JBI MQ9V//U2]M;BTRY]KA^,;4ZT51"2-+%SU'5APRER^XM?1_0!IMU%\_N./.Z9]D'=%%0V'DW+R_O MFD 3KS./SQX_/L2>FM]CC.ZGW7/6R)CU=!N+[.>L*7]$!N&U6L*ONS'J*.'; MV]1=>\./Q05)1]WETUCU4G]ZQ$AWVPD[^J&;2+*VC65CN0A]"YS(7T(>K&V? M3MI53-8J4@M(&;)5J/1:RFZB] MF_IU./#2+. :(A3!@[B&'8!!KJ]HGB[" R%"\F(-80O=BW0'"\-TKE1)=&KJ MH4A8P:%AU9KHZ;,'WE&?O*U_D#&?T,RAVL]K&@2_B,:4PXOP=!'^-FH1(V6N M-;C6QIIZNEM3(7FZCUP<*[SV66/&JT_#YZ:YHJ*"FHKCS3Y)W9,)SS:TC;Q$1$8Q(/A2\V/_4KU=36R2HOP>/)H*WUJ1^V_\[3Y2%'RSSEUH':%L86'U(*X\K8^SX5670QTO9-"5<]%7$TLDG\X2!9VG7C%S0 M17N77'QS\::K\0>1KIA6/ PC2.:V< MZ1,161D\,U]\J56FJ&)+TF^*'+"FWF7$TN5[$K2^]B?/PR6-L>2/X XC1_%O, M_GBY62L%#0=^L:SYOULU5QK"$ST)"T7O"*?U\ M*)H*)!(-)&U>MXG'J9T.,C.W%<5\_5X2;APU*BYZ5%M;>-D92BL"5L8"9./(BDV\< M?$9SQ];LUX1#*)/-^]Y8W:V:%TX88?)X7ICL_3RDC?67:-'<7'/[T 515X$R MOIK0DU\_/GJ$PO1BB[#!3 BYU;Q28W*3?X6E?84XP.5HJ]11@A)9<,TIH6TK M[8&;1N@$11#G8IU$:WA/M_6Y;V2?)X1CB_.K@UT4Y3/M2,N[?8;% MKQ5VM\Y'"<3?">7J28NR>R@J<\VL(./#N+YJ%ZC>:"L(AA"/J3,1H)JYX>>B> M29W;0_BK]D*QY4ZA+@^D\)#-1>(I.*B MHB>S3[(&WB3G([FQ96[I3F7JV"MO M''>]WG*J_>37Z+O*=;*U7BXQ_ =J0S]K\1G2E)E-54 )*)&%]B%_=:9&&_J0 MC(WJJZ2+@\UZ58WBE(>_JCM_S/CX.E[_E]%-9XEG]^W+W,/>[_@WOK_X5[_- M^-D$5,3/7!Q##$XR-]^F(*B^X)7+KO0+O6H#38$Y=8#K_ U7^W+AEB3U#U'- MW)_OEYO+^,E/E^]A7R PN3UI>E,(\KE\4 8"R%$/VMWT@KR?7G7KX09;Y-.-J"ZV74\_US[U_R'.!\54@F!'L, M6\S;=!7OD/>99N!=*_U[!*W#4WDF#HNB^9_);4,QQ]TK*SY%]',2(8CH@9A?!&[$# Y/' MWQ2#*V/SP58)H*[NHYPB;S.N&WE(O7:B]+YK$99;+QV*EJE,LML0PXNDK#KZ<>;(AFQQ?G]NE1-L(:( M"REG :%H>^);LT$+YBHV'756N5-Z&'TQZYY2F_<!9@V>VJ M7,HE;?;A$Q![>#LWVW498+.499LM%Q0?:G]E 9Q5>S#]\65!FXJ\6>B(LQ=K:Y;AQ4>$ILX)SD9,;!!*X8""ZH\0AI6I^UH ML(47=L\TU*MOZ#I;;)BZF!QS/<@XCVLH.L4@M^>B4! 71UX[)ZEMYJZ[<%@R MMD9I&=\_KS#&P+AM56H0S:U17Z'R.<^3A+L'YPVVFG)_<&BVCHG<_D2(9GQI M,H@)H\N0W1XMNSTU?'EL*(NH@N'I R<]:CR3K>MNN+*Y M#=WM/'QA9>SN1^4 9)K'6]DKW1Z8GT2Z[)ZN:]&_TV& @U8FO,KH,^D!!8@?DT M!4PSLG"EGD^N<>!8?@-#G11/5AE\&ZMZH<"X0NVLWF/SDK3 M/WZMWRM0 $\S-]*#5!"M]J2).,SQOL8U3\PGIK#$X$%AV4A4Z?TWD7^Z:U2\2X[&6D-AI/".8X( M&S7&?OVH8.SBMSI67-H9C7+<^M)Z,,ON4H7ZE%8&,9\?916;F#.M!2^LJ.Q4 ME!PSK'A3;"A3^(SD;65P\?[!@E!#Z?VO=U^]IGE0R+U#1E<\5/3"E5\>^>]A M7VP:W2@I0"ZCBYBUU"(*&.F)+N0J[*?!4^64\(R@*)'36_/R6I);I<(V4U.O M7Q=XLEA2=2_3#*$[G0C>)@<0U6MFM:8-04,ROJY*N+BJ')4PZ,;O^/A"D_N1 M:?F=2IMY/HK6!%YU.!M(WOZJ$37;-D"@$AE/\5W'B NLM/"\Y('@?9( '18:0C'/AN4XTI MS,"QIU5\= M)-0JB/I^3T(1-_Z+AH29R,%$&>=Q*Y$UE>723Y\LCGJ']GZ/. M[^-(P%U+>ZG2KO<8V]<*,201P^G#^H.FQ&TN%+2KRQ(V!_ MEX:4'+=?W*W,1W6%G1[A\CI=R1U+QPZ-O.\<5M-!.7$WB:.F7CX'C@7J97NC MZN*7)W"9TTGPPK>O.Y7X1F*.#:<84"TYY!ZV;CT@J[XP'J.NR-\O<3M(R@\M M"BU %2EG4*O[V\H,SNT$&2M$JTT2E=CDG""-:473QR3>BSL:%]>7'!9L[ZD ML.M$+W7T"E5W D3. M75]R;Y1EJAP9%Z 'C0;<+%#&D&NOU>S; 4^3V7! [S8>I@6C[P;U^);+:B,# M1\3)]??2^LN[Q\C4D$W1PQ_OM>P)%/EPFS'1O/*A'..MP\)"-NAO<][L<%USG]]F&3*0_YX0BB,C$:!T_JP(Y:/;9K0GHU E M#!:$@*'UQ*F2<"2_!@4Z#!./2&//1,'?UK8U%AR\0'QJO MY4."=Q5;_6N?N4EQ#Z9I* ME_7(#H/=YD^S+BK2BZ.$QE%GA?B7]N/)EFZ": 6(N!5H&7 K;2NS&;G%HPVB M>^U[,#$%Q#4*3EF&W=1$$'D.IR?-4<&3)OV&7D';QQ*N1-O9PP\=@*?W&)WZ M/^V=9U!34;OOMZ("@B)=BD0Z2K-0%)#8$9$B2B]146E"1 6"A$1!0+J @J(0 M!1&5$NDJ,9N.*$6Z!(&$(E(""4C8D'8V[VWO>>_] M]7_^O[W7>A[&5&R%W/S\G2-;OGVS8D<=^9N1\4[!_>S=5F4[XVJVA<:]PRD4 ML?',!WS &_E@C="$EG7S\%0G/$&_^;-VY_*"8<3Q,!D1:_-!885Y/,%)B\+#)+)N/9>]R_7F" MMLV6=> @]F1LP]=(BO4>^5]_!F15S/9DTG5-FNF9RE,"DY3L%Y'@4(\ MR=:WWQGE-.]8,P-*TP E.(3!BT5?11=,K92':9']%W'76R>6/';]'^WXGI 0 M;AJF-S]U)C=.Y+M.HO3YHZUJ.8# %_-X@/,>&H6C?PZ>&C/>#SZ@B#:7Y@1Q MRRK"Q:)S-@Z\2HO897;X_4A!\K*_KXSS1)J5FXM*@ ;%P>+B+^M?S)C=;HV@ M_]JW!IZ(-'OK+UQ+#VZ40F@\XF8+'>+IR&]/'T\@;AU=-4F7R_@UK"8B_#'Y MI_OJ#SGU)'/_T/'-(A$6=GZNUY\7_;3.]UO#RH94BS_.H?Q65KNU9Z:H2.A2 MQ#8 J\UVG07++3C2MYO!#6:[V.J>5%\]^V M[TMCJ77X!I^Q3Y_-'>?O_]E'6T [R,#8,&J>#@$,V\E(EO*;[%,KFH MI5+V(;:]IC<0AH:JLJJ4W=^#S!84]Y\^'*9^:L%#+^Z53XY\CTJ7V>$\UVF6 MG>@QWVN!I:=V=MQ\^W)#Y\LW_IZP9XR3;R>=HK&UEPH\\W_GH ,D4.7N+Y4U M4FZ:JMFU"22*?Z0N'47(\[I00DA?/A"#9U@C**KCY"16'-*'@. <[ET^N.GK+1ENN?U-T9,\7I\ZULU.SPMFV]UB,WTW<[9 M#!UAI-""687OL0TCW=;'FZLM,]Z=Y0OBF4;%E%9N"B ,R M\6Y:%9]2 TLFO!W/-.X_G%HKGG&(6#BKUU/+V]K#.6&<4&2&R*\K=$]T]WLT MS2QNS..^VSB/;OPA.)'2B(#4,NGZL+?8TH#Q9QVO8DS.C1UU)4UT_-(AE2^"O*V3S)1:/,,1_"E"6YF[QE:! M.AH\F.B6!6DHK'*7[+D:RWG.GKPA=XOP=RB_\WN&?3+06T^H?),FL9PC,TW] ME[>\\QU18,RGO/7TH]A$7?,/?ON5^-9]R#77\E;M)8/$E[*[E83;@5M\0)*G MAC7@/B%O&8%6FM*L?&FCPM/[+:0K7VOXQU7-Q8QTCR@O60?IQ&A=B;O5;:FB M$NF\=;5\C%B/IL36$3YHTC>S+9V=V\ *IT9$S-U*>G95*C+;.);T7"0JW\=1 MCQ!1O"GQA+ZD9WO0OMK'>[FA)7#2RM%(INA+8'#?[:RT?Q)U^M>ZU'>X-P[E M/A,0J#H9Z-"\->>8=,@]I"K^J@9LJ_!^1$CC,:),+23!G\AKPRFGCQ_^T1RR(E11NUW7'*MQE>4^9[;.;3)6*]@RO3ZUF!-<_?_Y3_>7)X5#>U@ 8>'.A M61H1@44P4^A'& ONL:=)7QA325AA8IL,ZS=F\%56^YVAQRX+5B85?A]:=C_A M.:](; Z3Y4AZ\<3U(54$1_QV UF36QFLBZ[C*3)8KR+>>PZB?$.=5CP52ON" MWRDU]V.*\]).I4K,B!T*,'=/T=*<;(_H0U-1FRB8-%LY5\CT;(K38W&]0B6" MQ*^/S?NNB7QDMKAVDG75/X"5R1B-Q-<_VNZGG5+=[*PDI!H):XDX&PW- MLIQ@J?N"-81"&8*L8U Q#8QS+4))DPZ./2.=IPX?/W)<;)/S3\^6X.#P8+.3 MQ=D-E*+^4K>O]F%JGP&-QB<]='PB0H8DPE"EQ50S\6.>)3?N(,5^'NGCM$I: MJFZH;Y+RS\AP42P*:GQ)2IZ)AQD4=73= .]YHY% "]CRW;H\,7W7&X+?H\;7 MR_4O =Q%_Y%U_@RX7,9$QLY5:@40+Y&J8V#^="Y13H7Y<[N0BVJJ=%?+WF\[ M=QPUV+!84LH 61G=>*^%9$*E3Y<>/!<^J(<(T> PCNYKUX]9:)$BDXB>/UF; M:Y25-3V-BD3DJ^,2 MUQM^CTR/_NR_A;)\+[U*"*PF%5IU4A+NA7ZDO9D5-VO2F0+?1R3CT2EC[IV>4,+5T M;'1"]L34(6)/EI8 TX*%AB?M!O8NEXBG#I@2'YB@6XK]FRD%23C$]-V5!J30 M3%9$/LER$&<=^0TIC4.WQ "'N0X?&E:"VI7L*^X]N@BKWXK8ZYTK<7[5R>1;Y5 MNX?U.@&AV:=LV4BL._<#D70XZ!JSLX4@MBP&'3!*44$&/DI>_S>[BG6@$?@Z=:0__@$H9*YLRUCAB8@S;6VZB#VH M@86_ZHS342K#MG>\/WV4Z%2OL58.";&?:XJD;MSX5A'!V2'2[(C_4,W9,76* M6\X'_!"4A,8L8@,*.FT^&D!KQ1XHKZ/68 S=H.MLK;+HDD#',/6DB0/H10XI M\OW.@9EB(Y_+GZ+I\RKP^CG[V61BG]F.8S,PM\WRM@HPO5C'X(!JQ7W=L5[F MI72J67\;UI8IEH2U>.GI@L*<7M47BPJ@]@;,!QKZL\Y5/?6J3*:=UQ3_;I F M)&V9>H]=/89L1&WBJ#"V5#*MQFP?TO^FB$'AYY[;]0=;5:F8NOD\(J49;=#< M*@9(W 4L-Q9#H?4C.QFX;&XJ37^[LV](SF5\V72_[Z;P%$?*/=&."8FTE[ <6,2HTJH4# MZ914*TU7X]#K=.L>.1N'P.O/K_7] M-NE4J7<9KW@P,(6>NW]KS6F]H+6&#<@P=.?8#)!08Q^(L'L'9;ZNQ%/^Q9TQ&O\[0F_&=\3PCI7!YXLF]R_5:E4M64GLVS[9V6V8;1S%40\: M.\2YC(S^.]5'2_@6>S%\?50IB:-;BMG"CP2M$0:P!,S;QQAS'E)%.RXYY7HB) M9'(^2@Q9?S@S^?D6;H8>_2)]QO\!)$PEQH,2NB0']BU,3\/M:9XI$QU34 9Y MT)(\=Y=AG([69710G$P+25NQX 6F0TC.@QN MQKO+ILI9+>S]\)7Z5C75R4> AH!VMT29*T %/&$48Z 1 M)66F_7K&TYA$<$L?V[;P\"^4WZ*_1.)SF9V9U(W[0@D9\:/A\:EMXX2QN<\_\?,E.8$/8M>CL#D QO3;W MWI&]_Q4ULOX]_CW^.XSU6FZ%8!4?H)]@&^*ZY(WOXX0Y-KRF[A*.+!H?Y,]- MN':;3"M94/4>-M-KT);R L8G.P[8X(_Y+Z;S1/+Y@&8 ;92M:4180^%1[R'# MS&NK!0K'8XP2_1K2T!E!]DG=CB%I_B<6;>67=%KV4GW']CD4G"VHB/S]X,6U MZ\-]8SWE9E/_Z.2W>M%5A#IXD60[+AWXP*]>&]/ M7:@QBP7^K'(H5D#^>F]?*^,FP/M-WVW!*C MJN :[!=N6>+;^LW1VL73NF9W;KSV8M[RA]QX)I[RG76XC%L638@TU^1<8F8D M44W=G/Q'13&RC4[R.I2F<47!&E)EZRI8Y& M([=C3<=$BO6&/#-&M"8_]1NZZ*HENRWL]Z[>[U;S'-.P3VN>?!G@[LL%#_ ! MZMNLE020&DM!18'PK)0E5X\=)LLVC6M;2XX[U=$O-#K=3_?.MS54 MAS XD'KF/>'3U>0+:N&]T0&C9WD]8&DCR#C_!77F>3.J(C3IKWZ4:H-,->5T M-*.SR=YG"9.Q-O&5'A1Q>^LJ,4 *<6U??>+[;DOMKPHW,, :+IXS &=-"TVZ M(%L-7W<4]$5!&@-)9"2F8,RI'AWCJA$U9KL)RFRY^]QSQA-A?5KFT72/>[5. MC?0WXM;-I<$7E^3\$)#&_+-"?-U5/G =#\=+-;ZI\R%.M[O2=A>FQZV'+&S] M"LI9L57:T%7T?*Y?TJ5IT_M(1D>:K5G;Z[:0YMK&7!. JY=+/@M?APIO6,D M_OD 7V?*4676C'T^2C[[K_3>;)/1WV_&?PTA@+VAOB>RC\(EO1&'&5 M%-DW$8_:>P5]'0'YP&O[ >:1HP@\C$/GX2C KYFC.._G Y#4$4RJ4(XOBI3SG M _LS8Y"K+BC@_%'$<,K<9:9 TZ@,TJOS 1^0XNWV&Z7(K\21Y7U<2ZKQ+,P8 MVWJRF;"IQ[+,\*)UMZE1GUW>(4!TZ]_/S$Y($\7)6Z Z<5-!4?ST&\J7Y/^Q M675O2MQ+YK:!F&41E+"?8]7=HHP#)<_"POV\8T0B'UBHI18JITJSTEX]_K I M4*X=A\+7G0#7M^5+P[.$WLE1X;[F U?T*9WC1L7,%5<(S)O.A,,5B@K&>XV+ M',Z>Z)69KTT-0/MO(]VR^;XIJ$YTO\G#NL5O *Z@"[4-7^<#A^Y+I"QX';5> M)[)T8"[OG:LO'Y"%871TURE:B@@4S^H*O,)H3WF^*33K7339Y>I#]Z92Q8## M(,/?96E&*$<)!?>QC_@0Y/G 935EPJ^KCZ?$Z/ TB!%R8 M#I6Y0_KQ=ZHR?.:6#TK0[)UV()]*;6XX^7/S5\65V.64!)P8'XAZ%EN_S8T5 MQ00?L9G34%"KW5 Q-8T]G) ;0+R5K75AQ+$V:E+^0\8N>!7 E M+] W]K?5M M,_P#]IH^/=LJ9=^1N+1ZHX1Y7/67C,6V%J@%AE:.I"U/1(%AP<) 42_448! M3*;@]MD,28RV7;_WE\KUTY453_.R]>=.SM-OI+>8[;,4O7;ENOGUX0:##6OJ M__J&MXU0B:(+,_&TZJ981F)R!Y!UU'J_4YF2[(.4D8K3[I.QM3Z:E6>I]Y6707L2J-MYDR>2[ZQZVK->M%JH:K@XH+.]!TC[ T]ZY MID58/0-SVKCA'*JTLYD/Q".DL1>*?,E'F,@A6F5/M[/DG-VIR@3JB^9X6Z7* MQ:0(03@(5OA ZF@C@K4UA0^ZSV96&:6*=)P**OB9N^XVI.L!Q<\%P?S;\]0M')!4LK4OMSU1PZ@ M 4BE+@P>9#VN@&ROK2= ;B)9AV-=-8"3]7ODC]Q!5L"$CCF6>Q5@P :&26LP M8I!>XG EP^!XVX\'WM%O.J:<2^?(YMQ*L@BN>Y1Q#BG".<7-T%O>=6MAW/&) M8"Q.TB_V3V:!N7+SQ9.2M3?.&4L.?RMQ/53D?:,4V"+6KMM-A9NCYP( DA71I%M. M;RKR=(Q@TLGSTH(W'8F/<.I8D6[L$3X@N)-CRHW]FY*(E[L,N17CVM,QSR\P M"CCZ"[('.M^7Y+VKUSM'?_>L;I%.\\@]2M (F4@[BO30(D:#?HB?2?!Z1_[T M9[WN-Y-C\H&Q)QWIF@W9;DU*&Y\[0)4E(WXY4GVZ!O[%WP/"#7ML64%J1DM[ MS8B982>VU1P;0U+3"*5.]T$_)*1>4(],(DCAS+!AYB;,T*@,M@,S^3G[%*9* MI/1.]QGR+0ONZX!F0.#RP^:CD]MMCB+/:!';T9 F[']>L1UX[4C&1;0,ODX6 M#$Q).(BU\,7"VBKL5+L0+Y_]VL[O;M5C@8.#J-6SA69?4SO9]%<)+AW.'S#U MEFPO?!V"I\IQ@>3&Q2C?6^#TLM",VLX)^_ #;7;JM1]/'HH^DAE+VA\LJF]V M]UI^HMOY&UY;/U0\6.V.]G59.>P*<-5S06WS/7 N<,;[K5>'KR.!0GS K_BT M\PW>88YW@@4#'Q,<-I=JYU>]9"UU]UVL@G%E=D6FWRLLN#]]^*MC% MW$G&3-D5&;?*F5^X\5*LV^1?^B.8PQ<2.84;0E4LS 6OUPK@R;6,H3FJ!$8J M'PCX1^>IQHQO2W2$-ULPG0\@[%K+T03]X>;0VR]$L;"A$ZOXQU&9KC8XZSS+ MY0.+N]8+90L:X-LE^< G^!-!P:M.J ^,*I>,L0/RAGM_/'B]6O+KRFB37C'B M+>,WZAXQW3[[[/G'!*.2/6#>WH%O(!SFW>(&.DG%O S7_#!^H/Y@^MCCAFAIKA29&#:NZ6 M$L;?&DQOWA(67'(DOX>[)F:]? !Z2PM],[/#N54'.RYX\)]O 22FGZ;XPJ5AA-]UN#+/W( CB8_!JOR_8:6,_/G[_T!@:2=69EBV'MMB&3)))4K7P#UW8X*MY MO-E6YZWM"SRU&%]>% U_*>NZ<3E'J+96<#98>BGV/I[Z8D04\F#.X!&0]MA"XS1I M5S%&:TKCT!4&3;>@(# M#=9N.\CZSB7P#*$>UA-HG%G32*F.@>=7''/A*!E/$6OJ3[J6[TKQ73RV-<'# M1EV'&+1G24@O5+1T*P!P[^:">F;^[-,\&!,8IQ>@/<1ZU&#GV/J1H3%\/%A. MH$N_-X^C:<,I3'84/4"2)*X^:GQD]/*B5:C?HKL;X'W]4O*4ZIO:1_FE4+?+'KA MX\^T7,5MWQIVW\/%G?=4A0-3@_LN&/^3P-H&%;,O0K* MUI4<>:1:O01,-&M@OM]/>6RL6HSU8,Y2"0DXI?75?&<4VB-61TCFZ2.5L/H, MHC7T+(BY=[8I-)WX4).MXQK-+1XNM&*%5:SF^HY;(75.2:P>-_2(O(>T_4,\ MQ$W!^VB+45I8]A":;3W]V>FG"G,ETJ =,\VNCDB=+\Y[1NN,2&Q[ME!M^.?O M?TG_V__JX32IR9&UXMD,-8 LFP#D7S(/=)R=1 P5\(1AC["M@(FV@6 ,%0%Y MXL0/F%N[M.>0C*2(\K;!H"#C9R!]OY'%D1=!2$%;@0Q[UA-W*KU]YY^GD(QCH^NFJ+%\8.':_A -WLKUXWX&'\97JF:G/W> M35\LQC(Y>GP LL2-TEHKB+!7J3=D(?4CFD@CU_E Q?<780HA=$3XX7'!F1F> M)],-^>U09D)^TG>_\+,V.YPJ\MZ[3JL1J'@'R*)AL$7TYIV;A[/UO1UL G]U M9205^LNJ0]%2YU'/$06;KW!., 1C<'LP^N2<8K9 ]-_T M?%^R&D.ST?K"B>PB4>*>JD?>OG2- MLG_[XJ2 $IJWS:EK&3U(H%:WP/]LJNDMLIRLPD% /6%ZQ/RV&J5Q:U)EE975 MG[K)L2?%UZ\%/='J4N2,@6=QHIQ-D ,;^<JK)!]\8DHO9S\.*M^"737Z M4[I:_NOCH*C+]=:]28NR',D:JB#=F[T3UXU3'P"I;\'MP<1$LFZ:RVYXL=O] ML1OQY]D\V>VQ9C6=NIKN8[&[QA(=^,'RMTFK=IC?8L0NMBML6M9/0:,8=LB' M_2A%O!\A,@M,J/QI\+B\)W "BAU3$"H.,&%J93E+DJ]G3/,B)^5!%MN,VMQ5SYQ*15H=\V'^4]OI+[4V\4 M%62B4?^#T M1D L T_M1T>/Z# 0'(D$&^9H_-^X.<%& F*6K-M=K.=T(^Y:T(%C(N)_9@-^ M[^&II3K?/(5+ @"P?>_P?]HXAUU_#)8'@\]97-]F"V"]O:^ #'V0; MT#*X-B584"(3L(>8!0EFZLSOU.4*>?">F=MK3 GTY+%[/>%2"*W:6 <0GB=3S1Y M6]%,_%E_O!C6C)F=D@A S?\DZ.7QFR\D@[>*?WG_DKMB%F@S,%CGM ML-TX?,+$S.9^]ZE+#H\3(\6"DIJ57,XVJ/QQJ.*5CO['D=? F<506H=J;(W&;-0J%(6.)2&H.J&3F,=89F>71 M*#RN/XAL1$F@;^@N>^CB7(H,VCW>2-:)M#R12>_XH'^T6#$>5&F/N!$]Z(7 M4S9;YR8I[=NG.WYB9_43N\@:>HYSG)S3I6-FW 6.),BR[T7Z_0$#V* P](RL M59>7K8*0$HMSA1;_CA^TN>'X"Q7QPBVLJ'-"B/.E,;MBPS?8ZQQ'4K/(XMQ/ MRV L2M8,R42[00',"S09TAJQ@? P1ZDBYK>;X./=.2/AOK&9P0%:2<8GFVY7 MRU&ZM3E!##1UM%E_Z#E/I)2VD&BN"]'#F*JUJ#+]6/1?NFW3+(WM86Q9PRQY M)7G*_'E!$Z >3=(532^W/FAAMO' Q0/%N$SL96A_'B>@*X_1$L?Q'2LV/GLM M&"QE@ ^GNK-6%1 ZF4;Y>G8W+>;S4Y23;SN1I;!JT&6&-HWUC)%'';U7012% MT*>C6GL,/&1:=U=7NZ?=? _HM%D=5"P_*'/%4N.>R=Y_A:O]W$_XB<_PHK_T M',_-(H606Z%)M@J^_@]S"#/ DY%E!H;*-6;;9*P<[%@SO3KW13H:=![PT M^V#8^X[G Y^UH=AD[&ZFY*%QT1!3PC-)XVY[OG<@5_83M0Q^([#W#X1RA3D1L*RTY5;B:<-XY>= M\8NC?& ^_J_^X +K"A^(%BN>D>_D:/ !"AA8X8P%YT95KRN$W/YMCGOAA(\A M2V+N/PIJ%MG70EW5ZDF_E5GQ>NZ%6E72Z9'B&\_:F[#>#2Z98DX-EPN7;"Q= M;K6C1FQ#I4#)/IB;>)U(P?4;H6"PW_WD#UN)SR9/[@1_O839'=7K-%'-V='" MN@4Y,-)Y6SO9 5A=AOGSV[(QYF)0@Q4J1DDI8W6BC/%U8.P3X:+,H_0R5>6> MHMQ?6VC2'\]1JQ;Z_6O)&?-U!T(LPF#*> MMQ7[%(W&:F1OJX[2X/W<[$Y824N)S=7^1[WW=\7=DW MC+(4;3J74GUKU_V?>AM4[AV9 ??A#N"_#?$!6&'F.N?Q?^E% ]/+&!G8V6UJ MYB:1+-F.%-S06DNDV7G])M-MAZ99YKJV\>8JR5;AJK^O]ZE8,;?6GBM#:&FT MU>SZ=/BE",BX$'(1%L4 W(_D.0 AP'&VU+R'+)TOA(GP/F(Q9G1P@=?*0:Z9 MN*ZILJ*YV3PI7N_HUDI\)$K!X,L%.P;YBY=N1N4;WQS-7@-BM=O9:/5(%QWO M&(NX'T^NZE;>WQTI3%1@X#D28JQ=#,$&$72D^;8NLJ8O3Z2\VH@ULB,*1AHB MR_6HI898V2[WAHDTFRO:'R8F;:P!K -5K7J]9 Z^KA?%Z,$+O.'U,,3FZAA/ M.)ICMC(_R6R1]ELT0P.C_=\*;J0I]WF+;CEJ=, ;LF1'L5[*@E7#_9_8VS@& M_9K5C-9YI>1^V\LH=1G M"(R 6(YXBGL?T9#KS[+I*UFH%/D42%P(Q.ECRBP#O5._M^HD4U[IS;6Y/$VS M5$M//ZID#1LU>8QF71>O#A3%J6)5HFS1HNLGN"N0#RJ14M-90J<33O7HBA=[ M;DN=^K9X:K+@.TK0\I<(T]H2_,H0;S78P)F0>F M9Q>?QV5=3EF]'B=W'?_YY<0C;3HZ$E^J/T=DF^':+-ER' WHX)N?G/UNVD.6 M9NH1.I0'LCL\+74R]Y@.D\ILU'Q?#_\V530:N;UBI#@4F.JEI;O.0?MD4#K@"+ M\B]*@]P+V[S?*:NY^)4#^'D]<._L"INWU1<.UN^PGB3 21VF&MERWHX%Z 18 M ?YVX_U@HR@\^(^V^U;#S=MY_71N:>%YXWJK3#-:X\9F>@'K^ M\2^>+BU9LQFV84:5EL7/UHQ.$*X=TGF?+=^GJQY>:+F@L:91Y3WI\?_JD#9# MA&)0/")L9O:#? !;V(>_@H*44SC[!^BF- +%E">?P)- 0A;F\$J3@,T&KH65 M4N%BZ\^KH9?=&)I:8,>:!C7?,BTWW_LU2"[@[L593_L':>YEPTWY+!M2P\-% M/VAK!>M&R<''O@[0SI(=3'K5C5#GRZC"J MI(]J BFJ^1GK9R&FMVX?5>*BLA ,E J25H*G$@I3T]E.TX<0+ H%M)JMQ_NN[WD! MY\+9U["G&(0F/.5@K2NOI@22=$BYR CH(S9ZA-NDG":?CLN8&5'0_GDE_M*/ MDR.7K >/WG[Q0[#&Z;<81[Z2#VB4LT_R@4$J!I:D,W>RN!J]9N*Y,Y[;T1M_ MC)VN2H4T MPCV> O2<.FSLWIO?&YP@)HK[,6)4&K/( " TRT+11NA@CJG%T(TX7BC!$B6+ $Y^Z@X>/_")F^YL%*-[;-ZD@>O9# MG2,0*;0%5 >IK_A &9J^A[T+5^MJS)% PC36.I82)T]H&II@>->!L;)DZ9Z\ MWN([)_9^F?4SB9]V!F3!UN!(0 ?'B]W&!F(K1-IM MFS_3W[O.*ADQC8K-"PK=W;0#W1P^?@KUT8V2J*<@](#Ò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

U1;^HN;-4*" M-Y[%BR#?IMJ,Z7,4K"JB- J#>2SRSQ>[P-X]#F6\ZNNPC?9\\D7@*[RQ=56= MJ19O1IGJ7I/RQG[N$F^C"_2B^6>\0/-^>>SNEGR7\>069XV\.9D-V6_!>?.- M!0DJF7-]^'XT:*;>YV<(5D#J;A]GC&,!-L=9+$ =\29Z(&;^1MU:_Q4+QQ?O M KC:CN4UVLK$PIR=[P\)3*-/')KP7#P?$!?JM$)!W!\$*"I(E\Q&BPQ (\C+!1LJ( M(#C2KQ0TD=MGR ..'RM:.SG5]47]T%Q90:.-276-QH'A=P(2^]'F<8,1#QQ6"?7[VJV"#Q,-(FC?EJJ> M;>[MW(8QID ;*#!0U:4F(-!()5SW,4+@F@PBLTN494-/FVR$:_C[,:Y09==3(TQSXIN>H\,TC+! UC0/W+;$D$WL)]5,T:[HN1YB+OD:] M0^A#Y,!EFG5GBY%>KT?/X,M_NF^Z_ALC3OMT-GQ(.:%68*<7>,>-;SC]M,0N M".4/X,A/M\RZX;=)C0*]A%EKRH]F8&W1[%:G1RP[FRY :9Z8'TS5:Z[ZU?8M MO2?4,,^ >S#:T\[BN/N5SV4Z,\?@" P:- <('''%';T+^@TR#,:,1])+]D#! MVOK5IR21U.SD&E%)MS!\.?0R+%SGU^ZJA,0H(6%9M[Y3)V_U(.X3R+EPP)U$ MS"#;T1X 0QPA?6A9KH/'7UW:M%*A3Q04 T/>=#&@C4*7" [J6C([I*E!BV;X$A3Q! /IW%,#DABG MQR<<9X=J7 Y>'1^>[ JP'=*=2["5BTXA':S'UMB=AVP_@;G(KH068QLF3$## M06V!_K4,XL1(MZZ-JNB7+F5P_R\GI9KU,R$I#$YX1T?&N?3+CBI-%U^]&7F4 M0GEGQ:I[!P>M8C@1<9PE-/N=Q]I?;#BN.X1 3B;)(<@-J%T8=2I\-V?N.CS% M&,%M\[*?4JSL"%J;?*.@-=+*S.2EPK4U+[1\T=:1"?P>V/KC'2R78049![(YVL^.R1F?@_&=A?%D;:*GL\GP?MQ,#.,R@%M=HUM3.1F+SN1*0FLW[ )F+7) >X]O+SL,$,>,Y@U8' MV?-7Z],UM&-^&2G"T1=NV:L-&ZU'$8O! . MA")7;S /8\(@C_TPSI-84Y8*L'3; R))LI'&-P)&^MHMS%X/^8?X^QOODGG@ MZ1_25G36]L!PQ:M4/RX((F(\G2AKLX6, /9#EF6IUT^<:!.DRP+QT[4D[EK8.Y.M&:C0=RZHNH!+'"$A0-F/_<2 $%9C M1#7+B$7+(.N(IPD2WT;7]"-_I!"%9,LXHVT. 3.7;AH65"L^+%07-H!JQQ^" MQYQM&#^.7$OB_X,6! D#9EAQ>D5J75DG8);3]$OS3?Z9>\=2/(-N-B1\ MUV_]7"#+U%TA",(, FBU-SP1(<#YY'U3RL+[IM)(EM+G^(=5ML\LM>M%CZKT M&/WJOT8"KB*S,$&+N: 9B8RZ@]W["'DK-E<>M&+Z&I5ZF#6 B6?OW7CWQRK0 MU*[FAB;S&$3_L(=WF&F7%483W*$%9T VF2 9[T.F=1)FN@3 &(KY8X5.QSBC MV;=]FQN^Y^T#?X_D^V:PMV)B+1*])V6%]UPA\Q3Q<.G,50>DSN-HGD[1&EB"%B0! M_KD-;'*&(23:\N^L@ZP@OX?^=VCM-H[A!N'"^%633:UD'/D12A4#D4;>PB[H MLWP,:>&4[/(W !\II09S#:K""H]LN_:4Q 1KKVW8Y5V;W#HM9<_.V>CF*X?P M/($F0-V@6XD%=2C>*T#<[2[%.IIO!<866,MNMF^VY@*CMVSFRZDGZR.E<6'G M=0><;<\.B),%KQP2%/B^R5)@;L,T-Q;7V)E;AIP'YZ?^^*(*"*_C6,K9BSA0 M"T6+6$1EDAI#:/^J?N)%+**KQ!O)V2B!GO:.Z?+!8I5[E](#(AC?%YFGG36Z MSM^6'\J_7+GUX!@<2H66NC2"/SX%!UQ!W>0OOU+JLU&RO#1NA9+RLEB1]8*1&). MM8#%KY8]L'NM]M#;?TTI\3UIF3PT]R_ZD<6M\GMVGJTWOOS^E"1TI.XM+@P% MFL[V$^0(Y*I-!.!:ETP SN*E,09=$[$*L6*VX]; 7,S*M<9LF\9B?8.%**5! M8[7[F?YWM:^Y-.@0YTN#&,$V;IGVG,%XFDAJ[,5ETR= MS_O,+6-YQY?\L_+"RDJ2$[]ZD8"8BH/XKK[$(TR>5+5%NKD9XKQ M1Z ^T7KN1]G9 M9+;KNW:K/'_*O/@(F=4:I?VZL^B?7YBRE[5:>';F&>X7T@'K;ATP#"3Q!?#Q MO:@)7"0N"2["\HC= \06IJ+.VA??RJ;)'WUL?8V$VD>_KE5XGQ#AN8G -?^(_LWER7GP1%\3C8$]>#O M$"*@SR!.RA\@].%YUPI[.4?&KQYB#&]H!/Q><+1]0I@I#\V;P/R(?R23$=7I ML$&@0>*;_Q]V 0Z<)27U"8VU3;L;WRU(#N@XU M"V$4YLEHU(J4M,#:M_@Q8P=9UZMCYK ;CZ#:<-F&W;?C?$8Q[/X@V!JG_N5R MQ*EL/"N.#C5:D9>_.'SCOPU&>NM4PTIT)_5KD@TF)7OC@HQH\(1 9O3'^0KE5Q^1H:F[]KG^^K*HV9M")H(H9$+<@54Q;NURWQ\O_3=K7JH&? M[ZJJ=/94\NZR-^;Z!U4SOS_+'MC,)) ?JNJ!"6%1NR8L#M*C620? [-_9J;N M+M8'>9X<]+H+(8:%/AM376/YR_(^5_L_SMUW*.GIT/K7KIVK\^+@$H./_>(OB9C( M$=R&,<]Z88R;Z &OXCLH$KFL(P;-E&*;'V!+%.@4K?%?E"JY-W M(PXMD*JC7GQ P6S[=DLA3\&6$8$$XB8#SR9 )\E<,&$WXD*G -E;],$>DNR' MY_$QW5:J;YLYGW-F3$1LC<[[HI!+C0_-DNH'=NT.VLK]7 <>FF)$@B;TF&/L M9ZQ >@CEQQUJM'X32J(WJ"ZLWO==@5G8]9,8*&6BT%=-HWQN] M%$R^=L@<3>N))*5V0(R*? OB6-9KJA#L*JYAT.7+A!:Y0KI$;Y?YO8\WD&?> M@('["N/0EJ_.U!M[\+@5G\!;_';/S)Q^$[2T!\X/3?K&D1I#A$C,N#+"V0]Q M(2.PL*Y=X'D+&ZKN!Y89Y:VEWA_0\$+.R.ITUAZ9@_+MJ4N*>K\'-?)]<:S= MW?[/IG'=;=NP1J>'+?;]A%N=TG(E2?!\5;FOMJ.TUV8HY'F/%0F6+ ]'J (P MY B7,PW\.)\0RA7MXUE^+\HI>*GE^BK?T*+;EWX6"M;T9;G;V=TF'S47K8J( M_:>[B&#M:F14LENPW!@%=A8A$C$KTN-!$K(2'0G9VYK4J1@;4AO_VMM;61?5 M[!@5IV<:V?)Y943)H:WLVCN-"-@_%*, RJ48[%<\X(X&]YBM9B^NW>S2]ZF[ MC1"UD+5Z7@H&,-WD-K%J8X4?6@QY<]ZQ7QRF-3'L F3^E0%Y.SX !XX:SC-[)>@HE,1DAC_.%Q4C4_Z5V.?Z1^=!DYM*G,$QYGG,?SL%L(%"6',=79)EV(N7YAW MSO-7N,OQ1T(.O4*:95<94SH4+&Q)PVG%+95@UK M73'2P-=#C7+<*M.PCV7C #G];50/, Y88ZU\Z ROB":=:7]/Y MLZM9NPOFB8>#-YS))9:A_\Z8'?U^SZ:7O< 'NY' A$+?K4^XL'.M6^XQ+IRY M!SM2%)*V9A)Z\WI7A_[P)O'!"K?R4&)5Q3V4X16Q[[IZB>DG4E$9J-:X'K0P M)@K2KA^-4>E^1\?5ND;K6%Z4(R:65M_CK!-$554:WX1JNO8.[LD.+/W8WJC# M*XT:,\%>8#E"8!S%2P%1Z ME_8EDD!SP81%$.43OXCOF>\!#7?_C5C8JQ U^<\Z6/25+84.+N%9BILOPG;R MO8E=NE970]V[.-#Z>K[S#?%+;287<6:19Q@W/$5;J*.PC?I5E=J!NMO&OYQ. MC3C7)SJYC"5>[HZ5N>7B%CK=XIQ\P2V_NWL?P;2+%UI"\6U86.ZT0"]>J4L M^M.<< DO&(82Y1@+>1D3;OE)=71][534>^T0N>XY@HY5\LV32=(NYA<]&*G? M/)P$E\=UYRP8T?^T;L.:$+V]%NN@GR#&_&7UF;[^")P:X=8#%1Y'F<"H%9OV MZQZZ4)N$L/AC+ZEIB9W),=Z&?6T]53P N9A'XFL, M6>"6EHT&I4PVWJ*W=%D*$<"?P^Y--(],FJ[Q(="9.ZB+LEM;K"+SDT^>4?U MN2HXW)!4EE(SF62UL^&B&3)J 0Z)L=4K8.PVK'QT%.K/+[9A'WYB1_ ,K?EM MV'*_[N]M&)')$5L!"4QW7+?S'PEP_W[L0KM\1NR:4/C6ON<4@L@@$!E>Y>9D M<+% ,%+S*-%X]F. K;.JM%H*O+/2@L-]WN%W6?"( M3C*V5I6XVNN_ZB\=[*Q_VU9\\69U7L:=OIHFHRJ!.448XOC/.E-VH94D*Q"T M!A:91HQD]K-FB4S.P:XW/G?"^Z:4++R#*F,S]WK6Z/D'YTSN4A?UB&FT7S<_ M."=[8U^2L/:S_\E15X"(0(/[I[HA\@1GW(7R5P;$=;=GY'0=Q+AWV CJ<8= M[VL"FYM#KC)C_PZWR0'!.J_/:5Q;O]BCTO94HO)G72&!#$4*.$=(P@/.-Y"# M)'&,VM.5!6DP$ZCKDPXE[<+P4?DS:Z_^6RSQ%'T])"W3EC0DFOG#0.&0?UZ< M6B2!\9?=AH$S15@'1CN1B>0:ZP$K?7INUN5.$V"#PL@X"B50IHG/(^YJ22-6 M_;-]_RX^Z#IY\LB1_8(";BZ[J MY+FK'/K9*'FLXK]?N_V'XP@'09$*8C\BD NM9(")J8'0YHB8?M7#7^]DI&"D M*>^IX33W"Z//CX05JZ?PA@6(Z;:J7A"NC:^U9NQ\YS44+\%H8;=U[<-U'\5X M ? ^52'P$3"PD%CL[,3R+BB,Y36R%DTW?_E ^'7X+7L)I731*S,*>^ AHRAS M7+5MK6D>[R M.(O[9W559^2>B[D[UUK<<-W1B$ DJ%NVH/7%BLL'S.[MT@!>.JQUZBPZ)H8: M5C1@M-\F^8P<JUCWS!)L)EM0QX?Z#A]ZG'-@;<#X*_]3" MK'+%^W-R2%6XED^?Z0D,M)W%[?2T*_P [/ MYZ?Q)HFG9.E^1$0@9UT9B9"?.,Y(.X%FR#P-]BVK*H]Y[3V9 C?]=;8]W^I< M>=.Q5+W?QWN^P60?93UKA$EX/.LZB0-U$#05,BF# '1UF>&Z];'[P7 *N5Y^ MLZ@$7[.LU-)<[B5+8CS^I+JP2)-\]4+)GF(TI/#Y)\=]L(DS &]N[87//F=$ M?=F&74*E;,/"T<)@T9J+DS"5P9_E6)7H9/OC0Z3P 3&%PE5.J"W7@XM<27NR M8'_W:]>9L.MP82+H&0E&##V$IEN%.3C%\BH#=6W:)DW89KV'O$7>-#%#_<*S MT^1C>G+4:7['0=J(EBRC60MENPX!9W)T<-P 0+9+(0_ MQ?>&<#[&)_-?-.+A+)E!CC / M0.((Y3%5P4)&&_B(TD&+)-F$ZE_]). 4M;O]P=^^E,-[-A1D,QVE1M0$+JGO MJIUU?KO>M=,??W"F\8UUJU#+Y*71D?UP(HILD$>WMILPK+D:H?5.Z6^9RTSX MT?O]9)!"-SC\,CO]4,VRH-;-+K_[*[9J\OV8L M&2V.2#BPR#"'3N4<[\H1]B$C,S; ))9CP^@493,C]DAGTE31@\<+MH61C[,$ M_=.O77DT]V55U P-SR0 [LA,4Y0*@7R+Q$T(-53"CI;(OZ'#LZW44REUR23Q MW[0FDGB\P/'6IJ^E3,W:_,C9(K>[)S3;VS8T;!^>O)WUZ0>G''1E1+'O;L,N M0PS%K(.!8M\CA.?*G@]U1^VR,*)$R'?[[6N8OCC:>9IX<6QZ:*.X#6?@>.,. MIY&V]X#;>Y5CEHED%.T3!$;\$RPOI@68/<# \5BILW1 4I4EU+'Z\#AER-!#LG,SL8JL2_0'.4\*KE^E&>37>L[[:I9.[$UKF/0HZ)]TL.6)R XW MSCO4QGGPDF=CDP&IIY3/J&U8[^15$JC>NMH;0;$TI/*V.[1-6J#I^\@8;E!4I+ R!)?XL$G$+. MHBB(U%6+!/(OFKN8?#])7&I=Q=#55"K +3'\0W"!/AW[%SZL_GV_VV[I17QK M'$O&CJ+5EPL:&J9MPRZ,S"SVX,2QLO%;Q.//6Y[ M7#9R-4WM 7GOI\A]&Q*/HIUW\0WC=7#=ZCZ4A7RHLP> "U.4I;XVC/-3FQO4 MGTTCTBNJ6A'>OLY2'S;/;#:8/RZ,J.W?W'4E*ND #%'VD>4!>?\$.[P-DR.$ MD, CZN2=TA@H4>EJ!TVP>L:?T /TGTI ]&2/W>H$'=$#M4$7U*PR1WB(;F;3 <3U2,B'Q$Y,(P%[B9E'_L!7O%W(C78OF0?4U#;9&ES4*Z6$.[GX572B_FOR] MV]WGHH:[RNG3-Y:#D0MAF MF/'IX]U<7^Y>B;>8(+*.LA]::8)KC B(6/=@=;$?"%PT'P^ZCU?E.VZM"81CY<&]&$DZQN";]V MUR$DSGA]YG3@ G_( V][XH%H9_Q&!P7>2Y+#J$ >3,];Z7F/B( 9?=Z<&LK0 MAP^2<]Y^\>[@[*&#B$-I^@**W/8?8_UV:,*=>-T!@A+$7>FH-%4I,#!X4QY: M+K/DO_H>JTD_E'45*%_KE$X[Y1/"O$4H;\ MZ/#RX @_9AZ2NW"0PCP1?5V"-E#W\WJ25 MI)%G/@O$\P.J1Z@W+O7[*B)%J\M2),Z&_]N"WEX#A01!"!T!S8PXPLJ4W-D, MAN;7.OVNW2O>&_.@LDL^YLMRXX' &,HO3HP&4C+/-8K?4\3_=IZYQ$]=CO!: M0GC%SEX.3%3BC>B[O;*,E#%'==@K_C;_#UKEUT-HX4P=E@PDNT,(TMAA?!,\ MS=4#(&1=%GO[[8B(?F?2[ZP?\MWK/[*.-:@S@A1Y+^Z2N&TA#0&JRL[F*#X; M4("IPQF#\."W')&*(IJ?:J2'I <]L1Q(?O4BL^I1S<7EM@2)W0^Y[>>58?>J MEO& )P[4K4N#B*$?-Y .]8&,WD&XK)5V.&YZ&R9N(8?N&I'MFZ7>^1T9U*W# M;0'4RD3F?3O'9[N)[$-.!S(4V)4(\CTH4:^0>DC3A53#3!.A3K4Z<-GDAKQS MTJ$PSOZ&E,_LRVN=G0^\J!O!=PHUG\4].*Y-P<_LY,DL4H%UB-U%"(94B*%; MXP2.(M< ;,,*PV->^#F@]RYXKCQ;H004':H1'="A?6QO>+UG%_9\DL2H;R!' MN(UI@QW 0["3CMBY0*.-?0"LN3:"$\^/:R5S]F!,QM::WE]E^SD0N5[X$A?F MYXU?C?/>,7"Q7P^^_=#-Z!_N"0HX#R>N<82UJ".@8=SJ-HRI$5[HQ]\TUJE# M#^\YNM:#%YC^U5I3MK P=XEN%Q)7??[& \V-1_GAMY[E13S+FS0TR>[$/[L^ MQ9*NX@ANTIE(T(&9$+]&'Z CR M_3;%.=%X@5*3?QU0^!.P'W!P2 1+@%IUZ1PUC/"HB5@P(EW5A+- M[I3_KR3 MVET3=).T=Y\7Y_.PR 6I^B%UX.4 P>U/,>[$5/]0J/=$^<_&CGN3J\3SU24G M?UZA6XU=:R]YE:#2CV$R0[$+"Z+L;%PH,AF2 E6UT\M^LF S-<*QUZ/H+9,W MYR/+NWK28%V*6_WC"VZDXAN7*S)WN?Z%0ZRI$:K$OBYE\/&I+QQAJ K.8-01 M&7]OE69]87D ?^M+>NA)PONZ&H__\#DXX&W/>\LK:Q6(?2 MS'+=E]ZW3Y8R6G[=2K$70<<8S&?\0(-FFXR'&8S3D.71'&/.%WA+85(('=V# M$@=;77)[K60G]:7B8ZL<;ZW6E/08%WL;A9L^-S_IX'YB/"**?:'=6LN$T(D=C]=B [[G"! MHTC'#3/GIK;4>)[A6QE9R^0 M)$""G$G+"WF.T8=:E=S\;)C2FIK'CP1L:ODF&> MS7FJ)J&10^:7(QYJ8.RV8?QKH/0@7 9!3D*U"O02TEL:S_\B?DIO#B^?F>4. M:G_ LDSFYIHH^W' O/ EA#9?\1FD!C0-JC2,*SO+RH1U"A7_6CKV;\UA%48QTJ_\(GS@N_*N!+>V%QW,%W4(CSH0)!Q\ M7'ZKT<"U#51D1NTH4A.D,G;$>RHGPHH?3O)0_J(7E='!15P^B!'*%"*!017W'DXG'H7(=9/+4K M?LH@;C$WYTX9B.IWWVK:7"Z/7_5\X["GK3.ZT7!+?;I!_9!B60%)QV #OB2_ M"HE&4*>"I3P$]8H<,(3)#_;V.U%1Z7@E"_^@BO*"8O-/9>'7/.)T0V,]_7%% MGW]/-SAH*T341P3?VV>W!S[6_%^APA+PM"@F'/N9T(KL%G-DQ+)?F/:3K7O M&.H<06@R[R_DC+DM.P-Z&O(X'JOPLVM/KD]N[^36IU5TW$N-R.R8J*N-(H_* ME+M%@]ZO+\+2;)S_S,MP;>!Z#$'-D-7G )Z1-(:[I+RXB%(&EWJ]W8I"4F-) MF5BKKYCC6NFKWT15=0U;3E'W?AQ^X=KNHIC.,@I9%H8,ST>$XD$U DMJB5'' MKA"@)="9#/=QC/5B&*^ K3-KW#7>V46KO2DG*(7R0-9UZ83*N7.],%@L MB;7K%TSYZ$+6LW+[S,@JTS MOEO+&FYX3!J?Y7)ZI&1?9/SHN5Z9T"[1RK^*O"$K@A7.QU0MF0K8/KP0P7^- MZU>7%!A3\XNS9\+"A]JQ)@6.#& /=*8O>=+Y*V/5$@P,RM,5 C4]+H=6*NU] MIBUR;WB&U%K(DFYD0*(I)0=C-,Y1QHYA93L>_=%WCD6(Q.>>[#(MJDV[_J:/ MT0I3N4D.4O0V)9;?O^]B^3$+]H_$<(>F7>1\1C54#.8J\_)FJD+U8L)X>+:C @5ES.!KQ0^??3/S]Y&!U M^N24A]Z -B%.8?V98,;'W/W7#"Q7(-M=&760[5JX;A-RC=-]"[_6NDY\4G'V)B-?)/)3 _KT8E/^'R=CLKD(N=VH:] MCEL=A,B$!LN87!22T2; 8G4R+\S34Q-D/QVC< M_104_>ICH=Q&WY">5-)P1U[ZN4=GSCU"OAH]!E?#=A. $U +)+&D\P?7,=[L M)UW"<[@>]X "781D?*$WWN7-^&+>M?[KM"'#CV-[,Q4=7+X[R$YB(7D# M.,"GI3G"YE2X1/P0HPE4*/K=0;FZWA21>&:RSGAV^NG"1::Y4Y@>6N/XAUAW MK4 C&:)7YI9M%FS)2I*U%XP X)3/#X!\BOS-B":$^,_7"DTTT_$HSUYS\PZC M>^OVOS^OJ1?$Q84$!P<@A9CNV&Y20P;M'<8,S71GJ8YW1@12'+,[[L =)N,L MGSE%":9]C^_FFMYW(G_38<[J0MGUOS)K^?2=W&DE\IQ)+0S5^.AVHNU\1WQ= !VWFL8TBO_%".I@ MW[&P!GQ.($36C-6>.Y"KS)&-7IIWNST7/4\]S'HM7IOFZVN=HL#CEVL#PX0 M0QRQ32@I3[(T05WJ6M*"+#OG:H(Q2L6KIBZS]J_3F?4UYS=I^QR>VZ\%/:IH M.5>@7<8M?QN=J9!B&UZ]LP.5%^)C*==8XNR"3CNF$NL@J!Q7%B\QH$F@&#:^ MIA?4H!-JGJL_MXZY(39V_@.7@P9*?7B]7IV%-P]9$=;F61J9SN4(A?W']U5' M0B;+V+>[)"]9B6;WJ2%:+GL,>D^6AEW]L*EANCF5?U*#9X^]C)60\FO[.E%P M$&K<7W#=<"LSS-5V^/;F8CTJ$L$N+7L<1FF+NQGZ!-XZD;\,NDB#5QG?9AT*XN181V60H M&"8O'3;9\BE"IOZ=#+$S>@_2Y&%$D/D[C9*83ZP]D+ONV(\((2QB&=P:,DQNLO-_?W/@Y\=EHI&_Q]W@_^/QV?@WX*&4+;+@ @TU1+=OS62@M7 F#5W3%BILNR!FNYL MY]$7!W^'OG=WU9-2*(R.=/_X747< 49@$C,@X[:5 MD'?\8P?Z@X(TR_2:D,IGRT,F=QB1FNE+U_TR XOE]@7*E.9_GQMC.;/;L7LQ M9]AUS1+3(@R%46,G9#]'9KRF&9Z-VF7AR-MZ5"LYHI;+=/(3KY2=)J?\:,J' MRYIIDEQYW\Q/QV[@6)*N'&%IIENHU7X R9+FX0BK 5/(U_2;)"$]"R< 1Y7( M4% Q[^>H.,:G#.Z%652]#]QC*FLMB-]_4_W3-SAP##\CT;\-:T&L:M+1C-MT M),V'[O%NP1*LI./[BG)J7H+J?3H5CA4KISYFZZ4?9LW>N^WY3]H>2!J\I!8< MP+5UG'GZ$KR%T$.8J6+R,,[EGP8SZ3B?2?UJ8WV/07?=L&=A_;/#;SJZ?&1M ML\:T]SX.]5TWKI-)+'XB#"XM>@SNW--9QPBE2_0Z(K)+]-EW8Q6PZIBSHRP5 M_XIXY#&ZQM0G_=F.3X?T-DZF[6E)_T'YX'_S)G"&+]&0MX MM+.K3)1O.%(%>E&92B-)+(>ZV6-Y!HVF)?Y[5U_!2K,^O^P_)CI:\&X^:V&* MAJ3M[+;.';WZCHH3YPQOPT2_3T2>8(]2ZZ3D6UK=1]Q33S6U1QX5BI_'7T?ZL[U M]-)ZN3^$Z1H]RGCJJ7%!RKV$1U.7["QKQ2_65:\2OL6]W8;5:1,>U=W&H5&@ M&9.AP&YF.=6R$K_\>1M'&1GXQ4Q^&8:2[U2CZD[7T6(5ONA)6]BB]Y_TS4N1 M=>[9]_6>E2!LE:.'G80W0S1Q$VH/D-A>8FR,=?)11S+]A$9KZ];^Y*9%^8@%K $*.6CA]8$\(X M?V$%+B+$0AF]RR:/PH4?>\[ MF\['59S-HX P?.\G#!YA.N*ZQ;&:+#FPAAD$^FU0[5:KB52XV,^BDC:KYU$ MC_?7,A&N&]T!7?92Q[GGC0,#%8=%(M=I[3"VX\YV2[:O:U\A?.<+!2D6]YM&IF4#>&J*7/.BOO.CM_65S>A+YB>2>(_+F5PN MB![N.!8.;T6SI!H9KH*8E([NZY?@OGT1&\P$V!2&&FE8!5Y M&Y;)LC,K?KE,-'VVZ8P+/O]AM+--WRN0AT?2_N/+VOH!KBWX_THP>Y@SCF^4 MIUG7L2Y_183FSF0LODA]\>$5QG0;=M.UCR#!\J)D&JS&OJ06_4[T>5CKWY[N M:/Z0N'Y5U-US)DBM\+#_GU@9+OK:ZLXM5^M@'IET"RY!N+1&W!QHQU8NDGA8 M*O6 7:J%UM-E7,@X2^N2?P:M>DQQ*7QVV4_SSF_9Y[?V7LZQD*)5 E4,/G"0 MJ<9"@L55G#Z\/$NW%#2D#M[Z0;=SW[[K_.'_,X9SS/J_WZ_5\/9_OY77$ M,+&APF'@^<%?=A%W;4L-KQ\T>%T7D7S&2=.T*.N&<3Y3CYN"4X!:D$ HY09% M+&A>;R+JYXS]X/*:1=UQ?#97\VZ\1K(9JM"'^2K M9G^]XM@Q2$E8ET BAD!+;Q6S:#W4D(/VZ[T=Z+*]O+_@.,TEC=PT2-:FB\3+ M\=5*SX;:";4V&/7#S'Y.%1+1HXJAJ90Y-W0^1V\ :SS8L)^U.U,1IED7S^YX M>FTFOQ,C5QZT&G6V5:)87#/3\=P+B2U]&&]F .R!!3\HDL;>.=,$NGWWAFDX MWU@0W<=^.(QQE.ZP,IJOGC;:>];E2WN$TJ,]6H%6/PN#K,C"=Z++(]5SW=R: M)^J/^YP_%E%XT=?E#/_D'\(F'P'$8:TK-XPE)Q M4$I?7_+LJ4GF&+U^-H3[S+UPY;%[FQNQ4K/&5VWTFW4UX>I$IADM?-:,;8$; M ->%=@\[,SM97ZGB6UC*.F8G,MIDQY3H,:V9N1-RY>Q70;2$"SJ?2LX*>U?% MY.X1%B$^+%E1:+1]_>J9^!.2S]K*<0<=3^:]/D@'ZJ!4$J.Q1N,DED7_J4%( M'GN$=3$L4?**>LK';%%F^M5T#U^+,PMW.A$_&[\?4(YF&^.ZF"2!>6.K"8H4 MYOU$:Z8QH_Z+K.D^1N3H8S>%9H'+1OX^.CT/*LIN;DW37+='^5+RO'9II]:J MEQ1@;_Z7#S[\.+@B ,,/J@S\X5AR%A+B 7>/D9;9AE",V__&GTC*BWX?_%\=< M"4Z>L(#._L8#/GA1\9"3/0_88@$VPESKQPII<2O&DP<\>$ 7E.*#Q=/_O?_^ M'FSLIM#/O9LG.-B.1$M:WH2OI;IBO.\>$@4OTU[R@-O9I/$:'K"$I:S$#O(OAM+QWF.%J:_Q?_N]8 > ').B@+B5@PTIEC M+$-Z-,UV[A$WATJ1YCC2F7CB%(5>Q#DH3BXHJM#":"1^2#SE(AD:U%F]]:SW MMB@^XON:7PC6#@W.BUQF! \H_4K5XQJ3>X1^R?XVSSQ%2I'0MF0S)H'[#%+! MJG(S&G1]2)M"D=$DY3K5<9MCE;'DV))"][$OS\WRSD M[#C;WH'*&EB;!Q%,A]_#>6:0!VRM0\(_M>"?$5@+-#\VK($Q'Z<_:GVB.CT\ MKLXSC,E2*0\\KKBYU$+EV,D,%]O[>Y_S@&O/$.'0>^@0-VM97(35;<8MVDXO M=YV/-KX0_-*N?6XEUJFI%M_>Y:GM!29%A^[B MNDB5&NUZK)T&]?D<,^Z]^:5Y08Y0[_+U)"TKUKV\*430 "679E[VI+45#?"_L2NN[R2+,BRP&>QT/ M:)3DR+*=<:U@97A+H$8KN!Z2]W%=DE=B$@4R%0<#9#25%SY&[M]N??6T8IFE MFLAWHQL>%I=U =-F;CDR4$\9J\5]WB *-B*1WOESAR9HA#;A^T":0BY_CF%0GI] 36W\U;%O;)G\_S?7.%MEV>D;4 M#>\[/4(44S56SCCA)D70V)&137,JK@'CL.HOIP]]K,4VJXQ])!L^]F['JNQI MQSU@G 'I=GHC./SGYZ(+)B MO#N)(,*)H%N?X&;K(^1<\((SRC)Q+5>FXRJ)'&DD,Q;+"T:#^"WH!(!EGAS@\RG!J6IJLH=.J=HW0Y1 MOGVKLR5?DH+%[^U]^[YPH^6K<4OE!BL6']N/H\^"J3/4@2S!SX4\8S$I;TNQ MDKUUWA,NQD@ZVW'P=$OEO-93+;/+I55WU4NVZ+3V52O0DL=$C<,E V'F&X4& M&RU@IDZZ3:&C2&2W%@_YN+:H$=I/_'B@7B/M%Y69%T2[;J/=;DCNL^0KL7D[ M%]&DE7PFY3 "A3W +4+Z=(\,,9-8 _1YYA'6/6JW $9K//RVT*T7#--"JF>! M-0TEK7;9^IV+*$-;QN!%N^1KW*KW9:\T=?O:/B3L=E4VA+D5MF$GP_ ,O;7(&_\ID$28%Z^=&_-(I ML$(((FT=_FFJ_ DF>@2I)&5S'N"TH--8?EI1_^+ M3SMD%M12;<)"?/5'P@7)9T@/M\KH=C*C>$#T97#\<:8^O0\3S71D@2#=D'8Y MMFFQ$;4%NXZ(LC!-!Q%=HGB1C[WO;S:EO74QB)(Y-N/A2!=O ^E79)O1&_UQ MF[D/>< E'C#,/LVZCFC1DW9G&3DQ!NO#E'.O>X814:,6:GF!UUX]6VG1_%Q8 MK$NM56-V,VJA395GM$DEA-EG+:(QRNJ?2B.K2<_$2WG .($DA]/@A'#O8A4F MB,D&!DSH4&74O!GCR]7$VZ=J<\:Z7_KIR $7Y']^O&J?+'V#>(F8OK;=]!K8 M7H]DBO2Y,5_0"XOB&?*+-#T\FN/[XO,)M&RJJ>N%^#D!]/!$CGH^]GHI8RR=R@-D M,1YNU[LW;@U[\$EWPNT5,44OH.]R&EKKO144[GCU_4WFLA3?HN';;M8.PR:" M($>:54^G3/RL-%6=096O+P3SL!>'BO1[+\CDJW_@_^)&'BE('KS::H;TXA-6_\]5@[G-L)FW'M!DBZ#2D15;$^HPBK6%Q9V9L[<)[^J1B3[4CO MJKO=\V/QB\@]M,**?7N@^F1P4*IT8(FYZDH^\P'<@J$Y&_8Z%CB!B&^0Y'BS M=(B?60HTP[>C1ZUPBOX:EH8&.R^8%%?4]>D6IEH^MCXX]Q8_&8IYM*6'4Y \ M?P-18I!/19$)+3R@*GQ.?,)]7RM"VMB0+?16P<-U%0EP:%J>XM2D3ZG=8'1 M3\W,S3N>J3Q :-X\/.+:'::;K9S[/"_I4=#%V.'0N4FEE(Y@;=5O5HE6 MR'A;M@8,40(]GT!?-RO0&T.\=;0'@[M R\.:5A'\;,4K> "Y+F7SML-!+2E!C8=&,CW?8FJ=B6LQ//TD2W M(T?Z(9DJ9CI'-PG1?!5!3P O1"#AYPP;@)Q4^@S*K/

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�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�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

;>+A]K:K/,+,F!O*?U[F1!L$F_GPE;#'/*@9?5]I(N 3+)(9-G23=BCHP/*0EX<:%C%=%3"WRL MDU]F(2:=0ZR5J4:!LII?OZL752SG6@F?FL3*GZ5JD H:70.-+_:'>F@\471@ M1CVUF1_S.J[FF^:!K_ZVF8?$= &VE84$GQDAOZH@TP%2XI-[KF!]$V# MM0:(&(BU8\33,>I^Q2_YQ^47,B9GG-F0C7-@!/%*F4*F(N<.BL/,Z9(GF[%) M$/5ETOK$VE&(&(BZ \73,>#N+%-KE>*:K@"'@8-BR5XWZ.59T<:B\1*;C'%] MD;)AL^O^/JKM,)%TC+$?M^14'_D?JUHP:4.P9&TP\#[1X>%T2IVP&8*)B6MF MDSKU9?J PCY5W('(&'RE'B.F7OW)=Y>?\^K&!WL7+N:?-I\\Q'=\\E.C^(G# M"#W2)[S!P/5BVT**>5[7#-*+Y?IJE6\]A,)D$BH62)$%4%@;<[I@@6NK<\I( M7D*34H2723M63SV]PD=B[P\7-?'?,ILWM?[_/WMONMS(L:N+/A'NR7GX*4_K M.,++[=NVUX[S2Y$#LIMGJTE?4NIE[Z>_2&JF)E:QDI645SBLUEB%!#X@@4P, MAM<&-2@=1"1B-9J<1.1H99/I8WO0-J]MFA@YN\9I:MF;!S8U M4<\1?3Q#Q1*/VRN;Y(NJ#3HR!.]3'?CJA.>2T*9.V%#]O%JFZYO[!^_: M(X14SFAR0[U1 91B#((*%/IHDYR27O/2C@5[$-B]R1J"H6=-UM12.C6[-?Y$ M_JTG-K5<+<[=A^R4)L2"14/8'B(482#6C.)DI4LR!!N2/DW3=1M,_+@D&>!O MX4_!], M:_<&;0BRGB;"MY7=W".OKZ5 !.PE*"#0L4;&:T!9.XW^.O$<'<$B76 QWV.ZW[&RW,A= ID M:8F#VSZ%F3C()0,?N'(R615SDQA@3_KV:UM[H@AL(:,.H'=+?IVI1UIUXW?? M6/AM/[I%66!^H%L""XO*(@2I$RBL[>9J ;#D3F>MA5>[R:W3NG![4[I?XXD3 MA6-;N74*S%HL'$D%\UEM4O<)MZU=7E^U8G7,;58@A",>.T.A61QEK M0B>('.K__5" MM,]Y$IE6H4JIC=>\ &=#[6ID!#*G5+%-*@O>(FPOP#4KKFH,N$FET@O*GE^) MECR2Q8[@$@I0J4B(DEM@+/*8!?,&FS0F>)FDO9#5K%CJ&,@Z7!+C,;6Z#!=' M3D$R+J-1U@ 34I-G(&HE#HO 0LK%^2SE[N"-+E.0FA5)=1 Q#Q=4!U;MI87= M5%]?-RRJJ[OO9'1>G&5&1@XV^-H5D&6(S#,P.>GB)*WVN-4+K]"Z'RI/]>:C MM?!ZO=7=KGD3EC7<^K*XW 96V_GU8RJL7GS6-.54^Y$ZT1WN]=ONL&5+R68[ M@%-Z!2KF!,&%;>^>:)"+[%B3%JJ/R3B\IK,^[4/Y"3<;Q.M9_"<,>"8@D868V!-TFE?H*++U9>/52H7#]JT?_@#UZ'V5KAFX6Y^G47)N9_ M81U=B/GL*^T/GRC8J.76M]M$3=^N+OKMQ(/:?GYWK3SKVLF+@4FIJB"/$*VU MH&Q4M:5JCGJ?!FN'TC%OALD$F#NZ,$XIBCV@ ]$K3VL6Q[:L<]B!FG1<8V:U ME4PM&@Z204"-8"US"HW3V33QPJ<.9.NYS/:9#QI+7!?]VT+QDZ>=G2M=BX4T M!5>!E"DG16'7=C!FHY9G+]+454 [! %/ ]II^#[C)K997YY_K/E)VS8DA?G$ M(AK0Z$O-K*O5]#R!(3\QV41A>MGGY(,>^@ H]-4N2!Z]=6XX3"3#U:$,[0$% M_\0O$=?G)5F=.(L@2ZG7F)J4PA'9G@7MD"5OQ#[G>_OCX/J]\R#A (GMRGP$ M^V:6^DW4>$-X-"99C@)X))J5=@8<%P)4Y-(()F/4^Q2U[27W1V^>6?)CY+:: M@HES2S_\^8#P8C +&0PD%HA<:PNXH"QMA=[XY .IQ3[Y\/M)_^&;YSE.G$SZ MHYDXL_1O6TUO[1YS-AN+#"CHQ(11?'7 MI3=*808G>89D8PC*&>_M,\-0#@4%O7D>$$PGOUU #&5F!P?QSUO-G^X:OHG: MPSN8!+0D7?N&!X@FRKHFGC,Y0[9-=\8WZ)K[ZF?:K::%,&8^3?\'+G%]PS#&?WN3V>.(P4V&HB[G5@5:YG M#5XSYJY>Z=RC$-*B!5,$V5:5.7BN2$GJ!,NLE*3%M; ESU+3H[-Z&'"F8WX' M"'JQ$S)>_K)>)<2\^7'Y%3.L#H'>IF6?)Y:%0NE!1DXA6V:D)R8&0@:C MF-T4>E&3;+9QY,Z-P;9<7H6+QXE&Y^3H1>FUA'KB0%I6IT(K M#'5>+SKR!(O@1VTU_!R1H.3-;#!-@'S53/B2E2.&X@ M:E,G4G,&48@,A4GD-MB J8F!>H&>>=N/3&B.IN!W![ 94UT;F"LR<7(-L4[Q M(5T \AHM2.F=3[5KE6C2$[95:72SYB-'V/VFDM,IY7ENO_?]G[4'%4Z<]/GL MHYME@+Z]D#;IH$(SJQ6S0,Z0JJD;A:(\^L!,L+3%68RZ26^#:=-!'QIN8Y:N8^@1\M]2?=: [F=0][ MW>?5^K+&HW<5FN?H-',F"="F-J9(.4#(UH*0FMA%QE+F)C6P3TGIZKSS$*@< MR.4.7B;]N*3GXN;RUC0RI71P/D+AM;N@$<2C+.L4\&PP6)$U;V)87J&IJ_/& M0Y S%=\[@]#'6M;UH?R^P;/-!B_/OI =7?S/5D#GP<8B=2PD;I(YL2O33DN? M!2S1:^-%C$V:O^Q)7U>'C%-!:RIYS'S$>+VD1W:6,2$1D;3"9@DJUAP_S@Q( M&Y5-&)G'?49J/'UR5P>%8W P <-.*9)^5%)_MR'3[^SRH%&-Y?CW-XO))V)) MF\!=\Y2900/>2T.[FPK@B[%D=I I2Y%N;? _=DDG-LKZ.^N\&=BWF__ MQHNO^,_5\O+SYEQ9<@59;8)?A*TJW_@V']V[]7YQH-,3 K2%S5!#!/O,PBD$J19F%0 MZ&63FOT]Z>OJ'**EK1LCCPY@MJ<2_;BDM=4E;LZ+,(P[+T"[0#&-50Z<\AQB MT63<R=H_4UYZ'+-7">PJ7:NUU1LLD0Z0MK=:=EUEF657'@ M9^K6;Y]QC:$N]%PC MV?7"&'A6ZSJM)AL?78)D%'*F:VW"G''N/:7[(? =W6*,%%('*'Q+QE&X).N-%*@+I2 F\E<-B\H96S#9?=J$'4;% M?M#K^1[BR)+H WK[Z-HOU\+\5[BXPE7Y&2]W?G[N&)>:7%0(M79519LABNT\ ML%A0D"P8[M-]8 I:]H-ASS<3LTAEYKUW'[5[<[T>K9,^:T!=;VA8\. \TGJY M*$;[8 *;R@Q.@\*>;RAFD4H'D<:SD=-M1J&( 3TW"D3:9K,22TFC,N0B#=-* M*0JKCA:X#LGNY"=[,3&&]?/OK,^'24\65>_L@C4>N(P.E,L<'.I"P9+,-GN7 M[#%JTD7<-![)\?4T_]@KL%+5?+=+,FJ925PD5()9.>.(I[7,@1&*; MBD&E4Q[LBCWSHOU TO.-P/3\[&#[>@'Q/]\OB!&VL0X6+.A$S6.QX++.M#-[ M6B@S0;1)'W^3LOT0=7HG_(<*X93J!A\..+T=>OKCLJS67\)U2[XIBP3W?%FS MBL QBVU3_L=48E;,O=73IAEC\2+-J6^1(/+"F$&QX;?Z-7H$WQ <,$JTE#0M" M[;'O'4I'5Y5^0V#Q2MS75AA]G?H/7VOQ&FWP#,AF!U"JSJ[P$L$JGA0F(Z(: M[G U MZQ-L^QP#NJ,&8&WF^KFVUCV JYS\+:J$'*.BK%6@>NF P$)E1%9&G2 M/G9NW-N[JNT;"[(C,+Z#0&"G2,&8L6<@2;)-CK@-H[JKT;PPRCRVW$X'H\W-93JR2(7=XND_6&[ MB^PL$95)B25!6KC#UE3=+_/->C(UW=5!SAV7"+AW@H-07.R@803CN5-$Z>&E:H&\HH5V=T!R"OZ82Z@"!K^C7PVWE%URG>I?# MG5.!AT#XJ+&69A9"3?QSK'@TF*+PS:L9WB:SJZ.;1M;O4.ET@+U7=>NY]7F> MK!&2N"@,Q?RQ3O6HD[2%,J($GRSF)N6#0PGMZH"FF?4[5$*]AB8?\2LNK_#F MGQ&QQ/_<.- F3--XCI% M":>XUB=O(6(%CSA8>__V4ZO\<20VT/TM9O'75PN2![?X<6B[DG$G+/UNIZ<;0]/MMPZE\9P MVH,B)%\([X1R"$728DR,-B6*"V,YCDG8A]Q^[,00$+QM)R8750?^ZV_T>Q_* M@V6<_;G8G(M8;! 4^^G*,J4] Y>]!*Y$H$4P(=OD'#Y+S;SG0,> P6IJF70 MK(Y22LS&D8O? MI+7/0#KG!>,$R%@=3TPSHG"SOCS_9;W*5^GRP_I77']=)-SR:MOPM"0)+)>: M%:(R1*X5Q,BESJ$4M/LT'*#G/X 8?;4+KY<(F/=0\8C&;!()](&@JA@W*]A\ MMZK'I>=9:Y8BDR!E8J!*<>"L$*"ET"R;I'G<)^-F"(R>4C&/+9I&L$]1%-6D?.Y[D><^G M9_#*CB3=4\3QEKF_41#_#3WFO\\9LRYKH\'5HQ,E-9*/$!-Y)E)P019"-,KV M.HSN$XLS1L)KDBAWG*P[/RL;GXBS\X I3\M:I,(\=U(2DQ"ESJ.(%$V ,K9 M<"J <'7MY$C&E9S2R$&%0 ZO\9$^A%285S&( M?2J)=I][8OO0"#FN)F)J1X"XB5@\Q20J,0\AJ>T(,P MA,2W5YG+UA9Y[LP[/ MF>3(+(BBZD!-\M!CQ&HBE1=99"R[;7.?A<1K[YCG.'%B/$S&Q+E-Q(JVQ^7V MX+RZY^O[,W.CDPOD4;%J,%5 "))%R%%+;4LTDNV#@Q<>/\]!S-0F80+6S=T2 M[_(SKG?1*W6)Q;($/A#5*B=)Z"7.&!$,=]$+F^0>HG_NV?,DZ$TL]X.9UL%Q MV:_$]:TK_,W59K'$S>97_'1]GU:]I2)T<"X%R+G6>$I/3,FTMXF"-D2=4?(F MPSA?I>HD;Z'&A!C3RZ@'P%W3?JMZ0AHA2=>\8>0M69/!A6" 3"?2MU";U*2< MXA$5\\:L$TIW%S>C63WSU>7W5^O5'WCK0VGO$D^T@0I9MU*RTS%J S%@D&2A M,TYW6_GPQ3.C8KSL5A,P0%F61;HC/FIN8=003 M/057G-RV*'4M-?2.2:UH1V53(>+)V^>]09X&$(>QM -?XOF,,J655_#A+L7OF?0[C7M@'\JL#2W! ,B=+GBG4&?@VNR+6!/H;YG_'RMHT"BU;).H'=6%[[F%G:!(Q(Q FN MF616<[[/'G?_Q!.[M3P,! -B<7G.3,B10@ HY*/51!Y: MOR(DAY1M#"KK&,0><'C^Z2=V1G@X-"9@<@?[RV[G%2^%)48$*$94;Q%UK636 MP(O*R5=O'YL< HYI=-//('+/N)%G7/W[6ISN?GU,U$6PP;S[1C0 M^\;0Y%SXK!'H7PTJ%PLQ&H1LN2 GNO#BFQQC'$;VP89IW[=_\_#M]V5QQH2H M,!3@,4E0J=;44& !T47EO;1.\";UO ?2/:^;?42D/C%^1Y3WZ1C+T=W#7GQ4 M(\/9H*?81*!4SH=,GCK8&+<=)2WXP!6(4)R,F0(ZV:2MS;SF\]?T&?/5Q( M,DLHQ.C@,-K0IJWY+*L]:5,]1"N>I&1VCZT. JM[)OV^7%\'$O_S=*D_KY9? M<5.[X?X[K/-N:7]"M)[' I9[68](%;B@/&29>6%:9@H!VJK3:-KG/2GJ0CF. M(_>NH/Z\3O]Z28OZ\,4L72Z^DN^PLV*AI4^<%9 4(].*"Z]M86I3,VME M#L$6UZ2]YN&DSWONU070CR+U4\!Y_>[F[.KR\VI=E?[W6D?W@ UU4Z.][?L_ M<9T6&_QEO4CXL>Z-]QS!*(*S48 PBB*HXA,X'C0$9NE'*6>6Y]&#@Y MSWIR7-3TIT=QER,?:6>D59)_]?C^Z,Q]2>M":9ZW'+[@NJ_67.M_EQI!4A_+W M6^_R^97G3"%4("LAG4V@G&(03!T!C3(%84PQIF6,._DQCDU8AX4G,Z) MZ<\U>Y[6>T SN3T>VN@4]77B^SA/%<[F7+0EL"@*3@4/$+F04%S@4E*LZK#) M!MO+>>KS&OCPE.N;OYX>@E5]O,Y[*\B@=Z@GWP8#/;@>M]7]WUZ$S8:6OW6V:L5!,)(7F1%DJG,* M%1?@K'>0C7#<>YNR;.-)O$31S 7O\R#DI58;!XFK ]P]I/^V(;FI=\E!0.84 M[RKK8TVORF"88S%HXZW>IWIL,.">DM))PXW#9+R:E.$]0&;UY5 M"TF$8),JH+,,M3,2!U=][EBT+\86JW.34NJGI,P+F4.%NXN5PSC=#5:V_+AM M=N:BSH%C;7E86]WI F1H"QBG*# K3/K8I)//$TKFO3YK@I2Q?)ZY G5[U+HU MK!B2$"X90'(;005%87O" $(F5I)*68M] I^]*D[OWCISSY99_9GQ[.\!,[?E M^NA84H9T)C$%BE8!,6R;6>H[@XUO MN]%$QY/A"1*W-2=2UJ[-GKY4SI(!S?2-R3I_/4O!S$@8(\?5E$SMP-&H5W@_ MAR_76A$U&3\1)$A=:E9_[6"66 #+K"HY:ZMXDRO>AT3,W/BIBRAYM% Z M2- M65B]H9PV<$=:Q@-76"E.R4XKM*64W4,K-XHX)I3R651U8 M^>N-[G;H1XK54:(=CN<2KR/PF 7AU->K#&59P#;C>1]2,6\65Q^.PWBQ=("I M\8R[7_8R[^AG(1X(Z2(PHAA4H1@OEJP@NY"-=*:X-K,S6RQFWNWM &SME2AR M1$%W /:=9+#;O;YV[@B1@^%(P:,H 7PR#'C27@N96:.JBF>IF?D6:7:0/&FX MH\!BN06UY2FPY2+U(T M\RE4;P"<1G(=0/!-SK[$V)_NVJA8DPSJ0J%XM*Q^<&3Q2P9MK*C5<<':)O-C M#R=]WES]/B*D(P.@ \@_N.+^):P_K+?I.?E?X>(*:5_9+O;<133DS&N(5G-0 M.C#P4GI0+I,*^V+1-2F.WX.VSKW0B>'RCW?_ZQ M6-^6%"Q6^9P<'V:25V""T=>30&,]?TN*\:)JIZLVH)UL!9U[N6VA/0\.YF[T M/);G#R* FU4+VN6$=P&IX90Y!6PF)1VD75*6O=]L-')"YM%I>W)NV:)_P\D!]&^[D M7^IQF5$*8A 2+#>6'%JOR9OM2K5>6\V\->^GJC^3X:.'J.:U4"Z^$,K11GYM M*9Y8D@>N\_ M".4A.OK,9I>4#6A-=OO&1!VL9R^MLN],JWH2P"! _0V5\/<__GC*LX*F;,<* M,"N1?.I )@Q3@B"\*=X8BV6OZ56=K&[BV3O$)N3<+P?U'RW M*/1Z)+58++];?%UD7.:/X1+K*$G+:J>]%!CM-:866S#A:=?A2B?B79!E&(!> M>M5^6'IO%]LMY-#!$=&#)5TGZ'VXNMQ+#^=9Q9R(&Z T[*VS&8/4\FKGXLVO]>79#,-O?[^:IL[T4>KLP&ECE* M 38YXIL7&BB8I6B6%QT+%U'LML=[R[CM\=;]D/8>[X4;2J<#DS>:L=?^PTT6 MX.;L:UA)#IL#/*16@D ,J>:(84+7I,]YH M0?LIP'N]T.T")J/5Y2NNXVK.O)]'7+B^[MXV8;_XBTS&#R3L2NO9,M_6#&_. M@\S:.:G!,,*X$DE"0 KC4LYVV* M1[BXL1]W,PS.K6*1(1. D9&T:NV6"^3?D=6HK:X+":NOG(:WU[2?"OWG_K4M M6$Y9;[[#35HOMH>(YQEMYD(I*,4K4,Z3K6!%@71.*X=*J#;C2:<@?C]->&]W MIK.)OX?KEL.=R]_H]S?7Q-?-\Y?U8K6^WC:3LG6ZF0+#:W^P.CS;)^;!(HLJ MRRS*[H#.AL[4RW3NA_IW>TG9"P).9Q+%\U=-W_]9/YUT.L5>+VHTL6+X(CN9 M8E'H/^,S%)29##!*\*)8D,AU4DRD$)J<%_;C$ U2]/MY@+&QWX]CO] M=Z1DM@0/7@8'2K/*3L= ,L>Y52X:W21]>'C+K2-,M)@-%:^WWQH@H@[P]:8K M-:;I!-.<<>6)FT%3,,$"@VA4J!%%EBD4KN1_VF_MA?8#L'6,]EM#!#USU+C3 MR"D\/YGQXZ^_W[;9"=GYB$)#8;7'DZ>UA9@26.MXTH5YMU>I[=#W=M[YH#E* M5D<260>V]\4&3T%&7^=0)%E[]@@;(?I4IY8X[7P)1JHF9]5_G[9<8Q YI=0Z M -_+S9U*U$;'2#Z[" &4M1J<1@O9RZ)XL5RQ)O#[.[7E.@2 TTBN PC^N$RK M+W@W..RG&T=]Z^H8F4N=F@!%1S+ER4<(FKSR8H.20:%FODF_K5=HZF7R32]Q MSU3BZQ>)-\HJO47KC(9@79T0Q:N>TMIRBIPIX:3#)C,E7Z5J7C]Q,MGOAZD1 M@N@ 5;_B!?WHTS]PB>MP09O 6?ZR6"[JT5@=J7QS)GWK/RBF@A H0$=EZO3K M J&D#,D[E"D+:?>:RS,\:!Y"99>H&X..W>BXF:@ZP.$WX>+:6T5\K*G6BL31 M9W <"ZB I*G*&C!9TQ=)'HO$=3+%*!>=MA)!-O!6D M2E$D<"(Y<(4QKZQ$69H,'W^9I'E-W#0BWP-'(_C? 9*FT!V]3$'IQ7#."9,.M.1F99B?7_B--W,N37&< M)00G11D65A$83FW36VX^\>>WPK C:O6"<7IRGD[3T^W)]Q]G& M:4M[OJI1XM*8A?:1NL09LAP)VU)S3CX$!?P>N8)L@[9*^6QTDSD.O:0NC3\A MOM[I%!.RN.2!Z=K9OF0'T<@ ,G,9&3H67!,?>+(5G'2*TA#TOIRB=$P,=.!A M/!IN*DO46'@"$YP&Y:P'EX*&["QM:ZB2U4U:L@\>('R$I*2CXN"U <)#A-(1 MH&["TBP#HK(.A*AUGH9G" N^3M191L#;EP#WE_HP7Y^L#A(?PM@-D7)>J MD"6_'J0S#:6U#)"'#&U_,*9:Q-9+FQ70;D+16]W 3.:6S&BZ4G3-U> MQQ>K7?8"; FU&L45\,99"%+I+%3P*C;QP';HZ"#7<)Q$7\+&"/;V@HZ[I,N( MR1:9+*"N+7E=G7GJ122^\)R*"%SD)IA!8]LXM'"*Y#B#X4I9N-IQI MC@J<%^36,.F JI(N+$Q8%(ZN"9GE7^?W.I#X#>%U$ZMSB0Z1&>"!^KFGKZ&@3 MA:O=GT-AY.BH[*_[^)9L%*E<+)ZWZ8KT$D6])#+,&>=,(ZX.0_AL5)5=: M110>)(K:9L:0BLIZM. 9+S;S$FR;D<-/2)G9\9M&QKL=;@]C^(R0V:POS[<3 M(+8\*%Y'+LG-S%D64"81O8%GP*"T$RERY_T>**&'/D (?;6+CD=O?2]STL>8 MGO'L[P$S-[NR11DXT0@DY$@+KZ/B,Q.@'6/!>/JAV6H>T##S++PN M')>Q(ND'37?5F3G;A!(*1@HDLG+@N900D17-;8J*M<13#P[*:%D^CXD1C.T M%1.TN-,N.1F"@4(&&I00'$)(F93*"YZBSEJUJ>HZF/29YQ!V8=&.#( .(-]L M%/=YD(4B#FF F>C)BL0 CCD+O&A1JU!BD:Z%)C1;4>=7!Q-#\U@CVP?AY'32 MV&]F8Y^ER\57^M&4:>LO/+I1FOH^"^DC+1V%]=XYXI^LW3"0:W#<(0B;C$#N M9!'ONJ/FH1NG]T7D1(H8=.W.*UP]-2*W+:0HI8V)JT8%Z?])2Q^(WG9IZ4,P MT('W\OQR=_O[;Z=F/+CAWO9\_N:O[__$=5IL\)RUL77&C .5 M' =G! Y;2UYRH";R+Z0LR99SB"K M&ZETHJ#>D/6*@D5CI4\6FWCW#=;2HU]_1'Q.IR^3@&7N=(Y*]H?R:"D?EK=G MYED45Z()((RI TNS!1]]G5GNM DY<8E[Y6Z\]I*3A>,TXE^UD$6'H/IA=;6^ M68F(@25Z)9ABMU? F+A'+Q3+$B-2;$T$E7W;^DQ\ZP?6(V41@>;^^-,YA*R M44I$B#$1\4$64HI00-I.$$RJ4.<3O'BZ4#3#7)UN,I$]N, M)%=$FSKYEKCIB+G$8L5<01MPGIN1$R]>&(2M8Q0O#!%T!V!_.04^\D3,+0FX MJ?J?G097N +/N#92LQPQMT#LWZEX81!8]BY>&"*Y#B XP=U.%B98Y3R$*,D* ME&H%0N" 6GI#;HN7JDFBY9'NG4^@U''Z0ZIF .@6\B,#@I]6_\;U]6>++XO+ MA \6* &\RHXU3LU143&AZN_QX+#]]7%U<_+!:UQ^>:Y.ET0+)<2VQ-A1#B-YRB($+ MJ^A_6XYX%7+HE)]<#F,^9= *Y"!")$Z!X3N""%A2>H='9 MV*ACDRY.DZ_D1+VP">'93F-&8&6TLORQ[=G[ZV587W:A,B2*@HO+*P+4C\OK MAL+GR91H72Z0T=2.3,@AU"Y*6FF2EV+,ZKY2R5]>RXFZ8/VJS:%X&:XX_EIQ MEOBI9K/]UO%F8W5ARBH-4062BS(% C,!K,:DO>9)]*DWXS:;_ERQ?K7F,*P< MN-E\O\S3*4Q\FPGQ!2;<)>G_%RX^?:[)^E]Q'3[A/^@!E[6)WP]AL?Y7N+C" MN]S4XLF$:.V!I]K_PF8'7M0/"F/!G(O*3;HX'7^I,_>CZ"#ZZ1=9[RLRVN'1 MH\.6<\X\UT8I**'V/R(>$4>" I>Y2"DG$FZ3"81'6E\'453',&^WZ4V&N=.) MNUZ\M'O9D7Z52^0<9,5, JP# )62 AQR5PND7?(RT\.B)8.W*?'=4FGK3HO-C[1DBGM30*&(5=+9$@DAB(6 MC Z9]E*D-E-\IE]+CSO&$?%YA-Y;0\#289ND^WY/1F2TSK%Z1JM!Z:C "54 M7>2LR)!I!WWCJ/!OV'MKD/CW[KTU1!8=@NJW?Z]N&T74XOS"-7"+Y-2AB.!* MC. 5J;!3ADF71X+J[B4=I-)T#*IQLN@15(2/6_W@C/C N"$OB1.#I^#S@;3]F;K\C-#C#Q>)CT Z?8]5 ["?]AV^>)Y*:3/JCF?C>SC%_NLO#BR8&1G848JQ^67+D2M4]E(D4 M@X_9N4;Y,$V6T_].AW:ZV,G D\LQ@@Y!D%7R'L@%,:!BDDGD M;+T]8M>#:1;UCHYC1X+VF'T0AR#HO6G3;F<[(;*/*3 @7XQX(0OM\5+4.@:K MI,)4+(KNM>D$^B"^'VTZ!$'O39MN"QT>Y+W?9,*?%Q*(1&G!!E;98C74(B&0 M.3"=F3+,]=^:]^7UO:,C^0YU;")<]:)N3XII1[+E*3MV*E8_8CT$IQ]_NUIN MD]ZOPL5ON/XBSI&L%,O*0HIUB)+PL68K!,@B>*FB+CRWB[_F7_\[NNB84%WG ME\L@7(Y69R(BKN8N'1U8;AXQ<9>=(&G:",K09Y&Q"$'[8 IY?,?=KGA8' M1ZZ_GE\A.\-5+_OGU&[%@_KU6[="")4X(V="QTR1L*N= FW)8$SD,GHNK&LR M3^U(Z^NQCKM#=9L75[VHVU1NP5-VO&:9^+F+46M)OCR+3I)I*@*<"98":Y>M MXTFRTJY28*9%[Z68]N^FF*> P--IS/ 1-Y>T/EKUEF-GZ7+QE7YERDX,;[RB M4>N%(0OKH]?"=EX*%QFLPGKTGK"V(=8@=-'6L'H9W&1Z6]^]%@;,7E,<$]8\ MG"@M*)X4>!4MY)B<3UR*DML'UO@@#Q-(!III40&>9?#*NEF4D M5KM227#1",@U 1*=2\SLD^/YG[X(AV#K&'T1A@AZ[B*)QQY>6.:=[_R^7%QN M/O[Z^^8FVX[9*+;+$L91O,U-/=X*!1@KF"QZ6J-XP[L=\]X>$UB.B9+5D41V M"K;W[::$D5:*6BJPI8Y&08J4@Y0(+'/G,^/1N[[.]G\:E/@X6P>$XW@.1P; M*4/^.F3_<4GZ?[65RH?+S[C^[7-8[O:*?C@Y*"JF0PQD:L@L@'+6@*-=$FS, M)EB-CK-Y&C1-NLS.MXR)03R5#K5'U-]#WV[[-BOKH@\:##H/REL-@5M'G^FH MA9$Z[?9:.!E5.^DYGD> ^?$U<@3F3F?^S&CV;%M"WP]WM":5$KP HW7MHEL AE9PK 1GP M>AZEA+"UO:P'9G@6M>-:EB?FKSY98X^IRG\SM3P,=W\'S=SUZ9V/)IGHP+)$ MGGS6"7R) JPH)J%1*%A?H[B;Q)']S8MZ3UIY".9.?2#;_LQY<^C>0T$[&:-F M14$VBLR:9\3"&#AX$:*U61K/3U5MA_#A1&/2DSF*;8;)=QV.[L^^\R@56H8. M2BKU("U)XID1P&VQ.1:')*(_[Y M +&(#,K$!-$S"46J4((LV9<3"Y 'IW[1(\/B]\FW$,1>*! MV]I[K@ZU$0A.$_>LC*YHG[5F?24:346HWL.& MM,#E8YL=22B4\)3OG\_AT8@$90GO3LOWFQ-GE! M9;7^$I8)MVQL4:W]UCL:E6L/6EH?]=K>YVQ"B+6)@0"%3H,S7D&2F)S,,17> M)!7]O=1K2RM][>JUAV"@ U?M MM@SN>LACX-YZBC!YE@6481IB,KENF:Z8ZG:Z)B[30R+>2[7V(!RL)A)*1X"Z MJ:MD21J>C045ZE2)[!EX-,0&P>N$B."9;]+EJ*<"Z?'B? $7(WC; 3*VRE$= MVRT?O ]>6\X!):<5:&)&$!C!"<AQB;\6+I"5.W _%2 M1MK^,S 4%.H%C:1=6H*E& \-9OJ\+:IZL#<'2/0E;(Q@;R_HN.M,85423"4$ M(YDA)Y&,KE?,@K&*A:"8KMEY-@R%8>-#V-?!YE+3_Q;+ M3]?+-QB+D4B0U[1\3XQP,A;0/$2/045D3;SH!S3,/"FC"\=EK$CZ0=/-ILF% MTTD;5F\5:C&)(56(W$!(F6,IOGC6Y!3A$17S.BBC9?D\)D8PM@-43%!BR:5, MAO.:,H44*IHZ=S"0>;8"<9N+5')?R7,_#>K9V6[$2!<6[<@ .&7(#Z[#MT8E MJ3T#87---1$%HI82V?@Y#MLL%8DNI:* :6. M#)0&1]$!&"F9<")@CB?6#:5%#X3^JAU/2S^GQ>&[5N"G_11C=!B+BU#/I$%5 M]Z'6*@!*G2/3,G,/JJ'6V1><"%&$'4%)) M<,D3!Z63Q22C0C(GJ8C3M04X\ECT]Z.CTR/P=&8NGVTV5U^NN3%EY>XSCVU4 MK/O6 N[J<__76*:=I73UY6I;R+@%4'W[&C\3 8NO^..2?@]_6FTV<4O6:DD+ M&\'"$2^9A*&'+FZB\N=KN=X5A)HBN>.D9J($1^:"+(5CKDY^X,S:D+/632ZQ M'I-Q<#K:4U[^O+K$WXAGW]#O_?=Y,*98H44MRDB@HJ_=NLDCB,E+CRAR4$UN M)-XB;-Z+A .P\"0_;4H)]&K4AZOP]IYRC*$?_:J9;-5S"VUCL4*),6CE@5E. M,73A#$)(!6S"R)01MJ0F&4'36JS[2_ ]>;UE\+TZ29.\KN/6G8BU,#8H"%9$ MX*QHBUG'B*J)EWX8W5W9NR%(>KD90GOY]7 2=+_<+ZLKC%$E4H@>4YLD\8GHG_>"L0U\CR;/][.K?_NY M!L2;Q7*//QT?ZQV'KIG\A8-9V,:YT.BSTL& +;$>/5@&+K$()0HT26>C;9-[ MVFF=BR%;TKD0*EO.R3%WU3%GJ"$&:2"X1#8D2^;VRJT?7O(]@,BNW(8A&'E2 MUMU*,CWX"+>%3_='1UM5WVPSC;F7A2&2C8NFSGCEH9[G&7!%*>>53\A*CL\6#(=P&QG#3?IYUX:(XP08- 3>T*HK>&)6]P79W(4/IDF MHSF?I::3 L3#I;V:FO4=X.>!UOVV#LO-Q;5@\O^]VEQ6KMW43'%C3!9"@S6U MI[!AQ"='/JZ5+B27DK2N32>4O@AAIT!.,Q[W M9:*^P[)88OX&E_3)96V \71U43EG>"*F12] I>0@1-(/$Q0QSVF61)N&7H/( MG#=%M*G)FEI(?4'P9[S\!S&KNJ(_$%^_HZC]TW+KM*[_WZMPL2A_+9:?O@V; MSS]@?8'XM0#KI[ODF9PL$$!52I"\X8T+X&$R3YM1#"9UW$S]: MW-I4?CW@\\.W/YY=7JX7\>IR>ZZ^^F4K %+0#^6W\.?# 0W$0L%]]L!3J7PT MI'55]:P+00DLWOHF*>P#:#R)TY218-E%9B/)]0#*_?AXN])S%)$CCPE\G;>M M@N2DVRJ28^,"4[;($)ODBPZDU?TF0W]R=;G:)SWUF"EJA] W4ZK:9"QMD[+&4U"Q MMH+@3M;&>_6 +5D/QFHK*;@K63;9+J=-6=MUCHC1>Z567Q\R6IM]SCQ"8(BT M%\4(#JV 4JS16A>/;=**#Z*ZASO\42AZR[%M)[L.@K?7LVN4\=PE$\$S56B3 M+^UM .L[P,_ = 4=O<=I]&.FQXO6XS4L&R=).E"*74C7Q M0@\C^S3#HN'PF@C7(V1]PLB^V9Q4-+:(;$'[FB-DF*PY0AZT1G0\61[:Q%>' MD7V:R!X#L(FP/4+:'6#[.UPOOM(ZZRIN.Z]]7&RNA\V1.>"".2(^1$5K\0D\ M9@2A7?!>R!RL;8'E ABNKKD/8I9K7DZ(5K$O"_1E0OF#I4]*M&K#:WP(W[%Y14QL9;V>Q7!IT3$%^\@\%BO>!&-CIXC-LD4 M?41%7Z')T;#PI%OF6,$<5_:2.Q-KV.C]7VDB'6$!IILDS4N1R267 ".YD8,HC-JDI.>(:^XK< MYU*67D'507KUW9)O+,;-O?6YC,Z(6/Z][K53%%7;EMJDO:"PGK5IRSB"UE.QC4-P]O+(BS8B/''3.+X(>. +CFD<6Y;A M[H_:["G$"(E#%+57AQ*UT5C1( 0!6/NDBFS2(6MNZWC_RJI5-_T +1J>G.%0 M6)W-ZV6 F#" X-:Y8%(*;7*%!]!X*M9P"*[VM(8'BZR#6^^[0L!OKC:+)6XV MO^*G+W>%@-P9$6+DD&JO/\6M@" 5!RL]-X8[7EB3OAZO4C5SY60K++Q4CWNP M8'I V37M-UE7(JD4HBA@;6UNHA1%4\J3WX!62-3)LM1F'-]#*CJIOSURN@.S 3TX)GT8)A$:5PV MPNRS5]%S'P"$OMH%Q^Z+YTV-.1P.!S%R9@#\O%I??C[[@NM%"K>9MYJG;%#5 MFPYB02)F..<$Q.R$%[P$I?8Y9=T+!D]?/V_JQS1@.)"I'6PCCSRSZH]MO;/M MT<5V?V7.>"&"!F9(H J%([],1A#>E9BX-5(V<6O?H&MF2W(DQW9*X72 M>N3 ML$>+NM&_0HJA4C*0I*H;:2S@,S/ R:(&[^LPG29%92]2U%&H?JC<5RV$T &: MOO_RQ\7J+\1?\2NNPS+=[LG"F%2\09!,Q'JGK\'Q','+0@;88\34Q -^@9YY MD321M'<;%TW ^@X0=%?EA.LOB^56)K<%NRX&IQ>24[\XA38N%I?D;44 M2$KF,*;FJ'M*5[?NU4@@O(:T Z72*QTEU?LY]'):45*8/(1=1I$Y%8DRVX('10C.78 MYGKC.6+FKML[$HC&L+Y3&W26TOHJ7-SG?G/R1U7,AB+C@JK.G1(56V!H0N%/=P+ M"$&2&I4DHJ;OA3:9-R\1-'?Y63M@32*"?FK*GMW/&9)68$EU 0@4^ KPBO9S M%X)3R9!F8/O0<(@KU;!N[,BNU!#6]SS09<^\Q9_#^KK^OGE6YI,W'3,]\_5E M'CU/LV#.FH<$27#RUSVS$"WS@,ED8[5Q#T85O_L\31V$,!1< TNU4,XX ]$Q M#5E:C-%;*723JYYWF*'Y&D.$5D'7MOK"6.63 ISVH)EPM%B+ <7HX5D MD!S0;=?R)DTUWDF>YB L#,K3'"*8'E#V*('$%6VEL0Z$K=/HBY(0C=!@#$;. M$G+:/__6>9J#I/MJGN805O>7,U-S".L[0-#+ MJ8+>))US%H"9D8(522Y?3A:8MXDQ%[543>Y.3BY3\Q 432$^GUE:C;RIL:)J3OHW23A&.L94AP#V0<) MM24,.,5C+4,+V7 ;69M.YJ/SG^;-R1PD\GV2H(;POS<,O9QE(X+Q21L&C@+C MNBH*;*/D4)S2R@46 S]::N;()*CCY-DUQ]DT,IH1>8NOZ>T+R=KM.=%W?@E_ MK:XN?]EF.YQ+\@"E2]B358/3+.\JSFQ)B MQQ%&!W;NQ:2O6 1&'AR82!9(Z5!;2BKR/J5$(;3GN31)[SR!O+L6MFP2.73> M[?C!3(41V5 /_WJ2#*<7R9DH:^GN^?<=6^_S21++%FOS'*=K,,=JZU9D$)-@ M'D,TVC6YQ'Z%ILG&1SS7H#88DXLV":25M6=W9A"T:+F M]<*G0L>+@R$.%4.OS3 ?J.T$.9:O/6UJ*W.47,G7<$6AER!)9M(2'T&ARK7] M/CDHZ(M1*B&VB8$;6IU_A8NK:YV]N%C]NQZ[7I^).!U1VTSAIJO-7J7P$&+- MW_-%*1NR9+:)@7V!GGYMS1!,[-J:*9C?@0],C+EVWK?W2)D99;0G&ZF9 &5% M 2]< N]U#IJ5E&R3Q(!'5,R+ETGDNGO%-IK)/2'DYH0_:B]+T H"VIK/0$Z^ M3RB 16TM$RIPT>389X>.F:_1QDOT)6R,8&\'Z'BJ+O-.94.*XK60M4<9 M+4HZ X8A^5Q!A-BF5^TK-,U[*MC"MDPE@-E/_[[2<\+%JFQ/,3'_U^+R\^?5 M15XL/VT=R-7R^[!>TE>;<_)@Z[@D3YY\4* 4"Z1N-H(P,A9EM0A%O.'Z#GQE M;UO22!&OVO.[ Y/T?2E8SRGOYUA^#)?X[%0V%W)PF2L@UZ\0]ZP&)YT&C %1 M*.-XFV[N^Y/8F\$Z#'F-1=0M^#YB6BW3XF)QS<6UEN&*GO?7HU\^ M)_:ES)(!]%+5OE01@O&!]T:))!?/)&]+AP;2?47L_P?\;+6\^Z3@S^93LV]LMJ^>MG M^K41I_BO/V^2<_P!)$]TDG_[.GK5]B5W"+1)J^0M@N:.MG%/" @F(P@5E8HF M9Z';J/4+!!ULZG:>>W]?Y2QWFOX'X6T&1?X#N2Z.O :59(RZ*-,F">%%BN8- M@B=!Q!.;- GW3]+2C)XENL]3VUN=AG-#7T2:$$[[Q#.P5,]!1"W]M:J0 IF$ M#'D(_B@:.7T_E=TW?!,VBW2VS-\M+JYJ;DQE]KUN,&U+RB4"M[%Z :[VW\8( MA5%T+D1T&9MYD[1J].D?5]?O6)4M+\(=+U[]P_%9 M%&WI:6])IV59:QMB=QF[,*1_+]K_;WS M;41M9T*KK65.M-KJ@%CG( A. 1<*:W=O.MJL]A%5G=K3(?/M=D[5J+^0E_OJHE=!_*=F&;#U>7FTM2<%KM=I'GI5[E%,XAH"9'-SJ* MYNN7JFCNI8U2M;D"&41E7Y [ !VK8XEJUOXSCX^2ZL[Q S'UV9-)GGDR(3M@ M C4HPQ*$F#1$97TRS(EHF\3S;Y,V[Z%Q.\Q-+)0.#!YY*?>+.M'L[Z+#6UW&3=ATAV+0G26XGK:H;.J MCYAG_T@?!SDM0\15A=&CC;X];;#:KAX<-JS.;N\7"_B MU>7V1'%U:\6W%<#UE\_6Z[#\M/V[S3G+*7@>%?!Z.ZN2C4 +I85[%XO-7,:] M1CZ/\>H/)+TO4SDE:H\LUGZ-Z@U3GZCKN62RF!($%%G;="26(>;B(1>G,_=* MV38WK@/I["NV.()AG41@X_&X(HTYUG$(:BUM$AZDJ3/78I'D'/D ,H8@:C%L MRDV:0DUT''*TR&1BPSBE6#HP?(^C=)?(!=&ACF#C&I2.$J)5"E+ Z'+D1,XV>@Q>: K+@-?AJ7K,1Q2@C%?(F_0Y? MH&L>^2V!X MF@]S76")*G''=884#;$GZPA., O&6*-H.\?@FMPR3;N,ODY41F'OY42FH\NY M@]WWP#5_\]?S#]C6I$O'M$*6(,8001DN(*14P :38RR!)]$$\@W7U,OXJN-# M=7?21">XZ5:%?@Y?\*:?0I)%<$T!&]>!U3,K 0[10>99%N<"EZQ)]/,68?." MN1L$[87LD>+L )YWC?$O5^F_/_SQL*6Y0UF"2^!HI(E"&@I;!#2 M-VFU\R)%/0)RK.!?&D]PD!0Z@-.!:OO3736TM[PD[NM@O%J-['*!P$H&XH)$ M':7GJDD*_U0+Z&7"XR?[U5>:,UE&)3 MEEH%KIKTLIJ$^AX-=FO@38O^$2CH /KW=[1U<;C7N/6N?;7 M.Q^Q!]=IL:FF9^?"[>8G^,MZD? \Q.2%+^3'&69JL1!"S(;8@J&8++EG;9*9 MCK2^>;>0+M2G1R3-W(?LAOX?PF)=N\EM[O0WY=K5,6 =<7?/O6R)KA5JB88-'?/X/JFYQJ6>^8L_:?!64Y6,U@)OC:0\KEH5V36 M\O]O[]N:XSAV--_WOV C[Y>7C9!L^8SCZ%@.7V(VYH6!O$GV]4TMWUV?!YQS/ 2- 2)3B0 7 X0<.-C,&$LNA8!-KIB;N*AZ M$C_9!;]4W:YRJFQ-UX3+#^'B_./V;W]87WZ?"UY?7*W+=]>;J_7G?/D^X\-_ M9?,[6>#R=KCC&2J;-(L1F!#UMD-PTI9(X(OR.=3[.&,'A%$MU]BS=QL#MH?1 M53I;#]N!R9CI7[W_^CZLZ^&O; M9D# ^K>L2$%W3'(DW0*&H(>G8") ."%!;\ZW4>PC>C3MA5*.(T13]4?[%%P@ M_6%""F42^IB;W+C,M/[7ZRW'8/9P">GIC-_#*^"=V!^N/M4@^,XOD1J^SYOS MCZOMQ-[-3O\/C%+)E6\Z.C^4'\Y7N(KG>/%SOJ0X^W,ES2>CW?_Q3EOOZX+H M?Q\KS22.-CF0W@E0TE+BE^B7:"6+PE$V*)L$%5U(OVP2MOQ^>RW ZVJW[C7; MCZL[U3S4S$X%=R]B]^);+Q7*9, 4$2F\U!HJQS\(=%DGSGCD34:$S"S'LB^> MR^^@TX.A_[UP,R?@PVKK7>J3\V7^E%>;N\$!M?/JD3-(*3&%G(/@LM+A<06A M-J3DX 5728J@&\=M,TFR;)-UI_NA,2"ZVA%WN[OIX6FTRE9:!9XK!*Y\2GZ(AEKNU].(N>R/>?+[Z;^P/0*+IP>)9'W 2UN ]I\1,/RE*_,?6DU M3;P.KK5TL)8'05%-%)58(4H(S"B(21D5*Z_Z9/@ 6'E-UXB(Z6 M2F)'0($>? E)9L<=LB;,IH_6\7JOF<9@Z/"E_'AC=!!B[%-;?6/==NS9LGT6 M*)!UJ"^G49 SMR1+MD5[GI-IP_;QW*)Z0=D$:P]XSIFD^JY@=%O[\1O]E[L6 M/99FBBDPU*=5\;E&]P.A8TQ_$U)%V6+@:YX?U M9:8 Y-U?\5/M.:#?UO:"WW_]_LWOW^]:-#FS=;H?R9 $5G:=1!JJH;$IAN3C M5B%[(? :]J5>H'*L1=?-U-LK6+Y[7L'RC[<_[Z3)/NM:W0\1A;F9'^YC$!!2RLH955A6 MQX#E[DN]W &? BS3U-LK6'[ZCUL_28[0"^LX%!'K8 .6 +7(H*7SSDA9?SD& M+'=?ZN6*\Q1@F:;>7L'RZ[M_WAZJTB=9NQE=YK8RCRAPTC&PBJMLO6E95DT3PN6:>KM%2S_^M]W?E)$[NK T*)KN&Z* F2LD)_,QOLKN9(B@;,D'?IQJ0:1\SZ=%-OV=Y^*5! M8/'?"%@FJ;=7L-R'ZTH;'8*U$/GV@5HEH,U VD+#G:>M$-ST8^CAEX9=RK%O M RW3]-LK6NY#,(6)LV1(,UEE4++VRIN"8*(K7'NEBA_"G/+REX:AY5NXPYVL MWU[1\M.'6VF<0N>3#Y"])&D2':LAT&^-,2BB-M:4> Q:[KXT#"W?PB7N9/UV MB9;O__G/>^Q;5C@=K0J"K$.199;@0W3@&3KEF; I3_O4EWG&BTN!CE)4P9 428#WIE(/ H)_6JW17>'L;E1FOA)+U32-S4#IE"**P^@ FK$V26=]F2MO3M?2& MFRE&?CRD[4B-=P":9ULK=R*AMK8PIT&DXD"Q5.,TD\ 683C7UKO4J$+XQ;4M M>XHU =7<%ND"9+>G_?M[/E>6HTJ&0YU>"(J[",$[ SE3^%@HLDNE2:_IGK7T M4D@S9U'P-$4OG&I]W49R+\R9SDDXE@MX'3(HS.14I4]0,*1*_^OY8P^T-\$Z M]/-[J=&<:+3US!KLRF/\@_QI[<7\L+K_LY_RU5G13B &2WJIU1J4#X(KM-V9 M=I%C*HK;QFTK!U;62V)U')C:&*(#9/V^NLQXUN3#(@8(*M/IR*4J.A>+ZF2M:@NU@1I401BE-M QQNCR>>3V?6#S]LOMWVSOZ7AF>EMC&U*MWNY60G2ED*H@:I/K(!A' MF4P*(%W@+*+5).><$%KRUKNQX:? :X(5.HCZGVV9=5$*2UX:,M9HL[;,8DH> M2I0)16)>Y)-QFXYJ5#_9\]P4IS6[ZKN"T9X'\!*"Y;GR!F*IG=<\ ,J@P6NF M4'AIU=^-ZE--/Z91?8P=.L#4?L^[N^B/HJ3JLX'YRKMM+8G!$@>ADX\\^T1) M> M,/;>H7C!UK.G7C>S093SUYO?O:TO*KCM?6DN)?'U=L'74E.)U-#"KNA(\ M.1^,]9-#J(=?6A8J\UGTQ4!ILGJ[!,MW;QY(DWF)51W -9.5]3 !17L:3 G( MG%,E/;X;&1-OOQD)EF8ASPG!,EF]78+EW>^_W$NCE--%D>_-A6.MPT$(6D5( ML@COE$167KK.'/:E9>_#3PB6R>KM$BS?__.?#Z OK0C<*M!H2CVR*:OPE%+Z M$EP2&A'Y],N@AU]:EOS@A&"9K-XNP?*/MS\_@'X,SG-%WE'4.5S"T3_)D "Q M%,>44NP(PJ:'7UJ6_."$8)FLWB[!\M.'!]#7.64N**.THMY.H45PT5*BHRVS M1_M"SYP0G!,EF]?8+E/QY&8!X3#UZ"J8!7=:BX=^@A!4N D%%Y M<43WQG^,#'";D1^<$BQ3U=LE6+[JSD)V5R0)Y./T M;*@?\H/3!KC3U-LK6.[[K9-2217I 84DZ,=L /W8)WTWO-H,YM^SS*ZG[T9 M^<%IP3)-O5V"Y.W:L= M^<%I;^6FZ;=+M'S5;AV2$[G0J>IXJ.^\%+1[:PQD33&8B<*GX(YQ+2/;V;^% M.]S)^NW@$>E 6YRVW =.V3\OUI."\ M:<^@[BY!LWM&,[H8S\A5\MIXHH0T=5ZE 1,D8RZ1FM*)8-/#*_8&6TG^,AF6283"R8<6!SRQ1.&[BMHT:>QZ/2VGHXP\H.5TC,8[ M ,V^9@)EN&**XK(<'>5]SFO 4D>J4-3FBRN^M"[!>C^J&_ $%!MS5EY-4W2O MW8#HO*HC!,"9(D%5)DVO+0++F?MLH\EAR%/ Z^D&'&6T(=V 8S38E<JH6:6)R:2?0J&[:%(G]0J[ :> J8TA)B/KSWP9UB?JW7J+ M%W5TX:^?.[>K,%"=-"+E0ME]!D=),T8J.@Y!%Y]L!3+>PK@202TH%&Z1)Z9)S)%B@ZM*!E$^)&*)I%^QV@Z-F&/5IX M"!HU/%.DFHJC3G) M05)Q" Z%B-=P":!^'"70QQ7]& SM'I'C/$XBBO894Q73.*%R57 M.F8M;&QRX?[LJA;N.>\STIK/CEV!\DZ6#^7^#[>WR6>IA) R#T#:L7706087 M99WFFQE&BC5$;GQ%<7AQO:251V/A(,IF,DP7^>4+4MW>/7\YBRDJ#)0OI^0I ME"U8"].] N&$X;ZX'-O<^ ]=8"\E<2>&W30#O0)V\]M2P//5K_1S;TYGZUD;M27YJZAFRYF!T5UO'"#PB1(Q6U9IC)X'B*$9%'*$AQB M8V[*!0G.'WSZUHAWX?OEQ19;/=_;=%R1]?:]^$Q()K="* M8,!@K..8Z!^A6S3/%4/+ M(6_Y-XVQX%!PX%)RYXHP0?4VXO2TH.T / ,OOT=8LDL\[BY.F"C>QMH3S@.I M!M& KP2QQ3MAN<400I/&LM=U^3W&V$,OO\=HO@,$[;LE"\HR+D6&9.O0M*@] M>"DU9!5L##I*%9OT0;^>5M911AYP+SE&XQV YMER"\FCLUXI\$XJDD4R"*7. M=;3:)EYJ"5CC/+RW>JE7?OS$CHP(ON$>-VMI;G46>4(*SAH)+WM(F=!73>Z&"Y\(\G MG,V:LSY=42_^LQT<]B>U1]JF Y!]AYM//URL_^].H-W9X)2/F>< W!L/2M(V M=2I(R"9Q^@O.F6MR7[UW-5UDML=:>CVWVCO SK/[[O[)U K)(F>5A#$74!HY MH"FQ$B>RH@.73)TLS7VZO%[8G%[O@3O-TAW@]Z:U<_V9OO\IKS9;Z:IJ7Q@^ M_N;R?%/ONJXOZ=>?Z<_7Z6TN%&K_AG^=Z4RRH'>@#4FO8J#C12@)$KWW+.9H M6<.>W%EEZ?A0GPBYO:V]R]F_@RWPK)9_R?$"-YOS?[Z^J+>Q M'[[[\7U9X5)JG:$C_.9&W$9R"JY(0O%$>M"]%2B9* M4OSD3O\(@3J^%YUG,W2!A%>P(]8?5]4S_+BZD?C'57XD\YM5NJ'3>_=7O+A. M-PJ[4\PJ;S:_YRN@3!+&M]&+:&N^3B"=KF6XF9<=W M&J?9.\MAIJL-537R\"0]XRQ(%6P&&RK/;4!!DO!<&1!DM-PGRYHTGAU>4L?9 MP-Q0/'J<81VAD(;Q['./K2:=DBL_T1I==#&&,\DCZ9QO\?C)2T[,^ZD MN#K*&EWAZA"%J:&5"QDD\")(($5 \)1;0PE"Q)1YMN4$;FLJEVRS87,G]U[' MVN85E,[_A)>7VW^:I3S^R4^;NP3^^>5V4.;NR>/(4GU1JFP4*BO"74K@BS)U M.*XC['RS9>XW]X#:R%*L(9FEJIVBDH'#1.$C:F1UCP37F G[E1>,C\'0800 JL]K SI763"J#]RUD6 M,L>;^07<3-!Y!\CY;KWZ,U]>G=,N^O4ZD!'.MT7 5:C=6REC43N,!9BL@T 3 MA7Q!I (I4?RG@V4E-?$Z+ZZL+SQ-,?_CM^I9;=$!N.K*[X_][8YS)4O%4X;$ M*YF8)3&<*Q9X]M)85(&[1JPUCY?2RT/#\2?8D6KN#B@_X>?;[223*M&H>O'* M:\^@MH B!RC2N1 S9TXVNF#:OZ"EPY[C#/TL;B9J?>'15 ]]9EZ=KR]_6E_E M#5[I_\G8#SE<7N/E%[(QWSE069PM*4E(Q110KG;)%(U@4O+%<";+H(%5X[[: M$VBF6GE]$I5W"B;U/_5#R<0M%522659.3*M(=ZI(!#36@-'1?GVK2"60H>"W(-,I5*2^(\8+ )+(5^.9M0_15?KS%()+35@I7E6Y^RA+#RIW'Z/V!;&S MN;PZ^Z7VS]WT>"HKM40+,F8ZZGUFX(6E\SXC]\'K[.T09T0_] %.Z'>/,?+5 M5WLI2YE^EDU78@^6OP6L8\8G7T=1\>W(G]HR*0/8[+-+3BC!A]PY#K?]DA[A M"(L]MOD$]2UL]7^=K\X_7W^^O=]4F46DA0N=:J=8P#H1EW3!9*8P'QTA?RZ[ M?_7EA2T_Q6[K.92XM/7QKP<+ST(6$[2"PB4%3HP2R> #AVQ9E($'RO&&U P, ML_[#+R^34\]F_X2R10_9^6[8631!2*=VD M&>_)2I9])6B'EN-4W@%F?LT7]%ZUXK.?ZN[_^R*O- MG7">14H DX>050"*ZS-XYS0D;JS0%ITS32*@4:M<]OZ_H6=J9JH.W0K925!N6< MA*!Y+>"5)?-8D VZ(1R-J5=*:CC*].-(#8?;H3-2P_=W'7))2,HT0H*<*X>( MB H\*QYLCMJ&5)D?&W?HO!_%CF1?U_$V3=']U(#58J=:>W3S1QNRQ0\9KZXO MR7F?7YWCQ=UPH;,8HDO%6>"%D>N6A=W,7O;&1%=X\9P_8MYZJ1)L\+=[<3X3 MC;V_%*R-YA=&UKVN?LZ7L5KI8_Y0R*U&W%SE]-LEKC;DO6LQP+^?7WWZ[IK6 MMXI??J',AG*-;6O<6=$)(R.U2F4HVT51P)4H((L44RJQ&*\' &V&I2Q=AS@? M[DYMEX5A^-.ZBD()[98'Y>%I]6ZH, MW2P!^- IU(P9XI04V,6 M@5[Y9>8&T5&J'P\B?P.B5?Y8.QQ/1"=#\2##(BA3C19!408+3A92%X60.0C- MK&B,IL[I9%IXIF,-T06V?KYQ MMONYJ[J1C-])]N2BQ!A,P3L+V3D2JW8+HV6Y,G>ED(0GG\NG@.CP)P!XR5",,]H*I"4U:08[ MM*!A\.K^*GU6O7=Q/?!0CA]7])/SYJK>OFZ+?M+]I>U9X,J;XBUH%01YW%J- MPU$!2SI(9,(7=P)$/;?$81CK_MJ\L6U> 5_HG5=>ET>^?!L6;&:A$1WZD;G9 M12<)=R3IZ-0=121+5FK4"DSBH=Y2U:&-1H(V6:+%R"2Z ='( MZ \W(89XGA9S<_,TC])BJ 7Y28I*BAEH'VF105"&ZTL0.80F):&35[S, W5[ M. TBCYC=I!T<%!04S+/:V!::7('US$W:% =# M6$S'&*5#8.UJV 13RI1$\2JO-6R^< I0;)U)CT'8H(N(35A)7@V+Z2@S#V,Q M':/S#I#S,G.F,8B6T8["C!&4U!*P%%/YR K%O]:+Y%N Z'6RF(XR_V@6TS&V MZ !<>U@73=#(?)(@@Z,XP25'$M"VLU*9%),S+#<:==TKB^DIS[HC#=(=I![0 MZ'&N!2?Y(1BD+-D*2L:M2X#!:46[#S$V<5.OAN]TE*&'\IV.T7H_=_9#^!*Y M=XD56PL1365^0@TNTUYS@H("*5$X_VCLW:DH*D_/=SK*RM,I*L>HO%,P'6!R MM4H*Z1#!%U_WGHR 0F6(294B4D3VF$GA5.2YI^<[G1M,,ZB\@W/M[N+P[9>[ M?_RW\WQ)B_KTY7W^,U]LG7A6K&BI/%B35=TB";RKA[_AVF'PG+*6%J?%Z@N._,E9%;77Y5+[=EHZT@LBR!(9!@Z)M3,)E#,6N6R9VL+F!Q"XNPVZPF0/Z[^N+[:;#4F=JY>"..2H;C!:2=!Y4Q*X])" M=!(3\U&Q-C<4SZRI$[#-CX1#F#O2+!T@[-D.\Q**TD4Q$!H=J!I2!,L=!)?0 MLU18YHWG:4[D=3CM(. 37&#,9*2N +>G_9Q9IA)6>6< M**0/$*-./88 88X=^9 1/TA3?KC,_W5=20*VQ[IBRD0F-=A@#&'> MD.,,O(")0@<3&-HVA(FPL10^Y0CS%/!Y#;G0G?Y\WYQ]4] M77EPDO9A?1OS6$#I.NS">@4Y9\6R\!Y%D^G4^Y?32R/_*8_3&0S3);QN]V'Q MJ&S2$&2D>)19#9[B4^"<%YMUML(UN98_M* NII8=9>P7\3-!\QT@:.*TP"09 M.5J30 NTH$)]M\@R0#2TZ5"G&%QC4I+99WV>@%-BZ=OZF0W; 7P/SR-$7TS" MS$ 7A:!LJ?,L@X)@G2M>Q^Q+D_3UVYH*.@H.@Z>"CK%-!R";LH'?WW>J.FLE M]Y2$N7H!+;2$D"*'[(QVF**4>++GR\&K[H5'97&/V<3,?5T1[WT]N>=OR$S* M)(N#$E)MO&<,?*4&$08E=R'$XEYJ#A[]T0Y]91L@C'S3FF:5[N#V])WE7C!) M"I-6,BBDJ=IQ'\ ).B"X,)%DU0P?]\U-?MD:![?9'[=.U^S;U@K+D[;LD>^) M;+>QSIFG\R IZT%H+D"ACY2@J3IHE&,,I11F)_BS@]];YBUL46S-H_M^O-9C M]JS[;5)'1HB0$@A*]"D\Y@Z<9QY2TCFEG-";D8TJ![^U3,798CB:1^?]8*CN MB]HTL17F;C\(;[R2M!^010VJ%A\'BE_!1.F#=R%J/^&P>_*=9=Y+%_5!Q^FZ M']PX[5^<(8 MNEOT9B\94B4TMDX8BXX!,RG66I@"SB4&4D2O##=9#*I$?/E+R]R_GA8_,^N[ M;_3<.=7H,2K+)626L+[W4D!GO8,84XK>J9#4D'*R@9];YE:J*QQ-TGROS'3W MLGZ]TD&,[ (IU46C$!/B4/RMD$E&!;$)[^ MT2(/(8NOU3%ST1%\V14DW:O M6:7HV'6-0>"3:>:+6;J#=^<');YO\:*.>?CU4\Y7_[A<7_]!$M[+)54*V@H+ M//@Z+U=[H/. ??9"^T-_7T3=M6A"URV>:@9.)O8I_\C]F8#XMX-B%?W+,PK M_'HS3B>7GN_;,Q_JLZKB%-& H/_S.5LHS-0K"$Y(]$6!D-*YHKFR;4;3G231 M&'@RT+_PTWIU^?2@J*^>116)8!/]HFK=DZ/]#U$Z009ES#1.PXZ5H.,H8 SR M#CK:DUJXAPC@?$7'RCE>/.(3]-DYSBE)TT:*VKL8P0=4D*(TD8ZO;'.; W__ M>CJ!W6G1\1BC,YBJ \1MYT;3EZL:?\V7?YY'4A%%WT^EV]2NVLW^O]K5>2HI M190*P5@;*.XA0 4?'7">O4:;K!.I!4SG%&)A;,^!JG4G)N[G5?4ETH@2&49N M!02I*RV3D> ]9V!9D,6X8G(0+\2LKXFC8SE$3./T&&.>OD#WF#< O0I9>04& M)45%/C (7 3(E1T_*)E\'DE..I6.H5GZW2.XCC%#!X?TLW1,WGO,@FLHM?%6 M9>;!&5' :"S.6)9B;M);>C1=6OL+H$4#Q-F,UA4 ]U"L9.L54W5$=JBUPU88 M"*G2#3.C59*51Z<)(^DKI4\;9?HQ]&EC[-#W*5GGA);,#-3F65!T](//)$Z, M%IW6QBLQ']64^_[AZ]U?\A*N/F7[[?_$R M[63QP0O21 +-N",]14VR5!+"Z+AW)AF;FHQ;>FY1'7.F34'4[';HR^D\EW D M+5&70$EV$GE'#6VE!6FC#@65(&=]^GQP&0:UF9S17.KNP3$-H6)*0GCC+#C4 M))*E#,,G3X%D8"YK$TIJ=&,[$YM:,ZSU$9S/;<*>4/D,79.3R"VG3)H.>PV* ME 3>: W.%AY#82(\K@#_FUUM&AXFL*N-,4ZG>'M*W^53,3D&8)6,3GGAP!>" MB,#$4V$E,-;DY!EJQL$]S48)='?\SF7(GN Y:!1($:5XA0%XK!/8, ?*G*P&;F.J M=T&TQ]L6GWPS@WQ&P>2H03YC;-83(!],C+F=V8:5$M:3*-;7$95>!@A:,;!* M1RV**73$-(7?TS5U K;YD3!@D,\4LW2*L-N91$PBI11 VQ2R=(DSN1,E<8RA%0AU:2BJJEX\BD#PQL& 4 MC]RVG=#X=$V=7*XL@K I9ND 87OF-X=L(@F@ )6D5%]S!$?9/7EA8]'S3 %N M$] M>"63U$<9>N@D]3%:[^?1:L@D9L>T+K6O%[GT)!G/$"IAH# ILZQ40C&2[&RN MX=>GGZ0^RLK3AU^/47D'KNC]>O61?MKGJK;ZRG;^07<3-!Y!\AYZ("O QGA?%5Y0ZM0MQF&%2I85>]&JD#% M!/+JS$,QQ9DZC)39)F'3BROK"T]3S+]N:8L.P#6'@W]_1_YL19(%M8.8 E8R ME4KQI6BSHN(HT,7(&YIUCOCLSZ\YL*C@%XXZ.4:#E#*2N-?-214!D$5A)0KA2C'S< M2OZ*&'<.$%]MHV\K58ZTLR&7REBI)47?(;CZBV%80BIMV@"'+*Z3J/!8O(PE M)!MMEPYRD2&5V,QSK9U58!FK#]<^@S.Q/@JI$LB[,VS#,S)7<\4I"N9F L2$ MOHDQUND)<,\48C,3C+6& T^.XE;I"7+/UU&; MHK6N=.,I\-UC@:\3]]TVTOVPYP@+DGMI[;K+ULJ9BWKK* MCQ%(:8GVL,Z2Q9RSLFWA]\I;(L8@841+Q!BS=(JPV]K[7 I*'C4DE2EN\%$ M2MJ6BFF/.G@><]O^ZU?>$C$SPJ:8I5.$W=;>R\R"#%R"#)9"7^$':"A+4[8VB)$FJG]XL516%&GGI>H=-*T51RV M\5]'\%"W1U:SE& &*W0 IED)07E2(8>8^)^"E)V'%?B"0S9: B\;*DV$# 9#CD7GQG76K ) MG(;/?/$;HI@>A8AG**!]NQ33,X'K&#-T<$@_2UFKLZ,PE=646QE2D:? ->L,.B41(U(*WJ;/^FB* MZ?8T.JUBO]GLT16V]M!+6H8H]\HTKBE\5>_0H MTX]ACQYCA[X.P.>.=:3CW'C-@6NE0*$60 EX]?4F,:6D#L>IAVO*__ M=C5-C1"%DD8XTHSVJ&X23U=_RR(ZP9+BSC6Y(3VTH$X8C%HE:K/8H5,\[3:< M4$*%; RDJ"J_ILN );O*JZ*4YMIQWR02.KRD9:/L>4P^ $<3]-\!DCY-(S=LDVSE#4G=VVXTZ2>'"J3M05F=-%!*RE+DU3_T(+Z0]$4@Z\; M:+\#%+V)<7V]NMK\C%^JCWZS2O0GE]?YZ];#FPS!H#1&>.!*U&KHVE6Z0ED]UV!M3_ZS>?MIMKM3^-]\B5:$)+\ MM2H9P8FD0(>D2[$EA<>#J)IUDSY97">UJ7.@X1#2YC)-!W#[>7VY- M*6_;6Y2V)J,&FVV-8X4"S.2]352HBP]U[%<+U(U88R?@FPT@Z]-8JP,@?H>7 MEU_H0/@E_T%"YG2CM,/B66-%YI;PXBL?GK5T9$C!0=B<3>:5%;])5]+(=792 M1]T*D"VMU@$HWVVNSC_C5?Y0!FRX))4JE6+,\+1MKC$04%N*H2T*VH@6V_2) MC%ED)Z6QK>#8S%Z+OB ]C6WV!-)WI4R_DCVW0<]W^$F&X3R/?0(_C:CM!MG(*RX^G9QMNA@Z?V)^6H]R+ICD+R"@NQOJT MIT2=>1YXA!*=9\ZPRCXQ4P%0;[2 "T)M9L.,QYR_P=PJ?ZQLQ;_-F+QL/KU9 MI?H_[_[K^OQ/O*B5Q&^N;L/C&]F"]3ZXS* 87:\[22PZ(C(=F#)@"!%U;'(A M/6AUG42&IT1G.^MUD+KL%VI/-'R&1<7D:;<9YRH_LD>H YF@.&E(** M'[S"7FJZNX'FL5;L 9[KS=6_\M6G=?J1SH+-U>=#S -[FL% _N(L(I11&48!A"4U;:#U8S2!\^6\<7U.MDK,WFU_QQ>_?S]7H'399Y M\B-F&1+S_,)FFO>R^^$WI4]UO-'M[ Y5+!*&G(9O(!#2@NSEUEAX-&I M)L'&H04=&V8]_KGW=RN_D2K?TK_ZGV>&1>,KHWHDR4'Q+.I4[4192K&"Z2C0 M-$D:!ZQMV2?^65#R.&*:VR*OQ<%L:VWF<#.[']3$V>Q;9&N78T24,J$&J>JX M(,0(/J8(FB4N?^''55E??MZ:Z>V7W5_>@]Y1 M8H I(2T5.2CM/(2@Z)"-.7GG0U*RC>N=MMY.7=,8-#UQ32>P7 >W]/=BOEM= MG5]]^??SE!\(^$O^,Z^N\P^D\W>T]2]7>/'=]>9J_9D6\/;+SY?K=!VO[GGJ M\FY4<YXV\BS;+U3HW!O935%X3^YO+J M;"?#A\N=!-N>*E3">VT-I% CF: CN&PHW$A&:A12!3;D\*&?_P"Q]+O':#VT M@(6]Z/*86,]HH#X ]E AMWT!6:-"K4 ;ED&)3-EX#6^S\M8Z:8T>U%XQ!F5/ M5[$,U.8Q[%.4'*GE#H[AL5ON_G*G:!.Y"1R"=:0Z2;O,%6&!*&24ODL, M'A23"$[6VT;ILU56&I?:9*Y]7$!M3S,ZL$1B5H(4C#+++#EEEKR&4K2)E)&* MQ39WX./7VNG%TQ@4'7GQ--IB?21&7\?_TD7E9"B@G:Q=IZF 4[Q " E]+L7H M_QZ9=R.+OY17CU%_'_#9D_$E.A4BHQ@\UGYEY8H'9(6#"-YJ&[F.%ZQ*P>T;\^Z"*"'*6.M#D^*@2!Z@ MW-U $FBT<[8X.81F^M#/7^:6HPT,9M'APCCX)6_^.+^L_\*7WS[E2_SC=B0F M5X$'J2E1]2;6JYO:58,.)$%9T6\E0S< !X=^_C+MR&UP,(L.%\;!EC]VMVP5 M312Z:$@\65!<9\!0:D\?_2IK1X(?8OH'/W*9#M\VUIZJJ0YN&@FH5Y>DC>M+ M\E6UNY.T0G]&>KD)BW1(0M@8((@Z!C;L;; M9B$MC-0!YNH$AP_E*Z%N28@-$Q&#!(UU E\=9Q6<]1!-\<%%D[QN,]/UT(J6 MS79GM?OC0:VS&*$#-+W[_,?%^DO.O^8_Z:!=Q;LQ+]G55CFLK9E5)8IR.40+ M= (SA8>PCJ/M1^_Q\V@^@X0=#=9)E]^/E]M;;(3A E,53^T MMSBCP]R9^EPCP4:A=,*L99MY%P=7M/"TU28HFD?]"U^VD1";]<5YVBY_^\*W M]=!TS-N8"]FX4NM3^H^ /C'0T1B5,TIAAQ#M#+IIV[^$94F>3GE?.X,)N@/1 MW?9RB7.>0;-<-T*T0">\ W*JVOL2I39#&'$FPFCIV[HY#/LL3B9HN8-CZ\,? M=.C6K73[,KSSFEA,(*^9H)1:[;4+X>6$]/N)EBZ,=3 M=6;0>@?@^7&U_5E;$=Y=G#\Z>%%QH[<4R5(4"N"0 CAC1)UF59!S.H2#:P&A M9U>UW#UQ$R#-9X$.X'374ONX6N4F3\54+"\!,&Z'_LA$T6$R@"*(Y%E*HH0F M51+/K6I9BL%37R'-9Z >T+:K>KJ]<16)D@U!ZU:T7S#6MFI/6F(8R2$+-*)) MDO;5*A8NBYC/NOO;3B>H>N%8^LWF''_&>%[.X\ZE:FN84=[3ID%67_CK'" Z MIKGU(F7//--#&@4'!=%/OMY%]=44*Z[G4FD'?N/-Q<7VJ>91Z&80119TN#*M M):A"+C4D%T Z+5%+SZ5KPH:[?SE=]- =@909E;VP"WEW?;G^X_9.,P:M'69>]54&[(J\(@&#S]_,(QZRQ@.%*I'1PC MST3L[^_Z.V)2S#@IP$1O0?DLP-=QNXGD1,T#$Z7)P_F0Q2U+8'WRU&=NO-'M2@;.HDF%1V8A"?*PRA2*UCDOH+$8*SP76369G[AO,5U$N2UQ7"63M3%:S80TFC>Y?AFVO"[" MY]/B[$@;]8:\[S[AY4?RP-$K7BAW .9C &6S W0\$3R"Y<)0#(F-3KJGB^DB M#C\1JJ;HOQ^J^W]0JO)^O=E\6/V*->2\O2 ]4RKD0JD&1/H?4*Z2<5H>@3L> MR ^K($63)ZY#"UHX)F\-J5GLT(%KNGO^_7$5UY]S%>G,Y% 384I?$_VB)(G@ MK9* E+9FG:PVK@D3WYZU+#L2ICF*CM7^TFUVM-Z/M!'6JT>$U/=TZ)NSP$HI M-GO@OJ:ZVM)97:2"(EC140:E'S]3[.^Y&_"M90>Z-$-+$U7W[=:26-J06YYZMKTMC.WZY7F[>9=)=O_KW?\*^\>??7U262!<]7>/EE MJ\J?UO2WJRM:VL56V3>Z.?/>,B43 ^,JO9@4')![!<)J$5Q(0I M9W]E6>@@"12B^,PA>:VX\P69?XFQZKF?O_! F*8AX"PZ[< 'W:_\/HF^_[,: M;7C#*,X@+XJD$% A4@IDI*N_=3$DE:1K\M;XXLH6'@?3W ?-:YI>"?5N(H"/ M>17/)TUB^/J_GX44[YDES41[]]WZ\^?SF_G&=1KWP^_=C]ZX9QC75B1A-/#D M*RMO8!"48I ,YX@\%:.:-)N.6N6QCJCB^_X37^X_L*GCGD,6PH(L-H+BU@*Z MDB '+9CUQBK=I,+[\)*6?9ANAY['+F@FH[P*W_.U'B=3>+[\,^?W42\O_!P FR$ !( !Q M,S(P,C!I=F-E>#,Q,2YH=&W=6FUO&S<2_GZ_@E5PK0WH;?5BQ[)CP+75BX'& MSJ4Z!/?I0"VY$N'=Y9;D2M;]^GN&7%FR)25RFFM2!XBL70Z'\_K,D-39#U>W MEZ-_OQ^RJRU;H:7;&WHW>_LEZS';&1X;E53NF< MIZW6\*;&:E/GBD&K-9_/F_-N4YM):_2A1:QZK51K*YO"B=KY&;W!I^3B_&]G M/S0:[$K'929SQV(CN9."E5;E$_912'O'&HV*ZE(7"Z,F4\>L%9[/6GZ1L[$6B_,SH69,B3GR4Z=UC/8'[X&MAL,'/RWC5XJB;YP*M4"U.7P[%.M1F\:OM_IS322'BF MTL7@IY'*I&4W1C\$G5;EBQV.O:!]H8UC.F>_:).%*5&[\4^F$W:=SWC,C000&%!Q@A[8 MZ^0%V*NSTUX_IY*,9'U8+;*6$)#D%P#/;$.5SGC^8*5N3.E MA![ 4P^M,"!G&9Z,XBE+>(Q7ANE,.>9TH-L@R&4LK>5F0209OY-8=XVGQ3L! M8;!DZG$9:Q!!K QP&&0YID,2(0V;3U4\9;:DC]7\N80[ Q-2(%,V!6 3]L^5 MFT)!6\C8"TA\"XBF!=2<89I@X\6Z&5Y()'2?'PF2)2J'KPC%.+X/4^/0MEXU3;$JE%B&!T&FQ? M&!U+@=>6'<#40L)WP9[#^QB5:"+9!9+M0YE*6R%OES>B_H$\]/.CO@A/X5%1 MV<^#XVD11FFY%@_!/R30\U9+'JV68#72^&FH@((*R9?7R^/.=^1^?KC+_5?2 MHLF"X3QT?MZU=4+UF)=V_RD$KV,)#U4K!< &RM@2V3=3UNXQ5@KQQ6K]"&!A60 :)8G2KANWU;CJT2BAM%\JM05CS&Y;[P2()Z MCV36UP6/ -A.0"#T^7Y2@09"Q67*";B@E1=B53(P(Q2@];J);V-)A, 6S)?B MR['DNPJF\9[!M'<";\34_JF_;V@A&F=*4,1PB\:8<(Y;1!NU$!1&W(BE2Q%D MBH]5JMR":LBV52F^O?>]8T-L/B)=:T$\G-Y7^A0E.DL+5U#-BV-MA!? -R,3 MF:.4I8@OC,B" I=(T&B%&$* J\*#V8N(HGAG% UG/"U]XI*-99*@&5 S6,=N M*>H_OGK=B8Y/[3XX%!ZWUWD*&LP#AMC03(QUZ78+L ]0\@=J29U2\OD>DXV7 M/9A/ QD,L=R&!.M@E;^^\\5N" F&W?0/;3JJNNY'M@;!,X"#BHR.X]*0&]80 M?0O73%N']W00 5XV!J-J1\D.=DQ)=&F0TT^H*\'1I$J_7Z*M5%X^R'48I)IR M^U#^" U\_$GA4=+;HX*P!79%=S*M-D]/Z.M_V$1?(>:^JQ:X_[DS [$,O?HJ M#X$*Z]Y?923Y[QD%;J-A>? '1]/BM+$/1<6_ ,L,6VYO>H)Z4AI:])R@8E6/N3LSA"I MNA%,@9_1--1#G;$H,K;,X"68RBM38>76_?A+JR&[V] +E(K$((_J\(#T)Q3P MH3\ JIQ=#TBK\IE.9Y+@-N>3ZAS+5(<:,BM2O9 8G4]U0 C^*)3@^J]2BYJ? M\\58.Z>S =T(K'FG[RWO?"];T8\1&](TX(&4%U8.EE]. 6U%RA<#E7L[^DFG M,SH71GFJSMG!L[IP.#EI'K>/Z<[!&?P72_;5=4337T>TG-@A4& M$4)!.^9/8=A2TB_5??O-YK>Z&?2FV7+5MA/'_T29/<>!%/O!OU44,,[ M&L(SPRG)D:S^^AZ2HX7E?9Y[2>KDNXL/YS>_7@]88K.4 M7?_GQ_>7YZS6:+4^]]IM*CULW'EF.UUTJ5,M045M1.3]P;?!(7I_\X^:[18!QJVT*9W.^)RT MPO-)RR]R,E1B>GHBY)A)\:8F>^(P.CQZO3\\ZL1[!YT#'AT==EZ+J-T=]J*H M2[]U(&0+Y&&.L=.4WM0RF3<2W"5R*.WW MKSH'[>->I]F]+_:R]ER/8 "KBOX16"_)'\'@I+^2 N>#CS>7;R_/SVXN/US] MLJ7T_W=9]];*>EEG/W.;I$0YNVZR]Y33*.%YG46DK8RGS"8NEPL8'X7.2ZBTG01&I57S(.E$7W"]P-U1U&F($ \*#C- M+V>\/!$W"8M3-3&S8-$TDL:BF;",NY=!;DA97_*YF0FS(NT+9P"39][D M,*$&[8# M4PN"[X(]!W<1*M&(V!F2[6.9DJF0M\<;G?T=VO7S._LB/(5'Z>I^'ASO%F$N M+9?B(?C'"?2TU>)[J\58S6G\,%1 X0K)\^OE8?<;3^"S+HLF X#YV/ MN[;N4#WBI=E^BH/7(<%#U4H!L($RID3VC:7Q.0TBRCT;UZ(-M="N##B6LQN MAJQ;U<6W][YW;(C->Z1++8B'T[M*GZ)$9VG@"E?SHDAIX07PS<@(#;M&(9RZ M$2I?^S,0,Q"K[[(0Z#"LO<7 M&>G\]X0"M]*PS/W!T;18IR0YB!!!C M'(3AKVN=9H%-OY<2XOL@+O/([YEV7WQ_>X:=I6L.9"PCU]B[?4(D"0ZJ"L*\ MT9P0OW40'ZJS!WG?5OACC-DN\TENKWI"=Z2T-FFYP$1#\YS=&")5-X(I\#.: MAGJH,P9%QI09O 13>64JK%R['W]I-61S&WJ&4A%KY%$='B!_0@$?^@.@RMGU M@+0R'ZMT3 YN*,'U7Z06-1_SQ5!9J[*^ MNQ)8\LZ^M[SUO6Q%/T1LD&[ RDO#/5G7XX!;47*IWV9>SOZ2<=C=RZ,\E0= MM(/GXL:AV0ZW#E;COYCQKX:;?JAEQ>K87K/7/MHXVFYV-HY]CNM^N]D[V#SU MN6SWNLUV;_/P,MN6-T0P!JQJ"IZ_J?5JLPE5EO3;K..],N/W94B[Q9TC7KT5 M>>C"$"A__5V)CY59!NXA^/TG^_GLYMW[P>#*7T<,K@8_O3N[FL?Z$ZRZ1G\' M1U])^Q4T\MI? %GN%]-G^?6;T^L#^HHA<*M[5/?WHENH5Z&0PRAHQ_PY#)M) M^ES=UU]N?JW+06^:=;=M&Z'\+Q3:<^Q+B]6B+=3XA7*)HO=?&1&[QL95NLKN MNXGS1%+,WLXKUH<8E8_TWU#'G>MP? (E5M39?7"7/@>FEB^32WINO']?LL&# M*_Q"A=\P],/1Y9A6+O476>.+?'LQA0^1.J5=G?+([P"JS_"K!/_[B-,_ 5!+ M P04 " "KA5U126=$V1H% #I$P $@ '$S,C R,&EV8V5X,S(Q+FAT M;=U8ZV_;-A#_OK_BZF!M EA/OV4W0.9X2X#FT<1%L$\#+5(644E423J.]]?O M2,EI&L=+.G2MMR"P9=WQ>'>_>Y&C5\<7X^GOEQ-(=9[!Y8=?WIV.H>%XWDUK M['G'TV,XF9Z]@[;K!S"5I%!<. \HC.$[- M-1;E2O)YJB'T0Q]NA/S(;TE%UUQG[' M9^15OT>>W60T$W1U.*+\%CA]V^"= MI$UGW58G'@2]MM]J][O)H,-\$ON=?L""_A\!*NDA>[5&Z57&WC9R7C@I,_M' M[=#M=4H]7'*JTRCP_9\;EO5PE(A"XWX2UU>/E9@-89K=:8=D?%Y$UJ1&M71- MCD4F9+3GV[^AH3@)R7FVBMY,> M_;FL5.ZAG(P7;&U"$!JE)WB_H^L-6Z 9?JOW0>B+GZ MRFB HA_H M'Z/#F?Q!!HR9U#SA,3%QN%7Y7='VN#?O7]P;UVQ^XC M6JOC-W?>-** 4%&:Y"VW63GPNSMOATA IPRNB9R1@BGGXBYC*SB*-2 E]/WP MJS*$%Q2-B<*VK1?_NDGM)TTZ+2 615$A 4NN4VOB^P61Z.=L!5>L%-(:>%K< MDIA(AK56XCN;5;!ON%_O]<])$):\24J M*RBP@II2?LTP-/(9DW6I\9M5$<>P27B&07.O%D;,0F);0?M)06%R%Z>DF!N- M\IPK913"?\-)L55 RB1#Q1_J6)FS5K%9[7C:A#.BD6L)$Q?.L&G-46X3+B53 MW(!D=QNGG"6X)^J@^2V#BP1K"Y-01T5M?1-B6W;PX6&L/YO$\,(D@6>#L(ET M@B9V^L.7Q&,7XZ0DU"#A9"S14:O[*$*=H/_#XG,_.%@;\?VW_](O7;?5-GZ8 MHO?KK$@6&::(03XS,7D?IY)]6G#)S+BA#"R/X-XGF!P2@LX^/;C'\W-HWX=U M#6HP:+41SL&P6H^Q^#_ -=Q)7'F!)2JO2AO614UP)<6W%J(UZ(2;PEAB<3#X M-@V99!G@,E2&9(B^*A%PU;2K$EZ0(C;O42"U,[$M)\BUR*KP$%@/[9[J43%Q MGP-Z)K06>63FS0?05^U$DUG&UOPS(2F3#OHW(Z5BT?IA2+DJ,[**>&&]9!<- M;TT)BTE6-UV468^S@X';\WMFHM4XQFJZ%E\/NZX==CU--VEMMQ5VME)]-]A* M^SNI'6R>W6\OMM5SN\%V\D.QGG5$Y0QTJD+8WC9:C?6".M(B'P(+REK>MV$- MRSO#O#EQ/T:PBI/OG^OV]%.5K==[[=Y0V4\X.YI.3R8WMMM>G!_]=G)T?A_I M7^'4)\PW&;U3QA]C5?BR%_\C6'?.KHM8"QS9(!Q4T]H+S*MKD*E0:!THD7$* M:TUW-:0W3@+6^B?&17.P?]' :!CW+R7'IE!B5]B@'VRF@F?+\G_I7'$$"D'" MWBDD1PW13MO9. Y)..5H5J!"F!GV8J>>EBC,5IOC;HIS\8PA?RG%+?J6FJ'X MR:.(F0&L;MTH=\L#,R M,BYH=&W=6&U3VS@0_GZ_8AOF6IB)7^- XJ3,<"$]F') 2WJ=^W2C6'*LJ2.Y MDD+(_?I;R0Y04@YZTVOI,8QC>[6KW7WVS1H^.SP;3?XX'T-AYB6!E94$I12:N930UO[0_L&KXS0_9^&SSP/#F6VF#-A(%.,&$9AH;F8P7O* M] ?PO&;52%8KQ6>%@3B,0W@OU0=^26JZX:9D^VLYPZ!^'@9ND^%4TM7^D/)+ MX/1EB_?C/NF'O9@E89)T^]->)R0)[*^3D;#[9X1*!KB\YM%F5;*7K3D7 M7L'L_FD2^WO=R@R6G)HBC<+PYY9;NC_,I3"XGT+^^K86LR',L"OCD9+/1.I, M:M6L:W(F2ZG2K=#]#2S%R\F]^O>= M?^&/_#NT3C=L/WG3B 9"9663M[K/RGZX^^3MD#F8@L$%45,BF/;.KDJV@H/, M %+B,/RR#.&"HC%IG+AZ\9^;E'S6I&,!F12B1@*6W!3.Q#<+HM#/Y0K>LDHJ M9^"QN"0940QKK<)W+JM@VZY^OM6+XW"0R7E%Q,H]18,=0/(KJ>9-I(;>&\BE M$U.4C DX]^&$"39# MP6W<3W!4^7>>,3A73'.+F-MZ5'"6PRLNB,@X*>$LQT+#%#0ATKBB#9FK07AS M._ ?S&AX9,; @Q'91CI!>[N]P6."#IB+4PN*5+#=I9_=.N'I1[[L%ZW:T MLS;BVV__J5]V_4YB_3!![S+?&D#]#IH%?NXX(K9V4-;6.[ O4TP M4Q1$W6VZWI[Y33/R'@)Y*8^0\MCKWF+(M&3K]5.I*%,>^KS+9^6,^W!H=:0]?R&[+O2(&AF[3$[X3] M>ZFA']U+^R>IW=#OAKVO+C:)_%ZO\RBQ@7-$[0STJD;<7K8ZK35#$VII")%# M92WOZRR-JRN[>'/^O@MA'2C?/ME=K-1UZ_E6LC?0[@JO#R9')^/QJ>N]X]/Q MKT<'I]>Q_@5>_3'L/\3*\&D__E?(VFKUI.PZRXS$&0[B?CV^/<*\I@[9*H76 M@98EI[#6]*FBNO%IX*S_W/QH/_6_>(*T3-OGBN/+"M]NT'8F^ MI79*_NR'BG7YDF-GGMJ)K.GE*/+>Q?E"":Z+6N1C/SX4<.SBJ'R>PZ+"-U9[ MILUF[[[W..@6?G=.E"I9'ZFEBI6HYR7;.&.Z22PW"80W+&2*V;4PFRP/'$LU MU_J0S!W7[?\-4$L! A0#% @ JX5=4==5_.9P-@0 \JLU ! M ( ! &EV8RTR,#(P,#DS,"YH=&U02P$"% ,4 " "KA5U1>JR* M4Q C #PK@$ $ @ &>-@0 :79C+3(P,C P.3,P+GAS9%!+ M 0(4 Q0 ( *N%75'S]@2_KC4 '8_ @ 4 " =Q9! !I M=F,M,C R,# Y,S!?8V%L+GAM;%!+ 0(4 Q0 ( *N%75&=(LK4K>$ /)+ M"@ 4 " ;R/! !I=F,M,C R,# Y,S!?9&5F+GAM;%!+ 0(4 M Q0 ( *N%75&.2S YW"(! (9$ 0 3 " 9MQ!0!I=F,M M,C R,# Y,S!?9S$N:G!G4$L! A0#% @ JX5=4<:G0&;_.0$ TP4" !, M ( !J)0& &EV8RTR,#(P,#DS,%]G,BYJ<&=02P$"% ,4 M" "KA5U10U__J@R* !0IP $P @ '8S@< :79C+3(P,C P M.3,P7V#,Q,2YH=&U02P$"% ,4 " "KA5U1J #,R,BYH=&U02P4& !, $P#-! #E4/ end

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�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